Citrus Sinensis ID: 039082

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470--
Protein Sequence
MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQNPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHccccccccEEEcccccccccEEEcccccEEEEEEEcccEEEEEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccccHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEcccccccEEEEccccEEEccccccEEcccccccccccccccHHHHHccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHHccccccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccEEEccccccccccccccccccccccccHHHHHHHHHHHccccccccccccccHHHHHHHcccccHHcccccccEEEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHccccHHcccccccccEEEEEEccccEEEEEEEcccccccccccHHHHHHHHHHHHHHHHHHHHHEEEEEEccccEEEEEEEcccccHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHHHcHccEEcccccHHHEEEcccccEEEccccccEEcccccEEEEEccccccHHHHHHcEEcHHHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHHHccccccccc
Coil and Loop (DISEMBL)
mniagtpqkkktgllgsrkspvvssagqqrkptstghsrgccrgfsdcmsmgsmvskkqqnpqcqqqhnrhqsTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTnnkedqhqsllssntgsviasplvqtplhqhshqtplhrycsqtpllqqsDLAVTVSQAkmngwyidpkeidlqekigqgttANIYRAIWRGLDVAVkciypdffhtnenavTFFAQEVDTLSRQRHRFVLQLMgacleppyrgwLVTELLGTTLKEWLHglgsqrrkermvplppFEERLARALEIAQAMQYLHEqkpkvihrdlkpsniflddakhvriadfgharflsdgemaltgtfvymapeviqcepyseksdvysFGIILNEiitgnhpyiekdykpakiamevgegklrpalpeedgQLRELIELICLswdgdasvrpsfssITCSLKNIQMKVTETI
Flexible Loop (DISEMBL)
mniagtpqkkktgllgsrkspvvssagqqrkptstghsrgcCRGFSDCMSMGSMVSKKQQNPQCQQQHNRHQSTlkleeqvgdltrevqrqkelRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHglgsqrrkermvplPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGdasvrpsfssitcslkniqmkvteti
Low Complexity Region (SEG)
MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKqqnpqcqqqhnrhqSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI
Disordered region (IsUnstruct)
*******************************************************************************************KELRIIYRKRLERTQDYLRHCLQIAQDNGVLELM*************************************LHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGS************FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG************GQLRELIELICLSWDGDASVRPSFSSITCSLKNI********
Disordered Region (DISOPRED)
********************************************************************************************************************************************************************************************GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR*ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT***
Disordered Region (DISEMBL)
***************************************GCCRGFSDCMSMG*********************TLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTP**********HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI
Disordered Region (DISPRO)
*************************************************SMGSMVSKK*QNPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQ*****************************************************************VTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFF*TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ*******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQNPQCQQQHNRHQSxxxxxxxxxxxxxxxxxxxxxRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	472	2.2.26 [Sep-21-2011]
Q05609	821	Serine/threonine-protein	no	no	0.519	0.298	0.368	2e-36
Q55GU0	916	Probable serine/threonine	yes	no	0.544	0.280	0.367	3e-35
P18160	2410	Dual specificity protein	no	no	0.555	0.108	0.342	8e-35
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.567	0.165	0.323	1e-34
Q54TA1	749	Probable serine/threonine	no	no	0.529	0.333	0.36	2e-34
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.557	0.158	0.315	6e-34
Q5UQG7	1651	Putative serine/threonine	N/A	no	0.561	0.160	0.316	4e-33
Q9FPR3	933	Serine/threonine-protein	no	no	0.548	0.277	0.353	5e-33
Q54RB7	527	Dual specificity protein	no	no	0.546	0.489	0.340	8e-33
Q54I36	1338	Dual specificity protein	no	no	0.521	0.183	0.352	2e-32

>sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1

 Score =  154 bits (388), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 148/269 (55%), Gaps = 24/269 (8%)

Query: 196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +++++EKIG G+   ++RA W G DVAVK +    FH     V  F +EV  + R RH  
Sbjct: 550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--VNEFLREVAIMKRLRHPN 607

Query: 256 VLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           ++  MGA  +PP    +VTE L   +L   LH  G++ + +          RL+ A ++A
Sbjct: 608 IVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDE-------RRRLSMAYDVA 659

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVY 369
           + M YLH + P ++HRDLK  N+ +D    V++ DFG +R     FLS    A  GT  +
Sbjct: 660 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEW 717

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           MAPEV++ EP +EKSDVYSFG+IL E+ T   P+   +  PA++   VG    R  +P  
Sbjct: 718 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPRN 775

Query: 430 -DGQLRELIELICLSWDGDASVRPSFSSI 457
            + Q+  +IE     W  +   RPSF++I
Sbjct: 776 LNPQVAAIIEGC---WTNEPWKRPSFATI 801

Acts as a negative regulator in the ethylene response pathway.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  149 bits (377), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 101/275 (36%), Positives = 148/275 (53%), Gaps = 18/275 (6%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           I   E+ +  K+G+GT   +Y+ +WRG  VA+K I  +    N   +  F +E+  LSR 
Sbjct: 657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINE-DVNNQVLEEFRKELTILSRL 715

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           RH  ++ LM AC  PP   ++   L G +L + LH   S++ K  M      +     A+
Sbjct: 716 RHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALH---SKKIKMNM------QLYKKLAI 766

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALT-GTFVY 369
           +IAQ M YLH     VIHRD+K  N+ LD+  +V+I DFG ++  S   EM  + G+ ++
Sbjct: 767 QIAQGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMTKSIGSPIW 824

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           M+PE++  E Y+EK DVY+FGIIL E+ TG  PY   D    ++A+ V    LRP +P  
Sbjct: 825 MSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLD--SVQLALAVTTKSLRPPIP-- 880

Query: 430 DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +    +L  LI   W  D   RPSF+ I   L  I
Sbjct: 881 NAWPYQLSHLIQACWHQDPLKRPSFTEILNLLNEI 915

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score =  148 bits (374), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 100/292 (34%), Positives = 151/292 (51%), Gaps = 30/292 (10%)

Query: 192  IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
            ID  E++  + IG+G    + R  WR  DVA+K IY D F T ++++  F  EV  LS+ 
Sbjct: 2110 IDFNELEFGQTIGKGFFGEVKRGYWRETDVAIKIIYRDQFKT-KSSLVMFQNEVGILSKL 2168

Query: 252  RHRFVLQLMGACLEPPY-RGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
            RH  V+Q +GAC         +VTE +G  +L+++L    +   +   +       RL  
Sbjct: 2169 RHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHI-------RLKL 2221

Query: 310  ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKH----------VRIADFGHARFL 356
            AL+IA+ M YLH   P ++HRDL   NI LD   D K+           +I+DFG +R  
Sbjct: 2222 ALDIAKGMNYLHGWTPPILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLK 2281

Query: 357  SDGEMALT---GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI 413
             +    +T   G   YMAPEV + +  SEKSDVYS+G++L E++T + P  ++D KP K+
Sbjct: 2282 MEQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEP--QQDMKPMKM 2339

Query: 414  AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
            A        RP +P       +  E++   WD +   RP+F  I   LK ++
Sbjct: 2340 AHLAAYESYRPPIPLTTSS--KWKEILTQCWDSNPDSRPTFKQIIVHLKEME 2389

Essential for spore differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  147 bits (372), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/291 (32%), Positives = 154/291 (52%), Gaps = 23/291 (7%)

Query: 182  VSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFF 241
            ++ A M  W I+  EI + ++IG G+   ++   W+G+DVAVK         +E  +  F
Sbjct: 1349 LTSANMCRWIINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQ--KLSETQLLEF 1406

Query: 242  AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLP 301
              E+  LS  +H  ++  +GAC++ P    +VTE +          +G+ R   +   + 
Sbjct: 1407 RAEMAFLSELKHSNIVTFIGACIKKP-NICIVTEYMR---------MGNLRDVLKNPDIK 1456

Query: 302  -PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG- 359
              F  +L      A  + YLH   P ++HRD+KP+NI +D+  +V+IADFG AR   D  
Sbjct: 1457 ITFANKLKLLYGAAMGIDYLHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDNT 1516

Query: 360  EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
             M   GT  + APEVI+ E Y EK+DV+SFG+++ E++TG  P+ E ++   K+++++ E
Sbjct: 1517 TMTRCGTPCWTAPEVIRGEKYCEKADVFSFGVVMWEVLTGKEPFAECNF--MKVSLDILE 1574

Query: 420  GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE 470
            G  RP +P +     E  +LI   W   A  RP+ + +   L    M +TE
Sbjct: 1575 GG-RPIIPSDCPH--EFAKLIKKCWHAKAHKRPTMTEVVQQL----MLITE 1618

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  147 bits (371), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 99/275 (36%), Positives = 144/275 (52%), Gaps = 25/275 (9%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVK---CIYPDFFHTNENAVTFFAQEVDTL 248
           ID  EI +Q +IG+G+ A ++   WRG+ VA+K    +  D    +E+ +   AQE   +
Sbjct: 486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKLLNED----DEDFLNELAQEATIM 541

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           S+ RH  + Q +G C  PP    ++  +   +L   LH         RM          +
Sbjct: 542 SQLRHPNICQFLGTCNNPPEILIVMEYMPLGSLYRILHDPSISLDWPRM---------KS 592

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLS--DGEMALT- 364
            AL+IA+ M YLH   P VIHRDLK  N+ +D+   V+I+DFG   RF    D + A+T 
Sbjct: 593 MALDIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTP 652

Query: 365 -GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  + APEV++ +PY+EK+DV+SF I+L EI+T   PY  +     +I + VG+ KLR
Sbjct: 653 VGTPCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPY--QGMPTFQIVISVGQHKLR 710

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
           P +P +         LI   W  D   RPSF  I 
Sbjct: 711 PIVPPQVSA--PFTRLITECWSEDPQQRPSFQEIV 743

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  145 bits (366), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 152/282 (53%), Gaps = 19/282 (6%)

Query: 182  VSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFF 241
            ++ A +  W I+  EI + E+IG G+   +YR  W+ +DVA+K         +EN +   
Sbjct: 1384 LTSAGLCSWVINYDEIKMGEQIGLGSYGVVYRGKWKNVDVAIKKFIKQ--KIDENHLLGI 1441

Query: 242  AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-VPL 300
             +E+  L +  H  ++ ++GA L+ P    +VTE +           G+ R   R   P 
Sbjct: 1442 REEIAFLKKLHHPNIITMVGASLKKP-NICIVTEYMAK---------GNLRDAMRTCTPK 1491

Query: 301  PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
              + +++   + IA+ + YLH   P +IHRD+KPSNI +D+  +V+IADFG AR   +  
Sbjct: 1492 LEWHQKIKILVNIAKGISYLHSFDPPIIHRDIKPSNILIDENWNVKIADFGFARIKEENA 1551

Query: 361  -MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
             M   GT  + APE+I+ + Y EK DV+SFGI++ E++T   P+I  ++   KI M++ E
Sbjct: 1552 IMTRCGTPCWTAPEIIRNDIYDEKVDVFSFGIVMWEVLTCKEPFIGANF--MKITMDILE 1609

Query: 420  GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
              +RP +P++  +  E  +L+   W   ++ RP+   +   L
Sbjct: 1610 -DVRPKIPQDCPE--EFAKLMRKCWHAKSTKRPTMDDVIIVL 1648

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1

 Score =  142 bits (359), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 90/284 (31%), Positives = 151/284 (53%), Gaps = 19/284 (6%)

Query: 182  VSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFF 241
            +S A +  W I+  +I + ++IG G+   +    W+ ++VAVK         +E  +  F
Sbjct: 1379 LSSAGLCRWIINYDDIQIGKQIGVGSYGIVNMGKWKNINVAVKKFVKQ--KIDEKQMLEF 1436

Query: 242  AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLP 301
              E+  LS+ RH  ++ ++GACL+ P    +VTE +G          GS R   +    P
Sbjct: 1437 RAEIAFLSQLRHPHIILMIGACLKRP-NICIVTEFMGN---------GSLRNVIKTTK-P 1485

Query: 302  PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE- 360
             ++ ++    + A  + YLH   P +IHRD+KPSNI +DD+ +V+IADFG AR   +   
Sbjct: 1486 EWKLKIKMLYQTALGIGYLHNSDPIIIHRDIKPSNILVDDSMNVKIADFGFARIKEENSV 1545

Query: 361  MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
            M   GT  + APE+I+ E Y+EK DV+SFGI++ E++T   P+   ++   K++M++ EG
Sbjct: 1546 MTRCGTPCWTAPEIIRGEKYTEKVDVFSFGIVMWEVLTCKEPFSGCNF--MKVSMDILEG 1603

Query: 421  KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              RP +P +     +  +L+   W      RPS   +   L ++
Sbjct: 1604 A-RPQIPSD--CPIDFTKLMKQCWHAKPDKRPSMEDVIMGLNDM 1644

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1

 Score =  142 bits (358), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 100/283 (35%), Positives = 144/283 (50%), Gaps = 24/283 (8%)

Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
            ++ + E+IG G+   +Y A W G +VAVK      F  +  A+  F  EV  + R RH 
Sbjct: 667 NDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDF--SGAALAEFRSEVRIMRRLRHP 724

Query: 255 FVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
            V+  +GA   PP    +VTE L   +L   LH   S   + R         R+  AL++
Sbjct: 725 NVVFFLGAVTRPPNLS-IVTEFLPRGSLYRILHRPKSHIDERR---------RIKMALDV 774

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-----HARFLSDGEMALTGTFV 368
           A  M  LH   P ++HRDLK  N+ +D+  +V++ DFG     H  FLS    A  GT  
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTA--GTPE 832

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           +MAPEV++ EP +EK DVYSFG+IL E+ T   P+  +   P ++   VG    R  +P+
Sbjct: 833 WMAPEVLRNEPSNEKCDVYSFGVILWELATLRLPW--RGMNPMQVVGAVGFQNRRLEIPK 890

Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET 471
           E   +   I L C  W  D ++RPSF+ +T  LK +   V  T
Sbjct: 891 ELDPVVGRIILEC--WQTDPNLRPSFAQLTEVLKPLNRLVLPT 931

MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54RB7|SHKA_DICDI Dual specificity protein kinase shkA OS=Dictyostelium discoideum GN=shkA PE=2 SV=1

 Score =  142 bits (357), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 95/279 (34%), Positives = 143/279 (51%), Gaps = 21/279 (7%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           I   EI  +  +G G+   +Y+   R  DVAVK +       ++  +T F +EV  +S+ 
Sbjct: 40  ISETEITTESILGDGSFGTVYKGRCRLKDVAVKVMLK---QVDQKTLTDFRKEVAIMSKI 96

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
            H  ++  +GAC   P +  + TEL+   L+  L         + MV LP    R+  A 
Sbjct: 97  FHPNIVLFLGACTSTPGKLMICTELMKGNLESLLL--------DPMVKLP-LITRMRMAK 147

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF------LSDGEMALTG 365
           + A  + +LH   P  IHRDLK SN+ +D    V++ DFG ++       L DG+    G
Sbjct: 148 DAALGVLWLHSSNPVFIHRDLKTSNLLVDANLTVKVCDFGLSQIKQRGENLKDGQDGAKG 207

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T ++MAPEV+Q   ++EK+DVYSFG++L +I T    + E D    K    + E +LRP+
Sbjct: 208 TPLWMAPEVLQGRLFNEKADVYSFGLVLWQIFTRQELFPEFD-NFFKFVAAICEKQLRPS 266

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P  D   + L ELI   WD +  VRPSF  I   L+ I
Sbjct: 267 IP--DDCPKSLKELIQKCWDPNPEVRPSFEGIVSELEEI 303

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1

 Score =  140 bits (354), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 98/278 (35%), Positives = 154/278 (55%), Gaps = 32/278 (11%)

Query: 196  EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            E+ + EK+G G+ AN++  IW G  VA+K +  +    +E     F +EV +L +  H  
Sbjct: 1056 EVAIVEKVGAGSFANVFLGIWNGYKVAIKILKNESISNDEK----FIKEVSSLIKSHHPN 1111

Query: 256  VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
            V+  MGAC++PP    + TE L G +L + LH      +K ++ PL  ++       +++
Sbjct: 1112 VVTFMGACIDPP---CIFTEYLQGGSLYDVLH-----IQKIKLNPLMMYK----MIHDLS 1159

Query: 315  QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--YMAP 372
              M++LH    +++HRDL   NI LD+ K+++IADFG A  LSD +M L+G     + +P
Sbjct: 1160 LGMEHLH--SIQMLHRDLTSKNILLDEFKNIKIADFGLATTLSD-DMTLSGITNPRWRSP 1216

Query: 373  EVIQCEPYSEKSDVYSFGIILNEIITGNHPY--IEKDYKPAKIAMEVGEGKLRPALPEE- 429
            E+ +   Y+EK DVYSFG+++ EI TG  P+  ++     AK A E      RPA+P + 
Sbjct: 1217 ELTKGLVYNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFE----NYRPAIPPDC 1272

Query: 430  DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
               LR   +LI   W  D S RPSF+ I   L+ ++ K
Sbjct: 1273 PVSLR---KLITKCWASDPSQRPSFTEILTELETMKSK 1307

Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	472
343887310	479	serine/threonine-protein kinase [Citrus	1.0	0.985	0.981	0.0
224092105	406	predicted protein [Populus trichocarpa]	0.843	0.980	0.642	1e-154
356518171	446	PREDICTED: putative serine/threonine-pro	0.923	0.977	0.579	1e-151
357465817	447	Protein kinase C [Medicago truncatula] g	0.925	0.977	0.598	1e-151
356554110	381	PREDICTED: serine/threonine-protein kina	0.779	0.965	0.655	1e-145
449486787	433	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.853	0.930	0.556	1e-131
449447349	433	PREDICTED: serine/threonine-protein kina	0.853	0.930	0.556	1e-129
255550137	286	serine-threonine protein kinase, putativ	0.582	0.961	0.759	1e-125
225429642	404	PREDICTED: probable serine/threonine-pro	0.841	0.982	0.496	1e-117
357153826	435	PREDICTED: probable serine/threonine-pro	0.817	0.887	0.514	1e-109

>gi|343887310|dbj|BAK61856.1| serine/threonine-protein kinase [Citrus unshiu]

 Score =  957 bits (2473), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 470/479 (98%), Positives = 472/479 (98%), Gaps = 7/479 (1%)

Query: 1   MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQ 60
           MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQ
Sbjct: 1   MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQ 60

Query: 61  NPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNG 120
           NPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNG
Sbjct: 61  NPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNG 120

Query: 121 VLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAV 180
           VLELMTNNKEDQHQSLLSSNTGSVIASPL+QTPLHQHSHQTPLHRYCSQTPLLQQSDLAV
Sbjct: 121 VLELMTNNKEDQHQSLLSSNTGSVIASPLLQTPLHQHSHQTPLHRYCSQTPLLQQSDLAV 180

Query: 181 TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF 240
           TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF
Sbjct: 181 TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF 240

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL 300
           FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL
Sbjct: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL 300

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE
Sbjct: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360

Query: 361 MALTG-------TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI 413
           MALTG       TFVYMAPEVI+CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI
Sbjct: 361 MALTGETGKKQRTFVYMAPEVIRCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI 420

Query: 414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI 472
           AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI
Sbjct: 421 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI 479

Source: Citrus unshiu

Species: Citrus unshiu

Genus: Citrus

Family: Rutaceae

Order: Sapindales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224092105|ref|XP_002309475.1| predicted protein [Populus trichocarpa] gi|222855451|gb|EEE92998.1| predicted protein [Populus trichocarpa]

 Score =  550 bits (1418), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 275/428 (64%), Positives = 332/428 (77%), Gaps = 30/428 (7%)

Query: 49  MSMGSMVSKKQQNPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDY 108
           M  GS+VS K+   Q Q +        +L +QV DL REV +QKELRI+YRKR+E TQDY
Sbjct: 1   MGKGSIVSTKESQQQQQSRS-------ELRQQVADLEREVLKQKELRIMYRKRMETTQDY 53

Query: 109 LRHCLQIAQDNGVLELMTNNKEDQH--QSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRY 166
           L++CLQ+AQ+NG L+L+  NK+DQ   +  L +N    I SP + +P     HQ P    
Sbjct: 54  LKYCLQVAQENGFLDLIIQNKDDQQGIKDALPTN----IVSPRITSP-----HQLP---- 100

Query: 167 CSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCI 226
            +Q P  Q  +LA T+ QAKMNGWYI+  EI+ QEKIGQG+TA+IYRAIWRG DVAVKC+
Sbjct: 101 -TQVP--QLPNLAFTIDQAKMNGWYIESHEIEFQEKIGQGSTADIYRAIWRGFDVAVKCM 157

Query: 227 YPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLH 286
           +PDFF +NEN V FFAQE+DTLSRQRH +VLQL+GAC++PP   W+VTE+LG TLKEWLH
Sbjct: 158 FPDFFLSNENGVNFFAQELDTLSRQRHCYVLQLLGACIDPPSNAWVVTEILGMTLKEWLH 217

Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR 346
           G GS RR ER VP+PPF+ R+  ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD+ HVR
Sbjct: 218 GPGS-RRNERSVPIPPFQNRVTVALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDSNHVR 276

Query: 347 IADFGHARFLSDGEMAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           +ADFGHARFL D EMAL   TGT+VYMAPEVI+CEPY+EKSDVYSF +ILNE++TG++PY
Sbjct: 277 VADFGHARFLDDAEMALTGETGTYVYMAPEVIRCEPYNEKSDVYSFAVILNELMTGDYPY 336

Query: 404 IEKDYKPAKIAMEVGEGKLRPALPEEDG-QLRELIELICLSWDGDASVRPSFSSITCSLK 462
           IE D+ P+KIAMEV EGKLRP LP ED  QL ELI+LI  SWD DASVRPSF++IT SL+
Sbjct: 337 IETDFGPSKIAMEVAEGKLRPMLPHEDNDQLGELIDLISQSWDQDASVRPSFATITSSLR 396

Query: 463 NIQMKVTE 470
            IQ ++ E
Sbjct: 397 KIQQRIIE 404

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356518171|ref|XP_003527755.1| PREDICTED: putative serine/threonine-protein kinase/receptor R831-like [Glycine max]

 Score =  542 bits (1397), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 274/473 (57%), Positives = 342/473 (72%), Gaps = 37/473 (7%)

Query: 1   MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQ 60
           MN+  +P+ ++     S KS    + G +++  ++  S GCCRG S   ++ S     QQ
Sbjct: 1   MNLRESPRTQQKLSRQSSKS----NRGVKQEAAASPLSSGCCRGLSSVRTVSSTAPTSQQ 56

Query: 61  NPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNG 120
           + Q QQ++       KLE +V  L +EVQRQ ELR++YRKR+ERTQDYL++CLQIAQ+NG
Sbjct: 57  HDQLQQRYE------KLEAKVAGLEKEVQRQTELRVMYRKRMERTQDYLKYCLQIAQENG 110

Query: 121 VLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAV 180
           +L+L+ ++K +  QS LS  T +  ++P + TP H                     +L  
Sbjct: 111 ILDLIVHSKVELSQSPLSLYTAN--STPPIPTPSHH-------------------PNLTA 149

Query: 181 TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF 240
            + QAK+NGWYI+P EI+L EKIGQGTTA+I++  WRG DVAVKC+   FF TNEN V F
Sbjct: 150 IIDQAKINGWYINPSEIELVEKIGQGTTADIHKGTWRGFDVAVKCMSTAFFRTNENGVVF 209

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL 300
           FAQE++TLSRQRHRFVL LMGACLEPP+  W+VTE L TTLKEWLHG  ++R K R VPL
Sbjct: 210 FAQELETLSRQRHRFVLHLMGACLEPPHHAWIVTEYLNTTLKEWLHG-PAKRPKNRSVPL 268

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           PPF++RL RALE AQAMQYLH+QKPKV+HRDLKPSNIFLDDA HVR+ADFGHARFL D E
Sbjct: 269 PPFKDRLIRALETAQAMQYLHDQKPKVVHRDLKPSNIFLDDALHVRVADFGHARFLGDDE 328

Query: 361 MAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
           MAL   TGT+VYMAPEVI+CEPY+EK DVYSFGIILNE++TG +PYIE  + PAKIAMEV
Sbjct: 329 MALTGETGTYVYMAPEVIRCEPYNEKCDVYSFGIILNELLTGKYPYIETQFGPAKIAMEV 388

Query: 418 GEGKLRPALPEED--GQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV 468
            EGKLRP LP  D   QL ELI+LICL WDG+ S RPSF++I+ SLK+   +V
Sbjct: 389 VEGKLRPLLPSRDDGDQLGELIDLICLCWDGNPSTRPSFATISRSLKSYAKRV 441

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357465817|ref|XP_003603193.1| Protein kinase C [Medicago truncatula] gi|355492241|gb|AES73444.1| Protein kinase C [Medicago truncatula]

 Score =  542 bits (1396), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 285/476 (59%), Positives = 343/476 (72%), Gaps = 39/476 (8%)

Query: 1   MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQ 60
           MN   +PQ +K+    SR+S   S A Q+  P S   S GCCRGF+   ++ S  S  QQ
Sbjct: 1   MNTRNSPQIQKSL---SRQSSKNSKAKQE--PLSP-FSGGCCRGFTSVKTVASTTSTLQQ 54

Query: 61  NPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNG 120
           + Q QQ   R++S   LE +V DL +EVQ+Q ELR++YRKR+ERTQDYLR+CLQIAQ+NG
Sbjct: 55  H-QLQQ---RYES---LEVKVADLEKEVQKQTELRVMYRKRMERTQDYLRYCLQIAQENG 107

Query: 121 VLELMTNNK-EDQHQSLLSSNTGSVIASPLVQT--PLHQHSHQTPLHRYCSQTPLLQQSD 177
           +LE + ++K E QH  L   N  S+  SP + T  P HQH                   +
Sbjct: 108 ILEHIIHSKGELQHSPLSVYNVSSITNSPRIPTHSPKHQH-----------------HPN 150

Query: 178 LAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENA 237
           L   + QAK+NGWYI+P EI L++KIGQGTTA I+R  WRG DVAVKCI P+FF TN N 
Sbjct: 151 LEAIIDQAKINGWYINPTEIQLEDKIGQGTTAEIHRGTWRGFDVAVKCISPEFFRTNANG 210

Query: 238 VTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           V FFAQEV+TLS+QRHRFVL LMGACL+PP   W+VTE L TTLKEWL+G G +RR++R+
Sbjct: 211 VEFFAQEVETLSKQRHRFVLNLMGACLDPPNHAWVVTEYLSTTLKEWLYGPG-KRRRDRI 269

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           VPLPPF+ERL R +EIAQAMQYLHEQKPK+IHRDLKPSNIF+D   HVR+ADFGHARFL 
Sbjct: 270 VPLPPFKERLTRVIEIAQAMQYLHEQKPKIIHRDLKPSNIFMDFNLHVRVADFGHARFLG 329

Query: 358 DGEMAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA 414
           DGEMAL   TGT+VYM+PEVI+CEPY+EK DVYSFG+ILNEI+TG HPYIE +Y PAKIA
Sbjct: 330 DGEMALTGETGTYVYMSPEVIRCEPYNEKCDVYSFGVILNEILTGKHPYIETEYGPAKIA 389

Query: 415 MEVGEGKLRPALPEEDG--QLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV 468
           MEV EGKLRP LP  D    L ELI+LI L WDG  S RPSF +IT  LK+   +V
Sbjct: 390 MEVVEGKLRPTLPSRDDGEHLGELIDLIRLCWDGTPSTRPSFDTITRILKSYTNRV 445

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356554110|ref|XP_003545392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max]

 Score =  523 bits (1346), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 255/389 (65%), Positives = 304/389 (78%), Gaps = 21/389 (5%)

Query: 80  QVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSS 139
           +V DL +EVQ+Q EL ++YRKR+ERTQDYLR+CLQIAQ NG+L+L+ N K +  QS +S 
Sbjct: 2   EVADLEKEVQKQTELGVMYRKRMERTQDYLRYCLQIAQANGILDLIVNCKGEFQQSPVSV 61

Query: 140 NTGSVIASPLVQTPLH-QHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEID 198
            T S I SP +  P    H H                 +LA  + QAK+NGWYIDP EI 
Sbjct: 62  PTISSITSPQIHIPTPPNHGHH---------------PNLAAIIDQAKINGWYIDPNEIQ 106

Query: 199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           L+EKIGQG+TA I+R  WRG +VAVKCI  DFF TN+N V +F+QE++TLSRQRHRFVL 
Sbjct: 107 LEEKIGQGSTAEIHRGTWRGFEVAVKCISEDFFRTNQNGVAYFSQELETLSRQRHRFVLH 166

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           LMGAC+ PP R W+VTE L TTLKEWLHG G+ RR+ERMVPLPPF++R+ RALEIAQAMQ
Sbjct: 167 LMGACIHPPRRAWVVTEHLSTTLKEWLHGPGT-RRRERMVPLPPFKDRVIRALEIAQAMQ 225

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEVI 375
           YLHEQKPK++HRDLKPSNIFLDDA HVR+ADFGHARFL D EMAL   TGT+VYMAPEVI
Sbjct: 226 YLHEQKPKLVHRDLKPSNIFLDDAMHVRVADFGHARFLGDEEMALTGETGTYVYMAPEVI 285

Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED-GQLR 434
           +CEPY+EK DVYSFGIILNE++TGN+PY+E +Y P KIAMEV EGKLRP LP +D GQL 
Sbjct: 286 RCEPYNEKCDVYSFGIILNELLTGNYPYVETEYGPTKIAMEVVEGKLRPKLPCDDVGQLG 345

Query: 435 ELIELICLSWDGDASVRPSFSSITCSLKN 463
           ELI+LICL WD + S RPSF++IT  LK+
Sbjct: 346 ELIDLICLCWDKNPSTRPSFATITLCLKS 374

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449486787|ref|XP_004157402.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase CTR1-like [Cucumis sativus]

 Score =  473 bits (1217), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 242/435 (55%), Positives = 316/435 (72%), Gaps = 32/435 (7%)

Query: 35  TGHSRGCCRGFSDCMSMGSMVSKKQQNPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKEL 94
           T  SR       +C+ MGS VS  ++           +S++ LE +V +L +E+ +QKE+
Sbjct: 26  TSQSRRYSPSLCNCVGMGSNVSSSRR----------PRSSVMLELKVAELEKELLKQKEI 75

Query: 95  RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPL 154
           +++++KR++R QD L+  L+ AQD G L L+  ++E+       +   S  +SP + +  
Sbjct: 76  QLMFKKRMDRAQDSLKCFLEKAQDRGFLHLIIGDRENVDGDGSPNCIQSAGSSPAMSS-- 133

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
                        S+ P    +DL   + QAK++GWYI+P EI+L+EKIGQGTTANIY+A
Sbjct: 134 -------------SRNPF--AADLQPLIDQAKLHGWYIEPHEIELREKIGQGTTANIYKA 178

Query: 215 IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT 274
            WRGL+VAVKC+  DFF +NE  V++FAQE++TL RQRHRFVLQLMGACL+PP  GW+VT
Sbjct: 179 TWRGLEVAVKCLNQDFFCSNECGVSYFAQELETLCRQRHRFVLQLMGACLQPPGCGWVVT 238

Query: 275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKP 334
           E L  TL+EWLHG G +R+K R +PL PF+ERL +ALEI+Q MQYLHEQKP+VIHRDLKP
Sbjct: 239 EYLRMTLQEWLHGPG-KRQKGRTIPLHPFQERLLKALEISQGMQYLHEQKPRVIHRDLKP 297

Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGI 391
           SNIFLDDA HVR+ADFGHARFL D EMAL   TGT+VYMAPEVI+CEPY+EK D+YSFGI
Sbjct: 298 SNIFLDDAFHVRVADFGHARFLHDKEMALTGETGTYVYMAPEVIRCEPYTEKXDIYSFGI 357

Query: 392 ILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP-EEDGQLRELIELICLSWDGDASV 450
           ILNE+ITG +PYIE DY P KIAMEVGEG LRP LP +E+  LRE++ LIC  W+G+ ++
Sbjct: 358 ILNELITGKYPYIEIDYSPFKIAMEVGEGNLRPELPLDENEDLREVLALICACWNGNPNL 417

Query: 451 RPSFSSITCSLKNIQ 465
           RPSF+SIT +L+ IQ
Sbjct: 418 RPSFASITTALRRIQ 432

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449447349|ref|XP_004141431.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus]

 Score =  468 bits (1205), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 242/435 (55%), Positives = 312/435 (71%), Gaps = 32/435 (7%)

Query: 35  TGHSRGCCRGFSDCMSMGSMVSKKQQNPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKEL 94
           T  SR       +C+ MGS VS  ++           +S++ LE +V +L +E+ +QKE+
Sbjct: 26  TSQSRRYSPSLCNCVGMGSNVSSSRR----------PRSSVMLELKVAELEKELLKQKEI 75

Query: 95  RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPL 154
           +++++KR++R QD L+  L+ AQD G L L+  ++E+          GS        +  
Sbjct: 76  QLMFKKRMDRAQDSLKCFLEKAQDRGFLHLIIGDREN------VDGDGSPNCIQSAGSSP 129

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
              S   P             +DL   + QAK++GWYI+P EI+L+EKIGQGTTANIY+A
Sbjct: 130 AMSSSSNPF-----------AADLQPLIDQAKLHGWYIEPHEIELREKIGQGTTANIYKA 178

Query: 215 IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT 274
            WRGL+VAVKC+  DFF +NE  V++FAQE++TL RQRHRFVLQLMGACL+PP  GW+VT
Sbjct: 179 TWRGLEVAVKCLNQDFFCSNECGVSYFAQELETLCRQRHRFVLQLMGACLQPPGCGWVVT 238

Query: 275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKP 334
           E L  TL+EWLHG G +R+K R +PL PF+ERL +ALEI+Q MQYLHEQKP+VIHRDLKP
Sbjct: 239 EYLRMTLQEWLHGPG-KRQKGRTIPLHPFQERLLKALEISQGMQYLHEQKPRVIHRDLKP 297

Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGI 391
           SNIFLDDA HVR+ADFGHARFL D EMAL   TGT+VYMAPEVI+CEPY+EKSD+YSFGI
Sbjct: 298 SNIFLDDAFHVRVADFGHARFLHDKEMALTGETGTYVYMAPEVIRCEPYTEKSDIYSFGI 357

Query: 392 ILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP-EEDGQLRELIELICLSWDGDASV 450
           ILNE+ITG +PYIE DY P KIAMEVGEG LRP LP +E+  LRE++ LIC  W+G+ ++
Sbjct: 358 ILNELITGKYPYIEIDYSPFKIAMEVGEGNLRPELPLDENEDLREVLALICACWNGNPNL 417

Query: 451 RPSFSSITCSLKNIQ 465
           RPSF+SIT +L+ IQ
Sbjct: 418 RPSFASITTALRRIQ 432

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255550137|ref|XP_002516119.1| serine-threonine protein kinase, putative [Ricinus communis] gi|223544605|gb|EEF46121.1| serine-threonine protein kinase, putative [Ricinus communis]

 Score =  454 bits (1169), Expect = e-125,   Method: Compositional matrix adjust.
 Identities = 212/279 (75%), Positives = 244/279 (87%), Gaps = 4/279 (1%)

Query: 197 IDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           I+LQEKIGQG+TA IYRA WRGLDVAVKCI+PDFF +NE+ V FFAQE+DTLSRQRHR+V
Sbjct: 4   IELQEKIGQGSTAVIYRASWRGLDVAVKCIFPDFFQSNESGVAFFAQELDTLSRQRHRYV 63

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           LQLMGACL+PP   W+VTELLG TLKEWL+G G+ R+KER+ PL PF ER+ARALEIAQA
Sbjct: 64  LQLMGACLDPPKHAWVVTELLGMTLKEWLYGPGNSRQKERLTPLAPFGERIARALEIAQA 123

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPE 373
           MQYLHEQKPK+IHRDLKPSNIFLDDA HVRIADFGHARFL D EMAL   TGT+VYMAPE
Sbjct: 124 MQYLHEQKPKIIHRDLKPSNIFLDDANHVRIADFGHARFLGDEEMALTGETGTYVYMAPE 183

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DGQ 432
           VI+CEPY+EK DVYSFG+ILNEIITGNHPYI  ++ P+KIAMEV EG LRP LPE+  GQ
Sbjct: 184 VIRCEPYNEKCDVYSFGVILNEIITGNHPYIGTNFGPSKIAMEVAEGNLRPMLPEDHSGQ 243

Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET 471
           L ELI LICLSWD DAS+RPSF+++T +LK IQ+++ E+
Sbjct: 244 LGELINLICLSWDQDASIRPSFATVTSTLKKIQLRIIES 282

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225429642|ref|XP_002279738.1| PREDICTED: probable serine/threonine-protein kinase drkC-like [Vitis vinifera]

 Score =  428 bits (1101), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 237/477 (49%), Positives = 296/477 (62%), Gaps = 80/477 (16%)

Query: 1   MNIAGTPQKKKTGLLGSRKSPVVSSAGQQRKPTSTGHSRGCCRGFSDCMSMGSMVSKKQQ 60
           M   G   KK T       SP  +S+  ++    T   + CC  F  C+ MGS VS    
Sbjct: 1   MYTNGNTNKKTTIFSPRITSPASASSSGKQGKHGTAQVQTCC--FGKCVKMGSSVS---- 54

Query: 61  NPQCQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNG 120
                Q H ++Q            T +V++Q+E                RH  Q +++  
Sbjct: 55  -----QPHQQNQQA----------TAKVEQQQE----------------RHGEQSSKNGK 83

Query: 121 VLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAV 180
             E   N                   SP   TP+H   HQ                 L  
Sbjct: 84  STEKPQNR-----------------PSPRTPTPVH---HQ-----------------LET 106

Query: 181 TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF 240
            + +AK +GWYI+P EI+ QE + +G+TA +Y+  WRGLDVAVKCI+P++FH NE AV F
Sbjct: 107 LIDEAKNSGWYIEPHEIEFQELVAEGSTARVYKGTWRGLDVAVKCIFPEYFHNNEGAVLF 166

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL 300
           F QE+DTLSRQRHR VLQLMGACL PP  GWLVTE L TTLKEWLHG G +R +ER  PL
Sbjct: 167 FTQELDTLSRQRHRSVLQLMGACLRPPDHGWLVTEFLSTTLKEWLHGRG-ERGEERTAPL 225

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           PPF ERLA+ALEIA+AMQYLH+Q+P VIHRDLKPSNIFLDDAKHVR+ADFG+ARFL DGE
Sbjct: 226 PPFWERLAKALEIAEAMQYLHDQRPMVIHRDLKPSNIFLDDAKHVRVADFGNARFLCDGE 285

Query: 361 MAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
            AL   TGTFVYMAPEV + +PY+EK DV+SFGIILNE+ITG +PY+E +Y P +IA  V
Sbjct: 286 KALSGETGTFVYMAPEVTRSQPYNEKCDVFSFGIILNELITGEYPYVETEYGPFQIASGV 345

Query: 418 -GEGKLRPALPEEDGQ-LRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI 472
            G+ KLRPALP++DGQ ++ELI LI LSW+ + S+RPSF+ I  +LK IQ +  E+I
Sbjct: 346 CGQEKLRPALPKKDGQIMKELIHLILLSWNENPSIRPSFAKIASTLKRIQSQPFESI 402

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357153826|ref|XP_003576579.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0267514-like [Brachypodium distachyon]

 Score =  402 bits (1033), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 212/412 (51%), Positives = 273/412 (66%), Gaps = 26/412 (6%)

Query: 74  TLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTN--NKED 131
            L+  EQV  L  EVQ+Q +L+   + RLE TQ+YLR CL++AQ++G L L++N  N E 
Sbjct: 34  NLQCSEQVAKLRDEVQKQSDLKETCKARLESTQEYLRFCLEVAQEHGFLHLISNSSNDES 93

Query: 132 QHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSD--LAVTVSQAKMNG 189
            HQ   +    +  A    +    +   + P             SD  LA T   A  +G
Sbjct: 94  PHQDDETDAATAAGADGEDERAKAEAEAEAP------------PSDPYLAATRELALQHG 141

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHT------NENAVTFFAQ 243
           W I P EI+L E IGQG+TA+I+RA WRGLDVAVK + P+FF +        +A  FFAQ
Sbjct: 142 WSISPDEIELHEMIGQGSTADIHRATWRGLDVAVKWVRPEFFFSLSSNGMAGDAEAFFAQ 201

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E D LSRQRH  VL+LMGACL PP   +LVTELL G TL EWLHG   +RR++R  P P 
Sbjct: 202 EADLLSRQRHPHVLRLMGACLRPPDSCFLVTELLSGATLGEWLHGAKDRRRRQRDHPTPT 261

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
             +R++RALEIA AM+YLHEQ P+V+HRDLKPSN+ LD     R+ADFGHARFL DG+ A
Sbjct: 262 LADRVSRALEIALAMRYLHEQTPRVLHRDLKPSNVLLDGDWSARVADFGHARFLPDGKAA 321

Query: 363 LTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           LTG   T+VYMAPEVI+CEPY+EK DVYSFG+ILNE++TG HPYI+  Y P+KIA+EV +
Sbjct: 322 LTGETGTYVYMAPEVIRCEPYTEKCDVYSFGVILNELVTGEHPYIDTSYGPSKIALEVAD 381

Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET 471
           GKLRP LPE+D     L++LIC +W  +   RPSF +IT +L+ I+ ++  T
Sbjct: 382 GKLRPRLPEDDANSGALVDLICRTWHAEPLNRPSFDTITSALREIKEQLETT 433

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	472
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.552	0.453	0.360	2.9e-39
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.559	0.483	0.341	8.3e-39
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.550	0.456	0.346	1.9e-36
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.745	0.854	0.314	4.4e-36
DICTYBASE|DDB_G0281899	749	drkC "DRK subfamily protein ki	0.540	0.340	0.366	2.7e-35
TAIR|locus:2200296	765	AT1G67890 [Arabidopsis thalian	0.548	0.338	0.363	3.6e-35
TAIR|locus:2144613	821	CTR1 "CONSTITUTIVE TRIPLE RESP	0.519	0.298	0.371	5e-35
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.677	0.349	0.337	6.6e-35
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.555	0.598	0.358	2.2e-34
TAIR|locus:2061092	411	AT2G24360 [Arabidopsis thalian	0.559	0.642	0.341	4.6e-34

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 419 (152.6 bits), Expect = 2.9e-39, P = 2.9e-39
 Identities = 103/286 (36%), Positives = 170/286 (59%)

Query:   190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             W I+ K +    KI  G+  ++Y+  +   +VA+K + P+    + +    FAQEV  + 
Sbjct:   283 WEINLKHLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPE--RLDSDLEKEFAQEVFIMR 340

Query:   250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             + RH+ V+Q +GAC +PP+   +VTE + G ++ ++LH      +++ +  LP       
Sbjct:   341 KVRHKNVVQFIGACTKPPHL-CIVTEFMPGGSVYDYLH------KQKGVFKLPTL---FK 390

Query:   309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-GEM-ALTGT 366
              A++I + M YLH+    +IHRDLK +N+ +D+ + V++ADFG AR  +  G M A TGT
Sbjct:   391 VAIDICKGMSYLHQNN--IIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTAETGT 448

Query:   367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIAMEVGEGKLRPA 425
             + +MAPEVI+ +PY  K+DV+S+GI+L E++TG  PY   +Y  P + A+ V +  LRP 
Sbjct:   449 YRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPY---EYMTPLQAAVGVVQKGLRPT 505

Query:   426 LPEEDG-QLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE 470
             +P+    +L EL+E +   W+ D++ RP FS I   L+ I  +V E
Sbjct:   506 IPKNTHPKLAELLERL---WEHDSTQRPDFSEIIEQLQEIAKEVGE 548

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 391 (142.7 bits), Expect = 8.3e-39, Sum P(2) = 8.3e-39
 Identities = 98/287 (34%), Positives = 165/287 (57%)

Query:   190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             W ID  ++ +++K+  G+  +++R  +   +VA+K + PD    N   +  F+QEV  + 
Sbjct:   279 WEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPD--RVNNEMLREFSQEVFIMR 336

Query:   250 RQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             + RH+ V+Q +GAC   P    +VTE +   ++ ++LH    Q+   ++  L      L 
Sbjct:   337 KVRHKNVVQFLGACTRSPTL-CIVTEFMARGSIYDFLH---KQKCAFKLQTL------LK 386

Query:   309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEM-ALTGT 366
              AL++A+ M YLH+    +IHRDLK +N+ +D+   V++ADFG AR  +  G M A TGT
Sbjct:   387 VALDVAKGMSYLHQNN--IIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTAETGT 444

Query:   367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             + +MAPEVI+ +PY+ K+DV+S+ I+L E++TG+ PY      P + A+ V +  LRP +
Sbjct:   445 YRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAF--LTPLQAAVGVVQKGLRPKI 502

Query:   427 PEEDG-QLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI 472
             P++   +++ L+E  C  W  D   RP F  I   L+ I  +V   +
Sbjct:   503 PKKTHPKVKGLLER-C--WHQDPEQRPLFEEIIEMLQQIMKEVNVVV 546

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 393 (143.4 bits), Expect = 1.9e-36, P = 1.9e-36
 Identities = 98/283 (34%), Positives = 166/283 (58%)

Query:   190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             W ID K++ +++K+  G+   ++R  +   +VA+K + P+    N   +  F+QEV  + 
Sbjct:   285 WEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPE--RVNAEMLREFSQEVYIMR 342

Query:   250 RQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             + RH+ V+Q +GAC   P    +VTE +   ++ ++LH       K + V     +  L 
Sbjct:   343 KVRHKNVVQFIGACTRSPNL-CIVTEFMTRGSIYDFLH-------KHKGVF--KIQSLLK 392

Query:   309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-GEM-ALTGT 366
              AL++++ M YLH+    +IHRDLK +N+ +D+ + V++ADFG AR  ++ G M A TGT
Sbjct:   393 VALDVSKGMNYLHQNN--IIHRDLKTANLLMDEHEVVKVADFGVARVQTESGVMTAETGT 450

Query:   367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             + +MAPEVI+ +PY  ++DV+S+ I+L E++TG  PY      P + A+ V +  LRP +
Sbjct:   451 YRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPY--SYLTPLQAAVGVVQKGLRPKI 508

Query:   427 PEEDG-QLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV 468
             P+E   +L EL+E  C  W  D ++RP+F+ I   L  +  +V
Sbjct:   509 PKETHPKLTELLEK-C--WQQDPALRPNFAEIIEMLNQLIREV 548

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 389 (142.0 bits), Expect = 4.4e-36, P = 4.4e-36
 Identities = 122/388 (31%), Positives = 198/388 (51%)

Query:   105 TQDYLRHCLQIAQDNGVLELMTNNKEDQ-HQSLLSSNTGS---VIASPLVQTPLHQHSHQ 160
             TQD+ +   +   +  V  + T+N       S+ +S+ GS   +I  P ++   H +S  
Sbjct:    25 TQDFYQKLGEEGTNMSVDSMQTSNAGGSVSMSVDNSSVGSSDALIGHPGLKPMRHPYSLS 84

Query:   161 T--PLHRYCSQTPLLQQSDLAVTVSQAKM--NG------WYIDPKEIDLQEKIGQGTTAN 210
                 + R    T  L    LA  +  +K    G      W ID +++ +     QG    
Sbjct:    85 DGQSVFRPGKVTHALNDDALAQALMDSKYPTEGLVNYEEWTIDLRKLHMGPAFAQGAFGK 144

Query:   211 IYRAIWRGLDVAVKCIY-PDFFHTNENAVTF-FAQEVDTLSRQRHRFVLQLMGACLEPPY 268
             +YR  + G DVA+K +   D       A+   F QEV  L+  +H  +++ +GAC++P  
Sbjct:   145 LYRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSMLAFLKHPNIVRFIGACIKPMV 204

Query:   269 RGW-LVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPK 326
               W +VTE   G +++++L      +R+ R VPL   +  + +AL++A+ M Y+HE+   
Sbjct:   205 --WCIVTEYAKGGSVRQFL-----TKRQNRAVPL---KLAVMQALDVARGMAYVHERN-- 252

Query:   327 VIHRDLKPSNIFLDDAKHVRIADFGHARF--LSDGEMALTGTFVYMAPEVIQCEPYSEKS 384
              IHRDLK  N+ +   + ++IADFG AR    ++G    TGT+ +MAPE+IQ  PY++K 
Sbjct:   253 FIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETGTYRWMAPEMIQHRPYTQKV 312

Query:   385 DVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSW 444
             DVYSFGI+L E+ITG  P+       A  A+ V  G +RP +P +   L  L E++   W
Sbjct:   313 DVYSFGIVLWELITGLLPFQNMTAVQAAFAV-VNRG-VRPTVPADC--LPVLGEIMTRCW 368

Query:   445 DGDASVRPSFSSITCSLKNIQMKVTETI 472
             D D  VRP F+ I   L+  + ++   +
Sbjct:   369 DADPEVRPCFAEIVNLLEAAETEIMTNV 396

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

DICTYBASE|DDB_G0281899 drkC "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 369 (135.0 bits), Expect = 2.7e-35, Sum P(2) = 2.7e-35
 Identities = 102/278 (36%), Positives = 150/278 (53%)

Query:   192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
             ID  EI +Q +IG+G+ A ++   WRG+ VA+K         +E+ +   AQE   +S+ 
Sbjct:   486 IDISEIVVQNRIGRGSCAEVFTGTWRGIIVAIKKAKL-LNEDDEDFLNELAQEATIMSQL 544

Query:   252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR--KERMVPLPPFEERLAR 309
             RH  + Q +G C  PP       E+L   + E++  LGS  R   +  + L  +    + 
Sbjct:   545 RHPNICQFLGTCNNPP-------EIL--IVMEYMP-LGSLYRILHDPSISLD-WPRMKSM 593

Query:   310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLS--DGEMALT-- 364
             AL+IA+ M YLH   P VIHRDLK  N+ +D+   V+I+DFG   RF    D + A+T  
Sbjct:   594 ALDIAKGMNYLHCCDPIVIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPV 653

Query:   365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
             GT  + APEV++ +PY+EK+DV+SF I+L EI+T   PY  +     +I + VG+ KLRP
Sbjct:   654 GTPCWTAPEVLRNDPYTEKADVFSFAIVLWEIVTREDPY--QGMPTFQIVISVGQHKLRP 711

Query:   425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
              +P +         LI   W  D   RPSF  I   L+
Sbjct:   712 IVPPQVSA--PFTRLITECWSEDPQQRPSFQEIVKRLE 747

GO:0032010 "phagolysosome" evidence=IDA

GO:0030670 "phagocytic vesicle membrane" evidence=IDA

GO:0006909 "phagocytosis" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;IC

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0001845 "phagolysosome assembly" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

TAIR|locus:2200296 AT1G67890 [Arabidopsis thaliana (taxid:3702)]

 Score = 376 (137.4 bits), Expect = 3.6e-35, Sum P(2) = 3.6e-35
 Identities = 101/278 (36%), Positives = 149/278 (53%)

Query:   195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
             +++ + E+IGQG+   +Y  +W G DVAVK      +  +E  +T F QEV  + R RH 
Sbjct:   485 EDLTIGEQIGQGSCGTVYHGLWFGSDVAVKVFSKQEY--SEEIITSFKQEVSLMKRLRHP 542

Query:   255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
              VL  MGA +  P R  +VTE L    +  L  L  QR K ++        R+  A +IA
Sbjct:   543 NVLLFMGA-VASPQRLCIVTEFLP---RGSLFRL-LQRNKSKL----DLRRRIHMASDIA 593

Query:   315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG--TFVYMAP 372
             + M YLH   P +IHRDLK SN+ +D    V++ADFG +R   +  +   G  T  +MAP
Sbjct:   594 RGMNYLHHCSPPIIHRDLKSSNLLVDRNWTVKVADFGLSRIKHETYLTTNGRGTPQWMAP 653

Query:   373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DG 431
             EV++ E   EKSDVYSFG++L E++T   P+  ++    ++   VG    R  +P++ D 
Sbjct:   654 EVLRNEAADEKSDVYSFGVVLWELVTEKIPW--ENLNAMQVIGAVGFMNQRLEVPKDVDP 711

Query:   432 QLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
             Q   L+E  C  W  +   RPSF  +   L+ +Q K T
Sbjct:   712 QWIALMES-C--WHSEPQCRPSFQELMDKLRELQRKYT 746

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004871 "signal transducer activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 388 (141.6 bits), Expect = 5.0e-35, P = 5.0e-35
 Identities = 100/269 (37%), Positives = 149/269 (55%)

Query:   196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
             +++++EKIG G+   ++RA W G DVAVK +    FH     V  F +EV  + R RH  
Sbjct:   550 DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--VNEFLREVAIMKRLRHPN 607

Query:   256 VLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
             ++  MGA  +PP    +VTE L   +L   LH  G++ + +          RL+ A ++A
Sbjct:   608 IVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDE-------RRRLSMAYDVA 659

Query:   315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVY 369
             + M YLH + P ++HRDLK  N+ +D    V++ DFG +R     FLS    A  GT  +
Sbjct:   660 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEW 717

Query:   370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
             MAPEV++ EP +EKSDVYSFG+IL E+ T   P+   +  PA++   VG    R  +P  
Sbjct:   718 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPRN 775

Query:   430 -DGQLRELIELICLSWDGDASVRPSFSSI 457
              + Q+  +IE  C  W  +   RPSF++I
Sbjct:   776 LNPQVAAIIEG-C--WTNEPWKRPSFATI 801

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009744 "response to sucrose stimulus" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0010105 "negative regulation of ethylene mediated signaling pathway" evidence=TAS

GO:0010182 "sugar mediated signaling pathway" evidence=TAS

GO:0005789 "endoplasmic reticulum membrane" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009686 "gibberellin biosynthetic process" evidence=IMP

GO:0048510 "regulation of timing of transition from vegetative to reproductive phase" evidence=IMP

GO:2000035 "regulation of stem cell division" evidence=IMP

GO:2000069 "regulation of post-embryonic root development" evidence=IMP

GO:0071281 "cellular response to iron ion" evidence=IEP

GO:0009750 "response to fructose stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009723 "response to ethylene stimulus" evidence=IMP

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 388 (141.6 bits), Expect = 6.6e-35, P = 6.6e-35
 Identities = 116/344 (33%), Positives = 180/344 (52%)

Query:   127 NNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAV---TVS 183
             N+  + H +  ++N  + I +       H  ++ +P ++Y +Q  +L+ S   V   +  
Sbjct:   590 NHNNNNHNNNNNNNNQNNIFNHNQNQNNHLINNHSP-NQYNNQGNILKNSGSVVEPPSQQ 648

Query:   184 QAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQ 243
             Q   +   I   E+ +  K+G+GT   +Y+ +WRG  VA+K I  +    N   +  F +
Sbjct:   649 QQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINE-DVNNQVLEEFRK 707

Query:   244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
             E+  LSR RH  ++ LM AC  PP   ++   L G +L + LH   S++ K  M      
Sbjct:   708 ELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALH---SKKIKMNM----QL 760

Query:   304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMA 362
              ++LA  ++IAQ M YLH     VIHRD+K  N+ LD+  +V+I DFG ++  S   EM 
Sbjct:   761 YKKLA--IQIAQGMNYLHLSG--VIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKSTEMT 816

Query:   363 LT-GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
              + G+ ++M+PE++  E Y+EK DVY+FGIIL E+ TG  PY   D    ++A+ V    
Sbjct:   817 KSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLD--SVQLALAVTTKS 874

Query:   422 LRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             LRP +P     QL  LI+  C  W  D   RPSF+ I   L  I
Sbjct:   875 LRPPIPNAWPYQLSHLIQA-C--WHQDPLKRPSFTEILNLLNEI 915

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 373 (136.4 bits), Expect = 2.2e-34, P = 2.2e-34
 Identities = 106/296 (35%), Positives = 155/296 (52%)

Query:   190 WYIDPKEIDLQEK--IGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
             W I+P E+D      IG+G+   I +A WRG  VAVK I P     +   +  F  EVD 
Sbjct:   153 WEIEPAELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPSL-SDDRLVIQDFRHEVDL 211

Query:   248 LSRQRHRFVLQLMGACLE-PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
             L + RH  ++Q +GA  E  P    L+TE L G  L ++L      + K  + P      
Sbjct:   212 LVKLRHPNIVQFLGAVTERKPLM--LITEYLRGGDLHQYL------KEKGGLTPTTAVNF 263

Query:   306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL--DDAKHVRIADFGHARFL----SDG 359
                 AL+IA+ M YLH +   +IHRDLKP N+ L    A H+++ DFG ++ +    S  
Sbjct:   264 ----ALDIARGMTYLHNEPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHD 319

Query:   360 EMALTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
                +TG   ++ YMAPEV +   Y +K DV+SF +IL E++ G  P+   +++P + A  
Sbjct:   320 VYKMTGETGSYRYMAPEVFKHRRYDKKVDVFSFAMILYEMLEGEPPFA--NHEPYEAAKH 377

Query:   417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI 472
             V +G  RP    + G   +L ELI   WD D + RPSF  I   LK ++ K+ ET+
Sbjct:   378 VSDGH-RPTFRSK-GCTPDLRELIVKCWDADMNQRPSFLDI---LKRLE-KIKETL 427

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)]

 Score = 370 (135.3 bits), Expect = 4.6e-34, P = 4.6e-34
 Identities = 99/290 (34%), Positives = 161/290 (55%)

Query:   190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIY-PDFFHTNENAVTF---FAQEV 245
             W ID +++++     QG    +Y+  + G DVA+K +  P+  ++ E A      F QEV
Sbjct:   123 WTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPE--NSPEKAQFMEQQFQQEV 180

Query:   246 DTLSRQRHRFVLQLMGACLEPPYRGW-LVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
               L+  +H  +++ +GAC +P    W +VTE   G +++++L      RR+ R VPL   
Sbjct:   181 SMLANLKHPNIVRFIGACRKPMV--WCIVTEYAKGGSVRQFL-----TRRQNRAVPL--- 230

Query:   304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF--LSDGEM 361
             +  + +AL++A+ M Y+H +    IHRDLK  N+ +   K ++IADFG AR    ++G  
Sbjct:   231 KLAVKQALDVARGMAYVHGRN--FIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMT 288

Query:   362 ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
               TGT+ +MAPE+IQ   Y++K DVYSFGI+L E+ITG  P+       A  A+ V  G 
Sbjct:   289 PETGTYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAV-VNRG- 346

Query:   422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET 471
             +RP +P +   L  L +++   WD +  VRP F  +   L+  + ++  T
Sbjct:   347 VRPTVPNDC--LPVLSDIMTRCWDANPEVRPCFVEVVKLLEAAETEIMTT 394

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IDA

GO:0006487 "protein N-linked glycosylation" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.10.2	LOW CONFIDENCE prediction!
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00061564 hypothetical protein (406 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	472
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-55
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-45
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-42
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-39
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-36
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-34
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	8e-33
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	7e-32
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-30
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-30
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-26
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-25
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-25
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-25
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-24
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	6e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-22
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	6e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-21
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-21
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-20
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-20
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	4e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-20
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	8e-20
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-19
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-19
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-19
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-19
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-19
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-18
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-18
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	4e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	9e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-17
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-17
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-17
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	6e-17
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-17
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-17
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-17
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-17
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-16
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-16
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-16
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-16
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-16
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-16
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	7e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-16
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-15
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-15
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-15
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-15
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-15
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-15
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-14
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-14
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-14
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-14
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-14
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-14
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-14
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-14
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-14
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-14
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-14
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	7e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	7e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-14
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	9e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-13
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-13
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	5e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-13
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	5e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	8e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-12
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-12
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-12
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-12
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-12
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-12
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-12
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-11
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-11
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-11
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-11
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-11
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	5e-11
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	5e-11
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	9e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-10
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	7e-10
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	9e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	9e-10
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-09
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-09
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-07
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	4e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	9e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  183 bits (468), Expect = 4e-55
 Identities = 81/269 (30%), Positives = 127/269 (47%), Gaps = 31/269 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++ EK+G+G+   +Y A  +  G  VA+K I       +   +    +E+  L + +H  
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERIL---REIKILKKLKHPN 58

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALE 312
           +++L     +     +LV E   G  L + L   G               E  AR    +
Sbjct: 59  IVRLYDVFEDEDKL-YLVMEYCEGGDLFDLLKKRG------------RLSEDEARFYLRQ 105

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           I  A++YLH +   ++HRDLKP NI LD+  HV++ADFG AR L  GE   T  GT  YM
Sbjct: 106 ILSALEYLHSKG--IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYM 163

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           APEV+  + Y +  D++S G+IL E++TG  P+   D +  ++  ++G+ K     P E 
Sbjct: 164 APEVLLGKGYGKAVDIWSLGVILYELLTGKPPF-PGDDQLLELFKKIGKPKPPF-PPPEW 221

Query: 431 GQLRELIELI--CLSWDGDASVRPSFSSI 457
               E  +LI   L    D   R +    
Sbjct: 222 DISPEAKDLIRKLLVK--DPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  172 bits (437), Expect = 2e-50
 Identities = 84/269 (31%), Positives = 124/269 (46%), Gaps = 27/269 (10%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L  K+G G+   +Y+A  +  G  VAVK +                +E+  L R  H  +
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNI 60

Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEI 313
           ++L+ A  +  +  +LV E   G  L ++L   G            P  E  A+  AL+I
Sbjct: 61  VRLIDAFEDKDHL-YLVMEYCEGGDLFDYLSRGG------------PLSEDEAKKIALQI 107

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEM-ALTGTFVYM 370
            + ++YLH     +IHRDLKP NI LD+   V+IADFG A+ L  S   +    GT  YM
Sbjct: 108 LRGLEYLHSNG--IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYM 165

Query: 371 APEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY-IEKDYKPAKIAMEVGEGKLRPALPE 428
           APEV+     Y  K DV+S G+IL E++TG  P+  E      ++   +    L    P+
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPK 225

Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSI 457
                 E  +LI    + D S RP+   I
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  160 bits (407), Expect = 1e-46
 Identities = 68/203 (33%), Positives = 106/203 (52%), Gaps = 25/203 (12%)

Query: 203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G+G    +Y A  +  G  VA+K I  +   +         +E++ L +  H  +++L 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE---LLREIEILKKLNHPNIVKLY 57

Query: 261 GACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQ 318
           G   +  +  +LV E   G +LK+ L        KE    L   E+ + R  L+I + ++
Sbjct: 58  GVFEDENHL-YLVMEYCEGGSLKDLL--------KENEGKLS--EDEILRILLQILEGLE 106

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHARFLSDGEMALT---GTFVYMAPEV 374
           YLH     +IHRDLKP NI LD     V++ADFG ++ L+  +  L    GT  YMAPEV
Sbjct: 107 YLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEV 164

Query: 375 IQCEP-YSEKSDVYSFGIILNEI 396
           +  +  YSEKSD++S G+IL E+
Sbjct: 165 LLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  158 bits (401), Expect = 3e-45
 Identities = 82/277 (29%), Positives = 130/277 (46%), Gaps = 31/277 (11%)

Query: 197 IDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           + L +K+G+G    +Y+   +G      ++VAVK +  D    +E  +  F +E   + +
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED---ASEQQIEEFLREARIMRK 57

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLAR 309
             H  +++L+G C E      +V E +         G L    RK R   L    + L+ 
Sbjct: 58  LDHPNIVKLLGVCTEEE-PLMIVMEYMP-------GGDLLDYLRKNRPKELSL-SDLLSF 108

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTF 367
           AL+IA+ M+YL  +    IHRDL   N  + +   V+I+DFG +R L D +      G  
Sbjct: 109 ALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL 166

Query: 368 VY--MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
               MAPE ++   ++ KSDV+SFG++L EI T G  PY       A++   + +G  R 
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS--NAEVLEYLKKGY-RL 223

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
             P       EL +L+   W  D   RP+FS +   L
Sbjct: 224 PKPPNCPP--ELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  158 bits (401), Expect = 3e-45
 Identities = 80/280 (28%), Positives = 135/280 (48%), Gaps = 37/280 (13%)

Query: 197 IDLQEKIGQGTTANIYRAIWRGL------DVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           ++L +K+G+G    +Y+   +G        VAVK +       +E     F +E   + +
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG---ASEEEREEFLEEASIMKK 57

Query: 251 QRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
             H  +++L+G C   EP Y   +VTE + G  L ++L      +  E++      ++ L
Sbjct: 58  LSHPNIVRLLGVCTQGEPLY---IVTEYMPGGDLLDFLR-----KHGEKL----TLKDLL 105

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTG 365
             AL+IA+ M+YL  +    +HRDL   N  + +   V+I+DFG +R + + +      G
Sbjct: 106 QMALQIAKGMEYLESKN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGG 163

Query: 366 TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
             +   +MAPE ++   ++ KSDV+SFG++L EI T G  PY        ++   + +G 
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY--PGMSNEEVLELLEDGY 221

Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
            R   PE      EL EL+   W  D   RP+FS +   L
Sbjct: 222 -RLPRPENCPD--ELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  154 bits (391), Expect = 9e-44
 Identities = 83/277 (29%), Positives = 132/277 (47%), Gaps = 32/277 (11%)

Query: 197 IDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           + L +K+G+G    +Y+   +G      ++VAVK +  D    +E  +  F +E   + +
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED---ASEQQIEEFLREARIMRK 57

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLAR 309
             H  V++L+G C E     ++V E +         G L S  RK R  P     + L+ 
Sbjct: 58  LDHPNVVKLLGVCTEEE-PLYIVMEYME-------GGDLLSYLRKNR--PKLSLSDLLSF 107

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGTFV 368
           AL+IA+ M+YL  +    IHRDL   N  + +   V+I+DFG +R L D +     G  +
Sbjct: 108 ALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL 165

Query: 369 ---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              +MAPE ++   ++ KSDV+SFG++L EI T G  PY        ++   +  G  R 
Sbjct: 166 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS--NEEVLEYLKNGY-RL 222

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
             P       EL +L+   W  D   RP+FS +   L
Sbjct: 223 PQPPNCPP--ELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (380), Expect = 5e-42
 Identities = 82/274 (29%), Positives = 132/274 (48%), Gaps = 34/274 (12%)

Query: 201 EKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +K+G+G    +Y+   +G      +VAVK +  D    +E     F +E   + +  H  
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED---ASEEERKDFLKEARVMKKLGHPN 57

Query: 256 VLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP---FEERLAR 309
           V++L+G C   EP Y   LV E + G  L ++L     + R     P       ++ L+ 
Sbjct: 58  VVRLLGVCTEEEPLY---LVLEYMEGGDLLDYLR----KSRPVFPSPEKSTLSLKDLLSF 110

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT--- 366
           A++IA+ M+YL  +K   +HRDL   N  + +   V+I+DFG +R + D +     T   
Sbjct: 111 AIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGK 168

Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
               +MAPE ++   ++ KSDV+SFG++L EI T G  PY        ++   + +G  R
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKGY-R 225

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
              PE      EL EL+   W  D   RP+FS +
Sbjct: 226 LPKPEYCPD--ELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  143 bits (362), Expect = 1e-39
 Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 28/240 (11%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           E +G+G+  ++Y A+ +  G  +AVK +       +E  +    +E+  LS  +H  +++
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVE--LSGDSEEELEALEREIRILSSLQHPNIVR 63

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERLAR--ALEIA 314
             G+  +       +         E++ G  L S  +K          E + R    +I 
Sbjct: 64  YYGSERDEEKNTLNI-------FLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTRQIL 111

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA-----LTGTFVY 369
           + + YLH     ++HRD+K +NI +D    V++ADFG A+ L D E       + GT  +
Sbjct: 112 EGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           MAPEVI+ E Y   +D++S G  + E+ TG  P+ E    P     ++G     P +PE 
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEPPEIPEH 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  133 bits (338), Expect = 4e-36
 Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 23/214 (10%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++ EKIG+G    +Y+A  +  G +VA+K I       ++        E+  L + +H  
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIK----LESKEKKEKIINEIQILKKCKHPN 58

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEI 313
           +++  G+ L+     W+V E   G +LK+ L        K     L   E ++A    E+
Sbjct: 59  IVKYYGSYLKKD-ELWIVMEFCSGGSLKDLL--------KSTNQTLT--ESQIAYVCKEL 107

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG--EMALTGTFVYMA 371
            + ++YLH     +IHRD+K +NI L     V++ DFG +  LSD      + GT  +MA
Sbjct: 108 LKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMA 165

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           PEVI  +PY  K+D++S GI   E+  G  PY E
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPPYSE 199

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  128 bits (323), Expect = 4e-34
 Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 55/293 (18%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W I+ KE+ L   IG+G   ++    +RG  VAVKC+  D       A   F  E   ++
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDD-----STAAQAFLAEASVMT 55

Query: 250 RQRHRFVLQLMGACLE--PPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEER 306
             RH  ++QL+G  L+  P Y   +VTE +   +L ++L      R + R V      ++
Sbjct: 56  TLRHPNLVQLLGVVLQGNPLY---IVTEYMAKGSLVDYL------RSRGRAV--ITLAQQ 104

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           L  AL++ + M+YL E+    +HRDL   N+ + +    +++DFG A+   +        
Sbjct: 105 LGFALDVCEGMEYLEEK--NFVHRDLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSG 159

Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKPA 411
                + APE ++ + +S KSDV+SFGI+L EI + G  PY           +EK Y+  
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR-- 217

Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              ME  EG      P       E+ +++   W+ D + RP+F  +   L  I
Sbjct: 218 ---MEAPEG-----CPP------EVYKVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  124 bits (315), Expect = 8e-33
 Identities = 80/272 (29%), Positives = 136/272 (50%), Gaps = 34/272 (12%)

Query: 198 DLQEKIGQGTTANIYRAIWRGLD---VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           ++ ++IG+G+   +Y    R  D     +K I  D  + +E        EV  L +  H 
Sbjct: 3   EIIKQIGKGSFGKVYLVR-RKSDGKLYVLKEI--DLSNMSEKEREDALNEVKILKKLNHP 59

Query: 255 FVLQLMGACLEPPYRGWL--VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER--LAR 309
            +++   +  E      L  V E   G  L        SQ+ K++     PF E   L  
Sbjct: 60  NIIKYYESFEEKGK---LCIVMEYADGGDL--------SQKIKKQKKEGKPFPEEQILDW 108

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALT--GT 366
            +++  A++YLH +K  ++HRD+KP NIFL     V++ DFG ++ L S  ++A T  GT
Sbjct: 109 FVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGT 166

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             Y++PE+ Q +PY+ KSD++S G +L E+ T  HP+  +     ++A+++ +G+  P +
Sbjct: 167 PYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKILKGQYPP-I 223

Query: 427 PEE-DGQLRELIELICLSWDGDASVRPSFSSI 457
           P +   +LR L+    L    D   RPS + I
Sbjct: 224 PSQYSSELRNLVS-SLLQ--KDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 9e-33
 Identities = 90/279 (32%), Positives = 128/279 (45%), Gaps = 36/279 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L+ K+G G    ++   W G   VAVK + P            F QE   +
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-----FLQEAQIM 55

Query: 249 SRQRHRFVLQLMGAC--LEPPYRGWLVTELLGT-TLKEWLH-GLGSQRRKERMVPLPPFE 304
            + RH  ++QL   C   EP Y   +VTE +   +L ++L  G G + R  ++V +    
Sbjct: 56  KKLRHDKLVQLYAVCSEEEPIY---IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDM---- 108

Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MAL 363
                A +IA+ M YL  +    IHRDL   NI + +    +IADFG AR + D E  A 
Sbjct: 109 -----AAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161

Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L EI+T G  PY      P     EV E
Sbjct: 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY------PGMTNREVLE 215

Query: 420 GKLRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
              R   +P       EL +L+   WD D   RP+F  +
Sbjct: 216 QVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYL 254

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  124 bits (312), Expect = 1e-32
 Identities = 89/283 (31%), Positives = 131/283 (46%), Gaps = 32/283 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W ID   I L  K+G G    ++  +W     VAVK + P      +     F  E   +
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKD-----FLAEAQIM 55

Query: 249 SRQRHRFVLQLMGACL--EPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEE 305
            + RH  ++QL   C   EP Y   +VTEL+   +L E+L     Q    R + LP   +
Sbjct: 56  KKLRHPKLIQLYAVCTLEEPIY---IVTELMKYGSLLEYL-----QGGAGRALKLP---Q 104

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALT 364
            +  A ++A  M YL  Q    IHRDL   N+ + +    ++ADFG AR + +    A  
Sbjct: 105 LIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE 162

Query: 365 GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
           G      + APE      +S KSDV+SFGI+L EI+T G  PY       A++  +V +G
Sbjct: 163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY--PGMTNAEVLQQVDQG 220

Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
              P  P    +L + I L C  W  D   RP+F ++   L++
Sbjct: 221 YRMPCPPGCPKELYD-IMLDC--WKEDPDDRPTFETLQWKLED 260

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  122 bits (308), Expect = 7e-32
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 25/211 (11%)

Query: 202 KIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
            +GQG++  +Y+      G   A+K I+ D        +    +E+ TL      +V++ 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCESPYVVKC 64

Query: 260 MGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
            GA  +      +V E    G+     L  L    +K   +P  P    +AR  +I + +
Sbjct: 65  YGAFYKEGEIS-IVLEYMDGGS-----LADL---LKKVGKIP-EPVLAYIAR--QILKGL 112

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV----YMAPE 373
            YLH  K  +IHRD+KPSN+ ++    V+IADFG ++ L +  +    TFV    YM+PE
Sbjct: 113 DYLH-TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT-LDQCNTFVGTVTYMSPE 170

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
            IQ E YS  +D++S G+ L E   G  P++
Sbjct: 171 RIQGESYSYAADIWSLGLTLLECALGKFPFL 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  122 bits (307), Expect = 8e-32
 Identities = 81/281 (28%), Positives = 130/281 (46%), Gaps = 26/281 (9%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W    +E  L+ K+G G    ++  +W+  + VA+K +  D    +      F +EV  L
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDFQKEVQAL 56

Query: 249 SRQRHRFVLQLMGAC-LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            R RH+ ++ L   C +  P   +++TEL+       L  L S   + +++P+      +
Sbjct: 57  KRLRHKHLISLFAVCSVGEPV--YIITELM--EKGSLLAFLRSP--EGQVLPVASL---I 107

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
             A ++A+ M YL EQ    IHRDL   NI + +    ++ADFG AR + +     +   
Sbjct: 108 DMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKK 165

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
           +   + APE      +S KSDV+SFGI+L E+ T G  PY   +        ++  G   
Sbjct: 166 IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV--YDQITAGYRM 223

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P  P +  Q    I L C  W  +   RPSF ++   L NI
Sbjct: 224 PC-PAKCPQEIYKIMLEC--WAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 2e-31
 Identities = 80/269 (29%), Positives = 126/269 (46%), Gaps = 43/269 (15%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L E IG+G+   +Y+AI +     VA+K I  D     +  +    QE+  LS+ R  ++
Sbjct: 5   LLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDE-IEDIQQEIQFLSQCRSPYI 61

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIAQ 315
            +  G+ L+   + W++ E  G          GS     +   L   E  +A  L E+  
Sbjct: 62  TKYYGSFLKG-SKLWIIMEYCGG---------GSCLDLLKPGKLD--ETYIAFILREVLL 109

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----GTFV--- 368
            ++YLHE+    IHRD+K +NI L +   V++ADFG +     G++  T     TFV   
Sbjct: 110 GLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTP 162

Query: 369 -YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            +MAPEVI+   Y EK+D++S GI   E+  G  P    D  P ++   +   K  P   
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL--SDLHPMRVLFLI--PKNNPPSL 218

Query: 428 EEDG---QLRELIELICLSWDGDASVRPS 453
           E +      ++ + L CL  + D   RPS
Sbjct: 219 EGNKFSKPFKDFVSL-CL--NKDPKERPS 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  118 bits (298), Expect = 3e-30
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 29/269 (10%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+E+    EKIG+G +  +Y+A  R  G +VA+K +       N+  +     E+  + 
Sbjct: 16  DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM--RLRKQNKELI---INEILIMK 70

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             +H  ++    + L      W+V E + G +L + +              +   E ++A
Sbjct: 71  DCKHPNIVDYYDSYLVGDEL-WVVMEYMDGGSLTDII----------TQNFVRMNEPQIA 119

Query: 309 R-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALT 364
               E+ Q ++YLH Q   VIHRD+K  NI L     V++ADFG A  L+  +    ++ 
Sbjct: 120 YVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
           GT  +MAPEVI+ + Y  K D++S GI+  E+  G  PY+     P + A+ +   K  P
Sbjct: 178 GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--REPPLR-ALFLITTKGIP 234

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPS 453
            L   +    E  + +      D   RPS
Sbjct: 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  117 bits (295), Expect = 5e-30
 Identities = 87/282 (30%), Positives = 123/282 (43%), Gaps = 56/282 (19%)

Query: 199 LQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L E IG G TA +Y AI       VA+K I  +   T+   V    +EV  +S+  H  V
Sbjct: 5   LIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS---VDELRKEVQAMSQCNHPNV 61

Query: 257 LQ-----LMGACLEPPYRGWLVTELLGTTLKEWLHGLGS----QRRKERMVPLPPFEERL 307
           ++     ++G  L      WLV   L           GS     +      P    +E +
Sbjct: 62  VKYYTSFVVGDEL------WLVMPYLSG---------GSLLDIMKSS---YPRGGLDEAI 103

Query: 308 ARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG------ 359
              +  E+ + ++YLH      IHRD+K  NI L +   V+IADFG +  L+DG      
Sbjct: 104 IATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161

Query: 360 -EMALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
                 GT  +MAPEV+ Q   Y  K+D++SFGI   E+ TG  PY    Y P K+ M  
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPY--SKYPPMKVLMLT 219

Query: 418 GEGKLRPALPEEDGQ------LRELIELICLSWDGDASVRPS 453
            +    P+L             R++I L CL    D S RP+
Sbjct: 220 LQND-PPSLETGADYKKYSKSFRKMISL-CLQ--KDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  117 bits (294), Expect = 6e-30
 Identities = 87/295 (29%), Positives = 139/295 (47%), Gaps = 53/295 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E   
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAV 55

Query: 248 LSRQRHRFVLQLMGAC-LEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEE 305
           +   +H  ++QL+G C  EPP+  +++TE +    L ++L      R   R   +     
Sbjct: 56  MKEIKHPNLVQLLGVCTREPPF--YIITEFMTYGNLLDYL------RECNRQE-VNAVV- 105

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALT 364
            L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A  
Sbjct: 106 LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 163

Query: 365 GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYK 409
           G      + APE +    +S KSDV++FG++L EI T G  PY           +EK Y+
Sbjct: 164 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR 223

Query: 410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                ME  EG      P       ++ EL+   W  + S RPSF+ I  + + +
Sbjct: 224 -----MERPEG-----CPP------KVYELMRACWQWNPSDRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  114 bits (284), Expect = 7e-28
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 29/225 (12%)

Query: 199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +  K+G+G+   +Y A      VA+K +       +   V  F +E+  L+   H   + 
Sbjct: 4   ILRKLGEGSFGEVYLAR-DRKLVALKVLAKKLESKS-KEVERFLREIQILASLNHPPNIV 61

Query: 259 LMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
            +    +     +LV E + G +L++ L  +G +          P  E  A  +  +I  
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKG---------PLSESEALFILAQILS 112

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGEMALT---------G 365
           A++YLH +   +IHRD+KP NI LD D + V++ DFG A+ L D     +         G
Sbjct: 113 ALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 366 TFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           T  YMAPEV+        S  SD++S GI L E++TG  P+  + 
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215

Length = 384

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  110 bits (278), Expect = 1e-27
 Identities = 48/154 (31%), Positives = 79/154 (51%), Gaps = 13/154 (8%)

Query: 311 LEIAQAMQYLH---EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
            ++  A+   H   +    V+HRDLKP+NIFLD   +V++ DFG A+ L         T+
Sbjct: 112 TQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-FAKTY 170

Query: 368 V----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
           V    YM+PE +    Y EKSD++S G ++ E+   + P+  ++    ++A ++ EGK R
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIKEGKFR 228

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                   +L E+I+   L  + D   RPS   +
Sbjct: 229 RIPYRYSSELNEVIKS-ML--NVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  111 bits (279), Expect = 1e-27
 Identities = 72/285 (25%), Positives = 123/285 (43%), Gaps = 48/285 (16%)

Query: 202 KIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++G+G    +    +       G  VAVK +        E   + F +E++ L    H  
Sbjct: 11  QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS---GEEQHRSDFEREIEILRTLDHEN 67

Query: 256 VLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           +++  G C +P  R   L+ E L + +L+++L     Q   +R+         L  + +I
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL---------LLFSSQI 118

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG-------T 366
            + M YL  Q+   IHRDL   NI ++    V+I+DFG A+ L + +             
Sbjct: 119 CKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVGEGKLRPA 425
           F Y APE ++   +S  SDV+SFG+ L E+ T    Y +    P A+    +G  + +  
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT----YGDPSQSPPAEFLRMIGIAQGQMI 231

Query: 426 -------------LPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                        LP       E+ +L+ L W+ +   RPSF+ +
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 9e-27
 Identities = 70/218 (32%), Positives = 108/218 (49%), Gaps = 35/218 (16%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G    +Y+ +    G  VA+K I  +     E A+    QE+D L   +H  +
Sbjct: 4   LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNI 61

Query: 257 LQLMGACLEPPYRGWLVTEL-----LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           ++ +G  +E     +++ E      L   +K+   G              PF E L  A+
Sbjct: 62  VKYIG-SIETSDSLYIILEYAENGSLRQIIKK--FG--------------PFPESLV-AV 103

Query: 312 EIAQAMQ---YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD---GEMALTG 365
            + Q +Q   YLHEQ   VIHRD+K +NI       V++ADFG A  L+D    + ++ G
Sbjct: 104 YVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG 161

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           T  +MAPEVI+    S  SD++S G  + E++TGN PY
Sbjct: 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPY 199

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 82/297 (27%), Positives = 132/297 (44%), Gaps = 43/297 (14%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y  + +G         VA+K         NENA     
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKT-------VNENASMRER 53

Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLGT-TLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L     +    
Sbjct: 54  IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL---VVMELMAKGDLKSYLRSRRPEAENN 110

Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR- 354
             +  P  ++ +  A EIA  M YL  +K   +HRDL   N  + +   V+I DFG  R 
Sbjct: 111 PGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRD 168

Query: 355 ------FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
                 +   G+  L     +MAPE ++   ++ KSDV+SFG++L E+ T    PY    
Sbjct: 169 IYETDYYRKGGKGLLP--VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226

Query: 408 YKPAKIAMEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
            +  ++   V +G     LPE    +L EL+ + C  W  +  +RP+F  I  SLK+
Sbjct: 227 NE--EVLKFVIDGGHLD-LPENCPDKLLELMRM-C--WQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  106 bits (267), Expect = 3e-26
 Identities = 78/282 (27%), Positives = 132/282 (46%), Gaps = 39/282 (13%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTF--FAQEVDTL 248
           IDP E+   +++G G    ++   WRG +DVA+K I        E A++   F +E   +
Sbjct: 1   IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMI-------REGAMSEDDFIEEAKVM 53

Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            +  H  ++QL G C +  P +   +VTE +       L+ L  ++ K         E  
Sbjct: 54  MKLSHPNLVQLYGVCTKQRPIF---IVTEYM--ANGCLLNYLRERKGKLGT------EWL 102

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
           L    ++ +AM+YL       IHRDL   N  + +   V+++DFG AR++ D +  +  G
Sbjct: 103 LDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160

Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG- 420
           T     +  PEV     +S KSDV+SFG+++ E+ + G  PY  + +  +++   V  G 
Sbjct: 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPY--ERFSNSEVVESVSAGY 218

Query: 421 KL-RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
           +L RP L        E+  ++   W      RP+F  +   L
Sbjct: 219 RLYRPKLAPT-----EVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  105 bits (265), Expect = 8e-26
 Identities = 74/251 (29%), Positives = 110/251 (43%), Gaps = 34/251 (13%)

Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GT 279
            A+K I        +N V     E D LS+ +  +V++L     +     +LV E L G 
Sbjct: 21  YAIKVIKKADMI-RKNQVDQVLTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPGG 78

Query: 280 TLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNI 337
            L   L  +GS             +E +AR    EI  A++YLH     +IHRDLKP NI
Sbjct: 79  DLASLLENVGS------------LDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNI 124

Query: 338 FLDDAKHVRIADFGHARF-----------LSDGEMALTGTFVYMAPEVIQCEPYSEKSDV 386
            +D   H+++ DFG ++                +  + GT  Y+APEVI  + +S+  D 
Sbjct: 125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDW 184

Query: 387 YSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDG 446
           +S G IL E + G  P+  +   P +I   +  GK+    PE+     E I+LI      
Sbjct: 185 WSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEW--PEDVEVSDEAIDLISKLLVP 240

Query: 447 DASVRPSFSSI 457
           D   R    SI
Sbjct: 241 DPEKRLGAKSI 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 1e-25
 Identities = 62/167 (37%), Positives = 88/167 (52%), Gaps = 23/167 (13%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPP 302
           E + LSR  H F+++L     +   + +LV E           G L S   KE       
Sbjct: 43  ERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPG-------GELFSHLSKEGRFS--- 91

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
            EER AR  A EI  A++YLH     +I+RDLKP NI LD   H+++ DFG A+ LS  E
Sbjct: 92  -EER-ARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSS-E 146

Query: 361 MALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            + T TF     Y+APEV+  + Y +  D +S G++L E++TG  P+
Sbjct: 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF 193

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  104 bits (262), Expect = 1e-25
 Identities = 48/145 (33%), Positives = 66/145 (45%), Gaps = 13/145 (8%)

Query: 302 PFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
            F E   +    EI  A++YLH +   +IHRD+KP NI LD+  HV I DF  A  ++  
Sbjct: 96  KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK--IAM 415
            +  +  GT  YMAPEV+  + YS   D +S G+   E + G  PY            A 
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Query: 416 EVGEGKLRPALPEEDGQLRELIELI 440
           +     L PA         E I+ I
Sbjct: 214 QETADVLYPA-----TWSTEAIDAI 233

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 3e-25
 Identities = 81/288 (28%), Positives = 128/288 (44%), Gaps = 46/288 (15%)

Query: 194 PKEIDLQEKI---GQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQE 244
            KE +L EKI   G G    +Y+ +W        + VA+K +  +   T+  A      E
Sbjct: 4   LKETEL-EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE---TSPKANKEILDE 59

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTL---KEWLHGLGSQRRKERMVP 299
              ++   H  V++L+G CL    +  L+T+L  LG  L   +     +GSQ        
Sbjct: 60  AYVMASVDHPHVVRLLGICLSS--QVQLITQLMPLGCLLDYVRNHKDNIGSQ-------- 109

Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
                  L   ++IA+ M YL E++  ++HRDL   N+ +   +HV+I DFG A+ L   
Sbjct: 110 -----YLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162

Query: 360 EMAL--TGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI 413
           E      G  V   +MA E I    Y+ KSDV+S+G+ + E++T G  PY          
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222

Query: 414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
            +E GE   +P +   D     +  ++   W  DA  RP+F  +    
Sbjct: 223 LLEKGERLPQPPICTID-----VYMVLVKCWMIDAESRPTFKELINEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  103 bits (259), Expect = 8e-25
 Identities = 47/142 (33%), Positives = 79/142 (55%), Gaps = 9/142 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E +AR  A ++  A++YLH     +++RDLKP N+ LD   +++I DFG A+ +    
Sbjct: 98  FPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155

Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y +  D ++ GI++ E++ G  P+   D  P +I  ++ EG
Sbjct: 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF--FDDNPIQIYEKILEG 213

Query: 421 KLRPALPEE-DGQLRELIELIC 441
           K+R   P       ++LI  + 
Sbjct: 214 KVR--FPSFFSPDAKDLIRNLL 233

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  102 bits (257), Expect = 9e-25
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 26/217 (11%)

Query: 195 KEIDLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
            +++   ++G G +  + +      G  +AVK I  +    NE       +E+D L +  
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLE---INEAIQKQILRELDILHKCN 57

Query: 253 HRFVLQLMGACLEPPYRG--WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
             +++   GA       G   +  E + G +L + L        KE    +P  E  L +
Sbjct: 58  SPYIVGFYGAFY---NNGDISICMEYMDGGSLDKIL--------KEVQGRIP--ERILGK 104

Query: 310 -ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GT 366
            A+ + + + YLHE+  K+IHRD+KPSNI ++    +++ DFG +  L +  +A T  GT
Sbjct: 105 IAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN-SLAKTFVGT 162

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             YMAPE IQ   YS KSD++S G+ L E+ TG  PY
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  102 bits (255), Expect = 1e-24
 Identities = 80/277 (28%), Positives = 136/277 (49%), Gaps = 23/277 (8%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W ++ KE+ L + IG+G   ++    +RG  VAVKCI       N+     F  E   ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------KNDATAQAFLAEASVMT 54

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           + RH  ++QL+G  +E     ++VTE +   +L ++L      R + R V     +  L 
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL------RSRGRSV--LGGDCLLK 106

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV 368
            +L++ +AM+YL  +    +HRDL   N+ + +    +++DFG  +  S  +        
Sbjct: 107 FSLDVCEAMEYL--EANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 164

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
           + APE ++ + +S KSDV+SFGI+L EI + G  PY     K     +E G     P   
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP--- 221

Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             DG    + +++   W  DA+ RPSF  +   L++I
Sbjct: 222 --DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  102 bits (255), Expect = 1e-24
 Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 36/273 (13%)

Query: 201 EKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +K+G G+   + R  W     + + VAVKC+  D      + +  F +E   +    H  
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL---SDIMDDFLKEAAIMHSLDHEN 57

Query: 256 VLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALE 312
           +++L G  L  P    +VTEL  LG+ L + L      +       +      L   A++
Sbjct: 58  LIRLYGVVLTHPLM--MVTELAPLGSLL-DRLR-----KDALGHFLIS----TLCDYAVQ 105

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE------MALTGT 366
           IA  M+YL  ++   IHRDL   NI L     V+I DFG  R L   E        L   
Sbjct: 106 IANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP 163

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           F + APE ++   +S  SDV+ FG+ L E+ T G  P+       ++I  ++ +   R  
Sbjct: 164 FAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWA--GLSGSQILKKIDKEGERLE 221

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            PE   Q  ++  ++   W  + + RP+F+++ 
Sbjct: 222 RPEACPQ--DIYNVMLQCWAHNPADRPTFAALR 252

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 3e-24
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 32/272 (11%)

Query: 201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           EKIG+G   ++Y+ + +   +VAVK          +     F QE + L +  H  +++L
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK---FLQEAEILKQYDHPNIVKL 57

Query: 260 MGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           +G C+  +P Y   +V EL+ G +L  +L    ++   ++++ +         +L+ A  
Sbjct: 58  IGVCVQKQPIY---IVMELVPGGSLLTFLRKKKNRLTVKKLLQM---------SLDAAAG 105

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG-----TFVYMA 371
           M+YL E K   IHRDL   N  + +   ++I+DFG +R    G   ++         + A
Sbjct: 106 MEYL-ESK-NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTA 163

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           PE +    Y+ +SDV+S+GI+L E  + G+ PY     +  +  +E G       +P   
Sbjct: 164 PEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-----RMPAPQ 218

Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLK 462
               E+  L+   W  D   RPSFS I   L+
Sbjct: 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (250), Expect = 5e-24
 Identities = 83/285 (29%), Positives = 132/285 (46%), Gaps = 37/285 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-DVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE   +
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQVM 55

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + RH  ++QL     E P   ++VTE +   +L ++L G        + + LP   + +
Sbjct: 56  KKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKG-----EMGKYLRLP---QLV 105

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGT 366
             A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A  G 
Sbjct: 106 DMAAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163

Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE--- 419
                + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +   
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLDQVE 217

Query: 420 -GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
            G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 218 RGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  100 bits (251), Expect = 6e-24
 Identities = 77/289 (26%), Positives = 126/289 (43%), Gaps = 42/289 (14%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVK----CIYPDFFHTNENAVTFFA 242
           I  ++I L   IG+G   ++Y+ ++       + VAVK    C  P      E     F 
Sbjct: 3   IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPS---VREK----FL 55

Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPL 300
           QE   + +  H  +++L+G   E P   W+V EL  LG  L+ +L     Q  K  +   
Sbjct: 56  QEAYIMRQFDHPHIVKLIGVITENPV--WIVMELAPLGE-LRSYL-----QVNKYSL--- 104

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
                 +  + +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R+L D  
Sbjct: 105 -DLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161

Query: 361 M--ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
              A  G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+           +
Sbjct: 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           E GE   R  +P        L  L+   W  D S RP F+ +   L +I
Sbjct: 222 ENGE---RLPMPPNCPP--TLYSLMTKCWAYDPSKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 77/234 (32%), Positives = 108/234 (46%), Gaps = 41/234 (17%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP  I +L E IG+GT   +Y+A  +  G  VA+K +  D     E  +    +E + L 
Sbjct: 3   DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEI---KEEYNILR 57

Query: 250 R-QRHRFVLQLMGACLEPPYRG-----WLVTELLG----TTLKEWLHGLGSQRRKERMVP 299
           +   H  +    GA ++    G     WLV EL G    T L + L   G + +      
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK------ 111

Query: 300 LPPFEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
               EE +A  L E  + + YLHE K  VIHRD+K  NI L     V++ DFG +  L D
Sbjct: 112 ----EEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKLVDFGVSAQL-D 164

Query: 359 GEMALTGTFV----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPY 403
             +    TF+    +MAPEVI C+      Y  +SDV+S GI   E+  G  P 
Sbjct: 165 STLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL 218

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.9 bits (246), Expect = 2e-23
 Identities = 80/273 (29%), Positives = 120/273 (43%), Gaps = 33/273 (12%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           I P E+ L ++IG G    ++   W     VA+K I        +     F +E   + +
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-----FIEEAQVMMK 55

Query: 251 QRHRFVLQLMGACLE--PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
             H  ++QL G C E  P     LV E +    L ++L    +QR K         E  L
Sbjct: 56  LSHPKLVQLYGVCTERSPIC---LVFEFMEHGCLSDYLR---AQRGKFSQ------ETLL 103

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMALTGT 366
              L++ + M YL      VIHRDL   N  + + + V+++DFG  RF L D   + TGT
Sbjct: 104 GMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT 161

Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G    
Sbjct: 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLY 221

Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
           +P L       + + EL+   W      RPSFS
Sbjct: 222 KPRLAS-----QSVYELMQHCWKERPEDRPSFS 249

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 27/220 (12%)

Query: 194 PKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           P+E+ D+ EK+G+G+  ++Y+AI +  G  VA+K +        E  +    +E+  L +
Sbjct: 1   PEEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV------PVEEDLQEIIKEISILKQ 54

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
               ++++  G         W+V E  G          GS     ++      EE +A  
Sbjct: 55  CDSPYIVKYYG-SYFKNTDLWIVMEYCG---------AGSVSDIMKITNKTLTEEEIAAI 104

Query: 311 L-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV- 368
           L +  + ++YLH  K   IHRD+K  NI L++    ++ADFG +  L+D  MA   T + 
Sbjct: 105 LYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD-TMAKRNTVIG 161

Query: 369 ---YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
              +MAPEVIQ   Y+ K+D++S GI   E+  G  PY +
Sbjct: 162 TPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 73/259 (28%), Positives = 131/259 (50%), Gaps = 28/259 (10%)

Query: 196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           + ++  KIG+G+   +++ + +      A+K I     +  E        E   L++   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI--DEARVLAKLDS 58

Query: 254 RFVLQLMGACLEPPYRGWL--VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            ++++   + L+   +G L  V E      L + L         +R  PLP  E+++ R 
Sbjct: 59  SYIIRYYESFLD---KGKLNIVMEYAENGDLHKLLK-------MQRGRPLP--EDQVWRF 106

Query: 311 -LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALTGT 366
            ++I   + +LH    K++HRD+K  N+FLD   +V+I D G A+ LSD       + GT
Sbjct: 107 FIQILLGLAHLH--SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGT 164

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             Y++PE+ + +PY+EKSDV++ G++L E  TG HP+ + + + A I +++  G   P  
Sbjct: 165 PYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPF-DANNQGALI-LKIIRGVFPPVS 222

Query: 427 PEEDGQLRELIELICLSWD 445
                QL +LI+  CL+ D
Sbjct: 223 QMYSQQLAQLIDQ-CLTKD 240

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 73/278 (26%), Positives = 128/278 (46%), Gaps = 37/278 (13%)

Query: 201 EKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +++G G   ++ + ++       ++VAVK +  +     +     F +E   +++  H  
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKE---FLREASVMAQLDHPC 57

Query: 256 VLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           +++L+G C   P    LV EL  LG  LK +L       +K R +P+    +    A ++
Sbjct: 58  IVRLIGVCKGEPL--MLVMELAPLGPLLK-YL-------KKRREIPV---SDLKELAHQV 104

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTG---TF 367
           A  M YL  +    +HRDL   N+ L +    +I+DFG +R L  G     A T      
Sbjct: 105 AMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPL 162

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
            + APE I    +S KSDV+S+G+ L E  + G  PY   + K A++ + + E   R  L
Sbjct: 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY--GEMKGAEV-IAMLESGER--L 217

Query: 427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P  +   +E+  ++   W      RP+FS +  + +  
Sbjct: 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 97.0 bits (241), Expect = 8e-23
 Identities = 89/283 (31%), Positives = 132/283 (46%), Gaps = 33/283 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-DVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L  K+GQG    ++   W G   VA+K + P            F QE   +
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-----FLQEAQIM 55

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWL-HGLGSQRRKERMVPLPPFEER 306
            + RH  ++ L     E P   ++VTE +G  +L ++L  G G   +  ++V +      
Sbjct: 56  KKLRHDKLVPLYAVVSEEPI--YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDM------ 107

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
              A +IA  M Y+  ++   IHRDL+ +NI + D    +IADFG AR + D E  A  G
Sbjct: 108 ---AAQIADGMAYI--ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162

Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 + APE      ++ KSDV+SFGI+L E++T G  PY      P  +  EV E  
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY------PGMVNREVLEQV 216

Query: 422 LRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
            R   +P   G    L EL+ L W  D   RP+F  I   L++
Sbjct: 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 96.5 bits (241), Expect = 1e-22
 Identities = 48/116 (41%), Positives = 68/116 (58%), Gaps = 8/116 (6%)

Query: 303 FEERLARALEIAQ---AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
           F+E  AR   IA    A +YLH +   +I+RDLKP N+ LD   +V++ DFG A+ L  G
Sbjct: 90  FDEYTARFY-IACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG 146

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI 413
           +   T  GT  Y+APE+I  + Y    D +S GI+L E++TG  P+ E D  P +I
Sbjct: 147 QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEI 202

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 59/232 (25%), Positives = 102/232 (43%), Gaps = 45/232 (19%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVL 257
           + IG+G+ + +  A  +    + A+K I        E  V +   E + L+R   H  ++
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIK-ILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 258 QLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIA 314
           +L     +     + V E      L +++   GS             +E+  R  A EI 
Sbjct: 66  KLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGS------------LDEKCTRFYAAEIL 112

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----------- 363
            A++YLH +   +IHRDLKP NI LD   H++I DFG A+ L                  
Sbjct: 113 LALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 364 --------TGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                     +FV    Y++PE++  +P  + SD+++ G I+ +++TG  P+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 96.2 bits (239), Expect = 2e-22
 Identities = 86/283 (30%), Positives = 127/283 (44%), Gaps = 33/283 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L +K+G G    ++   W G   VAVK + P            F +E   +
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-----FLEEAQIM 55

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            + RH  ++QL     E P   ++VTE +  G+ L     G G      R + LP   + 
Sbjct: 56  KKLRHDKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKDGEG------RALKLPNLVDM 107

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
            A   ++A  M Y+  ++   IHRDL+ +NI + D    +IADFG AR + D E  A  G
Sbjct: 108 AA---QVAAGMAYI--ERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 + APE      ++ KSDV+SFGI+L E++T G  PY      P     EV E  
Sbjct: 163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY------PGMNNREVLEQV 216

Query: 422 LRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
            R   +P        L EL+   W  D   RP+F  +   L++
Sbjct: 217 ERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 56/155 (36%), Positives = 88/155 (56%), Gaps = 14/155 (9%)

Query: 304 EERL-ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
           EER+    +++  A++YLH++K +++HRDL P+NI L +   V I DFG A+     E  
Sbjct: 112 EERIWNIFVQMVLALRYLHKEK-RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESK 169

Query: 363 LT---GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           LT   GT +Y  PE+++ EPY EK+DV++FG IL ++ T   P+   +     +A ++ E
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--LSLATKIVE 227

Query: 420 GKLRPALPEE--DGQLRELIELICLSWDGDASVRP 452
               P LPE      + ++I   CL+   DA  RP
Sbjct: 228 AVYEP-LPEGMYSEDVTDVITS-CLT--PDAEARP 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 76/279 (27%), Positives = 140/279 (50%), Gaps = 33/279 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W ++ +++ L E IG+G    + +  + G  VAVK I  D           F +E   ++
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV------TAQAFLEETAVMT 54

Query: 250 RQRHRFVLQLMGACLEPPYRG-WLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERL 307
           +  H+ +++L+G  L   + G ++V EL+    L  +L     + R   +V +    + L
Sbjct: 55  KLHHKNLVRLLGVIL---HNGLYIVMELMSKGNLVNFL-----RTRGRALVSVI---QLL 103

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
             +L++A+ M+YL  +K  ++HRDL   NI + +    +++DFG AR    G M +  + 
Sbjct: 104 QFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSK 158

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
           +   + APE ++ + +S KSDV+S+G++L E+ + G  PY +   K  K  +E G  ++ 
Sbjct: 159 LPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY-RME 217

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           P  PE       ++   C  W+ +   RPSF  +   L+
Sbjct: 218 P--PEGCPADVYVLMTSC--WETEPKKRPSFHKLREKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 95.6 bits (238), Expect = 4e-22
 Identities = 81/255 (31%), Positives = 125/255 (49%), Gaps = 35/255 (13%)

Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH---RF 255
           E IG+G    +YR   +  G  VA+K I  D   T ++ V+   +EV  LS+ R      
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVALKIINLD---TPDDDVSDIQREVALLSQLRQSQPPN 63

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           + +  G+ L+ P R W++ E        +  G GS R   +  P+    E+    +  E+
Sbjct: 64  ITKYYGSYLKGP-RLWIIME--------YAEG-GSVRTLMKAGPI---AEKYISVIIREV 110

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL---SDGEMALTGTFVYM 370
             A++Y+H  K  VIHRD+K +NI + +  +V++ DFG A  L   S       GT  +M
Sbjct: 111 LVALKYIH--KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWM 168

Query: 371 APEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           APEVI   + Y  K+D++S GI + E+ TGN PY + D    +  M + + K  P L + 
Sbjct: 169 APEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMMLIPKSK-PPRLEDN 225

Query: 430 DGQ--LRELIELICL 442
                LRE +   CL
Sbjct: 226 GYSKLLREFVAA-CL 239

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 80/301 (26%), Positives = 135/301 (44%), Gaps = 56/301 (18%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W +    + L + +G+G    + +A   GLD       VAVK +  D     E  ++   
Sbjct: 7   WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD---ATEKDLSDLV 63

Query: 243 QEVDTLSR-QRHRFVLQLMGACLE--PPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMV 298
            E++ +    +H+ ++ L+G C +  P Y   +V E      L+++L             
Sbjct: 64  SEMEMMKMIGKHKNIINLLGVCTQEGPLY---VVVEYAAHGNLRDFLRARRPPGEYASPD 120

Query: 299 PLPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
              P EE L +      A ++A+ M++L  +K   IHRDL   N+ + +   ++IADFG 
Sbjct: 121 DPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTEDHVMKIADFGL 178

Query: 353 ARFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHP 402
           AR +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  P
Sbjct: 179 ARDIHHIDYYRKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234

Query: 403 Y----IEKDYKPAKIAMEVGEGKL--RPALPEEDGQLRELIELICLSWDGDASVRPSFSS 456
           Y    +E+ +K  K      EG    +P    +     EL  L+   W    S RP+F  
Sbjct: 235 YPGIPVEELFKLLK------EGYRMEKPQNCTQ-----ELYHLMRDCWHEVPSQRPTFKQ 283

Query: 457 I 457
           +
Sbjct: 284 L 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 41/283 (14%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   + +
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVMMK 55

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLG-----TTLKEWLHGLGSQRRKERMVPLPPFEE 305
             H  ++QL G C +     ++VTE +        L+E                     +
Sbjct: 56  LSHEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHGKRFQPS-------------Q 101

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE----M 361
            L    ++ + M YL  ++   IHRDL   N  +DD   V+++DFG +R++ D E    +
Sbjct: 102 LLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159

Query: 362 ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
                  +  PEV+    +S KSDV++FG+++ E+ + G  PY  + +  ++   +V +G
Sbjct: 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY--ERFNNSETVEKVSQG 217

Query: 421 K--LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
               RP L  E     ++  ++   W   A  RP+F  +  S+
Sbjct: 218 LRLYRPHLASE-----KVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 16/148 (10%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-----GEM--A 362
            L++ + + YLH     ++HRD+KP+NIFLD    +++ DFG A  L +     GE   +
Sbjct: 105 TLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162

Query: 363 LTGTFVYMAPEVIQCEPYSEK---SDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           L GT  YMAPEVI           +D++S G ++ E+ TG  P+ E D +   I   VG 
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGA 221

Query: 420 GKLRPALPEEDGQLRELIELI--CLSWD 445
           G  +P +P+      E  + +  CL  D
Sbjct: 222 GH-KPPIPDSLQLSPEGKDFLDRCLESD 248

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 93.7 bits (233), Expect = 2e-21
 Identities = 77/293 (26%), Positives = 129/293 (44%), Gaps = 54/293 (18%)

Query: 198 DLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            +++KIG+G  + +Y+AI    G  VA+K +   F   +  A     +E+D L +  H  
Sbjct: 5   KIEKKIGKGQFSVVYKAICLLDGRVVALKKV-QIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           V++ + + +E      +V EL     L   +     Q+R           ER       +
Sbjct: 64  VIKYLASFIENNELN-IVLELADAGDLSRMIKHFKKQKR--------LIPERTIWKYFVQ 114

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---LTGTFVY 369
           +  A++++H ++  ++HRD+KP+N+F+     V++ D G  RF S    A   L GT  Y
Sbjct: 115 LCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYY 172

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY-------------IEK-DYKPAKIAM 415
           M+PE I    Y+ KSD++S G +L E+     P+             IEK DY P     
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP----- 227

Query: 416 EVGEGKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM 466
                     LP +    +LR+L+   C+  + D   RP  S +    K +  
Sbjct: 228 ----------LPADHYSEELRDLVS-RCI--NPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 2e-21
 Identities = 70/265 (26%), Positives = 118/265 (44%), Gaps = 35/265 (13%)

Query: 203 IGQGTTANIYRA--IWRGLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +GQG    +Y    +  G ++AVK +   PD   T +  V     E+  L   +H  ++Q
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPET-KKEVNALECEIQLLKNLQHERIVQ 68

Query: 259 LMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQ 315
             G CL       +  E + G ++K+ L   G               E + R    +I +
Sbjct: 69  YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYG------------ALTETVTRKYTRQILE 115

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL------SDGEMALTGTFVY 369
            ++YLH     ++HRD+K +NI  D A +V++ DFG ++ L        G  ++TGT  +
Sbjct: 116 GVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           M+PEVI  E Y  K+DV+S G  + E++T   P+   +++      ++      P LP  
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPW--AEFEAMAAIFKIATQPTNPQLPSH 231

Query: 430 -DGQLRELIELICLSWDGDASVRPS 453
                R  +      +  +A  RPS
Sbjct: 232 VSPDARNFLRRT---FVENAKKRPS 253

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 81/268 (30%), Positives = 129/268 (48%), Gaps = 29/268 (10%)

Query: 193 DPKEIDLQ-EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+E+  + E+IG+G+   +++ I       VA+K I        E+ +    QE+  LS
Sbjct: 1   DPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIID---LEEAEDEIEDIQQEITVLS 57

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           +    +V +  G+ L+   + W++ E LG          GS     R  P   F+  +A 
Sbjct: 58  QCDSPYVTKYYGSYLKGT-KLWIIMEYLGG---------GSALDLLRAGPFDEFQ--IAT 105

Query: 310 AL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALTG 365
            L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG A  L+D ++      G
Sbjct: 106 MLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  +MAPEVIQ   Y  K+D++S GI   E+  G  P    D  P ++   + +      
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP--NSDMHPMRVLFLIPKNNPPTL 221

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPS 453
             E     +E I+  CL  + D S RP+
Sbjct: 222 TGEFSKPFKEFID-ACL--NKDPSFRPT 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 3e-21
 Identities = 74/269 (27%), Positives = 119/269 (44%), Gaps = 44/269 (16%)

Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT 279
           VAVK +     H+    +  F +E++ L   +H  +++  G C     R   LV E L  
Sbjct: 36  VAVKKLQ----HSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPY 91

Query: 280 -TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF 338
            +L+++L     Q+ +ER+       + L  A +I + M+YL  ++   +HRDL   NI 
Sbjct: 92  GSLRDYL-----QKHRERL----DHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNIL 140

Query: 339 LDDAKHVRIADFGHARFLSDG-------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGI 391
           ++    V+I DFG  + L          E   +  F Y APE +    +S  SDV+SFG+
Sbjct: 141 VESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGV 199

Query: 392 ILNEIITGNHPYIEKDYKPAKIAME-VGEGKLRPA--------------LPEEDGQLREL 436
           +L E+ T    Y +K   P    M  +G  K                  LP   G   E+
Sbjct: 200 VLYELFT----YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEI 255

Query: 437 IELICLSWDGDASVRPSFSSITCSLKNIQ 465
             ++   W+ D S RPSFS +   ++ I+
Sbjct: 256 YAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 92.1 bits (229), Expect = 7e-21
 Identities = 59/168 (35%), Positives = 87/168 (51%), Gaps = 21/168 (12%)

Query: 271 WLVTELLGTTL-KEWLHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVI 328
           W+  E++ T+L K +             +P    E+ L + A+ I +A++YLH +   VI
Sbjct: 76  WICMEVMDTSLDKFYKKVYDKGLT----IP----EDILGKIAVSIVKALEYLHSKL-SVI 126

Query: 329 HRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFVYMAPEVIQCE----PYS 381
           HRD+KPSN+ ++    V++ DFG + +L D  +A T   G   YMAPE I  E     Y 
Sbjct: 127 HRDVKPSNVLINRNGQVKLCDFGISGYLVD-SVAKTIDAGCKPYMAPERINPELNQKGYD 185

Query: 382 EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
            KSDV+S GI + E+ TG  PY +    P +   +V E    P LP E
Sbjct: 186 VKSDVWSLGITMIELATGRFPY-DSWKTPFQQLKQVVEEP-SPQLPAE 231

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 60/170 (35%), Positives = 90/170 (52%), Gaps = 10/170 (5%)

Query: 291 QRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
            + KE+   L P  + +   ++IA A+QYLHE+   ++HRDLK  N+FL     +++ D 
Sbjct: 89  HKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDL 146

Query: 351 GHARFL-SDGEMA--LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G AR L +  +MA  L GT  YM+PE+   +PY+ KSDV++ G  + E+ T  H +  KD
Sbjct: 147 GIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                +   + EGKL P   +   +L ELI  +          RPS  SI
Sbjct: 207 MN--SLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEK---RPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 60/219 (27%), Positives = 106/219 (48%), Gaps = 32/219 (14%)

Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTN----ENAVTFFAQEVDTLSRQRHR 254
           +++G G  ++ Y+A  +  G  +AVK +   +        E  V    +E+  ++R  H 
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQV--TYVRNTSSEQEEVVEALRKEIRLMARLNHP 63

Query: 255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA--LE 312
            +++++GA  E  +    V  + G ++   L   G             F+E +      +
Sbjct: 64  HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG------------AFKEAVIINYTEQ 111

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIADFGHA-RFLSDGEMA------LT 364
           + + + YLHE +  +IHRD+K +N+ +D   + +RIADFG A R  + G  A      L 
Sbjct: 112 LLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL 169

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           GT  +MAPEV++ E Y    DV+S G ++ E+ T   P+
Sbjct: 170 GTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 78/281 (27%), Positives = 130/281 (46%), Gaps = 29/281 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIW-RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L++K+G G    ++ A + +   VAVK + P        +V  F  E + +
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEANVM 55

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERL 307
              +H  +++L     + P   +++TE +   +L ++L      +      PLP   +  
Sbjct: 56  KTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSK-----QPLPKLIDFS 108

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGT 366
           A   +IA+ M ++  ++   IHRDL+ +NI +  +   +IADFG AR + D E  A  G 
Sbjct: 109 A---QIAEGMAFI--EQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA 163

Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY          A+E G    
Sbjct: 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--- 220

Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
              +P  +    EL  ++   W      RP+F  I   L +
Sbjct: 221 --RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 76/274 (27%), Positives = 127/274 (46%), Gaps = 33/274 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L +K+G G    ++   + G   VA+K +          +   F  E + +
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQ-----GSMSPEAFLAEANLM 55

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            + +H  +++L     + P   +++TE +  G+ +       G +    +++ +      
Sbjct: 56  KQLQHPRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPEGIKLTINKLIDM------ 107

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
              A +IA+ M ++ E+K   IHRDL+ +NI + +    +IADFG AR + D E  A  G
Sbjct: 108 ---AAQIAEGMAFI-ERK-NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162

Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 + APE I    ++ KSDV+SFGI+L EI+T G  PY      P     EV +  
Sbjct: 163 AKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY------PGMTNPEVIQNL 216

Query: 422 LRP-ALPEEDGQLRELIELICLSWDGDASVRPSF 454
            R   +P  D    EL EL+ L W      RP+F
Sbjct: 217 ERGYRMPRPDNCPEELYELMRLCWKEKPEERPTF 250

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 90.5 bits (224), Expect = 2e-20
 Identities = 77/282 (27%), Positives = 130/282 (46%), Gaps = 30/282 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + I L +K+G G    ++   +     VAVK + P        +V  F +E + +
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANLM 55

Query: 249 SRQRHRFVLQLMGACL--EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
              +H  +++L       EP Y   ++TE +       L  L S    + ++P     + 
Sbjct: 56  KTLQHDKLVRLYAVVTKEEPIY---IITEYMAK--GSLLDFLKSDEGGKVLLP-----KL 105

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
           +  + +IA+ M Y+  ++   IHRDL+ +N+ + ++   +IADFG AR + D E  A  G
Sbjct: 106 IDFSAQIAEGMAYI--ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163

Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 + APE I    ++ KSDV+SFGI+L EI+T G  PY          A++ G   
Sbjct: 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY-- 221

Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               +P  +    EL +++   W   A  RP+F  +   L +
Sbjct: 222 ---RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 82/295 (27%), Positives = 124/295 (42%), Gaps = 59/295 (20%)

Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFF------HTNENAVTFFAQE 244
            I    + L + + +GT   I+  I        +    + F      H +E  VT   QE
Sbjct: 2   AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEE---EVFVKTVKDHASEIQVTLLLQE 58

Query: 245 VDTLSRQRHRFVLQLMGACLEP--------PYRGWLVTELLGTTLKEWLHGLGSQRRKER 296
              L    H+ +L ++  C+E         PY  W         LK +L       ++ R
Sbjct: 59  SCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNW-------GNLKLFL-------QQCR 104

Query: 297 MVPLPPFEERLAR-----ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
           +      +    +     A++IA  M YLH  K  VIH+D+   N  +D+   V+I D  
Sbjct: 105 LGEANNPQALSTQQLVHMAIQIACGMSYLH--KRGVIHKDIAARNCVIDEELQVKITDNA 162

Query: 352 HAR--F------LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHP 402
            +R  F      L D E        +MA E +  + YS  SDV+SFG++L E++T G  P
Sbjct: 163 LSRDLFPMDYHCLGDNE---NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTP 219

Query: 403 YIEKDYKPAKIAMEVGEGKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFS 455
           Y+E D  P ++A  + +G  R A P    D    EL  ++   W  D   RPSFS
Sbjct: 220 YVEID--PFEMAAYLKDGY-RLAQPINCPD----ELFAVMACCWALDPEERPSFS 267

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 90.1 bits (223), Expect = 3e-20
 Identities = 81/268 (30%), Positives = 132/268 (49%), Gaps = 29/268 (10%)

Query: 193 DPKEIDLQ-EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+E+  + EKIG+G+   +++ I       VA+K I        E+ +    QE+  LS
Sbjct: 1   DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQEITVLS 57

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           +    +V +  G+ L+   + W++ E LG          GS    + + P P  E ++A 
Sbjct: 58  QCDSPYVTKYYGSYLKDT-KLWIIMEYLGG---------GSAL--DLLEPGPLDETQIAT 105

Query: 310 AL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---LTG 365
            L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG A  L+D ++      G
Sbjct: 106 ILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  +MAPEVI+   Y  K+D++S GI   E+  G  P+ E    P K+   + +      
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSE--LHPMKVLFLIPKNNPPTL 221

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPS 453
                  L+E +E  CL  + + S RP+
Sbjct: 222 EGNYSKPLKEFVE-ACL--NKEPSFRPT 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 90.2 bits (224), Expect = 4e-20
 Identities = 40/96 (41%), Positives = 55/96 (57%), Gaps = 3/96 (3%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLSDGEMALTGTFV 368
           A  + + + YLH +K  +IHRD+KPSNI L     V++ DFG     ++      TGT  
Sbjct: 111 AESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF 168

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           YMAPE IQ +PYS  SDV+S G+ L E+     P+ 
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 89.4 bits (222), Expect = 4e-20
 Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 40/268 (14%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVK--CIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           E +G G+  ++Y  +    G   AVK   +  D     E AV    QE+  LS+ +H  +
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQE-AVKQLEQEIALLSKLQHPNI 64

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLK---EWLHG--LGSQRRKERMVPLPPFEERLARAL 311
           +Q         Y G   TE     L    E + G  L    +K        F E + R  
Sbjct: 65  VQ---------YLG---TEREEDNLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLY 107

Query: 312 --EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTF 367
             +I   ++YLH++    +HRD+K +NI +D    V++ADFG A+ + +   A +  G+ 
Sbjct: 108 TRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165

Query: 368 VYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
            +MAPEVI Q   Y   +D++S G  + E+ TG  P+     +      ++G  K  P +
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW--SQLEGVAAVFKIGRSKELPPI 223

Query: 427 PEE-DGQLRELIELICLSWDGDASVRPS 453
           P+    + ++ I L CL    D S+RP+
Sbjct: 224 PDHLSDEAKDFI-LKCLQ--RDPSLRPT 248

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 89.4 bits (222), Expect = 8e-20
 Identities = 68/249 (27%), Positives = 97/249 (38%), Gaps = 79/249 (31%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRA-------------------------IWRGLDVAVKCI 226
            D  +++   +IG GT   +Y+                          I   LDV +K  
Sbjct: 12  ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKS- 70

Query: 227 YPDFFHTNENAVT---FFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKE 283
                H     V    +F  + D          ++LM  CL+               L +
Sbjct: 71  -----HDCPYIVKCYGYFITDSDV------FICMELMSTCLD--------------KLLK 105

Query: 284 WLHGLGSQRRKERMVPLPPFEERLARALEIA--QAMQYLHEQKPKVIHRDLKPSNIFLDD 341
            + G              P  E +   + +A  +A+ YL E K  VIHRD+KPSNI LD 
Sbjct: 106 RIQG--------------PIPEDILGKMTVAIVKALHYLKE-KHGVIHRDVKPSNILLDA 150

Query: 342 AKHVRIADFGHARFLSDGEMALT---GTFVYMAPEVIQCEP----YSEKSDVYSFGIILN 394
           + +V++ DFG +  L D   A T   G   YMAPE I        Y  ++DV+S GI L 
Sbjct: 151 SGNVKLCDFGISGRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLV 209

Query: 395 EIITGNHPY 403
           E+ TG  PY
Sbjct: 210 ELATGQFPY 218

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 88.3 bits (219), Expect = 8e-20
 Identities = 58/170 (34%), Positives = 88/170 (51%), Gaps = 13/170 (7%)

Query: 291 QRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            +RK++   +P  E+ + R  +++ + +Q LHEQK  ++HRDLK +NI L     V+I D
Sbjct: 91  SKRKKKRKLIP--EQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGD 146

Query: 350 FGHARFLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
            G ++ L    MA T  GT  YMAPEV +  PYS KSD++S G +L E+ T   P+  + 
Sbjct: 147 LGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                +  +V  GK  P +P    Q  +L   I         +RP+   I
Sbjct: 206 M--QDLRYKVQRGKY-PPIPPIYSQ--DLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 89.5 bits (222), Expect = 1e-19
 Identities = 48/128 (37%), Positives = 77/128 (60%), Gaps = 7/128 (5%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           E+  A +YLH +   +I+RDLKP N+ LD+  HV++ DFG A+ + D    L GT  Y+A
Sbjct: 126 ELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLA 183

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE-ED 430
           PEVIQ + + +  D ++ G++L E I G  P+   D  P +I  ++  G+L+   P   D
Sbjct: 184 PEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF--DDTPFRIYEKILAGRLK--FPNWFD 239

Query: 431 GQLRELIE 438
           G+ R+L++
Sbjct: 240 GRARDLVK 247

Length = 329

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 70/247 (28%), Positives = 120/247 (48%), Gaps = 35/247 (14%)

Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCI-YPDFFHTNENA-----VTFFAQEVDTLSRQR 252
           E IG+GT   +Y A  +  G  +AVK +  P       ++     V     E++TL    
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 253 HRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
           H  ++Q         Y G+  TE   +   E++ G GS     R      FEE+L R   
Sbjct: 67  HLNIVQ---------YLGFETTEEYLSIFLEYVPG-GSIGSCLRT--YGRFEEQLVRFFT 114

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTG 365
            ++ + + YLH +   ++HRDLK  N+ +D     +I+DFG ++     + +D  M++ G
Sbjct: 115 EQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172

Query: 366 TFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM-EVGEGKL 422
           +  +MAPEVI    + YS K D++S G ++ E+  G  P+ +++   A  AM ++G  + 
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE---AIAAMFKLGNKRS 229

Query: 423 RPALPEE 429
            P +P +
Sbjct: 230 APPIPPD 236

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 88.6 bits (220), Expect = 1e-19
 Identities = 44/114 (38%), Positives = 71/114 (62%), Gaps = 4/114 (3%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVY 369
           A EI  A++YLH ++  +++RDLKP NI LD   H+++ DFG A+ L D    L GT  Y
Sbjct: 107 ASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEY 164

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
           +APEVIQ + +++  D ++ GI++ E++ G  P+ + +  P  I  ++  GKL 
Sbjct: 165 LAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--PFGIYEKILAGKLE 216

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 88.2 bits (218), Expect = 1e-19
 Identities = 80/272 (29%), Positives = 133/272 (48%), Gaps = 37/272 (13%)

Query: 193 DPKEIDLQ-EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+E+  + E+IG+G+   +Y+ I       VA+K I        E+ +    QE+  LS
Sbjct: 1   DPEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIID---LEEAEDEIEDIQQEITVLS 57

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           +    ++ +  G+ L+   + W++ E LG          GS    + + P P  E  +A 
Sbjct: 58  QCDSPYITRYYGSYLKGT-KLWIIMEYLGG---------GSAL--DLLKPGPLEETYIAT 105

Query: 310 AL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALTG 365
            L EI + + YLH ++   IHRD+K +N+ L +   V++ADFG A  L+D ++      G
Sbjct: 106 ILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVG 163

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  +MAPEVI+   Y  K+D++S GI   E+  G  P    D  P ++   + +     +
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN--SDLHPMRVLFLIPKN----S 217

Query: 426 LPEEDGQ----LRELIELICLSWDGDASVRPS 453
            P  +GQ     +E +E  CL  + D   RP+
Sbjct: 218 PPTLEGQYSKPFKEFVE-ACL--NKDPRFRPT 246

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 40/226 (17%)

Query: 198 DLQEK--IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           DL++   IG+G    + + + +  G  +AVK I       +E        ++D + R   
Sbjct: 5   DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST---VDEKEQKRLLMDLDVVMRSSD 61

Query: 254 -RFVLQLMGA------CLEPPYRGWLVTELLGTTLKEW---LHGLGSQRRKERMVPLPPF 303
             ++++  GA      C       W+  EL+  +L ++   ++ +      E ++     
Sbjct: 62  CPYIVKFYGALFREGDC-------WICMELMDISLDKFYKYVYEVLKSVIPEEILG---- 110

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
                 A+   +A+ YL E + K+IHRD+KPSNI LD   ++++ DFG +  L D  +A 
Sbjct: 111 ----KIAVATVKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD-SIAK 164

Query: 364 T---GTFVYMAPEVI---QCEPYSEKSDVYSFGIILNEIITGNHPY 403
           T   G   YMAPE I     + Y  +SDV+S GI L E+ TG  PY
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY 210

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 65/234 (27%), Positives = 114/234 (48%), Gaps = 20/234 (8%)

Query: 203 IGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA 262
           +G+GT   +Y A  R L   V+    +    +   V    +E+   S  +HR ++Q +G+
Sbjct: 16  LGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGS 73

Query: 263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA-RALEIAQAMQYLH 321
             E  +    + ++ G +L   L        + +  PL   E+ +     +I + ++YLH
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALL--------RSKWGPLKDNEQTIIFYTKQILEGLKYLH 125

Query: 322 EQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSD---GEMALTGTFVYMAPEVIQC 377
           + +  ++HRD+K  N+ ++    V +I+DFG ++ L+         TGT  YMAPEVI  
Sbjct: 126 DNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 378 EP--YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
            P  Y   +D++S G  + E+ TG  P+IE   +P     +VG  K+ P +PE 
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELG-EPQAAMFKVGMFKIHPEIPES 236

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 67/273 (24%), Positives = 132/273 (48%), Gaps = 37/273 (13%)

Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENA-----VTFFAQEVDTLSRQRHRF 255
           IG G+  ++Y  +    G  +AVK +       +        +   A+E+  L   +H  
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           ++Q +G+ L+  +    +  + G ++   L+  G+            FEE L R    +I
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA------------FEETLVRNFVRQI 115

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---------ALT 364
            + + YLH +   +IHRD+K +NI +D+   ++I+DFG ++ L    +         +L 
Sbjct: 116 LKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ 173

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
           G+  +MAPEV++   Y+ K+D++S G ++ E++TG HP+ +     A    ++GE    P
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--IFKIGE-NASP 230

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +P       E I+ +  +++ D + RP+ + +
Sbjct: 231 EIPSNISS--EAIDFLEKTFEIDHNKRPTAAEL 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 86.8 bits (216), Expect = 4e-19
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 32/212 (15%)

Query: 200 QEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNE----NAVTFFAQEVDTLSRQRH 253
            EK+G+GT   +Y+A  +     VA+K I  D  +  E     A+    +E+  L   +H
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTAL----REISLLKELKH 57

Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--AL 311
             +++L+        + +LV E     LK++L     +R         P    L +    
Sbjct: 58  PNIVKLLDVIHTE-RKLYLVFEYCDMDLKKYLD----KRP-------GPLSPNLIKSIMY 105

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFV 368
           ++ + + Y H  +  ++HRDLKP NI ++    +++ADFG AR         T    T  
Sbjct: 106 QLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW 163

Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE++   + YS   D++S G I  E+ITG
Sbjct: 164 YRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.4 bits (214), Expect = 4e-19
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 37/278 (13%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTF--FAQEVDTL 248
           I+P E+   +++G G    ++   WR  + VA+K I       NE A++   F +E   +
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAI-------NEGAMSEEDFIEEAKVM 53

Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            +  H  ++QL G C +  P Y   +VTE +    L  +L     +  K+ +        
Sbjct: 54  MKLSHPKLVQLYGVCTQQKPLY---IVTEFMENGCLLNYLRQRQGKLSKDML-------- 102

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
            L+   ++ + M+YL  ++   IHRDL   N  +     V+++DFG  R++ D E   + 
Sbjct: 103 -LSMCQDVCEGMEYL--ERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159

Query: 366 ----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
                  +  PEV     YS KSDV+SFG+++ E+ T G  P+ +K        +  G  
Sbjct: 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR 219

Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
             RP L         + E++   W      RP+F+ + 
Sbjct: 220 LYRPKLAS-----MTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 31/211 (14%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH---TNENAVTFFAQEVDTLSRQRHRF 255
            +IG+G    +++A  R  G  VA+K +                   +E+  L   +H +
Sbjct: 6   GRIGEGAHGIVFKAKDRETGETVALKKV-----ALRRLEGGIPNQALREIKALQACQHPY 60

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           V++L+           LV E + + L E L      R +ER     P  E   ++    +
Sbjct: 61  VVKLLDVFPHGS-GFVLVMEYMPSDLSEVL------RDEER-----PLPEAQVKSYMRML 108

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGTFVY 369
            + + Y+H     ++HRDLKP+N+ +     ++IADFG AR  S+ E  L      T  Y
Sbjct: 109 LKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166

Query: 370 MAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
            APE++     Y    D+++ G I  E++ G
Sbjct: 167 RAPELLYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.9 bits (212), Expect = 1e-18
 Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 31/291 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  I +G+        VA+K +       NE A     
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV-------NEAASMRER 53

Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     + 
Sbjct: 54  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P  ++ +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171

Query: 359 GEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGMSNEQ 229

Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K 
Sbjct: 230 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 66/234 (28%), Positives = 103/234 (44%), Gaps = 50/234 (21%)

Query: 194 PKEI-DLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           P+E  +L ++IG GT  ++Y+A  I  G  VA+K I  +      +      QE+  L  
Sbjct: 1   PQEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKE 56

Query: 251 QRHRFVLQLMGACLEPPYRG----WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            RH  ++   G+     Y      W+V E   G +L++              V   P  E
Sbjct: 57  CRHPNIVAYFGS-----YLRRDKLWIVMEYCGGGSLQDIYQ-----------VTRGPLSE 100

Query: 306 RLARALEIA-------QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
                L+IA       + + YLHE     IHRD+K +NI L +   V++ADFG +  L+ 
Sbjct: 101 -----LQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153

Query: 359 GEMALTGTFV----YMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIE 405
             +A   +F+    +MAPEV   E    Y  K D+++ GI   E+     P  +
Sbjct: 154 -TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 58/177 (32%), Positives = 89/177 (50%), Gaps = 30/177 (16%)

Query: 244 EVDTLSRQRHRFVLQLMGA-------CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKER 296
           E   L +   RFV+ L  A       CL       ++T + G  LK  ++ +G+      
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCL-------VLTLMNGGDLKFHIYNMGN------ 96

Query: 297 MVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
               P F+E  A   A EI   ++ LH ++  +++RDLKP NI LDD  H+RI+D G A 
Sbjct: 97  ----PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAV 150

Query: 355 FLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            + +GE      GT  YMAPEV++ E Y+   D +  G ++ E+I G  P+ ++  K
Sbjct: 151 EIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 77/289 (26%), Positives = 128/289 (44%), Gaps = 44/289 (15%)

Query: 195 KEIDLQ--EKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           KE +L+  + +G G    +Y+ IW        + VA+K +      T   A   F  E  
Sbjct: 5   KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEAL 61

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLH----GLGSQRRKERMVPLP 301
            ++   H  +++L+G CL P  +  LVT+L+    L +++H     +GSQ          
Sbjct: 62  IMASMDHPHLVRLLGVCLSPTIQ--LVTQLMPHGCLLDYVHEHKDNIGSQLL-------- 111

Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
                L   ++IA+ M YL E++  ++HRDL   N+ +    HV+I DFG AR L   E 
Sbjct: 112 -----LNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164

Query: 362 ALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
                       +MA E I    ++ +SDV+S+G+ + E++T G  PY     +     +
Sbjct: 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           E GE   +P +   D     +  ++   W  DA  RP F  +      +
Sbjct: 225 EKGERLPQPPICTID-----VYMVMVKCWMIDADSRPKFKELAAEFSRM 268

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 57/170 (33%), Positives = 94/170 (55%), Gaps = 10/170 (5%)

Query: 291 QRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
           Q+ K +   L P +  L   +++   +Q++HE++  V+HRD+K  NIFL     V++ DF
Sbjct: 87  QKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDF 144

Query: 351 GHARFLSD-GEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G AR L+  G  A T  GT  Y+ PE+ +  PY+ KSD++S G IL E+ T  HP+    
Sbjct: 145 GSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +K   + ++V +G  +P       +LR LI+ +   +  +   RPS ++I
Sbjct: 205 WK--NLILKVCQGSYKPLPSHYSYELRSLIKQM---FKRNPRSRPSATTI 249

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 67/229 (29%), Positives = 105/229 (45%), Gaps = 34/229 (14%)

Query: 192 IDPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           ++P +I ++  ++G G    +Y+A  +  GL  A K I       +E  +  F  E+D L
Sbjct: 1   VNPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII--QI--ESEEELEDFMVEIDIL 56

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLP-PFEERL 307
           S  +H  ++ L  A      + W++ E            L S      M+ L     E  
Sbjct: 57  SECKHPNIVGLYEAYFYEN-KLWILIEFCDGG------ALDSI-----MLELERGLTEPQ 104

Query: 308 ARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
            R +  ++ +A+ +LH  K  VIHRDLK  NI L     V++ADFG +       +    
Sbjct: 105 IRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS-TLQKRD 161

Query: 366 TFV----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIE 405
           TF+    +MAPEV+ CE     PY  K+D++S GI L E+     P+ E
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHE 210

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 51/151 (33%), Positives = 87/151 (57%), Gaps = 11/151 (7%)

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG-EMALT--GT 366
           ++I+  ++++H++K  ++HRD+K  NIFL  +    ++ DFG AR L+D  E+A T  GT
Sbjct: 108 VQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             Y++PE+ Q  PY+ K+D++S G +L E+ T  HP+   +    ++ +++ +G   P  
Sbjct: 166 PYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH--QLVLKICQGYFAPIS 223

Query: 427 PEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           P     LR LI  +      D   RPS +SI
Sbjct: 224 PNFSRDLRSLISQLFKVSPRD---RPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 45/106 (42%), Positives = 67/106 (63%), Gaps = 7/106 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F+E  AR  A EI   +Q+LH  K  +I+RDLK  N+ LD   H++IADFG  +   +GE
Sbjct: 93  FDEARARFYAAEIICGLQFLH--KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE 150

Query: 361 -MALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             A T  GT  Y+APE+++ + Y+E  D +SFG++L E++ G  P+
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 83.8 bits (207), Expect = 4e-18
 Identities = 78/244 (31%), Positives = 116/244 (47%), Gaps = 41/244 (16%)

Query: 241 FAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERM 297
           F +E   +S   H  +++L+G CL  EP Y   ++ EL+ G  L   L  L   R +   
Sbjct: 46  FLKEAHLMSNFNHPNIVKLLGVCLLNEPQY---IIMELMEGGDL---LSYLRDARVERFG 99

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL-----DDAKHVRIADFGH 352
            PL   +E L   L++A+   YL  ++   IHRDL   N  +     D  + V+I DFG 
Sbjct: 100 PPLLTLKELLDICLDVAKGCVYL--EQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157

Query: 353 AR--FLSD-----GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI 404
           AR  + SD     GE  L     +MAPE +    ++ +SDV+SFG+++ EI+T G  PY 
Sbjct: 158 ARDIYKSDYYRKEGEGLLP--VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY- 214

Query: 405 EKDYKPAKIAMEV-----GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
                PA    EV       G+L+        ++ +L+   C  W  D S RP+F  I  
Sbjct: 215 -----PALNNQEVLQHVTAGGRLQKP-ENCPDKIYQLMTN-C--WAQDPSERPTFDRIQE 265

Query: 460 SLKN 463
            L+N
Sbjct: 266 ILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 44/113 (38%), Positives = 64/113 (56%), Gaps = 8/113 (7%)

Query: 301 PPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P F E  A   A +I   +++LH+++  +++RDLKP N+ LDD  +VRI+D G A  L  
Sbjct: 90  PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147

Query: 359 GE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           G+      GT  YMAPEV+Q E Y    D ++ G  L E+I G  P+  +  K
Sbjct: 148 GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF--RQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 84.1 bits (208), Expect = 5e-18
 Identities = 88/303 (29%), Positives = 134/303 (44%), Gaps = 60/303 (19%)

Query: 191 YIDPKEIDLQEK-------------IGQGTTANIYRAIWRGL-------DVAVKCIYPDF 230
           YIDP ++    K             +G G    +  A   GL        VAVK + P  
Sbjct: 18  YIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA 77

Query: 231 FHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLE--PPYRGWLVTELLG-TTLKEWLH 286
             +   A+     E+  +S    H  ++ L+GAC    P     ++TE      L  +L 
Sbjct: 78  HSSEREALM---SELKIMSHLGNHENIVNLLGACTIGGPIL---VITEYCCYGDLLNFLR 131

Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR 346
                R++E  +     E+ L+ + ++A+ M +L  +    IHRDL   N+ L   K V+
Sbjct: 132 -----RKRESFLT---LEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVK 181

Query: 347 IADFGHAR-FLSDGEMALTG-TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN 400
           I DFG AR  ++D    + G   +   +MAPE I    Y+ +SDV+S+GI+L EI + G+
Sbjct: 182 ICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241

Query: 401 HPYI-----EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
           +PY       K YK  K      EG  R A PE      E+ +++   WD D   RP+F 
Sbjct: 242 NPYPGMPVDSKFYKLIK------EG-YRMAQPEHAPA--EIYDIMKTCWDADPLKRPTFK 292

Query: 456 SIT 458
            I 
Sbjct: 293 QIV 295

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.5 bits (209), Expect = 5e-18
 Identities = 40/101 (39%), Positives = 65/101 (64%), Gaps = 5/101 (4%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFV 368
           E+A A+ +LH     +I+RDLKP NI LD+  H+++ DFG ++   D E    +  GT  
Sbjct: 106 ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVE 163

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YMAPEV+    +++ +D +SFG+++ E++TG+ P+  KD K
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 73/261 (27%), Positives = 112/261 (42%), Gaps = 31/261 (11%)

Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTEL--L 277
           VAVK + PD    ++NA   F +EV  LSR     + +L+G C  +PP    ++ E    
Sbjct: 49  VAVKVLRPD---ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL--CMIMEYMEN 103

Query: 278 GTTLKEWLHGLGSQRRKERM------VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           G  L ++L     Q+                F   L  A +IA  M+YL       +HRD
Sbjct: 104 GD-LNQFL-----QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRD 155

Query: 332 LKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGTFV----YMAPEVIQCEPYSEKSDV 386
           L   N  +     ++IADFG +R L   +   + G       +MA E +    ++ KSDV
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215

Query: 387 YSFGIILNEIIT--GNHPYIE-KDYKPAKIAMEVGEG-KLRPALPEEDGQLRELIELICL 442
           ++FG+ L EI+T     PY    D +  + A         +  LP      +++ EL+  
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLE 275

Query: 443 SWDGDASVRPSFSSITCSLKN 463
            W  D   RP+F  I   L+ 
Sbjct: 276 CWRRDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 51/162 (31%), Positives = 85/162 (52%), Gaps = 15/162 (9%)

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-------MAL 363
           L++A+ M+YL  +K   +HRDL   N  LD++  V++ADFG AR + D E          
Sbjct: 105 LQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                +MA E +Q + ++ KSDV+SFG++L E++T G  PY   D     I + + +G+ 
Sbjct: 163 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVDSFDITVYLLQGR- 219

Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              L + +     L E++   W     +RP+FS +   ++ I
Sbjct: 220 --RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 74/266 (27%), Positives = 113/266 (42%), Gaps = 29/266 (10%)

Query: 201 EKIGQGTTANIYRAIW-RGLDVAVK--CIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           E +G+G    +Y  +  +G  +AVK   +        E       +EVD L   +H  ++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLP-PFEERLARALEIAQA 316
           Q +G CL+         +   +   E++ G        R  PLP P   +  +  +I   
Sbjct: 66  QYLGTCLD---------DNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK--QILDG 114

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL---------SDGEMALTGTF 367
           + YLH     V+HRD+K +N+ L     +++ DFG AR L         S+   ++ GT 
Sbjct: 115 VAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTP 172

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            +MAPEVI    Y  KSD++S G  + E+ TG  P    D   A   +    G L P LP
Sbjct: 173 YWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRG-LMPRLP 231

Query: 428 EEDGQLRELIELICLSWDGDASVRPS 453
           +            CL+ D     RPS
Sbjct: 232 DSFSAAAIDFVTSCLTRDQHE--RPS 255

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 41/106 (38%), Positives = 63/106 (59%), Gaps = 7/106 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F+E  AR  A EI   +Q+LHE+   +I+RDLK  N+ LD   H++IADFG  +  +  G
Sbjct: 93  FDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG 150

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
               T  GT  Y+APE++  +PY    D ++ G++L E++ G  P+
Sbjct: 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 44/110 (40%), Positives = 59/110 (53%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLS 357
           F E  AR  A EIA A+ YLH     +I+RDLKP NI LD   HV + DFG  +     S
Sbjct: 93  FPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS 150

Query: 358 DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
                  GT  Y+APEV++ +PY    D +  G +L E++ G  P+  +D
Sbjct: 151 KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 51/161 (31%), Positives = 87/161 (54%), Gaps = 12/161 (7%)

Query: 302 PFEER--LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SD 358
            F E   L   ++I  A++++H++K  ++HRD+K  NIFL     +++ DFG AR L S 
Sbjct: 97  LFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154

Query: 359 GEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
            E+A T  GT  Y++PE+ +  PY+ KSD+++ G +L E+ T  H +   + K   + ++
Sbjct: 155 VELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NLVLK 212

Query: 417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +  G   P        LR L+  +   +  +   RPS +SI
Sbjct: 213 IIRGSYPPVSSHYSYDLRNLVSQL---FKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 26/198 (13%)

Query: 217 RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL 276
            G +VA+K I   F        T+  +E+  L   RH  ++ L    + P    + VTEL
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTY--RELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91

Query: 277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKP 334
           LGT L              R++   P E++  +    +I + ++Y+H     V+HRDLKP
Sbjct: 92  LGTDL-------------HRLLTSRPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKP 136

Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV-IQCEPYSEKSDVYSFG 390
           SNI +++   ++I DFG AR + D +M  TG   T  Y APE+ +  + Y  + D++S G
Sbjct: 137 SNILINENCDLKICDFGLAR-IQDPQM--TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAG 193

Query: 391 IILNEIITGNHPYIEKDY 408
            I  E++ G   +  KD+
Sbjct: 194 CIFAEMLEGKPLFPGKDH 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
            KIG+GT   +Y+A  +     VA+K I   F            +E+  L    H  +++
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTAL--REIKLLKELNHPNIIK 62

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIAQAM 317
           L+          +LV E + T L + +        K+R   LP  E  +   L ++ Q +
Sbjct: 63  LL-DVFRHKGDLYLVFEFMDTDLYKLI--------KDRQRGLP--ESLIKSYLYQLLQGL 111

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFVYMAPEV 374
            + H     ++HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+
Sbjct: 112 AFCH--SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169

Query: 375 I-QCEPYSEKSDVYSFGIILNEIITG 399
           +   + YS   D++S G I  E+++ 
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 49/144 (34%), Positives = 81/144 (56%), Gaps = 11/144 (7%)

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL---SDGEMALTGTFVYMAPE 373
           + Y+H+++  ++HRDLK  NIFL +   ++I DFG +R L    D     TGT  YM+PE
Sbjct: 119 VHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
            ++ + Y  KSD++S G IL E+    H +  +++    + + + EG   P+LPE     
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSVVLRIVEGP-TPSLPETYS-- 230

Query: 434 RELIELICLSWDGDASVRPSFSSI 457
           R+L  ++    + D S+RPS + I
Sbjct: 231 RQLNSIMQSMLNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.1 bits (200), Expect = 5e-17
 Identities = 84/267 (31%), Positives = 122/267 (45%), Gaps = 39/267 (14%)

Query: 217 RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTE 275
           R L VAVK + PD    N+NA   F +EV  LSR +   +++L+G C+ E P    ++TE
Sbjct: 45  RPLLVAVKILRPD---ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL--CMITE 99

Query: 276 LLGT-TLKEWL--HGL-------GSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP 325
            +    L ++L  H L                +P   +   L  AL+IA  M+YL     
Sbjct: 100 YMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL--SSL 157

Query: 326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGTFV----YMAPEVIQCEPY 380
             +HRDL   N  + +   ++IADFG +R L  G+   + G  V    +MA E I    +
Sbjct: 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF 217

Query: 381 SEKSDVYSFGIILNEIIT--GNHPYIE-KDYKPAKIAMEVGEGKLR-------PALPEED 430
           +  SDV++FG+ L EI+      PY E  D +  + A E    + R       P  P+  
Sbjct: 218 TTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQ-- 275

Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
                L EL+   W  D   RPSFS I
Sbjct: 276 ----GLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 54/164 (32%), Positives = 81/164 (49%), Gaps = 16/164 (9%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           E   L +   +FV+ L  A         ++T + G  LK  ++ +G+          P F
Sbjct: 50  EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN----------PGF 99

Query: 304 EER--LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           EE   L  A EI   ++ LH +    ++RDLKP NI LDD  H+RI+D G A  + +GE 
Sbjct: 100 EEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157

Query: 362 --ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                GT  YMAPEV+  + Y+   D +  G ++ E+I G  P+
Sbjct: 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 80.5 bits (198), Expect = 6e-17
 Identities = 68/264 (25%), Positives = 124/264 (46%), Gaps = 16/264 (6%)

Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +++KIG+G  + +YRA  +  G+ VA+K +   F   +  A     +E+D L +  H  V
Sbjct: 6   IEKKIGRGQFSEVYRATCLLDGVPVALKKVQI-FDLMDAKARADCIKEIDLLKQLNHPNV 64

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           ++   + +E      ++       L   +     Q+R      L P +      +++  A
Sbjct: 65  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR------LIPEKTVWKYFVQLCSA 118

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---LTGTFVYMAPE 373
           ++++H ++  V+HRD+KP+N+F+     V++ D G  RF S    A   L GT  YM+PE
Sbjct: 119 LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
            I    Y+ KSD++S G +L E+     P+         +  ++ +    P LP  D   
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-PPLP-SDHYS 234

Query: 434 RELIELICLSWDGDASVRPSFSSI 457
            EL +L+ +  + D   RP  + +
Sbjct: 235 EELRQLVNMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 60/190 (31%), Positives = 95/190 (50%), Gaps = 20/190 (10%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           E   L +   RFV+ L  A         ++T + G  LK  ++ +G             F
Sbjct: 50  EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA----------GF 99

Query: 304 EERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           EE  A   A EI   ++ LH+++  +++RDLKP NI LDD  H+RI+D G A  + +G+ 
Sbjct: 100 EEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157

Query: 362 --ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
                GT  YMAPEV++ E Y+   D ++ G +L E+I G  P+ ++  K  +  +E   
Sbjct: 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE--- 214

Query: 420 GKLRPALPEE 429
            +L   + EE
Sbjct: 215 -RLVKEVQEE 223

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 79.8 bits (197), Expect = 7e-17
 Identities = 50/163 (30%), Positives = 84/163 (51%), Gaps = 18/163 (11%)

Query: 303 FEER--LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDG 359
           FEE   L    +I  A+ Y+H+    ++HRD+K  NIFL  A  +++ DFG ++ L S+ 
Sbjct: 98  FEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK---PAKIA 414
            MA T  GT  YM+PE+ Q   Y+ KSD+++ G +L E++T     +++ +    P  + 
Sbjct: 156 SMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT-----LKRTFDATNPLNLV 210

Query: 415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +++ +G      P       ELI L+      D   RP+   +
Sbjct: 211 VKIVQGNYT---PVVSVYSSELISLVHSLLQQDPEKRPTADEV 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 80.4 bits (198), Expect = 7e-17
 Identities = 73/274 (26%), Positives = 125/274 (45%), Gaps = 44/274 (16%)

Query: 221 VAVKCIYPDFFHTNENAVTFFA--QEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTEL 276
           VAVK         N ++        E + L +  H  V++L GAC    P     L+ E 
Sbjct: 33  VAVK-----MLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL---LIVEY 84

Query: 277 LG-TTLKEWLH--------GLGSQRRKERMVPLPPFEERL------ARALEIAQAMQYLH 321
               +L+ +L          LGS   +       P E  L      + A +I++ MQYL 
Sbjct: 85  AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA 144

Query: 322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT-----FVYMAPEVIQ 376
           E K  ++HRDL   N+ + + + ++I+DFG +R + + +  +  +       +MA E + 
Sbjct: 145 EMK--LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202

Query: 377 CEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI--AMEVGEGKLRPALPEEDGQL 433
              Y+ +SDV+SFG++L EI+T G +PY      P ++   ++ G    RP    E    
Sbjct: 203 DHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIAPERLFNLLKTGYRMERPENCSE---- 256

Query: 434 RELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
            E+  L+   W  +   RP+F+ I+  L+ + +K
Sbjct: 257 -EMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 48/160 (30%), Positives = 75/160 (46%), Gaps = 25/160 (15%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM------AL 363
           A+ + + + YL+    +++HRD+KPSNI ++    +++ DFG       GE+        
Sbjct: 109 AVAVVEGLTYLYN-VHRIMHRDIKPSNILVNSRGQIKLCDFG-----VSGELINSIADTF 162

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL- 422
            GT  YM+PE IQ   Y+ KSDV+S GI + E+  G  P+   +         +G   L 
Sbjct: 163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222

Query: 423 -------RPALPEED--GQLRELIELICLSWDGDASVRPS 453
                   P LP  D    LR+ ++  CL  D     RP+
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVD-ACLLKDPTE--RPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 55/164 (33%), Positives = 84/164 (51%), Gaps = 16/164 (9%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           E   L +   RFV+ L  A         ++T + G  LK  ++ +G+          P F
Sbjct: 50  EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN----------PGF 99

Query: 304 EERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           +E+ A   A E+   ++ L  Q+ ++++RDLKP NI LDD  H+RI+D G A  + +GE 
Sbjct: 100 DEQRAIFYAAELCCGLEDL--QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET 157

Query: 362 --ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                GT  YMAPEVI  E Y+   D +  G ++ E+I G  P+
Sbjct: 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 80.7 bits (199), Expect = 1e-16
 Identities = 53/173 (30%), Positives = 89/173 (51%), Gaps = 24/173 (13%)

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FL 356
           E+ ++ + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       ++
Sbjct: 173 EDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 230

Query: 357 SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPA 411
             G+  L     +MAPE I  + Y+ +SDV+SFG++L EI + G  PY    I++++   
Sbjct: 231 RKGDARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--- 285

Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                + EG  R   PE      E+  ++   W  +   RP+FS +   L ++
Sbjct: 286 --CRRLKEG-TRMRAPEYATP--EIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.9 bits (198), Expect = 1e-16
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 33/214 (15%)

Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNEN---AVTFFAQEVDTLSRQRHR 254
             +IG+GT   +Y+A  +  G  VA+K I  +    NE     +T   +E+  L + RH 
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKIRME----NEKEGFPITA-IREIKLLQKLRHP 58

Query: 255 FVLQLMGACLEPPYRG--WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
            +++L         +G  ++V E +   L   L             P   F E   +   
Sbjct: 59  NIVRLKEIVTSKG-KGSIYMVFEYMDHDLTGLLD-----------SPEVKFTESQIKCYM 106

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTG---T 366
            ++ + +QYLH     ++HRD+K SNI +++   +++ADFG AR          T    T
Sbjct: 107 KQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVIT 164

Query: 367 FVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
             Y  PE++     Y  + D++S G IL E+  G
Sbjct: 165 LWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 72/274 (26%), Positives = 125/274 (45%), Gaps = 34/274 (12%)

Query: 194 PKEIDLQEKIGQGTTANIYRA--IWRGLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLS 249
           P    L + +GQG    +Y       G ++AVK +   P+   T++  V     E+  L 
Sbjct: 1   PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLK 59

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
              H  ++Q  G   +P  R          TL  ++  +     K+++       E + R
Sbjct: 60  NLLHERIVQYYGCLRDPMER----------TLSIFMEHMPGGSIKDQLKSYGALTENVTR 109

Query: 310 --ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD------GEM 361
               +I + + YLH     ++HRD+K +NI  D   +V++ DFG ++ L        G  
Sbjct: 110 KYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMK 167

Query: 362 ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA--KIAMEVGE 419
           ++TGT  +M+PEVI  E Y  K+D++S G  + E++T   P+ E +   A  KIA +   
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 227

Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
             L P + +     R+ ++ I +    +A +RPS
Sbjct: 228 PVLPPHVSD---HCRDFLKRIFV----EAKLRPS 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 76/268 (28%), Positives = 119/268 (44%), Gaps = 46/268 (17%)

Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG-WLVTELLGT 279
           VAVK +  +    N +    + +E++ L    H  +++  G C E   +G  L+ E +  
Sbjct: 36  VAVKTLKRECGQQNTSG---WKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP- 91

Query: 280 TLKEWLHGLGSQRRKERMVPLPPFEERLAR----ALEIAQAMQYLHEQKPKVIHRDLKPS 335
                   LGS R       LP  +  LA+    A +I + M YLH Q    IHRDL   
Sbjct: 92  --------LGSLRDY-----LPKHKLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAAR 136

Query: 336 NIFLDDAKHVRIADFGHARFLSDGEMAL-------TGTFVYMAPEVIQCEPYSEKSDVYS 388
           N+ LD+ + V+I DFG A+ + +G           +  F Y A E ++   +S  SDV+S
Sbjct: 137 NVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWS 195

Query: 389 FGIILNEIITGNHPYIEKDYK------PAKIAM------EVGEGKLRPALPEEDGQLREL 436
           FG+ L E++T          K      P +  M      E+ E  +R  LP      +E+
Sbjct: 196 FGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMR--LPCPKNCPQEV 253

Query: 437 IELICLSWDGDASVRPSFSSITCSLKNI 464
             L+   W+ +A  RP+F S+   LK +
Sbjct: 254 YILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 66/238 (27%), Positives = 117/238 (49%), Gaps = 20/238 (8%)

Query: 235 ENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRGWLVTEL--LGTTLKEWLHGLGS 290
           EN  + F +E+D   +  H+ V++L+G C E  P Y   ++ E   LG  LK++L    S
Sbjct: 49  ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY---MILEYTDLGD-LKQFLRATKS 104

Query: 291 QRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
           +  K +  PL   ++++A   +IA  M +L     + +HRDL   N  +   + V+++  
Sbjct: 105 KDEKLKPPPLST-KQKVALCTQIALGMDHLS--NARFVHRDLAARNCLVSSQREVKVSLL 161

Query: 351 GHAR-FLSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE 405
             ++   +     L    +   ++APE +Q + +S KSDV+SFG+++ E+ T G  P+  
Sbjct: 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-- 219

Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
                 ++   +  GKL   LP  +G    L +L+   W  +   RPSFS +  +L  
Sbjct: 220 YGLSDEEVLNRLQAGKLE--LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 78/280 (27%), Positives = 122/280 (43%), Gaps = 35/280 (12%)

Query: 203 IGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           IGQG    +++A   GL        VAVK +  +    + +    F +E   ++   H  
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPN 69

Query: 256 VLQLMGACLEPPYRGWL--------VTELLGTTLKEWLHGLGSQRRKERMVPLPPFE--- 304
           +++L+G C        L        + E L          L       R   L P     
Sbjct: 70  IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 305 -ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEM 361
            E+L  A ++A  M YL E+K   +HRDL   N  + +   V+IADFG +R  + +D   
Sbjct: 130 TEQLCIAKQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 362 ALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           A     +   +M PE I    Y+ +SDV+++G++L EI + G  PY    ++  ++   V
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE--EVIYYV 245

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +G +   L   D    EL  L+ L W    S RPSF+SI
Sbjct: 246 RDGNV---LSCPDNCPLELYNLMRLCWSKLPSDRPSFASI 282

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 40/108 (37%), Positives = 62/108 (57%), Gaps = 7/108 (6%)

Query: 301 PPFEERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P F E  A     +I   +++LH+++  +I+RDLKP N+ LD+  +VRI+D G A  L D
Sbjct: 92  PGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149

Query: 359 GE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           G+       GT  +MAPE++Q E Y    D ++ G+ L E+I    P+
Sbjct: 150 GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           EKIG+GT   +Y+   +  G  VA+K I      + E  V   A +E+  L   +H  ++
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVAMKKIR---LESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
            L    ++   R +L+ E L   LK++L  L   +  +           L ++   +I Q
Sbjct: 63  CLQDVLMQES-RLYLIFEFLSMDLKKYLDSLPKGQYMDAE---------LVKSYLYQILQ 112

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            + + H ++  V+HRDLKP N+ +D+   +++ADFG AR         T   V   Y AP
Sbjct: 113 GILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAP 170

Query: 373 EVIQCEP-YSEKSDVYSFGIILNEIIT 398
           EV+   P YS   D++S G I  E+ T
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 31/209 (14%)

Query: 203 IGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAV-TFFAQEVDTL---SRQRHRFV 256
           IG+G    +Y+A  +  G  VA+K +       +E  +     +E+  L       H  +
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 257 LQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
           ++L+  C  P         LV E +   L  +L             P P       + L 
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYL----------SKCPKPGLPPETIKDLM 113

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV-- 368
            ++ + + +LH  +  ++HRDLKP NI +     V+IADFG AR  S  EMALT   V  
Sbjct: 114 RQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVVTL 170

Query: 369 -YMAPEVIQCEPYSEKSDVYSFGIILNEI 396
            Y APEV+    Y+   D++S G I  E+
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 20/218 (9%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           E   L    H  +++     LE      ++    G TL E++     +R       L   
Sbjct: 49  ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ----KRCNS----LLDE 100

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMA 362
           +  L   ++I  A+ ++H +   ++HRDLK  NI LD  K V +I DFG ++ LS    A
Sbjct: 101 DTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158

Query: 363 LT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
            T  GT  Y++PE+ + +PY++KSD+++ G +L E+ +    + E    PA + +++  G
Sbjct: 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAF-EAANLPA-LVLKIMSG 216

Query: 421 KLRPALPEEDGQLRELIE-LICLSWDGDASVRPSFSSI 457
              P        LR+LI  ++ L    D S RP  S I
Sbjct: 217 TFAPISDRYSPDLRQLILSMLNL----DPSKRPQLSQI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 45/118 (38%), Positives = 62/118 (52%), Gaps = 8/118 (6%)

Query: 293 RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
           ++ER  P P      A   EIA A+ YLH     +++RDLKP NI LD   HV + DFG 
Sbjct: 88  QRERSFPEPRARFYAA---EIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGL 142

Query: 353 AR---FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
            +     SD      GT  Y+APEVI+ +PY    D +  G +L E++ G  P+  +D
Sbjct: 143 CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 77.7 bits (191), Expect = 4e-16
 Identities = 79/273 (28%), Positives = 124/273 (45%), Gaps = 43/273 (15%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVK----CIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           E+IG+G    ++    R  +  VAVK     + PD           F QE   L +  H 
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-------FLQEARILKQYSHP 53

Query: 255 FVLQLMGACLE--PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
            +++L+G C +  P Y   +V EL+ G     +L   G + + + ++          + +
Sbjct: 54  NIVRLIGVCTQKQPIY---IVMELVQGGDFLTFLRTEGPRLKVKELI----------QMV 100

Query: 312 EIAQA-MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF--- 367
           E A A M+YL  +    IHRDL   N  + +   ++I+DFG +R   DG  A TG     
Sbjct: 101 ENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158

Query: 368 --VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE +    YS +SDV+SFGI+L E  + G  PY     +  + A+E G     P
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP 218

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            L  +      +  L+   W+ D   RPSFS++
Sbjct: 219 ELCPDA-----VYRLMERCWEYDPGQRPSFSTV 246

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 77.8 bits (191), Expect = 7e-16
 Identities = 72/213 (33%), Positives = 105/213 (49%), Gaps = 34/213 (15%)

Query: 202 KIGQGTTA--NIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           KIG+G+T    I R    G  VAVK +  D        + F   EV  +   +H+ V+++
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMM--DLRKQQRRELLF--NEVVIMRDYQHQNVVEM 83

Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLHG-----LGSQRRKERMVPLPPFEERLARALE-I 313
                   Y+ +LV E L   L E+L G     + SQ R          EE++A   E +
Sbjct: 84  --------YKSYLVGEEL-WVLMEFLQGGALTDIVSQTRLN--------EEQIATVCESV 126

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMALTGTFVYM 370
            QA+ YLH Q   VIHRD+K  +I L     V+++DFG    +S       +L GT  +M
Sbjct: 127 LQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWM 184

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           APEVI   PY  + D++S GI++ E++ G  PY
Sbjct: 185 APEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 77.0 bits (190), Expect = 8e-16
 Identities = 74/289 (25%), Positives = 120/289 (41%), Gaps = 46/289 (15%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           IDP  + +++ IG G    + R   +      +DVA+K +       ++     F  E  
Sbjct: 1   IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS---SDKQRLDFLTEAS 57

Query: 247 TLSRQRHRFVLQLMGACL--EPPYRGWLVTEL-----LGTTLKEWLHGLGSQRRKERMVP 299
            + +  H  +++L G      P     ++TE      L   L+E            +   
Sbjct: 58  IMGQFDHPNIIRLEGVVTKSRPVM---IITEYMENGSLDKFLRE---------NDGKFTV 105

Query: 300 LPPFEERLARALE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
                 +L   L  IA  M+YL E     +HRDL   NI ++     +++DFG +R L D
Sbjct: 106 -----GQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158

Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            E   T         + APE I    ++  SDV+SFGI++ E+++ G  PY   D     
Sbjct: 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY--WDMSNQD 216

Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
           +   V +G   P  P +      L +L+   W  D + RP+FS I  +L
Sbjct: 217 VIKAVEDGYRLPP-PMDCPSA--LYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 77.5 bits (191), Expect = 8e-16
 Identities = 41/108 (37%), Positives = 64/108 (59%), Gaps = 8/108 (7%)

Query: 304 EERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM- 361
           EE++A   L + +A+ +LH Q   VIHRD+K  +I L     V+++DFG    +S  E+ 
Sbjct: 114 EEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-EVP 170

Query: 362 ---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK 406
              +L GT  +MAPEVI   PY  + D++S GI++ E++ G  PY  +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 78.0 bits (193), Expect = 8e-16
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 37/199 (18%)

Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQ----EVDTLSRQRHRFVLQLMGACLEPPYRG--- 270
           G  VA+K I   F           A+    E+  L   RH  ++ L+   L PP      
Sbjct: 25  GRKVAIKKISNVFDDL------IDAKRILREIKLLRHLRHENIIGLLDI-LRPPSPEDFN 77

Query: 271 --WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIAQAMQYLHEQKPKV 327
             ++VTEL+ T L + +    S +      PL   ++ +   L +I + ++YLH     V
Sbjct: 78  DVYIVTELMETDLHKVIK---SPQ------PLT--DDHIQYFLYQILRGLKYLHSAN--V 124

Query: 328 IHRDLKPSNIFLDDAKHVRIADFGHARFL---SDGEMALTGTFV---YMAPEVI-QCEPY 380
           IHRDLKPSNI ++    ++I DFG AR +    D +  LT   V   Y APE++     Y
Sbjct: 125 IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRY 184

Query: 381 SEKSDVYSFGIILNEIITG 399
           ++  D++S G I  E++T 
Sbjct: 185 TKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 80/309 (25%), Positives = 138/309 (44%), Gaps = 56/309 (18%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 10  WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 66

Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 67  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 122

Query: 298 ------VPLPP--FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 123 SYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 180

Query: 350 FGHARFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-G 399
           FG AR +         ++G + +     +MAPE +    Y+ +SDV+SFG+++ EI T G
Sbjct: 181 FGLARDVNNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236

Query: 400 NHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
             PY    +E+ +K     ++ G    +PA         EL  ++   W    S RP+F 
Sbjct: 237 GSPYPGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAIPSHRPTFK 287

Query: 456 SITCSLKNI 464
            +   L  I
Sbjct: 288 QLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 70/248 (28%), Positives = 114/248 (45%), Gaps = 29/248 (11%)

Query: 194 PKEIDLQEKIGQGTTANIYRA--IWRGLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLS 249
           P    L + +G+G    +Y       G ++AVK +   PD   T++  V     E+  L 
Sbjct: 1   PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLK 59

Query: 250 RQRHRFVLQLMGACLEPPYRGWL---VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
             RH  ++Q  G CL  P    L   V  + G ++K+ L   G+               R
Sbjct: 60  NLRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTEN--------VTRR 110

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD------GE 360
             R  +I Q + YLH     ++HRD+K +NI  D A +V++ DFG ++ +        G 
Sbjct: 111 YTR--QILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGI 166

Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
            ++TGT  +M+PEVI  E Y  K+DV+S    + E++T   P+ E  Y+      ++   
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE--YEAMAAIFKIATQ 224

Query: 421 KLRPALPE 428
             +P LP+
Sbjct: 225 PTKPMLPD 232

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 73/276 (26%), Positives = 129/276 (46%), Gaps = 22/276 (7%)

Query: 199 LQEKIGQGTTANIYRAIWRGLD---VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +++KIG+G  + +YRA    LD   VA+K +   F   +  A     +E+D L +  H  
Sbjct: 6   IEKKIGRGQFSEVYRATCL-LDRKPVALKKVQI-FEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           V++ + + +E      ++       L + +     Q+R      L P        +++  
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKR------LIPERTVWKYFVQLCS 117

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---LTGTFVYMAP 372
           A++++H ++  V+HRD+KP+N+F+     V++ D G  RF S    A   L GT  YM+P
Sbjct: 118 AVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE--D 430
           E I    Y+ KSD++S G +L E+     P+         +  ++ +    P LP E   
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY-PPLPTEHYS 234

Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM 466
            +LREL+ + C+  D D   RP    +    K + +
Sbjct: 235 EKLRELVSM-CIYPDPDQ--RPDIGYVHQIAKQMHV 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 75/264 (28%), Positives = 123/264 (46%), Gaps = 32/264 (12%)

Query: 203 IGQGTTANIYRA--IWRGLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +GQG    +Y    +  G ++A K +   P+   T++  V+    E+  L   +H  ++Q
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKE-VSALECEIQLLKNLQHERIVQ 68

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQA 316
             G CL    R     E   T   E++ G GS   K+++       E + R    +I + 
Sbjct: 69  YYG-CLRD--RA----EKTLTIFMEYMPG-GSV--KDQLKAYGALTESVTRKYTRQILEG 118

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD------GEMALTGTFVYM 370
           M YLH     ++HRD+K +NI  D A +V++ DFG ++ L        G  ++TGT  +M
Sbjct: 119 MSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           +PEVI  E Y  K+DV+S G  + E++T   P+ E  Y+      ++      P LP   
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE--YEAMAAIFKIATQPTNPQLPSHI 234

Query: 431 G-QLRELIELICLSWDGDASVRPS 453
               R+ +  I +    +A  RPS
Sbjct: 235 SEHARDFLGCIFV----EARHRPS 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 73/269 (27%), Positives = 120/269 (44%), Gaps = 42/269 (15%)

Query: 203 IGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +G G    +Y+ +W        + VA+K +      T+  A      E   ++   +  V
Sbjct: 15  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE---ATSPKANKEILDEAYVMASVDNPHV 71

Query: 257 LQLMGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARAL 311
            +L+G CL    +  L+T+L+  G  L   +E    +GSQ               L   +
Sbjct: 72  CRLLGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCV 116

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +IA+ M YL E++  ++HRDL   N+ +   +HV+I DFG A+ L   E           
Sbjct: 117 QIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP 174

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             +MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  
Sbjct: 175 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER-- 229

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSF 454
           LP+      ++  ++   W  DA  RP F
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDADSRPKF 258

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 32/231 (13%)

Query: 197 IDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           I L+ ++G+G    ++      L+       VAVK +       + +A   F +E + L+
Sbjct: 7   IVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLT 63

Query: 250 RQRHRFVLQLMGACLE--PPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEER 306
             +H  +++  G C E  PP    +V E +    L ++L   G       +         
Sbjct: 64  NFQHENIVKFYGVCTEGDPP---IMVFEYMEHGDLNKFLRSHGPDAA--FLKSPDSPMGE 118

Query: 307 LAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           L        A++IA  M YL  Q    +HRDL   N  +     V+I DFG +R   +  
Sbjct: 119 LTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTD 176

Query: 360 EMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE 405
              + G  +    +M PE I    ++ +SDV+SFG++L EI T G  P+  
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 78.7 bits (194), Expect = 2e-15
 Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 27/196 (13%)

Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL 277
           G +VA+K +  D     E+    F +E    +R  H  ++ L+ +   PP   + V E +
Sbjct: 3   GHEVAIKLLRTDAP-EEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 278 -GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
            G TL+E L   G          LP   E     L++  A+   H Q   ++HRDLKP N
Sbjct: 62  PGRTLREVLAADG---------ALPA-GETGRLMLQVLDALACAHNQG--IVHRDLKPQN 109

Query: 337 IFL---DDAKHVRIADFGHARFLSDGEMALT----------GTFVYMAPEVIQCEPYSEK 383
           I +       H ++ DFG    L     A            GT  Y APE ++ EP +  
Sbjct: 110 IMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPN 169

Query: 384 SDVYSFGIILNEIITG 399
           SD+Y++G+I  E +TG
Sbjct: 170 SDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 81/296 (27%), Positives = 133/296 (44%), Gaps = 46/296 (15%)

Query: 195 KEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           ++I  ++ IG+G    + RA+ +     ++ A+K +       +EN    FA E++ L +
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE---FASENDHRDFAGELEVLCK 58

Query: 251 -QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF------ 303
              H  ++ L+GAC     RG+L   +        L  L    RK R++   P       
Sbjct: 59  LGHHPNIINLLGACEN---RGYLYIAIEYAPYGNLLDFL----RKSRVLETDPAFAKEHG 111

Query: 304 -------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
                  ++ L  A ++A  MQYL E++   IHRDL   N+ + +    +IADFG    L
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENLASKIADFG----L 165

Query: 357 SDGEMALTGTFV------YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK 409
           S GE       +      +MA E +    Y+ KSDV+SFG++L EI++ G  PY      
Sbjct: 166 SRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC--GMT 223

Query: 410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
            A++  ++ +G  R   P       E+ EL+   W      RP F+ I+  L  + 
Sbjct: 224 CAELYEKLPQG-YRMEKPRNCDD--EVYELMRQCWRDRPYERPPFAQISVQLSRML 276

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLSDGEMALTGT 366
           A EIA  + +LH +   +I+RDLK  N+ LD   H++IADFG  +   F         GT
Sbjct: 107 AAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGT 164

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+I  +PY +  D ++FG++L E++ G  P+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 12/125 (9%)

Query: 283 EWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD 340
           E+L+G       + +  LP   E  A+    E+   ++ LH++   +IHRD+KP N+ +D
Sbjct: 77  EYLNGGDCASLIKTLGGLP---EDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLID 131

Query: 341 DAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT 398
              H+++ DFG +R   +G       GT  Y+APE I      + SD +S G ++ E + 
Sbjct: 132 QTGHLKLTDFGLSR---NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188

Query: 399 GNHPY 403
           G  P+
Sbjct: 189 GYPPF 193

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 50/174 (28%), Positives = 81/174 (46%), Gaps = 17/174 (9%)

Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQ 291
             +E+      +EV  L + RH  ++ L  A      R +LV E +  TL E L      
Sbjct: 38  EDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKG-RLYLVFEYVERTLLELL------ 90

Query: 292 RRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
             +     LPP   R     ++ QA+ Y H     +IHRD+KP NI + ++  +++ DFG
Sbjct: 91  --EASPGGLPPDAVRSY-IWQLLQAIAYCH--SHNIIHRDIKPENILVSESGVLKLCDFG 145

Query: 352 HARFLSDGEMALTGTFV----YMAPEVIQCEP-YSEKSDVYSFGIILNEIITGN 400
            AR L     +    +V    Y APE++  +  Y +  DV++ G I+ E++ G 
Sbjct: 146 FARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 60/189 (31%), Positives = 98/189 (51%), Gaps = 23/189 (12%)

Query: 222 AVKCIYPDFFHTNENA-VTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GT 279
           AVK +  D    +++   T   + + +L+R  H F+ QL   C + P R + V E + G 
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQLY-CCFQTPDRLFFVMEFVNGG 81

Query: 280 TLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNI 337
            L    H   S+R          F+E  AR  A EI  A+ +LH++   +I+RDLK  N+
Sbjct: 82  DLM--FHIQKSRR----------FDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNV 127

Query: 338 FLDDAKHVRIADFGHAR-FLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILN 394
            LD   H ++ADFG  +  + +G+   T  GT  Y+APE++Q   Y    D ++ G++L 
Sbjct: 128 LLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLY 187

Query: 395 EIITGNHPY 403
           E++ G+ P+
Sbjct: 188 EMLCGHAPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 77/293 (26%), Positives = 128/293 (43%), Gaps = 35/293 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R +        VAVK +       NE+A     
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 53

Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERM 297
             F  E   +       V++L+G  +       +V EL+    LK +L  L  +      
Sbjct: 54  IEFLNEASVMKGFTCHHVVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPG 112

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
            P P  +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R + 
Sbjct: 113 RPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIY 170

Query: 358 DGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDYKP 410
           + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + + 
Sbjct: 171 ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV 230

Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
            K  M+ G       L + D     + +L+ + W  +  +RP+F  I   LK+
Sbjct: 231 LKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 76.1 bits (188), Expect = 4e-15
 Identities = 40/93 (43%), Positives = 55/93 (59%), Gaps = 11/93 (11%)

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALT---GTF 367
           A++Y+H     VIHRDLKPSNI L+    V++ADFG AR LS+ E       LT    T 
Sbjct: 119 ALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 368 VYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
            Y APE+ +    Y++  D++S G IL E++ G
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 72/279 (25%), Positives = 131/279 (46%), Gaps = 41/279 (14%)

Query: 192 IDPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           +DP E+ ++  ++G G    +Y+A  +  G   A K I       +E  +  +  E++ L
Sbjct: 8   LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIEIL 63

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTEL-----LGTTLKEWLHGLGSQRRKERMVPLPPF 303
           +   H ++++L+GA      + W++ E      +   + E   GL             P 
Sbjct: 64  ATCNHPYIVKLLGAFYWDG-KLWIMIEFCPGGAVDAIMLELDRGLTE-----------PQ 111

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSDG 359
            + + R  ++ +A+QYLH  K  +IHRDLK  N+ L     +++ADFG    + + L   
Sbjct: 112 IQVICR--QMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167

Query: 360 EMALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA 414
           + +  GT  +MAPEV+ CE     PY  K+D++S GI L E+     P+ E +  P ++ 
Sbjct: 168 D-SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVL 224

Query: 415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
           +++ + +  P L +      E  + +  + D     RPS
Sbjct: 225 LKIAKSE-PPTLSQPSKWSMEFRDFLKTALDKHPETRPS 262

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 4e-15
 Identities = 46/173 (26%), Positives = 72/173 (41%), Gaps = 38/173 (21%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDG 359
           F E  AR    E+  A+  +H+     IHRD+KP NI +D   H+++ADFG   +     
Sbjct: 98  FPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155

Query: 360 E-----------------------------MALT--GTFVYMAPEVIQCEPYSEKSDVYS 388
           +                              A +  GT  Y+APEV++  PY  + D +S
Sbjct: 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215

Query: 389 FGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELIC 441
            G+IL E++ G  P+        +   ++   K     P +     E I+LIC
Sbjct: 216 LGVILYEMLYGFPPFYSDT--LQETYNKIINWKESLRFPPDPPVSPEAIDLIC 266

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 44/110 (40%), Positives = 60/110 (54%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A E+A A+ YLH     +I+RDLKP NI LD   HV + DFG  +   + E
Sbjct: 93  FLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE 150

Query: 361 ---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
                  GT  Y+APEV++ EPY    D +  G +L E++ G  P+  +D
Sbjct: 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 84/312 (26%), Positives = 141/312 (45%), Gaps = 49/312 (15%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   G+D         VAVK +  D     +  ++ 
Sbjct: 7   WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSD 63

Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      LV       L+E+L      RR   M  
Sbjct: 64  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRA----RRPPGMDY 119

Query: 298 ----VPLP----PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 LP     F++ ++ A ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 120 SFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVTEDNVMKIAD 177

Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR + + +     T       +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237

Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 238 PGIPVEELFK----LLKEGHRMDKPA-----NCTHELYMIMRECWHAVPSQRPTFKQLVE 288

Query: 460 SLKNIQMKVTET 471
            L  + + VT T
Sbjct: 289 DLDRV-LTVTST 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 75.7 bits (186), Expect = 5e-15
 Identities = 41/108 (37%), Positives = 65/108 (60%), Gaps = 13/108 (12%)

Query: 296 RMVPLPPFEERLARAL----EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
           R  PLP     + +AL    +I + ++YLH Q+  +IHRD+K  NIF++D   V I D G
Sbjct: 150 RSRPLP-----IDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLG 202

Query: 352 HARF--LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEII 397
            A+F  ++   + L GT    APEV+  + Y+ K+D++S GI+L E++
Sbjct: 203 AAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 79/282 (28%), Positives = 131/282 (46%), Gaps = 44/282 (15%)

Query: 195 KEIDLQEK--IGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           KE +L++   +G G    +Y+ IW        + VA+K +  +   T+  A      E  
Sbjct: 5   KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAY 61

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLP 301
            ++     +V +L+G CL    +  LVT+L+  G  L   +E    +GSQ          
Sbjct: 62  VMAGVGSPYVCRLLGICLTSTVQ--LVTQLMPYGCLLDYVRENKDRIGSQ---------- 109

Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDG 359
              + L   ++IA+ M YL E +  ++HRDL   N+ +    HV+I DFG AR L   + 
Sbjct: 110 ---DLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164

Query: 360 EMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
           E    G  V   +MA E I    ++ +SDV+S+G+ + E++T G  PY   D  PA+   
Sbjct: 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPY---DGIPAREIP 221

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           ++ E   R  LP+      ++  ++   W  D+  RP F  +
Sbjct: 222 DLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFREL 261

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 74.8 bits (184), Expect = 6e-15
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 21/205 (10%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           EKIG+GT   +Y+A  +  G  VA+K I  D   T    V   A +E+  L    H  ++
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD---TETEGVPSTAIREISLLKELNHPNIV 62

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
           +L+   +    + +LV E L   LK+++            +PLP  +  L + L   Q +
Sbjct: 63  KLLDV-IHTENKLYLVFEFLHQDLKKFMDASPLSG-----IPLPLIKSYLFQLL---QGL 113

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEV 374
            + H  +  V+HRDLKP N+ ++    +++ADFG AR         T   V   Y APE+
Sbjct: 114 AFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 171

Query: 375 -IQCEPYSEKSDVYSFGIILNEIIT 398
            + C+ YS   D++S G I  E++T
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 29/218 (13%)

Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           K+  +  ++GQG    ++ A  +     VA+K +         N V     E D L+  +
Sbjct: 1   KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLF-KLNEVRHVLTERDILTTTK 59

Query: 253 HRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-- 309
             ++++L+ A  +  Y  +L  E + G   +  L+ LG               E  AR  
Sbjct: 60  SEWLVKLLYAFQDDEYL-YLAMEYVPGGDFRTLLNNLGVLS------------EDHARFY 106

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV- 368
             E+ +A+  LHE     IHRDLKP N  +D + H+++ DFG    LS G +    + V 
Sbjct: 107 MAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFG----LSKGIVTYANSVVG 160

Query: 369 ---YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              YMAPEV++ + Y    D +S G +L E + G  P+
Sbjct: 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPF 198

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 33/210 (15%)

Query: 203 IGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G    +  A        VA+K +   F        T+  +E+  L    H  V+ L+
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHENVIGLL 80

Query: 261 -----GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
                 + LE     +LVT L+G  L    + +  Q+  +  +          + L  +I
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGADLN---NIVKCQKLSDDHI----------QFLVYQI 127

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYM 370
            + ++Y+H     +IHRDLKPSNI +++   ++I DFG AR  +D EM  TG   T  Y 
Sbjct: 128 LRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDEM--TGYVATRWYR 182

Query: 371 APEVIQCE-PYSEKSDVYSFGIILNEIITG 399
           APE++     Y++  D++S G I+ E++TG
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTG 212

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 27/211 (12%)

Query: 203 IGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENA-VTFFAQEVDTLSRQRHRFVLQL 259
           +G+G+   +  A  +G D   A+K +  D    +++   T   + +  L+  +H F+  L
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61

Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERLAR--ALEIAQ 315
              C +   R + V E        +++G  L  Q ++ R      F+E  +R  A E+  
Sbjct: 62  H-CCFQTKDRLFFVME--------YVNGGDLMFQIQRSR-----KFDEPRSRFYAAEVTL 107

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFVYMAP 372
           A+ +LH     VI+RDLK  NI LD   H ++ADFG  +  + +G    T  GT  Y+AP
Sbjct: 108 ALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           E++Q   Y    D ++ G+++ E++ G  P+
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 55/174 (31%), Positives = 89/174 (51%), Gaps = 24/174 (13%)

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------F 355
            E+ +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       +
Sbjct: 178 LEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKP 410
           +  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I++++  
Sbjct: 236 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 291

Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 + EG  R   P+      E+ + +   W G+ S RP+FS +   L N+
Sbjct: 292 ---CRRLKEGT-RMRAPDYTTP--EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 72/246 (29%), Positives = 109/246 (44%), Gaps = 41/246 (16%)

Query: 235 ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRR 293
           +  V+FF +E D LS     ++ QL  A  +     +LV E   G  L   L+      R
Sbjct: 42  QETVSFFEEERDILSISNSPWIPQLQYA-FQDKDNLYLVMEYQPGGDLLSLLN------R 94

Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
            E       F+E +A+    E+  A+  +H+     +HRD+KP N+ +D   H+++ADFG
Sbjct: 95  YE-----DQFDEDMAQFYLAELVLAIHSVHQM--GYVHRDIKPENVLIDRTGHIKLADFG 147

Query: 352 HARFLSDGEMALT----GTFVYMAPEVIQCEPYSEKS------DVYSFGIILNEIITGNH 401
            A  L+  +M  +    GT  Y+APEV+       K       D +S G+I  E+I G  
Sbjct: 148 SAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207

Query: 402 PYIE----KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIE-LIC-----LSWDGDASVR 451
           P+ E    K Y    I M        P  P+      +LI+ L+C     L ++G     
Sbjct: 208 PFHEGTSAKTY--NNI-MNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEG-LCCH 263

Query: 452 PSFSSI 457
           P FS I
Sbjct: 264 PFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 76/259 (29%), Positives = 115/259 (44%), Gaps = 27/259 (10%)

Query: 219 LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG 278
           L VAVK +  D    +E  +  F  E   +    H  V++L+G C E      +   ++ 
Sbjct: 28  LKVAVKTMKLDIHTYSE--IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMV- 84

Query: 279 TTLKEWLHG-LGSQRRKERMVPLP---PFEERLARALEIAQAMQYLHEQKPKVIHRDLKP 334
             L    HG L S     R+  LP   P +  L   ++IA  M+YL  +    IHRDL  
Sbjct: 85  -ILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAA 141

Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV-----YMAPEVIQCEPYSEKSDVYSF 389
            N  L +   V +ADFG ++ +  G+    G        ++A E +    Y+ KSDV++F
Sbjct: 142 RNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 201

Query: 390 GIILNEIIT-GNHPYIEKDYKPAKIAMEVGE---GKLRPALPEEDGQLRELIELICLSWD 445
           G+ + EI T G  PY      P     E+ +      R   PE+   L EL +L+   W 
Sbjct: 202 GVTMWEIATRGQTPY------PGVENHEIYDYLRHGNRLKQPED--CLDELYDLMYSCWR 253

Query: 446 GDASVRPSFSSITCSLKNI 464
            D   RP+F+ +   L+NI
Sbjct: 254 ADPKDRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 43/121 (35%), Positives = 65/121 (53%), Gaps = 12/121 (9%)

Query: 293 RKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
            +ER+     F E  AR    EI  A+ YLH     V++RDLK  N+ LD   H++I DF
Sbjct: 87  SRERV-----FSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDF 139

Query: 351 GHARF-LSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G  +  +SDG    T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D
Sbjct: 140 GLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199

Query: 408 Y 408
           +
Sbjct: 200 H 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 78/295 (26%), Positives = 138/295 (46%), Gaps = 46/295 (15%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           ++  +I  Q+ IG+G    + +A  +     +D A+K +     + +++    FA E++ 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEV 60

Query: 248 LSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF--- 303
           L +   H  ++ L+GAC    +RG+L   +        L  L    RK R++   P    
Sbjct: 61  LCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAI 113

Query: 304 ----------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
                     ++ L  A ++A+ M YL +++   IHRDL   NI + +    +IADFG +
Sbjct: 114 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS 171

Query: 354 RFLSDGEMALTGTF-----VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           R     E+ +  T       +MA E +    Y+  SDV+S+G++L EI++ G  PY    
Sbjct: 172 R---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--G 226

Query: 408 YKPAKIAMEVGEG-KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
              A++  ++ +G +L   L  +D    E+ +L+   W      RPSF+ I  SL
Sbjct: 227 MTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 78/289 (26%), Positives = 129/289 (44%), Gaps = 43/289 (14%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQE 244
           +    I L   +G G    +Y  ++RG D       VAVK +       +E   + F  E
Sbjct: 3   VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLP---ESCSEQDESDFLME 59

Query: 245 VDTLSRQRHRFVLQLMGACLEP-PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
              +S+  H+ +++L+G   E  P   +++ EL+ G  LK +L       R+ R  P  P
Sbjct: 60  ALIMSKFNHQNIVRLIGVSFERLPR--FILLELMAGGDLKSFL-------RENRPRPERP 110

Query: 303 F----EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---KHVRIADFGHAR- 354
                ++ L  A ++A+  +YL E     IHRD+   N  L      +  +IADFG AR 
Sbjct: 111 SSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168

Query: 355 -----FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY 408
                +   G  A+     +M PE      ++ K+DV+SFG++L EI + G  PY  +  
Sbjct: 169 IYRASYYRKGGRAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227

Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +   +    G G+L P  P+  G    +  ++   W      RP+F++I
Sbjct: 228 QEV-MEFVTGGGRLDP--PK--GCPGPVYRIMTDCWQHTPEDRPNFATI 271

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 40/101 (39%), Positives = 62/101 (61%), Gaps = 5/101 (4%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GT 366
           A EIA  + +LH +   +I+RDLK  N+ LD   H++IADFG  +  + DG    T  GT
Sbjct: 107 AAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGT 164

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE+I  +PY +  D ++FG++L E++ G  P+  +D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 77/245 (31%), Positives = 115/245 (46%), Gaps = 32/245 (13%)

Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+E +D   KIG+G+T  +  A  +  G  VAVK +  D        + F   EV  + 
Sbjct: 19  DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLF--NEVVIMR 74

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
              H  V+ +        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 75  DYHHENVVDM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRMN-----EEQI 120

Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD---GEMAL 363
           A   L + +A+ YLH Q   VIHRD+K  +I L     ++++DFG    +S       +L
Sbjct: 121 ATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPEVI   PY  + D++S GI++ E+I G  PY     +P   AM      L 
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN---EPPLQAMRRIRDNLP 235

Query: 424 PALPE 428
           P + +
Sbjct: 236 PRVKD 240

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 43/143 (30%), Positives = 72/143 (50%), Gaps = 16/143 (11%)

Query: 293 RKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
           +K   +P    E  L + ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG
Sbjct: 91  KKAGRIP----ENILGKISIAVLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFG 145

Query: 352 HARFLSDGEMA--LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY------ 403
            +  L D  MA    GT  YM+PE +Q   Y+ +SD++S G+ L E+  G +P       
Sbjct: 146 VSGQLID-SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204

Query: 404 -IEKDYKPAKIAMEVGEGKLRPA 425
            +E  +       E  E     +
Sbjct: 205 ELEAMFGRPVSEGEAKESHRPVS 227

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 43/119 (36%), Positives = 72/119 (60%), Gaps = 9/119 (7%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFV 368
           EI+ A+++LH+Q   +I+RDLKP NI LD   HV++ DFG  +  + +G +  T  GT  
Sbjct: 108 EISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIE 165

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
           YMAPE++    + +  D +S G ++ +++TG  P+  ++ K  K   ++ +GKL   LP
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KTIDKILKGKL--NLP 220

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 38/101 (37%), Positives = 62/101 (61%), Gaps = 5/101 (4%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GT 366
           A EI+  + +LH +   +I+RDLK  N+ LD   H++IADFG  +  + DG    T  GT
Sbjct: 107 AAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGT 164

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE+I  +PY +  D +++G++L E++ G  P+  +D
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 56/171 (32%), Positives = 87/171 (50%), Gaps = 20/171 (11%)

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMA 362
           E+ +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR    D +  
Sbjct: 174 EDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV 231

Query: 363 LTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKI 413
             G+      +MAPE I  + Y+ +SDV+SFG++L EI + G  PY    I +++     
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF----- 286

Query: 414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              + +G  R   PE        I L C  W GD   RP+FS++   L ++
Sbjct: 287 CQRLKDGT-RMRAPENATPEIYRIMLAC--WQGDPKERPTFSALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 48/266 (18%)

Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTEL 276
           G  VAVK + P+   +  N +    +E++ L    H  +++  G C E    G  L+ E 
Sbjct: 33  GEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 89

Query: 277 LGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS 335
           L + +LKE+L      R K ++      +++L  A++I + M YL  ++   +HRDL   
Sbjct: 90  LPSGSLKEYL-----PRNKNKI----NLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAAR 138

Query: 336 NIFLDDAKHVRIADFGHARFLSDGEMALT------GTFVYMAPE-VIQCEPYSEKSDVYS 388
           N+ ++    V+I DFG  + +   +   T          + APE +IQ + Y   SDV+S
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYI-ASDVWS 197

Query: 389 FGIILNEIITGNHPYIEKDYKP-----------------AKIAMEVGEGKLRPALPEEDG 431
           FG+ L E++T    Y + +  P                  ++   + EGK    LP    
Sbjct: 198 FGVTLYELLT----YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK---RLPRPPN 250

Query: 432 QLRELIELICLSWDGDASVRPSFSSI 457
              E+ +L+   W+   S R +F ++
Sbjct: 251 CPEEVYQLMRKCWEFQPSKRTTFQNL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 40/107 (37%), Positives = 63/107 (58%), Gaps = 7/107 (6%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL--TGTFVY 369
           +I   + +LH     +++RD+KP N+ LDD  + R++D G A  L DG+      GT  Y
Sbjct: 103 QITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
           MAPE+++ EPYS   D ++ G  + E++ G  P+  KD+K  K+A E
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF--KDHK-EKVAKE 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 73.1 bits (179), Expect = 5e-14
 Identities = 53/177 (29%), Positives = 86/177 (48%), Gaps = 22/177 (12%)

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLS 357
           P   + + +  + ++A  M++L  +    +HRDL   N+ + + K V+I DFG AR  + 
Sbjct: 234 PALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLICEGKLVKICDFGLARDIMR 291

Query: 358 DGEMALTG-TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI-----EKD 407
           D      G TF+   +MAPE I    Y+  SDV+SFGI+L EI T G  PY      E+ 
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           Y   K    +     +PA   +     E+ E++   W+    +RP FS +   + ++
Sbjct: 352 YNAIKRGYRMA----KPAHASD-----EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 47/132 (35%), Positives = 73/132 (55%), Gaps = 6/132 (4%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMALTGTFV 368
           A EI   ++++H +   V++RDLKP+NI LD+  HVRI+D G A  F      A  GT  
Sbjct: 103 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160

Query: 369 YMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
           YMAPEV+Q    Y   +D +S G +L +++ G+ P+ +   K  K  ++     +   LP
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKHEIDRMTLTMAVELP 219

Query: 428 EEDG-QLRELIE 438
           +    +LR L+E
Sbjct: 220 DSFSPELRSLLE 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 36/278 (12%)

Query: 199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           L E +G+G      + +     VAVK +  D     + A   F +E+  +SR ++  +++
Sbjct: 29  LAEFLGEGAPEFDGQPVL----VAVKMLRAD---VTKTARNDFLKEIKIMSRLKNPNIIR 81

Query: 259 LMGACL-EPPYRGWLVTELL-GTTLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIA 314
           L+G C+ + P    ++TE +    L ++L    + S       +P       L  A++IA
Sbjct: 82  LLGVCVSDDPL--CMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGTFV----Y 369
             M+YL       +HRDL   N  + +   ++IADFG +R L  G+   + G  V    +
Sbjct: 140 SGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRW 197

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT--GNHPY-IEKDYKPAKIAMEVGEGKLR--- 423
           MA E I    ++  SDV++FG+ L E+ T     PY +  D +  +   E    + R   
Sbjct: 198 MAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY 257

Query: 424 ----PALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               P  P        + +L+   W  D   RP+F+ I
Sbjct: 258 LSQTPLCPS------PVFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 73.0 bits (179), Expect = 5e-14
 Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 17/174 (9%)

Query: 294 KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
            E   PL   ++ L  + ++AQ M +L  +    IHRD+   N+ L D +  +I DFG A
Sbjct: 203 TEDSWPLD-LDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLA 259

Query: 354 R-FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IE 405
           R  ++D    + G       +MAPE I    Y+ +SDV+S+GI+L EI + G  PY  I 
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319

Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
            + K  K+    G    RP     D    E+  ++ + W+ + + RP+FS I+ 
Sbjct: 320 VNSKFYKMVKR-GYQMSRP-----DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 6e-14
 Identities = 49/141 (34%), Positives = 79/141 (56%), Gaps = 15/141 (10%)

Query: 291 QRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA 348
           QR KE +    PF+E     L  +I  A+  +H +K  ++HRDLK +NIFL     +++ 
Sbjct: 158 QRLKEHL----PFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLG 211

Query: 349 DFGHARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           DFG ++  SD        +  GT  Y+APE+ + + YS+K+D++S G+IL E++T + P+
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPF 271

Query: 404 IEKDYKPAKIAMEVGEGKLRP 424
             K     +I  +V  GK  P
Sbjct: 272 --KGPSQREIMQQVLYGKYDP 290

Length = 478

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 19/204 (9%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  +    +E   +   +E+  L    H  +++
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLE--TEDEGVPSTAIREISLLKELNHPNIVR 62

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++           ++         +   ++ Q + 
Sbjct: 63  LLDV-VHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIK--------SYLYQLLQGIA 113

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEV- 374
           Y H  +  V+HRDLKP N+ +D    +++ADFG AR         T   V   Y APE+ 
Sbjct: 114 YCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 171

Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           +    YS   D++S G I  E++ 
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 72.0 bits (177), Expect = 7e-14
 Identities = 50/167 (29%), Positives = 75/167 (44%), Gaps = 30/167 (17%)

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           T + +RH F++ L  AC +       V E   G  L   +H        +       F E
Sbjct: 55  TANSERHPFLVNLF-ACFQTEDHVCFVMEYAAGGDLMMHIH-------TDV------FSE 100

Query: 306 RLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
             A   A  +   +QYLHE K  +++RDLK  N+ LD    V+IADFG    L    M  
Sbjct: 101 PRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFG----LCKEGMGF 154

Query: 364 ---TGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              T TF     ++APEV+    Y+   D +  G+++ E++ G  P+
Sbjct: 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 71.4 bits (175), Expect = 7e-14
 Identities = 40/109 (36%), Positives = 61/109 (55%), Gaps = 10/109 (9%)

Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E   R    EI  A+ +LH  +  +I+RD+K  NI LD   HV + DFG ++ FL++ 
Sbjct: 102 FTESEVRVYIAEIVLALDHLH--QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159

Query: 360 E---MALTGTFVYMAPEVIQCEP--YSEKSDVYSFGIILNEIITGNHPY 403
           E    +  GT  YMAPEVI+     + +  D +S G++  E++TG  P+
Sbjct: 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 71.1 bits (174), Expect = 8e-14
 Identities = 51/169 (30%), Positives = 76/169 (44%), Gaps = 38/169 (22%)

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL E     +HRDL   NI ++     +++DFG +RFL D     T T      
Sbjct: 115 IAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKPAK 412
               + APE I    ++  SDV+S+GI++ E+++ G  PY           IE+DY+   
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR--- 229

Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
                      P   +    L +L+ L C  W  D + RP F  I  +L
Sbjct: 230 ----------LPPPMDCPTALHQLM-LDC--WQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 81/309 (26%), Positives = 139/309 (44%), Gaps = 56/309 (18%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 13  WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD---ATEKDLSD 69

Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 70  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 125

Query: 298 ------VP--LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++ A ++A+ M+YL  +K   IHRDL   N+ + +   ++IAD
Sbjct: 126 CYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIAD 183

Query: 350 FGHARFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-G 399
           FG AR +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG 239

Query: 400 NHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
             PY    +E+ +K     ++ G    +P+         EL  ++   W    S RP+F 
Sbjct: 240 GSPYPGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFK 290

Query: 456 SITCSLKNI 464
            +   L  I
Sbjct: 291 QLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 71.4 bits (175), Expect = 8e-14
 Identities = 41/105 (39%), Positives = 59/105 (56%), Gaps = 6/105 (5%)

Query: 304 EERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
           E  L R A+ + + + YL   K  ++HRD+KPSN+ ++    V++ DFG +  L +  +A
Sbjct: 94  EHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN-SIA 150

Query: 363 LT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
            T  GT  YMAPE I  E Y   SDV+S GI   E+  G  PY +
Sbjct: 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 73/258 (28%), Positives = 119/258 (46%), Gaps = 29/258 (11%)

Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT 280
           VAVK +  D F +++  +  F +E   +    H  V++L+G  L    +G L   ++   
Sbjct: 30  VAVKMLKADIFSSSD--IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMV--I 85

Query: 281 LKEWLHG-----LGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIHRDLKP 334
           L    HG     L   R  E    LP   + L R  ++IA  M+YL  +    IHRDL  
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFTLP--LQTLVRFMIDIASGMEYLSSKN--FIHRDLAA 141

Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSF 389
            N  L++   V +ADFG ++ +  G+    G        ++A E +    Y+  SDV++F
Sbjct: 142 RNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAF 201

Query: 390 GIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDG 446
           G+ + EI+T G  PY  +E     ++I   + +G      P+    L ++ EL+C  W  
Sbjct: 202 GVTMWEIMTRGQTPYAGVEN----SEIYNYLIKGNRLKQPPD---CLEDVYELMCQCWSP 254

Query: 447 DASVRPSFSSITCSLKNI 464
           +   RPSF  +   L+ I
Sbjct: 255 EPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 72.0 bits (176), Expect = 9e-14
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 6/112 (5%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 92  FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 150

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 151 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 75/243 (30%), Positives = 116/243 (47%), Gaps = 32/243 (13%)

Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  +  G  VAVK +  D        + F   EV  + 
Sbjct: 17  DPRTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 72

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 73  DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRMN-----EEQI 118

Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + +A+  LH Q   VIHRD+K  +I L     V+++DFG    +S       +L
Sbjct: 119 AAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 176

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 233

Query: 424 PAL 426
           P L
Sbjct: 234 PKL 236

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 76/310 (24%), Positives = 135/310 (43%), Gaps = 46/310 (14%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W      + L + +G+G    + RA   G+D         VAVK +  +   T+++    
Sbjct: 7   WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN--ATDKDLADL 64

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM--- 297
            ++        +H+ ++ L+G C +      +V       L+E+L      RR       
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRA----RRPPGPDYT 120

Query: 298 -----VPLPP--FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
                VP     F++ ++ A ++A+ M+YL  ++   IHRDL   N+ + +   ++IADF
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTEDNVMKIADF 178

Query: 351 GHARFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN 400
           G AR +         S+G + +     +MAPE +    Y+ +SDV+SFGI++ EI T G 
Sbjct: 179 GLARGVHDIDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234

Query: 401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS 460
            PY     +     +  G    +P+         EL  L+   W    + RP+F  +  +
Sbjct: 235 SPYPGIPVEELFKLLREGHRMDKPS-----NCTHELYMLMRECWHAVPTQRPTFKQLVEA 289

Query: 461 LKNIQMKVTE 470
           L  +   V+E
Sbjct: 290 LDKVLAAVSE 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 37/97 (38%), Positives = 57/97 (58%), Gaps = 5/97 (5%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLSDGEMALTGT 366
           A EI   +Q+LH +   +I+RDLK  N+ LD   H++IADFG  +   F  +      GT
Sbjct: 102 AAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE++Q   Y+   D +SFG++L E++ G  P+
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 8/105 (7%)

Query: 302 PFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
           PF E   +   L++ + +QYLHE    +IHRDLK SN+ L D   ++IADFG AR     
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161

Query: 360 EMALTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITGN 400
              +T   V   Y APE++  C  Y+   D+++ G IL E++   
Sbjct: 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 38/98 (38%), Positives = 59/98 (60%), Gaps = 7/98 (7%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV- 368
           A EI   +Q+LH +   +++RDLK  NI LD   H++IADFG  +    G+ A T TF  
Sbjct: 102 AAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTFCG 158

Query: 369 ---YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              Y+APE++  + Y+   D +SFG++L E++ G  P+
Sbjct: 159 TPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 69/230 (30%), Positives = 107/230 (46%), Gaps = 30/230 (13%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP +  ++ E IG+GT   +++ + +  G   AVK + P   H  +  +      +  LS
Sbjct: 15  DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP--IHDIDEEIEAEYNILKALS 72

Query: 250 RQRHRFVLQLMGACLEPPYRG----WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFE 304
              H  V++  G   +   +     WLV EL  G ++ + + G    +R ERM      E
Sbjct: 73  D--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGF--LKRGERME-----E 123

Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-- 361
             +A  L E    +Q+LH  K   IHRD+K +NI L     V++ DFG +  L+   +  
Sbjct: 124 PIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 362 -ALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIE 405
               GT  +MAPEVI CE      Y  + DV+S GI   E+  G+ P  +
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLAD 231

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 29/106 (27%), Positives = 51/106 (48%), Gaps = 6/106 (5%)

Query: 301 PPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHARFLS 357
               E   +    ++ +A+  LH  K  +IH D+K  N+  D AK  + + D+G  + + 
Sbjct: 104 GKLSEAEVKKIIRQLVEALNDLH--KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-II 160

Query: 358 DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                  GT  Y +PE I+   Y    D ++ G++  E++TG HP+
Sbjct: 161 GTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 31/266 (11%)

Query: 201 EKIGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           E +G+G    +++  +     VAVK    D     E  + F   E   L +  H  +++L
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFL-SEARILKQYDHPNIVKL 57

Query: 260 MGACLE--PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           +G C +  P Y   +V EL+ G     +L     +++K+ +      ++ +  AL+ A  
Sbjct: 58  IGVCTQRQPIY---IVMELVPGGDFLSFL-----RKKKDEL----KTKQLVKFALDAAAG 105

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG----TFVYMAP 372
           M YL  +    IHRDL   N  + +   ++I+DFG +R   DG  + +G       + AP
Sbjct: 106 MAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAP 163

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG 431
           E +    YS +SDV+S+GI+L E  + G  PY     + A+  +E G    R + P++  
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG---YRMSCPQKCP 220

Query: 432 QLRELIELICLSWDGDASVRPSFSSI 457
              ++ +++   WD     RP FS +
Sbjct: 221 D--DVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 7/112 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 92  FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 80/296 (27%), Positives = 119/296 (40%), Gaps = 61/296 (20%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYP---------------DFFHTN 234
           DP +  ++ E IG+GT   +Y+   +  G   AVK + P                    +
Sbjct: 19  DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNH 78

Query: 235 ENAVTFFAQ--EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGL--G 289
            N V F+    + D           +L+G  L      WLV EL  G ++ E + GL   
Sbjct: 79  PNVVKFYGMFYKAD-----------KLVGGQL------WLVLELCNGGSVTELVKGLLIC 121

Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            QR  E M+    +   L         +Q+LH    ++IHRD+K +NI L     V++ D
Sbjct: 122 GQRLDEAMISYILYGALL--------GLQHLHNN--RIIHRDVKGNNILLTTEGGVKLVD 171

Query: 350 FGHARFLSDGEM---ALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNH 401
           FG +  L+   +      GT  +MAPEVI CE      Y  + DV+S GI   E+  G+ 
Sbjct: 172 FGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Query: 402 PYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           P    D  P K   ++      P L   +   R     I      D   RPS + +
Sbjct: 232 PLF--DMHPVKTLFKIPRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHL 284

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 14/156 (8%)

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGT----- 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D  E A T       
Sbjct: 115 IASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    ++  SDV+S+GI++ E+++ G  PY E   +    A+E  EG   PA
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE--EGYRLPA 230

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
             +    L +L+ L C  W  D + RP F  I   L
Sbjct: 231 PMDCPAALHQLM-LDC--WQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)

Query: 201 EKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIGQG +  +Y AI    G +VA+K +        +        E+  +   +H  ++ 
Sbjct: 25  EKIGQGASGTVYTAIDVATGQEVAIKQMN----LQQQPKKELIINEILVMRENKHPNIVN 80

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQA 316
            + +        +LV + L   + E+L G GS      +V     +E    A+  E  QA
Sbjct: 81  YLDS--------YLVGDELWVVM-EYLAG-GSL---TDVVTETCMDEGQIAAVCRECLQA 127

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFVYMAPE 373
           +++LH  +  VIHRD+K  NI L     V++ DFG    ++  +     + GT  +MAPE
Sbjct: 128 LEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE 185

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           V+  + Y  K D++S GI+  E++ G  PY+ ++
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 14/159 (8%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE----MALTGTF 367
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E        G +
Sbjct: 103 QVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160

Query: 368 --VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE +    +S KSDV+SFG+++ E  + G  PY  K  K  ++   +  G+ R 
Sbjct: 161 PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPY--KGMKGNEVTQMIESGE-RM 217

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
             P+      E+ +L+ L W      RP F+ +   L+N
Sbjct: 218 ECPQ--RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 43/111 (38%), Positives = 64/111 (57%), Gaps = 6/111 (5%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDG 359
           F E+  R  A EI   ++++H +   V++RDLKP+NI LD+  HVRI+D G A  F    
Sbjct: 94  FSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 151

Query: 360 EMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
             A  GT  YMAPEV+Q    Y   +D +S G +L +++ G+ P+ +   K
Sbjct: 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 70.7 bits (173), Expect = 3e-13
 Identities = 55/162 (33%), Positives = 84/162 (51%), Gaps = 16/162 (9%)

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMA 362
           E+ L+ + ++A+ M +L  +    IHRDL   NI L   +  +I DFG AR + +D    
Sbjct: 214 EDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271

Query: 363 LTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAM 415
           + G       +MAPE I    Y+ +SDV+S+GI+L EI + G+ PY  +  D K  K+  
Sbjct: 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM-- 329

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            + EG  R   PE      E+ +++   WD D   RP+F  I
Sbjct: 330 -IKEG-YRMLSPECAPS--EMYDIMKSCWDADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 69.6 bits (171), Expect = 3e-13
 Identities = 31/93 (33%), Positives = 49/93 (52%), Gaps = 6/93 (6%)

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV-- 368
           L++   + +LH+    ++HRDLK SN+ L++   ++I DFG AR         T   V  
Sbjct: 113 LQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL 170

Query: 369 -YMAPEVIQCEP-YSEKSDVYSFGIILNEIITG 399
            Y APE++     YS   D++S G I  E++T 
Sbjct: 171 WYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK 203

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 57/216 (26%), Positives = 105/216 (48%), Gaps = 37/216 (17%)

Query: 203 IGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF----- 255
           IG+G+ A +     +      A+K I  +  + +E        ++D +  ++H F     
Sbjct: 3   IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE--------DIDWVQTEKHVFETASN 54

Query: 256 --VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--A 310
              L  + +C +   R + V E + G  L   +  +  QR+      LP   E  AR  +
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRK------LP---EEHARFYS 102

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTF 367
            EI+ A+ +LHE+   +I+RDLK  N+ LD   H+++ D+G  +  +  G+   T  GT 
Sbjct: 103 AEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            Y+APE+++ E Y    D ++ G+++ E++ G  P+
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 70.4 bits (172), Expect = 4e-13
 Identities = 55/178 (30%), Positives = 79/178 (44%), Gaps = 33/178 (18%)

Query: 242 AQEVDTLSRQRHRFVLQLMGA-------CLE-PPYRGWLVTELLGTTLKEWLHGLGSQRR 293
           A E   L    H  ++QL G        CL  P Y+         T L  +L    + +R
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK---------TDLYCYL----AAKR 177

Query: 294 KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
              +  +   E  + RA+      QYLHE +  +IHRD+K  NIF++    V + DFG A
Sbjct: 178 NIAICDILAIERSVLRAI------QYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAA 229

Query: 354 RFLSD----GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
            F  D          GT    APE++  +PY    D++S GI+L E+ T +    EKD
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287

Length = 391

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 52/180 (28%), Positives = 88/180 (48%), Gaps = 14/180 (7%)

Query: 291 QRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
           Q  K R      F E  A  L I   +   H     +IHRD+K +NI L     V++ DF
Sbjct: 128 QEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187

Query: 351 GHARFLS-----DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           G ++  +     D      GT  Y+APE+ + +PYS+K+D++S G++L E++T   P+  
Sbjct: 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247

Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI----TCSL 461
           ++ +  ++  +   G+  P  P    +++E++  + LS   D   RPS S +     C L
Sbjct: 248 ENME--EVMHKTLAGRYDPLPPSISPEMQEIVTAL-LS--SDPKRRPSSSKLLNMPICKL 302

Length = 496

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 42/127 (33%), Positives = 73/127 (57%), Gaps = 10/127 (7%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDG 359
           F E  A+    E+  A+++LH+    +++RDLKP NI LD   H+ + DFG ++  L+D 
Sbjct: 93  FSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN 150

Query: 360 EMALT--GTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
           +   T  GT  Y+APEV+  E  Y++  D +S G+++ E+  G  P+  +D +  ++   
Sbjct: 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ--QMYRN 208

Query: 417 VGEGKLR 423
           +  GK+R
Sbjct: 209 IAFGKVR 215

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 69.0 bits (169), Expect = 5e-13
 Identities = 58/210 (27%), Positives = 102/210 (48%), Gaps = 29/210 (13%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EK+G+GT A +Y+   R  G  VA+K I+ D     E   +   +E+  +   +H  +++
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVALKEIHLD---AEEGTPSTAIREISLMKELKHENIVR 62

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    +    +  LV E +   LK+++   G +        L P   + +   ++ + + 
Sbjct: 63  LHDV-IHTENKLMLVFEYMDKDLKKYMDTHGVRG------ALDPNTVK-SFTYQLLKGIA 114

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--------FLSDGEMALTGTFVYM 370
           + HE +  V+HRDLKP N+ ++    +++ADFG AR        F ++       T  Y 
Sbjct: 115 FCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-----VVTLWYR 167

Query: 371 APEVIQ-CEPYSEKSDVYSFGIILNEIITG 399
           AP+V+     YS   D++S G I+ E+ITG
Sbjct: 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITG 197

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.0 bits (168), Expect = 5e-13
 Identities = 70/229 (30%), Positives = 107/229 (46%), Gaps = 35/229 (15%)

Query: 193 DPKEI-DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP  I +L E +G GT   +Y  R +  G   A+K +  D     E  +    QE++ L 
Sbjct: 3   DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIK---QEINMLK 57

Query: 250 R-QRHRFVLQLMGACLE--PPY---RGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPP 302
           +   HR +    GA ++  PP    + WLV E  G  ++ + +        KE  +    
Sbjct: 58  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-- 115

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
               + R  EI + + +LH+ K  VIHRD+K  N+ L +   V++ DFG +  L D  + 
Sbjct: 116 ----ICR--EILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVG 166

Query: 363 LTGTFV----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHP 402
              TF+    +MAPEVI C+      Y  KSD++S GI   E+  G  P
Sbjct: 167 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 68.9 bits (168), Expect = 5e-13
 Identities = 75/284 (26%), Positives = 125/284 (44%), Gaps = 46/284 (16%)

Query: 203 IGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVL 257
           IG+G    + +A  +     +D A+K +     + +++    FA E++ L +   H  ++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER----------- 306
            L+GAC     RG+L   +        L  L    RK R++   P               
Sbjct: 60  NLLGACEH---RGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAIANSTASTLSSQ 112

Query: 307 --LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT 364
             L  A ++A+ M YL +++   IHRDL   NI + +    +IADFG    LS G+    
Sbjct: 113 QLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFG----LSRGQEVYV 166

Query: 365 GTFV------YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
              +      +MA E +    Y+  SDV+S+G++L EI++ G  PY       A++  ++
Sbjct: 167 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKL 224

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
            +G  R   P       E+ +L+   W      RPSF+ I  SL
Sbjct: 225 PQG-YRLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 69.7 bits (170), Expect = 5e-13
 Identities = 40/119 (33%), Positives = 69/119 (57%), Gaps = 7/119 (5%)

Query: 293 RKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
           ++ + +P    EE L + ++ + + + YL E K +++HRD+KPSNI ++    +++ DFG
Sbjct: 95  KEAKRIP----EEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFG 149

Query: 352 HARFLSDGEM-ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            +  L D    +  GT  YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 150 VSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK 208

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 69/280 (24%), Positives = 120/280 (42%), Gaps = 35/280 (12%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I P  I  Q+ IG G    ++R I +      + VA+K + P +          F  E  
Sbjct: 2   IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD---FLSEAS 58

Query: 247 TLSRQRHRFVLQLMGACLEPPYR-GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            + +  H  +++L G   +  ++   ++TE +        +G   +  ++       ++ 
Sbjct: 59  IMGQFSHHNIIRLEGVVTK--FKPAMIITEYME-------NGALDKYLRDHDGEFSSYQ- 108

Query: 306 RLARALE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD---GEM 361
            L   L  IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   G  
Sbjct: 109 -LVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY 165

Query: 362 ALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
             +G  +   + APE I    ++  SDV+SFGI++ E+++ G  PY +        A+  
Sbjct: 166 TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND 225

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           G    R  LP        + +L+   W  D + RP F  I
Sbjct: 226 G---FR--LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDI 260

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 109 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 167

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 38/224 (16%)

Query: 198 DLQEKIGQGTTANIYRAIW----RGLDVAVKCIYPDFFHTNENAVTFFAQ----EVDTLS 249
           +++  IG+GT   +Y+A       G + A+K    D         T  +Q    E+  L 
Sbjct: 3   EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQY-----TGISQSACREIALLR 57

Query: 250 RQRHRFVLQLMGACLEPPYRG-WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             +H  V+ L+   LE   +  +L+ +     L      +   R+ +R V +PP    + 
Sbjct: 58  ELKHENVVSLVEVFLEHADKSVYLLFDYAEHDL---WQIIKFHRQAKR-VSIPP---SMV 110

Query: 309 RAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARF------- 355
           ++L  +I   + YLH     V+HRDLKP+NI +     +   V+I D G AR        
Sbjct: 111 KSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP 168

Query: 356 LSDGEMALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIIT 398
           L+D +  +  T  Y APE++     Y++  D+++ G I  E++T
Sbjct: 169 LADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 69.4 bits (170), Expect = 8e-13
 Identities = 36/87 (41%), Positives = 48/87 (55%), Gaps = 6/87 (6%)

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            +++LH     +IHRDLKPSNI +     ++I DFG AR      M +T   V   Y AP
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM-MTPYVVTRYYRAP 186

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITG 399
           EVI    Y E  D++S G I+ E+I G
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 203 IGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           IG+G+ A +     +  +   A+K +  +  + +E+ + +   E     +  +   L  +
Sbjct: 3   IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDED-IDWVQTEKHVFEQASNHPFLVGL 61

Query: 261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL 320
            +C +   R + V E        +++G       +R   LP    R   A EI+ A+ YL
Sbjct: 62  HSCFQTESRLFFVIE--------YVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYL 112

Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLSDGEMALTGTFVYMAPEVIQC 377
           HE+   +I+RDLK  N+ LD   H+++ D+G  +      D      GT  Y+APE+++ 
Sbjct: 113 HERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 378 EPYSEKSDVYSFGIILNEIITGNHPY 403
           E Y    D ++ G+++ E++ G  P+
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 41/110 (37%), Positives = 60/110 (54%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSD 358
           F E  AR  A EIA A+ YLH     +++RDLKP NI LD   H+ + DFG  +     +
Sbjct: 93  FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 150

Query: 359 GEMA-LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G  +   GT  Y+APEV+  +PY    D +  G +L E++ G  P+  ++
Sbjct: 151 GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 35/229 (15%)

Query: 193 DPKEI-DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP  I +L E +G GT   +Y  R +  G   A+K +        E+       E++ L 
Sbjct: 13  DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTEDEEEEIKLEINMLK 67

Query: 250 R-QRHRFVLQLMGACLE--PPYRG---WLVTELLGT-TLKEWLHGLGSQRRKERMVPLPP 302
           +   HR +    GA ++  PP      WLV E  G  ++ + +        KE  +    
Sbjct: 68  KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-- 125

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
               + R  EI + + +LH  K  VIHRD+K  N+ L +   V++ DFG +  L D  + 
Sbjct: 126 ----ICR--EILRGLAHLHAHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVG 176

Query: 363 LTGTFV----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHP 402
              TF+    +MAPEVI C+      Y  +SD++S GI   E+  G  P
Sbjct: 177 RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 16/160 (10%)

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTG 365
           L+   ++A+ M++L  +    +HRDL   N+ L   K V+I DFG AR  + D      G
Sbjct: 240 LSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 366 -TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
            TF+   +MAPE I    Y+  SDV+S+GI+L EI + G  PY      P  I       
Sbjct: 298 STFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY------PGMIVDSTFYN 351

Query: 421 KLRPA--LPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
           K++    + + D   +E+ +++   W+ +   RPSF  ++
Sbjct: 352 KIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLS 391

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 70/289 (24%), Positives = 125/289 (43%), Gaps = 37/289 (12%)

Query: 197 IDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAV----TFFAQEV 245
           +   E++G+G    +Y+    G +       VA+K +        ENA       F QE 
Sbjct: 7   VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTL-------KENAEPKVQQEFRQEA 59

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVP 299
           + +S  +H  ++ L+G C +      L   L    L E+L        +G++   E +  
Sbjct: 60  ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKS 119

Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLS 357
                + L  A++IA  M+YL       +HRDL   N  + +   V+I+DFG +R  + +
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSA 177

Query: 358 DGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI 413
           D     + + +   +M PE I    ++ +SD++SFG++L EI + G  PY    +   ++
Sbjct: 178 DYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYY--GFSNQEV 235

Query: 414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
              +     R  LP  +     +  L+   W+   + RP F  I   L+
Sbjct: 236 IEMIRS---RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 21/235 (8%)

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYR-GWLVTELLGTTLKEWLHG-LGSQRRKERMV 298
           F  E   +    H  V++L+G CL+     G+    ++   +K   HG L S     R+ 
Sbjct: 47  FLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMK---HGDLHSFLLYSRLG 103

Query: 299 PLP---PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
             P   P +  +    +IA  M+YL  +    IHRDL   N  L++  +V +ADFG ++ 
Sbjct: 104 DCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVADFGLSKK 161

Query: 356 LSDGEMALTGTFVYMAPEVIQCEP-----YSEKSDVYSFGIILNEIIT-GNHPYIEKDYK 409
           + +G+    G    M  + I  E      Y+ KSDV+SFG+ + EI T G  PY   +  
Sbjct: 162 IYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS 221

Query: 410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                +  G    +P        L  L  L+   W  +   RPSF ++ C L+  
Sbjct: 222 EIYDYLRQGNRLKQPP-----DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 37/110 (33%), Positives = 61/110 (55%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF---LS 357
           F+   AR    E+  A++ LH+    VI+RDLKP NI LD   H+ + DFG  +      
Sbjct: 90  FDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD 147

Query: 358 DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           D      GT  Y+APE++    Y++  D ++ G++L E++TG  P+ +++
Sbjct: 148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 41/114 (35%), Positives = 64/114 (56%), Gaps = 14/114 (12%)

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSDGEMALTGTFVYM 370
           +A+ YLHE K  +IHRDLK  NI       +++ADFG    + R +   + +  GT  +M
Sbjct: 114 EALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-SFIGTPYWM 170

Query: 371 APEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           APEV+ CE     PY  K+DV+S GI L E+     P+ E +  P ++ +++ +
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAK 222

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 31/213 (14%)

Query: 203 IGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF----- 255
           IG+G+ A +     +  D   A+K +  +  H +E        ++D +  ++H F     
Sbjct: 3   IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDE--------DIDWVQTEKHVFEQASS 54

Query: 256 --VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
              L  + +C +   R +LV E        +++G       +R   LP    R   A EI
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIE--------YVNGGDLMFHMQRQRKLPEEHARF-YAAEI 105

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFVYM 370
             A+ +LHE+   +I+RDLK  N+ LD   H+++ D+G  +  L  G+   T  GT  Y+
Sbjct: 106 CIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYI 163

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           APE+++ E Y    D ++ G+++ E++ G  P+
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 20/210 (9%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           +K+G+GT A +Y+A  +     VA+K I        ++ + F A +E+  L   +H  ++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
            L+           LV E + T L++ +        K++ + L P + + +  L   + +
Sbjct: 66  GLLDVFGHKSNIN-LVFEFMETDLEKVI--------KDKSIVLTPADIK-SYMLMTLRGL 115

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEV 374
           +YLH     ++HRDLKP+N+ +     +++ADFG AR        +T   V   Y APE+
Sbjct: 116 EYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 375 I-QCEPYSEKSDVYSFGIILNEIITGNHPY 403
           +     Y    D++S G I  E++    P+
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV-PF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 67/207 (32%), Positives = 95/207 (45%), Gaps = 24/207 (11%)

Query: 193 DPKEI--DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           DP+++  DL+E IG G+   +Y  R +     VA+K +      +NE       +EV  L
Sbjct: 12  DPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVRFL 69

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            + RH   ++  G C    +  WLV E          + LGS      +   P  E  +A
Sbjct: 70  QQLRHPNTIEYKG-CYLREHTAWLVME----------YCLGSASDILEVHKKPLQEVEIA 118

Query: 309 RALEIA-QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
                A Q + YLH  +   IHRD+K  NI L +   V++ADFG A  +S    +  GT 
Sbjct: 119 AICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-SFVGTP 175

Query: 368 VYMAPEVIQCE---PYSEKSDVYSFGI 391
            +MAPEVI       Y  K DV+S GI
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.5 bits (165), Expect = 3e-12
 Identities = 36/102 (35%), Positives = 57/102 (55%), Gaps = 10/102 (9%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGT 366
           A +I   + YLH  +  ++HRD+KPSN+ ++ AK+V+IADFG +R L+   D   +  GT
Sbjct: 174 ARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGT 231

Query: 367 FVYMAPEVIQCEPYSEK-----SDVYSFGIILNEIITGNHPY 403
             YM+PE I  +           D++S G+ + E   G  P+
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 24/148 (16%)

Query: 271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVI 328
           ++V +L+ + L   +H    Q          P  E   R    ++ + ++Y+H     VI
Sbjct: 84  YVVMDLMESDLHHIIHS--DQ----------PLTEEHIRYFLYQLLRGLKYIHSAN--VI 129

Query: 329 HRDLKPSNIFLDDAKHVRIADFGHARFLS----DGEMALT---GTFVYMAPEVIQCEP-Y 380
           HRDLKPSN+ +++   +RI DFG AR LS    + +  +T    T  Y APE++   P Y
Sbjct: 130 HRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEY 189

Query: 381 SEKSDVYSFGIILNEIITGNHPYIEKDY 408
           +   D++S G I  E++     +  K+Y
Sbjct: 190 TTAIDMWSVGCIFAEMLGRRQLFPGKNY 217

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 5/101 (4%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFV 368
           EI  A+ YLH  K  +++RDLK  N+ LD   H++I DFG  +  ++D     T  GT  
Sbjct: 103 EIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 38/97 (39%), Positives = 61/97 (62%), Gaps = 7/97 (7%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGE---MALTGTF 367
           EI  A+++LH  K  +++RD+K  NI LD   HV + DFG ++ FLS+ +    +  GT 
Sbjct: 113 EIILALEHLH--KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 368 VYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
            YMAPE+I+ +    K+ D +S GI++ E++TG  P+
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 32/276 (11%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
             E+   + +G G    +++ IW        + VA+K I           +T     + +
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           L    H ++++L+G C     +  LVT+L          G      ++    L P +  L
Sbjct: 66  LD---HAYIVRLLGICPGASLQ--LVTQLSP-------LGSLLDHVRQHRDSLDP-QRLL 112

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
              ++IA+ M YL E +  ++HR+L   NI L     V+IADFG A  L   +     + 
Sbjct: 113 NWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170

Query: 368 V-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 +MA E I    Y+ +SDV+S+G+ + E+++ G  PY           +E GE  
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL 230

Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +P +   D     +  ++   W  D +VRP+F  +
Sbjct: 231 AQPQICTID-----VYMVMVKCWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 5/99 (5%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---LTGTFV 368
           E  QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++  +     + GT  
Sbjct: 124 ECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           +MAPEV+  + Y  K D++S GI+  E+I G  PY+ ++
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 65.9 bits (160), Expect = 6e-12
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 31/225 (13%)

Query: 193 DPKEIDLQ-EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DPK+   + EKIGQG +  +Y A  I  G +VA+K                   +++   
Sbjct: 16  DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIK-------------------QMNLQQ 56

Query: 250 RQRHRFVLQ---LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           + +   ++    +M     P    +L + L+G  L   +  L      + +      E +
Sbjct: 57  QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ 116

Query: 307 LARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---A 362
           +A    E  QA+ +LH  +  VIHRD+K  NI L     V++ DFG    ++  +     
Sbjct: 117 IAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 174

Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           + GT  +MAPEV+  + Y  K D++S GI+  E++ G  PY+ ++
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.9 bits (161), Expect = 6e-12
 Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 25/173 (14%)

Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT----LKEWLHGLGSQRRKERMV 298
           +E+  L + RH  ++ L+        R +LV E +  T    L+++ +GL   R ++ + 
Sbjct: 49  REIRMLKQLRHENLVNLIEVFRRKK-RLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL- 106

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
                        +I + +++ H     +IHRD+KP NI +  +  V++ DFG AR L+ 
Sbjct: 107 ------------FQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152

Query: 359 GEMALT---GTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKD 407
                T    T  Y APE++  +  Y    D+++ G ++ E++TG  P    D
Sbjct: 153 PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE-PLFPGD 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHR-FV 256
           EKIG+GT   +Y+A     G  VA+K         +E  +   A +E+  L       ++
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIYI 63

Query: 257 LQLMGACLE------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
           ++L+   +E           +LV E L + LK+++    S  R     P  P   +  ++
Sbjct: 64  VRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMD---SNGRG----PGRPLPAKTIKS 114

Query: 311 L--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMALTGTF 367
              ++ + + + H  K  V+HRDLKP N+ +D  K + +IAD G  R  S    + T   
Sbjct: 115 FMYQLLKGVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 368 V---YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGN 400
           V   Y APEV +    YS   D++S G I  E+    
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 66.2 bits (161), Expect = 8e-12
 Identities = 48/177 (27%), Positives = 84/177 (47%), Gaps = 14/177 (7%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           E   L+   H F + L G+  +  Y   ++  ++G     +L      RR +R     P 
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------RRNKRF----PN 130

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
           +     A +I    +YL  Q   +++RDLKP N+ LD    +++ DFG A+ +      L
Sbjct: 131 DVGCFYAAQIVLIFEYL--QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL 188

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
            GT  Y+APE++    + + +D ++ GI + EI+ G  P+   +  P  I  ++ EG
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--PLLIYQKILEG 243

Length = 340

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 34/99 (34%), Positives = 57/99 (57%), Gaps = 5/99 (5%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALTGTFV 368
           E  QA+++LH  +  VIHRD+K  N+ L     V++ DFG    ++  +     + GT  
Sbjct: 123 ECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           +MAPEV+  + Y  K D++S GI+  E++ G  PY+ ++
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 9/96 (9%)

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPE 373
           ++Y+H     +IHRDLKP N+ +++   ++I DFG AR  +D EM  TG  V   Y APE
Sbjct: 130 LKYIH--SAGIIHRDLKPGNLAVNEDCELKILDFGLARH-ADAEM--TGYVVTRWYRAPE 184

Query: 374 VI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           VI     Y++  D++S G I+ E++TG   +  KDY
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 220

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 24/212 (11%)

Query: 193 DPKEI--DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           DP+++  DL+E IG G+   +Y  R +     VA+K +      +NE       +EV  L
Sbjct: 12  DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII-KEVRFL 69

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            + RH   +Q  G C    +  WLV E          + LGS      +   P  E  +A
Sbjct: 70  QKLRHPNTIQYRG-CYLREHTAWLVME----------YCLGSASDLLEVHKKPLQEVEIA 118

Query: 309 RALEIA-QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
                A Q + YLH     +IHRD+K  NI L +   V++ DFG A  ++       GT 
Sbjct: 119 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-XFVGTP 175

Query: 368 VYMAPEVIQCE---PYSEKSDVYSFGIILNEI 396
            +MAPEVI       Y  K DV+S GI   E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 73/294 (24%), Positives = 124/294 (42%), Gaps = 35/294 (11%)

Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I    I L+ ++G+G    ++ A    L        VAVK +       ++NA   F +
Sbjct: 1   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLK----DASDNARKDFHR 56

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLP 301
           E + L+  +H  +++  G C+E      +   +    L ++L  HG  +    E      
Sbjct: 57  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN---R 113

Query: 302 PFEERLARALEIAQ----AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           P E   ++ L IAQ     M YL  Q    +HRDL   N  + +   V+I DFG +R + 
Sbjct: 114 PAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171

Query: 358 DGEMALTGTFV-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPA 411
             +    G        +M PE I    ++ +SDV+S G++L EI T G  P+ +      
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 231

Query: 412 KIAMEVGEGKLRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +  G    RP   P+      E+ +L+   W  +  +R +   I   L+N+
Sbjct: 232 IECITQGRVLQRPRTCPK------EVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 66.7 bits (163), Expect = 1e-11
 Identities = 41/118 (34%), Positives = 58/118 (49%), Gaps = 23/118 (19%)

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-------LSD------- 358
           I   ++Y+H +   V+HRDLKP NI L     V I D+G A F       L D       
Sbjct: 122 ICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179

Query: 359 ---GEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                M + G  V    YMAPE +   P SE +D+Y+ G+IL +++T + PY  K  +
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Length = 932

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 34/179 (18%)

Query: 244 EVDTLSRQRHRFVLQLMGA-------CLE-PPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
           E+D L    HR ++ L+ A       C+  P Y+  L T +                  +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYV------------------D 177

Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           R  PLP  E+ +     + +A+ YLH +   +IHRD+K  NIFLD+ ++  + DFG A  
Sbjct: 178 RSGPLP-LEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACK 234

Query: 356 LSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           L            +GT    +PE++  +PY  K+D++S G++L E+   N     K  K
Sbjct: 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVK 293

Length = 392

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 35/212 (16%)

Query: 202 KIGQGTTANIYRAIWRGLD----VAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQR---H 253
           +IG G    +Y+A  R       VA+K +      TNE+ +     +EV  L R     H
Sbjct: 7   EIGVGAYGTVYKA--RDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 254 RFVLQLMGAC----LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLP--PFEERL 307
             +++LM  C     +   +  LV E +   L+ +L            VP P  P E   
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLD----------KVPPPGLPAETIK 111

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
               +  + + +LH     ++HRDLKP NI +     V++ADFG AR  S  +MALT   
Sbjct: 112 DLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLADFGLARIYS-CQMALTPVV 168

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEI 396
           V   Y APEV+    Y+   D++S G I  E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 71/256 (27%), Positives = 115/256 (44%), Gaps = 25/256 (9%)

Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-PYRGWLVTELL-G 278
           VAVK +  D    N+NA   F +E+  +SR +   +++L+  C+   P    ++TE +  
Sbjct: 49  VAVKMLRED---ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL--CMITEYMEN 103

Query: 279 TTLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
             L ++L  H       K   V    +   +  A +IA  M+YL       +HRDL   N
Sbjct: 104 GDLNQFLSRHEPQEAAEKAD-VVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRN 160

Query: 337 IFLDDAKHVRIADFGHARFLSDGE-MALTGTFV----YMAPEVIQCEPYSEKSDVYSFGI 391
             +     ++IADFG +R L  G+   + G  V    +M+ E I    ++  SDV++FG+
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 392 ILNEIIT--GNHPYIEKDYKPAKIAMEVGE----GKLRPALPEEDGQLRELIELICLSWD 445
            L EI+T     PY +      ++    GE       +  LP+       L +L+   W 
Sbjct: 221 TLWEILTLCKEQPYSQ--LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWR 278

Query: 446 GDASVRPSFSSITCSL 461
            +A  RPSF  I  +L
Sbjct: 279 RNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 41/128 (32%), Positives = 62/128 (48%), Gaps = 27/128 (21%)

Query: 297 MVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
           +  LP    R+  A E   A++YLH     ++HRDLKP N+ +    H+++ DFG ++  
Sbjct: 95  IGALPVDMARMYFA-ETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI- 150

Query: 357 SDGEMALT---------------------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNE 395
             G M+LT                     GT  Y+APEVI  + Y +  D ++ GIIL E
Sbjct: 151 --GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Query: 396 IITGNHPY 403
            + G  P+
Sbjct: 209 FLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 66/226 (29%), Positives = 111/226 (49%), Gaps = 40/226 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ---- 243
           W +  +  DL++ +G G    +  A+ R  G  VA+K +Y  F          FA+    
Sbjct: 11  WEVPDRYRDLKQ-VGSGAYGTVCSALDRRTGAKVAIKKLYRPF------QSELFAKRAYR 63

Query: 244 EVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
           E+  L   +H  V+ L+        L+  +  +LV   +GT L       G   + E++ 
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDL-------GKLMKHEKLS 116

Query: 299 PLPPFEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
                E+R+   + ++ + ++Y+H     +IHRDLKP N+ +++   ++I DFG AR  +
Sbjct: 117 -----EDRIQFLVYQMLKGLKYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QT 168

Query: 358 DGEMALTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           D EM  TG  V   Y APEVI     Y++  D++S G I+ E++TG
Sbjct: 169 DSEM--TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 70/212 (33%), Positives = 94/212 (44%), Gaps = 24/212 (11%)

Query: 193 DPKEI--DLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           DP+EI   L E IG G+   +Y A     +  VAVK +      TNE       +EV  L
Sbjct: 18  DPEEIFVGLHE-IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDII-KEVKFL 75

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            + +H   ++  G C    +  WLV E          + LGS      +   P  E  +A
Sbjct: 76  QQLKHPNTIEYKG-CYLKEHTAWLVME----------YCLGSASDLLEVHKKPLQEVEIA 124

Query: 309 RALEIA-QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
                A Q + YLH     +IHRD+K  NI L +   V++ADFG A   S    +  GT 
Sbjct: 125 AITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN-SFVGTP 181

Query: 368 VYMAPEVIQCE---PYSEKSDVYSFGIILNEI 396
            +MAPEVI       Y  K DV+S GI   E+
Sbjct: 182 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 45/163 (27%), Positives = 70/163 (42%), Gaps = 52/163 (31%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG--------- 351
           FEE LAR    E+  A++ +H  K   IHRD+KP NI +D   H+++ DFG         
Sbjct: 98  FEEDLARFYIAELTCAIESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155

Query: 352 ---------HARF-----------LSDGEM-----------------ALTGTFVYMAPEV 374
                    H R            +    +                 +L GT  Y+APEV
Sbjct: 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215

Query: 375 IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
           +    Y++  D +S G+IL E++ G  P++     PA+  ++V
Sbjct: 216 LLRTGYTQLCDWWSVGVILYEMLVGQPPFL--ADTPAETQLKV 256

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 37/119 (31%), Positives = 61/119 (51%), Gaps = 17/119 (14%)

Query: 300 LPPFEERLARAL------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
           L  FE+RL   +      E+  A+  +H+     +HRD+KP N+ LD   H+R+ADFG  
Sbjct: 92  LSKFEDRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSC 149

Query: 354 -RFLSDGEM---ALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPY 403
            +   DG +      GT  Y++PE++Q        Y  + D +S G+ + E++ G  P+
Sbjct: 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 63.5 bits (154), Expect = 3e-11
 Identities = 59/233 (25%), Positives = 101/233 (43%), Gaps = 24/233 (10%)

Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I  ++I L+ ++G+G    ++ A    L        VAVK +       +E+A   F +
Sbjct: 1   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQR 56

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR---KERMVPL 300
           E + L+  +H+ +++  G C E      +   +    L  +L   G   +       V  
Sbjct: 57  EAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAP 116

Query: 301 PPF--EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
                 + LA A +IA  M YL       +HRDL   N  +     V+I DFG +R +  
Sbjct: 117 GQLTLGQMLAIASQIASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 174

Query: 359 GEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE 405
            +    G        +M PE I    ++ +SD++SFG++L EI T G  P+ +
Sbjct: 175 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 37/105 (35%), Positives = 58/105 (55%), Gaps = 9/105 (8%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF---LSDGEMALT---G 365
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR      D    LT    
Sbjct: 114 QILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 366 TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           T  Y APE+ +  + Y++  D++S G IL E+++    +  KDY 
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 65.3 bits (159), Expect = 4e-11
 Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 22/163 (13%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E+  + + +H  +++L+G C       +L+ E + G  L E L  L  +RR++  +    
Sbjct: 733 EIADMGKLQHPNIVKLIGLC-RSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAI---- 787

Query: 303 FEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLD--DAKHVRIADFGHARFLSDG 359
                     IA+A+++LH +  P V+  +L P  I +D  D  H+R++  G     +D 
Sbjct: 788 ---------GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPG--LLCTDT 836

Query: 360 EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
           +  ++    Y+APE  + +  +EKSD+Y FG+IL E++TG  P
Sbjct: 837 KCFISSA--YVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877

Length = 968

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 39/119 (32%), Positives = 63/119 (52%), Gaps = 17/119 (14%)

Query: 300 LPPFEERLARAL------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
           L  FE+RL   +      E+  A+  +H+     +HRD+KP N+ LD   H+R+ADFG  
Sbjct: 92  LSKFEDRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSC 149

Query: 354 -RFLSDGEMA---LTGTFVYMAPEVIQCEP-----YSEKSDVYSFGIILNEIITGNHPY 403
            R L+DG +      GT  Y++PE++Q        Y  + D +S G+ + E++ G  P+
Sbjct: 150 LRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 56/238 (23%), Positives = 93/238 (39%), Gaps = 67/238 (28%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ-EVDTLSRQRHRFVL 257
            K+G+GT   +Y+A     G  VA+K I     H  ++     A  E+  L + +H  V+
Sbjct: 14  GKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNVV 70

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKER----MVPLPPFEERLARALE- 312
            L+   +E P                       + +++R    MV  P  +  L+  LE 
Sbjct: 71  PLIDMAVERP----------------------DKSKRKRGSVYMV-TPYMDHDLSGLLEN 107

Query: 313 ----------------IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
                           + + + YLHE    ++HRD+K +NI +D+   ++IADFG AR  
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKIADFGLARPY 165

Query: 357 SD-----------GEMALTGTFV---YMAPE-VIQCEPYSEKSDVYSFGIILNEIITG 399
                        G    T   V   Y  PE ++    Y+   D++  G +  E+ T 
Sbjct: 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 62.7 bits (152), Expect = 6e-11
 Identities = 41/134 (30%), Positives = 72/134 (53%), Gaps = 9/134 (6%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG---EMALTGTF 367
           EI  A+++LH  K  +I+RD+K  NI LD   HV + DFG ++ F  D      +  GT 
Sbjct: 113 EIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Query: 368 VYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
            YMAP++++     + +  D +S G+++ E++TG  P+     K ++  +     K  P 
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 230

Query: 426 LPEEDGQL-RELIE 438
            P+E   L +++I+
Sbjct: 231 YPQEMSALAKDIIQ 244

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 20/205 (9%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  R  +  +A+K I  +    +E   +   +E+  L   +H  +++
Sbjct: 8   EKIGEGTYGVVYKARDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEMQHGNIVR 65

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    +    R +LV E L   LK+ +       +  R++    ++        I + + 
Sbjct: 66  LQDV-VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQ--------ILRGIA 116

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKH-VRIADFGHARFLSDGEMALTGTFV---YMAPEV 374
           Y H  +  V+HRDLKP N+ +D   + +++ADFG AR         T   V   Y APE+
Sbjct: 117 YCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEI 174

Query: 375 -IQCEPYSEKSDVYSFGIILNEIIT 398
            +    YS   D++S G I  E++ 
Sbjct: 175 LLGSRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 62.7 bits (152), Expect = 9e-11
 Identities = 55/188 (29%), Positives = 89/188 (47%), Gaps = 21/188 (11%)

Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM-----GACLEPPYRGWL 272
           GL VAVK +   F        T+  +E+  L   +H  V+ L+        LE     +L
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYL 99

Query: 273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL 332
           VT L+G  L   +     Q+  +  V    ++        I + ++Y+H     +IHRDL
Sbjct: 100 VTHLMGADLNNIVK---CQKLTDDHVQFLIYQ--------ILRGLKYIHSAD--IIHRDL 146

Query: 333 KPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGI 391
           KPSN+ +++   ++I DFG AR   D       T  Y APE+ +    Y++  D++S G 
Sbjct: 147 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206

Query: 392 ILNEIITG 399
           I+ E++TG
Sbjct: 207 IMAELLTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 62.4 bits (151), Expect = 9e-11
 Identities = 69/218 (31%), Positives = 97/218 (44%), Gaps = 24/218 (11%)

Query: 193 DPKEI--DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           DP+++  DL+E IG G+   +Y  R +     VA+K +      +NE       +EV  L
Sbjct: 22  DPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDII-KEVKFL 79

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            R +H   ++  G C    +  WLV E          + LGS      +   P  E  +A
Sbjct: 80  QRIKHPNSIEYKG-CYLREHTAWLVME----------YCLGSASDLLEVHKKPLQEVEIA 128

Query: 309 RALEIA-QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
                A Q + YLH     +IHRD+K  NI L +   V++ADFG A   S    +  GT 
Sbjct: 129 AITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN-SFVGTP 185

Query: 368 VYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHP 402
            +MAPEVI       Y  K DV+S GI   E+     P
Sbjct: 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 63/256 (24%), Positives = 118/256 (46%), Gaps = 31/256 (12%)

Query: 211 IYRAIWRGLDVAVKCIYPDFFHTNENAVT-FFAQEVDTLSRQRHRFVLQLMGACLEPPYR 269
           +Y+   + +DVA+K +  +    NE +V     +E + + +  + ++++++G C      
Sbjct: 15  VYKMRKKQIDVAIKVLKNE----NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALM 70

Query: 270 GWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVI 328
             LV E+  G  L ++L G   +     +V L           +++  M+YL  +    +
Sbjct: 71  --LVMEMASGGPLNKFLSGKKDEITVSNVVEL---------MHQVSMGMKYLEGKN--FV 117

Query: 329 HRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTGTF-----VYMAPEVIQCEPYSE 382
           HRDL   N+ L +  + +I+DFG ++ L +D       +       + APE I    +S 
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 383 KSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELIC 441
           +SDV+S+GI + E  + G  PY  K  K  ++   + +GK R   P E     E+  L+ 
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPY--KKMKGPEVMSFIEQGK-RLDCPAECPP--EMYALMK 232

Query: 442 LSWDGDASVRPSFSSI 457
             W      RP+F+ +
Sbjct: 233 DCWIYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 39/104 (37%), Positives = 57/104 (54%), Gaps = 8/104 (7%)

Query: 298 VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           VP P  P E       ++ + + +LH  +  V+HRDLKP NI +  +  +++ADFG AR 
Sbjct: 102 VPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 159

Query: 356 LSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEI 396
            S  +MALT   V   Y APEV+    Y+   D++S G I  E+
Sbjct: 160 YS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 13/159 (8%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEMALTGTF 367
           A++IA  M+YL       +H+DL   NI + +  HV+I+D G +R  + +D       + 
Sbjct: 130 AIQIAAGMEYLSSHF--FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
           +   +M PE I    +S  SD++SFG++L EI + G  PY    +   ++   V + +L 
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY--GFSNQEVIEMVRKRQLL 245

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           P    ED   R +  L+   W    S RP F  I   L+
Sbjct: 246 PC--SEDCPPR-MYSLMTECWQEGPSRRPRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 67/264 (25%), Positives = 116/264 (43%), Gaps = 36/264 (13%)

Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I  ++I L+ ++G+G    ++ A    L        VAVK +          A   F +
Sbjct: 1   HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQR 56

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWL--HGL-------GSQRRK 294
           E + L+  +H  +++  G C +      +   +    L ++L  HG        G  R+ 
Sbjct: 57  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116

Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
           +  + L    + L  A +IA  M YL  Q    +HRDL   N  +     V+I DFG +R
Sbjct: 117 KGELGL---SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 355 FLSDGEMALTGTFV-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY 408
            +   +    G        +M PE I    ++ +SDV+SFG+IL EI T G  P+ +   
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ--L 229

Query: 409 KPAKIAMEVGEGKL--RPAL-PEE 429
              ++   + +G++  RP + P+E
Sbjct: 230 SNTEVIECITQGRVLERPRVCPKE 253

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 36/101 (35%), Positives = 56/101 (55%), Gaps = 6/101 (5%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           ++ + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR  S+    +T   V   
Sbjct: 116 QLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW 173

Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           Y APE++  C  Y+   DV+S G I  E++     +  KDY
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 30/92 (32%), Positives = 48/92 (52%), Gaps = 6/92 (6%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFV 368
           +  QA+ + H+     IHRD+KP NI +     +++ DFG AR L+      T    T  
Sbjct: 108 QTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW 165

Query: 369 YMAPEVIQCE-PYSEKSDVYSFGIILNEIITG 399
           Y APE++  +  Y    DV++ G +  E++TG
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 17/119 (14%)

Query: 300 LPPFEERLARAL------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
           L  FE+RL   +      E+  A+  +H+     +HRD+KP NI +D   H+R+ADFG  
Sbjct: 92  LSKFEDRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSC 149

Query: 354 -RFLSDGEM---ALTGTFVYMAPEVIQCEP-----YSEKSDVYSFGIILNEIITGNHPY 403
            + + DG +      GT  Y++PE++Q        Y  + D +S G+ + E++ G  P+
Sbjct: 150 LKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (151), Expect = 2e-10
 Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 49/239 (20%)

Query: 201 EKIGQGTTANIYRAIWRGLDV--AVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           + +G+G    ++    +G     A+K +         N V     E + L+   H F+  
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-IKRNKVKRVLTEQEILATLDHPFLPT 65

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQA 316
           L  +     Y   ++    G  L   L     QR+  +        E +AR  A E+  A
Sbjct: 66  LYASFQTETYLCLVMDYCPGGELFRLL-----QRQPGKC-----LSEEVARFYAAEVLLA 115

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF---------GHARF--LSDGE----- 360
           ++YLH     +++RDLKP NI L ++ H+ ++DF                L  G      
Sbjct: 116 LEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 361 ----------------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                            +  GT  Y+APEVI  + +    D ++ GI+L E++ G  P+
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 39/124 (31%), Positives = 62/124 (50%), Gaps = 23/124 (18%)

Query: 285 LHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA 342
           L+ L   R+        PF E + R++  +I Q + ++H+      HRDLKP N+ +   
Sbjct: 84  LYQLMKDRKG------KPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGP 135

Query: 343 KHVRIADFGHARFLSDGEMA----LT---GTFVYMAPEVI-QCEPYSEKSDVYSFGIILN 394
           + V+IADFG AR     E+      T    T  Y APE++ +   YS   D+++ G I+ 
Sbjct: 136 EVVKIADFGLAR-----EIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMA 190

Query: 395 EIIT 398
           E+ T
Sbjct: 191 ELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 35/105 (33%), Positives = 55/105 (52%), Gaps = 10/105 (9%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG------ 365
           +I   ++Y+H     V+HRDLKP N+ ++    ++I DFG AR  S+      G      
Sbjct: 113 QILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170

Query: 366 -TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            T  Y APE+ +  + Y++  DV+S G IL E++     +  KDY
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.5 bits (146), Expect = 3e-10
 Identities = 64/243 (26%), Positives = 111/243 (45%), Gaps = 31/243 (12%)

Query: 193 DPKE-IDLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +P+E  +L ++IG GT  ++Y+A  +  G   A+K I        E+      QE+  + 
Sbjct: 6   NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGED-FAVVQQEIIMMK 61

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             +H  ++   G+ L    + W+  E  G  +L++  H  G           P  E ++A
Sbjct: 62  DCKHSNIVAYFGSYLRRD-KLWICMEFCGGGSLQDIYHVTG-----------PLSESQIA 109

Query: 309 R-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALT 364
             + E  Q + YLH +    +HRD+K +NI L D  HV++ADFG +  ++       +  
Sbjct: 110 YVSRETLQGLYYLHSKGK--MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI 167

Query: 365 GTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           GT  +MAPEV   E    Y++  D+++ GI   E+     P    D  P +    + +  
Sbjct: 168 GTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMTKSN 225

Query: 422 LRP 424
            +P
Sbjct: 226 FQP 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 25/174 (14%)

Query: 240 FFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
           FF +E D ++     +V+QL  A  +  Y   ++  + G  L   +            VP
Sbjct: 89  FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--------VP 140

Query: 300 LPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
                E+ AR    E+  A+  +H      IHRD+KP N+ LD + H+++ADFG    ++
Sbjct: 141 -----EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193

Query: 358 DGEM----ALTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPY 403
              M       GT  Y++PEV++ +     Y  + D +S G+ L E++ G+ P+
Sbjct: 194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 37/114 (32%), Positives = 63/114 (55%), Gaps = 11/114 (9%)

Query: 304 EERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
           E+ L R    + + +++L E+   +IHRD+KP+N+ ++    V++ DFG +  L    +A
Sbjct: 101 EDVLRRITYAVVKGLKFLKEEH-NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLA 158

Query: 363 LT--GTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            T  G   YMAPE I+         Y+ +SDV+S G+ + E+  G +PY  + Y
Sbjct: 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY 212

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 60.8 bits (147), Expect = 5e-10
 Identities = 57/190 (30%), Positives = 87/190 (45%), Gaps = 23/190 (12%)

Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWL 272
           G++VAVK +   F   N+       +E+  L    H+ ++ L+        LE     +L
Sbjct: 46  GINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYL 103

Query: 273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL 332
           V EL+   L + +H    +   ERM  L           ++   +++LH     +IHRDL
Sbjct: 104 VMELMDANLCQVIH---MELDHERMSYL---------LYQMLCGIKHLHSAG--IIHRDL 149

Query: 333 KPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFG 390
           KPSNI +     ++I DFG AR      M      T  Y APEVI    Y E  D++S G
Sbjct: 150 KPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 209

Query: 391 IILNEIITGN 400
            I+ E++ G+
Sbjct: 210 CIMGELVKGS 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 4/108 (3%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           ++ + ++Y+H     +IHRDLKPSN+ +++   +RI DFG AR   D       T  Y A
Sbjct: 126 QLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRA 183

Query: 372 PEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-KPAKIAMEV 417
           PE+ +    Y++  D++S G I+ E++ G   +   DY    K  MEV
Sbjct: 184 PEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEV 231

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.2 bits (146), Expect = 7e-10
 Identities = 32/100 (32%), Positives = 57/100 (57%), Gaps = 10/100 (10%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEM---ALTGTF 367
           E+  A+  +H      IHRD+KP N+ LD + H+++ADFG   +  ++G +      GT 
Sbjct: 150 EVVLALDAIH--SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTP 207

Query: 368 VYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPY 403
            Y++PEV++ +     Y  + D +S G+ L E++ G+ P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           ++ +A+ + H  K  ++HRD+KP N+ +     +++ DFG AR LS+G  A    +V   
Sbjct: 108 QLIKAIHWCH--KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATR 165

Query: 369 -YMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            Y +PE++   PY +  D++S G IL E+  G
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 60.9 bits (147), Expect = 9e-10
 Identities = 51/168 (30%), Positives = 82/168 (48%), Gaps = 31/168 (18%)

Query: 312 EIAQAMQYLHEQK-----PKVIHRDLKPSNIFLDDA-KHV----------------RIAD 349
           ++  A+ Y H  K      +V+HRDLKP NIFL    +H+                +I D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 350 FGHARFLSDGEMA--LTGTFVYMAPEVI--QCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           FG ++ +    MA    GT  Y +PE++  + + Y +KSD+++ G I+ E+ +G  P+  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF-- 243

Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
             +K    +  + E K  P LP + G+ +EL  LI    +  A  RPS
Sbjct: 244 --HKANNFSQLISELKRGPDLPIK-GKSKELNILIKNLLNLSAKERPS 288

Length = 1021

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 32/100 (32%), Positives = 55/100 (55%), Gaps = 10/100 (10%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGTF 367
           E+  A+  +H     +IHRD+KP N+ LD   H+++ADFG    + +  M       GT 
Sbjct: 150 EVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTP 207

Query: 368 VYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPY 403
            Y++PEV++ +     Y  + D +S G+ L E++ G+ P+
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 201 EKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +K+G+GT A ++  R+      VA+K I        E A     +EV  L   +H  ++ 
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKNLKHANIVT 67

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    +       LV E L + LK++L   G+      M  +  F  +L R L       
Sbjct: 68  LHD-IIHTERCLTLVFEYLDSDLKQYLDNCGNLMS---MHNVKIFMFQLLRGL------S 117

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEV- 374
           Y H++K  ++HRDLKP N+ +++   +++ADFG AR  S      +   V   Y  P+V 
Sbjct: 118 YCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175

Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    YS   D++  G IL E+ TG
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 60.3 bits (146), Expect = 1e-09
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 30/197 (15%)

Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE-LLGTTLKEWLHGLGSQR 292
           N+N V     E D L+  +  F++ L  + L+     +LV E L+G  +K  LH  G   
Sbjct: 44  NKNMVHQVQAERDALALSKSPFIVHLYYS-LQSANNVYLVMEYLIGGDVKSLLHIYGY-- 100

Query: 293 RKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
                     F+E +A     E+A A+ YLH     +IHRDLKP N+ + +  H+++ DF
Sbjct: 101 ----------FDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDF 148

Query: 351 GHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSF--GIILNEI--ITGNHPYIEK 406
           G ++   + E+ +         +++     ++  + YS   G +L+ I  +  N P  EK
Sbjct: 149 GLSKVTLNRELNMM--------DILTTPSMAKPKNDYSRTPGQVLSLISSLGFNTPVGEK 200

Query: 407 DYKPAKIAMEVGEGKLR 423
           D          G   +R
Sbjct: 201 DQGSVNSGQNNGTSSVR 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 63/289 (21%), Positives = 118/289 (40%), Gaps = 37/289 (12%)

Query: 191 YIDPKEIDLQEK--IGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVT-FFAQEVDT 247
            I+  +ID      I +    +IY+ I+   +V ++      FH     +      E+  
Sbjct: 14  CIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTF--KKFHKGHKVLIDITENEIKN 71

Query: 248 LSRQRHRFVLQLMGACLE---PPYRGWLVTELLGTT-LKEWLHGLGSQRRKERMVPLPPF 303
           L R     +L++ G  ++      R  L+ E      L+E L        KE+ +    F
Sbjct: 72  LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-------DKEKDLS---F 121

Query: 304 EERLARALEIAQAMQYLHE--QKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           + +L  A++  + +  L++   KP   +++L   +  + +   ++I   G  + LS    
Sbjct: 122 KTKLDMAIDCCKGLYNLYKYTNKP---YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178

Query: 362 ALTGTFVYMAPEVIQ--CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA--KIAMEV 417
                 VY + +++      Y+ K D+YS G++L EI TG  P+     K     I  + 
Sbjct: 179 KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKN 238

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM 466
              KL    P E   ++ ++E  C S   D+  RP+   I   L N+ +
Sbjct: 239 NSLKLPLDCPLE---IKCIVEA-CTS--HDSIKRPNIKEI---LYNLSL 278

Length = 283

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 28/215 (13%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +QE IG+G+   +  AI    G  VA+K I   F H ++   T   +E+  L   RH  +
Sbjct: 4   IQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSD--ATRILREIKLLRLLRHPDI 61

Query: 257 LQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
           +++    L P  R     ++V EL+ + L + +        +        F  +L RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQF----FLYQLLRAL- 116

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMAL-----TGT 366
                +Y+H     V HRDLKP NI  +    ++I DFG AR   +D   A+       T
Sbjct: 117 -----KYIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 367 FVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITG 399
             Y APE+       Y+   D++S G I  E++TG
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +K+G+GT A +Y+   +  D  VA+K I        E A     +EV  L   +H  ++ 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    +       LV E L   LK++L   G+      M  +  F  +L R L       
Sbjct: 69  LHD-IIHTEKSLTLVFEYLDKDLKQYLDDCGNSIN---MHNVKLFLFQLLRGL------N 118

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEV- 374
           Y H +K  V+HRDLKP N+ +++   +++ADFG AR  S      +   V   Y  P++ 
Sbjct: 119 YCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDIL 176

Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    YS + D++  G I  E+ TG
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTG 201

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 23/206 (11%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           EK+G+G+ A +Y+ I R  G  VA+K I        E  V F A +E   L   +H  ++
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMK----TEEGVPFTAIREASLLKGLKHANIV 66

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
            L            + T+   T + E++H   +Q   +    L P+  RL    ++ + +
Sbjct: 67  LL---------HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLF-MFQLLRGL 116

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEV 374
            Y+H Q   ++HRDLKP N+ +     +++ADFG AR  S      +   V   Y  P+V
Sbjct: 117 AYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 375 IQ-CEPYSEKSDVYSFGIILNEIITG 399
           +     YS   D++  G I  E++ G
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 44/152 (28%), Positives = 68/152 (44%), Gaps = 16/152 (10%)

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF----- 367
           +A  M+YL E     +H+ L    + ++     +I+ F   R   D   A+  T      
Sbjct: 116 LASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSP 171

Query: 368 -VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
            ++ APE IQ   +S  SDV+SFGI++ E+++ G  PY +   +    A+E G    R  
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG---FRLP 228

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            P     L   + L C  W  +   RP FS I
Sbjct: 229 APRNCPNLLHQLMLDC--WQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 57.7 bits (140), Expect = 3e-09
 Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 24/205 (11%)

Query: 202 KIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQ 258
           KIG+GT + + +A     G   A+KC+    F + E       +E+  L R   H  +L+
Sbjct: 6   KIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNL--REIQALRRLSPHPNILR 62

Query: 259 LMGACLEPPY-RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIAQA 316
           L+    +    R  LV EL+   L E + G    R++    PLP  E+R+   + ++ ++
Sbjct: 63  LIEVLFDRKTGRLALVFELMDMNLYELIKG----RKR----PLP--EKRVKSYMYQLLKS 112

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--MALTGTFVYMAPE- 373
           + ++H  +  + HRD+KP NI + D   +++ADFG  R +           T  Y APE 
Sbjct: 113 LDHMH--RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 374 VIQCEPYSEKSDVYSFGIILNEIIT 398
           ++    Y  K D+++ G +  EI++
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 34/97 (35%), Positives = 50/97 (51%), Gaps = 3/97 (3%)

Query: 304 EERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
           EE + R A E+  A+  LH +   ++ RDL P+NI LDD  H+++  F     + D    
Sbjct: 84  EECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG 141

Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
                +Y APEV      +E  D +S G IL E++TG
Sbjct: 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 196 EIDLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           + +L +++G GT  ++Y+A  +  G   AVK I  +      +  +   QE+  +   +H
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKH 65

Query: 254 RFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
             ++   G+ L    + W+  E  G  +L++  H  G           P  E ++A    
Sbjct: 66  CNIVAYFGSYLSRE-KLWICMEYCGGGSLQDIYHVTG-----------PLSELQIAYVCR 113

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFV 368
           E  Q + YLH +    +HRD+K +NI L D   V++ADFG A  ++       +  GT  
Sbjct: 114 ETLQGLAYLHSKGK--MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY 171

Query: 369 YMAPEVIQCEP---YSEKSDVYSFGIILNEI 396
           +MAPEV   E    Y++  D+++ GI   E+
Sbjct: 172 WMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 35/93 (37%), Positives = 47/93 (50%), Gaps = 8/93 (8%)

Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVYMAPEVI 375
           H     +IHRDLKPSNI +     ++I DFG AR     F+    +    T  Y APEVI
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVI 197

Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y E  D++S G I+ E+I G   +   D+
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 230

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 54/222 (24%), Positives = 85/222 (38%), Gaps = 69/222 (31%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG--------- 351
           F E LAR    E+  A++ +H  K   IHRD+KP NI +D   H+++ DFG         
Sbjct: 98  FPEVLARFYIAELTLAIESVH--KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155

Query: 352 --------------------------------------------HARFLSDGEMALTGTF 367
                                                       H R L+    +L GT 
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH---SLVGTP 212

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR-PAL 426
            Y+APEV+  + Y++  D +S G+IL E++ G  P++       ++ +   E  L  P  
Sbjct: 213 NYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQ 272

Query: 427 PEEDGQLRELIELICLSWD--------GDASVRPSFSSITCS 460
            +   +  +LI  +C S +         D    P FS +  S
Sbjct: 273 VKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFS 314

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 36/107 (33%), Positives = 49/107 (45%), Gaps = 20/107 (18%)

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR----------FLSDGE 360
           L+I   +  LH  K   +HRDL P+NIF++     +IADFG AR             D  
Sbjct: 126 LQILNGLNVLH--KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDET 183

Query: 361 MALTG-------TFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITG 399
           M           T  Y APE++   E Y    D++S G I  E++TG
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230

Length = 335

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 30/213 (14%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +++A  R     VA+K +  D    +E   +   +E+  L   +H+ +++
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVR 63

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA--LEIAQA 316
           L    L    +  LV E     LK++                   +  + ++   ++ + 
Sbjct: 64  LYDV-LHSDKKLTLVFEYCDQDLKKYFDSCNGD-----------IDPEIVKSFMFQLLKG 111

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS------DGEMALTGTFVYM 370
           + + H     V+HRDLKP N+ ++    +++ADFG AR           E+    T  Y 
Sbjct: 112 LAFCHSH--NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYR 166

Query: 371 APEVI-QCEPYSEKSDVYSFGIILNEIITGNHP 402
            P+V+   + YS   D++S G I  E+     P
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.1 bits (132), Expect = 3e-08
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193

Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 52/179 (29%), Positives = 81/179 (45%), Gaps = 26/179 (14%)

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEP-PYRGWLVTEL--LGTTLKEWLHGLGSQRRKERM 297
           F QEV       H  VLQ +G C+E  PY   LV E   LG  LK +L    S R     
Sbjct: 42  FLQEVQPYRELNHPNVLQCLGQCIESIPY--LLVLEFCPLGD-LKNYLR---SNRGMVAQ 95

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG--HARF 355
           +      +R+A   E+A  + +LH  +   IH DL   N  L     V+I D+G    ++
Sbjct: 96  MAQKDVLQRMA--CEVASGLLWLH--QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151

Query: 356 LSDGEMALTGTFV---YMAPEV-------IQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
             D  +      V   ++APE+       +  +  ++KS+++S G+ + E+ T  + PY
Sbjct: 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 32/92 (34%), Positives = 48/92 (52%), Gaps = 7/92 (7%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG----TF 367
           ++ + + Y H  K   +HRD+K SNI L++   +++ADFG AR  +  E         T 
Sbjct: 124 QLLEGLNYCH--KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITL 181

Query: 368 VYMAPEVIQCEP-YSEKSDVYSFGIILNEIIT 398
            Y  PE++  E  Y    DV+S G IL E+ T
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFT 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 59/241 (24%), Positives = 97/241 (40%), Gaps = 53/241 (21%)

Query: 187 MNGWYIDP-KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA- 242
               + D   + +   KIGQGT   +++A  +     VA+K +        EN    F  
Sbjct: 3   YEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV------LMENEKEGFPI 56

Query: 243 ---QEVDTLSRQRHRFVLQLMGACLEPP-----YRG--WLVTELLGTTLKEWLHGLGSQR 292
              +E+  L   +H  V+ L+  C         Y+G  +LV E     L     GL S +
Sbjct: 57  TALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLA----GLLSNK 112

Query: 293 RKERMVPLPPFEERLARALEIAQAMQ-------YLHEQKPKVIHRDLKPSNIFLDDAKHV 345
             +  +             EI + M+       Y+H  K  ++HRD+K +NI +     +
Sbjct: 113 NVKFTLS------------EIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGIL 158

Query: 346 RIADFGHARFLSDGEMA----LTG---TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEII 397
           ++ADFG AR  S  + +     T    T  Y  PE+ +    Y    D++  G I+ E+ 
Sbjct: 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW 218

Query: 398 T 398
           T
Sbjct: 219 T 219

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.8 bits (129), Expect = 7e-08
 Identities = 54/205 (26%), Positives = 92/205 (44%), Gaps = 21/205 (10%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EK+G+GT A +++   +  +  VA+K I        E A     +EV  L   +H  ++ 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    +       LV E L   LK+++   G+      +              +I + + 
Sbjct: 69  LHD-IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIF---------LYQILRGLA 118

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           Y H  + KV+HRDLKP N+ +++   +++ADFG AR  S      +    T  Y  P+V 
Sbjct: 119 YCH--RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176

Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    YS + D++  G I  E+ +G
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASG 201

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 37/133 (27%), Positives = 55/133 (41%), Gaps = 43/133 (32%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG------------HARFL--- 356
           E   A+  +H  K   IHRD+KP N+ LD   H++++DFG              R L   
Sbjct: 109 ETILAIDSIH--KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHA 166

Query: 357 -------------SDGEMALT-------------GTFVYMAPEVIQCEPYSEKSDVYSFG 390
                        S    A T             GT  Y+APEV     Y+++ D +S G
Sbjct: 167 LPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLG 226

Query: 391 IILNEIITGNHPY 403
           +I+ E++ G  P+
Sbjct: 227 VIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 8e-08
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 7/93 (7%)

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-----SDGEMA 362
           A A ++  A+ Y+H +   +IHRD+K  N+ ++  + + + DFG A F      +     
Sbjct: 264 AVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNE 395
           + GT    APEV+  +PY+   D++S G+++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 61/216 (28%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           +K+G+G+ A +Y+   +     VA+K I  +    +E    F A +E   L   +H  ++
Sbjct: 11  DKLGEGSYATVYKGRSKLTGQLVALKEIRLE----HEEGAPFTAIREASLLKDLKHANIV 66

Query: 258 QL-----MGACLEPPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLPPFEERLARA 310
            L         L       LV E L T LK+++   G G      R+     F  +L R 
Sbjct: 67  TLHDIIHTKKTLT------LVFEYLDTDLKQYMDDCGGGLSMHNVRL-----FLFQLLRG 115

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS------DGEMALT 364
           L       Y H+++  V+HRDLKP N+ + +   +++ADFG AR  S        E+   
Sbjct: 116 LA------YCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-- 165

Query: 365 GTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
            T  Y  P+V+     YS   D++  G I  E+ TG
Sbjct: 166 -TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 31/95 (32%), Positives = 52/95 (54%), Gaps = 18/95 (18%)

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHAR----------FLSDGEMALTG 365
           ++Y+H     V+HRDLKP+N+F++    V +I DFG AR          +LS+G      
Sbjct: 127 LKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG----LV 180

Query: 366 TFVYMAPE-VIQCEPYSEKSDVYSFGIILNEIITG 399
           T  Y +P  ++    Y++  D+++ G I  E++TG
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 43/158 (27%), Positives = 75/158 (47%), Gaps = 13/158 (8%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEMALTGTFV- 368
           +IA  M++L      V+H+DL   N+ + D  +V+I+D G  R  + +D    +  + + 
Sbjct: 132 QIAAGMEFLSSHH--VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 369 --YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             +M+PE I    +S  SD++S+G++L E+ + G  PY    Y    +   +   + R  
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC--GYSNQDVIEMI---RNRQV 244

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           LP  D     +  L+   W+   S RP F  I   L+ 
Sbjct: 245 LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 34/104 (32%), Positives = 61/104 (58%), Gaps = 7/104 (6%)

Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-VRIADFGHARFLSD 358
           LP F  +L  + ++ +A+ Y+H +   + HRDLKP N+ +D   H +++ DFG A+ L  
Sbjct: 167 LPLFLVKL-YSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA 223

Query: 359 GEMALT--GTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           G+ +++   +  Y APE+ +    Y+   D++S G I+ E+I G
Sbjct: 224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 31/216 (14%)

Query: 202 KIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFV 256
           K+G+GT  ++Y+A  +      D A+K I           ++  A +E+  L   +H  V
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQI-------EGTGISMSACREIALLRELKHPNV 60

Query: 257 LQLMGACLEPPYRG-WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           + L    L    R  WL+ +     L   +    + +  ++ V LP     + ++L  +I
Sbjct: 61  ISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP---RGMVKSLLYQI 117

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEMALTG---- 365
              + YLH     V+HRDLKP+NI +     +   V+IAD G AR  +     L      
Sbjct: 118 LDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175

Query: 366 --TFVYMAPE-VIQCEPYSEKSDVYSFGIILNEIIT 398
             TF Y APE ++    Y++  D+++ G I  E++T
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 56/167 (33%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG--------- 351
           F E LAR    E+  A++ +H  K   IHRD+KP NI +D   H+++ DFG         
Sbjct: 98  FPEDLARFYIAELTCAVESVH--KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155

Query: 352 HARFLSDGE-----------------------------------------MALTGTFVYM 370
            +++   G+                                          +L GT  Y+
Sbjct: 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYI 215

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
           APEV+    Y++  D +S G+IL E++ G  P++ +   P +  M+V
Sbjct: 216 APEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ--TPLETQMKV 260

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 50.1 bits (120), Expect = 3e-07
 Identities = 33/103 (32%), Positives = 48/103 (46%), Gaps = 12/103 (11%)

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
           EE  A  L+   A++ LH Q         K  NI L     +++      +     E + 
Sbjct: 17  EEIWAVCLQCLGALRELHRQA--------KSGNILLTWDGLLKLDGSVAFKT---PEQSR 65

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK 406
              +  MAPEVIQ + Y+EK+D+YS GI L E +    PY E+
Sbjct: 66  PDPYF-MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 29/93 (31%), Positives = 49/93 (52%), Gaps = 7/93 (7%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTGTFV-- 368
           +I + ++YLH     ++HRD+KP N+ ++    ++I DFG AR    D    +T   V  
Sbjct: 111 QILRGLKYLH--SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168

Query: 369 -YMAPEVIQ-CEPYSEKSDVYSFGIILNEIITG 399
            Y APE++     Y+   D++S G I  E++  
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 58/251 (23%), Positives = 105/251 (41%), Gaps = 44/251 (17%)

Query: 198 DLQEKIG----QGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           +L   IG         ++ +       VAVK I  D    ++  +    QE+ T  + +H
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLD--SCSKEDLKLLQQEIITSRQLQH 58

Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKER-MVPLPPFEERLARAL- 311
             +L  + + +      ++V+ L+        +G      K      LP  E  +A  L 
Sbjct: 59  PNILPYVTSFIVDSEL-YVVSPLMA-------YGSCEDLLKTHFPEGLP--ELAIAFILK 108

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTGTFVY- 369
           ++  A+ Y+H      IHR +K S+I L     V ++   ++   +  G+       V+ 
Sbjct: 109 DVLNALDYIH--SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHD 163

Query: 370 -----------MAPEVIQ--CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
                      ++PEV+Q   + Y+EKSD+YS GI   E+  G+ P+  KD    ++ +E
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF--KDMPATQMLLE 221

Query: 417 VGEGKLRPALP 427
               K+R  +P
Sbjct: 222 ----KVRGTVP 228

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.7 bits (121), Expect = 6e-07
 Identities = 56/179 (31%), Positives = 85/179 (47%), Gaps = 26/179 (14%)

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLE-PPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERM 297
           F +E       +H  +LQ +G C E  PY   LV E   LG  LK +L    S R+ E M
Sbjct: 42  FLEEAQPYRSLQHSNLLQCLGQCTEVTPY--LLVMEFCPLGD-LKGYLR---SCRKAELM 95

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG--HARF 355
            P P   +R+A   EIA  + +LH  K   IH DL   N  L     V+I D+G  H ++
Sbjct: 96  TPDPTTLQRMA--CEIALGLLHLH--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151

Query: 356 LSDGEMALTGTFV---YMAPEVIQ-------CEPYSEKSDVYSFGIILNEIIT-GNHPY 403
             D  +     +V   ++APE++            +++S+V+S G+ + E+   G+ PY
Sbjct: 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.5 bits (120), Expect = 8e-07
 Identities = 54/220 (24%), Positives = 87/220 (39%), Gaps = 48/220 (21%)

Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQ 243
           ++K+NG  +  K I LQE+ G   TA    ++ +GL  A   +  D  HT E     F  
Sbjct: 25  KSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF-- 82

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
                                                  E++H    Q   +    L P 
Sbjct: 83  ---------------------------------------EYVHTDLCQYMDKHPGGLHPE 103

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
             +L    ++ + + Y+H++   ++HRDLKP N+ + D   +++ADFG AR  S      
Sbjct: 104 NVKLF-LFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160

Query: 364 TG---TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           +    T  Y  P+V +    YS   D++  G I  E+I G
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 23/212 (10%)

Query: 202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVLQLM 260
           K+G+GT  ++Y+A  +  D   +  Y          ++  A +E+  L   +H  V+ L 
Sbjct: 8   KVGRGTYGHVYKA--KRKDGKDEKEYA-LKQIEGTGISMSACREIALLRELKHPNVIALQ 64

Query: 261 GACLEPPYRG-WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAM 317
              L    R  WL+ +     L   +    + +  ++ + LP     + ++L  +I   +
Sbjct: 65  KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP---RSMVKSLLYQILDGI 121

Query: 318 QYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEMALTG------TF 367
            YLH     V+HRDLKP+NI +     +   V+IAD G AR  +     L        TF
Sbjct: 122 HYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 368 VYMAPE-VIQCEPYSEKSDVYSFGIILNEIIT 398
            Y APE ++    Y++  D+++ G I  E++T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 39/159 (24%), Positives = 61/159 (38%), Gaps = 43/159 (27%)

Query: 328 IHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--------------------------- 360
           IHRD+KP N+ LD   HV+++DFG    L                               
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 361 -----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                       +  GT  Y+APEV     Y++  D +S G+I+ E++ G  P+  +   
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE--T 240

Query: 410 PAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWD 445
           P +   +V   K     P E     + ++LI   C  W+
Sbjct: 241 PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWE 279

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 29/87 (33%), Positives = 51/87 (58%), Gaps = 6/87 (6%)

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGTFVYMA 371
           A++Y+H++K  +IHRD+K  NIFL+    + + DFG A        A      GT    +
Sbjct: 279 AVEYIHDKK--LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNS 336

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIIT 398
           PE++  + Y E +D++S G+IL ++++
Sbjct: 337 PEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 51/281 (18%)

Query: 201 EKIGQGTTANIYRAIWR----------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           E +GQGT  NIY+ + R          G +V+V        H   +++ FF +    +S+
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH--RDSLAFF-ETASLMSQ 57

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
             H+ +++L G C+       +V E +    L  +LH         R         +L  
Sbjct: 58  LSHKHLVKLYGVCVRDENI--MVEEYVKFGPLDVFLH---------REKNNVSLHWKLDV 106

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---------VRIADFGHAR-FLSDG 359
           A ++A A+ YL ++  K++H ++   NI +  A++         ++++D G     LS  
Sbjct: 107 AKQLASALHYLEDK--KLVHGNVCGKNILV--ARYGLNEGYVPFIKLSDPGIPITVLSRE 162

Query: 360 EMALTGTFVYMAPEVIQCEPYSEKS--DVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
           E      ++  APE I+    S     D +SFG  L EI + G  P        ++    
Sbjct: 163 ERVERIPWI--APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPL--STLSSSE-KER 217

Query: 417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
             + + R  +P+      EL  LI   W  D + RPSF +I
Sbjct: 218 FYQDQHRLPMPDCA----ELANLINQCWTYDPTKRPSFRAI 254

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 30/114 (26%), Positives = 45/114 (39%), Gaps = 38/114 (33%)

Query: 328 IHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--------------------------- 360
           IHRD+KP N+ LD   HV+++DFG    L                               
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 361 -----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                       +  GT  Y+APEV     Y++  D +S G+I+ E++ G  P+
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.4 bits (100), Expect = 9e-05
 Identities = 33/158 (20%), Positives = 61/158 (38%), Gaps = 26/158 (16%)

Query: 201 EKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS--RQRHRFVLQ 258
           + +  G T  +Y    +  D  +K       + +        +EV  L    ++   V +
Sbjct: 4   KLLKGGLTNRVYLLGTKDEDYVLK------INPSREKGADREREVAILQLLARKGLPVPK 57

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           ++ +     +   L+  + G TL E                    EE+   A ++A+ + 
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLDE-----------------VSEEEKEDIAEQLAELLA 100

Query: 319 YLHEQKPKV-IHRDLKPSNIFLDDAKHVRIADFGHARF 355
            LH+    V  H DL P NI +DD K + I D+ +A +
Sbjct: 101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 38/130 (29%), Positives = 57/130 (43%), Gaps = 31/130 (23%)

Query: 302 PFEER-LARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLD----------------DAK 343
           PF  R LA+ + +   A+ Y H +   ++H DLKP NI ++                D  
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTEL-HLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285

Query: 344 HVRIADFG------HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEII 397
            VRI D G      H+R       A+  T  Y +PEV+    +   +D++S G I+ E+ 
Sbjct: 286 RVRICDLGGCCDERHSR------TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339

Query: 398 TGNHPYIEKD 407
           TG   Y   D
Sbjct: 340 TGKLLYDTHD 349

Length = 467

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 20/51 (39%), Positives = 30/51 (58%), Gaps = 4/51 (7%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
           F E + R    E   A++ +H  K   IHRD+KP NI +D   H++++DFG
Sbjct: 98  FSEDVTRFYMAECVLAIEAVH--KLGFIHRDIKPDNILIDRGGHIKLSDFG 146

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 14/103 (13%)

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH----------ARFLSDGEMALT 364
           + + YLH+     IHR++K S+I +     V ++   H          A+ + D     T
Sbjct: 112 RGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 365 GTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIE 405
               +++PE+++ +   Y+ KSD+YS GI   E+ TG  P+ +
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	472
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PRK10345	210	hypothetical protein; Provisional	99.79
PRK14879	211	serine/threonine protein kinase; Provisional	99.77
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.75
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
smart00090	237	RIO RIO-like kinase.	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.63
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.37
KOG1243	690	consensus Protein kinase [General function predict	99.37
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.36
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.34
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.32
COG4248	637	Uncharacterized protein with protein kinase and he	99.31
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.21
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.09
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.99
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.48
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.48
PRK09902	216	hypothetical protein; Provisional	98.47
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.35
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.25
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.19
PF01636	239	APH: Phosphotransferase enzyme family This family	98.18
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.13
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.12
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.04
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.98
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.86
PLN02876	822	acyl-CoA dehydrogenase	97.81
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.8
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.78
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.67
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.57
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.54
PRK10593	297	hypothetical protein; Provisional	97.41
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.4
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.2
PF00017	77	SH2: SH2 domain; InterPro: IPR000980 The Src homol	97.06
smart00252	84	SH2 Src homology 2 domains. Src homology 2 domains	97.06
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.06
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.04
PRK05231	319	homoserine kinase; Provisional	96.92
PLN02236	344	choline kinase	96.77
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.75
KOG4792	293	consensus Crk family adapters [Signal transduction	96.71
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.71
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.65
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.59
cd00173	94	SH2 Src homology 2 domains; Signal transduction, i	96.51
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.5
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.43
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.12
PLN02756	418	S-methyl-5-thioribose kinase	96.1
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.08
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.02
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.29
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.21
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.13
PTZ00384	383	choline kinase; Provisional	95.0
PRK06148	1013	hypothetical protein; Provisional	94.7
KOG2270	520	consensus Serine/threonine protein kinase involved	94.68
PTZ00296	442	choline kinase; Provisional	94.5
KOG0790	600	consensus Protein tyrosine phosphatase Corkscrew a	94.46

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-66  Score=518.88  Aligned_cols=354  Identities=25%  Similarity=0.384  Sum_probs=299.6

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhc------CCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQD------NGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~------~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      +++++.|....++|||| +|++.+|.|+|||...      ..|+||+|+..+++.+..   +......|+.++..+.+++
T Consensus        94 e~~ll~p~~~~G~flvR-~se~~~g~yslsv~~~~~~~~~~~v~hyri~~~~~~~~~~---~~~~~~~F~~l~~lv~~~~  169 (468)
T KOG0197|consen   94 ERQLLAPENKEGAFLVR-ESESDKGDYSLSVREGDSGGLGAKVKHYRIRQLDGGGLYP---YIDERELFSSLQQLVNYYS  169 (468)
T ss_pred             HHhhcCCCCCccceeee-cccCCcCCeeEEEEeccccCCccceeeeeeeEcCCCCeec---CCCHHHhhhhHHHHHhhhh
Confidence            44677899999999999 9999999999999433      399999999999987711   3778889999999888887


Q ss_pred             C-----CCccccccCCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEECCe-eEEEEEeccCCCC
Q 039082          159 H-----QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL-DVAVKCIYPDFFH  232 (472)
Q Consensus       159 ~-----~~~l~~~~~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~-~vAVK~l~~~~~~  232 (472)
                      .     ++.+..+|.......+..     .......|+++++.+.+++.||+|.||+||+|.|++. +||+|.++...  
T Consensus       170 ~~~~gl~~~l~~p~~~~~~~~p~~-----~~~~~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--  242 (468)
T KOG0197|consen  170 KNADGLCTRLRDPCSKQGHTKPQT-----PDLARDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--  242 (468)
T ss_pred             ccCcchhhcccCchhccCCCCCCC-----CccccCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc--
Confidence            6     445556664432100100     0112788999999999999999999999999999987 99999998753  


Q ss_pred             CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHH
Q 039082          233 TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE  312 (472)
Q Consensus       233 ~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~q  312 (472)
                         ...+.|.+|+.+|++|+|+|||++||+|..++++|+|+||+..|+|.+||+.....        .......+.++.|
T Consensus       243 ---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~--------~l~~~~Ll~~a~q  311 (468)
T KOG0197|consen  243 ---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGG--------LLNLPQLLDFAAQ  311 (468)
T ss_pred             ---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCC--------ccchHHHHHHHHH
Confidence               33355889999999999999999999999999999999999999999999762221        2236789999999


Q ss_pred             HHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcccc-cc---CCcccccccccCCCCCchHHHHH
Q 039082          313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL-TG---TFVYMAPEVIQCEPYSEKSDVYS  388 (472)
Q Consensus       313 ia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~g---t~~y~APE~~~~~~~s~~sDvwS  388 (472)
                      ||+||+||++++  +|||||.++||||++++.|||+|||+|+...++.+.. .|   ++.|+|||++..+.|+.+|||||
T Consensus       312 IaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWS  389 (468)
T KOG0197|consen  312 IAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWS  389 (468)
T ss_pred             HHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceee
Confidence            999999999999  9999999999999999999999999999776665433 22   89999999999999999999999


Q ss_pred             HHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          389 FGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       389 lGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      |||+||||+| |+.||.+++  ..++...+..|. |++.|  ..++..++++|..||+.+|++||||+.+...|+++...
T Consensus       390 FGVlL~E~fT~G~~py~~ms--n~ev~~~le~Gy-Rlp~P--~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  390 FGVLLWELFTYGRVPYPGMS--NEEVLELLERGY-RLPRP--EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             hhhhHHHHhccCCCCCCCCC--HHHHHHHHhccC-cCCCC--CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence            9999999999 999999988  677888999987 44444  45888999999999999999999999999999988653

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-57  Score=455.91  Aligned_cols=345  Identities=26%  Similarity=0.424  Sum_probs=294.7

Q ss_pred             HHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-----CCcccc
Q 039082           91 QKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-----QTPLHR  165 (472)
Q Consensus        91 ~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-----~~~l~~  165 (472)
                      -..+.++|||| |||+..|+|++|+.++..|.||+|+...+++.     |..+-..|..+..++|||+.     .+.|+.
T Consensus       169 sSgInGSFLVR-ESEsSpgQ~sISlRyeGRVyHYRINt~~dgK~-----yvt~EsrF~TLaELVHHHStvADGLittLhY  242 (1157)
T KOG4278|consen  169 SSGINGSFLVR-ESESSPGQYSISLRYEGRVYHYRINTDNDGKM-----YVTQESRFRTLAELVHHHSTVADGLITTLHY  242 (1157)
T ss_pred             hcCcccceEEe-eccCCCcceeEEEEecceEEEEEeeccCCccE-----EEeehhhhhHHHHHHhhccccccceeEeeec
Confidence            35678999999 99999999999999999999999999999998     88888899999999999986     456665


Q ss_pred             ccCCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHH
Q 039082          166 YCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ  243 (472)
Q Consensus       166 ~~~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~  243 (472)
                      +.+...   ...+ ..++ +....|+..+.++.+..+||-|.||.||.|.|+  ...||||.++.+     .+..+.|+.
T Consensus       243 PApK~n---Kptv-ygvS-Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-----tMeveEFLk  312 (1157)
T KOG4278|consen  243 PAPKKN---KPTV-YGVS-PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLK  312 (1157)
T ss_pred             cCccCC---CCce-eeec-CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-----chhHHHHHH
Confidence            432211   1111 1222 344889999999999999999999999999998  567999998754     456778999


Q ss_pred             HHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 039082          244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ  323 (472)
Q Consensus       244 E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~  323 (472)
                      |+.+|+.+.|||+|+|+|+|..+.++|||.|||+.|+|.+||+.+....        .+-..++.|+.||+.||+||..+
T Consensus       313 EAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~e--------v~avvLlyMAtQIsSaMeYLEkk  384 (1157)
T KOG4278|consen  313 EAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSE--------VPAVVLLYMATQISSAMEYLEKK  384 (1157)
T ss_pred             HHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhh--------cchhHHHHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999999999999999998766432        12345778899999999999999


Q ss_pred             CCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-cccc---CCcccccccccCCCCCchHHHHHHHHHHHHHHc-
Q 039082          324 KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-  398 (472)
Q Consensus       324 ~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~g---t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-  398 (472)
                      +  +|||||.++|+||+++..|||+|||+++++..+.+ ...|   ++.|+|||.+....|+.++|||+|||+|||+.| 
T Consensus       385 n--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATY  462 (1157)
T KOG4278|consen  385 N--FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATY  462 (1157)
T ss_pred             h--hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhc
Confidence            9  99999999999999999999999999999985544 3445   799999999999999999999999999999999 


Q ss_pred             CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          399 GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       399 G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      |-.||++.+  ...++.-+.+|+ |+.-|+  .|++.++++|..||+.+|.+||+|.+|-..|+.+..
T Consensus       463 GMsPYPGid--lSqVY~LLEkgy-RM~~Pe--GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  463 GMSPYPGID--LSQVYGLLEKGY-RMDGPE--GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             CCCCCCCcc--HHHHHHHHhccc-cccCCC--CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            999999987  445555555555 666555  477788999999999999999999999999987653

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-52  Score=417.40  Aligned_cols=269  Identities=40%  Similarity=0.649  Sum_probs=236.1

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECCee-EEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~-vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ...|.++.+++.+.+.||+|+||+||+|.|+|.. ||||++.....  +....+.|.+|+.+|.+++|||||+++|+|.+
T Consensus        33 ~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~--~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~  110 (362)
T KOG0192|consen   33 LPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDF--DDESRKAFRREASLLSRLRHPNIVQFYGACTS  110 (362)
T ss_pred             ccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhc--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            4568899999999999999999999999999998 99999976543  22337789999999999999999999999999


Q ss_pred             CC-CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-
Q 039082          266 PP-YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-  343 (472)
Q Consensus       266 ~~-~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-  343 (472)
                      .. ..++|+||+.+|+|..++...        .....++..++.++.|||+||.|||++++ ||||||||+||||+.++ 
T Consensus       111 ~~~~~~iVtEy~~~GsL~~~l~~~--------~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~  181 (362)
T KOG0192|consen  111 PPGSLCIVTEYMPGGSLSVLLHKK--------RKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGK  181 (362)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhc--------ccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCC
Confidence            88 788999999999999999764        11234578899999999999999999986 99999999999999998 


Q ss_pred             cEEEeecccceecCC---CccccccCCccccccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          344 HVRIADFGHARFLSD---GEMALTGTFVYMAPEVIQ--CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 ~vkL~DFGla~~~~~---~~~~~~gt~~y~APE~~~--~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      ++||+|||+++....   ......||+.|||||++.  ...|+.++|||||||++|||+||+.||.+..  +..+...+.
T Consensus       182 ~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~--~~~~~~~v~  259 (362)
T KOG0192|consen  182 TLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA--PVQVASAVV  259 (362)
T ss_pred             EEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC--HHHHHHHHH
Confidence            999999999998774   233367999999999999  6699999999999999999999999998887  466777777


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                      .+..|+.+|..  ++..+..+|..||+.||+.||+|.+|+..|+.+...+..
T Consensus       260 ~~~~Rp~~p~~--~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  260 VGGLRPPIPKE--CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             hcCCCCCCCcc--CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence            77778887775  666788888899999999999999999999999887653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-52  Score=424.23  Aligned_cols=341  Identities=21%  Similarity=0.317  Sum_probs=280.8

Q ss_pred             HHHHHHhhhhhHHHHH---H-HHHHhhc--CCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-CCcccccc
Q 039082           95 RIIYRKRLERTQDYLR---H-CLQIAQD--NGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-QTPLHRYC  167 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~---~-~Lsv~~~--~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-~~~l~~~~  167 (472)
                      .++|||| .|+...|.   + +|||...  ..++||.|+..++ ++     +......|+.+..+..+|.. ..++...+
T Consensus        68 ~GDfLvR-~s~~~~~~~~~~~vlSv~~~~~~~~~h~vi~~~~~-~~-----~~~~~~~F~si~~li~~~~~~~~~~~~~~  140 (474)
T KOG0194|consen   68 DGDFLVR-ASEPKEGEKREFVVLSVKWSVFKKIKHYVIKRNGN-LF-----FFEGLRKFPTISELVNYYKFSKLEITGKN  140 (474)
T ss_pred             CCceEEE-eecccCCcceeEEEEEEEeecCCceeEEEEEEcCC-ee-----EEeccccCCcHHHHHHHHHhcccceeccc
Confidence            7899999 88877654   3 8999664  7899999999887 55     55666778888877666643 22222111


Q ss_pred             CCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEEC---C--ee-EEEEEeccCCCCCChHHHHHH
Q 039082          168 SQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR---G--LD-VAVKCIYPDFFHTNENAVTFF  241 (472)
Q Consensus       168 ~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---g--~~-vAVK~l~~~~~~~~~~~~~~f  241 (472)
                      .           ....+..+..|++.++++.+.++||+|+||+||+|.++   +  .. ||||..+-+. ....+.+..|
T Consensus       141 ~-----------~L~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~-~~~~~~~~e~  208 (474)
T KOG0194|consen  141 F-----------FLKRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSS-ELTKEQIKEF  208 (474)
T ss_pred             e-----------eecccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccc-cccHHHHHHH
Confidence            1           13334678889999999999999999999999999875   2  23 8999887532 2467888999


Q ss_pred             HHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 039082          242 AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH  321 (472)
Q Consensus       242 ~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH  321 (472)
                      ++|+++|+.++|||||++||++....++++|||.+.||+|.+||++.+.         ..+..++..+++++|.||+|||
T Consensus       209 m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~---------~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  209 MKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK---------SLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             HHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHhHHHHHH
Confidence            9999999999999999999999999999999999999999999987553         1357889999999999999999


Q ss_pred             hcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc
Q 039082          322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT  398 (472)
Q Consensus       322 ~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt  398 (472)
                      +++  +|||||.++|+|++.++.+||+|||+++....-..   ...-++.|+|||.+..+.|+.++|||||||++||+++
T Consensus       280 ~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~  357 (474)
T KOG0194|consen  280 SKN--CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFE  357 (474)
T ss_pred             HCC--CcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeec
Confidence            999  99999999999999999999999999986641111   1124789999999999999999999999999999999


Q ss_pred             -CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          399 -GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       399 -G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                       |..||.+..  ...+...+....++...|.  ..+..+..++..||..+|+.||++.++.+.|+.+.....
T Consensus       358 ~g~~Py~g~~--~~~v~~kI~~~~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  358 NGAEPYPGMK--NYEVKAKIVKNGYRMPIPS--KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             cCCCCCCCCC--HHHHHHHHHhcCccCCCCC--CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence             999999888  6678888855555666665  456677888889999999999999999999999877643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-49  Score=380.62  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=222.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      ..+..++++.++.||+|..|+||+++++  +..+|+|++..+   .++...+++.+|+++++..+||+||.+||.|..+.
T Consensus        74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~---~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~  150 (364)
T KOG0581|consen   74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN---IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG  150 (364)
T ss_pred             cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc---CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence            4466679999999999999999999997  778999999543   46677888999999999999999999999999998


Q ss_pred             C-ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcE
Q 039082          268 Y-RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 ~-~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      . ..++||||.+|+|.+++...+.          .+......++.+|++||.|||+ ++  ||||||||+||||+..|.|
T Consensus       151 ~~isI~mEYMDgGSLd~~~k~~g~----------i~E~~L~~ia~~VL~GL~YLh~~~~--IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  151 EEISICMEYMDGGSLDDILKRVGR----------IPEPVLGKIARAVLRGLSYLHEERK--IIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             ceEEeehhhcCCCCHHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhhccC--eeeccCCHHHeeeccCCCE
Confidence            5 9999999999999999975432          3467788999999999999996 77  9999999999999999999


Q ss_pred             EEeecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC---CCCHHHHHHHHhcCC
Q 039082          346 RIADFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK---DYKPAKIAMEVGEGK  421 (472)
Q Consensus       346 kL~DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~---~~~~~~i~~~i~~~~  421 (472)
                      ||||||.+..+... ..+++||..|||||.+.+..|+.++||||||++++|+.+|+.||...   .....+....|..+.
T Consensus       219 KicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p  298 (364)
T KOG0581|consen  219 KICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP  298 (364)
T ss_pred             EeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC
Confidence            99999999877654 36788999999999999999999999999999999999999999775   224667777788876


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .|.+|.. .+.+++..|+..||.+||.+||++.+|+.
T Consensus       299 -pP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  299 -PPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             -CCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             5666653 57788999999999999999999999985

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-48  Score=374.45  Aligned_cols=244  Identities=27%  Similarity=0.406  Sum_probs=210.4

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      .+..++|+++++||+|+||+||.++.+  ++.||+|++++..+... ...+....|..+|..++||+||+++..|++.+.
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~-~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k   99 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEK-KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK   99 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhh-hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe
Confidence            356789999999999999999999876  77899999988766433 456778899999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      +|+|++++.||.|...|+..+..          +...+.-++.+|+.||.|||++|  ||||||||+|||||++|+++|+
T Consensus       100 LylVld~~~GGeLf~hL~~eg~F----------~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~Lt  167 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREGRF----------SEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLT  167 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcCCc----------chhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEe
Confidence            99999999999999999765532          24557778899999999999999  9999999999999999999999


Q ss_pred             ecccceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          349 DFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       349 DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |||+|+..-   +...+.|||+.|||||++....|+..+|||||||++|||++|..||.+.+  ...+...+..+..+ .
T Consensus       168 DFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~--~~~~~~~I~~~k~~-~  244 (357)
T KOG0598|consen  168 DFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED--VKKMYDKILKGKLP-L  244 (357)
T ss_pred             ccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc--HHHHHHHHhcCcCC-C
Confidence            999999543   33456799999999999999999999999999999999999999998887  56677777777622 2


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCC
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRP  452 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RP  452 (472)
                      .|.  -...+..+++.+++..||+.|.
T Consensus       245 ~p~--~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  245 PPG--YLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCc--cCCHHHHHHHHHHhccCHHHhc
Confidence            222  1345677888899999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.7e-48  Score=409.14  Aligned_cols=270  Identities=26%  Similarity=0.404  Sum_probs=236.1

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL  259 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l  259 (472)
                      .....|++.++.+.+.||+|+||+||+|...       ...||||.++.+   .+.....+|.+|+++|..++|||||+|
T Consensus       478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~---a~~~~~~dF~REaeLla~l~H~nIVrL  554 (774)
T KOG1026|consen  478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK---AENQARQDFRREAELLAELQHPNIVRL  554 (774)
T ss_pred             cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc---ccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            3456789999999999999999999999864       246999999765   344577889999999999999999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM----VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~----~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      +|+|.++++.|+|+|||..|+|..||............    .+..+..+.+.|+.|||.||+||-++.  +|||||..+
T Consensus       555 lGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATR  632 (774)
T KOG1026|consen  555 LGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATR  632 (774)
T ss_pred             EEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhh
Confidence            99999999999999999999999999876654433322    233567889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCCcccccc-----CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~~~~~~g-----t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                      |+||+++..|||+|||+++......+...+     +++|||||.|..+.||.+||||||||+|||+++ |+-||.+..  
T Consensus       633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS--  710 (774)
T KOG1026|consen  633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS--  710 (774)
T ss_pred             hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc--
Confidence            999999999999999999977654443332     799999999999999999999999999999999 999998887  


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ..++...+..|..   ++....++.+++.+|..||+.+|.+||+|++|-..|...-.
T Consensus       711 n~EVIe~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~  764 (774)
T KOG1026|consen  711 NQEVIECIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ  764 (774)
T ss_pred             hHHHHHHHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence            5679999999875   55556788899999999999999999999999999987654

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-48  Score=380.49  Aligned_cols=253  Identities=24%  Similarity=0.312  Sum_probs=212.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh---HHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE---NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~---~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      .+.|.+.+.||+|+||.|-+|..+  |+.||||++++.......   .......+|+++|++|+|||||+++++|..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            467889999999999999999876  789999999876543322   122335699999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC---CcE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---KHV  345 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~---~~v  345 (472)
                      .|+|+||+.||+|.+++-..+..+          ...-..+++|++.|+.|||++|  |+||||||+|||+..+   ..+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~l~----------ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~ll  318 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKYLR----------EDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCLL  318 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccccc----------cchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceEE
Confidence            999999999999999996555432          2345678999999999999999  9999999999999765   789


Q ss_pred             EEeecccceecCCCc--cccccCCcccccccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~---~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ||+|||+|+......  .++||||.|.|||++.++.   +..++|+||+||+||-+++|.+||.+... +.....++..|
T Consensus       319 KItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~-~~sl~eQI~~G  397 (475)
T KOG0615|consen  319 KITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT-DPSLKEQILKG  397 (475)
T ss_pred             EecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC-CccHHHHHhcC
Confidence            999999999986443  5789999999999998654   33488999999999999999999977652 33478889999


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+...-+.......+..++|.+||..||++|||+.++++
T Consensus       398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            876544444667788899999999999999999999875

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-48  Score=390.31  Aligned_cols=263  Identities=36%  Similarity=0.626  Sum_probs=231.3

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ...|+|+.+++.+...||+|.||+||+|.|.| +||||+++.+..  ..+..+.|.+|+.++++.+|.||+-|+|+|..+
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~p--t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p  460 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDP--TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP  460 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCC--CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence            36799999999999999999999999999987 799999987643  556889999999999999999999999999887


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      .. .+|.-++.|-+|+.+|+.....         ..+...+.|+.||+.||.|||.++  |||||||..||||.+++.||
T Consensus       461 ~~-AIiTqwCeGsSLY~hlHv~etk---------fdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVk  528 (678)
T KOG0193|consen  461 PL-AIITQWCEGSSLYTHLHVQETK---------FDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVK  528 (678)
T ss_pred             ce-eeeehhccCchhhhhccchhhh---------hhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEE
Confidence            76 7888999999999999754422         236778999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCC-----CccccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSD-----GEMALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~-----~~~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||++..-..     ......|.+.|||||+++.   .+|++.+|||||||++|||+||.+||...  ..+.+.-.+.
T Consensus       529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~--~~dqIifmVG  606 (678)
T KOG0193|consen  529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ--NRDQIIFMVG  606 (678)
T ss_pred             EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC--ChhheEEEec
Confidence            999999976542     2234557899999999974   47999999999999999999999999833  3677888899


Q ss_pred             cCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       419 ~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .|++++.+... ..++.++.+|+..||..++++||.|.+|+..|+++..
T Consensus       607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            99888777665 7788899999999999999999999999999988765

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5e-47  Score=370.14  Aligned_cols=247  Identities=30%  Similarity=0.519  Sum_probs=208.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+|.+.++||+|+||+||+|+++  +..||||.+.+...  .....+.+..|+.+|+.++|||||.+++++..++..|+|
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l--~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL--NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc--CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            58999999999999999999986  78999999977643  567778899999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC------CcEE
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA------KHVR  346 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~------~~vk  346 (472)
                      ||||.||+|..|++..+.          .+....+.++.|||.||++||+++  ||||||||.||||+..      -.+|
T Consensus        88 MEyC~gGDLs~yi~~~~~----------l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LK  155 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGR----------LPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLK  155 (429)
T ss_pred             EEeCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEE
Confidence            999999999999986552          235678888999999999999999  9999999999999764      4699


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||+|+.+..+.  .+.||++.|||||++....|+.|+|+||+|+++|++++|+.||...+  ..+....+..+..-.
T Consensus       156 IADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t--~~eL~~~~~k~~~~~  233 (429)
T KOG0595|consen  156 IADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET--PKELLLYIKKGNEIV  233 (429)
T ss_pred             ecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC--HHHHHHHHhcccccc
Confidence            99999999998665  46789999999999999999999999999999999999999998877  566777777765333


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      +.+.. .....+.+++...+..+|..|-++.+..
T Consensus       234 ~~~~~-~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  234 PVLPA-ELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             Cchhh-hccCchhhhhhHHHhcCccccCchHHhh
Confidence            22222 2223345677778888888887766543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-47  Score=355.77  Aligned_cols=241  Identities=26%  Similarity=0.407  Sum_probs=215.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      ...++|+.++.||.|+||+|++++.+  |..||+|++.+..+ ..-...+...+|.++|+.+.||+++++++.|.+....
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~v-VklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKV-VKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHH-HHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            45578999999999999999999986  77899999987654 3445667788999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++||+|+.||.|.++|++.+..          +...++.++.+|+.||+|||+++  |++|||||+|||||.+|++||+|
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF----------~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitD  187 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRF----------SEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITD  187 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCC----------CchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEe
Confidence            9999999999999999876542          34668889999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      ||+|+.+.+...+.||||.|+|||++..+.|..++|+|||||++|||+.|..||.+.+  +..+...|..+.++.  |..
T Consensus       188 FGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~--~~~iY~KI~~~~v~f--P~~  263 (355)
T KOG0616|consen  188 FGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN--PIQIYEKILEGKVKF--PSY  263 (355)
T ss_pred             ccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC--hHHHHHHHHhCcccC--Ccc
Confidence            9999999999999999999999999999999999999999999999999999998877  688999999998653  332


Q ss_pred             chhHHHHHHHHHHhccCCCCCC
Q 039082          430 DGQLRELIELICLSWDGDASVR  451 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~R  451 (472)
                        ...++.+++.+++..|-.+|
T Consensus       264 --fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  264 --FSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             --cCHHHHHHHHHHHhhhhHhh
Confidence              23457777888898888888

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-46  Score=383.09  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=216.1

Q ss_pred             CCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+|+..+.||+|+|+.||.+++  .|..||+|++.+..+ ......+...+|+++.+.|+|||||++|++|.+.++.|+|
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l-~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLL-KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHh-cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEE
Confidence            5799999999999999999988  488999999987655 3445667789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      .|.+..++|..+++..+          ..+..+++.++.||+.||.|||+++  |||||||..|+||+++.+|||+||||
T Consensus        97 LELC~~~sL~el~Krrk----------~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGL  164 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRK----------PLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGL  164 (592)
T ss_pred             EEecCCccHHHHHHhcC----------CCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccce
Confidence            99999999999986322          3457889999999999999999999  99999999999999999999999999


Q ss_pred             ceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      |..+.   ....+.||||.|.|||++....++..+||||+||+||-|++|++||...+  -.+....|....+  .+|. 
T Consensus       165 At~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--vkety~~Ik~~~Y--~~P~-  239 (592)
T KOG0575|consen  165 ATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--VKETYNKIKLNEY--SMPS-  239 (592)
T ss_pred             eeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--HHHHHHHHHhcCc--cccc-
Confidence            99887   44678999999999999999999999999999999999999999998776  4456666665544  3343 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ....+..++|..+|+.||.+|||+++|+.
T Consensus       240 -~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 -HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             34556788999999999999999999985

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=407.73  Aligned_cols=266  Identities=30%  Similarity=0.475  Sum_probs=230.1

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC---Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR---GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~---g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ++++.+++.+.||+|+||.||.|.+.   |.    .||||.+++.   .+......|++|+.+|+.++|||||+++|+|.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~---~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL---SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc---CCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            66789999999999999999999985   32    4999998764   46677888999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +....++++|||+||+|.+||++.......   ...+++..++.++.+||+|+.||++++  +|||||.++|+||++...
T Consensus       766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~---~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~  840 (1025)
T KOG1095|consen  766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQ---PSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRV  840 (1025)
T ss_pred             CCCCcEEEehhcccCcHHHHHHhcccccCC---CCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCc
Confidence            999999999999999999999876443322   445678999999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCccccc-c----CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          345 VRIADFGHARFLSDGEMALT-G----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~~~~-g----t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |||+|||+|+.+.+..+... |    +.+|||||.+..+.|+.++|||||||++||++| |..||.+.+  ..++...+.
T Consensus       841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~--n~~v~~~~~  918 (1025)
T KOG1095|consen  841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRS--NFEVLLDVL  918 (1025)
T ss_pred             EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcc--hHHHHHHHH
Confidence            99999999995544433322 2    689999999999999999999999999999999 999998887  566777666


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                      .|. |  ++....++..++++|..||+.+|++||+|..|++.+..+......
T Consensus       919 ~gg-R--L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  919 EGG-R--LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             hCC-c--cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            666 3  444456788899999999999999999999999999888776543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-47  Score=357.25  Aligned_cols=251  Identities=27%  Similarity=0.424  Sum_probs=213.6

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE-EEEcCCC-
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG-ACLEPPY-  268 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g-~~~~~~~-  268 (472)
                      +..+|+++++||+|+||+||++...  |..||.|.+..+.+  +.........|+.+|+.|+|||||++|+ .|.++.. 
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m--d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ev   94 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM--DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEV   94 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc--cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchh
Confidence            3468999999999999999999864  88999999985543  5667788999999999999999999999 4555554 


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc--eeecCCCCCcEEEcCCCcEE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPK--VIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~--iiHrDLkp~NILl~~~~~vk  346 (472)
                      +++|||++.+|+|...++......      ...+...+|.++.|++.||..+|++-++  |+||||||.||+|+.+|.||
T Consensus        95 lnivmE~c~~GDLsqmIk~~K~qk------r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvK  168 (375)
T KOG0591|consen   95 LNIVMELCDAGDLSQMIKHFKKQK------RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVK  168 (375)
T ss_pred             hHHHHHhhcccCHHHHHHHHHhcc------ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCcee
Confidence            788999999999999997544332      2345788999999999999999994333  99999999999999999999


Q ss_pred             EeecccceecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+|||+++.+.....   +.+|||.||+||.+...+|+.+|||||+||++|||+.-..||.+.+  ...+...|..|.++
T Consensus       169 LGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  169 LGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCKKIEQGDYP  246 (375)
T ss_pred             eccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHHHHHcCCCC
Confidence            999999999876543   5679999999999999999999999999999999999999999986  66788888888643


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFS  455 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~  455 (472)
                       ++|. .....++..+|..|+..||+.||+.-
T Consensus       247 -~~p~-~~YS~~l~~li~~ci~vd~~~RP~t~  276 (375)
T KOG0591|consen  247 -PLPD-EHYSTDLRELINMCIAVDPEQRPDTV  276 (375)
T ss_pred             -CCcH-HHhhhHHHHHHHHHccCCcccCCCcc
Confidence             3443 35667888999999999999999843

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=6.8e-45  Score=365.51  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=217.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +..+||+++++||+|+||.||+|+.+  |..+|+|++++..+. ....++....|.++|...++|+||+||..|.+.+++
T Consensus       138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~-~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEML-KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHH-hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45689999999999999999999875  789999999887653 456678899999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      |+||||+.||++..+|...+..          +...+..++.+++.|++.||..|  +|||||||+|+|||..|++||+|
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L----------~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSD  284 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTL----------TEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSD  284 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcC----------chHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeecc
Confidence            9999999999999999765543          45678888999999999999999  99999999999999999999999


Q ss_pred             cccceecCC------------------------Cc--------------------------cccccCCcccccccccCCC
Q 039082          350 FGHARFLSD------------------------GE--------------------------MALTGTFVYMAPEVIQCEP  379 (472)
Q Consensus       350 FGla~~~~~------------------------~~--------------------------~~~~gt~~y~APE~~~~~~  379 (472)
                      ||||.-+..                        ..                          ...+|||.|+|||++.+..
T Consensus       285 FGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg  364 (550)
T KOG0605|consen  285 FGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG  364 (550)
T ss_pred             ccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC
Confidence            999853210                        00                          0234999999999999999


Q ss_pred             CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCC---CHHH
Q 039082          380 YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRP---SFSS  456 (472)
Q Consensus       380 ~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP---s~~~  456 (472)
                      |+..+|+||||||+|||+.|.+||.+.+  +.+....|.........|.......+..++|.+|+. ||+.|-   +++|
T Consensus       365 Y~~~cDwWSLG~ImyEmLvGyPPF~s~t--p~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  365 YGKECDWWSLGCIMYEMLVGYPPFCSET--PQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             CCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHH
Confidence            9999999999999999999999998887  778888888876555666666667889999999999 999995   4555


Q ss_pred             HH
Q 039082          457 IT  458 (472)
Q Consensus       457 ll  458 (472)
                      |.
T Consensus       442 IK  443 (550)
T KOG0605|consen  442 IK  443 (550)
T ss_pred             Hh
Confidence            54

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=366.40  Aligned_cols=250  Identities=26%  Similarity=0.408  Sum_probs=213.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~  268 (472)
                      -...||.+.+.||.|+|++|++|+.+  ++.||||++.+..+ ..+...+....|.++|..| .||.||+||..|.++..
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~I-ike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYI-IKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHH-HhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34579999999999999999999986  77899999987655 3455567788999999999 89999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      +|||++|+.+|+|.++|.+.+...          ....+.++.+|+.||+|||++|  ||||||||+|||||+||++||+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfd----------e~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikIT  216 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFD----------ETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKIT  216 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcch----------HHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEe
Confidence            999999999999999998876532          3456788999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc----------------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHH
Q 039082          349 DFGHARFLSDGE----------------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK  412 (472)
Q Consensus       349 DFGla~~~~~~~----------------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~  412 (472)
                      |||-|+.+.+..                ..++||..|.+||++.....+..+|+|+|||+||.|+.|.+||.+.+  +-.
T Consensus       217 DFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N--eyl  294 (604)
T KOG0592|consen  217 DFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN--EYL  294 (604)
T ss_pred             eccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc--HHH
Confidence            999998875321                34679999999999999999999999999999999999999998876  444


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      +...|.+-.+  .+|+.  .+..+.+||.+.|..||.+|+++.+|.+.
T Consensus       295 iFqkI~~l~y--~fp~~--fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  295 IFQKIQALDY--EFPEG--FPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHHHHhcc--cCCCC--CCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            5555655332  33332  33567888889999999999999888754

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.3e-44  Score=351.49  Aligned_cols=260  Identities=19%  Similarity=0.268  Sum_probs=217.8

Q ss_pred             eeeCCCCeeEe--ceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc--
Q 039082          190 WYIDPKEIDLQ--EKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--  265 (472)
Q Consensus       190 ~~i~~~~~~l~--~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~--  265 (472)
                      +.++.++++..  ..||+|++|.||+|.++|..||||.++.... ......+.|.+|+.+|++++|||||+++|++.+  
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHK-GHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEecccccc-ccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            45666677666  6899999999999999999999999976432 233445778899999999999999999999877  


Q ss_pred             --CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCC
Q 039082          266 --PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       266 --~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~  342 (472)
                        ....++++|++.+|+|.+++....          ..++...+.++.+++.||+|||+. +  ++||||||+|||++++
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~  159 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDKEK----------DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTEN  159 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhhCC----------CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCC
Confidence              345678999999999999996432          134677889999999999999985 7  8999999999999999


Q ss_pred             CcEEEeecccceecCCCccccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          343 KHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      +.+||+|||+++..........|+..|+|||.+.+  ..++.++|||||||++|||++|..||.+.+  ...+...+..+
T Consensus       160 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~--~~~~~~~i~~~  237 (283)
T PHA02988        160 YKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT--TKEIYDLIINK  237 (283)
T ss_pred             CcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhc
Confidence            99999999999877665556678999999999976  689999999999999999999999998765  45566666555


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ..++.++.  ..+..+.+++.+||+.||++|||+.+++..|+.++.
T Consensus       238 ~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 NNSLKLPL--DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCCCC--cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            44544442  356678899999999999999999999999998864

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-44  Score=361.72  Aligned_cols=268  Identities=26%  Similarity=0.423  Sum_probs=212.7

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMG  261 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g  261 (472)
                      |.++.++|++.++||+|+||.||+|.+.       +..||||+++..   ........+.+|+.+|..+ +|||||++++
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~niv~~~~   78 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG---ATASEHKALMSELKILIHIGNHLNVVNLLG   78 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc---cchHHHHHHHHHHHHHHHhccCcceeeEEe
Confidence            8899999999999999999999999752       357999998653   2334456789999999999 8999999999


Q ss_pred             EEEcCC-CceEEEEeccCCcHHHHHhhccccccc----------------------------------------------
Q 039082          262 ACLEPP-YRGWLVTELLGTTLKEWLHGLGSQRRK----------------------------------------------  294 (472)
Q Consensus       262 ~~~~~~-~~~~vve~~~ggsL~~~l~~~~~~~~~----------------------------------------------  294 (472)
                      +|...+ ..+++++|+.+|+|.+++.........                                              
T Consensus        79 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (338)
T cd05102          79 ACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN  158 (338)
T ss_pred             EecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence            987654 467889999999999999753211000                                              


Q ss_pred             ------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-----cc
Q 039082          295 ------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----AL  363 (472)
Q Consensus       295 ------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~  363 (472)
                            .......++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++.......     ..
T Consensus       159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~  236 (338)
T cd05102         159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA  236 (338)
T ss_pred             cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCC
Confidence                  000123456778889999999999999999  99999999999999999999999999986543211     22


Q ss_pred             ccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHH
Q 039082          364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICL  442 (472)
Q Consensus       364 ~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~  442 (472)
                      .+++.|+|||++.+..++.++|||||||++|||++ |..||.+..... .....+..+. .+..+  ...+..+.+++.+
T Consensus       237 ~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~~~-~~~~~--~~~~~~l~~li~~  312 (338)
T cd05102         237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKDGT-RMRAP--ENATPEIYRIMLA  312 (338)
T ss_pred             CCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhcCC-CCCCC--CCCCHHHHHHHHH
Confidence            34678999999998999999999999999999997 999998765332 2333344433 22222  2345678899999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHH
Q 039082          443 SWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       443 cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ||..||++||++.+|++.|+++..
T Consensus       313 cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         313 CWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=382.59  Aligned_cols=261  Identities=25%  Similarity=0.425  Sum_probs=235.5

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ..+|+...+.+.++||.|.||+|++|+.+  |   ..||||.++..   ..+.....|+.|+.||-.++||||++|-|+.
T Consensus       623 akEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G---ytekqrrdFL~EAsIMGQFdHPNIIrLEGVV  699 (996)
T KOG0196|consen  623 AKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG---YTEKQRRDFLSEASIMGQFDHPNIIRLEGVV  699 (996)
T ss_pred             hhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC---ccHHHHhhhhhhhhhcccCCCCcEEEEEEEE
Confidence            45788899999999999999999999986  3   46999999765   4677888999999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      ....+.++|.|||++|+|+.||+..+..         .++.++..|.+.|+.||.||-++|  +|||||.++||||+.+.
T Consensus       700 Tks~PvMIiTEyMENGsLDsFLR~~DGq---------ftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnL  768 (996)
T KOG0196|consen  700 TKSKPVMIITEYMENGSLDSFLRQNDGQ---------FTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNL  768 (996)
T ss_pred             ecCceeEEEhhhhhCCcHHHHHhhcCCc---------eEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccce
Confidence            9999999999999999999999876643         246778999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCccc---cc-c--CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGEMA---LT-G--TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~~---~~-g--t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      .+|++|||+++.+.++...   .. |  +++|+|||.|..+.++.++|||||||+|||.++ |..||.+++  ..++...
T Consensus       769 vCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS--NQdVIka  846 (996)
T KOG0196|consen  769 VCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVIKA  846 (996)
T ss_pred             EEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc--hHHHHHH
Confidence            9999999999998755421   12 3  789999999999999999999999999999988 999999988  6778999


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +..|+   .+|+...++..|.+||..||++|-.+||.|.+|+..|+++.++-
T Consensus       847 Ie~gy---RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  847 IEQGY---RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHhcc---CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            99987   57777889999999999999999999999999999999998764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-44  Score=351.12  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=219.1

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      .....|.++.++|++..+||.|..+.||+|++.  +..||||++.-+...   ...+.+.+|+..|+.++|||||+++..
T Consensus        16 ~~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~---~~ld~l~kE~~~msl~~HPNIv~~~~s   92 (516)
T KOG0582|consen   16 SSEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN---NDLDALRKEVQTMSLIDHPNIVTYHCS   92 (516)
T ss_pred             cccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh---hhHHHHHHHHHHhhhcCCCCcceEEEE
Confidence            345679999999999999999999999999985  889999999876542   336779999999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      |..+..++.||.+|.+|++.+.++..-...        .....+..+.+++++||.|||.+|  .||||||+.||||+.+
T Consensus        93 Fvv~~~LWvVmpfMa~GS~ldIik~~~~~G--------l~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~d  162 (516)
T KOG0582|consen   93 FVVDSELWVVMPFMAGGSLLDIIKTYYPDG--------LEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSD  162 (516)
T ss_pred             EEecceeEEeehhhcCCcHHHHHHHHcccc--------ccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCC
Confidence            999999999999999999999996533221        234567788899999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCc-------cccccCCccccccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH
Q 039082          343 KHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQ--CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI  413 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~--~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i  413 (472)
                      |.|||+|||.+..+.+..       ..+.||+.|||||++.  ...|+.|+|||||||+..||.+|..||...  .+..+
T Consensus       163 G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~--pPmkv  240 (516)
T KOG0582|consen  163 GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY--PPMKV  240 (516)
T ss_pred             CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC--ChHHH
Confidence            999999999987765432       3457999999999954  467999999999999999999999999554  48888


Q ss_pred             HHHHhcCCCCCCC----CCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          414 AMEVGEGKLRPAL----PEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       414 ~~~i~~~~~~~~l----~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......+..+...    +..  ......+.+++..||..||.+|||++++++
T Consensus       241 Ll~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  241 LLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             HHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            8887777632111    111  334567889999999999999999999985

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=367.50  Aligned_cols=245  Identities=23%  Similarity=0.336  Sum_probs=209.7

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      -.++.++|.++++||+|+||+|+++..+  +..||||+++++.+-. .+..+..+.|.+++... +||+++++++.|...
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~-~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQ-RDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceec-cccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            4577789999999999999999999987  4579999999987754 45667788999999888 599999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +.+++||||+.||++.-+.+. +          ..+...+..+++.|+.||.|||++|  |||||||.+|||||.+|++|
T Consensus       442 ~~l~fvmey~~Ggdm~~~~~~-~----------~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~k  508 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDLMHHIHT-D----------VFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVK  508 (694)
T ss_pred             CeEEEEEEecCCCcEEEEEec-c----------cccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEE
Confidence            999999999999994333221 1          1235667888999999999999999  99999999999999999999


Q ss_pred             EeecccceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+|||+++..-   +...++||||.|+|||++.+..|+.++|||||||+||||++|..||.+.+  ++++...|.....+
T Consensus       509 iADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gdd--Eee~FdsI~~d~~~  586 (694)
T KOG0694|consen  509 IADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDD--EEEVFDSIVNDEVR  586 (694)
T ss_pred             ecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCCCC
Confidence            99999998643   45668899999999999999999999999999999999999999999888  67788887775432


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                        .|.  -.+.+.+.+|.++|..+|++|-..
T Consensus       587 --yP~--~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  587 --YPR--FLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCC--cccHHHHHHHHHHhccCcccccCC
Confidence              222  245678889999999999999654

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-44  Score=361.85  Aligned_cols=262  Identities=26%  Similarity=0.483  Sum_probs=224.6

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEEC----Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR----GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ  258 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~----g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~  258 (472)
                      +....+++.++.+++.+.||.|.||.||.|.+.    |.  .||||+.+.+.   +.+..+.|+.|+.+|+.++|||||+
T Consensus       379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~---t~d~tekflqEa~iMrnfdHphIik  455 (974)
T KOG4257|consen  379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC---TPDDTEKFLQEASIMRNFDHPHIIK  455 (974)
T ss_pred             CCCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC---ChhhHHHHHHHHHHHHhCCCcchhh
Confidence            445568889999999999999999999999874    33  49999998763   3445778999999999999999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ++|+|.+. +.++|||.+.-|.|..||+.....         .+......+++||+.||+|||+++  .|||||.++|||
T Consensus       456 LIGv~~e~-P~WivmEL~~~GELr~yLq~nk~s---------L~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiL  523 (974)
T KOG4257|consen  456 LIGVCVEQ-PMWIVMELAPLGELREYLQQNKDS---------LPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNIL  523 (974)
T ss_pred             eeeeeecc-ceeEEEecccchhHHHHHHhcccc---------chHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhhee
Confidence            99998774 567888888899999999754432         235668888999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCcccc--cc--CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGEMAL--TG--TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~~~~--~g--t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      |.....|||+|||+++.+.+.....  .|  ++.|||||.+....|+.++|||.|||++||++. |.-||.+-.+  .++
T Consensus       524 VsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN--sDV  601 (974)
T KOG4257|consen  524 VSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN--SDV  601 (974)
T ss_pred             ecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc--cce
Confidence            9999999999999999998765432  33  789999999999999999999999999999988 9999988774  347


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ...+..|. |.+.|  +.|++.|+.++.+||+.+|.+||.|.+|...|.++..
T Consensus       602 I~~iEnGe-RlP~P--~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  602 IGHIENGE-RLPCP--PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             EEEecCCC-CCCCC--CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            77777776 44444  4578889999999999999999999999999998876

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-43  Score=354.44  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=211.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh-HHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE-NAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPP  267 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~-~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~  267 (472)
                      .....|.+.+.||+|+||.|++|.+.  |..||||++.+....... ...+.+.+|+.+++.++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568999999999999999999874  789999988765332122 34455668999999998 999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vk  346 (472)
                      ..++||||+.||+|.+++...+..          ...++..++.|++.|++|||++|  |+||||||+|||++.+ +.+|
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l----------~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~K  161 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRL----------KEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLK  161 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCC----------ChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEE
Confidence            999999999999999999763322          24778899999999999999999  9999999999999999 9999


Q ss_pred             EeecccceecC---CCccccccCCcccccccccCCC-CC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          347 IADFGHARFLS---DGEMALTGTFVYMAPEVIQCEP-YS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       347 L~DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~-~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      |+|||++....   ....+.+|++.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+  .......+..+.
T Consensus       162 l~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--~~~l~~ki~~~~  239 (370)
T KOG0583|consen  162 LSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--VPNLYRKIRKGE  239 (370)
T ss_pred             EeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--HHHHHHHHhcCC
Confidence            99999999883   3445788999999999999877 86 78999999999999999999998855  555666667765


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      +  .+|.... ..++..++.+|+..||.+|+++.+|+
T Consensus       240 ~--~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  240 F--KIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             c--cCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            4  3444322 67789999999999999999999998

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=363.16  Aligned_cols=255  Identities=31%  Similarity=0.484  Sum_probs=220.1

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ...|+|+.+.+.-++-||+|+-|.||+|+.++..||||.++.    ..       ..+++-|++|+||||+.|.|+|...
T Consensus       116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e----lk-------ETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE----LK-------ETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh----hh-------hhhHHHHHhccCcceeeEeeeecCC
Confidence            456999999999999999999999999999999999997642    11       2467889999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ..+||||||+..|.|...|+....          .+-.....+..+||.||.|||.++  |||||||.-||||..+..||
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~----------itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VK  252 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRP----------ITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVK  252 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCc----------cCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEE
Confidence            999999999999999999964332          234667889999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||-++...+.  .+.++||..|||||+|+..+.++|+|||||||+||||+||..||.+.+  ...+.-.+....+..
T Consensus       253 IsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVd--ssAIIwGVGsNsL~L  330 (904)
T KOG4721|consen  253 ISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVD--SSAIIWGVGSNSLHL  330 (904)
T ss_pred             eccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccc--hheeEEeccCCcccc
Confidence            9999999988754  457889999999999999999999999999999999999999997766  444555555555554


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ++|  ..++..+.-||..||.-.|..||+|.+|+..|+-+..++
T Consensus       331 pvP--stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  331 PVP--STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             cCc--ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            444  457778888899999999999999999999997655444

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=347.21  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=205.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--Cc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--YR  269 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--~~  269 (472)
                      ..++...+.||+|+||.||++.++  |...|||.+...    +....+.+.+|+.+|.+++|||||+++|......  ..
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~----~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~   91 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELE----DSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEY   91 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecc----cchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeee
Confidence            346778999999999999999986  689999988654    1122666899999999999999999999755444  57


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL~  348 (472)
                      +++|||+.+|+|.+++.+.+. .        .+...+..++.||+.||+|||++|  +|||||||+||||+. ++.+||+
T Consensus        92 ~i~mEy~~~GsL~~~~~~~g~-~--------l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~Kla  160 (313)
T KOG0198|consen   92 NIFMEYAPGGSLSDLIKRYGG-K--------LPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLA  160 (313)
T ss_pred             EeeeeccCCCcHHHHHHHcCC-C--------CCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEec
Confidence            789999999999999976653 1        246778999999999999999999  999999999999999 7999999


Q ss_pred             ecccceecCC------CccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          349 DFGHARFLSD------GEMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       349 DFGla~~~~~------~~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      |||++.....      ......||+.|||||++..+ ....++|||||||++.||+||..||.+. .........+....
T Consensus       161 DFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~~~~~~~ig~~~  239 (313)
T KOG0198|consen  161 DFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEEAEALLLIGRED  239 (313)
T ss_pred             cCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cchHHHHHHHhccC
Confidence            9999987763      12345699999999999853 3345999999999999999999999774 23444555555554


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ..|.+|..  .+.+..+++.+|+..+|++||||++++..-.
T Consensus       240 ~~P~ip~~--ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  240 SLPEIPDS--LSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CCCCCCcc--cCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            44555554  5567888999999999999999999997653

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-43  Score=334.24  Aligned_cols=249  Identities=22%  Similarity=0.310  Sum_probs=200.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.|+.+.++|+|+||+||+++++  |+.||||.+...  ..+....+..++|+++|+.++|||+|.++.+|......++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es--edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVES--EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccC--CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            46788899999999999999986  889999998654  23455667788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+...-|..+-+...+          .+......+++|++.|+.|+|+++  +|||||||+||||+.+|.+||||||+
T Consensus        80 FE~~dhTvL~eLe~~p~G----------~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGF  147 (396)
T KOG0593|consen   80 FEYCDHTVLHELERYPNG----------VPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGF  147 (396)
T ss_pred             eeecchHHHHHHHhccCC----------CCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchh
Confidence            988876666554322221          234668899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CCC----
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GKL----  422 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~~----  422 (472)
                      |+.+..+.   +-.+.|.+|+|||.+.+ ..|...+||||+||++.||++|..-|++.+  +.+....|..  |.+    
T Consensus       148 AR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~S--DiDQLy~I~ktLG~L~prh  225 (396)
T KOG0593|consen  148 ARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRS--DIDQLYLIRKTLGNLIPRH  225 (396)
T ss_pred             hHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcc--hHHHHHHHHHHHcccCHHH
Confidence            99887432   33456999999999987 689999999999999999999999998876  3233222221  111    


Q ss_pred             -------------CCCCCC--------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 -------------RPALPE--------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 -------------~~~l~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                   +.+-|+        .+....-+.+++..||+.||++|++.++++.
T Consensus       226 q~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  226 QSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             HHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                         111111        1334456789999999999999999999984

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=351.61  Aligned_cols=259  Identities=34%  Similarity=0.510  Sum_probs=210.5

Q ss_pred             CCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC-ceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY-RGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~-~~~v  272 (472)
                      ++|.-.+.||+|+||.||+|...+ ..||||.+......   . ...|.+|+.+|.+++|||+|+|+|+|.+.+. .++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~---~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ---G-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc---c-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            677788899999999999999875 89999988654221   1 3449999999999999999999999999985 9999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK-PKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~-~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +||+.+|+|.++|+.....        ..+|..++.|+.++|+||+|||+.. ++||||||||+|||||++..+||+|||
T Consensus       151 YEym~nGsL~d~L~~~~~~--------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG  222 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGE--------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG  222 (361)
T ss_pred             EEccCCCCHHHHhCCCCCC--------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence            9999999999999753321        3479999999999999999999954 479999999999999999999999999


Q ss_pred             cceecCC-Ccccc---ccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC----CCHHHH-HHHHhcCCC
Q 039082          352 HARFLSD-GEMAL---TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD----YKPAKI-AMEVGEGKL  422 (472)
Q Consensus       352 la~~~~~-~~~~~---~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~----~~~~~i-~~~i~~~~~  422 (472)
                      +|+.... .....   .||..|+|||.+..+..+.++|||||||+|.||+||+.|.....    ....++ ...+.++..
T Consensus       223 La~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~  302 (361)
T KOG1187|consen  223 LAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKL  302 (361)
T ss_pred             CcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcch
Confidence            9977654 33322   79999999999999999999999999999999999998876432    111222 223333332


Q ss_pred             C----CCCC--CCc--hhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          423 R----PALP--EED--GQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       423 ~----~~l~--~~~--~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .    +.+.  ...  .....+..+...|+..+|.+||++.++++.|+.+.
T Consensus       303 ~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  303 REIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             hheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            2    3332  222  45677888999999999999999999999996654

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.4e-43  Score=342.33  Aligned_cols=247  Identities=24%  Similarity=0.429  Sum_probs=219.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      -+|++.+.||+|.||.|-+|+..  |+.||||.++++.+ .++...-.+.+|++||..|+||||+.+|.+|...+.+.+|
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkI-kdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKI-KDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhc-ccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            47999999999999999999873  89999999999877 4556667799999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      |||..+|.|++|+...+..          +..+.+.+++||+.|+.|+|.++  ++|||||.+|||+|.++.+||+|||+
T Consensus       132 MEYaS~GeLYDYiSer~~L----------sErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSL----------SEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             EEecCCccHHHHHHHhccc----------cHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccch
Confidence            9999999999999865543          46788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +..+.+..  .++||++-|++||++.+.+|. +.+|-|||||+||-|+.|..||.+.+  ...+..+|..|.++.+-.+ 
T Consensus       200 SNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--hk~lvrQIs~GaYrEP~~P-  276 (668)
T KOG0611|consen  200 SNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--HKRLVRQISRGAYREPETP-  276 (668)
T ss_pred             hhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--HHHHHHHhhcccccCCCCC-
Confidence            99887665  478999999999999999985 78999999999999999999999988  4568888999987753332 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                          .....+|.+||..||++|.|+++|....
T Consensus       277 ----SdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  277 ----SDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----chHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                2456677899999999999999998653

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.9e-42  Score=353.14  Aligned_cols=271  Identities=23%  Similarity=0.336  Sum_probs=215.9

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCcee
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL  257 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv  257 (472)
                      ....|.++.++|++.+.||+|+||.||+|.+.       +..||||+++...   .......+.+|+.+++.+ +|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~il~~l~~h~nIv  105 (374)
T cd05106          29 YNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA---HTDEREALMSELKILSHLGQHKNIV  105 (374)
T ss_pred             ccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC---CHHHHHHHHHHHHHHHhhccCCcee
Confidence            45678999999999999999999999999863       2469999997542   334456788999999999 899999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccc--------------------------------------------
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR--------------------------------------------  293 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~--------------------------------------------  293 (472)
                      +++++|...+..++|++|+.+|+|.+++........                                            
T Consensus       106 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (374)
T cd05106         106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMR  185 (374)
T ss_pred             eEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccC
Confidence            999999999999999999999999999965321100                                            


Q ss_pred             ----------------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          294 ----------------KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       294 ----------------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                                      ........++..++.++.||+.||+|||+++  ++||||||+|||+++++.+||+|||+++...
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~  263 (374)
T cd05106         186 PVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIM  263 (374)
T ss_pred             CccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeecc
Confidence                            0001123456788999999999999999999  9999999999999999999999999998764


Q ss_pred             CCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          358 DGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       358 ~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      ....     ...++..|+|||++....++.++|||||||++|+|++ |+.||.......  ..........++..+.  .
T Consensus       264 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~~~~~~~~~--~  339 (374)
T cd05106         264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKRGYQMSRPD--F  339 (374)
T ss_pred             CCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHcccCccCCC--C
Confidence            3321     1224567999999988899999999999999999997 999997765322  2222233322333332  2


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .+.++.+++.+||..+|++||++.+|++.|+++.
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            3467889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=9e-42  Score=338.81  Aligned_cols=264  Identities=29%  Similarity=0.431  Sum_probs=206.9

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC------------------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR------------------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH  253 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~------------------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H  253 (472)
                      ++.++|++.++||+|+||.||+|.++                  +..||||++...   ........|.+|+.+|.+++|
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h   78 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD---ANKNARNDFLKEVKILSRLKD   78 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC---CCHHHHHHHHHHHHHHhhcCC
Confidence            45678999999999999999999753                  236999998764   234556779999999999999


Q ss_pred             CceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc---------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 039082          254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK---------ERMVPLPPFEERLARALEIAQAMQYLHEQK  324 (472)
Q Consensus       254 pnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~---------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~  324 (472)
                      |||+++++++.+.+..++++|++.+++|.+++.........         .......++..++.++.||+.||+|||+.|
T Consensus        79 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~  158 (304)
T cd05096          79 PNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN  158 (304)
T ss_pred             CCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC
Confidence            99999999999999999999999999999999653321111         111234567788999999999999999999


Q ss_pred             CceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-
Q 039082          325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-  398 (472)
Q Consensus       325 ~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-  398 (472)
                        |+||||||+|||++.++.+||+|||+++.......     ...++..|+|||++....++.++||||||+++|+|++ 
T Consensus       159 --ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 --FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             --ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence              99999999999999999999999999987653321     2234788999999988899999999999999999987 


Q ss_pred             -CCCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          399 -GNHPYIEKDYKPAKIAMEVG----EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       399 -G~~Pf~~~~~~~~~i~~~i~----~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                       +..||...+  ...+...+.    ...........+.++..+.+++.+||..+|++|||+.+|...|+
T Consensus       237 ~~~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         237 CKEQPYGELT--DEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             cCCCCCCcCC--HHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             667886654  222222211    11101111112345678999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-42  Score=348.45  Aligned_cols=247  Identities=28%  Similarity=0.439  Sum_probs=209.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  +..||||++.+... ........+.+|+.+|+.++||||+++++++.+++..++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREI-LKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence            478999999999999999999986  67899999975422 122345668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++...+.          .+...+..++.|++.||+|||++|  |+||||||+||||+.++.+||+|||
T Consensus        96 v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg  163 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGR----------FPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFG  163 (329)
T ss_pred             EEcCCCCChHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeecc
Confidence            9999999999999864321          235667788999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       352 la~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      ++...........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+..  .+|..  
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~--~~p~~--  237 (329)
T PTZ00263        164 FAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT--PFRIYEKILAGRL--KFPNW--  237 (329)
T ss_pred             CceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCCc--CCCCC--
Confidence            99988766667789999999999999999999999999999999999999997665  5556666666542  23332  


Q ss_pred             hHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      ....+.++|.+||..||.+||+     +++|+.
T Consensus       238 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        238 FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            3456788999999999999986     677764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-42  Score=342.10  Aligned_cols=247  Identities=27%  Similarity=0.375  Sum_probs=208.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++..... ........+.+|+.+++.++||||+++++++.+....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEV-IRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEE
Confidence            47899999999999999999986  78899999865322 1223456688999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++|+.+++|.+++...+.          .+......++.|++.||+|||++|  ++||||||+|||++.+|.+||+|||+
T Consensus        80 ~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~  147 (291)
T cd05612          80 MEYVPGGELFSYLRNSGR----------FSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGF  147 (291)
T ss_pred             EeCCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCc
Confidence            999999999999964321          245677888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchh
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ  432 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~  432 (472)
                      +...........|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+..  .++.  ..
T Consensus       148 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~--~~~~--~~  221 (291)
T cd05612         148 AKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN--PFGIYEKILAGKL--EFPR--HL  221 (291)
T ss_pred             chhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCc--CCCc--cC
Confidence            9887766666779999999999999999999999999999999999999997765  5556666666542  2232  23


Q ss_pred             HHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 039082          433 LRELIELICLSWDGDASVRPS-----FSSITCS  460 (472)
Q Consensus       433 ~~~l~~li~~cl~~dP~~RPs-----~~~ll~~  460 (472)
                      ...+.++|.+||..||.+||+     ++++++.
T Consensus       222 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         222 DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            456788999999999999995     8877653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.3e-41  Score=331.30  Aligned_cols=254  Identities=22%  Similarity=0.364  Sum_probs=210.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      |+..+|++.+.||+|+||.||+|.++     +..||+|.++..   ........|.+|+.+++.++||||+++++++...
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   78 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG---CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG   78 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC---CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC
Confidence            56678999999999999999999764     457999998754   2334456799999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++|+||+.+++|.+++.....         ..++..++.++.+++.||+|||+++  ++||||||+|||++.++.++
T Consensus        79 ~~~~lv~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          79 NTMMIVTEYMSNGALDSFLRKHEG---------QLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             CCcEEEEEeCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEE
Confidence            999999999999999999864321         2346788999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCC
Q 039082          347 IADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       347 L~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      ++|||.+........    ...++..|+|||.+.+..++.++|||||||++||+++ |..||.+.+  .......+.++.
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~~  225 (266)
T cd05064         148 ISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS--GQDVIKAVEDGF  225 (266)
T ss_pred             ECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHHCCC
Confidence            999998765432211    2234678999999999999999999999999999886 999997765  444555555553


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                       +++.+  ...+..+.+++..||..+|++||++++|.+.|.++
T Consensus       226 -~~~~~--~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         226 -RLPAP--RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CCCCC--CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             22233  33566788999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-42  Score=339.14  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=215.5

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECC--eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g--~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..-.+..++|++++.||.|.-|+||++..+|  ..+|+|++.++... ..........|.+||..++||+++.||+.|..
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~-~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet  148 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLA-SRKKLKRAQTEREILSLLDHPFLPTLYASFET  148 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHh-hhhHHHHHHHHHHHHHhcCCCccchhhheeec
Confidence            3456777899999999999999999999986  57999999887653 34555667789999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      ++..|++||||.||+|..++++.....        .+...++.++.+|+.||+|||..|  ||+|||||+||||.++|++
T Consensus       149 ~~~~cl~meyCpGGdL~~LrqkQp~~~--------fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHI  218 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQKQPGKR--------FSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHI  218 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhhCCCCc--------cchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcE
Confidence            999999999999999999987654432        345678888999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCC-----------------------------------C------------------------ccccccC
Q 039082          346 RIADFGHARFLSD-----------------------------------G------------------------EMALTGT  366 (472)
Q Consensus       346 kL~DFGla~~~~~-----------------------------------~------------------------~~~~~gt  366 (472)
                      .|+||+++.....                                   .                        ...++||
T Consensus       219 MLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGT  298 (459)
T KOG0610|consen  219 MLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGT  298 (459)
T ss_pred             EeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccc
Confidence            9999999743210                                   0                        0124589


Q ss_pred             CcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccC
Q 039082          367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDG  446 (472)
Q Consensus       367 ~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~  446 (472)
                      -.|.|||++.+...+.++|||+|||++|||++|..||.+.+.  .+....|...  ...+|..+.....+.+||.++|.+
T Consensus       299 hEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~--~~Tl~NIv~~--~l~Fp~~~~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  299 HEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNN--KETLRNIVGQ--PLKFPEEPEVSSAAKDLIRKLLVK  374 (459)
T ss_pred             cccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCc--hhhHHHHhcC--CCcCCCCCcchhHHHHHHHHHhcc
Confidence            999999999999999999999999999999999999998874  3345555554  345666667778899999999999


Q ss_pred             CCCCCCC----HHHHH
Q 039082          447 DASVRPS----FSSIT  458 (472)
Q Consensus       447 dP~~RPs----~~~ll  458 (472)
                      ||.+|..    +.+|.
T Consensus       375 dP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIK  390 (459)
T ss_pred             ChhhhhccccchHHhh
Confidence            9999987    66654

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=9.8e-42  Score=330.33  Aligned_cols=255  Identities=27%  Similarity=0.467  Sum_probs=212.6

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |.|+.++|++.++||+|+||.||+|.++ +..||+|.+...     ....+.+.+|+.+++.++|+||+++++.+...+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-----TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP   75 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-----chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            7889999999999999999999999876 567999987643     2234678999999999999999999999999888


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..++.++.+++.||+|||+.+  ++||||||+||+++.++.++|+
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~  145 (261)
T cd05072          76 IYIITEYMAKGSLLDFLKSDEG--------GKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIA  145 (261)
T ss_pred             cEEEEecCCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEEC
Confidence            9999999999999999864321        12346778889999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+.+..++.++|||||||++|+|+| |..||....  .......+..+. +
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~-~  222 (261)
T cd05072         146 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS--NSDVMSALQRGY-R  222 (261)
T ss_pred             CCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCC-C
Confidence            9999987754322    2234678999999998889999999999999999998 999997655  444555555443 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .  +.....+.++.+++.+||..+|++||++++|.+.|+++
T Consensus       223 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         223 M--PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             C--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            2  22233556788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=350.81  Aligned_cols=260  Identities=27%  Similarity=0.423  Sum_probs=218.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      -+++++...+.++||+|.||+|+++...| ..||||.++++   ...+....|.+|+++|.+|+|||||+++|+|..+++
T Consensus       533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~---a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP  609 (807)
T KOG1094|consen  533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD---ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP  609 (807)
T ss_pred             hhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc---cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence            45778899999999999999999999886 89999999886   455667889999999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      +++|+||+++|+|.+|+..+....        ..-....+|+.||+.||+||.+.+  +|||||.++|+|+|.++++||+
T Consensus       610 icmI~EYmEnGDLnqFl~aheapt--------~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKia  679 (807)
T KOG1094|consen  610 LCMITEYMENGDLNQFLSAHELPT--------AETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIA  679 (807)
T ss_pred             hHHHHHHHhcCcHHHHHHhccCcc--------cccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEec
Confidence            999999999999999997653211        112446679999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCccccc-----cCCcccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCCCCCHHHHHHHHhc--
Q 039082          349 DFGHARFLSDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT--GNHPYIEKDYKPAKIAMEVGE--  419 (472)
Q Consensus       349 DFGla~~~~~~~~~~~-----gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt--G~~Pf~~~~~~~~~i~~~i~~--  419 (472)
                      |||+++.+..+.+...     -+++|||||.+..+.++.++|||+||+++||+++  ...||...+  .+.+......  
T Consensus       680 dfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt--~e~vven~~~~~  757 (807)
T KOG1094|consen  680 DFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT--DEQVVENAGEFF  757 (807)
T ss_pred             CcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh--HHHHHHhhhhhc
Confidence            9999997766554433     3799999999999999999999999999999976  888997765  3344433322  


Q ss_pred             -C-CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          420 -G-KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       420 -~-~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                       . ...-.++....++..++++|.+||..+.++||+|++|...|.+.
T Consensus       758 ~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  758 RDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence             1 11112222356788999999999999999999999999888754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-42  Score=345.87  Aligned_cols=251  Identities=25%  Similarity=0.338  Sum_probs=208.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++++... ........+.+|+.++..++||||+++++++...+..++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLL-FKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEE
Confidence            47899999999999999999986  67899999976432 1223456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.|++|.+++...+.          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~e~~~g~~L~~~l~~~~~----------l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~  147 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGV----------LSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGL  147 (333)
T ss_pred             EeCCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcC
Confidence            999999999999964321          245778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC---
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE---  429 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~---  429 (472)
                      +...........|++.|+|||++.+..++.++|||||||++|||++|..||...+  ..+....+.........|..   
T Consensus       148 a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~  225 (333)
T cd05600         148 SKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST--PNETWENLKYWKETLQRPVYDDP  225 (333)
T ss_pred             CcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC--HHHHHHHHHhccccccCCCCCcc
Confidence            9877665556679999999999999999999999999999999999999997765  34444444332211111111   


Q ss_pred             -chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 -DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 -~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                       .....++.++|.+||..+|++||++.++++.
T Consensus       226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             2346778999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-43  Score=353.09  Aligned_cols=246  Identities=25%  Similarity=0.366  Sum_probs=212.2

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ...|...++||+|+.|.||.|...  +..||||.+.....    ...+.+++|+.+|+..+|+|||++++.|...+.++.
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q----~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ----PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC----CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence            357788899999999999999875  66899999976432    233458899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ||||+.||+|.+.+....           .+..++..++++++.||+|||.+|  |||||||.+|||++.+|.+||+|||
T Consensus       348 VMEym~ggsLTDvVt~~~-----------~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFG  414 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVTKTR-----------MTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFG  414 (550)
T ss_pred             EEeecCCCchhhhhhccc-----------ccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeee
Confidence            999999999999886432           346789999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      +|..+....   .+.+|||.|||||++....|++++||||||++++||+-|..||-..+  +......+.... .+.+..
T Consensus       415 Fcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAlyLIa~ng-~P~lk~  491 (550)
T KOG0578|consen  415 FCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNG-TPKLKN  491 (550)
T ss_pred             eeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--hHHHHHHHhhcC-CCCcCC
Confidence            999877443   45679999999999999999999999999999999999999997654  444445555444 555655


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .......+.+|+.+||..|+++||++.+||+
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            5667788999999999999999999999985

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-41  Score=330.38  Aligned_cols=246  Identities=35%  Similarity=0.620  Sum_probs=200.4

Q ss_pred             eEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          198 DLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++.+.||.|.||.||+|.++      +..|+||.++..   ...+....|.+|++.+++++||||++++|++...+..++
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~l   78 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS---SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFL   78 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT---SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc---cccccceeeeecccccccccccccccccccccccccccc
Confidence            57889999999999999987      568999999553   345557889999999999999999999999998888889


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++.+|+|.++|....        ....++..++.++.||+.||+|||+++  ++|+||+++|||++.++.+||+|||
T Consensus        79 v~e~~~~g~L~~~L~~~~--------~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~  148 (259)
T PF07714_consen   79 VMEYCPGGSLDDYLKSKN--------KEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFG  148 (259)
T ss_dssp             EEE--TTEBHHHHHHHTC--------TTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTT
T ss_pred             cccccccccccccccccc--------ccccccccccccccccccccccccccc--ccccccccccccccccccccccccc
Confidence            999999999999997651        122357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          352 HARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       352 la~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      ++.......     ........|+|||.+....++.++||||||+++|||++ |..||.+.+  ...+...+.++. +..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~--~~~~~~~~~~~~-~~~  225 (259)
T PF07714_consen  149 LSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD--NEEIIEKLKQGQ-RLP  225 (259)
T ss_dssp             TGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC--HHHHHHHHHTTE-ETT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccccccccc-cce
Confidence            998873221     12235788999999998889999999999999999999 789997664  666677776654 332


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      .+  ..++..+.++|..||+.+|++||++.+|++.|
T Consensus       226 ~~--~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 IP--DNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             SB--TTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ec--cchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            32  33566788999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.3e-41  Score=348.41  Aligned_cols=270  Identities=26%  Similarity=0.366  Sum_probs=214.0

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCcee
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL  257 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv  257 (472)
                      ....|.++.++|++.+.||+|+||.||+|.+.       +..||||+++...   .......+.+|+.+|..+ +|||||
T Consensus        26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~Ei~il~~l~~HpnIv  102 (375)
T cd05104          26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA---HLTEREALMSELKVLSYLGNHINIV  102 (375)
T ss_pred             CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc---CcHHHHHHHHHHHHHHHhcCCccee
Confidence            34568899999999999999999999999752       4579999987542   223446688999999999 899999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc-------------------------------------------
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK-------------------------------------------  294 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-------------------------------------------  294 (472)
                      +++++|...+..++|+||+.+|+|.+++.........                                           
T Consensus       103 ~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  182 (375)
T cd05104         103 NLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTK  182 (375)
T ss_pred             eeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccc
Confidence            9999999999999999999999999999753311000                                           


Q ss_pred             ----------------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          295 ----------------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       295 ----------------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                                            .......++..++.++.||+.||+|||+++  ++||||||+|||++.++.+||+|||+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~  260 (375)
T cd05104         183 ADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGL  260 (375)
T ss_pred             cccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCcc
Confidence                                  000112456788899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          353 ARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       353 a~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +........     ...++..|+|||.+.+..++.++|||||||++|||++ |..||...... ......+..+. ++..
T Consensus       261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~-~~~~~~~~~~~-~~~~  338 (375)
T cd05104         261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD-SKFYKMIKEGY-RMLS  338 (375)
T ss_pred             ceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch-HHHHHHHHhCc-cCCC
Confidence            987653321     1224567999999999999999999999999999998 89999765432 22333333332 3333


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      +.  ..+.++.+++..||..||++||++.+|++.|++.
T Consensus       339 ~~--~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         339 PE--CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CC--CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            32  2345788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-43  Score=319.60  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=214.9

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.  .++|++.+.||+|.||.||+|+.+  +..||+|++.++.+ .......++.+|+++-..|+||||+++|++|.+
T Consensus        17 ~~~~--l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi-~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd   93 (281)
T KOG0580|consen   17 KTWT--LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQI-LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD   93 (281)
T ss_pred             cccc--hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHH-HHhcchhhhhheeEeecccCCccHHhhhhheec
Confidence            4454  479999999999999999999986  56899999987654 233455778999999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      +...|+++||..+|+|.+.|......+.        .......++.|+|.||.|+|.++  ||||||||+|+|++.+|.+
T Consensus        94 ~~riyLilEya~~gel~k~L~~~~~~~f--------~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~l  163 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQEGRMKRF--------DEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGEL  163 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHhcccccc--------cccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCe
Confidence            9999999999999999999974332211        23446788999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCC-CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          346 RIADFGHARFLSD-GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       346 kL~DFGla~~~~~-~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      ||+|||-+..... ...+.|||..|.+||+..+..++..+|+|++|++.||++.|..||...+  ..+....+.+-..  
T Consensus       164 kiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~--~~etYkrI~k~~~--  239 (281)
T KOG0580|consen  164 KIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS--HSETYKRIRKVDL--  239 (281)
T ss_pred             eccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh--hHHHHHHHHHccc--
Confidence            9999999987753 3467899999999999999999999999999999999999999998777  5556666665432  


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+|  .....+..++|.+|+..+|.+|....++...
T Consensus       240 ~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  240 KFP--STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cCC--cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            233  3345578889999999999999998887653

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-42  Score=353.01  Aligned_cols=246  Identities=26%  Similarity=0.358  Sum_probs=215.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      -|++.+.||.|+.|.|-+|++.  |+.+|||++.+.. ...+.....+.+|+-+|+.+.||||+++|+++.+...+|+|+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeecccc-ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3567999999999999999884  8999999997653 234445566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      ||+.||.|++||-..+..          +..+++.+++||+.|+.|+|..+  |+||||||+|+|||..+.+||+|||+|
T Consensus        92 Eyv~gGELFdylv~kG~l----------~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMA  159 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGPL----------PEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMA  159 (786)
T ss_pred             EecCCchhHHHHHhhCCC----------CCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeecccee
Confidence            999999999999765543          35778999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc--cccccCCcccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE--MALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~--~~~~gt~~y~APE~~~~~~~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .....+.  .+.||.|.|+|||++.+..|+ .++||||.|||||.|+||++||.+.+  -..+...+..|.+.++    .
T Consensus       160 sLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--ir~LLlKV~~G~f~MP----s  233 (786)
T KOG0588|consen  160 SLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--IRVLLLKVQRGVFEMP----S  233 (786)
T ss_pred             ecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--HHHHHHHHHcCcccCC----C
Confidence            8776654  467899999999999999996 68999999999999999999998665  6778888999987543    3


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ..+.+..+||.+|++.||++|.|.++|++.
T Consensus       234 ~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  234 NISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            355677888899999999999999999864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.4e-42  Score=345.29  Aligned_cols=254  Identities=22%  Similarity=0.349  Sum_probs=212.5

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECC---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ..+.+..++|++.+.||+|+||.||+|.+++   ..||+|++..... ........+.+|+.+++.++||||+++++++.
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~  101 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKI-IKQKQVDHVFSERKILNYINHPFCVNLYGSFK  101 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence            3455677899999999999999999998752   5799999865432 12344566889999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +.+..++|++|+.+|+|.+++.....          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.
T Consensus       102 ~~~~~~lv~Ey~~~g~L~~~i~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~  169 (340)
T PTZ00426        102 DESYLYLVLEFVIGGEFFTFLRRNKR----------FPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGF  169 (340)
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCC
Confidence            99999999999999999999964321          246778889999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          345 VRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||.+.+  .......+..+... 
T Consensus       170 ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i~~~~~~-  246 (340)
T PTZ00426        170 IKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANE--PLLIYQKILEGIIY-  246 (340)
T ss_pred             EEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCC--HHHHHHHHhcCCCC-
Confidence            999999999987766666789999999999998889999999999999999999999998765  55556666665432 


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRP-----SFSSITCS  460 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~~  460 (472)
                       +|..  ....+.++|.+||..+|++|+     +++++++.
T Consensus       247 -~p~~--~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        247 -FPKF--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             -CCCC--CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence             2322  334678899999999999995     88888753

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4.5e-41  Score=329.02  Aligned_cols=263  Identities=27%  Similarity=0.447  Sum_probs=211.8

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      |.+..++|++.+.||+|+||.||+|.+++       ..||||++...   ........|.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~   77 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRLLGV   77 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            77888999999999999999999998753       46999988543   122344568899999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      +.+....+++++++.+++|.+++................++..++.++.+++.||+|||+.+  ++||||||+|||++++
T Consensus        78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~  155 (277)
T cd05062          78 VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAED  155 (277)
T ss_pred             EcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCC
Confidence            99888889999999999999999754322111111223457788889999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      +.++|+|||++........     ...+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..  .......
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~--~~~~~~~  233 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS--NEQVLRF  233 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHH
Confidence            9999999999876543221     2234778999999998899999999999999999999 789997665  3444444


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +..+.. +..+  ...+..+.+++.+||..+|++||++.++++.|+
T Consensus       234 ~~~~~~-~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VMEGGL-LDKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHcCCc-CCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            444432 2222  234567889999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.7e-41  Score=334.12  Aligned_cols=248  Identities=24%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |++.+.||+|+||.||+|.++  |..||||.+.+.... .......+.+|+.+++.++|+||+++++++.+.+..+++++
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhh-hhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            678999999999999999875  789999998764332 22334567899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+|+|..++.....        ...++..+..++.|++.||+|||+++  |+||||||+|||+++++.+||+|||++.
T Consensus        81 ~~~~g~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~  150 (285)
T cd05631          81 IMNGGDLKFHIYNMGN--------PGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAV  150 (285)
T ss_pred             ecCCCcHHHHHHhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcE
Confidence            9999999988753221        12346778889999999999999999  9999999999999999999999999998


Q ss_pred             ecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCc
Q 039082          355 FLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       355 ~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--~~i~~~i~~~~~~~~l~~~~  430 (472)
                      ......  ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.......  ..+...+....  ...+  .
T Consensus       151 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~--~  226 (285)
T cd05631         151 QIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ--EEYS--E  226 (285)
T ss_pred             EcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc--ccCC--c
Confidence            765332  34568999999999999999999999999999999999999997755321  22222222221  1111  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      .....+.+++.+||..||++||+     ++++++
T Consensus       227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            34567888999999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2e-41  Score=345.44  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=202.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.+... ........+.+|+.++..++||||+++++.+.+....++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM-LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEE
Confidence            47899999999999999999885  67899999975422 1234456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.||+|.+++...+.          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~E~~~gg~L~~~l~~~~~----------l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGl  147 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDT----------LTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGL  147 (363)
T ss_pred             EcCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccC
Confidence            999999999999964321          346778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC--------------------------------------ccccccCCcccccccccCCCCCchHHHHHHHHHHH
Q 039082          353 ARFLSDG--------------------------------------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILN  394 (472)
Q Consensus       353 a~~~~~~--------------------------------------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~  394 (472)
                      ++.+...                                      ....+||+.|+|||++.+..++.++|||||||++|
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~  227 (363)
T cd05628         148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (363)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence            8754321                                      01346899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhcc--CCCCCCCCHHHHHHH
Q 039082          395 EIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWD--GDASVRPSFSSITCS  460 (472)
Q Consensus       395 elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~--~dP~~RPs~~~ll~~  460 (472)
                      ||++|+.||.+.+  .......+........+|.......++.++|.+++.  .++..||++++|++.
T Consensus       228 ell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         228 EMLIGYPPFCSET--PQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             HHHhCCCCCCCCC--HHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            9999999997765  455556665543333444433344566777766443  334456999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=347.18  Aligned_cols=245  Identities=27%  Similarity=0.370  Sum_probs=208.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|...+.||+|+||.||+|.+.  ++.||+|++.-+   ..+..++.+.+|+.+|..++++||.++||.+.....++++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le---~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE---EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechh---hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            46777899999999999999986  678999999765   4566778899999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      |+|+.||++.+.|+.....          ...++..++++++.||.|||+++  .+|||||+.|||+..+|.|||+|||.
T Consensus        90 Mey~~gGsv~~lL~~~~~~----------~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgV  157 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNIL----------DEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGV  157 (467)
T ss_pred             HHHhcCcchhhhhccCCCC----------ccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecce
Confidence            9999999999998654431          23445667889999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +..+...   ..++.||+.|||||++.+..|+.++||||||++.+||++|.+||.+..  +..+...|.+.. +|.+.. 
T Consensus       158 a~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h--PmrvlflIpk~~-PP~L~~-  233 (467)
T KOG0201|consen  158 AGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH--PMRVLFLIPKSA-PPRLDG-  233 (467)
T ss_pred             eeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC--cceEEEeccCCC-CCcccc-
Confidence            9877643   256789999999999999999999999999999999999999997665  444444444432 333333 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ...+.+.+|+..||++||+.||+|.+|++
T Consensus       234 -~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 -DFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence             56677899999999999999999999985

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=328.68  Aligned_cols=263  Identities=27%  Similarity=0.443  Sum_probs=215.3

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      |+++.++|++.+.||+|+||.||+|.+++       ..||+|.+...   ........|.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   77 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN---ASMRERIEFLNEASVMKEFNCHHVVRLLGV   77 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc---cCHHHHHHHHHHHHHHHhCCCCceeEEEEE
Confidence            78899999999999999999999998752       57999988543   233445668899999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      +......+++++++.+++|.+++...............+++..++.++.|++.||.|||+.+  ++||||||+|||++.+
T Consensus        78 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~  155 (277)
T cd05032          78 VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAED  155 (277)
T ss_pred             EcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCC
Confidence            99999999999999999999999754432221112234567888999999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      +.+||+|||+++......     ....++..|+|||.+....++.++|||||||++|||++ |..||.+.+  .......
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~~~~  233 (277)
T cd05032         156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS--NEEVLKF  233 (277)
T ss_pred             CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC--HHHHHHH
Confidence            999999999997654322     22345788999999988889999999999999999998 999997665  4445555


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +..+. .+..|.  ..+..+.+++.+||..+|++|||+.+|++.|+
T Consensus       234 ~~~~~-~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 VIDGG-HLDLPE--NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             HhcCC-CCCCCC--CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            55443 233333  34678889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.2e-41  Score=325.52  Aligned_cols=255  Identities=29%  Similarity=0.504  Sum_probs=212.8

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |.++..+|.+.+.||+|+||.||+|.++  +..||+|++..+     ......+.+|+++++.++||||+++++++..++
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP   75 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCC
Confidence            7788899999999999999999999985  678999988643     233456889999999999999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++++.+++|.+++.....        ...++..++.++.|++.||+|||+++  ++||||||+|||+++++.+||
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl  145 (263)
T cd05052          76 PFYIITEFMTYGNLLDYLRECNR--------QEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKV  145 (263)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEe
Confidence            99999999999999999864321        12346778889999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCccc----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          348 ADFGHARFLSDGEMA----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       348 ~DFGla~~~~~~~~~----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      +|||++.........    ..++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+  .......+..+. 
T Consensus       146 ~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~~~-  222 (263)
T cd05052         146 ADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKGY-  222 (263)
T ss_pred             CCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCC-
Confidence            999999876543322    123567999999998999999999999999999998 999997765  344444444432 


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ++..+  ...+..+.+++.+||..+|++||++.++++.|+.+
T Consensus       223 ~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 RMERP--EGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CCCCC--CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            33333  33556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=5.3e-41  Score=346.34  Aligned_cols=271  Identities=24%  Similarity=0.368  Sum_probs=216.4

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCcee
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVL  257 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv  257 (472)
                      ....|.+++++|++.+.||+|+||.||+|.+.       +..||||++++.   ......+.|.+|+.+|+.+. |||||
T Consensus        28 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~~Ei~~l~~l~~HpnIv  104 (400)
T cd05105          28 YDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT---ARSSEKQALMSELKIMTHLGPHLNIV  104 (400)
T ss_pred             CCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC---CChHHHHHHHHHHHHHHhcCCCCCee
Confidence            34579999999999999999999999999864       236999999654   23444567999999999995 99999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc-------------------------------------------
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK-------------------------------------------  294 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-------------------------------------------  294 (472)
                      +++++|.+.+..++|+||+.+|+|.+++.........                                           
T Consensus       105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (400)
T cd05105         105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD  184 (400)
T ss_pred             eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence            9999999999999999999999999999754211000                                           


Q ss_pred             -------------------------------------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecC
Q 039082          295 -------------------------------------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD  331 (472)
Q Consensus       295 -------------------------------------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrD  331 (472)
                                                                 .......++..+..++.|++.||+|||+++  ++|||
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~d  262 (400)
T cd05105         185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRD  262 (400)
T ss_pred             ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCC
Confidence                                                       000112456778889999999999999999  99999


Q ss_pred             CCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          332 LKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       332 Lkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      |||+|||++.++.+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus       263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            99999999999999999999998764322     12235778999999998899999999999999999997 9999976


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .... ......+..+. ++..+  ...+..+.+++.+||..+|++||++.+|.+.|+.+.
T Consensus       343 ~~~~-~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         343 MIVD-STFYNKIKSGY-RMAKP--DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             cchh-HHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            5432 22233333332 33322  345667899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-41  Score=329.86  Aligned_cols=262  Identities=25%  Similarity=0.424  Sum_probs=213.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ++.++|++.+.||+|+||.||+|.+.+       ..||+|.++..   ........|.+|+.++..++||||+++++++.
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~---~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   78 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN---AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT   78 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC---CCHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence            345689999999999999999998753       46999988643   23445667899999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      .....+++++++.+++|.+++.........      .......++..++.++.|++.||+|||+++  ++||||||+|||
T Consensus        79 ~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil  156 (283)
T cd05048          79 KEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCL  156 (283)
T ss_pred             CCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEE
Confidence            988899999999999999999754321110      001123456778899999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK  412 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~  412 (472)
                      +++++.++|+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..  ..+
T Consensus       157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~--~~~  234 (283)
T cd05048         157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS--NQE  234 (283)
T ss_pred             EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence            9999999999999998654322     12345788999999988899999999999999999998 999997765  455


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      +...+..+... ..+  ...+.++.+++.+||+.+|.+||++.+|++.|++
T Consensus       235 ~~~~i~~~~~~-~~~--~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 VIEMIRSRQLL-PCP--EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCcC-CCc--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            66666555422 222  3456789999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=343.87  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=202.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~  270 (472)
                      .++|.++++||.|+||.||+|..+  |..||||.+++.... .++.  .=++|+..|++++ |||||++..++.+.+...
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            468999999999999999999875  778999999876442 2222  2468999999998 999999999999988555


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      ++++|++..+|..+++..         ....+...+..|++||+.||+|+|.+|  +.||||||+||||.....+||+||
T Consensus        86 ~fVfE~Md~NLYqLmK~R---------~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDF  154 (538)
T KOG0661|consen   86 YFVFEFMDCNLYQLMKDR---------NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADF  154 (538)
T ss_pred             eeeHHhhhhhHHHHHhhc---------CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEeccc
Confidence            555566699999999643         224567889999999999999999999  999999999999999999999999


Q ss_pred             ccceecCC--CccccccCCcccccccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--C-----
Q 039082          351 GHARFLSD--GEMALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--G-----  420 (472)
Q Consensus       351 Gla~~~~~--~~~~~~gt~~y~APE~~-~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~-----  420 (472)
                      |+|+....  ..+..+.|.+|+|||++ +.+.|+.+.|+||+||+++|+.+=+..|++.+  +.+....+..  |     
T Consensus       155 GLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s--E~Dqi~KIc~VLGtP~~~  232 (538)
T KOG0661|consen  155 GLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS--EIDQIYKICEVLGTPDKD  232 (538)
T ss_pred             ccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc--HHHHHHHHHHHhCCCccc
Confidence            99998873  45566789999999996 56789999999999999999999999998876  2222222211  0     


Q ss_pred             ------------CCC-CCCCC-----C-chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 ------------KLR-PALPE-----E-DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 ------------~~~-~~l~~-----~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                  +++ |..+.     . +....+.+++|.+|+..||++||||.+.++.
T Consensus       233 ~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  233 SWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             cchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                        001 11111     1 4467788999999999999999999998864

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-42  Score=353.53  Aligned_cols=256  Identities=27%  Similarity=0.471  Sum_probs=218.6

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC---Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR---GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      ..-.|+.+++.+.++||+|.||+||+|.|+   |.  .||||+++.+...   .....|++|+.+|.+|+|||+|+|||+
T Consensus       103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~---~~mddflrEas~M~~L~H~hliRLyGv  179 (1039)
T KOG0199|consen  103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN---AIMDDFLREASHMLKLQHPHLIRLYGV  179 (1039)
T ss_pred             cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc---hhHHHHHHHHHHHHhccCcceeEEeee
Confidence            345578889999999999999999999996   33  6999999876442   267789999999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      ..+ ....+|+|.+..|+|.+.|++-.        ........+-.++.|||.||.||.+++  +|||||.++||||-..
T Consensus       180 Vl~-qp~mMV~ELaplGSLldrLrka~--------~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasp  248 (1039)
T KOG0199|consen  180 VLD-QPAMMVFELAPLGSLLDRLRKAK--------KAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASP  248 (1039)
T ss_pred             ecc-chhhHHhhhcccchHHHHHhhcc--------ccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheeccc
Confidence            887 67778888888999999997511        112235677889999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCcccc------ccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGEMAL------TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~~~------~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~  415 (472)
                      ..|||+|||+.+.+..+....      .-+..|+|||.++...|+.++|||+|||++|||+| |..||.+..  ...+..
T Consensus       249 rtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~--g~qIL~  326 (1039)
T KOG0199|consen  249 RTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR--GIQILK  326 (1039)
T ss_pred             ceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC--HHHHHH
Confidence            999999999999887543322      13778999999999999999999999999999999 999998877  677888


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .+.+|.   .++....++.++++++..||.++|.+||+|..|.+.+-
T Consensus       327 ~iD~~e---rLpRPk~csedIY~imk~cWah~paDRptFsair~~~~  370 (1039)
T KOG0199|consen  327 NIDAGE---RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV  370 (1039)
T ss_pred             hccccc---cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence            888654   45555678899999999999999999999999986553

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.6e-42  Score=346.97  Aligned_cols=244  Identities=26%  Similarity=0.440  Sum_probs=208.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|.+.+.||+|+||.||+|+.+  .+.||+|.+.+..  ..+...+.+.+|+++++.++|||||.++++|......++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g--r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG--RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcC--CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            57889999999999999999987  4679999997653  4566778899999999999999999999999998888777


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.| +|+.+|...+.          .+.+.+..++.+++.||.|||+++  |+|||+||.|||++.+|++|++|||+
T Consensus        80 te~a~g-~L~~il~~d~~----------lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~  146 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGK----------LPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGL  146 (808)
T ss_pred             ehhhhh-hHHHHHHhccC----------CCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhh
Confidence            777766 99999976543          246889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccc---cccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGEMA---LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~~~---~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      |+.+..+...   ..|||.|||||.+.+..|+..+|+|||||++||+++|++||...+  -......|.....+++    
T Consensus       147 Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~~I~~d~v~~p----  220 (808)
T KOG0597|consen  147 ARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVKSILKDPVKPP----  220 (808)
T ss_pred             hhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHHHHhcCCCCCc----
Confidence            9998876543   459999999999999999999999999999999999999997766  3445555555432221    


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+..++...|.+||..|.+-.+++.
T Consensus       221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  221 STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            345567888899999999999999887764

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.4e-40  Score=327.75  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=214.9

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      |+++.++|++.++||+|+||.||+|..+       +..||+|.+....   .......+.+|+.+++.++||||++++++
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA---SLRERIEFLNEASVMKGFTCHHVVRLLGV   77 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            8899999999999999999999999754       3479999876432   22334458899999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      +.+.+..+++++|+.+|+|.+++.............+.+++..+..++.+++.||.|||+++  ++||||||+|||++++
T Consensus        78 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~  155 (288)
T cd05061          78 VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHD  155 (288)
T ss_pred             EcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCC
Confidence            99998999999999999999999764432222222345567788899999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      +.++|+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+  ..++...
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--~~~~~~~  233 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--NEQVLKF  233 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH
Confidence            9999999999986543221     2234678999999998899999999999999999999 889997655  4455555


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      +..+... ..+.  ..+..+.+++.+||+.+|++||++.++++.|++.
T Consensus       234 ~~~~~~~-~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGGYL-DQPD--NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCCCC-CCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            5554422 2222  2346789999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2e-40  Score=322.04  Aligned_cols=260  Identities=25%  Similarity=0.395  Sum_probs=213.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||.+..... ........|.+|+.+++.++||||+++++++...+..+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            57899999999999999999874  78999998865322 2345566789999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++......      ....+...+..++.+++.||+|||+++  ++|+||||+|||++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~  152 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQ------KRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             EEecCCCcHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECcccc
Confidence            9999999999988542211      112346778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +........   ...|++.|+|||.+.+..++.++|+||||+++|+|++|..||.........+...+.....++ .+. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~-  230 (267)
T cd08228         153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP-LPT-  230 (267)
T ss_pred             ceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-CCh-
Confidence            987654322   345788999999998888999999999999999999999999766544445555555444222 221 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ...+..+.+++.+||..+|++||++.++++.|+.+.
T Consensus       231 ~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         231 EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            234467889999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=344.67  Aligned_cols=249  Identities=24%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++..... ........+.+|+.+|..++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEM-LEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEE
Confidence            47899999999999999999985  77899999975422 1234456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.+|+|.+++...+.          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~E~~~~g~L~~~l~~~~~----------l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~  147 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDT----------FTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGL  147 (364)
T ss_pred             ECCCCCcHHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeeccc
Confidence            999999999999864321          346778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc-----------------------------------------cccccCCcccccccccCCCCCchHHHHHHHH
Q 039082          353 ARFLSDGE-----------------------------------------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGI  391 (472)
Q Consensus       353 a~~~~~~~-----------------------------------------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGv  391 (472)
                      +..+....                                         ...+||+.|+|||++....++.++|||||||
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~  227 (364)
T cd05599         148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV  227 (364)
T ss_pred             ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence            87543211                                         1235899999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 039082          392 ILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS---FSSITC  459 (472)
Q Consensus       392 ll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~ll~  459 (472)
                      ++|||++|..||...+  .......+........++........+.++|.+|+. +|.+|++   +.+++.
T Consensus       228 il~el~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         228 IMYEMLVGYPPFCSDN--PQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HHHHhhcCCCCCCCCC--HHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999999997765  445555555544333444444456678889989996 9999997   888765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.3e-41  Score=345.21  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=201.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|++++.||+|+||.||+|.++  +..||||++..... ........+.+|+.+++.++|||||++++++.+.+..++|+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDV-LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            6889999999999999999985  67899999975432 23345567899999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      |++.||+|.+++.....          .+...+..++.||+.||+|||+.|  |+||||||+||||+.++.+||+|||++
T Consensus        81 E~~~gg~L~~~l~~~~~----------~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~  148 (381)
T cd05626          81 DYIPGGDMMSLLIRMEV----------FPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLC  148 (381)
T ss_pred             ecCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCC
Confidence            99999999999864321          235667788899999999999999  999999999999999999999999997


Q ss_pred             eecCCC--------------------------------------------------ccccccCCcccccccccCCCCCch
Q 039082          354 RFLSDG--------------------------------------------------EMALTGTFVYMAPEVIQCEPYSEK  383 (472)
Q Consensus       354 ~~~~~~--------------------------------------------------~~~~~gt~~y~APE~~~~~~~s~~  383 (472)
                      ..+...                                                  ....+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (381)
T cd05626         149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL  228 (381)
T ss_pred             cccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc
Confidence            543100                                                  012468999999999998899999


Q ss_pred             HHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHH--hccCCCCCCCCHHHHHHH
Q 039082          384 SDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICL--SWDGDASVRPSFSSITCS  460 (472)
Q Consensus       384 sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~--cl~~dP~~RPs~~~ll~~  460 (472)
                      +|||||||++|||+||..||...+  .......+.........|.......++.++|.+  |+..++..||++++++..
T Consensus       229 ~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         229 CDWWSVGVILFEMLVGQPPFLAPT--PTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             cceeehhhHHHHHHhCCCCCcCCC--HHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            999999999999999999997765  333444444332223334333445677788877  556677779999999863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1e-40  Score=322.52  Aligned_cols=254  Identities=29%  Similarity=0.485  Sum_probs=211.6

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-CC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-PY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-~~  268 (472)
                      |-++.++|++.+.||+|+||.||+|..+|..||+|.++.+      .....|.+|+.+++.++|+|++++++++... +.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   74 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCc
Confidence            6678889999999999999999999999999999988543      2245688999999999999999999986554 45


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..++.++.+++.||+|||++|  ++||||||+||++++++.+||+
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~  144 (256)
T cd05082          75 LYIVTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVS  144 (256)
T ss_pred             eEEEEECCCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEec
Confidence            6788888889999999864321        12346788899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          349 DFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       349 DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      |||++...........++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+  ...+...+..+. .+..+
T Consensus       145 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~  221 (256)
T cd05082         145 DFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY-KMDAP  221 (256)
T ss_pred             CCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC-CCCCC
Confidence            99999876655545556778999999998899999999999999999998 999997665  444555554443 22222


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                        +..+..+.+++.+||..+|++|||+.++++.|+++
T Consensus       222 --~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         222 --DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              34556788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.7e-40  Score=334.28  Aligned_cols=252  Identities=22%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +..++|++.+.||+|+||.||++.++  |..||+|++..+   ........+.+|+++|+.++||||+++++++..++..
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEE
Confidence            45689999999999999999999986  678999998754   2344567799999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCCCcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      ++|++|+.+++|.+++....          ..+...+..++.+++.||.|||+. +  |+||||||+|||++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~  146 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEAK----------RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLC  146 (331)
T ss_pred             EEEeecCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEc
Confidence            99999999999999986432          124677888999999999999985 6  9999999999999999999999


Q ss_pred             ecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC-------
Q 039082          349 DFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG-------  420 (472)
Q Consensus       349 DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~-------  420 (472)
                      |||++...... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+  ...+...+...       
T Consensus       147 Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~~~~~~~~~~~~  224 (331)
T cd06649         147 DFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD--AKELEAIFGRPVVDGEEG  224 (331)
T ss_pred             cCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccccC
Confidence            99999866433 234568999999999999999999999999999999999999997654  22222111100       


Q ss_pred             --------------------------------------CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          421 --------------------------------------KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       421 --------------------------------------~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                                                            ..++..+. .....++.++|.+||..||++|||+.+|++.-
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         225 EPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPN-GVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             CccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCC-ccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                                  00111111 12456789999999999999999999998653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.1e-40  Score=333.01  Aligned_cols=256  Identities=25%  Similarity=0.425  Sum_probs=207.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +...+|++.+.||+|+||.||+|.+.  +.    .||||+++..   ........|.+|+.+++.++||||++++|+|..
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~   80 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICLT   80 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC
Confidence            45678999999999999999999874  33    4899988643   233455678899999999999999999999876


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      . ..+++++++.+|+|.+++.....         ..++...+.++.||+.||+|||+++  |+||||||+|||++.++.+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~l~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~  148 (316)
T cd05108          81 S-TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHV  148 (316)
T ss_pred             C-CceeeeecCCCCCHHHHHHhccc---------cCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcE
Confidence            4 56789999999999999864321         2346778889999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCccc-----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGEMA-----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~~-----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++........     ..++..|+|||.+....++.++|||||||++|||++ |..||.+..  ...+...+..
T Consensus       149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--~~~~~~~~~~  226 (316)
T cd05108         149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILEK  226 (316)
T ss_pred             EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhC
Confidence            99999999876533221     223678999999999999999999999999999998 999997654  3344443444


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      +. +...+  ..+...+.+++.+||..+|++||++.+++..|..+..+
T Consensus       227 ~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         227 GE-RLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CC-CCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            33 22222  33456788999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.2e-41  Score=339.52  Aligned_cols=240  Identities=23%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccC
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      +.||+|+||.||+|.++  |..||||++++... ........+.+|+.+++.++||||+++++++...+..++|+|++.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875  77899999976432 2234456688999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCC
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      ++|..++...+          ..++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+++....
T Consensus        80 ~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~  147 (323)
T cd05571          80 GELFFHLSRER----------VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             CcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCccccc
Confidence            99999986432          1246778888999999999999999  99999999999999999999999999975432


Q ss_pred             ---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHH
Q 039082          359 ---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE  435 (472)
Q Consensus       359 ---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~  435 (472)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|..||...+  .......+..+..  .+|.  ....+
T Consensus       148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~~~~~~~--~~p~--~~~~~  221 (323)
T cd05571         148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEI--RFPR--TLSPE  221 (323)
T ss_pred             CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC--HHHHHHHHHcCCC--CCCC--CCCHH
Confidence               2234568999999999999999999999999999999999999997765  3444444444432  2232  34567


Q ss_pred             HHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          436 LIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       436 l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      +.++|.+||..||++||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         222 AKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             HHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            88899999999999999     7888874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-40  Score=321.01  Aligned_cols=254  Identities=30%  Similarity=0.513  Sum_probs=215.1

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      |.++.++|++.+.||.|+||.||+|...|..||||.++.+.     .....+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   75 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS-----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPL   75 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccch-----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCe
Confidence            56778899999999999999999999999999999986532     2456789999999999999999999999988889


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++++.+++|.+++.....        ...++..+..++.|++.||.|||+++  ++|+||||+||+++.++.+||+|
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d  145 (256)
T cd05039          76 YIVTEYMAKGSLVDYLRSRGR--------AVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSD  145 (256)
T ss_pred             EEEEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEcc
Confidence            999999999999999964331        12357889999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ||++............+..|+|||.+....++.++||||||+++|+|++ |..||....  ...+...+..+. +...+ 
T Consensus       146 ~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~-  221 (256)
T cd05039         146 FGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPHVEKGY-RMEAP-  221 (256)
T ss_pred             cccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhcCC-CCCCc-
Confidence            9999887544444445778999999988889999999999999999998 999997665  444544444432 22222 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                       ...+..+.++|.+||..+|++||+++++++.|..
T Consensus       222 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         222 -EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -cCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             2345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-40  Score=321.57  Aligned_cols=255  Identities=31%  Similarity=0.518  Sum_probs=211.3

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |+++.++|++.+.||+|+||.||+|.++ +..||||.++....     ..+.|.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP   75 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-----cHHHHHHHHHHHHHCCCCCccceeEEEecCCC
Confidence            7788999999999999999999999875 56799999865422     23558899999999999999999999999988


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++....        ....++..+..++.+++.||.|||+++  ++||||||+||+++.++.+||+
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~  145 (261)
T cd05068          76 IYIVTELMKYGSLLEYLQGGA--------GRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVA  145 (261)
T ss_pred             eeeeeecccCCcHHHHHhccC--------CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEEC
Confidence            899999988999999986432        112357888999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc-cccc---CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM-ALTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~-~~~g---t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........ ...|   +..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+  .......+..+. +
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~-~  222 (261)
T cd05068         146 DFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT--NAEVLQQVDQGY-R  222 (261)
T ss_pred             CcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-C
Confidence            9999987763322 1222   457999999998899999999999999999999 999997665  444444444332 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .  +.....+..+.+++.+||..+|++||++.+|++.|+++
T Consensus       223 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 M--PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             C--CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            2  22234556789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.6e-40  Score=321.16  Aligned_cols=248  Identities=25%  Similarity=0.439  Sum_probs=205.1

Q ss_pred             CCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      +.++|++.+.||+|+||.||++.++. ..+|+|.+....     .....|.+|+.+|++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-----MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-----ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            45789999999999999999999874 589999876432     223558899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++.....         ..++..++.++.+++.||+|||+++  ++||||+|+||++++++.+||+|||
T Consensus        77 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g  145 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQG---------KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFG  145 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCC
Confidence            9999999999999864221         1346778899999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          352 HARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       352 la~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +++.......    ...++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+  .......+..+. ++..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~-~~~~  222 (256)
T cd05114         146 MTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGF-RLYR  222 (256)
T ss_pred             CccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCC-CCCC
Confidence            9986543221    1234668999999998899999999999999999999 999997665  444555565554 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      +.  ..+..+.+++.+||..+|++||++.+++..|
T Consensus       223 ~~--~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         223 PK--LASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CC--CCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            22  2345788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=343.17  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=209.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++++.... .......+.+|+.++..++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMI-KRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHh-hccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEE
Confidence            47899999999999999999987  789999999764321 224456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++...+          ..+...+..++.||+.||+|||++|  |+||||||+||||+.++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~  147 (350)
T cd05573          80 MEYMPGGDLMNLLIRKD----------VFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGL  147 (350)
T ss_pred             EcCCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCC
Confidence            99999999999996532          1246778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--------------------------------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC
Q 039082          353 ARFLSDGE--------------------------------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN  400 (472)
Q Consensus       353 a~~~~~~~--------------------------------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~  400 (472)
                      +.......                                ....||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~  227 (350)
T cd05573         148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF  227 (350)
T ss_pred             CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence            98765432                                2345899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC-HHHHHHH
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS-FSSITCS  460 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs-~~~ll~~  460 (472)
                      .||...+  .......+........+|.....+..+.++|..||. +|.+||+ ++++++.
T Consensus       228 ~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         228 PPFYSDT--LQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCCCC--HHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            9998766  444555555522223344444456788999999997 9999999 9999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-41  Score=332.72  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=203.6

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC----------ChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT----------NENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~----------~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      -.++|++.+.||+|.||.|-+|++.  ++.||||++.+.....          .....+...+|+.+|++++|||||+|+
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            3468999999999999999999985  7789999996543211          112235788999999999999999999


Q ss_pred             EEEEc--CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          261 GACLE--PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       261 g~~~~--~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      .+..+  .+.+|+|+||+..|.+.+--.          ..+...+.+++.++++++.||+|||.+|  ||||||||+|+|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~----------d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiHRDIKPsNLL  242 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPP----------DKPELSEQQARKYLRDVVLGLEYLHYQG--IIHRDIKPSNLL  242 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCC----------CcccccHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheE
Confidence            98776  457899999999888754211          0112467889999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCc--------cccccCCcccccccccCCC---C-CchHHHHHHHHHHHHHHcCCCCCCCC
Q 039082          339 LDDAKHVRIADFGHARFLSDGE--------MALTGTFVYMAPEVIQCEP---Y-SEKSDVYSFGIILNEIITGNHPYIEK  406 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~--------~~~~gt~~y~APE~~~~~~---~-s~~sDvwSlGvll~elltG~~Pf~~~  406 (472)
                      |+++|+|||+|||.+.....+.        ....|||.|+|||...++.   + +.+.||||+||+||.|+.|..||.+.
T Consensus       243 l~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  243 LSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             EcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence            9999999999999998763221        1246999999999987632   3 46899999999999999999999776


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .  ..+....|....  ..+|..+..-..+.++|.++|.+||+.|.++.+|...
T Consensus       323 ~--~~~l~~KIvn~p--L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  323 F--ELELFDKIVNDP--LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             h--HHHHHHHHhcCc--ccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            5  555666666653  3456555667788999999999999999999888643

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-40  Score=320.67  Aligned_cols=253  Identities=26%  Similarity=0.437  Sum_probs=210.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      +.++|++.+.||+|+||.||+|.++     ...||||.++..   ........|.+|+.+++.++||||+++++.+...+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG---SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSR   78 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC---CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCC
Confidence            4578999999999999999999885     246999988654   23445667899999999999999999999999988


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++++.+++|.+++.....         ..++..++.++.+++.||+|||+++  ++|+||||+|||+++++.++|
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l  147 (266)
T cd05033          79 PVMIITEYMENGSLDKFLRENDG---------KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKV  147 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEE
Confidence            99999999999999999864321         2346788999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCC
Q 039082          348 ADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       348 ~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +|||++........     ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||....  .......+..+.
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~  225 (266)
T cd05033         148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS--NQDVIKAVEDGY  225 (266)
T ss_pred             CccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC--HHHHHHHHHcCC
Confidence            99999987752111     1224678999999998899999999999999999998 999997655  444555555543


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                       +...+  ...+..+.+++.+||..+|++||++.+|++.|+++
T Consensus       226 -~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 -RLPPP--MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             -CCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             22222  33566789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4.6e-40  Score=327.14  Aligned_cols=271  Identities=27%  Similarity=0.411  Sum_probs=217.8

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECC---------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCce
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG---------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFV  256 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g---------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnI  256 (472)
                      ...|.+..++|.+.+.||+|+||.||+|.+.+         ..+|+|.++.+.   .......+.+|+.+++.+ +||||
T Consensus        10 ~~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~l~~h~~i   86 (307)
T cd05098          10 DPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA---TEKDLSDLISEMEMMKMIGKHKNI   86 (307)
T ss_pred             CCcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC---ChHHHHHHHHHHHHHHHhcCCCCE
Confidence            44688888999999999999999999998632         469999987542   334456688999999999 89999


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      +++++++...+..+++++++.+++|.+++.........      .......++..++.++.|++.||+|||++|  ++||
T Consensus        87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~  164 (307)
T cd05098          87 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHR  164 (307)
T ss_pred             eeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence            99999999999999999999999999999754321100      001123467889999999999999999999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI  404 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~  404 (472)
                      ||||+|||++.++.+||+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus       165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999997654321     11223578999999998889999999999999999998 899997


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ...  ...+...+..+. +...+  ...+.++.+++.+||..+|++||++.++++.|+++...
T Consensus       245 ~~~--~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         245 GVP--VEELFKLLKEGH-RMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             cCC--HHHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence            654  444554544443 22222  23456788899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.1e-40  Score=336.82  Aligned_cols=269  Identities=27%  Similarity=0.403  Sum_probs=211.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLM  260 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~  260 (472)
                      .|.++.++|++.+.||.|+||.||+|.+.       ++.||+|+++...   .......+.+|+.++.++ +||||++++
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~E~~~~~~l~~h~niv~~~   77 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA---TASEYKALMTELKILIHIGHHLNVVNLL   77 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC---CHHHHHHHHHHHHHHHhhccCcchhhee
Confidence            48999999999999999999999999753       3579999886432   234456688999999999 899999999


Q ss_pred             EEEEcC-CCceEEEEeccCCcHHHHHhhcccccc----------------------------------------------
Q 039082          261 GACLEP-PYRGWLVTELLGTTLKEWLHGLGSQRR----------------------------------------------  293 (472)
Q Consensus       261 g~~~~~-~~~~~vve~~~ggsL~~~l~~~~~~~~----------------------------------------------  293 (472)
                      ++|... ...+++++|+.+++|.+++........                                              
T Consensus        78 ~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          78 GACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             eeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            988765 456677888889999999864321100                                              


Q ss_pred             -----cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-----cc
Q 039082          294 -----KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----AL  363 (472)
Q Consensus       294 -----~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~  363 (472)
                           ........++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++..+.....     ..
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~  235 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  235 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCC
Confidence                 0000113467888999999999999999999  99999999999999999999999999987643221     22


Q ss_pred             ccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHH
Q 039082          364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICL  442 (472)
Q Consensus       364 ~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~  442 (472)
                      .++..|+|||.+.+..++.++|||||||++|||++ |..||.+..... .....+..+. ++..+.  ....++.+++.+
T Consensus       236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~--~~~~~~~~l~~~  311 (337)
T cd05054         236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT-RMRAPE--YATPEIYSIMLD  311 (337)
T ss_pred             CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC-CCCCCc--cCCHHHHHHHHH
Confidence            34678999999999999999999999999999998 999997654322 2233333332 333332  345678999999


Q ss_pred             hccCCCCCCCCHHHHHHHHHHHHH
Q 039082          443 SWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       443 cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ||..+|++||++.+|++.|+.+..
T Consensus       312 cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         312 CWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3e-40  Score=340.71  Aligned_cols=271  Identities=25%  Similarity=0.377  Sum_probs=216.1

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCcee
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVL  257 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv  257 (472)
                      ....|.++.++|.+.+.||+|+||.||+|++++       ..||||+++...   .......+.+|+.+|.++. |||||
T Consensus        28 ~~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~~E~~~l~~l~~H~niv  104 (401)
T cd05107          28 YDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA---RSSEKQALMSELKIMSHLGPHLNIV  104 (401)
T ss_pred             CCCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC---ChhHHHHHHHHHHHHHhcCCCCCeE
Confidence            344699999999999999999999999999753       479999997542   2333456889999999997 99999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccc--------------------------------------------
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR--------------------------------------------  293 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~--------------------------------------------  293 (472)
                      +++++|...+..++|+||+.+|+|.++++.......                                            
T Consensus       105 ~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (401)
T cd05107         105 NLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKD  184 (401)
T ss_pred             EEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCc
Confidence            999999999999999999999999999975432100                                            


Q ss_pred             --------------------------------------------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceee
Q 039082          294 --------------------------------------------KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIH  329 (472)
Q Consensus       294 --------------------------------------------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiH  329 (472)
                                                                  .....+..++...+.++.|++.||+|||+.+  ++|
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH  262 (401)
T cd05107         185 ESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVH  262 (401)
T ss_pred             cccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCc
Confidence                                                        0001123456678889999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 039082          330 RDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY  403 (472)
Q Consensus       330 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf  403 (472)
                      |||||+|||+++++.+||+|||+++......     ....+++.|+|||.+.+..++.++|||||||++|||++ |..||
T Consensus       263 rdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~  342 (401)
T cd05107         263 RDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY  342 (401)
T ss_pred             ccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCC
Confidence            9999999999999999999999998653221     12346788999999998889999999999999999998 89999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       404 ~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .....  .+.......+..++..|.  ....++.+++.+||..+|.+||++++|+..|+.+.
T Consensus       343 ~~~~~--~~~~~~~~~~~~~~~~p~--~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         343 PELPM--NEQFYNAIKRGYRMAKPA--HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCCc--hHHHHHHHHcCCCCCCCC--CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            76542  222223233333333332  34567889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6e-41  Score=342.88  Aligned_cols=258  Identities=21%  Similarity=0.351  Sum_probs=212.0

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ...+.+..++|++.+.||+|+||.||+|.++  +..||+|++.+... ........+.+|+.+++.++||||+++++++.
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~  113 (370)
T cd05596          35 ITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEM-IKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ  113 (370)
T ss_pred             hccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            3456677889999999999999999999986  67899999965322 12233455789999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +.+..++|+||+.||+|..++....           .+...+..++.||+.||+|||+++  |+||||||+|||++.++.
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~l~~~~-----------l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~  180 (370)
T cd05596         114 DDKYLYMVMEYMPGGDLVNLMSNYD-----------IPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGH  180 (370)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCC
Confidence            9999999999999999999985421           235667788899999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc----cccccCCcccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~----~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      +||+|||++.......    ....||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+.+  .......
T Consensus       181 ~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~  258 (370)
T cd05596         181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSK  258 (370)
T ss_pred             EEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC--HHHHHHH
Confidence            9999999998765332    235689999999998653    47899999999999999999999998766  4445555


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASV--RPSFSSITCS  460 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~~  460 (472)
                      +..+......|.....+.++.++|.+||..+|.+  ||+++++++.
T Consensus       259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            6554434445554456678899999999999988  9999999754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=3e-40  Score=325.62  Aligned_cols=269  Identities=26%  Similarity=0.403  Sum_probs=216.9

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ  258 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~  258 (472)
                      ...|.++.++|++.+.||+|+||.||++.+++       ..+|+|.+....   .......+.+|+.+++.+ +||||++
T Consensus         4 ~~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~i~~   80 (293)
T cd05053           4 DPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA---TEKDLSDLVSEMEMMKMIGKHKNIIN   80 (293)
T ss_pred             CcccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC---CHHHHHHHHHHHHHHHhhcCCCCeee
Confidence            34688999999999999999999999998752       469999887542   334456688999999999 8999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE------RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL  332 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL  332 (472)
                      +++++...+..+++++++.+++|..++..........      ......++..++.++.|++.||+|||+++  ++||||
T Consensus        81 ~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dl  158 (293)
T cd05053          81 LLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDL  158 (293)
T ss_pred             EEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--cccccc
Confidence            9999999999999999999999999997532111000      11223467888999999999999999999  999999


Q ss_pred             CCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 039082          333 KPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK  406 (472)
Q Consensus       333 kp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~  406 (472)
                      ||+|||++.++.+||+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus       159 kp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         159 AARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             ceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999999999987654321     1224678999999988899999999999999999998 99999766


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .  .......+..+. .+..+  ...+..+.+++.+||..+|++|||+.++++.|+++.
T Consensus       239 ~--~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         239 P--VEELFKLLKEGY-RMEKP--QNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             C--HHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            5  334444444433 22222  234567889999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-41  Score=338.37  Aligned_cols=255  Identities=25%  Similarity=0.316  Sum_probs=200.1

Q ss_pred             ceee-CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          189 GWYI-DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       189 ~~~i-~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      .|.- ..+.|+.+++||+|+||.||+|++.  |..||+|.++.+.  ..+.......+||.+|++|+||||++|.+...+
T Consensus       110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~--~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~  187 (560)
T KOG0600|consen  110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN--EKEGFPITAIREIKILRRLDHPNIIKLEEIVTS  187 (560)
T ss_pred             cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc--CCCcchHHHHHHHHHHHhcCCCcccceeeEEEe
Confidence            4543 2368999999999999999999985  7889999998763  245566778899999999999999999999888


Q ss_pred             C--CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          266 P--PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       266 ~--~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .  ..+|+|+|| +.-+|..++...+-         ..+..++..++.||+.||+|||++|  |+|||||.+|||||.+|
T Consensus       188 ~~~~siYlVFeY-MdhDL~GLl~~p~v---------kft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G  255 (560)
T KOG0600|consen  188 KLSGSIYLVFEY-MDHDLSGLLSSPGV---------KFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNG  255 (560)
T ss_pred             cCCceEEEEEec-ccchhhhhhcCCCc---------ccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCC
Confidence            7  345555555 57788888754332         1346889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc----cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          344 HVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      .+||+|||||+++....    +..+-|.+|+|||.+.| ..|+.++|+||.||||.||++|+..|.+.+  +.+....|.
T Consensus       256 ~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t--EveQl~kIf  333 (560)
T KOG0600|consen  256 VLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT--EVEQLHKIF  333 (560)
T ss_pred             CEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc--HHHHHHHHH
Confidence            99999999999877443    33456999999999886 479999999999999999999999998877  333322221


Q ss_pred             c--CC-----CC-CCCCC----------C-------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 E--GK-----LR-PALPE----------E-------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ~--~~-----~~-~~l~~----------~-------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +  |.     ++ ..+|.          .       ...+...++|+..+|..||++|.|+...+.
T Consensus       334 klcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  334 KLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             HHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  10     00 01110          0       123345678899999999999999988764

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=7.6e-41  Score=354.29  Aligned_cols=258  Identities=22%  Similarity=0.334  Sum_probs=214.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEE-EE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGA-CL  264 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~-~~  264 (472)
                      -..|..-++++.+.|.+|+|+.||+|.+.  |..||+|.+.-    .++...+...+|+++|+.|+ |+|||.+++. ..
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~----~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~  106 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYV----NDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAI  106 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeec----CCHHHHHHHHHHHHHHHHhcCCCceeeEeccccc
Confidence            45677788999999999999999999986  37999998854    37888899999999999996 9999999993 22


Q ss_pred             cC--C----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          265 EP--P----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       265 ~~--~----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ..  +    ..+++||||.||.|.++|......+        .+..+++.|++++++|+++||...++|||||||.||||
T Consensus       107 ~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~--------lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvL  178 (738)
T KOG1989|consen  107 NRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR--------LTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVL  178 (738)
T ss_pred             cccCCCceeEEEeehhhccCCcHHHHHHHHHhcc--------CChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheE
Confidence            21  1    2346777777899999996533221        45788999999999999999999999999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCcc------------ccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCC
Q 039082          339 LDDAKHVRIADFGHARFLSDGEM------------ALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPY  403 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~~------------~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf  403 (472)
                      |+.+|..||||||.|...-....            ....|+.|+|||++.   +...++|+|||+|||+||.|+....||
T Consensus       179 ls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PF  258 (738)
T KOG1989|consen  179 LSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPF  258 (738)
T ss_pred             EcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCc
Confidence            99999999999999875432221            112599999999974   677899999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       404 ~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .+..      ...|..+++  .+|..+.+...|.+||..||..||++||++.+++..+.++..
T Consensus       259 e~sg------~laIlng~Y--~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  259 EESG------KLAILNGNY--SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             CcCc------ceeEEeccc--cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence            7663      245667765  466667889999999999999999999999999999988764

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.5e-40  Score=320.57  Aligned_cols=253  Identities=26%  Similarity=0.467  Sum_probs=208.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |+|..++|++.++||+|+||.||+|..+ +..||+|.+.....     ....|.+|+.++++++||||+++++++. .+.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   74 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEP   74 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCC
Confidence            7889999999999999999999999875 67899999865422     2356889999999999999999999864 456


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++......        ..++.....++.+++.||+|||+.+  ++||||||+||+++.++.++|+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGI--------KLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIA  144 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEc
Confidence            78899999999999998543211        2346778889999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+....++.++||||||+++|+|++ |+.||.+.+  .......+..+. +
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~  221 (260)
T cd05067         145 DFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT--NPEVIQNLERGY-R  221 (260)
T ss_pred             cCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC--hHHHHHHHHcCC-C
Confidence            9999987653221    2235678999999998889999999999999999999 999997765  344444444432 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      ...+  ...+.++.+++.+||..+|++||++++|+..|+.
T Consensus       222 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         222 MPRP--DNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            2222  3345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-40  Score=323.65  Aligned_cols=260  Identities=24%  Similarity=0.369  Sum_probs=211.5

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..++|.+.+.||+|+||.||+|.+.       +..||||+++..   ...+....|.+|+++|+.++||||+++++++..
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---ASNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc---CCHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            4567899999999999999999863       357999998653   233456779999999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccc----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKE----RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ....+++++++.+++|.+++...+......    ......++..+..++.+++.||.|||+++  ++||||||+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~  157 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGY  157 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcC
Confidence            999999999999999999997654322111    11223456788899999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 039082          342 AKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~  415 (472)
                      ++.+||+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+  ......
T Consensus       158 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~--~~~~~~  235 (280)
T cd05049         158 DLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS--NEEVIE  235 (280)
T ss_pred             CCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHHHH
Confidence            9999999999998654322     12234678999999999999999999999999999998 999997665  444555


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .+..+.... .+  ...+..+.+++.+||..||++||++.++++.|+
T Consensus       236 ~~~~~~~~~-~~--~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         236 CITQGRLLQ-RP--RTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHcCCcCC-CC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            555554322 12  235567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.8e-40  Score=322.12  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEE------CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~------~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ++.++|++.+.||+|+||.||+|.+      .+..||+|.+...   ........|.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   78 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI---NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ   78 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec
Confidence            3457899999999999999999985      2467999988643   234455678899999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhccccc-------ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQR-------RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~-------~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      .+..+++++++.+++|.+++.......       .........++...+.++.+++.||+|||+++  ++||||||+|||
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nil  156 (283)
T cd05090          79 EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNIL  156 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEE
Confidence            999999999999999999985322100       00011123456778889999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK  412 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~  412 (472)
                      +++++.+||+|||++.......     ....++..|+|||.+.+..++.++||||||+++|||++ |..||.+..  ...
T Consensus       157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~--~~~  234 (283)
T cd05090         157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS--NQE  234 (283)
T ss_pred             EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence            9999999999999998664322     22335678999999988889999999999999999999 999997765  444


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      +...+..+.. +..+  ...+..+.+++..||..+|++||++.+|++.|..
T Consensus       235 ~~~~~~~~~~-~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         235 VIEMVRKRQL-LPCS--EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHHcCCc-CCCC--CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            5555555432 2222  2345678889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-41  Score=343.21  Aligned_cols=250  Identities=21%  Similarity=0.292  Sum_probs=202.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++++.||+|+||.||++.++  +..||||++.+... ........+.+|+++++.++|||||++++++.+.+..|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEM-FKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHH-HHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEE
Confidence            47899999999999999999885  77899999865322 1234556788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.||+|.+++...+.          .+...+..++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~E~~~gg~L~~~l~~~~~----------~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGl  147 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDT----------FSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGL  147 (377)
T ss_pred             EeCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeeccc
Confidence            999999999999864321          235667788999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC--------------------------------------------------ccccccCCcccccccccCCCCCc
Q 039082          353 ARFLSDG--------------------------------------------------EMALTGTFVYMAPEVIQCEPYSE  382 (472)
Q Consensus       353 a~~~~~~--------------------------------------------------~~~~~gt~~y~APE~~~~~~~s~  382 (472)
                      ++.+...                                                  ....+||+.|+|||++.+..++.
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  227 (377)
T cd05629         148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ  227 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence            8632110                                                  00235899999999999999999


Q ss_pred             hHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 039082          383 KSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVR---PSFSSITC  459 (472)
Q Consensus       383 ~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~~ll~  459 (472)
                      ++|||||||++|||++|..||...+  .......+........+|.......++.++|.+|+. +|.+|   +++.+++.
T Consensus       228 ~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~  304 (377)
T cd05629         228 ECDWWSLGAIMFECLIGWPPFCSEN--SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS  304 (377)
T ss_pred             ceeeEecchhhhhhhcCCCCCCCCC--HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence            9999999999999999999997765  444445554433333444433455678889999997 66665   69988876


Q ss_pred             H
Q 039082          460 S  460 (472)
Q Consensus       460 ~  460 (472)
                      .
T Consensus       305 h  305 (377)
T cd05629         305 H  305 (377)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7.5e-40  Score=326.83  Aligned_cols=274  Identities=26%  Similarity=0.417  Sum_probs=219.8

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCce
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFV  256 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnI  256 (472)
                      ...|.++.++|.+.++||+|+||.||+|...         ...||+|.++..   ........+.+|+.+++.+ +||||
T Consensus         4 ~~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i   80 (314)
T cd05099           4 DPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN---ATDKDLADLISEMELMKLIGKHKNI   80 (314)
T ss_pred             cccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC---CChHHHHHHHHHHHHHHhccCCCCe
Confidence            4568888999999999999999999999752         346999988653   2334566788999999999 69999


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      +++++++...+..+++++|+.+++|.+++.........      .......++..+..++.|++.||.|||++|  ++||
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~  158 (314)
T cd05099          81 INLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHR  158 (314)
T ss_pred             eeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeec
Confidence            99999999888889999999999999999764321100      011123567888999999999999999999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI  404 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~  404 (472)
                      ||||+|||++.++.+||+|||+++......     ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998665321     11224567999999998899999999999999999999 999997


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                      ...  .......+..+. +...+  ...+.++.+++.+||..+|++||++.++++.|.++...+.+
T Consensus       239 ~~~--~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         239 GIP--VEELFKLLREGH-RMDKP--SNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             CCC--HHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence            655  444555555443 22222  23456788999999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-40  Score=337.63  Aligned_cols=249  Identities=25%  Similarity=0.355  Sum_probs=198.2

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      .....++|+..++||+|+||.||+|.++  |..||||++...   ........|.+|+++++.++|+||+++++++...+
T Consensus        69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  145 (353)
T PLN00034         69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN---HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG  145 (353)
T ss_pred             CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC---CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence            3445578999999999999999999986  789999998653   23445667899999999999999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+||+.+++|.....              .....+..++.||+.||+|||++|  |+||||||+||||++++.+||
T Consensus       146 ~~~lv~e~~~~~~L~~~~~--------------~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL  209 (353)
T PLN00034        146 EIQVLLEFMDGGSLEGTHI--------------ADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKI  209 (353)
T ss_pred             eEEEEEecCCCCccccccc--------------CCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEE
Confidence            9999999999999864321              124557788999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc---cccccCCcccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-HHHHHHHh
Q 039082          348 ADFGHARFLSDGE---MALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVG  418 (472)
Q Consensus       348 ~DFGla~~~~~~~---~~~~gt~~y~APE~~~~-----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-~~i~~~i~  418 (472)
                      +|||++.......   ....|+..|+|||.+..     ...+.++|||||||++|||++|+.||....... ......+.
T Consensus       210 ~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~  289 (353)
T PLN00034        210 ADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC  289 (353)
T ss_pred             cccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh
Confidence            9999998765332   34568999999998743     234568999999999999999999997433221 22222222


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+. .+..+  .....++.++|.+||..||++||++.++++.
T Consensus       290 ~~~-~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 MSQ-PPEAP--ATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ccC-CCCCC--CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            221 11122  3345678999999999999999999999864

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-40  Score=319.31  Aligned_cols=255  Identities=28%  Similarity=0.474  Sum_probs=208.8

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |.++.++|++.++||+|+||.||+|.+++ ..||+|.+.....     ..+.|.+|+.+++.++||||+++++.+. .+.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEP   74 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCC
Confidence            77888999999999999999999998864 4799999875322     2245889999999999999999999864 456


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..+..++.+++.||+|||+.+  ++||||||+||++++++.++|+
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~  144 (262)
T cd05071          75 IYIVTEYMSKGSLLDFLKGEMG--------KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVA  144 (262)
T ss_pred             cEEEEEcCCCCcHHHHHhhccc--------cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEec
Confidence            7889999999999999964221        12356788999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+.+..++.++||||||+++|+|+| |..||.+..  .......+..+. .
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~--~~~~~~~~~~~~-~  221 (262)
T cd05071         145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVERGY-R  221 (262)
T ss_pred             cCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--hHHHHHHHhcCC-C
Confidence            9999987654332    2235678999999988889999999999999999999 889997665  334444444432 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .  +.....+..+.+++.+||..+|++||++.++++.|+++.
T Consensus       222 ~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         222 M--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             C--CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            2  222345677899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.5e-40  Score=322.15  Aligned_cols=266  Identities=24%  Similarity=0.395  Sum_probs=215.6

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      |...+|.+.+.||+|+||.||++...       +..+|+|.+...    .......+.+|+.++++++||||+++++++.
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGVCV   77 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc----CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            45678999999999999999999752       345899988542    3445667999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhccccccc---ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRK---ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ..+..+++++++.+++|.+++...+.....   .......++..++.++.|++.||+|||++|  ++||||||+|||+++
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~  155 (288)
T cd05093          78 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGE  155 (288)
T ss_pred             cCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEcc
Confidence            999999999999999999999754321111   111223567889999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 039082          342 AKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~  415 (472)
                      ++.+||+|||++........     ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||....  ......
T Consensus       156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~--~~~~~~  233 (288)
T cd05093         156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEVIE  233 (288)
T ss_pred             CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence            99999999999986543221     2234678999999998899999999999999999998 999997665  444555


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+..+... ..+  ...+.++.+++.+||..+|.+||++.++++.|+++....
T Consensus       234 ~i~~~~~~-~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         234 CITQGRVL-QRP--RTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHHcCCcC-CCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            66665422 222  234567899999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-40  Score=321.89  Aligned_cols=256  Identities=29%  Similarity=0.507  Sum_probs=212.1

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |+.+..+|++.++||.|+||.||+|.++ +..+|+|++...    .......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   76 (261)
T cd05148           1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD----DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP   76 (261)
T ss_pred             CcCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEecccc----chhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC
Confidence            4556678999999999999999999987 578999998653    22334568899999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++......        ..++..++.++.+++.||.|||++|  ++|+||+|+|||+++++.+||+
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~  146 (261)
T cd05148          77 VYIITELMEKGSLLAFLRSPEGQ--------VLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVA  146 (261)
T ss_pred             eEEEEeecccCCHHHHHhcCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEc
Confidence            99999999999999999643211        1346778899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          349 DFGHARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       349 DFGla~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |||++........   ...++..|+|||.+....++.++||||||+++|+|++ |..||...+  .......+..+. +.
T Consensus       147 d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~  223 (261)
T cd05148         147 DFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN--NHEVYDQITAGY-RM  223 (261)
T ss_pred             cccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHHhCC-cC
Confidence            9999987654322   2234678999999988889999999999999999998 899997665  344444444432 32


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ..+  ...+..+.+++.+||..+|++||++.+|++.|+.+
T Consensus       224 ~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 PCP--AKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            222  34566788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.5e-40  Score=319.52  Aligned_cols=253  Identities=28%  Similarity=0.470  Sum_probs=208.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |.+..++|++.++||+|+||.||+|.++ +..||+|.+.+...     ....|.+|+.++++++||||+++++++. ...
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~   74 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEP   74 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCC
Confidence            7888999999999999999999999876 56899999876432     2345889999999999999999999875 456


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..+..++.+++.||+|||+++  ++||||||+||++++++.++|+
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~  144 (260)
T cd05070          75 IYIVTEYMSKGSLLDFLKDGEG--------RALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIA  144 (260)
T ss_pred             cEEEEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeC
Confidence            7899999999999999864321        12357788999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+  ..+....+..+. +
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~  221 (260)
T cd05070         145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN--NREVLEQVERGY-R  221 (260)
T ss_pred             CceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-C
Confidence            9999987654321    1234567999999988889999999999999999999 999997765  444555554432 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      +..+  ...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus       222 ~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCP--QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCC--CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2222  3355678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.4e-40  Score=324.67  Aligned_cols=270  Identities=26%  Similarity=0.411  Sum_probs=218.0

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ  258 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~  258 (472)
                      .|.+..++|.+.+.||+|+||.||+|.+.         +..||+|.+..+   ........+.+|+.+++.+ +||||++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~   85 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIIN   85 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc---cchHHHHHHHHHHHHHHhhccCCCchh
Confidence            47888899999999999999999999752         246999988643   2334456788999999999 8999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE------RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL  332 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL  332 (472)
                      +++++......+++++++.+++|.+++..........      ......++..+..++.||+.||.|||++|  ++||||
T Consensus        86 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dl  163 (304)
T cd05101          86 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDL  163 (304)
T ss_pred             eeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeeccc
Confidence            9999999999999999999999999997543211100      01123467788999999999999999999  999999


Q ss_pred             CCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 039082          333 KPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK  406 (472)
Q Consensus       333 kp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~  406 (472)
                      ||+|||++.++.+||+|||+++.......     ...+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~  243 (304)
T cd05101         164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  243 (304)
T ss_pred             ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence            99999999999999999999987653221     2234678999999998889999999999999999998 88999766


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +  ...+...+..+. +...+  ...+..+.+++.+||..+|++||++.++++.|+++..--
T Consensus       244 ~--~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         244 P--VEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             C--HHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence            5  445555554443 32222  335567889999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.8e-40  Score=318.37  Aligned_cols=249  Identities=27%  Similarity=0.477  Sum_probs=205.7

Q ss_pred             CCCCeeEeceeeccCceEEEEEEECCe-eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWRGL-DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~g~-~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      +.++|++.+.||+|+||.||+|.+++. .+|||.+.....     ....|.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            457899999999999999999998754 699998865322     23458899999999999999999999998888899


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++.....         ..++..++.++.+++.||+|||+.+  ++|+||||+|||++.++.+||+|||
T Consensus        77 v~e~~~~~~l~~~i~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g  145 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGK---------RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFG  145 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCc
Confidence            9999999999999864321         1346788999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCccc----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          352 HARFLSDGEMA----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       352 la~~~~~~~~~----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +++........    ..++..|+|||.+.+..++.++|||||||++|+|++ |..||....  .......+..+. ++..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~  222 (256)
T cd05113         146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN--NSETVEKVSQGL-RLYR  222 (256)
T ss_pred             cceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHhcCC-CCCC
Confidence            99876543221    224677999999998889999999999999999999 999997655  444555555543 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +.  ..+..+.+++.+||..+|++||++.+|+..|+
T Consensus       223 ~~--~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 PH--LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CC--CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            22  24567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.6e-41  Score=309.91  Aligned_cols=250  Identities=21%  Similarity=0.278  Sum_probs=198.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|...++||+|.||.||+|++.  |+.||||.++....  .+.......+|++.|+.++|+||+.++++|...+...+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~--kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lV   79 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA--KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLV   79 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc--ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEE
Confidence            46888999999999999999985  88999999976533  222234467999999999999999999999999998888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+ ..+|...++....         ..+...+..++.++++||+|||++.  |+||||||.|+||+.+|.+||+|||+
T Consensus        80 fEfm-~tdLe~vIkd~~i---------~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGL  147 (318)
T KOG0659|consen   80 FEFM-PTDLEVVIKDKNI---------ILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGL  147 (318)
T ss_pred             EEec-cccHHHHhccccc---------ccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccc
Confidence            8777 7899988854322         2234778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccc---cccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh--cCCC----
Q 039082          353 ARFLSDGEMA---LTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG--EGKL----  422 (472)
Q Consensus       353 a~~~~~~~~~---~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~--~~~~----  422 (472)
                      |+.+......   .+-|.+|+|||.+.| +.|+..+|+||.||++.||+.|.+-|++.+.  .+....+.  -|..    
T Consensus       148 Ar~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP~~~~  225 (318)
T KOG0659|consen  148 ARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTPTPDQ  225 (318)
T ss_pred             hhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCCCccc
Confidence            9998755433   346999999999875 5799999999999999999999887777652  11111111  1110    


Q ss_pred             -----------------CCCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          423 -----------------RPALPE-EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       423 -----------------~~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                       .+.+.. .+....++.+++..+|..||.+|+++.+.++.
T Consensus       226 WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  226 WPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                             011110 14455677999999999999999999998753

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.2e-40  Score=331.13  Aligned_cols=251  Identities=23%  Similarity=0.380  Sum_probs=201.4

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +..++|++.++||+|+||.||+|.++  +..+|+|++..+   ........+.+|+++++.++||||++++++|.+.+..
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   78 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEE
Confidence            56689999999999999999999986  678999988654   2344556789999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCCCcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      ++|++|+.+++|.+++...+.          .+......++.+++.||+|||+. +  ++||||||+|||++.++.+||+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~l~~~l~~lH~~~~--ivH~dlkp~Nili~~~~~~kL~  146 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKAGR----------IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC  146 (333)
T ss_pred             EEEEecCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChhhEEEcCCCCEEEe
Confidence            999999999999999964321          23566788899999999999985 6  9999999999999999999999


Q ss_pred             ecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH------------
Q 039082          349 DFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM------------  415 (472)
Q Consensus       349 DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~------------  415 (472)
                      |||++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||............            
T Consensus       147 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (333)
T cd06650         147 DFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE  226 (333)
T ss_pred             eCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence            99999765432 23456899999999999888999999999999999999999999755421111000            


Q ss_pred             ------------------------------HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 ------------------------------EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ------------------------------~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                                    .+.... .+.++. .....++.++|.+||..||++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP-PPKLPS-GVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             cCcccCCccchhhhhcccccccccHHHHHHHHhcCC-CccCCC-CCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                          000000 011111 123456889999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.3e-41  Score=343.13  Aligned_cols=250  Identities=24%  Similarity=0.300  Sum_probs=200.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++++.||+|+||.||+|.++  +..||||++.+... ........+.+|+.+|+.++||||+++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADV-LMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHH-HhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEE
Confidence            37899999999999999999986  67899999865322 1223456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ||++.+|+|.+++...+.          .+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~E~~~~g~L~~~i~~~~~----------~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~  147 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGI----------FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGL  147 (376)
T ss_pred             EeCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCC
Confidence            999999999999964321          235667778899999999999999  99999999999999999999999999


Q ss_pred             ceecCC----------------------------------------------CccccccCCcccccccccCCCCCchHHH
Q 039082          353 ARFLSD----------------------------------------------GEMALTGTFVYMAPEVIQCEPYSEKSDV  386 (472)
Q Consensus       353 a~~~~~----------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~~sDv  386 (472)
                      |..+..                                              .....+||+.|+|||++.+..++.++||
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence            753210                                              0012468999999999999999999999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCC---CHHHHHHH
Q 039082          387 YSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRP---SFSSITCS  460 (472)
Q Consensus       387 wSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP---s~~~ll~~  460 (472)
                      |||||++|+|++|+.||.+.+  .......+........++........+.++|.+|+ .+|.+|+   ++.++++.
T Consensus       228 wSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         228 WSVGVILYEMLVGQPPFLADT--PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eeccceeeehhhCCCCCCCCC--HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999999999999998765  34444444443323333333344566777887876 5999999   88888754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-40  Score=324.76  Aligned_cols=262  Identities=21%  Similarity=0.332  Sum_probs=210.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ++..+|++.+.||.|+||.||+|.+.       +..||||+++...   .......|.+|+.++..++||||+++++++.
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~   78 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA---EGPLREEFKHEAMMRSRLQHPNIVCLLGVVT   78 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC---CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            34567889999999999999999864       3579999987532   2344566889999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhccccc------ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQR------RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ..+..+++++++.+++|.+++.......      .........++..+..++.|++.||.|||++|  ++||||||+|||
T Consensus        79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil  156 (283)
T cd05091          79 KEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVL  156 (283)
T ss_pred             CCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheE
Confidence            9999999999999999999985322110      00111123456778889999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK  412 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~  412 (472)
                      +++++.+||+|||+++.......     ...+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..  ...
T Consensus       157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~  234 (283)
T cd05091         157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQD  234 (283)
T ss_pred             ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--HHH
Confidence            99999999999999886643221     2234778999999988889999999999999999998 889997655  455


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      +...+..+... ..+  ...+..+.+++..||+.+|++||++.+|+..|+.
T Consensus       235 ~~~~i~~~~~~-~~~--~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         235 VIEMIRNRQVL-PCP--DDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHHcCCcC-CCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            66666665522 222  3355678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.1e-40  Score=342.03  Aligned_cols=248  Identities=23%  Similarity=0.304  Sum_probs=200.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|+++++||+|+||.||+|.++  +..||||++.+... ........+.+|+.+++.++|||||++++.+.+.+..++|+
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDV-LLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            5889999999999999999985  67899999865322 22345567889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      |++.+|+|.+++...+.          .+...+..++.||+.||+|||+++  |+||||||+|||++.+|.+||+|||++
T Consensus        81 E~~~gg~L~~~l~~~~~----------~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla  148 (382)
T cd05625          81 DYIPGGDMMSLLIRMGI----------FPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLC  148 (382)
T ss_pred             eCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCC
Confidence            99999999999864321          235667788999999999999999  999999999999999999999999997


Q ss_pred             eecCC--------------------------------------------------CccccccCCcccccccccCCCCCch
Q 039082          354 RFLSD--------------------------------------------------GEMALTGTFVYMAPEVIQCEPYSEK  383 (472)
Q Consensus       354 ~~~~~--------------------------------------------------~~~~~~gt~~y~APE~~~~~~~s~~  383 (472)
                      ..+..                                                  .....+||+.|+|||++.+..++.+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~  228 (382)
T cd05625         149 TGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL  228 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe
Confidence            53210                                                  0012358999999999999999999


Q ss_pred             HHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 039082          384 SDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS---FSSITC  459 (472)
Q Consensus       384 sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~ll~  459 (472)
                      +|||||||++|||++|+.||...+  +......+.........|.......++.++|.+++ .+|++|++   +.+++.
T Consensus       229 ~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         229 CDWWSVGVILYEMLVGQPPFLAQT--PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             eeEEechHHHHHHHhCCCCCCCCC--HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence            999999999999999999998765  44444555544333344443444566777777765 59999987   777664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1e-39  Score=317.94  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=203.5

Q ss_pred             eEeceeeccCceEEEEEEECC--e--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC------C
Q 039082          198 DLQEKIGQGTTANIYRAIWRG--L--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP------P  267 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g--~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~------~  267 (472)
                      .+.+.||+|+||.||+|.++.  .  .||+|.++...  ......+.|.+|+.+++.++||||+++++++...      .
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI--CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            467899999999999998753  2  59999886542  2345567789999999999999999999987542      2


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++|+.+++|..++......    ......++.....++.|++.||+|||+++  |+||||||+|||+++++.+||
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl  153 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLG----DCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCV  153 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhccc----CCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEE
Confidence            356888999999999988532211    11123457788899999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCC
Q 039082          348 ADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       348 ~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +|||++........     ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||....  ...+...+..+.
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~~  231 (272)
T cd05075         154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE--NSEIYDYLRQGN  231 (272)
T ss_pred             CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHcCC
Confidence            99999987654321     2235778999999999999999999999999999999 899997654  455556666554


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      . ...+  ...+..+.++|.+||..+|++|||+.+|++.|+++
T Consensus       232 ~-~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 R-LKQP--PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             C-CCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            2 1222  33556789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-41  Score=333.36  Aligned_cols=237  Identities=25%  Similarity=0.361  Sum_probs=195.3

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||+|+||.||+|.++  +..||+|++.+... ........+.+|+.+++.++||||+++++++...+..++|++++.+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHI-VSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            799999999999986  66899999875432 133445678899999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCC-
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-  359 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  359 (472)
                      |.+++...+.          .+...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++..... 
T Consensus        80 L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  147 (312)
T cd05585          80 LFHHLQREGR----------FDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD  147 (312)
T ss_pred             HHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence            9999964321          246778889999999999999999  999999999999999999999999999864322 


Q ss_pred             --ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q 039082          360 --EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELI  437 (472)
Q Consensus       360 --~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~  437 (472)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+..  .++.  .....+.
T Consensus       148 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--~~~~~~~~~~~~~--~~~~--~~~~~~~  221 (312)
T cd05585         148 DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--VNEMYRKILQEPL--RFPD--GFDRDAK  221 (312)
T ss_pred             CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--HHHHHHHHHcCCC--CCCC--cCCHHHH
Confidence              234568999999999999999999999999999999999999997765  4445555555432  2222  3446788


Q ss_pred             HHHHHhccCCCCCCCC---HHHHH
Q 039082          438 ELICLSWDGDASVRPS---FSSIT  458 (472)
Q Consensus       438 ~li~~cl~~dP~~RPs---~~~ll  458 (472)
                      ++|.+||..||++||+   +.+++
T Consensus       222 ~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         222 DLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHcCCCHHHcCCCCCHHHHH
Confidence            8999999999999986   45554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.9e-40  Score=324.19  Aligned_cols=250  Identities=23%  Similarity=0.295  Sum_probs=195.1

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|++.++||.|+||.||+|..+  +..||+|+++....   ......+.+|+.+++.++||||+++++++..++..+
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   79 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT   79 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc---CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3468999999999999999999886  67899999865421   222345779999999999999999999998888777


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|++++. ++|.+++...+.         ..+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus        80 lv~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Df  147 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNCGN---------LMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADF  147 (288)
T ss_pred             EEEeCCC-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcC
Confidence            7777775 589998854321         2346778889999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC---
Q 039082          351 GHARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK---  421 (472)
Q Consensus       351 Gla~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~---  421 (472)
                      |+++......   ....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.+.  .+....+..  +.   
T Consensus       148 G~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~  225 (288)
T cd07871         148 GLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV--KEELHLIFRLLGTPTE  225 (288)
T ss_pred             cceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCh
Confidence            9998654322   23457899999999865 5689999999999999999999999977652  222211111  00   


Q ss_pred             -----------C-CCCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 -----------L-RPALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 -----------~-~~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 + ...++.         .+....++.++|.+||..||.+|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                       0 000110         0123456789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-39  Score=319.87  Aligned_cols=256  Identities=24%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +..++|++.+.||+|+||.||+|.+.  +.    ++++|.+...   ........+..|+.+++.++||||+++++++. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-   79 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR---SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-   79 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc---cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-
Confidence            45578999999999999999999984  43    4778876432   22344566888999999999999999999875 


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      ....+++++++.+|+|.+++.....         ..++..+..++.|++.||+|||+++  ++||||||+|||+++++.+
T Consensus        80 ~~~~~~i~e~~~~gsL~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~  148 (279)
T cd05111          80 GASLQLVTQLSPLGSLLDHVRQHRD---------SLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIV  148 (279)
T ss_pred             CCccEEEEEeCCCCcHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcE
Confidence            4556789999999999999964321         2346788899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+..  ...+...+..
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~--~~~~~~~~~~  226 (279)
T cd05111         149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR--PHEVPDLLEK  226 (279)
T ss_pred             EEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHC
Confidence            9999999987643321     2335778999999998899999999999999999998 999997765  3444444444


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      +. .+..+.  .++..+.+++.+||..+|++||++.++++.|..+..+
T Consensus       227 ~~-~~~~~~--~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         227 GE-RLAQPQ--ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CC-cCCCCC--CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            43 222222  2455778899999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.1e-40  Score=316.65  Aligned_cols=254  Identities=30%  Similarity=0.497  Sum_probs=211.1

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |+++.++|++.+.||+|+||.||+|.++ +..||||.+..+.     ...+.+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP   75 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc
Confidence            7889999999999999999999999886 4579999886532     223568899999999999999999999998888


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..+..++.+++.||+|||+++  ++|+||+|+||+++.++.+||+
T Consensus        76 ~~~v~e~~~~~~L~~~i~~~~~--------~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~  145 (261)
T cd05034          76 IYIVTEYMSKGSLLDFLKSGEG--------KKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIA  145 (261)
T ss_pred             eEEEEeccCCCCHHHHHhcccc--------CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEEC
Confidence            9999999999999999965321        12356788899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+  .......+..+. +
T Consensus       146 d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~--~~~~~~~~~~~~-~  222 (261)
T cd05034         146 DFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT--NREVLEQVERGY-R  222 (261)
T ss_pred             ccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-C
Confidence            9999987653221    1224578999999998889999999999999999999 999997665  444455554432 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      ...+  ...+..+.+++.+||..+|++||++++|.+.|+.
T Consensus       223 ~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 MPRP--PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            2222  2335678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.7e-40  Score=333.09  Aligned_cols=242  Identities=25%  Similarity=0.341  Sum_probs=198.3

Q ss_pred             eceeeccCceEEEEEEE-----CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          200 QEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~-----~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      ++.||+|+||.||++..     .+..||||+++.............+.+|+.+|+.++||||+++++++..++..++|++
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999975     3678999999764332233444567899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++...+.          .....+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~~L~~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~  148 (323)
T cd05584          81 YLSGGELFMHLEREGI----------FMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCK  148 (323)
T ss_pred             CCCCchHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCe
Confidence            9999999999864331          234667778899999999999999  9999999999999999999999999987


Q ss_pred             ecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          355 FLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       355 ~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      .....   .....|++.|+|||++.+..++.++|||||||++|||++|+.||...+  .......+..+..  .+|.  .
T Consensus       149 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~--~~~~~~~~~~~~~--~~~~--~  222 (323)
T cd05584         149 ESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN--RKKTIDKILKGKL--NLPP--Y  222 (323)
T ss_pred             ecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC--CCCC--C
Confidence            54322   223468999999999998889999999999999999999999997765  4445555555532  2332  2


Q ss_pred             hHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      ....+.++|.+||..+|++||     ++.++++
T Consensus       223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            445788999999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.3e-41  Score=336.02  Aligned_cols=250  Identities=25%  Similarity=0.356  Sum_probs=205.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||+++.... ...+....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVL-LAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEE
Confidence            47899999999999999999885  77899999976432 2334566788999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++|+.+++|.+++.....         ..+...+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~  148 (330)
T cd05601          80 MEYQPGGDLLSLLNRYED---------QFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGS  148 (330)
T ss_pred             ECCCCCCCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCC
Confidence            999999999999965321         1346778888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc----cccccCCccccccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          353 ARFLSDGE----MALTGTFVYMAPEVIQ------CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       353 a~~~~~~~----~~~~gt~~y~APE~~~------~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      +.......    ....||+.|+|||++.      ...++.++|||||||++|+|++|..||...+  .......+.....
T Consensus       149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~  226 (330)
T cd05601         149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT--SAKTYNNIMNFQR  226 (330)
T ss_pred             CeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC--HHHHHHHHHcCCC
Confidence            98765432    2345899999999986      4567899999999999999999999997665  3444455544432


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....|.....+..+.+++..||. +|.+||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            23344434456778889999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.1e-40  Score=323.69  Aligned_cols=249  Identities=20%  Similarity=0.258  Sum_probs=196.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|+++  +..||||++.....  .......+.+|+.+++.++||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE--NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLV   78 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc--cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEE
Confidence            36899999999999999999986  67899999875432  334456688999999999999999999999998888899


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.++.+..+....          ...+...+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||+
T Consensus        79 ~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~  146 (287)
T cd07848          79 FEYVEKNMLELLEEMP----------NGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGF  146 (287)
T ss_pred             EecCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccC
Confidence            9998887666544211          12346778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CCC----
Q 039082          353 ARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GKL----  422 (472)
Q Consensus       353 a~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~~----  422 (472)
                      +.......    ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+...  ....+..  +..    
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~  224 (287)
T cd07848         147 ARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID--QLFTIQKVLGPLPAEQ  224 (287)
T ss_pred             cccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhCCCCHHH
Confidence            98765322    23458999999999998889999999999999999999999998755211  1111110  100    


Q ss_pred             -----------CCCCCCC-----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 -----------RPALPEE-----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 -----------~~~l~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 ....+..           ...+..+.++|.+||..||++|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         225 MKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             HHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                       0000100           123456899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.4e-40  Score=332.19  Aligned_cols=240  Identities=23%  Similarity=0.319  Sum_probs=198.0

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccC
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      +.||+|+||.||++.++  |..||+|+++.... ........+.+|+.+++.++||||+++++.|...+..++|+||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence            46999999999999875  77899999976433 2334556688999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCC
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      ++|..++...+          ..++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++.....
T Consensus        80 ~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  147 (323)
T cd05595          80 GELFFHLSRER----------VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  147 (323)
T ss_pred             CcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccC
Confidence            99998885432          1346778889999999999999999  99999999999999999999999999876432


Q ss_pred             C---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHH
Q 039082          359 G---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE  435 (472)
Q Consensus       359 ~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~  435 (472)
                      .   .....|++.|+|||++.+..++.++|||||||++|+|++|..||...+  .......+..+..  .+|.  .....
T Consensus       148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~~~~~~~--~~p~--~~~~~  221 (323)
T cd05595         148 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEI--RFPR--TLSPE  221 (323)
T ss_pred             CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCC--CCCC--CCCHH
Confidence            2   123568999999999999999999999999999999999999997665  3444444444332  2222  24467


Q ss_pred             HHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          436 LIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       436 l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      +.++|.+||..||++||     ++.++++
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         222 AKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            88899999999999998     7888765

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.6e-39  Score=320.32  Aligned_cols=261  Identities=25%  Similarity=0.406  Sum_probs=209.3

Q ss_pred             CeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      +|++.+.||+|+||.||+|.+..       ..+|+|.+....   .......+.+|+.+++.++||||+++++.+...+.
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA---SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP   77 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC---CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC
Confidence            47889999999999999998742       458999886542   23445678999999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhccccccc--------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCC
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRK--------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKP  334 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp  334 (472)
                      .+++++++.+++|.+++.........              .......++..++.++.+++.||+|||+++  ++||||||
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp  155 (290)
T cd05045          78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAA  155 (290)
T ss_pred             cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhh
Confidence            99999999999999998653221100              001123457788999999999999999999  99999999


Q ss_pred             CcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCC
Q 039082          335 SNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY  408 (472)
Q Consensus       335 ~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~  408 (472)
                      +|||+++++.+||+|||+++......     ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.. 
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-  234 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA-  234 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC-
Confidence            99999999999999999998654221     12235678999999988889999999999999999998 999997655 


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       409 ~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                       +..+...+..+. +...+  ...+.++.+++..||+.+|++||++.++++.|+++..
T Consensus       235 -~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         235 -PERLFNLLKTGY-RMERP--ENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             -HHHHHHHHhCCC-CCCCC--CCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence             444544444432 33333  2345678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.9e-40  Score=339.26  Aligned_cols=256  Identities=22%  Similarity=0.343  Sum_probs=207.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ...+..++|++.+.||+|+||.||++.++  +..||+|++.+... ........+.+|+.+++.++||||+++++++.++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            45566789999999999999999999986  67899999865322 1223345688999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++|+||+.+|+|.+++....           .+...+..++.||+.||+|||+++  |+||||||+|||++.++.+|
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~~-----------~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~k  182 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNYD-----------VPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLK  182 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEE
Confidence            99999999999999999985321           235678888999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc----cccccCCcccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSDGE----MALTGTFVYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~----~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||+|.......    ....||+.|+|||++...    .++.++|||||||++|+|++|..||.+.+  .......+.
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~--~~~~~~~i~  260 (370)
T cd05621         183 LADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS--LVGTYSKIM  260 (370)
T ss_pred             EEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence            99999998765332    245689999999998754    37889999999999999999999998765  444555555


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASV--RPSFSSITCS  460 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~~  460 (472)
                      .......+|........+.+++..|+..++.+  ||++.++++.
T Consensus       261 ~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         261 DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            54434445544445667888888999765544  8899998764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-39  Score=315.38  Aligned_cols=253  Identities=30%  Similarity=0.481  Sum_probs=207.0

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |+++.++|++.+.||+|+||.||+|.+++ ..+|+|.+..+.     .....|.+|+.+++.++|||++++++++. .+.
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   74 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-----MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEP   74 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-----ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCC
Confidence            77888899999999999999999999874 479999876532     22345889999999999999999999875 456


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..+..++.+++.||+|||+.+  ++|+||+|+||++++++.++|+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~  144 (260)
T cd05069          75 IYIVTEFMGKGSLLDFLKEGDG--------KYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIA  144 (260)
T ss_pred             cEEEEEcCCCCCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEEC
Confidence            7889999999999999964221        12357778899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+.+..++.++||||||+++|+|+| |..||.+..  .......+..+. .
T Consensus       145 dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~-~  221 (260)
T cd05069         145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV--NREVLEQVERGY-R  221 (260)
T ss_pred             CCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-C
Confidence            9999987654322    1235678999999988889999999999999999999 999997755  334444444432 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      +..+  ...+..+.+++.+||..+|++||+++++++.|++
T Consensus       222 ~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 MPCP--QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCC--cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            2222  2355678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.1e-40  Score=335.56  Aligned_cols=248  Identities=23%  Similarity=0.292  Sum_probs=199.2

Q ss_pred             CeeEeceeeccCceEEEEEEE-----CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCc
Q 039082          196 EIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~-----~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~  269 (472)
                      +|++.+.||+|+||.||++..     .+..||+|++.+..........+.+.+|+.++..+ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            588999999999999999876     36789999997643333344556788999999999 589999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++|+.+|+|.+++....          ..+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~D  148 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD----------NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTD  148 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEee
Confidence            99999999999999986432          1246778889999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC----ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCCC
Q 039082          350 FGHARFLSDG----EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGKL  422 (472)
Q Consensus       350 FGla~~~~~~----~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~~  422 (472)
                      ||+++.....    .....||+.|+|||++.+. .++.++|||||||++|||+||..||.....  ....+...+...  
T Consensus       149 fG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--  226 (332)
T cd05614         149 FGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--  226 (332)
T ss_pred             CcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC--
Confidence            9999865322    2235689999999999865 478999999999999999999999964332  233333333332  


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      .+.++.  .....+.+++.+||..||++||     +++++++
T Consensus       227 ~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 DPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            222332  3455678899999999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.9e-40  Score=318.20  Aligned_cols=260  Identities=25%  Similarity=0.413  Sum_probs=212.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||.+..... ........|.+|+.+++.++||||+++++++...+..+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhh-hhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            46888999999999999999974  78999998865322 2334556789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++......      ....++..++.++.+++.||+|||++|  ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~  152 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQ------KRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             EEecCCCCHHHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchh
Confidence            9999999999998642211      123457788899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+...........+......+ .+. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~-  230 (267)
T cd08229         153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP-LPS-  230 (267)
T ss_pred             hhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC-CCc-
Confidence            88765332   2345789999999999888999999999999999999999999766543344444444433221 221 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ...+..+.+++.+||..+|++|||+.+|++.++++.
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         231 DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            235567889999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.1e-39  Score=321.93  Aligned_cols=263  Identities=27%  Similarity=0.399  Sum_probs=208.2

Q ss_pred             CCCCeeEeceeeccCceEEEEEEECC------------------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWRG------------------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR  254 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~g------------------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hp  254 (472)
                      +..+|++.+.||+|+||.||+|.+.+                  ..||+|.+..+.   .....+.|.+|+++++.++||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA---SDNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc---CHHHHHHHHHHHHHHHhcCCC
Confidence            45689999999999999999998642                  358999987542   335567799999999999999


Q ss_pred             ceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc-ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCC
Q 039082          255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK-ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLK  333 (472)
Q Consensus       255 nIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLk  333 (472)
                      ||+++++++..++..+++++++.+++|.+++......... .......++..++.++.|++.||+|||+++  ++|||||
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlk  157 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLA  157 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccc
Confidence            9999999999999999999999999999999754421111 111223467888999999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 039082          334 PSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT--GNHPYIEK  406 (472)
Q Consensus       334 p~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt--G~~Pf~~~  406 (472)
                      |+||+++.++.++|+|||++.......     ....+++.|+|||.+.+..++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         158 TRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             hhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            999999999999999999998654332     12335778999999988889999999999999999998  77888655


Q ss_pred             CCCHHHHHHHHhcC----CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          407 DYKPAKIAMEVGEG----KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       407 ~~~~~~i~~~i~~~----~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +  ...+...+...    ......+.....+.++.+++.+||..+|++||++.+|++.|+
T Consensus       238 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         238 T--DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             C--hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            4  33333333222    112222222334578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.5e-40  Score=329.74  Aligned_cols=250  Identities=25%  Similarity=0.319  Sum_probs=190.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----C
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----Y  268 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----~  268 (472)
                      +|++.+.||+|+||.||+|.++  |..||||.+.....  .......+.+|+.+++.++||||+++++++....     .
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   78 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE--HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD   78 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc--cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCce
Confidence            4889999999999999999985  67899999864322  2233456889999999999999999999886543     2


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|++++ +++|.+++....          ..++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+
T Consensus        79 ~~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~  145 (338)
T cd07859          79 IYVVFELM-ESDLHQVIKAND----------DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKIC  145 (338)
T ss_pred             EEEEEecC-CCCHHHHHHhcc----------cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEc
Confidence            45555555 789999885432          1346788899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc------cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH----------
Q 039082          349 DFGHARFLSDGE------MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP----------  410 (472)
Q Consensus       349 DFGla~~~~~~~------~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~----------  410 (472)
                      |||+++......      ....|++.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+...          
T Consensus       146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~  225 (338)
T cd07859         146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLG  225 (338)
T ss_pred             cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhC
Confidence            999998653221      23458999999999875  678999999999999999999999997654211          


Q ss_pred             ---HHHHHHHhcCC-------CCCCCC----C-CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          411 ---AKIAMEVGEGK-------LRPALP----E-EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       411 ---~~i~~~i~~~~-------~~~~l~----~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                         ......+....       .....+    . .+.....+.+++.+||..||++||+++++++.
T Consensus       226 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         226 TPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             CCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence               00000000000       000001    0 02334567899999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.6e-40  Score=330.02  Aligned_cols=240  Identities=23%  Similarity=0.347  Sum_probs=198.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-CceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~g~~~~~~~~~~v  272 (472)
                      +|++.+.||+|+||.||+|.++  +..||||++.++.. ........+..|+.++..++| ++|+++++++...+..++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVI-IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEE
Confidence            5889999999999999999986  56899999976533 223445668899999999976 5688899999988899999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.+++|..++.....          .+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~E~~~~g~L~~~~~~~~~----------~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~  147 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGK----------FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGM  147 (324)
T ss_pred             EcCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCc
Confidence            999999999999864321          246778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.....   .....+||+.|+|||++.+..++.++|||||||++|+|+||+.||.+.+  .......+.....  .+|. 
T Consensus       148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~~~--~~~~-  222 (324)
T cd05587         148 CKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQSIMEHNV--SYPK-  222 (324)
T ss_pred             ceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCC--CCCC-
Confidence            875421   2234568999999999999999999999999999999999999997765  4555555655432  2332 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                       .....+.+++.+||..||.+|++.
T Consensus       223 -~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         223 -SLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -CCCHHHHHHHHHHhhcCHHHcCCC
Confidence             244578889999999999999976

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.5e-40  Score=332.76  Aligned_cols=241  Identities=23%  Similarity=0.314  Sum_probs=199.1

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccC
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      +.||+|+||.||++.++  |..||||++.+... ........+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875  77899999976533 2334556788999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCC
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      ++|..++....          ..++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+++....
T Consensus        80 g~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~  147 (328)
T cd05593          80 GELFFHLSRER----------VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT  147 (328)
T ss_pred             CCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCC
Confidence            99998885432          1346778889999999999999999  99999999999999999999999999876432


Q ss_pred             C---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHH
Q 039082          359 G---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE  435 (472)
Q Consensus       359 ~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~  435 (472)
                      .   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+..  .+|.  ....+
T Consensus       148 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~--~~~~~~~~~~~~~--~~p~--~~~~~  221 (328)
T cd05593         148 DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEDI--KFPR--TLSAD  221 (328)
T ss_pred             cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC--HHHHHHHhccCCc--cCCC--CCCHH
Confidence            2   223568999999999998999999999999999999999999997765  3444444443322  2332  34557


Q ss_pred             HHHHHHHhccCCCCCCC-----CHHHHHHH
Q 039082          436 LIELICLSWDGDASVRP-----SFSSITCS  460 (472)
Q Consensus       436 l~~li~~cl~~dP~~RP-----s~~~ll~~  460 (472)
                      +.++|.+||..||++||     ++.++++.
T Consensus       222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            88899999999999997     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-39  Score=343.57  Aligned_cols=247  Identities=23%  Similarity=0.295  Sum_probs=205.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .|.+.+.||+|+||.||+|...   +..||+|.+..+    .......+.+|+.+|+.++|||||+++++|...+..++|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv  143 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN----DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI  143 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence            4899999999999999999864   457899976432    344456688899999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.||+|.+++......      ....+...+..++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+
T Consensus       144 ~E~~~gg~L~~~l~~~~~~------~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgl  215 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKE------HLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGF  215 (478)
T ss_pred             EECCCCCCHHHHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcC
Confidence            9999999999988642211      112346778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC-----ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          353 ARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       353 a~~~~~~-----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      +......     ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+  ...+...+..+... ..+
T Consensus       216 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~--~~~~~~~~~~~~~~-~~~  292 (478)
T PTZ00267        216 SKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS--QREIMQQVLYGKYD-PFP  292 (478)
T ss_pred             ceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC-CCC
Confidence            9876543     234468999999999999999999999999999999999999997665  45566666665532 222


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        ......+.++|.+||..+|++||++++++.
T Consensus       293 --~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        293 --CPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --ccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              234567889999999999999999999874

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-39  Score=316.02  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=205.9

Q ss_pred             eeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC---
Q 039082          197 IDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY---  268 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~---  268 (472)
                      |.+.+.||+|+||.||+|...     +..||||.++.+..  .......+.+|+..++.++||||+++++++...+.   
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   78 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH--TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK   78 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence            567899999999999999874     25699999875432  34456679999999999999999999998876554   


Q ss_pred             ---ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          269 ---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       269 ---~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                         .+++++|+.+++|..++.......    .....++.....++.|++.||+|||+++  ++||||||+||++++++.+
T Consensus        79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~----~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~  152 (273)
T cd05035          79 IPKPMVILPFMKHGDLHSFLLYSRLGG----LPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTV  152 (273)
T ss_pred             CcccEEEEeccCCCCHHHHHHHhhccC----CcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeE
Confidence               678889999999999985432111    1123456788899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |..||.+..  ...+...+..
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~--~~~~~~~~~~  230 (273)
T cd05035         153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE--NHEIYDYLRH  230 (273)
T ss_pred             EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc
Confidence            9999999987654322     1234678999999988889999999999999999999 999997655  4455555555


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      +. ....+  ...+..+.+++.+||..||++||++.++++.|+++
T Consensus       231 ~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN-RLKQP--EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC-CCCCC--cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            43 22222  34556889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-39  Score=318.01  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=208.1

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +..++|++.+.||+|+||.||+|.+.  |.    .||+|++...   ........+.+|+.++..++||||+++++++..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN---TSPKANKEILDEAYVMAGVGSPYVCRLLGICLT   80 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC---CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC
Confidence            45678999999999999999999874  33    4899988654   234455678899999999999999999999875


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       ...+++++++.+|+|.+++.....         ..++..++.++.|++.||+|||+++  ++||||||+|||+++++.+
T Consensus        81 -~~~~l~~~~~~~g~l~~~l~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~  148 (279)
T cd05109          81 -STVQLVTQLMPYGCLLDYVRENKD---------RIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHV  148 (279)
T ss_pred             -CCcEEEEEcCCCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcE
Confidence             456789999999999999864321         2346788999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCccc-----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGEMA-----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~~-----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++........     ..+++.|+|||.+.+..++.++|||||||++|||++ |..||....  ...+...+..
T Consensus       149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~  226 (279)
T cd05109         149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP--AREIPDLLEK  226 (279)
T ss_pred             EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHC
Confidence            99999999877533221     224678999999998899999999999999999998 999996654  3444444444


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      +. ....+  ...+..+.+++.+||..||+.||++.+++..|+++...
T Consensus       227 ~~-~~~~~--~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         227 GE-RLPQP--PICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             CC-cCCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            43 22222  34556788999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-39  Score=317.38  Aligned_cols=264  Identities=29%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECC------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ++.++|++.+.||+|+||.||+|.+.+      ..|++|.+...   ........+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH---ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            567899999999999999999998753      67999988643   345556778999999999999999999998877


Q ss_pred             C-CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          266 P-PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       266 ~-~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      . ...+++++++.+++|.+++........  ......++..++.++.+++.||+|||+++  ++||||||+|||+++++.
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~  155 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEA--NNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQ  155 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhcccccc--ccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCc
Confidence            4 455566677778999999965432110  01123457888999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          345 VRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +||+|||+++.+.....     ...++..|+|||.+.+..++.++||||||+++|++++ |+.||...+  +..+...+.
T Consensus       156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~  233 (280)
T cd05043         156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID--PFEMAAYLK  233 (280)
T ss_pred             EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC--HHHHHHHHH
Confidence            99999999986643322     1235678999999988889999999999999999999 999997654  445555555


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .+. +...+  ...+..+.+++.+||..+|++||++.+++..|.++..+
T Consensus       234 ~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DGY-RLAQP--INCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cCC-CCCCC--CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            443 22222  23456789999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.6e-39  Score=315.01  Aligned_cols=253  Identities=27%  Similarity=0.480  Sum_probs=208.3

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      |.+..++|++.++||+|+||.||+|.+. +..+|+|.+...     ......|.+|+.+++.++|+||+++++.+.. ..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   74 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP   74 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC
Confidence            8899999999999999999999999875 567999988643     3345678899999999999999999999877 66


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....        ...++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.+||+
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~  144 (260)
T cd05073          75 IYIITEFMAKGSLLDFLKSDEG--------SKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIA  144 (260)
T ss_pred             eEEEEEeCCCCcHHHHHHhCCc--------cccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEEC
Confidence            7888888889999999964321        12346778889999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++........    ...++..|+|||.+....++.++|+|||||++|+++| |..||...+  .......+..+. .
T Consensus       145 d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~~~-~  221 (260)
T cd05073         145 DFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--NPEVIRALERGY-R  221 (260)
T ss_pred             CCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCC-C
Confidence            9999987654322    1234677999999998889999999999999999999 999997765  333444444432 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      .  +.....+.++.+++.+||..+|++||++.++.+.|+.
T Consensus       222 ~--~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 M--PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             C--CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2  2223455678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=323.15  Aligned_cols=250  Identities=26%  Similarity=0.354  Sum_probs=201.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|++.+.||+|+||.||++.+.  +..||||++...... .......+.+|+.+++.++||||+++++.+...+..++|+
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhh-hhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEE
Confidence            3788999999999999999875  778999998654321 2233456788999999999999999999999989999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|..++.....        ...+...+..++.|++.||.|||+++  ++||||||+||++++++.++|+|||++
T Consensus        80 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05605          80 TLMNGGDLKFHIYNMGN--------PGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLA  149 (285)
T ss_pred             eccCCCcHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCc
Confidence            99999999988854221        12346778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCC
Q 039082          354 RFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       354 ~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--~~i~~~i~~~~~~~~l~~~  429 (472)
                      .......  ....|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+...  ..+...+..+.  ...+  
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~--  225 (285)
T cd05605         150 VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ--EEYS--  225 (285)
T ss_pred             eecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcc--cccC--
Confidence            8765332  23468999999999998899999999999999999999999997654211  11222222211  1111  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRP-----SFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~~  460 (472)
                      ...+..+.++|.+||..||++||     ++++++..
T Consensus       226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         226 EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            23455788899999999999999     88888653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.7e-39  Score=320.18  Aligned_cols=264  Identities=28%  Similarity=0.414  Sum_probs=209.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCc
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~  269 (472)
                      ++|++.+.||+|+||.||+|.++  +.  .+++|.++..   ........|.+|+.++.++ +||||+++++++...+..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF---ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc---CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            58999999999999999999875  32  4788877532   2334456789999999999 799999999999998889


Q ss_pred             eEEEEeccCCcHHHHHhhcccccc------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRR------KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      +++++++.+++|.+++........      ........++..++.++.|++.||+|||++|  ++||||||+|||+++++
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~  156 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGENL  156 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCCC
Confidence            999999999999999965332110      0111223567888999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCccc--cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcC
Q 039082          344 HVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~~--~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      .+||+|||++.........  ...+..|+|||.+.+..++.++|||||||++|||++ |..||....  .......+..+
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~--~~~~~~~~~~~  234 (297)
T cd05089         157 ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT--CAELYEKLPQG  234 (297)
T ss_pred             eEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcC
Confidence            9999999998654322111  223567999999998889999999999999999998 999997766  44444444443


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      . .+..+  ...+..+.+++.+||..+|.+||++++++..|+.+....
T Consensus       235 ~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         235 Y-RMEKP--RNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             C-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            2 22223  234567889999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-39  Score=323.17  Aligned_cols=250  Identities=21%  Similarity=0.236  Sum_probs=192.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  +..||||++.....   ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE---EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTL   80 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc---cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEE
Confidence            468999999999999999999985  77899999865421   2223457789999999999999999999998888877


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++ +++|.+++.....         ..+...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||
T Consensus        81 v~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg  148 (303)
T cd07869          81 VFEYV-HTDLCQYMDKHPG---------GLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFG  148 (303)
T ss_pred             EEECC-CcCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCC
Confidence            77776 6788888754321         1235678889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CCC---
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GKL---  422 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~~---  422 (472)
                      ++.......   ....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+...... ....+..  +..   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~  227 (303)
T cd07869         149 LARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLERIFLVLGTPNED  227 (303)
T ss_pred             cceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhCCCChh
Confidence            997654322   23457899999999865 4589999999999999999999999976542111 1111110  000   


Q ss_pred             ----------------CCCCCCC-------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 ----------------RPALPEE-------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ----------------~~~l~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                      ....+..       ......+.+++.+||..||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         228 TWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence                            0000000       012246778999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.2e-40  Score=337.26  Aligned_cols=249  Identities=23%  Similarity=0.308  Sum_probs=201.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||+++.... ........+.+|+.++..++||||+++++.+.+.+..++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM-LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            47899999999999999999885  67899999975322 2234556788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.||+|.+++...+.          .+...+..++.|++.||+|||++|  |+||||||+||||+.+|.+||+|||+
T Consensus        80 ~E~~~gg~L~~~l~~~~~----------l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~  147 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDT----------LSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGL  147 (360)
T ss_pred             EeCCCCccHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccC
Confidence            999999999999864321          245778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC--------------------------------------ccccccCCcccccccccCCCCCchHHHHHHHHHHH
Q 039082          353 ARFLSDG--------------------------------------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILN  394 (472)
Q Consensus       353 a~~~~~~--------------------------------------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~  394 (472)
                      +......                                      ....+||+.|+|||++.+..++.++|||||||++|
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily  227 (360)
T cd05627         148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY  227 (360)
T ss_pred             CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence            8754311                                      11346899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 039082          395 EIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS---FSSITC  459 (472)
Q Consensus       395 elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~ll~  459 (472)
                      ||++|+.||.+.+  +......+........+|.......++.++|.+++ .+|.+|++   +.++++
T Consensus       228 el~tG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~  292 (360)
T cd05627         228 EMLIGYPPFCSET--PQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKS  292 (360)
T ss_pred             ecccCCCCCCCCC--HHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence            9999999997766  44455555543323334443345567788888876 49999985   555553

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.9e-39  Score=343.46  Aligned_cols=253  Identities=22%  Similarity=0.301  Sum_probs=207.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC--
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY--  268 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~--  268 (472)
                      ..++|++.+.||+|+||.||+|.+.  |..||||++..+..  .+.....+.+|+.++..++|+||+++++.+...+.  
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~--~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM--SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            4469999999999999999999874  78999999976533  44556678899999999999999999887754332  


Q ss_pred             ------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          269 ------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       269 ------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                            .++|++|+.+|+|.+++......      ....+...+..++.|++.||.|||+++  |+||||||+|||++.+
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~------~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~  179 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKT------NRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSN  179 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhcc------CCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCC
Confidence                  46788999999999999643211      123356778889999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCC-----ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~-----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      +.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+  ...+...+
T Consensus       180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--~~~~~~~~  257 (496)
T PTZ00283        180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--MEEVMHKT  257 (496)
T ss_pred             CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHH
Confidence            99999999999875432     234568999999999999999999999999999999999999997765  45555666


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ..+... .++.  ..+..+.+++.+||..+|.+||++.+++..
T Consensus       258 ~~~~~~-~~~~--~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        258 LAGRYD-PLPP--SISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             hcCCCC-CCCC--CCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            655433 2332  345678889999999999999999998763

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1e-39  Score=330.27  Aligned_cols=269  Identities=27%  Similarity=0.412  Sum_probs=210.7

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLM  260 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~  260 (472)
                      .|.++.++|++.+.||+|+||.||+|.+.       ++.||||+++.+.   .......+.+|+.+|..+ +||||++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~niv~~~   77 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA---THSEHRALMSELKILIHIGHHLNVVNLL   77 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC---ChHHHHHHHHHHHHHHhccCCccHhhhc
Confidence            48899999999999999999999999752       5679999997542   234456688999999999 689999999


Q ss_pred             EEEEcCC-CceEEEEeccCCcHHHHHhhccccccc---------------------------------------------
Q 039082          261 GACLEPP-YRGWLVTELLGTTLKEWLHGLGSQRRK---------------------------------------------  294 (472)
Q Consensus       261 g~~~~~~-~~~~vve~~~ggsL~~~l~~~~~~~~~---------------------------------------------  294 (472)
                      +++...+ ..+++++|+.+|+|.+++.........                                             
T Consensus        78 ~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (343)
T cd05103          78 GACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS  157 (343)
T ss_pred             ceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCc
Confidence            9887654 567888999999999999653211000                                             


Q ss_pred             ------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-
Q 039082          295 ------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-  361 (472)
Q Consensus       295 ------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-  361 (472)
                                  .......++..+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++........ 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  235 (343)
T cd05103         158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY  235 (343)
T ss_pred             cccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcch
Confidence                        000112457778889999999999999999  99999999999999999999999999986542211 


Q ss_pred             ----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHH
Q 039082          362 ----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLREL  436 (472)
Q Consensus       362 ----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l  436 (472)
                          ...++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .....+..+. +...|..  ...++
T Consensus       236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~--~~~~~  311 (343)
T cd05103         236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT-RMRAPDY--TTPEM  311 (343)
T ss_pred             hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccC-CCCCCCC--CCHHH
Confidence                1234677999999988899999999999999999997 999997654322 2333333332 3333322  34568


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          437 IELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       437 ~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .+++..||..+|++||++.+|++.|+.+..
T Consensus       312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1e-39  Score=315.19  Aligned_cols=252  Identities=28%  Similarity=0.484  Sum_probs=208.7

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      |.+..++|++.+.||+|+||.||+|...+..||+|.++.+      .....+.+|+.+++.++||||+++++++..+ ..
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~   73 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GL   73 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCc------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-Cc
Confidence            5567788999999999999999999988999999988543      1235688999999999999999999988654 56


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      +++++++.+++|.+++.....        ...++..++.++.|++.||.|||+.|  ++||||||+|||++.++.+||+|
T Consensus        74 ~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~D  143 (254)
T cd05083          74 YIVMELMSKGNLVNFLRTRGR--------ALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSD  143 (254)
T ss_pred             EEEEECCCCCCHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECC
Confidence            889999999999999965321        12346778899999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ||++............+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+  .......+..+. ++..+ 
T Consensus       144 fg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~-  219 (254)
T cd05083         144 FGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMS--LKEVKECVEKGY-RMEPP-  219 (254)
T ss_pred             CccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCC--HHHHHHHHhCCC-CCCCC-
Confidence            9999876544334445678999999988899999999999999999998 999997766  334445554443 33222 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                       ...+..+.+++.+||..+|++||++++|+..|++
T Consensus       220 -~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 -EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             3355678899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=315.48  Aligned_cols=248  Identities=27%  Similarity=0.459  Sum_probs=204.0

Q ss_pred             CCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      +..+|++.+.||+|+||.||+|.+++ ..+|+|++.+...     ....|.+|+++++.++||||+++++++...+..++
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            45678999999999999999998874 4799998864322     22358889999999999999999999999989999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++.....         ..++..++.++.|++.||+|||+.+  ++||||||+||++++++.+||+|||
T Consensus        77 v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg  145 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG---------KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFG  145 (256)
T ss_pred             EEecCCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcc
Confidence            9999999999999864321         2346788999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCccc-c---ccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          352 HARFLSDGEMA-L---TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       352 la~~~~~~~~~-~---~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +++...+.... .   .++..|+|||.+.+..++.++||||||+++|+|++ |..||...+  .......+..+. +...
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~  222 (256)
T cd05059         146 LARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS--NSEVVESVSAGY-RLYR  222 (256)
T ss_pred             cceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC--HHHHHHHHHcCC-cCCC
Confidence            99876543221 1   13457999999998899999999999999999999 899997654  444455554432 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      +  ...+..+.+++.+||..+|++||++.++++.|
T Consensus       223 ~--~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 P--KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             C--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            2  33566899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-39  Score=325.92  Aligned_cols=269  Identities=27%  Similarity=0.418  Sum_probs=217.3

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCcee
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL  257 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv  257 (472)
                      ..|++...+|++.+.||+|+||.||+|.+.         +..||+|+++.+   ........+.+|+.+++++ +||||+
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv   81 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD---ATDKDLSDLVSEMEMMKMIGKHKNII   81 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc---cCHHHHHHHHHHHHHHHhhcCCCCee
Confidence            569999999999999999999999999753         236899988643   2344567789999999999 899999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccc------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecC
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR------KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD  331 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrD  331 (472)
                      +++++|...+..+++++|+.+++|.+++........      ........++..++.++.|++.||+|||++|  ++|||
T Consensus        82 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~d  159 (334)
T cd05100          82 NLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRD  159 (334)
T ss_pred             eeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccc
Confidence            999999999989999999999999999975321100      0001123457788899999999999999999  99999


Q ss_pred             CCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          332 LKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       332 Lkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      |||+|||++.++.+||+|||+++.......     ...++..|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus       160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            999999999999999999999987654321     1223567999999999999999999999999999998 8999977


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .+  ..+....+..+. ++..+  ...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       240 ~~--~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         240 IP--VEELFKLLKEGH-RMDKP--ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             CC--HHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            65  444555554443 22222  2345678899999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.7e-39  Score=312.57  Aligned_cols=260  Identities=25%  Similarity=0.406  Sum_probs=214.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.+.  |..||+|.++.... ........+.+|++++++++|+||+++++.+...+..+++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            57899999999999999999986  78999998875332 2334466789999999999999999999999999889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++......      ....+...+..++.+++.||+|||+.|  ++||||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~  152 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQ------KRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGL  152 (267)
T ss_pred             EecCCCCCHHHHHHHhccc------CCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEeccce
Confidence            9999999999998643211      112356788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.............+..+.. +..+. 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-  230 (267)
T cd08224         153 GRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDY-PPLPA-  230 (267)
T ss_pred             eeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCC-CCCCh-
Confidence            98765332   23457899999999998889999999999999999999999997665444445455554432 22332 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ...+..+.++|.+||..+|++||++.+|++.|.++.
T Consensus       231 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         231 DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            234567889999999999999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=5.8e-40  Score=335.72  Aligned_cols=256  Identities=22%  Similarity=0.349  Sum_probs=206.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .+.+..++|++.+.||+|+||.||+|.++  +..||+|++.+... ........+.+|+.+++.++||||+++++.+.+.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHh-hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            45667789999999999999999999986  67899999864322 1223445688999999999999999999999998


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...++|++++.||+|.+++....           .+...+..++.||+.||+|||+++  |+||||||+|||++.++.+|
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ik  182 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSNYD-----------VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLK  182 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEE
Confidence            88999999999999999985321           234667788999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc----cccccCCcccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSDGE----MALTGTFVYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~----~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||++.......    ....||+.|+|||++...    .++.++|||||||++|||++|..||...+  .......+.
T Consensus       183 L~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~  260 (371)
T cd05622         183 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIM  260 (371)
T ss_pred             EEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence            99999998765332    245689999999998754    37899999999999999999999998765  444555555


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASV--RPSFSSITCS  460 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~~  460 (472)
                      .......+|........+.++|..|+..++.+  ||+++++++.
T Consensus       261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         261 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             cCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            54333344444456677888999999844433  7899888864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.2e-40  Score=329.07  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=197.7

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHH---HhcCCCceeEEEEEEEcCCCceE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL---SRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il---~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      |++.+.||+|+||.||+|.++  |..||||++++... ......+.+.+|++++   ..++||||+++++++...+..|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEE
Confidence            578999999999999999986  67899999976432 1223445577777665   45689999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++.+++|..++...           ..++..+..++.||+.||+|||++|  ++||||||+|||++.++.+||+|||
T Consensus        80 v~E~~~~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg  146 (324)
T cd05589          80 VMEYAAGGDLMMHIHTD-----------VFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFG  146 (324)
T ss_pred             EEcCCCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCccc
Confidence            99999999998887431           1346788899999999999999999  9999999999999999999999999


Q ss_pred             cceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++.....   ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+..  ..|.
T Consensus       147 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~~~--~~p~  222 (324)
T cd05589         147 LCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD--EEEVFDSIVNDEV--RYPR  222 (324)
T ss_pred             CCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCC--CCCC
Confidence            9875432   2234568999999999999999999999999999999999999998765  4555555555432  2222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                        ..+..+.++|.+||..||.+||     ++.++++
T Consensus       223 --~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         223 --FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              2456788899999999999999     5666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.4e-39  Score=313.34  Aligned_cols=245  Identities=22%  Similarity=0.398  Sum_probs=200.9

Q ss_pred             ceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          201 EKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      ++||+|+||.||+|.++    +..+|+|+++.+.  ......+.|.+|+.+++.++||||+++++++. .+..+++++++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~   77 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN--NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA   77 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC--CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence            36899999999999763    5689999986542  23455677999999999999999999999875 45667899999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .+++|.+++....          ..+...+..++.|++.||+|||++|  ++||||||.|||++.++.+||+|||++...
T Consensus        78 ~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~  145 (257)
T cd05116          78 ELGPLNKFLQKNK----------HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKAL  145 (257)
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCcccccc
Confidence            8999999985422          1246778899999999999999999  999999999999999999999999999876


Q ss_pred             CCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          357 SDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       357 ~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      .....      ...++..|+|||.+....++.++|+|||||++|||++ |..||...+  ...+...+..+. ++..|. 
T Consensus       146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~i~~~~-~~~~~~-  221 (257)
T cd05116         146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMK--GNEVTQMIESGE-RMECPQ-  221 (257)
T ss_pred             CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCCC-CCCCCC-
Confidence            53321      1223578999999988889999999999999999998 999997655  455666666554 333333 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                       ..+.++.++|..||..||++||++.+|...|+++.
T Consensus       222 -~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~  256 (257)
T cd05116         222 -RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY  256 (257)
T ss_pred             -CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence             35567889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.6e-39  Score=318.12  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=212.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ...+|.+.+.||+|+||.||+|.+.       +..+++|.+...    .......+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc----cHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            4567899999999999999999753       245889987542    33445668899999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccc------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRR------KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      .+..++|++++.+++|.+++...+....      ........++..++.++.+++.||+|||+++  ++||||||+|||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~  156 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLV  156 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEE
Confidence            9999999999999999999976442110      0011123467889999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      +.++.++|+|||++.......     ....++..|+|||.+.+..++.++||||||+++|+|+| |..||....  ....
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~--~~~~  234 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS--NTEV  234 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHH
Confidence            999999999999997654332     12335788999999999999999999999999999999 999997655  3444


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ...+..+.. +..+  ...+..+.+++.+||..+|++||++.++++.|+++...
T Consensus       235 ~~~~~~~~~-~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         235 IECITQGRV-LERP--RVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HHHHhCCCC-CCCC--ccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            444544432 2222  23456788999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.3e-39  Score=320.48  Aligned_cols=250  Identities=22%  Similarity=0.292  Sum_probs=190.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc---CCCceeEEEEEEEc---
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---RHRFVLQLMGACLE---  265 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~g~~~~---  265 (472)
                      ++|++.+.||+|+||.||+|.+.   +..||||.++....  .+.....+.+|+.+++.+   +||||++++++|..   
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~   78 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG--EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   78 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC--CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccC
Confidence            36889999999999999999873   56899999875432  222233466777777766   69999999999863   


Q ss_pred             --CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          266 --PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       266 --~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                        ....+++++++ +++|.+++.....        ...++..+..++.|++.||+|||++|  |+||||||+|||++.++
T Consensus        79 ~~~~~~~lv~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~  147 (290)
T cd07862          79 DRETKLTLVFEHV-DQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSG  147 (290)
T ss_pred             CCCCcEEEEEccC-CCCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCC
Confidence              23345555555 6799999864321        12346788899999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          344 HVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      .+||+|||++......  .....|++.|+|||.+.+..++.++|||||||++|||++|..||.+.+  ..+....+.+..
T Consensus       148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~--~~~~~~~i~~~~  225 (290)
T cd07862         148 QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVI  225 (290)
T ss_pred             CEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC--HHHHHHHHHHHh
Confidence            9999999999876543  233458999999999988899999999999999999999999998765  223333332211


Q ss_pred             CCC---C-----------C---C-----CC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 LRP---A-----------L---P-----EE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ~~~---~-----------l---~-----~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+   .           +   +     .. +..+..+.+++.+||..||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         226 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             CCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000   0           0   0     00 123456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8e-40  Score=328.13  Aligned_cols=240  Identities=24%  Similarity=0.350  Sum_probs=198.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +|++.+.||+|+||.||+|.++  +..||||++.++.. ........+..|..++..+ +||+|+++++++...+..++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEE
Confidence            5889999999999999999986  56899999976533 2233445677888888877 589999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.+|+|..++...+.          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~E~~~~g~L~~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~  147 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGR----------FKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             EcCCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCC
Confidence            999999999998864322          245778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.....   ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+  ...+...+..+..  .+|. 
T Consensus       148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~--~~~~~~~i~~~~~--~~p~-  222 (323)
T cd05616         148 CKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNV--AYPK-  222 (323)
T ss_pred             ceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCC--CCCC-
Confidence            986432   2234568999999999999999999999999999999999999997765  5556666666543  2232 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                       ....++.+++.+||..+|++|+++
T Consensus       223 -~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         223 -SMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -cCCHHHHHHHHHHcccCHHhcCCC
Confidence             244578889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.1e-39  Score=316.15  Aligned_cols=258  Identities=27%  Similarity=0.432  Sum_probs=206.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      +..++|.+.+.||+|+||.||+|.+++       ..||+|.+...   ........|.+|+.+++.++|+||+++++++.
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES---CSEQDESDFLMEALIMSKFNHQNIVRLIGVSF   79 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            345679999999999999999998854       56899977543   23344566899999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-  343 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-  343 (472)
                      +.+..+++++++.|++|.+++........   .....++..++.++.||+.||+|||+++  ++||||||+|||++.++ 
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~  154 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPE---RPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGP  154 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCC
Confidence            99899999999999999999976542211   1123467888999999999999999999  99999999999998655 


Q ss_pred             --cEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 039082          344 --HVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       344 --~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~  415 (472)
                        .+||+|||+++.......     ....+..|+|||.+.+..++.++|||||||++|+|++ |..||...+  ...+..
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~--~~~~~~  232 (277)
T cd05036         155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT--NQEVME  232 (277)
T ss_pred             CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHH
Confidence              699999999987643221     1123567999999998899999999999999999997 999997765  333444


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .+.... +...+  ...+..+.+++.+||..+|++||++.+|++.|.
T Consensus       233 ~~~~~~-~~~~~--~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 FVTGGG-RLDPP--KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            443332 22222  234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=2.1e-39  Score=322.07  Aligned_cols=268  Identities=26%  Similarity=0.399  Sum_probs=210.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      +..++|++.+.||+|+||.||+|.++  +.  .+|+|.++..   ........|.+|+.++.++ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~   80 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   80 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc---CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence            34568999999999999999999875  43  4677766432   2344556788999999999 899999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      +..+++++++.+++|.+++...+.....      .......++..++.++.|++.||+|||++|  ++||||||+|||++
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~  158 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG  158 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEec
Confidence            9999999999999999999754422110      111234567889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 039082          341 DAKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i  417 (472)
                      .++.+||+|||++.......  ....++..|+|||.+.+..++.++|||||||++|+|+| |..||...+  ..+....+
T Consensus       159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~  236 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL  236 (303)
T ss_pred             CCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--hHHHHHHH
Confidence            99999999999986433211  12224677999999988889999999999999999998 999997665  33333333


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ..+. +...+  ...+..+.+++.+||..+|++||++.+++..|..+...-.
T Consensus       237 ~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         237 PQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             hcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence            3321 22222  2244578899999999999999999999999988766543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-39  Score=320.27  Aligned_cols=264  Identities=25%  Similarity=0.404  Sum_probs=205.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECC----------------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRG----------------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF  255 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g----------------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn  255 (472)
                      ++..+|++.++||+|+||.||++.+.+                ..||||.++++.   .......|.+|++++++++|||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~ei~~l~~l~h~~   78 (295)
T cd05097           2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV---TKTARNDFLKEIKIMSRLKNPN   78 (295)
T ss_pred             CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhCCCCC
Confidence            455789999999999999999987642                248999887542   3445567999999999999999


Q ss_pred             eeEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccc--ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCC
Q 039082          256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQR--RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLK  333 (472)
Q Consensus       256 Iv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLk  333 (472)
                      |+++++++...+..++++|++.+++|.+++.......  ......+..++..++.++.+++.||+|||+++  ++|||||
T Consensus        79 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlk  156 (295)
T cd05097          79 IIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLA  156 (295)
T ss_pred             cCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccC
Confidence            9999999999999999999999999999996533111  01111223457788899999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCCC
Q 039082          334 PSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT--GNHPYIEK  406 (472)
Q Consensus       334 p~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt--G~~Pf~~~  406 (472)
                      |+|||+++++.+||+|||++........     ...++..|+|||.+.+..++.++|||||||++|+|++  |..||...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999999986543321     1234678999999998889999999999999999998  66788665


Q ss_pred             CCCHHHHHHHHhc----CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          407 DYKPAKIAMEVGE----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       407 ~~~~~~i~~~i~~----~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .  ...+...+..    ..........+..+..+.+++.+||..+|++||++.+|++.|.
T Consensus       237 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 S--DEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             C--hHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            4  2222222211    1111111112335568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.6e-39  Score=320.41  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=210.5

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQL  259 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l  259 (472)
                      ..|.+..++|.+.+.||+|+||.||+|.+.       +..||||.++...   .....+.+.+|+.+++++ +||||+++
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~h~~iv~~  104 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA---HSSEREALMSELKIMSHLGNHENIVNL  104 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC---ChHHHHHHHHHHHHHHhccCCCCcceE
Confidence            357788889999999999999999999752       3479999886542   234456789999999999 79999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      ++++...+..+++++++.+++|.+++.....        ...++..+..++.+++.||+|||+++  ++|+||||+|||+
T Consensus       105 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~--------~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~  174 (302)
T cd05055         105 LGACTIGGPILVITEYCCYGDLLNFLRRKRE--------SFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLL  174 (302)
T ss_pred             EEEEecCCceEEEEEcCCCCcHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEE
Confidence            9999999999999999999999999964221        11357888999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      +.++.++|+|||++........     ...++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ..
T Consensus       175 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~  253 (302)
T cd05055         175 THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KF  253 (302)
T ss_pred             cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HH
Confidence            9999999999999986543221     1234678999999998899999999999999999998 999997665322 22


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ...+..+ .++..+  ...+..+.+++.+||..+|++||++.++++.|+++
T Consensus       254 ~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         254 YKLIKEG-YRMAQP--EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            2222332 222222  22345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=3.7e-39  Score=313.74  Aligned_cols=253  Identities=25%  Similarity=0.406  Sum_probs=208.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      +..+|++.+.||+|+||.||+|.++     +..+|+|.++...   .......|.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY---TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSK   78 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            4568899999999999999999874     2369999886542   3345567899999999999999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++++.+++|.+++.....         ..++..+..++.+++.||+|||+++  ++||||||+|||++.++.++|
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l  147 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHDG---------QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKV  147 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEe
Confidence            99999999999999999964321         2356778899999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCccc------cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcC
Q 039082          348 ADFGHARFLSDGEMA------LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       348 ~DFGla~~~~~~~~~------~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      +|||++.........      ..++..|+|||.+.+..++.++|+||||+++|++++ |..||.+.+  .......+..+
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~--~~~~~~~~~~~  225 (267)
T cd05066         148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS--NQDVIKAIEEG  225 (267)
T ss_pred             CCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC--HHHHHHHHhCC
Confidence            999999876543221      112567999999998889999999999999999887 999997665  34455555554


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      . +.  +.....+..+.+++.+||..+|.+||++.++++.|+++
T Consensus       226 ~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 Y-RL--PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             C-cC--CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            3 22  22233556788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3e-39  Score=319.45  Aligned_cols=264  Identities=26%  Similarity=0.403  Sum_probs=206.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC------------------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR------------------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH  253 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~------------------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H  253 (472)
                      ++.++|++.+.||+|+||.||++.+.                  +..||+|++...   ........|.+|+.+|+.++|
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~~E~~~l~~l~~   78 (296)
T cd05095           2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED---ANKNARNDFLKEIKIMSRLKD   78 (296)
T ss_pred             CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---CCHHHHHHHHHHHHHHHhCCC
Confidence            34568999999999999999998643                  235899988654   234456679999999999999


Q ss_pred             CceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc-ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC
Q 039082          254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK-ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL  332 (472)
Q Consensus       254 pnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL  332 (472)
                      |||+++++++...+..+++++++.+++|.+++......... .......++..+..++.+++.||+|||++|  ++||||
T Consensus        79 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl  156 (296)
T cd05095          79 PNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDL  156 (296)
T ss_pred             CCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccC
Confidence            99999999999999999999999999999999764322111 111223456788999999999999999999  999999


Q ss_pred             CCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc--CCCCCCC
Q 039082          333 KPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT--GNHPYIE  405 (472)
Q Consensus       333 kp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt--G~~Pf~~  405 (472)
                      ||+|||++.++.++|+|||++..+.....     ...+++.|+|||...++.++.++|||||||++|||++  |..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999999999986543221     1223678999999888889999999999999999998  7789865


Q ss_pred             CCCCHHHHHHHHh----cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVG----EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       406 ~~~~~~~i~~~i~----~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .+  ..++.....    .......++....++..+.+++..||..||++||++.+|.+.|+
T Consensus       237 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LS--DEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cC--hHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            54  222222211    11111122223345578899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6e-40  Score=328.83  Aligned_cols=235  Identities=23%  Similarity=0.330  Sum_probs=194.8

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||++.++.. ........+..|..++..+ +||||+++++++...+..++|+||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHH-hhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999986  67899999976432 1234456678898998876 79999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++.....          .+...+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||++....
T Consensus        80 ~g~L~~~i~~~~~----------l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~  147 (320)
T cd05590          80 GGDLMFHIQKSRR----------FDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  147 (320)
T ss_pred             CchHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecC
Confidence            9999998864322          245778889999999999999999  9999999999999999999999999987643


Q ss_pred             C---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 D---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+  ...+...+..+..  ..+.  ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--~~~~~~~i~~~~~--~~~~--~~~~  221 (320)
T cd05590         148 FNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEV--VYPT--WLSQ  221 (320)
T ss_pred             cCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCC--CCCC--CCCH
Confidence            2   2234568999999999999999999999999999999999999997765  5556666655432  2222  2456


Q ss_pred             HHHHHHHHhccCCCCCCCCH
Q 039082          435 ELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~  454 (472)
                      ++.++|.+||..||++||++
T Consensus       222 ~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         222 DAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             HHHHHHHHHcccCHHHCCCC
Confidence            78899999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=4.5e-39  Score=311.92  Aligned_cols=244  Identities=22%  Similarity=0.423  Sum_probs=199.5

Q ss_pred             eeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          202 KIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      .||+|+||.||+|.++    +..||+|++...   ......+.|.+|+.++++++||||+++++++. .+..++|+|++.
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~   77 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE---NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS   77 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc---cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence            4899999999999874    446999988654   23445567999999999999999999999875 456788999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|.+++.....         ..++..++.++.+++.||+|||+++  ++||||||+|||++.++.+||+|||++....
T Consensus        78 ~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  146 (257)
T cd05115          78 GGPLNKFLSGKKD---------EITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALG  146 (257)
T ss_pred             CCCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCcccccc
Confidence            9999999863221         2346788999999999999999999  9999999999999999999999999998654


Q ss_pred             CCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          358 DGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       358 ~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      ....      ...++..|+|||.+....++.++|||||||++|+|++ |..||.+..  ...+...+..+. ++..+.  
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~--  221 (257)
T cd05115         147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMK--GPEVMSFIEQGK-RLDCPA--  221 (257)
T ss_pred             CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCC--HHHHHHHHHCCC-CCCCCC--
Confidence            3321      1123578999999988889999999999999999997 999997765  445555555554 333333  


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ..+.++.++|.+||..+|++||++.+|.+.|+.+.
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence            34568889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=5.2e-39  Score=312.45  Aligned_cols=254  Identities=26%  Similarity=0.461  Sum_probs=209.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      |..++|+..+.||+|+||.||+|..+  +   ..+|+|.++...   .......+.+|+++++.++||||+++++++...
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY---TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF   78 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC---CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC
Confidence            45678899999999999999999875  2   369999886542   334456789999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..+++++++.+++|.+++.....         ..++..+..++.+++.||+|||+.+  ++||||||+||+++.++.+|
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHDG---------EFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEE
Confidence            999999999999999999864321         2346778899999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCccc------cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          347 IADFGHARFLSDGEMA------LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       347 L~DFGla~~~~~~~~~------~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      |+|||++.........      ...++.|+|||.+.+..++.++|||||||++|||++ |..||...+  .......+..
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~--~~~~~~~i~~  225 (268)
T cd05063         148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS--NHEVMKAIND  225 (268)
T ss_pred             ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhc
Confidence            9999999876532211      112457999999998889999999999999999998 999997665  4455555555


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      +. +  .+.....+.++.+++.+||..+|++||++.++++.|+++
T Consensus       226 ~~-~--~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         226 GF-R--LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CC-C--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            43 2  222234566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-39  Score=317.76  Aligned_cols=261  Identities=28%  Similarity=0.408  Sum_probs=210.6

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ++.++|++.+.||+|+||.||+|.++       +..||+|++...   ........|.+|+.+++.++||||+++++++.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~   78 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDHPNIVKLLGVCA   78 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC---cCHHHHHHHHHHHHHHHhcCCCchheEEEEEc
Confidence            45678999999999999999999874       467999988653   23345567999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhccccccc------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRK------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL  332 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL  332 (472)
                      ..+..+++++++.+++|.+++.........            .......++..++.++.+++.||+|||+++  ++||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl  156 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDL  156 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccc
Confidence            988899999999999999999753321110            011123456778899999999999999999  999999


Q ss_pred             CCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCC
Q 039082          333 KPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK  406 (472)
Q Consensus       333 kp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~  406 (472)
                      ||+|||+++++.++|+|||++.......     .....+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.
T Consensus       157 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~  236 (288)
T cd05050         157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM  236 (288)
T ss_pred             cHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987654221     12234667999999998899999999999999999998 88999766


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .  ..++...+..+... ..+  ...+..+.+++.+||..+|++||++.+|++.|+
T Consensus       237 ~--~~~~~~~~~~~~~~-~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         237 A--HEEVIYYVRDGNVL-SCP--DNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             C--HHHHHHHHhcCCCC-CCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            5  44555555555432 122  234567899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.1e-39  Score=310.36  Aligned_cols=243  Identities=28%  Similarity=0.439  Sum_probs=198.8

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccC
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      +.||+|+||.||+|.++  +..||+|.+...   ...+....|.+|+++++.++||||+++++++......++|+|++.+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   77 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQG   77 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc---CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence            46999999999999884  778999987643   2345567799999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCC
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      ++|.+++...+.         ..++..++.++.|++.||+|||+++  ++||||||+|||++.++.+||+|||++.....
T Consensus        78 ~~L~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  146 (252)
T cd05084          78 GDFLTFLRTEGP---------RLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEED  146 (252)
T ss_pred             CcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCccccc
Confidence            999999854221         2346778899999999999999999  99999999999999999999999999986553


Q ss_pred             Ccccc-----ccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchh
Q 039082          359 GEMAL-----TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ  432 (472)
Q Consensus       359 ~~~~~-----~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~  432 (472)
                      .....     ..+..|+|||.+.+..++.++||||||+++|+|++ |..||....  .......+..+. +...+  ...
T Consensus       147 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~--~~~~~~~~~~~~-~~~~~--~~~  221 (252)
T cd05084         147 GVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS--NQQTREAIEQGV-RLPCP--ELC  221 (252)
T ss_pred             ccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC--HHHHHHHHHcCC-CCCCc--ccC
Confidence            32211     12457999999998899999999999999999998 999997655  333334443332 22222  234


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          433 LRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       433 ~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +..+.+++.+||..+|++||++.++++.|.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-39  Score=319.80  Aligned_cols=244  Identities=23%  Similarity=0.315  Sum_probs=194.6

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||+|+||+||++.++  +..||+|.+...... .......+..|+.+++.++||||+++++++......++|++++.+++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLK-KRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHh-hhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            799999999999875  778999998654321 22334567889999999999999999999999888999999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE  360 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  360 (472)
                      |..++......      ....++..+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.......
T Consensus        80 L~~~~~~~~~~------~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  151 (280)
T cd05608          80 LRYHIYNVDEE------NPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ  151 (280)
T ss_pred             HHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence            99887532211      122356788899999999999999999  9999999999999999999999999998765432


Q ss_pred             ---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCchhHHH
Q 039082          361 ---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--PAKIAMEVGEGKLRPALPEEDGQLRE  435 (472)
Q Consensus       361 ---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--~~~i~~~i~~~~~~~~l~~~~~~~~~  435 (472)
                         ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||......  ...+...+..+.    .......+..
T Consensus       152 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  227 (280)
T cd05608         152 SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----VTYPDKFSPA  227 (280)
T ss_pred             ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC----CCCcccCCHH
Confidence               2346899999999999999999999999999999999999999765432  122222222221    1111335567


Q ss_pred             HHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          436 LIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       436 l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      +.+++.+||+.||++||     +++++++
T Consensus       228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         228 SKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             HHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            88999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.2e-40  Score=328.21  Aligned_cols=240  Identities=21%  Similarity=0.288  Sum_probs=197.7

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||++.++.. ........+..|++++..+ +||||+++++++...+..++|+|++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVI-LQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence            46999999999999986  56899999976432 2234456678899999876 89999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++.....          .++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~  147 (321)
T cd05591          80 GGDLMFQIQRSRK----------FDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGI  147 (321)
T ss_pred             CCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecc
Confidence            9999998864322          245678889999999999999999  9999999999999999999999999998643


Q ss_pred             CC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 DG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ..   .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+  .......+..+..  ..|.  ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~--~~~~~~~i~~~~~--~~p~--~~~~  221 (321)
T cd05591         148 LNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN--EDDLFESILHDDV--LYPV--WLSK  221 (321)
T ss_pred             cCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC--CCCC--CCCH
Confidence            22   233468999999999999899999999999999999999999998766  5556666665542  1222  2345


Q ss_pred             HHHHHHHHhccCCCCCCC-------CHHHHHH
Q 039082          435 ELIELICLSWDGDASVRP-------SFSSITC  459 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RP-------s~~~ll~  459 (472)
                      ++.++|.+||..||++||       ++.++++
T Consensus       222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            788999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-39  Score=310.70  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=203.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC-ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||.|...  +..||+|.+....... .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            46888999999999999999874  7899999987543211 12334678899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++...+.          .+......++.+++.||.|||+.|  ++||||+|+||++++++.++|+|||
T Consensus        82 v~e~~~~~~l~~~~~~~~~----------~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg  149 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGA----------LTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  149 (263)
T ss_pred             EEEECCCCcHHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecc
Confidence            9999999999999864321          235677889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          352 HARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       352 la~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      ++.......      ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+  ..............+.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~~  227 (263)
T cd06625         150 ASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPTNPQ  227 (263)
T ss_pred             cceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc--hHHHHHHHhccCCCCC
Confidence            997654321      23457889999999999889999999999999999999999997654  3333333333332333


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ++.  .....+.++|.+||..+|++||++.++++.
T Consensus       228 ~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         228 LPS--HVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCc--cCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            333  345678889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4.6e-39  Score=315.67  Aligned_cols=260  Identities=24%  Similarity=0.391  Sum_probs=208.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      +...+|.+.++||+|+||.||++...       +..+|+|.+...    .......|.+|+++++.++||||+++++++.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   77 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTVLQHQHIVRFYGVCT   77 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC----CHHHHHHHHHHHHHHhcCCCCCCceEEEEEe
Confidence            45578999999999999999999742       457999987542    3455667999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhccccccc-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRK-----ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      ..+..+++++++.+++|.+++.........     .......++..++.++.|++.||+|||+.+  ++||||||+|||+
T Consensus        78 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~  155 (280)
T cd05092          78 EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLV  155 (280)
T ss_pred             cCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEE
Confidence            988899999999999999999754421110     011123457888999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      ++++.+||+|||++........     ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||....  ....
T Consensus       156 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~  233 (280)
T cd05092         156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLS--NTEA  233 (280)
T ss_pred             cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCC--HHHH
Confidence            9999999999999986643221     1224678999999998999999999999999999998 999997655  3444


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ...+..+. ....+  ...+..+.+++.+||..+|++||++.+|++.|+
T Consensus       234 ~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         234 IECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            44454443 22222  335567889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-39  Score=325.60  Aligned_cols=239  Identities=26%  Similarity=0.395  Sum_probs=192.9

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||+++.+... .......+..|..++..+ +||||+++++++...+..++|+|++.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVL-EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999986  567999999765322 223344556677777654 89999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      |++|..++...+.          .+...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||++....
T Consensus        80 gg~L~~~~~~~~~----------~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~  147 (316)
T cd05592          80 GGDLMFHIQSSGR----------FDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENM  147 (316)
T ss_pred             CCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence            9999998864321          245678888999999999999999  9999999999999999999999999998653


Q ss_pred             CC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 DG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ..   ....+||+.|+|||.+.+..++.++|||||||++|+|++|..||.+.+  ...+...+...  .+.+|.  ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~--~~~~~~--~~~~  221 (316)
T cd05592         148 NGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED--EDELFDSILND--RPHFPR--WISK  221 (316)
T ss_pred             CCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcC--CCCCCC--CCCH
Confidence            22   234568999999999999999999999999999999999999998765  44455555443  223332  2445


Q ss_pred             HHHHHHHHhccCCCCCCCCHH-HHH
Q 039082          435 ELIELICLSWDGDASVRPSFS-SIT  458 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~-~ll  458 (472)
                      ++.++|.+||..+|++||++. +++
T Consensus       222 ~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         222 EAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            678899999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=306.49  Aligned_cols=264  Identities=22%  Similarity=0.287  Sum_probs=216.0

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      -.|+.++|.+.+.||+|+|+-||++..  .+..||+|.+...    ..+..+..++|++..++++||||+++++++..+.
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~----~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH----SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc----chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            458899999999999999999999875  4778999998654    3466677899999999999999999998776543


Q ss_pred             C-----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          268 Y-----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       268 ~-----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      .     .|+++.|+..|+|.+.+......      ....+..+.+.++.+|++||.+||+..++++||||||.|||+.++
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~k------g~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~  165 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIK------GNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDS  165 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhc------CCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCC
Confidence            3     88999999999999999653322      223457889999999999999999999999999999999999999


Q ss_pred             CcEEEeecccceecCCCc------------cccccCCcccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 039082          343 KHVRIADFGHARFLSDGE------------MALTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKD  407 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~------------~~~~gt~~y~APE~~~~~---~~s~~sDvwSlGvll~elltG~~Pf~~~~  407 (472)
                      +.++|.|||.+....-..            .....|..|+|||.+...   ..++++|||||||+||+|+.|..||...-
T Consensus       166 ~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~  245 (302)
T KOG2345|consen  166 GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY  245 (302)
T ss_pred             CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh
Confidence            999999999987654211            112358999999998754   56889999999999999999999995433


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       408 ~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .....+...+..+.  ..+|.....+..+.++|..|+..||.+||++.+|+..++++.
T Consensus       246 ~~GgSlaLAv~n~q--~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  246 QQGGSLALAVQNAQ--ISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             hcCCeEEEeeeccc--cccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            22333444455543  345666668889999999999999999999999999988763

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=5.9e-39  Score=312.48  Aligned_cols=253  Identities=25%  Similarity=0.418  Sum_probs=207.0

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      ...+|++.+.||+|+||.||+|.++  +   ..||||++...   ........|..|+.+++.++||||+++++++..+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   78 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSR   78 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCC
Confidence            3457899999999999999999875  2   35999998654   23455677999999999999999999999999988


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++++|++.+++|.+++.....         ..++..++.++.|++.||+|||++|  ++|+||||+|||++.++.+||
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl  147 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKV  147 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEE
Confidence            88999999999999999864321         2346778999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCccc-----cc---cCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          348 ADFGHARFLSDGEMA-----LT---GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       348 ~DFGla~~~~~~~~~-----~~---gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +|||++.........     ..   .+..|+|||.+.+..++.++|||||||++|||++ |..||...+  ...+...+.
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~--~~~~~~~i~  225 (269)
T cd05065         148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS--NQDVINAIE  225 (269)
T ss_pred             CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC--HHHHHHHHH
Confidence            999998765432211     11   1457999999998999999999999999999987 999997665  344555554


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ... +  .+.....+..+.+++..||..+|++||++.+|+..|+++
T Consensus       226 ~~~-~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         226 QDY-R--LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             cCC-c--CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            432 2  222234556788999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.8e-40  Score=329.18  Aligned_cols=236  Identities=27%  Similarity=0.345  Sum_probs=191.2

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHH-HHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD-TLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  |..||||++.+...... .....+..|.. +++.++||||+++++.+...+..++|++|+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKK-KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhh-hHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            46999999999999985  78899999976433222 23344555555 5678999999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+.          .+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~g~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~  147 (323)
T cd05575          80 GGELFFHLQRERS----------FPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (323)
T ss_pred             CCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccc
Confidence            9999999864321          235677888999999999999999  9999999999999999999999999987543


Q ss_pred             CC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 DG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+  .......+..+...  ++  +..+.
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~--~~--~~~~~  221 (323)
T cd05575         148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--TAEMYDNILNKPLR--LK--PNISV  221 (323)
T ss_pred             cCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--HHHHHHHHHcCCCC--CC--CCCCH
Confidence            22   233568999999999999999999999999999999999999998765  44555555554322  22  22356


Q ss_pred             HHHHHHHHhccCCCCCCCCHH
Q 039082          435 ELIELICLSWDGDASVRPSFS  455 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~  455 (472)
                      .+.++|.+||..||.+||++.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         222 SARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             HHHHHHHHHhhcCHHhCCCCC
Confidence            788899999999999999874

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-39  Score=334.44  Aligned_cols=245  Identities=28%  Similarity=0.356  Sum_probs=191.4

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +...+|++.+.||+|+||.||+|.++  +..||||....          ..+.+|+.+|+.++|||||++++++......
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~----------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~  158 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR----------GGTATEAHILRAINHPSIIQLKGTFTYNKFT  158 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh----------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence            55678999999999999999999985  67899996432          2367899999999999999999999888877


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      +++++++ +++|..++....          ..++..++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|
T Consensus       159 ~lv~e~~-~~~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~D  225 (391)
T PHA03212        159 CLILPRY-KTDLYCYLAAKR----------NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGD  225 (391)
T ss_pred             EEEEecC-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEe
Confidence            7777776 678888875422          1246778999999999999999999  99999999999999999999999


Q ss_pred             cccceecCC----CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-----CH-HHHHH----
Q 039082          350 FGHARFLSD----GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-----KP-AKIAM----  415 (472)
Q Consensus       350 FGla~~~~~----~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-----~~-~~i~~----  415 (472)
                      ||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|..||...+.     .. ..+..    
T Consensus       226 FG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~  305 (391)
T PHA03212        226 FGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR  305 (391)
T ss_pred             CCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence            999975432    12235689999999999999999999999999999999999988754321     00 00000    


Q ss_pred             ---------------------HHhcCCCCC--CCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 ---------------------EVGEGKLRP--ALPEE---DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ---------------------~i~~~~~~~--~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                           .........  ..+..   ...+.++.++|.+||..||++|||++++++
T Consensus       306 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        306 SGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                                 000000000  00100   123567889999999999999999999985

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.3e-39  Score=308.58  Aligned_cols=247  Identities=25%  Similarity=0.405  Sum_probs=206.4

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|.+.+.||+|+||.||+|.++  +..|++|.+.....  .......+.+|+.+++.++||||+++++++.+.+..++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM--NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVM   78 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC--CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEE
Confidence            5788999999999999999985  67899999865432  3445667899999999999999999999999998899999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++.....        ...+...++.++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~  148 (256)
T cd08529          79 EYAENGDLHKLLKMQRG--------RPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVA  148 (256)
T ss_pred             EeCCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccc
Confidence            99999999999965311        12346778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|++.|+|||++....++.++|+||||+++|+|++|+.||...+  .......+..+. .+.++.  
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~--  223 (256)
T cd08529         149 KLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN--QGALILKIIRGV-FPPVSQ--  223 (256)
T ss_pred             eeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCC-CCCCcc--
Confidence            8765432   23457899999999999889999999999999999999999997665  444455555543 222332  


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.+++.+||..+|++||++.+++.
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence            34567899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.9e-40  Score=329.38  Aligned_cols=241  Identities=23%  Similarity=0.315  Sum_probs=197.8

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccC
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      +.||+|+||.||++.++  |..||+|++.+... ........+.+|+.++..++||||+++++++...+..++|+||+.+
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875  77899999976533 2334456678999999999999999999999999999999999999


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      ++|..++....          ..++..+..++.||+.||+|||+ +|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~  147 (325)
T cd05594          80 GELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  147 (325)
T ss_pred             CcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecC
Confidence            99998885422          23467788899999999999997 78  9999999999999999999999999987543


Q ss_pred             CC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 DG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+..  .+|.  ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~--~~~~~~~i~~~~~--~~p~--~~~~  221 (325)
T cd05594         148 KDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEI--RFPR--TLSP  221 (325)
T ss_pred             CCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC--HHHHHHHHhcCCC--CCCC--CCCH
Confidence            22   223468999999999999999999999999999999999999997765  3444444444332  2232  2445


Q ss_pred             HHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 039082          435 ELIELICLSWDGDASVRP-----SFSSITCS  460 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RP-----s~~~ll~~  460 (472)
                      ++.++|.+||..||++|+     ++.++++.
T Consensus       222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            788899999999999996     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-39  Score=315.17  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=200.7

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +.++|++.+.||+|+||.||+|.++  +..||+|++...    .......+.+|+.+++.++||||+++++++...+..+
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~----~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLE----PGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecC----ccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            3468999999999999999999974  678999998653    2233456889999999999999999999999998899


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|++++.+++|.+++...+.          .+...+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+||
T Consensus        83 iv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~df  150 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGP----------LSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADF  150 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcC
Confidence            99999999999998853221          246778889999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc---cccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          351 GHARFLSDGE---MALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       351 Gla~~~~~~~---~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |++.......   ....|++.|+|||.+.   ...++.++|||||||++|+|++|..||....  +......+......+
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~~  228 (267)
T cd06646         151 GVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLH--PMRALFLMSKSNFQP  228 (267)
T ss_pred             ccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccc--hhhhheeeecCCCCC
Confidence            9998765322   2345789999999884   4457889999999999999999999996544  222222222222222


Q ss_pred             C-CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          425 A-LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       425 ~-l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      . .+.....+..+.++|.+||..+|++||++++|++.|
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1 111133457889999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1e-38  Score=310.97  Aligned_cols=256  Identities=24%  Similarity=0.418  Sum_probs=208.5

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEECC-----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      .++.++|.+.+.||.|+||.||+|.+.+     ..||||.....   ......+.|.+|+.+++.++||||+++++++.+
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   78 (270)
T cd05056           2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC---TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE   78 (270)
T ss_pred             eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc---CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC
Confidence            3567789999999999999999998742     36899987643   224556679999999999999999999998865


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       +..+++++++.+++|.+++.....         ..++..++.++.+++.||+|||+.+  ++||||||+|||++.++.+
T Consensus        79 -~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~  146 (270)
T cd05056          79 -NPVWIVMELAPLGELRSYLQVNKY---------SLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCV  146 (270)
T ss_pred             -CCcEEEEEcCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCe
Confidence             556789999999999999964321         1346788899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcC
Q 039082          346 RIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       346 kL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ||+|||++........    ...++..|+|||.+....++.++||||||+++|+|++ |..||...+  .......+..+
T Consensus       147 ~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~  224 (270)
T cd05056         147 KLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK--NNDVIGRIENG  224 (270)
T ss_pred             EEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHcC
Confidence            9999999987654321    1223567999999988889999999999999999986 999997766  33344444444


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      . +...+  ...+..+.+++.+||..+|++||++.++++.|+++..
T Consensus       225 ~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         225 E-RLPMP--PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             C-cCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            3 22222  3345678899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.7e-39  Score=325.22  Aligned_cols=240  Identities=24%  Similarity=0.346  Sum_probs=197.7

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||++++... ........+.+|+.++..+ +||||+++++++...+..++|++++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVI-LQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999986  56899999976532 1234456678899999888 79999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+.          .++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~~L~~~~~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  147 (318)
T cd05570          80 GGDLMFHIQRSGR----------FDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGI  147 (318)
T ss_pred             CCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecC
Confidence            9999988864321          346778889999999999999999  9999999999999999999999999997532


Q ss_pred             C---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 D---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      .   .....+|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+..  ..+.  ..+.
T Consensus       148 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--~~~~~~~i~~~~~--~~~~--~~~~  221 (318)
T cd05570         148 LGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--EDELFQSILEDEV--RYPR--WLSK  221 (318)
T ss_pred             cCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCC--CCCC--cCCH
Confidence            2   2233468999999999999999999999999999999999999997665  4455555554432  2222  2456


Q ss_pred             HHHHHHHHhccCCCCCCCCH-----HHHHH
Q 039082          435 ELIELICLSWDGDASVRPSF-----SSITC  459 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~-----~~ll~  459 (472)
                      .+.++|.+||..||++||++     .++++
T Consensus       222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            78899999999999999999     77664

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=7.6e-39  Score=314.19  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=198.2

Q ss_pred             eeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--C
Q 039082          197 IDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--Y  268 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--~  268 (472)
                      |++.+.||+|+||.||++.++      +..||+|+++...   .......|.+|+.+|+.++||||+++++++...+  .
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC---GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            388999999999999987642      5679999986542   2234566889999999999999999999887643  4


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++....           .++..++.++.+++.||+|||+++  ++||||||+|||++.++.+||+
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~-----------l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~  149 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK-----------LNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIG  149 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC-----------CCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEe
Confidence            678888999999999985321           357888999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH---------
Q 039082          349 DFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI---------  413 (472)
Q Consensus       349 DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i---------  413 (472)
                      |||++........      ...++..|+|||.+....++.++||||||+++|+|+||..||..........         
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05080         150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT  229 (283)
T ss_pred             ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccc
Confidence            9999987654322      1234677999999988889999999999999999999999986533111100         


Q ss_pred             ---HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          414 ---AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       414 ---~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                         ...........  +.....+..+.+++..||..+|++||++++|++.|+++.
T Consensus       230 ~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         230 VVRLIELLERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhhhhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence               01111111111  222345678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=7.9e-40  Score=328.47  Aligned_cols=239  Identities=24%  Similarity=0.299  Sum_probs=190.2

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHH-HHHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV-DTLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~-~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||+|++.+........ ...+..|. .+++.++||||+++++++...+..++|+|++.
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~-~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKE-EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhH-HHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999986  5679999997543222222 23344444 45678899999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+.          ........++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~~~L~~~~~~~~~----------~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~  147 (325)
T cd05602          80 GGELFYHLQRERC----------FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENI  147 (325)
T ss_pred             CCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccc
Confidence            9999999864321          234567778999999999999999  9999999999999999999999999997543


Q ss_pred             C---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 D---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+...  ++  +..+.
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~--~~--~~~~~  221 (325)
T cd05602         148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNKPLQ--LK--PNITN  221 (325)
T ss_pred             cCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCC--HHHHHHHHHhCCcC--CC--CCCCH
Confidence            2   2234568999999999999999999999999999999999999997665  44444555443321  11  23456


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHH
Q 039082          435 ELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      .+.++|.+||..+|.+||++.+.+
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         222 SARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             HHHHHHHHHcccCHHHCCCCCCCH
Confidence            788899999999999999887433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=325.03  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=199.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++..+  +..||||++.+... ........|.+|+.++..++||||+++++++.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEM-LKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHH-hhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEE
Confidence            47999999999999999999986  67899999865321 1233456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.|++|.+++.....         ..+...+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~e~~~g~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~  148 (331)
T cd05597          80 MDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGS  148 (331)
T ss_pred             EecCCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCc
Confidence            999999999999964321         1245678888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCcc----ccccCCcccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          353 ARFLSDGEM----ALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       353 a~~~~~~~~----~~~gt~~y~APE~~~~-----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      +........    ...||+.|+|||++..     ..++.++|||||||++|+|++|+.||.+.+  .......+......
T Consensus       149 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--~~~~~~~i~~~~~~  226 (331)
T cd05597         149 CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKEH  226 (331)
T ss_pred             eeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCc
Confidence            977653322    2458999999999863     457889999999999999999999997655  33444444443322


Q ss_pred             CCCCCC-chhHHHHHHHHHHhccCCCC--CCCCHHHHHHH
Q 039082          424 PALPEE-DGQLRELIELICLSWDGDAS--VRPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~-~~~~~~l~~li~~cl~~dP~--~RPs~~~ll~~  460 (472)
                      ..++.. ...+..+.++|.+|+..+++  .||++.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            233332 23456778888887755433  37899888764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=325.74  Aligned_cols=250  Identities=25%  Similarity=0.361  Sum_probs=219.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~  270 (472)
                      ...|++.+.||+|.||.||+++.+  |..+|+|++.+..... ......+.+|+.+|+.+. |||||.++++|.+.+..+
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-KEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-cccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            357899999999999999999986  7789999998765533 335567889999999998 999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC----CCcEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD----AKHVR  346 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~----~~~vk  346 (472)
                      +|+|.+.||.|.+.+...          . .+...+..++.+++.|+.|||+.|  |+||||||+|+|+..    ++.+|
T Consensus       113 lvmEL~~GGeLfd~i~~~----------~-~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----------H-YSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEEEecCCchHHHHHHHc----------c-CCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEE
Confidence            999999999999999654          1 346778899999999999999999  999999999999963    35799


Q ss_pred             EeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      ++|||++.....+  ....+||+.|+|||++....|+..+||||+|+++|.|++|..||.+.+  .......+..+.+..
T Consensus       180 ~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~--~~~~~~~i~~~~~~f  257 (382)
T KOG0032|consen  180 LIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGET--EFEIFLAILRGDFDF  257 (382)
T ss_pred             EeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCC--hhHHHHHHHcCCCCC
Confidence            9999999988873  345679999999999999999999999999999999999999998887  555667888888765


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.....+.++|..++..||.+|+++.++++
T Consensus       258 ~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  258 TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            55555777888999999999999999999999886

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-39  Score=309.42  Aligned_cols=244  Identities=24%  Similarity=0.426  Sum_probs=199.7

Q ss_pred             ceeeccCceEEEEEEEC--C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          201 EKIGQGTTANIYRAIWR--G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      ++||+|+||.||+|.+.  +   ..||+|.+..+..   ......+.+|+.+++.++|||||++++++. .+..++++++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI---AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            47999999999999874  2   5799999876532   245567899999999999999999999875 4556788899


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +.+++|.+++....          ..++..+..++.|++.||+|||..+  ++|+||||+|||++.++.+||+|||+++.
T Consensus        77 ~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~  144 (257)
T cd05060          77 APLGPLLKYLKKRR----------EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRA  144 (257)
T ss_pred             CCCCcHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccce
Confidence            89999999996533          1246788999999999999999999  99999999999999999999999999987


Q ss_pred             cCCCccc------cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          356 LSDGEMA------LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       356 ~~~~~~~------~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      .......      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||...+  ...+...+..+. +..  .
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~--~~~~~~~~~~~~-~~~--~  219 (257)
T cd05060         145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK--GAEVIAMLESGE-RLP--R  219 (257)
T ss_pred             eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC--HHHHHHHHHcCC-cCC--C
Confidence            6543321      113467999999998899999999999999999998 999997665  444555555443 222  2


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ....+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            2345567889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=348.56  Aligned_cols=268  Identities=27%  Similarity=0.395  Sum_probs=223.8

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ  258 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~  258 (472)
                      .|++++++..+.+.||+|.||.||+|..+         ...||||.++...   .....+.+..|+++|+.+ .|||||.
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~---~~~~~~~~~~El~~m~~~g~H~niv~  366 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA---SSSEKKDLMSELNVLKELGKHPNIVN  366 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc---CcHHHHHHHHHHHHHHHhcCCcchhh
Confidence            89999999999999999999999999753         2369999987653   336677899999999999 6999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccC----C--CCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM----V--PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL  332 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~----~--~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL  332 (472)
                      ++|.|....+.++++||+..|+|.+||+...........    .  ...+....+.+++|||.||+||++.+  +|||||
T Consensus       367 llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDL  444 (609)
T KOG0200|consen  367 LLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDL  444 (609)
T ss_pred             heeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhh
Confidence            999999999999999999999999999876611111111    1  12567889999999999999999999  999999


Q ss_pred             CCCcEEEcCCCcEEEeecccceecCCCcccc-c-----cCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          333 KPSNIFLDDAKHVRIADFGHARFLSDGEMAL-T-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       333 kp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~-----gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      .++||||..+..+||+|||+|+......... .     -+..|||||.+....|+.++|||||||+|||++| |..||.+
T Consensus       445 AaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  445 AARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             hhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999999999999999999655432221 2     2567999999999999999999999999999999 9999988


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ... ..++...+.+|+ ++..|..  +..+++++|..||+.+|++||+|.++.+.|....
T Consensus       525 ~~~-~~~l~~~l~~G~-r~~~P~~--c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  525 IPP-TEELLEFLKEGN-RMEQPEH--CSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCc-HHHHHHHHhcCC-CCCCCCC--CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            442 344555677776 6666654  5678889999999999999999999999999854

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-39  Score=316.09  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=193.1

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||+|+||.||++..+  |..||+|++....... ......+..|+++++.++||||+++++++......++++|++.|++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK-KSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhc-chhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            799999999999875  7899999986543321 2223445679999999999999999999999889999999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE  360 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  360 (472)
                      |.+++......        ...+..+..++.|++.||+|||+.|  ++||||||+|||++.++.++|+|||++.......
T Consensus        80 L~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~  149 (277)
T cd05607          80 LKYHIYNVGER--------GLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK  149 (277)
T ss_pred             HHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc
Confidence            99888543211        1246778888999999999999999  9999999999999999999999999998765432


Q ss_pred             --cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCchhHHHH
Q 039082          361 --MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--PAKIAMEVGEGKLRPALPEEDGQLREL  436 (472)
Q Consensus       361 --~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--~~~i~~~i~~~~~~~~l~~~~~~~~~l  436 (472)
                        ....|+..|+|||++.+..++.++|||||||++|+|++|..||......  ...+..........  .+ ......++
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~-~~~~~~~~  226 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVK--FE-HQNFTEES  226 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccc--cc-cccCCHHH
Confidence              2346899999999999888999999999999999999999999764321  12222222222211  11 12345678


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHH
Q 039082          437 IELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       437 ~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+++.+||..||++||++.++++.
T Consensus       227 ~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         227 KDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             HHHHHHHhccCHhhCCCCccchhh
Confidence            899999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.4e-39  Score=325.70  Aligned_cols=236  Identities=21%  Similarity=0.328  Sum_probs=191.5

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||+++++.. ........+.+|+.++..+ +||||+++++++.+.+..++|+||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~-~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELV-NDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence            46999999999999986  67899999986543 2334456688999999998 79999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+.          .+...+..++.|++.||+|||++|  ++||||||+|||++.++.+||+|||++....
T Consensus        80 ~g~L~~~~~~~~~----------l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~  147 (329)
T cd05588          80 GGDLMFHMQRQRK----------LPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI  147 (329)
T ss_pred             CCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccc
Confidence            9999988854321          346788899999999999999999  9999999999999999999999999987532


Q ss_pred             ---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-------CHHHHHHHHhcCCCCCCCC
Q 039082          358 ---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-------KPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       358 ---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-------~~~~i~~~i~~~~~~~~l~  427 (472)
                         ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....       ........+..+.  ..+|
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p  225 (329)
T cd05588         148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--IRIP  225 (329)
T ss_pred             cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--CCCC
Confidence               222345689999999999999999999999999999999999999963211       1122333333332  2233


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCC
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPS  453 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs  453 (472)
                      .  .....+.++|.+||..||.+||+
T Consensus       226 ~--~~~~~~~~li~~~L~~dP~~R~~  249 (329)
T cd05588         226 R--SLSVKASSVLKGFLNKDPKERLG  249 (329)
T ss_pred             C--CCCHHHHHHHHHHhccCHHHcCC
Confidence            2  24456888999999999999997

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=311.13  Aligned_cols=255  Identities=25%  Similarity=0.448  Sum_probs=209.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--C----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--G----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +...+|++.+.||+|+||.||+|.++  |    ..||+|.+..+.   .......+.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET---SPKANKEILDEAYVMASVDHPHVVRLLGICLS   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            44578999999999999999999874  2    258999886542   24455678899999999999999999999887


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       ...+++++++.+++|.+++.....         ..++..++.++.|++.||+|||+.+  ++||||||+|||++.++.+
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~  148 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRNHKD---------NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHV  148 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeE
Confidence             677889999999999999864322         1346788999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCccc-----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGEMA-----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~~-----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++........     ..++..|+|||.+....++.++|+||||+++||+++ |..||....  ...+...+..
T Consensus       149 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~  226 (279)
T cd05057         149 KITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP--AVEIPDLLEK  226 (279)
T ss_pred             EECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhC
Confidence            99999999876533221     113568999999988889999999999999999999 999997665  4556666665


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +. ....+  ......+.+++.+||..+|++||++.++++.|+++..
T Consensus       227 ~~-~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         227 GE-RLPQP--PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CC-CCCCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            43 22222  2344578899999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.9e-39  Score=323.35  Aligned_cols=239  Identities=25%  Similarity=0.363  Sum_probs=193.9

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  |..||||+++++... .......+..|..++..+ +||||+++++++.+.+..++|+|++.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL-IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence            47999999999999986  678999999764321 123345567788888765 89999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+.          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~g~L~~~i~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05620          80 GGDLMFHIQDKGR----------FDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENV  147 (316)
T ss_pred             CCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecc
Confidence            9999998864321          246778889999999999999999  9999999999999999999999999987542


Q ss_pred             ---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 ---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                         .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+.  +.++.  ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~--~~~~~~~~~~~~--~~~~~--~~~~  221 (316)
T cd05620         148 FGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD--EDELFESIRVDT--PHYPR--WITK  221 (316)
T ss_pred             cCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC--CCCCC--CCCH
Confidence               22234568999999999999999999999999999999999999997665  444555444432  22332  2445


Q ss_pred             HHHHHHHHhccCCCCCCCCHH-HHH
Q 039082          435 ELIELICLSWDGDASVRPSFS-SIT  458 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~-~ll  458 (472)
                      ++.++|.+||..||++||++. +++
T Consensus       222 ~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         222 ESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             HHHHHHHHHccCCHHHcCCChHHHH
Confidence            788899999999999999974 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.6e-38  Score=307.67  Aligned_cols=247  Identities=29%  Similarity=0.466  Sum_probs=196.0

Q ss_pred             ceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc-CCCceEEEE
Q 039082          201 EKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE-PPYRGWLVT  274 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~-~~~~~~vve  274 (472)
                      +.||+|+||.||+|.+.     +..||||.+...   ........+.+|+.+++.++||||+++++++.. +...+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI---TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc---CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            46899999999999863     246999987532   233456778899999999999999999998765 445678888


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++.....         ...+..+..++.+++.||+|||+.+  ++||||||+|||+++++.+||+|||+++
T Consensus        78 ~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~  146 (262)
T cd05058          78 YMKHGDLRNFIRSETH---------NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLAR  146 (262)
T ss_pred             cCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccc
Confidence            8889999999964221         1235667888999999999999999  9999999999999999999999999998


Q ss_pred             ecCCCc-------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          355 FLSDGE-------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       355 ~~~~~~-------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ......       ....++..|+|||.+.+..++.++|||||||++|||++ |..||...+  .......+..+. .+..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~  223 (262)
T cd05058         147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD--SFDITVYLLQGR-RLLQ  223 (262)
T ss_pred             cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHhcCC-CCCC
Confidence            654321       12235778999999988899999999999999999999 566776544  444555555543 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +  ...+..+.+++..||..+|++||++.+|++.|+++..
T Consensus       224 ~--~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         224 P--EYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             C--CcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            2  2235678899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.3e-39  Score=322.14  Aligned_cols=239  Identities=24%  Similarity=0.363  Sum_probs=194.1

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||++++.... .+.....+..|..++..+ +||||+++++++.+.+..++|++|+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence            46999999999999986  568999999765321 123345567788888764 99999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +|+|..++.....          .++..+..++.|++.||+|||+++  ++||||||+|||++.++.+||+|||++....
T Consensus        80 ~g~L~~~l~~~~~----------~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  147 (316)
T cd05619          80 GGDLMFHIQSCHK----------FDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENM  147 (316)
T ss_pred             CCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECC
Confidence            9999999864321          246778889999999999999999  9999999999999999999999999997643


Q ss_pred             C---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 D---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+.  +..|.  ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~i~~~~--~~~~~--~~~~  221 (316)
T cd05619         148 LGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDN--PCYPR--WLTR  221 (316)
T ss_pred             CCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC--CCCCc--cCCH
Confidence            2   2234568999999999999899999999999999999999999997765  444555554432  22332  2345


Q ss_pred             HHHHHHHHhccCCCCCCCCHH-HHH
Q 039082          435 ELIELICLSWDGDASVRPSFS-SIT  458 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~-~ll  458 (472)
                      ++.+++.+||..+|++||++. ++.
T Consensus       222 ~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         222 EAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             HHHHHHHHHhccCHhhcCCChHHHH
Confidence            678899999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.5e-39  Score=337.71  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=189.9

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC------CceeEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH------RFVLQLMGAC  263 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H------pnIv~l~g~~  263 (472)
                      +...+|++.++||+|+||.||+|.+.  +..||||+++..     ......+..|+.+++.++|      .+++++++++
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-----PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-----hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            34578999999999999999999885  678999998642     1222335567777776654      4689999998


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~  342 (472)
                      ..+...+++++++.|++|.+++...+.          .++..+..++.||+.||+|||+ .|  ||||||||+|||++.+
T Consensus       201 ~~~~~~~~iv~~~~g~~l~~~l~~~~~----------l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~  268 (467)
T PTZ00284        201 QNETGHMCIVMPKYGPCLLDWIMKHGP----------FSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETS  268 (467)
T ss_pred             EcCCceEEEEEeccCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecC
Confidence            877666666667779999998864321          3467788999999999999998 48  9999999999999876


Q ss_pred             C----------------cEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 039082          343 K----------------HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK  406 (472)
Q Consensus       343 ~----------------~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~  406 (472)
                      +                .+||+|||++...........||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.
T Consensus       269 ~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        269 DTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             CcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            5                499999999876655556678999999999999999999999999999999999999999765


Q ss_pred             CCCHHHHHHHHhc--C-----------------------CCCCCCCC-------------CchhHHHHHHHHHHhccCCC
Q 039082          407 DYKPAKIAMEVGE--G-----------------------KLRPALPE-------------EDGQLRELIELICLSWDGDA  448 (472)
Q Consensus       407 ~~~~~~i~~~i~~--~-----------------------~~~~~l~~-------------~~~~~~~l~~li~~cl~~dP  448 (472)
                      +.  .+....+..  |                       .+++....             .......+.+||.+||..||
T Consensus       349 ~~--~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP  426 (467)
T PTZ00284        349 DN--LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR  426 (467)
T ss_pred             Ch--HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence            52  111111110  0                       00000000             00112456799999999999


Q ss_pred             CCCCCHHHHHH
Q 039082          449 SVRPSFSSITC  459 (472)
Q Consensus       449 ~~RPs~~~ll~  459 (472)
                      ++|||++++++
T Consensus       427 ~~R~ta~e~L~  437 (467)
T PTZ00284        427 QKRLNARQMTT  437 (467)
T ss_pred             hhCCCHHHHhc
Confidence            99999999986

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-38  Score=307.28  Aligned_cols=247  Identities=26%  Similarity=0.367  Sum_probs=205.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||.|+||.||++.++  +..||+|.++...   .....+.+.+|+.+++.++||||+++++.+...+..++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK---SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVM   77 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc---chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            5789999999999999999886  6789999986432   2344567889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++.....        ...+....+.++.+++.||.|||++|  ++|+||||+||+++.++.++|+|||++
T Consensus        78 e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~  147 (255)
T cd08219          78 EYCDGGDLMQKIKLQRG--------KLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSA  147 (255)
T ss_pred             eeCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcc
Confidence            99999999998854221        11245778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|++.|+|||++.+..++.++|+||||+++|+|++|..||...+  .......+..+... .++.  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~~--  222 (255)
T cd08219         148 RLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--WKNLILKVCQGSYK-PLPS--  222 (255)
T ss_pred             eeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--HHHHHHHHhcCCCC-CCCc--
Confidence            8765432   23457899999999998889999999999999999999999997665  44455555555433 2332  


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .....+.+++.+||..+|++||++.+|+..
T Consensus       223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            234568889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-38  Score=314.15  Aligned_cols=249  Identities=26%  Similarity=0.339  Sum_probs=199.5

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |+..+.||+|+||+||+|.+.  +..||+|.+.+.... .......+.+|+.+|+.++|+||+.+++.+...+..+++++
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIK-KRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhh-hhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            677899999999999999985  678999998664332 22334557889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|..++...+.        ...++..+..++.|++.||.|||+++  |+||||||+||++++++.++|+|||++.
T Consensus        81 ~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~  150 (285)
T cd05632          81 IMNGGDLKFHIYNMGN--------PGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAV  150 (285)
T ss_pred             eccCccHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcce
Confidence            9999999988854321        12357888999999999999999999  9999999999999999999999999997


Q ss_pred             ecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHhcCCCCCCCCCCc
Q 039082          355 FLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       355 ~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--~~i~~~i~~~~~~~~l~~~~  430 (472)
                      ......  ....|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+.....  ..+...+..+.  ...+  .
T Consensus       151 ~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~--~  226 (285)
T cd05632         151 KIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE--EVYS--A  226 (285)
T ss_pred             ecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc--cccC--c
Confidence            664322  23468999999999998899999999999999999999999997654211  11222222221  1111  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCC-----HHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPS-----FSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~~  460 (472)
                      .....+.+++..||..+|++||+     +.+++..
T Consensus       227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         227 KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            34456788999999999999999     6677653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6e-40  Score=330.05  Aligned_cols=250  Identities=27%  Similarity=0.368  Sum_probs=217.2

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC-ce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY-RG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~-~~  270 (472)
                      .++|+.++.+|+|+||.+++.+.+  +..|++|.+.-...  .+.......+|+.++++++|||||.+++.|.+++. .+
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~--t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKL--TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEecccc--CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            367899999999999999999886  56899999976654  33444467899999999999999999999999988 88


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +||+|+.||+|.+.+.....        ...+.+.+..++.|++.|+.|||+++  |+|||||+.|||++.++.|||+||
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~--------~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDf  150 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKG--------VLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDF  150 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhh--------ccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecch
Confidence            99999999999999965441        23356788999999999999999998  999999999999999999999999


Q ss_pred             ccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          351 GHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       351 Gla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      |+|+.+....   .+..||+.|++||++.+.+|..|+|||||||++|||++=+++|.+.+  .......+..+.+. ++|
T Consensus       151 GlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~--m~~Li~ki~~~~~~-Plp  227 (426)
T KOG0589|consen  151 GLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN--MSELILKINRGLYS-PLP  227 (426)
T ss_pred             hhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc--hHHHHHHHhhccCC-CCC
Confidence            9999988654   45679999999999999999999999999999999999999998887  56677777777632 233


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                        ..+..++..+|..|+..+|..||++.+|+..
T Consensus       228 --~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  228 --SMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence              4567788899999999999999999999976

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.2e-39  Score=327.21  Aligned_cols=237  Identities=27%  Similarity=0.350  Sum_probs=191.6

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHH-HHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD-TLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  |..||||++.+.... .......+..|.. +++.++||||+++++++...+..++|++|+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVL-NRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence            46999999999999885  789999999754322 2233344556655 4677899999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++.....          .+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~  147 (325)
T cd05604          80 GGELFFHLQRERS----------FPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGI  147 (325)
T ss_pred             CCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCC
Confidence            9999988854321          246778889999999999999999  9999999999999999999999999987543


Q ss_pred             ---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 ---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                         .......|++.|+|||++.+..++.++|||||||++|+|++|..||...+  ...+...+..+...  ++  +....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~--~~~~~~~~~~~~~~--~~--~~~~~  221 (325)
T cd05604         148 AQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD--VAEMYDNILHKPLV--LR--PGASL  221 (325)
T ss_pred             CCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC--HHHHHHHHHcCCcc--CC--CCCCH
Confidence               22234568999999999999999999999999999999999999997765  44455555554321  11  23445


Q ss_pred             HHHHHHHHhccCCCCCCCCHHH
Q 039082          435 ELIELICLSWDGDASVRPSFSS  456 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~~  456 (472)
                      .+.++|.+|+..+|.+||++.+
T Consensus       222 ~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         222 TAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             HHHHHHHHHhccCHHhcCCCCC
Confidence            6788999999999999998753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.1e-38  Score=349.44  Aligned_cols=266  Identities=25%  Similarity=0.294  Sum_probs=207.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.++||+|+||.||+|.+.  |..||||++..+.. ..+.....|.+|+.+++.++||||+++++++.+.+..+++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            57999999999999999999985  77899999976432 2344566799999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccc-cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRR-KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+++.|++|.+++........ ........++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEEEEecC
Confidence            999999999999965321110 0011122345677889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---------------------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH
Q 039082          352 HARFLSDG---------------------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP  410 (472)
Q Consensus       352 la~~~~~~---------------------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~  410 (472)
                      ++......                     .....||+.|+|||.+.+..++.++|||||||++|||+||..||...+.. 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            99876210                     01235899999999999999999999999999999999999999765422 


Q ss_pred             HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHH
Q 039082          411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRP-SFSSITCSLKNIQM  466 (472)
Q Consensus       411 ~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-s~~~ll~~L~~i~~  466 (472)
                       .+........ ..........+..+.+++.+||..||++|| +++++.+.|+.+..
T Consensus       238 -ki~~~~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        238 -KISYRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             -hhhhhhhccC-hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence             1211111110 111111134556788999999999999995 67778888877654

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-38  Score=308.73  Aligned_cols=255  Identities=27%  Similarity=0.396  Sum_probs=200.4

Q ss_pred             ceeeccCceEEEEEEECC--e--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEe
Q 039082          201 EKIGQGTTANIYRAIWRG--L--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g--~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      +.||+|+||.||+|.+++  .  .+|+|.++..   ........+.+|+.++.++ +||||+++++++...+..++++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~   77 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY   77 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc---CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEe
Confidence            368999999999999853  2  4788877642   2334556788999999999 899999999999999889999999


Q ss_pred             ccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          276 LLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      +.+++|.+++.........      .......++..+..++.+++.||+|||+++  ++||||||+|||+++++.+||+|
T Consensus        78 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~d  155 (270)
T cd05047          78 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIAD  155 (270)
T ss_pred             CCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEECC
Confidence            9999999999754321100      011123457888999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ||++.......  .....+..|+|||.+....++.++||||||+++|||++ |..||.+.+  .......+..+. +...
T Consensus       156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~--~~~~~~~~~~~~-~~~~  232 (270)
T cd05047         156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQGY-RLEK  232 (270)
T ss_pred             CCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC--HHHHHHHHhCCC-CCCC
Confidence            99986433211  11223567999999988889999999999999999997 999997665  333444443332 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      +  ...+.++.+++.+||..+|.+||++.+++..|+.+.
T Consensus       233 ~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         233 P--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             C--CcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            2  234457889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-38  Score=309.42  Aligned_cols=248  Identities=23%  Similarity=0.318  Sum_probs=191.1

Q ss_pred             ceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          201 EKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      ++||+|+||.||+|...    ...+|+|.+...   ........|.+|+.+++.++||||+++++.+......++++|++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS---ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc---CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            46899999999999753    346888876543   23445567889999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .+++|.+++.......     ....++.....++.|++.||+|||+++  |+||||||+|||+++++.+||+|||++...
T Consensus        78 ~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  150 (269)
T cd05042          78 PLGDLKNYLRSNRGMV-----AQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQ  150 (269)
T ss_pred             CCCcHHHHHHhccccc-----cccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEecccccccc
Confidence            9999999996543211     112235667889999999999999999  999999999999999999999999998754


Q ss_pred             CCCc-----cccccCCcccccccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH-HHhcCCC
Q 039082          357 SDGE-----MALTGTFVYMAPEVIQC-------EPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM-EVGEGKL  422 (472)
Q Consensus       357 ~~~~-----~~~~gt~~y~APE~~~~-------~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~-~i~~~~~  422 (472)
                      ....     ....+++.|+|||++..       ..++.++|||||||++|||++ |..||....  ...... .+..+..
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~~~  228 (269)
T cd05042         151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS--DEQVLKQVVREQDI  228 (269)
T ss_pred             ccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCC--HHHHHHHHhhccCc
Confidence            3221     12235678999998743       356889999999999999999 888997654  222333 3333332


Q ss_pred             CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          423 RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       423 ~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ....+.. ...+..+.+++..|| .||++||++++|++.|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         229 KLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            2222221 345566777888999 5999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-39  Score=311.04  Aligned_cols=249  Identities=32%  Similarity=0.472  Sum_probs=198.6

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |++.+.||+|+||.||++.+.  +..||+|++.....  .........+|+.+++.++||||+++++++......+++++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~   78 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEI--EEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVME   78 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTH--HHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccc--cccccchhhhhhhcccccccccccccccccccccccccccc
Confidence            788999999999999999997  55799999976522  22223344669999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++.....          .++..+..++.|++.||++||+++  ++|+||||+|||++.++.++|+|||.+.
T Consensus        79 ~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~  146 (260)
T PF00069_consen   79 YCPGGSLQDYLQKNKP----------LSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSV  146 (260)
T ss_dssp             EETTEBHHHHHHHHSS----------BBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred             cccccccccccccccc----------cccccccccccccccccccccccc--cccccccccccccccccccccccccccc
Confidence            9999999999972221          247889999999999999999999  9999999999999999999999999998


Q ss_pred             ecC---CCccccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHhcCCCCCCCCCC
Q 039082          355 FLS---DGEMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-KPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       355 ~~~---~~~~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      ...   .......++..|+|||++. +..++.++||||||+++|+|++|..||..... +....................
T Consensus       147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (260)
T PF00069_consen  147 KLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQS  226 (260)
T ss_dssp             ESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccccc
Confidence            632   2233456799999999998 88899999999999999999999999987621 122222222221111111111


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......+.++|.+||+.||++||++.++++
T Consensus       227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  227 REKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             chhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            222478999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-40  Score=336.63  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             eEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC--ceEEE
Q 039082          198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY--RGWLV  273 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~--~~~vv  273 (472)
                      ++..+||+|+|-+||+|.+.  |..||=-.++.+.+.......+.|..|+.+|+.|+|||||++|.++.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            56789999999999999986  555554333333344566777889999999999999999999999988766  66788


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEEEeeccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVRIADFGH  352 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vkL~DFGl  352 (472)
                      |.+..|+|..|+.+++...          ++.+..|++||++||.|||++.|||||||||.+||+|+.+ |.|||+|+|+
T Consensus       123 EL~TSGtLr~Y~kk~~~vn----------~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGL  192 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVN----------IKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGL  192 (632)
T ss_pred             ecccCCcHHHHHHHhccCC----------HHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhH
Confidence            9999999999998766432          5678899999999999999999999999999999999865 9999999999


Q ss_pred             ceecCCCccc-cccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          353 ARFLSDGEMA-LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       353 a~~~~~~~~~-~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      |..+...... ..|||.|||||++. ..|++.+||||||+++.||+|+..||..-. .+..++..+..|..+..+..-  
T Consensus       193 Atl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-n~AQIYKKV~SGiKP~sl~kV--  268 (632)
T KOG0584|consen  193 ATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-NPAQIYKKVTSGIKPAALSKV--  268 (632)
T ss_pred             HHHhhccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-CHHHHHHHHHcCCCHHHhhcc--
Confidence            9998865544 57999999999998 779999999999999999999999997755 378899999999755444433  


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+++.+||.+|+.. .++|||+.+|+.
T Consensus       269 ~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence            234677888899999 999999999985

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2e-38  Score=306.06  Aligned_cols=248  Identities=28%  Similarity=0.479  Sum_probs=204.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      +..+|++.+.||+|+||.||+|.+. +..+|+|.+.....     ....|.+|+++++.++||||+++++++......++
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            4568999999999999999999886 77899998865422     22458899999999999999999999999889999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++.....         ..++..++.++.+++.||+|||+.+  ++|+||||+||+++.++.++|+|||
T Consensus        77 v~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g  145 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQRG---------KFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFG  145 (256)
T ss_pred             EEEcCCCCcHHHHHHhCcc---------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCc
Confidence            9999999999999864321         1246778889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          352 HARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       352 la~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ++........    ...++..|+|||.+.+..++.++||||||+++|+|++ |..||....  .......+..+. +...
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~  222 (256)
T cd05112         146 MTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS--NSEVVETINAGF-RLYK  222 (256)
T ss_pred             ceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC--HHHHHHHHhCCC-CCCC
Confidence            9986643321    1224678999999998899999999999999999998 999997655  444555555443 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      +.  ..+..+.+++.+||..+|++||++.++++.|
T Consensus       223 ~~--~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         223 PR--LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CC--CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            22  2346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-39  Score=326.58  Aligned_cols=237  Identities=26%  Similarity=0.340  Sum_probs=195.4

Q ss_pred             eceeeccCceEEEEEEE-----CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          200 QEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~-----~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      ++.||+|+||.||++..     .|..||+|++.....  .......+.+|+++|+.++||||+++++++...+..++|++
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL--KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh--hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            36799999999999875     367899999975432  22234457789999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++....          ..+...+..++.||+.||+|||+++  |+||||||+|||++.++.+||+|||++.
T Consensus        79 ~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  146 (318)
T cd05582          79 FLRGGDLFTRLSKEV----------MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSK  146 (318)
T ss_pred             CCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCc
Confidence            999999999985422          2346788999999999999999999  9999999999999999999999999998


Q ss_pred             ecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          355 FLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       355 ~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      .....   .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+  .......+.....  .+|.  .
T Consensus       147 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~--~~~~~~~i~~~~~--~~p~--~  220 (318)
T cd05582         147 ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--RKETMTMILKAKL--GMPQ--F  220 (318)
T ss_pred             ccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC--HHHHHHHHHcCCC--CCCC--C
Confidence            66433   234568999999999998889999999999999999999999997765  4455555555432  2232  2


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSS  456 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~  456 (472)
                      ....+.++|.+||..||++||++.+
T Consensus       221 ~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         221 LSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            3456888999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.1e-39  Score=324.32  Aligned_cols=252  Identities=20%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++.++  +..||+|++.+... ........+.+|+.++..++|+||+++++++.+.+..++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEM-LKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            47999999999999999999986  56899999865321 1233445688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.||+|.+++.....         ..+...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~Ey~~gg~L~~~l~~~~~---------~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~  148 (331)
T cd05624          80 MDYYVGGDLLTLLSKFED---------RLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGS  148 (331)
T ss_pred             EeCCCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccc
Confidence            999999999999965321         1235667888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc----cccccCCcccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          353 ARFLSDGE----MALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       353 a~~~~~~~----~~~~gt~~y~APE~~~~-----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      +.......    ....|++.|+|||++.+     ..++.++|||||||++|+|++|+.||...+  .......+.....+
T Consensus       149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~  226 (331)
T cd05624         149 CLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHEER  226 (331)
T ss_pred             eeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC--HHHHHHHHHcCCCc
Confidence            98765432    23468999999999875     467899999999999999999999997665  34445555544333


Q ss_pred             CCCCCC-chhHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 039082          424 PALPEE-DGQLRELIELICLSWDGDASV--RPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~-~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~~  460 (472)
                      ..+|.. ...+..+.+++.+|+..++.+  |++++++++.
T Consensus       227 ~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            444443 334567888999999866544  4678777653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.3e-39  Score=325.95  Aligned_cols=237  Identities=21%  Similarity=0.329  Sum_probs=190.5

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||+|++++.... .......+.+|+.++..+ +||||+++++++...+..++|+||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhc-chhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence            46999999999999986  678999999865432 334456678899998877 89999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++.....          .+...+..++.|++.||+|||+++  |+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~~~L~~~~~~~~~----------l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~  147 (329)
T cd05618          80 GGDLMFHMQRQRK----------LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  147 (329)
T ss_pred             CCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCcccccc
Confidence            9999988854321          246778889999999999999999  9999999999999999999999999997542


Q ss_pred             C---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC------CC-HHHHHHHHhcCCCCCCCC
Q 039082          358 D---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD------YK-PAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       358 ~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~------~~-~~~i~~~i~~~~~~~~l~  427 (472)
                      .   ......||+.|+|||++.+..++.++|||||||++|+|++|..||....      .. ...+...+..+.  ..+|
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p  225 (329)
T cd05618         148 RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIP  225 (329)
T ss_pred             CCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCC
Confidence            2   2234568999999999999999999999999999999999999995311      11 112222333332  2333


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                      .  .....+.++|.+||..||++||++
T Consensus       226 ~--~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         226 R--SLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             C--CCCHHHHHHHHHHhcCCHHHcCCC
Confidence            3  244567889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.1e-38  Score=311.10  Aligned_cols=253  Identities=24%  Similarity=0.413  Sum_probs=198.2

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-  266 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-  266 (472)
                      ..+|++.+.||+|+||.||+|.++      +..||||.+...    .......|.+|+.+++.++||||+++++++... 
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   78 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS----TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   78 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCC
Confidence            457899999999999999999753      668999988643    345567789999999999999999999987643 


Q ss_pred             -CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          267 -PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       267 -~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       ...+++++++.+++|.+++.....         ..++..+..++.+++.||+|||++|  ++||||||+|||+++++.+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~---------~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~  147 (284)
T cd05081          79 RRNLRLVMEYLPYGSLRDYLQKHRE---------RLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRV  147 (284)
T ss_pred             CCceEEEEEecCCCCHHHHHHhcCc---------CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeE
Confidence             356788888989999999864321         1346778899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCccc------cccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH---------
Q 039082          346 RIADFGHARFLSDGEMA------LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP---------  410 (472)
Q Consensus       346 kL~DFGla~~~~~~~~~------~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~---------  410 (472)
                      ||+|||++.........      ..++..|+|||.+.+..++.++||||||+++|||++|..|+.......         
T Consensus       148 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~  227 (284)
T cd05081         148 KIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ  227 (284)
T ss_pred             EECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccc
Confidence            99999999876543221      123456999999998889999999999999999999877764332100         


Q ss_pred             -----HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          411 -----AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       411 -----~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                           ......+..+. +  ++.....+..+.+++.+||..+|++|||+.+|++.|+.+
T Consensus       228 ~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         228 GQMIVYHLIELLKNNG-R--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             cccchHHHHHHHhcCC-c--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                 00111111111 1  122233556789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.1e-38  Score=308.73  Aligned_cols=249  Identities=22%  Similarity=0.283  Sum_probs=191.5

Q ss_pred             ceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          201 EKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      +.||+|+||.||+|.+.    +..+|+|.++...   .......|.+|+.+++.++||||+++++.+.+....++|+||+
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA---SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            46899999999999864    3469999886542   2334456889999999999999999999999988899999999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .+++|.+++.......     ....++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        78 ~~g~L~~~l~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~  150 (269)
T cd05087          78 PLGDLKGYLRSCRKAE-----LMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNK  150 (269)
T ss_pred             CCCcHHHHHHHhhhcc-----cccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccc
Confidence            9999999996532211     112345667788999999999999999  999999999999999999999999999754


Q ss_pred             CCCc-----cccccCCcccccccccCC-------CCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHH-HHHhcCCC
Q 039082          357 SDGE-----MALTGTFVYMAPEVIQCE-------PYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIA-MEVGEGKL  422 (472)
Q Consensus       357 ~~~~-----~~~~gt~~y~APE~~~~~-------~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~-~~i~~~~~  422 (472)
                      ....     ....++..|+|||++...       .++.++||||||+++|||++ |..||.....  .... ..+.....
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~~  228 (269)
T cd05087         151 YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSD--EQVLTYTVREQQL  228 (269)
T ss_pred             cCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCCh--HHHHHHHhhcccC
Confidence            4322     123467889999998642       35789999999999999997 9999976552  2222 22222222


Q ss_pred             CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          423 RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       423 ~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +...+.. ......+.+++..|| .+|++|||+++|...|.
T Consensus       229 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         229 KLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222221 234556788888999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=313.13  Aligned_cols=256  Identities=28%  Similarity=0.365  Sum_probs=197.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .|.++ ..|..++.||.|+||.|+.|.++  |..||||.+....  ......+.-.+|+++|+.++|+||+.+++++..+
T Consensus        17 ~~~i~-~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~   93 (359)
T KOG0660|consen   17 LFEIP-RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPP   93 (359)
T ss_pred             EEecc-ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccc
Confidence            34443 45555899999999999999986  7899999886322  2344556678999999999999999999998762


Q ss_pred             ----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          267 ----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       267 ----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                          -.-.++++++++.+|...++.....          +-.....+++|+++||.|+|+.|  |+||||||.|+|++.+
T Consensus        94 ~~~~f~DvYiV~elMetDL~~iik~~~~L----------~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~  161 (359)
T KOG0660|consen   94 SRDKFNDVYLVFELMETDLHQIIKSQQDL----------TDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNAD  161 (359)
T ss_pred             cccccceeEEehhHHhhHHHHHHHcCccc----------cHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccC
Confidence                2233566666699999999754422          24567788899999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCC----Cc-cccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-------
Q 039082          343 KHVRIADFGHARFLSD----GE-MALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-------  409 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~----~~-~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-------  409 (472)
                      ..+||+|||+|+....    +. +..+.|.+|.|||++. ...|+.+.||||.||++.||++|+.-|++.+.-       
T Consensus       162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~  241 (359)
T KOG0660|consen  162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL  241 (359)
T ss_pred             CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence            9999999999998853    22 3344699999999865 578999999999999999999999999887631       


Q ss_pred             ------HHHHHHHH---------hcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          410 ------PAKIAMEV---------GEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       410 ------~~~i~~~i---------~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                            ..+....+         ..-...+..|-.   +...+..++++.+||..||.+|+|+++.+.
T Consensus       242 ~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  242 ELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  11111111         111112222211   445567789999999999999999999875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.2e-38  Score=313.86  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|+..+.||+|+||.||++.++  +..||||.+.+.... .......+.+|+.+++.++|++|+.+++.+.+.+..++++
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhcc-chHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEE
Confidence            3678899999999999999986  678999998765332 2333456788999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +|+.+++|.+++...+..        ..+...+..++.|++.||.|||+.+  ++||||||+||+++.++.++|+|||++
T Consensus        80 e~~~g~~L~~~l~~~~~~--------~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~  149 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEA--------GFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLA  149 (285)
T ss_pred             EecCCCcHHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccce
Confidence            999999999988543221        1245778888999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......  ....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ........... ....+  .
T Consensus       150 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-~~~~~--~  226 (285)
T cd05630         150 VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-QEEYS--E  226 (285)
T ss_pred             eecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-hhhcC--c
Confidence            8765332  23468999999999998899999999999999999999999997654221 11122221111 11122  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      .....+.+++..||..||++||+     ++++++
T Consensus       227 ~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         227 KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            24456888999999999999999     788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-38  Score=305.29  Aligned_cols=251  Identities=29%  Similarity=0.449  Sum_probs=206.3

Q ss_pred             ceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          201 EKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      +.||+|+||.||+|.+.     +..||+|.+.....   ......+.+|++++..++|+||+++++++......++++++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS---EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc---hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            46999999999999886     66899999876532   22467789999999999999999999999998888899999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +.+++|.+++....... ........++..++.++.+++.||+|||+++  ++||||+|+||+++.++.+||+|||.+..
T Consensus        78 ~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~  154 (262)
T cd00192          78 MEGGDLLDYLRKSRPVF-PSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRD  154 (262)
T ss_pred             ccCCcHHHHHhhccccc-cccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEcccccccc
Confidence            99999999997542110 0011123467889999999999999999999  99999999999999999999999999987


Q ss_pred             cCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          356 LSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       356 ~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      .....     ....+++.|+|||.+....++.++||||||+++|+|++ |..||...+  ...+...+..+. +...+  
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~--  229 (262)
T cd00192         155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--NEEVLEYLRKGY-RLPKP--  229 (262)
T ss_pred             cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHcCC-CCCCC--
Confidence            76432     23346889999999988889999999999999999999 699997775  555666666543 32233  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ...+.++.+++.+||..+|++||++.++++.|+
T Consensus       230 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         230 EYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            234568899999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=7.4e-39  Score=321.34  Aligned_cols=240  Identities=23%  Similarity=0.356  Sum_probs=197.5

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +|++.+.||+|+||.||+|.++  |..||||++.++.. ........+..|+.++..+. |++|+++++++...+..++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEE
Confidence            4788999999999999999986  67899999976432 12334566788999998885 57788899999888889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.|++|..++...+.          .++..+..++.|++.||+|||++|  ++||||||+|||++.++.+||+|||+
T Consensus        80 ~Ey~~~g~L~~~i~~~~~----------l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~  147 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGK----------FKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGM  147 (323)
T ss_pred             EcCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEecccc
Confidence            999999999999864321          346788899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+..  ..|. 
T Consensus       148 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~--~~~~~~~i~~~~~--~~p~-  222 (323)
T cd05615         148 CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED--EDELFQSIMEHNV--SYPK-  222 (323)
T ss_pred             ccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCC--CCCc-
Confidence            9864322   224468999999999999999999999999999999999999997765  4555566655442  2222 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                       .....+.+++.+||..+|.+|++.
T Consensus       223 -~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         223 -SLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -cCCHHHHHHHHHHcccCHhhCCCC
Confidence             234577889999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-38  Score=312.00  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=205.9

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      .+|..+.+.|+++++||.|+||.||+|.++  +..||+|++...    .......+.+|+.+++.++||||+++++.+..
T Consensus         5 ~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (292)
T cd06644           5 RRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYMVEIEILATCNHPYIVKLLGAFYW   80 (292)
T ss_pred             hcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence            356667788999999999999999999985  678999998643    34556778899999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      +...++|++++.+++|..++.....         ..++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~  149 (292)
T cd06644          81 DGKLWIMIEFCPGGAVDAIMLELDR---------GLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDI  149 (292)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCE
Confidence            8889999999999999888753221         1246778899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          346 RIADFGHARFLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       346 kL~DFGla~~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      +|+|||++......   .....+++.|+|||.+.     ...++.++|||||||++|+|++|..||...+  .......+
T Consensus       150 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~  227 (292)
T cd06644         150 KLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKI  227 (292)
T ss_pred             EEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc--HHHHHHHH
Confidence            99999998764332   22345788999999984     3457889999999999999999999996654  33344444


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .... .+..+.....+.++.++|.+||..+|++||+++++++
T Consensus       228 ~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         228 AKSE-PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             hcCC-CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            3332 2222222345567889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.3e-39  Score=324.40  Aligned_cols=236  Identities=26%  Similarity=0.352  Sum_probs=189.6

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHH-HHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD-TLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~-il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  |..||+|++.+..... ......+.+|.. +++.++||||+++++++.+.+..++|+|++.
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILK-KKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHH-hhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence            46999999999999985  6789999987543222 223344555554 6788999999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++.....          .+......++.||+.||+|||+++  |+||||||+||||+.+|.+||+|||++....
T Consensus        80 ~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~  147 (321)
T cd05603          80 GGELFFHLQRERC----------FLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGV  147 (321)
T ss_pred             CCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCC
Confidence            9999988854221          235667788999999999999999  9999999999999999999999999987542


Q ss_pred             CC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          358 DG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       358 ~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ..   .....|++.|+|||++.+..++.++|||||||++|||++|..||...+  .......+..+..  .++  .....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~--~~~--~~~~~  221 (321)
T cd05603         148 EPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--VSQMYDNILHKPL--QLP--GGKTV  221 (321)
T ss_pred             CCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--HHHHHHHHhcCCC--CCC--CCCCH
Confidence            21   233568999999999998899999999999999999999999997765  4445555554432  222  23455


Q ss_pred             HHHHHHHHhccCCCCCCCCHH
Q 039082          435 ELIELICLSWDGDASVRPSFS  455 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~  455 (472)
                      .+.+++.+||..+|.+||++.
T Consensus       222 ~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         222 AACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             HHHHHHHHHccCCHhhcCCCC
Confidence            788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-38  Score=323.70  Aligned_cols=248  Identities=25%  Similarity=0.283  Sum_probs=190.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----  267 (472)
                      .++|++.+.||+|+||.||+|.++  |..||||++.....  .......+.+|+.+++.++||||+++++++....    
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ--NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc--chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            368999999999999999999875  77899999865432  3344566889999999999999999999987544    


Q ss_pred             --CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          268 --YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 --~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                        ..+++++++ +++|..++...            .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+
T Consensus        98 ~~~~~lv~e~~-~~~l~~~~~~~------------~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~  162 (359)
T cd07876          98 FQDVYLVMELM-DANLCQVIHME------------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  162 (359)
T ss_pred             cceeEEEEeCC-CcCHHHHHhcc------------CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCE
Confidence              245566555 56677666321            235667788999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC---
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG---  420 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~---  420 (472)
                      ||+|||+++......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..  .....+...   
T Consensus       163 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~  240 (359)
T cd07876         163 KILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI--DQWNKVIEQLGT  240 (359)
T ss_pred             EEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHhcCC
Confidence            999999998654322  2346799999999999999999999999999999999999999766421  111000000   


Q ss_pred             -----------------CCCCCCCC--------------C----chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 -----------------KLRPALPE--------------E----DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 -----------------~~~~~l~~--------------~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                       ..++..+.              .    ......+.++|.+||..||++|||+.+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                             00000000              0    1123567899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.4e-39  Score=322.92  Aligned_cols=252  Identities=20%  Similarity=0.295  Sum_probs=201.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.++||+|+||.||++.++  +..||+|++.+... ........|.+|+.++..++|+||+++++.+.+.+..++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHH-HHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEE
Confidence            47899999999999999999986  56799999864321 1223345688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||+.+|+|.+++.....         ..+...+..++.|++.||.|||+++  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~ey~~~g~L~~~l~~~~~---------~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~  148 (332)
T cd05623          80 MDYYVGGDLLTLLSKFED---------RLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGS  148 (332)
T ss_pred             EeccCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecch
Confidence            999999999999965321         1245677888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc----cccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          353 ARFLSDGE----MALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       353 a~~~~~~~----~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      +.......    ....||+.|+|||++.     ...++.++|||||||++|||++|+.||...+  .......+.....+
T Consensus       149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--~~~~~~~i~~~~~~  226 (332)
T cd05623         149 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGKIMNHKER  226 (332)
T ss_pred             heecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCcc
Confidence            97654322    2346899999999986     3468899999999999999999999998765  44455555554433


Q ss_pred             CCCCCC-chhHHHHHHHHHHhccCCCCC--CCCHHHHHHH
Q 039082          424 PALPEE-DGQLRELIELICLSWDGDASV--RPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~-~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~~  460 (472)
                      ..+|.. ...+..+.+++.+|+..++++  |++++++++.
T Consensus       227 ~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            334443 345667888888988655444  6889888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=304.71  Aligned_cols=249  Identities=24%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||.|+||.||+|.+.  +..+|+|++...    .......+.+|+.+++.++||||+++++++...+..++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l   77 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE----PGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWI   77 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcC----chhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEE
Confidence            468999999999999999999985  578999998754    22355678899999999999999999999999988999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++.....         ..+...+..++.|++.||+|||+++  ++|+||+|+||+++.++.+||+|||
T Consensus        78 ~~e~~~~~~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g  146 (262)
T cd06613          78 VMEYCGGGSLQDIYQVTRG---------PLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFG  146 (262)
T ss_pred             EEeCCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccc
Confidence            9999999999998864311         1346778889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~---~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      ++.......   ....++..|+|||.+...   .++.++|+||||+++|+|++|..||.+.+  .......+....+.+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~--~~~~~~~~~~~~~~~~  224 (262)
T cd06613         147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--PMRALFLISKSNFPPP  224 (262)
T ss_pred             cchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCc
Confidence            997665322   334578899999998776   88999999999999999999999997655  3333333333322222


Q ss_pred             C-CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 L-PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l-~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      . ......+.++.+++.+||..+|.+||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            2 222345677899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-38  Score=315.49  Aligned_cols=249  Identities=23%  Similarity=0.279  Sum_probs=194.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|.+.+.||+|+||.||+|.++  +..||+|.++....   ......+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc---CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            468999999999999999999886  66899999875422   2223457789999999999999999999998888888


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++. ++|..++...+.         ..+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        82 v~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg  149 (309)
T cd07872          82 VFEYLD-KDLKQYMDDCGN---------IMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFG  149 (309)
T ss_pred             EEeCCC-CCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccc
Confidence            887775 588888754321         2346778888999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC----
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK----  421 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~----  421 (472)
                      ++.......   ....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||.+.+..  +....+..  +.    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~--~~~~~~~~~~~~~~~~  227 (309)
T cd07872         150 LARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVE--DELHLIFRLLGTPTEE  227 (309)
T ss_pred             cceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHH
Confidence            998654322   23357899999999865 56899999999999999999999999776521  11111111  00    


Q ss_pred             ---------------CCCC-----CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 ---------------LRPA-----LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ---------------~~~~-----l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                     ....     .........++.++|.+||..||.+|||+.+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         228 TWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             HHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                           0000     0001223457789999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.7e-38  Score=314.02  Aligned_cols=258  Identities=26%  Similarity=0.459  Sum_probs=206.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +..++|+..+.||+|+||.||+|.+.  |.    .||+|.+....   .......+.+|+.+++.++||||++++|+|..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~   80 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMASMDHPHLVRLLGVCLS   80 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC---CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC
Confidence            45578899999999999999999874  33    57999886542   23344568899999999999999999999875


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      . ..+++++++.+|+|.+++.....         ..++..++.++.|++.||+|||+++  ++||||||+|||++.++.+
T Consensus        81 ~-~~~~v~e~~~~g~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~  148 (303)
T cd05110          81 P-TIQLVTQLMPHGCLLDYVHEHKD---------NIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHV  148 (303)
T ss_pred             C-CceeeehhcCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCce
Confidence            4 45688899999999999864321         1246778899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++.......     ...++..|+|||.+.+..++.++||||||+++|||++ |..||.+..  .......+..
T Consensus       149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~  226 (303)
T cd05110         149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEK  226 (303)
T ss_pred             EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHC
Confidence            9999999987653221     1234678999999999999999999999999999998 999997654  3333333433


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      +. ....+  ..++..+.+++..||..+|++||+++++++.|+++.....
T Consensus       227 ~~-~~~~~--~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~  273 (303)
T cd05110         227 GE-RLPQP--PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQ  273 (303)
T ss_pred             CC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchh
Confidence            33 22222  3345678899999999999999999999999998876543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-38  Score=312.53  Aligned_cols=246  Identities=24%  Similarity=0.366  Sum_probs=201.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ..+|++.+.||+|+||.||+|.+.  +..||+|.+.....    .....+.+|+.+++.++||||+++++.+......++
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~----~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc----chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEE
Confidence            358999999999999999999875  67899998865432    234568899999999999999999999999888999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|.+++....           .++..+..++.|++.||+|||+.|  ++||||||+|||++.++.+||+|||
T Consensus        95 v~e~~~~~~L~~~~~~~~-----------~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg  161 (296)
T cd06654          95 VMEYLAGGSLTDVVTETC-----------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFG  161 (296)
T ss_pred             eecccCCCCHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccc
Confidence            999999999999985321           246778899999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++.......   ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.  ........... .+.++.
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~~~~~~~~~~-~~~~~~  238 (296)
T cd06654         162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNG-TPELQN  238 (296)
T ss_pred             cchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HHhHHHHhcCC-CCCCCC
Confidence            987654322   234678999999999988899999999999999999999999976652  22222222221 222222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+..+.+++.+||..+|++||++.+|+.
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            2334567889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.1e-38  Score=309.59  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=198.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.+.  +..||+|++..+.   .......|.+|++++++++||||+++++.+...+..+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI---TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISIC   77 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC---ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEE
Confidence            46889999999999999999874  6789999986542   334556789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|..+..              .+......++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||+
T Consensus        78 ~e~~~~~~l~~~~~--------------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~  141 (279)
T cd06619          78 TEFMDGGSLDVYRK--------------IPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGV  141 (279)
T ss_pred             EecCCCCChHHhhc--------------CCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCc
Confidence            99999999865531              135667788999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-----HHHHHHHHhcCCCCCCC
Q 039082          353 ARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-----PAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       353 a~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-----~~~i~~~i~~~~~~~~l  426 (472)
                      +...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||......     .......+.... .+.+
T Consensus       142 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~  220 (279)
T cd06619         142 STQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPVL  220 (279)
T ss_pred             ceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCCC
Confidence            9876543 33456899999999999889999999999999999999999999653211     112222222221 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      +. .....++.+++.+||..+|++||++++++..
T Consensus       221 ~~-~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 PV-GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CC-CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            22 2244578899999999999999999998764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.3e-38  Score=301.49  Aligned_cols=243  Identities=26%  Similarity=0.414  Sum_probs=199.3

Q ss_pred             ceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCC
Q 039082          201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT  279 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~gg  279 (472)
                      +.||+|+||.||+|... +..||+|.++...   .......|.+|+.+++.++||||+++++++...+..++|+|++.++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcC---CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            46899999999999875 5689999886542   3344556889999999999999999999999999999999999999


Q ss_pred             cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCC
Q 039082          280 TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG  359 (472)
Q Consensus       280 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  359 (472)
                      +|.+++.....         ...+..++.++.+++.||.|||++|  ++||||+|+||+++.++.+||+|||++......
T Consensus        78 ~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  146 (250)
T cd05085          78 DFLSFLRKKKD---------ELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDG  146 (250)
T ss_pred             cHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceecccc
Confidence            99999853221         1246778899999999999999999  999999999999999999999999999765433


Q ss_pred             cc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          360 EM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       360 ~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ..    ...++..|+|||.+.+..++.++||||||+++|++++ |..||....  .......+..+. +...+  ...+.
T Consensus       147 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~--~~~~~  221 (250)
T cd05085         147 IYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT--NQQAREQVEKGY-RMSCP--QKCPD  221 (250)
T ss_pred             ccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHHcCC-CCCCC--CCCCH
Confidence            22    1233667999999998889999999999999999998 999997765  334444444433 22222  33556


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          435 ELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .+.+++.+||..+|++||++.++++.|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            7899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.7e-38  Score=313.88  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=200.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++.+.  +..+|+|.+..+   ........+.+|+++++.++||||+++++.|..++..+++
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   77 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE---IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISIC   77 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEE
Confidence            47899999999999999999886  678999988653   2344556788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +||+.+++|.+++...+.          .+...+..++.|++.||+|||+ .+  ++||||||+|||++.++.+||+|||
T Consensus        78 ~ey~~~~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg  145 (308)
T cd06615          78 MEHMDGGSLDQVLKKAGR----------IPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG  145 (308)
T ss_pred             eeccCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCC
Confidence            999999999999964321          2467788999999999999998 57  9999999999999999999999999


Q ss_pred             cceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC----------
Q 039082          352 HARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG----------  420 (472)
Q Consensus       352 la~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~----------  420 (472)
                      ++...... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.  ..........          
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~  223 (308)
T cd06615         146 VSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESH  223 (308)
T ss_pred             CcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch--hhHHHhhcCccccccccCCc
Confidence            98765432 3345689999999999888899999999999999999999999965441  1111111100          


Q ss_pred             -------------------------CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 -------------------------KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 -------------------------~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                               ..++.+|. .....++.+++.+||..+|++||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                     00111111 1234578899999999999999999999875

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=304.44  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=213.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .+.|++.++||+|.|+.|+++.+.  |+.+|+|+++...+...  ..+.+.+|++|-+.|+|||||++...+.++...|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~--~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR--DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc--cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            367889999999999999999875  88999999976655443  55668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CCcEEEe
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIA  348 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~~vkL~  348 (472)
                      |++.+.|++|..-+-...          ..+...+--++.||+.+|.|+|.+|  |||||+||+|+|+-.   .--+||+
T Consensus        88 vFe~m~G~dl~~eIV~R~----------~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~  155 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVARE----------FYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLA  155 (355)
T ss_pred             EEecccchHHHHHHHHHH----------HHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeec
Confidence            999999999876553210          1123334566789999999999999  999999999999953   3469999


Q ss_pred             ecccceecCCCcc--ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          349 DFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       349 DFGla~~~~~~~~--~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      |||+|..+.++..  ...|||.|+|||+++..+|+..+|||+-||+||-|+.|.+||.+.+  ...+..+|..|.+..+-
T Consensus       156 ~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~--~~rlye~I~~g~yd~~~  233 (355)
T KOG0033|consen  156 DFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYEQIKAGAYDYPS  233 (355)
T ss_pred             ccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhccccCCCC
Confidence            9999999985543  4568999999999999999999999999999999999999998876  67899999999887766


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      |..+...++..+++.+||..||.+|.|+.|.++
T Consensus       234 ~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            666777788889999999999999999998763

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-39  Score=308.18  Aligned_cols=249  Identities=23%  Similarity=0.259  Sum_probs=194.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYR  269 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~  269 (472)
                      .++|+.+.+|++|+||.||+|+++  +..||+|.++.+.-  .+--.-.-++|+++|.+.+|||||.+-.+....  +..
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke--k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE--KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc--cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            468999999999999999999997  67899999987642  222223367999999999999999998876643  345


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      |+| ++++.-+|..++...+.         .....+..-++.|+++|++|||.+.  |+|||||++|+|++..|.+||+|
T Consensus       153 y~V-Me~~EhDLksl~d~m~q---------~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaD  220 (419)
T KOG0663|consen  153 YIV-MEYVEHDLKSLMETMKQ---------PFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIAD  220 (419)
T ss_pred             eee-HHHHHhhHHHHHHhccC---------CCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecc
Confidence            444 45557899999976552         2235778888999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC---ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC--
Q 039082          350 FGHARFLSDG---EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK--  421 (472)
Q Consensus       350 FGla~~~~~~---~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~--  421 (472)
                      ||+|+.+...   .+..+-|.+|+|||.+.+ ..|+.++|+||+|||+.||+++++-|.+.+.  .+....|..  |.  
T Consensus       221 FGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE--~dQl~~If~llGtPt  298 (419)
T KOG0663|consen  221 FGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE--IDQLDKIFKLLGTPS  298 (419)
T ss_pred             cchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch--HHHHHHHHHHhCCCc
Confidence            9999999876   344557999999999875 5799999999999999999999999988763  222222111  11  


Q ss_pred             -------------------------CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 -------------------------LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 -------------------------~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                               ++..++.. .....-++++..+|..||.+|.|+++-++
T Consensus       299 e~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~-~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  299 EAIWPGYSELPAVKKMTFSEHPYNNLRKKFGAL-SLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cccCCCccccchhhccccCCCCchhhhhhcccc-ccchhHHHHHHHHhccCccccccHHHhhc
Confidence                                     01111111 02245578899999999999999998764

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-38  Score=309.02  Aligned_cols=249  Identities=22%  Similarity=0.336  Sum_probs=199.9

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +.++|++.+.||+|+||.||+|.+.  +..||+|+++..    .......+.+|+.+++.++||||+++++.+...+..+
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~----~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLE----PGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecC----chhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            3457889999999999999999885  678999998654    2233455789999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      ++++++.+++|.+++...+.          .+...+..++.|++.||.|||+.|  ++|+||||+||+++.++.++|+||
T Consensus        83 lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~df  150 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTGP----------LSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADF  150 (267)
T ss_pred             EEEeccCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcc
Confidence            99999999999999864321          246778899999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc---cccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          351 GHARFLSDGE---MALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       351 Gla~~~~~~~---~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |++.......   ....|+..|+|||.+.   ...++.++|+|||||++|+|++|..||.....  .............+
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~~  228 (267)
T cd06645         151 GVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTKSNFQP  228 (267)
T ss_pred             eeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--hhhHHhhhccCCCC
Confidence            9997665322   2346899999999974   45688999999999999999999999965542  22222222222222


Q ss_pred             -CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 -ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 -~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ........+..+.+++.+||..+|++||++++|+.
T Consensus       229 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence             11111234557888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.2e-38  Score=302.59  Aligned_cols=249  Identities=23%  Similarity=0.282  Sum_probs=207.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|+..+.||.|+||.||.+...  +..+++|.+.....  .......+.+|+.+++.++|+||+++++++.+.+..++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~   78 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL--SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEM   78 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc--chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEE
Confidence            4889999999999999988874  67899998865432  3445567889999999999999999999999998888999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++....        ....+...+..++.+++.||+|||+.+  ++|+||+|+||++++++.+||+|||++
T Consensus        79 e~~~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~  148 (256)
T cd08221          79 EYANGGTLYDKIVRQK--------GQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGIS  148 (256)
T ss_pred             EecCCCcHHHHHHhcc--------ccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcce
Confidence            9999999999986432        112356788899999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+..+...+..   .
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~~~~~~---~  223 (256)
T cd08221         149 KILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN--PLNLVVKIVQGNYTPVV---S  223 (256)
T ss_pred             EEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCc---c
Confidence            8765433   33458999999999988889999999999999999999999997655  44555566665543321   3


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ..+..+.+++.+||..+|++||++.++++.+
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            3456788899999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5e-38  Score=306.70  Aligned_cols=261  Identities=25%  Similarity=0.413  Sum_probs=209.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ++.++|++.+.||+|+||.||+|..+       ...|++|.+...   ........|.+|++++++++||||+++++++.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   78 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT---KDENLQSEFRRELDMFRKLSHKNVVRLLGLCR   78 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc---cchHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence            45578999999999999999999864       246999987542   23335677999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +.+..+++++++.+++|.+++......... ......++..+..++.|++.||+|||+.+  ++||||||+|||++.++.
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~-~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~  155 (275)
T cd05046          79 EAEPHYMILEYTDLGDLKQFLRATKSKDEK-LKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQRE  155 (275)
T ss_pred             CCCcceEEEEecCCCcHHHHHHhccccccc-ccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCc
Confidence            988899999999999999999654421111 11123457889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          345 VRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ++|+|||++.......    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||....  ...+...+..
T Consensus       156 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~--~~~~~~~~~~  233 (275)
T cd05046         156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS--DEEVLNRLQA  233 (275)
T ss_pred             EEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc--hHHHHHHHHc
Confidence            9999999987543221    12235778999999988889999999999999999999 889996654  3445555554


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +......+  ...+..+.+++.+||..+|++||++.+++..|.
T Consensus       234 ~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKLELPVP--EGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCcCCCCC--CCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            44332222  345668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.5e-38  Score=321.28  Aligned_cols=248  Identities=23%  Similarity=0.248  Sum_probs=192.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----  267 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||.+....  ........+.+|+.+++.++||||+++++++....    
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc--cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            468999999999999999999875  7789999986542  23344566889999999999999999999886543    


Q ss_pred             --CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          268 --YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 --~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                        ..+++++++ +++|..++...            .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+
T Consensus        94 ~~~~~lv~e~~-~~~l~~~~~~~------------l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~  158 (355)
T cd07874          94 FQDVYLVMELM-DANLCQVIQME------------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  158 (355)
T ss_pred             cceeEEEhhhh-cccHHHHHhhc------------CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCE
Confidence              245566655 56777766421            235667888999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh-----
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG-----  418 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~-----  418 (472)
                      ||+|||+++......  ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..  .....+.     
T Consensus       159 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~  236 (355)
T cd07874         159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI--DQWNKVIEQLGT  236 (355)
T ss_pred             EEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            999999998765432  2346899999999999999999999999999999999999999765521  1111100     


Q ss_pred             -----------------cCCC-------CCC-----CCC----CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          419 -----------------EGKL-------RPA-----LPE----EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       419 -----------------~~~~-------~~~-----l~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                       ....       ...     .+.    .......+.++|.+||..||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                             0000       000     000    01124567899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.4e-38  Score=319.96  Aligned_cols=237  Identities=21%  Similarity=0.299  Sum_probs=191.7

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|+||.||+|.++  +..||||++.++.. ........+.+|+.++..+ +||||+++++++...+..++|+|++.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELV-HDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence            47999999999999885  67899999976543 2334566788999999888 69999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+          ..++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~  147 (327)
T cd05617          80 GGDLMFHMQRQR----------KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGL  147 (327)
T ss_pred             CCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceecc
Confidence            999998885432          1346788899999999999999999  9999999999999999999999999997532


Q ss_pred             ---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC----C-HHHHHHHHhcCCCCCCCCCC
Q 039082          358 ---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY----K-PAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       358 ---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~----~-~~~i~~~i~~~~~~~~l~~~  429 (472)
                         ......+||+.|+|||.+.+..++.++|||||||++|+|++|..||.....    . ...+...+....  ..+|. 
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~-  224 (327)
T cd05617         148 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPR-  224 (327)
T ss_pred             CCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCC-
Confidence               223345689999999999999999999999999999999999999964221    1 122333333322  22333 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                       ..+..+.+++.+||..||.+|+++
T Consensus       225 -~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         225 -FLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCCHHHHHHHHHHhccCHHHcCCC
Confidence             234567889999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.8e-38  Score=304.29  Aligned_cols=244  Identities=27%  Similarity=0.443  Sum_probs=199.9

Q ss_pred             ceeeccCceEEEEEEEC---Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          201 EKIGQGTTANIYRAIWR---GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~---g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      +.||+|+||.||+|.+.   +.  .||||.+..+...   ...+.|.+|+.++++++||||+++++++.. ...++++++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS---DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH---HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            46899999999999874   22  6999999765332   566789999999999999999999999888 777888888


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +.+++|.+++.....        ...++..++.++.|++.||+|||+++  ++|+||+|+||+++.++.+||+|||++..
T Consensus        77 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~  146 (257)
T cd05040          77 APLGSLLDRLRKDAL--------GHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRA  146 (257)
T ss_pred             cCCCcHHHHHHhccc--------ccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEecccccccc
Confidence            889999999965331        12357888999999999999999999  99999999999999999999999999987


Q ss_pred             cCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          356 LSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       356 ~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      .....      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||...+  ..++...+.........+ 
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~~~~~-  223 (257)
T cd05040         147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS--GSQILKKIDKEGERLERP-  223 (257)
T ss_pred             ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhcCCcCCCC-
Confidence            65421      12346788999999998899999999999999999998 999997654  444444444322222222 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                       ...+..+.+++.+||..+|++||++.++++.|.
T Consensus       224 -~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         224 -EACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             234567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-38  Score=310.26  Aligned_cols=249  Identities=26%  Similarity=0.359  Sum_probs=205.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||.|+||.||+|.++  +..||+|++...    .......|.+|+.+++.++||||+++++++......++
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE----SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWI   79 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC----CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEE
Confidence            467899999999999999999985  678999998643    34455779999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|..++...+.         ..+...+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||
T Consensus        80 v~e~~~~~~L~~~~~~~~~---------~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g  148 (280)
T cd06611          80 LIEFCDGGALDSIMLELER---------GLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFG  148 (280)
T ss_pred             EeeccCCCcHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCc
Confidence            9999999999999864321         2346788899999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ++......   .....+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||...+  .......+..+. .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~  225 (280)
T cd06611         149 VSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN--PMRVLLKILKSE-P  225 (280)
T ss_pred             cchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCC--HHHHHHHHhcCC-C
Confidence            98765432   22345789999999975     3457789999999999999999999997665  444455555443 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      +.+......+..+.++|.+||..+|.+||++.++++.
T Consensus       226 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            2233223455678899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-39  Score=322.90  Aligned_cols=255  Identities=26%  Similarity=0.366  Sum_probs=197.3

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.+ .++|++.+.||+|+||.||+|.+.  +..||||.+.....  .......+.+|+.+|+.++||||+++++++..
T Consensus         9 ~~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07878           9 TVWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ--SLIHARRTYRELRLLKHMKHENVIGLLDVFTP   85 (343)
T ss_pred             HHhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh--hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcc
Confidence            44655 378999999999999999999875  66899999865421  22344567799999999999999999998764


Q ss_pred             CC-----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          266 PP-----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       266 ~~-----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ..     ..+++++++.+++|..++...           ..+...+..++.||+.||+|||+++  |+||||||+|||++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~  152 (343)
T cd07878          86 ATSIENFNEVYLVTNLMGADLNNIVKCQ-----------KLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVN  152 (343)
T ss_pred             cccccccCcEEEEeecCCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEEC
Confidence            32     234566666799998887421           1346778899999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          341 DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      .++.+||+|||++...........|++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.  ......+..
T Consensus       153 ~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~  230 (343)
T cd07878         153 EDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDY--IDQLKRIME  230 (343)
T ss_pred             CCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHH
Confidence            9999999999999987766666678999999999876 5689999999999999999999999976542  111111111


Q ss_pred             --CCC-------------------CCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          420 --GKL-------------------RPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       420 --~~~-------------------~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                        +..                   .+..+..      ......+.++|.+||..||++|||+.+++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         231 VVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence              000                   0001100      1123457889999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.4e-38  Score=306.69  Aligned_cols=249  Identities=28%  Similarity=0.454  Sum_probs=200.2

Q ss_pred             ceeeccCceEEEEEEECC--------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          201 EKIGQGTTANIYRAIWRG--------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g--------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.||+|+||.||+|.+++        ..+|||.+....   .......|.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA---TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYII   77 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc---chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEE
Confidence            468999999999998752        569999886532   224456788999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-----cEEE
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-----HVRI  347 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-----~vkL  347 (472)
                      ++++.+++|.+++........   .....++..++.++.+++.||+|||+.+  ++|+||+|+||+++.++     .++|
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          78 MELMEGGDLLSYLRDARVERF---GPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EeccCCCcHHHHHHHhhhccc---CCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEE
Confidence            999999999999965332110   1223457888999999999999999999  99999999999999877     8999


Q ss_pred             eecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCC
Q 039082          348 ADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       348 ~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +|||++........     ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+  .......+..+.
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~  230 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN--NQEVLQHVTAGG  230 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC--HHHHHHHHhcCC
Confidence            99999976543221     2234688999999999999999999999999999998 999997655  344444444332


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                       +...+  ...+..+.+++.+||..+|++||++.+|++.|.
T Consensus       231 -~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -RLQKP--ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -ccCCc--ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             22222  335677899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.2e-38  Score=320.20  Aligned_cols=248  Identities=25%  Similarity=0.250  Sum_probs=192.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----  267 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||++.....  .......+.+|+.+++.++||||+++++++...+    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc--CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            468999999999999999999885  67899999875432  3344566889999999999999999999876543    


Q ss_pred             --CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          268 --YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 --~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                        ..++|++++ +++|..++...            .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+
T Consensus       101 ~~~~~lv~e~~-~~~l~~~~~~~------------~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~  165 (364)
T cd07875         101 FQDVYIVMELM-DANLCQVIQME------------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  165 (364)
T ss_pred             cCeEEEEEeCC-CCCHHHHHHhc------------CCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcE
Confidence              245566655 66787777421            235667888999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC-
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL-  422 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~-  422 (472)
                      ||+|||+++......  ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.  ......+..... 
T Consensus       166 kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~  243 (364)
T cd07875         166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH--IDQWNKVIEQLGT  243 (364)
T ss_pred             EEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhcCC
Confidence            999999998765432  234689999999999999999999999999999999999999976652  222111111000 


Q ss_pred             -------------------CCCC--------------CCC----chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          423 -------------------RPAL--------------PEE----DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       423 -------------------~~~l--------------~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                         ++..              +..    ......+.++|.+||..||.+|||+.++++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             CCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                               0000              000    1123467899999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.1e-38  Score=307.62  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=199.0

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |++.+.||.|+||.||+|.++  +..+++|.+...    .......+.+|+.+++.++||||+++++++...+..+++++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e   82 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   82 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC----CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence            578899999999999999986  567899988543    34456678999999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      |+.+++|..++....         ...++..+..++.|++.||+|||+.+  ++||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~~~~l~~~~~~~~---------~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~  151 (282)
T cd06643          83 FCAGGAVDAVMLELE---------RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSA  151 (282)
T ss_pred             ecCCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccc
Confidence            999999998875321         12346788899999999999999999  9999999999999999999999999987


Q ss_pred             ecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          355 FLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       355 ~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      .....   .....++..|+|||.+.     ...++.++|||||||++|+|++|..||...+  .......+.... .+.+
T Consensus       152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~-~~~~  228 (282)
T cd06643         152 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSE-PPTL  228 (282)
T ss_pred             cccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHHHhhcC-CCCC
Confidence            65432   22345789999999984     4567889999999999999999999997654  334444443332 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+..+.++|.+||..+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222334567899999999999999999999874

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.7e-38  Score=330.33  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=186.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--  267 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--  267 (472)
                      ....+|++.+.||+|+||.||+|.+.  +..||||.+..+.        ....+|+.+|+.++|||||++++++....  
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--------QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--------chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            34578999999999999999999985  6789999885431        12347999999999999999998875421  


Q ss_pred             ------CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          268 ------YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       268 ------~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                            ..++|+|| .+++|.+++......      ....++..++.++.||+.||+|||+++  |+||||||+||||+.
T Consensus       135 ~~~~~~~l~lvmE~-~~~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~  205 (440)
T PTZ00036        135 KNEKNIFLNVVMEF-IPQTVHKYMKHYARN------NHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDP  205 (440)
T ss_pred             cCCCceEEEEEEec-CCccHHHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcC
Confidence                  13345554 567888877532211      122356778889999999999999999  999999999999996


Q ss_pred             CC-cEEEeecccceecCCCc--cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          342 AK-HVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       342 ~~-~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      ++ .+||+|||+|+.+....  ....||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+.  .+....+
T Consensus       206 ~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i  283 (440)
T PTZ00036        206 NTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRI  283 (440)
T ss_pred             CCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHH
Confidence            64 79999999998765332  34568999999999865 4689999999999999999999999977652  2222111


Q ss_pred             hc--CC------------C-CCCCCCC----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GE--GK------------L-RPALPEE----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~--~~------------~-~~~l~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..  +.            + ...+|..          ...+.++.++|.+||..||.+|||+.+++.
T Consensus       284 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        284 IQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            11  00            0 0001110          123467889999999999999999999884

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-40  Score=331.59  Aligned_cols=246  Identities=24%  Similarity=0.384  Sum_probs=211.8

Q ss_pred             CeeEeceeeccCceEEEEEEECCe--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|+++..||.|+||.||+|..+..  ..|.|++..    ..++..+.|+-|++||...+||+||++|+.|+.++.+++++
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet----kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET----KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc----cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            446789999999999999998744  468888753    35677888999999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +||.||-+...+-..+.         ..+..++..++++++.||.|||+++  |||||||+.|||++-+|.++|+|||.+
T Consensus       109 EFC~GGAVDaimlEL~r---------~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVS  177 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGR---------VLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVS  177 (1187)
T ss_pred             eecCCchHhHHHHHhcc---------ccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeeccccc
Confidence            99999999888754332         2356788899999999999999999  999999999999999999999999998


Q ss_pred             eecCC---CccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          354 RFLSD---GEMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       354 ~~~~~---~~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      .-...   ....+.|||.|||||+..     ..+|+.++|||||||+|.||.-+.+|....+  +..+...+.+.. +|.
T Consensus       178 AKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln--pMRVllKiaKSe-PPT  254 (1187)
T KOG0579|consen  178 AKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSE-PPT  254 (1187)
T ss_pred             ccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc--hHHHHHHHhhcC-CCc
Confidence            65432   234678999999999875     4579999999999999999999999986665  888998888876 455


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +-....+...+.+++.+||.+||..||++++|++
T Consensus       255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            5555678889999999999999999999999874

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.2e-38  Score=323.89  Aligned_cols=248  Identities=22%  Similarity=0.312  Sum_probs=191.4

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----C
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----Y  268 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----~  268 (472)
                      +|++.+.||+|+||.||+|.+.  |..||||.+....  .+......+.+|+.+++.++||||+++++++...+     .
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   78 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF--QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEE   78 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc--cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccce
Confidence            5788999999999999999974  7899999886432  23344567889999999999999999999988766     4


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|++++ +++|.+++....          ..+...+..++.||+.||+|||++|  ++||||||+|||++.++.+||+
T Consensus        79 ~~lv~e~~-~~~l~~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~  145 (372)
T cd07853          79 IYVVTELM-QSDLHKIIVSPQ----------PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKIC  145 (372)
T ss_pred             EEEEeecc-ccCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEec
Confidence            55555554 678888774322          2346778899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc----cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh-----
Q 039082          349 DFGHARFLSDGE----MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG-----  418 (472)
Q Consensus       349 DFGla~~~~~~~----~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~-----  418 (472)
                      |||+++......    ....+++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.+  +......+.     
T Consensus       146 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~g~  223 (372)
T cd07853         146 DFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS--PIQQLDLITDLLGT  223 (372)
T ss_pred             cccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHHcCC
Confidence            999998764322    123468899999998764 58999999999999999999999997655  222211111     


Q ss_pred             ------------------cCCCCCC-CC----CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          419 ------------------EGKLRPA-LP----EEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       419 ------------------~~~~~~~-l~----~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                        .....+. .+    .......++.++|.+||..||++|||+.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         224 PSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             CCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                              1111110 00    012235678899999999999999999998863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.7e-38  Score=301.64  Aligned_cols=247  Identities=30%  Similarity=0.514  Sum_probs=205.1

Q ss_pred             eeEeceeeccCceEEEEEEECC------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          197 IDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~g------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +++.+.||.|+||.||++.+.+      ..||+|+++...   .......+.+|+.++..++|+||+++++++.+.+..+
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   77 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA---DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLM   77 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC---ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeE
Confidence            3567899999999999999864      679999996542   2235677899999999999999999999999998999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      ++++++.+++|.+++.......        .++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.++|+||
T Consensus        78 ~i~e~~~~~~l~~~~~~~~~~~--------~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~df  147 (258)
T smart00219       78 IVMEYMEGGDLLDYLRKNRPKE--------LSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDF  147 (258)
T ss_pred             EEEeccCCCCHHHHHHhhhhcc--------CCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEccc
Confidence            9999999999999996533210        357888999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCccc----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          351 GHARFLSDGEMA----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       351 Gla~~~~~~~~~----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |++.........    ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+  ...+...+..+. ...
T Consensus       148 g~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~--~~~~~~~~~~~~-~~~  224 (258)
T smart00219      148 GLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS--NEEVLEYLKKGY-RLP  224 (258)
T ss_pred             CCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhcCC-CCC
Confidence            999877644222    226789999999988889999999999999999998 889997654  455555555554 222


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      .+  ...+.++.+++.+||..+|++|||+.++++.|
T Consensus       225 ~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KP--ENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CC--CcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            22  23566789999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.3e-38  Score=309.64  Aligned_cols=246  Identities=25%  Similarity=0.398  Sum_probs=206.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++.+.  +..||+|++.+... ........+.+|++++++++||||+++++++...+..+++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEE
Confidence            47899999999999999999985  67899999865432 1234456788999999999999999999999999989999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++...+          ..+...+..++.|++.||+|||+.|  ++|+||+|+||||+.++.+||+|||+
T Consensus        80 ~e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~  147 (290)
T cd05580          80 MEYVPGGELFSHLRKSG----------RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGF  147 (290)
T ss_pred             EecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCC
Confidence            99999999999986532          1246778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchh
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ  432 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~  432 (472)
                      +...........|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+..+.  ..++..  .
T Consensus       148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~--~~~~~~--~  221 (290)
T cd05580         148 AKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN--PIQIYEKILEGK--VRFPSF--F  221 (290)
T ss_pred             ccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCC--ccCCcc--C
Confidence            9887766666678999999999988889999999999999999999999997665  444455555443  233332  3


Q ss_pred             HHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          433 LRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       433 ~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      ...+.+++.+||..+|.+||     ++++++.
T Consensus       222 ~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         222 SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            45788899999999999998     7777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.7e-38  Score=302.93  Aligned_cols=246  Identities=26%  Similarity=0.411  Sum_probs=202.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  +..|++|.+...      .....+.+|+.+++.++||||+++++.+......++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l   75 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE------EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWI   75 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH------HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEE
Confidence            468999999999999999999986  578999988543      125679999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++...+         ...++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||
T Consensus        76 ~~e~~~~~~L~~~l~~~~---------~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg  144 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN---------KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFG  144 (256)
T ss_pred             EEecCCCCcHHHHHHhCc---------cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccc
Confidence            999999999999986432         12356888899999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++.......   ....++..|+|||.+.+..++.++||||||+++|+|++|+.||....  +......+.... .+.+..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~  221 (256)
T cd06612         145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH--PMRAIFMIPNKP-PPTLSD  221 (256)
T ss_pred             cchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--hhhhhhhhccCC-CCCCCc
Confidence            998765432   23457889999999998899999999999999999999999997654  222222222211 122222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .......+.++|.+||..+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            2234567899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.4e-38  Score=307.98  Aligned_cols=253  Identities=24%  Similarity=0.412  Sum_probs=199.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--  266 (472)
                      .-|++++.||+|+||.||++.+.      +..||+|.++..   ........+.+|+.+++.++||||+++++++...  
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc---ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            45788999999999999999752      567999998654   2344456799999999999999999999998875  


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...++++|++.|++|.+++.....         ..++..+..++.+++.||+|||++|  ++||||||+|||++.++.++
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~---------~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~  149 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKN---------KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVK  149 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEE
Confidence            456788888989999999853221         2356788999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-------------
Q 039082          347 IADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD-------------  407 (472)
Q Consensus       347 L~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~-------------  407 (472)
                      |+|||++.......      ....++..|+|||.+.+..++.++||||||+++|+|+|+..|+....             
T Consensus       150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd05079         150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ  229 (284)
T ss_pred             ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence            99999998765332      12345778999999988889999999999999999999876653211             


Q ss_pred             CCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       408 ~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .........+..+. +.  +.....+..+.+++.+||..+|++||++.++++.|+.+
T Consensus       230 ~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         230 MTVTRLVRVLEEGK-RL--PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccHHHHHHHHHcCc-cC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            01111122222222 21  22234567899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.2e-38  Score=304.63  Aligned_cols=255  Identities=26%  Similarity=0.408  Sum_probs=201.2

Q ss_pred             eeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC---
Q 039082          197 IDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY---  268 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~---  268 (472)
                      |.+.+.||+|+||.||+|.++     +..||||++..+..  .....+.+.+|+.+++.++||||+++++++...+.   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF--SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR   78 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC--ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence            567889999999999999863     56899999976532  34456778999999999999999999998865432   


Q ss_pred             ---ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          269 ---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       269 ---~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                         .+++++++.+++|..++.......    .....+......++.|++.||+|||+++  ++||||||+|||++.++.+
T Consensus        79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~  152 (273)
T cd05074          79 LPIPMVILPFMKHGDLHTFLLMSRIGE----EPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTV  152 (273)
T ss_pred             ccceEEEEecCCCCcHHHHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCE
Confidence               246677888999998875322110    0112356778999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          346 RIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      ||+|||+++......     ....+++.|++||.+....++.++||||||+++|+|++ |..||...+  .......+..
T Consensus       153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~  230 (273)
T cd05074         153 CVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVE--NSEIYNYLIK  230 (273)
T ss_pred             EECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCC--HHHHHHHHHc
Confidence            999999998664322     12234678999999998889999999999999999999 899997655  3444444444


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      +.. ...  ....+..+.+++.+||..+|++||++.+++..|+++
T Consensus       231 ~~~-~~~--~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GNR-LKQ--PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCc-CCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            431 111  133456889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.2e-37  Score=302.48  Aligned_cols=246  Identities=25%  Similarity=0.447  Sum_probs=200.2

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC-----hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN-----ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~-----~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      |.+.+.||.|+||.||+|.+.  +..||+|.+........     ....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL   81 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence            567889999999999999875  67899998865433221     22346788999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      +++++++.+++|.+++...+.          .+...+..++.+++.||+|||+++  ++||||+|+||+++.++.++|+|
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~----------l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~d  149 (267)
T cd06628          82 NIFLEYVPGGSVAALLNNYGA----------FEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISD  149 (267)
T ss_pred             EEEEEecCCCCHHHHHHhccC----------ccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEecc
Confidence            999999999999999964322          235667889999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCc---------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          350 FGHARFLSDGE---------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       350 FGla~~~~~~~---------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ||+++......         ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||.+.+  .......+...
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~  227 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT--QLQAIFKIGEN  227 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc--HHHHHHHHhcc
Confidence            99998765211         12347889999999998889999999999999999999999997654  22333333332


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      . .+.++.  ..+..+.++|.+||..+|++||++.++++
T Consensus       228 ~-~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 A-SPEIPS--NISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             C-CCcCCc--ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            2 333333  34567888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-38  Score=305.72  Aligned_cols=245  Identities=27%  Similarity=0.403  Sum_probs=204.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||.|+||.||+|.+.  +..||+|++..+.   .......+.+|+.+++.++||||+++++++.++...+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   77 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE---AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWII   77 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc---cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEE
Confidence            36888999999999999999985  6789999986542   234456688999999999999999999999999889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++...           ..++..+..++.|++.||.|||+++  ++|+||+|+||++++++.++|+|||+
T Consensus        78 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~  144 (274)
T cd06609          78 MEYCGGGSCLDLLKPG-----------KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGV  144 (274)
T ss_pred             EEeeCCCcHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccccc
Confidence            9999999999998642           2346888999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +......   .....+++.|+|||.+.+..++.++||||||+++|+|+||..||...+  +......+..+. .+.++. 
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~--~~~~~~~~~~~~-~~~~~~-  220 (274)
T cd06609         145 SGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH--PMRVLFLIPKNN-PPSLEG-  220 (274)
T ss_pred             ceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc--hHHHHHHhhhcC-CCCCcc-
Confidence            9887643   234567889999999998889999999999999999999999997654  344444444443 222222 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.+++.+||..+|++||+++++++
T Consensus       221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         221 NKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            125567889999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.3e-38  Score=304.44  Aligned_cols=239  Identities=22%  Similarity=0.347  Sum_probs=188.9

Q ss_pred             ceeeccCceEEEEEEEC--------------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          201 EKIGQGTTANIYRAIWR--------------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--------------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      +.||+|+||.||+|.+.              ...||+|++...    .......|.+|+.++..++||||+++++++...
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~   76 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS----HRDISLAFFETASMMRQVSHKHIVLLYGVCVRD   76 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh----hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            46899999999999853              235899987553    234456788999999999999999999999998


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc--
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--  344 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~--  344 (472)
                      ...+++++++.+++|..++.....         ..++..++.++.||+.||+|||+++  |+||||||+|||++.++.  
T Consensus        77 ~~~~lv~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~  145 (262)
T cd05077          77 VENIMVEEFVEFGPLDLFMHRKSD---------VLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDG  145 (262)
T ss_pred             CCCEEEEecccCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccC
Confidence            889999999999999988854221         2346778899999999999999999  999999999999987664  


Q ss_pred             -----EEEeecccceecCCCccccccCCccccccccc-CCCCCchHHHHHHHHHHHHHH-cCCCCCCCCCCCHHHHHHHH
Q 039082          345 -----VRIADFGHARFLSDGEMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEII-TGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       345 -----vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~ell-tG~~Pf~~~~~~~~~i~~~i  417 (472)
                           ++++|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.......  . ...
T Consensus       146 ~~~~~~~l~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~-~~~  221 (262)
T cd05077         146 ECGPFIKLSDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE--K-ERF  221 (262)
T ss_pred             CCCceeEeCCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH--H-HHH
Confidence                 899999998765432 2345788899999986 567899999999999999998 4899987654221  1 111


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ..+...    ...+....+.++|.+||..||++||++.+|+..|+
T Consensus       222 ~~~~~~----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 YEGQCM----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HhcCcc----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            222211    11233467889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=8.2e-38  Score=303.51  Aligned_cols=248  Identities=29%  Similarity=0.410  Sum_probs=200.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCC--CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFH--TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~--~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +|++.+.||.|+||.||+|... +..+|||.+..+...  ........+.+|+.+++.++|+||+++++++.+.+..+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4678899999999999999874 778999988654321  1233456788999999999999999999999999888999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++...+.          .+...+..++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~  148 (265)
T cd06631          81 MEFVPGGSISSILNRFGP----------LPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGC  148 (265)
T ss_pred             EecCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchh
Confidence            999999999999964321          235677888999999999999999  99999999999999999999999999


Q ss_pred             ceecCC---------CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC-CC
Q 039082          353 ARFLSD---------GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG-KL  422 (472)
Q Consensus       353 a~~~~~---------~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~-~~  422 (472)
                      +.....         ......|+..|+|||.+.+..++.++||||||+++|+|++|..||...+.  ......+... ..
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~~~~~~  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAMFYIGAHRGL  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHHHHhhhccCC
Confidence            876431         11234578899999999988899999999999999999999999976552  2222222222 11


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.++  .....++.++|.+||..+|++||++.+++.
T Consensus       227 ~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 MPRLP--DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCC--CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22222  335567889999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.3e-37  Score=298.59  Aligned_cols=247  Identities=29%  Similarity=0.394  Sum_probs=201.5

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-CceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-YRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~v  272 (472)
                      +|++.+.||+|+||.||++.++  +..||+|.+..+..  .......+.+|+.+++.++|||++++++.+...+ ..+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv   78 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA--SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIV   78 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEE
Confidence            4889999999999999999885  67899999865432  3344566889999999999999999999876544 45788


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++.....        ...++..++.++.+++.||+|||++|  ++||||+|+||+++.++.++|+|||+
T Consensus        79 ~e~~~~~~l~~~l~~~~~--------~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~  148 (257)
T cd08223          79 MGFCEGGDLYHKLKEQKG--------KLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGI  148 (257)
T ss_pred             ecccCCCcHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccc
Confidence            888889999999864211        12356888999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +......   .....+++.|+|||.+.+..++.++||||||+++++|++|+.||...+  .......+..+.. +.++  
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--~~~~~~~~~~~~~-~~~~--  223 (257)
T cd08223         149 ARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--MNSLVYRIIEGKL-PPMP--  223 (257)
T ss_pred             eEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCC-CCCc--
Confidence            9876532   223457899999999999999999999999999999999999997665  3344444545442 2222  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.+++.+||..+|++||++.++++
T Consensus       224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         224 KDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            234567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-38  Score=308.07  Aligned_cols=255  Identities=25%  Similarity=0.339  Sum_probs=198.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc-eeEEEEEEEcCCC--
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPY--  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~g~~~~~~~--  268 (472)
                      ...|+.+++||+|+||+||+|+.+  |..||+|.++-+...  +-....-.+|+.+|+.++|+| ||++++++.....  
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~--EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~   87 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE--EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHR   87 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc--cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccc
Confidence            456788899999999999999985  789999999765321  224455679999999999999 9999999998773  


Q ss_pred             ---ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          269 ---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       269 ---~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                         ..++++++...+|..|+.......      ...+...+..+++||+.||+|||+++  |+||||||.||||+.+|.+
T Consensus        88 ~~~~l~lvfe~~d~DL~~ymd~~~~~~------~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~l  159 (323)
T KOG0594|consen   88 GIGKLYLVFEFLDRDLKKYMDSLPKKP------QGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVL  159 (323)
T ss_pred             ccceEEEEEEeecccHHHHHHhccccc------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcE
Confidence               444555556999999997655321      11123678899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc---cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--
Q 039082          346 RIADFGHARFLSDGE---MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--  419 (472)
                      ||+|||+|+...-+.   ....+|.+|+|||++.+. .|+...||||+||++.||++++.-|++...  .+....+..  
T Consensus       160 KlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~l  237 (323)
T KOG0594|consen  160 KLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLL  237 (323)
T ss_pred             eeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHc
Confidence            999999999776332   344579999999998876 799999999999999999999999988762  222222211  


Q ss_pred             CC--------------CCCCCCCC----------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          420 GK--------------LRPALPEE----------DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       420 ~~--------------~~~~l~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      |.              +....+..          +.......+++.+|+..+|.+|.|++..+..
T Consensus       238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            00              11111111          1112467899999999999999999998875

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.5e-37  Score=307.89  Aligned_cols=245  Identities=24%  Similarity=0.384  Sum_probs=201.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+|++.+.||.|+||.||+|.+.  |..||+|.+....    ......+.+|+.+++.++||||+++++.+...+..++|
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK----QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc----CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence            57999999999999999999874  7899999886432    22345688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|..++...           ..++..+..++.+++.||+|||+.|  ++||||+|+||+++.++.+||+|||+
T Consensus        95 ~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~  161 (296)
T cd06655          95 MEYLAGGSLTDVVTET-----------CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGF  161 (296)
T ss_pred             EEecCCCcHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCcc
Confidence            9999999999988531           1346889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....++..|+|||.+.+..++.++|||||||++|+|++|..||...+  .......+.... .+.+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~--~~~~~~~~~~~~-~~~~~~~  238 (296)
T cd06655         162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNG-TPELQNP  238 (296)
T ss_pred             chhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcC-CcccCCc
Confidence            88665332   23457899999999998889999999999999999999999997765  222223333222 2222222


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..+|++||++.+|+.
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            334567888999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.2e-38  Score=307.64  Aligned_cols=249  Identities=24%  Similarity=0.318  Sum_probs=187.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc---CCCceeEEEEEEEcC----
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---RHRFVLQLMGACLEP----  266 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~g~~~~~----  266 (472)
                      +|++.+.||+|+||.||+|.++  +..||+|.++.....  ......+.+|+.+++.+   +||||+++++++...    
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~   78 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE--DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDR   78 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC--CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCC
Confidence            4789999999999999999986  678999998754321  11223355677777665   799999999988653    


Q ss_pred             -CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          267 -PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       267 -~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       ...+++++++ .++|.+++.....        ...+...+..++.|++.||+|||++|  ++||||||+|||++.++.+
T Consensus        79 ~~~~~lv~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~  147 (288)
T cd07863          79 ETKVTLVFEHV-DQDLRTYLDKVPP--------PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQV  147 (288)
T ss_pred             CceEEEEEccc-ccCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCE
Confidence             2245556655 5689888864321        12356788999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc----
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE----  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~----  419 (472)
                      ||+|||++.......  ....|+..|+|||++.+..++.++|||||||++|+|++|+.||.+..  .......+..    
T Consensus       148 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~--~~~~~~~~~~~~~~  225 (288)
T cd07863         148 KLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDLIGL  225 (288)
T ss_pred             EECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCC--HHHHHHHHHHHhCC
Confidence            999999998765332  23457899999999998899999999999999999999999997654  2222222111    


Q ss_pred             --------------CCCCCCCCC-----CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 --------------GKLRPALPE-----EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 --------------~~~~~~l~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                    ..+.+..+.     .+.....+.+++.+||..||++||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         226 PPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             CChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                          000000000     0234556789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-38  Score=344.04  Aligned_cols=257  Identities=23%  Similarity=0.312  Sum_probs=200.9

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-  266 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-  266 (472)
                      ..+...+|++++.||+|+||.||+|.++  +..||+|++.....  .......|..|+.+|+.++|||||+++++|... 
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l--~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL--KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            3444579999999999999999999986  56899999875432  345567789999999999999999999988654 


Q ss_pred             -CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CceeecCCCCCcEEEc
Q 039082          267 -PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK-----PKVIHRDLKPSNIFLD  340 (472)
Q Consensus       267 -~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~-----~~iiHrDLkp~NILl~  340 (472)
                       ...++||+|+.+++|..+|......      ....++..++.++.||+.||+|||+.+     .+||||||||+||||+
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~  159 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKM------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS  159 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEee
Confidence             3467888888899999999643211      112357788999999999999999843     2399999999999996


Q ss_pred             C-----------------CCcEEEeecccceecCCCc--cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcC
Q 039082          341 D-----------------AKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITG  399 (472)
Q Consensus       341 ~-----------------~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG  399 (472)
                      .                 .+.+||+|||++.......  ....||+.|+|||++.+  ..++.++|||||||+||+|+||
T Consensus       160 s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTG  239 (1021)
T PTZ00266        160 TGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSG  239 (1021)
T ss_pred             cCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHC
Confidence            4                 3459999999998765332  23468999999999854  4589999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          400 NHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       400 ~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..||...+. ...+...+..+.   .++. ...+..+.+||..||..+|.+||++.+++.
T Consensus       240 k~PF~~~~~-~~qli~~lk~~p---~lpi-~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        240 KTPFHKANN-FSQLISELKRGP---DLPI-KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCCCCcCCc-HHHHHHHHhcCC---CCCc-CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            999976542 223333333322   2221 234567889999999999999999999984

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-40  Score=310.46  Aligned_cols=243  Identities=24%  Similarity=0.327  Sum_probs=204.1

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      -.+..++|+.+++||+|.||.|-+++-+  |+.||||+++++.+. ..+....-+.|-++|+..+||++..+--.|...+
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee-ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            3466789999999999999999999886  788999999998764 4455666778999999999999999988899999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      .+|+||+|..||.|..+|.....          .+....+.+..+|+.||.|||+++  ||+||||.+|+|+|.+|++||
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~----------FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKi  309 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERV----------FSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKI  309 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhc----------ccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEe
Confidence            99999999999999988864332          223445667789999999999999  999999999999999999999


Q ss_pred             eecccceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||+++.--   +...++||||.|.|||++....|..++|||.+||++|||++|++||.+.+.  ..+..-|..+.++ 
T Consensus       310 tDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh--~kLFeLIl~ed~k-  386 (516)
T KOG0690|consen  310 TDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH--EKLFELILMEDLK-  386 (516)
T ss_pred             eecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch--hHHHHHHHhhhcc-
Confidence            9999998543   344578999999999999999999999999999999999999999988773  3344444444332 


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCC
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVR  451 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~R  451 (472)
                       +|..  ..++...++..+|.+||.+|
T Consensus       387 -FPr~--ls~eAktLLsGLL~kdP~kR  410 (516)
T KOG0690|consen  387 -FPRT--LSPEAKTLLSGLLKKDPKKR  410 (516)
T ss_pred             -CCcc--CCHHHHHHHHHHhhcChHhh
Confidence             2322  33456778889999999999

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.8e-38  Score=310.39  Aligned_cols=245  Identities=24%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+|++.+.||+|+||.||+|.+.  +..||+|.+....    ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   94 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ----QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   94 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc----cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence            68899999999999999999874  7899999986542    22345688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++....           .+...+..++.+++.||.|||+.+  ++||||||+|||++.++.++|+|||+
T Consensus        95 ~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~  161 (297)
T cd06656          95 MEYLAGGSLTDVVTETC-----------MDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF  161 (297)
T ss_pred             ecccCCCCHHHHHHhCC-----------CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCcc
Confidence            99999999999985321           246778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.  ......+..+. .+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~--~~~~~~~~~~~-~~~~~~~  238 (297)
T cd06656         162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNG-TPELQNP  238 (297)
T ss_pred             ceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--chheeeeccCC-CCCCCCc
Confidence            98765332   234578999999999988899999999999999999999999976542  11111222221 2222222


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.+++.+||..+|++||+++++++
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         239 ERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            334566788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.1e-38  Score=308.03  Aligned_cols=255  Identities=25%  Similarity=0.418  Sum_probs=203.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc--
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~--  265 (472)
                      .++|++.+.||+|+||.||+|.+.      +..||||++.....   ......|.+|+++++.++||||+++++++..  
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~---~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~   79 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE---EQHRSDFEREIEILRTLDHENIVKYKGVCEKPG   79 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc---hHHHHHHHHHHHHHHhCCCCChheEEeeeecCC
Confidence            457888999999999999999864      56899999976432   1456779999999999999999999999877  


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      ....+++++++.+++|.+++.....         ..++..+..++.+++.||+|||+++  ++|+||||+|||++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~l~~~l~~~~~---------~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~  148 (284)
T cd05038          80 GRSLRLIMEYLPSGSLRDYLQRHRD---------QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLV  148 (284)
T ss_pred             CCceEEEEecCCCCCHHHHHHhCcc---------ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCE
Confidence            4567888999989999999964331         2356778899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH---------
Q 039082          346 RIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP---------  410 (472)
Q Consensus       346 kL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~---------  410 (472)
                      +|+|||++........      ...++..|+|||.+.+..++.++||||||+++|+|++|..||.......         
T Consensus       149 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~  228 (284)
T cd05038         149 KISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQG  228 (284)
T ss_pred             EEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccc
Confidence            9999999987763321      1224567999999988889999999999999999999999986543211         


Q ss_pred             ---HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          411 ---AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       411 ---~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                         ............+  .+....++.++.+++.+||..+|++||++.+|++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         229 QMIVTRLLELLKEGER--LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccHHHHHHHHHcCCc--CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence               1111112222212  222233456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.2e-37  Score=303.68  Aligned_cols=247  Identities=20%  Similarity=0.245  Sum_probs=188.2

Q ss_pred             ceeeccCceEEEEEEEC-C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          201 EKIGQGTTANIYRAIWR-G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      +.||+|+||.||+|... +   ..+++|.+...   ........|.+|+.+++.++||||+++++.|......++++|++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN---ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC---CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            36999999999999753 2   24667766543   22344677999999999999999999999999999999999999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .+++|.+++......      ....+......++.||+.||+|||+.+  ++||||||+|||++.++.+||+|||++...
T Consensus        78 ~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~  149 (268)
T cd05086          78 ELGDLKSYLSQEQWH------RRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSR  149 (268)
T ss_pred             CCCcHHHHHHhhhcc------cccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEeccccccccc
Confidence            999999999753321      112235567788999999999999999  999999999999999999999999998643


Q ss_pred             CCC-----ccccccCCcccccccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCC-C
Q 039082          357 SDG-----EMALTGTFVYMAPEVIQC-------EPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK-L  422 (472)
Q Consensus       357 ~~~-----~~~~~gt~~y~APE~~~~-------~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~-~  422 (472)
                      ...     .....++..|+|||++..       ..++.++|||||||++|||++ |..||...+  .......+..+. .
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--~~~~~~~~~~~~~~  227 (268)
T cd05086         150 YKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--DREVLNHVIKDQQV  227 (268)
T ss_pred             CcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHhhccc
Confidence            221     223457889999999753       245789999999999999997 677886554  333333333322 1


Q ss_pred             CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          423 RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       423 ~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ....|.. ......+.+++..|| .+|++||++++|++.|
T Consensus       228 ~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         228 KLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             ccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            1111111 234567788888999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.4e-38  Score=307.89  Aligned_cols=251  Identities=23%  Similarity=0.425  Sum_probs=201.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++++.||+|+||.||++.++  |..||+|.++..   ........+.+|+.+++.++||||+++++.+...+..+++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMC   77 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc---cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEE
Confidence            47899999999999999999986  789999988643   2344556789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +|++.+++|..++.....       ....++..+..++.+++.||.|||+ .+  ++||||||+||+++.++.+||+|||
T Consensus        78 ~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg  148 (286)
T cd06622          78 MEYMDAGSLDKLYAGGVA-------TEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFG  148 (286)
T ss_pred             EeecCCCCHHHHHHhccc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCC--EeeCCCCHHHEEECCCCCEEEeecC
Confidence            999999999998864211       1123567889999999999999997 47  9999999999999999999999999


Q ss_pred             cceecCCC-ccccccCCcccccccccCC------CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-HHHHHHHhcCCCC
Q 039082          352 HARFLSDG-EMALTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVGEGKLR  423 (472)
Q Consensus       352 la~~~~~~-~~~~~gt~~y~APE~~~~~------~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-~~i~~~i~~~~~~  423 (472)
                      ++...... .....+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||....... ......+..+. .
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~  227 (286)
T cd06622         149 VSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGD-P  227 (286)
T ss_pred             CcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-C
Confidence            99766432 2334578899999998544      35889999999999999999999997654222 11122233332 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      +.++.  ....++.++|.+||..+|++||++.+++..
T Consensus       228 ~~~~~--~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 PTLPS--GYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCCc--ccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            23332  356678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-37  Score=309.05  Aligned_cols=252  Identities=21%  Similarity=0.317  Sum_probs=202.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++.++  +..||+|.+..... ........+.+|+++++.++||||+++++.+...+..+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNL-ILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhh-hhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEE
Confidence            37899999999999999999986  56899998876432 1223456788999999999999999999999998888999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.|++|.+++...+.          .++..+..++.+++.||+|||+++  ++||||||+||+++.++.+||+|||+
T Consensus        80 ~e~~~g~~L~~~l~~~~~----------~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~  147 (305)
T cd05609          80 MEYVEGGDCATLLKNIGA----------LPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGL  147 (305)
T ss_pred             EecCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCC
Confidence            999999999999964321          245677888899999999999999  99999999999999999999999999


Q ss_pred             ceecCCC------------------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 039082          353 ARFLSDG------------------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA  414 (472)
Q Consensus       353 a~~~~~~------------------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~  414 (472)
                      ++.....                  .....++..|+|||.+....++.++|+|||||++|+|++|..||.+.+  ...+.
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~--~~~~~  225 (305)
T cd05609         148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELF  225 (305)
T ss_pred             ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHH
Confidence            8742110                  011346788999999988889999999999999999999999997665  44455


Q ss_pred             HHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ..+..+....+.. ....+..+.++|.+||..+|++||++..+.+.|+
T Consensus       226 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         226 GQVISDDIEWPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             HHHHhcccCCCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            5555443221111 1245667899999999999999999665555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=298.39  Aligned_cols=243  Identities=28%  Similarity=0.463  Sum_probs=199.4

Q ss_pred             ceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCC
Q 039082          201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT  279 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~gg  279 (472)
                      ++||.|+||.||+|.++ +..||+|.+.....   ......|.+|+++++.++||||+++++++......+++++++.++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP---PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCC---HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            47999999999999886 78999998865432   245567899999999999999999999999999999999999999


Q ss_pred             cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCC
Q 039082          280 TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG  359 (472)
Q Consensus       280 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~  359 (472)
                      +|.+++.....         ..++..+..++.+++.||+|||+++  ++||||+|+|||++.++.+||+|||++......
T Consensus        78 ~l~~~l~~~~~---------~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  146 (251)
T cd05041          78 SLLTFLRKKKN---------RLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGG  146 (251)
T ss_pred             cHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence            99999864321         1246778889999999999999999  999999999999999999999999999866532


Q ss_pred             ccc-----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhH
Q 039082          360 EMA-----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL  433 (472)
Q Consensus       360 ~~~-----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~  433 (472)
                      ...     ..++..|+|||.+.+..++.++|+||||+++|+|+| |..||....  .......+..+. +...+  ...+
T Consensus       147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~--~~~~~~~~~~~~-~~~~~--~~~~  221 (251)
T cd05041         147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS--NQQTRERIESGY-RMPAP--QLCP  221 (251)
T ss_pred             cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC--HHHHHHHHhcCC-CCCCC--ccCC
Confidence            221     123567999999988889999999999999999999 899997665  333444443332 22222  3345


Q ss_pred             HHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          434 RELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       434 ~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ..+.+++.+||..+|++||++.+|++.|+
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            67899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=317.09  Aligned_cols=245  Identities=24%  Similarity=0.344  Sum_probs=210.3

Q ss_pred             CeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      =|.+.+.||+|.|++|-+|++  .|.+||||++.+...  +.-....+++|++.|+..+|||||++|.+......+|+|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl--D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL--DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc--chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            367899999999999999976  699999999987654  4556677899999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc-CCCcEEEeeccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGH  352 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~-~~~~vkL~DFGl  352 (472)
                      |.-.+|+|++|+-++....         .......++.||+.|+.|+|...  +|||||||+||.+- .-|-|||+|||+
T Consensus        97 ELGD~GDl~DyImKHe~Gl---------~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGL---------NEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             EecCCchHHHHHHhhhccc---------cHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeeccc
Confidence            9999999999997665432         24567889999999999999999  99999999998775 568999999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +..+..+.  .+.||...|-|||++.+..|+ +++||||||||||-|++|+.||...+  ..+....|++.++  .+|  
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAN--DSETLTmImDCKY--tvP--  239 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAN--DSETLTMIMDCKY--TVP--  239 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcccccc--chhhhhhhhcccc--cCc--
Confidence            98877654  467899999999999999997 68999999999999999999997765  4556666777654  233  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+..++|..||..||.+|.+.++|..
T Consensus       240 shvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  240 SHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            346678889999999999999999999874

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.6e-37  Score=302.52  Aligned_cols=245  Identities=28%  Similarity=0.411  Sum_probs=202.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|+..++||.|+||.||+|.++  +..||||++...   ........+.+|+.+++.++||||+++++.+.+....++|
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII   80 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc---ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            35778899999999999999885  678999988653   2234567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++....           .+...+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~i~~~~-----------l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~  147 (277)
T cd06640          81 MEYLGGGSALDLLRAGP-----------FDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             EecCCCCcHHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEccccc
Confidence            99999999999985321           235677888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+  +......+..+. .+.++  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~~~-~~~~~--  222 (277)
T cd06640         148 AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH--PMRVLFLIPKNN-PPTLT--  222 (277)
T ss_pred             ceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC--hHhHhhhhhcCC-CCCCc--
Confidence            98765422   23457889999999988889999999999999999999999997655  333333333322 22222  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ...+..+.+++.+||..+|++||++.+++..
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2356778899999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.8e-37  Score=300.48  Aligned_cols=250  Identities=30%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||.|+||.||+|.+.  +..+|+|++..+..   ......+.+|+.+++.++|+||+++++.+...+..+++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   77 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLV   77 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCc---chHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEE
Confidence            47899999999999999999874  67899999865432   22567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++.....       ....++..+..++.|++.||+|||+.|  ++|+||+|+||++++++.++|+|||+
T Consensus        78 ~e~~~~~~l~~~~~~~~~-------~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~  148 (267)
T cd06610          78 MPYLSGGSLLDIMKSSYP-------RGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGV  148 (267)
T ss_pred             EeccCCCcHHHHHHHhcc-------cCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccch
Confidence            999999999999964322       012346778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc-------cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          353 ARFLSDGE-------MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       353 a~~~~~~~-------~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +.......       ....|+..|+|||.+... .++.++|+||||+++|+|++|+.||...+  ..........+. .+
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~  225 (267)
T cd06610         149 SASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYP--PMKVLMLTLQND-PP  225 (267)
T ss_pred             HHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccC--hhhhHHHHhcCC-CC
Confidence            87665432       223578999999998766 78999999999999999999999997654  223333333332 22


Q ss_pred             CCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEE---DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .++..   ...+..+.+++.+||..||++||++.+|+.
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            22222   245677899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.1e-37  Score=299.70  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=196.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCC-CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CC
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PY  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~  268 (472)
                      +.+|++.+.||+|+||.||+|.++  |..||||.+..+... ........+.+|+.+++.++||||+++++++.+.  ..
T Consensus         1 ~~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CCcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCce
Confidence            357899999999999999999875  678999988643221 2234567789999999999999999999988764  34


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++.+++|.+++.....          .+......++.+++.||+|||+.+  ++|+||+|+|||++.++.++|+
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~  148 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGA----------LTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLG  148 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEEC
Confidence            5678888889999999864321          235667888999999999999999  9999999999999999999999


Q ss_pred             ecccceecCC------CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          349 DFGHARFLSD------GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       349 DFGla~~~~~------~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      |||++.....      ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....  .............
T Consensus       149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~  226 (265)
T cd06652         149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFKIATQPT  226 (265)
T ss_pred             cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHHHHHhcCCC
Confidence            9999976532      1223457889999999988889999999999999999999999997654  2222233333222


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.+|.  .....+.+++.+||. +|++||++++|+.
T Consensus       227 ~~~~~~--~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         227 NPVLPP--HVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCCch--hhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            232332  234567788889995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-37  Score=304.97  Aligned_cols=250  Identities=24%  Similarity=0.297  Sum_probs=193.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||+|.++  +..||||.+.....  ++.....+.+|+.+++.++||||+++++++.+++..++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIF   78 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc--cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEE
Confidence            5889999999999999999985  77899999865422  2333456789999999999999999999999888888888


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++. ++|.+++.....       ....+...+..++.|++.||+|||+++  ++||||+|+|||++.++.++|+|||++
T Consensus        79 e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  148 (285)
T cd07861          79 EFLS-MDLKKYLDSLPK-------GQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLA  148 (285)
T ss_pred             ecCC-CCHHHHHhcCCC-------CCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccce
Confidence            8775 789888854321       112346778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC------
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK------  421 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~------  421 (472)
                      .......   ....+++.|+|||.+.+. .++.++|||||||++|+|+||+.||.+....  ........  +.      
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  226 (285)
T cd07861         149 RAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEI--DQLFRIFRILGTPTEDVW  226 (285)
T ss_pred             eecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhh
Confidence            8665332   223468899999988654 5789999999999999999999999765421  11111100  00      


Q ss_pred             --------CCCCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 --------LRPALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 --------~~~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              ++...+.         ......++.++|.+||..||++|||+.+|++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                    0000000         0223467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=315.21  Aligned_cols=243  Identities=24%  Similarity=0.362  Sum_probs=209.2

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEECCe--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWRGL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP  267 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~  267 (472)
                      .|...+|.++.+||+|+||.|.+|..+|+  .||||+++++.+..+ +..+.-+.|.++|... +-|+++.++..|..-+
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQd-DDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQD-DDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeec-CcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            56678999999999999999999999876  599999999876544 3445566788888877 6789999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      .+|+||||+.||+|...++..+...          ...+..++.+||.||-|||++|  ||+||||.+|||+|.+|++||
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFK----------Ep~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi  491 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFK----------EPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKI  491 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccC----------CchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEe
Confidence            9999999999999999998877532          3457788999999999999999  999999999999999999999


Q ss_pred             eecccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||+++.--.   ...+++|||.|+|||++...+|+.++|||||||+||||+.|..||.+.+  .+++...|.+-+.. 
T Consensus       492 ~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD--E~elF~aI~ehnvs-  568 (683)
T KOG0696|consen  492 ADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED--EDELFQAIMEHNVS-  568 (683)
T ss_pred             eecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHccCc-
Confidence            99999986442   2456889999999999999999999999999999999999999999888  67788888776532 


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCC
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRP  452 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RP  452 (472)
                       .|  .....+.+.++...+.+.|.+|.
T Consensus       569 -yP--KslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  569 -YP--KSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -Cc--ccccHHHHHHHHHHhhcCCcccc
Confidence             22  33556788899999999999994

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=320.26  Aligned_cols=239  Identities=23%  Similarity=0.321  Sum_probs=191.0

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc---CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      ||+|+||.||+|.++  +..||||++.+.... .......+..|..++..+   +||||+++++++.+.+..++|++|+.
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIV-AKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHh-hhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence            799999999999886  788999998654321 223344566777777665   69999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|..++...+.          .+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||++....
T Consensus        80 ~g~L~~~l~~~~~----------~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          80 GGELFWHLQKEGR----------FSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             CChHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            9999998864321          246778889999999999999999  9999999999999999999999999987643


Q ss_pred             CC---ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhH
Q 039082          358 DG---EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL  433 (472)
Q Consensus       358 ~~---~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~  433 (472)
                      ..   ....+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+  .......+..+..+  ++. ....
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~--~~~-~~~~  222 (330)
T cd05586         148 TDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMYRNIAFGKVR--FPK-NVLS  222 (330)
T ss_pred             CCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC--HHHHHHHHHcCCCC--CCC-ccCC
Confidence            22   2345689999999998754 58999999999999999999999997765  44555566655433  222 1234


Q ss_pred             HHHHHHHHHhccCCCCCCC----CHHHHHH
Q 039082          434 RELIELICLSWDGDASVRP----SFSSITC  459 (472)
Q Consensus       434 ~~l~~li~~cl~~dP~~RP----s~~~ll~  459 (472)
                      ..+.++|.+||..||.+||    ++.++++
T Consensus       223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            5678899999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-37  Score=308.98  Aligned_cols=250  Identities=23%  Similarity=0.294  Sum_probs=203.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|...  +..||||.+.++... .......+.+|+++++.++||||+++++.+......+++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccc-hHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEE
Confidence            47899999999999999999885  678999999765332 224556789999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++.....        ...+......++.|++.||+|||+.|  ++|+||||+||+++.++.++|+|||+
T Consensus        80 ~e~~~~~~L~~~~~~~~~--------~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~  149 (316)
T cd05574          80 MDYCPGGELFRLLQRQPG--------KCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDL  149 (316)
T ss_pred             EEecCCCCHHHHHHhCCC--------CccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecch
Confidence            999999999999864221        12346778888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--------------------------------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC
Q 039082          353 ARFLSDGE--------------------------------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN  400 (472)
Q Consensus       353 a~~~~~~~--------------------------------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~  400 (472)
                      +.......                                ....|+..|+|||.+.+..++.++||||||+++|+|++|.
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~  229 (316)
T cd05574         150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT  229 (316)
T ss_pred             hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence            87543211                                1224788899999999888999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC----HHHHHH
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS----FSSITC  459 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs----~~~ll~  459 (472)
                      .||.+.+  .......+....  ...+.....+..+.++|.+||..+|++||+    +++++.
T Consensus       230 ~pf~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         230 TPFKGSN--RDETFSNILKKE--VTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCCCCc--hHHHHHHHhcCC--ccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            9997766  333333333332  223333335678999999999999999999    777665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-37  Score=303.34  Aligned_cols=246  Identities=24%  Similarity=0.315  Sum_probs=194.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC-----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP-----  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~-----  266 (472)
                      +.|++.+.||+|+||.||+|.+.  +..||+|++....     .....+.+|+.+++++ +||||+++++++...     
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            46888999999999999999885  6789999986431     2234578899999998 799999999998763     


Q ss_pred             -CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          267 -PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       267 -~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       +..+++++++.+++|.+++.....        ...++..+..++.|++.||+|||+++  ++|+||+|+||++++++.+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~  150 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEV  150 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCE
Confidence             346788889889999999865321        12346778889999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          346 RIADFGHARFLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       346 kL~DFGla~~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      +|+|||++......   .....|++.|+|||.+.     ...++.++|||||||++|+|++|..||....  ........
T Consensus       151 ~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~--~~~~~~~~  228 (272)
T cd06637         151 KLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLI  228 (272)
T ss_pred             EEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC--HHHHHHHH
Confidence            99999999876432   23456889999999986     3458889999999999999999999996554  22222222


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+. .. ....+..+.+++.+||..+|.+||++.++++
T Consensus       229 ~~~~~~~-~~-~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         229 PRNPAPR-LK-SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             hcCCCCC-CC-CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            2222111 11 1234567889999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.9e-37  Score=304.34  Aligned_cols=255  Identities=24%  Similarity=0.343  Sum_probs=197.6

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc-
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE-  265 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~-  265 (472)
                      +....++|++.+.||+|+||.||+|.++  +..+|+|++...     ......+.+|+.+++.+ +||||+++++++.. 
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-----~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-----HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-----cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            3345678999999999999999999885  678999987542     12234577899999999 79999999998853 


Q ss_pred             ----CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          266 ----PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       266 ----~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                          .+..++++||+.+++|.+++......      ....+...+..++.+++.||.|||+.+  ++||||||+||+++.
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~  159 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR------GERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTT  159 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhcc------CccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECC
Confidence                34578889999999999988642211      112346778889999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc---cccccCCcccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH
Q 039082          342 AKHVRIADFGHARFLSDGE---MALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI  413 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~-----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i  413 (472)
                      ++.+||+|||++.......   ....|++.|+|||.+..     ..++.++|||||||++|+|++|..||....  ....
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~--~~~~  237 (286)
T cd06638         160 EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH--PMRA  237 (286)
T ss_pred             CCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc--hhHH
Confidence            9999999999998765322   23458999999999753     457899999999999999999999997654  2222


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ......+. .+.+.........+.++|.+||..+|++||++.++++.
T Consensus       238 ~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 LFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             HhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            22222221 12222222244578899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-37  Score=311.15  Aligned_cols=255  Identities=19%  Similarity=0.234  Sum_probs=194.9

Q ss_pred             Eeceeecc--CceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          199 LQEKIGQG--TTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       199 l~~~LG~G--~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      ++++||+|  +||.||++.++  |..||||.+..+..  .......+.+|+.+++.++||||++++++|..++..++|++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   79 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC--TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS   79 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc--cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence            57889999  78999999886  67899999865432  33455668889999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++......        ..++..+..++.|++.||+|||+++  |+||||||+|||++.++.++++||+.+.
T Consensus        80 ~~~~~~l~~~~~~~~~~--------~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~  149 (327)
T cd08227          80 FMAYGSAKDLICTHFMD--------GMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNL  149 (327)
T ss_pred             ccCCCcHHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhh
Confidence            99999999998543211        1346778899999999999999999  9999999999999999999999998754


Q ss_pred             ecCCC----------ccccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          355 FLSDG----------EMALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       355 ~~~~~----------~~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      .....          .....++..|+|||++.+  ..++.++|||||||++|+|++|..||.....  .........+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~~  227 (327)
T cd08227         150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKLNGTV  227 (327)
T ss_pred             ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcch--hHHHHHHhcCCc
Confidence            33211          112245778999999875  4689999999999999999999999976442  111111111110


Q ss_pred             CCC---------------------------------C---------CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH-
Q 039082          423 RPA---------------------------------L---------PEEDGQLRELIELICLSWDGDASVRPSFSSITC-  459 (472)
Q Consensus       423 ~~~---------------------------------l---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~-  459 (472)
                      ...                                 .         +........+.+++.+||..||++|||++++++ 
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            000                                 0         000123457889999999999999999999986 


Q ss_pred             -HHHHHHHH
Q 039082          460 -SLKNIQMK  467 (472)
Q Consensus       460 -~L~~i~~~  467 (472)
                       .|..+...
T Consensus       308 p~f~~~~~~  316 (327)
T cd08227         308 SFFKQIKRR  316 (327)
T ss_pred             hhhhhcchh
Confidence             34444433

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.5e-37  Score=299.26  Aligned_cols=248  Identities=29%  Similarity=0.414  Sum_probs=204.6

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|.+.+.||+|+||.||+|.+.  +..||+|.++....  .......+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN--DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFM   78 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc--chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEE
Confidence            4788999999999999999874  67899999976533  2456788999999999999999999999998888888999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++....          ..++..+..++.+++.||+|||+.+  ++|+||+|+||++++++.+||+|||++
T Consensus        79 e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~  146 (264)
T cd06626          79 EYCSGGTLEELLEHGR----------ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCA  146 (264)
T ss_pred             ecCCCCcHHHHHhhcC----------CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccc
Confidence            9999999999986422          1246778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCcc-------ccccCCcccccccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          354 RFLSDGEM-------ALTGTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       354 ~~~~~~~~-------~~~gt~~y~APE~~~~~~---~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ........       ...+++.|+|||.+.+..   ++.++||||||+++|+|++|..||...+. .......+..+ ..
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~-~~~~~~~~~~~-~~  224 (264)
T cd06626         147 VKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN-EFQIMFHVGAG-HK  224 (264)
T ss_pred             cccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc-hHHHHHHHhcC-CC
Confidence            87654322       235688999999998766   88999999999999999999999976542 22333333333 24


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.+|........+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            445544434667889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.1e-37  Score=297.22  Aligned_cols=247  Identities=24%  Similarity=0.353  Sum_probs=203.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||++.++  +..+|||.+.....  .......+.+|+.+++.++||||+++++.+...+..++|+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM--TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVM   78 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc--ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEE
Confidence            4889999999999999999875  67899999876433  3345677999999999999999999999998888889999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEEEeeccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVRIADFGH  352 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vkL~DFGl  352 (472)
                      +++.+++|.+++.....        ...+...+..++.+++.||+|||++|  ++|+||+|+||+++.+ +.+||+|||+
T Consensus        79 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~  148 (256)
T cd08220          79 EYAPGGTLAEYIQKRCN--------SLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGI  148 (256)
T ss_pred             ecCCCCCHHHHHHHhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCC
Confidence            99999999999965321        12346778899999999999999999  9999999999999865 4689999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      +.......  ....++..|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+..+... .++  .
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~--~  223 (256)
T cd08220         149 SKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN--LPALVLKIMSGTFA-PIS--D  223 (256)
T ss_pred             ceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc--hHHHHHHHHhcCCC-CCC--C
Confidence            98776433  23457899999999998889999999999999999999999997765  33444455444322 222  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.+++.+||..+|++||++.+++.
T Consensus       224 ~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         224 RYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            34567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-37  Score=299.57  Aligned_cols=237  Identities=26%  Similarity=0.390  Sum_probs=189.2

Q ss_pred             ceeeccCceEEEEEEECCe------------eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          201 EKIGQGTTANIYRAIWRGL------------DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g~------------~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      +.||+|+||.||+|.+++.            .+++|++....     .....|.+|+.+++.++||||+++++++.. +.
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch-----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC
Confidence            4689999999999998632            37888765431     115678899999999999999999999988 77


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-----
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-----  343 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-----  343 (472)
                      .+++++++.+++|.+++.....         ..++..+..++.||+.||+|||+++  ++||||||+|||++.++     
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~  143 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHREKN---------NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGY  143 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCC
Confidence            8899999999999999965331         2346778889999999999999999  99999999999999887     


Q ss_pred             --cEEEeecccceecCCCccccccCCcccccccccCC--CCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          344 --HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 --~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~--~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                        .+||+|||++..... .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||...+.  ........
T Consensus       144 ~~~~kl~Dfg~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~--~~~~~~~~  220 (259)
T cd05037         144 VPFIKLSDPGIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS--SEKERFYQ  220 (259)
T ss_pred             ceeEEeCCCCccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc--hhHHHHHh
Confidence              799999999987654 3334567889999999876  78999999999999999999 6888866542  22222222


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ... .  .+..  ....+.+++.+||..+|++||++.++++.|+
T Consensus       221 ~~~-~--~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH-R--LPMP--DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC-C--CCCC--CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            211 1  1111  1267889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.9e-37  Score=303.82  Aligned_cols=249  Identities=21%  Similarity=0.283  Sum_probs=196.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||+|++.....  .....+.+.+|+.+++.++||||+++++++......+++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   78 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLV   78 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc--CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEE
Confidence            46899999999999999999986  77899998865421  222345578999999999999999999999998888999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.++.|..++....          ..++..+..++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||+
T Consensus        79 ~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~  146 (286)
T cd07847          79 FEYCDHTVLNELEKNPR----------GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGF  146 (286)
T ss_pred             EeccCccHHHHHHhCCC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECcccc
Confidence            99998888887764321          1346788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC-----
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK-----  421 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~-----  421 (472)
                      +.......   ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+..  +....+..  +.     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~  224 (286)
T cd07847         147 ARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDV--DQLYLIRKTLGDLIPRH  224 (286)
T ss_pred             ceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCChHH
Confidence            98775433   23457889999999876 56889999999999999999999999766522  22211110  00     


Q ss_pred             --------C--CCCCCCC----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 --------L--RPALPEE----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 --------~--~~~l~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              +  ....+..          +..+..+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             hhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                    0  0000100          123466889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=3.5e-37  Score=297.38  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=205.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||++...  |..||+|.+.....  .......+.+|+.+++.++||||+++++++...+..++++
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM--SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVM   78 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC--ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEE
Confidence            4889999999999999999875  67899999865322  2344567889999999999999999999999988899999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++.....        ...+...++.++.|++.||.|||+++  ++|+||+|+|||++.++.++|+|||++
T Consensus        79 e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~  148 (256)
T cd08218          79 DYCEGGDLYKKINAQRG--------VLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIA  148 (256)
T ss_pred             ecCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccce
Confidence            99999999998864221        11246778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|++.|+|||.+.+..++.++|+|||||++++|++|..||...+  .......+..+.. +..+  .
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--~~~~~~~~~~~~~-~~~~--~  223 (256)
T cd08218         149 RVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--MKNLVLKIIRGSY-PPVS--S  223 (256)
T ss_pred             eecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--HHHHHHHHhcCCC-CCCc--c
Confidence            8765432   23357889999999998889999999999999999999999997655  4555555555542 2222  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....++.++|.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         224 HYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            34567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-37  Score=308.25  Aligned_cols=258  Identities=22%  Similarity=0.250  Sum_probs=197.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.++||.|+||.||+|.++  +..||+|.+.....   ......+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc---cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            468999999999999999999886  67899999865422   2223457789999999999999999999998888877


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++. ++|..++.....         ..++..+..++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||
T Consensus        82 v~e~~~-~~l~~~l~~~~~---------~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg  149 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGN---------SINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFG  149 (301)
T ss_pred             EEeccc-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCc
Confidence            777774 689888854321         1246778889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC-------
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG-------  420 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~-------  420 (472)
                      ++.......   ....+++.|+|||.+.+ ..++.++|||||||++|+|+||+.||...+.  ......+...       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~--~~~~~~~~~~~~~~~~~  227 (301)
T cd07873         150 LARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV--EEQLHFIFRILGTPTEE  227 (301)
T ss_pred             chhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCChh
Confidence            997654322   22346889999999865 4578999999999999999999999976652  1111111100       


Q ss_pred             ---------C-CCCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHHHHHH
Q 039082          421 ---------K-LRPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITC--SLKNIQMKV  468 (472)
Q Consensus       421 ---------~-~~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~--~L~~i~~~~  468 (472)
                               . .....+..         ...+..+.++|.+||..||.+|||+++++.  .+..+.+++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~  296 (301)
T cd07873         228 TWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERI  296 (301)
T ss_pred             hchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchh
Confidence                     0 00011110         123456789999999999999999999986  444444443

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.9e-37  Score=299.16  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=202.9

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||.|+||.||+|.++  +..||+|++.+.... .....+.+.+|+.+++.++||||+++++.+.++...+++++++.+++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIV-ETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcch-hhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            699999999999997  789999999765332 23445679999999999999999999999999999999999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCC-
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-  359 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  359 (472)
                      |.+++.+...          .+...+..++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 L~~~l~~~~~----------l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~  147 (262)
T cd05572          80 LWTILRDRGL----------FDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ  147 (262)
T ss_pred             HHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc
Confidence            9999964321          346778888999999999999999  999999999999999999999999999877643 


Q ss_pred             -ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHH
Q 039082          360 -EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIE  438 (472)
Q Consensus       360 -~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~  438 (472)
                       .....+++.|+|||.+....++.++|+||||+++|+|++|..||.....+.......+..+......|..  .+..+.+
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  225 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNY--IDKAAKD  225 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcc--cCHHHHH
Confidence             2334678999999999888899999999999999999999999977664455566666654433333332  2567899


Q ss_pred             HHHHhccCCCCCCCC-----HHHHHH
Q 039082          439 LICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       439 li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      +|.+||..+|++||+     ++++++
T Consensus       226 ~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         226 LIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHccCChhhCcCCcccCHHHHhc
Confidence            999999999999999     787775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.4e-37  Score=299.78  Aligned_cols=248  Identities=25%  Similarity=0.353  Sum_probs=194.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCC-CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCc
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYR  269 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~  269 (472)
                      .+|+..+.||+|+||.||+|.+.  +..||+|.+...... ........+.+|+.+++.++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46888999999999999999875  678999988654322 1223456788999999999999999999988763  445


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      +++++++.+++|.+++.....          .+....+.++.|++.||+|||+.+  ++||||+|+||+++.++.+||+|
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~----------l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~d  149 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGA----------LTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGD  149 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEcc
Confidence            678888889999999864321          235677888999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          350 FGHARFLSDG------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       350 FGla~~~~~~------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ||++......      .....++..|+|||.+.+..++.++|||||||++|+|++|..||...+.  .............
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~--~~~~~~~~~~~~~  227 (266)
T cd06651         150 FGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA--MAAIFKIATQPTN  227 (266)
T ss_pred             CCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch--HHHHHHHhcCCCC
Confidence            9998765321      1224478899999999988899999999999999999999999976542  2222233322223


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.++.  .....+.+++ .||..+|++||++++|++
T Consensus       228 ~~~~~--~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         228 PQLPS--HISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCch--hcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            33332  2334556666 788899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-37  Score=320.33  Aligned_cols=246  Identities=24%  Similarity=0.355  Sum_probs=192.1

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      ...+|++++.||+|+||.||+|...    +..||+|.+...         ..+.+|+++|+.++|||||++++++.....
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            3467999999999999999999764    357999987542         124589999999999999999999988887


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++ +++|..++....          ..++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+
T Consensus       161 ~~lv~e~~-~~~l~~~l~~~~----------~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~  227 (392)
T PHA03207        161 VCMVMPKY-KCDLFTYVDRSG----------PLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLG  227 (392)
T ss_pred             EEEEehhc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEc
Confidence            77777766 678888884322          2357889999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-HHHHHHHhc---
Q 039082          349 DFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVGE---  419 (472)
Q Consensus       349 DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-~~i~~~i~~---  419 (472)
                      |||++.......     ....||+.|+|||++.+..|+.++|||||||++|||++|+.||.+..... ......+..   
T Consensus       228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~  307 (392)
T PHA03207        228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ  307 (392)
T ss_pred             cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence            999998665332     23468999999999999999999999999999999999999997654221 011111100   


Q ss_pred             ----------------------CCCCCCCC--CC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          420 ----------------------GKLRPALP--EE---DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       420 ----------------------~~~~~~l~--~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                            ...++..+  ..   .....++.++|.+||..||++||++.+++..
T Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        308 VHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                  00011111  10   1224567889999999999999999999864

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6e-38  Score=303.89  Aligned_cols=272  Identities=28%  Similarity=0.410  Sum_probs=231.0

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      .-.+.+.++++...+-+|.||+||.|.|+.       +.|-+|+++..   ..+.....|+.|.-++..+.|||+..+.+
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~---AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH---ASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc---ccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            345667788889999999999999998752       34888888654   46677888999999999999999999999


Q ss_pred             EEEcCCCceEEEEec-cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          262 ACLEPPYRGWLVTEL-LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       262 ~~~~~~~~~~vve~~-~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ++.++....+|.-.. .-|+|+.||..+...  +.......+..+...++.|++.||+|||+++  +||.||.++|++||
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~--~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvId  430 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGD--DPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVID  430 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccC--CCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceeh
Confidence            999877766665444 468999999865532  2222333445678888999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCcccccc-----CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHH
Q 039082          341 DAKHVRIADFGHARFLSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIA  414 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~~~~g-----t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~  414 (472)
                      +...|||+|-.+++.+....+...|     +..||+||.+....|+.++||||||++||||+| |+.||.+.+  +.++.
T Consensus       431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID--PfEm~  508 (563)
T KOG1024|consen  431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID--PFEME  508 (563)
T ss_pred             hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC--HHHHH
Confidence            9999999999999988766655444     788999999999999999999999999999999 999998877  88999


Q ss_pred             HHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 039082          415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI  472 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~~i  472 (472)
                      ..+.+|+ |...|  ..++++|+.+|.-||+..|++||+|+++..-|.++..++...|
T Consensus       509 ~ylkdGy-RlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt~YV  563 (563)
T KOG1024|consen  509 HYLKDGY-RLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLTRYV  563 (563)
T ss_pred             HHHhccc-eecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHhhcC
Confidence            9999998 44444  4588899999999999999999999999999999999988764

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.5e-37  Score=302.86  Aligned_cols=237  Identities=24%  Similarity=0.350  Sum_probs=186.0

Q ss_pred             eeeccCceEEEEEEEC--------------------------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc
Q 039082          202 KIGQGTTANIYRAIWR--------------------------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF  255 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~--------------------------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn  255 (472)
                      .||+|+||.||+|.+.                          ...||+|++...    .......|.+|+.+++.++|||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~~~~~~~~l~h~n   77 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIH   77 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH----HHHHHHHHHHHHHHHhcCCCCC
Confidence            6999999999999742                          135899988543    2234456889999999999999


Q ss_pred             eeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       256 Iv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      |++++++|......++|+||+.+++|..++.....         ..++..+..++.|++.||+|||+++  |+||||||+
T Consensus        78 iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~  146 (274)
T cd05076          78 LAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG---------RVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAK  146 (274)
T ss_pred             eeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcc
Confidence            99999999999999999999999999998854221         2346778899999999999999999  999999999


Q ss_pred             cEEEcCCC-------cEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHH-cCCCCCCCC
Q 039082          336 NIFLDDAK-------HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEII-TGNHPYIEK  406 (472)
Q Consensus       336 NILl~~~~-------~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~ell-tG~~Pf~~~  406 (472)
                      |||++..+       .+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||...
T Consensus       147 Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  225 (274)
T cd05076         147 NILLARLGLAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER  225 (274)
T ss_pred             cEEEeccCcccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc
Confidence            99997643       4899999998654322 22356888999998865 56899999999999999995 699999765


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ..  ..........   ..++.  +....+.++|.+||..+|++||++.+|++.|
T Consensus       226 ~~--~~~~~~~~~~---~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         226 TP--SEKERFYEKK---HRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             Ch--HHHHHHHHhc---cCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            52  2222222211   12222  1234688899999999999999999999877

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.2e-38  Score=307.21  Aligned_cols=253  Identities=22%  Similarity=0.374  Sum_probs=204.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +..++|++.+.||+|+||.||++.+.  |..||+|++...   ......+.+.+|+.+++.++||||+++++.+...+..
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG---AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec---CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            34578999999999999999999986  788999988654   2344567789999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      ++++||+.+++|..++...+          ..++.....++.+++.||.|||+ .+  ++||||+|+||+++.++.++|+
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~  146 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGG----------PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLC  146 (284)
T ss_pred             EEEEecCCCCCHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEc
Confidence            99999999999999885432          13467788999999999999997 57  9999999999999999999999


Q ss_pred             ecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC------H---HHHHHHHh
Q 039082          349 DFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK------P---AKIAMEVG  418 (472)
Q Consensus       349 DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~------~---~~i~~~i~  418 (472)
                      |||++...... .....|+..|+|||.+.+..++.++|||||||++|+|++|..||......      +   ......+.
T Consensus       147 d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  226 (284)
T cd06620         147 DFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV  226 (284)
T ss_pred             cCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHh
Confidence            99998765322 23456899999999998888999999999999999999999999754321      0   11122222


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ... .+.++. ...+..+.+++.+||..||++||++.++++..
T Consensus       227 ~~~-~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         227 QEP-PPRLPS-SDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             hcc-CCCCCc-hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            211 122221 22456788999999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.6e-37  Score=296.13  Aligned_cols=249  Identities=26%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCceE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYRGW  271 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~~~  271 (472)
                      +|++.+.||.|+||.||++.+.  +..||+|++.....  .......+.+|+.+++.++||||+++++++...  ...++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM--TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYI   78 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC--CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEE
Confidence            5788999999999999999875  67899999875432  345567788999999999999999999987653  34567


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-----hcCCceeecCCCCCcEEEcCCCcEE
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH-----EQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH-----~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +++++.+++|.+++......      ....++..++.++.+++.||+|||     +.+  ++|+||+|+||++++++.+|
T Consensus        79 ~~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~k  150 (265)
T cd08217          79 VMEYCEGGDLAQLIQKCKKE------RKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVK  150 (265)
T ss_pred             EehhccCCCHHHHHHHHhhc------ccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEE
Confidence            88888899999999653211      122356788999999999999999     888  99999999999999999999


Q ss_pred             EeecccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+|||++.......   ....+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+  .......+..+..+
T Consensus       151 l~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~  228 (265)
T cd08217         151 LGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--QLQLASKIKEGKFR  228 (265)
T ss_pred             EecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--HHHHHHHHhcCCCC
Confidence            99999998776433   23457999999999998889999999999999999999999998766  45566666665432


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .++  ...+..+.+++.+||..+|++||++.+|++
T Consensus       229 -~~~--~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         229 -RIP--YRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             -CCc--cccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence             233  234567889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-37  Score=310.07  Aligned_cols=251  Identities=23%  Similarity=0.295  Sum_probs=182.0

Q ss_pred             eceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-CCceEEEE
Q 039082          200 QEKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-PYRGWLVT  274 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~vve  274 (472)
                      .++||+|+||.||+|.++    +..||+|.+.....      ...+.+|+.+|+.++||||+++++++... +..+++++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC------cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            468999999999999864    46799998864321      22367899999999999999999988653 33445556


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE----cCCCcEEEeec
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADF  350 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl----~~~~~vkL~DF  350 (472)
                      ++.+++|..++.......... .....+...+..++.||+.||+|||++|  |+||||||+|||+    +.++.+||+||
T Consensus        80 e~~~~~l~~~~~~~~~~~~~~-~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYAEHDLWHIIKFHRASKANK-KPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eccCCCHHHHHHhcccccccC-CcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            666889998886433221111 1122456778899999999999999999  9999999999999    45678999999


Q ss_pred             ccceecCCCc------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-------HHHHHH
Q 039082          351 GHARFLSDGE------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-------AKIAME  416 (472)
Q Consensus       351 Gla~~~~~~~------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-------~~i~~~  416 (472)
                      |+++......      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......       ......
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            9998765332      23457999999999876 458999999999999999999999996533210       000000


Q ss_pred             Hhc--CC---------------------C-CCCCC---------C-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGE--GK---------------------L-RPALP---------E-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~--~~---------------------~-~~~l~---------~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..  +.                     . +....         . .......+.++|.+||..||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000  00                     0 00000         0 0011235788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=9.5e-38  Score=321.59  Aligned_cols=196  Identities=29%  Similarity=0.378  Sum_probs=170.6

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-C-----CceeEEEEEEEcCC
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-H-----RFVLQLMGACLEPP  267 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-H-----pnIv~l~g~~~~~~  267 (472)
                      +|++++.||+|+||.|-+|.+.  +..||||+++..     .....+-..|+.+|..|+ |     -|+|+++++|...+
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            7899999999999999999986  678999999753     344455668999999996 4     49999999999988


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC--CcE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA--KHV  345 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~--~~v  345 (472)
                      ..|+ +.|+.+.+|.+||+.....        ..++..++.++.||+.||.+||+.+  |||+||||+||||.+.  ..|
T Consensus       262 Hlci-VfELL~~NLYellK~n~f~--------Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  262 HLCI-VFELLSTNLYELLKNNKFR--------GLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             ceee-eehhhhhhHHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence            8754 5556699999999764432        2457889999999999999999999  9999999999999754  479


Q ss_pred             EEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 039082          346 RIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD  407 (472)
Q Consensus       346 kL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~  407 (472)
                      ||+|||.|+.......+...+..|+|||++.+.+|+.+.||||||||+.||++|.+.|++.+
T Consensus       331 KVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n  392 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN  392 (586)
T ss_pred             eEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence            99999999998887778888999999999999999999999999999999999988887765

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=316.39  Aligned_cols=251  Identities=27%  Similarity=0.323  Sum_probs=206.9

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |.+..+.|...++||+|+||.||-+..+  |..||.|.+.+..+. .......-++|..+|.+++.++||.+--.|...+
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiK-kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd  258 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIK-KRKGETMALNEKQILEKVSSPFIVSLAYAFETKD  258 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHH-HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCC
Confidence            5677889999999999999999988764  889999998766542 2233455678999999999999999988899999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      .+|+|+.-|.||+|.-+|.+.+.        +..+....+.++.+|+.||++||..+  ||+|||||+|||+|+.|+|+|
T Consensus       259 ~LClVLtlMNGGDLkfHiyn~g~--------~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~GhvRI  328 (591)
T KOG0986|consen  259 ALCLVLTLMNGGDLKFHIYNHGN--------PGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHGHVRI  328 (591)
T ss_pred             ceEEEEEeecCCceeEEeeccCC--------CCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCCCeEe
Confidence            99999999999999999987764        23356778888999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCcc--ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHHhcCCCC
Q 039082          348 ADFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--PAKIAMEVGEGKLR  423 (472)
Q Consensus       348 ~DFGla~~~~~~~~--~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--~~~i~~~i~~~~~~  423 (472)
                      +|+|+|..+.++..  ..+||..|||||++.+..|+...|||||||++|||+.|+.||.....+  ..++...+....  
T Consensus       329 SDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--  406 (591)
T KOG0986|consen  329 SDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--  406 (591)
T ss_pred             eccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--
Confidence            99999999886654  457999999999999999999999999999999999999999765422  222333332221  


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFS  455 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~  455 (472)
                      ...+  +....++.+++...|..||++|....
T Consensus       407 ~ey~--~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  407 EEYS--DKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhcc--cccCHHHHHHHHHHHccCHHHhccCC
Confidence            1122  34556778888899999999996543

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-37  Score=301.19  Aligned_cols=249  Identities=27%  Similarity=0.432  Sum_probs=203.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++.++  +..||+|.+....   .......+.+|+++++.++||||+++++.+......+++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv   77 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI---NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISIC   77 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc---ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEE
Confidence            46888999999999999999986  7789999987642   235556788999999999999999999999999888899


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ++++.+++|.+++....         ...+......++.+++.||+|||+ .+  ++|+||+|+||++++++.++|+|||
T Consensus        78 ~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g  146 (265)
T cd06605          78 MEYMDGGSLDKILKEVQ---------GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFG  146 (265)
T ss_pred             EEecCCCcHHHHHHHcc---------CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999986432         123457788899999999999999 88  9999999999999999999999999


Q ss_pred             cceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC---CHHHHHHHHhcCCCCCCCC
Q 039082          352 HARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY---KPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       352 la~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~---~~~~i~~~i~~~~~~~~l~  427 (472)
                      .+...... .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.   ........+.... .+.++
T Consensus       147 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  225 (265)
T cd06605         147 VSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-PPRLP  225 (265)
T ss_pred             cchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-CCCCC
Confidence            98765422 1225678999999999989999999999999999999999999976532   1222333333322 22333


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .. .....+.++|.+||..+|++||++.+++.
T Consensus       226 ~~-~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         226 SG-KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hh-hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            22 25567889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.3e-37  Score=295.68  Aligned_cols=248  Identities=27%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCC-CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +|+..+.||+|+||.||+|.++  +..|++|.+...... ...+....+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3567789999999999999985  789999998653221 2244567789999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++....          ..++..+..++.+++.||+|||+.+  ++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~  148 (258)
T cd06632          81 LELVPGGSLAKLLKKYG----------SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGM  148 (258)
T ss_pred             EEecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCcc
Confidence            99999999999996432          1246778888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~-~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......  ....|+..|+|||.+.... ++.++|+||||+++|+|++|..||....  .......+......+.++  
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~--  224 (258)
T cd06632         149 AKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE--GVAAVFKIGRSKELPPIP--  224 (258)
T ss_pred             ceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc--HHHHHHHHHhcccCCCcC--
Confidence            98765432  3455789999999987766 8999999999999999999999997655  333333333322222232  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         225 DHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             CCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            234567888999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=7.5e-37  Score=297.48  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=196.1

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      ++.+.+.....||+|+||.||+|.+.  +..||+|.+...    .......+.+|+.+++.++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC----CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            33445555678999999999999875  567999988653    234556789999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL~  348 (472)
                      +++++++.+++|.+++......       ...+...+..++.|++.||+|||+++  |+||||||+||+++. ++.++|+
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~  151 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKWGP-------LKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKIS  151 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhccc-------CCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEe
Confidence            9999999999999999643211       01135667788899999999999999  999999999999986 6799999


Q ss_pred             ecccceecCCC---ccccccCCcccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDG---EMALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~---~~~~~gt~~y~APE~~~~~--~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |||++......   .....|++.|+|||.+...  .++.++||||||+++|+|++|..||............ .......
T Consensus       152 dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~  230 (268)
T cd06624         152 DFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIH  230 (268)
T ss_pred             cchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccC
Confidence            99999765422   2234578999999998654  3789999999999999999999999765432222211 1111112


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.++.  ....++.+++.+||+.+|++||++.+|+.
T Consensus       231 ~~~~~--~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         231 PEIPE--SLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             CCCCc--ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            22332  34567888999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5.1e-37  Score=298.61  Aligned_cols=255  Identities=26%  Similarity=0.428  Sum_probs=205.6

Q ss_pred             CeeEeceeeccCceEEEEEEECC---eeEEEEEeccCCCC------CChHHHHHHHHHHHHHHh-cCCCceeEEEEEEEc
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRG---LDVAVKCIYPDFFH------TNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLE  265 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g---~~vAVK~l~~~~~~------~~~~~~~~f~~E~~il~~-l~HpnIv~l~g~~~~  265 (472)
                      +|++.+.||+|+||.||+|.+++   ..+|+|.+......      ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999864   67999988643211      233455667889998875 699999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCc
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      .+..++++||+.+++|.+++......      ....+...++.++.+++.||.|||+ .+  ++|+||+|+|||++.++.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lh~~~~--i~H~dl~~~nil~~~~~~  152 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEK------KQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDK  152 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhc------cCCCCHHHHHHHHHHHHHHHHHhccCCc--eeecCCCHHHEEECCCCc
Confidence            99999999999999999988542211      1224567789999999999999996 67  999999999999999999


Q ss_pred             EEEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          345 VRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       345 vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      ++|+|||++.......  ....|+..|+|||.+.+..++.++|+||||+++|+|++|..||....  .......+..+..
T Consensus       153 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~--~~~~~~~~~~~~~  230 (269)
T cd08528         153 VTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN--MLSLATKIVEAVY  230 (269)
T ss_pred             EEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC--HHHHHHHHhhccC
Confidence            9999999998765432  23457899999999998889999999999999999999999996654  3444445555443


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .+ .+. ...+..+.+++.+||..||++||++.++...|+
T Consensus       231 ~~-~~~-~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 EP-LPE-GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             Cc-CCc-ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            32 111 234567899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=331.42  Aligned_cols=253  Identities=26%  Similarity=0.467  Sum_probs=216.0

Q ss_pred             CeeEeceeeccCceEEEEEEE--C----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          196 EIDLQEKIGQGTTANIYRAIW--R----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~--~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +....++||+|+||.||+|.|  +    ..+||||++....   ....-..|++|+-+|.+++|||+++++|+|.... .
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t---~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~  772 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT---SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-L  772 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC---CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-H
Confidence            455678999999999999998  2    3479999986543   2334456999999999999999999999998876 6


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      .+|+.++..|+|.+|++.+....         .....+.|..|||+||.|||+++  +|||||.++||||..-.+|||+|
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~i---------gsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNI---------GSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccc---------cHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEe
Confidence            68889999999999998654322         24678899999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCcc---cccc--CCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          350 FGHARFLSDGEM---ALTG--TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       350 FGla~~~~~~~~---~~~g--t~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ||+++.+.....   ...|  .+.|||-|.+....|+.++|||||||++||++| |..||.+..  ..++...+.+|. |
T Consensus       842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~--~~eI~dlle~ge-R  918 (1177)
T KOG1025|consen  842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP--AEEIPDLLEKGE-R  918 (1177)
T ss_pred             cchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC--HHHhhHHHhccc-c
Confidence            999998874332   2223  789999999999999999999999999999999 999998887  566777777776 3


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                        ++..+.+.-+++.++.+||..|++.||+|+++...+.++.++.
T Consensus       919 --LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  919 --LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             --CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence              5655667889999999999999999999999999999887653

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-37  Score=299.10  Aligned_cols=250  Identities=24%  Similarity=0.390  Sum_probs=199.2

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC------ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT------NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~------~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      +|.+.+.||.|+||.||+|...  |..||||.++......      .....+.+.+|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4678899999999999999874  7789999885432111      1123456889999999999999999999999988


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+|++.+++|.+++...+.          .+...+..++.+++.||.|||+++  ++||||+|+||+++.++.++|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~----------l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l  149 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGR----------FEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKI  149 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccC----------CCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEE
Confidence            89999999999999999965421          235667888999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc-----cccccCCcccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          348 ADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEP--YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       348 ~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~--~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      +|||++.......     ....|+..|+|||.+....  ++.++|+||||+++|++++|..||...+  .......+...
T Consensus       150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~  227 (272)
T cd06629         150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--AIAAMFKLGNK  227 (272)
T ss_pred             eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--hHHHHHHhhcc
Confidence            9999998654321     2345789999999987654  8899999999999999999999996554  22223333333


Q ss_pred             CCCCCCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+.++..  ...+..+.+++.+||..+|++||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         228 RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            223333332  344678899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.7e-37  Score=303.62  Aligned_cols=244  Identities=26%  Similarity=0.392  Sum_probs=200.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.|+..+.||+|+||.||+|.+.  +..||+|.+....   .......+.+|+.+++.++||||+++++.+...+..++|
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE---AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII   80 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc---chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence            34677889999999999999875  6789999886442   234556789999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.+++|.+++...           ..+...+..++.+++.||.|||+++  ++|+||+|+||++++++.++|+|||+
T Consensus        81 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~  147 (277)
T cd06642          81 MEYLGGGSALDLLKPG-----------PLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGV  147 (277)
T ss_pred             EEccCCCcHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEccccc
Confidence            9999999999988531           1246778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....|+..|+|||.+.+..++.++|||||||++|+|++|..||....  +......+..+. .+.++  
T Consensus       148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~--~~~~~~~~~~~~-~~~~~--  222 (277)
T cd06642         148 AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH--PMRVLFLIPKNS-PPTLE--  222 (277)
T ss_pred             cccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc--hhhHHhhhhcCC-CCCCC--
Confidence            98765432   23457889999999999899999999999999999999999996544  333333333332 22222  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.+++.+||..+|++||++.+++.
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            234567889999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.2e-37  Score=299.99  Aligned_cols=250  Identities=25%  Similarity=0.385  Sum_probs=194.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHH-HHhcCCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT-LSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~i-l~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||.++....   ......+..|..+ ++.++||||+++++++..++..++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~l   77 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN---SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWI   77 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC---cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEE
Confidence            47899999999999999999986  78999999876432   2223345556665 666799999999999998888877


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +++++ .++|.+++......      ....++..++.++.|++.||+|||++ +  ++||||||+|||++.++.+||+||
T Consensus        78 v~e~~-~~~l~~~l~~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~~~~--i~h~dlkp~nil~~~~~~~kl~df  148 (283)
T cd06617          78 CMEVM-DTSLDKFYKKVYDK------GLTIPEDILGKIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDF  148 (283)
T ss_pred             Ehhhh-cccHHHHHHHhccC------CCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeec
Confidence            77776 57888888543211      12345788889999999999999997 8  999999999999999999999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccC----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQC----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |++.......  ....|+..|+|||.+.+    ..++.++|+|||||++|+|++|..||.........+. .+..+. .+
T Consensus       149 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~-~~  226 (283)
T cd06617         149 GISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK-QVVEEP-SP  226 (283)
T ss_pred             ccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHH-HHHhcC-CC
Confidence            9998664322  22457889999998865    4578899999999999999999999965443222222 222322 22


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .++. ...+.++.++|.+||..+|++||++.++++
T Consensus       227 ~~~~-~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 QLPA-EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCc-cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2322 234567889999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=321.35  Aligned_cols=247  Identities=23%  Similarity=0.265  Sum_probs=203.5

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      -|.-++.||.|+||.||-|++.  ...||||.+.-.... ..+....++.|++.|.+++|||+|.+-|.|..+...++||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQ-s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccc-cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            4666899999999999999985  568999998655432 3455677999999999999999999999887776665555


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      ||| -|+-.+++.-+...         ....++..|+.+++.||+|||+.+  .||||||+.|||+++.|.|||+|||.|
T Consensus       106 EYC-lGSAsDlleVhkKp---------lqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSA  173 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKKP---------LQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSA  173 (948)
T ss_pred             HHH-hccHHHHHHHHhcc---------chHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccch
Confidence            555 56666666433321         224678889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGEMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .... +..+++|||.|||||+|.   .+.|+-++|||||||+..||.-.++|+.+++  .......|.... .|.++. +
T Consensus       174 si~~-PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN--AMSALYHIAQNe-sPtLqs-~  248 (948)
T KOG0577|consen  174 SIMA-PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNE-SPTLQS-N  248 (948)
T ss_pred             hhcC-chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch--HHHHHHHHHhcC-CCCCCC-c
Confidence            7664 445689999999999985   5789999999999999999999999998877  555666666655 455554 5


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+...+..|+..||.+-|.+|||.++++..
T Consensus       249 eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  249 EWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             hhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            777888999999999999999999988753

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-37  Score=298.52  Aligned_cols=250  Identities=27%  Similarity=0.387  Sum_probs=199.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC--
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY--  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~--  268 (472)
                      .++|++.+.||+|+||.||+|.++  +..+++|++...     ......|.+|+.+++++ .||||+++++++.....  
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC-----chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            468999999999999999999985  578999988653     22345688999999999 79999999999976553  


Q ss_pred             ----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          269 ----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       269 ----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                          .+++++++.+++|.+++......      ....+...+..++.|++.||.|||+.+  ++|+||+|+||+++.++.
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~  151 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKK------GKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAE  151 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhc------CCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCe
Confidence                67899999999999998643210      112346778899999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc---cccccCCcccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDGE---MALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~-----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      ++|+|||++.......   ....|+..|+|||.+..     ..++.++||||||+++|+|++|..||....  .......
T Consensus       152 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~  229 (275)
T cd06608         152 VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--PMRALFK  229 (275)
T ss_pred             EEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc--hHHHHHH
Confidence            9999999998654322   23457899999998753     346789999999999999999999997543  3333444


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..+. .+.+.........+.++|.+||..||++|||+.++++
T Consensus       230 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            44432 2222222335568899999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-36  Score=298.00  Aligned_cols=253  Identities=26%  Similarity=0.375  Sum_probs=201.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--Cce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--YRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--~~~  270 (472)
                      ++|+..++||.|++|.||+|.++  +..||+|.+....   .......+.+|+++++.++||||++++++|...+  ..+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP---NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC---chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEE
Confidence            46889999999999999999985  6789999987542   2345567899999999999999999999987643  467


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      ++++++.+++|.+++......      ....+...+..++.+++.||+|||+.+  ++|+||+|+||++++++.++|+||
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~df  149 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKR------GGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDF  149 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeec
Confidence            888999999999987542211      122346778899999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc-cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC---CCHHHHHHHHhcCCCCCCC
Q 039082          351 GHARFLSDGE-MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD---YKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       351 Gla~~~~~~~-~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~---~~~~~i~~~i~~~~~~~~l  426 (472)
                      |++....... ....++..|+|||.+.+..++.++||||||+++|+|++|..||....   ....+....+.... .+.+
T Consensus       150 g~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~  228 (287)
T cd06621         150 GVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPEL  228 (287)
T ss_pred             cccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC-chhh
Confidence            9987654332 23457889999999998999999999999999999999999997652   12333333333322 2222


Q ss_pred             CCC----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEE----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..    ...+..+.+++.+||..+|++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            221    234678899999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-37  Score=304.36  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=194.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~  270 (472)
                      .++|+..+.||+|+||.||++.++  +..||||.+....   .......+.+|+.++.++. ||||+++++++..+...+
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV---DEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhcc---ChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            357788899999999999999985  6789999987542   2245567889999999996 999999999988877766


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCCCcEEEee
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++++++ +++|.++.......     .....+...+..++.+++.||+|||+. +  ++||||||+|||++.++.+||+|
T Consensus        80 ~~~e~~-~~~l~~l~~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~d  151 (288)
T cd06616          80 ICMELM-DISLDKFYKYVYEV-----LKSVIPEEILGKIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCD  151 (288)
T ss_pred             EEEecc-cCCHHHHHHHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHhhcCC--eeccCCCHHHEEEccCCcEEEee
Confidence            666554 56666554221100     011235677889999999999999975 7  99999999999999999999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~---~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      ||++.......  ....|++.|+|||.+...   .++.++|||||||++|+|++|+.||..... .......+..+. .+
T Consensus       152 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~~~~-~~  229 (288)
T cd06616         152 FGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-VFDQLTQVVKGD-PP  229 (288)
T ss_pred             cchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-HHHHHhhhcCCC-CC
Confidence            99997654322  234578999999998766   689999999999999999999999976541 222222222222 22


Q ss_pred             CCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          425 ALPEE--DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       425 ~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .++..  ...+..+.+++.+||..+|++||++++|+..
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22221  2356788999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-38  Score=292.23  Aligned_cols=255  Identities=26%  Similarity=0.424  Sum_probs=206.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      +..+.++++.+..||+|+.|.||+++++  |...|||.+...   .+.+..+.++..+.++..- +.|+||+.+|+|..+
T Consensus        87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt---~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n  163 (391)
T KOG0983|consen   87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITN  163 (391)
T ss_pred             cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc---CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeC
Confidence            3445567888899999999999999987  589999999765   4566777788888887665 589999999999887


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ... ++.+++++..+..++.....         ..+...+-.+...+++||.||.++. +|||||+||+|||+|+.|.+|
T Consensus       164 ~dV-~IcMelMs~C~ekLlkrik~---------piPE~ilGk~tva~v~AL~YLKeKH-~viHRDvKPSNILlDe~GniK  232 (391)
T KOG0983|consen  164 TDV-FICMELMSTCAEKLLKRIKG---------PIPERILGKMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGNIK  232 (391)
T ss_pred             chH-HHHHHHHHHHHHHHHHHhcC---------CchHHhhhhhHHHHHHHHHHHHHhc-ceeecccCccceEEccCCCEE
Confidence            665 46667778888887753221         1233445577889999999999874 499999999999999999999


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      |||||++-.+.+..  ....|-+.|||||.+..   ..|+.++|||||||+++||.||..||.+.+- ..++...+....
T Consensus       233 lCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltkvln~e  311 (391)
T KOG0983|consen  233 LCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTKVLNEE  311 (391)
T ss_pred             eecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHHHHhcC
Confidence            99999998876554  34568899999999964   4689999999999999999999999988542 355666666643


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                       +|.++........+.+++..||.+|+.+||.+.+|++.
T Consensus       312 -PP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  312 -PPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             -CCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence             57777766677888999999999999999999998853

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-37  Score=301.29  Aligned_cols=239  Identities=25%  Similarity=0.367  Sum_probs=188.5

Q ss_pred             ceeeccCceEEEEEEECC---------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          201 EKIGQGTTANIYRAIWRG---------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g---------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      +.||+|+||.||+|.+++         ..||+|.+...    .....+.|.+|+.+++.++||||+++++++...+..++
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~----~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~l   76 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS----HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIM   76 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch----hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEE
Confidence            468999999999998742         24888877432    23445678899999999999999999999999889999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc-------
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-------  344 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~-------  344 (472)
                      |+||+.+|+|..++...+.         ..++..++.++.||+.||+|||+++  ++||||||+|||++.++.       
T Consensus        77 v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~  145 (258)
T cd05078          77 VQEYVKFGSLDTYLKKNKN---------LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPP  145 (258)
T ss_pred             EEecCCCCcHHHHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCc
Confidence            9999999999999965332         1246778889999999999999999  999999999999987765       


Q ss_pred             -EEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHhcCC
Q 039082          345 -VRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITG-NHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       345 -vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG-~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                       ++++|||++..... .....+++.|+|||.+.+ ..++.++||||||+++|+|++| ..||...+  ..... .+... 
T Consensus       146 ~~~l~d~g~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~--~~~~~-~~~~~-  220 (258)
T cd05078         146 FIKLSDPGISITVLP-KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD--SQKKL-QFYED-  220 (258)
T ss_pred             eEEecccccccccCC-chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhcc--HHHHH-HHHHc-
Confidence             69999999876543 233467889999999986 4589999999999999999998 46665444  22221 12222 


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                       +..+|.  ....++.+++.+||+.+|++||++++|++.|+
T Consensus       221 -~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -RHQLPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -cccCCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence             222332  23357889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=297.66  Aligned_cols=245  Identities=23%  Similarity=0.285  Sum_probs=192.3

Q ss_pred             ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHH-HhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL-SRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il-~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||.|+||.||+|.++  |..||||++.+..... ......+..|..++ ...+||||+++++++...+..++++||+.
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIA-KNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhH-HHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            57999999999999885  6799999986542211 22233345555544 44589999999999999888999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|.+++....          ..+...+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  148 (260)
T cd05611          81 GGDCASLIKTLG----------GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL  148 (260)
T ss_pred             CCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence            999999986432          1346778899999999999999999  9999999999999999999999999988654


Q ss_pred             CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q 039082          358 DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELI  437 (472)
Q Consensus       358 ~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~  437 (472)
                      . .....+++.|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+..+............+..+.
T Consensus       149 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (260)
T cd05611         149 E-NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET--PDAVFDNILSRRINWPEEVKEFCSPEAV  225 (260)
T ss_pred             c-cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccCCCCcccccCCHHHH
Confidence            3 334468899999999988889999999999999999999999997665  4444444444432211111123567889


Q ss_pred             HHHHHhccCCCCCCCCHHHHHHHH
Q 039082          438 ELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       438 ~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ++|.+||..+|++||++.++.+.|
T Consensus       226 ~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         226 DLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             HHHHHHccCCHHHccCCCcHHHHH
Confidence            999999999999999775554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.1e-37  Score=303.78  Aligned_cols=252  Identities=17%  Similarity=0.154  Sum_probs=181.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECCe-----eEEEEEeccCCCCCChHH-------HHHHHHHHHHHHhcCCCceeEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRGL-----DVAVKCIYPDFFHTNENA-------VTFFAQEVDTLSRQRHRFVLQL  259 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g~-----~vAVK~l~~~~~~~~~~~-------~~~f~~E~~il~~l~HpnIv~l  259 (472)
                      +..++|++.+.||+|+||.||+|.+.+.     .+|+|+..........+.       ......+...+..+.|++|+++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4557899999999999999999997633     567775432211000000       0112234445566789999999


Q ss_pred             EEEEEcCCCc----eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          260 MGACLEPPYR----GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       260 ~g~~~~~~~~----~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      ++.+......    +++++ ....++.+.+.....          .+...+..++.|++.||+|||+++  ++||||||+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~  155 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLE-KLVENTKEIFKRIKC----------KNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPE  155 (294)
T ss_pred             EEeeeEecCCceEEEEEEe-hhccCHHHHHHhhcc----------CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHH
Confidence            9876654422    23333 335566666543211          134667889999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCC----------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDG----------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE  405 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~----------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~  405 (472)
                      |||++.++.++|+|||+|+.+...          .....||+.|+|||++.+..++.++|||||||++|||++|..||.+
T Consensus       156 Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~  235 (294)
T PHA02882        156 NIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG  235 (294)
T ss_pred             HEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCc
Confidence            999999999999999999876421          1224589999999999999999999999999999999999999977


Q ss_pred             CCCCHHHH-------HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          406 KDYKPAKI-------AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       406 ~~~~~~~i-------~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      .......+       ...+..+..  .+   ...+..+.+++..||..+|++||++.+|.+.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        236 FGHNGNLIHAAKCDFIKRLHEGKI--KI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             cccchHHHHHhHHHHHHHhhhhhh--cc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            64322211       122222221  11   23456788999999999999999999999876

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-38  Score=293.29  Aligned_cols=252  Identities=26%  Similarity=0.392  Sum_probs=213.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC----ChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT----NENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP  267 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~----~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~  267 (472)
                      ..|+-.+.||.|..++|-++..+  |..+|+|++.-.....    ..+..+.-.+|+.+|+++ .||+|+.+.+++..+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            35667789999999999999876  6789999885432222    223345567899999998 7999999999998888


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|++.+..|.|++||...-.          .+.++.+.+++|+..|++|||.++  ||||||||+|||+|++..+||
T Consensus        97 F~FlVFdl~prGELFDyLts~Vt----------lSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~i  164 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSKVT----------LSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIKI  164 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhhee----------ecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceEE
Confidence            88788888889999999965332          245778899999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCcc--ccccCCcccccccccC------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          348 ADFGHARFLSDGEM--ALTGTFVYMAPEVIQC------EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       348 ~DFGla~~~~~~~~--~~~gt~~y~APE~~~~------~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +|||+|..+..+..  ..||||.|.|||.+.+      ..|+..+|+|+.||++|-|+.|..||....  ..-+...+..
T Consensus       165 sDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--QmlMLR~Ime  242 (411)
T KOG0599|consen  165 SDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QMLMLRMIME  242 (411)
T ss_pred             eccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HHHHHHHHHh
Confidence            99999999887654  5789999999999974      358889999999999999999999997655  5567777899


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      |++...-|+.........++|.+||..||.+|.|+++.+..
T Consensus       243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            99877777767777888999999999999999999998753

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-36  Score=299.15  Aligned_cols=250  Identities=26%  Similarity=0.362  Sum_probs=196.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC---
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP---  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~---  267 (472)
                      .++|++.+.||+|+||.||+|..+  +..+|+|++...     ......+.+|+.++.++ +|||++++++++...+   
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-----~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~   95 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-----SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV   95 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-----ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence            468999999999999999999985  678999988542     12234577899999998 8999999999987643   


Q ss_pred             --CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          268 --YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 --~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                        ..+++++|+.+++|.+++......      ....++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+
T Consensus        96 ~~~~~lv~ey~~~~sL~~~~~~~~~~------~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          96 GGQLWLVLELCNGGSVTELVKGLLIC------GQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             CCeeEEEEEECCCCcHHHHHHHhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCE
Confidence              467888999999999988642211      112356788899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc---cccccCCcccccccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          346 RIADFGHARFLSDGE---MALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       346 kL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~-----~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      ||+|||++.......   ....|+..|+|||.+...     .++.++|||||||++|+|++|+.||....  .......+
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--PVKTLFKI  245 (291)
T ss_pred             EEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--HHHHHHHH
Confidence            999999988655322   234578999999998643     36889999999999999999999997654  22233333


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+. .+.+.........+.++|.+||..+|++||++.+|+.
T Consensus       246 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 PRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            3332 2222222234467889999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=325.41  Aligned_cols=241  Identities=28%  Similarity=0.461  Sum_probs=197.9

Q ss_pred             eeeccCceEEEEEEECC--eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCC
Q 039082          202 KIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT  279 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~g--~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~gg  279 (472)
                      +||+|.||+||.|++..  ..+|||.+...    +.....-+..|+.+-+.|+|.|||+++|.|.+...+-++||.+.||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek----dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK----DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccc----cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            79999999999999874  46899987542    3344566889999999999999999999999999888999999999


Q ss_pred             cHHHHHhhcc-cccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEEeecccceecC
Q 039082          280 TLKEWLHGLG-SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIADFGHARFLS  357 (472)
Q Consensus       280 sL~~~l~~~~-~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL~DFGla~~~~  357 (472)
                      +|.++|+..- ....        -....-.+..||+.||.|||++.  |||||||-+||||+. .|.+||+|||-++.+.
T Consensus       658 SLSsLLrskWGPlKD--------NEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA  727 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKD--------NESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA  727 (1226)
T ss_pred             cHHHHHHhccCCCcc--------chhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhc
Confidence            9999996432 2111        12445567889999999999999  999999999999975 6899999999998775


Q ss_pred             C---CccccccCCcccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchh
Q 039082          358 D---GEMALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ  432 (472)
Q Consensus       358 ~---~~~~~~gt~~y~APE~~~~~--~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~  432 (472)
                      .   -..+++||..|||||++..+  .|..++|||||||++.||.||++||.+..... .....+.--+..|++|+.  .
T Consensus       728 ginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AAMFkVGmyKvHP~iPee--l  804 (1226)
T KOG4279|consen  728 GINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AAMFKVGMYKVHPPIPEE--L  804 (1226)
T ss_pred             cCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-HhhhhhcceecCCCCcHH--H
Confidence            3   34567899999999999754  68999999999999999999999998876433 333334433445666653  5


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          433 LRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       433 ~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+...+|.+|+.++|.+||++.+|+.
T Consensus       805 saeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  805 SAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            567788999999999999999999874

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.2e-37  Score=312.26  Aligned_cols=246  Identities=23%  Similarity=0.310  Sum_probs=187.1

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +...+|++.+.||+|+||.||+|.++  +..||+|+.....          ...|+.+++.++||||+++++++...+..
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~----------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT----------TLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc----------cHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            34457999999999999999999986  4589999754321          34689999999999999999999998888


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++++ .++|.+++....         ...++..+..++.||+.||.|||++|  ||||||||+|||++.++.+||+|
T Consensus       133 ~lv~e~~-~~~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~D  200 (357)
T PHA03209        133 CMVLPHY-SSDLYTYLTKRS---------RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGD  200 (357)
T ss_pred             EEEEEcc-CCcHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEec
Confidence            8888776 678888885422         12357888999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCC-CCCCCCCCHH--------HHHHHHh
Q 039082          350 FGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNH-PYIEKDYKPA--------KIAMEVG  418 (472)
Q Consensus       350 FGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~-Pf~~~~~~~~--------~i~~~i~  418 (472)
                      ||++......  .....||+.|+|||++.+..++.++|||||||++|||+++.. +|........        .+...+.
T Consensus       201 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~  280 (357)
T PHA03209        201 LGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS  280 (357)
T ss_pred             CccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHH
Confidence            9999754322  234568999999999999999999999999999999998544 4443222111        0111011


Q ss_pred             c-CCCCCCCCC----------------------------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 E-GKLRPALPE----------------------------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ~-~~~~~~l~~----------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      . +.....++.                            ....+..+.++|.+||..||.+|||+.++++
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        281 TLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            0 110111110                            0112334566899999999999999999875

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.2e-37  Score=303.49  Aligned_cols=246  Identities=25%  Similarity=0.382  Sum_probs=200.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||++...  +..||+|.+...    .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ----QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc----cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            58899999999999999999874  678999988543    223346688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|..++....           .++..+..++.+++.||+|||+++  ++|+||+|+||+++.++.++|+|||+
T Consensus        95 ~e~~~~~~L~~~~~~~~-----------l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~  161 (293)
T cd06647          95 MEYLAGGSLTDVVTETC-----------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGF  161 (293)
T ss_pred             EecCCCCcHHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcc
Confidence            99999999999985321           246778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....|++.|+|||.+....++.++|+||||+++|++++|..||...+.  ......+..+. .+..+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~--~~~~~~~~~~~-~~~~~~~  238 (293)
T cd06647         162 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNG-TPELQNP  238 (293)
T ss_pred             eecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--hhheeehhcCC-CCCCCCc
Confidence            87665332   223578899999999888899999999999999999999999976552  22222222221 2222222


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ...+..+.++|.+||..+|++||++.+++..
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         239 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            3345678899999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-37  Score=296.71  Aligned_cols=250  Identities=25%  Similarity=0.388  Sum_probs=200.2

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC--ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT--NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~--~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      +|+..+.||+|+||.||+|...  +..||+|++.......  .......+.+|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            3677899999999999999874  7789999987543211  12345779999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEEEeec
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADF  350 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vkL~DF  350 (472)
                      |++++.+++|.+++...+.          .++.....++.|++.||.|||++|  ++|+||+|+||+++.++ .+||+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~df  148 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGA----------FKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADF  148 (268)
T ss_pred             EEeccCCCcHHHHHHHhCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccc
Confidence            9999999999999864321          235778889999999999999999  99999999999998776 5999999


Q ss_pred             ccceecCCCc-------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHHHHHHhcCCC
Q 039082          351 GHARFLSDGE-------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIAMEVGEGKL  422 (472)
Q Consensus       351 Gla~~~~~~~-------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i~~~i~~~~~  422 (472)
                      |++.......       ....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .......+.....
T Consensus       149 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (268)
T cd06630         149 GAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATT  228 (268)
T ss_pred             ccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCC
Confidence            9997765321       1235788999999998888999999999999999999999999654422 2223333332222


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.++  ......+.+++.+||..+|++||++.++++
T Consensus       229 ~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         229 APSIP--EHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CCCCc--hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            22222  234567888999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.9e-37  Score=306.63  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=198.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|.....||.|+||.||++...  +..||||.+...    .....+.+.+|+.+++.++||||+++++.+...+..++++
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR----KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc----hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            4455678999999999999874  678999988542    2344566889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++...           ..++..+..++.+|+.||+|||+++  ++||||||+||+++.++.++|+|||++
T Consensus        99 e~~~~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~  165 (292)
T cd06658          99 EFLEGGALTDIVTHT-----------RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFC  165 (292)
T ss_pred             eCCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcch
Confidence            999999999988431           1246778899999999999999999  999999999999999999999999998


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|+..|+|||.+.+..++.++||||||+++|||++|..||...+  .......+... ..+.++...
T Consensus       166 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~  242 (292)
T cd06658         166 AQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP--PLQAMRRIRDN-LPPRVKDSH  242 (292)
T ss_pred             hhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhc-CCCcccccc
Confidence            7654222   23457899999999988889999999999999999999999997655  22232222222 222333323


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .....+.+++.+||..+|.+|||++++++.
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            345578889999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.8e-36  Score=296.66  Aligned_cols=244  Identities=28%  Similarity=0.412  Sum_probs=202.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      -|++.+.||+|+||.||+|.++  +..||||++...   ........|.+|+.+++.++||||+++++.+...+..++|+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE---EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc---cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEE
Confidence            4677899999999999999875  678999988543   22344567889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|..++...           ..++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        82 e~~~~~~l~~~i~~~-----------~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~  148 (277)
T cd06641          82 EYLGGGSALDLLEPG-----------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVA  148 (277)
T ss_pred             EeCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccc
Confidence            999999999998531           1346788899999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....++..|+|||.+.+..++.++|+|||||++|+|++|..||....  .......+..+. .+.++  .
T Consensus       149 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~--~  223 (277)
T cd06641         149 GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH--PMKVLFLIPKNN-PPTLE--G  223 (277)
T ss_pred             eecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc--hHHHHHHHhcCC-CCCCC--c
Confidence            8765432   23457889999999988889999999999999999999999997654  344444444332 22222  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ..+..+.+++.+||..+|++||++.+++..
T Consensus       224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         224 NYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            345678889999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.5e-38  Score=302.74  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=186.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc---e
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR---G  270 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~---~  270 (472)
                      .|.-.+++|+|+||.||.|...  +..||||....+..-.        .+|+.+|+.++|||||+|.-+|......   |
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k--------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~   96 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK--------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY   96 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC--------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence            4677899999999999999876  5789999887654322        2789999999999999998887653222   2


Q ss_pred             --EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEEE
Q 039082          271 --WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVRI  347 (472)
Q Consensus       271 --~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vkL  347 (472)
                        +|+|| +..+|..+++..-....      ..+...+.-+++||.+||+|||+.|  |+||||||.|+|||.+ |.+||
T Consensus        97 lnlVley-mP~tL~~~~r~~~~~~~------~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKi  167 (364)
T KOG0658|consen   97 LNLVLEY-MPETLYRVIRHYTRANQ------RMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKI  167 (364)
T ss_pred             HHHHHHh-chHHHHHHHHHHhhcCC------CCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEe
Confidence              45555 48889988864322111      1234557778999999999999999  9999999999999965 99999


Q ss_pred             eecccceecCCCcc--ccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC-
Q 039082          348 ADFGHARFLSDGEM--ALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK-  421 (472)
Q Consensus       348 ~DFGla~~~~~~~~--~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~-  421 (472)
                      ||||.|+.+..+..  +...+..|+|||.+.+ ..|+.+.||||.||++.||+-|+.-|++.+.  .+....+.+  |. 
T Consensus       168 cDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~P  245 (364)
T KOG0658|consen  168 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTP  245 (364)
T ss_pred             ccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCC
Confidence            99999998876544  3456899999999875 5799999999999999999999999998762  222222111  10 


Q ss_pred             ---------C---C---CCCCC-------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 ---------L---R---PALPE-------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ---------~---~---~~l~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                               .   .   +.+..       ....+.++++++.+++..+|.+|.++.+++.
T Consensus       246 t~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  246 TREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                     0   0   11111       1334578899999999999999999988874

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.9e-36  Score=289.49  Aligned_cols=246  Identities=27%  Similarity=0.421  Sum_probs=204.5

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||++.++  +..+++|++.....    .....+.+|+.+++.++||||+++++.+......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~   76 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK----EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVM   76 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            5788999999999999999986  77899999865422    35567899999999999999999999999988888999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++....         ...++..+..++.+++.||.|||+.|  ++|+||+|+||++++++.++|+|||.+
T Consensus        77 e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~  145 (253)
T cd05122          77 EFCSGGSLKDLLKSTN---------QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLS  145 (253)
T ss_pred             ecCCCCcHHHHHhhcC---------CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccc
Confidence            9999999999986432         12357788899999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          354 RFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       354 ~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      .......  ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.  ........... .+.++....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~~~~~~~~  222 (253)
T cd05122         146 AQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--MKALFKIATNG-PPGLRNPEK  222 (253)
T ss_pred             ccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--HHHHHHHHhcC-CCCcCcccc
Confidence            8876553  455689999999999888899999999999999999999999976642  22222222221 223333232


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+..+.+++.+||..||++|||+.++++
T Consensus       223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            3567899999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-36  Score=298.08  Aligned_cols=248  Identities=23%  Similarity=0.289  Sum_probs=197.2

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||.|+||.||+|.+.  |..||||++.....  .......+.+|+.+++.++||||+++++++......++|+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~   78 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL--EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVM   78 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc--cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEe
Confidence            5889999999999999999985  77899999876432  2344567899999999999999999999999988888888


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++ +++|.+++....         ...+...++.++.||+.||+|||+.+  ++|+||||+||+++.++.++|+|||++
T Consensus        79 e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~  146 (286)
T cd07832          79 EYM-PSDLSEVLRDEE---------RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLA  146 (286)
T ss_pred             ccc-CCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeec
Confidence            888 999999986432         12356788999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc----cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC-----
Q 039082          354 RFLSDGE----MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR-----  423 (472)
Q Consensus       354 ~~~~~~~----~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~-----  423 (472)
                      .......    ....|+..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+.  ......+......     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~  224 (286)
T cd07832         147 RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEET  224 (286)
T ss_pred             ccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCChHH
Confidence            8776432    234578999999998654 468999999999999999999888865541  1111111110000     


Q ss_pred             ------------CCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 ------------PALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ------------~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                  ...+.         .+.....+.++|.+||..+|++||++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                        00000         0223478899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-37  Score=304.84  Aligned_cols=254  Identities=31%  Similarity=0.445  Sum_probs=208.7

Q ss_pred             CCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh--cCCCceeEEEEEEEcCCC----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR--QRHRFVLQLMGACLEPPY----  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~g~~~~~~~----  268 (472)
                      .++.+.+.||+|.||+||+|.|+|..||||++..    .++   ..+.+|.++...  |+|+||+.|++.=..+..    
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~s----rdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSS----RDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecc----cch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            5788999999999999999999999999999842    122   236678888766  599999999986444332    


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh------cCCceeecCCCCCcEEEcCC
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE------QKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~------~~~~iiHrDLkp~NILl~~~  342 (472)
                      +++|.+|.+.|||++||...           ..+....+++++.+|.||++||.      .+|.|.|||||..||||..+
T Consensus       284 LwLvTdYHe~GSL~DyL~r~-----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn  352 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN-----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN  352 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc-----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccC
Confidence            56788999999999999642           22467789999999999999995      34679999999999999999


Q ss_pred             CcEEEeecccceecCCC-------ccccccCCcccccccccCCC----C--CchHHHHHHHHHHHHHHc----C------
Q 039082          343 KHVRIADFGHARFLSDG-------EMALTGTFVYMAPEVIQCEP----Y--SEKSDVYSFGIILNEIIT----G------  399 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~-------~~~~~gt~~y~APE~~~~~~----~--s~~sDvwSlGvll~ellt----G------  399 (472)
                      |.+-|+|+|+|......       ....+||.+|||||++...-    |  -..+||||||.++||++.    |      
T Consensus       353 ~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey  432 (513)
T KOG2052|consen  353 GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEY  432 (513)
T ss_pred             CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhh
Confidence            99999999999765532       34567999999999996431    2  246899999999999964    2      


Q ss_pred             CCCCCC---CCCCHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          400 NHPYIE---KDYKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       400 ~~Pf~~---~~~~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ..||.+   .+...+++...+...++||.+|..   .+....+.++|..||..||.-|-|+-.|.+.|.++.+
T Consensus       433 ~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  433 QLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             cCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            368865   344567788888888899999875   7788899999999999999999999999999998875

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.6e-37  Score=305.67  Aligned_cols=251  Identities=22%  Similarity=0.304  Sum_probs=180.3

Q ss_pred             eceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-CCceEEEE
Q 039082          200 QEKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-PYRGWLVT  274 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~vve  274 (472)
                      ..+||+|+||.||+|..+    +..||+|.+.....      ...+.+|+.+|+.++||||+++++++... +...++++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI------SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF   79 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC------cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence            368999999999999875    35799998864321      23477899999999999999999988643 33344555


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE----cCCCcEEEeec
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADF  350 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl----~~~~~vkL~DF  350 (472)
                      ++.+++|.+++......... ......++..+..++.||+.||.|||+.+  ++||||||+|||+    +.++.+||+||
T Consensus        80 e~~~~~l~~~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          80 DYAEHDLWHIIKFHRASKAN-KKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeeCCcHHHHHHhhhccccC-CCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            55677888888543221111 11122456778899999999999999999  9999999999999    56679999999


Q ss_pred             ccceecCCCc------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--------HHHHH
Q 039082          351 GHARFLSDGE------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--------AKIAM  415 (472)
Q Consensus       351 Gla~~~~~~~------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--------~~i~~  415 (472)
                      |+++......      ....||+.|+|||.+.+ ..++.++|||||||++|||+||..||.......        .....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            9998765332      23457899999999876 458999999999999999999999996533110        00000


Q ss_pred             HHh-cCC---------------------C-CCCC---------CC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVG-EGK---------------------L-RPAL---------PE-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~-~~~---------------------~-~~~l---------~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ... -+.                     . ....         +. .......+.++|.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence            000 000                     0 0000         00 0112345778999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-36  Score=292.04  Aligned_cols=249  Identities=28%  Similarity=0.439  Sum_probs=206.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||.|++|.||+|.++  +..||||.+.....   ......+.+|+.++..++||||+++++++...+..+++
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD---EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIV   77 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc---hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEE
Confidence            36889999999999999999986  77899999876422   24567799999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ++++.+++|.+++....          ..+...++.++.+++.||+|||+ .+  ++|+||+|+||+++.++.++|+|||
T Consensus        78 ~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~  145 (264)
T cd06623          78 LEYMDGGSLADLLKKVG----------KIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFG  145 (264)
T ss_pred             EEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCc
Confidence            99999999999996432          23467788999999999999999 99  9999999999999999999999999


Q ss_pred             cceecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHhcCCCCCCCC
Q 039082          352 HARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-KPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       352 la~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-~~~~i~~~i~~~~~~~~l~  427 (472)
                      ++........   ...++..|+|||.+....++.++|+||||+++|+|+||..||..... ........+.... .+.++
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~-~~~~~  224 (264)
T cd06623         146 ISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP-PPSLP  224 (264)
T ss_pred             cceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCC-CCCCC
Confidence            9987754332   34578999999999988999999999999999999999999976642 2333444444332 12222


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      . ...+..+.++|.+||..+|++||++.++++.
T Consensus       225 ~-~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         225 A-EEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             c-ccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1 1156789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9e-37  Score=319.30  Aligned_cols=245  Identities=20%  Similarity=0.302  Sum_probs=190.2

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ...|.+.+.||+|+||.||+|.+.  +..||||....          ..+.+|+.+|++++|||||++++++...+..++
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~----------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY----------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc----------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            457999999999999999999986  57899995321          125689999999999999999999998888888


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++ .++|..++.....         ..++..++.++.||+.||+|||++|  ||||||||+||||+.++.+||+|||
T Consensus       238 v~e~~-~~~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFG  305 (461)
T PHA03211        238 VLPKY-RSDLYTYLGARLR---------PLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFG  305 (461)
T ss_pred             EEEcc-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccC
Confidence            88877 5788888853211         2357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC------CHHHHHHHHhcC
Q 039082          352 HARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY------KPAKIAMEVGEG  420 (472)
Q Consensus       352 la~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~------~~~~i~~~i~~~  420 (472)
                      +++......     ....||+.|+|||++.+..++.++|||||||++|||++|..|+.....      ....+...+...
T Consensus       306 la~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~  385 (461)
T PHA03211        306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQA  385 (461)
T ss_pred             CceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhh
Confidence            998764321     234589999999999999999999999999999999998766532211      112222222221


Q ss_pred             CCC-CCCC---------------------CC--------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 KLR-PALP---------------------EE--------DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 ~~~-~~l~---------------------~~--------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ... ..++                     ..        ......+.++|.+||..||.+|||+.++++.
T Consensus       386 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        386 QVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             ccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            110 0000                     00        0112367889999999999999999999864

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=3e-37  Score=298.38  Aligned_cols=247  Identities=27%  Similarity=0.316  Sum_probs=202.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||.|+||.||+|.++  +..||+|++.+... ......+.+.+|+.++++++||||+++++.+.+.+..++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKC-VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhh-cchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEE
Confidence            4789999999999999999986  78899999976433 22345677999999999999999999999999888899999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.|++|..++....          ..+...+..++.+++.||.|||+++  ++|+||+|+||++++++.++|+|||++
T Consensus        80 e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~  147 (258)
T cd05578          80 DLLLGGDLRYHLSQKV----------KFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIA  147 (258)
T ss_pred             eCCCCCCHHHHHHhcC----------CcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeecccc
Confidence            9999999999996432          1235778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          354 RFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       354 ~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      ......  .....|+..|+|||.+....++.++|+||||+++|+|++|..||...+............. ..+..+.  .
T Consensus       148 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~  224 (258)
T cd05578         148 TKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-ADVLYPA--T  224 (258)
T ss_pred             cccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-ccccCcc--c
Confidence            876543  2334578899999999888899999999999999999999999987664323333332222 1223332  3


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCH--HHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSF--SSIT  458 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~--~~ll  458 (472)
                      .+..+.++|.+||..+|.+||++  .+++
T Consensus       225 ~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         225 WSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            45788899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=343.73  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=208.7

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .-.+.++||+++++||+|+||.|.+++.+  +..||+|++.+..+. .......|..|..+|..-+.+.||.++-.|.++
T Consensus        69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMl-Kr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEML-KRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHh-hchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            34577899999999999999999999987  568999999764332 223457799999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      .++|+||+||.||+|.++|.+.+.          .+...++.++.+|+.||+-||+.|  +|||||||+|||||.+|++|
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~~~----------~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKFDR----------LPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhcCC----------ChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEe
Confidence            999999999999999999976552          235667788889999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCcc----ccccCCccccccccc----C-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          347 IADFGHARFLSDGEM----ALTGTFVYMAPEVIQ----C-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       347 L~DFGla~~~~~~~~----~~~gt~~y~APE~~~----~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      |+|||.|-.+.....    ..+|||.|++||++.    + +.|+..+||||+||++|||++|..||...+  -...+-.|
T Consensus       216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads--lveTY~KI  293 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS--LVETYGKI  293 (1317)
T ss_pred             eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH--HHHHHHHH
Confidence            999999988874433    456999999999986    3 579999999999999999999999997766  34445555


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC---HHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS---FSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs---~~~ll~  459 (472)
                      ..-.-...+|.....+....++|.+.+. +|+.|..   +++|..
T Consensus       294 m~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  294 MNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             hchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence            5543345566544566777777766554 5667766   776654

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8.2e-37  Score=299.44  Aligned_cols=247  Identities=24%  Similarity=0.334  Sum_probs=193.5

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc-----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE-----  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~-----  265 (472)
                      .+.|++.+.||.|+||.||+|.++  +..||+|++...     ......+..|+.+++++ +||||+++++++..     
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   89 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG   89 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence            357888999999999999999985  678999988542     23345688899999998 79999999999863     


Q ss_pred             -CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          266 -PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       266 -~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                       .+..+++++++.+++|.+++......        ..+...+..++.|++.||+|||+.+  ++|+||+|+||++++++.
T Consensus        90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~  159 (282)
T cd06636          90 HDDQLWLVMEFCGAGSVTDLVKNTKGN--------ALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             CCCEEEEEEEeCCCCcHHHHHHHccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCC
Confidence             34567888898899999998643211        1235667788999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      ++|+|||++......   .....|++.|+|||.+.     ...++.++|||||||++|+|++|..||....  +......
T Consensus       160 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~--~~~~~~~  237 (282)
T cd06636         160 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH--PMRALFL  237 (282)
T ss_pred             EEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC--HHhhhhh
Confidence            999999998765422   23455889999999985     3468889999999999999999999996554  2222222


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.... .+... ....+..+.++|.+||..||.+||++.+|++
T Consensus       238 ~~~~~-~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 IPRNP-PPKLK-SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             HhhCC-CCCCc-ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            22221 11111 1234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.5e-37  Score=304.59  Aligned_cols=246  Identities=26%  Similarity=0.362  Sum_probs=199.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|.....||+|+||.||+|.++  +..||||++....    ....+.+.+|+.+++.++||||+++++.+...+..+++
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc----cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            34555678999999999999875  7899999986532    22345588999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|..++...           ..++..++.++.|++.||+|||+++  ++||||+|+||+++.++.+||+|||+
T Consensus        97 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~  163 (297)
T cd06659          97 MEFLQGGALTDIVSQT-----------RLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGF  163 (297)
T ss_pred             EecCCCCCHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechh
Confidence            9999999999877431           1246778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +......   .....|+..|+|||.+.+..++.++|||||||++|+|++|..||...+  .......+.... .+.....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~  240 (297)
T cd06659         164 CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSP-PPKLKNA  240 (297)
T ss_pred             HhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhccC-CCCcccc
Confidence            8755432   233458999999999998889999999999999999999999997654  333333333221 1111112


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ......+.++|.+||..+|++||++++|++.
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            3345678899999999999999999999874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.7e-37  Score=300.62  Aligned_cols=249  Identities=22%  Similarity=0.243  Sum_probs=190.4

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||+|.++  |..||+|.++....  .......+.+|+.+++.++||||+++++++.+....++++
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVF   78 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc--cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEE
Confidence            4788999999999999999985  78899999865422  2223345778999999999999999999998888777777


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++ +++|.+++.....         ..++..++.++.||+.||.|||+++  ++||||||+||+++.++.+||+|||++
T Consensus        79 e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~  146 (284)
T cd07839          79 EYC-DQDLKKYFDSCNG---------DIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLA  146 (284)
T ss_pred             ecC-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchh
Confidence            776 5688888754221         1346788999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCcc---ccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc----------
Q 039082          354 RFLSDGEM---ALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE----------  419 (472)
Q Consensus       354 ~~~~~~~~---~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~----------  419 (472)
                      ........   ...+++.|+|||.+.+. .++.++|||||||++|+|+||..||..... .......+..          
T Consensus       147 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07839         147 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEESW  225 (284)
T ss_pred             hccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC-HHHHHHHHHHHhCCCChHHh
Confidence            86653322   23468899999998764 478999999999999999999988643322 1111111110          


Q ss_pred             --------CCCCCCCCCC-------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 --------GKLRPALPEE-------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 --------~~~~~~l~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              ....+..+..       +....++.++|.+||..||.+|||+++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         226 PGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             HHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                    0000001100       123467789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-36  Score=296.30  Aligned_cols=244  Identities=29%  Similarity=0.421  Sum_probs=198.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC---CCceeEEEEEEEcCCCce
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR---HRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~g~~~~~~~~~  270 (472)
                      .|++.+.||+|+||.||+|.+.  +..||+|.+..+.   .......+.+|+.+++.++   |||++++++++...+..+
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~   78 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT---PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLW   78 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC---CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEE
Confidence            4678899999999999999985  7789999986542   3344566889999999996   999999999999888888


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      ++++++.+++|.+++...           ..++..++.++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+||
T Consensus        79 lv~e~~~~~~L~~~~~~~-----------~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~df  145 (277)
T cd06917          79 IIMEYAEGGSVRTLMKAG-----------PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDF  145 (277)
T ss_pred             EEEecCCCCcHHHHHHcc-----------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccC
Confidence            999999999999988532           1246778899999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          351 GHARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       351 Gla~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      |++.......   ....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+  .......+.... .+.+
T Consensus       146 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~--~~~~~~~~~~~~-~~~~  222 (277)
T cd06917         146 GVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMMLIPKSK-PPRL  222 (277)
T ss_pred             CceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC--hhhhhhccccCC-CCCC
Confidence            9998775432   23458889999999865 457899999999999999999999997655  222222222221 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +. ...+.++.+++.+||..||++||++.+++.
T Consensus       223 ~~-~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 ED-NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Cc-ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            22 225568899999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2.9e-36  Score=299.84  Aligned_cols=248  Identities=24%  Similarity=0.268  Sum_probs=197.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|.+.+.||+|+||.||+|.+.  |..||+|++..... ...+....+.+|+.+++.++||||++++++|...+..++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEecccc-CcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            56888999999999999999875  77899998864322 2334456688999999999999999999999988888777


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++ .|+|.+++.....         ..++..+..++.|++.||.|||+.+  ++||||+|+||+++.++.++|+|||+
T Consensus        94 ~e~~-~g~l~~~~~~~~~---------~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~  161 (307)
T cd06607          94 MEYC-LGSASDILEVHKK---------PLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGS  161 (307)
T ss_pred             HHhh-CCCHHHHHHHccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCc
Confidence            7776 4677777643221         2356778899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +...... ....+++.|+|||.+.   ...++.++||||||+++|+|++|..||...+  .......+..+. .+.++. 
T Consensus       162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~--~~~~~~~~~~~~-~~~~~~-  236 (307)
T cd06607         162 ASLVSPA-NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQND-SPTLSS-  236 (307)
T ss_pred             ceecCCC-CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc--HHHHHHHHhcCC-CCCCCc-
Confidence            9766433 3456788999999874   4568899999999999999999999997655  333333333322 122221 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ...+..+.++|.+||..+|++||++.+|+..
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         237 NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            2345678999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-37  Score=317.07  Aligned_cols=245  Identities=26%  Similarity=0.383  Sum_probs=211.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|.+.+.||+|.|+.|.+|++.  +..||||.+.+...  +......+.+|+.+|+.++|||||+++.+......+|+|
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~l--n~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQL--NPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhccc--ChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            46889999999999999999875  88999999988654  444445588999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +||..+|.+++|+.+++...          ...+..++.|++.|++|||+++  |||||||++||||+.+..+||+|||+
T Consensus       134 ~eya~~ge~~~yl~~~gr~~----------e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGRMK----------EKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             EEeccCchhHHHHHhcccch----------hhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeecccc
Confidence            99999999999998877543          2557788999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +..+..+.  .+.+|++.|+|||++.+..|+ +.+|+||+|+++|.|+.|.+||.+.+.+  .....+..|+++.+..-.
T Consensus       202 S~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk--~Lr~rvl~gk~rIp~~ms  279 (596)
T KOG0586|consen  202 STFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK--ELRPRVLRGKYRIPFYMS  279 (596)
T ss_pred             ceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc--cccchheeeeecccceee
Confidence            99988543  467899999999999998874 7999999999999999999999988743  356666777665444333


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                          .+..++|.+++-.+|.+|++.+++.+
T Consensus       280 ----~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  280 ----CDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ----chhHHHHHHhhccCccccCCHHHhhh
Confidence                24566777899999999999998864

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=291.92  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=197.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCC-CCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--Cc
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFF-HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--YR  269 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~-~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--~~  269 (472)
                      .+|++.+.||+|+||.||+|.++  +..||+|++..+.. .........|.+|+.+++.++||||+++++.+.+..  ..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999999875  67899998754321 123345677899999999999999999999887643  46


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      +++++++.+++|.+++...+.          .+......++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~----------l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~d  149 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGA----------LTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGD  149 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECc
Confidence            678888889999999864321          235667888999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          350 FGHARFLSDG------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       350 FGla~~~~~~------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ||+++.....      .....++..|+|||.+.+..++.++|+|||||++|+|++|+.||.+..  .......+.....+
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~  227 (264)
T cd06653         150 FGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIFKIATQPTK  227 (264)
T ss_pred             cccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC--HHHHHHHHHcCCCC
Confidence            9999865321      123457899999999998889999999999999999999999997654  33333333333323


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.+|.  .....+.+++.+||. +|.+||++.+++.
T Consensus       228 ~~~p~--~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         228 PMLPD--GVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCCc--ccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            33443  344678889999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.8e-36  Score=298.32  Aligned_cols=244  Identities=26%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|.-.+.||+|+||.||++.++  +..+++|.+...    .....+.+.+|+.+++.++||||+++++++...+..++++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~----~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~   95 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR----KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM   95 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc----chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence            4555689999999999999875  678999988532    2234456889999999999999999999999989999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++...           ..+...+..++.+++.||+|||+++  ++||||+|+||+++.++.++|+|||++
T Consensus        96 e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~  162 (285)
T cd06648          96 EFLEGGALTDIVTHT-----------RMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFC  162 (285)
T ss_pred             eccCCCCHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccc
Confidence            999999999998641           1246778899999999999999999  999999999999999999999999988


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  +......+..+. .+......
T Consensus       163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~~  239 (285)
T cd06648         163 AQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP--PLQAMKRIRDNL-PPKLKNLH  239 (285)
T ss_pred             hhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHhcC-CCCCcccc
Confidence            7554322   23458899999999988889999999999999999999999997654  333444444332 22222222


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.+++.+||..+|++||++.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            35567899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-36  Score=298.99  Aligned_cols=249  Identities=22%  Similarity=0.306  Sum_probs=196.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||.++....  .......+.+|+.+++.++|+||+++++++...+..+++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv   78 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLV   78 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc--cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEE
Confidence            36899999999999999999986  67899998865422  334456789999999999999999999999998888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.++.+..++....          ..+...+..++.+++.||+|||+++  ++|+||+|+||++++++.+||+|||+
T Consensus        79 ~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~  146 (288)
T cd07833          79 FEYVERTLLELLEASPG----------GLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGF  146 (288)
T ss_pred             EecCCCCHHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeec
Confidence            88888776665553211          1246788899999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc----cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--C-----
Q 039082          353 ARFLSDGE----MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--G-----  420 (472)
Q Consensus       353 a~~~~~~~----~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~-----  420 (472)
                      +.......    ....++..|+|||.+.+. .++.++||||||+++|+|++|..||.+...  .+....+..  +     
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~  224 (288)
T cd07833         147 ARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSD--IDQLYLIQKCLGPLPPS  224 (288)
T ss_pred             ccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCHH
Confidence            98766433    234568889999999887 889999999999999999999999976542  111111100  0     


Q ss_pred             ---------CCCC-CCCCC-----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 ---------KLRP-ALPEE-----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ---------~~~~-~l~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                               .... .++..           ...+..+.++|.+||..+|++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         225 HQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             HhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                     0000 00000           112567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-36  Score=292.78  Aligned_cols=247  Identities=26%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||+|.++  |..||+|.+.....  .......+.+|+.+++.++|+||+++++.+...+..++++
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~   78 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM--PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVM   78 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc--cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEE
Confidence            4788999999999999999986  67899999865432  2234456889999999999999999999999988889999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEEEeeccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGH  352 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vkL~DFGl  352 (472)
                      +++.+++|.+++.....        ...++..+..++.+++.||+|||+.+  ++|+||+|+||++++++ .+||+|||.
T Consensus        79 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~  148 (257)
T cd08225          79 EYCDGGDLMKRINRQRG--------VLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGI  148 (257)
T ss_pred             ecCCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEeccccc
Confidence            99999999999864221        12356788999999999999999999  99999999999999886 469999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....|++.|+|||.+....++.++|+||||+++|+|++|..||...+  .......+..+...+..   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~---  223 (257)
T cd08225         149 ARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--LHQLVLKICQGYFAPIS---  223 (257)
T ss_pred             chhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhcccCCCCC---
Confidence            98765432   22357899999999988889999999999999999999999997655  34445555554432211   


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..+..+.+++.+||..+|++||++.+++.
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         224 PNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            234567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=7.6e-37  Score=299.84  Aligned_cols=249  Identities=20%  Similarity=0.263  Sum_probs=196.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||+|++.....  .....+.+.+|+++++.++||||+++++++..+...++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   78 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED--DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLV   78 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC--cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEE
Confidence            46889999999999999999985  67899998865432  223456688999999999999999999999998889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++|+.+++|..+.....          ..++..+..++.|++.||+|||+.+  ++|+||+|+||++++++.++|+|||+
T Consensus        79 ~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~  146 (286)
T cd07846          79 FEFVDHTVLDDLEKYPN----------GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGF  146 (286)
T ss_pred             EecCCccHHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeee
Confidence            99999988887764321          1347888999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCcc---ccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc---------
Q 039082          353 ARFLSDGEM---ALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE---------  419 (472)
Q Consensus       353 a~~~~~~~~---~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~---------  419 (472)
                      +........   ...++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+.  .+....+..         
T Consensus       147 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~  224 (286)
T cd07846         147 ARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNLIPRH  224 (286)
T ss_pred             eeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCCchhh
Confidence            987643322   2347889999999865 4578899999999999999999999975542  111111110         


Q ss_pred             -----------CCCCCCCCC-------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 -----------GKLRPALPE-------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 -----------~~~~~~l~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 +...+....       .+..+..+.+++.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         225 QEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                       000000000       1234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.3e-36  Score=297.11  Aligned_cols=246  Identities=26%  Similarity=0.374  Sum_probs=203.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.|+..+.||+|+||.||+|.++  +..||+|++.....     ....+.+|+++++.++|+||+++++.+...+..+++
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            56888899999999999999986  78899999865321     456688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++....         ...++..+..++.+++.||+|||+.|  ++|+||+|+||+++.++.++|+|||+
T Consensus        94 ~e~~~~~~L~~~l~~~~---------~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~  162 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---------VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGF  162 (286)
T ss_pred             EeccCCCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccch
Confidence            99999999999997533         12356788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+  +......+.... .+..+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~~  239 (286)
T cd06614         163 AAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP--PLRALFLITTKG-IPPLKNP  239 (286)
T ss_pred             hhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcC-CCCCcch
Confidence            87654322   23447889999999988889999999999999999999999997654  333334443333 1222222


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..+|.+||++.+++.
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            335678899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3e-36  Score=297.00  Aligned_cols=250  Identities=22%  Similarity=0.232  Sum_probs=190.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+|.+.+.||+|+||.||+|.++  |..||+|++..+..   ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE---EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc---CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            67999999999999999999875  77999999865432   22233567899999999999999999999988888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++ +++|.+++.....         ..+...+..++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||+
T Consensus        82 ~e~~-~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~  149 (291)
T cd07870          82 FEYM-HTDLAQYMIQHPG---------GLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGL  149 (291)
T ss_pred             Eecc-cCCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccc
Confidence            8887 5778777643211         1235667788999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc-C-------
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE-G-------  420 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~-~-------  420 (472)
                      ++.....   .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||...+.....+...... +       
T Consensus       150 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  229 (291)
T cd07870         150 ARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTW  229 (291)
T ss_pred             ccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhh
Confidence            9764322   2233468899999998754 58899999999999999999999997654221111111100 0       


Q ss_pred             --------C----CCCCCCC-------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 --------K----LRPALPE-------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 --------~----~~~~l~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              .    .....+.       .......+.+++.+|+..||++|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                    0    0000000       0112456788999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.5e-36  Score=286.94  Aligned_cols=247  Identities=28%  Similarity=0.418  Sum_probs=206.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCceE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYRGW  271 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~~~  271 (472)
                      +|.+.+.||+|++|.||+|.++  +..|++|++.....  .......+.+|+.++++++||||+++++.+...  ...++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~l   78 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD--SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNI   78 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc--chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEE
Confidence            4778899999999999999986  78899999876532  245567799999999999999999999999887  77788


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++....          ..++..++.++.+++.||+|||+.+  ++|+||+|+||+++.++.++|+|||
T Consensus        79 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~  146 (260)
T cd06606          79 FLEYVSGGSLSSLLKKFG----------KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFG  146 (260)
T ss_pred             EEEecCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccc
Confidence            888888999999986432          2346788999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          352 HARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       352 la~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      .+.......     ....++..|+|||.+....++.++||||||+++|+|++|..||...+ ........+..+...+.+
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~  225 (260)
T cd06606         147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-NPMAALYKIGSSGEPPEI  225 (260)
T ss_pred             cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-chHHHHHhccccCCCcCC
Confidence            998876543     34557899999999988889999999999999999999999997765 233344444433323333


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.  ..+..+.+++.+||..+|++||++.+++.
T Consensus       226 ~~--~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         226 PE--HLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             Cc--ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            33  33568899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=296.71  Aligned_cols=251  Identities=22%  Similarity=0.264  Sum_probs=191.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|..+  +..||||.+..+...   .....+.+|+++++.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE---GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc---CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            368999999999999999999885  678999998754321   122346789999999999999999999998888888


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++. ++|.+++.....         ..++..+..++.|++.||.|||+++  ++||||||+|||++.++.+||+|||
T Consensus        81 v~e~~~-~~L~~~~~~~~~---------~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg  148 (291)
T cd07844          81 VFEYLD-TDLKQYMDDCGG---------GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFG  148 (291)
T ss_pred             EEecCC-CCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccc
Confidence            888876 589998864321         2246778889999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh--cC-----
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG--EG-----  420 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~--~~-----  420 (472)
                      +++......   ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.......+.....  ..     
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (291)
T cd07844         149 LARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEET  228 (291)
T ss_pred             cccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhh
Confidence            987654221   12246788999999865 55899999999999999999999999665421111111000  00     


Q ss_pred             -----------CCCCCC--CC-----Cchh--HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 -----------KLRPAL--PE-----EDGQ--LRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 -----------~~~~~l--~~-----~~~~--~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 ......  +.     ....  ...+.+++.+||..+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                       000000  00     0011  256789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.8e-36  Score=298.27  Aligned_cols=258  Identities=26%  Similarity=0.415  Sum_probs=201.0

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGA  262 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~  262 (472)
                      ....|.++.++|++.+.||+|+||.||+|.++  +..||||.++...   .......+..|+.++... .||||++++++
T Consensus         6 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618           6 DGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG---NKEENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             cceeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccC---ChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence            34567888899999999999999999999997  7899999987542   223345566777777666 59999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~  341 (472)
                      |.+....+++++++ +++|.+++.....         ..++..+..++.+++.||+|||+ .+  ++||||+|+||++++
T Consensus        83 ~~~~~~~~~v~e~~-~~~l~~l~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~~--i~H~dl~p~nill~~  150 (296)
T cd06618          83 FITDSDVFICMELM-STCLDKLLKRIQG---------PIPEDILGKMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDA  150 (296)
T ss_pred             eecCCeEEEEeecc-CcCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhhCC--EecCCCcHHHEEEcC
Confidence            99888887777775 6677777643221         23467788899999999999997 57  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc--cccccCCcccccccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          342 AKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~----~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      ++.+||+|||++.......  ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||..... ..+...
T Consensus       151 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~  229 (296)
T cd06618         151 SGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-EFEVLT  229 (296)
T ss_pred             CCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-HHHHHH
Confidence            9999999999997664322  2234688999999987553    78999999999999999999999965432 223333


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+.... .+..+.....+.++.+++.+||..+|++||++.+++..
T Consensus       230 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         230 KILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            333332 22233323356788999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.2e-36  Score=295.77  Aligned_cols=243  Identities=28%  Similarity=0.355  Sum_probs=188.2

Q ss_pred             eeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh---cCCCceeEEEEEEEcCCCceEEEEec
Q 039082          202 KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR---QRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~---l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      .||+|+||.||++.+.  +..||+|++.+...... .....+.+|..++..   .+||||+.+++.+...+..++|++|+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc-hHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence            4899999999999885  67899999976543222 222334555544443   47999999999999988999999999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .+++|..++...+          ..++..+..++.|++.||+|||+.+  ++||||||+|||+++++.++|+|||++...
T Consensus        80 ~~~~L~~~i~~~~----------~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~  147 (279)
T cd05633          80 NGGDLHYHLSQHG----------VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF  147 (279)
T ss_pred             CCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceec
Confidence            9999999886432          2357788899999999999999999  999999999999999999999999999765


Q ss_pred             CCCc-cccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          357 SDGE-MALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       357 ~~~~-~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      .... ....|++.|+|||.+. +..++.++|||||||++|+|++|..||................ .....++  ...+.
T Consensus       148 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~  224 (279)
T cd05633         148 SKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-TVNVELP--DSFSP  224 (279)
T ss_pred             cccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-cCCcCCc--cccCH
Confidence            4332 2346899999999986 4568999999999999999999999997654322222211111 1122232  23456


Q ss_pred             HHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 039082          435 ELIELICLSWDGDASVRP-----SFSSITCS  460 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RP-----s~~~ll~~  460 (472)
                      ++.++|.+||..||++||     ++.++++.
T Consensus       225 ~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         225 ELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             HHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            788999999999999999     58888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.5e-36  Score=298.36  Aligned_cols=250  Identities=20%  Similarity=0.234  Sum_probs=195.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC-ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +|++.+.||+|+||.||+|.++  |..||||.++...... .......+.+|+.+++.++|+||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999985  6799999997654321 123345577899999999999999999999998888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++ +++|..++....         ...++..++.++.||+.||+|||++|  ++|+||+|+|||++.++.++|+|||+
T Consensus        81 ~e~~-~~~L~~~i~~~~---------~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~  148 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---------IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGL  148 (298)
T ss_pred             Eccc-CCCHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEcccee
Confidence            8888 999999986422         12357888999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC-------
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK-------  421 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~-------  421 (472)
                      +.......   ....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+.  ......+....       
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~  226 (298)
T cd07841         149 ARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD--IDQLGKIFEALGTPTEEN  226 (298)
T ss_pred             eeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc--HHHHHHHHHHcCCCchhh
Confidence            98765432   22345788999998854 4678999999999999999999888865542  11111111100       


Q ss_pred             ----------C----CCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 ----------L----RPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ----------~----~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                .    .+..+.   .......+.++|.+||..+|++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                      0    000000   0223567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2e-36  Score=296.31  Aligned_cols=242  Identities=27%  Similarity=0.351  Sum_probs=192.2

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||+|+||.||+|.++  |..||+|++...... .......+.+|+++|+.++||||+++++++...+..++|++|+.+++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLK-KRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhh-hhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            699999999999875  789999998754322 22344567889999999999999999999999899999999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE  360 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  360 (472)
                      |.+++.....        ...+...+..++.|++.||.|||+.+  ++||||+|+||++++++.++|+|||++.......
T Consensus        80 L~~~l~~~~~--------~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~  149 (277)
T cd05577          80 LKYHIYNVGE--------PGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK  149 (277)
T ss_pred             HHHHHHHcCc--------CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC
Confidence            9999864332        12356778889999999999999999  9999999999999999999999999987654322


Q ss_pred             --cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHHhcCCCCCCCCCCchhHHHH
Q 039082          361 --MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--PAKIAMEVGEGKLRPALPEEDGQLREL  436 (472)
Q Consensus       361 --~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--~~~i~~~i~~~~~~~~l~~~~~~~~~l  436 (472)
                        ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......  ...+...+...  ....+  ......+
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~  225 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--AVEYP--DKFSPEA  225 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc--cccCC--ccCCHHH
Confidence              2345688999999998888999999999999999999999999765531  12222221111  11122  2345678


Q ss_pred             HHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          437 IELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       437 ~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      .++|.+||..+|++||     ++.+++.
T Consensus       226 ~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         226 KDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHccCChhHccCCCcccHHHHHh
Confidence            8999999999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.1e-36  Score=296.60  Aligned_cols=249  Identities=23%  Similarity=0.296  Sum_probs=192.6

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||.|+||.||+|.++  |..||||.+..+..  .......+.+|++++++++||||+++++++.+.+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   78 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc--ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEe
Confidence            4788999999999999999985  77899998865432  2233456889999999999999999999999888888888


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++ .++|.+++.....        ...++..++.++.+++.||+|||+.+  ++|+||+|+||+++.++.+||+|||++
T Consensus        79 e~~-~~~l~~~~~~~~~--------~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~  147 (284)
T cd07860          79 EFL-HQDLKKFMDASPL--------SGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLA  147 (284)
T ss_pred             ecc-ccCHHHHHHhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccch
Confidence            887 5689888854321        12346778899999999999999999  999999999999999999999999998


Q ss_pred             eecCCCc---cccccCCcccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc-CCCC-----
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE-GKLR-----  423 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~-~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~-~~~~-----  423 (472)
                      .......   ....+++.|+|||.+.+.. ++.++||||||+++|+|+||+.||...+.  ......+.. ....     
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07860         148 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPDEVVW  225 (284)
T ss_pred             hhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCChhhh
Confidence            7664322   2234688899999887644 68899999999999999999999976542  111111111 0000     


Q ss_pred             ----------CCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 ----------PALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ----------~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                ..++.         .+.....+.++|.+||..||++||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                      00000         0123456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-36  Score=322.94  Aligned_cols=258  Identities=19%  Similarity=0.290  Sum_probs=187.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEECC---eeEEEEEec-------------cCCCCCChHHHHHHHHHHHHHHhcCCCcee
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWRG---LDVAVKCIY-------------PDFFHTNENAVTFFAQEVDTLSRQRHRFVL  257 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~g---~~vAVK~l~-------------~~~~~~~~~~~~~f~~E~~il~~l~HpnIv  257 (472)
                      .++|+++++||+|+||.||+|.++.   ..+++|.+.             .............+.+|+.+|+.++|||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            3689999999999999999987642   122222110             001112233456688999999999999999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcE
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI  337 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NI  337 (472)
                      ++++++...+..+++++++ +++|..++.......     ...+.......++.||+.||+|||++|  ||||||||+||
T Consensus       227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-----~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NI  298 (501)
T PHA03210        227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDW-----KDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENI  298 (501)
T ss_pred             cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccc-----cccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence            9999999888887777766 677888775432111     112235667789999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCC-CCCCCCCCHHH
Q 039082          338 FLDDAKHVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNH-PYIEKDYKPAK  412 (472)
Q Consensus       338 Ll~~~~~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~-Pf~~~~~~~~~  412 (472)
                      ||+.++.+||+|||++..+....    ....||+.|+|||++.+..++.++|||||||++|||++|.. ||......+..
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            99999999999999998775432    23468999999999999999999999999999999999775 45433322222


Q ss_pred             HHHHHhcCC--CCCCCC-----------------------CC---chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          413 IAMEVGEGK--LRPALP-----------------------EE---DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       413 i~~~i~~~~--~~~~l~-----------------------~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+....  ....++                       ..   ...+..+.++|.+||..||.+|||+.+++.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            222211110  000011                       00   112345667788999999999999999986

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=303.01  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=205.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      -|.++.+||+|+||.||+|.++  |..+|||.+.-+      .....+..|+.+|...+.|++|++||.++....+++||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM  107 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM  107 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc------chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence            4678999999999999999886  889999987532      34556889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      ||+-.|++.+.++-..         ...+..++..+....++||+|||...  -||||||+.|||++.+|++||+|||.|
T Consensus       108 EYCGAGSiSDI~R~R~---------K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVA  176 (502)
T KOG0574|consen  108 EYCGAGSISDIMRARR---------KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVA  176 (502)
T ss_pred             hhcCCCcHHHHHHHhc---------CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhcccc
Confidence            9999999999985322         23346778888999999999999998  899999999999999999999999999


Q ss_pred             eecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      -.+.+.   ..+..|||.|||||++..-.|+.++||||||++..||..|++||.+.-  +......+-... +|.+....
T Consensus       177 GQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH--PMRAIFMIPT~P-PPTF~KPE  253 (502)
T KOG0574|consen  177 GQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH--PMRAIFMIPTKP-PPTFKKPE  253 (502)
T ss_pred             chhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc--ccceeEeccCCC-CCCCCChH
Confidence            877643   345679999999999999999999999999999999999999996644  433333333332 33333335


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ....++-+++..||-++|++|.++-+|++.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            567889999999999999999999988753

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8e-36  Score=286.60  Aligned_cols=249  Identities=27%  Similarity=0.419  Sum_probs=207.6

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||++.+.  +..||+|++.....  .......+.+|+++++.++|||++++++.+...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~   78 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM--SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVM   78 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC--ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEE
Confidence            5788999999999999999986  78999999865432  3455667889999999999999999999999988888999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++.....      .....+...+..++.+++.||+|||+.|  ++|+||+|+||+++.++.++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~------~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~  150 (258)
T cd08215          79 EYADGGDLSQKIKKQKK------EGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGIS  150 (258)
T ss_pred             EecCCCcHHHHHHHhhc------cCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccce
Confidence            99999999999965321      1123457889999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      .......   ....|++.|+|||.+....++.++|+||||+++|+|++|..||...+  ...+......+. .+.++.  
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~~--  225 (258)
T cd08215         151 KVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--LLELALKILKGQ-YPPIPS--  225 (258)
T ss_pred             eecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--HHHHHHHHhcCC-CCCCCC--
Confidence            8765432   23457889999999988889999999999999999999999997665  444555555443 223332  


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+.+++.+||..+|++||++.++++
T Consensus       226 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         226 QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            34567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.1e-36  Score=289.14  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=206.2

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||.|+||.||++.++  +..+|+|.+.....  .......+.+|+.+++.++||||+++++++......++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM--SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVM   78 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc--cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEe
Confidence            4789999999999999999875  67899999875432  3344567889999999999999999999999888888899


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|..++......      ....++..+..++.+++.||+|||+.|  ++|+||+|+||++++++.+||+|||++
T Consensus        79 e~~~~~~L~~~~~~~~~~------~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~  150 (256)
T cd08530          79 EYAPFGDLSKAISKRKKK------RKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGIS  150 (256)
T ss_pred             hhcCCCCHHHHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccch
Confidence            999999999998652211      122356778899999999999999999  999999999999999999999999999


Q ss_pred             eecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchh
Q 039082          354 RFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ  432 (472)
Q Consensus       354 ~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~  432 (472)
                      ...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+  .......+..+... .++  ...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~~-~~~--~~~  225 (256)
T cd08530         151 KVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS--MQDLRYKVQRGKYP-PIP--PIY  225 (256)
T ss_pred             hhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCCC-CCc--hhh
Confidence            876543 223457899999999999899999999999999999999999997766  44455555555432 222  245


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          433 LRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       433 ~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..++.+++.+||..+|++||++.+++.
T Consensus       226 ~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         226 SQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            567899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.5e-36  Score=295.27  Aligned_cols=253  Identities=22%  Similarity=0.235  Sum_probs=190.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCC---
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPY---  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~---  268 (472)
                      ++|++.+.||+|+||.||+|.+.  |..||||.+.....  .......+.+|+.+++.++ ||||+++++++...+.   
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~   78 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD--EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGK   78 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc--ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCC
Confidence            46899999999999999999985  67899998865422  2223355788999999995 6999999999887665   


Q ss_pred             --ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcE
Q 039082          269 --RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHV  345 (472)
Q Consensus       269 --~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~v  345 (472)
                        .+++++++. ++|.+++......     .....++..++.++.||+.||.|||+++  ++||||+|+||+++. ++.+
T Consensus        79 ~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~  150 (295)
T cd07837          79 PSLYLVFEYLD-SDLKKFMDSNGRG-----PGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLL  150 (295)
T ss_pred             ceEEEEeeccC-cCHHHHHHHhccc-----CCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeE
Confidence              566777665 5898888643211     0112357888999999999999999999  999999999999998 8999


Q ss_pred             EEeecccceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC-
Q 039082          346 RIADFGHARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG-  420 (472)
Q Consensus       346 kL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~-  420 (472)
                      ||+|||++.......   ....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.  ......+... 
T Consensus       151 kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~  228 (295)
T cd07837         151 KIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIFKLL  228 (295)
T ss_pred             EEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHHh
Confidence            999999998654321   22346888999998864 4579999999999999999999999976542  2211111110 


Q ss_pred             ---CC--------------CCCCC-C-----CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 ---KL--------------RPALP-E-----EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ---~~--------------~~~l~-~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                         ..              .+... .     .+.....+.++|.+||..||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               00              00000 0     0234567889999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.1e-36  Score=296.78  Aligned_cols=251  Identities=24%  Similarity=0.253  Sum_probs=192.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--C
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--Y  268 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--~  268 (472)
                      +.++|++.+.||+|+||.||+|.++  |..||+|+++.+..  .......+.+|+.+++.++|+||+++++++....  .
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE--RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC--CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            4578999999999999999999985  78999999875432  1222234668999999999999999999987653  3


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|++++ +++|.+++....         ...++..+..++.|++.||+|||+.|  ++||||||+||+++.++.+||+
T Consensus        83 ~~lv~e~~-~~~l~~~l~~~~---------~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~  150 (309)
T cd07845          83 IFLVMEYC-EQDLASLLDNMP---------TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIA  150 (309)
T ss_pred             EEEEEecC-CCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEC
Confidence            55555555 668988886422         12356788999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC---
Q 039082          349 DFGHARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK---  421 (472)
Q Consensus       349 DFGla~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~---  421 (472)
                      |||++.......   ....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+  .......+....   
T Consensus       151 dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~--~~~~~~~~~~~~~~~  228 (309)
T cd07845         151 DFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS--EIEQLDLIIQLLGTP  228 (309)
T ss_pred             ccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCCC
Confidence            999998776432   12235788999999865 568999999999999999999999998765  333333222210   


Q ss_pred             ---C-----------CCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 ---L-----------RPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ---~-----------~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                         .           ...++..         ......+.++|.+||..||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               0           0000000         112466788999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-35  Score=283.81  Aligned_cols=245  Identities=29%  Similarity=0.459  Sum_probs=203.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.+.||+|+||.||+|.++  +..||+|.+.....  .+.....+.+|++++++++|||++++++++......++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI--KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIIL   78 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc--CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEE
Confidence            4788999999999999999875  67899999976532  2355677999999999999999999999999888888889


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.+++|.+++...+          ..++..+..++.+++.||.|||++|  ++||||+|+||+++.++.++|+|||++
T Consensus        79 e~~~~~~L~~~~~~~~----------~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~  146 (254)
T cd06627          79 EYAENGSLRQIIKKFG----------PFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVA  146 (254)
T ss_pred             ecCCCCcHHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccc
Confidence            9998999999986432          2346788899999999999999999  999999999999999999999999999


Q ss_pred             eecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      ........   ...++..|+|||.+.+..++.++||||||+++|+|++|..||...+  ............ .+.++  .
T Consensus       147 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~--~  221 (254)
T cd06627         147 TKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PMAALFRIVQDD-HPPLP--E  221 (254)
T ss_pred             eecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHhccC-CCCCC--C
Confidence            87765433   3457899999999988888999999999999999999999997655  323333333222 22233  2


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.+++.+||..+|++||++.+++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         222 GISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            34567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-37  Score=306.89  Aligned_cols=254  Identities=21%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      -..+....|+++++||+|+.+.||++...+ +.||+|.+...  ..+.....-|.+|+..|.+| .|.+||.+|+|-..+
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~--~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d  432 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL--EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD  432 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh--hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence            356778899999999999999999998864 56787766543  34677788899999999999 689999999997777


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +.+|+|| |+-..+|..+|.+....        .+.| .+..+..|++.++.++|.+|  |||.||||.|+|+- .|.+|
T Consensus       433 ~~lYmvm-E~Gd~DL~kiL~k~~~~--------~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LK  499 (677)
T KOG0596|consen  433 GYLYMVM-ECGDIDLNKILKKKKSI--------DPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLK  499 (677)
T ss_pred             ceEEEEe-ecccccHHHHHHhccCC--------CchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEE
Confidence            6665555 55589999999764432        1222 67788889999999999999  99999999999987 67999


Q ss_pred             EeecccceecCCCcc-----ccccCCcccccccccCCC-----------CCchHHHHHHHHHHHHHHcCCCCCCCCCCCH
Q 039082          347 IADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEP-----------YSEKSDVYSFGIILNEIITGNHPYIEKDYKP  410 (472)
Q Consensus       347 L~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~-----------~s~~sDvwSlGvll~elltG~~Pf~~~~~~~  410 (472)
                      |+|||+|..+....+     ..+||+.||+||.+....           .+.++|||||||+||+|+.|+.||..-.+ .
T Consensus       500 LIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-~  578 (677)
T KOG0596|consen  500 LIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-Q  578 (677)
T ss_pred             eeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-H
Confidence            999999998876544     457999999999986433           34689999999999999999999954321 1


Q ss_pred             HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       411 ~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      -.-...+.+..-...+|..+ ...++++++..||..||++||++.+|++
T Consensus       579 ~aKl~aI~~P~~~Iefp~~~-~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  579 IAKLHAITDPNHEIEFPDIP-ENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             HHHHHhhcCCCccccccCCC-CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            11223344433333444432 2234999999999999999999999985

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.1e-35  Score=291.17  Aligned_cols=249  Identities=23%  Similarity=0.311  Sum_probs=193.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      +|++.++||.|++|.||+|.++  |..||||+++....   ......+.+|+.+++.++||||+++++++...+..++++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   77 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVF   77 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc---ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEE
Confidence            5889999999999999999985  77899999976432   223455778999999999999999999999988888888


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++. ++|.+++.....       ....++..+..++.|++.||+|||+.|  ++||||+|+||++++++.++|+|||++
T Consensus        78 e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~  147 (284)
T cd07836          78 EYMD-KDLKKYMDTHGV-------RGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLA  147 (284)
T ss_pred             ecCC-ccHHHHHHhcCC-------CCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchh
Confidence            8876 588888864332       112357888999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC---------
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG---------  420 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~---------  420 (472)
                      .......   ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+.+.  .+....+...         
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  225 (284)
T cd07836         148 RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN--EDQLLKIFRIMGTPTESTW  225 (284)
T ss_pred             hhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCChhhH
Confidence            7654322   22346888999998865 4578999999999999999999999976652  1121111110         


Q ss_pred             -------CCCCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 -------KLRPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 -------~~~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                             .+....+..         +..+..+.+++.+||..+|.+||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                   000111110         123456789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.7e-35  Score=300.49  Aligned_cols=247  Identities=23%  Similarity=0.248  Sum_probs=191.5

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----  267 (472)
                      .++|++.+.||+|+||.||+|.+.  |..||||++.....  .......+.+|+.+++.++||||++++++|....    
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ--NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc--ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            367999999999999999999975  77899998865322  3344456778999999999999999999886543    


Q ss_pred             --CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          268 --YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 --~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                        ..++|++++ +++|..++...            .+...+..++.|++.||+|||++|  ++||||||+|||++.++.+
T Consensus        93 ~~~~~lv~e~~-~~~l~~~~~~~------------l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~  157 (353)
T cd07850          93 FQDVYLVMELM-DANLCQVIQMD------------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  157 (353)
T ss_pred             cCcEEEEEecc-CCCHHHHHhhc------------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCE
Confidence              345666655 67888877421            235667888999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc--ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc----
Q 039082          346 RIADFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE----  419 (472)
Q Consensus       346 kL~DFGla~~~~~~~~--~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~----  419 (472)
                      ||+|||++........  ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.  ......+..    
T Consensus       158 kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~  235 (353)
T cd07850         158 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH--IDQWNKIIEQLGT  235 (353)
T ss_pred             EEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHhcCC
Confidence            9999999987654332  34578899999999999999999999999999999999999976542  111111100    


Q ss_pred             -------------------CC-C-----CCCCC-----C-----CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 -------------------GK-L-----RPALP-----E-----EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 -------------------~~-~-----~~~l~-----~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                         .. .     ....+     .     ....+..+.++|.+||..||++||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         236 PSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             CCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                               00 0     00000     0     0123556789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-35  Score=294.86  Aligned_cols=249  Identities=24%  Similarity=0.269  Sum_probs=198.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|...+.||+|+||.||+|.+.  +..||+|.+..... ...+....+.+|+.+++.++|||++++++++..++..++|
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv  103 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-QSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV  103 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-CchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence            34788999999999999999875  67899999865432 2334556788999999999999999999999988888777


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++|+. |+|.+++.....         ..++..+..++.+++.||.|||+++  ++||||+|+||+++.++.++|+|||+
T Consensus       104 ~e~~~-g~l~~~~~~~~~---------~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~  171 (317)
T cd06635         104 MEYCL-GSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGS  171 (317)
T ss_pred             EeCCC-CCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCC
Confidence            77775 577777643221         1346778889999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +..... .....|++.|+|||.+.   .+.++.++|||||||++|+|++|..||...+  .......+..+.... .+ .
T Consensus       172 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~~-~~-~  246 (317)
T cd06635         172 ASIASP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPT-LQ-S  246 (317)
T ss_pred             ccccCC-cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhccCCC-CC-C
Confidence            876543 23456889999999973   4568999999999999999999999997654  333344444433211 11 1


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      ...+..+.+++.+||..+|.+||++.+++..+
T Consensus       247 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             ccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            33456788999999999999999999999754

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-35  Score=292.21  Aligned_cols=250  Identities=23%  Similarity=0.288  Sum_probs=191.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||.|+||.||+|.++  |..||||.+.....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE--DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc--cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            57999999999999999999985  67899998865422  223445688999999999999999999999988888778


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL~DFG  351 (472)
                      ++|+ +++|..++......        ..+...+..++.||+.||+|||+++  ++|+||+|+||+++. ++.+||+|||
T Consensus        80 ~e~~-~~~l~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg  148 (294)
T PLN00009         80 FEYL-DLDLKKHMDSSPDF--------AKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFG  148 (294)
T ss_pred             Eecc-cccHHHHHHhCCCC--------CcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccc
Confidence            7777 56888887532211        1235667788999999999999999  999999999999985 5679999999


Q ss_pred             cceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CCC---
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GKL---  422 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~~---  422 (472)
                      ++.......   ....+++.|+|||.+.+ ..++.++||||||+++|+|+||..||...+.  ......+..  +..   
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~~~~  226 (294)
T PLN00009        149 LARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE--IDELFKIFRILGTPNEE  226 (294)
T ss_pred             cccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCChh
Confidence            997654322   22346889999999865 4578999999999999999999999976552  222221111  000   


Q ss_pred             -----------C---CCCCC------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 -----------R---PALPE------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 -----------~---~~l~~------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 .   +..+.      .+.....+.+++.+||+.+|++||++.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       0   00000      0223456888999999999999999999886

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-36  Score=292.69  Aligned_cols=248  Identities=23%  Similarity=0.270  Sum_probs=192.9

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |++.+.||.|++|.||+|.++  |..||+|++..+..  .......+.+|+.+++.++|||++++++++.+.+..+++++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e   78 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE--DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFE   78 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc--cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEe
Confidence            567889999999999999875  78999999876532  22334568899999999999999999999998888888888


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++ +++|.+++.....        ...++..+..++.|++.||+|||+++  ++||||+|+||+++.++.++|+|||++.
T Consensus        79 ~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~  147 (283)
T cd07835          79 FL-DLDLKKYMDSSPL--------TGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLAR  147 (283)
T ss_pred             cc-CcCHHHHHhhCCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence            87 6789999864331        12357888999999999999999999  9999999999999999999999999997


Q ss_pred             ecCCCc---cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC---------
Q 039082          355 FLSDGE---MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK---------  421 (472)
Q Consensus       355 ~~~~~~---~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~---------  421 (472)
                      ......   ....++..|+|||.+.+. .++.++||||||+++|+|++|..||...+  .......+....         
T Consensus       148 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~  225 (283)
T cd07835         148 AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS--EIDQLFRIFRTLGTPDEDVWP  225 (283)
T ss_pred             ccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHHhh
Confidence            654322   223468889999987654 57899999999999999999999997654  211111111100         


Q ss_pred             -------CC--------CCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 -------LR--------PALPE-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 -------~~--------~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                             ..        ..... ....+..+.++|.+||+.+|.+||++++++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         226 GVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                   00        00000 1233467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-35  Score=289.70  Aligned_cols=247  Identities=21%  Similarity=0.225  Sum_probs=192.6

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCceEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYRGWL  272 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~~~v  272 (472)
                      |++.+.||+|+||.||+|.+.  |..+|+|.+....  ........+.+|+.+++.++|||++++++++...  +..+++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   78 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMV   78 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc--ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEE
Confidence            578899999999999999986  5789999997653  2233445688999999999999999999999887  667777


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++. ++|.+++....         ...++..++.++.+++.||+|||+.+  ++|+||+|+|||+++++.+||+|||+
T Consensus        79 ~e~~~-~~l~~~~~~~~---------~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~  146 (287)
T cd07840          79 FEYMD-HDLTGLLDSPE---------VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGL  146 (287)
T ss_pred             ecccc-ccHHHHHhccC---------CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccc
Confidence            77764 68888875321         12356788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc----cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC----
Q 039082          353 ARFLSDGE----MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR----  423 (472)
Q Consensus       353 a~~~~~~~----~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~----  423 (472)
                      +.......    ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+  .......+......    
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~--~~~~~~~~~~~~~~~~~~  224 (287)
T cd07840         147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST--ELEQLEKIFELCGSPTDE  224 (287)
T ss_pred             eeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCchh
Confidence            98776442    23346888999998764 457899999999999999999999997655  22222222111000    


Q ss_pred             -----------------CCCCC----C-ch-hHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 -----------------PALPE----E-DG-QLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 -----------------~~l~~----~-~~-~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                       ...+.    . .. .+..+.+++.+||..+|++||+++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         225 NWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                             00000    0 01 2567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=9.9e-36  Score=293.55  Aligned_cols=249  Identities=22%  Similarity=0.233  Sum_probs=192.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~~  270 (472)
                      ++|++.+.||.|+||.||+|.++  +..+|+|.++....  .+.....+.+|+.+++.++||||+++++++...  +..+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY   82 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccc--cccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence            57899999999999999999986  67899999975432  223334577899999999999999999998876  6666


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      ++++++ +++|.+++.....         ..++..+..++.|++.||+|||+++  ++|+||||+|||++.++.+||+||
T Consensus        83 lv~e~~-~~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~  150 (293)
T cd07843          83 MVMEYV-EHDLKSLMETMKQ---------PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDF  150 (293)
T ss_pred             EEehhc-CcCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeec
Confidence            777766 5699988864321         2357888999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc---cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC------
Q 039082          351 GHARFLSDGE---MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG------  420 (472)
Q Consensus       351 Gla~~~~~~~---~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~------  420 (472)
                      |++.......   ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+  .......+...      
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~--~~~~~~~~~~~~~~~~~  228 (293)
T cd07843         151 GLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS--EIDQLNKIFKLLGTPTE  228 (293)
T ss_pred             CceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCch
Confidence            9998765432   223468889999998754 46899999999999999999999997654  22222111110      


Q ss_pred             ---------------CCCCC----C-CCCch--hHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 ---------------KLRPA----L-PEEDG--QLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ---------------~~~~~----l-~~~~~--~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                     .....    + ...+.  ....+.++|.+||..+|++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         229 KIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                           00000    0 00011  2566889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.6e-36  Score=289.69  Aligned_cols=243  Identities=29%  Similarity=0.375  Sum_probs=198.9

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||.|+||.||++.+.  |..||+|++..+.. ........+.+|++++++++||||+++++.+......+++++++.+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADM-IRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhh-hhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence            689999999999986  78999999876533 223456778899999999999999999999998888999999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE  360 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  360 (472)
                      |.+++...+          ..+...+..++.||+.||+|||+.+  ++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~  147 (265)
T cd05579          80 LASLLENVG----------SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRR  147 (265)
T ss_pred             HHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCc
Confidence            999996432          1246778899999999999999999  9999999999999999999999999987654321


Q ss_pred             -----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          361 -----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       361 -----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                                 ....++..|+|||.+....++.++||||||+++|+|++|..||....  .......+..+..  ..+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~~--~~~~~  223 (265)
T cd05579         148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKI--EWPED  223 (265)
T ss_pred             ccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCCc--CCCcc
Confidence                       22347889999999988889999999999999999999999997665  4455555555432  22222


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      ...+..+.+++.+||..+|++||++..+.+.|+
T Consensus       224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         224 VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            223677899999999999999999955555443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.7e-35  Score=297.72  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=193.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||.|+||.||+|.++  +..||||.+.+...  .......+.+|+.+++.++||||++++++|......++
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS--TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            467999999999999999999875  67899998865422  22344567799999999999999999999876544444


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|..++....           .+......++.|++.||+|||+++  ++||||+|+|||+++++.++|+|||
T Consensus        87 lv~e~~~~~L~~~~~~~~-----------~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          87 FVTELLGTDLHRLLTSRP-----------LEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             EEeehhccCHHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccc
Confidence            455556889988875321           234567788999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-------------HHHHHHH
Q 039082          352 HARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-------------AKIAMEV  417 (472)
Q Consensus       352 la~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-------------~~i~~~i  417 (472)
                      ++...........++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+...             .++...+
T Consensus       154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            99876655455567889999998765 568999999999999999999999997654211             0001000


Q ss_pred             hcC---------CCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          418 GEG---------KLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       418 ~~~---------~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ..+         ......+..   +.....+.++|.+||..+|++||++++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000         001111111   2345678999999999999999999998754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.2e-36  Score=294.12  Aligned_cols=248  Identities=22%  Similarity=0.301  Sum_probs=196.0

Q ss_pred             CeeEeceeeccCceEEEEEEE-----CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCc
Q 039082          196 EIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~-----~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~  269 (472)
                      +|++.+.||.|+||.||++..     .|..||+|+++...........+.+.+|+.++..+ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999986     46789999987543322333456678999999999 689999999999888888


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++++.+++|.+++.....          .+...+..++.|++.||.|||+.+  ++||||+|+|||++.++.+||+|
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~d  148 (290)
T cd05613          81 HLILDYINGGELFTHLSQRER----------FKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTD  148 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEee
Confidence            899999999999999864321          235667788889999999999999  99999999999999999999999


Q ss_pred             cccceecCCCc----cccccCCcccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCC
Q 039082          350 FGHARFLSDGE----MALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGK  421 (472)
Q Consensus       350 FGla~~~~~~~----~~~~gt~~y~APE~~~~~--~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~  421 (472)
                      ||++.......    ....|+..|+|||.+...  .++.++||||||+++|+|++|..||.....  ....+...+....
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~  228 (290)
T cd05613         149 FGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE  228 (290)
T ss_pred             CccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC
Confidence            99998765432    234578999999998753  478899999999999999999999964321  2233333333332


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                        +..+  ......+.+++.+||..+|++||     ++++++.
T Consensus       229 --~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 --PPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --CCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence              2222  22445678899999999999997     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-36  Score=296.39  Aligned_cols=255  Identities=22%  Similarity=0.257  Sum_probs=190.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--CCc
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYR  269 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--~~~  269 (472)
                      .|++.+.||+|+||.||+|.++    +..||+|.+..... ........+.+|+.+++.++||||+++++++.+.  ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceE
Confidence            4788999999999999999984    57899999976432 1223345578899999999999999999999887  556


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC----CCcE
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD----AKHV  345 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~----~~~v  345 (472)
                      ++|+|++ +++|.+++.......     ....+...++.++.|++.||+|||+++  ++||||||+|||++.    ++.+
T Consensus        80 ~lv~e~~-~~~l~~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          80 YLLFDYA-EHDLWQIIKFHRQAK-----RVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             EEEEeCC-CcCHHHHHHhhccCC-----CcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceE
Confidence            6666665 567877775332211     112346778889999999999999999  999999999999999    8999


Q ss_pred             EEeecccceecCCCcc------ccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-------H
Q 039082          346 RIADFGHARFLSDGEM------ALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-------A  411 (472)
Q Consensus       346 kL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-------~  411 (472)
                      ||+|||++........      ...+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.......       .
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9999999987653322      2346888999998766 458999999999999999999999997654321       0


Q ss_pred             HHHHHHh------------------------cCCCCCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          412 KIAMEVG------------------------EGKLRPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       412 ~i~~~i~------------------------~~~~~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      .....+.                        +.......+..         ......+.+++.+||..||++|||+.+++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence            0000000                        00001111100         02345688999999999999999999987


Q ss_pred             H
Q 039082          459 C  459 (472)
Q Consensus       459 ~  459 (472)
                      .
T Consensus       312 ~  312 (316)
T cd07842         312 E  312 (316)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.7e-35  Score=293.49  Aligned_cols=250  Identities=22%  Similarity=0.256  Sum_probs=187.5

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc--
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR--  269 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~--  269 (472)
                      .++|++.++||+|+||.||+|.++  +..||||.+.....  .......+.+|+.++++++||||+++++++...+..  
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC--cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccccc
Confidence            357999999999999999999985  67899998865422  222233467899999999999999999998765432  


Q ss_pred             ------eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          270 ------GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       270 ------~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                            +++++++ +++|.+++.....         ..++..++.++.|++.||+|||+++  ++|+||||+||+++.++
T Consensus        89 ~~~~~~~lv~e~~-~~~l~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~  156 (310)
T cd07865          89 RYKGSFYLVFEFC-EHDLAGLLSNKNV---------KFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDG  156 (310)
T ss_pred             CCCceEEEEEcCC-CcCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCC
Confidence                  5555554 6788888753221         2357888999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCcc-------ccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          344 HVRIADFGHARFLSDGEM-------ALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~-------~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      .+||+|||++........       ...++..|+|||.+.+. .++.++||||||+++|+|++|..||.+.+.  .....
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~--~~~~~  234 (310)
T cd07865         157 ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE--QHQLT  234 (310)
T ss_pred             cEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHH
Confidence            999999999986643221       23467889999988654 478999999999999999999999976542  11111


Q ss_pred             HHh--cCCCCC---------------CCCCC-----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVG--EGKLRP---------------ALPEE-----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~--~~~~~~---------------~l~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.  .+...+               .++..           ......+.++|.+||..||++||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            111  111000               00100           011245678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.1e-35  Score=296.67  Aligned_cols=253  Identities=21%  Similarity=0.257  Sum_probs=192.6

Q ss_pred             eceeecc--CceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          200 QEKIGQG--TTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       200 ~~~LG~G--~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      ...||.|  +||.||++.+.  |+.||||++..+..  .....+.+.+|+.+++.++||||++++++|...+..++|+++
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~   80 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC--TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPF   80 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEec
Confidence            3466776  99999999984  78999999875432  334567889999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +.+++|.+++......        ..+...+..++.|++.||+|||+++  ++||||||+|||++.++.++++||+.+..
T Consensus        81 ~~~~~l~~~l~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~  150 (328)
T cd08226          81 MAYGSANSLLKTYFPE--------GMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYS  150 (328)
T ss_pred             ccCCCHHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhh
Confidence            9999999998654321        1346677889999999999999999  99999999999999999999999986543


Q ss_pred             cCCCc----------cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          356 LSDGE----------MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       356 ~~~~~----------~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      .....          ....++..|+|||.+.+  ..++.++|||||||++|+|++|..||......  ........+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~  228 (328)
T cd08226         151 LVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPY  228 (328)
T ss_pred             hhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCC
Confidence            32110          11224567999999876  35789999999999999999999999765422  111111111000


Q ss_pred             -C------------------------------------------CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH-
Q 039082          424 -P------------------------------------------ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC-  459 (472)
Q Consensus       424 -~------------------------------------------~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~-  459 (472)
                       +                                          ..+........+.+++.+||..||++|||++++++ 
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         229 SPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             CCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             0                                          00011234567899999999999999999999974 


Q ss_pred             -HHHHHHH
Q 039082          460 -SLKNIQM  466 (472)
Q Consensus       460 -~L~~i~~  466 (472)
                       .|+.+++
T Consensus       309 ~~~~~~~~  316 (328)
T cd08226         309 AFFKQVKE  316 (328)
T ss_pred             HHHHHHHH
Confidence             3444444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4e-36  Score=295.63  Aligned_cols=252  Identities=23%  Similarity=0.289  Sum_probs=199.2

Q ss_pred             CeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCc
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~  269 (472)
                      +|++.+.||+|+||.||++.+.     +..||||++++............+.+|+.++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999753     5679999987543322334456788999999999 699999999999888888


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++++.+++|.+++....          ..+......++.|++.||+|||+.+  ++||||+|+||+++.++.++|+|
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~d  148 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE----------HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTD  148 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC----------CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEE
Confidence            89999999999999985422          1245677888999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCc----cccccCCcccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCC
Q 039082          350 FGHARFLSDGE----MALTGTFVYMAPEVIQCEP--YSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGK  421 (472)
Q Consensus       350 FGla~~~~~~~----~~~~gt~~y~APE~~~~~~--~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~  421 (472)
                      ||++.......    ....|+..|+|||.+.+..  ++.++||||||+++|+|++|..||.....  ....+...+....
T Consensus       149 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd05583         149 FGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSK  228 (288)
T ss_pred             CccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccC
Confidence            99987654322    2245789999999987654  78899999999999999999999964321  1223333333322


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                        +..+.  .....+.+++.+||..+|++|||+.++.+.|+.
T Consensus       229 --~~~~~--~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         229 --PPFPK--TMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --CCCCc--ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              12222  234578889999999999999998888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-38  Score=311.59  Aligned_cols=245  Identities=23%  Similarity=0.354  Sum_probs=212.6

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECCee--EEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~--vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +...+++.+..||-|+||.|=++..++..  +|+|++++..+ .+....+....|.++|...+.|+||++|-.|.++.+.
T Consensus       417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI-VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI-VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc-cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            45568888999999999999999888665  89999988665 3445667788999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      |++||-+.||.|+..|++.+....          .....++.-++.|++|||++|  ||+|||||+|+++|.+|-+||.|
T Consensus       496 YmLmEaClGGElWTiLrdRg~Fdd----------~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVD  563 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRGSFDD----------YTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVD  563 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcCCccc----------chhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEee
Confidence            999999999999999987664321          235566778999999999999  99999999999999999999999


Q ss_pred             cccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||+|+.+..+  ..++||||.|.|||++.++..+.++|.||||+++|||++|.+||.+.+  +...+..|.+|--...+|
T Consensus       564 FGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~d--pmktYn~ILkGid~i~~P  641 (732)
T KOG0614|consen  564 FGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVD--PMKTYNLILKGIDKIEFP  641 (732)
T ss_pred             hhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCc--hHHHHHHHHhhhhhhhcc
Confidence            9999988755  457899999999999999999999999999999999999999998887  788888888887555555


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCC
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPS  453 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs  453 (472)
                      ..  ..+...++|.++...+|.+|..
T Consensus       642 r~--I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  642 RR--ITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             cc--cchhHHHHHHHHHhcCcHhhhc
Confidence            43  4456677888888999999965

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7e-36  Score=291.35  Aligned_cols=246  Identities=24%  Similarity=0.368  Sum_probs=201.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.++  |..||+|++.+... ........+.+|+.+++.++ ||||+++++++...+..++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEE
Confidence            47899999999999999999985  78999999876433 23344567889999999998 9999999999988888889


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++...+          ..++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||
T Consensus        80 v~e~~~~~~L~~~l~~~~----------~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~  147 (280)
T cd05581          80 VLEYAPNGELLQYIRKYG----------SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFG  147 (280)
T ss_pred             EEcCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCc
Confidence            999998999999996532          2357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCcc-----------------------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC
Q 039082          352 HARFLSDGEM-----------------------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY  408 (472)
Q Consensus       352 la~~~~~~~~-----------------------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~  408 (472)
                      ++........                       ...++..|+|||.+....++.++|+||||++++++++|..||...+ 
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-  226 (280)
T cd05581         148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN-  226 (280)
T ss_pred             cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc-
Confidence            9886643221                       2346889999999988889999999999999999999999998765 


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCH----HHHHH
Q 039082          409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSF----SSITC  459 (472)
Q Consensus       409 ~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~----~~ll~  459 (472)
                       .......+....  ..++  ...+..+.+++.+||+.+|++||++    +++++
T Consensus       227 -~~~~~~~~~~~~--~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         227 -EYLTFQKILKLE--YSFP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHHHHHHhcC--CCCC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             222333333222  1222  2234568889999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2e-35  Score=288.99  Aligned_cols=245  Identities=22%  Similarity=0.323  Sum_probs=187.4

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcC--CCceE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEP--PYRGW  271 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~--~~~~~  271 (472)
                      |++.++||+|+||.||+|.++  +..||+|.++....  .... ....+|+.++.++. ||||+++++++.+.  +..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEE
Confidence            578899999999999999875  67899999875432  1122 23457889999885 99999999999887  67777


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++ +++|.+++....         ...++..++.++.|++.||+|||+.+  ++||||+|+||+++. +.+||+|||
T Consensus        78 v~e~~-~~~l~~~l~~~~---------~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg  144 (282)
T cd07831          78 VFELM-DMNLYELIKGRK---------RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFG  144 (282)
T ss_pred             EEecC-CccHHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEecc
Confidence            77777 468888775422         12357888999999999999999999  999999999999999 999999999


Q ss_pred             cceecCCCc--cccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC-----
Q 039082          352 HARFLSDGE--MALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK-----  421 (472)
Q Consensus       352 la~~~~~~~--~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~-----  421 (472)
                      ++.......  ....++..|+|||.+. +..++.++|||||||++|||++|..||.+.+.  .+....+.+  +.     
T Consensus       145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~--~~~~~~~~~~~~~~~~~~  222 (282)
T cd07831         145 SCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE--LDQIAKIHDVLGTPDAEV  222 (282)
T ss_pred             cccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH--HHHHHHHHHHcCCCCHHH
Confidence            998765332  2345788999999765 45578999999999999999999999976552  221111111  00     


Q ss_pred             ---------CCCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 ---------LRPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ---------~~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                               .....+..         ...+..+.++|.+||..+|++||++++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         223 LKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             HHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                     00011110         134578999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=299.05  Aligned_cols=254  Identities=28%  Similarity=0.379  Sum_probs=206.9

Q ss_pred             CCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh--cCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR--QRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~g~~~~~~----  267 (472)
                      ...+++...||+|.||.||+|.+.++.||||++       .....+.|.+|.+|.+.  ++|+||++|++.-....    
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKif-------p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~  281 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIF-------PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM  281 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhccCceeEEEec-------CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence            456788999999999999999999999999988       44566779999888776  48999999998755444    


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-------CCceeecCCCCCcEEEc
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-------KPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-------~~~iiHrDLkp~NILl~  340 (472)
                      ...+|+++...|+|.+||..+           ..+|....+++.-+++||+|||+.       +++|+|||||..||||.
T Consensus       282 eywLVt~fh~kGsL~dyL~~n-----------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK  350 (534)
T KOG3653|consen  282 EYWLVTEFHPKGSLCDYLKAN-----------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK  350 (534)
T ss_pred             ceeEEeeeccCCcHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence            566788888899999999643           236999999999999999999973       35799999999999999


Q ss_pred             CCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCC-CC-----chHHHHHHHHHHHHHHcCCC--------
Q 039082          341 DAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEP-YS-----EKSDVYSFGIILNEIITGNH--------  401 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~-~s-----~~sDvwSlGvll~elltG~~--------  401 (472)
                      +|+++.|+|||+|..+..+..     ..+||.+|||||++.+.- +.     ...||||+|.+||||++...        
T Consensus       351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            999999999999998874332     356999999999997642 22     46899999999999987432        


Q ss_pred             ----CCC---CCCCCHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          402 ----PYI---EKDYKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       402 ----Pf~---~~~~~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                          ||.   +....-+++...+...+.||.+|..   ...+.-+.+.+..||++||+.|.|+.=+.+.+.++.
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~  504 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM  504 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence                332   1222345666667777778989886   456777889999999999999999998888776654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-35  Score=298.72  Aligned_cols=253  Identities=24%  Similarity=0.328  Sum_probs=195.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |.+ .++|++.+.||+|+||.||+|.+.  +..||+|++.....  .......+.+|+.+++.++||||+++++++....
T Consensus        13 ~~~-~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~   89 (345)
T cd07877          13 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ--SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR   89 (345)
T ss_pred             hhc-cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch--hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence            443 377999999999999999999874  77899999865321  2233456889999999999999999999886432


Q ss_pred             -----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          268 -----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       268 -----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                           ..+++++++.+++|.+++...           ..++..+..++.|++.||+|||+.+  ++||||||+||+++.+
T Consensus        90 ~~~~~~~~~lv~~~~~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~  156 (345)
T cd07877          90 SLEEFNDVYLVTHLMGADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED  156 (345)
T ss_pred             cccccccEEEEehhcccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC
Confidence                 235677777799998887531           1246778889999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          343 KHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +.+||+|||++...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.  ......+....
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~--~~~~~~~~~~~  234 (345)
T cd07877         157 CELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH--IDQLKLILRLV  234 (345)
T ss_pred             CCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHh
Confidence            99999999999877655555678999999999866 5688999999999999999999999976542  11111111100


Q ss_pred             C---------------------CCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          422 L---------------------RPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       422 ~---------------------~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .                     .+..+..      ......+.++|.+||..+|.+||++.+++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0                     0000100      1234567899999999999999999998753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-35  Score=299.93  Aligned_cols=259  Identities=22%  Similarity=0.314  Sum_probs=196.1

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ..-|.+. .+|.+.+.||+|+||.||+|.+.  |..||||.+.....  .+.....+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~   84 (342)
T cd07879           8 KTVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ--SEIFAKRAYRELTLLKHMQHENVIGLLDVFT   84 (342)
T ss_pred             hhhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc--cccchhHHHHHHHHHHhcCCCCccchhheec
Confidence            3457774 57999999999999999999875  78999999875422  2233455789999999999999999999887


Q ss_pred             cCCC------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          265 EPPY------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       265 ~~~~------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ....      .++++++ ...+|..++..            ..++..+..++.|++.||+|||+++  ++||||||+|||
T Consensus        85 ~~~~~~~~~~~~lv~e~-~~~~l~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIl  149 (342)
T cd07879          85 SAVSGDEFQDFYLVMPY-MQTDLQKIMGH------------PLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLA  149 (342)
T ss_pred             ccccCCCCceEEEEecc-cccCHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEE
Confidence            5432      3455554 45677665421            1246778889999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      ++.++.+||+|||+++..........++..|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+.  ......+
T Consensus       150 l~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~--~~~~~~~  227 (342)
T cd07879         150 VNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--LDQLTQI  227 (342)
T ss_pred             ECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHH
Confidence            999999999999999876554445567889999999876 4689999999999999999999999977552  1111111


Q ss_pred             hcCC--C-------------------CCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH--HHHHH
Q 039082          418 GEGK--L-------------------RPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITCS--LKNIQ  465 (472)
Q Consensus       418 ~~~~--~-------------------~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~--L~~i~  465 (472)
                      ....  .                   .+..+..      +.....+.++|.+||..||++||++++++..  ++.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            1100  0                   0001110      1234568899999999999999999999854  55543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.5e-35  Score=289.08  Aligned_cols=242  Identities=27%  Similarity=0.345  Sum_probs=187.6

Q ss_pred             eeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHH---HHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          202 KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT---LSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~i---l~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      .||+|+||.||+|.+.  +..||+|++.+...... .....+..|..+   +....||+|+++++++...+..++|+||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence            4899999999999874  67899999876543222 222224445443   44457999999999999999999999999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .|++|..++...+          ..++..+..++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||++...
T Consensus        80 ~g~~L~~~l~~~~----------~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~  147 (278)
T cd05606          80 NGGDLHYHLSQHG----------VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDF  147 (278)
T ss_pred             CCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCcccc
Confidence            9999998885322          2457889999999999999999999  999999999999999999999999998765


Q ss_pred             CCC-ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          357 SDG-EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       357 ~~~-~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                      ... .....|+..|+|||.+.++ .++.++||||||+++|+|++|+.||.+............... ....++.  ..+.
T Consensus       148 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~~s~  224 (278)
T cd05606         148 SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVELPD--SFSP  224 (278)
T ss_pred             CccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-cCCCCCC--cCCH
Confidence            432 2345689999999998754 689999999999999999999999976643221111111111 1223332  2356


Q ss_pred             HHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          435 ELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      .+.+++.+||..+|.+||     ++.++++
T Consensus       225 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             HHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            788899999999999999     9999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=299.27  Aligned_cols=249  Identities=22%  Similarity=0.321  Sum_probs=188.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----  267 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----  267 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++.+.   ........+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF---EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc---ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence            68999999999999999999875  778999998642   22334566889999999999999999999876543     


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++ +.+++|..++...           ..+...+..++.|++.||+|||+.+  ++||||||+|||++.++.+||
T Consensus        82 ~~~lv~e-~~~~~l~~~~~~~-----------~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl  147 (336)
T cd07849          82 DVYIVQE-LMETDLYKLIKTQ-----------HLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKI  147 (336)
T ss_pred             eEEEEeh-hcccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEE
Confidence            2344444 4567888777431           1346778889999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH---------
Q 039082          348 ADFGHARFLSDGE------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA---------  411 (472)
Q Consensus       348 ~DFGla~~~~~~~------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~---------  411 (472)
                      +|||++.......      ....|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+....         
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~  227 (336)
T cd07849         148 CDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLG  227 (336)
T ss_pred             CcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            9999998764322      12357889999998654 5689999999999999999999999976542110         


Q ss_pred             ----HHHHHHhcCC---------CCCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          412 ----KIAMEVGEGK---------LRPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       412 ----~i~~~i~~~~---------~~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                          +....+....         ..+..+.   .+.....+.++|.+||..+|++||++.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         228 TPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000000000         0000000   01234568899999999999999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.8e-35  Score=288.64  Aligned_cols=240  Identities=18%  Similarity=0.256  Sum_probs=185.7

Q ss_pred             CeeEecee--eccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCce
Q 039082          196 EIDLQEKI--GQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       196 ~~~l~~~L--G~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  270 (472)
                      +|++.+.+  |+|+||.||++..+  +..+|+|++.+.....         .|+.....+ +||||+++++.+...+..+
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~   85 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV   85 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence            45555555  99999999999875  6789999986542211         122222222 7999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEEEee
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIAD  349 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vkL~D  349 (472)
                      +|+|++.+++|.+++....          ..++..+..++.|++.||.|||+.+  ++||||||+||+++.++ .++|+|
T Consensus        86 iv~e~~~~~~L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~d  153 (267)
T PHA03390         86 LIMDYIKDGDLFDLLKKEG----------KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLCD  153 (267)
T ss_pred             EEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEec
Confidence            9999999999999996432          2346888999999999999999999  99999999999999988 999999


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      ||++...... ....++..|+|||++.+..++.++||||||+++|+|++|..||.................  ....+..
T Consensus       154 fg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~  230 (267)
T PHA03390        154 YGLCKIIGTP-SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFI  230 (267)
T ss_pred             CccceecCCC-ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcc
Confidence            9999876533 334689999999999988999999999999999999999999975542221111111111  1111222


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPS-FSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs-~~~ll~  459 (472)
                      ......+.++|.+||+.+|.+||+ ++++++
T Consensus       231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            345567889999999999999995 688874

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.9e-35  Score=292.42  Aligned_cols=243  Identities=27%  Similarity=0.368  Sum_probs=197.0

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |+...+||+|+||.||++..+  +..||||.+...    .......+.+|+.+++.++|+||+++++.+...+..+++++
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   97 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR----KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME   97 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc----chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence            344578999999999999885  678999987432    23345668899999999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++...           ..++.....++.|++.||+|||+.|  ++|+||+|+||+++.++.++|+|||++.
T Consensus        98 ~~~~~~L~~~~~~~-----------~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~  164 (292)
T cd06657          98 FLEGGALTDIVTHT-----------RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCA  164 (292)
T ss_pred             cCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccce
Confidence            99999999887431           1246778889999999999999999  9999999999999999999999999987


Q ss_pred             ecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          355 FLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       355 ~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      .....   .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....  .......+..+ .+..+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~--~~~~~~~~~~~-~~~~~~~~~~  241 (292)
T cd06657         165 QVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDN-LPPKLKNLHK  241 (292)
T ss_pred             ecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhh-CCcccCCccc
Confidence            65432   223457899999999988889999999999999999999999997654  22222222222 2223323234


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+..+.+++.+||..+|.+||++.+++.
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            4567888999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.3e-35  Score=291.79  Aligned_cols=251  Identities=23%  Similarity=0.253  Sum_probs=191.0

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC---
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP---  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~---  267 (472)
                      ..++|++.+.||+|+||.||+|.++  |..||||.++....  .......+.+|+.+++.++||||+++++++.+.+   
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE--KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc--ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            3468999999999999999999985  67899999875422  2233345778999999999999999999987655   


Q ss_pred             -------CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          268 -------YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       268 -------~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                             ..+++++++ +++|..++....         ...++..++.++.|++.||+|||+.+  |+|+||+|+||+++
T Consensus        83 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~  150 (302)
T cd07864          83 DFKKDKGAFYLVFEYM-DHDLMGLLESGL---------VHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLN  150 (302)
T ss_pred             hccccCCcEEEEEccc-CccHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEC
Confidence                   455666665 457777764321         12356889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCcc----ccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          341 DAKHVRIADFGHARFLSDGEM----ALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      +++.+||+|||++........    ...++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.  .....
T Consensus       151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~--~~~~~  228 (302)
T cd07864         151 NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE--LAQLE  228 (302)
T ss_pred             CCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh--HHHHH
Confidence            999999999999987654331    2235788999998864 4578999999999999999999999976542  22221


Q ss_pred             HHhc---CCCC---CCC--------------------CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVGE---GKLR---PAL--------------------PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~~---~~~~---~~l--------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+..   +...   +.+                    ......+..+.+++..||..+|++||++++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111   1100   000                    001123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.9e-35  Score=292.12  Aligned_cols=248  Identities=24%  Similarity=0.275  Sum_probs=196.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..|...+.||.|+||.||+|.++  +..+|+|.+...... .......+.+|+.+++.++|+|++++++++...+..++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQ-SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence            45777899999999999999985  678999988643222 234456688999999999999999999999988877777


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++. ++|.+++.....         ..+...+..++.+++.||.|||+.+  ++||||+|+|||++.++.++|+|||+
T Consensus        94 ~e~~~-~~l~~~~~~~~~---------~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~  161 (308)
T cd06634          94 MEYCL-GSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS  161 (308)
T ss_pred             EEccC-CCHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCccc
Confidence            77774 688777643221         1246778888999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +...... ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||...+  .......+..+.. +.... 
T Consensus       162 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~~-  236 (308)
T cd06634         162 ASIMAPA-NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNES-PALQS-  236 (308)
T ss_pred             ceeecCc-ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc--HHHHHHHHhhcCC-CCcCc-
Confidence            8876532 3456889999999974   3567889999999999999999999997654  3333334444332 21111 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ......+.++|.+||..+|++||++.+++..
T Consensus       237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            2355678899999999999999999988864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.9e-35  Score=296.09  Aligned_cols=251  Identities=24%  Similarity=0.324  Sum_probs=194.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |.+ .++|++.+.||+|+||.||+|.+.  +..||||.+....  ........+.+|+.+|+.++||||+++++++....
T Consensus        11 ~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (343)
T cd07880          11 WEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDL   87 (343)
T ss_pred             hcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCc
Confidence            554 467999999999999999999875  7789999986532  23334456889999999999999999999987654


Q ss_pred             C------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          268 Y------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       268 ~------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      .      .++|+++ .+++|..++...           ..++..+..++.|++.||+|||+.|  ++||||||+||+++.
T Consensus        88 ~~~~~~~~~lv~e~-~~~~l~~~~~~~-----------~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~  153 (343)
T cd07880          88 SLDRFHDFYLVMPF-MGTDLGKLMKHE-----------KLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNE  153 (343)
T ss_pred             cccccceEEEEEec-CCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence            3      2455554 588998887421           1246778889999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          342 AKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ++.++|+|||++...........+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.  ......+...
T Consensus       154 ~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~  231 (343)
T cd07880         154 DCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKV  231 (343)
T ss_pred             CCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHh
Confidence            999999999999877665555667899999999875 4588999999999999999999999976542  1121111110


Q ss_pred             CCC------------------CCCCC--------C-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLR------------------PALPE--------E-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~------------------~~l~~--------~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...                  ..++.        . ......+.++|.+|+..||++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         232 TGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             cCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000                  00000        0 223456889999999999999999999883

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=285.67  Aligned_cols=248  Identities=23%  Similarity=0.299  Sum_probs=191.1

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc---CCCceeEEEEEEEcCCC---
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---RHRFVLQLMGACLEPPY---  268 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~g~~~~~~~---  268 (472)
                      |++.+.||+|+||.||+|.++  +..||||+++....  .......+.+|+.+++.+   +||||+++++++...+.   
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~   78 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS--EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRE   78 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc--cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCC
Confidence            578899999999999999986  68999999975432  222334566788877766   59999999999988776   


Q ss_pred             --ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          269 --RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       269 --~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                        .+++++++ +++|.+++......        ..++..++.++.+++.||.|||+.+  ++|+||+|+||+++.++.+|
T Consensus        79 ~~~~l~~e~~-~~~l~~~l~~~~~~--------~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~  147 (287)
T cd07838          79 LKLTLVFEHV-DQDLATYLSKCPKP--------GLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVK  147 (287)
T ss_pred             ceeEEEehhc-ccCHHHHHHHccCC--------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEE
Confidence              66666666 46898888643221        2356788999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC--
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL--  422 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~--  422 (472)
                      |+|||++.......  ....++..|+|||.+.+..++.++|+|||||++|+|++|..||....  ..+....+.....  
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~  225 (287)
T cd07838         148 IADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS--EADQLDKIFDVIGLP  225 (287)
T ss_pred             EeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC--hHHHHHHHHHHcCCC
Confidence            99999998775432  23347889999999998889999999999999999999999997654  2222222211000  


Q ss_pred             ------------CCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 ------------RPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ------------~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                  ....+..         +.....+.++|.+||..||++||++.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         226 SEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             ChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                        0000000         123466789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.2e-35  Score=291.97  Aligned_cols=248  Identities=20%  Similarity=0.227  Sum_probs=190.2

Q ss_pred             eEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          198 DLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      .+.+.+|.|+++.|+++...+..||||++..+.  ........+.+|+.+++.++||||+++++++.+.+..+++++++.
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS--CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc--cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            345556666666666666678999999997642  234566779999999999999999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++|.+++......        ..+......++.|++.||+|||+++  |+||||||+|||++.++.+||+|||.+....
T Consensus        83 ~~~l~~~l~~~~~~--------~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~  152 (314)
T cd08216          83 YGSCEDLLKTHFPE--------GLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMI  152 (314)
T ss_pred             CCCHHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeec
Confidence            99999999643211        1235667888999999999999999  9999999999999999999999999987554


Q ss_pred             CCc----------cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          358 DGE----------MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       358 ~~~----------~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      ...          ....++..|+|||.+..  ..++.++|+|||||++|+|++|..||......  ........+.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~  230 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCL  230 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccc
Confidence            221          12335778999999875  45889999999999999999999999765422  12111111110000


Q ss_pred             ------------------------------CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 ------------------------------LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 ------------------------------l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                                    .+.......++.+++..||..||++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                                          0000122356788999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.4e-34  Score=288.86  Aligned_cols=246  Identities=24%  Similarity=0.270  Sum_probs=194.0

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |...++||+|+||.||+|.+.  |..||+|.+..... ........+.+|+.+++.++|||++++++++.+.+..+++++
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence            566788999999999999874  77899999865432 233445668899999999999999999999999888877887


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++ .++|..++.....         ..++..+..++.+++.||.|||++|  ++|+||+|+||+++.++.+||+|||++.
T Consensus       102 ~~-~~~l~~~l~~~~~---------~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~  169 (313)
T cd06633         102 YC-LGSASDLLEVHKK---------PLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSAS  169 (313)
T ss_pred             cC-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCc
Confidence            77 5677777753221         1346778889999999999999999  9999999999999999999999999986


Q ss_pred             ecCCCccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          355 FLSDGEMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       355 ~~~~~~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      .... .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...+  .......+..... +... ...
T Consensus       170 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~-~~~~-~~~  244 (313)
T cd06633         170 KSSP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNDS-PTLQ-SNE  244 (313)
T ss_pred             ccCC-CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCC-CCCC-ccc
Confidence            5432 23456889999999984   4568899999999999999999999997665  2233333333221 1111 123


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+..+.+++.+||..+|.+||++.+++..
T Consensus       245 ~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         245 WTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            44568889999999999999999998853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-35  Score=298.17  Aligned_cols=250  Identities=24%  Similarity=0.288  Sum_probs=190.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC----CC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP----PY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~----~~  268 (472)
                      ++|++.+.||.|+||.||+|..+  |..||+|++.....  .......+.+|+.+|+.++||||+++++++...    ..
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD--VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc--cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            68899999999999999999875  78999999875432  223455677899999999999999999987643    23


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|++++ +++|.+++....          ..+...+..++.|++.||+|||+++  ++||||||+|||++.++.+||+
T Consensus        83 ~~lv~e~~-~~~l~~~~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~  149 (334)
T cd07855          83 VYVVMDLM-ESDLHHIIHSDQ----------PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIG  149 (334)
T ss_pred             EEEEEehh-hhhHHHHhccCC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEec
Confidence            45555555 678988885322          1357889999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc-------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          349 DFGHARFLSDGE-------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       349 DFGla~~~~~~~-------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      |||++.......       ....|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+............|
T Consensus       150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g  229 (334)
T cd07855         150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG  229 (334)
T ss_pred             ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhC
Confidence            999998764322       12357889999999865 5689999999999999999999999977653211000000000


Q ss_pred             ----------------------CCCCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 ----------------------KLRPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ----------------------~~~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                            ......+.   .+..+..+.++|.+||..+|++||++++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             CChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                                  00011110   0224567899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3e-35  Score=296.56  Aligned_cols=248  Identities=25%  Similarity=0.316  Sum_probs=189.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC--Cc
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP--YR  269 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~--~~  269 (472)
                      ++|++.+.||+|+||.||+|.++  |..+|||.+.....  .......+.+|+.+++.+ +||||++++++|...+  ..
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR--NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC--cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            57889999999999999999985  67899998865322  223345577899999999 9999999999987644  34


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++++ +++|..++...           ...+..+..++.|++.||+|||++|  ++||||||+|||++.++.+||+|
T Consensus        85 ~lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d  150 (337)
T cd07852          85 YLVFEYM-ETDLHAVIRAN-----------ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLAD  150 (337)
T ss_pred             EEEeccc-ccCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEee
Confidence            5555555 57999888532           1235667788999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCcc--------ccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          350 FGHARFLSDGEM--------ALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       350 FGla~~~~~~~~--------~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ||++........        ...|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+...  ......+...
T Consensus       151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~--~~~~~~~~~~  228 (337)
T cd07852         151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST--LNQLEKIIEV  228 (337)
T ss_pred             ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHH
Confidence            999986643221        2347889999998754 5678999999999999999999999976441  1111111000


Q ss_pred             --------------------------CCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 --------------------------KLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 --------------------------~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                                .....+... +..+..+.++|.+||..+|++||++.+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                                      000011111 2246778999999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.6e-35  Score=283.41  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=198.0

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC-ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~-~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +|.+.++||+|+||.||++.+.  +..+++|+++...... .......+..|+.+++.++||||+++++++.+....+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4788999999999999999886  3457777765432211 222334567899999999999999999999988888899


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++......      ....++..++.++.|++.||.|||+++  ++|+||+|+||++++ +.++|+|||+
T Consensus        81 ~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHT------GKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhc------ccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCc
Confidence            9999999999998643211      123356788899999999999999999  999999999999975 5799999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......   ....|++.|+|||.+.+..++.++|+||||+++|+|++|..||....  .......+..+. .+.++  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~--  226 (260)
T cd08222         152 SRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--FLSVVLRIVEGP-TPSLP--  226 (260)
T ss_pred             eeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHcCC-CCCCc--
Confidence            98764332   23457889999999988889999999999999999999999996554  334444444433 22222  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..+|++||++.+++.
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            345567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=286.50  Aligned_cols=249  Identities=21%  Similarity=0.335  Sum_probs=204.8

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGAC  263 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~  263 (472)
                      ...|.+...+|.++++||+|+|+.|.+++.+  .+.||+|+++++.+..+ +.+.....|..+.... +||++|-++..|
T Consensus       242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~ndd-edidwvqtek~vfe~asn~pflvglhscf  320 (593)
T KOG0695|consen  242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDD-EDIDWVQTEKHVFEQASNNPFLVGLHSCF  320 (593)
T ss_pred             ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCc-ccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence            3569999999999999999999999999886  56799999999877544 4556677788887776 799999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      ..+..+++|+||+.||+|.-.++....          .+.+.++.+..+|+.||.|||+.|  ||+||||.+|||+|..|
T Consensus       321 qtesrlffvieyv~ggdlmfhmqrqrk----------lpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeg  388 (593)
T KOG0695|consen  321 QTESRLFFVIEYVNGGDLMFHMQRQRK----------LPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEG  388 (593)
T ss_pred             cccceEEEEEEEecCcceeeehhhhhc----------CcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCC
Confidence            999999999999999999877754322          245778888999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC-----CCCCHHH-HH
Q 039082          344 HVRIADFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE-----KDYKPAK-IA  414 (472)
Q Consensus       344 ~vkL~DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~-----~~~~~~~-i~  414 (472)
                      ++||+|+|+++.--   +...++||||.|.|||++++..|..++|||+|||+++||+.|+.||.-     .+.+..+ +.
T Consensus       389 hikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylf  468 (593)
T KOG0695|consen  389 HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLF  468 (593)
T ss_pred             ceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHH
Confidence            99999999998653   345678999999999999999999999999999999999999999952     2222333 34


Q ss_pred             HHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCC
Q 039082          415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRP  452 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP  452 (472)
                      ..+.+...|  +|..  .......++...|++||.+|.
T Consensus       469 qvilekqir--iprs--lsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  469 QVILEKQIR--IPRS--LSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHhhhccc--ccce--eehhhHHHHHHhhcCCcHHhc
Confidence            445555433  3433  223445677788999999994

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.6e-36  Score=324.30  Aligned_cols=246  Identities=28%  Similarity=0.397  Sum_probs=185.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY----  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~----  268 (472)
                      .||+.++.||+|+||.||+++++  |+.||||.+.-..   .......+.+|+.+|.+|+|||||++|..+.+...    
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~---s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA---SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch---HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            58889999999999999999987  9999999986542   45566778899999999999999999876543211    


Q ss_pred             --------------------------------------------------------------------------------
Q 039082          269 --------------------------------------------------------------------------------  268 (472)
Q Consensus       269 --------------------------------------------------------------------------------  268 (472)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -----------------------------------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHH
Q 039082          269 -----------------------------------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI  313 (472)
Q Consensus       269 -----------------------------------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  313 (472)
                                                         +|+=|+||....|.++++......         .....+.++++|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---------~~d~~wrLFreI  706 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---------QRDEAWRLFREI  706 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---------hhHHHHHHHHHH
Confidence                                               112233333333444433222110         134578899999


Q ss_pred             HHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC--------------------C-CccccccCCccccc
Q 039082          314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--------------------D-GEMALTGTFVYMAP  372 (472)
Q Consensus       314 a~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~--------------------~-~~~~~~gt~~y~AP  372 (472)
                      +.||+|+|++|  ||||||||.||++++++.|||+|||+|....                    + ..+..+||..|+||
T Consensus       707 lEGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAP  784 (1351)
T KOG1035|consen  707 LEGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAP  784 (1351)
T ss_pred             HHHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecH
Confidence            99999999999  9999999999999999999999999998721                    0 11245689999999


Q ss_pred             ccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCC
Q 039082          373 EVIQCEP---YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DGQLRELIELICLSWDGDA  448 (472)
Q Consensus       373 E~~~~~~---~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP  448 (472)
                      |.+.+..   |+.|+|+|||||+++||+.   ||.... ....+...+.++.++.+ +.. .+....-..+|.+++++||
T Consensus       785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM-ERa~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM-ERASILTNLRKGSIPEP-ADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             HHhcccccccccchhhhHHHHHHHHHHhc---cCCchH-HHHHHHHhcccCCCCCC-cccccccchHHHHHHHHHhcCCC
Confidence            9997654   9999999999999999986   664332 24556666666665433 111 3344445678889999999


Q ss_pred             CCCCCHHHHHH
Q 039082          449 SVRPSFSSITC  459 (472)
Q Consensus       449 ~~RPs~~~ll~  459 (472)
                      ++||||.+|+.
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999984

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.5e-35  Score=296.23  Aligned_cols=249  Identities=23%  Similarity=0.253  Sum_probs=190.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----  267 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----  267 (472)
                      .+|.+.+.||+|+||.||+|.++  +..||||.+.....  .......+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc--ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            46999999999999999999975  77899999875422  2233455778999999999999999999876543     


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++++ +++|.+++...+          ..+...+..++.|++.||.|||+++  ++||||||+||+++.++.+||
T Consensus        83 ~~~lv~e~~-~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL  149 (337)
T cd07858          83 DVYIVYELM-DTDLHQIIRSSQ----------TLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKI  149 (337)
T ss_pred             cEEEEEeCC-CCCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEE
Confidence            245555554 688988885432          1346778899999999999999999  999999999999999999999


Q ss_pred             eecccceecCCC---ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh-----
Q 039082          348 ADFGHARFLSDG---EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG-----  418 (472)
Q Consensus       348 ~DFGla~~~~~~---~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~-----  418 (472)
                      +|||++......   .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.+...  ....+.     
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~  227 (337)
T cd07858         150 CDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH--QLKLITELLGS  227 (337)
T ss_pred             CcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH--HHHHHHHHhCC
Confidence            999999876533   123457889999998764 468999999999999999999999997654211  110000     


Q ss_pred             ----------cCC-----------CCCCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          419 ----------EGK-----------LRPALPE-EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       419 ----------~~~-----------~~~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                ...           .+..... .+.....+.++|.+||..+|++||+++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         228 PSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                      000           0000000 12345678899999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.7e-35  Score=288.46  Aligned_cols=250  Identities=22%  Similarity=0.272  Sum_probs=186.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC---
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY---  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~---  268 (472)
                      .++|++.++||+|+||.||+|.++  +..||||.+.....  .......+.+|+++++.++||||+++++++.+...   
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   84 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE--KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK   84 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC--CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence            368999999999999999999986  67899998865432  11222346789999999999999999998765443   


Q ss_pred             -----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          269 -----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       269 -----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                           .++++++ .+++|..++....         ...++..+..++.|++.||+|||++|  ++|+||||+|||+++++
T Consensus        85 ~~~~~~~lv~~~-~~~~l~~~~~~~~---------~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~  152 (311)
T cd07866          85 RKRGSVYMVTPY-MDHDLSGLLENPS---------VKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQG  152 (311)
T ss_pred             ccCceEEEEEec-CCcCHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCC
Confidence                 3455554 5667777765321         12357888999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCcc--------------ccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCC
Q 039082          344 HVRIADFGHARFLSDGEM--------------ALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDY  408 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~--------------~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~  408 (472)
                      .++|+|||++........              ...+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+ 
T Consensus       153 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~-  231 (311)
T cd07866         153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKS-  231 (311)
T ss_pred             CEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCC-
Confidence            999999999986543211              1235788999998765 458999999999999999999999997654 


Q ss_pred             CHHHHHHHHhcC--CC-------------------CCCCCCC-----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          409 KPAKIAMEVGEG--KL-------------------RPALPEE-----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       409 ~~~~i~~~i~~~--~~-------------------~~~l~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .......+...  ..                   ....+..     ......+.++|.+||..+|++|||+.+++.
T Consensus       232 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         232 -DIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             -HHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             22222211110  00                   0000000     112256789999999999999999998875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-35  Score=284.01  Aligned_cols=247  Identities=21%  Similarity=0.267  Sum_probs=193.8

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |++.+.||+|++|.||+|...  +..+++|.+.....  .......+.+|+.+++.++||||+++++++...+..+++++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   78 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE--SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFE   78 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc--cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEe
Confidence            467789999999999999875  77899999876432  22345678899999999999999999999988888888888


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++. ++|..++....         ...++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||.+.
T Consensus        79 ~~~-~~l~~~l~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~  146 (283)
T cd05118          79 FMD-TDLYKLIKDRQ---------RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLAR  146 (283)
T ss_pred             ccC-CCHHHHHHhhc---------ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeE
Confidence            775 58888875422         12346788899999999999999999  9999999999999999999999999998


Q ss_pred             ecCCCc---cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC--CC------
Q 039082          355 FLSDGE---MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG--KL------  422 (472)
Q Consensus       355 ~~~~~~---~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~--~~------  422 (472)
                      ......   ....++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+.  .+....+...  ..      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd05118         147 SFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE--IDQLFKIFRTLGTPDPEVWP  224 (283)
T ss_pred             ecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHcCCCchHhcc
Confidence            776543   223468889999998776 789999999999999999999999976552  1111111110  00      


Q ss_pred             ---------CCCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 ---------RPALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ---------~~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                               ....+.         .+..+.++.++|.+||..||.+||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         225 KFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             cchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                     000000         0234567889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-34  Score=315.42  Aligned_cols=148  Identities=27%  Similarity=0.398  Sum_probs=130.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|.+.++||+|+||.||+|.+.  +..||||+++.... ........+.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~-~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADM-INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhc-cCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            368999999999999999999987  78999999976433 234556778899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++|+.|++|.+++...+.          .+...++.++.||+.||+|||.++  ||||||||+||||+.++.+||+|||
T Consensus        82 VmEy~~g~~L~~li~~~~~----------l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFG  149 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGY----------FDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFG  149 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCC
Confidence            9999999999999864321          235678899999999999999999  9999999999999999999999999


Q ss_pred             cce
Q 039082          352 HAR  354 (472)
Q Consensus       352 la~  354 (472)
                      +++
T Consensus       150 ls~  152 (669)
T cd05610         150 LSK  152 (669)
T ss_pred             CCc
Confidence            875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=286.95  Aligned_cols=264  Identities=27%  Similarity=0.355  Sum_probs=205.4

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGA  262 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~  262 (472)
                      ...-|.+..++.+-+..||.|+||.|++-.++  |...|||.++..   ..+....+|+.|.+...+- +.||||++||.
T Consensus        55 ~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~---n~~keq~rll~e~d~~mks~~cp~IVkfyGa  131 (361)
T KOG1006|consen   55 DAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSN---NIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA  131 (361)
T ss_pred             cccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeec---cchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence            45568889999999999999999999999886  889999999754   3456667788888876554 78999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      ++.+.. +|+.+|++..+|..+....-...     ....+...+-.++.-.+.||.||-..- .|||||+||+||||+..
T Consensus       132 ~F~EGd-cWiCMELMd~SlDklYk~vy~vq-----~~~ipE~Ilg~ItvatV~AL~yLK~~l-kiIHRDvKPSNILldr~  204 (361)
T KOG1006|consen  132 LFSEGD-CWICMELMDISLDKLYKRVYSVQ-----KSRIPENILGHITVATVDALDYLKEEL-KIIHRDVKPSNILLDRH  204 (361)
T ss_pred             hhcCCc-eeeeHHHHhhhHHHHHHHHHHHH-----hccCcHhhhhheeeeehhHHHHHHHHh-hhhhccCChhheEEecC
Confidence            887665 57778888999887664311111     011223445566667889999998752 39999999999999999


Q ss_pred             CcEEEeecccceecCCCc--cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          343 KHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |.|||||||++-.+.+..  +...|-..|||||.+..  ..|+.+|||||||++|||+.||+.||.+-+. ..+...++.
T Consensus       205 G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv  283 (361)
T KOG1006|consen  205 GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVV  283 (361)
T ss_pred             CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHH
Confidence            999999999998766543  34457888999999964  4599999999999999999999999987663 344455566


Q ss_pred             cCCCCCCCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          419 EGKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       419 ~~~~~~~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .|..+..+...  ......+..+|..|+.+|-+.||.+.+|++.
T Consensus       284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            66633333322  3466789999999999999999999998763

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-35  Score=292.86  Aligned_cols=248  Identities=26%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----C
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----Y  268 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----~  268 (472)
                      +|++.+.||+|+||.||+|.+.  +..||||.+....  ......+.+.+|+.+++.++||||+++++++...+     .
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~   78 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF--DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFND   78 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc--ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccc
Confidence            4788999999999999999985  6789999987542  12344566889999999999999999999988775     4


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .+++++++ +++|..++....          ..++..+..++.+++.||+|||++|  ++||||||+|||++.++.++|+
T Consensus        79 ~~lv~e~~-~~~l~~~l~~~~----------~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~  145 (330)
T cd07834          79 VYIVTELM-ETDLHKVIKSPQ----------PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKIC  145 (330)
T ss_pred             eEEEecch-hhhHHHHHhCCC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEc
Confidence            55555555 568888885322          2346778889999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc------cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC-
Q 039082          349 DFGHARFLSDGE------MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG-  420 (472)
Q Consensus       349 DFGla~~~~~~~------~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~-  420 (472)
                      |||++.......      ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+.  ......+... 
T Consensus       146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~--~~~~~~i~~~~  223 (330)
T cd07834         146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY--IDQLNLIVEVL  223 (330)
T ss_pred             ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHhc
Confidence            999999876543      233468899999999877 789999999999999999999999976652  2222221110 


Q ss_pred             -CC----------------------CCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 -KL----------------------RPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 -~~----------------------~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                       ..                      ....+.   .+..+..+.++|.+||..+|++||++++++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence             00                      000000   02235678899999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-35  Score=295.69  Aligned_cols=254  Identities=24%  Similarity=0.315  Sum_probs=196.6

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.+. ++|++.+.||+|+||.||+|.+.  +..||||++.....  .......+.+|+.+++.++||||+++++++..
T Consensus         9 ~~~~~~-~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851           9 TVWEVP-DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ--SAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             ceeccc-CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc--hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            345553 57999999999999999999986  67899998865321  23344567889999999999999999988766


Q ss_pred             CCC-----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          266 PPY-----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       266 ~~~-----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      .+.     ..++++++.+++|.+++...           ..++..+..++.+++.||+|||+.|  ++||||+|+||+++
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~-----------~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~  152 (343)
T cd07851          86 ASSLEDFQDVYLVTHLMGADLNNIVKCQ-----------KLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVN  152 (343)
T ss_pred             cccccccccEEEEEecCCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEC
Confidence            554     23455555688999988531           2346788899999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          341 DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      .++.++|+|||++...........++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.  ......+..
T Consensus       153 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~  230 (343)
T cd07851         153 EDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMN  230 (343)
T ss_pred             CCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHH
Confidence            9999999999999877655555667899999999865 4678999999999999999999999976552  222222211


Q ss_pred             CCC--------------------------CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 GKL--------------------------RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ~~~--------------------------~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...                          ++.+... ......+.++|.+||..+|++|||+.+|+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         231 LVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            100                          0000000 123567889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.8e-34  Score=290.40  Aligned_cols=249  Identities=22%  Similarity=0.260  Sum_probs=189.0

Q ss_pred             Cee-EeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh----------HHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          196 EID-LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE----------NAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       196 ~~~-l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~----------~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      +|. +.+.||.|+||.||+|.++  +..||||++.........          .....+.+|+.+++.++||||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            444 5678999999999999875  778999998654322110          001247789999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      +...+..+++++++ .++|.+++....          ..+......++.|++.||+|||+.+  ++|+||+|+|||++.+
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~l~~~~----------~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~~  155 (335)
T PTZ00024         89 YVEGDFINLVMDIM-ASDLKKVVDRKI----------RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINSK  155 (335)
T ss_pred             EecCCcEEEEEecc-ccCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECCC
Confidence            99888888888777 478998885322          2346778899999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCC-----------------ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCC
Q 039082          343 KHVRIADFGHARFLSDG-----------------EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYI  404 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~-----------------~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~  404 (472)
                      +.++|+|||++......                 .....+++.|+|||.+.+. .++.++|||||||++|+|++|..||.
T Consensus       156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        156 GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999866511                 1122357889999998764 47899999999999999999999997


Q ss_pred             CCCCCHHHHHHHHhc--C-CCC----------------CCCCCC-----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          405 EKDYKPAKIAMEVGE--G-KLR----------------PALPEE-----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~--~-~~~----------------~~l~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.+  .......+..  + ...                ...+..     ......+.++|.+||+.+|++||++++++.
T Consensus       236 ~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        236 GEN--EIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             CCC--HHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            665  2222222211  0 000                000000     123466889999999999999999999985

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=330.39  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=203.6

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      ++.-...||.|.||.||-|.+.  |...|||.++....  .........+|..++..+.|||+|++||+=.+.+..++.|
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~--~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDS--DHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCcc--ccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence            3455678999999999999874  77899998865432  2344566789999999999999999999988888999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      ||+.+|+|.+.+...+-.          +......+..|++.|++|||++|  ||||||||+||||+.+|.+|++|||.|
T Consensus      1314 EyC~~GsLa~ll~~gri~----------dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa 1381 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRIE----------DEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSA 1381 (1509)
T ss_pred             HHhccCcHHHHHHhcchh----------hhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeecccce
Confidence            999999999998643221          13334566789999999999999  999999999999999999999999999


Q ss_pred             eecCCCcc-------ccccCCcccccccccCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          354 RFLSDGEM-------ALTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       354 ~~~~~~~~-------~~~gt~~y~APE~~~~~---~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ..+.....       ...||+.|||||++.+.   ....+.|||||||++.||+||+.||...++ .-.+...+..|. .
T Consensus      1382 ~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-e~aIMy~V~~gh-~ 1459 (1509)
T KOG4645|consen 1382 VKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-EWAIMYHVAAGH-K 1459 (1509)
T ss_pred             eEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-hhHHHhHHhccC-C
Confidence            87765432       23489999999999753   456789999999999999999999988774 345667777776 5


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      |.+|+.  ...+-.++|.+||..||+.|.++.+|++.
T Consensus      1460 Pq~P~~--ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1460 PQIPER--LSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CCCchh--hhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            667765  55667889999999999999999888764

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=282.93  Aligned_cols=247  Identities=23%  Similarity=0.292  Sum_probs=191.6

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      |++.+.||+|+||.||+|.++  +..||||.+......   .......+|+..+++++ ||||+++++++...+..++|+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   77 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVF   77 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc---hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEE
Confidence            578899999999999999985  678999988654321   22233557999999998 999999999999988888888


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++ +++|.+++....        ....++..+..++.|++.||.|||+++  ++|+||+|+||+++.++.++|+|||++
T Consensus        78 e~~-~~~l~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~  146 (283)
T cd07830          78 EYM-EGNLYQLMKDRK--------GKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLA  146 (283)
T ss_pred             ecC-CCCHHHHHHhcc--------cccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccc
Confidence            888 889998886433        112357888999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc--cccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc-----------
Q 039082          354 RFLSDGE--MALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE-----------  419 (472)
Q Consensus       354 ~~~~~~~--~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~-----------  419 (472)
                      .......  ....++..|+|||.+. ...++.++|+||||+++|+|++|..||.....  .+....+..           
T Consensus       147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  224 (283)
T cd07830         147 REIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE--IDQLYKICSVLGTPTKQDWP  224 (283)
T ss_pred             eeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh--HHHHHHHHHhcCCCChhhhh
Confidence            8765432  2345788999999875 45678999999999999999999999976542  111111110           


Q ss_pred             ------CCCCCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 ------GKLRPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ------~~~~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                            ......++..         +.....+.++|.+||..+|++||++++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         225 EGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                  0000011100         112467889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-34  Score=277.19  Aligned_cols=235  Identities=29%  Similarity=0.372  Sum_probs=195.1

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||.|+||.||++.++  +..||+|++..... ........+.+|+.+++.++||||+++++.+...+..+++++++.+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKI-IKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhh-cchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            699999999999986  77899999876543 233456678999999999999999999999998888899999999999


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCC-
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-  359 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-  359 (472)
                      |.+++....          ..+...+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 L~~~l~~~~----------~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  147 (250)
T cd05123          80 LFSHLSKEG----------RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG  147 (250)
T ss_pred             HHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC
Confidence            999996432          1246778889999999999999999  999999999999999999999999999876543 


Q ss_pred             --ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHH
Q 039082          360 --EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELI  437 (472)
Q Consensus       360 --~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~  437 (472)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+  .......+....  ..++.  ..+..+.
T Consensus       148 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~--~~~~~~~~~~~~--~~~~~--~~~~~l~  221 (250)
T cd05123         148 SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED--RKEIYEKILKDP--LRFPE--FLSPEAR  221 (250)
T ss_pred             CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHhcCC--CCCCC--CCCHHHH
Confidence              334557889999999988888999999999999999999999997665  344444444432  22332  2356788


Q ss_pred             HHHHHhccCCCCCCCCHHH
Q 039082          438 ELICLSWDGDASVRPSFSS  456 (472)
Q Consensus       438 ~li~~cl~~dP~~RPs~~~  456 (472)
                      +++.+||..||++||++.+
T Consensus       222 ~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         222 DLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHhcCCHhhCCCccc
Confidence            9999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=330.83  Aligned_cols=245  Identities=22%  Similarity=0.334  Sum_probs=190.9

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      +...+.||+|+||.||+|.++  +..||||.+.....  .      ..+|+.++++++|||||+++|+|.+.+..++|+|
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--I------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--c------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            445678999999999999974  78999998854211  1      1246888999999999999999999999999999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH---EQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH---~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+.+|+|.++++.             .+|..+..++.+++.||+|||   +.+  |+||||||+||+++.++..++. ||
T Consensus       764 y~~~g~L~~~l~~-------------l~~~~~~~i~~~ia~~L~yLH~~~~~~--iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        764 YIEGKNLSEVLRN-------------LSWERRRKIAIGIAKALRFLHCRCSPA--VVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             CCCCCcHHHHHhc-------------CCHHHHHHHHHHHHHHHHHhccCCCCC--eecCCCCHHhEEECCCCceEEE-ec
Confidence            9999999999952             247788999999999999999   456  9999999999999999888875 66


Q ss_pred             cceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC---HHHHHHHHh---------c
Q 039082          352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK---PAKIAMEVG---------E  419 (472)
Q Consensus       352 la~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~---~~~i~~~i~---------~  419 (472)
                      .+..... .....+++.|+|||++.+..++.++|||||||++|||+||+.||......   .........         +
T Consensus       828 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  906 (968)
T PLN00113        828 LPGLLCT-DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID  906 (968)
T ss_pred             ccccccc-CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC
Confidence            6544322 22336789999999999999999999999999999999999999543211   111111110         1


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ...+...+.......++.+++.+||..+|++||++.++++.|+++..
T Consensus       907 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        907 PSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            11111111223455678899999999999999999999999998865

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.9e-34  Score=288.87  Aligned_cols=250  Identities=23%  Similarity=0.285  Sum_probs=187.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC---C
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP---P  267 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~---~  267 (472)
                      +|++.+.||+|+||.||++.+.    +..||||.+....  ........+.+|+.+++.+ +||||+++++.+...   .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~   78 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF--SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNF   78 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc--ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccC
Confidence            4788999999999999999986    4579999886432  1223455688999999999 599999999875432   2


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ...++++++.+++|.+++....          ..+...+..++.||+.||+|||++|  ++||||||+|||++.++.+||
T Consensus        79 ~~~~~~~e~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl  146 (332)
T cd07857          79 NELYLYEELMEADLHQIIRSGQ----------PLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKI  146 (332)
T ss_pred             CcEEEEEecccCCHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEe
Confidence            3446666777889999885322          2346788899999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc-------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH---------
Q 039082          348 ADFGHARFLSDGE-------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP---------  410 (472)
Q Consensus       348 ~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~---------  410 (472)
                      +|||++.......       ....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+...         
T Consensus       147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~  226 (332)
T cd07857         147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL  226 (332)
T ss_pred             CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence            9999998654321       12357899999998765 568999999999999999999999997654110         


Q ss_pred             ----HHHHHHHhc-----------CCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          411 ----AKIAMEVGE-----------GKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       411 ----~~i~~~i~~-----------~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                          ......+..           ......++.. +.....+.+++.+||..+|++||++.+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                001000000           0000111111 223467889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=305.33  Aligned_cols=259  Identities=25%  Similarity=0.388  Sum_probs=197.5

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC------C
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP------Y  268 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~------~  268 (472)
                      +...+.||+|+||.||+|+++  |..||||++++..   .....+...+|+++|++++|||||++.++=.+..      .
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~---~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~   91 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES---SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL   91 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhc---ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence            345788999999999999976  8899999998754   2334455789999999999999999998744332      2


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc--CCC--c
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAK--H  344 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~--~~~--~  344 (472)
                      ..++|||+.||+|...|....+-       .-.+..+.+.+..+++.||.|||++|  ||||||||.||++-  ++|  .
T Consensus        92 ~vlvmEyC~gGsL~~~L~~PEN~-------~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~I  162 (732)
T KOG4250|consen   92 PVLVMEYCSGGSLRKVLNSPENA-------YGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSI  162 (732)
T ss_pred             ceEEEeecCCCcHHHHhcCcccc-------cCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceE
Confidence            45799999999999999654331       12346788999999999999999999  99999999999983  444  4


Q ss_pred             EEEeecccceecCCCcc--ccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHHhc
Q 039082          345 VRIADFGHARFLSDGEM--ALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--PAKIAMEVGE  419 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~--~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--~~~i~~~i~~  419 (472)
                      -||+|||.|+.++++..  +..||..|.+||.+. .+.|+..+|.|||||++|+++||..||......  ..++...+..
T Consensus       163 yKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~t  242 (732)
T KOG4250|consen  163 YKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIIT  242 (732)
T ss_pred             EeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhc
Confidence            79999999999987764  456999999999998 588999999999999999999999999653322  1112222222


Q ss_pred             CC-----------------CCCCCCCC----chhHHHHHHHHHHhccCCCCCCC--CHHHHHHHHHHHHHH
Q 039082          420 GK-----------------LRPALPEE----DGQLRELIELICLSWDGDASVRP--SFSSITCSLKNIQMK  467 (472)
Q Consensus       420 ~~-----------------~~~~l~~~----~~~~~~l~~li~~cl~~dP~~RP--s~~~ll~~L~~i~~~  467 (472)
                      ++                 +...+|..    ......+-..+..+|..+|.+|.  .+.+....+.+|...
T Consensus       243 kkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  243 KKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             cCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            11                 11223322    33344455677788899999998  777777777666543

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.2e-34  Score=289.87  Aligned_cols=245  Identities=20%  Similarity=0.239  Sum_probs=185.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----  267 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----  267 (472)
                      .+|.+.+.||.|+||.||+|.++  |..||+|.+....    ....+.+.+|+.+++.++||||+++++++....     
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~----~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD----PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC----CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            68999999999999999999985  6789999886542    234466889999999999999999998766543     


Q ss_pred             ---------CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          268 ---------YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       268 ---------~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                               ..+++++++ +++|.+++...           ..+...+..++.||+.||.|||+.|  ++||||||+|||
T Consensus        81 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nil  146 (342)
T cd07854          81 DVGSLTELNSVYIVQEYM-ETDLANVLEQG-----------PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVF  146 (342)
T ss_pred             ccccccccceEEEEeecc-cccHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEE
Confidence                     234555555 67888887421           1246778899999999999999999  999999999999


Q ss_pred             Ec-CCCcEEEeecccceecCCCc------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH
Q 039082          339 LD-DAKHVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP  410 (472)
Q Consensus       339 l~-~~~~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~  410 (472)
                      ++ +++.+||+|||++.......      ....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+..  +
T Consensus       147 i~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~  224 (342)
T cd07854         147 INTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH--E  224 (342)
T ss_pred             EcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC--H
Confidence            97 45678999999998764321      12346888999998654 568899999999999999999999997654  2


Q ss_pred             HHHHHHHhcC-----------------------CCCCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          411 AKIAMEVGEG-----------------------KLRPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       411 ~~i~~~i~~~-----------------------~~~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..........                       ......+.   ......++.+++.+||..||++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            1221111110                       00000000   0123456889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=280.68  Aligned_cols=247  Identities=24%  Similarity=0.292  Sum_probs=193.7

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |++.+.||+|.||.||+|...  +..||+|++....  ........+.+|+.+++.++|+||+++++++...+..+++++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   78 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFE   78 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc--ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEec
Confidence            567889999999999999986  6899999997653  223344567899999999999999999999988877777777


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++. ++|.+++....         ...++..+..++.+++.||+|||+.+  ++||||+|+||++++++.++|+|||++.
T Consensus        79 ~~~-~~l~~~i~~~~---------~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~  146 (282)
T cd07829          79 YCD-MDLKKYLDKRP---------GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLAR  146 (282)
T ss_pred             CcC-cCHHHHHHhhc---------cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCccc
Confidence            765 68999996532         12346888999999999999999999  9999999999999999999999999998


Q ss_pred             ecCCCc---cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC----------
Q 039082          355 FLSDGE---MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG----------  420 (472)
Q Consensus       355 ~~~~~~---~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~----------  420 (472)
                      ......   ....++..|+|||.+... .++.++|||||||++|+|++|..||...+.  ......+...          
T Consensus       147 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  224 (282)
T cd07829         147 AFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE--IDQLFKIFQILGTPTEESWP  224 (282)
T ss_pred             ccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHHHhCCCcHHHHH
Confidence            765432   223457889999998766 789999999999999999999999976552  1111111100          


Q ss_pred             ------CCCCCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 ------KLRPALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ------~~~~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                            .....++.         .+.....+.++|.+||..+|++||++.+++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         225 GVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             hhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                  00000111         0123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=282.37  Aligned_cols=253  Identities=24%  Similarity=0.307  Sum_probs=199.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC---ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc-CCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT---NENAVTFFAQEVDTLSRQRHRFVLQLMGACLE-PPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~---~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~-~~~  268 (472)
                      ++|-++..||+|+|++||+|.+-  .+.||||+-..+..-.   .+...+...+|.+|-+.|+||.||++|++|.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            56778999999999999999874  6789999754322111   22344667799999999999999999999875 566


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc---CCCcE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKHV  345 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~---~~~~v  345 (472)
                      +|-|+||+.|.+|.-||+.+..          .+..+++.|+.||+.||.||.+..++|||-||||.|||+.   ..|.+
T Consensus       543 FCTVLEYceGNDLDFYLKQhkl----------mSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeI  612 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQHKL----------MSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEI  612 (775)
T ss_pred             ceeeeeecCCCchhHHHHhhhh----------hhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCccccee
Confidence            7789999999999999976553          3468899999999999999999999999999999999995   45889


Q ss_pred             EEeecccceecCCCcc----------ccccCCcccccccccCC----CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH
Q 039082          346 RIADFGHARFLSDGEM----------ALTGTFVYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA  411 (472)
Q Consensus       346 kL~DFGla~~~~~~~~----------~~~gt~~y~APE~~~~~----~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~  411 (472)
                      ||+|||+++.+++...          ...||.+|++||++--+    ..+.++||||.||++|..+.|+-||..... ..
T Consensus       613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs-QQ  691 (775)
T KOG1151|consen  613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS-QQ  691 (775)
T ss_pred             EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh-HH
Confidence            9999999999876543          24589999999997533    467899999999999999999999965542 22


Q ss_pred             HHHHH--HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          412 KIAME--VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       412 ~i~~~--i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ++...  |.+.. .-.+|..+....+...+|.+||.+.-++|.+..+|..
T Consensus       692 dILqeNTIlkAt-EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 DILQENTILKAT-EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             HHHhhhchhcce-eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            23222  22221 2334444555667888999999999999998887753

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=293.75  Aligned_cols=242  Identities=27%  Similarity=0.374  Sum_probs=197.4

Q ss_pred             eceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      .++||+|.||+||-|.++  |+.||||++.+..+....  ...+.+|+.||..++||.||.+...|...+..+.|||.+.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq--esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ--ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch--HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc
Confidence            478999999999999875  899999999887765443  3678899999999999999999999988888776777665


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC---CcEEEeecccce
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---KHVRIADFGHAR  354 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~---~~vkL~DFGla~  354 (472)
                      |--|.-.|.....+.         +...-..++.||+.||.|||-+|  |+|+||||+|||+...   ..+||||||+|+
T Consensus       647 GDMLEMILSsEkgRL---------~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRL---------PERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             chHHHHHHHhhcccc---------hHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeecccccee
Confidence            555655554433221         22333455679999999999999  9999999999999643   579999999999


Q ss_pred             ecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchh
Q 039082          355 FLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ  432 (472)
Q Consensus       355 ~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~  432 (472)
                      .+.+..  ...+|||.|.|||+++.+.|...-|+||.||++|--+.|..||.+.    +++..+|....+..+..+..+.
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd----EdIndQIQNAaFMyPp~PW~ei  791 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED----EDINDQIQNAAFMYPPNPWSEI  791 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc----cchhHHhhccccccCCCchhhc
Confidence            988654  4567999999999999999999999999999999999999999554    4577788877655433333667


Q ss_pred             HHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          433 LRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       433 ~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      ....+++|...|...-.+|-+.+.-+
T Consensus       792 s~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  792 SPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            78889999999999999998887654

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=275.40  Aligned_cols=246  Identities=20%  Similarity=0.309  Sum_probs=201.6

Q ss_pred             CCeeEe-ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh-cCCCceeEEEEEEEcC----
Q 039082          195 KEIDLQ-EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLEP----  266 (472)
Q Consensus       195 ~~~~l~-~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~-l~HpnIv~l~g~~~~~----  266 (472)
                      +||.+- ++||-|-.|.|..+..+  |.++|+|++...     .    ...+|+++--. -.|||||.++++|...    
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r  131 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----P----KARREVELHWMASGHPHIVSIIDVYENSYQGR  131 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----H----HHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence            566665 58999999999999886  789999988532     1    14577777443 4799999999988653    


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CC
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AK  343 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~  343 (472)
                      ..+.+|||.+.||.|+..++..+...        .+..++..|+.||+.|+.|||+.+  |.||||||+|+|...   |-
T Consensus       132 kcLLiVmE~meGGeLfsriq~~g~~a--------fTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na  201 (400)
T KOG0604|consen  132 KCLLIVMECMEGGELFSRIQDRGDQA--------FTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNA  201 (400)
T ss_pred             eeeEeeeecccchHHHHHHHHccccc--------chHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCc
Confidence            33557888888999999998766532        356789999999999999999999  999999999999964   45


Q ss_pred             cEEEeecccceecCC--CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhc
Q 039082          344 HVRIADFGHARFLSD--GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGE  419 (472)
Q Consensus       344 ~vkL~DFGla~~~~~--~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~  419 (472)
                      .+||+|||+|+.-..  .-.+.+-||.|.|||++....|+..+|+||+||++|-|++|..||..+..  -...+...|..
T Consensus       202 ~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~  281 (400)
T KOG0604|consen  202 PLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRT  281 (400)
T ss_pred             ceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhc
Confidence            799999999987663  33466789999999999999999999999999999999999999965432  12346777888


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      |.+..+-|+.+....+..++|..+|..+|.+|.|+.++.+
T Consensus       282 gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  282 GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            8776555555778888999999999999999999998864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=294.37  Aligned_cols=202  Identities=25%  Similarity=0.361  Sum_probs=173.7

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +..-|..++.||-|+||+|.++...  ...||+|.+++..+ ...........|..||...+.+.||+||-.|.+.+.+|
T Consensus       627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDV-l~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADV-LMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHH-HhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            4567888999999999999999764  45699999977544 34566677889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      |||+|+.||++..+|-+.+-          .....++.++.++..|+++.|..|  +|||||||+|||||.+|++||+||
T Consensus       706 FVMdYIPGGDmMSLLIrmgI----------FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDF  773 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGI----------FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDF  773 (1034)
T ss_pred             EEEeccCCccHHHHHHHhcc----------CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeec
Confidence            99999999999999865543          234556677889999999999999  999999999999999999999999


Q ss_pred             ccceecCC---------Cc------------------------------------cccccCCcccccccccCCCCCchHH
Q 039082          351 GHARFLSD---------GE------------------------------------MALTGTFVYMAPEVIQCEPYSEKSD  385 (472)
Q Consensus       351 Gla~~~~~---------~~------------------------------------~~~~gt~~y~APE~~~~~~~s~~sD  385 (472)
                      |||.-+..         +.                                    -..+||+.|+|||++....|+..+|
T Consensus       774 GLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  774 GLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             cccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence            99964320         00                                    0245899999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC
Q 039082          386 VYSFGIILNEIITGNHPYIEKD  407 (472)
Q Consensus       386 vwSlGvll~elltG~~Pf~~~~  407 (472)
                      |||.|||||||+.|+.||.+.+
T Consensus       854 wws~gvil~em~~g~~pf~~~t  875 (1034)
T KOG0608|consen  854 WWSVGVILYEMLVGQPPFLADT  875 (1034)
T ss_pred             hhHhhHHHHHHhhCCCCccCCC
Confidence            9999999999999999997766

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=295.99  Aligned_cols=238  Identities=25%  Similarity=0.307  Sum_probs=198.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  270 (472)
                      .++|++...+|.|+|+.|..+..+  +...++|++.+....        -.+|+.++... +||||+++++++.+....|
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~--------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD--------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccccc--------cccccchhhhhcCCCcceeecceecCCceee
Confidence            578999999999999999999875  678999999765221        23566666555 8999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE-cCCCcEEEee
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL-DDAKHVRIAD  349 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl-~~~~~vkL~D  349 (472)
                      +|++.+.|+-|.+.+.....          . ..++..|+++|+.|+.|||++|  +|||||||+|||+ ++.|+++|+|
T Consensus       393 ~v~e~l~g~ell~ri~~~~~----------~-~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrlty  459 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPE----------F-CSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTY  459 (612)
T ss_pred             eeehhccccHHHHHHHhcch----------h-HHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEE
Confidence            99999999888776643221          1 2556779999999999999999  9999999999999 6899999999


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      ||.++.........+-|..|.|||++....|++++||||||++||+|++|+.||...... .++...+..+.+.      
T Consensus       460 FG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~i~~~~~s------  532 (612)
T KOG0603|consen  460 FGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTRIQMPKFS------  532 (612)
T ss_pred             echhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHhhcCCccc------
Confidence            999999887766667799999999999999999999999999999999999999776543 4555555555432      


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ........+++..||..||.+||++.++..
T Consensus       533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  533 ECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             cccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence            334456788888999999999999999864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-34  Score=273.78  Aligned_cols=243  Identities=25%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             ceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEecc
Q 039082          201 EKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      +.||+|++|.|--+..  .|..||||++.+.    .........+|++++... .|+||+.++.+|.++..+|+|+|.+.
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq----~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ----PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC----CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            5799999999987764  5889999999764    345567788999999998 69999999999999999999999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC---cEEEeecccce
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHAR  354 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~---~vkL~DFGla~  354 (472)
                      ||+|...+.+..-          ....++..+..+|+.||.|||.+|  |.||||||+|||.....   -|||+||++..
T Consensus       160 GGplLshI~~~~~----------F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPvKiCDfDLgS  227 (463)
T KOG0607|consen  160 GGPLLSHIQKRKH----------FNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPVKICDFDLGS  227 (463)
T ss_pred             CchHHHHHHHhhh----------ccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCceeeecccccc
Confidence            9999999976442          235778889999999999999999  99999999999997654   48999999876


Q ss_pred             ecCC----------CccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-----------
Q 039082          355 FLSD----------GEMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-----------  408 (472)
Q Consensus       355 ~~~~----------~~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-----------  408 (472)
                      -+..          .-.+.+|+..|||||+..     ...|+.++|.|||||++|-|+.|..||.+.-.           
T Consensus       228 g~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~C  307 (463)
T KOG0607|consen  228 GIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVC  307 (463)
T ss_pred             ccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCcc
Confidence            4321          113467899999999874     34589999999999999999999999976431           


Q ss_pred             --CHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          409 --KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       409 --~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        -...+...|.+|++..+-.+......+..+++..++..++..|.++..++.
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              134567778899864332223566777888999999999999999887764

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.8e-33  Score=269.56  Aligned_cols=218  Identities=21%  Similarity=0.183  Sum_probs=176.1

Q ss_pred             cCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHH
Q 039082          206 GTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKE  283 (472)
Q Consensus       206 G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~  283 (472)
                      |.||.||++.++  +..||+|.++...         .+.+|...+....||||+++++++...+..++++|++.|++|.+
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~---------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   74 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS---------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWS   74 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh---------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHH
Confidence            899999999985  7789999986532         13345556666789999999999999999999999999999999


Q ss_pred             HHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcccc
Q 039082          284 WLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL  363 (472)
Q Consensus       284 ~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~  363 (472)
                      ++.....          .++..+..++.|++.||+|||+++  ++||||||+||+++.++.++++|||.+..........
T Consensus        75 ~l~~~~~----------l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~  142 (237)
T cd05576          75 HISKFLN----------IPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE  142 (237)
T ss_pred             HHHHhcC----------CCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccccccC
Confidence            9854321          346778899999999999999999  9999999999999999999999999887766544445


Q ss_pred             ccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHh
Q 039082          364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLS  443 (472)
Q Consensus       364 ~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~c  443 (472)
                      .++..|+|||.+....++.++|+||+|+++|+|++|..||.....   .+    . ......+|.  .....+.++|.+|
T Consensus       143 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~---~~----~-~~~~~~~~~--~~~~~~~~li~~~  212 (237)
T cd05576         143 AVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPS---GI----N-THTTLNIPE--WVSEEARSLLQQL  212 (237)
T ss_pred             CcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCch---hc----c-cccccCCcc--cCCHHHHHHHHHH
Confidence            567889999999888899999999999999999999988754321   11    0 011112222  2345688899999


Q ss_pred             ccCCCCCCCCH
Q 039082          444 WDGDASVRPSF  454 (472)
Q Consensus       444 l~~dP~~RPs~  454 (472)
                      |+.||++||++
T Consensus       213 l~~dp~~R~~~  223 (237)
T cd05576         213 LQFNPTERLGA  223 (237)
T ss_pred             ccCCHHHhcCC
Confidence            99999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.5e-35  Score=274.62  Aligned_cols=203  Identities=26%  Similarity=0.372  Sum_probs=164.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      ..|+....||+|+||.||+|..+      ...+|||.++.+....  -......+|+.+++.++|||||.+..+|...+.
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t--GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT--GISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC--CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            57899999999999999999653      2369999887553211  111235689999999999999999999988666


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC----Cc
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA----KH  344 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~----~~  344 (472)
                      ..+++.+++.-+|...++-+.....     ...+-..+.++++||+.|+.|||++.  |+||||||.||||..+    |.
T Consensus       102 ~v~l~fdYAEhDL~~II~fHr~~~~-----~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~  174 (438)
T KOG0666|consen  102 KVWLLFDYAEHDLWHIIKFHRASKA-----KQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGR  174 (438)
T ss_pred             eEEEEehhhhhhHHHHHHHhccchh-----ccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCe
Confidence            6666777778899998875543322     13345678899999999999999999  9999999999999877    89


Q ss_pred             EEEeecccceecCCCccc------cccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 039082          345 VRIADFGHARFLSDGEMA------LTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEK  406 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~~------~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~  406 (472)
                      |||+|||+++.+.+.-..      .+-|++|+|||.+.+ ..|+.+.|||+.||++.||+|-.+-|.+.
T Consensus       175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            999999999988754332      335999999999876 57999999999999999999988777543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-33  Score=295.53  Aligned_cols=249  Identities=25%  Similarity=0.364  Sum_probs=204.2

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc----
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE----  265 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~----  265 (472)
                      +.+-|++.++||.|.+|.||++..+  ++.+|||++.++.     +..+.+..|.++|+.+ .|||++.+||+|..    
T Consensus        17 p~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            3456778999999999999998764  8899999987653     2223366789999988 79999999999875    


Q ss_pred             -CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          266 -PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       266 -~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                       ++.+++|||+|.||+.-+++++..+.+        ..++.+..|++.++.||.+||.+.  +||||||-.|||++.++.
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~r--------l~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNR--------LKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccc--------hhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCc
Confidence             456889999999999999997655322        236778888999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC---ccccccCCcccccccccCC-----CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDG---EMALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~-----~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      |||.|||.+..++..   ..+.+||+.|||||++.+.     .|+..+|+||||++..||.-|.+|+.++-  +......
T Consensus       162 VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH--PmraLF~  239 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH--PMRALFL  239 (953)
T ss_pred             EEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc--hhhhhcc
Confidence            999999999887643   3466799999999999753     47889999999999999999999997665  5444444


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +-... +|.+-.......++.++|..||.+|.+.||+..+++.
T Consensus       240 IpRNP-PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 IPRNP-PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CCCCC-CccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            44332 3444434667889999999999999999999998874

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-33  Score=245.64  Aligned_cols=248  Identities=23%  Similarity=0.290  Sum_probs=191.4

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|.-.++||+|.||+||+|+.+  +..||+|.++-+.  .++......++|+-+|+.+.|.|||+++++...+....+|+
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd--ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC--CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            4566789999999999999876  5689999997653  34445566789999999999999999999988777776555


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      ++ +.-+|..|.......         .......+++.|+++||.|+|+++  +.||||||.|+||+.+|.+|++|||++
T Consensus        81 e~-cdqdlkkyfdslng~---------~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfgla  148 (292)
T KOG0662|consen   81 EF-CDQDLKKYFDSLNGD---------LDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLA  148 (292)
T ss_pred             HH-hhHHHHHHHHhcCCc---------CCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchh
Confidence            55 588899988655432         235778889999999999999999  999999999999999999999999999


Q ss_pred             eecCCCcc---ccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH--hcCCC----
Q 039082          354 RFLSDGEM---ALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV--GEGKL----  422 (472)
Q Consensus       354 ~~~~~~~~---~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i--~~~~~----  422 (472)
                      +.+.-+..   ..+-|.+|.+|+++.+. -|+.+.|+||.||++.|+.. |++.|++.+...  ....+  .-|..    
T Consensus       149 rafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd--qlkrif~~lg~p~ed~  226 (292)
T KOG0662|consen  149 RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEDQ  226 (292)
T ss_pred             hhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH--HHHHHHHHhCCCcccc
Confidence            98875543   33469999999998764 58999999999999999998 888888877432  22222  11211    


Q ss_pred             ---CCCCCCC------------chhHHH----HHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 ---RPALPEE------------DGQLRE----LIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ---~~~l~~~------------~~~~~~----l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                         ...+|..            ....+.    =.+++.+.+.-+|..|.++++.++
T Consensus       227 wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  227 WPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               0111111            111111    147788899999999999987664

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.4e-32  Score=256.04  Aligned_cols=236  Identities=31%  Similarity=0.400  Sum_probs=192.7

Q ss_pred             CceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHH
Q 039082          207 TTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEW  284 (472)
Q Consensus       207 ~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~  284 (472)
                      +||.||+|.+.  |..+|+|++......   .....+.+|+..++.++|+||+++++.+......+++++++.+++|..+
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~   77 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIK---KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDL   77 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccc---cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHH
Confidence            58999999986  578999998764321   1156799999999999999999999999988888889999888899999


Q ss_pred             HhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCC--ccc
Q 039082          285 LHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG--EMA  362 (472)
Q Consensus       285 l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~--~~~  362 (472)
                      +.....          .+...++.++.+++.+|.|||+.+  ++|+||+|+||++++++.++|+|||.+......  ...
T Consensus        78 ~~~~~~----------~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~  145 (244)
T smart00220       78 LKKRGR----------LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTT  145 (244)
T ss_pred             HHhccC----------CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccccccc
Confidence            864331          346778899999999999999999  999999999999999999999999999887653  344


Q ss_pred             cccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHH
Q 039082          363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICL  442 (472)
Q Consensus       363 ~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~  442 (472)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|..||.... ....+...+..+... ..+.....+..+.+++.+
T Consensus       146 ~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~  223 (244)
T smart00220      146 FVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD-QLLELFKKIGKPKPP-FPPPEWKISPEAKDLIRK  223 (244)
T ss_pred             ccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHhccCCC-CccccccCCHHHHHHHHH
Confidence            567899999999988889999999999999999999999997632 133344444443321 111111155688999999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 039082          443 SWDGDASVRPSFSSITC  459 (472)
Q Consensus       443 cl~~dP~~RPs~~~ll~  459 (472)
                      ||..+|++||++.++++
T Consensus       224 ~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      224 LLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HccCCchhccCHHHHhh
Confidence            99999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=271.87  Aligned_cols=250  Identities=24%  Similarity=0.305  Sum_probs=195.5

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-C-C----ceeEEEEEEEc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-H-R----FVLQLMGACLE  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-H-p----nIv~l~g~~~~  265 (472)
                      ..+|++++.+|+|+||.|-.+.++  +..||||+++.     -....+.-+-|+++|.++. + |    -+|.+.++|..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~-----V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN-----VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHH-----HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            568999999999999999999886  56899998863     2233444567899999993 2 2    46777777777


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC----
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD----  341 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~----  341 (472)
                      .+..|+ +.++.|-|++++|...+-        ...++..+..|++|++.+++|||+.+  ++|-||||+|||+.+    
T Consensus       163 rghiCi-vfellG~S~~dFlk~N~y--------~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~  231 (415)
T KOG0671|consen  163 RGHICI-VFELLGLSTFDFLKENNY--------IPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYF  231 (415)
T ss_pred             cCceEE-EEeccChhHHHHhccCCc--------cccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceE
Confidence            766654 555569999999965432        12357889999999999999999999  999999999999831    


Q ss_pred             ----------------CCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 039082          342 ----------------AKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE  405 (472)
Q Consensus       342 ----------------~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~  405 (472)
                                      +-.|+|+|||.|+.........+.|-.|.|||++.+-.++..+||||+||||+|+.||...|..
T Consensus       232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT  311 (415)
T ss_pred             EEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence                            2358999999999888877888899999999999999999999999999999999999999987


Q ss_pred             CCCCHHHHHHHHhcCCC----------------------------------CCCCCC------CchhHHHHHHHHHHhcc
Q 039082          406 KDYKPAKIAMEVGEGKL----------------------------------RPALPE------EDGQLRELIELICLSWD  445 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~----------------------------------~~~l~~------~~~~~~~l~~li~~cl~  445 (472)
                      .++.+.-..++..-|..                                  .+..|-      .+.....|+++|.+||.
T Consensus       312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~  391 (415)
T KOG0671|consen  312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE  391 (415)
T ss_pred             CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence            76433222222111110                                  001111      14556779999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 039082          446 GDASVRPSFSSITC  459 (472)
Q Consensus       446 ~dP~~RPs~~~ll~  459 (472)
                      .||.+|+|+.|++.
T Consensus       392 fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  392 FDPARRITLREALS  405 (415)
T ss_pred             cCccccccHHHHhc
Confidence            99999999999875

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-32  Score=247.72  Aligned_cols=229  Identities=28%  Similarity=0.403  Sum_probs=179.3

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGAC  263 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~  263 (472)
                      ..+++++.++..-+..||+|++|.|-+-++  +|...|+|.+...   .+....+..++|+++..+. .+|++|.+||..
T Consensus        38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t---vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~  114 (282)
T KOG0984|consen   38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT---VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL  114 (282)
T ss_pred             cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh---cChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence            344778888888999999999999876655  5899999998653   3456667788899887665 899999999988


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      ..+...+ +.+|.+..+|..|-.+.-..      ....+...+-+|+..++.||.|||++= .+||||+||.||||+.+|
T Consensus       115 ~regdvw-IcME~M~tSldkfy~~v~~~------g~~ipE~vlGkIa~Svv~al~~L~~kL-~vIHRDvKPsNiLIn~~G  186 (282)
T KOG0984|consen  115 FREGDVW-ICMELMDTSLDKFYRKVLKK------GGTIPEDVLGKIAVSVVHALEFLHSKL-SVIHRDVKPSNILINYDG  186 (282)
T ss_pred             hccccEE-EeHHHhhhhHHHHHHHHHhc------CCcCchHHhhHhHHHHHHHHHHHHHHh-hhhhccCCcceEEEccCC
Confidence            8777764 55555689998887542211      112234567788999999999999972 399999999999999999


Q ss_pred             cEEEeecccceecCCCcc--ccccCCcccccccccC----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGEM--ALTGTFVYMAPEVIQC----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~--~~~gt~~y~APE~~~~----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      .|||||||++-.+.+...  ...|--.|||||.+..    ..|+.++||||||+++.||.+++.||.... .+.....++
T Consensus       187 qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~-tpF~qLkqv  265 (282)
T KOG0984|consen  187 QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG-TPFQQLKQV  265 (282)
T ss_pred             cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC-CHHHHHHHH
Confidence            999999999988876543  2457888999999863    479999999999999999999999997654 355666666


Q ss_pred             hcCCCCCCCCC
Q 039082          418 GEGKLRPALPE  428 (472)
Q Consensus       418 ~~~~~~~~l~~  428 (472)
                      .+.. .|.+|.
T Consensus       266 Veep-~P~Lp~  275 (282)
T KOG0984|consen  266 VEEP-SPQLPA  275 (282)
T ss_pred             hcCC-CCCCcc
Confidence            6654 455554

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=2.3e-31  Score=284.99  Aligned_cols=258  Identities=18%  Similarity=0.109  Sum_probs=167.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      .+.+..++|++.++||+|+||.||+|.+.      +..||||.+....    .  .+.+..|  .+....+.+++.++..
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~----~--~e~~~~e--~l~~~~~~~~~~~~~~  197 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG----A--VEIWMNE--RVRRACPNSCADFVYG  197 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc----h--hHHHHHH--HHHhhchhhHHHHHHh
Confidence            34556789999999999999999999885      5689999875421    1  1111111  1122222222222111


Q ss_pred             ------EEcCCCceEEEEeccCCcHHHHHhhccccccc----------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 039082          263 ------CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK----------ERMVPLPPFEERLARALEIAQAMQYLHEQKPK  326 (472)
Q Consensus       263 ------~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~----------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~  326 (472)
                            +...+..++|++|+.+++|.+++.........          ...........+..++.||+.||+|||+++  
T Consensus       198 ~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--  275 (566)
T PLN03225        198 FLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--  275 (566)
T ss_pred             hhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--
Confidence                  23456678889999999999998643211000          000000112335578899999999999999  


Q ss_pred             eeecCCCCCcEEEcC-CCcEEEeecccceecCCCc----cccccCCcccccccccCC----------------------C
Q 039082          327 VIHRDLKPSNIFLDD-AKHVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCE----------------------P  379 (472)
Q Consensus       327 iiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~----------------------~  379 (472)
                      |+||||||+|||++. ++.+||+|||+|+.+....    ....+++.|+|||.+...                      .
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~  355 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN  355 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence            999999999999985 5899999999998664322    345689999999976422                      2


Q ss_pred             CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC-------------CCCCCC----CCchhHHHHHHHHHH
Q 039082          380 YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK-------------LRPALP----EEDGQLRELIELICL  442 (472)
Q Consensus       380 ~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~-------------~~~~l~----~~~~~~~~l~~li~~  442 (472)
                      ++.++|||||||++|||+++..|+....   ......+....             ..+.+.    ..+.......+||.+
T Consensus       356 ~~~k~DVwSlGviL~el~~~~~~~~~~~---~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~  432 (566)
T PLN03225        356 LPDRFDIYSAGLIFLQMAFPNLRSDSNL---IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKS  432 (566)
T ss_pred             CCCCcccHHHHHHHHHHHhCcCCCchHH---HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHH
Confidence            3456799999999999999776653321   11111111100             000000    001122345689999


Q ss_pred             hccCCCCCCCCHHHHHH
Q 039082          443 SWDGDASVRPSFSSITC  459 (472)
Q Consensus       443 cl~~dP~~RPs~~~ll~  459 (472)
                      ||..||++|||+.++++
T Consensus       433 mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        433 MMRFKGRQRISAKAALA  449 (566)
T ss_pred             HccCCcccCCCHHHHhC
Confidence            99999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=4.8e-31  Score=276.75  Aligned_cols=267  Identities=16%  Similarity=0.148  Sum_probs=183.3

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEE------------------CCeeEEEEEeccCCCCCChH----------HHHHHH
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIW------------------RGLDVAVKCIYPDFFHTNEN----------AVTFFA  242 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~------------------~g~~vAVK~l~~~~~~~~~~----------~~~~f~  242 (472)
                      .++.++|++.++||+|+||.||+|.+                  +++.||||.++.......++          ..+.+.
T Consensus       141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~  220 (507)
T PLN03224        141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM  220 (507)
T ss_pred             CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence            45788999999999999999999964                  24579999986532110000          112344


Q ss_pred             HHHHHHHhcCCCce-----eEEEEEEEc--------CCCceEEEEeccCCcHHHHHhhccccc--------------ccc
Q 039082          243 QEVDTLSRQRHRFV-----LQLMGACLE--------PPYRGWLVTELLGTTLKEWLHGLGSQR--------------RKE  295 (472)
Q Consensus       243 ~E~~il~~l~HpnI-----v~l~g~~~~--------~~~~~~vve~~~ggsL~~~l~~~~~~~--------------~~~  295 (472)
                      .|+.++.+++|.++     ++++++|..        .+..++|++|+.+++|.++++......              ...
T Consensus       221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~  300 (507)
T PLN03224        221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN  300 (507)
T ss_pred             HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence            57777888876654     677777653        345678999999999999997532110              000


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc----ccccCCcccc
Q 039082          296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGTFVYMA  371 (472)
Q Consensus       296 ~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~gt~~y~A  371 (472)
                      .......+..+..++.+++.||.|||+.+  |+||||||+|||++.++.+||+|||++........    ...+++.|+|
T Consensus       301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence            00112346778889999999999999999  99999999999999999999999999976543221    1234789999


Q ss_pred             cccccCCC--------------------C--CchHHHHHHHHHHHHHHcCCC-CCCCCCCCHHHHHH------H-HhcCC
Q 039082          372 PEVIQCEP--------------------Y--SEKSDVYSFGIILNEIITGNH-PYIEKDYKPAKIAM------E-VGEGK  421 (472)
Q Consensus       372 PE~~~~~~--------------------~--s~~sDvwSlGvll~elltG~~-Pf~~~~~~~~~i~~------~-i~~~~  421 (472)
                      ||.+....                    |  ..+.||||+||++++|++|.. ||.+..........      . .....
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875322                    1  234799999999999999875 77542211111100      0 00011


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCC---CCCCCHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDA---SVRPSFSSITC  459 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP---~~RPs~~~ll~  459 (472)
                      ....++..+.......+++.+++..+|   .+|+|++++++
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            122333334456778889999999766   68999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.3e-33  Score=257.47  Aligned_cols=256  Identities=21%  Similarity=0.292  Sum_probs=187.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--  267 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--  267 (472)
                      ...+.|+-+.+||+|.||+||+|+.+  |+.||+|.+..+.  ..+-....-.+|+++|..+.|+|++.++.+|....  
T Consensus        14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen--eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN--EKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc--cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            34456777889999999999999875  6789998664321  11122234678999999999999999998876422  


Q ss_pred             -----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          268 -----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       268 -----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                           ..+++++.++..+|..+|.....+         .+..++..++.++..||.|+|.+.  |+|||+||+|+||+.+
T Consensus        92 ~~r~r~t~ylVf~~cehDLaGlLsn~~vr---------~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~d  160 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCEHDLAGLLSNRKVR---------FSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKD  160 (376)
T ss_pred             cccccceeeeeHHHhhhhHHHHhcCcccc---------ccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCC
Confidence                 123555556678888888643221         246788999999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCc-------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 039082          343 KHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA  414 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~  414 (472)
                      |.+||+|||+++.+....       +..+.|.+|.+||.+.+ ..|+++.|||+.||++.||+||.+-+.+++....-..
T Consensus       161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~  240 (376)
T KOG0669|consen  161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL  240 (376)
T ss_pred             ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence            999999999998775322       22334999999999875 5799999999999999999999988876653211111


Q ss_pred             HHHhcCCC------------------CCCCCCC-----chh------HHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          415 MEVGEGKL------------------RPALPEE-----DGQ------LRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       415 ~~i~~~~~------------------~~~l~~~-----~~~------~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ....-|..                  .+++|..     ...      ..+..+++..++..||.+|+++++.+..
T Consensus       241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            11111110                  0112221     111      1256788889999999999999988753

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-31  Score=280.05  Aligned_cols=239  Identities=24%  Similarity=0.425  Sum_probs=182.5

Q ss_pred             eEeceeeccCce-EEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEEEe
Q 039082          198 DLQEKIGQGTTA-NIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       198 ~l~~~LG~G~fG-~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      .-.+.+|.|+-| .||+|.+.|+.||||.+-.       +......+|+..|+.- +|||||++|+.-.+.... ||.-+
T Consensus       512 ~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~-YIalE  583 (903)
T KOG1027|consen  512 SPKEILGYGSNGTVVFRGVYEGREVAVKRLLE-------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL-YIALE  583 (903)
T ss_pred             ccHHHcccCCCCcEEEEEeeCCceehHHHHhh-------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceE-EEEeh
Confidence            334678999886 5799999999999997743       3444567999999887 799999999875555444 55556


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---C--CcEEEeec
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---A--KHVRIADF  350 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~--~~vkL~DF  350 (472)
                      .+..+|.+++..........      .-...+....|++.||++||+.+  ||||||||.||||+.   +  ..++|+||
T Consensus       584 LC~~sL~dlie~~~~d~~~~------~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQ------SDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             HhhhhHHHHHhccccchhhc------ccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            66899999997641111110      01335677889999999999999  999999999999975   3  47899999


Q ss_pred             ccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          351 GHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       351 Gla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+++.+..+..      ...||-+|+|||++....-+.++|||||||++|..++ |.+||.+..    .-...|..+...
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~----~R~~NIl~~~~~  731 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL----ERQANILTGNYT  731 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH----HhhhhhhcCccc
Confidence            99998875543      3458999999999998888889999999999999999 699996654    223344455432


Q ss_pred             C-CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          424 P-ALPEEDGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       424 ~-~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      . .+.....+  +..++|.+|++++|..||++.+++
T Consensus       732 L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  732 LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1 11112222  778999999999999999999997

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=4.3e-31  Score=263.89  Aligned_cols=252  Identities=24%  Similarity=0.302  Sum_probs=201.2

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC------CceeEEEEEEE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH------RFVLQLMGACL  264 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H------pnIv~l~g~~~  264 (472)
                      -..+|.+....|.|-|+.|..|.+.  |..||||++..     ++...+.=+.|+++|++|..      -|+++|+..|.
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-----NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-----NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-----chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence            3468888999999999999999885  78999999964     45555666789999999942      48899999998


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-C
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-K  343 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~  343 (472)
                      ...++|+|+|. ...+|...|++.+..-       -..+..+..++.|+..||..|-..|  |+|.||||+||||++. .
T Consensus       505 hknHLClVFE~-LslNLRevLKKyG~nv-------GL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVNE~k~  574 (752)
T KOG0670|consen  505 HKNHLCLVFEP-LSLNLREVLKKYGRNV-------GLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVNESKN  574 (752)
T ss_pred             hcceeEEEehh-hhchHHHHHHHhCccc-------ceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEeccCcc
Confidence            88888766655 4899999998877532       1235778899999999999999999  9999999999999865 6


Q ss_pred             cEEEeecccceecCCCccc-cccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          344 HVRIADFGHARFLSDGEMA-LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~~-~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      .+||||||.|....+...+ ...+-.|.|||++.|.+|+...|+||.||+||||.||+..|++.+++.+--...-.+|.+
T Consensus       575 iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  575 ILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            7899999999887765433 335778999999999999999999999999999999999999887554332222222211


Q ss_pred             -----------------------------------------------------CCCCCCC-chhHHHHHHHHHHhccCCC
Q 039082          423 -----------------------------------------------------RPALPEE-DGQLRELIELICLSWDGDA  448 (472)
Q Consensus       423 -----------------------------------------------------~~~l~~~-~~~~~~l~~li~~cl~~dP  448 (472)
                                                                           ...+|.. +.....|.+|+.+||..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence                                                                 1123333 3456778899999999999


Q ss_pred             CCCCCHHHHHH
Q 039082          449 SVRPSFSSITC  459 (472)
Q Consensus       449 ~~RPs~~~ll~  459 (472)
                      ++|.+..+.+.
T Consensus       735 ~KRit~nqAL~  745 (752)
T KOG0670|consen  735 EKRITVNQALK  745 (752)
T ss_pred             hhcCCHHHHhc
Confidence            99999988765

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.4e-32  Score=250.27  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=185.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce--
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG--  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~--  270 (472)
                      .|++-.+.||.|+||+||.+.+.  |+.||+|.+..-.  .+-..-+.+.+|+++|..++|.|++..+++.......+  
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf--q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFq  130 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF--QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQ  130 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHH--HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHH
Confidence            36677899999999999999874  8999999875321  23345577889999999999999999998876554332  


Q ss_pred             --EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          271 --WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       271 --~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                        +|+.+++..+|.+.+-...          ..+-..+..+.+||++||.|||+.+  |.||||||.|+|++.+..+||+
T Consensus       131 EiYV~TELmQSDLHKIIVSPQ----------~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKIC  198 (449)
T KOG0664|consen  131 ELYVLTELMQSDLHKIIVSPQ----------ALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKIC  198 (449)
T ss_pred             HHHHHHHHHHhhhhheeccCC----------CCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEec
Confidence              4666777777777663211          1223556777899999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCccc----cccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--------------
Q 039082          349 DFGHARFLSDGEMA----LTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--------------  409 (472)
Q Consensus       349 DFGla~~~~~~~~~----~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--------------  409 (472)
                      |||+++..+.....    .+-|-.|.|||++.+ ..|+.+.||||.||++.||+-.+..|...+.-              
T Consensus       199 DFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs  278 (449)
T KOG0664|consen  199 DFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS  278 (449)
T ss_pred             ccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence            99999976643322    234888999999876 56999999999999999999988888654410              


Q ss_pred             HHHHHH-------HHhcCCC-CCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          410 PAKIAM-------EVGEGKL-RPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       410 ~~~i~~-------~i~~~~~-~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .+.+..       .+..+.. .|.++-.      .....+.+.++..++..+|++|.+.++.+..
T Consensus       279 ~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  279 QEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            011110       1111111 1222211      2333556778889999999999988776644

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-29  Score=248.91  Aligned_cols=137  Identities=23%  Similarity=0.306  Sum_probs=110.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-----C---CceeE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-----H---RFVLQ  258 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-----H---pnIv~  258 (472)
                      +-.+...+|.+.++||.|.|++||+|.+.  .+.||+|+.+.     .+...+.-+.|+++|+.++     |   ..||+
T Consensus        72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~  146 (590)
T KOG1290|consen   72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ  146 (590)
T ss_pred             cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence            34456689999999999999999999986  56899999863     3455566789999999983     2   47999


Q ss_pred             EEEEEEcCCC---ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          259 LMGACLEPPY---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       259 l~g~~~~~~~---~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      |++.|....+   ..++|.++.|-+|..++....-+        -.++..+..|++||+.||.|||..- +|||-||||+
T Consensus       147 LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~Yr--------Glpl~~VK~I~~qvL~GLdYLH~ec-gIIHTDlKPE  217 (590)
T KOG1290|consen  147 LLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYR--------GLPLSCVKEICRQVLTGLDYLHREC-GIIHTDLKPE  217 (590)
T ss_pred             eeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCC--------CCcHHHHHHHHHHHHHHHHHHHHhc-CccccCCCcc
Confidence            9999987543   33566677799999999764432        1347889999999999999999862 3999999999


Q ss_pred             cEEE
Q 039082          336 NIFL  339 (472)
Q Consensus       336 NILl  339 (472)
                      |||+
T Consensus       218 NvLl  221 (590)
T KOG1290|consen  218 NVLL  221 (590)
T ss_pred             eeee
Confidence            9998

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=6.5e-29  Score=229.19  Aligned_cols=208  Identities=34%  Similarity=0.494  Sum_probs=180.6

Q ss_pred             eeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCc
Q 039082          203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       203 LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      ||+|++|.||++...  +..+++|++......   .....+.+|+..++.++|++|+++++++......+++++++.+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~---~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~   77 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSS---SLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGS   77 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccch---hHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCc
Confidence            689999999999997  789999998754221   145678999999999999999999999998888888999988899


Q ss_pred             HHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEEeecccceecCCC
Q 039082          281 LKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIADFGHARFLSDG  359 (472)
Q Consensus       281 L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL~DFGla~~~~~~  359 (472)
                      |..++....         ...+...++.++.+++.+|.+||+.+  ++|+||+|.||+++. ++.++|+|||.+......
T Consensus        78 l~~~~~~~~---------~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~  146 (215)
T cd00180          78 LKDLLKENE---------GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD  146 (215)
T ss_pred             HHHHHHhcc---------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence            999986432         12346788999999999999999999  999999999999999 899999999999887655


Q ss_pred             ---ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHH
Q 039082          360 ---EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE  435 (472)
Q Consensus       360 ---~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~  435 (472)
                         .....+...|++||.+... .++.++|+|+||+++++|                                     ..
T Consensus       147 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------~~  189 (215)
T cd00180         147 KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------PE  189 (215)
T ss_pred             cchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------HH
Confidence               3445578899999999877 888999999999999999                                     46


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          436 LIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       436 l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      +.+++..|+..+|++||++.++++.|
T Consensus       190 ~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         190 LKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            88899999999999999999998653

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.8e-31  Score=265.91  Aligned_cols=207  Identities=23%  Similarity=0.392  Sum_probs=169.9

Q ss_pred             cCceeeC---CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh----HHHHHHHHHHHHHHhcC---CC
Q 039082          187 MNGWYID---PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE----NAVTFFAQEVDTLSRQR---HR  254 (472)
Q Consensus       187 ~~~~~i~---~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~----~~~~~f~~E~~il~~l~---Hp  254 (472)
                      ..+|+..   ..+|..+++||+|+||.||+|.++  ...|+||.+.++.+-.+.    ...-..-.|+.||.+++   |+
T Consensus       550 ~~~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~  629 (772)
T KOG1152|consen  550 NIGCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHE  629 (772)
T ss_pred             cccceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCcc
Confidence            3345443   357899999999999999999997  447999999887653321    11223456999999996   99


Q ss_pred             ceeEEEEEEEcCCCceEEEEecc-CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCC
Q 039082          255 FVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLK  333 (472)
Q Consensus       255 nIv~l~g~~~~~~~~~~vve~~~-ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLk  333 (472)
                      ||++++++|.++++.|++++-.- |.+|++|+..+..          .+..++..|+.||+.|+++||+.|  |||||||
T Consensus       630 NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~----------m~E~eAk~IFkQV~agi~hlh~~~--ivhrdik  697 (772)
T KOG1152|consen  630 NILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPR----------MDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIK  697 (772)
T ss_pred             chhhhhheeecCCeeEEEecCCCCCcchhhhhhccCc----------cchHHHHHHHHHHHhccccccccC--ceecccc
Confidence            99999999888877766665543 6789999964332          346778899999999999999999  9999999


Q ss_pred             CCcEEEcCCCcEEEeecccceecCCCc-cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCC
Q 039082          334 PSNIFLDDAKHVRIADFGHARFLSDGE-MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIE  405 (472)
Q Consensus       334 p~NILl~~~~~vkL~DFGla~~~~~~~-~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~  405 (472)
                      -+||.++.+|.+||+|||.|.....+. ..+.||..|+|||++.+..| ...-|||++|++||-++....||.+
T Consensus       698 denvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  698 DENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             cccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999999999999999999998776544 46789999999999999887 4678999999999999999999854

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=3.2e-28  Score=228.88  Aligned_cols=211  Identities=30%  Similarity=0.456  Sum_probs=176.8

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      |.+.+.||+|++|.||++...  +..+|+|.+......   .....+.+|++.++.++|+|++++++.+...+..+++++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   77 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE---KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVME   77 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch---HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEe
Confidence            467889999999999999986  578999998764321   256778899999999999999999999998888889999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++.+++|.+++......         .++.....++.+++.+|.+||+.+  ++|+||+|.||+++.++.++|+|||.+.
T Consensus        78 ~~~~~~L~~~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~  146 (225)
T smart00221       78 YCEGGDLFDYLRKKGGK---------LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLAR  146 (225)
T ss_pred             ccCCCCHHHHHHhcccC---------CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceee
Confidence            99888999998643311         346778899999999999999999  9999999999999999999999999998


Q ss_pred             ecCCCc----cccccCCcccccccc-cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          355 FLSDGE----MALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       355 ~~~~~~----~~~~gt~~y~APE~~-~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      ......    ....++..|++||.+ ....++.++|+|+||+++++|++|+.||.........+...+..+.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~  218 (225)
T smart00221      147 FIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGV  218 (225)
T ss_pred             EecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCC
Confidence            876543    445678899999998 6677888999999999999999999999662333445566666654

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=267.11  Aligned_cols=250  Identities=24%  Similarity=0.331  Sum_probs=203.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      -+.++|+++.++|+|++|.||+++++  +...|+|+++-+.    .+...-+.+|+-+++..+|||||.++|.+...+..
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep----~dd~~~iqqei~~~~dc~h~nivay~gsylr~dkl   87 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP----GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKL   87 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccC----CccccccccceeeeecCCCcChHHHHhhhhhhcCc
Confidence            35679999999999999999999986  7889999998753    24445577899999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++.|||+-||+|.+.-+..+..          +.-++..++++.+.||+|||++|  -+|||||-.|||+++.|.+|++|
T Consensus        88 wicMEycgggslQdiy~~Tgpl----------selqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaD  155 (829)
T KOG0576|consen   88 WICMEYCGGGSLQDIYHVTGPL----------SELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLAD  155 (829)
T ss_pred             EEEEEecCCCcccceeeecccc----------hhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecc
Confidence            9999999999998876544432          23456677889999999999999  99999999999999999999999


Q ss_pred             cccceecCCC---ccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh-cCCC
Q 039082          350 FGHARFLSDG---EMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG-EGKL  422 (472)
Q Consensus       350 FGla~~~~~~---~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~-~~~~  422 (472)
                      ||.+..+...   ...+.||+.|||||+..   .+.|...+|||++|++..|+---..|..+.-  +.....-.. .+..
T Consensus       156 fgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh--pmr~l~LmTkS~~q  233 (829)
T KOG0576|consen  156 FGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH--PMRALFLMTKSGFQ  233 (829)
T ss_pred             cCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc--hHHHHHHhhccCCC
Confidence            9998766532   34567999999999863   5679999999999999999977666653322  333333333 3443


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ++.+.+.......+-+|+..|+.++|++||+++.++.
T Consensus       234 pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  234 PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            4455554666777888999999999999999998775

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=2.1e-29  Score=229.57  Aligned_cols=245  Identities=19%  Similarity=0.326  Sum_probs=186.6

Q ss_pred             CCCCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCC--
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPP--  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~--  267 (472)
                      ..++|++.+++|+|.+++||.|..  ++.+++||++++-       ..+.+.+|+.+|..|+ ||||++++++..+..  
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sk  108 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESK  108 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-------HHHHHHHHHHHHHhccCCCCeeehhhhhcCcccc
Confidence            568999999999999999999985  5779999999752       3455889999999996 999999999987743  


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vk  346 (472)
                      ...+++|++.+.+...+....             +-..+..++.++++||.|+|++|  |+|||+||.|++||.. -.++
T Consensus       109 tpaLiFE~v~n~Dfk~ly~tl-------------~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLr  173 (338)
T KOG0668|consen  109 TPSLIFEYVNNTDFKQLYPTL-------------TDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLR  173 (338)
T ss_pred             CchhHhhhhccccHHHHhhhh-------------chhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceee
Confidence            334788888888877655321             23457788999999999999999  9999999999999954 5799


Q ss_pred             EeecccceecCCCcc--ccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH----------
Q 039082          347 IADFGHARFLSDGEM--ALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI----------  413 (472)
Q Consensus       347 L~DFGla~~~~~~~~--~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i----------  413 (472)
                      |+|+|+|.+...+..  ..+.+..|--||.+- ...|+.+-|+|||||++..|+..+.||.....+.+..          
T Consensus       174 lIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~  253 (338)
T KOG0668|consen  174 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTD  253 (338)
T ss_pred             eeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChH
Confidence            999999988775543  344577788999875 5678999999999999999999999985432222111          


Q ss_pred             --HHHHhc--------------CCCC----CCCCC-C-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          414 --AMEVGE--------------GKLR----PALPE-E-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       414 --~~~i~~--------------~~~~----~~l~~-~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        ...+.+              ...+    .-++. + ....++.++++.+.|..|-.+|+|+.|...
T Consensus       254 el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  254 ELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence              111110              0001    01111 1 112367889999999999999999998764

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=1.5e-28  Score=233.81  Aligned_cols=251  Identities=26%  Similarity=0.289  Sum_probs=187.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC-
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY-  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~-  268 (472)
                      .-..+|.-++.+|.|+- .|-.|.+.  +++||+|.+-....  +....+.-.+|..+|..+.|+||++++.+|..... 
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~--n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l   90 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ--NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL   90 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc--cCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence            33457778889999998 67777664  88999998866522  23444556789999999999999999999875432 


Q ss_pred             ----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          269 ----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       269 ----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                          -.+++++++..+|...+....+            =.....+.+|++.|+.|||+.|  |+||||||+||++..++.
T Consensus        91 ~~~~e~y~v~e~m~~nl~~vi~~elD------------H~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~  156 (369)
T KOG0665|consen   91 EEFQEVYLVMELMDANLCQVILMELD------------HETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCT  156 (369)
T ss_pred             HHHHhHHHHHHhhhhHHHHHHHHhcc------------hHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhh
Confidence                1244555558888888752221            2446788999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH--HHHHH----
Q 039082          345 VRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA--KIAME----  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~--~i~~~----  416 (472)
                      +||.|||+|+.....  -+..+.|..|.|||++-+..|.+.+||||+||++.||++|..-|.+.+.-..  .+...    
T Consensus       157 lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtp  236 (369)
T KOG0665|consen  157 LKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTP  236 (369)
T ss_pred             eeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCC
Confidence            999999999876644  2234578999999999998899999999999999999999999987652100  00000    


Q ss_pred             ---------------Hhc------CCCCCCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 ---------------VGE------GKLRPALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 ---------------i~~------~~~~~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                     +..      -.+...+|+         +......+.+++.+||..||++|.|+++++.
T Consensus       237 d~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  237 DPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             CHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                           000      001111221         1233455678899999999999999999875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4e-28  Score=226.09  Aligned_cols=252  Identities=20%  Similarity=0.258  Sum_probs=188.6

Q ss_pred             CCeeEeceeeccCceEEEEEEECC--eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc-CCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE-PPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g--~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~-~~~~~  270 (472)
                      +.|.+.+.||+|.||.+-++.+++  +.+++|.+...     ....+.|.+|...--.| .|.||+.-|++... .+...
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            578899999999999999999984  57999977543     35567799988776666 58999999886554 45455


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc--CCCcEEEe
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIA  348 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~--~~~~vkL~  348 (472)
                      +++|++.-|+|.+-+...|-           .......++.|++.||.|+|+++  +||||||.+||||-  +...||||
T Consensus        99 F~qE~aP~gdL~snv~~~Gi-----------gE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlc  165 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAAGI-----------GEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLC  165 (378)
T ss_pred             EeeccCccchhhhhcCcccc-----------cHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEee
Confidence            67777779999887754332           13456778999999999999999  99999999999994  34589999


Q ss_pred             ecccceecCCCccccccCCcccccccccC---C--CCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCC
Q 039082          349 DFGHARFLSDGEMALTGTFVYMAPEVIQC---E--PYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGK  421 (472)
Q Consensus       349 DFGla~~~~~~~~~~~gt~~y~APE~~~~---~--~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~  421 (472)
                      |||+.+..+.--....-+..|.|||....   +  ...+.+|+|.|||++|.++||..||.....  .+-.-......+.
T Consensus       166 DFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk  245 (378)
T KOG1345|consen  166 DFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK  245 (378)
T ss_pred             ecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence            99998766543333445677999997642   2  246789999999999999999999964321  1222333344443


Q ss_pred             CCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          422 LRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       422 ~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                       .+.+|.. ......++.+..+-+.+++++|=-+.+..+.-...+
T Consensus       246 -~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  246 -NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             -CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence             5567765 566677888888999999999966666555554444

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=8.5e-26  Score=205.92  Aligned_cols=167  Identities=25%  Similarity=0.285  Sum_probs=129.0

Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCC
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      |+|.+++...+.         ..++..++.++.|++.||+|||+++        ||+|||++.++.+|+  ||++.....
T Consensus         1 GsL~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~   61 (176)
T smart00750        1 VSLADILEVRGR---------PLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTP   61 (176)
T ss_pred             CcHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecc
Confidence            688888864321         2357889999999999999999886        999999999999999  999987654


Q ss_pred             CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC----CchhHH
Q 039082          359 GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE----EDGQLR  434 (472)
Q Consensus       359 ~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~----~~~~~~  434 (472)
                      ..  ..|++.|+|||++.+..++.++|||||||++|||+||..||...... ......+..+. ....+.    ......
T Consensus        62 ~~--~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~  137 (176)
T smart00750       62 EQ--SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGM-PADDPRDRSNLESVSA  137 (176)
T ss_pred             cc--CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHh-ccCCccccccHHHHHh
Confidence            33  36899999999999999999999999999999999999999654421 12222222222 111111    112222


Q ss_pred             --HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          435 --ELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       435 --~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                        .+.+++.+||..+|++||++.++++.+..+..+.
T Consensus       138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~~  173 (176)
T smart00750      138 ARSFADFMRVCASRLPQRREAANHYLAHCRALFAET  173 (176)
T ss_pred             hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHHH
Confidence              5899999999999999999999999998776554

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3.3e-27  Score=263.87  Aligned_cols=192  Identities=19%  Similarity=0.201  Sum_probs=135.6

Q ss_pred             hcCC-CceeEEEEEEEc------CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 039082          250 RQRH-RFVLQLMGACLE------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE  322 (472)
Q Consensus       250 ~l~H-pnIv~l~g~~~~------~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~  322 (472)
                      .++| +||++++++|..      .+...+.++++.+++|.++|....         ...+...++.++.||+.||+|||+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~   98 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPD---------RSVDAFECFHVFRQIVEIVNAAHS   98 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhccc---------ccccHHHHHHHHHHHHHHHHHHHh
Confidence            4555 688888887721      112334555566889999996321         113467788999999999999999


Q ss_pred             cCCceeecCCCCCcEEEcC-------------------CCcEEEeecccceecCCC-------------------ccccc
Q 039082          323 QKPKVIHRDLKPSNIFLDD-------------------AKHVRIADFGHARFLSDG-------------------EMALT  364 (472)
Q Consensus       323 ~~~~iiHrDLkp~NILl~~-------------------~~~vkL~DFGla~~~~~~-------------------~~~~~  364 (472)
                      +|  ||||||||+||||+.                   ++.+||+|||+++.....                   .....
T Consensus        99 ~g--IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (793)
T PLN00181         99 QG--IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAM  176 (793)
T ss_pred             CC--eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccC
Confidence            99  999999999999954                   445666777776542210                   01134


Q ss_pred             cCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhc
Q 039082          365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSW  444 (472)
Q Consensus       365 gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl  444 (472)
                      ||+.|+|||++.+..|+.++|||||||+||||++|..|+....    .....+......+.   ..........++.+||
T Consensus       177 gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L  249 (793)
T PLN00181        177 EMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHRVLPPQ---ILLNWPKEASFCLWLL  249 (793)
T ss_pred             CCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHhhcChh---hhhcCHHHHHHHHHhC
Confidence            7888999999999999999999999999999999988875432    11222222211111   1112334567888999


Q ss_pred             cCCCCCCCCHHHHHH
Q 039082          445 DGDASVRPSFSSITC  459 (472)
Q Consensus       445 ~~dP~~RPs~~~ll~  459 (472)
                      ..+|.+||++.++++
T Consensus       250 ~~~P~~Rps~~eil~  264 (793)
T PLN00181        250 HPEPSCRPSMSELLQ  264 (793)
T ss_pred             CCChhhCcChHHHhh
Confidence            999999999999975

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.1e-24  Score=208.24  Aligned_cols=258  Identities=20%  Similarity=0.270  Sum_probs=202.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  270 (472)
                      .-.|.+.++||+|+||+++.|..  ++..||||.-.. .     ...-++..|.+..+.| ..++|...|-+-.+..+. 
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr-k-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N-   99 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR-K-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN-   99 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccc-c-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh-
Confidence            45799999999999999999975  689999994322 1     2223477889999888 568998888554444444 


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-----CcE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-----KHV  345 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-----~~v  345 (472)
                      ++|.++.|-+|.+++.-++..         .+.+.+.-+|.|++.-++|+|+++  +|+|||||+|+||+..     ..+
T Consensus       100 iLVidLLGPSLEDLFD~CgR~---------FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~I  168 (449)
T KOG1165|consen  100 ILVIDLLGPSLEDLFDLCGRR---------FSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVI  168 (449)
T ss_pred             hhhhhhhCcCHHHHHHHhcCc---------ccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceE
Confidence            566667799999988766643         246778889999999999999999  9999999999999743     468


Q ss_pred             EEeecccceecCCCcc----------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHHH
Q 039082          346 RIADFGHARFLSDGEM----------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIA  414 (472)
Q Consensus       346 kL~DFGla~~~~~~~~----------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i~  414 (472)
                      -|+|||+|+...+..+          ...||..||+-....+.+.+.+.|+-|||-+++.++-|.+||.+.... .....
T Consensus       169 hiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY  248 (449)
T KOG1165|consen  169 HIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY  248 (449)
T ss_pred             EEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH
Confidence            9999999998876543          456999999999999999999999999999999999999999876543 23345


Q ss_pred             HHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          415 MEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ..|.+.+...++... ...+.++...+.-.-..+-++-|+++.+...|.++..+.-
T Consensus       249 eKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g  304 (449)
T KOG1165|consen  249 EKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG  304 (449)
T ss_pred             HHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence            556665533333222 3456677777777888899999999999999998887654

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=2.9e-26  Score=225.59  Aligned_cols=244  Identities=22%  Similarity=0.310  Sum_probs=187.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~  268 (472)
                      +.|.++++||+|+|++||++.+.     ...||+|.+...      .....+.+|+++|..+ .+.||+++.+.+...+.
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t------s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT------SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc------cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            56788999999999999999753     467999988643      2334488999999999 68999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRI  347 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL  347 (472)
                      ..+|++|+......++....+             +.++..+++.++.||+++|.+|  ||||||||.|+|.+. .+.-.|
T Consensus       110 v~ivlp~~~H~~f~~l~~~l~-------------~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~L  174 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRSLS-------------LAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVL  174 (418)
T ss_pred             eEEEecccCccCHHHHHhcCC-------------HHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceE
Confidence            999999999999988885432             5778899999999999999999  999999999999974 577899


Q ss_pred             eecccceecC-----------------C--C----------------c------------cccccCCccccccccc-CCC
Q 039082          348 ADFGHARFLS-----------------D--G----------------E------------MALTGTFVYMAPEVIQ-CEP  379 (472)
Q Consensus       348 ~DFGla~~~~-----------------~--~----------------~------------~~~~gt~~y~APE~~~-~~~  379 (472)
                      .|||+|....                 .  +                .            ....||++|.|||++. ...
T Consensus       175 vDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~  254 (418)
T KOG1167|consen  175 VDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPR  254 (418)
T ss_pred             EechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccC
Confidence            9999986210                 0  0                0            0123899999999975 566


Q ss_pred             CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH-------------HhcCC---------------------C---
Q 039082          380 YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME-------------VGEGK---------------------L---  422 (472)
Q Consensus       380 ~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~-------------i~~~~---------------------~---  422 (472)
                      .+.++||||.||++..+++++.||.....+...+...             ..-|.                     +   
T Consensus       255 QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~  334 (418)
T KOG1167|consen  255 QTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIE  334 (418)
T ss_pred             cCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChh
Confidence            7899999999999999999999996433211111100             00011                     0   


Q ss_pred             --CC-C---CC---CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 --RP-A---LP---EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 --~~-~---l~---~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        .+ .   +.   ..+..+..+++++.+|+..||.+|.++++.++
T Consensus       335 ~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  335 SIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             hcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence              00 0   00   01223447889999999999999999999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.3e-23  Score=210.96  Aligned_cols=256  Identities=20%  Similarity=0.256  Sum_probs=188.0

Q ss_pred             CeeEeceeeccCceEEEEEEECC---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC----CceeEEEEEEEcCCC
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRG---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH----RFVLQLMGACLEPPY  268 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H----pnIv~l~g~~~~~~~  268 (472)
                      .|.+.++||+|+||.||++.+..   ..+|+|+.........    ..+..|+.+|..+..    +++..+++.....+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~----~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP----SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC----ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCc
Confidence            78899999999999999999864   3699998765422111    136678888888862    688888887753444


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-----C
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-----K  343 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-----~  343 (472)
                      ..++++.+.|.+|.++......        ...+....+.++.|++.+|++||+.|  ++||||||.|++++..     -
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~~--------~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~  164 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNPP--------GRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVR  164 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCCC--------CCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccc
Confidence            4566677889999998754441        12345779999999999999999999  9999999999999865     3


Q ss_pred             cEEEeecccce--ecC-CC----------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH
Q 039082          344 HVRIADFGHAR--FLS-DG----------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP  410 (472)
Q Consensus       344 ~vkL~DFGla~--~~~-~~----------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~  410 (472)
                      .+.|.|||+++  ... ..          .....||..|+++.+..+...+.+.|+||++.++.+++.|..||.......
T Consensus       165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~  244 (322)
T KOG1164|consen  165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD  244 (322)
T ss_pred             eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence            69999999998  321 11          112349999999999999999999999999999999999999997655322


Q ss_pred             HHHHH-HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          411 AKIAM-EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       411 ~~i~~-~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ..... ...........  ....+..+..+...+-..+...+|++..+...|......
T Consensus       245 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  245 LKSKFEKDPRKLLTDRF--GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             hHHHHHHHhhhhccccc--cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            21111 11111111111  122334555555556668999999999999998776654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-24  Score=199.18  Aligned_cols=260  Identities=22%  Similarity=0.259  Sum_probs=197.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-CceeEEEEEEEcCCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQLMGACLEPPY  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~g~~~~~~~  268 (472)
                      |-...|.++++||+|+||.+|+|..  .|..||||+-......      ..+.-|.++...|++ ..|..+..+..+.+.
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h------pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y   85 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH------PQLLYESKVYRILQGGVGIPHIRHYGTEKDY   85 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC------cchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence            4457899999999999999999986  4899999976544322      236789999999975 566666666666665


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CCcE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHV  345 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~~v  345 (472)
                      .. +++++.|-+|.+++.-+...         .++...+-.+-|++.-++|+|.++  +|||||||+|+|++-   ...+
T Consensus        86 nv-lVMdLLGPsLEdLfnfC~R~---------ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl  153 (341)
T KOG1163|consen   86 NV-LVMDLLGPSLEDLFNFCSRR---------FTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKL  153 (341)
T ss_pred             ce-eeeeccCccHHHHHHHHhhh---------hhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceE
Confidence            54 45556699999888544322         235667777889999999999999  999999999999974   3568


Q ss_pred             EEeecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-HHHH
Q 039082          346 RIADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIA  414 (472)
Q Consensus       346 kL~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-~~i~  414 (472)
                      .++|||+|+.+.+..          ...+||..|++-....+...+.+.|+-|+|.+|..+.-|..||.+..... ....
T Consensus       154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy  233 (341)
T KOG1163|consen  154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY  233 (341)
T ss_pred             EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence            999999998776533          24568999999888888888999999999999999999999998865432 2233


Q ss_pred             HHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          415 MEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ..|.+.+...++... ...|.++...+..|-...-++-|+...|...++-+...+-
T Consensus       234 EkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln  289 (341)
T KOG1163|consen  234 EKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN  289 (341)
T ss_pred             HHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence            334444322222111 3456778888889999999999999999988887776553

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=3.2e-23  Score=202.46  Aligned_cols=253  Identities=28%  Similarity=0.340  Sum_probs=196.7

Q ss_pred             eeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCC-ceeEEEEEEEcCCCceEEEEe
Q 039082          197 IDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR-FVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~~vve~  275 (472)
                      |.+.+.||.|+||.||++.+. ..+++|.+....... ......|.+|+.++..+.|+ +|+++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESK-SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccc-hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            678899999999999999988 889999997754322 23567799999999999988 799999999766667889999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEEEeecccce
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHAR  354 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vkL~DFGla~  354 (472)
                      +.++++..++......       ..........++.+++.++.|+|+.+  ++||||||+||+++..+ .++++|||++.
T Consensus        80 ~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-------GPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             CCCCcHHHHHHhcccc-------cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            9999999776543211       12345778889999999999999999  99999999999999988 79999999998


Q ss_pred             ecCCCc---------cccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcC
Q 039082          355 FLSDGE---------MALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEG  420 (472)
Q Consensus       355 ~~~~~~---------~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~  420 (472)
                      ......         ....|+..|+|||.+.+   ..++...|+||+|++++++++|..||.....  ........+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            665432         45568999999999987   5788999999999999999999999866653  122333333332


Q ss_pred             CCC-CCCCCCc----hhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          421 KLR-PALPEED----GQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       421 ~~~-~~l~~~~----~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ... ...+...    .....+.+++..++..+|..|.+.......
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            211 0111111    112567888889999999999988876654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.6e-25  Score=208.66  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      |+..++.++.+|.+...|+.|+|+|.|..+++|+++-...  .......|..|.-.|+-+.||||+.++|.|....+..+
T Consensus       187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~--t~risrdfneefp~lrifshpnilpvlgacnsppnlv~  264 (448)
T KOG0195|consen  187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREV--TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI  264 (448)
T ss_pred             cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhc--chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence            5556778899999999999999999999999998865432  22334568889889999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe--e
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA--D  349 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~--D  349 (472)
                      +..|+.-|+|++.|+.....-        ..-.++.++++++++||+|||+..+-|----|....++||++.+++|+  |
T Consensus       265 isq~mp~gslynvlhe~t~vv--------vd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad  336 (448)
T KOG0195|consen  265 ISQYMPFGSLYNVLHEQTSVV--------VDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMAD  336 (448)
T ss_pred             eeeeccchHHHHHHhcCccEE--------EecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheeccc
Confidence            999999999999997543221        123568899999999999999987534444689999999999988774  2


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCC---chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYS---EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s---~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      --++..    .....-.|.|++||.+...+-+   .++|+|||++++|||.|...||.+..  +.+.-+.+.-..+|..+
T Consensus       337 ~kfsfq----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadls--pmecgmkialeglrv~i  410 (448)
T KOG0195|consen  337 TKFSFQ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLS--PMECGMKIALEGLRVHI  410 (448)
T ss_pred             ceeeee----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCC--chhhhhhhhhccccccC
Confidence            222211    1111237889999999866543   57999999999999999999997766  77788888777778777


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      |+.  ....+..++.-|++.||-+||.|..|+-.|+++.
T Consensus       411 ppg--is~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  411 PPG--ISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCC--ccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            764  3445566666799999999999999999998764

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=1.7e-23  Score=211.25  Aligned_cols=161  Identities=19%  Similarity=0.172  Sum_probs=125.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCC-CChHHHHHHHHHHHHHHhcCCCceeE-EEEEEEcCCC
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQ-LMGACLEPPY  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~-l~g~~~~~~~  268 (472)
                      .++|.+.+.||+|+||.||+|.++   +..||||++...... ........|.+|+++|+.++|+|++. +++.    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            467999999999999999999874   567899987533110 12344567999999999999999985 5432    45


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC-CCCcEEEcCCCcEEE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL-KPSNIFLDDAKHVRI  347 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL-kp~NILl~~~~~vkL  347 (472)
                      .++||||+.|++|.. +...               . ...++.+++.||+|||++|  |+|||| ||+|||++.++.+||
T Consensus        93 ~~LVmE~~~G~~L~~-~~~~---------------~-~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~ikL  153 (365)
T PRK09188         93 DGLVRGWTEGVPLHL-ARPH---------------G-DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEAAV  153 (365)
T ss_pred             cEEEEEccCCCCHHH-hCcc---------------c-hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCEEE
Confidence            688999999999962 2100               0 1356789999999999999  999999 999999999999999


Q ss_pred             eecccceecCCCc-----------cccccCCcccccccccC
Q 039082          348 ADFGHARFLSDGE-----------MALTGTFVYMAPEVIQC  377 (472)
Q Consensus       348 ~DFGla~~~~~~~-----------~~~~gt~~y~APE~~~~  377 (472)
                      +|||+|+.+....           ....+++.|+|||.+..
T Consensus       154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999765332           12346888999999864

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-23  Score=216.71  Aligned_cols=226  Identities=23%  Similarity=0.253  Sum_probs=181.5

Q ss_pred             eeeccCceEEEEEE-----ECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEEe
Q 039082          202 KIGQGTTANIYRAI-----WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~-----~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      .+|.|+||.|++++     +.|.-+|+|++++.........  ....|..++...+ ||++|++.-.+..+...++++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~--~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~   78 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT--HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDF   78 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc--ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhh
Confidence            47999999999764     3367799999987655443333  4567888888886 99999999999999999999999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      ..||.|...+.+...          ........+...++.+++++|+.+  ++|||+|++||+++.+|++++.|||+++.
T Consensus        79 ~rgg~lft~l~~~~~----------f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske  146 (612)
T KOG0603|consen   79 LRGGDLFTRLSKEVM----------FDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKE  146 (612)
T ss_pred             cccchhhhccccCCc----------hHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhH
Confidence            999999887754332          234455666779999999999999  99999999999999999999999999998


Q ss_pred             cCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHH
Q 039082          356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE  435 (472)
Q Consensus       356 ~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~  435 (472)
                      .-+.... |||..|||||++.  .....+|+||||++++||+||..||..      ++...|.+..+  ..|  ......
T Consensus       147 ~v~~~~~-cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------~~~~~Il~~~~--~~p--~~l~~~  213 (612)
T KOG0603|consen  147 AVKEKIA-CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------DTMKRILKAEL--EMP--RELSAE  213 (612)
T ss_pred             hHhhhhc-ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------HHHHHHhhhcc--CCc--hhhhHH
Confidence            7665544 9999999999998  568899999999999999999999966      45555555432  222  234455


Q ss_pred             HHHHHHHhccCCCCCCCCH
Q 039082          436 LIELICLSWDGDASVRPSF  454 (472)
Q Consensus       436 l~~li~~cl~~dP~~RPs~  454 (472)
                      +.+++..++..+|..|-..
T Consensus       214 a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  214 ARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHHHhhCHHHHhcc
Confidence            6677778999999988543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=2.1e-22  Score=190.12  Aligned_cols=173  Identities=14%  Similarity=0.103  Sum_probs=135.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHH------HHHHHHHHHhcCCCceeEEEEEEEcC-
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF------FAQEVDTLSRQRHRFVLQLMGACLEP-  266 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~------f~~E~~il~~l~HpnIv~l~g~~~~~-  266 (472)
                      ..+|.+.+.||.|+||.||++...+..+|||+++++... .+.....      |.+|+..+.++.||+|..+.+++... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~-~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKR-TERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCc-hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            578999999999999999998777789999999876442 2333233      67999999999999999999886643 


Q ss_pred             -------CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          267 -------PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       267 -------~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                             ...+++|||+.|.+|.++...              +    .....+++.+|..+|..|  ++||||+|.||++
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~~--------------~----~~~~~~i~~~l~~lH~~g--i~H~Dikp~Nili  168 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPEI--------------S----EDVKAKIKASIESLHQHG--MVSGDPHKGNFIV  168 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhhc--------------c----HHHHHHHHHHHHHHHHcC--CccCCCChHHEEE
Confidence                   246789999999999876310              0    123559999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEII  397 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ell  397 (472)
                      +.+| ++|+|||...........         ........|..++|+||||+++.-+.
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence            9988 999999988755322211         11333455778999999999987654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.3e-22  Score=217.52  Aligned_cols=249  Identities=19%  Similarity=0.143  Sum_probs=179.1

Q ss_pred             eEeceeeccCceEEEEEEEC--CeeEEEEEeccC--CCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPD--FFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~--~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      ...+.+|.|++|.|+.....  ...++.|.....  ...........+..|..+-..+.|||++..+..+.+.+.....|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999988877653  233444432210  11111222222667888888899999988887777766666667


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      |++.+ +|..++...+.          .+..++-.++.|++.|+.|+|+.|  |.|||||++|+++..+|.+||+|||.+
T Consensus       401 E~~~~-Dlf~~~~~~~~----------~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~  467 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGK----------LTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAA  467 (601)
T ss_pred             hcccH-HHHHHHhcccc----------cchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcc
Confidence            88878 99999864311          124567788999999999999999  999999999999999999999999999


Q ss_pred             eecCCCcc-------ccccCCcccccccccCCCCCc-hHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          354 RFLSDGEM-------ALTGTFVYMAPEVIQCEPYSE-KSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       354 ~~~~~~~~-------~~~gt~~y~APE~~~~~~~s~-~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      ..+..+..       ..+|...|+|||++.+..|++ ..||||.|++++.|++|+.||................+.....
T Consensus       468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~  547 (601)
T KOG0590|consen  468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF  547 (601)
T ss_pred             eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence            87763322       356899999999999999985 6899999999999999999996554222111111111111111


Q ss_pred             CCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEE---DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+..   ...+..-..+|.++|+.+|.+|.++++|++
T Consensus       548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            1111   334556678889999999999999999874

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=3.6e-21  Score=187.02  Aligned_cols=240  Identities=18%  Similarity=0.206  Sum_probs=150.9

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC----------CCceeEEEEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR----------HRFVLQLMGAC  263 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~----------HpnIv~l~g~~  263 (472)
                      .+...+.||.|+|+.||.+.+.  |..+|||++.... .......+.+.+|.-....+.          |-.++.-++..
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~-~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPA-DASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESS-TTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEeccc-ccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3566789999999999999996  5899999987655 344556677777764444422          21222222222


Q ss_pred             Ec---------C--CCce-----EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCce
Q 039082          264 LE---------P--PYRG-----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKV  327 (472)
Q Consensus       264 ~~---------~--~~~~-----~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~i  327 (472)
                      ..         .  ...+     ++.+.-+.++|.+++.-.......   ........++.+..|+++.+++||+.|  +
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~---~~~l~~~arl~lT~Q~I~lvA~Lh~~G--l  166 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQT---HSPLAFAARLSLTVQMIRLVANLHSYG--L  166 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTT---SHHHHHHHHHHHHHHHHHHHHHHHHTT--E
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccc---cchhHHHHHHHHHHHHHHHHHHHhhcc--e
Confidence            11         1  1122     344555588888886532211111   011123455667789999999999999  9


Q ss_pred             eecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccC--------CCCCchHHHHHHHHHHHHHHcC
Q 039082          328 IHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC--------EPYSEKSDVYSFGIILNEIITG  399 (472)
Q Consensus       328 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~--------~~~s~~sDvwSlGvll~elltG  399 (472)
                      +|+||+|+|+|++.+|.++|+||+.....++.......+..|.+||....        -.++.+.|.|+||+++|.|.+|
T Consensus       167 VHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  167 VHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             EEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             EecccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999999999988776654443345677999997643        2478999999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCC
Q 039082          400 NHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVR  451 (472)
Q Consensus       400 ~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~R  451 (472)
                      ..||...........   .-+..       ...+..+..+|..+|+.||.+|
T Consensus       247 ~lPf~~~~~~~~~~~---~f~~C-------~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW---DFSRC-------RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG---GGTTS-------S---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc---cchhc-------CCcCHHHHHHHHHHccCCcccC
Confidence            999976542110000   11111       1345578888999999999987

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=7.3e-21  Score=176.31  Aligned_cols=186  Identities=16%  Similarity=0.034  Sum_probs=140.8

Q ss_pred             EeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEEecc
Q 039082          199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      ....|++|+||+||.+...+.+++.+.+.....-...-....|.+|+++|+.+. |++|++++++    +..+++++++.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            467899999999998888888999887754322111222335889999999995 5889999885    34678899999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCC-CCCcEEEcCCCcEEEeecccceec
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL-KPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDL-kp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      |.+|...+..                 ....++.+++.+|.++|++|  |+|||| ||+|||++.+|.++|+|||+|...
T Consensus        82 G~~L~~~~~~-----------------~~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         82 GAAMYQRPPR-----------------GDLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             CccHHhhhhh-----------------hhHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            9988653310                 11346779999999999999  999999 799999999999999999999865


Q ss_pred             CCCcc----------------ccccCCcccccccccCC-CCC-chHHHHHHHHHHHHHHcCCCCCCCCC
Q 039082          357 SDGEM----------------ALTGTFVYMAPEVIQCE-PYS-EKSDVYSFGIILNEIITGNHPYIEKD  407 (472)
Q Consensus       357 ~~~~~----------------~~~gt~~y~APE~~~~~-~~s-~~sDvwSlGvll~elltG~~Pf~~~~  407 (472)
                      .....                ....++.|++|+....- ..+ ...++++.|.-+|.++|+..|+.+..
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            53321                01147778888764422 334 67899999999999999998875544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.83  E-value=5.2e-21  Score=206.20  Aligned_cols=237  Identities=20%  Similarity=0.230  Sum_probs=171.4

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      ++...+.||++.|=+|.+|.++.-.|+||++-+......-....+-..|++ ...+++||.+.+.-+... +...+++..
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-DKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-hHHHHHHHH
Confidence            688899999999999999998866699999866533233333333444555 555699999998765333 333345555


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +..-+|++.|..          .|.....++..|+.|++.||..+|..|  |+|||||.+||||+.-+-+.|+||..-+.
T Consensus       102 yvkhnLyDRlST----------RPFL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen  102 YVKHNLYDRLST----------RPFLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHhhhhhhhhcc----------chHHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCC
Confidence            556777776642          233346778889999999999999999  99999999999999999999999987653


Q ss_pred             cC---CCcc-------ccccCCcccccccccCC----------C-CCchHHHHHHHHHHHHHHc-CCCCCCCC-------
Q 039082          356 LS---DGEM-------ALTGTFVYMAPEVIQCE----------P-YSEKSDVYSFGIILNEIIT-GNHPYIEK-------  406 (472)
Q Consensus       356 ~~---~~~~-------~~~gt~~y~APE~~~~~----------~-~s~~sDvwSlGvll~ellt-G~~Pf~~~-------  406 (472)
                      ..   ++..       +...-.+|.|||.+...          . .+++-||||+||++.||++ |++||.-.       
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~  249 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRS  249 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhc
Confidence            32   1111       11124679999987431          1 5788999999999999999 89998421       


Q ss_pred             --CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          407 --DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       407 --~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                        ...+......+.+              ..+..+|..|++.||++|.++++.++.
T Consensus       250 ~~~~~~e~~Le~Ied--------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIED--------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cCccCHHHHHHhCcC--------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence              1112222222111              257888999999999999999999876

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=3.7e-20  Score=171.71  Aligned_cols=143  Identities=17%  Similarity=0.123  Sum_probs=104.8

Q ss_pred             eceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChH----------------------HHHHHHHHHHHHHhcCCCce
Q 039082          200 QEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNEN----------------------AVTFFAQEVDTLSRQRHRFV  256 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~----------------------~~~~f~~E~~il~~l~HpnI  256 (472)
                      ...||+|+||.||+|... |..||||+++++.......                      ......+|+.+|..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999999875 8899999998753211110                      01223459999999987776


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCceeecCCCCC
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL-HEQKPKVIHRDLKPS  335 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yL-H~~~~~iiHrDLkp~  335 (472)
                      .....+..  ...++|||++.|+++...+....          ..+......++.|++.+|.|+ |+.|  |+||||||+
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~----------~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~  147 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA----------PLSESKARELYLQVIQIMRILYQDCR--LVHADLSEY  147 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHH
Confidence            44332222  23368888888876654431111          124677889999999999999 7999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecC
Q 039082          336 NIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~  357 (472)
                      |||++ ++.++|+|||+|....
T Consensus       148 NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         148 NLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             HEEEE-CCcEEEEEccccccCC
Confidence            99998 5789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.83  E-value=5.3e-21  Score=206.00  Aligned_cols=200  Identities=26%  Similarity=0.463  Sum_probs=149.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+|+.++.|..|++|.||..+++  -+++|+|+-+.+.+          .+.  ++.....|++|               
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~kiNkq~li----------lRn--ilt~a~npfvv---------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQNLI----------LRN--ILTFAGNPFVV---------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhcccccchh----------hhc--cccccCCccee---------------
Confidence            68899999999999999999988  56899974433211          111  34444555544               


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                            |+-.+.++..+.         ++         .+++.+++|||+.+  |+|||+||+|+||..-|++|++|||+
T Consensus       136 ------gDc~tllk~~g~---------lP---------vdmvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgL  189 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGP---------LP---------VDMVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGL  189 (1205)
T ss_pred             ------chhhhhcccCCC---------Cc---------chhhHHhHhhccCC--eecCCCCCCcceeeecccccccchhh
Confidence                  444444433221         11         13488999999999  99999999999999999999999999


Q ss_pred             ceecCCC------------------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 039082          353 ARFLSDG------------------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA  414 (472)
Q Consensus       353 a~~~~~~------------------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~  414 (472)
                      ++..-..                  ....+||+.|+|||++.-..|...+|||++|+++||++.|..||.+.+  ++++.
T Consensus       190 sk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdt--peelf  267 (1205)
T KOG0606|consen  190 SKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT--PEELF  267 (1205)
T ss_pred             hhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCC--HHHHH
Confidence            8743211                  123579999999999999999999999999999999999999999887  55555


Q ss_pred             HHHhcCCCCCCCCC-CchhHHHHHHHHHHhccCCCCCC
Q 039082          415 MEVGEGKLRPALPE-EDGQLRELIELICLSWDGDASVR  451 (472)
Q Consensus       415 ~~i~~~~~~~~l~~-~~~~~~~l~~li~~cl~~dP~~R  451 (472)
                      .++.....  ..|+ ....+.++.++|..+|..+|..|
T Consensus       268 g~visd~i--~wpE~dea~p~Ea~dli~~LL~qnp~~R  303 (1205)
T KOG0606|consen  268 GQVISDDI--EWPEEDEALPPEAQDLIEQLLRQNPLCR  303 (1205)
T ss_pred             hhhhhhhc--cccccCcCCCHHHHHHHHHHHHhChHhh
Confidence            55443221  1122 24556678888889999999999

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=7.6e-20  Score=169.66  Aligned_cols=143  Identities=20%  Similarity=0.139  Sum_probs=107.8

Q ss_pred             eceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCC----------------------hHHHHHHHHHHHHHHhcCCCce
Q 039082          200 QEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTN----------------------ENAVTFFAQEVDTLSRQRHRFV  256 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~----------------------~~~~~~f~~E~~il~~l~HpnI  256 (472)
                      .+.||+|+||.||+|.+. |..||||+++++.....                      ......+..|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            578999999999999885 89999999987532100                      0112334689999999999987


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHH-HhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCC
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEW-LHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKP  334 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp  334 (472)
                      .....+...  ..++|||++.|+++... +...           ..+......++.+++.+|.++|+ .|  |+||||||
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP  146 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----------PLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSE  146 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhc-----------cCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCh
Confidence            544443332  24688888887754332 3211           12346788899999999999999 99  99999999


Q ss_pred             CcEEEcCCCcEEEeecccceecCC
Q 039082          335 SNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       335 ~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      +|||++ ++.++|+|||++.....
T Consensus       147 ~NIll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         147 YNILYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             hhEEEE-CCCEEEEEcccceecCC
Confidence            999999 88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=2e-20  Score=192.69  Aligned_cols=209  Identities=25%  Similarity=0.385  Sum_probs=164.6

Q ss_pred             HHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCce
Q 039082          248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKV  327 (472)
Q Consensus       248 l~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~i  327 (472)
                      |+.+.|.|+.+++|.+.+....+.|.+++..|+|.+.+....-         ...+.....++++|+.||+|||.-.. .
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~---------~~d~~F~~s~~rdi~~Gl~ylh~s~i-~   70 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI---------KLDYFFILSFIRDISKGLAYLHNSPI-G   70 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc---------CccHHHHHHHHHHHHHHHHHHhcCcc-e
Confidence            4568999999999999999888889999999999999975221         12356677888999999999998762 2


Q ss_pred             eecCCCCCcEEEcCCCcEEEeecccceecCC-----CccccccCCcccccccccCCC-------CCchHHHHHHHHHHHH
Q 039082          328 IHRDLKPSNIFLDDAKHVRIADFGHARFLSD-----GEMALTGTFVYMAPEVIQCEP-------YSEKSDVYSFGIILNE  395 (472)
Q Consensus       328 iHrDLkp~NILl~~~~~vkL~DFGla~~~~~-----~~~~~~gt~~y~APE~~~~~~-------~s~~sDvwSlGvll~e  395 (472)
                      .|+.|++.|+++|....+||+|||+......     ......-..-|.|||.++...       .+.+.|+||||++++|
T Consensus        71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            9999999999999999999999999887743     111112356799999997641       4677999999999999


Q ss_pred             HHcCCCCCCC--CCCCHHHHHHHHhcCC---CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          396 IITGNHPYIE--KDYKPAKIAMEVGEGK---LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       396 lltG~~Pf~~--~~~~~~~i~~~i~~~~---~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +++...||..  ....+.++...+.++.   ++|.+........++..++..||..+|++||+++.+...++.+..
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9999999976  4444556777766633   344444333445578999999999999999999999988876654

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=1.4e-18  Score=163.20  Aligned_cols=134  Identities=16%  Similarity=0.170  Sum_probs=98.6

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-----CCCceeEEEEEEEcCCC---ce-
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-----RHRFVLQLMGACLEPPY---RG-  270 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-----~HpnIv~l~g~~~~~~~---~~-  270 (472)
                      .+.||+|+||.||.-...+. .+||++..+..    ...+.+.+|+.+++.+     +||||+++||++.++..   .+ 
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~----~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD----GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cceecCCCceEEEECCCCcC-eEEEEEecccc----chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            56899999999996222233 47998865421    2345689999999999     57999999999988753   23 


Q ss_pred             EEEEe--ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCceeecCCCCCcEEEcC----CC
Q 039082          271 WLVTE--LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM-QYLHEQKPKVIHRDLKPSNIFLDD----AK  343 (472)
Q Consensus       271 ~vve~--~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL-~yLH~~~~~iiHrDLkp~NILl~~----~~  343 (472)
                      +|+++  ..+++|.+++....             +.+...++.+++.++ +|||+++  |+||||||+|||++.    ++
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~~-------------~~e~~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~  146 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQCR-------------YEEDVAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEV  146 (210)
T ss_pred             EEecCCCCcchhHHHHHHccc-------------ccHhHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCC
Confidence            34555  33589999995421             111235577888888 9999999  999999999999973    34


Q ss_pred             cEEEeecccc
Q 039082          344 HVRIADFGHA  353 (472)
Q Consensus       344 ~vkL~DFGla  353 (472)
                      .++|+||+.+
T Consensus       147 ~~~LiDg~G~  156 (210)
T PRK10345        147 IPVVCDNIGE  156 (210)
T ss_pred             cEEEEECCCC
Confidence            7999995444

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.77  E-value=5.8e-18  Score=159.09  Aligned_cols=138  Identities=27%  Similarity=0.364  Sum_probs=114.9

Q ss_pred             ceeeccCceEEEEEEECCeeEEEEEeccCCCCCCh----HHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          201 EKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNE----NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~----~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      +.||+|++|.||+|.+.|..|+||+.........+    .....+.+|+.++..+.|++|+....++...+..+++++++
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            67999999999999999999999987654332211    12345788999999999998887777777777888999999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      .|++|.+++....             . ....++.+++.+|.++|+.+  ++|+|++|.|||++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~~-------------~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG-------------M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc-------------H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999885321             1 57788999999999999999  99999999999999 78999999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=6.3e-18  Score=157.45  Aligned_cols=135  Identities=24%  Similarity=0.306  Sum_probs=109.0

Q ss_pred             eeeccCceEEEEEEECCeeEEEEEeccCCCCCCh----HHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEecc
Q 039082          202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNE----NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~----~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      .||+|+||.||+|.+.|..|++|+.........+    .....+.+|++++..++|+++.....++...+..+++++++.
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            3899999999999999999999987654322211    123667899999999998876555555556667789999999


Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      |++|.+++....                 ..++.+++.+|.+||+.+  ++|+|++|+||+++ ++.++++|||++...
T Consensus        81 g~~l~~~~~~~~-----------------~~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGN-----------------DELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcH-----------------HHHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999998874211                 067889999999999999  99999999999999 889999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=1.8e-17  Score=181.97  Aligned_cols=247  Identities=18%  Similarity=0.243  Sum_probs=176.8

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC---CCceeEEEEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR---HRFVLQLMGAC  263 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~g~~  263 (472)
                      ....+..+.|.+.+.||.|+||.||+|... |+.||+|+=++...  .+-.+     =..++.+|+   -+.|..++..+
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~--WEfYI-----~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP--WEFYI-----CLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc--eeeee-----hHHHHHhhchhhhcchHHHHHHH
Confidence            346778889999999999999999999864 88999998876422  22111     122333443   23444555544


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc---
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---  340 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~---  340 (472)
                      .-.+..++|.+|..-|+|.+++...          ..+++.....++.|++..++.||..+  |||+||||+|+||.   
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~~----------~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~  831 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINTN----------KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREI  831 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhccC----------CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeeccc
Confidence            5566677899999999999999622          23446667788899999999999999  99999999999994   


Q ss_pred             ----CCCcEEEeecccceecC---CCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH
Q 039082          341 ----DAKHVRIADFGHARFLS---DGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA  411 (472)
Q Consensus       341 ----~~~~vkL~DFGla~~~~---~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~  411 (472)
                          +.-.++|+|||.+..+.   ++.  ...++|-.+-.+|+..|+.++..+|.|.|+.+++-|+.|+.-         
T Consensus       832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~---------  902 (974)
T KOG1166|consen  832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM---------  902 (974)
T ss_pred             CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH---------
Confidence                23469999999997654   331  234568889999999999999999999999999999998631         


Q ss_pred             HHHHHHhcCCCCCC---CCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          412 KIAMEVGEGKLRPA---LPEE--DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       412 ~i~~~i~~~~~~~~---l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                          +...|.....   ++..  ...+.   +++..+|+.+-..=|...+|...|++++.+-.
T Consensus       903 ----q~~~g~~~~~~~~~~Ry~~~~~W~---~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  903 ----EVKNGSSWMVKTNFPRYWKRDMWN---KFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             ----HhcCCcceeccccchhhhhHHHHH---HHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence                1333332221   2222  12223   34445666444455899999998888776543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.75  E-value=1e-17  Score=179.51  Aligned_cols=147  Identities=20%  Similarity=0.286  Sum_probs=117.9

Q ss_pred             ceeeCCCC---eeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCC----hHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          189 GWYIDPKE---IDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTN----ENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       189 ~~~i~~~~---~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      .|......   |...+.||+|+||.||+|.+.+..+++|..........    ....+.+.+|++++..++|++++..+.
T Consensus       324 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        324 TWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             eeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            35544432   34578999999999999999887777775533222111    122356889999999999999998887


Q ss_pred             EEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ++......++|+||+.|++|.+++.                  ....++.+++.+|.|||+.+  ++||||||+|||+ +
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~------------------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~  462 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE------------------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-R  462 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH------------------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-E
Confidence            7777778889999999999999874                  24567889999999999999  9999999999999 5


Q ss_pred             CCcEEEeecccceec
Q 039082          342 AKHVRIADFGHARFL  356 (472)
Q Consensus       342 ~~~vkL~DFGla~~~  356 (472)
                      ++.++|+|||+++..
T Consensus       463 ~~~~~liDFGla~~~  477 (535)
T PRK09605        463 DDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCcEEEEeCcccccC
Confidence            789999999999753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=7.4e-18  Score=165.06  Aligned_cols=193  Identities=25%  Similarity=0.354  Sum_probs=135.8

Q ss_pred             CCCceeEEEEEEEcCCC--------------------------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHH
Q 039082          252 RHRFVLQLMGACLEPPY--------------------------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE  305 (472)
Q Consensus       252 ~HpnIv~l~g~~~~~~~--------------------------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~  305 (472)
                      +|||||++.+.|.++-.                          ..|++|.--..+|..|+.....           +...
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~~-----------s~r~  342 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRHR-----------SYRT  342 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCCC-----------chHH
Confidence            69999999988865311                          2234444447788888854322           2345


Q ss_pred             HHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc--CC--CcEEEeecccceecCC---------CccccccCCccccc
Q 039082          306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DA--KHVRIADFGHARFLSD---------GEMALTGTFVYMAP  372 (472)
Q Consensus       306 ~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~--~~--~~vkL~DFGla~~~~~---------~~~~~~gt~~y~AP  372 (472)
                      .+-+..|+++|+.|||.+|  |.|||||.+||||.  +|  ..+.|+|||.+-.-+.         .....-|...-|||
T Consensus       343 ~~~~laQlLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAP  420 (598)
T KOG4158|consen  343 GRVILAQLLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAP  420 (598)
T ss_pred             HHHHHHHHHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecch
Confidence            6677889999999999999  99999999999993  33  3588999998754332         11123368889999


Q ss_pred             ccccCCC------CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-chhHHHHHHHHHHhcc
Q 039082          373 EVIQCEP------YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DGQLRELIELICLSWD  445 (472)
Q Consensus       373 E~~~~~~------~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~  445 (472)
                      |+....+      --.++|.|+.|.+.||+++...||....  .  ....... +....+|.. +.++..+.+++...|+
T Consensus       421 Ei~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rG--e--m~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~  495 (598)
T KOG4158|consen  421 EIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRG--E--MLLDTRT-YQESQLPALPSRVPPVARQLVFDLLK  495 (598)
T ss_pred             hhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccc--h--heechhh-hhhhhCCCCcccCChHHHHHHHHHhc
Confidence            9986432      1258999999999999999999997633  1  1111111 112233433 3456678888899999


Q ss_pred             CCCCCCCCHHHHHHHHH
Q 039082          446 GDASVRPSFSSITCSLK  462 (472)
Q Consensus       446 ~dP~~RPs~~~ll~~L~  462 (472)
                      .||++|++..-....|.
T Consensus       496 r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  496 RDPSKRVSPNIAANVLN  512 (598)
T ss_pred             CCccccCCccHHHhHHH
Confidence            99999999877666664

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=4.9e-17  Score=151.71  Aligned_cols=140  Identities=20%  Similarity=0.146  Sum_probs=107.5

Q ss_pred             eeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCCh------------------HHHHHHHHHHHHHHhcCCC--c
Q 039082          197 IDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNE------------------NAVTFFAQEVDTLSRQRHR--F  255 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~------------------~~~~~f~~E~~il~~l~Hp--n  255 (472)
                      |.+.+.||+|+||.||+|.+. |..||||++..+......                  .....+..|..++..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            667899999999999999885 889999998654211000                  1112367789999999877  4


Q ss_pred             eeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       256 Iv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      ++..++    ....+++++++.|++|..+...                .....++.+++.++.++|..|  ++||||+|+
T Consensus        97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~  154 (198)
T cd05144          97 VPKPID----WNRHAVVMEYIDGVELYRVRVL----------------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEF  154 (198)
T ss_pred             CCceee----cCCceEEEEEeCCcchhhcccc----------------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcc
Confidence            455544    2445789999999998765320                124567889999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      ||++++++.++|+|||++.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999976554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=4.3e-17  Score=156.36  Aligned_cols=146  Identities=21%  Similarity=0.188  Sum_probs=107.5

Q ss_pred             CeeEeceeeccCceEEEEEE-E--CCeeEEEEEeccCCCCCC--------------------hHHHHHHHHHHHHHHhcC
Q 039082          196 EIDLQEKIGQGTTANIYRAI-W--RGLDVAVKCIYPDFFHTN--------------------ENAVTFFAQEVDTLSRQR  252 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~-~--~g~~vAVK~l~~~~~~~~--------------------~~~~~~f~~E~~il~~l~  252 (472)
                      .|.+.+.||+|+||.||+|. +  .|..||||+++.......                    ......+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            57788999999999999998 3  488999999976432100                    011234678999999997


Q ss_pred             CC--ceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          253 HR--FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       253 Hp--nIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      +.  .+.++++.    ...++|+|++.|.+|..++....          .........++.+++.+|.+||..| .++||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~g-~iiH~  173 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV----------EPEEEEEFELYDDILEEMRKLYKEG-ELVHG  173 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC----------CcchHHHHHHHHHHHHHHHHHHhcC-CEEeC
Confidence            53  34444442    23478888888878765442111          1123446788999999999999986 49999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      ||||+||+++ ++.++|+|||.+....
T Consensus       174 Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      174 DLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CCChhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999999 8899999999987543

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.70  E-value=5e-18  Score=172.33  Aligned_cols=168  Identities=30%  Similarity=0.474  Sum_probs=127.6

Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      .+|+.|.++...+|.+||......       ...++.....++.|++.|++|   ++  .+|+|+||.||+...+..+||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~-------e~~s~s~~~~~~~q~~~~~~y---k~--~ihrdlkp~nif~~~d~q~kI  397 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG-------EERSLSLMLDIFKQIAPAVEY---KG--LIHRDLKPSNIFFSDDDQLKI  397 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc-------cccchhHHHHHHHhhccchhh---cc--chhhhccccccccccchhhhh
Confidence            466788888899999999533321       223467788999999999999   78  999999999999999999999


Q ss_pred             eecccceecCCCc---------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 039082          348 ADFGHARFLSDGE---------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       348 ~DFGla~~~~~~~---------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i  417 (472)
                      +|||+........         ....||..||+||.+.+..|+.++||||||++|+||++ =..+|.     .......+
T Consensus       398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----r~~t~~d~  472 (516)
T KOG1033|consen  398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----RIATLTDI  472 (516)
T ss_pred             hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----HHHhhhhh
Confidence            9999998776443         23458999999999999999999999999999999987 222221     22234445


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS  455 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~  455 (472)
                      .+|.+++..-.+.+   .-+.|+..++.+.|.+||++.
T Consensus       473 r~g~ip~~~~~d~p---~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  473 RDGIIPPEFLQDYP---EEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             hcCCCChHHhhcCc---HHHHHHHHhcCCCcccCchHH
Confidence            56654432222222   235677799999999999443

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.64  E-value=1.4e-15  Score=140.03  Aligned_cols=140  Identities=22%  Similarity=0.208  Sum_probs=97.6

Q ss_pred             eceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHH--------------------HHHHHHHHHHHhcCCCc--e
Q 039082          200 QEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAV--------------------TFFAQEVDTLSRQRHRF--V  256 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~--------------------~~f~~E~~il~~l~Hpn--I  256 (472)
                      .+.||+|+||.||+|.+. |..||||+++++.........                    .....|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            568999999999999987 889999998764321111100                    01135666676664432  4


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHH-HHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCC
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKE-WLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKP  334 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp  334 (472)
                      .+.++.    ...+++++++.++.+.. .+.....            ......++.+++.++.++|. .+  ++|+||||
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~------------~~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p  143 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL------------LEDPEELYDQILELMRKLYREAG--LVHGDLSE  143 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhhh------------cccHHHHHHHHHHHHHHHhhccC--cCcCCCCh
Confidence            444443    23578889888744321 1111000            03467788999999999999 88  99999999


Q ss_pred             CcEEEcCCCcEEEeecccceecCC
Q 039082          335 SNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       335 ~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                      +||+++ ++.++|+|||.+.....
T Consensus       144 ~Nili~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         144 YNILVD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             hhEEEE-CCcEEEEECcccccccC
Confidence            999999 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.5e-15  Score=131.71  Aligned_cols=134  Identities=24%  Similarity=0.204  Sum_probs=110.3

Q ss_pred             EeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC--CceeEEEEEEEcCCCceEEEEec
Q 039082          199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      +++.||.|.++.||++...+..++||.......      ...+.+|+.++..+++  .+++++++++...+..+++++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~   75 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK------GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI   75 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence            457899999999999999888999998865421      3458899999999976  58999998887777888999998


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC-CceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK-PKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~-~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      .|+.+..+                 +......++.+++.+|+++|... .+++|+||+|+|||++..+.++++|||.+..
T Consensus        76 ~g~~~~~~-----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          76 EGETLDEV-----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CCeecccC-----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            88777543                 12445667889999999999842 2399999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.63  E-value=3.6e-15  Score=143.28  Aligned_cols=139  Identities=17%  Similarity=0.136  Sum_probs=104.1

Q ss_pred             ceee-ccCceEEEEEEECCeeEEEEEeccCCC-----C----CChHHHHHHHHHHHHHHhcCCCce--eEEEEEEEcCCC
Q 039082          201 EKIG-QGTTANIYRAIWRGLDVAVKCIYPDFF-----H----TNENAVTFFAQEVDTLSRQRHRFV--LQLMGACLEPPY  268 (472)
Q Consensus       201 ~~LG-~G~fG~Vy~a~~~g~~vAVK~l~~~~~-----~----~~~~~~~~f~~E~~il~~l~HpnI--v~l~g~~~~~~~  268 (472)
                      ..|| .|+.|+||.+...+..++||.+.....     .    ........+.+|+.++..++|++|  +..+++......
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            4677 788889999888889999998754211     0    112334568899999999998775  677776544322


Q ss_pred             -c---eEEEEeccC-CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          269 -R---GWLVTELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       269 -~---~~vve~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                       .   ++|++++.| .+|.+++....           .+.    ..+.+++.+|.+||..|  |+||||||+|||++.++
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~~-----------l~~----~~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~~  179 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEAP-----------LSE----EQWQAIGQLIARFHDAG--VYHADLNAHNILLDPDG  179 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcCC-----------CCH----HHHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCCC
Confidence             2   378888886 68988874311           011    23568999999999999  99999999999999989


Q ss_pred             cEEEeecccceec
Q 039082          344 HVRIADFGHARFL  356 (472)
Q Consensus       344 ~vkL~DFGla~~~  356 (472)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999998653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.59  E-value=7.9e-17  Score=173.06  Aligned_cols=252  Identities=22%  Similarity=0.245  Sum_probs=182.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYR  269 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~  269 (472)
                      ...|.+.+.||+|+|+.|-.....   ...+|+|.+....  ...........|..+-+.+. |+|++.+++.....+..
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~--~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP--KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC--CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            456778888999999999887664   3356776554332  23334444556777777786 99999999998888888


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCceeecCCCCCcEEEcCCC-cEEE
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH-EQKPKVIHRDLKPSNIFLDDAK-HVRI  347 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH-~~~~~iiHrDLkp~NILl~~~~-~vkL  347 (472)
                      +++.++..|+++...+....        ....+-...-.++.|+..++.|+| ..+  +.||||||+|.+++..+ ..++
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~--------~~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~  166 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPD--------STGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKI  166 (601)
T ss_pred             ccccCcccccccccccccCC--------ccCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccC
Confidence            88888877999887663111        001112346677889999999999 888  99999999999999999 9999


Q ss_pred             eecccceecCC-Cc-----ccccc-CCcccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          348 ADFGHARFLSD-GE-----MALTG-TFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       348 ~DFGla~~~~~-~~-----~~~~g-t~~y~APE~~~~~~-~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +|||+|..... ..     ...+| ++.|+|||...+.. ..+..|+||.|+++..+++|..||................
T Consensus       167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~  246 (601)
T KOG0590|consen  167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN  246 (601)
T ss_pred             CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc
Confidence            99999987765 22     13458 99999999988754 4678999999999999999999997655333211111111


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      .. +..............+++.+++..+|+.|.+.+++.
T Consensus       247 ~~-~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  247 KG-RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cc-ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence            11 111122233344567777789999999999988764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.49  E-value=2.3e-12  Score=134.37  Aligned_cols=143  Identities=22%  Similarity=0.215  Sum_probs=99.3

Q ss_pred             ceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCCh--------------------------H----------HHHHHHH
Q 039082          201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNE--------------------------N----------AVTFFAQ  243 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~--------------------------~----------~~~~f~~  243 (472)
                      +.||+|++|.||+|+.+ |+.||||+.+++....-.                          .          ..-.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999985 899999999875311000                          0          0013666


Q ss_pred             HHHHHHhcC----CCceeEEEEEEEc-CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHH-HH
Q 039082          244 EVDTLSRQR----HRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ-AM  317 (472)
Q Consensus       244 E~~il~~l~----HpnIv~l~g~~~~-~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~-gL  317 (472)
                      |+..+.++.    +.+-|.+-.++.+ ....+++|||+.|++|.++.......        .    ....++..++. .+
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--------~----~~~~ia~~~~~~~l  270 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--------L----DRKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--------C----CHHHHHHHHHHHHH
Confidence            777777763    3333333333322 34567899999999998876421100        0    12345555555 47


Q ss_pred             HHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       318 ~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      ..+|..|  ++|+|++|.||+++.+|.++|+|||++..+.
T Consensus       271 ~ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8899999  9999999999999999999999999997664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.37  E-value=2.9e-12  Score=115.74  Aligned_cols=130  Identities=18%  Similarity=0.099  Sum_probs=96.0

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCce-eEEEEEEEcCCCceEEEEeccC
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV-LQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~vve~~~g  278 (472)
                      ++.|+.|.++.||++...+..|++|+...+..     ....+..|+.+++.+.+.++ .+++...  ....++|++++.|
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-----~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G   75 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-----LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG   75 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc-----cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence            46789999999999999999999998754421     11235689999998865444 4555443  3345789999988


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC---ceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP---KVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~---~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      .++....                  ......+.+++.+|+.||..+.   .++|+|++|.||+++ ++.++++|||.+..
T Consensus        76 ~~l~~~~------------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          76 SELLTED------------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             Ccccccc------------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            8775420                  0012346789999999999871   249999999999999 67899999999853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.37  E-value=4.1e-12  Score=133.00  Aligned_cols=160  Identities=19%  Similarity=0.261  Sum_probs=119.2

Q ss_pred             CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccC
Q 039082          218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM  297 (472)
Q Consensus       218 g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~  297 (472)
                      +.+|.|.+.+..    +........+-++.|+.++||||+++++.+..++..|+|+|-+.  .|..++...+.       
T Consensus        37 ~~~vsVF~~~~~----~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~~-------  103 (690)
T KOG1243|consen   37 GGPVSVFVYKRS----NGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELGK-------  103 (690)
T ss_pred             CCceEEEEEeCC----CchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhHH-------
Confidence            667888877543    22444556778899999999999999999999988888888884  45555544331       


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc---ccccCCccccccc
Q 039082          298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM---ALTGTFVYMAPEV  374 (472)
Q Consensus       298 ~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~---~~~gt~~y~APE~  374 (472)
                            .....-+.||+.||.|||..+ +++|++|....|+|+..|.+||++|.++........   ...--..|..|+.
T Consensus       104 ------~~v~~Gl~qIl~AL~FL~~d~-~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  104 ------EEVCLGLFQILAALSFLNDDC-NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEE  176 (690)
T ss_pred             ------HHHHHHHHHHHHHHHHHhccC-CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhh
Confidence                  234445779999999998543 399999999999999999999999999876543321   1112334666766


Q ss_pred             ccCCCCCchHHHHHHHHHHHHHHcC
Q 039082          375 IQCEPYSEKSDVYSFGIILNEIITG  399 (472)
Q Consensus       375 ~~~~~~s~~sDvwSlGvll~elltG  399 (472)
                      +....  -..|.|.|||+++|++.|
T Consensus       177 ~~~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  177 IDPSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cCccc--cchhhhhHHHHHHHHhCc
Confidence            54332  356999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=7.6e-13  Score=137.08  Aligned_cols=245  Identities=21%  Similarity=0.279  Sum_probs=174.0

Q ss_pred             CCeeEeceeec--cCceEEEEEEE--C--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC
Q 039082          195 KEIDLQEKIGQ--GTTANIYRAIW--R--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP  267 (472)
Q Consensus       195 ~~~~l~~~LG~--G~fG~Vy~a~~--~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~  267 (472)
                      ..+.+.+.+|.  |.+|.||.+..  +  +..+|+|.-+....  .......=.+|+...+.. .|+|.++.+..+...+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s--~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS--PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC--CccccccccchhhcccccCccccccccCcccccCC
Confidence            45667788999  99999999877  3  66799986332211  111111123555555666 5899999887766665


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCceeecCCCCCcEEEcCC-
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ----AMQYLHEQKPKVIHRDLKPSNIFLDDA-  342 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~----gL~yLH~~~~~iiHrDLkp~NILl~~~-  342 (472)
                      .. ++.++.++.+|..+.......         .+...++....+...    ||+++|+.+  ++|-|+||+||++..+ 
T Consensus       192 ~l-fiqtE~~~~sl~~~~~~~~~~---------~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~  259 (524)
T KOG0601|consen  192 IL-FIQTELCGESLQSYCHTPCNF---------LPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDW  259 (524)
T ss_pred             cc-eeeeccccchhHHhhhccccc---------CCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheeccccc
Confidence            55 677788899999988654431         123556677777777    999999999  9999999999999999 


Q ss_pred             CcEEEeecccceecCCCccc--------cccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 039082          343 KHVRIADFGHARFLSDGEMA--------LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA  414 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~~--------~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~  414 (472)
                      ..++++|||+...+.++...        ..|...|++||..++ -++...|+|+||.++.+..+|-.+.....+.   ..
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~---~W  335 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS---SW  335 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC---Cc
Confidence            88999999999988765422        247888999999864 4789999999999999999987766544211   12


Q ss_pred             HHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .++..++....+-  .....++...+..+++.+|-.|+++..+..
T Consensus       336 ~~~r~~~ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 SQLRQGYIPLEFC--EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccccCchhhh--cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            2222222111111  233445566888999999999999886653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=5.5e-11  Score=125.91  Aligned_cols=146  Identities=18%  Similarity=0.263  Sum_probs=94.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC-------------------------C-h----HHH----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-------------------------N-E----NAV----  238 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~-------------------------~-~----~~~----  238 (472)
                      .+|+. +.||+|++|.||+|+.+  |+.||||+++++....                         + .    +..    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 79999999999999985  7899999998763100                         0 0    111    


Q ss_pred             --HHHHHHHHHHHhcC----CCceeEEEEEEEc-CCCceEEEEeccCCcHHHHH--hhcccccccccCCCCCCHHHHHHH
Q 039082          239 --TFFAQEVDTLSRQR----HRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLPPFEERLAR  309 (472)
Q Consensus       239 --~~f~~E~~il~~l~----HpnIv~l~g~~~~-~~~~~~vve~~~ggsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~i  309 (472)
                        -.|.+|+..+.+++    +.+.+.+-.++.+ ....+++||++.|+.|.++-  ...+...           .   .+
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~-----------~---~l  264 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDM-----------K---LL  264 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCH-----------H---HH
Confidence              12555666666553    4444444444433 34567899999999998742  2211110           0   11


Q ss_pred             HHH-HHHHHHHHHhcCCceeecCCCCCcEEEcCCC----cEEEeecccceecC
Q 039082          310 ALE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLS  357 (472)
Q Consensus       310 ~~q-ia~gL~yLH~~~~~iiHrDLkp~NILl~~~~----~vkL~DFGla~~~~  357 (472)
                      +.. +..-+.-+...|  ++|+|++|.||+++.+|    .++++|||++..++
T Consensus       265 a~~~v~~~~~Qif~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        265 AERGVEVFFTQVFRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHHHHHHHHHhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            111 111223344578  99999999999999888    99999999997664

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.34  E-value=1.5e-12  Score=125.52  Aligned_cols=197  Identities=18%  Similarity=0.218  Sum_probs=136.7

Q ss_pred             HHhcCCCceeEEEEEEEcC-----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 039082          248 LSRQRHRFVLQLMGACLEP-----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE  322 (472)
Q Consensus       248 l~~l~HpnIv~l~g~~~~~-----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~  322 (472)
                      |-.+-|.|||+++.++.+.     ....|+++|+..|+|..+|+.......      ......+.+|+-||+.||.|||+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~------a~~~~~wkkw~tqIlsal~yLhs  194 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK------ALFQKAWKKWCTQILSALSYLHS  194 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh------hhhHHHHHHHHHHHHhhhhhhhc
Confidence            4556799999999887653     346789999999999999976543221      12356677889999999999999


Q ss_pred             cCCceeecCCCCCcEEEcCCCcEEEeecccceecC-------CCccccccCCcccccccccCCCCCchHHHHHHHHHHHH
Q 039082          323 QKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-------DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNE  395 (472)
Q Consensus       323 ~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~-------~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~e  395 (472)
                      ..|+|+|+++..+-|++..+|-+||+--.....-.       .......+.+.|.|||.=.....+..+|||+||....+
T Consensus       195 ~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle  274 (458)
T KOG1266|consen  195 CDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE  274 (458)
T ss_pred             cCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence            99999999999999999999999885332211110       11122346788999998766667789999999999999


Q ss_pred             HHcCCCCCCCCC--CCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          396 IITGNHPYIEKD--YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       396 lltG~~Pf~~~~--~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      |..|..--.+..  .........+.-+.       .++.   -..++.+|+...|..||++..++-.
T Consensus       275 mailEiq~tnseS~~~~ee~ia~~i~~l-------en~l---qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  275 MAILEIQSTNSESKVEVEENIANVIIGL-------ENGL---QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HHHheeccCCCcceeehhhhhhhheeec-------cCcc---ccCcCcccccCCCCCCcchhhhhcC
Confidence            988764322211  11111111111110       1111   1335669999999999999988743

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.32  E-value=4.1e-13  Score=145.80  Aligned_cols=250  Identities=21%  Similarity=0.222  Sum_probs=178.8

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      +....+++.+.+.+-+|+|+.++.+.-.  |...++|+...... ......+....+-.++-.-++|.+++..-.+.-..
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~-i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs  877 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPK-IRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS  877 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchh-hccccccccCCccCccccCCCCceecccCCCCCCC
Confidence            4566778889999999999999988764  43455554432211 11111222344555555556788887765556677


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      +.+++++++.+++|...|+..+...          ..........+..+++|||+..  ++|+|++|.|+|+..+|+.++
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~s----------aepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l  945 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLS----------AEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPL  945 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcc----------cccccchhHHHHhhhhccccch--hhcccccccchhhcccCCccc
Confidence            8889999999999999988766321          1223455668889999999998  899999999999999999999


Q ss_pred             eecccceecCC------------------------------C----ccccccCCcccccccccCCCCCchHHHHHHHHHH
Q 039082          348 ADFGHARFLSD------------------------------G----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIIL  393 (472)
Q Consensus       348 ~DFGla~~~~~------------------------------~----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll  393 (472)
                      +|||.......                              .    .....||+.|.+||...+......+|+|++|+++
T Consensus       946 ~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l 1025 (1205)
T KOG0606|consen  946 TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCL 1025 (1205)
T ss_pred             CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhh
Confidence            99984332110                              0    1123479999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHH
Q 039082          394 NEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS  455 (472)
Q Consensus       394 ~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~  455 (472)
                      +|.++|..||....  +..+...+..+....+... ....+...+++...+..+|.+|-.+.
T Consensus      1026 ~e~l~g~pp~na~t--pq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1026 FEVLTGIPPFNAET--PQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhcCCCCCCCcc--hhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcc
Confidence            99999999997766  5556666665542221111 33445667777789999999996654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.31  E-value=5e-11  Score=118.64  Aligned_cols=258  Identities=17%  Similarity=0.258  Sum_probs=165.9

Q ss_pred             eEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE--------EEEEEEcCCC
Q 039082          198 DLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ--------LMGACLEPPY  268 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~--------l~g~~~~~~~  268 (472)
                      .+.+.||+|+-+.+|-.-. -...+.|+.........       .+.+..|... .||-+-.        ++|- .....
T Consensus        14 ~~gr~LgqGgea~ly~l~e-~~d~VAKIYh~Pppa~~-------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~   84 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE-VRDQVAKIYHAPPPAAQ-------AQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV   84 (637)
T ss_pred             CCCccccCCccceeeecch-hhchhheeecCCCchHH-------HHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence            4567899999999984321 12345676654422111       1223334443 5654332        1221 11222


Q ss_pred             ceEEEEeccCC-cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          269 RGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       269 ~~~vve~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      .+++|..+.|. .+..++.    -..+.+..+...|...++.++.++.+.+-||+.|  .+-+|+.++|+||++++.|.|
T Consensus        85 iGflmP~v~g~~pI~~~y~----p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~L  158 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYS----PATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVL  158 (637)
T ss_pred             eEEecccCCCccchhhhcC----chhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEE
Confidence            55666666654 2333332    2233344566778999999999999999999999  899999999999999999999


Q ss_pred             eecccceecCCCcc--ccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCC---CHHHHHHH
Q 039082          348 ADFGHARFLSDGEM--ALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY---KPAKIAME  416 (472)
Q Consensus       348 ~DFGla~~~~~~~~--~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~---~~~~i~~~  416 (472)
                      .|-+.-.....+..  ..+|...|++||.-.     +..-+...|.|.||+++++++. |++||.+...   .+......
T Consensus       159 VdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~  238 (637)
T COG4248         159 VDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD  238 (637)
T ss_pred             EcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence            98775544443333  345899999999765     3345678999999999999998 5999976321   01111112


Q ss_pred             HhcC-----------CCCCCCCC-CchhHHHHHHHHHHhccC--CCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          417 VGEG-----------KLRPALPE-EDGQLRELIELICLSWDG--DASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       417 i~~~-----------~~~~~l~~-~~~~~~~l~~li~~cl~~--dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                      |..|           ...++... ....+.++..+..+|+..  ++.-|||++.++..|..+..++.+
T Consensus       239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~  306 (637)
T COG4248         239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKK  306 (637)
T ss_pred             hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhh
Confidence            2222           11111111 134455666677788854  467899999999999999888764

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=1.2e-10  Score=104.94  Aligned_cols=136  Identities=26%  Similarity=0.313  Sum_probs=102.4

Q ss_pred             ceeeccCceEEEEEEECCeeEEEEEeccCCCCCChH----HHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEec
Q 039082          201 EKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNEN----AVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL  276 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~----~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~  276 (472)
                      ..+++|+-+.+|.+.+.|.++++|.=.++.....+-    ....-.+|++++.+++--.|..-+=+..+.+...++|+|+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            357899999999999999888888655544332211    1244668999999886544443333455666677899999


Q ss_pred             cCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       277 ~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .|..|.+++...                 ...++..+=.-+.-||..|  |||+||.++||++..++ +.++|||++...
T Consensus        82 ~G~~lkd~l~~~-----------------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA-----------------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc-----------------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999888532                 2345677778888999999  99999999999998765 999999999743

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.21  E-value=8.2e-12  Score=129.47  Aligned_cols=246  Identities=19%  Similarity=0.181  Sum_probs=173.2

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~  269 (472)
                      ..+|.++..||.|.|+.|+....+   +..|++|.+.+......  ....-+.|+-+...+ .|.+++.++..+...+..
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~--~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA--SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH--hhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            358899999999999999988754   56899998876543222  122234566666666 688999988887777777


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vkL~  348 (472)
                      |+=-||+.++++.....-          ..+......+++..+++.++.++|++.  ++|+|++|+||++..+ +..+++
T Consensus       342 ~ip~e~~~~~s~~l~~~~----------~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVT----------SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             cCchhhhcCcchhhhhHH----------HHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcc
Confidence            777788888887655411          011123457788899999999999999  9999999999999876 788999


Q ss_pred             ecccceecCCCccccccCCccc--ccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          349 DFGHARFLSDGEMALTGTFVYM--APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       349 DFGla~~~~~~~~~~~gt~~y~--APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      |||....+.-......+..++.  +|+......+-.+.|++|||..+.+.++|..--....     ....+..+.    +
T Consensus       410 ~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~~~~i~~~~----~  480 (524)
T KOG0601|consen  410 DFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----QSLTIRSGD----T  480 (524)
T ss_pred             ccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----cceeeeccc----c
Confidence            9999876443333333344444  5555566778899999999999999999763221111     223333332    2


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      +..+.....+..+...+...++..||.+.++....+
T Consensus       481 p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  481 PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            222222345566666888999999999988765544

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=5.3e-10  Score=103.59  Aligned_cols=140  Identities=15%  Similarity=0.113  Sum_probs=94.8

Q ss_pred             eceeeccCceEEEEEEEC--------CeeEEEEEeccCCCCC------------------ChHHHHHHH----HHHHHHH
Q 039082          200 QEKIGQGTTANIYRAIWR--------GLDVAVKCIYPDFFHT------------------NENAVTFFA----QEVDTLS  249 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~--------g~~vAVK~l~~~~~~~------------------~~~~~~~f~----~E~~il~  249 (472)
                      ...||.|.-+.||.|...        +..+|||+.+......                  .......+.    +|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            346899999999999754        3689999875432100                  011122333    7999999


Q ss_pred             hcCC--CceeEEEEEEEcCCCceEEEEeccCCcHHH-HHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHH-HhcCC
Q 039082          250 RQRH--RFVLQLMGACLEPPYRGWLVTELLGTTLKE-WLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL-HEQKP  325 (472)
Q Consensus       250 ~l~H--pnIv~l~g~~~~~~~~~~vve~~~ggsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yL-H~~~~  325 (472)
                      ++..  -++...+++    ...++|||++.+..+.. .+...           ..+......+..+++.+|..+ |..| 
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~-----------~~~~~~~~~i~~~i~~~l~~l~H~~g-  145 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA-----------KLNDEEMKNAYYQVLSMMKQLYKECN-  145 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc-----------ccCHHHHHHHHHHHHHHHHHHHHhCC-
Confidence            9843  455566654    34557788776543321 12110           011234556678999999999 8999 


Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                       +||+||++.|||++ ++.+.|+|||.+....
T Consensus       146 -lVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         146 -LVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             -eecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence             99999999999997 4679999999987664

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.09  E-value=2.3e-09  Score=96.38  Aligned_cols=148  Identities=21%  Similarity=0.208  Sum_probs=104.9

Q ss_pred             EeceeeccCceEEEEEEECCeeEEEEEeccCCCCCC----hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTN----ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      .+..|-+|+-+.|+++.+.|+.+.||.=.+....-.    .-......+|++.|.++.--.|.--.-++.+.....++||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            466788999999999999999999996544333211    2234567789999998854333322223455556667888


Q ss_pred             eccC-CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC---cEEEeec
Q 039082          275 ELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADF  350 (472)
Q Consensus       275 ~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~---~vkL~DF  350 (472)
                      |+.| .++.+|+.........        -......+..|=..+.-||.++  |||+||..+||+|..+|   .+.++||
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~--------d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESE--------DEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             eccchhHHHHHHHHHccCccc--------chhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEee
Confidence            8865 4888888654432111        1223577888899999999999  99999999999997554   4589999


Q ss_pred             ccceec
Q 039082          351 GHARFL  356 (472)
Q Consensus       351 Gla~~~  356 (472)
                      |++...
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.99  E-value=3.5e-09  Score=99.55  Aligned_cols=141  Identities=21%  Similarity=0.298  Sum_probs=95.0

Q ss_pred             ceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC--CceeEEEEEEEcCC---CceEEEE
Q 039082          201 EKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RFVLQLMGACLEPP---YRGWLVT  274 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~g~~~~~~---~~~~vve  274 (472)
                      +.||.|.++.||++...+ ..+++|+.......   .....+.+|+.++..+.+  .++.+++.+.....   ..++|++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~---~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL---PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC---cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence            678999999999998875 89999987553221   123457899999999965  34566776655432   4578999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-------------------------------  323 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-------------------------------  323 (472)
                      ++.|.++...+..           ...+......++.+++.+|..||+.                               
T Consensus        81 ~i~G~~l~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (223)
T cd05154          81 RVDGRVLRDRLLR-----------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDAS  149 (223)
T ss_pred             EeCCEecCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhh
Confidence            9988877654310           0011223334444444444444421                               


Q ss_pred             -----------------------CCceeecCCCCCcEEEcC--CCcEEEeeccccee
Q 039082          324 -----------------------KPKVIHRDLKPSNIFLDD--AKHVRIADFGHARF  355 (472)
Q Consensus       324 -----------------------~~~iiHrDLkp~NILl~~--~~~vkL~DFGla~~  355 (472)
                                             ...++|+|+.|.|||++.  ++.+.|+||+.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         150 RTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                   124899999999999998  67789999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.95  E-value=4.5e-08  Score=100.22  Aligned_cols=221  Identities=14%  Similarity=0.106  Sum_probs=149.8

Q ss_pred             eEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc----CCCceEEEEecc-CCcH
Q 039082          209 ANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE----PPYRGWLVTELL-GTTL  281 (472)
Q Consensus       209 G~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~----~~~~~~vve~~~-ggsL  281 (472)
                      ...|++..+  |..|++|.++-+.....    .....-+++++++.|+|||.+..+|..    +..+++|+.|+. .++|
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~----nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL  365 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQST----NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL  365 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCc----ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence            567888764  88999999954332221    113345788999999999999998873    445678888887 5678


Q ss_pred             HHHHhhccccc-----ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          282 KEWLHGLGSQR-----RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       282 ~~~l~~~~~~~-----~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      .++........     .........+...+|.++.|++.||.++|+.|  +..+-|.|.+||++++..++|...|+...+
T Consensus       366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccceeee
Confidence            87765544433     22222344467889999999999999999999  999999999999999999999988887766


Q ss_pred             CCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHH
Q 039082          357 SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLREL  436 (472)
Q Consensus       357 ~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l  436 (472)
                      ..+..           |-+.   --.+-|.=.||.+++.|.||..--...+.........+.           +....++
T Consensus       444 ~~d~~-----------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~  498 (655)
T KOG3741|consen  444 QEDPT-----------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDL  498 (655)
T ss_pred             cCCCC-----------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHH
Confidence            54331           1111   123568889999999999986431111111110011111           2344566


Q ss_pred             HHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          437 IELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       437 ~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      .+++......++++ -++.+++..+
T Consensus       499 rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  499 RNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHHHHHHhcCccc-ccHHHHHHHH
Confidence            67777777777776 6677766443

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.82  E-value=8.6e-08  Score=93.51  Aligned_cols=137  Identities=14%  Similarity=0.070  Sum_probs=91.2

Q ss_pred             eEEEEEEECCeeEEEEEeccCCCCC-------ChHHHHHHHHHHHHHHhcCCCce--eEEEEEEEc-----CCCceEEEE
Q 039082          209 ANIYRAIWRGLDVAVKCIYPDFFHT-------NENAVTFFAQEVDTLSRQRHRFV--LQLMGACLE-----PPYRGWLVT  274 (472)
Q Consensus       209 G~Vy~a~~~g~~vAVK~l~~~~~~~-------~~~~~~~f~~E~~il~~l~HpnI--v~l~g~~~~-----~~~~~~vve  274 (472)
                      ..|.+..+.|..|.||.........       ...-...+.+|...+.++..-+|  +..+++...     ....++|++
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            3466778888999999664322100       00011137789888888743222  233333322     123567788


Q ss_pred             eccCC-cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-------CCcEE
Q 039082          275 ELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-------AKHVR  346 (472)
Q Consensus       275 ~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-------~~~vk  346 (472)
                      ++.+. +|.+++.....        ..+.......++.+++..+.-||..|  |+|+||++.|||++.       ++.+.
T Consensus       116 ~l~~~~sL~~~~~~~~~--------~~~~~~~~~~ll~~la~~i~~LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~  185 (268)
T PRK15123        116 DLAPTISLEDYCADWAT--------NPPDPRLKRMLIKRVATMVRDMHAAG--INHRDCYICHFLLHLPFPGREEDLKLS  185 (268)
T ss_pred             eCCCCccHHHHHHhhcc--------cCCCHHHHHHHHHHHHHHHHHHHHCc--CccCCCChhhEEEeccccCCCCCceEE
Confidence            88775 79988853211        01224556788899999999999999  999999999999975       46899


Q ss_pred             Eeeccccee
Q 039082          347 IADFGHARF  355 (472)
Q Consensus       347 L~DFGla~~  355 (472)
                      |+||+.+..
T Consensus       186 LIDl~r~~~  194 (268)
T PRK15123        186 VIDLHRAQI  194 (268)
T ss_pred             EEECCcccc
Confidence            999998853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=1.6e-07  Score=86.59  Aligned_cols=129  Identities=26%  Similarity=0.231  Sum_probs=79.9

Q ss_pred             EEEEEEE-CCeeEEEEEeccCCCC----------------------CChHHHHHHHHHHHHHHhcCCC--ceeEEEEEEE
Q 039082          210 NIYRAIW-RGLDVAVKCIYPDFFH----------------------TNENAVTFFAQEVDTLSRQRHR--FVLQLMGACL  264 (472)
Q Consensus       210 ~Vy~a~~-~g~~vAVK~l~~~~~~----------------------~~~~~~~~f~~E~~il~~l~Hp--nIv~l~g~~~  264 (472)
                      .||.|.. .|..+|||+.+.....                      ..........+|++.|.++..-  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899987 4889999987543111                      0111234567899999999654  45666654  


Q ss_pred             cCCCceEEEEecc--CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCceeecCCCCCcEEEcC
Q 039082          265 EPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQY-LHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       265 ~~~~~~~vve~~~--ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~y-LH~~~~~iiHrDLkp~NILl~~  341 (472)
                        ....+||||+.  |..+..+.. ....           ......++.+++..+.. +|..|  |||+||.+.|||+++
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~-~~~~-----------~~~~~~~~~~il~~~~~~~~~~g--ivHGDLs~~NIlv~~  142 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKD-VDLS-----------PEEPKELLEEILEEIIKMLHKAG--IVHGDLSEYNILVDD  142 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHH-CGGG-----------GSTHHHHHHHHHHHHHHHHHCTT--EEESS-STTSEEEET
T ss_pred             --eCCEEEEEecCCCccchhhHHh-cccc-----------chhHHHHHHHHHHHHHHHHHhcC--ceecCCChhhEEeec
Confidence              23457888887  555544332 1100           01244556677775555 57888  999999999999997


Q ss_pred             CCcEEEeecccceecC
Q 039082          342 AKHVRIADFGHARFLS  357 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~  357 (472)
                      + .+.|+|||.+....
T Consensus       143 ~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  143 G-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             T-CEEE--GTTEEETT
T ss_pred             c-eEEEEecCcceecC
Confidence            7 89999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=3.5e-09  Score=111.71  Aligned_cols=145  Identities=20%  Similarity=0.310  Sum_probs=104.9

Q ss_pred             HHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcccc------------ccCCcccccccccCC
Q 039082          311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL------------TGTFVYMAPEVIQCE  378 (472)
Q Consensus       311 ~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~------------~gt~~y~APE~~~~~  378 (472)
                      .+++.||.|+|.. ..+||++|.|++|.++.++.+||+.|+++.....+....            .-...|.|||.+.+.
T Consensus       106 ~~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  106 GNVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             hcccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            3566999999976 249999999999999999999999999986554321111            125779999999988


Q ss_pred             CCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHH
Q 039082          379 PYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI  457 (472)
Q Consensus       379 ~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~l  457 (472)
                      ..+.++|+||||+++|.+.. |+.-+....... .......... ..........+.++.+-+.+++..++..||++..+
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~-~~~~~~~~~~-~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL-SYSFSRNLLN-AGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcc-hhhhhhcccc-cccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence            88999999999999999985 666555443211 1111111111 11222225567789999999999999999977665


Q ss_pred             H
Q 039082          458 T  458 (472)
Q Consensus       458 l  458 (472)
                      .
T Consensus       263 ~  263 (700)
T KOG2137|consen  263 L  263 (700)
T ss_pred             h
Confidence            4

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.53  E-value=9.2e-07  Score=83.03  Aligned_cols=106  Identities=22%  Similarity=0.261  Sum_probs=76.7

Q ss_pred             HHHHHHHHHHHhcCCC--ceeEEEEEEEcCC----CceEEEEeccCC-cHHHHHhhcccccccccCCCCCCHHHHHHHHH
Q 039082          239 TFFAQEVDTLSRQRHR--FVLQLMGACLEPP----YRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARAL  311 (472)
Q Consensus       239 ~~f~~E~~il~~l~Hp--nIv~l~g~~~~~~----~~~~vve~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  311 (472)
                      ....+|...+..|..-  .+.+.+++.....    ..++|++++.+. +|.+++.....          ........++.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----------~~~~~~~~ll~  125 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----------LDPSQRRELLR  125 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----------cchhhHHHHHH
Confidence            3467788887777432  2334444443322    235788888774 79998864221          11345677888


Q ss_pred             HHHHHHHHHHhcCCceeecCCCCCcEEEcCCC---cEEEeecccceec
Q 039082          312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFL  356 (472)
Q Consensus       312 qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~---~vkL~DFGla~~~  356 (472)
                      +++..++-||..|  |+|+|+++.|||++.++   .+.++||+.++..
T Consensus       126 ~l~~~i~~lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  126 ALARLIAKLHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999999  99999999999999887   8999999988754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=1e-05  Score=85.54  Aligned_cols=142  Identities=21%  Similarity=0.241  Sum_probs=92.2

Q ss_pred             ceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCC--------------------------hHH----------HHHHHH
Q 039082          201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTN--------------------------ENA----------VTFFAQ  243 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~--------------------------~~~----------~~~f~~  243 (472)
                      +.|++++-|.||+|+.+ |+.||||+.+|+....-                          .+.          .-.|.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            68999999999999997 89999999987632100                          001          122556


Q ss_pred             HHHHHHhcC-----CCceeEEEEEEEc-CCCceEEEEeccCCcHHHHH--hhcccccccccCCCCCCHHHHHHHHHHHHH
Q 039082          244 EVDTLSRQR-----HRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQ  315 (472)
Q Consensus       244 E~~il~~l~-----HpnIv~l~g~~~~-~~~~~~vve~~~ggsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~i~~qia~  315 (472)
                      |+..+.+++     .|++ ++=.++.+ .....++|||+.|..+.+..  +..+..           ...+.....++. 
T Consensus       211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d-----------~k~ia~~~~~~f-  277 (517)
T COG0661         211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGID-----------RKELAELLVRAF-  277 (517)
T ss_pred             HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCC-----------HHHHHHHHHHHH-
Confidence            777776652     2333 23233332 45566899999999888874  332211           112222222222 


Q ss_pred             HHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCC
Q 039082          316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD  358 (472)
Q Consensus       316 gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~  358 (472)
                       +.-+=..|  ++|.|..|.||+++.+|.+.+.|||+...+.+
T Consensus       278 -~~q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         278 -LRQLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -HHHHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             22222357  99999999999999999999999999876543

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.48  E-value=9.9e-07  Score=84.40  Aligned_cols=138  Identities=20%  Similarity=0.173  Sum_probs=91.5

Q ss_pred             eEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCC----------------C--hHHHHHHHHHHHHHHhcCCC--ce
Q 039082          198 DLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHT----------------N--ENAVTFFAQEVDTLSRQRHR--FV  256 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~----------------~--~~~~~~f~~E~~il~~l~Hp--nI  256 (472)
                      .+...||-|.-+.||.|.+. |.++|||.=+-.....                .  ........+|.++|..|...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            45789999999999999985 9999999543221100                0  11223456788899988554  56


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCc
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN  336 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~N  336 (472)
                      .+.+++    +...+||+++.|..|...--               ..+....++..|+.-+.-+-..|  +||+|+++-|
T Consensus       174 P~P~~~----nRHaVvMe~ieG~eL~~~r~---------------~~en~~~il~~il~~~~~~~~~G--iVHGDlSefN  232 (304)
T COG0478         174 PKPIAW----NRHAVVMEYIEGVELYRLRL---------------DVENPDEILDKILEEVRKAYRRG--IVHGDLSEFN  232 (304)
T ss_pred             CCcccc----ccceeeeehcccceeecccC---------------cccCHHHHHHHHHHHHHHHHHcC--ccccCCchhe
Confidence            665543    44456777777766543210               01122233344444444444677  9999999999


Q ss_pred             EEEcCCCcEEEeecccceec
Q 039082          337 IFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       337 ILl~~~~~vkL~DFGla~~~  356 (472)
                      ||++++|.+.++||--+...
T Consensus       233 IlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             EEEecCCCEEEEeCcccccC
Confidence            99999999999999876544

>PRK09902 hypothetical protein; Provisional

Probab=98.47  E-value=4.5e-06  Score=77.86  Aligned_cols=142  Identities=14%  Similarity=0.147  Sum_probs=97.4

Q ss_pred             eccCceEEEEEEECCeeEEEEEeccCCCCC-C-hHHHHHHHHHHHHHHhcCCC--ceeEEEEEEE-cCC----CceEEEE
Q 039082          204 GQGTTANIYRAIWRGLDVAVKCIYPDFFHT-N-ENAVTFFAQEVDTLSRQRHR--FVLQLMGACL-EPP----YRGWLVT  274 (472)
Q Consensus       204 G~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~-~-~~~~~~f~~E~~il~~l~Hp--nIv~l~g~~~-~~~----~~~~vve  274 (472)
                      |+|+.+-|+.....|..+-+|.-....... . ..-...|.+|...+..|..-  .+.+.. ++. ...    ...+|++
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe  105 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE  105 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence            668999999988888888888653211110 0 22346699999999988432  133333 222 111    1335666


Q ss_pred             eccC-CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc--EEEeecc
Q 039082          275 ELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VRIADFG  351 (472)
Q Consensus       275 ~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~--vkL~DFG  351 (472)
                      .+.| .+|.+++.....        ..++...+..+..+++..++-||..|  +.|+|+.+.|||++.+|.  |+++||.
T Consensus       106 ~L~g~~~L~~~l~~~~~--------~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDlE  175 (216)
T PRK09902        106 DMAGFISIADWYAQHAV--------SPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDLE  175 (216)
T ss_pred             eCCCCccHHHHHhcCCc--------CCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEhh
Confidence            5653 588888854221        12234567788999999999999999  999999999999986677  9999999


Q ss_pred             cceec
Q 039082          352 HARFL  356 (472)
Q Consensus       352 la~~~  356 (472)
                      -++..
T Consensus       176 k~r~~  180 (216)
T PRK09902        176 KSRRR  180 (216)
T ss_pred             ccchh
Confidence            87643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.35  E-value=7.6e-06  Score=78.00  Aligned_cols=146  Identities=12%  Similarity=0.189  Sum_probs=83.9

Q ss_pred             ceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc--eeEEEEEEEcCCCceEEEEeccC
Q 039082          201 EKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF--VLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      ..||.|..+.||+.  .|..+++|...+..      ......+|.++++.+..-.  +.+.+++....+..++|++++.|
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G   78 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG   78 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCC------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence            56899999999984  36678899775432      1123578999998885332  45667776666777889999888


Q ss_pred             Cc-HHHHH-----------hhcccccccccCC--CCCCHHHHHHHHH-----------HHH-HHHHHHH--hcCCceeec
Q 039082          279 TT-LKEWL-----------HGLGSQRRKERMV--PLPPFEERLARAL-----------EIA-QAMQYLH--EQKPKVIHR  330 (472)
Q Consensus       279 gs-L~~~l-----------~~~~~~~~~~~~~--~~~~~~~~~~i~~-----------qia-~gL~yLH--~~~~~iiHr  330 (472)
                      .+ +...+           ........+.-..  +...+........           .+. ...++|.  ...+.++|+
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence            63 21111           1000000000000  0011111111100           011 1122222  223358999


Q ss_pred             CCCCCcEEEcCCCcEEEeeccccee
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      |+.|.||++++++ +.|+||+.+..
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcCc
Confidence            9999999999888 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.25  E-value=1.1e-05  Score=75.62  Aligned_cols=141  Identities=15%  Similarity=0.127  Sum_probs=93.1

Q ss_pred             CCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHH------HHHHHHHHHhcCC---CceeEEEEEE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTF------FAQEVDTLSRQRH---RFVLQLMGAC  263 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~------f~~E~~il~~l~H---pnIv~l~g~~  263 (472)
                      -..+|.+.+++-.....-|.+-...|..+++|..+..... .+.....      ..+++..+.+++.   -....++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            4468889999998888889988889999999988764321 1111111      2234444444422   2222222222


Q ss_pred             Ec-----CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          264 LE-----PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       264 ~~-----~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ..     .....+++||+.|..|.++..-                .  -.++-.++.+|.-||..|  ++|+|..|.|++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i----------------~--e~~~~ki~~~ikqlH~~G--~~HGD~hpgNFl  167 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIEDI----------------D--EDLAEKIVEAIKQLHKHG--FYHGDPHPGNFL  167 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchhc----------------C--HHHHHHHHHHHHHHHHcC--CccCCCCcCcEE
Confidence            21     2334478999999888664310                0  023346778899999999  999999999999


Q ss_pred             EcCCCcEEEeeccccee
Q 039082          339 LDDAKHVRIADFGHARF  355 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~  355 (472)
                      +++++ ++++||+..+.
T Consensus       168 v~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  168 VSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             EECCc-EEEEECccccc
Confidence            99655 99999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.19  E-value=1.1e-05  Score=72.56  Aligned_cols=134  Identities=22%  Similarity=0.228  Sum_probs=92.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCcee-EEEEEEEcCCCceEE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL-QLMGACLEPPYRGWL  272 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv-~l~g~~~~~~~~~~v  272 (472)
                      .......+.||+|.+|.||+|.|+|..+|+|+-+.+..      ...+..|+++|..+.--++. ++|.+-  .  ..+.
T Consensus        21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~------r~~l~kEakiLeil~g~~~~p~vy~yg--~--~~i~   90 (201)
T COG2112          21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP------RRNLEKEAKILEILAGEGVTPEVYFYG--E--DFIR   90 (201)
T ss_pred             chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCcc------hhhHHHHHHHHHHhhhcCCCceEEEec--h--hhhh
Confidence            34456678899999999999999999999998765532      34488999999999765554 444331  2  2245


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCC-CCcEEEcCCCcEEEeecc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLK-PSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLk-p~NILl~~~~~vkL~DFG  351 (472)
                      |+|..|-.|.++-....                 ..-...++..---|-..|  |-|+-|. |...+|..++.+.|+||.
T Consensus        91 me~i~G~~L~~~~~~~~-----------------rk~l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~~~~~iIDFd  151 (201)
T COG2112          91 MEYIDGRPLGKLEIGGD-----------------RKHLLRVLEKAYKLDRLG--IEHGELSRPWKNVLVNDRDVYIIDFD  151 (201)
T ss_pred             hhhhcCcchhhhhhccc-----------------HHHHHHHHHHHHHHHHhc--cchhhhcCCceeEEecCCcEEEEEcc
Confidence            88888888887653211                 122334455544455567  8888884 555555556699999999


Q ss_pred             cceec
Q 039082          352 HARFL  356 (472)
Q Consensus       352 la~~~  356 (472)
                      -|+..
T Consensus       152 ~At~k  156 (201)
T COG2112         152 SATFK  156 (201)
T ss_pred             chhhc
Confidence            99744

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.18  E-value=4.5e-05  Score=71.82  Aligned_cols=148  Identities=22%  Similarity=0.299  Sum_probs=83.5

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCC--ceeEEEEEEEcC---CCceEEEE
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR--FVLQLMGACLEP---PYRGWLVT  274 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hp--nIv~l~g~~~~~---~~~~~vve  274 (472)
                      ++.|+.|..+.||+....+..+++|....      ......+.+|+.+++.+...  .+.+++......   ...+++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~------~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~   75 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRP------PDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME   75 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESS------HHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCC------CCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence            57899999999999999888999998643      24556677899998888432  355666644332   23467888


Q ss_pred             eccCCcHHH----------------HHhhcccccccccCCCCCCHHH--------HHHH------------HHHHHH-HH
Q 039082          275 ELLGTTLKE----------------WLHGLGSQRRKERMVPLPPFEE--------RLAR------------ALEIAQ-AM  317 (472)
Q Consensus       275 ~~~ggsL~~----------------~l~~~~~~~~~~~~~~~~~~~~--------~~~i------------~~qia~-gL  317 (472)
                      ++.|..+..                .+.......  ....+...+..        ....            ...+.. .+
T Consensus        76 ~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (239)
T PF01636_consen   76 YIPGRPLDDELSPEQRPELLRQLGRALAQLHQVP--PPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLL  153 (239)
T ss_dssp             EESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSH--TTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHH
T ss_pred             Eeccccccccccccccccccccchhhhhhccccc--ccccccccccccccccccccccccccccchhhhhhhHHHHHHHH
Confidence            888887776                221111100  00000111110        0000            001222 33


Q ss_pred             HHHHh-----cCCceeecCCCCCcEEEc-CCCcEEEeeccccee
Q 039082          318 QYLHE-----QKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARF  355 (472)
Q Consensus       318 ~yLH~-----~~~~iiHrDLkp~NILl~-~~~~vkL~DFGla~~  355 (472)
                      ..++.     ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  154 QELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            34442     223499999999999999 666668999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.13  E-value=4.5e-05  Score=73.26  Aligned_cols=146  Identities=19%  Similarity=0.231  Sum_probs=83.6

Q ss_pred             eeeccCc-eEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEEeccCC
Q 039082          202 KIGQGTT-ANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVTELLGT  279 (472)
Q Consensus       202 ~LG~G~f-G~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve~~~gg  279 (472)
                      .|-.|.. ..||+....+..+.||......       ...+.+|+.+++.+. +--+.+++++....+..++|++++.|.
T Consensus         5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~   77 (244)
T cd05150           5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV   77 (244)
T ss_pred             ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence            3455555 7899998777789999764321       223667888888883 334557777666655667888988887


Q ss_pred             cHHHHHh---------hcccccccccCCCCC--C----HHHHHHHHH--------------------HHHHHHHHHHh--
Q 039082          280 TLKEWLH---------GLGSQRRKERMVPLP--P----FEERLARAL--------------------EIAQAMQYLHE--  322 (472)
Q Consensus       280 sL~~~l~---------~~~~~~~~~~~~~~~--~----~~~~~~i~~--------------------qia~gL~yLH~--  322 (472)
                      +|.....         ..+....+....+..  +    +........                    .+...+..|-.  
T Consensus        78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  157 (244)
T cd05150          78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR  157 (244)
T ss_pred             cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence            7664321         000000000000000  0    000000000                    01111222211  


Q ss_pred             ---cCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          323 ---QKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       323 ---~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                         ..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence               12359999999999999998888899999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.12  E-value=6.7e-05  Score=69.58  Aligned_cols=129  Identities=17%  Similarity=0.239  Sum_probs=89.5

Q ss_pred             CCeeEeceeeccCc-eEEEEEEECCeeEEEEEeccCCC----------CCCh-------HHHHHHHHHHHHHHhcC---C
Q 039082          195 KEIDLQEKIGQGTT-ANIYRAIWRGLDVAVKCIYPDFF----------HTNE-------NAVTFFAQEVDTLSRQR---H  253 (472)
Q Consensus       195 ~~~~l~~~LG~G~f-G~Vy~a~~~g~~vAVK~l~~~~~----------~~~~-------~~~~~f~~E~~il~~l~---H  253 (472)
                      .+++.++.||.|.- |.||++...|..||+|+++.-..          ...+       ....-|..|.+...+|+   +
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~  116 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGR  116 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccc
Confidence            79999999999999 99999999999999999322100          0000       22345888988877774   4


Q ss_pred             Cce--eEEEEEEEcCC-----------------Cc-eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHH
Q 039082          254 RFV--LQLMGACLEPP-----------------YR-GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI  313 (472)
Q Consensus       254 pnI--v~l~g~~~~~~-----------------~~-~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  313 (472)
                      .++  |+.+|+..-..                 .. .+|-+++....                       .....-+.++
T Consensus       117 e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------------------~~~~~~~~~~  173 (207)
T PF13095_consen  117 EGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------------------PLQIRDIPQM  173 (207)
T ss_pred             cCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------------------ccchhHHHHH
Confidence            455  99999864321                 11 12222222111                       1122336688


Q ss_pred             HHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       314 a~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      .+-|..+|..|  |+-+|+++.|..   +  -||+|||.+
T Consensus       174 ~~dl~~~~k~g--I~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKLG--IVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHCC--eeeccCcccccc---C--CEEEecccC
Confidence            88999999999  999999999987   3  389999975

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.04  E-value=0.0001  Score=70.00  Aligned_cols=142  Identities=23%  Similarity=0.187  Sum_probs=88.8

Q ss_pred             EeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCCh--------------------HHHHHHHHHHHHHHhcC--CCc
Q 039082          199 LQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNE--------------------NAVTFFAQEVDTLSRQR--HRF  255 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~--------------------~~~~~f~~E~~il~~l~--Hpn  255 (472)
                      +.-.|++|.-+.||+|... +..+|||+.+........                    .....-..|...|+++.  +=.
T Consensus        52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            3447888999999999864 789999998654331111                    11122345777777763  223


Q ss_pred             eeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCC
Q 039082          256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKP  334 (472)
Q Consensus       256 Iv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp  334 (472)
                      +.+-+++.    ...+|||++ |..-        .........+... .+...+..+++..|.-|-. .+  +||+||+.
T Consensus       132 vP~Pi~~~----~nVLvMEfI-g~~g--------~pAP~LkDv~~e~-~e~~~~~~~~v~~~~~l~~~a~--LVHgDLSE  195 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFI-GDDG--------LPAPRLKDVPLEL-EEAEGLYEDVVEYMRRLYKEAG--LVHGDLSE  195 (268)
T ss_pred             CCCceeec----CCeEEEEec-cCCC--------CCCCCcccCCcCc-hhHHHHHHHHHHHHHHHHHhcC--cccccchh
Confidence            33333321    223555555 4331        0112222222222 2455666788888888777 67  99999999


Q ss_pred             CcEEEcCCCcEEEeecccceecC
Q 039082          335 SNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       335 ~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      -|||+. ++.+.|+|||-|....
T Consensus       196 yNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         196 YNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             hheEEE-CCeEEEEECccccccC
Confidence            999999 8899999999887654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.98  E-value=6.1e-07  Score=94.15  Aligned_cols=181  Identities=15%  Similarity=0.093  Sum_probs=124.8

Q ss_pred             eEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc-eeEEEEEEEcCCCceEEEEe
Q 039082          198 DLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~~vve~  275 (472)
                      .....+++|+.+.+++.+... +....+.+..     .    ....-++++|.+++||| .+..++-+..++...+.+++
T Consensus       245 ~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----T----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCChhhheeceeecc-----c----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            556778999999999988653 2333554422     1    12445788999999999 77777666666666555555


Q ss_pred             ccCC-cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          276 LLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       276 ~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ..++ +....+..  ..      . ....-+.....+.-+++++++|+.-  -+|+|    |||..+ +.++.+||+...
T Consensus       316 ~s~~rs~~~~~~~--se------~-~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~  379 (829)
T KOG0576|consen  316 CSTGRSSALEMTV--SE------I-ALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPP  379 (829)
T ss_pred             hcCCccccccCCh--hh------H-hhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCc
Confidence            5444 11110000  00      0 0001122334557778999999874  48999    887765 689999999998


Q ss_pred             ecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 039082          355 FLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY  403 (472)
Q Consensus       355 ~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf  403 (472)
                      .+...  .....+++.|+|||+.....+....|+|++|+--.++.-|..|-
T Consensus       380 ~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  380 QLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            87755  55667899999999999999999999999998777777777664

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=4.6e-05  Score=70.42  Aligned_cols=105  Identities=18%  Similarity=0.204  Sum_probs=79.2

Q ss_pred             HHHHHHHHhcCC-CceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Q 039082          242 AQEVDTLSRQRH-RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL  320 (472)
Q Consensus       242 ~~E~~il~~l~H-pnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yL  320 (472)
                      ..|.-+|+.+.+ +++++++|+|..    .+++|+...+++...-       .........+|..+..++.+++..+++|
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~-------~~l~~~~~~~w~~R~~iA~~lL~~l~~l   75 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIY-------RPLSQFLQSPWEQRAKIALQLLELLEEL   75 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccc-------cccccccccCHHHHHHHHHHHHHHHHHH
Confidence            357888888866 699999999844    4788888766554210       0000011246899999999999999999


Q ss_pred             HhcCC-ceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          321 HEQKP-KVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       321 H~~~~-~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +..-. .+.-.|++|+|+-|+++|.+|++|.+.+....
T Consensus        76 ~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   76 DHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             hcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            98311 28899999999999999999999999886554

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.86  E-value=0.00032  Score=65.31  Aligned_cols=135  Identities=19%  Similarity=0.288  Sum_probs=90.9

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCC------------ChHHHHHHHHHHHHHHhcC------CCceeEEEE
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHT------------NENAVTFFAQEVDTLSRQR------HRFVLQLMG  261 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~------------~~~~~~~f~~E~~il~~l~------HpnIv~l~g  261 (472)
                      ...||+|+.-.||.- -.+....||++++.....            .......+.+|+.-...+.      +.+|.++||
T Consensus         6 ~~~i~~G~~R~cy~H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G   84 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG   84 (199)
T ss_pred             CcccccCCCceEEEC-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence            356899999988853 234568999998765000            0112345667777666665      789999999


Q ss_pred             EEEcCCCceEEEEeccC------CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          262 ACLEPPYRGWLVTELLG------TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~g------gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      +..++...++|+|-+.+      -+|.+++.....             ..  .+...+-.-..||-..+  |+.+||+|.
T Consensus        85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~-------------~~--~~~~~L~~f~~~l~~~~--Iv~~dl~~~  147 (199)
T PF10707_consen   85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGGL-------------TE--ELRQALDEFKRYLLDHH--IVIRDLNPH  147 (199)
T ss_pred             EEecCCceEEEEEEEECCCCCcCccHHHHHHcCCc-------------cH--HHHHHHHHHHHHHHHcC--CeecCCCcc
Confidence            99999999999988763      358888843221             11  22223334556777788  999999999


Q ss_pred             cEEEcCC--C--cEEEee-ccc
Q 039082          336 NIFLDDA--K--HVRIAD-FGH  352 (472)
Q Consensus       336 NILl~~~--~--~vkL~D-FGl  352 (472)
                      ||++...  +  .+.|+| ||-
T Consensus       148 NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             cEEEEecCCCceEEEEEeCCCC
Confidence            9999532  2  466666 343

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PLN02876 acyl-CoA dehydrogenase

Probab=97.81  E-value=0.00026  Score=80.06  Aligned_cols=79  Identities=13%  Similarity=0.130  Sum_probs=55.6

Q ss_pred             EeceeeccCceEEEEEEECC----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCce--eEEEEEEEcC---CC
Q 039082          199 LQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFV--LQLMGACLEP---PY  268 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnI--v~l~g~~~~~---~~  268 (472)
                      -++.|+.|.++.+|+....+    ..+++|...+....   .....+.+|+++|+.+. |+++  .+++++|.+.   ..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~---~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL---QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC---ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            36778999999999987764    46888865443211   12235789999999995 6654  7888887664   34


Q ss_pred             ceEEEEeccCCc
Q 039082          269 RGWLVTELLGTT  280 (472)
Q Consensus       269 ~~~vve~~~ggs  280 (472)
                      .++||+++.|..
T Consensus       119 ~flVME~v~G~~  130 (822)
T PLN02876        119 AFYIMEYLEGRI  130 (822)
T ss_pred             ceEEEEecCCcc
Confidence            668888887754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.80  E-value=0.00013  Score=69.83  Aligned_cols=30  Identities=30%  Similarity=0.566  Sum_probs=25.8

Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      .++|+|+.+.|||+++++..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            389999999999999776667999998743

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.78  E-value=0.00013  Score=81.83  Aligned_cols=197  Identities=21%  Similarity=0.258  Sum_probs=137.1

Q ss_pred             HHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE----EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHH
Q 039082          238 VTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW----LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI  313 (472)
Q Consensus       238 ~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~----vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  313 (472)
                      +....-|.+.+.+..|+|++.++++-.+.....+    +.+++.+.++...+...+.          .+....+.+..++
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~----------i~~~~~r~~~~~~  295 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGS----------IPLETLRILHQKL  295 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccc----------cCHHHHHHHHHHH
Confidence            3334457777888899999999988766544432    3345556677766654332          2356677788899


Q ss_pred             HHHHHHHHhcCCceeecCCCCC---cEEEcCCCcEEEe--ecccceecCCCcccc--ccCCcccccccccCCCCCch--H
Q 039082          314 AQAMQYLHEQKPKVIHRDLKPS---NIFLDDAKHVRIA--DFGHARFLSDGEMAL--TGTFVYMAPEVIQCEPYSEK--S  384 (472)
Q Consensus       314 a~gL~yLH~~~~~iiHrDLkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~--~gt~~y~APE~~~~~~~s~~--s  384 (472)
                      ..||+|+|+..  +.|.-|...   +..++.++.+.++  ||+.+....+.....  .-+..|.|||......++.+  .
T Consensus       296 ~~GL~~~h~~~--l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~  373 (1351)
T KOG1035|consen  296 LEGLAYLHSLS--LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLT  373 (1351)
T ss_pred             hhhHHHHHHhc--cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhh
Confidence            99999999987  777777777   6666777888888  999998877654433  34777899999877666554  7


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          385 DVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       385 DvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      |+|.+|.++..+..|..+-...-     ....        .++..  ....+.+...+|+..++++|+++.+++...
T Consensus       374 dL~~lgll~~~~~~~~~i~~~~~-----~~~~--------~l~~~--~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  374 DLWCLGLLLLQLSQGEDISEKSA-----VPVS--------LLDVL--STSELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHHHHHHHHhhhhhcCccccccc-----chhh--------hhccc--cchhhhhhhhhhcchhhhhccchhhhhhch
Confidence            99999999999988654321110     0000        11111  111567777899999999999999988653

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.67  E-value=0.00066  Score=64.63  Aligned_cols=73  Identities=15%  Similarity=0.103  Sum_probs=46.8

Q ss_pred             eceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEEe
Q 039082          200 QEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      ++.|..|-...+|+....   +..|++|+.......     .-...+|+.+++.+. +....++++.+.    ..+++++
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-----~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-----IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-----eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEe
Confidence            467888999999998865   468999976543111     011236888888884 333445554332    2479999


Q ss_pred             ccCCcH
Q 039082          276 LLGTTL  281 (472)
Q Consensus       276 ~~ggsL  281 (472)
                      +.|.++
T Consensus        74 i~G~~l   79 (235)
T cd05157          74 IPGRTL   79 (235)
T ss_pred             eCCCcC
Confidence            887654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.57  E-value=0.00034  Score=74.13  Aligned_cols=141  Identities=21%  Similarity=0.249  Sum_probs=87.6

Q ss_pred             ceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCC---------------------------hHH------HHHHHHHHH
Q 039082          201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTN---------------------------ENA------VTFFAQEVD  246 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~---------------------------~~~------~~~f~~E~~  246 (472)
                      +.||.-+.|.||+|+.+ |..||||+-++.....-                           ++.      .-.|.+|++
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            67999999999999987 78999999877532110                           000      112566766


Q ss_pred             HHHhc----CCCc------eeEEEEEEEcCCCceEEEEeccCCcHHHH--HhhcccccccccCCCCCCHHHHHHHHHHHH
Q 039082          247 TLSRQ----RHRF------VLQLMGACLEPPYRGWLVTELLGTTLKEW--LHGLGSQRRKERMVPLPPFEERLARALEIA  314 (472)
Q Consensus       247 il~~l----~Hpn------Iv~l~g~~~~~~~~~~vve~~~ggsL~~~--l~~~~~~~~~~~~~~~~~~~~~~~i~~qia  314 (472)
                      ...+.    .|-+      |.++|-.+  .....++|||+.|..+.+.  |.+.+-.           ...+...+.++.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~-----------~~~i~~~l~~~~  313 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGIS-----------PHDILNKLVEAY  313 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCC-----------HHHHHHHHHHHH
Confidence            65554    3444      33333221  2345689999998876654  3222211           112222222222


Q ss_pred             HHHHHHHhcCCceeecCCCCCcEEEc----CCCcEEEeecccceecCC
Q 039082          315 QAMQYLHEQKPKVIHRDLKPSNIFLD----DAKHVRIADFGHARFLSD  358 (472)
Q Consensus       315 ~gL~yLH~~~~~iiHrDLkp~NILl~----~~~~vkL~DFGla~~~~~  358 (472)
                      .-+-+  ..|  .+|+|=.|-||+++    .++.+.+.|||+......
T Consensus       314 ~~qIf--~~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  314 LEQIF--KTG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHHH--hcC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            22222  346  99999999999998    367899999999887654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.54  E-value=0.00046  Score=66.81  Aligned_cols=142  Identities=17%  Similarity=0.091  Sum_probs=77.6

Q ss_pred             eeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCce-eEEEEEEEcCCCceEEEEeccCCc
Q 039082          202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV-LQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       202 ~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      .+..|-.+.+|+....+..+++|...+.....   . -...+|..+++.+....+ .++++.+    ..++|++++.|..
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~---~-~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~   74 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKAL---G-VDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEV   74 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCcccccc---c-CcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCcc
Confidence            35668888999988778889999754321110   0 124678888888853322 3444432    1358899988765


Q ss_pred             HHH--------------HHhhcccccccccCCCCCCHHH-HHHHHH---------HHHHHHHHHHhc------CCceeec
Q 039082          281 LKE--------------WLHGLGSQRRKERMVPLPPFEE-RLARAL---------EIAQAMQYLHEQ------KPKVIHR  330 (472)
Q Consensus       281 L~~--------------~l~~~~~~~~~~~~~~~~~~~~-~~~i~~---------qia~gL~yLH~~------~~~iiHr  330 (472)
                      +..              .+.+......   ......+.. ...+..         .+...+..+-..      ...++|+
T Consensus        75 ~~~~~~~~~~~~~~la~~l~~lH~~~~---~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        75 ITLDQFVALDLLLELAALLHQLHSQPR---FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             cccccccCchhHHHHHHHHHHHhCCCC---CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            431              1111111100   000111111 111111         111122222221      2248999


Q ss_pred             CCCCCcEEEcCCCcEEEeeccccee
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      |+.|.||++++++ +.|+||+.|..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999877 78999998854

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.41  E-value=0.002  Score=64.05  Aligned_cols=80  Identities=15%  Similarity=0.042  Sum_probs=57.5

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC---CceeEEEEEEEcC---CCc
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH---RFVLQLMGACLEP---PYR  269 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H---pnIv~l~g~~~~~---~~~  269 (472)
                      .+.-.+.||.|..+.||.....+..+.+|..+. .     .....|..|+..|+.+.-   -.+.++++++...   +..
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~-~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~   88 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQGNPMPLMARS-F-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD   88 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCCCEEEEEecc-c-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence            344567899999999999877666788887432 1     112358899999998843   3677888877543   557


Q ss_pred             eEEEEeccCCcH
Q 039082          270 GWLVTELLGTTL  281 (472)
Q Consensus       270 ~~vve~~~ggsL  281 (472)
                      ++|||++.|.++
T Consensus        89 ~LVmE~i~G~~~  100 (297)
T PRK10593         89 VLLLERLRGVSV  100 (297)
T ss_pred             EEEEeccCCEec
Confidence            889999887654

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.40  E-value=0.0044  Score=63.87  Aligned_cols=78  Identities=17%  Similarity=0.129  Sum_probs=53.2

Q ss_pred             eceeeccCceEEEEEEECC--eeEEEEEeccCCCCCC---hHHHHHHHHHHHHHHhcC---CCceeEEEEEEEcCCCceE
Q 039082          200 QEKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTN---ENAVTFFAQEVDTLSRQR---HRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g--~~vAVK~l~~~~~~~~---~~~~~~f~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~  271 (472)
                      .+.||-|.+..||++...+  +.|+||.-.+......   ....+.+..|++.|..+.   ..++.++|.+  +++..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            4689999999999998864  4899997643211111   123456778888888862   3467777765  4455678


Q ss_pred             EEEeccCC
Q 039082          272 LVTELLGT  279 (472)
Q Consensus       272 vve~~~gg  279 (472)
                      ||+++.+.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            88888753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.20  E-value=0.0098  Score=59.21  Aligned_cols=154  Identities=18%  Similarity=0.120  Sum_probs=82.7

Q ss_pred             CCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc--eeEEEEEE------EcC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF--VLQLMGAC------LEP  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~g~~------~~~  266 (472)
                      ....-.+.++.|....+|+....+..+++|+....   ...+   ....|++++..|....  +.+++...      ...
T Consensus        22 ~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~---~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~   95 (307)
T TIGR00938        22 GELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKR---VKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA   95 (307)
T ss_pred             CCceeccccCCccccceEEEEeCCCcEEEEEecCC---CCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence            34555778888888899998776668889977542   1112   2345666666663211  33433311      113


Q ss_pred             CCceEEEEeccCCcHH-----------HHHhhcccccccc---cC--CCCCCHHHHH------------HHHHHHHHHHH
Q 039082          267 PYRGWLVTELLGTTLK-----------EWLHGLGSQRRKE---RM--VPLPPFEERL------------ARALEIAQAMQ  318 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~-----------~~l~~~~~~~~~~---~~--~~~~~~~~~~------------~i~~qia~gL~  318 (472)
                      +..++|++++.|..+.           ..+..........   ..  .....|....            .....+...++
T Consensus        96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~  175 (307)
T TIGR00938        96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD  175 (307)
T ss_pred             CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence            3456788888764321           1111111000000   00  0011111110            00112334566


Q ss_pred             HHHh-----cCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          319 YLHE-----QKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       319 yLH~-----~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++..     ....++|+|+.+.||++++++.+.|+||+.+.
T Consensus       176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            6643     12249999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF00017 SH2: SH2 domain; InterPro: IPR000980 The Src homology 2 (SH2) domain is a protein domain of about 100 amino-acid residues first identified as a conserved sequence region between the oncoproteins Src and Fps []

Probab=97.06  E-value=1.6e-06  Score=67.91  Aligned_cols=57  Identities=12%  Similarity=0.021  Sum_probs=44.8

Q ss_pred             HHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCcc
Q 039082           92 KELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPL  154 (472)
Q Consensus        92 ~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~  154 (472)
                      ..-.++|||| .|.+..+.|+|||.....|.||.|...+++.|     +......|+++..++
T Consensus        18 ~~~~G~FLvR-~s~~~~~~~~Lsv~~~~~v~h~~I~~~~~~~~-----~~~~~~~F~sl~~LV   74 (77)
T PF00017_consen   18 GKPDGTFLVR-PSSSKPGKYVLSVRFDGKVKHFRINRTENGGY-----FLSDGKKFPSLSDLV   74 (77)
T ss_dssp             TSSTTEEEEE-EESSSTTSEEEEEEETTEEEEEEEEEETTSEE-----ESSTSSEBSSHHHHH
T ss_pred             cCCCCeEEEE-eccccccccccccccccccEEEEEEecCCceE-----EccCCCcCCCHHHHH
Confidence            5668999999 88888889999998888999999999998756     333334466655544

Similar sequences were later found in many other intracellular signal-transducing proteins []. SH2 domains function as regulatory modules of intracellular signalling cascades by interacting with high affinity to phosphotyrosine-containing target peptides in a sequence-specific, SH2 domains recognise between 3-6 residues C-terminal to the phosphorylated tyrosine in a fashion that differs from one SH2 domain to another, and strictly phosphorylation-dependent manner [, , , ]. They are found in a wide variety of protein contexts e.g., in association with catalytic domains of phospholipase Cy (PLCy) and the non-receptor protein tyrosine kinases; within structural proteins such as fodrin and tensin; and in a group of small adaptor molecules, i.e Crk and Nck. The domains are frequently found as repeats in a single protein sequence and will then often bind both mono- and di-phosphorylated substrates. The structure of the SH2 domain belongs to the alpha+beta class, its overall shape forming a compact flattened hemisphere. The core structural elements comprise a central hydrophobic anti-parallel beta-sheet, flanked by 2 short alpha-helices. The loop between strands 2 and 3 provides many of the binding interactions with the phosphate group of its phosphopeptide ligand, and is hence designated the phosphate binding loop, the phosphorylated ligand binds perpendicular to the beta-sheet and typically interacts with the phosphate binding loop and a hydrophobic binding pocket that interacts with a pY+3 side chain. The N- and C-termini of the domain are close together in space and on the opposite face from the phosphopeptide binding surface and it has been speculated that this has facilitated their integration into surface-exposed regions of host proteins [].; GO: 0005515 protein binding; PDB: 1M27_A 1KA6_A 1D4W_B 1D4T_A 1D1Z_B 1KA7_A 1UUR_A 1UUS_A 1BLJ_A 1BLK_A ....

>smart00252 SH2 Src homology 2 domains

Probab=97.06  E-value=6.1e-06  Score=65.70  Aligned_cols=58  Identities=12%  Similarity=0.015  Sum_probs=46.4

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      .++|||| .|++..+.|+|||.....|+||.|...+++.|.+     .....|+.+..++.++.
T Consensus        22 ~G~FLvR-~s~~~~~~~~Lsv~~~~~~~h~~I~~~~~~~~~l-----~~~~~F~sl~eLI~~y~   79 (84)
T smart00252       22 DGDFLVR-DSESEPGDYVLSVRVKGKVKHYRIRRNEDGKFYL-----DGGRKFPSLVELVEHYQ   79 (84)
T ss_pred             CcEEEEE-cCCCCCCCEEEEEEECCEEEEEEEEECCCCcEEE-----CCCCccCCHHHHHHHHh
Confidence            7999999 8888789999999989999999999888777743     33456677766665554

Src homology 2 domains bind phosphotyrosine-containing polypeptides via 2 surface pockets. Specificity is provided via interaction with residues that are distinct from the phosphotyrosine. Only a single occurrence of a SH2 domain has been found in S. cerevisiae.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.06  E-value=0.011  Score=58.32  Aligned_cols=150  Identities=17%  Similarity=0.070  Sum_probs=82.7

Q ss_pred             eEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCC--ceeEEEEE------EEcCCCc
Q 039082          198 DLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR--FVLQLMGA------CLEPPYR  269 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hp--nIv~l~g~------~~~~~~~  269 (472)
                      .-.+.|..|....+|+....+..+++|+....    .   ...+..|+.++..+.+.  .+.+++..      ....+..
T Consensus        17 ~~i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~----~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~   89 (296)
T cd05153          17 LSFEGISAGIENTNYFVTTDSGRYVLTLFEKV----S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKP   89 (296)
T ss_pred             hheecccCccccceEEEEeCCCcEEEEEcCCC----C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCce
Confidence            33667888888899998777778999977531    1   12355677777777432  24444331      1223345


Q ss_pred             eEEEEeccCCcHHH-----------HHhhccccccc--cc--CCCCCCHHHHH----------HHHHHHHHHHHHHHh--
Q 039082          270 GWLVTELLGTTLKE-----------WLHGLGSQRRK--ER--MVPLPPFEERL----------ARALEIAQAMQYLHE--  322 (472)
Q Consensus       270 ~~vve~~~ggsL~~-----------~l~~~~~~~~~--~~--~~~~~~~~~~~----------~i~~qia~gL~yLH~--  322 (472)
                      ++|++++.|..+..           .+.........  ..  ......|....          .....+..++.++..  
T Consensus        90 ~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~  169 (296)
T cd05153          90 AALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFD  169 (296)
T ss_pred             EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhh
Confidence            67888887755321           11111000000  00  00000111110          011123344555553  


Q ss_pred             ---cCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          323 ---QKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       323 ---~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                         ....++|+|+.|.|||+++++.+.|.||+.+.
T Consensus       170 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         170 PSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence               11249999999999999988778899999874

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.04  E-value=0.0098  Score=58.96  Aligned_cols=74  Identities=19%  Similarity=0.179  Sum_probs=45.3

Q ss_pred             eceeeccCceEEEEEEEC--------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCC-ceeEEEEEEEcCCCce
Q 039082          200 QEKIGQGTTANIYRAIWR--------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR-FVLQLMGACLEPPYRG  270 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~--------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hp-nIv~l~g~~~~~~~~~  270 (472)
                      ++.|..|-...||+....        +..+++|+......     ......+|..++..+... -..++++.+.    ..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~   73 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-----LLIDRERELVVFARLSERNLGPKLYGIFP----NG   73 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-----ceechHHHHHHHHHHHhCCCCCceEEEeC----CC
Confidence            355677777889988765        36899998654321     112245788888887432 2345555442    23


Q ss_pred             EEEEeccCCcHH
Q 039082          271 WLVTELLGTTLK  282 (472)
Q Consensus       271 ~vve~~~ggsL~  282 (472)
                      .|++++.|..+.
T Consensus        74 ~v~e~i~G~~l~   85 (302)
T cd05156          74 RIEEFIPSRTLT   85 (302)
T ss_pred             chhheeCCCcCC
Confidence            577887776553

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=96.92  E-value=0.018  Score=57.46  Aligned_cols=29  Identities=31%  Similarity=0.425  Sum_probs=25.5

Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      ++||+|+.|.|||++++...-|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            49999999999999977666899999874

>PLN02236 choline kinase

Probab=96.77  E-value=0.014  Score=59.17  Aligned_cols=158  Identities=18%  Similarity=0.265  Sum_probs=83.3

Q ss_pred             cCcee--eCCCCeeEeceeeccCceEEEEEEEC------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-Ccee
Q 039082          187 MNGWY--IDPKEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVL  257 (472)
Q Consensus       187 ~~~~~--i~~~~~~l~~~LG~G~fG~Vy~a~~~------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv  257 (472)
                      ...|.  ++.+.+.+. .|-.|-.-.+|+....      +..|++|+.....    +..+. -.+|..+++.+.. .--.
T Consensus        27 ~~~w~~~~~~~~~~i~-~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t----~~~id-R~~E~~~~~~l~~~gl~P  100 (344)
T PLN02236         27 ASKWGDVVDDEALQVI-PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV----ELFFD-RDDEIRTFECMSRHGQGP  100 (344)
T ss_pred             cchhcCCCCcCcEEEE-EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC----Ceeec-hHHHHHHHHHHHHcCCCC
Confidence            34574  244455554 5555888999998753      2579999775431    11111 2568888888743 2333


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHH--------------HhhcccccccccCCCCCCHHHHHHHHHH-----------
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEW--------------LHGLGSQRRKERMVPLPPFEERLARALE-----------  312 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~--------------l~~~~~~~~~~~~~~~~~~~~~~~i~~q-----------  312 (472)
                      ++++.+..    +.|.+|+.+.+|...              |.+......... .....+.....+..+           
T Consensus       101 ~~~~~~~~----g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~-~~~~~~~~i~~~~~~~~~l~~~~~~~  175 (344)
T PLN02236        101 RLLGRFPN----GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGP-KNVLLWDRLRNWLKEAKNLCSPEEAK  175 (344)
T ss_pred             ceEEEECC----ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCC-CCchHHHHHHHHHHHHHhhcCcchhh
Confidence            55555422    257777766554311              111111100000 001112222222211           


Q ss_pred             ------HHHHHHHH----Hh--cCCceeecCCCCCcEEEcC-CCcEEEeeccccee
Q 039082          313 ------IAQAMQYL----HE--QKPKVIHRDLKPSNIFLDD-AKHVRIADFGHARF  355 (472)
Q Consensus       313 ------ia~gL~yL----H~--~~~~iiHrDLkp~NILl~~-~~~vkL~DFGla~~  355 (472)
                            +...+..|    ..  ....++|+|+++.|||+++ ++.+.|+||..|..
T Consensus       176 ~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        176 EFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             hcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence                  11112222    21  1124899999999999986 47899999998854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.75  E-value=0.011  Score=58.26  Aligned_cols=77  Identities=18%  Similarity=0.036  Sum_probs=49.0

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC---CCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR---HRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .++-.+.+|-|....+|+....+..+.||+-..       .....|..|+.-|+.|.   --.+.+.+++....+..++|
T Consensus        18 ~i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   18 KITSIEPVSGGDINEAYRLDTDGGSYFVKVNSE-------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             ---EEEEE--SSSSEEEEEETTS-EEEEEEEEG-------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             ceeeeEecCCCChhheEEEECCCccEEEEecCh-------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            355677899999999999887788999997742       22234888999888883   34577888887777777899


Q ss_pred             EEeccCC
Q 039082          273 VTELLGT  279 (472)
Q Consensus       273 ve~~~gg  279 (472)
                      +|++..+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9998755

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG4792 consensus Crk family adapters [Signal transduction mechanisms]

Probab=96.71  E-value=8.9e-05  Score=68.04  Aligned_cols=62  Identities=11%  Similarity=0.004  Sum_probs=43.7

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcc-cCcccccCCCCCccCCCCCCCccccC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKED-QHQSLLSSNTGSVIASPLVQTPLHQH  157 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~-~~~~~~s~~~~s~~~~~~~~~~~~~~  157 (472)
                      .+.||+| +|.+.+|+|+|||.-...|.||.|+...- ....+.+-....-..|+.+..+..++
T Consensus        32 ~G~FLvR-DSst~pGdYvLsV~E~srVshYiIn~~~p~~~~~~~~~~rIgdQ~Fd~lPaLL~fy   94 (293)
T KOG4792|consen   32 HGVFLVR-DSSTSPGDYVLSVSENSRVSHYIINSSPPSPAQPPPSRLRIGDQEFDSLPALLEFY   94 (293)
T ss_pred             eeeEEEe-cCCCCCCceEEEEecCcceeeeeecCCCCCccCCCcceeeeccccccchHHHHhhe
Confidence            8999999 99999999999998888999999988432 22222222333334566666555444

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.71  E-value=0.001  Score=65.53  Aligned_cols=136  Identities=17%  Similarity=0.183  Sum_probs=86.0

Q ss_pred             eEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCC-----CCh--------H-----HHHHHHHHHHHHHhcC-CCc-e
Q 039082          198 DLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFH-----TNE--------N-----AVTFFAQEVDTLSRQR-HRF-V  256 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~-----~~~--------~-----~~~~f~~E~~il~~l~-Hpn-I  256 (472)
                      .+.+.||-|.-+.||.+-+. |++.++|.-+-....     .+.        .     ..-...+|...|+.|. |-+ |
T Consensus        95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV  174 (465)
T KOG2268|consen   95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV  174 (465)
T ss_pred             hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence            45788999999999999886 899999953221110     000        0     0112346777787773 322 2


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCc
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN  336 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~N  336 (472)
                      .+.++    .+..+.||+.+.|..|...-+-                .....+...+..-+--|..+|  +||+|..-=|
T Consensus       175 PkpiD----~~RH~Vvmelv~g~Pl~~v~~v----------------~d~~~ly~~lm~~Iv~la~~G--lIHgDFNEFN  232 (465)
T KOG2268|consen  175 PKPID----HNRHCVVMELVDGYPLRQVRHV----------------EDPPTLYDDLMGLIVRLANHG--LIHGDFNEFN  232 (465)
T ss_pred             CCccc----ccceeeHHHhhcccceeeeeec----------------CChHHHHHHHHHHHHHHHHcC--ceecccchhe
Confidence            22232    2344556666667776543211                112233445555566677888  9999999999


Q ss_pred             EEEcCCCcEEEeeccccee
Q 039082          337 IFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       337 ILl~~~~~vkL~DFGla~~  355 (472)
                      |+|++++.++++||--...
T Consensus       233 imv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  233 IMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             eEEecCCCEEEeechHhhc
Confidence            9999999999999976543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.65  E-value=0.00034  Score=80.33  Aligned_cols=160  Identities=11%  Similarity=-0.007  Sum_probs=112.0

Q ss_pred             HHHHHHHHHHHHhcCCCceeEEEEEEEc--CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHH-H
Q 039082          238 VTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI-A  314 (472)
Q Consensus       238 ~~~f~~E~~il~~l~HpnIv~l~g~~~~--~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi-a  314 (472)
                      .+....|.+.++...|+++...+.-...  ....+..++++.+|.+.+.+-+.-.....     ..  ..-.....++ +
T Consensus      1273 kemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~-----ld--~~~v~~~~kvsv 1345 (2724)
T KOG1826|consen 1273 KEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPD-----LD--RSPVHLRHKVSV 1345 (2724)
T ss_pred             HHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCc-----ch--hchHHHHHHHHH
Confidence            3445567777777889998887765443  23456788888999999988543322111     10  1111112233 4


Q ss_pred             HHHHHHHhc---CCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc---cccccCCcccccccccCCCCCchHHHHH
Q 039082          315 QAMQYLHEQ---KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYS  388 (472)
Q Consensus       315 ~gL~yLH~~---~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwS  388 (472)
                      .+..-+|+.   |...+|++||+.|.+|..+..+|++++|+.+......   ....+++.|++|+....-.++.++|+|.
T Consensus      1346 l~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1346 LNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred             hccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence            555555542   3347999999999999999999999999998443222   2334688899999988888999999999


Q ss_pred             HHHHHHHHHcCCCCCC
Q 039082          389 FGIILNEIITGNHPYI  404 (472)
Q Consensus       389 lGvll~elltG~~Pf~  404 (472)
                      .|+.+|+...|..+|.
T Consensus      1426 ~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             HHHHHHHHhcccHHHH
Confidence            9999999988888773

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.59  E-value=0.028  Score=56.15  Aligned_cols=159  Identities=18%  Similarity=0.237  Sum_probs=89.8

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC--CceeEEEEEEEcCC--CceE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RFVLQLMGACLEPP--YRGW  271 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~g~~~~~~--~~~~  271 (472)
                      ...+++.+..|.--.+|.....++++++. . +.. ...........+|..+++.+.-  --+...++.|.++.  ..++
T Consensus        26 ~~~~v~~~~~G~sn~t~~~~~~~~~~vlR-~-P~~-~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~  102 (321)
T COG3173          26 GLLIVEEISGGWSNDTFRLGDTGQKYVLR-K-PPR-GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFY  102 (321)
T ss_pred             CCceeeeccCCcccceEEEecCCceEEEe-c-CCc-cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceE
Confidence            33455666556556677776678888888 3 321 1223344456678888887743  23445677777766  5578


Q ss_pred             EEEeccCCcHH------------------HHHhhcccccc-cc---------cCCCCCCHHHHHHHH--------HHHHH
Q 039082          272 LVTELLGTTLK------------------EWLHGLGSQRR-KE---------RMVPLPPFEERLARA--------LEIAQ  315 (472)
Q Consensus       272 vve~~~ggsL~------------------~~l~~~~~~~~-~~---------~~~~~~~~~~~~~i~--------~qia~  315 (472)
                      ||+++.|..+.                  ++|........ ..         .......+......+        -....
T Consensus       103 v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~  182 (321)
T COG3173         103 VMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADR  182 (321)
T ss_pred             EEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHH
Confidence            88888773222                  12211000000 00         000001111111100        02333


Q ss_pred             HHHHHHhcCC------ceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          316 AMQYLHEQKP------KVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       316 gL~yLH~~~~------~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      -..||+.+.+      .++|+|+.+.||+++.++-+-|.||+++..-+
T Consensus       183 ~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         183 LIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            4666665443      59999999999999998889999999986543

>cd00173 SH2 Src homology 2 domains; Signal transduction, involved in recognition of phosphorylated tyrosine (pTyr)

Probab=96.51  E-value=3e-05  Score=62.89  Aligned_cols=61  Identities=10%  Similarity=0.022  Sum_probs=48.7

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| .|++..+.|+|||.....|.||.|...+++.+     .......|+++..++.++..
T Consensus        19 ~~~G~FLiR-~s~~~~~~~~Lsv~~~~~v~H~~I~~~~~~~~-----~~~~~~~f~sl~eLv~~y~~   79 (94)
T cd00173          19 KPDGTFLVR-DSESSPGDYVLSVRVKGKVKHYRIERTDDGYY-----LLGEGRSFPSLPELIEHYQK   79 (94)
T ss_pred             CCCceEEEE-ecCCCCCCEEEEEEECCEEEEEEEEECCCCeE-----EecCCCccCCHHHHHHHHhh
Confidence            567999999 88878889999998888999999999988655     22245677777777766653

SH2 domains typically bind pTyr-containing ligands via two surface pockets, a pTyr and hydrophobic binding pocket, allowing proteins with SH2 domains to localize to tyrosine phosphorylated sites.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.50  E-value=0.0086  Score=62.50  Aligned_cols=156  Identities=19%  Similarity=0.123  Sum_probs=92.1

Q ss_pred             HHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Q 039082          241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL  320 (472)
Q Consensus       241 f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yL  320 (472)
                      ++-...+++.+.|+|...++++........+||++..+.+|.+++..... .                 ..+   ++   
T Consensus        29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~l-~-----------------~~s---~~---   84 (725)
T KOG1093|consen   29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGNL-K-----------------DES---LL---   84 (725)
T ss_pred             HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhccc-c-----------------hhh---hc---
Confidence            55567789999999999999988877778899999999999998853221 0                 001   11   


Q ss_pred             HhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC
Q 039082          321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN  400 (472)
Q Consensus       321 H~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~  400 (472)
                       .++  +.|-     |+       .+++|     .+.+......|                +++|||++|.++.++..|.
T Consensus        85 -~~~--~~~~-----~~-------~~~td-----~~~t~~~~~~~----------------pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   85 -AHG--VLHL-----NI-------IYITD-----HFLTKYPSPIG----------------PKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             -ccc--ccee-----hh-------hhccc-----cccccCCCCCC----------------cchhhhhHHHHHHHHHHhh
Confidence             122  3321     22       23334     11111111111                4999999999999999988


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCC-CCCCC-------chhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRP-ALPEE-------DGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~-~l~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      .-+...+.  .+....+.+-...+ .+...       -.+...+..+...|+-..|..||.+.++.
T Consensus       129 ~l~~~~~~--s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  129 SLEAELTE--SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHH--HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            77655442  22222222211100 00000       12233456677799999999988766554

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.43  E-value=0.027  Score=55.27  Aligned_cols=30  Identities=27%  Similarity=0.629  Sum_probs=25.3

Q ss_pred             ceeecCCCCCcEEEcCCCc-EEEeeccccee
Q 039082          326 KVIHRDLKPSNIFLDDAKH-VRIADFGHARF  355 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~-vkL~DFGla~~  355 (472)
                      .++|+|+.|.|||+++++. .-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4999999999999997555 56999998854

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.12  E-value=0.059  Score=53.73  Aligned_cols=30  Identities=23%  Similarity=0.440  Sum_probs=27.3

Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +++|+|+.+.|||+++++.+.|+||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            499999999999999999999999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.10  E-value=0.09  Score=54.30  Aligned_cols=78  Identities=13%  Similarity=0.002  Sum_probs=51.3

Q ss_pred             EeceeeccCceEEEEEEECCeeEEEEEeccCCCCCCh---HHHHHHHHHHHHHHhcC---CCceeEEEEEEEcCCCceEE
Q 039082          199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNE---NAVTFFAQEVDTLSRQR---HRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~---~~~~~f~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ..+.||-|....||+....+..|+||.-.+.......   .....-..|++.|+.+.   ..++.++|.++.  +..+++
T Consensus        36 ~~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             eEEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            4678999999999999887778999976533221111   12233344567776653   247888887765  445678


Q ss_pred             EEeccC
Q 039082          273 VTELLG  278 (472)
Q Consensus       273 ve~~~g  278 (472)
                      ||++.+
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            888865

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.08  E-value=0.077  Score=53.52  Aligned_cols=83  Identities=19%  Similarity=0.313  Sum_probs=47.6

Q ss_pred             cee-eCCCCeeEeceeeccCceEEEEEEECC-----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCce-eEEEE
Q 039082          189 GWY-IDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV-LQLMG  261 (472)
Q Consensus       189 ~~~-i~~~~~~l~~~LG~G~fG~Vy~a~~~g-----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~g  261 (472)
                      +|. ++.+++++.. |..|-...+|+....+     ..|++|+.....    +. .-.-.+|..+++.+..-++ .++++
T Consensus         8 ~w~~~~~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t----~~-~IdR~~E~~il~~l~~~gl~P~~l~   81 (330)
T PLN02421          8 GWSDLDDSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT----DY-VIDRERELQAIKYLSAAGFGAKLLG   81 (330)
T ss_pred             ccccCCcCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc----Ce-EechHHHHHHHHHHHhcCCCCceeE
Confidence            353 3344555554 4448888899887653     279999775431    11 1113478888888854333 45565


Q ss_pred             EEEcCCCceEEEEeccCCcH
Q 039082          262 ACLEPPYRGWLVTELLGTTL  281 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~ggsL  281 (472)
                      ++.  .  ++|.+++.|..|
T Consensus        82 ~~~--~--G~i~~fi~g~~l   97 (330)
T PLN02421         82 VFG--N--GMIQSFINARTL   97 (330)
T ss_pred             EeC--C--cEeehhhcCCCC
Confidence            542  2  257777765543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.02  E-value=0.19  Score=49.72  Aligned_cols=28  Identities=32%  Similarity=0.482  Sum_probs=24.8

Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      +++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            4999999999999987 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.29  E-value=0.15  Score=51.87  Aligned_cols=76  Identities=14%  Similarity=0.128  Sum_probs=46.5

Q ss_pred             ceeeccCceEEEEEEECC--eeEEEEEeccCCCC---CChHHHHHHHHHHHHHHhcC--CC-ceeEEEEEEEcCCCceEE
Q 039082          201 EKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFH---TNENAVTFFAQEVDTLSRQR--HR-FVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~g--~~vAVK~l~~~~~~---~~~~~~~~f~~E~~il~~l~--Hp-nIv~l~g~~~~~~~~~~v  272 (472)
                      +.||-|...-||++...+  ..|+||.-.+....   ...-......-|++.|+...  -| .+.++|.  .+++...++
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--Eccccceeh
Confidence            357999999999998864  57999965432111   11222333456777777663  24 5566664  344455578


Q ss_pred             EEeccC
Q 039082          273 VTELLG  278 (472)
Q Consensus       273 ve~~~g  278 (472)
                      ||++..
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            887753

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.21  E-value=0.067  Score=53.92  Aligned_cols=53  Identities=26%  Similarity=0.346  Sum_probs=45.7

Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       303 ~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      +++...++++.+..++-+..+ .+.=||||.-.||||+ +|.|.|+||-+++...
T Consensus       320 ~~e~lsff~s~~sil~~lekk-f~fehrnlt~~niLId-~GnvtLIDfklsRl~~  372 (488)
T COG5072         320 SEEELSFFWSCISILDILEKK-FPFEHRNLTLDNILID-EGNVTLIDFKLSRLSY  372 (488)
T ss_pred             HHHHHHHHHHHHHHHhhhhhc-CCcccccccccceeee-cCceEEEEeeeeeccc
Confidence            788999999988877777665 4589999999999999 9999999999999543

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.13  E-value=0.12  Score=48.65  Aligned_cols=121  Identities=12%  Similarity=0.149  Sum_probs=75.3

Q ss_pred             HHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHH
Q 039082          239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ  318 (472)
Q Consensus       239 ~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~  318 (472)
                      ..|.++.++++++.  .|+++..-  .....++++|.+-.....                       -..++.-=+.+|.
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~-----------------------~~N~i~agi~~L~  155 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN-----------------------FSNFITAGIKDLM  155 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc-----------------------hhHHHHHhHHHHH
Confidence            45778888888874  57777632  233345677766332210                       0011112256788


Q ss_pred             HHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc
Q 039082          319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT  398 (472)
Q Consensus       319 yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt  398 (472)
                      -.|+.+.+.+|+|-.|+||+-|..|.+||.|=+..-.         .+..|.- +  .....+.++.+-+|=.-+++++.
T Consensus       156 ~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---------~~V~~vN-~--~Y~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  156 DFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---------NQVNMVN-I--EYESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             HhhccCCCeecCCCChhheeecCCCCEEecChhhhhh---------heeeEEe-e--eccccChHHHHHHHHHHHHHHHH
Confidence            8997666799999999999999999999999775421         1222322 1  12345666776666666666654

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=95.00  E-value=0.18  Score=51.95  Aligned_cols=88  Identities=17%  Similarity=0.187  Sum_probs=47.1

Q ss_pred             cee-eCCCCeeEeceeeccCceEEEEEEECC---eeEEEEE-eccCCCCCChHHHHHHHHHHHHHHhcCC-CceeEEEEE
Q 039082          189 GWY-IDPKEIDLQEKIGQGTTANIYRAIWRG---LDVAVKC-IYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQLMGA  262 (472)
Q Consensus       189 ~~~-i~~~~~~l~~~LG~G~fG~Vy~a~~~g---~~vAVK~-l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~g~  262 (472)
                      .|. ++.+++++ +.|..|-...+|++...+   ..+.+|. +..... ......-.-.+|..+++.+.. ..-.++++.
T Consensus        44 ~w~~~~~~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g-~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~  121 (383)
T PTZ00384         44 FWNNVNPEFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSS-TYNSLVIDNDLQYNIAKLLGDNNFGPKIIGR  121 (383)
T ss_pred             ccccCCcccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEecc-CCCceEeccHHHHHHHHHHHhCCCCCeEEEe
Confidence            464 23344444 456569999999987542   2332231 111100 111111112468889998854 455566666


Q ss_pred             EEcCCCceEEEEeccCCcHH
Q 039082          263 CLEPPYRGWLVTELLGTTLK  282 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~  282 (472)
                      +.    .++|.+++.|.+|.
T Consensus       122 f~----~g~l~efIeGr~l~  137 (383)
T PTZ00384        122 FG----DFTIQEWVEGNTMG  137 (383)
T ss_pred             cC----CEEEEEEeccccCC
Confidence            53    35788888876653

>PRK06148 hypothetical protein; Provisional

Probab=94.70  E-value=2.8  Score=48.88  Aligned_cols=29  Identities=38%  Similarity=0.664  Sum_probs=24.8

Q ss_pred             ceeecCCCCCcEEEcCCC--cEE-Eeecccce
Q 039082          326 KVIHRDLKPSNIFLDDAK--HVR-IADFGHAR  354 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~--~vk-L~DFGla~  354 (472)
                      .+||+|+.+.|||++.++  .+. |+|||-+.
T Consensus       204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        204 QVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             ceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            399999999999999775  555 99999874

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.68  E-value=0.35  Score=49.06  Aligned_cols=145  Identities=19%  Similarity=0.195  Sum_probs=84.8

Q ss_pred             eEeceeeccCceEEEEEEEC-CeeEEEEEeccCCC---------------------CC-ChHHHHHHHHHHHHHHhcCCC
Q 039082          198 DLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFF---------------------HT-NENAVTFFAQEVDTLSRQRHR  254 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~---------------------~~-~~~~~~~f~~E~~il~~l~Hp  254 (472)
                      ++...|..|.-+.||.|... |..+|||+.+....                     ++ ..........|++.|+++...
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            44567888999999999875 88899998754321                     01 112222344678888888543


Q ss_pred             ceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCC
Q 039082          255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLK  333 (472)
Q Consensus       255 nIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLk  333 (472)
                      .|.----+..  ....+||+++ |.+=+-        ..+.....+ +...+..+-.+++.-|.-|-. .+  +||.||.
T Consensus       227 GIP~PePIlL--k~hVLVM~Fl-Grdgw~--------aPkLKd~~l-s~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLS  292 (520)
T KOG2270|consen  227 GIPCPEPILL--KNHVLVMEFL-GRDGWA--------APKLKDASL-STSKARELYQQCVRIMRRLYQKCR--LVHADLS  292 (520)
T ss_pred             CCCCCCceee--ecceEeeeec-cCCCCc--------CcccccccC-ChHHHHHHHHHHHHHHHHHHHHhc--eeccchh
Confidence            3221100000  0122455554 433111        111111111 123455566677777776655 45  9999999


Q ss_pred             CCcEEEcCCCcEEEeecccceecC
Q 039082          334 PSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       334 p~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      --|+|+- +|.+.|+|.+-+....
T Consensus       293 EfN~Lyh-dG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  293 EFNLLYH-DGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hhhheEE-CCEEEEEEccccccCC
Confidence            9999986 6789999998876544

>PTZ00296 choline kinase; Provisional

Probab=94.50  E-value=0.44  Score=50.03  Aligned_cols=83  Identities=14%  Similarity=0.190  Sum_probs=50.1

Q ss_pred             Ccee-eCCCCeeEeceeeccCceEEEEEEEC----------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCce
Q 039082          188 NGWY-IDPKEIDLQEKIGQGTTANIYRAIWR----------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV  256 (472)
Q Consensus       188 ~~~~-i~~~~~~l~~~LG~G~fG~Vy~a~~~----------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnI  256 (472)
                      .+|. ++.+++ -++.|..|-.-.+|++...          +..|.+++.-...    +... .-.+|..+++.+...+|
T Consensus        98 p~W~~~~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t----e~lI-dR~~E~~v~~~ls~~gi  171 (442)
T PTZ00296         98 PEWRRFTEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV----DELY-NPISEFEVYKTMSKYRI  171 (442)
T ss_pred             CccccCCcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc----ccee-CHHHHHHHHHHHHHCCC
Confidence            4575 455666 6777888888899998754          3578898774431    1111 23457777777743333


Q ss_pred             -eEEEEEEEcCCCceEEEEeccCCc
Q 039082          257 -LQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       257 -v~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                       .++++.+.    .+.|.+|+.|.+
T Consensus       172 ~P~l~~~f~----gg~I~efi~g~~  192 (442)
T PTZ00296        172 APQLLNTFS----GGRIEEWLYGDP  192 (442)
T ss_pred             CCceEEEeC----CCEEEEeeCCcc
Confidence             24555442    345777777653

>KOG0790 consensus Protein tyrosine phosphatase Corkscrew and related SH2 domain enzymes [Signal transduction mechanisms]

Probab=94.46  E-value=0.0018  Score=65.35  Aligned_cols=69  Identities=13%  Similarity=0.098  Sum_probs=58.9

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcC---------CeEEEeccCCcccCcccccCCCCCccCCCCCCCcc
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDN---------GVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPL  154 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~---------~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~  154 (472)
                      .-+.|+.++.+.++|||| ||-+.+|.|.|||..++         .|.|.+|.-.+ ++|     +.+....|.++..++
T Consensus       121 eAekLl~ekgk~gsfLvR-eSqs~PGdfVlSvrTdd~~~~~~~~~kVtHvmI~~q~-~ky-----dVGgge~F~sltdLi  193 (600)
T KOG0790|consen  121 EAEKLLQEKGKHGSFLVR-ESQSHPGDFVLSVRTDDKKESNDSKLKVTHVMIRCQE-GKY-----DVGGGERFDSLTDLV  193 (600)
T ss_pred             hHHHHHHhcCCCccEEEe-ccccCCCceEEEEEcCCcccCCCCccceEEEEEEecc-ccc-----ccCCccccchHHHHH
Confidence            345667789999999999 99999999999995554         89999999887 689     888888999988888


Q ss_pred             ccCCC
Q 039082          155 HQHSH  159 (472)
Q Consensus       155 ~~~~~  159 (472)
                      .+|..
T Consensus       194 dhykk  198 (600)
T KOG0790|consen  194 EHYKK  198 (600)
T ss_pred             HHhcc
Confidence            87764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	472
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-37
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-37
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-29
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-29
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-29
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-29
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-28
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		3e-28
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		3e-28
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		3e-28
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		3e-28
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-28
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-28
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-28
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-28
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-28
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-28
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-27
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-26
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-25
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		5e-25
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		2e-24
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-24
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-24
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-23
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-23
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-23
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-23
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-23
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-23
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-23
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-23
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-23
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-23
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-23
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		7e-23
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		7e-23
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-23
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		7e-23
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-23
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		9e-23
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		9e-23
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-23
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-22
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-22
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-22
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-22
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-22
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-22
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-22
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		8e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		9e-21
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-20
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-20
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-20
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-20
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-20
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-20
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-19
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-19
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-19
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-19
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-18
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-18
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-18
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-18
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-18
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		7e-18
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-18
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-18
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-17
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-17
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-17
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-17
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-17
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-17
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-17
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-17
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-17
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		5e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-17
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-17
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-16
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-16
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-16
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-16
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-16
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-16
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-16
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-16
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-16
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-16
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		6e-16
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-16
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-16
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-16
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-16
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		8e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-16
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-16
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-16
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-15
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-15
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-15
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-15
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-15
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-15
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-15
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-15
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-15
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-15
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-15
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-15
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-15
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-15
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		4e-15
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-15
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-15
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		7e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		9e-15
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-15
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-15
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-14
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-14
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-14
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-14
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-14
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-14
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-14
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		6e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		7e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-14
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		9e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		9e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-13
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-13
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-13
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-13
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-13
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-13
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-13
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-13
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-13
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		5e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-13
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		6e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-13
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		6e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		6e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		7e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		7e-13
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-13
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		7e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-13
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		7e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		7e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		7e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		7e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		7e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		8e-13
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		8e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		8e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		8e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		9e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		9e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		9e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-12
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-12
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-12
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-12
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-12
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-12
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		1e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-12
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-12
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-12
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-12
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-12
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-12
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-12
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-12
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-12
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-12
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-12
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-12
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-12
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-12
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-12
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-12
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-12
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-12
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-12
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-12
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-12
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-12
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-12
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-12
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-12
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		5e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		5e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		7e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		7e-12
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		9e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-12
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-11
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-11
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-11
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-11
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-11
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-11
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		4e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		5e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		5e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-11
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		6e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		6e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		6e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		6e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		6e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		6e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		7e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		9e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-10
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-10
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-10
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-10
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-10
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-10
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-10
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		3e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		4e-10
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		6e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		7e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		7e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-10
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-09
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-09
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-09
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-09
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-09
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-09
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-09
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3soa_A	444	Full-Length Human Camkii Length = 444		3e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		3e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		6e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		6e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		8e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-09
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		9e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		1e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		1e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-08
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-08
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-08
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-08
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-08
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		3e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-08
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-08
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		4e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		4e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-08
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		5e-08
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-08
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-08
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-08
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-08
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-08
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		8e-08
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-08
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-08
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		8e-08
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		8e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-08
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-08
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-08
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		9e-08
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		9e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		1e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-07
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-07
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-07
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-07
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		2e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		2e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		3e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-07
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-07
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-07
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-07
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		6e-07
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		6e-07
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-07
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		6e-07
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-07
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		6e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		7e-07
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-07
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-07
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-07
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-07
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		8e-07
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		8e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		8e-07
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-07
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-07
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-07
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-07
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-07
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-07

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 150/274 (54%), Gaps = 24/274 (8%)
Query: 196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +++++EKIG G+   ++RA W G DVAVK +    FH     V  F +EV  + R RH  
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--VNEFLREVAIMKRLRHPN 95
Query: 256 VLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           ++  MGA  +PP    +VTE L   +L   LH  G++ + +          RL+ A ++A
Sbjct: 96  IVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDE-------RRRLSMAYDVA 147
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVY 369
           + M YLH + P ++HR+LK  N+ +D    V++ DFG +R     FLS    A  GT  +
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA--GTPEW 205
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           MAPEV++ EP +EKSDVYSFG+IL E+ T   P+   +  PA++   VG    R  +P  
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 430 -DGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
            + Q+  +IE     W  +   RPSF++I   L+
Sbjct: 264 LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  152 bits (384), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 149/274 (54%), Gaps = 24/274 (8%)
Query: 196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +++++EKIG G+   ++RA W G DVAVK +    FH     V  F +EV  + R RH  
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAER--VNEFLREVAIMKRLRHPN 95
Query: 256 VLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           ++  MGA  +PP    +VTE L   +L   LH  G++ + +          RL+ A ++A
Sbjct: 96  IVLFMGAVTQPPNLS-IVTEYLSRGSLYRLLHKSGAREQLDE-------RRRLSMAYDVA 147
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVY 369
           + M YLH + P ++HRDLK  N+ +D    V++ DFG +R     FL     A  GT  +
Sbjct: 148 KGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAA--GTPEW 205
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
           MAPEV++ EP +EKSDVYSFG+IL E+ T   P+   +  PA++   VG    R  +P  
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPRN 263
Query: 430 -DGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
            + Q+  +IE     W  +   RPSF++I   L+
Sbjct: 264 LNPQVAAIIE---GCWTNEPWKRPSFATIMDLLR 294

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 138/273 (50%), Gaps = 28/273 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           ID KEI+++E +G+G    + +A WR  DVA+K I       +E+    F  E+  LSR 
Sbjct: 5   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI------ESESERKAFIVELRQLSRV 58
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF--EERLA 308
            H  +++L GACL P     LV E   G +L   LHG           PLP +     ++
Sbjct: 59  NHPNIVKLYGACLNPVC---LVMEYAEGGSLYNVLHGAE---------PLPYYTAAHAMS 106
Query: 309 RALEIAQAMQYLHEQKPK-VIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMALTGT 366
             L+ +Q + YLH  +PK +IHRDLKP N+ L     V +I DFG A  +        G+
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 166
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             +MAPEV +   YSEK DV+S+GIIL E+IT   P+ E      +I   V  G  RP L
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPL 225
Query: 427 PEEDGQLRELIE-LICLSWDGDASVRPSFSSIT 458
            +    L + IE L+   W  D S RPS   I 
Sbjct: 226 IK---NLPKPIESLMTRCWSKDPSQRPSMEEIV 255

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 101/273 (36%), Positives = 138/273 (50%), Gaps = 28/273 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           ID KEI+++E +G+G    + +A WR  DVA+K I       +E+    F  E+  LSR 
Sbjct: 6   IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI------ESESERKAFIVELRQLSRV 59
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF--EERLA 308
            H  +++L GACL P     LV E   G +L   LHG           PLP +     ++
Sbjct: 60  NHPNIVKLYGACLNPVC---LVMEYAEGGSLYNVLHGAE---------PLPYYTAAHAMS 107
Query: 309 RALEIAQAMQYLHEQKPK-VIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMALTGT 366
             L+ +Q + YLH  +PK +IHRDLKP N+ L     V +I DFG A  +        G+
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 167
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             +MAPEV +   YSEK DV+S+GIIL E+IT   P+ E      +I   V  G  RP L
Sbjct: 168 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPL 226
Query: 427 PEEDGQLRELIE-LICLSWDGDASVRPSFSSIT 458
            +    L + IE L+   W  D S RPS   I 
Sbjct: 227 IK---NLPKPIESLMTRCWSKDPSQRPSMEEIV 256

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 93/294 (31%), Positives = 150/294 (51%), Gaps = 31/294 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 5   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 61
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH   ++   ++++ +      
Sbjct: 62  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHASETKFEMKKLIDI------ 113
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + A+ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 114 ---ARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFE 168
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 169 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEM-VG 227
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLKNIQMKVT 469
            G L P L +      + ++ +   CL    D   RPSF  I   ++ +  +++
Sbjct: 228 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE--RPSFPRILAEIEELARELS 279

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 94/299 (31%), Positives = 153/299 (51%), Gaps = 31/299 (10%)
Query: 183 SQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFA 242
           S+   + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F 
Sbjct: 12  SRDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFK 68
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
            EV  L + RH  +L  MG   +P     +VT+   G++L   LH   ++   ++++ + 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHASETKFEMKKLIDI- 125
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA----RFLS 357
                   A + A+ M YLH +   +IHRDLK +NIFL +   V+I DFG A    R+  
Sbjct: 126 --------ARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 358 DGEMA-LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI 413
             +   L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 414 AMEVGEGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLKNIQMKVT 469
            M VG G L P L +      + ++ +   CL    D   RPSF  I   ++ +  +++
Sbjct: 236 EM-VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE--RPSFPRILAEIEELARELS 291

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 94/294 (31%), Positives = 149/294 (50%), Gaps = 31/294 (10%)
Query: 183 SQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFA 242
           S+   + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F 
Sbjct: 12  SRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFK 68
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
            EV  L + RH  +L  MG    P     +VT+   G++L   LH   ++   ++++ + 
Sbjct: 69  NEVGVLRKTRHVNILLFMGYSTAPQLA--IVTQWCEGSSLYHHLHASETKFEMKKLIDI- 125
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA----RFLS 357
                   A + A+ M YLH +   +IHRDLK +NIFL +   V+I DFG A    R+  
Sbjct: 126 --------ARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175
Query: 358 DGEMA-LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI 413
             +   L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 414 AMEVGEGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLKNI 464
            M VG G L P L +      + ++ +   CL    D   RPSF  I   ++ +
Sbjct: 236 EM-VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDE--RPSFPRILAEIEEL 286

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  123 bits (308), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 28  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 84
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 85  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 136
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 137 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 191
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 192 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 250
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 251 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 295

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 85
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 86  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 137
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 138 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 192
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 251
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 252 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 296

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 3   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 59
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 60  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 111
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 112 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 166
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 167 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 225
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 226 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 270

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 6   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 62
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 63  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 114
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 115 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 228
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 229 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 273

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  122 bits (307), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 57
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 58  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 109
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 110 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 223
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 268

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 146/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 6   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 62
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 63  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 114
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 115 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 170 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 228
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 229 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 273

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 147/287 (51%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 29  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 85
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 86  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 137
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA----RFLSDGEMA 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A    R+    +  
Sbjct: 138 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 193 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 251
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 252 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 296

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 147/287 (51%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 21  DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 77
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 78  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 129
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA----RFLSDGEMA 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A    R+    +  
Sbjct: 130 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 185 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 243
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 244 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 288

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 145/287 (50%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 57
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG    P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 58  LRKTRHVNILLFMGYSTAPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 109
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---- 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S    +    
Sbjct: 110 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 223
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 268

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 147/287 (51%), Gaps = 31/287 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           + W I   +I + ++IG G+   +Y+  W G DVAVK +  +        +  F  EV  
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKML--NVTAPTPQQLQAFKNEVGV 57
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           L + RH  +L  MG   +P     +VT+   G++L   LH + ++    +++ +      
Sbjct: 58  LRKTRHVNILLFMGYSTKPQLA--IVTQWCEGSSLYHHLHIIETKFEMIKLIDI------ 109
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA----RFLSDGEMA 362
              A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A    R+    +  
Sbjct: 110 ---ARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 164
Query: 363 -LTGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
            L+G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   + +   I M VG
Sbjct: 165 QLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM-VG 223
Query: 419 EGKLRPALPEEDGQLRELIELI---CLSWDGDASVRPSFSSITCSLK 462
            G L P L +      + ++ +   CL    D   RP F  I  S++
Sbjct: 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDE--RPLFPQILASIE 268

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 139/283 (49%), Gaps = 25/283 (8%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           ID  E+ L+E IG G    +YRA W G +VAVK    D        +    QE    +  
Sbjct: 4   IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           +H  ++ L G CL+ P    ++    G  L   L G    +R      +PP +  +  A+
Sbjct: 64  KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG----KR------IPP-DILVNWAV 112
Query: 312 EIAQAMQYLHEQK-PKVIHRDLKPSNIFLD--------DAKHVRIADFGHAR-FLSDGEM 361
           +IA+ M YLH++    +IHRDLK SNI +           K ++I DFG AR +    +M
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKM 172
Query: 362 ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           +  G + +MAPEVI+   +S+ SDV+S+G++L E++TG  P+   D     +A+  G   
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----GLAVAYGVAM 228
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            + ALP          +L+   W+ D   RPSF++I   L  I
Sbjct: 229 NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 90/251 (35%), Positives = 129/251 (51%), Gaps = 36/251 (14%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCI-----YPDFFHTNENAVTFFAQE 244
           W I+  E+ L  +IG G+   +Y+  W G DVAVK +      P+ F         F  E
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQA-------FRNE 82
Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
           V  L + RH  +L  MG   +      +VT+   G++L + LH    Q  K +M  L   
Sbjct: 83  VAVLRKTRHVNILLFMGYMTKDNLA--IVTQWCEGSSLYKHLH---VQETKFQMFQL--- 134
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEM 361
              +  A + AQ M YLH +   +IHRD+K +NIFL +   V+I DFG A   S   G  
Sbjct: 135 ---IDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189
Query: 362 AL---TGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
            +   TG+ ++MAPEVI+ +   P+S +SDVYS+GI+L E++TG  PY   + +   I M
Sbjct: 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM 249
Query: 416 EVGEGKLRPAL 426
            VG G   P L
Sbjct: 250 -VGRGYASPDL 259

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 138/282 (48%), Gaps = 27/282 (9%)
Query: 196 EIDLQEKIGQGTTANIY--RAIWRGLDVAVKC-IYPDFFHTNENAVTF--FAQEVDTLSR 250
           EI+ +++IG+G    ++  R +     VA+K  I  D     E    F  F +EV  +S 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
             H  +++L G    PP    +V E +         G    R  ++  P+  +  +L   
Sbjct: 80  LNHPNIVKLYGLMHNPPR---MVMEFVPC-------GDLYHRLLDKAHPIK-WSVKLRLM 128
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHV--RIADFGHARFLSDGEMALTG 365
           L+IA  ++Y+  Q P ++HRDL+  NIFL   D+   V  ++ADFG ++        L G
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLG 188
Query: 366 TFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            F +MAPE I  E   Y+EK+D YSF +IL  I+TG  P+ E  Y   K    + E  LR
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 424 PALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P +PE+   +LR +IE   L W GD   RP FS I   L  +
Sbjct: 249 PTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  112 bits (280), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 138/282 (48%), Gaps = 27/282 (9%)
Query: 196 EIDLQEKIGQGTTANIY--RAIWRGLDVAVKC-IYPDFFHTNENAVTF--FAQEVDTLSR 250
           EI+ +++IG+G    ++  R +     VA+K  I  D     E    F  F +EV  +S 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
             H  +++L G    PP    +V E +         G    R  ++  P+  +  +L   
Sbjct: 80  LNHPNIVKLYGLMHNPPR---MVMEFVPC-------GDLYHRLLDKAHPIK-WSVKLRLM 128
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHV--RIADFGHARFLSDGEMALTG 365
           L+IA  ++Y+  Q P ++HRDL+  NIFL   D+   V  ++ADFG ++        L G
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLG 188
Query: 366 TFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            F +MAPE I  E   Y+EK+D YSF +IL  I+TG  P+ E  Y   K    + E  LR
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 424 PALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P +PE+   +LR +IE   L W GD   RP FS I   L  +
Sbjct: 249 PTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 92/282 (32%), Positives = 137/282 (48%), Gaps = 27/282 (9%)
Query: 196 EIDLQEKIGQGTTANIY--RAIWRGLDVAVKC-IYPDFFHTNENAVTF--FAQEVDTLSR 250
           EI+ +++IG+G    ++  R +     VA+K  I  D     E    F  F +EV  +S 
Sbjct: 20  EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSN 79
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
             H  +++L G    PP    +V E +         G    R  ++  P+  +  +L   
Sbjct: 80  LNHPNIVKLYGLMHNPPR---MVMEFVPC-------GDLYHRLLDKAHPIK-WSVKLRLM 128
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHV--RIADFGHARFLSDGEMALTG 365
           L+IA  ++Y+  Q P ++HRDL+  NIFL   D+   V  ++ADF  ++        L G
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLG 188
Query: 366 TFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            F +MAPE I  E   Y+EK+D YSF +IL  I+TG  P+ E  Y   K    + E  LR
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 424 PALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P +PE+   +LR +IE   L W GD   RP FS I   L  +
Sbjct: 249 PTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           ++ W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E
Sbjct: 3   LDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKE 57
Query: 245 VDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
              +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +   
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVSAVV--- 110
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMA 362
              L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A
Sbjct: 111 --LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166
Query: 363 LTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
             G      + APE +    +S KSDV++FG++L EI T G  PY   D  P+++  E+ 
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--PSQV-YELL 223
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           E   R   PE  G   ++ EL+   W  + S RPSF+ I
Sbjct: 224 EKDYRMERPE--GCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 140/279 (50%), Gaps = 29/279 (10%)
Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           ++ W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKE 57
Query: 245 VDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
              +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +   
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVSAVV--- 110
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMA 362
              L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A
Sbjct: 111 --LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTA 166
Query: 363 LTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
             G      + APE +    +S KSDV++FG++L EI T G  PY   D  P+++  E+ 
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--PSQV-YELL 223
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           E   R   PE  G   ++ EL+   W  + S RPSF+ I
Sbjct: 224 EKDYRMERPE--GCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 142/298 (47%), Gaps = 51/298 (17%)
Query: 179 AVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNEN 236
           A+  S    + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E 
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE- 60
Query: 237 AVTFFAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
               F +E   +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E
Sbjct: 61  ----FLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQE 112
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
               +      L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R 
Sbjct: 113 VNAVV-----LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165
Query: 356 LS-DGEMALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY------- 403
           ++ D   A  G      + APE +    +S KSDV++FG++L EI T G  PY       
Sbjct: 166 MTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               +EKDY+     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 226 VYELLEKDYR-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 267

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 142/298 (47%), Gaps = 51/298 (17%)
Query: 179 AVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNEN 236
           A+  S    + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E 
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE- 60
Query: 237 AVTFFAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
               F +E   +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E
Sbjct: 61  ----FLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQE 112
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
               +      L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R 
Sbjct: 113 VSAVV-----LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165
Query: 356 LS-DGEMALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY------- 403
           ++ D   A  G      + APE +    +S KSDV++FG++L EI T G  PY       
Sbjct: 166 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               +EKDY+     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 226 VYELLEKDYR-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 92/298 (30%), Positives = 142/298 (47%), Gaps = 51/298 (17%)
Query: 179 AVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNEN 236
           A+  S    + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E 
Sbjct: 2   AMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE- 60
Query: 237 AVTFFAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
               F +E   +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E
Sbjct: 61  ----FLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQE 112
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
               +      L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R 
Sbjct: 113 VNAVV-----LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 165
Query: 356 LS-DGEMALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY------- 403
           ++ D   A  G      + APE +    +S KSDV++FG++L EI T G  PY       
Sbjct: 166 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 225
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               +EKDY+     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 226 VYELLEKDYR-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 139/279 (49%), Gaps = 29/279 (10%)
Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           ++ W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKE 57
Query: 245 VDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
              +   +H  ++QL+G C  EPP+  +++ E +  T    L  L    R+E    +   
Sbjct: 58  AAVMKEIKHPNLVQLLGVCTREPPF--YIIIEFM--TYGNLLDYLRECNRQEVSAVV--- 110
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMA 362
              L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A
Sbjct: 111 --LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTA 166
Query: 363 LTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
             G      + APE +    +S KSDV++FG++L EI T G  PY   D  P+++  E+ 
Sbjct: 167 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--PSQV-YELL 223
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           E   R   PE  G   ++ EL+   W  + S RPSF+ I
Sbjct: 224 EKDYRMERPE--GCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 60
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVSAVV---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 113 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 140/294 (47%), Gaps = 51/294 (17%)
Query: 183 SQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF 240
           S    + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----- 60
Query: 241 FAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
           F +E   +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAV 116
Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-D 358
           +      L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D
Sbjct: 117 V-----LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 359 GEMALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----------- 403
              A  G      + APE +    +S KSDV++FG++L EI T G  PY           
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 229
Query: 404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +EKDY+     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 LEKDYR-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 60
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVSAVV---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 113 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 262

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 61
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 113
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 114 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAP 170
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 230
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 231 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 62
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 114
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 115 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 171
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 231
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 232 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 62
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 114
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 115 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAP 171
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 231
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 232 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 8   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 62
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 63  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 114
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 115 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 171
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 172 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 231
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 232 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 19  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 73
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 74  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 125
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 126 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 182
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 183 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 242
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 243 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 60
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 113 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 262

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 138/287 (48%), Gaps = 51/287 (17%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E   
Sbjct: 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAV 269
Query: 248 LSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +      
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVSAVV-----L 320
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTG 365
           L  A +I+ AM+YL  +K   IHR+L   N  + +   V++ADFG +R ++ D   A  G
Sbjct: 321 LYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKP 410
                 + APE +    +S KSDV++FG++L EI T G  PY           +EKDY+ 
Sbjct: 379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR- 437
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 438 ----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 469

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 64
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 65  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 116
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 117 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 233
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 234 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 90/289 (31%), Positives = 139/289 (48%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 60
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E    +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVV---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 113 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 262

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 137/280 (48%), Gaps = 23/280 (8%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +GW ++ KE+ L + IG+G   ++    +RG  VAVKCI       N+     F  E   
Sbjct: 14  SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------KNDATAQAFLAEASV 67
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEER 306
           +++ RH  ++QL+G  +E     ++VTE +   +L ++L   G        +        
Sbjct: 68  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-------- 119
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           L  +L++ +AM+YL  +    +HRDL   N+ + +    +++DFG  +  S  +      
Sbjct: 120 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 177
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE ++ + +S KSDV+SFGI+L EI + G  PY     K     +E G     P 
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP- 236
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
               DG    + E++   W  DA++RPSF  +   L++I+
Sbjct: 237 ----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 91/288 (31%), Positives = 139/288 (48%), Gaps = 53/288 (18%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E   
Sbjct: 254 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAV 308
Query: 248 LSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKE-RMVPLPPFEE 305
           +   +H  ++QL+G C  EPP+  +++TE +  T    L  L    R+E   V L     
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPF--YIITEFM--TYGNLLDYLRECNRQEVNAVVL----- 359
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALT 364
            L  A +I+ AM+YL  +K   IHR+L   N  + +   V++ADFG +R ++ D   A  
Sbjct: 360 -LYMATQISSAMEYL--EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 416
Query: 365 GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYK 409
           G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY+
Sbjct: 417 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR 476
Query: 410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 477 -----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 508

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 80/280 (28%), Positives = 136/280 (48%), Gaps = 23/280 (8%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +GW ++ KE+ L + IG+G   ++    +RG  VAVKCI       N+     F  E   
Sbjct: 5   SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------KNDATAQAFLAEASV 58
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEER 306
           +++ RH  ++QL+G  +E     ++VTE +   +L ++L   G        +        
Sbjct: 59  MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-------- 110
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           L  +L++ +AM+YL  +    +HRDL   N+ + +    +++DFG  +  S  +      
Sbjct: 111 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 168
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE ++   +S KSDV+SFGI+L EI + G  PY     K     +E G     P 
Sbjct: 169 VKWTAPEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP- 227
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
               DG    + E++   W  DA++RPSF  +   L++I+
Sbjct: 228 ----DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 139/294 (47%), Gaps = 51/294 (17%)
Query: 183 SQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF 240
           S    + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     
Sbjct: 6   SSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----- 60
Query: 241 FAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
           F +E   +   +H  ++QL+G C  EPP+  +++ E +  T    L  L    R+E    
Sbjct: 61  FLKEAAVMKEIKHPNLVQLLGVCTREPPF--YIIIEFM--TYGNLLDYLRECNRQEVNAV 116
Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-D 358
           +      L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D
Sbjct: 117 V-----LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 359 GEMALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----------- 403
              A  G      + APE +    +S KSDV++FG++L EI T G  PY           
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 229
Query: 404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +EKDY+     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 LEKDYR-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 138/289 (47%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 7   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 61
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++ E +  T    L  L    R+E    +    
Sbjct: 62  AVMKEIKHPNLVQLLGVCTREPPF--YIIIEFM--TYGNLLDYLRECNRQEVNAVV---- 113
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 114 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAH 170
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 171 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 230
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 231 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 263

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 138/289 (47%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 60
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++ E +  T    L  L    R+E    +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF--YIIIEFM--TYGNLLDYLRECNRQEVSAVV---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 113 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 89/289 (30%), Positives = 138/289 (47%), Gaps = 51/289 (17%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           + W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E 
Sbjct: 6   DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEA 60
Query: 246 DTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             +   +H  ++QL+G C  EPP+  +++ E +  T    L  L    R+E    +    
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREPPF--YIIIEFM--TYGNLLDYLRECNRQEVSAVV---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMAL 363
             L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A 
Sbjct: 113 -LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           +     ME  EG      PE      ++ EL+   W  + S RPSF+ I
Sbjct: 230 R-----MERPEG-----CPE------KVYELMRACWQWNPSDRPSFAEI 262

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 136/280 (48%), Gaps = 23/280 (8%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +GW ++ KE+ L + IG+G   ++    +RG  VAVKCI       N+     F  E   
Sbjct: 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------KNDATAQAFLAEASV 239
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEER 306
           +++ RH  ++QL+G  +E     ++VTE +   +L ++L   G        +        
Sbjct: 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL-------- 291
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           L  +L++ +AM+YL  +    +HRDL   N+ + +    +++DFG  +  S  +      
Sbjct: 292 LKFSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP 349
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE ++ + +S KSDV+SFGI+L EI + G  PY     K     +E G     P 
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP- 408
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
               DG    + +++   W  DA+ RP+F  +   L++I+
Sbjct: 409 ----DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 134/277 (48%), Gaps = 29/277 (10%)
Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           M+ W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEE-----FLKE 78
Query: 245 VDTLSRQRHRFVLQLMGAC-LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
              +   +H  ++QL+G C LEPP+  ++VTE +       L  L    R+E    +   
Sbjct: 79  AAVMKEIKHPNLVQLLGVCTLEPPF--YIVTEYM--PYGNLLDYLRECNREEVTAVV--- 131
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMA 362
              L  A +I+ AM+YL  +K   IHRDL   N  + +   V++ADFG +R ++ D   A
Sbjct: 132 --LLYMATQISSAMEYL--EKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTA 187
Query: 363 LTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
             G      + APE +    +S KSDV++FG++L EI T G  PY   D       +E G
Sbjct: 188 HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKG 247
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
               +P     +G   ++ EL+   W    + RPSF+
Sbjct: 248 YRMEQP-----EGCPPKVYELMRACWKWSPADRPSFA 279

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 23/278 (8%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W ++ KE+ L + IG+G   ++    +RG  VAVKCI       N+     F  E   ++
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------KNDATAQAFLAEASVMT 54
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           + RH  ++QL+G  +E     ++VTE +   +L ++L   G        +        L 
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL--------LK 106
Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV 368
            +L++ +AM+YL  +    +HRDL   N+ + +    +++DFG  +  S  +        
Sbjct: 107 FSLDVCEAMEYL--EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK 164
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
           + APE ++ + +S KSDV+SFGI+L EI + G  PY     K     +E G     P   
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP--- 221
Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
             DG    + E++   W  DA++RPSF  +   L++I+
Sbjct: 222 --DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 83/293 (28%), Positives = 142/293 (48%), Gaps = 38/293 (12%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W I  +++++ E IG+G    +Y   W G +VA++ I  D    NE+ +  F +EV    
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLI--DIERDNEDQLKAFKREVMAYR 84
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           + RH  V+  MGAC+ PP+   + +   G TL        S  R  ++V       ++A+
Sbjct: 85  QTRHENVVLFMGACMSPPHLAIITSLCKGRTLY-------SVVRDAKIVLDVNKTRQIAQ 137
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG--------HARFLSDGEM 361
             EI + M YLH +   ++H+DLK  N+F D+ K V I DFG         A    D   
Sbjct: 138 --EIVKGMGYLHAK--GILHKDLKSKNVFYDNGK-VVITDFGLFSISGVLQAGRREDKLR 192
Query: 362 ALTGTFVYMAPEVIQ---------CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK 412
              G   ++APE+I+           P+S+ SDV++ G I  E+     P+     +PA+
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF---KTQPAE 249
Query: 413 -IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            I  ++G G ++P L  + G  +E+ +++   W  +   RP+F+ +   L+ +
Sbjct: 250 AIIWQMGTG-MKPNL-SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G +G   R  ++V +    
Sbjct: 66  VMKKIRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 2   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 56
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G +G   R  ++V +    
Sbjct: 57  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 110
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 111 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 163
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 164 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 217
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 218 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 262

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +    L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 133/287 (46%), Gaps = 39/287 (13%)
Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVDT 247
            W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE   
Sbjct: 1   AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQV 55
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFEE 305
           + + RH  ++QL     E P   ++VTE +   +L ++L G +G   R  ++V +     
Sbjct: 56  MKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM----- 108
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALT 364
               A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A  
Sbjct: 109 ----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 162
Query: 365 GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE- 419
           G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV + 
Sbjct: 163 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLDQ 216
Query: 420 ---GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
              G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 217 VERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 260

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL  +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 134/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P        +   F QE  
Sbjct: 178 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-----GNMSPEAFLQEAQ 232
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G +G   R  ++V +    
Sbjct: 233 VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 286
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG  R + D E  A 
Sbjct: 287 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTAR 339
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 340 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 393
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 394 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 438

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++V E +   +L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++V E +   +L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++V E +   +L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 231
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G  G   R  ++V +    
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM---- 285
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 286 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 392
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 393 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 231
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G  G   R  ++V +    
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM---- 285
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 286 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 392
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 393 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 11  DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 65
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++V E +    L ++L G +G   R  ++V +    
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI--YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDM---- 119
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 120 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 172
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 173 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 226
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  D   RP+F  +   L++
Sbjct: 227 QVERGYRMPCPPECPESLH---DLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 314
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G  G   R  ++V +    
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM---- 368
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MAL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 369 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 475
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 476 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 520

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 4   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 58
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G  G   R  ++V +    
Sbjct: 59  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM---- 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 113 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 165
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 166 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 219
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 220 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 264

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 130/285 (45%), Gaps = 35/285 (12%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTF--FAQEVD 246
           W IDP E+   ++IG G    ++   W   D VA+K I        E A++   F +E +
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-------REGAMSEEDFIEEAE 55
Query: 247 TLSRQRHRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFE 304
            + +  H  ++QL G CLE  P    LVTE +        HG L    R +R   L   E
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPIC--LVTEFME-------HGCLSDYLRTQR--GLFAAE 104
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMAL 363
             L   L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF L D   + 
Sbjct: 105 TLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 162
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
           TGT     + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G 
Sbjct: 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222
Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +P L         + +++   W      RP+FS +   L  I
Sbjct: 223 RLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 132/288 (45%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 1   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 55
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P    +VTE +   +L ++L G  G   R  ++V +    
Sbjct: 56  VMKKLRHEKLVQLYAVVSEEPIX--IVTEYMSKGSLLDFLKGETGKYLRLPQLVDM---- 109
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 110 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTAR 162
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 163 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 216
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 217 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 261

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 62
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G  G   R  ++V +    
Sbjct: 63  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM---- 116
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                + +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 117 -----SAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 170 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 223
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 224 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 8   DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 62
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++VTE +   +L ++L G  G   R  ++V +    
Sbjct: 63  VMKKLRHEKLVQLYAVVSEEPI--YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDM---- 116
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                + +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 117 -----SAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTAR 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 170 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 223
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 224 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 132/288 (45%), Gaps = 39/288 (13%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE  
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQ 231
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHG-LGSQRRKERMVPLPPFE 304
            + + RH  ++QL     E P   ++V E +   +L ++L G  G   R  ++V +    
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPI--YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDM---- 285
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
                A +IA  M Y+  ++   +HRDL+ +NI + +    ++ADFG AR + D E  A 
Sbjct: 286 -----AAQIASGMAYV--ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE      ++ KSDV+SFGI+L E+ T G  PY      P  +  EV +
Sbjct: 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY------PGMVNREVLD 392
Query: 420 ----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
               G   P  PE    L    +L+C  W  +   RP+F  +   L++
Sbjct: 393 QVERGYRMPCPPECPESLH---DLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 85/285 (29%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTF--FAQEVD 246
           W IDP E+   ++IG G    ++   W   D VA+K I        E A++   F +E +
Sbjct: 5   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-------REGAMSEEDFIEEAE 57
Query: 247 TLSRQRHRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFE 304
            + +  H  ++QL G CLE  P    LV E +        HG L    R +R   L   E
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPIC--LVFEFME-------HGCLSDYLRTQR--GLFAAE 106
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMAL 363
             L   L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF L D   + 
Sbjct: 107 TLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS 164
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
           TGT     + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G 
Sbjct: 165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 224
Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +P L         + +++   W      RP+FS +   L  I
Sbjct: 225 RLYKPRLAS-----THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 67
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 68  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 117
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 118 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 173
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 231
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 232 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/293 (25%), Positives = 138/293 (47%), Gaps = 45/293 (15%)
Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEV 245
           M  W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E 
Sbjct: 1   MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEA 55
Query: 246 DTLSRQRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMV 298
             +    H  ++QL G C +  P +   ++TE +        L+E  H   +Q       
Sbjct: 56  KVMMNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ------- 105
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
                 + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R++ D
Sbjct: 106 ------QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 157
Query: 359 GEM--ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI 413
            E   ++   F   +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ 
Sbjct: 158 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSET 215
Query: 414 AMEVGEG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           A  + +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 216 AEHIAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 263

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 67
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 68  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 117
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 118 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 173
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 174 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 231
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 232 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 269

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 73
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 123
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 124 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV 179
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 237
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 238 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 73
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 74  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 123
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 124 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 179
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 237
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 238 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 275

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 113
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 114 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXV 169
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 227
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 228 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 113
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 114 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 227
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 228 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 134/280 (47%), Gaps = 33/280 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  K++ L EK+G G+   + R  W     + + VAVKC+ PD     E A+  F +EV+
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE-AMDDFIREVN 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +    HR +++L G  L PP +  +VTEL  LG+ L         + RK +   L    
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPPMK--MVTELAPLGSLL--------DRLRKHQGHFLLGTL 113
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMA 362
            R A  +++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L  +D    
Sbjct: 114 SRYA--VQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169
Query: 363 LTG----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
           +       F + APE ++   +S  SD + FG+ L E+ T G  P+I      ++I  ++
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI--GLNGSQILHKI 227
Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +   R   PE+  Q  ++  ++   W      RP+F ++
Sbjct: 228 DKEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVAL 265

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/285 (29%), Positives = 135/285 (47%), Gaps = 37/285 (12%)
Query: 180 VTVSQAKMNGWYIDPKEIDLQ-EKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFH 232
           V V    M     DP+E+  + E+IG+G+   +++    G+D      VA+K I      
Sbjct: 7   VAVQVPGMQNNIADPEELFTKLERIGKGSFGEVFK----GIDNRTQQVVAIKIID---LE 59
Query: 233 TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQR 292
             E+ +    QE+  LS+    +V +  G+ L+   + W++ E LG          GS  
Sbjct: 60  EAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGS-KLWIIMEYLGG---------GSAL 109
Query: 293 RKERMVPLPPFEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
              R  P   F+  +A  L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG
Sbjct: 110 DLLRAGPFDEFQ--IATMLKEILKGLDYLHSEKK--IHRDIKAANVLLSEQGDVKLADFG 165
Query: 352 HARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            A  L+D ++      GT  +MAPEVIQ   Y  K+D++S GI   E+  G  P    D 
Sbjct: 166 VAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP--NSDM 223
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
            P ++   + +      + +     +E I+  CL  + D S RP+
Sbjct: 224 HPMRVLFLIPKNNPPTLVGDFTKSFKEFID-ACL--NKDPSFRPT 265

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVM 73
Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMVPLP 301
               H  ++QL G C +  P +   ++TE +        L+E  H   +Q          
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ---------- 120
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGE 360
              + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R+ L D E
Sbjct: 121 ---QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEE 175
Query: 361 MALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
            +  G+     +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEH 233
Query: 417 VGEG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           + +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 234 IAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 278

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 203 IGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           +G+G    +Y+  +  G  VAVK +  +     E     F  EV+ +S   HR +L+L G
Sbjct: 46  LGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ---FQTEVEMISMAVHRNLLRLRG 102
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE--ERLARALEIAQAMQY 319
            C+ P  R  +   +   ++   L        +ER    PP +  +R   AL  A+ + Y
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCL--------RERPESQPPLDWPKRQRIALGSARGLAY 154
Query: 320 LHEQ-KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGTFVYMAPEV 374
           LH+   PK+IHRD+K +NI LD+     + DFG A+ +   +     A+ GT  ++APE 
Sbjct: 155 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEY 214
Query: 375 IQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           +     SEK+DV+ +G++L E+ITG   +
Sbjct: 215 LSTGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 48/122 (39%), Positives = 75/122 (61%), Gaps = 9/122 (7%)
Query: 288 LGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV 345
           L S  RK +  P P     +A+  A E+  A++YLH +   +I+RDLKP NI LD   H+
Sbjct: 93  LFSLLRKSQRFPNP-----VAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHI 145
Query: 346 RIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           +I DFG A+++ D    L GT  Y+APEV+  +PY++  D +SFGI++ E++ G  P+ +
Sbjct: 146 KITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 205
Query: 406 KD 407
            +
Sbjct: 206 SN 207

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 129/286 (45%), Gaps = 35/286 (12%)
Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVT--FFAQEV 245
           G  IDP E+   ++IG G    ++   W   D VA+K I        E A++   F +E 
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-------REGAMSEEDFIEEA 53
Query: 246 DTLSRQRHRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPF 303
           + + +  H  ++QL G CLE  P    LV E +        HG L    R +R   L   
Sbjct: 54  EVMMKLSHPKLVQLYGVCLEQAPIC--LVFEFME-------HGCLSDYLRTQR--GLFAA 102
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMA 362
           E  L   L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF L D   +
Sbjct: 103 ETLLGMCLDVCEGMAYLEE--ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 160
Query: 363 LTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
            TGT     + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G
Sbjct: 161 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               +P L         + +++   W      RP+FS +   L  I
Sbjct: 221 FRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +
Sbjct: 3   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVM 57
Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMVPLP 301
               H  ++QL G C +  P +   ++TE +        L+E  H   +Q          
Sbjct: 58  MNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ---------- 104
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
              + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R++ D E 
Sbjct: 105 ---QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 159
Query: 362 --ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
             ++   F   +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  
Sbjct: 160 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEH 217
Query: 417 VGEG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           + +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 218 IAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 262

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVM 73
Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMVPLP 301
               H  ++QL G C +  P +   ++TE +        L+E  H   +Q          
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ---------- 120
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
              + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R++ D E 
Sbjct: 121 ---QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175
Query: 362 --ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
             ++   F   +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  
Sbjct: 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEH 233
Query: 417 VGEG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           + +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 234 IAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 278

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +
Sbjct: 10  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVM 64
Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMVPLP 301
               H  ++QL G C +  P +   ++TE +        L+E  H   +Q          
Sbjct: 65  MNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ---------- 111
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
              + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R++ D E 
Sbjct: 112 ---QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 166
Query: 362 --ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
             ++   F   +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  
Sbjct: 167 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEH 224
Query: 417 VGEG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           + +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 225 IAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 269

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 85/286 (29%), Positives = 129/286 (45%), Gaps = 35/286 (12%)
Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVT--FFAQEV 245
           G  IDP E+   ++IG G    ++   W   D VA+K I        E A++   F +E 
Sbjct: 1   GSVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-------REGAMSEEDFIEEA 53
Query: 246 DTLSRQRHRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPF 303
           + + +  H  ++QL G CLE  P    LV E +        HG L    R +R   L   
Sbjct: 54  EVMMKLSHPKLVQLYGVCLEQAPIC--LVFEFME-------HGCLSDYLRTQR--GLFAA 102
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMA 362
           E  L   L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF L D   +
Sbjct: 103 ETLLGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 160
Query: 363 LTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
            TGT     + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G
Sbjct: 161 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 220
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               +P L         + +++   W      RP+FS +   L  I
Sbjct: 221 FRLYKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 137/290 (47%), Gaps = 45/290 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +
Sbjct: 4   WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVM 58
Query: 249 SRQRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMVPLP 301
               H  ++QL G C +  P +   ++TE +        L+E  H   +Q          
Sbjct: 59  MNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ---------- 105
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
              + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R++ D E 
Sbjct: 106 ---QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 160
Query: 362 ALT-GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
             + G+     +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  
Sbjct: 161 TSSRGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEH 218
Query: 417 VGEG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           + +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 219 IAQGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 263

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 82/281 (29%), Positives = 126/281 (44%), Gaps = 31/281 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           IDP E+   ++IG G    ++   W   D VA+K I       ++     F +E + + +
Sbjct: 24  IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD-----FIEEAEVMMK 78
Query: 251 QRHRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLA 308
             H  ++QL G CLE  P    LV E +        HG L    R +R   L   E  L 
Sbjct: 79  LSHPKLVQLYGVCLEQAPIC--LVFEFME-------HGCLSDYLRTQR--GLFAAETLLG 127
Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMALTGT- 366
             L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF L D   + TGT 
Sbjct: 128 MCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK 185
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
               + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G    +
Sbjct: 186 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK 245
Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P L         + +++   W      RP+FS +   L  I
Sbjct: 246 PRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 203 IGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           +G+G    +Y+  +  G  VAVK +  +     E     F  EV+ +S   HR +L+L G
Sbjct: 38  LGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLRG 94
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE--ERLARALEIAQAMQY 319
            C+ P  R  +   +   ++   L        +ER    PP +  +R   AL  A+ + Y
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCL--------RERPESQPPLDWPKRQRIALGSARGLAY 146
Query: 320 LHEQ-KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGTFVYMAPEV 374
           LH+   PK+IHRD+K +NI LD+     + DFG A+ +   +     A+ G   ++APE 
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEY 206
Query: 375 IQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           +     SEK+DV+ +G++L E+ITG   +
Sbjct: 207 LSTGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/283 (29%), Positives = 128/283 (45%), Gaps = 35/283 (12%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTF--FAQEVDTL 248
           IDP E+   ++IG G    ++   W   D VA+K I        E A++   F +E + +
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-------REGAMSEEDFIEEAEVM 54
Query: 249 SRQRHRFVLQLMGACLE-PPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEER 306
            +  H  ++QL G CLE  P    LV E +        HG L    R +R   L   E  
Sbjct: 55  MKLSHPKLVQLYGVCLEQAPIC--LVFEFME-------HGCLSDYLRTQR--GLFAAETL 103
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMALTG 365
           L   L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF L D   + TG
Sbjct: 104 LGMCLDVCEGMAYLEE--ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161
Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           T     + +PEV     YS KSDV+SFG+++ E+ + G  PY  +        +  G   
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRL 221
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +P L         + +++   W      RP+FS +   L  I
Sbjct: 222 YKPRLAS-----THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 133/286 (46%), Gaps = 33/286 (11%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIW-RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L++K+G G    ++ A + +   VAVK + P        +V  F  E +
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEAN 235
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +   +H  +++L     + P   +++TE +  G+ L       GS++      PLP   
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQ------PLPKL- 286
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
             +  + +IA+ M ++ ++    IHRDL+ +NI +  +   +IADFG AR + D E  A 
Sbjct: 287 --IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE I    ++ KSDV+SFGI+L EI+T G  PY          A+E G 
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 402
Query: 420 GKLRPA-LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              RP   PE      EL  ++   W      RP+F  I   L + 
Sbjct: 403 RMPRPENCPE------ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 134/287 (46%), Gaps = 33/287 (11%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIW-RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L++K+G G    ++ A + +   VAVK + P        +V  F  E +
Sbjct: 8   DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEAN 62
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +   +H  +++L     + P   +++TE +  G+ L       GS++      PLP   
Sbjct: 63  VMKTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQ------PLPKL- 113
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
             +  + +IA+ M ++ ++    IHRDL+ +NI +  +   +IADFG AR + D E  A 
Sbjct: 114 --IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 169
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE I    ++ KSDV+SFGI+L EI+T G  PY          A+E G 
Sbjct: 170 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 229
Query: 420 GKLRPA-LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
              RP   PE      EL  ++   W      RP+F  I   L + +
Sbjct: 230 RMPRPENCPE------ELYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 130/284 (45%), Gaps = 29/284 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W +  + + L E++G G    ++   + G   VAVK +          +   F  E +
Sbjct: 6   DAWEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEAN 60
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            + + +H+ +++L     + P   +++TE +   +L ++L      +            +
Sbjct: 61  LMKQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INK 110
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALT 364
            L  A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  
Sbjct: 111 LLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTARE 168
Query: 365 GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
           G      + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G  
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR 228
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 229 MVRP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 128/289 (44%), Gaps = 44/289 (15%)
Query: 195 KEIDLQ--EKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           KE +L+  + +G G    +Y+ IW        + VA+K +      T   A   F  E  
Sbjct: 36  KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEAL 92
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLG-TTLKEWLH----GLGSQRRKERMVPLP 301
            ++   H  +++L+G CL P  +  LVT+L+    L E++H     +GSQ          
Sbjct: 93  IMASMDHPHLVRLLGVCLSPTIQ--LVTQLMPHGCLLEYVHEHKDNIGSQLL-------- 142
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
                L   ++IA+ M YL E++  ++HRDL   N+ +    HV+I DFG AR L   E 
Sbjct: 143 -----LNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 195
Query: 362 ALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
                       +MA E I    ++ +SDV+S+G+ + E++T G  PY     +     +
Sbjct: 196 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255
Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           E GE   +P +   D  +     ++   W  DA  RP F  +      +
Sbjct: 256 EKGERLPQPPICTIDVYM-----VMVKCWMIDADSRPKFKELAAEFSRM 299

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 192 IDPKEIDLQ-EKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQE 244
           +DP+E+  + EKIG+G+   +++    G+D      VA+K I        E+ +    QE
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFK----GIDNRTQKVVAIKIID---LEEAEDEIEDIQQE 55
Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
           +  LS+    +V +  G+ L+   + W++ E LG          GS    + + P P  E
Sbjct: 56  ITVLSQCDSPYVTKYYGSYLKDT-KLWIIMEYLGG---------GSAL--DLLEPGPLDE 103
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-- 361
            ++A  L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG A  L+D ++  
Sbjct: 104 TQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 161
Query: 362 -ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
               GT  +MAPEVI+   Y  K+D++S GI   E+  G  P+ E    P K+   + + 
Sbjct: 162 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--LHPMKVLFLIPKN 219
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
                       L+E +E  CL  + + S RP+
Sbjct: 220 NPPTLEGNYSKPLKEFVE-ACL--NKEPSFRPT 249

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 117/240 (48%), Gaps = 26/240 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W I+  + +LQE IG G TA +  A    +   VA+K I  +   T+ + +    +E+  
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQA 66
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           +S+  H  ++    + +      WLV +LL  G+ L    H +     K  ++     E 
Sbjct: 67  MSQCHHPNIVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD----ES 121
Query: 306 RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
            +A  L E+ + ++YLH  K   IHRD+K  NI L +   V+IADFG + FL+ G     
Sbjct: 122 TIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 360 ---EMALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
                   GT  +MAPEV+ Q   Y  K+D++SFGI   E+ TG  PY    Y P K+ M
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY--HKYPPMKVLM 237

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 136/288 (47%), Gaps = 45/288 (15%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVMMN 55
Query: 251 QRHRFVLQLMGACLE--PPYRGWLVTELLGT-----TLKEWLHGLGSQRRKERMVPLPPF 303
             H  ++QL G C +  P +   ++TE +        L+E  H   +Q            
Sbjct: 56  LSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQ------------ 100
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-- 361
            + L    ++ +AM+YL  +  + +HRDL   N  ++D   V+++DFG +R++ D E   
Sbjct: 101 -QLLEMCKDVCEAMEYL--ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157
Query: 362 ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
           ++   F   +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  + 
Sbjct: 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEHIA 215
Query: 419 EG--KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +G    RP L  E     ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 216 QGLRLYRPHLASE-----KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 136/273 (49%), Gaps = 37/273 (13%)
Query: 192 IDPKEIDLQ-EKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQE 244
           +DP+E+  + EKIG+G+    +  +++G+D      VA+K I        E+ +    QE
Sbjct: 23  MDPEELFTKLEKIGKGS----FGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQE 75
Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
           +  LS+    +V +  G+ L+   + W++ E LG          GS    + + P P  E
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDT-KLWIIMEYLGG---------GSAL--DLLEPGPLDE 123
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-- 361
            ++A  L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG A  L+D ++  
Sbjct: 124 TQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 181
Query: 362 -ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
               GT  +MAPEVI+   Y  K+D++S GI   E+  G  P+ E    P K+   + + 
Sbjct: 182 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--LHPMKVLFLIPKN 239
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
                       L+E +E  CL  + + S RP+
Sbjct: 240 NPPTLEGNYSKPLKEFVE-ACL--NKEPSFRPT 269

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/273 (30%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 192 IDPKEIDLQ-EKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQE 244
           +DP+E+  + EKIG+G+   +++    G+D      VA+K I        E+ +    QE
Sbjct: 3   LDPEELFTKLEKIGKGSFGEVFK----GIDNRTQKVVAIKIID---LEEAEDEIEDIQQE 55
Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
           +  LS+    +V +  G+ L+   + W++ E LG          GS    + + P P  E
Sbjct: 56  ITVLSQCDSPYVTKYYGSYLKDT-KLWIIMEYLGG---------GSAL--DLLEPGPLDE 103
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-- 361
            ++A  L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG A  L+D ++  
Sbjct: 104 TQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 161
Query: 362 -ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
               GT  +MAPEVI+   Y  K+D++S GI   E+  G  P+ E    P K+   + + 
Sbjct: 162 NXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--LHPMKVLFLIPKN 219
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
                       L+E +E  CL  + + S RP+
Sbjct: 220 NPPTLEGNYSKPLKEFVE-ACL--NKEPSFRPT 249

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 117/240 (48%), Gaps = 26/240 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W I+  + +LQE IG G TA +  A    +   VA+K I  +   T+ + +    +E+  
Sbjct: 5   WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELL---KEIQA 61
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           +S+  H  ++    + +      WLV +LL  G+ L    H +     K  ++     E 
Sbjct: 62  MSQCHHPNIVSYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD----ES 116
Query: 306 RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
            +A  L E+ + ++YLH  K   IHRD+K  NI L +   V+IADFG + FL+ G     
Sbjct: 117 TIATILREVLEGLEYLH--KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 360 ---EMALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
                   GT  +MAPEV+ Q   Y  K+D++SFGI   E+ TG  PY    Y P K+ M
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY--HKYPPMKVLM 232

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 122/279 (43%), Gaps = 42/279 (15%)
Query: 203 IGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +G G    +Y+ IW        + VA+K +      T   A   F  E   ++   H  +
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNET---TGPKANVEFMDEALIMASMDHPHL 79
Query: 257 LQLMGACLEPPYRGWLVTELLG-TTLKEWLH----GLGSQRRKERMVPLPPFEERLARAL 311
           ++L+G CL P  +  LVT+L+    L E++H     +GSQ               L   +
Sbjct: 80  VRLLGVCLSPTIQ--LVTQLMPHGCLLEYVHEHKDNIGSQLL-------------LNWCV 124
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +IA+ M YL E++  ++HRDL   N+ +    HV+I DFG AR L   E           
Sbjct: 125 QIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP 182
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             +MA E I    ++ +SDV+S+G+ + E++T G  PY     +     +E GE   +P 
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 242
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +   D  +     ++   W  DA  RP F  +      +
Sbjct: 243 ICTIDVYM-----VMVKCWMIDADSRPKFKELAAEFSRM 276

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 133/274 (48%), Gaps = 29/274 (10%)
Query: 187 MNGWYIDPKEIDLQ-EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQ 243
           M     DP+E+  + EKIG+G+   +++ I       VA+K I        E+ +    Q
Sbjct: 13  MQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID---LEEAEDEIEDIQQ 69
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           E+  LS+    +V +  G+ L+   + W++ E LG          GS    + + P P  
Sbjct: 70  EITVLSQCDSPYVTKYYGSYLKDT-KLWIIMEYLGG---------GSAL--DLLEPGPLD 117
Query: 304 EERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM- 361
           E ++A  L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG A  L+D ++ 
Sbjct: 118 ETQIATILREILKGLDYLHSEKK--IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 362 --ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
                GT  +MAPEVI+   Y  K+D++S GI   E+  G  P+ E    P K+   + +
Sbjct: 176 RNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE--LHPMKVLFLIPK 233
Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
                        L+E +E  CL  + + S RP+
Sbjct: 234 NNPPTLEGNYSKPLKEFVE-ACL--NKEPSFRPT 264

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 16  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 70
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 71  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 120
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 121 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 178
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 179 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 238
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 239 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 275

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 18  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 72
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 73  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 122
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 123 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 180
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 181 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 240
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 241 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 277

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 30/280 (10%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +++ L   +G+G    +Y  ++       ++VAVK    D    N+     F  E   + 
Sbjct: 24  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSEAVIMK 80
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
              H  +++L+G   E P   W++ EL      E  H L   +   +++ L      +  
Sbjct: 81  NLDHPHIVKLIGIIEEEP--TWIIMELY--PYGELGHYLERNKNSLKVLTL------VLY 130
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT--- 366
           +L+I +AM YL  +    +HRD+   NI +   + V++ DFG +R++ D +         
Sbjct: 131 SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 188
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              +M+PE I    ++  SDV+ F + + EI++ G  P+   + K     +E G+     
Sbjct: 189 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----- 243
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            LP+ D     L  L+   WD D S RP F+ + CSL ++
Sbjct: 244 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 283

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 68
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 69  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 118
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 119 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 176
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 236
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 237 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 17  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 71
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 72  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 121
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 122 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 179
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 180 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 239
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 240 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 276

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 30/280 (10%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +++ L   +G+G    +Y  ++       ++VAVK    D    N+     F  E   + 
Sbjct: 8   EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSEAVIMK 64
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
              H  +++L+G   E P   W++ EL      E  H L   +   +++ L      +  
Sbjct: 65  NLDHPHIVKLIGIIEEEP--TWIIMELY--PYGELGHYLERNKNSLKVLTL------VLY 114
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT--- 366
           +L+I +AM YL  +    +HRD+   NI +   + V++ DFG +R++ D +         
Sbjct: 115 SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 172
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              +M+PE I    ++  SDV+ F + + EI++ G  P+   + K     +E G+     
Sbjct: 173 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----- 227
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            LP+ D     L  L+   WD D S RP F+ + CSL ++
Sbjct: 228 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 127/280 (45%), Gaps = 30/280 (10%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +++ L   +G+G    +Y  ++       ++VAVK    D    N+     F  E   + 
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEK---FMSEAVIMK 68
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
              H  +++L+G   E P   W++ EL      E  H L   +   +++ L      +  
Sbjct: 69  NLDHPHIVKLIGIIEEEP--TWIIMELY--PYGELGHYLERNKNSLKVLTL------VLY 118
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT--- 366
           +L+I +AM YL  +    +HRD+   NI +   + V++ DFG +R++ D +         
Sbjct: 119 SLQICKAMAYL--ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL 176
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              +M+PE I    ++  SDV+ F + + EI++ G  P+   + K     +E G+     
Sbjct: 177 PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGD----- 231
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            LP+ D     L  L+   WD D S RP F+ + CSL ++
Sbjct: 232 RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 134/284 (47%), Gaps = 37/284 (13%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           +EI L +++G G    +    W+G  DVAVK I       +E     F QE  T+ +  H
Sbjct: 8   EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-----FFQEAQTMMKLSH 62
Query: 254 RFVLQLMGACLEPPYRGWLVTELLGT-TLKEWL--HGLGSQRRKERMVPLPPFEERLARA 310
             +++  G C    Y  ++VTE +    L  +L  HG G          L P  + L   
Sbjct: 63  PKLVKFYGVC-SKEYPIYIVTEYISNGCLLNYLRSHGKG----------LEP-SQLLEMC 110
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-LSDGEMALTGT--- 366
            ++ + M +L  +  + IHRDL   N  +D    V+++DFG  R+ L D  ++  GT   
Sbjct: 111 YDVCEGMAFL--ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK--LR 423
             + APEV     YS KSDV++FGI++ E+ + G  PY    Y  +++ ++V +G    R
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY--DLYTNSEVVLKVSQGHRLYR 226
Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
           P L  +      + +++   W      RP+F  +  S++ ++ K
Sbjct: 227 PHLASDT-----IYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 31/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L +++G G    ++   W G   VA+K + P            F +E   +
Sbjct: 4   WEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-----FLEEAQIM 58
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            + +H  ++QL     E P   ++VTE +  G+ L     G G   +   +V +      
Sbjct: 59  KKLKHDKLVQLYAVVSEEPI--YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDM------ 110
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTG 365
              A ++A  M Y+  ++   IHRDL+ +NI + +    +IADFG AR + D E  A  G
Sbjct: 111 ---AAQVAAGMAYI--ERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQG 165
Query: 366 T---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 + APE      ++ KSDV+SFGI+L E++T G  PY   + +  ++  +V  G 
Sbjct: 166 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGY 223
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
             P    +D  +  L EL+   W  D   RP+F  +   L++
Sbjct: 224 RMPC--PQDCPI-SLHELMIHCWKKDPEERPTFEYLQSFLED 262

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 3   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 57
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 58  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 107
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 108 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 165
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 166 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 225
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 226 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 262

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 68
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 69  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 118
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 119 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 176
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 236
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 237 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 62
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 63  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 112
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 113 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 231 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 10  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 64
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 65  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 114
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 115 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 172
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 173 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 232
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 233 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 269

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 13  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 67
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 68  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 117
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 118 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 175
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 176 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 235
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 236 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 272

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 9   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 63
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 64  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 113
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 114 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 171
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 172 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 231
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 232 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 62
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 63  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 112
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 113 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 170
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 231 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 62
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 63  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 112
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 113 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 231 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 124/296 (41%), Gaps = 39/296 (13%)
Query: 194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           P ++   E +G+G      +   R  +     +  +    +E     F +EV  +    H
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHR--ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
             VL+ +G   +     ++   + G TL+  +  + SQ          P+ +R++ A +I
Sbjct: 67  PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY---------PWSQRVSFAKDI 117
Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE------------- 360
           A  M YLH     +IHRDL   N  + + K+V +ADFG AR + D +             
Sbjct: 118 ASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 361 ----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
                 + G   +MAPE+I    Y EK DV+SFGI+L EII       + DY P    M+
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII--GRVNADPDYLPR--TMD 231
Query: 417 VG---EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
            G    G L    P         I + C   D D   RPSF  +   L+ ++M + 
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCC--DLDPEKRPSFVKLEHWLETLRMHLA 285

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 91/321 (28%), Positives = 150/321 (46%), Gaps = 46/321 (14%)
Query: 164 HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD--V 221
           H   +Q PL ++S + +  +  K + W ++ +++ L E+IG+G    ++    R  +  V
Sbjct: 84  HLLSTQQPLTKKSGVVLHRAVPK-DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142
Query: 222 AVKC----IYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRGWLVTE 275
           AVK     + PD           F QE   L +  H  +++L+G C +  P Y   +V E
Sbjct: 143 AVKSCRETLPPDLKAK-------FLQEARILKQYSHPNIVRLIGVCTQKQPIY---IVME 192
Query: 276 LL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKP 334
           L+ G     +L   G++ R + +         L    + A  M+YL  +    IHRDL  
Sbjct: 193 LVQGGDFLTFLRTEGARLRVKTL---------LQMVGDAAAGMEYLESKC--CIHRDLAA 241
Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMALTGTF-----VYMAPEVIQCEPYSEKSDVYSF 389
            N  + +   ++I+DFG +R  +DG  A +G        + APE +    YS +SDV+SF
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 390 GIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE--EDGQLRELIELICLSWDG 446
           GI+L E  + G  PY     +  +  +E G G+L    PE   D   R    L+   W  
Sbjct: 302 GILLWETFSLGASPYPNLSNQQTREFVEKG-GRL--PCPELCPDAVFR----LMEQCWAY 354
Query: 447 DASVRPSFSSITCSLKNIQMK 467
           +   RPSFS+I   L++I+ +
Sbjct: 355 EPGQRPSFSTIYQELQSIRKR 375

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 91/321 (28%), Positives = 150/321 (46%), Gaps = 46/321 (14%)
Query: 164 HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD--V 221
           H   +Q PL ++S + +  +  K + W ++ +++ L E+IG+G    ++    R  +  V
Sbjct: 84  HLLSTQQPLTKKSGVVLHRAVPK-DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142
Query: 222 AVKC----IYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRGWLVTE 275
           AVK     + PD           F QE   L +  H  +++L+G C +  P Y   +V E
Sbjct: 143 AVKSCRETLPPDLKAK-------FLQEARILKQYSHPNIVRLIGVCTQKQPIY---IVME 192
Query: 276 LL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKP 334
           L+ G     +L   G++ R + +         L    + A  M+YL  +    IHRDL  
Sbjct: 193 LVQGGDFLTFLRTEGARLRVKTL---------LQMVGDAAAGMEYLESKC--CIHRDLAA 241
Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMALTGTF-----VYMAPEVIQCEPYSEKSDVYSF 389
            N  + +   ++I+DFG +R  +DG  A +G        + APE +    YS +SDV+SF
Sbjct: 242 RNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSF 301
Query: 390 GIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE--EDGQLRELIELICLSWDG 446
           GI+L E  + G  PY     +  +  +E G G+L    PE   D   R    L+   W  
Sbjct: 302 GILLWETFSLGASPYPNLSNQQTREFVEKG-GRL--PCPELCPDAVFR----LMEQCWAY 354
Query: 447 DASVRPSFSSITCSLKNIQMK 467
           +   RPSFS+I   L++I+ +
Sbjct: 355 EPGQRPSFSTIYQELQSIRKR 375

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 129/282 (45%), Gaps = 29/282 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +          +   F  E + +
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-----KQGSMSPDAFLAEANLM 58
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 59  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLT--------INKLL 108
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGT 366
             A +IA+ M ++ E+    IHR+L+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 109 DMAAQIAEGMAFIEERN--YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 166
Query: 367 ---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E G   +
Sbjct: 167 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 226
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           RP     D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 227 RP-----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 263

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 130/282 (46%), Gaps = 35/282 (12%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIW-RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + + L++K+G G    ++ A + +   VAVK + P        +V  F  E +
Sbjct: 175 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP-----GSMSVEAFLAEAN 229
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +   +H  +++L     + P   +++TE +  G+ L       GS++      PLP   
Sbjct: 230 VMKTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFLKSDEGSKQ------PLPKL- 280
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT 364
             +  + +IA+ M ++ ++    IHRDL+ +NI +  +   +IADFG AR  +   +  T
Sbjct: 281 --IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT 336
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
                 APE I    ++ KSDV+SFGI+L EI+T G  PY          A+E G    R
Sbjct: 337 ------APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR 390
Query: 424 PA-LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P   PE      EL  ++   W      RP+F  I   L + 
Sbjct: 391 PENCPE------ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 136/277 (49%), Gaps = 45/277 (16%)
Query: 192 IDPKEIDLQ-EKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQE 244
           +DP+E+  + ++IG+G+   +Y+    G+D      VA+K I        E+ +    QE
Sbjct: 15  VDPEELFTKLDRIGKGSFGEVYK----GIDNHTKEVVAIKIID---LEEAEDEIEDIQQE 67
Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
           +  LS+    ++ +  G+ L+   + W++ E LG          GS    + + P P  E
Sbjct: 68  ITVLSQCDSPYITRYFGSYLKST-KLWIIMEYLGG---------GSAL--DLLKPGPLEE 115
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-- 361
             +A  L EI + + YLH ++   IHRD+K +N+ L +   V++ADFG A  L+D ++  
Sbjct: 116 TYIATILREILKGLDYLHSERK--IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR 173
Query: 362 -ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
               GT  +MAPEVI+   Y  K+D++S GI   E+  G  P    D  P ++   + + 
Sbjct: 174 NXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP--NSDLHPMRVLFLIPKN 231
Query: 421 KLRPALPEEDGQ----LRELIELICLSWDGDASVRPS 453
               + P  +GQ     +E +E  CL  + D   RP+
Sbjct: 232 ----SPPTLEGQHSKPFKEFVE-ACL--NKDPRFRPT 261

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 132/285 (46%), Gaps = 30/285 (10%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           + W I  + I L +++G G    ++   +     VAVK + P        +V  F +E +
Sbjct: 6   DAWEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEAN 60
Query: 247 TLSRQRHRFVLQLMGACL--EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
            +   +H  +++L       EP Y   ++TE +       L  L S    + ++P     
Sbjct: 61  LMKTLQHDKLVRLYAVVTREEPIY---IITEYMAKG--SLLDFLKSDEGGKVLLP----- 110
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-AL 363
           + +  + +IA+ M Y+  ++   IHRDL+ +N+ + ++   +IADFG AR + D E  A 
Sbjct: 111 KLIDFSAQIAEGMAYI--ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 168
Query: 364 TGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE 419
            G      + APE I    ++ KSDV+SFGI+L EI+T G  PY  +       A+  G 
Sbjct: 169 EGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGY 228
Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 +P  +    EL +++ + W   A  RP+F  +   L + 
Sbjct: 229 -----RMPRVENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 268

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           K+G+G    +Y+       VAVK +      T E     F QE+  +++ +H  +++L+G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH 321
              +      +   +   +L + L  L          P   +  R   A   A  + +LH
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDG-------TPPLSWHMRCKIAQGAANGINFLH 150
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF---LSDGEMA--LTGTFVYMAPEVIQ 376
           E     IHRD+K +NI LD+A   +I+DFG AR     +   M   + GT  YMAPE ++
Sbjct: 151 ENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALR 208
Query: 377 CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
            E  + KSD+YSFG++L EIITG  P +++  +P
Sbjct: 209 GE-ITPKSDIYSFGVVLLEIITG-LPAVDEHREP 240

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           K+G+G    +Y+       VAVK +      T E     F QE+  +++ +H  +++L+G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH 321
              +      +   +   +L + L  L          P   +  R   A   A  + +LH
Sbjct: 98  FSSDGDDLCLVYVYMPNGSLLDRLSCLDG-------TPPLSWHMRCKIAQGAANGINFLH 150
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF---LSDGEMA--LTGTFVYMAPEVIQ 376
           E     IHRD+K +NI LD+A   +I+DFG AR     +   M   + GT  YMAPE ++
Sbjct: 151 ENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALR 208
Query: 377 CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
            E  + KSD+YSFG++L EIITG  P +++  +P
Sbjct: 209 GE-ITPKSDIYSFGVVLLEIITG-LPAVDEHREP 240

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 16/214 (7%)
Query: 202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           K+G+G    +Y+       VAVK +      T E     F QE+  +++ +H  +++L+G
Sbjct: 32  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 91
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH 321
              +      +   +   +L + L  L          P   +  R   A   A  + +LH
Sbjct: 92  FSSDGDDLCLVYVYMPNGSLLDRLSCLDG-------TPPLSWHMRCKIAQGAANGINFLH 144
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF---LSDGEMA--LTGTFVYMAPEVIQ 376
           E     IHRD+K +NI LD+A   +I+DFG AR     +   M   + GT  YMAPE ++
Sbjct: 145 ENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALR 202
Query: 377 CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
            E  + KSD+YSFG++L EIITG  P +++  +P
Sbjct: 203 GE-ITPKSDIYSFGVVLLEIITG-LPAVDEHREP 234

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 131/284 (46%), Gaps = 30/284 (10%)
Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
            W I  + I L +K+G G    ++   +     VAVK + P        +V  F +E + 
Sbjct: 6   AWEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP-----GTMSVQAFLEEANL 60
Query: 248 LSRQRHRFVLQLMGACL--EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           +   +H  +++L       EP Y   ++TE +       L  L S    + ++P     +
Sbjct: 61  MKTLQHDKLVRLYAVVTKEEPIY---IITEFMAKG--SLLDFLKSDEGGKVLLP-----K 110
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALT 364
            +  + +IA+ M Y+  ++   IHRDL+ +N+ + ++   +IADFG AR + D E  A  
Sbjct: 111 LIDFSAQIAEGMAYI--ERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE 168
Query: 365 GT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
           G      + APE I    ++ KS+V+SFGI+L EI+T G  PY  +       A+  G  
Sbjct: 169 GAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGY- 227
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                +P  +    EL +++ + W   A  RP+F  +   L + 
Sbjct: 228 ----RMPRMENCPDELYDIMKMCWKEKAEERPTFDYLQSVLDDF 267

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 123/264 (46%), Gaps = 16/264 (6%)
Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +++KIG+G  + +YRA  +  G+ VA+K +   F   +  A     +E+D L +  H  V
Sbjct: 36  IEKKIGRGQFSEVYRAACLLDGVPVALKKV-QIFDLMDAKARADCIKEIDLLKQLNHPNV 94
Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           ++   + +E      ++       L   +     Q+R      L P        +++  A
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR------LIPERTVWKYFVQLCSA 148
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA---LTGTFVYMAPE 373
           ++++H ++  V+HRD+KP+N+F+     V++ D G  RF S    A   L GT  YM+PE
Sbjct: 149 LEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 206
Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
            I    Y+ KSD++S G +L E+     P+         +  ++ +    P LP  D   
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY-PPLP-SDHYS 264
Query: 434 RELIELICLSWDGDASVRPSFSSI 457
            EL +L+ +  + D   RP  + +
Sbjct: 265 EELRQLVNMCINPDPEKRPDVTYV 288

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 113/225 (50%), Gaps = 22/225 (9%)
Query: 193 DPKEIDLQEKIGQGTTANIY--RAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           DP   +L + +GQG+   ++  R + R   G   A+K +        +   T    E D 
Sbjct: 26  DPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT--KMERDI 83
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           L+   H FV++L  A  +   + +L+ + L          L ++  KE M      +  L
Sbjct: 84  LADVNHPFVVKLHYA-FQTEGKLYLILDFLRGG------DLFTRLSKEVMFTEEDVKFYL 136
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALT 364
           A   E+A  + +LH     +I+RDLKP NI LD+  H+++ DFG ++   D E    +  
Sbjct: 137 A---ELALGLDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFC 191
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  YMAPEV+  + +S  +D +S+G+++ E++TG+ P+  KD K
Sbjct: 192 GTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRK 236

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 5   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 57
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 58  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 117
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 118 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 175
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 176 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 233
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L+EL+ + W  +  +RPSF  I  S+K
Sbjct: 234 VLRFVMEGGL---LDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 87/334 (26%), Positives = 141/334 (42%), Gaps = 50/334 (14%)
Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           H    + PL  +C + P                + W      ++L + +G+G    +  A
Sbjct: 1   HMDPDELPLDEHCERLPY-------------DASKWEFPRDRLNLGKPLGRGAFGQVIEA 47
Query: 215 IWRGLD-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEP 266
              G+D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P
Sbjct: 48  DAFGIDKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKP 104
Query: 267 PYRGWLVTEL-----LGTTLKEWLHGLGSQRRKERMVP-LPPFEERLARALEIAQAMQYL 320
                ++ E      L T L+   +     +  E +       E  +  + ++A+ M++L
Sbjct: 105 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL 164
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTGT----FVYMAPEVI 375
             +K   IHRDL   NI L +   V+I DFG AR    D +    G       +MAPE I
Sbjct: 165 ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETI 222
Query: 376 QCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALPEED 430
               Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A    D
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA---PD 274
Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               E+ + +   W G+ S RP+FS +   L N+
Sbjct: 275 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 66
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE 184
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 185 TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 242
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 243 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 88/337 (26%), Positives = 140/337 (41%), Gaps = 67/337 (19%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      + L + +G+G    +  A   G+
Sbjct: 7   ELPLDEHCERLPY-------------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 53
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 54  DKTATXRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 110
Query: 272 LVTEL-----LGTTLKEWLHGLGSQRRKERMVPLPP---------FEERLARALEIAQAM 317
           ++ E      L T L+          ++   VP  P          E  +  + ++A+ M
Sbjct: 111 VIVEFCKFGNLSTYLRS---------KRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGM 161
Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTGT----FVYMAP 372
           ++L  +K   IHRDL   NI L +   V+I DFG AR    D +    G       +MAP
Sbjct: 162 EFLASRK--XIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAP 219
Query: 373 EVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALP 427
           E I    Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A  
Sbjct: 220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA-- 272
Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 273 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 42/302 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      + L + +G+G    +  A   G+D       VAVK +     H+   A+    
Sbjct: 13  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--- 69
Query: 243 QEVDTLSRQRHRF-VLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVP- 299
            E+  L    H   V+ L+GAC +P     ++TE      L  +L    ++    ++ P 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 300 -----LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
                    E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 355 -------FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--- 403
                  ++  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY   
Sbjct: 188 DIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 404 -IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
            I++++        + EG    A    D    E+ + +   W G+ S RP+FS +   L 
Sbjct: 246 KIDEEF-----CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 297
Query: 463 NI 464
           N+
Sbjct: 298 NL 299

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 82/302 (27%), Positives = 134/302 (44%), Gaps = 42/302 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      + L + +G+G    +  A   G+D       VAVK +     H+   A+    
Sbjct: 13  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--- 69
Query: 243 QEVDTLSRQRHRF-VLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVP- 299
            E+  L    H   V+ L+GAC +P     ++TE      L  +L    ++    ++ P 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 300 -----LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
                    E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 355 -------FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--- 403
                  ++  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY   
Sbjct: 188 DIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 245
Query: 404 -IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
            I++++        + EG    A    D    E+ + +   W G+ S RP+FS +   L 
Sbjct: 246 KIDEEF-----CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 297
Query: 463 NI 464
           N+
Sbjct: 298 NL 299

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 23/211 (10%)
Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +K+G G  + +Y A      + VA+K I+  P      E  +  F +EV   S+  H+ +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP---REKEETLKRFEREVHNSSQLSHQNI 73
Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           + ++    E      ++  + G TL E++   G         PL   +  +    +I   
Sbjct: 74  VSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG---------PLS-VDTAINFTNQILDG 123
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----GTFVYMAP 372
           +++ H+ +  ++HRD+KP NI +D  K ++I DFG A+ LS+  +  T    GT  Y +P
Sbjct: 124 IKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSP 181
Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           E  + E   E +D+YS GI+L E++ G  P+
Sbjct: 182 EQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 38/300 (12%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      + L + +G+G    +  A   G+D       VAVK +     H+   A+    
Sbjct: 13  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--- 69
Query: 243 QEVDTLSRQRHRF-VLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVP- 299
            E+  L    H   V+ L+GAC +P     ++TE      L  +L    ++    ++ P 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 300 -----LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
                    E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 355 -FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----I 404
               D +    G       +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           ++++        + EG    A    D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 248 DEEF-----CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 91/336 (27%), Positives = 147/336 (43%), Gaps = 49/336 (14%)
Query: 143 SVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEK 202
           S I+SPL+Q  +H            +  P L Q+   V +  + +         +   E 
Sbjct: 12  SDISSPLLQNTVHI--------DLSALNPELVQAVQHVVIGPSSL--------IVHFNEV 55
Query: 203 IGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           IG+G    +Y         + +  AVK +      T+   V+ F  E   +    H  VL
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARALEIAQA 316
            L+G CL       +V   +        HG L +  R E   P    ++ +   L++A+ 
Sbjct: 113 SLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFGLQVAKG 163
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGTFV---Y 369
           M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG  +   +
Sbjct: 164 MKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 221
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L+P    
Sbjct: 222 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 281
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +      L E++   W   A +RPSFS +   +  I
Sbjct: 282 D-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 90/334 (26%), Positives = 146/334 (43%), Gaps = 49/334 (14%)
Query: 145 IASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIG 204
           I+SPL+Q  +H            +  P L Q+   V +  + +         +   E IG
Sbjct: 15  ISSPLLQNTVHI--------DLSALNPELVQAVQHVVIGPSSL--------IVHFNEVIG 58
Query: 205 QGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G    +Y         + +  AVK +      T+   V+ F  E   +    H  VL L
Sbjct: 59  RGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           +G CL       +V   +        HG L +  R E   P    ++ +   L++A+ M+
Sbjct: 116 LGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMK 166
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGTFV---YMA 371
           YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG  +   +MA
Sbjct: 167 YLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
            E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L+P    + 
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD- 283
Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                L E++   W   A +RPSFS +   +  I
Sbjct: 284 ----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 87
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 138
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 139 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 256
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 257 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+E+L    
Sbjct: 52  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL---- 107
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 108 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 160
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 161 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 216
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 217 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 276
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 277 NQRPSFRDLALRVDQIR 293

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 193 DPKEIDLQEKIGQGTTANIY--RAIWRGLDV----AVKCIYPDFFHTNENAVTFFAQEVD 246
           DP + +L + +GQG+   ++  + I  G D     A+K +        +   T    E D
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLKKATLKVRDRVRT--KMERD 78
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            L    H F+++L  A  +   + +L+ + L          L ++  KE M      +  
Sbjct: 79  ILVEVNHPFIVKLHYA-FQTEGKLYLILDFLRGG------DLFTRLSKEVMFTEEDVKFY 131
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MAL 363
           LA   E+A A+ +LH     +I+RDLKP NI LD+  H+++ DFG ++   D E    + 
Sbjct: 132 LA---ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            GT  YMAPEV+    +++ +D +SFG+++ E++TG  P+  KD K
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 49/123 (39%), Positives = 75/123 (60%), Gaps = 18/123 (14%)
Query: 280 TLKEWLHGLGSQRRKERM---VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
           TL++W+     +RR E++   + L  FE+       I + + Y+H +K  +IHRDLKPSN
Sbjct: 120 TLEQWIE----KRRGEKLDKVLALELFEQ-------ITKGVDYIHSKK--LIHRDLKPSN 166
Query: 337 IFLDDAKHVRIADFGHARFL-SDGEMALT-GTFVYMAPEVIQCEPYSEKSDVYSFGIILN 394
           IFL D K V+I DFG    L +DG+   + GT  YM+PE I  + Y ++ D+Y+ G+IL 
Sbjct: 167 IFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 226
Query: 395 EII 397
           E++
Sbjct: 227 ELL 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 59
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 235
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 236 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 88
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 139
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 140 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 258 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 193 DPKEIDLQEKIGQGTTANIY--RAIWRGLDV----AVKCIYPDFFHTNENAVTFFAQEVD 246
           DP + +L + +GQG+   ++  + I  G D     A+K +        +   T    E D
Sbjct: 23  DPSQFELLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLKKATLKVRDRVRT--KMERD 79
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            L    H F+++L  A  +   + +L+ + L          L ++  KE M      +  
Sbjct: 80  ILVEVNHPFIVKLHYA-FQTEGKLYLILDFLRGG------DLFTRLSKEVMFTEEDVKFY 132
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MAL 363
           LA   E+A A+ +LH     +I+RDLKP NI LD+  H+++ DFG ++   D E    + 
Sbjct: 133 LA---ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            GT  YMAPEV+    +++ +D +SFG+++ E++TG  P+  KD K
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 31  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 87
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 88  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 138
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 139 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 197 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 256
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 257 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 88
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 139
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 140 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 258 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 42  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 94
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 95  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 154
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 213 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 270
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 271 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 66
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 67  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 126
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 185 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 242
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 243 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 29  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 85
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 136
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 137 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 254
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 255 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 65
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 359 GEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 241
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 242 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 129/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 59
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 60  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 178 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 235
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L+EL+ + W  +  +RPSF  I  S+K
Sbjct: 236 VLRFVMEGGL---LDKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 11  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 63
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 64  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 359 GEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 182 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 239
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 240 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 286

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 65
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 66  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 184 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 241
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 242 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 27  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 83
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 134
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 135 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 252
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 253 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 24  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 80
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 81  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 131
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 132 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 190 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 249
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 250 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 86
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 137
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL----TGT 366
           L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 138 LQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 255
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 256 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 113/226 (50%), Gaps = 24/226 (10%)
Query: 193 DPKEIDLQEKIGQGTTANIY--RAIWRGLDV----AVKCIYPDFFHTNENAVTFFAQEVD 246
           DP + +L + +GQG+   ++  + I  G D     A+K +        +   T    E D
Sbjct: 22  DPSQFELLKVLGQGSFGKVFLVKKI-SGSDARQLYAMKVLKKATLKVRDRVRT--KMERD 78
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            L    H F+++L  A  +   + +L+ + L          L ++  KE M      +  
Sbjct: 79  ILVEVNHPFIVKLHYA-FQTEGKLYLILDFLRGG------DLFTRLSKEVMFTEEDVKFY 131
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MAL 363
           LA   E+A A+ +LH     +I+RDLKP NI LD+  H+++ DFG ++   D E    + 
Sbjct: 132 LA---ELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            GT  YMAPEV+    +++ +D +SFG+++ E++TG  P+  KD K
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 72
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L  +     ++
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 132
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 359 GEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 248
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 249 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 142/337 (42%), Gaps = 69/337 (20%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      ++L + +G+G    +  A   G+
Sbjct: 5   ELPLDEHCERLPY-------------DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGI 51
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 52  DKTATXRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 272 LVTEL-----LGTTLKEWLHGLGSQRRKERMVP-------LPPFEERLARALEIAQAMQY 319
           ++ E      L T L+          ++   VP           E  +  + ++A+ M++
Sbjct: 109 VIVEFCKFGNLSTYLRS---------KRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEF 159
Query: 320 LHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FLSDGEMALTGTFVYMAP 372
           L  +K   IHRDL   NI L +   V+I DFG AR       ++  G+  L     +MAP
Sbjct: 160 LASRK--XIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAP 215
Query: 373 EVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALP 427
           E I    Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A  
Sbjct: 216 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA-- 268
Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 269 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/172 (31%), Positives = 92/172 (53%), Gaps = 15/172 (8%)
Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           P  ++ ++  L++A+ M+YL EQK   +HRDL   N  LD++  V++ADFG AR + D E
Sbjct: 121 PTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
Query: 361 MALTG-------TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
                          + A E +Q   ++ KSDV+SFG++L E++T G  PY   D  P  
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFD 236
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +   + +G+    LP+ +     L +++   W+ D +VRP+F  +   ++ I
Sbjct: 237 LTHFLAQGR---RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 141/332 (42%), Gaps = 55/332 (16%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      + L + +G+G    +  A   G+
Sbjct: 42  ELPLDEHCERLPY-------------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 88
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 89  DKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 145
Query: 272 LVTELLG-TTLKEWLHGLGSQRRKERMVP------LPPFEERLARALEIAQAMQYLHEQK 324
           ++ E      L  +L    ++    ++ P          E  +  + ++A+ M++L  +K
Sbjct: 146 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 205
Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FLSDGEMALTGTFVYMAPEVIQC 377
              IHRDL   NI L +   V+I DFG AR       ++  G+  L     +MAPE I  
Sbjct: 206 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFD 261
Query: 378 EPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
             Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A    D  
Sbjct: 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA---PDYT 313
Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             E+ + +   W G+ S RP+FS +   L N+
Sbjct: 314 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 117/258 (45%), Gaps = 40/258 (15%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 49  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 104
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 105 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 157
Query: 350 FGHAR-------FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
           FG  +       F    E   +  F Y APE +    +S  SDV+SFG++L E+ T    
Sbjct: 158 FGLTKVLPQDKEFFKVKEPGESPIFWY-APESLTESKFSVASDVWSFGVVLYELFT---- 212
Query: 403 YIEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGD 447
           YIEK    PA+    +G  K                  LP  DG   E+  ++   W+ +
Sbjct: 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNN 272
Query: 448 ASVRPSFSSITCSLKNIQ 465
            + RPSF  +   +  I+
Sbjct: 273 VNQRPSFRDLALRVDQIR 290

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 87/337 (25%), Positives = 142/337 (42%), Gaps = 69/337 (20%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      ++L + +G+G    +  A   G+
Sbjct: 5   ELPLDEHCERLPY-------------DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGI 51
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 52  DKTATXRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 272 LVTEL-----LGTTLKEWLHGLGSQRRKERMVP-------LPPFEERLARALEIAQAMQY 319
           ++ E      L T L+          ++   VP           E  +  + ++A+ M++
Sbjct: 109 VIVEFCKFGNLSTYLRS---------KRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEF 159
Query: 320 LHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FLSDGEMALTGTFVYMAP 372
           L  +K   IHRDL   NI L +   V+I DFG AR       ++  G+  L     +MAP
Sbjct: 160 LASRK--XIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL--PLKWMAP 215
Query: 373 EVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALP 427
           E I    Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A  
Sbjct: 216 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----XRRLKEGTRMRA-- 268
Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 269 -PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 304

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 8/122 (6%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTF 367
           A EI   ++ LH ++  +++RDLKP NI LDD  H+RI+D G A  + +G+      GT 
Sbjct: 292 AAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            YMAPEV++ E Y+   D ++ G +L E+I G  P+ ++  K  +  +E    +L   +P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----RLVKEVP 405
Query: 428 EE 429
           EE
Sbjct: 406 EE 407

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 88
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 139
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 140 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 258 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 141/332 (42%), Gaps = 55/332 (16%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      + L + +G+G    +  A   G+
Sbjct: 5   ELPLDEHCERLPY-------------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 51
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 52  DKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 272 LVTELLG-TTLKEWLHGLGSQRRKERMVP------LPPFEERLARALEIAQAMQYLHEQK 324
           ++ E      L  +L    ++    ++ P          E  +  + ++A+ M++L  +K
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FLSDGEMALTGTFVYMAPEVIQC 377
              IHRDL   NI L +   V+I DFG AR       ++  G+  L     +MAPE I  
Sbjct: 169 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFD 224
Query: 378 EPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
             Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A    D  
Sbjct: 225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA---PDYT 276
Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             E+ + +   W G+ S RP+FS +   L N+
Sbjct: 277 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 71/122 (58%), Gaps = 8/122 (6%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTF 367
           A EI   ++ LH ++  +++RDLKP NI LDD  H+RI+D G A  + +G+      GT 
Sbjct: 292 AAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTV 349
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            YMAPEV++ E Y+   D ++ G +L E+I G  P+ ++  K  +  +E    +L   +P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE----RLVKEVP 405
Query: 428 EE 429
           EE
Sbjct: 406 EE 407

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 30  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 86
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 87  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 137
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 138 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 196 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 255
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 256 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 85/330 (25%), Positives = 139/330 (42%), Gaps = 51/330 (15%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      + L + +G+G    +  A   G+
Sbjct: 5   ELPLDEHCERLPY-------------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 51
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 52  DKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 272 LVTELLG-TTLKEWLHGLGSQRRKERMVP------LPPFEERLARALEIAQAMQYLHEQK 324
           ++ E      L  +L    ++    ++ P          E  +  + ++A+ M++L  +K
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTGT----FVYMAPEVIQCEP 379
              IHRDL   NI L +   V+I DFG AR    D +    G       +MAPE I    
Sbjct: 169 --CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRV 226
Query: 380 YSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLR 434
           Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A    D    
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA---PDYTTP 278
Query: 435 ELIELICLSWDGDASVRPSFSSITCSLKNI 464
           E+ + +   W G+ S RP+FS +   L N+
Sbjct: 279 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 32  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 88
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 89  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 139
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 140 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 198 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 257
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 258 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 67  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 122
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 123 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 175
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 231
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 232 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 291
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 292 NQRPSFRDLALRVDQIR 308

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 89
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 140
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 141 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 258
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 259 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 37  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 93
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 94  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 144
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 145 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 203 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 262
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 263 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y A  +     +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYG-YFHDSTRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H +K  VIHRD+KP N+ L  A  ++IADFG   HA   S    AL 
Sbjct: 112 TYITELANALSYCHSKK--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRAALC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 85/330 (25%), Positives = 139/330 (42%), Gaps = 51/330 (15%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      + L + +G+G    +  A   G+
Sbjct: 5   ELPLDEHCERLPY-------------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 51
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 52  DKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 108
Query: 272 LVTELLG-TTLKEWLHGLGSQRRKERMVP------LPPFEERLARALEIAQAMQYLHEQK 324
           ++ E      L  +L    ++    ++ P          E  +  + ++A+ M++L  +K
Sbjct: 109 VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTGT----FVYMAPEVIQCEP 379
              IHRDL   NI L +   V+I DFG AR    D +    G       +MAPE I    
Sbjct: 169 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRV 226
Query: 380 YSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLR 434
           Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A    D    
Sbjct: 227 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA---PDYTTP 278
Query: 435 ELIELICLSWDGDASVRPSFSSITCSLKNI 464
           E+ + +   W G+ S RP+FS +   L N+
Sbjct: 279 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 91  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 147
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V       L    HG L +  R E   P    ++ +   
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVV-------LPYMKHGDLRNFIRNETHNP--TVKDLIGFG 198
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 199 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 316
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 317 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 49  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 104
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 105 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 157
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 158 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 213
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 273
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 274 NQRPSFRDLALRVDQIR 290

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 67  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 122
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 123 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 175
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 176 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 231
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 232 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 291
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 292 NQRPSFRDLALRVDQIR 308

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/300 (27%), Positives = 131/300 (43%), Gaps = 38/300 (12%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      + L + +G+G    +  A   G+D       VAVK +     H+   A+    
Sbjct: 13  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM--- 69
Query: 243 QEVDTLSRQRHRF-VLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVP- 299
            E+  L    H   V+ L+GAC +P     ++ E      L  +L    ++    ++ P 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 129
Query: 300 -----LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
                    E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR
Sbjct: 130 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 187
Query: 355 -FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----I 404
               D +    G       +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I
Sbjct: 188 DIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 247
Query: 405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           ++++        + EG    A    D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 248 DEEF-----CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 33/282 (11%)
Query: 197 IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y         + +  AVK +      T+   V+ F  E   +   
Sbjct: 33  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 89
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-LGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +        HG L +  R E   P    ++ +   
Sbjct: 90  SHPNVLSLLGICLRSEGSPLVVLPYMK-------HGDLRNFIRNETHNP--TVKDLIGFG 140
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGT 366
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E       TG 
Sbjct: 141 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
            +   +MA E +Q + ++ KSDV+SFG++L E++T G  PY + +     + +  G   L
Sbjct: 199 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 258
Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +P    +      L E++   W   A +RPSFS +   +  I
Sbjct: 259 QPEYCPD-----PLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 80  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 135
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 136 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 188
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 189 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 244
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 304
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 305 NQRPSFRDLALRVDQIR 321

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 49  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 104
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 105 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 157
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 158 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 213
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 273
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 274 NQRPSFRDLALRVDQIR 290

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 10  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 62
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L        ++
Sbjct: 63  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 181 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 238
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 239 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 33/287 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           ID K+++   K+ +  +  +++  W+G D+ VK +    + T ++    F +E   L   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRD--FNEECPRLRIF 64
Query: 252 RHRFVLQLMGACLEPP------YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            H  VL ++GAC  PP         W+    L   L E  + +  Q +  +         
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-------- 116
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI--ADFGHARFLSDGEMAL 363
               AL++A+ M +LH  +P +    L   ++ +D+    RI  AD   + F S G M  
Sbjct: 117 ----ALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-FQSPGRMYA 171
Query: 364 TGTFVYMAPEVIQCEPYS---EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
                ++APE +Q +P       +D++SF ++L E++T   P+   D    +I M+V   
Sbjct: 172 PA---WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF--ADLSNMEIGMKVALE 226
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
            LRP +P   G    + +L+ +  + D + RP F  I   L+ +Q K
Sbjct: 227 GLRPTIPP--GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 48  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 103
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 104 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 156
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 157 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 212
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 213 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 272
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 273 NQRPSFRDLALRVDQIR 289

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 52  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 107
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 108 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 160
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 161 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 216
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 217 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 276
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 277 NQRPSFRDLALRVDQIR 293

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 56  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 111
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 112 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 164
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 165 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 220
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 221 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 280
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 281 NQRPSFRDLALRVDQIR 297

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 55  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 110
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 111 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 163
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 164 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 219
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 220 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 279
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 280 NQRPSFRDLALRVDQIR 296

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 47  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 102
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 103 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 155
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 156 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 211
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 212 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 271
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 272 NQRPSFRDLALRVDQIR 288

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 68
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 69  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 114
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S    AL 
Sbjct: 115 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRAALC 170
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 54  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 109
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 110 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 162
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 163 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 218
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 219 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 278
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 279 NQRPSFRDLALRVDQIR 295

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R   R   +A+K ++       +  V     +EV+  S  
Sbjct: 5   EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 62
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 63  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 108
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 109 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLC 164
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 209

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 127/290 (43%), Gaps = 31/290 (10%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTF-- 240
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       NE A     
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRER 72
Query: 241 --FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
             F  E   +       V++L+G   +      ++  +    LK +L  L        ++
Sbjct: 73  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 132
Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + +
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 359 GEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M+PE ++   ++  SDV+SFG++L EI T    PY  +     +
Sbjct: 191 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQ 248
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           +   V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K
Sbjct: 249 VLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 53  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 108
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 109 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 161
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 162 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 217
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 218 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 277
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 278 NQRPSFRDLALRVDQIR 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 93/177 (52%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 72  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGS--- 128
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 129 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 177
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A   +FV    Y++PE++  +  S+ SD+++ G I+ +++ G  P+
Sbjct: 178 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 32/235 (13%)
Query: 185 AKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-F 241
            K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V    
Sbjct: 1   GKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQL 56
Query: 242 AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVP 299
            +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             +  
Sbjct: 57  RREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQK 102
Query: 300 LPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HAR 354
           L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA 
Sbjct: 103 LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSCHAP 160
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
             S     L+GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 161 --SSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 4   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 59
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 60  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 105
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 106 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 164 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 2   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 57
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 58  LRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQ 103
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 104 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 161
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 162 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 16  ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 71
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 72  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 117
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 118 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 175
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 176 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 1   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 56
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 57  LRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQ 102
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 103 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 160
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 161 P--SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 214

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 113/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  + ++   +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 25  ESKKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 80
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 81  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 126
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 127 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 184
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 185 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 238

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 85/332 (25%), Positives = 140/332 (42%), Gaps = 55/332 (16%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGL 219
           + PL  +C + P                + W      + L + +G+G    +  A   G+
Sbjct: 7   ELPLDEHCERLPY-------------DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGI 53
Query: 220 D-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGW 271
           D       VAVK +     H+   A+     E+  L    H   V+ L+GAC +P     
Sbjct: 54  DKTATCRTVAVKMLKEGATHSEHRALM---SELKILIHIGHHLNVVNLLGACTKPGGPLM 110
Query: 272 LVTELLG-TTLKEWLHGLGSQRRKERMVP------LPPFEERLARALEIAQAMQYLHEQK 324
           ++ E      L  +L    ++    +  P          E  +  + ++A+ M++L  +K
Sbjct: 111 VIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 170
Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FLSDGEMALTGTFVYMAPEVIQC 377
              IHRDL   NI L +   V+I DFG AR       ++  G+  L     +MAPE I  
Sbjct: 171 --CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFD 226
Query: 378 EPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
             Y+ +SDV+SFG++L EI + G  PY    I++++        + EG    A    D  
Sbjct: 227 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-----CRRLKEGTRMRA---PDYT 278
Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             E+ + +   W G+ S RP+FS +   L N+
Sbjct: 279 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 48/123 (39%), Positives = 75/123 (60%), Gaps = 18/123 (14%)
Query: 280 TLKEWLHGLGSQRRKERM---VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
           TL++W+     +RR E++   + L  FE+       I + + Y+H +K  +I+RDLKPSN
Sbjct: 106 TLEQWIE----KRRGEKLDKVLALELFEQ-------ITKGVDYIHSKK--LINRDLKPSN 152
Query: 337 IFLDDAKHVRIADFGHARFL-SDGEMALT-GTFVYMAPEVIQCEPYSEKSDVYSFGIILN 394
           IFL D K V+I DFG    L +DG+   + GT  YM+PE I  + Y ++ D+Y+ G+IL 
Sbjct: 153 IFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILA 212
Query: 395 EII 397
           E++
Sbjct: 213 ELL 215

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 109/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S    AL 
Sbjct: 112 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRAALC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 111/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 4   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 59
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 60  LRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQ 105
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 106 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 164 P--SSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 194 PKEIDLQEKIGQGT--TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P++    + +G+G+  T  + R +    + A+K +        EN V +  +E D +SR 
Sbjct: 9   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRL 67
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-- 309
            H F ++L     +     + ++      L +++  +GS            F+E   R  
Sbjct: 68  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------FDETCTRFY 115
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTGTFV 368
             EI  A++YLH +   +IHRDLKP NI L++  H++I DFG A+ LS + + A    FV
Sbjct: 116 TAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 173
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
               Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 174 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 194 PKEIDLQEKIGQGT--TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P++    + +G+G+  T  + R +    + A+K +        EN V +  +E D +SR 
Sbjct: 8   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRL 66
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-- 309
            H F ++L     +     + ++      L +++  +GS            F+E   R  
Sbjct: 67  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------FDETCTRFY 114
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTGTFV 368
             EI  A++YLH +   +IHRDLKP NI L++  H++I DFG A+ LS + + A    FV
Sbjct: 115 TAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 172
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
               Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 173 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 2   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 57
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 58  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 103
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 104 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 161
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 162 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 2   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 57
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 58  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 103
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 104 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 161
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 162 P--SSRRXXLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 194 PKEIDLQEKIGQGT--TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P++    + +G+G+  T  + R +    + A+K +        EN V +  +E D +SR 
Sbjct: 6   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRL 64
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-- 309
            H F ++L     +     + ++      L +++  +GS            F+E   R  
Sbjct: 65  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------FDETCTRFY 112
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTGTFV 368
             EI  A++YLH +   +IHRDLKP NI L++  H++I DFG A+ LS + + A    FV
Sbjct: 113 TAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 170
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
               Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 171 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 24/219 (10%)
Query: 194 PKEIDLQEKIGQGT--TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P++    + +G+G+  T  + R +    + A+K +        EN V +  +E D +SR 
Sbjct: 7   PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-- 309
            H F ++L     +     + ++      L +++  +GS            F+E   R  
Sbjct: 66  DHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------FDETCTRFY 113
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTGTFV 368
             EI  A++YLH +   +IHRDLKP NI L++  H++I DFG A+ LS + + A    FV
Sbjct: 114 TAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV 171
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
               Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 172 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 15/203 (7%)
Query: 202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           K G+G    +Y+       VAVK +      T E     F QE+   ++ +H  +++L+G
Sbjct: 29  KXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLG 88
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH 321
              +      +       +L + L  L          P   +  R   A   A  + +LH
Sbjct: 89  FSSDGDDLCLVYVYXPNGSLLDRLSCLDG-------TPPLSWHXRCKIAQGAANGINFLH 141
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR----FLSDGEMA-LTGTFVYMAPEVIQ 376
           E     IHRD+K +NI LD+A   +I+DFG AR    F      + + GT  Y APE ++
Sbjct: 142 ENHH--IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 377 CEPYSEKSDVYSFGIILNEIITG 399
            E  + KSD+YSFG++L EIITG
Sbjct: 200 GE-ITPKSDIYSFGVVLLEIITG 221

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           LQ+ IG+G  A +   R +  G +VAVK I  D    N  ++    +EV  +    H  +
Sbjct: 19  LQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 77  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR----------AKFRQIVS 125
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G       G+  Y APE
Sbjct: 126 AVQYCHQKY--IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPE 183
Query: 374 VIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 198 DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +L E +G G  + ++  R +    DVAVK +  D    + +    F +E    +   H  
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA 73
Query: 256 VLQL--MGACLEP----PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           ++ +   G    P    PY   +V E + G TL++ +H  G         P+ P      
Sbjct: 74  IVAVYDTGEAETPAGPLPY---IVMEYVDGVTLRDIVHTEG---------PMTP-----K 116
Query: 309 RALEI----AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
           RA+E+     QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D      
Sbjct: 117 RAIEVIADACQALNFSHQNG--IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVX 174
Query: 360 -EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              A+ GT  Y++PE  + +    +SDVYS G +L E++TG  P+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 32/235 (13%)
Query: 185 AKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-F 241
           +K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V    
Sbjct: 5   SKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQL 60
Query: 242 AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVP 299
            +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             +  
Sbjct: 61  RREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQK 106
Query: 300 LPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HAR 354
           L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA 
Sbjct: 107 LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
             S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 165 --SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 112 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 116/257 (45%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 50  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 105
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q+ KER+  +    + L    +I + M+YL  ++   IHR+L   NI +++   V+I D
Sbjct: 106 -QKHKERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRNLATRNILVENENRVKIGD 158
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 159 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 214
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 215 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 274
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 275 NQRPSFRDLALRVDQIR 291

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 132/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 64
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 121
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R 
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  + ++RP+F  I   LK+
Sbjct: 240 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 1   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 56
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 57  LRREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQ 102
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IA+FG   HA
Sbjct: 103 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHA 160
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 161 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 214

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 126
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 127 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 175
Query: 352 HARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS         A  GT  Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 176 TAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 32/235 (13%)
Query: 185 AKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-F 241
           +K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V    
Sbjct: 1   SKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQL 56
Query: 242 AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVP 299
            +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             +  
Sbjct: 57  RREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQK 102
Query: 300 LPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HAR 354
           L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA 
Sbjct: 103 LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
             S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 161 --SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 30/290 (10%)
Query: 185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVT 239
           A    + I  + I+L   IG+G   ++++ I+       L VA+K        T+++   
Sbjct: 2   ASTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVRE 58
Query: 240 FFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
            F QE  T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  
Sbjct: 59  KFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLAS 114
Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
           L      +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D 
Sbjct: 115 L------ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 166
Query: 360 EM--ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIA 414
               A  G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   + 
Sbjct: 167 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVI 224
Query: 415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +  G+  P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 225 GRIENGERLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE  
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEAL 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 64  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLASL------ 113
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 114 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 229
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 230 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 20/252 (7%)
Query: 203 IGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA 262
           +G+GT   +Y    R L   V+    +    +        +E+      +H+ ++Q +G+
Sbjct: 30  LGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA-RALEIAQAMQYLH 321
             E  +    + ++ G +L   L        + +  PL   E+ +     +I + ++YLH
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALL--------RSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSD---GEMALTGTFVYMAPEVIQC 377
           + +  ++HRD+K  N+ ++    V +I+DFG ++ L+         TGT  YMAPE+I  
Sbjct: 140 DNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197
Query: 378 EP--YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE 435
            P  Y + +D++S G  + E+ TG  P+ E   +P     +VG  K+ P +PE      +
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPPFYELG-EPQAAMFKVGMFKVHPEIPESMSAEAK 256
Query: 436 LIELICLSWDGD 447
              L C   D D
Sbjct: 257 AFILKCFEPDPD 268

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 198 DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +L E +G G  + ++  R +    DVAVK +  D    + +    F +E    +   H  
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA 73
Query: 256 VLQL--MGACLEP----PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           ++ +   G    P    PY   +V E + G TL++ +H  G         P+ P      
Sbjct: 74  IVAVYDTGEAETPAGPLPY---IVMEYVDGVTLRDIVHTEG---------PMTP-----K 116
Query: 309 RALEI----AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
           RA+E+     QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D      
Sbjct: 117 RAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 360 -EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              A+ GT  Y++PE  + +    +SDVYS G +L E++TG  P+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 112 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTELC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE  
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEAL 91
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 92  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLASL------ 141
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 142 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 200 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 257
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 258 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 297

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 198 DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +L E +G G  + ++  R +    DVAVK +  D    + +    F +E    +   H  
Sbjct: 15  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA 73
Query: 256 VLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           ++ +          G   ++V E + G TL++ +H  G         P+ P      RA+
Sbjct: 74  IVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTP-----KRAI 119
Query: 312 EI----AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG------EM 361
           E+     QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D         
Sbjct: 120 EVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 362 ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           A+ GT  Y++PE  + +    +SDVYS G +L E++TG  P+
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 198 DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +L E +G G  + ++  R +    DVAVK +  D    + +    F +E    +   H  
Sbjct: 15  ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA 73
Query: 256 VLQL--MGACLEP----PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           ++ +   G    P    PY   +V E + G TL++ +H  G         P+ P      
Sbjct: 74  IVAVYDTGEAETPAGPLPY---IVMEYVDGVTLRDIVHTEG---------PMTP-----K 116
Query: 309 RALEI----AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
           RA+E+     QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D      
Sbjct: 117 RAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 360 -EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              A+ GT  Y++PE  + +    +SDVYS G +L E++TG  P+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE  
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEAL 68
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 69  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLASL------ 118
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 119 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 234
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 235 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 9   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 61
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 62  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 118
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R 
Sbjct: 119 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD 176
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 177 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 236
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  +  +RP+F  I   LK+
Sbjct: 237 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 285

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE  
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEAL 66
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 67  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLASL------ 116
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 117 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 175 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 232
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 233 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 64
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 121
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R 
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  +  +RP+F  I   LK+
Sbjct: 240 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/114 (37%), Positives = 66/114 (57%), Gaps = 5/114 (4%)
Query: 327 VIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEK 383
           V+HRDLKP+N+FLD  ++V++ DFG AR L+   D      GT  YM+PE +    Y+EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEK 196
Query: 384 SDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELI 437
           SD++S G +L E+     P+    +   ++A ++ EGK R        +L E+I
Sbjct: 197 SDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFRRIPYRYSDELNEII 248

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 111/235 (47%), Gaps = 32/235 (13%)
Query: 185 AKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-F 241
           +K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V    
Sbjct: 1   SKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQL 56
Query: 242 AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVP 299
            +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             +  
Sbjct: 57  RREVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQK 102
Query: 300 LPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HAR 354
           L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA 
Sbjct: 103 LSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
             S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 161 --SSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/236 (29%), Positives = 113/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  + ++   +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 25  ESKKRQWALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 80
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 81  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 126
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 127 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 184
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 185 P--SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 238

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 43/114 (37%), Positives = 66/114 (57%), Gaps = 5/114 (4%)
Query: 327 VIHRDLKPSNIFLDDAKHVRIADFGHARFL---SDGEMALTGTFVYMAPEVIQCEPYSEK 383
           V+HRDLKP+N+FLD  ++V++ DFG AR L   +    A  GT  YM+PE +    Y+EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 196
Query: 384 SDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELI 437
           SD++S G +L E+     P+    +   ++A ++ EGK R        +L E+I
Sbjct: 197 SDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFRRIPYRYSDELNEII 248

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 12  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 69
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 70  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 115
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 116 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLC 171
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 216

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/338 (25%), Positives = 150/338 (44%), Gaps = 51/338 (15%)
Query: 160 QTPLHRYCSQTPLLQQSDLAVTVSQAKMN---GWYIDPKEIDLQEKIGQGTTANIYRAIW 216
            TPL R  ++      + +   VS+ ++     W     ++ L + +G+G    +  A  
Sbjct: 43  NTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEA 102
Query: 217 RGLD---------VAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLEP 266
            G+D         VAVK +  D     E  ++    E++ +    +H+ ++ L+GAC + 
Sbjct: 103 VGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159
Query: 267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERM--------VPLP--PFEERLARALEIAQA 316
                +V       L+E+L      RR   M        VP     F++ ++   ++A+ 
Sbjct: 160 GPLYVIVEYASKGNLREYLRA----RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARG 215
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT-----FVYMA 371
           M+YL  QK   IHRDL   N+ + +   ++IADFG AR +++ +     T       +MA
Sbjct: 216 MEYLASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMA 273
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPAKIAMEVGEGKLRPAL 426
           PE +    Y+ +SDV+SFG+++ EI T G  PY    +E+ +K     ++ G    +PA 
Sbjct: 274 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLKEGHRMDKPA- 328
Query: 427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                   EL  ++   W    S RP+F  +   L  I
Sbjct: 329 ----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE  
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN---CTSDSVREKFLQEAL 60
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 61  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLASL------ 110
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 111 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 226
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 227 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/114 (39%), Positives = 68/114 (59%), Gaps = 5/114 (4%)
Query: 327 VIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALT--GTFVYMAPEVIQCEPYSEK 383
           V+HRDLKP+N+FLD  ++V++ DFG AR L+ D   A T  GT  YM+PE +    Y+EK
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196
Query: 384 SDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELI 437
           SD++S G +L E+     P+    +   ++A ++ EGK R        +L E+I
Sbjct: 197 SDIWSLGCLLYELCALMPPFTA--FSQKELAGKIREGKFRRIPYRYSDELNEII 248

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 92/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 73  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 129
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 130 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 178
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A   +FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 179 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAVK I  D    N +++    +EV  +    H  +
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 76  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR----------AKFRQIVS 124
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G    A  G   Y APE
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 198 DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +L E +G G  + ++  R +    DVAVK +  D    + +    F +E    +   H  
Sbjct: 15  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA 73
Query: 256 VLQL--MGACLEP----PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           ++ +   G    P    PY   +V E + G TL++ +H  G         P+ P      
Sbjct: 74  IVAVYDTGEAETPAGPLPY---IVMEYVDGVTLRDIVHTEG---------PMTP-----K 116
Query: 309 RALEI----AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
           RA+E+     QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D      
Sbjct: 117 RAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174
Query: 360 -EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              A+ GT  Y++PE  + +    +SDVYS G +L E++TG  P+
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 7   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 64
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 65  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 110
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 111 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTTLC 166
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 211

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 112 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRXXLC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 110/234 (47%), Gaps = 32/234 (13%)
Query: 186 KMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FA 242
           K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V     
Sbjct: 1   KKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLR 56
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPL 300
           +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             +  L
Sbjct: 57  REVEIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRE-------------LQKL 102
Query: 301 PPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARF 355
             F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA  
Sbjct: 103 SKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 159
Query: 356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 160 -SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 112 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTXLC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ D+   +G+G   N+Y A  R     +A+K ++       +  V     +EV+  S  
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT--QLEKAGVEHQLRREVEIQSHL 69
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 70  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSRFDEQRTA 115
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L     ++IADFG   HA   S     L 
Sbjct: 116 TYITELANALSYCHSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAP--SSRRTTLC 171
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 8/113 (7%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV---RIADFGHARFLSDGEMA--LTGT 366
           +I+ A++YLHE +  +IHRDLKP NI L         +I D G+A+ L  GE+     GT
Sbjct: 130 DISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 187
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
             Y+APE+++ + Y+   D +SFG +  E ITG  P++  +++P +   +V E
Sbjct: 188 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-PNWQPVQWHGKVRE 239

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 42/113 (37%), Positives = 67/113 (59%), Gaps = 8/113 (7%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV---RIADFGHARFLSDGEMA--LTGT 366
           +I+ A++YLHE +  +IHRDLKP NI L         +I D G+A+ L  GE+     GT
Sbjct: 129 DISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
             Y+APE+++ + Y+   D +SFG +  E ITG  P++  +++P +   +V E
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFL-PNWQPVQWHGKVRE 238

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 2   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 57
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E   LGT  +E             + 
Sbjct: 58  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQ 103
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IA+FG   HA
Sbjct: 104 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIANFGWSVHA 161
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 162 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 8   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 65
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 66  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 111
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 112 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRTDLC 167
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 212

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       + VA+K        T+++    F QE  
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEAL 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 64  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKFSLDLASL------ 113
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D        
Sbjct: 114 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171
Query: 367 ----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 229
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 230 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 93/178 (52%), Gaps = 23/178 (12%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL-VTELLGTTLKEWLHGLGSQR 292
            EN V +  +E D +SR  H F ++L   C +   + +  ++      L +++  +GS  
Sbjct: 77  KENKVPYVTRERDVMSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGS-- 133
Query: 293 RKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
                     F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DF
Sbjct: 134 ----------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF 181
Query: 351 GHARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           G A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 182 GTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VA+K I  D    N  ++    +EV  +    H  +
Sbjct: 19  LLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +L+ E   G  + ++L   G  + KE            ++  +I  
Sbjct: 77  VKLF-EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR----------SKFRQIVS 125
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEM-ALTGTFVYMAPE 373
           A+QY H+++  ++HRDLK  N+ LD   +++IADFG +  F   G++ A  G   Y APE
Sbjct: 126 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPE 183
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 214

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 72  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 128
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 129 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 177
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   +RIAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMRIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 92/176 (52%), Gaps = 21/176 (11%)
Query: 235 ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK 294
           EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS    
Sbjct: 70  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---- 125
Query: 295 ERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
                   F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG 
Sbjct: 126 --------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGT 175
Query: 353 ARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           A+ LS + + A   +FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 176 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 72  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 128
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 129 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 177
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       + VA+K        T+++    F QE  
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEAL 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 64  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKYSLDLASL------ 113
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 114 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 229
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 230 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 198 DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +L E +G G  + ++  R +    DVAVK +  D    + +    F +E    +   H  
Sbjct: 32  ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLAR-DPSFYLRFRREAQNAAALNHPA 90
Query: 256 VLQL--MGACLEP----PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           ++ +   G    P    PY   +V E + G TL++ +H  G         P+ P      
Sbjct: 91  IVAVYDTGEAETPAGPLPY---IVMEYVDGVTLRDIVHTEG---------PMTP-----K 133
Query: 309 RALEI----AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
           RA+E+     QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D      
Sbjct: 134 RAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 360 -EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              A+ GT  Y++PE  + +    +SDVYS G +L E++TG  P+
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF 236

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 126
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 127 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 175
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 176 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 75  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 131
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 132 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 180
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 181 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 126
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 127 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 175
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 176 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 126
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 127 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 175
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 176 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 72  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 128
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 129 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 177
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 73  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 129
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 130 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 178
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 179 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/252 (25%), Positives = 116/252 (46%), Gaps = 20/252 (7%)
Query: 203 IGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA 262
           +G+GT   +Y    R L   V+    +    +        +E+      +H+ ++Q +G+
Sbjct: 16  LGKGTYGIVYAG--RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS 73
Query: 263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA-RALEIAQAMQYLH 321
             E  +    + ++ G +L   L        + +  PL   E+ +     +I + ++YLH
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALL--------RSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSD---GEMALTGTFVYMAPEVIQC 377
           + +  ++HRD+K  N+ ++    V +I+DFG ++ L+         TGT  YMAPE+I  
Sbjct: 126 DNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 183
Query: 378 EP--YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRE 435
            P  Y + +D++S G  + E+ TG  P+ E   +P     +VG  K+ P +PE      +
Sbjct: 184 GPRGYGKAADIWSLGCTIIEMATGKPPFYELG-EPQAAMFKVGMFKVHPEIPESMSAEAK 242
Query: 436 LIELICLSWDGD 447
              L C   D D
Sbjct: 243 AFILKCFEPDPD 254

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 72  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 128
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 129 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 177
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 72  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 128
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 129 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 177
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 178 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAVK I  D    N +++    +EV       H  +
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 76  VKLF-EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEAR----------AKFRQIVS 124
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G    A  G   Y APE
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPE 182
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEX 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 127/283 (44%), Gaps = 30/283 (10%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           I  + I+L   IG+G   ++++ I+       + VA+K        T+++    F QE  
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSDSVREKFLQEAL 63
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++    +  L      
Sbjct: 64  TMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKFSLDLASL------ 113
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALT 364
           +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     A  
Sbjct: 114 ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 365 GTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
           G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   +  G+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGE 229
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 230 RLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 91/177 (51%), Gaps = 21/177 (11%)
Query: 234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR 293
            EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS   
Sbjct: 54  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--- 110
Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                    F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG
Sbjct: 111 ---------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFG 159
Query: 352 HARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 160 TAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 110/218 (50%), Gaps = 27/218 (12%)
Query: 194 PKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           P+E+ D+ EK+G+G+  ++Y+AI +  G  VA+K +        E+ +    +E+  + +
Sbjct: 27  PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEIIKEISIMQQ 80
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
                V++  G+  +     W+V E  G          GS     R+      E+ +A  
Sbjct: 81  CDSPHVVKYYGSYFKNT-DLWIVMEYCGA---------GSVSDIIRLRNKTLTEDEIATI 130
Query: 311 LE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA----LTG 365
           L+   + ++YLH  +   IHRD+K  NI L+   H ++ADFG A  L+D  MA    + G
Sbjct: 131 LQSTLKGLEYLHFMRK--IHRDIKAGNILLNTEGHAKLADFGVAGQLTD-XMAKRNXVIG 187
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           T  +MAPEVIQ   Y+  +D++S GI   E+  G  PY
Sbjct: 188 TPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 30/294 (10%)
Query: 181 TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNE 235
           T +      + I  + I+L   IG+G   ++++ I+       + VA+K        T++
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSD 432
Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
           +    F QE  T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++   
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKFSL 488
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
            +  L      +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R+
Sbjct: 489 DLASL------ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSATDCVKLGDFGLSRY 540
Query: 356 LSDGEM--ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKP 410
           + D     A  G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K 
Sbjct: 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKN 598
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +   +  G+  P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 599 NDVIGRIENGERLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 131/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 64
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 121
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R 
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  +  +RP+F  I   LK+
Sbjct: 240 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ D+   +G+G   N+Y A  R     +A+K ++       +  V     +EV+  S  
Sbjct: 12  EDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKT--QLEKAGVEHQLRREVEIQSHL 69
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 70  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSRFDEQRTA 115
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L     ++IADFG   HA   S     L 
Sbjct: 116 TYITELANALSYCHSKR--VIHRDIKPENLLLGSNGELKIADFGWSVHAP--SSRRDTLC 171
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQ 216

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAVK I  D    N +++    +EV  +    H  +
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 76  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR----------AKFRQIVS 124
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G       G+  Y APE
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAVK I  D    N +++    +EV  +    H  +
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 76  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR----------AKFRQIVS 124
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G       G+  Y APE
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 30/294 (10%)
Query: 181 TVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNE 235
           T +      + I  + I+L   IG+G   ++++ I+       + VA+K        T++
Sbjct: 376 TYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKN---CTSD 432
Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
           +    F QE  T+ +  H  +++L+G   E P   W++ EL   TL E    L  ++   
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV--WIIMEL--CTLGELRSFLQVRKFSL 488
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
            +  L      +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R+
Sbjct: 489 DLASL------ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY 540
Query: 356 LSDGEM--ALTGTF--VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKP 410
           + D     A  G     +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K 
Sbjct: 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKN 598
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +   +  G+  P  P        L  L+   W  D S RP F+ +   L  I
Sbjct: 599 NDVIGRIENGERLPMPPNCPPT---LYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 114/257 (44%), Gaps = 38/257 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+ E  +  F +E++ L   +H  +++  G C     R   L+ E L   +L+++L    
Sbjct: 52  HSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---- 107
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            Q   ER+  +    + L    +I + M+YL  ++   IHRDL   NI +++   V+I D
Sbjct: 108 -QAHAERIDHI----KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGD 160
Query: 350 FGHARFL-SDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG  + L  D E             + APE +    +S  SDV+SFG++L E+ T    Y
Sbjct: 161 FGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----Y 216
Query: 404 IEKDYK-PAKIAMEVGEGKL--------------RPALPEEDGQLRELIELICLSWDGDA 448
           IEK    PA+    +G  K                  LP  DG   E+  ++   W+ + 
Sbjct: 217 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNV 276
Query: 449 SVRPSFSSITCSLKNIQ 465
           + RPSF  +   +  I+
Sbjct: 277 NQRPSFRDLALRVDQIR 293

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/130 (36%), Positives = 78/130 (60%), Gaps = 12/130 (9%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNI-FLDDAKH---VRIADFGHARFL 356
           F ER A A+   I + ++YLH Q   V+HRDLKPSNI ++D++ +   +RI DFG A+ L
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 357 -SDGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK-DYKPAK 412
            ++  + +T  +   ++APEV++ + Y    D++S G++L  ++TG  P+    D  P +
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 413 IAMEVGEGKL 422
           I   +G GK 
Sbjct: 231 ILARIGSGKF 240

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 4   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 59
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E    G   KE             + 
Sbjct: 60  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPRGEVYKE-------------LQ 105
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 106 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 164 P--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 91/176 (51%), Gaps = 21/176 (11%)
Query: 235 ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK 294
           EN V +  +E D +SR  H F ++L     +     + ++      L +++  +GS    
Sbjct: 70  ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---- 125
Query: 295 ERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
                   F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG 
Sbjct: 126 --------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGT 175
Query: 353 ARFLS-DGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           A+ LS + + A    FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 176 AKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           ++I L E +G+G    ++R  W+G +VAVK      F + +    F   E+      RH 
Sbjct: 37  RQITLLECVGKGRYGEVWRGSWQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHE 91
Query: 255 FVLQLMGACLEPPYRG---WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
            +L  + + +   +     WL+T           H +GS     ++  L      L   L
Sbjct: 92  NILGFIASDMTSRHSSTQLWLITH---------YHEMGSLYDYLQLTTLDTV-SCLRIVL 141
Query: 312 EIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-------LSD 358
            IA  + +LH      + KP + HRDLK  NI +       IAD G A         L  
Sbjct: 142 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 201
Query: 359 GEMALTGTFVYMAPEV------IQCEPYSEKSDVYSFGIILNEI---ITGNHPYIEKDYK 409
           G     GT  YMAPEV      + C    ++ D+++FG++L E+   +  N   I +DYK
Sbjct: 202 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG--IVEDYK 259
Query: 410 P 410
           P
Sbjct: 260 P 260

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/236 (29%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF- 240
           ++K   W ++  EI     +G+G   N+Y  R       +A+K ++       +  V   
Sbjct: 4   ESKKRQWALEDFEIG--RPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQ 59
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMV 298
             +EV+  S  RH  +L+L G       R +L+ E    G   KE             + 
Sbjct: 60  LRREVEIQSHLRHPNILRLYG-YFHDATRVYLILEYAPRGEVYKE-------------LQ 105
Query: 299 PLPPFEE-RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HA 353
            L  F+E R A  + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA
Sbjct: 106 KLSKFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHA 163
Query: 354 RFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              S     L GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 164 P--SSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 217

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/219 (33%), Positives = 108/219 (49%), Gaps = 25/219 (11%)
Query: 193 DPKEI-DLQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+ + D   KIG+G+T  +   R    G  VAVK +  D        + F   EV  + 
Sbjct: 42  DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLF--NEVVIMR 97
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
             +H  V+++        Y+ +LV E L   L E+L G G+       V L   EE++A 
Sbjct: 98  DYQHFNVVEM--------YKSYLVGEELWV-LMEFLQG-GALTDIVSQVRLN--EEQIAT 145
Query: 310 ALE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMALTG 365
             E + QA+ YLH Q   VIHRD+K  +I L     V+++DFG    +S        L G
Sbjct: 146 VCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVG 203
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  +MAPEVI    Y+ + D++S GI++ E++ G  PY 
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF 242

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 30/225 (13%)
Query: 195 KEIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQ 251
           ++ ++   +G+G   N+Y  R       +A+K ++       +  V     +EV+  S  
Sbjct: 11  EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKA--QLEKAGVEHQLRREVEIQSHL 68
Query: 252 RHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEE-RLA 308
           RH  +L+L G       R +L+ E   LGT  +E             +  L  F+E R A
Sbjct: 69  RHPNILRLYG-YFHDATRVYLILEYAPLGTVYRE-------------LQKLSKFDEQRTA 114
Query: 309 RAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALT 364
             + E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG   HA   S     L 
Sbjct: 115 TYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRDDLC 170
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 215

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VA+K I  D    N  ++    +EV  +    H  +
Sbjct: 16  LLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +L+ E   G  + ++L   G  + KE            ++  +I  
Sbjct: 74  VKLF-EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR----------SKFRQIVS 122
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEM-ALTGTFVYMAPE 373
           A+QY H+++  ++HRDLK  N+ LD   +++IADFG +  F   G++    G+  Y APE
Sbjct: 123 AVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPE 180
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 181 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 211

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 19  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 75
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 76  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 131
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 132 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 189
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 190 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 250 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 300
Query: 460 SLKNI 464
            L  I
Sbjct: 301 DLDRI 305

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 42/241 (17%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           ++I L E +G+G    ++R  W+G +VAVK      F + +    F   E+      RH 
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHE 62
Query: 255 FVLQLMGACLEPPYRG---WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
            +L  + + +   +     WL+T           H +GS     ++  L      L   L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITH---------YHEMGSLYDYLQLTTLDTV-SCLRIVL 112
Query: 312 EIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-------LSD 358
            IA  + +LH      + KP + HRDLK  NI +       IAD G A         L  
Sbjct: 113 SIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172
Query: 359 GEMALTGTFVYMAPEV------IQCEPYSEKSDVYSFGIILNEI---ITGNHPYIEKDYK 409
           G     GT  YMAPEV      + C    ++ D+++FG++L E+   +  N   I +DYK
Sbjct: 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG--IVEDYK 230
Query: 410 P 410
           P
Sbjct: 231 P 231

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 81/150 (54%), Gaps = 10/150 (6%)
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMALTGTF 367
           ++I  A++++H++K  ++HRD+K  NIFL     V++ DFG AR L+       A  GT 
Sbjct: 132 VQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            Y++PE+ + +PY+ KSD+++ G +L E+ T  H +     K   + +++  G   P   
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLVLKIISGSFPPVSL 247
Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSI 457
                LR L+  +   +  +   RPS +SI
Sbjct: 248 HYSYDLRSLVSQL---FKRNPRDRPSVNSI 274

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEEDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 17  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 73
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 74  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 129
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 130 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENNVMKIAD 187
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 188 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 248 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 298
Query: 460 SLKNI 464
            L  I
Sbjct: 299 DLDRI 303

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 48/272 (17%)
Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT 279
           VAVK +  D         + + QE+D L    H  +++  G C +       LV E +  
Sbjct: 63  VAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 280 -TLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
            +L+++L  H +G               + L  A +I + M YLH Q    IHRDL   N
Sbjct: 120 GSLRDYLPRHSIG-------------LAQLLLFAQQICEGMAYLHAQH--YIHRDLAARN 164
Query: 337 IFLDDAKHVRIADFGHARFLSDG-------EMALTGTFVYMAPEVIQCEPYSEKSDVYSF 389
           + LD+ + V+I DFG A+ + +G       E   +  F Y APE ++   +   SDV+SF
Sbjct: 165 VLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWY-APECLKEYKFYYASDVWSF 223
Query: 390 GIILNEIITGNHPYIEKDYKPAKIAME---VGEGKLR-----------PALPEEDGQLRE 435
           G+ L E++T    + +    P    +E   + +G++              LP  D    E
Sbjct: 224 GVTLYELLT----HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAE 279
Query: 436 LIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
           +  L+   W+ +AS RP+F ++   LK +  K
Sbjct: 280 VYHLMKNCWETEASFRPTFENLIPILKTVHEK 311

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 22  WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 78
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 79  LVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 134
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 135 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 192
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 193 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 253 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 303
Query: 460 SLKNI 464
            L  I
Sbjct: 304 DLDRI 308

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 130/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 64
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 121
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R 
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + +      G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 180 IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  +  +RP+F  I   LK+
Sbjct: 240 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 288

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 137/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W     ++ L + +G+G    +  A   G+D         VAVK +  D     E  ++ 
Sbjct: 30  WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSD 86
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM-- 297
              E++ +    +H+ ++ L+GAC +      +V       L+E+L      RR   M  
Sbjct: 87  LVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRA----RRPPGMEY 142
Query: 298 ------VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
                 VP     F++ ++   ++A+ M+YL  QK   IHRDL   N+ + +   ++IAD
Sbjct: 143 SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENNVMKIAD 200
Query: 350 FGHARFLSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           FG AR +++ +     T       +MAPE +    Y+ +SDV+SFG+++ EI T G  PY
Sbjct: 201 FGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +PA         EL  ++   W    S RP+F  +  
Sbjct: 261 PGIPVEELFK----LLKEGHRMDKPA-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 311
Query: 460 SLKNI 464
            L  I
Sbjct: 312 DLDRI 316

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 119 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 236
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 237 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 64
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 65  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 121
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HR+L   N  +     V+I DFG  R 
Sbjct: 122 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRD 179
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 239
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  + ++RP+F  I   LK+
Sbjct: 240 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAV+ I  D    N +++    +EV  +    H  +
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 76  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR----------AKFRQIVS 124
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G       G+  Y APE
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 182
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 477 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 535 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 594
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 595 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 39/295 (13%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV---- 238
           W +  ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A     
Sbjct: 13  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRER 65
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELLG-TTLKEWLHGLGSQRRKE 295
             F  E   +       V++L+G     +P     +V EL+    LK +L  L  +    
Sbjct: 66  IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL---VVMELMAHGDLKSYLRSLRPEAENN 122
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
              P P  +E +  A EIA  M YL+ +K   +HR+L   N  +     V+I DFG  R 
Sbjct: 123 PGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRNLAARNCMVAHDFTVKIGDFGMTRD 180
Query: 356 LSDGEMALTG-----TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDY 408
           + + +    G        +MAPE ++   ++  SD++SFG++L EI +    PY    + 
Sbjct: 181 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 240
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           +  K  M+ G       L + D     + +L+ + W  + ++RP+F  I   LK+
Sbjct: 241 QVLKFVMDGG------YLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKD 289

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 478 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 536 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 595
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 596 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 635

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 36/182 (19%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLE-----------PPYRGWLVTELL-GTTLKEWLHGLGS 290
           +EV  L++  H  +++   A LE           P    ++  +L     LK+W++G  +
Sbjct: 52  REVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT 111
Query: 291 QRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
              +ER V L  F       L+IA+A+++LH +   ++HRDLKPSNIF      V++ DF
Sbjct: 112 IEERERSVCLHIF-------LQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDF 162
Query: 351 GHARFLSDGEMALT---------------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNE 395
           G    +   E   T               GT +YM+PE I    YS K D++S G+IL E
Sbjct: 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
Query: 396 II 397
           ++
Sbjct: 223 LL 224

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAVK I  D    N +++    +EV  +    H  +
Sbjct: 11  LLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 69  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR----------AKFRQIVS 117
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G       G+  Y APE
Sbjct: 118 AVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPE 175
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 206

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 119 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 236
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 237 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 276

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 113 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 171 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 230
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 231 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 270

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 115 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 173 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 232
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 233 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 199 LQEKIGQGTTANI--YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L + IG+G  A +   R I  G +VAV+ I  D    N +++    +EV  +    H  +
Sbjct: 18  LLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           ++L    +E     +LV E   G  + ++L   G  + KE            A+  +I  
Sbjct: 76  VKLF-EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEAR----------AKFRQIVS 124
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYMAPE 373
           A+QY H++   ++HRDLK  N+ LD   +++IADFG +   + G       G+  Y APE
Sbjct: 125 AVQYCHQKF--IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPE 182
Query: 374 VIQCEPY-SEKSDVYSFGIILNEIITGNHPY 403
           + Q + Y   + DV+S G+IL  +++G+ P+
Sbjct: 183 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPF 213

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 125 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 242
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 243 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 133 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 191 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 250
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 251 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 290

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 102/240 (42%), Gaps = 42/240 (17%)
Query: 196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +I L E +G+G    ++R  W+G +VAVK      F + +    F   E+      RH  
Sbjct: 9   QITLLECVGKGRYGEVWRGSWQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHEN 63
Query: 256 VLQLMGACLEPPYRG---WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
           +L  + + +   +     WL+T           H +GS     ++  L      L   L 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITH---------YHEMGSLYDYLQLTTLDTV-SCLRIVLS 113
Query: 313 IAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF-------LSDG 359
           IA  + +LH      + KP + HRDLK  NI +       IAD G A         L  G
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 360 EMALTGTFVYMAPEV------IQCEPYSEKSDVYSFGIILNEI---ITGNHPYIEKDYKP 410
                GT  YMAPEV      + C    ++ D+++FG++L E+   +  N   I +DYKP
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG--IVEDYKP 231

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 135 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 252
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 253 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 76/165 (46%), Gaps = 14/165 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----- 366
           +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E           
Sbjct: 135 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 367 -FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRP 424
              + APE I    +S KSDV+SFG+++ E  + G  PY           +E GE    P
Sbjct: 193 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCP 252
Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT 469
           A     G  RE+ +L+ L W  D   RP F+++   L+N    V 
Sbjct: 253 A-----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 292

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 79
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNP 139
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 198 RDIHHIDXXKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 254 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 460 SLKNI 464
            L  I
Sbjct: 305 DLDRI 309

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/131 (38%), Positives = 74/131 (56%), Gaps = 14/131 (10%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNI-FLDDAKH---VRIADFGHARFL 356
           F ER A A+   I + ++YLH Q   V+HRDLKPSNI ++D++ +   +RI DFG A+ L
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 357 SDGEMALTGTFVY----MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK-DYKPA 411
              E  L  T  Y    +APEV++ + Y    D++S G++L   +TG  P+    D  P 
Sbjct: 171 R-AENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPE 229
Query: 412 KIAMEVGEGKL 422
           +I   +G GK 
Sbjct: 230 EILARIGSGKF 240

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 16  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 72
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 73  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 132
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 133 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 191 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 246
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 247 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 297
Query: 460 SLKNI 464
            L  I
Sbjct: 298 DLDRI 302

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 79
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 139
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 198 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 254 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 460 SLKNI 464
            L  I
Sbjct: 305 DLDRI 309

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 15  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 71
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 72  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 131
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 132 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 190 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 245
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 246 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 296
Query: 460 SLKNI 464
            L  I
Sbjct: 297 DLDRI 301

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 22/216 (10%)
Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-R 254
           DL E IG+G   ++ + + +  G  +AVK I       +E        ++D + R     
Sbjct: 26  DLGE-IGRGAYGSVNKMVHKPSGQIMAVKRIRS---TVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEI 313
           +++Q  GA        W+  EL+ T+  ++   + S    + ++P    EE L +  L  
Sbjct: 82  YIVQFYGALFREG-DCWICMELMSTSFDKFYKYVYSVL--DDVIP----EEILGKITLAT 134
Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD--GEMALTGTFVYMA 371
            +A+ +L E   K+IHRD+KPSNI LD + ++++ DFG +  L D   +    G   YMA
Sbjct: 135 VKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMA 193
Query: 372 PEVIQC----EPYSEKSDVYSFGIILNEIITGNHPY 403
           PE I      + Y  +SDV+S GI L E+ TG  PY
Sbjct: 194 PERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 79
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNP 139
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 198 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 254 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 460 SLKNI 464
            L  I
Sbjct: 305 DLDRI 309

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 12  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 68
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 69  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 128
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 129 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 187 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 242
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 243 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 293
Query: 460 SLKNI 464
            L  I
Sbjct: 294 DLDRI 298

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWL--HGLGSQRRKER 296
           + QE+D L    H  +++  G C +   +   LV E +   +L+++L  H +G       
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG------- 115
Query: 297 MVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
                   + L  A +I + M YLH Q    IHR+L   N+ LD+ + V+I DFG A+ +
Sbjct: 116 ------LAQLLLFAQQICEGMAYLHSQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 357 SDG-------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            +G       E   +  F Y APE ++   +   SDV+SFG+ L E++T    + +    
Sbjct: 168 PEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT----HCDSSQS 222
Query: 410 PAKIAME---VGEGKLR-----------PALPEEDGQLRELIELICLSWDGDASVRPSFS 455
           P    +E   + +G++              LP  D    E+  L+   W+ +AS RP+F 
Sbjct: 223 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFE 282
Query: 456 SITCSLKNIQMK 467
           ++   LK +  K
Sbjct: 283 NLIPILKTVHEK 294

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 18/165 (10%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +E+  L   RH  +++L    +  P    +V E  G  L +++        K+RM     
Sbjct: 58  REISYLKLLRHPHIIKLYDV-ITTPTDIVMVIEYAGGELFDYI------VEKKRMT---- 106
Query: 303 FEERLARALE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
            E+   R  + I  A++Y H  K  ++HRDLKP N+ LDD  +V+IADFG +  ++DG  
Sbjct: 107 -EDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163
Query: 362 ALT--GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
             T  G+  Y APEVI  + Y+  + DV+S GI+L  ++ G  P+
Sbjct: 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 64  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 120
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 121 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 239 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 294
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 295 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 345
Query: 460 SLKNI 464
            L  I
Sbjct: 346 DLDRI 350

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+  +    F +E+  L      F+++  G    P  +   LV E L +  L+++L    
Sbjct: 49  HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---- 104
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            QR + R+         L  + +I + M+YL  ++   +HRDL   NI ++   HV+IAD
Sbjct: 105 -QRHRARLDA----SRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIAD 157
Query: 350 FGHARFLS-DGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG A+ L  D +  +          + APE +    +S +SDV+SFG++L E+ T    Y
Sbjct: 158 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT----Y 213
Query: 404 IEKDYKP-AKIAMEVGEGKLRPA-------------LPEEDGQLRELIELICLSWDGDAS 449
            +K   P A+    +G  +  PA             LP       E+ EL+ L W     
Sbjct: 214 CDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQ 273
Query: 450 VRPSFSSI 457
            RPSFS++
Sbjct: 274 DRPSFSAL 281

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 105/213 (49%), Gaps = 26/213 (12%)
Query: 202 KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           ++G GT   +++  +R  G  +AVK +     +  EN       +V  L      +++Q 
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLDV-VLKSHDCPYIVQC 89
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA--QAM 317
            G  +      ++  EL+GT          +++ K+RM    P  ER+   + +A  +A+
Sbjct: 90  FGTFITNT-DVFIAMELMGTC---------AEKLKKRM--QGPIPERILGKMTVAIVKAL 137
Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVI 375
            YL E K  VIHRD+KPSNI LD+   +++ DFG +  L D +      G   YMAPE I
Sbjct: 138 YYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
Query: 376 Q----CEP-YSEKSDVYSFGIILNEIITGNHPY 403
                 +P Y  ++DV+S GI L E+ TG  PY
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 32/243 (13%)
Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  R  G  VAVK +  D        + F   EV  + 
Sbjct: 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 203
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 204 DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQI 249
Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + QA+  LH Q   VIHRD+K  +I L     V+++DFG    +S        L
Sbjct: 250 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 307
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 364
Query: 424 PAL 426
           P L
Sbjct: 365 PRL 367

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 45/252 (17%)
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWL--HGLGSQRRKER 296
           + QE+D L    H  +++  G C +   +   LV E +   +L+++L  H +G       
Sbjct: 63  WKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG------- 115
Query: 297 MVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
                   + L  A +I + M YLH Q    IHR+L   N+ LD+ + V+I DFG A+ +
Sbjct: 116 ------LAQLLLFAQQICEGMAYLHAQH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAV 167
Query: 357 SDG-------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            +G       E   +  F Y APE ++   +   SDV+SFG+ L E++T    + +    
Sbjct: 168 PEGHEYYRVREDGDSPVFWY-APECLKEYKFYYASDVWSFGVTLYELLT----HCDSSQS 222
Query: 410 PAKIAME---VGEGKLR-----------PALPEEDGQLRELIELICLSWDGDASVRPSFS 455
           P    +E   + +G++              LP  D    E+  L+   W+ +AS RP+F 
Sbjct: 223 PPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFE 282
Query: 456 SITCSLKNIQMK 467
           ++   LK +  K
Sbjct: 283 NLIPILKTVHEK 294

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 59/233 (25%)
Query: 203 IGQGTTANIYRAIWRGLD---VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +GQG    + +A    LD    A+K I     HT E   T  + EV  L+   H++V++ 
Sbjct: 14  LGQGAFGQVVKA-RNALDSRYYAIKKIR----HTEEKLSTILS-EVMLLASLNHQYVVRY 67
Query: 260 MGACLEPPYRGWLVTELLGT----------------TLKEWLHGLG-SQRRKERMVPLPP 302
             A LE   R   V  +                   TL + +H    +Q+R E       
Sbjct: 68  YAAWLE---RRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYW----- 119
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL------ 356
              RL R  +I +A+ Y+H Q   +IHRDLKP NIF+D++++V+I DFG A+ +      
Sbjct: 120 ---RLFR--QILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 357 -----------SDGEMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEII 397
                      SD   +  GT +Y+A EV+     Y+EK D+YS GII  E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 32/243 (13%)
Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  R  G  VAVK +  D        + F   EV  + 
Sbjct: 26  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 81
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 82  DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQI 127
Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + QA+  LH Q   VIHRD+K  +I L     V+++DFG    +S        L
Sbjct: 128 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 185
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 186 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 242
Query: 424 PAL 426
           P L
Sbjct: 243 PRL 245

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 129/294 (43%), Gaps = 23/294 (7%)
Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAV 238
           Q K+    ID   + L + +G+G   ++     +      L VAVK +  D  ++++  +
Sbjct: 23  QNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD--NSSQREI 80
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEW-LHGLGSQRRKERM 297
             F  E   +    H  V++L+G C+E   +G     ++   +K   LH      R E  
Sbjct: 81  EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
               P +  L   ++IA  M+YL  +    +HRDL   N  L D   V +ADFG ++ + 
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIY 198
Query: 358 DGEMALTGTFVYMAPEVIQCEP-----YSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPA 411
            G+    G    M  + I  E      Y+ KSDV++FG+ + EI T G  PY      P 
Sbjct: 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPY------PG 252
Query: 412 KIAMEVGEGKLRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               E+ +  L    L + +  L EL E++   W  D   RP+FS +   L+ +
Sbjct: 253 VQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 32/243 (13%)
Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  R  G  VAVK +  D        + F   EV  + 
Sbjct: 28  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 83
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 84  DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQI 129
Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + QA+  LH Q   VIHRD+K  +I L     V+++DFG    +S        L
Sbjct: 130 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 187
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 188 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 244
Query: 424 PAL 426
           P L
Sbjct: 245 PRL 247

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/233 (31%), Positives = 108/233 (46%), Gaps = 59/233 (25%)
Query: 203 IGQGTTANIYRAIWRGLD---VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +GQG    + +A    LD    A+K I     HT E   T  + EV  L+   H++V++ 
Sbjct: 14  LGQGAFGQVVKA-RNALDSRYYAIKKIR----HTEEKLSTILS-EVMLLASLNHQYVVRY 67
Query: 260 MGACLEPPYRGWLVTELLGT----------------TLKEWLHGLG-SQRRKERMVPLPP 302
             A LE   R   V  +                   TL + +H    +Q+R E       
Sbjct: 68  YAAWLE---RRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----- 119
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL------ 356
              RL R  +I +A+ Y+H Q   +IHRDLKP NIF+D++++V+I DFG A+ +      
Sbjct: 120 ---RLFR--QILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 357 -----------SDGEMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEII 397
                      SD   +  GT +Y+A EV+     Y+EK D+YS GII  E+I
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 70/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ADFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 70/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ADFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 70/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ADFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 41/123 (33%), Positives = 70/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ADFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 32/243 (13%)
Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  R  G  VAVK +  D        + F   EV  + 
Sbjct: 21  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 76
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 77  DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQI 122
Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + QA+  LH Q   VIHRD+K  +I L     V+++DFG    +S        L
Sbjct: 123 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 180
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 181 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 237
Query: 424 PAL 426
           P L
Sbjct: 238 PRL 240

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 128/288 (44%), Gaps = 35/288 (12%)
Query: 195 KEIDLQEKIGQGTTANIY----RAIWRG---LDVAVKCIYPDFFHTNENAV----TFFAQ 243
           ++I L  ++GQG+   +Y    R I +G     VAVK +       NE+A       F  
Sbjct: 16  EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTV-------NESASLRERIEFLN 68
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVPLPP 302
           E   +       V++L+G  +       +V EL+    LK +L  L  +       P P 
Sbjct: 69  EASVMKGFTCHHVVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 127
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
            +E +  A EIA  M YL+ +K   +HRDL   N  +     V+I DFG  R + + +  
Sbjct: 128 LQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 185
Query: 363 LTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE-KDYKPAKIAM 415
             G        +MAPE ++   ++  SD++SFG++L EI +    PY    + +  K  M
Sbjct: 186 RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 245
Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           + G       L + D     + +L+ + W  +  +RP+F  I   LK+
Sbjct: 246 DGG------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 32/243 (13%)
Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  R  G  VAVK +  D        + F   EV  + 
Sbjct: 71  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 126
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 127 DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQI 172
Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + QA+  LH Q   VIHRD+K  +I L     V+++DFG    +S        L
Sbjct: 173 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 230
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 287
Query: 424 PAL 426
           P L
Sbjct: 288 PRL 290

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 115/243 (47%), Gaps = 32/243 (13%)
Query: 193 DPKE-IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+  +D   KIG+G+T  +  A  R  G  VAVK +  D        + F   EV  + 
Sbjct: 17  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLF--NEVVIMR 72
Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERL 307
             +H  V+++        Y  +LV + L   + E+L G  L       RM      EE++
Sbjct: 73  DYQHENVVEM--------YNSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQI 118
Query: 308 ARA-LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG---EMAL 363
           A   L + QA+  LH Q   VIHRD+K  +I L     V+++DFG    +S        L
Sbjct: 119 AAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL 176
Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+I   PY  + D++S GI++ E++ G  PY     +P   AM++    L 
Sbjct: 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN---EPPLKAMKMIRDNLP 233
Query: 424 PAL 426
           P L
Sbjct: 234 PRL 236

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           ++ DL   IG+G+ A +     +  D   A+K +  +  + +E+        +D +  ++
Sbjct: 20  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED--------IDWVQTEK 71
Query: 253 HRF-------VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           H F        L  + +C +   R + V E        +++G       +R   LP    
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIE--------YVNGGDLMFHMQRQRKLPEEHA 123
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLSDGEMA 362
           R   A EI+ A+ YLHE+   +I+RDLK  N+ LD   H+++ D+G  +      D    
Sbjct: 124 RFYSA-EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSX 180
Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             GT  Y+APE+++ E Y    D ++ G+++ E++ G  P+
Sbjct: 181 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGAT 216
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 217 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 274
Query: 421 KLR 423
           K+R
Sbjct: 275 KVR 277

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/136 (31%), Positives = 77/136 (56%), Gaps = 12/136 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFVYM 370
           + +A+ +LH     ++HRDLKP NI LDD   +R++DFG +  L  GE    L GT  Y+
Sbjct: 209 LLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYL 266
Query: 371 APEVIQCE------PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
           APE+++C        Y ++ D+++ G+IL  ++ G+ P+  +  +   +   + EG+ + 
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR--RQILMLRMIMEGQYQF 324
Query: 425 ALPEEDGQLRELIELI 440
           + PE D +   + +LI
Sbjct: 325 SSPEWDDRSSTVKDLI 340

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 90/169 (53%), Gaps = 17/169 (10%)
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           ++ A +I+Q MQYL E K  ++HRDL   NI + + + ++I+DFG +R + + +  +  +
Sbjct: 153 ISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 367 -----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI--AMEVG 418
                  +MA E +    Y+ +SDV+SFG++L EI+T G +PY      P ++   ++ G
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPERLFNLLKTG 268
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
               RP     D    E+  L+   W  +   RP F+ I+  L+ + +K
Sbjct: 269 HRMERP-----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 23  WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 79
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 80  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNP 139
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 140 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 198 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 254 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 304
Query: 460 SLKNI 464
            L  I
Sbjct: 305 DLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/305 (25%), Positives = 136/305 (44%), Gaps = 48/305 (15%)
Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSD 64
Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
              E++ +    +H+ ++ L+GAC +      +V       L+E+L        +    P
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNP 124
Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               EE+L+       A ++A+ M+YL  +K   IHRDL   N+ + +   ++IADFG A
Sbjct: 125 SHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 354 RFL---------SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY 403
           R +         ++G + +     +MAPE +    Y+ +SDV+SFG++L EI T G  PY
Sbjct: 183 RDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 404 ----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC 459
               +E+ +K     ++ G    +P+         EL  ++   W    S RP+F  +  
Sbjct: 239 PGVPVEELFK----LLKEGHRMDKPS-----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289
Query: 460 SLKNI 464
            L  I
Sbjct: 290 DLDRI 294

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+  +    F +E+  L      F+++  G    P  +   LV E L +  L+++L    
Sbjct: 50  HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---- 105
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            QR + R+         L  + +I + M+YL  ++   +HRDL   NI ++   HV+IAD
Sbjct: 106 -QRHRARLDA----SRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIAD 158
Query: 350 FGHARFLS-DGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG A+ L  D +  +          + APE +    +S +SDV+SFG++L E+ T    Y
Sbjct: 159 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT----Y 214
Query: 404 IEKDYKP-AKIAMEVGEGKLRPA-------------LPEEDGQLRELIELICLSWDGDAS 449
            +K   P A+    +G  +  PA             LP       E+ EL+ L W     
Sbjct: 215 CDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQ 274
Query: 450 VRPSFSSI 457
            RPSFS++
Sbjct: 275 DRPSFSAL 282

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 112/248 (45%), Gaps = 37/248 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTELLGT-TLKEWLHGLG 289
           H+  +    F +E+  L      F+++  G    P  +   LV E L +  L+++L    
Sbjct: 62  HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---- 117
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            QR + R+         L  + +I + M+YL  ++   +HRDL   NI ++   HV+IAD
Sbjct: 118 -QRHRARLDA----SRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIAD 170
Query: 350 FGHARFLS-DGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG A+ L  D +  +          + APE +    +S +SDV+SFG++L E+ T    Y
Sbjct: 171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT----Y 226
Query: 404 IEKDYKP-AKIAMEVGEGKLRPA-------------LPEEDGQLRELIELICLSWDGDAS 449
            +K   P A+    +G  +  PA             LP       E+ EL+ L W     
Sbjct: 227 CDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQ 286
Query: 450 VRPSFSSI 457
            RPSFS++
Sbjct: 287 DRPSFSAL 294

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 192 IDPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           +DP E+ ++  ++G G    +Y+A  +  G   A K I       +E  +  +  E++ L
Sbjct: 15  LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYIVEIEIL 70
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           +   H ++++L+GA      + W++ E   G  +   +  L      +R +  P  +   
Sbjct: 71  ATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLEL------DRGLTEPQIQVVC 123
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLSDGEM--ALT 364
            + LE   A+ +LH ++  +IHRDLK  N+ +     +R+ADFG  A+ L   +   +  
Sbjct: 124 RQMLE---ALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 178
Query: 365 GTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           GT  +MAPEV+ CE     PY  K+D++S GI L E+     P+ E    P ++ +++ +
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAK 236
Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               P L        E  + + ++ D +   RPS + +
Sbjct: 237 SD-PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 273

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 31/221 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           ++ DL   IG+G+ A +     +  D   A++ +  +  + +E+        +D +  ++
Sbjct: 52  QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDED--------IDWVQTEK 103
Query: 253 HRF-------VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           H F        L  + +C +   R + V E        +++G       +R   LP    
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIE--------YVNGGDLMFHMQRQRKLPEEHA 155
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT 364
           R   A EI+ A+ YLHE+   +I+RDLK  N+ LD   H+++ D+G  +  L  G+   T
Sbjct: 156 RFYSA-EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
Query: 365 --GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             GT  Y+APE+++ E Y    D ++ G+++ E++ G  P+
Sbjct: 213 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/234 (30%), Positives = 112/234 (47%), Gaps = 37/234 (15%)
Query: 253 HRFVLQLMGAC-LEPPYRGWLVTELLGTTLKEWLHGLGSQRRK----------------E 295
           H  ++ L+GAC L  P   +L+ E       + L+ L S+R K                E
Sbjct: 108 HENIVNLLGACTLSGPI--YLIFEY--CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR- 354
             + +  FE+ L  A ++A+ M++L  +    +HRDL   N+ +   K V+I DFG AR 
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 355 FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKD 407
            +SD    + G       +MAPE +    Y+ KSDV+S+GI+L EI + G +PY  I  D
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 281
Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
               K+ ++ G    +P    E     E+  ++   W  D+  RPSF ++T  L
Sbjct: 282 ANFYKL-IQNGFKMDQPFYATE-----EIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 132/278 (47%), Gaps = 31/278 (11%)
Query: 192 IDPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           +DP E+ ++  ++G G    +Y+A  +  G   A K I       +E  +  +  E++ L
Sbjct: 7   LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYIVEIEIL 62
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           +   H ++++L+GA      + W++ E   G  +   +  L      +R +  P  +   
Sbjct: 63  ATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLEL------DRGLTEPQIQVVC 115
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLSDGEM--ALT 364
            + LE   A+ +LH ++  +IHRDLK  N+ +     +R+ADFG  A+ L   +   +  
Sbjct: 116 RQMLE---ALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI 170
Query: 365 GTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           GT  +MAPEV+ CE     PY  K+D++S GI L E+     P+ E    P ++ +++ +
Sbjct: 171 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE--LNPMRVLLKIAK 228
Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               P L        E  + + ++ D +   RPS + +
Sbjct: 229 SD-PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQL 265

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           G  +D +     EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+ 
Sbjct: 1   GPLVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREIS 58
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            L    H  +++L+   +    + +LV E L   LK+++            +PLP  +  
Sbjct: 59  LLKELNHPNIVKLLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSY 112
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG- 365
           L    ++ Q + + H  +  V+HRDLKP N+ ++    +++ADFG AR         T  
Sbjct: 113 L---FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 167
Query: 366 --TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIIT 398
             T  Y APE+ + C+ YS   D++S G I  E++T
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 90/169 (53%), Gaps = 17/169 (10%)
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           ++ A +I+Q MQYL E K  ++HRDL   NI + + + ++I+DFG +R + + +  +  +
Sbjct: 153 ISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRS 210
Query: 367 -----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI--AMEVG 418
                  +MA E +    Y+ +SDV+SFG++L EI+T G +PY      P ++   ++ G
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPERLFNLLKTG 268
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
               RP     D    E+  L+   W  +   RP F+ I+  L+ + +K
Sbjct: 269 HRMERP-----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/234 (31%), Positives = 110/234 (47%), Gaps = 35/234 (14%)
Query: 202 KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           KIG+G+T  +  A  +  G  VAVK +  D        + F   EV  +    H  V+ +
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLF--NEVVIMRDYHHDNVVDM 107
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERLARA-LEIAQA 316
                   Y  +LV + L   + E+L G  L       RM      EE++A   L + +A
Sbjct: 108 --------YSSYLVGDELWVVM-EFLEGGALTDIVTHTRM-----NEEQIATVCLSVLRA 153
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD---GEMALTGTFVYMAPE 373
           + YLH Q   VIHRD+K  +I L     ++++DFG    +S        L GT  +MAPE
Sbjct: 154 LSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE 211
Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
           VI   PY  + D++S GI++ E+I G  PY     +P   AM     ++R +LP
Sbjct: 212 VISRLPYGTEVDIWSLGIMVIEMIDGEPPYFN---EPPLQAMR----RIRDSLP 258

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           ++ DL   IG+G+ A +     +  D   A+K +  +  + +E        ++D +  ++
Sbjct: 5   QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--------DIDWVQTEK 56
Query: 253 HRF-------VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           H F        L  + +C +   R + V E        +++G       +R   LP    
Sbjct: 57  HVFEQASNHPFLVGLHSCFQTESRLFFVIE--------YVNGGDLMFHMQRQRKLPEEHA 108
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLSDGEMA 362
           R   A EI+ A+ YLHE+   +I+RDLK  N+ LD   H+++ D+G  +      D    
Sbjct: 109 RFYSA-EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSX 165
Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             GT  Y+APE+++ E Y    D ++ G+++ E++ G  P+
Sbjct: 166 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 70/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D+  ++++ DFG A+ +    
Sbjct: 125 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRT 182
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 183 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 240
Query: 421 KLR 423
           K+R
Sbjct: 241 KVR 243

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 34/227 (14%)
Query: 192 IDP---KEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVD 246
           +DP   ++ DL   IG+G+ A +     +  D   A+K +  +  + +E        ++D
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDE--------DID 54
Query: 247 TLSRQRHRF-------VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
            +  ++H F        L  + +C +   R + V E        +++G       +R   
Sbjct: 55  WVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE--------YVNGGDLMFHMQRQRK 106
Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FL 356
           LP    R   A EI+ A+ YLHE+   +I+RDLK  N+ LD   H+++ D+G  +     
Sbjct: 107 LPEEHARFYSA-EISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163
Query: 357 SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            D      GT  Y+APE+++ E Y    D ++ G+++ E++ G  P+
Sbjct: 164 GDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 37/248 (14%)
Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--PYRGWLVTELLGTTLKEWLHGLG 289
           H+  +    F +E+  L      F+++  G    P  P    ++  L    L+++L    
Sbjct: 46  HSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL---- 101
Query: 290 SQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD 349
            QR + R+         L  + +I + M+YL  ++   +HRDL   NI ++   HV+IAD
Sbjct: 102 -QRHRARLDA----SRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIAD 154
Query: 350 FGHARFLS-DGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG A+ L  D +  +          + APE +    +S +SDV+SFG++L E+ T    Y
Sbjct: 155 FGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT----Y 210
Query: 404 IEKDYKP-AKIAMEVGEGKLRPA-------------LPEEDGQLRELIELICLSWDGDAS 449
            +K   P A+    +G  +  PA             LP       E+ EL+ L W     
Sbjct: 211 CDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQ 270
Query: 450 VRPSFSSI 457
            RPSFS++
Sbjct: 271 DRPSFSAL 278

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 12/130 (9%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNI-FLDDAKH---VRIADFGHARFL 356
           F ER A  +   I + ++YLH Q   V+HRDLKPSNI ++D++ +   +RI DFG A+ L
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 357 -SDGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE-KDYKPAK 412
            ++  + +T  +   ++APEV++ + Y E  D++S GI+L  ++ G  P+       P +
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE 235
Query: 413 IAMEVGEGKL 422
           I   +G GK 
Sbjct: 236 ILTRIGSGKF 245

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENA-VTFFAQEVDTLSRQRHRFVLQL 259
           +G+G+   +  A  +  G   AVK +  D    +++   T   + + +L+R  H F+ QL
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN-HPFLTQL 89
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAM 317
              C + P R + V E +     + +  +   RR         F+E  AR  A EI  A+
Sbjct: 90  F-CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRR---------FDEARARFYAAEIISAL 137
Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFVYMAPEV 374
            +LH++   +I+RDLK  N+ LD   H ++ADFG  +  + +G    T  GT  Y+APE+
Sbjct: 138 MFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEI 195
Query: 375 IQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           +Q   Y    D ++ G++L E++ G+ P+
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 203 IGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G+G+ A +YRA  I  GL+VA+K I     +     V     EV    + +H  +L+L 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQ 318
               +  Y  +LV E+          G  ++  K R   + PF E  AR    +I   M 
Sbjct: 78  NYFEDSNYV-YLVLEMCHN-------GEMNRYLKNR---VKPFSENEARHFMHQIITGML 126
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMAPEVI 375
           YLH     ++HRDL  SN+ L    +++IADFG A  L    +    L GT  Y++PE+ 
Sbjct: 127 YLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIA 184
Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPY 403
               +  +SDV+S G +   ++ G  P+
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPF 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 67
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 68  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 118
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 119 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 176
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLS 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/289 (27%), Positives = 132/289 (45%), Gaps = 44/289 (15%)
Query: 195 KEIDLQEK--IGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           KE +L++   +G G    +Y+ IW        + VA+K +     +T+  A      E  
Sbjct: 15  KETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE---NTSPKANKEILDEAY 71
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLP 301
            ++     +V +L+G CL    +  LVT+L+  G  L   +E    LGSQ          
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQ--LVTQLMPYGCLLDHVRENRGRLGSQ---------- 119
Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDG 359
              + L   ++IA+ M YL + +  ++HRDL   N+ +    HV+I DFG AR L   + 
Sbjct: 120 ---DLLNWCMQIAKGMSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 174
Query: 360 EMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
           E    G  V   +MA E I    ++ +SDV+S+G+ + E++T G  PY   D  PA+   
Sbjct: 175 EYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY---DGIPAREIP 231
Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           ++ E   R  LP+      ++  ++   W  D+  RP F  +      +
Sbjct: 232 DLLEKGER--LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRM 278

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 77/140 (55%), Gaps = 15/140 (10%)
Query: 271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIH 329
           W+  EL+ T+L ++   +     K + +P    E+ L + A+ I +A+++LH  K  VIH
Sbjct: 126 WICMELMDTSLDKFYKQVID---KGQTIP----EDILGKIAVSIVKALEHLHS-KLSVIH 177
Query: 330 RDLKPSNIFLDDAKHVRIADFGHARFLSD--GEMALTGTFVYMAPEVIQCE----PYSEK 383
           RD+KPSN+ ++    V++ DFG + +L D   +    G   YMAPE I  E     YS K
Sbjct: 178 RDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVK 237
Query: 384 SDVYSFGIILNEIITGNHPY 403
           SD++S GI + E+     PY
Sbjct: 238 SDIWSLGITMIELAILRFPY 257

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 90  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 134
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 192
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 247
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGL-------DVAVKCIYPDFFHTNENAVTFFAQEVDT 247
             I+    IG+G    +++A   GL        VAVK +  +    + +    F +E   
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAAL 103
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQR-----------RKER 296
           ++   +  +++L+G C        L   +    L E+L  +               R   
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 297 MVPLPP---FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
             P PP     E+L  A ++A  M YL E+K   +HRDL   N  + +   V+IADFG +
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 354 R-------FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE 405
           R       + +DG  A+     +M PE I    Y+ +SDV+++G++L EI + G  PY  
Sbjct: 222 RNIYSADYYKADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
             ++  ++   V +G +  A PE      EL  L+ L W    + RPSF SI
Sbjct: 280 MAHE--EVIYYVRDGNIL-ACPENCPL--ELYNLMRLCWSKLPADRPSFCSI 326

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 83  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 240
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/130 (35%), Positives = 76/130 (58%), Gaps = 12/130 (9%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNI-FLDDAKH---VRIADFGHARFL 356
           F ER A  +   I + ++YLH Q   V+HRDLKPSNI ++D++ +   +RI DFG A+ L
Sbjct: 118 FSEREASFVLHTIGKTVEYLHSQG--VVHRDLKPSNILYVDESGNPECLRICDFGFAKQL 175
Query: 357 -SDGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK-DYKPAK 412
            ++  + +T  +   ++APEV++ + Y E  D++S GI+L  ++ G  P+       P +
Sbjct: 176 RAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEE 235
Query: 413 IAMEVGEGKL 422
           I   +G GK 
Sbjct: 236 ILTRIGSGKF 245

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 66  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 116
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 117 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 6/112 (5%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303
Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 355

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 73
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 74  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 124
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 125 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 66  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 116
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 117 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------F 355
            E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       +
Sbjct: 192 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKP 410
           +  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I++++  
Sbjct: 250 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 305
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 + EG    A    D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 306 ---CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 203 IGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           IG G    +Y+ + R G  VA+K   P+    +   +  F  E++TLS  RH  ++ L+G
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH 321
            C E      +   +    LK  L+G  S      M     +E+RL   +  A+ + YLH
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYG--SDLPTMSM----SWEQRLEICIGAARGLHYLH 156
Query: 322 EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-GEMALT----GTFVYMAPEVIQ 376
            +   +IHRD+K  NI LD+    +I DFG ++  ++ G+  L     GT  Y+ PE   
Sbjct: 157 TRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFI 214
Query: 377 CEPYSEKSDVYSFGIILNEII 397
               +EKSDVYSFG++L E++
Sbjct: 215 KGRLTEKSDVYSFGVVLFEVL 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 41/112 (36%), Positives = 63/112 (56%), Gaps = 6/112 (5%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 248 FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 306
Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 307 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 358

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 203 IGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           IG G    +Y+ + R G  VA+K   P+    +   +  F  E++TLS  RH  ++ L+G
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIG 102
Query: 262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLP----PFEERLARALEIAQAM 317
            C E      +   +    LK  L+G            LP     +E+RL   +  A+ +
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYG----------SDLPTMSMSWEQRLEICIGAARGL 152
Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAP 372
            YLH +   +IHRD+K  NI LD+    +I DFG ++  ++ +       + GT  Y+ P
Sbjct: 153 HYLHTRA--IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 373 EVIQCEPYSEKSDVYSFGIILNEII 397
           E       +EKSDVYSFG++L E++
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 28/223 (12%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           K  + +E +G G  + +  A  +  G   AVKCI        E+++     E+  L + +
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIE---NEIAVLRKIK 78
Query: 253 HRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           H  ++ L     E P   +LV +L+ G  L +            R+V    + E+ A  L
Sbjct: 79  HENIVALED-IYESPNHLYLVMQLVSGGELFD------------RIVEKGFYTEKDASTL 125
Query: 312 --EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT-- 364
             ++  A+ YLH  +  ++HRDLKP N+     D+   + I+DFG ++    G++  T  
Sbjct: 126 IRQVLDAVYYLH--RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTAC 183
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           GT  Y+APEV+  +PYS+  D +S G+I   ++ G  P+ +++
Sbjct: 184 GTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 226

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+   +  P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADE--PIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------F 355
            E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       +
Sbjct: 190 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKP 410
           +  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I++++  
Sbjct: 248 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 303
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 + EG    A    D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 304 ---CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------F 355
            E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       +
Sbjct: 199 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKP 410
           +  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I++++  
Sbjct: 257 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 312
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 + EG    A    D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 313 ---CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 360

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 124 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 181
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 182 WTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 239
Query: 421 KLR 423
           K+R
Sbjct: 240 KVR 242

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 55/174 (31%), Positives = 87/174 (50%), Gaps = 24/174 (13%)
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------F 355
            E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       +
Sbjct: 197 LEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 356 LSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKP 410
           +  G+  L     +MAPE I    Y+ +SDV+SFG++L EI + G  PY    I++++  
Sbjct: 255 VRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-- 310
Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 + EG    A    D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 311 ---CRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 358

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 69
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 70  LLD-VIHTENKLYLVFEFLSMDLKDFMDASALTG-----IPLPLIKSYL---FQLLQGLA 120
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 121 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 68
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 69  LLD-VIHTENKLYLVFEFLSMDLKDFMDASALTG-----IPLPLIKSYL---FQLLQGLA 119
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 120 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 131 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 188
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 246
Query: 421 KLR 423
           K+R
Sbjct: 247 KVR 249

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 159 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 216
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 274
Query: 421 KLR 423
           K+R
Sbjct: 275 KVR 277

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 159 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 216
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 217 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 274
Query: 421 KLR 423
           K+R
Sbjct: 275 KVR 277

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 39/101 (38%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG--EMALTGT 366
           A EIA  + +L  Q   +I+RDLK  N+ LD   H++IADFG  +  + DG       GT
Sbjct: 448 AAEIAIGLFFL--QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGT 505
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE+I  +PY +  D ++FG++L E++ G  P+  +D
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 69
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 70  LLD-VIHTENKLYLVFEFLSMDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 120
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 121 FCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 133 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 190
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 191 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 248
Query: 421 KLR 423
           K+R
Sbjct: 249 KVR 251

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 29  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 88
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 89  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 133
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 134 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 191
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 192 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 246
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 247 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 282

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFVYMA 371
           Q +QYLH  +  VIHRDLK  N+FL+D   V+I DFG A +   DGE    L GT  Y+A
Sbjct: 153 QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIA 210
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL-RPALPEED 430
           PEV+  + +S + D++S G IL  ++ G  P+     K   I ++  E  + R   P   
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
             +R ++         D ++RPS + +
Sbjct: 271 ALIRRMLH-------ADPTLRPSVAEL 290

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 85  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 129
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 242
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FAEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 139 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 196
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 197 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 254
Query: 421 KLR 423
           K+R
Sbjct: 255 KVR 257

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 131 FXEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 188
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 189 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 246
Query: 421 KLR 423
           K+R
Sbjct: 247 KVR 249

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 35/229 (15%)
Query: 193 DPKEI-DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP  I +L E +G GT   +Y  R +  G   A+K +  D     E  +    QE++ L 
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEEIK---QEINMLK 75
Query: 250 R-QRHRFVLQLMGACLE--PPYRG---WLVTELLGT-TLKEWLHGLGSQRRKERMVPLPP 302
           +   HR +    GA ++  PP      WLV E  G  ++ + +        KE  +    
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-- 133
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
               + R  EI + + +LH+ K  VIHRD+K  N+ L +   V++ DFG +  L D  + 
Sbjct: 134 ----ICR--EILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQL-DRTVG 184
Query: 363 LTGTFV----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHP 402
              TF+    +MAPEVI C+      Y  KSD++S GI   E+  G  P
Sbjct: 185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 67
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 68  LLD-VIHTENKLYLVFEFLSMDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 118
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 119 FCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 61/101 (60%), Gaps = 5/101 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMA--LTGT 366
           A EI+  + +LH  K  +I+RDLK  N+ LD   H++IADFG  +  + DG       GT
Sbjct: 126 AAEISIGLFFLH--KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGT 183
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE+I  +PY +  D +++G++L E++ G  P+  +D
Sbjct: 184 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 224

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EK+G GT A +Y+ + +  G+ VA+K +  D   + E   +   +E+  +   +H  +++
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLD---SEEGTPSTAIREISLMKELKHENIVR 67
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERLARALEIAQA 316
           L    +    +  LV E +   LK+++    +G+  R   +  +  F+ +L       Q 
Sbjct: 68  LYD-VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL------QG 120
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPE 373
           + + HE K  ++HRDLKP N+ ++    +++ DFG AR         +    T  Y AP+
Sbjct: 121 LAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPD 178
Query: 374 VIQ-CEPYSEKSDVYSFGIILNEIITG 399
           V+     YS   D++S G IL E+ITG
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITG 205

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 86  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 130
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 243
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 90/173 (52%), Gaps = 24/173 (13%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-------FL 356
           E+ ++ + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR       ++
Sbjct: 199 EDLISYSFQVARGMEFLSSRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYV 256
Query: 357 SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY----IEKDYKPA 411
             G+  L     +MAPE I  + YS KSDV+S+G++L EI + G  PY    +++D+   
Sbjct: 257 RKGDTRLP--LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDF--- 311
Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                + EG +R   PE      E+ +++   W  D   RP F+ +   L ++
Sbjct: 312 --CSRLREG-MRMRAPEYSTP--EIYQIMLDCWHRDPKERPRFAELVEKLGDL 359

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 83  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 240
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 17/169 (10%)
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           ++ A +I+Q MQYL E    ++HRDL   NI + + + ++I+DFG +R + + +  +  +
Sbjct: 153 ISFAWQISQGMQYLAEMS--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRS 210
Query: 367 -----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI--AMEVG 418
                  +MA E +    Y+ +SDV+SFG++L EI+T G +PY      P ++   ++ G
Sbjct: 211 QGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY--PGIPPERLFNLLKTG 268
Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
               RP     D    E+  L+   W  +   RP F+ I+  L+ + +K
Sbjct: 269 HRMERP-----DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 86  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 130
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 243
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFVYMA 371
           Q +QYLH  +  VIHRDLK  N+FL+D   V+I DFG A +   DGE    L GT  Y+A
Sbjct: 153 QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIA 210
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL-RPALPEED 430
           PEV+  + +S + D++S G IL  ++ G  P+     K   I ++  E  + R   P   
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
             +R ++         D ++RPS + +
Sbjct: 271 ALIRRMLH-------ADPTLRPSVAEL 290

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 83  LGICLTSTVQ--LITQLMPFGXLLDYVREHKDNIGSQYL-------------LNWCVQIA 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 240
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 139/298 (46%), Gaps = 46/298 (15%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +D  +I  Q+ IG+G    + +A  +     +D A+K +     + +++    FA E++ 
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEV 78
Query: 248 LSRQRHR-FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF--- 303
           L +  H   ++ L+GAC    +RG+L   +        L  L    RK R++   P    
Sbjct: 79  LCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAI 131
Query: 304 ----------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
                     ++ L  A ++A+ M YL +++   IHRDL   NI + +    +IADFG +
Sbjct: 132 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS 189
Query: 354 RFLSDGEMALTGTF-----VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           R     E+ +  T       +MA E +    Y+  SDV+S+G++L EI++ G  PY    
Sbjct: 190 R---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--G 244
Query: 408 YKPAKIAMEVGEG-KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              A++  ++ +G +L   L  +D    E+ +L+   W      RPSF+ I  SL  +
Sbjct: 245 MTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEM-ALTGT 366
           A EI   +Q+LH +   +++RDLK  NI LD   H++IADFG  +   L D +     GT
Sbjct: 124 AAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGT 181
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE++  + Y+   D +SFG++L E++ G  P+  +D
Sbjct: 182 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMA--LTGTFVYMA 371
           Q +QYLH  +  VIHRDLK  N+FL+D   V+I DFG A +   DGE    L GT  Y+A
Sbjct: 137 QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 194
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL-RPALPEED 430
           PEV+  + +S + D++S G IL  ++ G  P+     K   I ++  E  + R   P   
Sbjct: 195 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 254
Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
             +R ++         D ++RPS + +
Sbjct: 255 ALIRRMLH-------ADPTLRPSVAEL 274

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 20  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 79
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 80  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 124
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 125 EGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 182
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 183 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 237
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 238 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 273

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 85  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 129
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 242
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 243 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 30  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 90  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 134
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 247
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 48  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 107
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 108 LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 152
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 153 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 210
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 211 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 265
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 266 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 301

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/105 (41%), Positives = 61/105 (58%), Gaps = 7/105 (6%)
Query: 304 EERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           EE  AR L  +I  A+ Y H     V+HRDLKP N+ LD   + +IADFG +  +SDGE 
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 362 ALT--GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
             T  G+  Y APEVI    Y+  + D++S G+IL  ++ G  P+
Sbjct: 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 57  LGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRL 116
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 117 LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 161
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 162 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 219
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 220 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 274
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 275 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 310

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 139/298 (46%), Gaps = 46/298 (15%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +D  +I  Q+ IG+G    + +A  +     +D A+K +     + +++    FA E++ 
Sbjct: 12  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEV 68
Query: 248 LSRQRHR-FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF--- 303
           L +  H   ++ L+GAC    +RG+L   +        L  L    RK R++   P    
Sbjct: 69  LCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAI 121
Query: 304 ----------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
                     ++ L  A ++A+ M YL +++   IHRDL   NI + +    +IADFG +
Sbjct: 122 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLS 179
Query: 354 RFLSDGEMALTGTF-----VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           R     E+ +  T       +MA E +    Y+  SDV+S+G++L EI++ G  PY    
Sbjct: 180 R---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--G 234
Query: 408 YKPAKIAMEVGEG-KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              A++  ++ +G +L   L  +D    E+ +L+   W      RPSF+ I  SL  +
Sbjct: 235 MTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRM 288

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 38/101 (37%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEM-ALTGT 366
           A EI   +Q+LH +   +++RDLK  NI LD   H++IADFG  +   L D +     GT
Sbjct: 125 AAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGT 182
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE++  + Y+   D +SFG++L E++ G  P+  +D
Sbjct: 183 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 223

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 77/147 (52%), Gaps = 13/147 (8%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMA--LTGTFVYMA 371
           Q +QYLH  +  VIHRDLK  N+FL+D   V+I DFG A +   DGE    L GT  Y+A
Sbjct: 153 QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIA 210
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL-RPALPEED 430
           PEV+  + +S + D++S G IL  ++ G  P+     K   I ++  E  + R   P   
Sbjct: 211 PEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVAS 270
Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
             +R ++         D ++RPS + +
Sbjct: 271 ALIRRMLH-------ADPTLRPSVAEL 290

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 39/101 (38%), Positives = 60/101 (59%), Gaps = 5/101 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG--EMALTGT 366
           A EIA  + +L  Q   +I+RDLK  N+ LD   H++IADFG  +  + DG       GT
Sbjct: 127 AAEIAIGLFFL--QSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGT 184
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE+I  +PY +  D ++FG++L E++ G  P+  +D
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 17  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 77  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 121
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 122 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 234
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 235 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 129/314 (41%), Gaps = 65/314 (20%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+      RH 
Sbjct: 29  RTIVLQESIGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHE 83
Query: 255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVPLPPFEERLA 308
            +L  + A  +            GT  + WL      HG          V +   E  + 
Sbjct: 84  NILGFIAADNKDN----------GTWTQLWLVSDYHEHGSLFDYLNRYTVTV---EGMIK 130
Query: 309 RALEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSD 358
            AL  A  + +LH      + KP + HRDLK  NI +       IAD G    H      
Sbjct: 131 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 190
Query: 359 GEMA---LTGTFVYMAPEVI-------QCEPYSEKSDVYSFGIILNEI-----ITGNH-- 401
            ++A     GT  YMAPEV+         E + +++D+Y+ G++  EI     I G H  
Sbjct: 191 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHED 249
Query: 402 ---PYIEKDYKPAKIAME-----VGEGKLRPALP---EEDGQLRELIELICLSWDGDASV 450
              PY   D  P+  ++E     V E KLRP +P   +    LR + +++   W  + + 
Sbjct: 250 YQLPYY--DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 307
Query: 451 RPSFSSITCSLKNI 464
           R +   I  +L  +
Sbjct: 308 RLTALRIKKTLSQL 321

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 129/315 (40%), Gaps = 65/315 (20%)
Query: 194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
            + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+      RH
Sbjct: 8   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRH 62
Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVPLPPFEERL 307
             +L  + A  +            GT  + WL      HG          V +   E  +
Sbjct: 63  ENILGFIAADNKDN----------GTWTQLWLVSDYHEHGSLFDYLNRYTVTV---EGMI 109
Query: 308 ARALEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLS 357
             AL  A  + +LH      + KP + HRDLK  NI +       IAD G    H     
Sbjct: 110 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 169
Query: 358 DGEMA---LTGTFVYMAPEVI-------QCEPYSEKSDVYSFGIILNEI-----ITGNH- 401
             ++A     GT  YMAPEV+         E + +++D+Y+ G++  EI     I G H 
Sbjct: 170 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHE 228
Query: 402 ----PYIEKDYKPAKIAME-----VGEGKLRPALP---EEDGQLRELIELICLSWDGDAS 449
               PY   D  P+  ++E     V E KLRP +P   +    LR + +++   W  + +
Sbjct: 229 DYQLPYY--DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 286
Query: 450 VRPSFSSITCSLKNI 464
            R +   I  +L  +
Sbjct: 287 ARLTALRIKKTLSQL 301

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/140 (35%), Positives = 77/140 (55%), Gaps = 15/140 (10%)
Query: 271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIH 329
           W+  EL+ T+L ++   +     K + +P    E+ L + A+ I +A+++LH  K  VIH
Sbjct: 82  WICMELMDTSLDKFYKQVID---KGQTIP----EDILGKIAVSIVKALEHLH-SKLSVIH 133
Query: 330 RDLKPSNIFLDDAKHVRIADFGHARFLSD--GEMALTGTFVYMAPEVIQCE----PYSEK 383
           RD+KPSN+ ++    V++ DFG + +L D   +    G   YMAPE I  E     YS K
Sbjct: 134 RDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVK 193
Query: 384 SDVYSFGIILNEIITGNHPY 403
           SD++S GI + E+     PY
Sbjct: 194 SDIWSLGITMIELAILRFPY 213

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 129/315 (40%), Gaps = 65/315 (20%)
Query: 194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
            + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+      RH
Sbjct: 3   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRH 57
Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVPLPPFEERL 307
             +L  + A  +            GT  + WL      HG          V +   E  +
Sbjct: 58  ENILGFIAADNKDN----------GTWTQLWLVSDYHEHGSLFDYLNRYTVTV---EGMI 104
Query: 308 ARALEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLS 357
             AL  A  + +LH      + KP + HRDLK  NI +       IAD G    H     
Sbjct: 105 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 164
Query: 358 DGEMA---LTGTFVYMAPEVI-------QCEPYSEKSDVYSFGIILNEI-----ITGNH- 401
             ++A     GT  YMAPEV+         E + +++D+Y+ G++  EI     I G H 
Sbjct: 165 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHE 223
Query: 402 ----PYIEKDYKPAKIAME-----VGEGKLRPALP---EEDGQLRELIELICLSWDGDAS 449
               PY   D  P+  ++E     V E KLRP +P   +    LR + +++   W  + +
Sbjct: 224 DYQLPYY--DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 281
Query: 450 VRPSFSSITCSLKNI 464
            R +   I  +L  +
Sbjct: 282 ARLTALRIKKTLSQL 296

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/314 (27%), Positives = 129/314 (41%), Gaps = 65/314 (20%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+      RH 
Sbjct: 42  RTIVLQESIGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHE 96
Query: 255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVPLPPFEERLA 308
            +L  + A  +            GT  + WL      HG          V +   E  + 
Sbjct: 97  NILGFIAADNKDN----------GTWTQLWLVSDYHEHGSLFDYLNRYTVTV---EGMIK 143
Query: 309 RALEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSD 358
            AL  A  + +LH      + KP + HRDLK  NI +       IAD G    H      
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDT 203
Query: 359 GEMA---LTGTFVYMAPEVI-------QCEPYSEKSDVYSFGIILNEI-----ITGNH-- 401
            ++A     GT  YMAPEV+         E + +++D+Y+ G++  EI     I G H  
Sbjct: 204 IDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHED 262
Query: 402 ---PYIEKDYKPAKIAME-----VGEGKLRPALP---EEDGQLRELIELICLSWDGDASV 450
              PY   D  P+  ++E     V E KLRP +P   +    LR + +++   W  + + 
Sbjct: 263 YQLPYY--DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320
Query: 451 RPSFSSITCSLKNI 464
           R +   I  +L  +
Sbjct: 321 RLTALRIKKTLSQL 334

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 46/265 (17%)
Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTEL 276
           G  VAVK + P+   +  N +    +E++ L    H  +++  G C E    G  L+ E 
Sbjct: 50  GEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 277 LGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS 335
           L + +LKE+L      + K ++      +++L  A++I + M YL  ++   +HRDL   
Sbjct: 107 LPSGSLKEYL-----PKNKNKI----NLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAAR 155
Query: 336 NIFLDDAKHVRIADFGHARFLSDGEMALT------GTFVYMAPEVIQCEPYSEKSDVYSF 389
           N+ ++    V+I DFG  + +   +   T          + APE +    +   SDV+SF
Sbjct: 156 NVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 215
Query: 390 GIILNEIITGNHPYIEKDYKPAKIAME-----------------VGEGKLRPALPEEDGQ 432
           G+ L+E++T    Y + D  P  + ++                 + EGK  P  P     
Sbjct: 216 GVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPD- 270
Query: 433 LRELIELICLSWDGDASVRPSFSSI 457
             E+ +L+   W+   S R SF ++
Sbjct: 271 --EVYQLMRKCWEFQPSNRTSFQNL 293

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 46/265 (17%)
Query: 218 GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW-LVTEL 276
           G  VAVK + P+   +  N +    +E++ L    H  +++  G C E    G  L+ E 
Sbjct: 38  GEQVAVKSLKPE---SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 94
Query: 277 LGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS 335
           L + +LKE+L      + K ++      +++L  A++I + M YL  ++   +HRDL   
Sbjct: 95  LPSGSLKEYL-----PKNKNKI----NLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAAR 143
Query: 336 NIFLDDAKHVRIADFGHARFLSDGEMALT------GTFVYMAPEVIQCEPYSEKSDVYSF 389
           N+ ++    V+I DFG  + +   +   T          + APE +    +   SDV+SF
Sbjct: 144 NVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSF 203
Query: 390 GIILNEIITGNHPYIEKDYKPAKIAME-----------------VGEGKLRPALPEEDGQ 432
           G+ L+E++T    Y + D  P  + ++                 + EGK  P  P     
Sbjct: 204 GVTLHELLT----YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPD- 258
Query: 433 LRELIELICLSWDGDASVRPSFSSI 457
             E+ +L+   W+   S R SF ++
Sbjct: 259 --EVYQLMRKCWEFQPSNRTSFQNL 281

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 129/315 (40%), Gaps = 65/315 (20%)
Query: 194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
            + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+      RH
Sbjct: 5   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRH 59
Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVPLPPFEERL 307
             +L  + A  +            GT  + WL      HG          V +   E  +
Sbjct: 60  ENILGFIAADNKDN----------GTWTQLWLVSDYHEHGSLFDYLNRYTVTV---EGMI 106
Query: 308 ARALEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLS 357
             AL  A  + +LH      + KP + HRDLK  NI +       IAD G    H     
Sbjct: 107 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 166
Query: 358 DGEMA---LTGTFVYMAPEVI-------QCEPYSEKSDVYSFGIILNEI-----ITGNH- 401
             ++A     GT  YMAPEV+         E + +++D+Y+ G++  EI     I G H 
Sbjct: 167 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHE 225
Query: 402 ----PYIEKDYKPAKIAME-----VGEGKLRPALP---EEDGQLRELIELICLSWDGDAS 449
               PY   D  P+  ++E     V E KLRP +P   +    LR + +++   W  + +
Sbjct: 226 DYQLPYY--DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 283
Query: 450 VRPSFSSITCSLKNI 464
            R +   I  +L  +
Sbjct: 284 ARLTALRIKKTLSQL 298

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKDFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 6/112 (5%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 107 FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 165
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 166 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 217

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 86/315 (27%), Positives = 129/315 (40%), Gaps = 65/315 (20%)
Query: 194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
            + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+      RH
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRH 56
Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWL------HGLGSQRRKERMVPLPPFEERL 307
             +L  + A  +            GT  + WL      HG          V +   E  +
Sbjct: 57  ENILGFIAADNKDN----------GTWTQLWLVSDYHEHGSLFDYLNRYTVTV---EGMI 103
Query: 308 ARALEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLS 357
             AL  A  + +LH      + KP + HRDLK  NI +       IAD G    H     
Sbjct: 104 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 163
Query: 358 DGEMA---LTGTFVYMAPEVI-------QCEPYSEKSDVYSFGIILNEI-----ITGNH- 401
             ++A     GT  YMAPEV+         E + +++D+Y+ G++  EI     I G H 
Sbjct: 164 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF-KRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 402 ----PYIEKDYKPAKIAME-----VGEGKLRPALP---EEDGQLRELIELICLSWDGDAS 449
               PY   D  P+  ++E     V E KLRP +P   +    LR + +++   W  + +
Sbjct: 223 DYQLPYY--DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
Query: 450 VRPSFSSITCSLKNI 464
            R +   I  +L  +
Sbjct: 281 ARLTALRIKKTLSQL 295

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/230 (31%), Positives = 104/230 (45%), Gaps = 53/230 (23%)
Query: 203 IGQGTTANIYRAIWRGLD---VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +GQG    + +A    LD    A+K I     HT E   T  + EV  L+   H++V++ 
Sbjct: 14  LGQGAFGQVVKA-RNALDSRYYAIKKIR----HTEEKLSTILS-EVXLLASLNHQYVVRY 67
Query: 260 MGACLE-----PPYRGWLVTELL--------GTTLKEWLHGLG-SQRRKERMVPLPPFEE 305
             A LE      P         L          TL + +H    +Q+R E          
Sbjct: 68  YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYW-------- 119
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--------- 356
           RL R  +I +A+ Y+H Q   +IHR+LKP NIF+D++++V+I DFG A+ +         
Sbjct: 120 RLFR--QILEALSYIHSQG--IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 357 --------SDGEMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEII 397
                   SD   +  GT  Y+A EV+     Y+EK D YS GII  E I
Sbjct: 176 DSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 6/112 (5%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 105 FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 163
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 164 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 215

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ ++  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 62/112 (55%), Gaps = 6/112 (5%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 106 FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 164
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 216

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/123 (32%), Positives = 69/123 (56%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 67
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 68  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 118
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 119 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 122/262 (46%), Gaps = 41/262 (15%)
Query: 171 PLLQQSDLAVTVSQAKMNGWY--------IDPK----EIDLQEKIGQGTTANIYRAIWRG 218
           PL   S++A+++S+ K+  ++        + PK    E  + + +G G    +  A  R 
Sbjct: 113 PLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERK 172
Query: 219 L--DVAVKCIYPDFFHTNE----NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL 272
               VA++ I    F        +       E++ L +  H  ++++        Y  ++
Sbjct: 173 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY--YI 230
Query: 273 VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           V EL+ G  L + +  +G++R KE    L  ++  LA        +QYLHE    +IHRD
Sbjct: 231 VLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLA--------VQYLHENG--IIHRD 278
Query: 332 LKPSNIFLDDAKH---VRIADFGHARFLSDGEM--ALTGTFVYMAPEV---IQCEPYSEK 383
           LKP N+ L   +    ++I DFGH++ L +  +   L GT  Y+APEV   +    Y+  
Sbjct: 279 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 338
Query: 384 SDVYSFGIILNEIITGNHPYIE 405
            D +S G+IL   ++G  P+ E
Sbjct: 339 VDCWSLGVILFICLSGYPPFSE 360

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 69
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 70  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 120
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 121 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 68
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 69  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 119
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 120 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 69
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 70  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 120
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 121 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 67
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 68  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 118
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 119 FCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 68
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 69  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 119
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 120 FCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 11  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 68
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 69  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 119
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 120 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 177
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 178 LGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 66  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 116
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 117 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 10  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 67
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 68  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 118
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 119 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 176
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 13  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 70
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 71  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 121
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 122 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 179
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 33  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 92
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 93  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 137
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 138 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 195
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 196 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 250
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 251 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 286

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 66  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 116
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 117 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 174
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 28/295 (9%)
Query: 186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNENAVTF 240
           K+    I  ++  L   +G+G   ++  A  +  D     VAVK +  D   +++  +  
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSD--IEE 71
Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG-----LGSQRRKE 295
           F +E   +    H  V +L+G  L    +G L   ++   L    HG     L + R  E
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMV--ILPFMKHGDLHAFLLASRIGE 129
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
               LP  +  +   ++IA  M+YL  +    IHRDL   N  L +   V +ADFG +R 
Sbjct: 130 NPFNLP-LQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRK 186
Query: 356 LSDGEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK 409
           +  G+    G        ++A E +    Y+  SDV++FG+ + EI+T G  PY     +
Sbjct: 187 IYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY--AGIE 244
Query: 410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            A+I   +  G      PE    + E+ +L+   W  D   RPSF+ +   L+NI
Sbjct: 245 NAEIYNYLIGGNRLKQPPE---CMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 85  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 129
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 242
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 122/262 (46%), Gaps = 41/262 (15%)
Query: 171 PLLQQSDLAVTVSQAKMNGWY--------IDPK----EIDLQEKIGQGTTANIYRAIWRG 218
           PL   S++A+++S+ K+  ++        + PK    E  + + +G G    +  A  R 
Sbjct: 99  PLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERK 158
Query: 219 L--DVAVKCIYPDFFHTNE----NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL 272
               VA++ I    F        +       E++ L +  H  ++++        Y  ++
Sbjct: 159 TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY--YI 216
Query: 273 VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           V EL+ G  L + +  +G++R KE    L  ++  LA        +QYLHE    +IHRD
Sbjct: 217 VLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLLA--------VQYLHENG--IIHRD 264
Query: 332 LKPSNIFLDDAKH---VRIADFGHARFLSDGEM--ALTGTFVYMAPEV---IQCEPYSEK 383
           LKP N+ L   +    ++I DFGH++ L +  +   L GT  Y+APEV   +    Y+  
Sbjct: 265 LKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRA 324
Query: 384 SDVYSFGIILNEIITGNHPYIE 405
            D +S G+IL   ++G  P+ E
Sbjct: 325 VDCWSLGVILFICLSGYPPFSE 346

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 83  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 240
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+  I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALXKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+  I  D     E   +   +E+  L    H  +++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALXKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 66  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 116
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 117 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 86  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 130
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 243
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 244 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 279

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 87  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 131
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 132 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 189
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 244
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 105 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 162
Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 163 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 214

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/112 (35%), Positives = 64/112 (57%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 38/95 (40%), Positives = 60/95 (63%), Gaps = 4/95 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTF 367
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D EMA    GT 
Sbjct: 113 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-EMANEFVGTR 170
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
            YM+PE +Q   YS +SD++S G+ L E+  G +P
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/131 (35%), Positives = 74/131 (56%), Gaps = 9/131 (6%)
Query: 304 EERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EM 361
           EE L + ++ + + + YL E K +++HRD+KPSNI ++    +++ DFG +  L D    
Sbjct: 113 EEILGKVSIAVLRGLAYLRE-KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN 171
Query: 362 ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           +  GT  YMAPE +Q   YS +SD++S G+ L E+  G +P    D K     +E   G 
Sbjct: 172 SFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAK----ELEAIFG- 226
Query: 422 LRPALPEEDGQ 432
            RP +  E+G+
Sbjct: 227 -RPVVDGEEGE 236

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 69
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK ++            +PLP  +  L    ++ Q + 
Sbjct: 70  LLD-VIHTENKLYLVFEFLHQDLKTFMDASALTG-----IPLPLIKSYL---FQLLQGLA 120
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 121 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT  Y+AP +I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E++ L +  H  ++++        Y  ++V EL+ G  L + +  +G++R KE    L  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKV--VGNKRLKEATCKLYF 120
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDG 359
           ++  LA        +QYLHE    +IHRDLKP N+ L   +    ++I DFGH++ L + 
Sbjct: 121 YQMLLA--------VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 360 EM--ALTGTFVYMAPEV---IQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
            +   L GT  Y+APEV   +    Y+   D +S G+IL   ++G  P+ E
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E++ L +  H  ++++        Y  ++V EL+ G  L + +  +G++R KE    L  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKV--VGNKRLKEATCKLYF 120
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDG 359
           ++  LA        +QYLHE    +IHRDLKP N+ L   +    ++I DFGH++ L + 
Sbjct: 121 YQMLLA--------VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 360 EM--ALTGTFVYMAPEV---IQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
            +   L GT  Y+APEV   +    Y+   D +S G+IL   ++G  P+ E
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 172 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 230
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 271

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E++ L +  H  ++++        Y  ++V EL+ G  L + +  +G++R KE    L  
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKV--VGNKRLKEATCKLYF 120
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDG 359
           ++  LA        +QYLHE    +IHRDLKP N+ L   +    ++I DFGH++ L + 
Sbjct: 121 YQMLLA--------VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170
Query: 360 EM--ALTGTFVYMAPEV---IQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
            +   L GT  Y+APEV   +    Y+   D +S G+IL   ++G  P+ E
Sbjct: 171 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E++ L +  H  ++++        Y  ++V EL+ G  L + +  +G++R KE    L  
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKV--VGNKRLKEATCKLYF 119
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDG 359
           ++  LA        +QYLHE    +IHRDLKP N+ L   +    ++I DFGH++ L + 
Sbjct: 120 YQMLLA--------VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 169
Query: 360 EM--ALTGTFVYMAPEV---IQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
            +   L GT  Y+APEV   +    Y+   D +S G+IL   ++G  P+ E
Sbjct: 170 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 78/298 (26%), Positives = 139/298 (46%), Gaps = 46/298 (15%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +D  +I  Q+ IG+G    + +A  +     +D A+K +     + +++    FA E++ 
Sbjct: 19  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEV 75
Query: 248 LSRQRHR-FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF--- 303
           L +  H   ++ L+GAC    +RG+L   +        L  L    RK R++   P    
Sbjct: 76  LCKLGHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFL----RKSRVLETDPAFAI 128
Query: 304 ----------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
                     ++ L  A ++A+ M YL +++   IHR+L   NI + +    +IADFG +
Sbjct: 129 ANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRNLAARNILVGENYVAKIADFGLS 186
Query: 354 RFLSDGEMALTGTF-----VYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           R     E+ +  T       +MA E +    Y+  SDV+S+G++L EI++ G  PY    
Sbjct: 187 R---GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--G 241
Query: 408 YKPAKIAMEVGEG-KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              A++  ++ +G +L   L  +D    E+ +L+   W      RPSF+ I  SL  +
Sbjct: 242 MTCAELYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRM 295

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 27  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 86
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 87  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 131
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 132 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 189
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 190 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 244
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 280

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 84  LGICLTSTVQ--LIMQLMPFGXLLDYVREHKDNIGSQYL-------------LNWCVQIA 128
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 129 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 241
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 23/171 (13%)
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E++ L +  H  ++++        Y  ++V EL+ G  L + +  +G++R KE    L  
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKV--VGNKRLKEATCKLYF 126
Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDG 359
           ++  LA        +QYLHE    +IHRDLKP N+ L   +    ++I DFGH++ L + 
Sbjct: 127 YQMLLA--------VQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 176
Query: 360 EM--ALTGTFVYMAPEV---IQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
            +   L GT  Y+APEV   +    Y+   D +S G+IL   ++G  P+ E
Sbjct: 177 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE 227

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 85  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 129
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 187
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 242
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 278

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 24  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 83
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 84  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 128
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 129 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 186
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 187 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 241
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 277

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 26  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 85
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 86  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 130
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 131 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 188
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 189 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 243
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 279

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 107 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 164
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 165 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 216

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 137 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 195
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 39/112 (34%), Positives = 63/112 (56%), Gaps = 7/112 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 360 EM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D++
Sbjct: 160 ATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 125/295 (42%), Gaps = 53/295 (17%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           K+I + ++IG+G    ++   WRG  VAVK      F T E A  F   E+      RH 
Sbjct: 37  KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKV-----FFTTEEASWFRETEIYQTVLMRHE 91
Query: 255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
            +L  + A ++     W    L+        H  GS     +   L   +  L  A    
Sbjct: 92  NILGFIAADIKGT-GSWTQLYLITD-----YHENGSLYDYLKSTTLDA-KSMLKLAYSSV 144
Query: 315 QAMQYLHEQ------KPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSD-GEMAL--- 363
             + +LH +      KP + HRDLK  NI +       IAD G A +F+SD  E+ +   
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204
Query: 364 --TGTFVYMAPEVIQCEPYSEK-------SDVYSFGIILNEI----ITGN------HPYI 404
              GT  YM PEV+  E  +         +D+YSFG+IL E+    ++G        PY 
Sbjct: 205 TRVGTKRYMPPEVLD-ESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY- 262
Query: 405 EKDYKPAKIAME-----VGEGKLRPALPE---EDGQLRELIELICLSWDGDASVR 451
             D  P+  + E     V   KLRP+ P     D  LR++ +L+   W  + + R
Sbjct: 263 -HDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 196 EIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           + D+   +G+G   N+Y  R       +A+K ++       E       +E++  S  RH
Sbjct: 16  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLRH 74
Query: 254 RFVLQLMGACLEPPYRGWLVTELL--GTTLKEW-LHGLGSQRRKERMVPLPPFEERLARA 310
             +L+ M        R +L+ E    G   KE   HG   ++R    +            
Sbjct: 75  PNILR-MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----------- 122
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALTGTF 367
            E+A A+ Y HE+K  VIHRD+KP N+ +     ++IADFG   HA  L    M   GT 
Sbjct: 123 -ELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC--GTL 177
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            Y+ PE+I+ + + EK D++  G++  E + G  P+
Sbjct: 178 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 213

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 83  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 240
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 26/216 (12%)
Query: 196 EIDLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           + D+   +G+G   N+Y  R       +A+K ++       E       +E++  S  RH
Sbjct: 15  DFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQL-EKEGVEHQLRREIEIQSHLRH 73
Query: 254 RFVLQLMGACLEPPYRGWLVTELL--GTTLKEW-LHGLGSQRRKERMVPLPPFEERLARA 310
             +L+ M        R +L+ E    G   KE   HG   ++R    +            
Sbjct: 74  PNILR-MYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME----------- 121
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDGEMALTGTF 367
            E+A A+ Y HE+K  VIHRD+KP N+ +     ++IADFG   HA  L    M   GT 
Sbjct: 122 -ELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC--GTL 176
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            Y+ PE+I+ + + EK D++  G++  E + G  P+
Sbjct: 177 DYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF 212

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 35/94 (37%), Positives = 58/94 (61%), Gaps = 2/94 (2%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 129 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 187
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
           YM+PE +Q   YS +SD++S G+ L E+  G +P
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +G G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 25  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 84
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 85  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 129
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 130 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKW 187
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 188 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 242
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 243 PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 278

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 4/96 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMALTGTFV 368
           A EI   ++++H +   V++RDLKP+NI LD+  HVRI+D G A  F      A  GT  
Sbjct: 297 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 354
Query: 369 YMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
           YMAPEV+Q    Y   +D +S G +L +++ G+ P+
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +  G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 23  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 83  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 128 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 240
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 4/96 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMALTGTFV 368
           A EI   ++++H +   V++RDLKP+NI LD+  HVRI+D G A  F      A  GT  
Sbjct: 298 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 355
Query: 369 YMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
           YMAPEV+Q    Y   +D +S G +L +++ G+ P+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 7/108 (6%)
Query: 301 PPFEERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P F+E  A     +I   +++LH++   +I+RDLKP N+ LDD  +VRI+D G A  L  
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 359 GEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           G+       GT  +MAPE++  E Y    D ++ G+ L E+I    P+
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 60/105 (57%), Gaps = 7/105 (6%)
Query: 304 EERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           EE  AR L  +I  A+ Y H     V+HRDLKP N+ LD   + +IADFG +  +SDGE 
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 166
Query: 362 AL--TGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
                G+  Y APEVI    Y+  + D++S G+IL  ++ G  P+
Sbjct: 167 LRDSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 7/108 (6%)
Query: 301 PPFEERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P F+E  A     +I   +++LH++   +I+RDLKP N+ LDD  +VRI+D G A  L  
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 359 GEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           G+       GT  +MAPE++  E Y    D ++ G+ L E+I    P+
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIGQG +  +Y A  +  G +VA++                   +++   + +   ++ 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIR-------------------QMNLQQQPKKELIIN 66
Query: 259 ---LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIA 314
              +M     P    +L + L+G  L   +  L      + +      E ++A    E  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMA 371
           QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++        + GT  +MA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           PEV+  + Y  K D++S GI+  E+I G  PY+ ++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +  G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+T+L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 90  LGICLTSTVQ--LITQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 134
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 247
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/278 (25%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 195 KEIDLQE--KIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           KE +L++   +G G    +++ +W        + V +K I       +  AVT     + 
Sbjct: 11  KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           +L    H  +++L+G C  P     LVT+ L       L  L    R+ R    P  +  
Sbjct: 71  SLD---HAHIVRLLGLC--PGSSLQLVTQYLP------LGSLLDHVRQHRGALGP--QLL 117
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           L   ++IA+ M YL E    ++HR+L   N+ L     V++ADFG A  L   +  L  +
Sbjct: 118 LNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 367 -----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG 420
                  +MA E I    Y+ +SDV+S+G+ + E++T G  PY           +E GE 
Sbjct: 176 EAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER 235
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
             +P +   D     +  ++   W  D ++RP+F  + 
Sbjct: 236 LAQPQICTID-----VYMVMVKCWMIDENIRPTFKELA 268

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 7/108 (6%)
Query: 301 PPFEERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P F+E  A     +I   +++LH++   +I+RDLKP N+ LDD  +VRI+D G A  L  
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 359 GEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           G+       GT  +MAPE++  E Y    D ++ G+ L E+I    P+
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/108 (36%), Positives = 60/108 (55%), Gaps = 7/108 (6%)
Query: 301 PPFEERLA--RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P F+E  A     +I   +++LH++   +I+RDLKP N+ LDD  +VRI+D G A  L  
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 359 GEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           G+       GT  +MAPE++  E Y    D ++ G+ L E+I    P+
Sbjct: 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 4/96 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMALTGTFV 368
           A EI   ++++H +   V++RDLKP+NI LD+  HVRI+D G A  F      A  GT  
Sbjct: 298 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 355
Query: 369 YMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
           YMAPEV+Q    Y   +D +S G +L +++ G+ P+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 39/96 (40%), Positives = 58/96 (60%), Gaps = 4/96 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGEMALTGTFV 368
           A EI   ++++H +   V++RDLKP+NI LD+  HVRI+D G A  F      A  GT  
Sbjct: 298 AAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 355
Query: 369 YMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
           YMAPEV+Q    Y   +D +S G +L +++ G+ P+
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E +   LK ++            +PLP  +  L    ++ Q + 
Sbjct: 66  LLD-VIHTENKLYLVFEHVHQDLKTFMDASALTG-----IPLPLIKSYL---FQLLQGLA 116
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 117 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 115/268 (42%), Gaps = 32/268 (11%)
Query: 203 IGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +G G    +++ +W        + V +K I       +  AVT     + +L    H  +
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD---HAHI 95
Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           ++L+G C  P     LVT+ L       L  L    R+ R    P     L   ++IA+ 
Sbjct: 96  VRLLGLC--PGSSLQLVTQYLP------LGSLLDHVRQHRGALGPQL--LLNWGVQIAKG 145
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT-----FVYMA 371
           M YL E    ++HR+L   N+ L     V++ADFG A  L   +  L  +       +MA
Sbjct: 146 MYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 203
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
            E I    Y+ +SDV+S+G+ + E++T G  PY           +E GE   +P +   D
Sbjct: 204 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 263
Query: 431 GQLRELIELICLSWDGDASVRPSFSSIT 458
             +     ++   W  D ++RP+F  + 
Sbjct: 264 VYM-----VMVKCWMIDENIRPTFKELA 286

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIGQG +  +Y A  +  G +VA++                   +++   + +   ++ 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIR-------------------QMNLQQQPKKELIIN 66
Query: 259 ---LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIA 314
              +M     P    +L + L+G  L   +  L      + +      E ++A    E  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMA 371
           QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++        + GT  +MA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 184
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           PEV+  + Y  K D++S GI+  E+I G  PY+ ++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 37/101 (36%), Positives = 60/101 (59%), Gaps = 2/101 (1%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGTFV 368
           ++ + + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  
Sbjct: 110 SIAVIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRS 168
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YM+PE +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 120/267 (44%), Gaps = 32/267 (11%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCI--YPDFFHTNENAVTFFAQEVDTLSR 250
           K     E +G G  + ++    R  G   A+KCI   P F  ++         E+  L +
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS------LENEIAVLKK 62
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            +H  ++ L     E     +LV +L+         G    R  ER V    + E+ A  
Sbjct: 63  IKHENIVTLED-IYESTTHYYLVMQLVSG-------GELFDRILERGV----YTEKDASL 110
Query: 311 L--EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT- 364
           +  ++  A++YLHE    ++HRDLKP N+     ++   + I DFG ++   +G M+   
Sbjct: 111 VIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTAC 168
Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
           GT  Y+APEV+  +PYS+  D +S G+I   ++ G  P+ E+    +K+  ++ EG    
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE--TESKLFEKIKEGYYEF 226
Query: 425 ALPEEDGQLRELIELICLSWDGDASVR 451
             P  D       + IC   + D + R
Sbjct: 227 ESPFWDDISESAKDFICHLLEKDPNER 253

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 65/107 (60%), Gaps = 14/107 (13%)
Query: 306 RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--A 362
           ++ RAL E+  A+  L+     ++HRDLKP NI LDD  ++++ DFG +  L  GE   +
Sbjct: 128 KIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 363 LTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPY 403
           + GT  Y+APE+I+C        Y ++ D++S G+I+  ++ G+ P+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/133 (33%), Positives = 68/133 (51%), Gaps = 24/133 (18%)
Query: 280 TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL 339
            LK+W++   S   +E  V L  F       ++IA+A+++LH +   ++HRDLKPSNIF 
Sbjct: 147 NLKDWMNRRCSLEDREHGVCLHIF-------IQIAEAVEFLHSKG--LMHRDLKPSNIFF 197
Query: 340 DDAKHVRIADFGHARFLSDGEMALT---------------GTFVYMAPEVIQCEPYSEKS 384
                V++ DFG    +   E   T               GT +YM+PE I    YS K 
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 385 DVYSFGIILNEII 397
           D++S G+IL E++
Sbjct: 258 DIFSLGLILFELL 270

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 20/166 (12%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +E+  L   RH  +++L    ++      +V E  G  L +++     QR K        
Sbjct: 62  REISYLRLLRHPHIIKLYDV-IKSKDEIIMVIEYAGNELFDYI----VQRDK-------- 108
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
             E+ AR    +I  A++Y H  K  ++HRDLKP N+ LD+  +V+IADFG +  ++DG 
Sbjct: 109 MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 166
Query: 361 MALT--GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
              T  G+  Y APEVI  + Y+  + DV+S G+IL  ++    P+
Sbjct: 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 212

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIGQG +  +Y A  +  G +VA++                   +++   + +   ++ 
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIR-------------------QMNLQQQPKKELIIN 67
Query: 259 ---LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIA 314
              +M     P    +L + L+G  L   +  L      + +      E ++A    E  
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMA 371
           QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++        + GT  +MA
Sbjct: 128 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMA 185
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           PEV+  + Y  K D++S GI+  E+I G  PY+ ++
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 115/255 (45%), Gaps = 27/255 (10%)
Query: 210 NIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR 269
            +YR   + +DVA+K +      T +       +E   + +  + ++++L+G C      
Sbjct: 29  GVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 85
Query: 270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIH 329
             LV E+ G      LH     +R+E  +P+    E L    +++  M+YL E+    +H
Sbjct: 86  --LVMEMAGGGP---LHKFLVGKREE--IPVSNVAELLH---QVSMGMKYLEEKN--FVH 133
Query: 330 RDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------FVYMAPEVIQCEPYSEK 383
           RDL   N+ L +  + +I+DFG ++ L   +   T          + APE I    +S +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 384 SDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICL 442
           SDV+S+G+ + E ++ G  PY  K  K  ++   + +GK     PE      EL  L+  
Sbjct: 194 SDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIEQGKRMECPPECPP---ELYALMSD 248
Query: 443 SWDGDASVRPSFSSI 457
            W      RP F ++
Sbjct: 249 CWIYKWEDRPDFLTV 263

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 125/294 (42%), Gaps = 35/294 (11%)
Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I    I L+ ++G+G    ++ A    L        VAVK +       ++NA   F +
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHR 64
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLP 301
           E + L+  +H  +++  G C+E      +   +    L ++L  HG  +    E     P
Sbjct: 65  EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN---P 121
Query: 302 PFEERLARALEIAQ----AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           P E   ++ L IAQ     M YL  Q    +HRDL   N  + +   V+I DFG +R + 
Sbjct: 122 PTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKIGDFGMSRDVY 179
Query: 358 DGEMALTGTFV-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPA 411
             +    G        +M PE I    ++ +SDV+S G++L EI T G  P+ +      
Sbjct: 180 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV 239
Query: 412 KIAMEVGEGKLRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +  G    RP   P+      E+ EL+   W  +  +R +   I   L+N+
Sbjct: 240 IECITQGRVLQRPRTCPQ------EVYELMLGCWQREPHMRKNIKGIHTLLQNL 287

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 20/166 (12%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +E+  L   RH  +++L    ++      +V E  G  L +++     QR K        
Sbjct: 63  REISYLRLLRHPHIIKLYDV-IKSKDEIIMVIEYAGNELFDYI----VQRDK-------- 109
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
             E+ AR    +I  A++Y H  K  ++HRDLKP N+ LD+  +V+IADFG +  ++DG 
Sbjct: 110 MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 167
Query: 361 MALT--GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
              T  G+  Y APEVI  + Y+  + DV+S G+IL  ++    P+
Sbjct: 168 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 213

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 20/166 (12%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +E+  L   RH  +++L    ++      +V E  G  L +++     QR K        
Sbjct: 53  REISYLRLLRHPHIIKLYDV-IKSKDEIIMVIEYAGNELFDYI----VQRDK-------- 99
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
             E+ AR    +I  A++Y H  K  ++HRDLKP N+ LD+  +V+IADFG +  ++DG 
Sbjct: 100 MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 157
Query: 361 MALT--GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
              T  G+  Y APEVI  + Y+  + DV+S G+IL  ++    P+
Sbjct: 158 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIGQG +  +Y A  +  G +VA++                   +++   + +   ++ 
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIR-------------------QMNLQQQPKKELIIN 66
Query: 259 ---LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIA 314
              +M     P    +L + L+G  L   +  L      + +      E ++A    E  
Sbjct: 67  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMA 371
           QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++        + GT  +MA
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMA 184
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           PEV+  + Y  K D++S GI+  E+I G  PY+ ++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/166 (31%), Positives = 86/166 (51%), Gaps = 20/166 (12%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +E+  L   RH  +++L    ++      +V E  G  L +++     QR K        
Sbjct: 57  REISYLRLLRHPHIIKLYDV-IKSKDEIIMVIEYAGNELFDYI----VQRDK-------- 103
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
             E+ AR    +I  A++Y H  K  ++HRDLKP N+ LD+  +V+IADFG +  ++DG 
Sbjct: 104 MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN 161
Query: 361 MALT--GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
              T  G+  Y APEVI  + Y+  + DV+S G+IL  ++    P+
Sbjct: 162 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPF 207

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 28/182 (15%)
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG------- 359
           L  A +I + M YLH Q    IHR L   N+ LD+ + V+I DFG A+ + +G       
Sbjct: 115 LLFAQQICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 172
Query: 360 EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVG 418
           E   +  F Y APE ++   +   SDV+SFG+ L E++T    Y + +  P  K    +G
Sbjct: 173 EDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLT----YCDSNQSPHTKFTELIG 227
Query: 419 --EGKLR-----------PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
             +G++              LP  D    E+  L+   W+ +AS RP+F ++   L+  Q
Sbjct: 228 HTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQ 287
Query: 466 MK 467
            K
Sbjct: 288 EK 289

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 126/284 (44%), Gaps = 61/284 (21%)
Query: 183 SQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF 240
           S+  MN         D++E++G+G  + + R + +  GL+ A K I         N    
Sbjct: 17  SEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII---------NTKKL 67
Query: 241 FAQEVDTLSRQ-------RHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQR 292
            A++   L R+       +H  +++L  +  E  +  +LV +L+ G  L           
Sbjct: 68  SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH-YLVFDLVTGGEL----------- 115
Query: 293 RKERMVPLPPFEERLARAL-----------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD 341
                     FE+ +AR             +I +++ Y H     ++HR+LKP N+ L  
Sbjct: 116 ----------FEDIVAREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLAS 163
Query: 342 ---AKHVRIADFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEI 396
                 V++ADFG A  ++D E      GT  Y++PEV++ +PYS+  D+++ G+IL  +
Sbjct: 164 KAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 223
Query: 397 ITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELI 440
           + G  P+ ++D    ++  ++  G      PE D    E   LI
Sbjct: 224 LVGYPPFWDEDQH--RLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT   +APE+I  + Y++  D ++ G+++ E+  G  P+     +P +I  ++  G
Sbjct: 196 WXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD--QPIQIYEKIVSG 253
Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 28/182 (15%)
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG------- 359
           L  A +I + M YLH Q    IHR L   N+ LD+ + V+I DFG A+ + +G       
Sbjct: 114 LLFAQQICEGMAYLHAQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 171
Query: 360 EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEVG 418
           E   +  F Y APE ++   +   SDV+SFG+ L E++T    Y + +  P  K    +G
Sbjct: 172 EDGDSPVFWY-APECLKECKFYYASDVWSFGVTLYELLT----YCDSNQSPHTKFTELIG 226
Query: 419 --EGKLR-----------PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
             +G++              LP  D    E+  L+   W+ +AS RP+F ++   L+  Q
Sbjct: 227 HTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQ 286
Query: 466 MK 467
            K
Sbjct: 287 EK 288

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 26/195 (13%)
Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GT 279
           VA+KCI  +     E ++     E+  L + +H  ++ L     E     +L+ +L+ G 
Sbjct: 46  VAIKCIAKEALEGKEGSME---NEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGG 101
Query: 280 TLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI 337
            L + +   G  ++R   R++             ++  A++YLH+    ++HRDLKP N+
Sbjct: 102 ELFDRIVEKGFYTERDASRLI------------FQVLDAVKYLHDLG--IVHRDLKPENL 147
Query: 338 F---LDDAKHVRIADFGHARFLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGII 392
               LD+   + I+DFG ++    G +  T  GT  Y+APEV+  +PYS+  D +S G+I
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 393 LNEIITGNHPYIEKD 407
              ++ G  P+ +++
Sbjct: 208 AYILLCGYPPFYDEN 222

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 120/287 (41%), Gaps = 33/287 (11%)
Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           ID K+++   K+ +  +  +++  W+G D+ VK +    + T ++    F +E   L   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRD--FNEECPRLRIF 64
Query: 252 RHRFVLQLMGACLEPP------YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            H  VL ++GAC  PP         W     L   L E  + +  Q +  +         
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKF-------- 116
Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI--ADFGHARFLSDGEMAL 363
               AL+ A+   +LH  +P +    L   ++ +D+    RI  AD   + F S G    
Sbjct: 117 ----ALDXARGXAFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFS-FQSPGRXYA 171
Query: 364 TGTFVYMAPEVIQCEPYS---EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
                ++APE +Q +P       +D +SF ++L E++T   P+   D    +I  +V   
Sbjct: 172 PA---WVAPEALQKKPEDTNRRSADXWSFAVLLWELVTREVPF--ADLSNXEIGXKVALE 226
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
            LRP +P         +  IC   + D + RP F  I   L+  Q K
Sbjct: 227 GLRPTIPPGISPHVSKLXKICX--NEDPAKRPKFDXIVPILEKXQDK 271

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 12  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 69
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E +   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 70  LLD-VIHTENKLYLVFEHVDQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 120
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR              T  Y APE+ 
Sbjct: 121 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEIL 178
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           + C+ YS   D++S G I  E++T
Sbjct: 179 LGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 14/107 (13%)
Query: 306 RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--A 362
           ++ RAL E+  A+  L+     ++HRDLKP NI LDD  ++++ DFG +  L  GE    
Sbjct: 115 KIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 363 LTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPY 403
           + GT  Y+APE+I+C        Y ++ D++S G+I+  ++ G+ P+
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 77/172 (44%), Gaps = 19/172 (11%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           +   M+YL +     +HRDL   N+ +D     +++DFG +R L D   A   T      
Sbjct: 160 VGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    +S  SDV+SFG+++ E++  G  PY     +    ++E G       
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-----R 272
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI-----QMKVTETI 472
           LP   G    L +L+   W  D + RP FS I   L  +      ++ T T+
Sbjct: 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 19/172 (11%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-EMALTGT----- 366
           +   M+YL +     +HRDL   N+ +D     +++DFG +R L D  + A T T     
Sbjct: 160 VGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    +S  SDV+SFG+++ E++  G  PY     +    ++E G       
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-----R 272
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI-----QMKVTETI 472
           LP   G    L +L+   W  D + RP FS I   L  +      ++ T T+
Sbjct: 273 LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRATATV 324

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 26/195 (13%)
Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GT 279
           VA+KCI  +     E ++     E+  L + +H  ++ L     E     +L+ +L+ G 
Sbjct: 46  VAIKCIAKEALEGKEGSME---NEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGG 101
Query: 280 TLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI 337
            L + +   G  ++R   R++             ++  A++YLH+    ++HRDLKP N+
Sbjct: 102 ELFDRIVEKGFYTERDASRLI------------FQVLDAVKYLHDLG--IVHRDLKPENL 147
Query: 338 F---LDDAKHVRIADFGHARFLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGII 392
               LD+   + I+DFG ++    G +  T  GT  Y+APEV+  +PYS+  D +S G+I
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 393 LNEIITGNHPYIEKD 407
              ++ G  P+ +++
Sbjct: 208 AYILLCGYPPFYDEN 222

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           Q ++G+G+   ++R   +  G   AVK +  + F   E            LS  R   ++
Sbjct: 63  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPR---IV 113
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER----LARALEI 313
            L GA  E P+    +  L G +L + +  +G          LP  E+R    L +ALE 
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---------LP--EDRALYYLGQALE- 161
Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSD---GEMALTGTFV- 368
              ++YLH ++  ++H D+K  N+ L  D     + DFGHA  L     G+  LTG ++ 
Sbjct: 162 --GLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
               +MAPEV+  +P   K D++S   ++  ++ G HP+ +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFV 368
           +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG A +   DGE    L GT  
Sbjct: 149 QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 206
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           Y+APEV+  + +S + DV+S G I+  ++ G  P+
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 66
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 67  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 117
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 118 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 175
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           +  + YS   D++S G I  E++T
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 98/195 (50%), Gaps = 26/195 (13%)
Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GT 279
           VA+KCI  +     E ++     E+  L + +H  ++ L     E     +L+ +L+ G 
Sbjct: 46  VAIKCIAKEALEGKEGSME---NEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGG 101
Query: 280 TLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI 337
            L + +   G  ++R   R++             ++  A++YLH+    ++HRDLKP N+
Sbjct: 102 ELFDRIVEKGFYTERDASRLI------------FQVLDAVKYLHDLG--IVHRDLKPENL 147
Query: 338 F---LDDAKHVRIADFGHARFLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGII 392
               LD+   + I+DFG ++    G +  T  GT  Y+APEV+  +PYS+  D +S G+I
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 393 LNEIITGNHPYIEKD 407
              ++ G  P+ +++
Sbjct: 208 AYILLCGYPPFYDEN 222

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFV 368
           +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG A +   DGE    L GT  
Sbjct: 125 QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN 182
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           Y+APEV+  + +S + DV+S G I+  ++ G  P+
Sbjct: 183 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 88/180 (48%), Gaps = 18/180 (10%)
Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRK 294
           + V    +E+  L   RH  +++L    +  P   ++V E + G  L +++   G    K
Sbjct: 58  DVVGKIRREIQNLKLFRHPHIIKLY-QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEK 116
Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
           E          RL +  +I   + Y H     V+HRDLKP N+ LD   + +IADFG + 
Sbjct: 117 E--------SRRLFQ--QILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSN 164
Query: 355 FLSDGEM--ALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPA 411
            +SDGE      G+  Y APEVI    Y+  + D++S G+IL  ++ G  P+ + D+ P 
Sbjct: 165 MMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF-DDDHVPT 223

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 62/101 (61%), Gaps = 5/101 (4%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFV 368
           EI+ A+ +LH++   +I+RDLKP NI L+   HV++ DFG  +  + DG +  T  GT  
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIE 186
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YMAPE++    ++   D +S G ++ +++TG  P+  ++ K
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFV 368
           +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG A +   DGE    L GT  
Sbjct: 147 QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 204
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           Y+APEV+  + +S + DV+S G I+  ++ G  P+
Sbjct: 205 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFV 368
           +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG A +   DGE    L GT  
Sbjct: 125 QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN 182
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           Y+APEV+  + +S + DV+S G I+  ++ G  P+
Sbjct: 183 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFV 368
           +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG A +   DGE    L GT  
Sbjct: 129 QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPN 186
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           Y+APEV+  + +S + DV+S G I+  ++ G  P+
Sbjct: 187 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  +++
Sbjct: 16  EKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHPNIVK 73
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+   +    + +LV E L   LK+++            +PLP  +  L    ++ Q + 
Sbjct: 74  LLD-VIHTENKLYLVFEFLHQDLKKFMDASALTG-----IPLPLIKSYL---FQLLQGLA 124
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEV- 374
           + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y APE+ 
Sbjct: 125 FCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 182
Query: 375 IQCEPYSEKSDVYSFGIILNEIIT 398
           +  + YS   D++S G I  E++T
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           Q ++G+G+   ++R   +  G   AVK +  + F   E            LS  R   ++
Sbjct: 79  QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVAC------AGLSSPR---IV 129
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER----LARALEI 313
            L GA  E P+    +  L G +L + +  +G          LP  E+R    L +ALE 
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---------LP--EDRALYYLGQALE- 177
Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSD---GEMALTGTFV- 368
              ++YLH ++  ++H D+K  N+ L  D     + DFGHA  L     G+  LTG ++ 
Sbjct: 178 --GLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
               +MAPEV+  +P   K D++S   ++  ++ G HP+ +
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 274

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 97/195 (49%), Gaps = 26/195 (13%)
Query: 221 VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GT 279
           VA+KCI        E ++     E+  L + +H  ++ L     E     +L+ +L+ G 
Sbjct: 46  VAIKCIAKKALEGKEGSME---NEIAVLHKIKHPNIVAL-DDIYESGGHLYLIMQLVSGG 101
Query: 280 TLKEWL--HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI 337
            L + +   G  ++R   R++             ++  A++YLH+    ++HRDLKP N+
Sbjct: 102 ELFDRIVEKGFYTERDASRLI------------FQVLDAVKYLHDLG--IVHRDLKPENL 147
Query: 338 F---LDDAKHVRIADFGHARFLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGII 392
               LD+   + I+DFG ++    G +  T  GT  Y+APEV+  +PYS+  D +S G+I
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVI 207
Query: 393 LNEIITGNHPYIEKD 407
              ++ G  P+ +++
Sbjct: 208 AYILLCGYPPFYDEN 222

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 64/107 (59%), Gaps = 14/107 (13%)
Query: 306 RLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--A 362
           ++ RAL E+  A+  L+     ++HRDLKP NI LDD  ++++ DFG +  L  GE    
Sbjct: 128 KIMRALLEVICALHKLN-----IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 363 LTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPY 403
           + GT  Y+APE+I+C        Y ++ D++S G+I+  ++ G+ P+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 40/95 (42%), Positives = 57/95 (60%), Gaps = 5/95 (5%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSDGE--MALTGTFV 368
           +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG A +   DGE    L GT  
Sbjct: 123 QIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPN 180
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           Y+APEV+  + +S + DV+S G I+  ++ G  P+
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF 215

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           IG G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 141
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 142 GLKYIH--SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM 199
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           Q ++G+G+   ++R   +  G   AVK +  + F   E            LS  R   ++
Sbjct: 77  QPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA------CAGLSSPR---IV 127
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER----LARALEI 313
            L GA  E P+    +  L G +L + +  +G          LP  E+R    L +ALE 
Sbjct: 128 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---------LP--EDRALYYLGQALE- 175
Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSD---GEMALTGTFV- 368
              ++YLH ++  ++H D+K  N+ L  D     + DFGHA  L     G+  LTG ++ 
Sbjct: 176 --GLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
               +MAPEV+  +P   K D++S   ++  ++ G HP+ +
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 272

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 61/101 (60%), Gaps = 5/101 (4%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMA--LTGTFV 368
           EI+ A+ +LH++   +I+RDLKP NI L+   HV++ DFG  +  + DG +     GT  
Sbjct: 129 EISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIE 186
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           YMAPE++    ++   D +S G ++ +++TG  P+  ++ K
Sbjct: 187 YMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 102/244 (41%), Gaps = 48/244 (19%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           +++ L E +G+G    ++R +W G  VAVK      F + +    F   E+      RH 
Sbjct: 8   RQVALVECVGKGRYGEVWRGLWHGESVAVK-----IFSSRDEQSWFRETEIYNTVLLRHD 62
Query: 255 FVLQLMGACL---EPPYRGWLVTELLGTTLKEWLHGLGS-QRRKERMVPLPPFEERLARA 310
            +L  + + +       + WL+T           H  GS     +R    P    RL  A
Sbjct: 63  NILGFIASDMTSRNSSTQLWLITH---------YHEHGSLYDFLQRQTLEPHLALRL--A 111
Query: 311 LEIAQAMQYLH------EQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-------RFLS 357
           +  A  + +LH      + KP + HRD K  N+ +       IAD G A        +L 
Sbjct: 112 VSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLD 171
Query: 358 DGEMALTGTFVYMAPEVI------QCEPYSEKSDVYSFGIILNE-----IITGNHPYIEK 406
            G     GT  YMAPEV+       C    + +D+++FG++L E     I+ G    I +
Sbjct: 172 IGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVNG----IVE 227
Query: 407 DYKP 410
           DY+P
Sbjct: 228 DYRP 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/276 (25%), Positives = 121/276 (43%), Gaps = 36/276 (13%)
Query: 203 IGQGTTANIYRAIW--RGLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQL 259
           +  G    +Y+ +W   G  V +     +    T+  A      E   ++   +  V +L
Sbjct: 30  LSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 89
Query: 260 MGACLEPPYRGWLVTELL--GTTL---KEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           +G CL    +  L+ +L+  G  L   +E    +GSQ               L   ++IA
Sbjct: 90  LGICLTSTVQ--LIMQLMPFGCLLDYVREHKDNIGSQYL-------------LNWCVQIA 134
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS--DGEMALTGTFV---Y 369
           + M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   + E    G  V   +
Sbjct: 135 KGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 192
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           MA E I    Y+ +SDV+S+G+ + E++T G+ PY   D  PA     + E   R  LP+
Sbjct: 193 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSILEKGER--LPQ 247
Query: 429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                 ++  ++   W  DA  RP F  +      +
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 283

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + + SQ+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKSQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG  R   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 30/216 (13%)
Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIGQG +  +Y A  +  G +VA++                   +++   + +   ++ 
Sbjct: 27  EKIGQGASGTVYTAMDVATGQEVAIR-------------------QMNLQQQPKKELIIN 67
Query: 259 ---LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIA 314
              +M     P    +L + L+G  L   +  L      + +      E ++A    E  
Sbjct: 68  EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 127
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS---DGEMALTGTFVYMA 371
           QA+++LH  +  VIHR++K  NI L     V++ DFG    ++        + GT  +MA
Sbjct: 128 QALEFLHSNQ--VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 185
Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           PEV+  + Y  K D++S GI+  E+I G  PY+ ++
Sbjct: 186 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 221

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTGT-- 366
           + ++A+ M +L  +    IHRDL   NI L   +  +I DFG AR + +D    + G   
Sbjct: 174 SYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNAR 231
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGK 421
               +MAPE I    Y+ +SDV+S+GI L E+ + G+ PY  +  D K  K+   + EG 
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM---IKEG- 287
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            R   PE      E+ +++   WD D   RP+F  I 
Sbjct: 288 FRMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 93
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 142
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 143 GLKYIH--SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIM 200
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 138
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 139 GLKYIH--SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATRWYRAPEIM 196
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/269 (24%), Positives = 122/269 (45%), Gaps = 61/269 (22%)
Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---- 251
           D++E++G+G  + + R + +  GL+ A K I         N     A++   L R+    
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKII---------NTKKLSARDFQKLEREARIC 59
Query: 252 ---RHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
              +H  +++L  +  E  +  +LV +L+ G  L                     FE+ +
Sbjct: 60  RKLQHPNIVRLHDSIQEESFH-YLVFDLVTGGEL---------------------FEDIV 97
Query: 308 ARAL-----------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHA 353
           AR             +I +++ Y H     ++HR+LKP N+ L        V++ADFG A
Sbjct: 98  AREFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLA 155
Query: 354 RFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA 411
             ++D E      GT  Y++PEV++ +PYS+  D+++ G+IL  ++ G  P+ ++D    
Sbjct: 156 IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-- 213
Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELI 440
           ++  ++  G      PE D    E   LI
Sbjct: 214 RLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 40/110 (36%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR---FLS 357
           F E  AR  A EIA A+ YLH     +++RDLKP NI LD   H+ + DFG  +     +
Sbjct: 136 FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN 193
Query: 358 DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
                  GT  Y+APEV+  +PY    D +  G +L E++ G  P+  ++
Sbjct: 194 STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKXQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 141
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 142 GLKYIH--SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM 199
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG AR L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 98
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 147
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 148 GLKYIH--SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATRWYRAPEIM 205
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 118/268 (44%), Gaps = 59/268 (22%)
Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---- 251
           D++E++G+G  + + R + +  GL+ A K I         N     A++   L R+    
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKII---------NTKKLSARDFQKLEREARIC 59
Query: 252 ---RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
              +H  +++L  +  E  +   +   + G  L                     FE+ +A
Sbjct: 60  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---------------------FEDIVA 98
Query: 309 RAL-----------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHAR 354
           R             +I +++ Y H     ++HR+LKP N+ L        V++ADFG A 
Sbjct: 99  REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI 156
Query: 355 FLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK 412
            ++D E      GT  Y++PEV++ +PYS+  D+++ G+IL  ++ G  P+ ++D    +
Sbjct: 157 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--R 214
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELI 440
           +  ++  G      PE D    E   LI
Sbjct: 215 LYAQIKAGAYDYPSPEWDTVTPEAKSLI 242

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 118/268 (44%), Gaps = 59/268 (22%)
Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---- 251
           D++E++G+G  + + R + +  GL+ A K I         N     A++   L R+    
Sbjct: 8   DVKEELGKGAFSVVRRCVHKTTGLEFAAKII---------NTKKLSARDFQKLEREARIC 58
Query: 252 ---RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
              +H  +++L  +  E  +   +   + G  L                     FE+ +A
Sbjct: 59  RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL---------------------FEDIVA 97
Query: 309 RAL-----------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHAR 354
           R             +I +++ Y H     ++HR+LKP N+ L        V++ADFG A 
Sbjct: 98  REFYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAI 155
Query: 355 FLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK 412
            ++D E      GT  Y++PEV++ +PYS+  D+++ G+IL  ++ G  P+ ++D    +
Sbjct: 156 EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--R 213
Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELI 440
           +  ++  G      PE D    E   LI
Sbjct: 214 LYAQIKAGAYDYPSPEWDTVTPEAKSLI 241

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 99
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 148
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 149 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 206
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 143
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR  +D       T  Y APE+ 
Sbjct: 144 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM 201
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 143
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR  +D       T  Y APE+ 
Sbjct: 144 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM 201
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 25/258 (9%)
Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I  ++I L+ ++G+G    ++ A    L        VAVK +       +E+A   F +
Sbjct: 37  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQR 92
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR----KERMVP 299
           E + L+  +H+ +++  G C E      +   +    L  +L   G   +     E + P
Sbjct: 93  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152
Query: 300 LP-PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
            P    + LA A ++A  M YL       +HRDL   N  +     V+I DFG +R +  
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M PE I    ++ +SDV+SFG++L EI T G  P+ +     A 
Sbjct: 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270
Query: 413 IAMEVGEGKLRP-ALPEE 429
             +  G    RP A P E
Sbjct: 271 DCITQGRELERPRACPPE 288

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 143
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR  +D       T  Y APE+ 
Sbjct: 144 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIM 201
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 31/244 (12%)
Query: 164 HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAI--WRGLDV 221
           H +  + P   + +L  T+       W + P+       +G G   ++  A     GL V
Sbjct: 5   HHHSQERPTFYRQELNKTI-------WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRV 56
Query: 222 AVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTEL 276
           AVK +   F        T+  +E+  L   +H  V+ L+        LE     +LVT L
Sbjct: 57  AVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
           +G  L    + +  Q+  +  V    ++        I + ++Y+H     +IHRDLKPSN
Sbjct: 115 MGADLN---NIVKCQKLTDDHVQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSN 161
Query: 337 IFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNE 395
           + +++   ++I DFG AR   D       T  Y APE+ +    Y++  D++S G I+ E
Sbjct: 162 LAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 396 IITG 399
           ++TG
Sbjct: 222 LLTG 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL E     +HRDL   NI ++     +++DFG +RFL +     T T      
Sbjct: 127 IASGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
               + APE I    ++  SD +S+GI++ E+++ G  PY +   +    A+E  +    
Sbjct: 185 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE--QDYRL 242
Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P  P+    L +L+ L C  W  D + RP F  +  +L  +
Sbjct: 243 PPPPDCPTSLHQLM-LDC--WQKDRNARPRFPQVVSALDKM 280

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL E     +HRDL   NI ++     +++DFG +RFL +     T T      
Sbjct: 125 IASGMRYLAEMS--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
               + APE I    ++  SD +S+GI++ E+++ G  PY +   +    A+E  +    
Sbjct: 183 IPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIE--QDYRL 240
Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P  P+    L +L+ L C  W  D + RP F  +  +L  +
Sbjct: 241 PPPPDCPTSLHQLM-LDC--WQKDRNARPRFPQVVSALDKM 278

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 16/161 (9%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---- 368
           IA  M+YL +     +HRDL   NI ++     +++DFG +RFL D     T T      
Sbjct: 144 IAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
               + APE IQ   ++  SDV+S+GI++ E+++ G  PY +   +    A+E  + +L 
Sbjct: 202 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP 260
Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P +         L +L+   W  D + RP F  I  +L  +
Sbjct: 261 PPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 297

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTGT-- 366
           + ++A+ M +L  +    IHRDL   NI L   +  +I DFG AR + +D    + G   
Sbjct: 167 SYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 224
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGK 421
               +MAPE I    Y+ +SDV+S+GI L E+ + G+ PY  +  D K  K+   + EG 
Sbjct: 225 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM---IKEG- 280
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            R   PE      E+ +++   WD D   RP+F  I 
Sbjct: 281 FRMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIV 315

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 76/173 (43%), Gaps = 17/173 (9%)
Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
           N V    +E+  +    H F++ L  +  +      +V  LLG  L+   H   +   KE
Sbjct: 57  NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR--YHLQQNVHFKE 114
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
             V L           E+  A+ YL  Q+  +IHRD+KP NI LD+  HV I DF  A  
Sbjct: 115 ETVKL--------FICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM 164
Query: 356 LSDGEMALT--GTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITGNHPY 403
           L       T  GT  YMAPE+        YS   D +S G+   E++ G  PY
Sbjct: 165 LPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 110
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 159
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 160 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRAPEIM 217
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 25/258 (9%)
Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I  ++I L+ ++G+G    ++ A    L        VAVK +       +E+A   F +
Sbjct: 8   HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQR 63
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR----KERMVP 299
           E + L+  +H+ +++  G C E      +   +    L  +L   G   +     E + P
Sbjct: 64  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 123
Query: 300 LP-PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
            P    + LA A ++A  M YL       +HRDL   N  +     V+I DFG +R +  
Sbjct: 124 GPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 181
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M PE I    ++ +SDV+SFG++L EI T G  P+ +     A 
Sbjct: 182 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 241
Query: 413 IAMEVGEGKLRP-ALPEE 429
             +  G    RP A P E
Sbjct: 242 DCITQGRELERPRACPPE 259

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTGT-- 366
           + ++A+ M +L  +    IHRDL   NI L   +  +I DFG AR + +D    + G   
Sbjct: 174 SYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 231
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGK 421
               +MAPE I    Y+ +SDV+S+GI L E+ + G+ PY  +  D K  K+   + EG 
Sbjct: 232 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM---IKEG- 287
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            R   PE      E+ +++   WD D   RP+F  I 
Sbjct: 288 FRMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIV 322

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKXQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTGT-- 366
           + ++A+ M +L  +    IHRDL   NI L   +  +I DFG AR + +D    + G   
Sbjct: 169 SYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 226
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGK 421
               +MAPE I    Y+ +SDV+S+GI L E+ + G+ PY  +  D K  K+   + EG 
Sbjct: 227 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM---IKEG- 282
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            R   PE      E+ +++   WD D   RP+F  I 
Sbjct: 283 FRMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIV 317

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/157 (33%), Positives = 79/157 (50%), Gaps = 16/157 (10%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALTGT-- 366
           + ++A+ M +L  +    IHRDL   NI L   +  +I DFG AR + +D    + G   
Sbjct: 151 SYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNAR 208
Query: 367 --FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGK 421
               +MAPE I    Y+ +SDV+S+GI L E+ + G+ PY  +  D K  K+   + EG 
Sbjct: 209 LPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM---IKEG- 264
Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            R   PE      E+ +++   WD D   RP+F  I 
Sbjct: 265 FRMLSPEHAPA--EMYDIMKTCWDADPLKRPTFKQIV 299

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 99
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 148
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 149 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 206
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 68/258 (26%), Positives = 112/258 (43%), Gaps = 25/258 (9%)
Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I  ++I L+ ++G+G    ++ A    L        VAVK +       +E+A   F +
Sbjct: 14  HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK----EASESARQDFQR 69
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR----KERMVP 299
           E + L+  +H+ +++  G C E      +   +    L  +L   G   +     E + P
Sbjct: 70  EAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 129
Query: 300 LP-PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
            P    + LA A ++A  M YL       +HRDL   N  +     V+I DFG +R +  
Sbjct: 130 GPLGLGQLLAVASQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 187
Query: 359 GEMALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +    G        +M PE I    ++ +SDV+SFG++L EI T G  P+ +     A 
Sbjct: 188 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 247
Query: 413 IAMEVGEGKLRP-ALPEE 429
             +  G    RP A P E
Sbjct: 248 DCITQGRELERPRACPPE 265

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 99
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 100 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 148
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 149 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 206
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTG 231

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 98
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 99  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 147
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 148 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 205
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTG 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 93
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 94  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 142
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 143 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 200
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTG 225

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 138
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 139 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 196
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 115/255 (45%), Gaps = 27/255 (10%)
Query: 210 NIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR 269
            +YR   + +DVA+K +      T +       +E   + +  + ++++L+G C      
Sbjct: 355 GVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALM 411
Query: 270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIH 329
             LV E+ G      LH     +R+E  +P+    E L    +++  M+YL E+    +H
Sbjct: 412 --LVMEMAGGGP---LHKFLVGKREE--IPVSNVAELLH---QVSMGMKYLEEKN--FVH 459
Query: 330 RDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG------TFVYMAPEVIQCEPYSEK 383
           R+L   N+ L +  + +I+DFG ++ L   +   T          + APE I    +S +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 384 SDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICL 442
           SDV+S+G+ + E ++ G  PY  K  K  ++   + +GK     PE      EL  L+  
Sbjct: 520 SDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIEQGKRMECPPECPP---ELYALMSD 574
Query: 443 SWDGDASVRPSFSSI 457
            W      RP F ++
Sbjct: 575 CWIYKWEDRPDFLTV 589

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 110
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 111 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 159
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 160 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 217
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTG 242

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 127 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 242
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 243 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 278

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 141
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 142 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 199
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 86
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 87  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 135
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 136 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 193
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTG 218

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 94
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 95  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 143
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 144 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 201
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTG 226

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 127 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 242
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 243 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 278

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 138
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 139 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 196
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 14/115 (12%)
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSDGEMALTGTFVYMA 371
           A+ YLH+ K  +IHRDLK  NI       +++ADFG    + R +   + +  GT  +MA
Sbjct: 147 ALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD-SFIGTPYWMA 203
Query: 372 PEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           PEV+ CE     PY  K+DV+S GI L E+     P+ E    P ++ +++ + +
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVLLKIAKSE 256

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 89
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 90  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 138
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 139 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 196
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTG 221

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 144 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 259
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 260 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 295

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 81/159 (50%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL---TGTFV- 368
           IA  M+YL +     +HRDL   NI ++     +++DFG +R + D   A+   TG  + 
Sbjct: 154 IAAGMRYLADMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 369 --YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE IQ   ++  SDV+S+GI++ E+++ G  PY +   +    A+E  EG   PA
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE--EGYRLPA 269
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  + + RP F  I   L  +
Sbjct: 270 PMDCPAGLHQLM-LDC--WQKERAERPKFEQIVGILDKM 305

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 106
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 107 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 155
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 156 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 213
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 154 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 269
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 270 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 305

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 107
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 108 DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 156
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 157 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 214
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 92
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 93  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 141
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 142 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 199
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTG 224

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 84
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 133
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 134 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 191
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/135 (36%), Positives = 70/135 (51%), Gaps = 15/135 (11%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIADFGHARF-LSDGEMALTGTFVY 369
           +I + +Q+LH + P +IHRDLK  NIF+      V+I D G A    +    A+ GT  +
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEF 196
Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP----- 424
            APE  + E Y E  DVY+FG    E  T  +PY E     A+I   V  G ++P     
Sbjct: 197 XAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYSECQ-NAAQIYRRVTSG-VKPASFDK 253
Query: 425 -ALPEEDGQLRELIE 438
            A+PE    ++E+IE
Sbjct: 254 VAIPE----VKEIIE 264

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 130/313 (41%), Gaps = 63/313 (20%)
Query: 191 YIDPKEIDLQEK-------------IGQGTTANIYRAIWRGL-------DVAVKCIYPDF 230
           +IDP ++   EK             +G G    +  A   GL        VAVK +    
Sbjct: 29  FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KST 87
Query: 231 FHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLG 289
            H +E        E+  +S   +H  ++ L+GAC      G  V  L+ T    +   L 
Sbjct: 88  AHADEKEA--LMSELKIMSHLGQHENIVNLLGACTH----GGPV--LVITEYCCYGDLLN 139
Query: 290 SQRRKERMVPLPPF----------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL 339
             RRK R++   P            + L  + ++AQ M +L  +    IHRD+   N+ L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL 197
Query: 340 DDAKHVRIADFGHAR-FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILN 394
            +    +I DFG AR  ++D    + G       +MAPE I    Y+ +SDV+S+GI+L 
Sbjct: 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 395 EIIT-GNHPY-----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDA 448
           EI + G +PY       K YK  K   ++ +    P         + +  ++   W  + 
Sbjct: 258 EIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP---------KNIYSIMQACWALEP 308
Query: 449 SVRPSFSSITCSL 461
           + RP+F  I CS 
Sbjct: 309 THRPTFQQI-CSF 320

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 14/115 (12%)
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSDGEMALTGTFVYMA 371
           A+ YLH+ K  +IHRDLK  NI       +++ADFG    + R +   + +  GT  +MA
Sbjct: 147 ALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-SFIGTPYWMA 203
Query: 372 PEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           PEV+ CE     PY  K+DV+S GI L E+     P+ E    P ++ +++ + +
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVLLKIAKSE 256

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 85
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 86  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 134
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 135 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 192
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTG 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 193 DPKEI--DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           DP+++  DL+E IG G+   +Y  R +     VA+K +      +NE       +EV  L
Sbjct: 51  DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII-KEVRFL 108
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            + RH   +Q  G C    +  WLV E          + LGS      +   P  E  +A
Sbjct: 109 QKLRHPNTIQYRG-CYLREHTAWLVME----------YCLGSASDLLEVHKKPLQEVEIA 157
Query: 309 RALEIA-QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
                A Q + YLH     +IHRD+K  NI L +   V++ DFG A  ++       GT 
Sbjct: 158 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-XFVGTP 214
Query: 368 VYMAPEVIQCEP---YSEKSDVYSFGIILNEI 396
            +MAPEVI       Y  K DV+S GI   E+
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 83
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 132
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 133 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 190
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 84
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 85  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 133
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y APE+ 
Sbjct: 134 GLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIM 191
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTG 216

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/313 (26%), Positives = 130/313 (41%), Gaps = 63/313 (20%)
Query: 191 YIDPKEIDLQEK-------------IGQGTTANIYRAIWRGL-------DVAVKCIYPDF 230
           +IDP ++   EK             +G G    +  A   GL        VAVK +    
Sbjct: 29  FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KST 87
Query: 231 FHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLG 289
            H +E        E+  +S   +H  ++ L+GAC      G  V  L+ T    +   L 
Sbjct: 88  AHADEKEA--LMSELKIMSHLGQHENIVNLLGACTH----GGPV--LVITEYCCYGDLLN 139
Query: 290 SQRRKERMVPLPPF----------EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL 339
             RRK R++   P            + L  + ++AQ M +L  +    IHRD+   N+ L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLL 197
Query: 340 DDAKHVRIADFGHAR-FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILN 394
            +    +I DFG AR  ++D    + G       +MAPE I    Y+ +SDV+S+GI+L 
Sbjct: 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLW 257
Query: 395 EIIT-GNHPY-----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDA 448
           EI + G +PY       K YK  K   ++ +    P         + +  ++   W  + 
Sbjct: 258 EIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAP---------KNIYSIMQACWALEP 308
Query: 449 SVRPSFSSITCSL 461
           + RP+F  I CS 
Sbjct: 309 THRPTFQQI-CSF 320

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL +     +HRDL   NI ++     +++DFG  R L D   A   T      
Sbjct: 156 IASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + +PE I    ++  SDV+S+GI+L E+++ G  PY E   +   +   V EG   P 
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ--DVIKAVDEGYRLPP 271
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             +    L +L+ L C  W  D + RP F  I   L  +
Sbjct: 272 PMDCPAALYQLM-LDC--WQKDRNNRPKFEQIVSILDKL 307

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 41/104 (39%), Positives = 62/104 (59%), Gaps = 8/104 (7%)
Query: 304 EERLARALE-IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG---HARFLSDG 359
           E+R A  +E +A A+ Y H +K  VIHRD+KP N+ L     ++IADFG   HA  L   
Sbjct: 122 EQRTATIMEELADALMYCHGKK--VIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK 179
Query: 360 EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            M   GT  Y+ PE+I+   ++EK D++  G++  E++ GN P+
Sbjct: 180 TMC--GTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/115 (34%), Positives = 62/115 (53%), Gaps = 14/115 (12%)
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG----HARFLSDGEMALTGTFVYMA 371
           A+ YLH+ K  +IHRDLK  NI       +++ADFG    + R +   +    GT  +MA
Sbjct: 147 ALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRD-XFIGTPYWMA 203
Query: 372 PEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           PEV+ CE     PY  K+DV+S GI L E+     P+ E    P ++ +++ + +
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE--LNPMRVLLKIAKSE 256

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  AI +  G  VA+K +   F   +E       +E+  L   +H  V+ L+
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 261 -----GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                 + L   Y  +LV   + T L++ +    S+ + + +V             ++ +
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLV------------YQMLK 155
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            ++Y+H     V+HRDLKP N+ +++   ++I DFG AR  +D EM  TG  V   Y AP
Sbjct: 156 GLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEM--TGYVVTRWYRAP 210
Query: 373 EVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           EVI     Y++  D++S G I+ E++TG   +  KDY
Sbjct: 211 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 247

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/98 (35%), Positives = 60/98 (61%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMAL---TG 365
           +I +A++Y H+    +IHRD+KP N+ L   +++  V++ DFG A  L +  +      G
Sbjct: 138 QILEALRYCHDNN--IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVG 195
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           T  +MAPEV++ EPY +  DV+  G+IL  +++G  P+
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/140 (34%), Positives = 73/140 (52%), Gaps = 15/140 (10%)
Query: 271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIH 329
           W+  EL  T+L ++   +     K + +P    E+ L + A+ I +A+++LH  K  VIH
Sbjct: 109 WICXELXDTSLDKFYKQVID---KGQTIP----EDILGKIAVSIVKALEHLH-SKLSVIH 160
Query: 330 RDLKPSNIFLDDAKHVRIADFGHARFLSD--GEMALTGTFVYMAPEVIQCE----PYSEK 383
           RD+KPSN+ ++    V+  DFG + +L D   +    G   Y APE I  E     YS K
Sbjct: 161 RDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVK 220
Query: 384 SDVYSFGIILNEIITGNHPY 403
           SD++S GI   E+     PY
Sbjct: 221 SDIWSLGITXIELAILRFPY 240

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 95/212 (44%), Gaps = 24/212 (11%)
Query: 193 DPKEI--DLQEKIGQGTTANIY--RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           DP+++  DL+E IG G+   +Y  R +     VA+K +      +NE       +EV  L
Sbjct: 12  DPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII-KEVRFL 69
Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            + RH   +Q  G C    +  WLV E          + LGS      +   P  E  +A
Sbjct: 70  QKLRHPNTIQYRG-CYLREHTAWLVME----------YCLGSASDLLEVHKKPLQEVEIA 118
Query: 309 RALEIA-QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
                A Q + YLH     +IHRD+K  NI L +   V++ DFG A  ++       GT 
Sbjct: 119 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN-XFVGTP 175
Query: 368 VYMAPEVIQCEP---YSEKSDVYSFGIILNEI 396
            +MAPEVI       Y  K DV+S GI   E+
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 71/150 (47%), Gaps = 25/150 (16%)
Query: 272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           L+TEL    L E+L      ++ E   PL   +  L    +  +A+Q++H QKP +IHRD
Sbjct: 111 LLTELCKGQLVEFL------KKMESRGPLS-CDTVLKIFYQTCRAVQHMHRQKPPIIHRD 163
Query: 332 LKPSNIFLDDAKHVRIADFGHA---------------RFLSDGEMALTGTFVYMAPEVIQ 376
           LK  N+ L +   +++ DFG A               R L + E+    T +Y  PE+I 
Sbjct: 164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223
Query: 377 CE---PYSEKSDVYSFGIILNEIITGNHPY 403
                P  EK D+++ G IL  +    HP+
Sbjct: 224 LYSNFPIGEKQDIWALGCILYLLCFRQHPF 253

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 72/159 (45%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           IA  M+YL       +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 156 IAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    ++  SDV+SFGI++ E++T G  PY E        A+  G    R  
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FR-- 268
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           LP        + +L+   W  + + RP F+ I   L  +
Sbjct: 269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 53/306 (17%)
Query: 191 YIDPKEIDLQEK-------------IGQGTTANIYRAIWRGL-------DVAVKCIYPDF 230
           +IDP ++   EK             +G G    +  A   GL        VAVK +    
Sbjct: 29  FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KST 87
Query: 231 FHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLEP-PYRGWLVTEL--LGTTLKEWLH 286
            H +E        E+  +S   +H  ++ L+GAC    P    ++TE    G  L     
Sbjct: 88  AHADEKEA--LMSELKIMSHLGQHENIVNLLGACTHGGPVL--VITEYCCYGDLLNFLRR 143
Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR 346
              +   KE   PL    + L  + ++AQ M +L  +    IHRD+   N+ L +    +
Sbjct: 144 KAEADLDKEDGRPLE-LRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAK 200
Query: 347 IADFGHAR-FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN 400
           I DFG AR  ++D    + G       +MAPE I    Y+ +SDV+S+GI+L EI + G 
Sbjct: 201 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 260
Query: 401 HPY-----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
           +PY       K YK  K   ++ +    P         + +  ++   W  + + RP+F 
Sbjct: 261 NPYPGILVNSKFYKLVKDGYQMAQPAFAP---------KNIYSIMQACWALEPTHRPTFQ 311
Query: 456 SITCSL 461
            I CS 
Sbjct: 312 QI-CSF 316

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 106/217 (48%), Gaps = 30/217 (13%)
Query: 203 IGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  AI +  G  VA+K +   F   +E       +E+  L   +H  V+ L+
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 261 -----GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                 + L   Y  +LV   + T L++ +    S+ + + +V             ++ +
Sbjct: 90  DVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLV------------YQMLK 137
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            ++Y+H     V+HRDLKP N+ +++   ++I DFG AR  +D EM  TG  V   Y AP
Sbjct: 138 GLKYIHS--AGVVHRDLKPGNLAVNEDCELKILDFGLARH-ADAEM--TGYVVTRWYRAP 192
Query: 373 EVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           EVI     Y++  D++S G I+ E++TG   +  KDY
Sbjct: 193 EVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY 229

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 53/306 (17%)
Query: 191 YIDPKEIDLQEK-------------IGQGTTANIYRAIWRGL-------DVAVKCIYPDF 230
           +IDP ++   EK             +G G    +  A   GL        VAVK +    
Sbjct: 21  FIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML-KST 79
Query: 231 FHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLEP-PYRGWLVTEL--LGTTLKEWLH 286
            H +E        E+  +S   +H  ++ L+GAC    P    ++TE    G  L     
Sbjct: 80  AHADEKEA--LMSELKIMSHLGQHENIVNLLGACTHGGPVL--VITEYCCYGDLLNFLRR 135
Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR 346
              +   KE   PL    + L  + ++AQ M +L  +    IHRD+   N+ L +    +
Sbjct: 136 KAEADLDKEDGRPLE-LRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAK 192
Query: 347 IADFGHAR-FLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN 400
           I DFG AR  ++D    + G       +MAPE I    Y+ +SDV+S+GI+L EI + G 
Sbjct: 193 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL 252
Query: 401 HPY-----IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
           +PY       K YK  K   ++ +    P         + +  ++   W  + + RP+F 
Sbjct: 253 NPYPGILVNSKFYKLVKDGYQMAQPAFAP---------KNIYSIMQACWALEPTHRPTFQ 303
Query: 456 SITCSL 461
            I CS 
Sbjct: 304 QI-CSF 308

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 194 PKEIDLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P+       +G G   ++  +  +  GL +AVK +   F        T+  +E+  L   
Sbjct: 50  PERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTY--RELRLLKHM 107
Query: 252 RHRFVLQLM-----GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  V    ++  
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ-- 162
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
                 I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T
Sbjct: 163 ------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVAT 214
Query: 367 FVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
             Y APE+ +    Y+   D++S G I+ E++TG
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTG 248

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I D+G AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           I+  M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 133 ISAGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    ++  SDV+S+GI++ E+++ G  PY E   +    A+E G       
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGY-----R 245
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           LP        L +L+   W  + + RP F  I   L  +
Sbjct: 246 LPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/116 (35%), Positives = 70/116 (60%), Gaps = 10/116 (8%)
Query: 295 ERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIAD 349
           E+++    F+E  A  +  +I   + YLH  K  ++HRD+KP NI L++     +++I D
Sbjct: 135 EQIINRHKFDECDAANIMKQILSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVD 192
Query: 350 FGHARFLS-DGEM-ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           FG + F S D ++    GT  Y+APEV++ + Y+EK DV+S G+I+  ++ G  P+
Sbjct: 193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 126
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 127 VQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 177 DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 126
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 127 VQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 177 DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 8/105 (7%)
Query: 298 VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           VP P  P E       ++ + + +LH  +  V+HRDLKP NI +  +  +++ADFG AR 
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 356 LSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
            S  +MALT   V   Y APEV+    Y+   D++S G I  E+ 
Sbjct: 170 YS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 122
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 123 VQFLIYQ--------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 173 DEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDG 359
           EE  +   +I   + YLH +K  + H DLKP NI L D      H+++ DFG A  + DG
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 360 E--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
                + GT  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 28/231 (12%)
Query: 188 NGWYIDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEV 245
             W +     DLQ  +G G    +  A+    G  VA+K +Y  F   +E       +E+
Sbjct: 19  TAWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYREL 75
Query: 246 DTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL 300
             L   RH  V+ L+        L+     +LV   +GT L       G   + E++   
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL-------GKLMKHEKLG-- 126
Query: 301 PPFEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
              E+R+   + ++ + ++Y+H     +IHRDLKP N+ +++   ++I DFG AR  +D 
Sbjct: 127 ---EDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QADS 180
Query: 360 EM-ALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           EM     T  Y APEVI     Y++  D++S G I+ E+ITG   +   D+
Sbjct: 181 EMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 8/105 (7%)
Query: 298 VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           VP P  P E       ++ + + +LH  +  V+HRDLKP NI +  +  +++ADFG AR 
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 356 LSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
            S  +MALT   V   Y APEV+    Y+   D++S G I  E+ 
Sbjct: 170 YS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 8/105 (7%)
Query: 298 VPLP--PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           VP P  P E       ++ + + +LH  +  V+HRDLKP NI +  +  +++ADFG AR 
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI 169
Query: 356 LSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
            S  +MALT   V   Y APEV+    Y+   D++S G I  E+ 
Sbjct: 170 YS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
            FF +E D ++     +V+QL  A  +  Y   ++  + G  L   +            V
Sbjct: 114 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--------V 165
Query: 299 PLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
           P     E+ AR    E+  A+  +H      IHRD+KP N+ LD + H+++ADFG    +
Sbjct: 166 P-----EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 218
Query: 357 SDGEMA----LTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           +   M       GT  Y++PEV++ +     Y  + D +S G+ L E++ G+ P+    Y
Sbjct: 219 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF----Y 274
Query: 409 KPAKIAM--EVGEGKLRPALPEEDGQLRELIELIC 441
             + +    ++   K     P+++   +E   LIC
Sbjct: 275 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
            FF +E D ++     +V+QL  A  +  Y   ++  + G  L   +            V
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--------V 170
Query: 299 PLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
           P     E+ AR    E+  A+  +H      IHRD+KP N+ LD + H+++ADFG    +
Sbjct: 171 P-----EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 223
Query: 357 SDGEMA----LTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           +   M       GT  Y++PEV++ +     Y  + D +S G+ L E++ G+ P+    Y
Sbjct: 224 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF----Y 279
Query: 409 KPAKIAM--EVGEGKLRPALPEEDGQLRELIELIC 441
             + +    ++   K     P+++   +E   LIC
Sbjct: 280 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 314

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 34/230 (14%)
Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           Q ++G+G+   ++R   +  G   AVK +  + F          A+E+   +      ++
Sbjct: 98  QLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR---------AEELMACAGLTSPRIV 148
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
            L GA  E P+    +  L G +L       G   +++  +P       L +ALE    +
Sbjct: 149 PLYGAVREGPWVNIFMELLEGGSL-------GQLVKEQGCLPEDRALYYLGQALE---GL 198
Query: 318 QYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSD---GEMALTGTFV----- 368
           +YLH ++  ++H D+K  N+ L  D  H  + DFGHA  L     G+  LTG ++     
Sbjct: 199 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAME 416
           +MAPEV+       K DV+S   ++  ++ G HP+ +    P   KIA E
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASE 306

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDG 359
           EE  +   +I   + YLH +K  + H DLKP NI L D      H+++ DFG A  + DG
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 360 E--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
                + GT  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDG 359
           EE  +   +I   + YLH +K  + H DLKP NI L D      H+++ DFG A  + DG
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 360 E--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
                + GT  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           I   M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 125 IGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    ++  SDV+S+GI++ E+++ G  PY +   +    A+E  EG   P 
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE--EGYRLP- 239
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            P  D  +  L +L+   W  + S RP F  I   L  +
Sbjct: 240 -PPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           I   M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 140 IGSGMKYLSDMS--AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    ++  SDV+S+GI++ E+++ G  PY +   +    A+E  EG   P 
Sbjct: 198 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE--EGYRLP- 254
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            P  D  +  L +L+   W  + S RP F  I   L  +
Sbjct: 255 -PPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDG 359
           EE  +   +I   + YLH +K  + H DLKP NI L D      H+++ DFG A  + DG
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 360 E--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
                + GT  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 108/244 (44%), Gaps = 31/244 (12%)
Query: 164 HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAI--WRGLDV 221
           H +  + P   + +L  T+       W + P+       +G G   ++  A     G  V
Sbjct: 5   HHHSQERPTFYRQELNKTI-------WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGHRV 56
Query: 222 AVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTEL 276
           AVK +   F        T+  +E+  L   +H  V+ L+        LE     +LVT L
Sbjct: 57  AVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 114
Query: 277 LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN 336
           +G  L    + +  Q+  +  V    ++        I + ++Y+H     +IHRDLKPSN
Sbjct: 115 MGADLN---NIVKCQKLTDDHVQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSN 161
Query: 337 IFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNE 395
           + +++   ++I DFG AR   D       T  Y APE+ +    Y++  D++S G I+ E
Sbjct: 162 LAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 221
Query: 396 IITG 399
           ++TG
Sbjct: 222 LLTG 225

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 126
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 127 VQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/115 (33%), Positives = 67/115 (58%), Gaps = 10/115 (8%)
Query: 300 LPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           L P  E  AR    ++ + ++YLH QK  +IHRD+KPSN+ + +  H++IADFG +    
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 358 DGEMALT---GTFVYMAPEVIQ--CEPYSEKS-DVYSFGIILNEIITGNHPYIEK 406
             +  L+   GT  +MAPE +    + +S K+ DV++ G+ L   + G  P++++
Sbjct: 189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
            FF +E D ++     +V+QL  A  +  Y   ++  + G  L   +            V
Sbjct: 119 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD--------V 170
Query: 299 PLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
           P     E+ AR    E+  A+  +H      IHRD+KP N+ LD + H+++ADFG    +
Sbjct: 171 P-----EKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 223
Query: 357 SDGEMA----LTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           +   M       GT  Y++PEV++ +     Y  + D +S G+ L E++ G+ P+    Y
Sbjct: 224 NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF----Y 279
Query: 409 KPAKIAM--EVGEGKLRPALPEEDGQLRELIELIC 441
             + +    ++   K     P+++   +E   LIC
Sbjct: 280 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 314

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 122
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 123 VQFLIYQ--------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 172
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 173 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDG 359
           EE  +   +I   + YLH +K  + H DLKP NI L D      H+++ DFG A  + DG
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 360 E--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
                + GT  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---- 368
           IA  M+YL +     +HR L   NI ++     +++DFG +RFL D     T T      
Sbjct: 118 IAAGMKYLADMN--YVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLR 423
               + APE IQ   ++  SDV+S+GI++ E+++ G  PY +   +    A+E  + +L 
Sbjct: 176 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE-QDYRLP 234
Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           P +         L +L+   W  D + RP F  I  +L  +
Sbjct: 235 PPMDCPSA----LHQLMLDCWQKDRNHRPKFGQIVNTLDKM 271

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 60/107 (56%), Gaps = 8/107 (7%)
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDG 359
           EE  +   +I   + YLH +K  + H DLKP NI L D      H+++ DFG A  + DG
Sbjct: 115 EEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 360 E--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
                + GT  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 136
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 137 VQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 186
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 187 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 229

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------ 366
           I   M+YL +     +HRDL   NI ++     +++DFG +R L D   A   T      
Sbjct: 119 IGSGMKYLSDMS--YVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             + APE I    ++  SDV+S+GI++ E+++ G  PY +   +    A+E  EG   P 
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE--EGYRLP- 233
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            P  D  +  L +L+   W  + S RP F  I   L  +
Sbjct: 234 -PPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 146
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 147 VQFLIYQ--------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 196
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 197 DEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 146
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 147 VQFLIYQ--------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 196
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 197 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 145
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   
Sbjct: 146 VQFLIYQ--------ILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTD 195
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 196 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 238

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 68/123 (55%), Gaps = 12/123 (9%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD----DAKHVRIADFG-HARFLSDGEMA-LTG 365
           ++   + Y+H  K K++HRDLKP N+ L+    DA ++RI DFG    F +  +M    G
Sbjct: 157 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEASKKMKDKIG 213
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  Y+APEV+    Y EK DV+S G+IL  +++G  P+         I  +V +GK    
Sbjct: 214 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF--NGANEYDILKKVEKGKYTFE 270
Query: 426 LPE 428
           LP+
Sbjct: 271 LPQ 273

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 68/123 (55%), Gaps = 12/123 (9%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD----DAKHVRIADFG-HARFLSDGEMA-LTG 365
           ++   + Y+H  K K++HRDLKP N+ L+    DA ++RI DFG    F +  +M    G
Sbjct: 158 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEASKKMKDKIG 214
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  Y+APEV+    Y EK DV+S G+IL  +++G  P+         I  +V +GK    
Sbjct: 215 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF--NGANEYDILKKVEKGKYTFE 271
Query: 426 LPE 428
           LP+
Sbjct: 272 LPQ 274

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/123 (36%), Positives = 68/123 (55%), Gaps = 12/123 (9%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD----DAKHVRIADFG-HARFLSDGEMA-LTG 365
           ++   + Y+H  K K++HRDLKP N+ L+    DA ++RI DFG    F +  +M    G
Sbjct: 134 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEASKKMKDKIG 190
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  Y+APEV+    Y EK DV+S G+IL  +++G  P+         I  +V +GK    
Sbjct: 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF--NGANEYDILKKVEKGKYTFE 247
Query: 426 LPE 428
           LP+
Sbjct: 248 LPQ 250

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 302 PFEER--LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSD 358
           P E R  L  + ++AQ M +L  +    IHRD+   N+ L +    +I DFG AR  ++D
Sbjct: 154 PLELRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 359 GEMALTGT----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----IEKDY 408
               + G       +MAPE I    Y+ +SDV+S+GI+L EI + G +PY       K Y
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 271
Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
           K  K   ++ +    P         + +  ++   W  + + RP+F  I CS 
Sbjct: 272 KLVKDGYQMAQPAFAP---------KNIYSIMQACWALEPTHRPTFQQI-CSF 314

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +EV+ L +  H  +++L    LE     ++V EL   T  E    +  ++R         
Sbjct: 70  REVELLKKLDHPNIMKLF-EILEDSSSFYIVGELY--TGGELFDEIIKRKRFS------- 119
Query: 303 FEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHAR-FLS 357
            E   AR + ++   + Y+H  K  ++HRDLKP NI L+  +    ++I DFG +  F  
Sbjct: 120 -EHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 358 DGEMA-LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
           + +M    GT  Y+APEV++   Y EK DV+S G+IL  +++G  P+  K+     I   
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKR 233
Query: 417 VGEGKLRPALPE 428
           V  GK    LP+
Sbjct: 234 VETGKYAFDLPQ 245

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 110/241 (45%), Gaps = 32/241 (13%)
Query: 182 VSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVT 239
           V   K   + + P+   LQ  IG+G    +  A    R   VA+K I P F H      T
Sbjct: 31  VEMVKGQPFDVGPRYTQLQ-YIGEGAYGMVSSAYDHVRKTRVAIKKISP-FEHQTYCQRT 88
Query: 240 FFAQEVDTLSRQRHRFVLQ----LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE 295
              +E+  L R RH  V+     L  + LE     ++V +L+ T L + L    SQ+   
Sbjct: 89  L--REIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLK---SQQLSN 143
Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
             +             +I + ++Y+H     V+HRDLKPSN+ ++    ++I DFG AR 
Sbjct: 144 DHI--------CYFLYQILRGLKYIHSAN--VLHRDLKPSNLLINTTCDLKICDFGLAR- 192
Query: 356 LSDGEMALTGTFV-------YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           ++D E   TG          Y APE+ +  + Y++  D++S G IL E+++    +  K 
Sbjct: 193 IADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252
Query: 408 Y 408
           Y
Sbjct: 253 Y 253

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 34/230 (14%)
Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
           Q ++G+G+   ++R   +  G   AVK +  + F          A+E+   +      ++
Sbjct: 79  QLRLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR---------AEELMACAGLTSPRIV 129
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
            L GA  E P+    +  L G +L       G   +++  +P       L +ALE    +
Sbjct: 130 PLYGAVREGPWVNIFMELLEGGSL-------GQLVKEQGCLPEDRALYYLGQALE---GL 179
Query: 318 QYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSD---GEMALTGTFV----- 368
           +YLH ++  ++H D+K  N+ L  D  H  + DFGHA  L     G+  LTG ++     
Sbjct: 180 EYLHSRR--ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAME 416
           +MAPEV+       K DV+S   ++  ++ G HP+ +    P   KIA E
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASE 287

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFG-HARFLSDGEMA-LTGT 366
           ++     YLH  K  ++HRDLKP N+ L+       ++I DFG  A F   G+M    GT
Sbjct: 112 QVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGT 169
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APEV++ + Y EK DV+S G+IL  ++ G  P+
Sbjct: 170 AYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPF 205

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 23/161 (14%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALTGT---- 366
           ++AQ M +L  +    IHRD+   N+ L +    +I DFG AR  ++D    + G     
Sbjct: 174 QVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 231
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----IEKDYKPAKIAMEVGEG 420
             +MAPE I    Y+ +SDV+S+GI+L EI + G +PY       K YK  K   ++ + 
Sbjct: 232 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP 291
Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
              P         + +  ++   W  + + RP+F  I CS 
Sbjct: 292 AFAP---------KNIYSIMQACWALEPTHRPTFQQI-CSF 322

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 92/204 (45%), Gaps = 24/204 (11%)
Query: 204 GQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA- 262
            QG     +  +  G++VAVK +   F   N+       +E+  L    H+ ++ L+   
Sbjct: 34  AQGIVCAAFDTV-LGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVF 90
Query: 263 ----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
                LE     +LV EL+   L + +H    +   ERM  L           ++   ++
Sbjct: 91  TPQKTLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYL---------LYQMLCGIK 138
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQ 376
           +LH     +IHRDLKPSNI +     ++I DFG AR  S   M      T  Y APEVI 
Sbjct: 139 HLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVIL 196
Query: 377 CEPYSEKSDVYSFGIILNEIITGN 400
              Y E  D++S G I+ E++ G+
Sbjct: 197 GMGYKENVDIWSVGCIMGELVKGS 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 66/122 (54%), Gaps = 10/122 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFG-HARFLSDGEMA-LTGT 366
           ++   + Y+H  K K++HRDLKP N+ L+      ++RI DFG    F +  +M    GT
Sbjct: 140 QVLSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 197
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             Y+APEV+    Y EK DV+S G+IL  +++G  P+         I  +V +GK    L
Sbjct: 198 AYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF--NGANEYDILKKVEKGKYTFEL 254
Query: 427 PE 428
           P+
Sbjct: 255 PQ 256

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 56/97 (57%), Gaps = 8/97 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFG-HARFLSDGEMA-LTGT 366
           ++     YLH  K  ++HRDLKP N+ L+       ++I DFG  A F   G+M    GT
Sbjct: 129 QVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGT 186
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APEV++ + Y EK DV+S G+IL  ++ G  P+
Sbjct: 187 AYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGYPPF 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 72/135 (53%), Gaps = 10/135 (7%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHARFLSDGEMA---LTG 365
           +I +++ ++H+    ++HRDLKP N+ L        V++ADFG A  +   + A     G
Sbjct: 138 QILESVNHIHQHD--IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAG 195
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  Y++PEV++ +PY +  D+++ G+IL  ++ G  P+ ++D    K+  ++  G     
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQH--KLYQQIKAGAYDFP 253
Query: 426 LPEEDGQLRELIELI 440
            PE D    E   LI
Sbjct: 254 SPEWDTVTPEAKNLI 268

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 77/138 (55%), Gaps = 9/138 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSD-GEMA--LTGTF 367
           EI  A+++LH  K  +I+RD+K  NI LD   HV + DFG ++ F++D  E A    GT 
Sbjct: 167 EIVLALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 368 VYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
            YMAP++++     + +  D +S G+++ E++TG  P+     K ++  +     K  P 
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 426 LPEEDGQL-RELIELICL 442
            P+E   L ++LI+ + +
Sbjct: 285 YPQEMSALAKDLIQRLLM 302

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I  FG AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +EV+ L +  H  +++L    LE     ++V EL   T  E    +  ++R         
Sbjct: 70  REVELLKKLDHPNIMKLF-EILEDSSSFYIVGELY--TGGELFDEIIKRKRFS------- 119
Query: 303 FEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHAR-FLS 357
            E   AR + ++   + Y+H  K  ++HRDLKP NI L+  +    ++I DFG +  F  
Sbjct: 120 -EHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 358 DGEMA-LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
           + +M    GT  Y+APEV++   Y EK DV+S G+IL  +++G  P+  K+     I   
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKR 233
Query: 417 VGEGKLRPALPE 428
           V  GK    LP+
Sbjct: 234 VETGKYAFDLPQ 245

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 32/89 (35%), Positives = 53/89 (59%), Gaps = 3/89 (3%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           +I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y A
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 186
Query: 372 PEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           PE+ +    Y++  D++S G I+ E++TG
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTG 215

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/192 (30%), Positives = 95/192 (49%), Gaps = 22/192 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +EV+ L +  H  +++L    LE     ++V EL   T  E    +  ++R         
Sbjct: 70  REVELLKKLDHPNIMKLF-EILEDSSSFYIVGELY--TGGELFDEIIKRKRFS------- 119
Query: 303 FEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHAR-FLS 357
            E   AR + ++   + Y+H  K  ++HRDLKP NI L+  +    ++I DFG +  F  
Sbjct: 120 -EHDAARIIKQVFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 358 DGEMA-LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
           + +M    GT  Y+APEV++   Y EK DV+S G+IL  +++G  P+  K+     I   
Sbjct: 177 NTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKR 233
Query: 417 VGEGKLRPALPE 428
           V  GK    LP+
Sbjct: 234 VETGKYAFDLPQ 245

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 82/172 (47%), Gaps = 19/172 (11%)
Query: 243 QEVDTLSRQRHRFVLQLM-----GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        +E     +LVT L+G  L    + + SQ   +  
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLN---NIVKSQALSDEH 132
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        + + ++Y+H     +IHRDLKPSN+ +++   +RI DFG AR   
Sbjct: 133 VQFLVYQ--------LLRGLKYIH--SAGIIHRDLKPSNVAVNEDSELRILDFGLARQAD 182
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           +       T  Y APE+ +    Y++  D++S G I+ E++ G   +   DY
Sbjct: 183 EEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY 234

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 111/238 (46%), Gaps = 52/238 (21%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           ++ +L +K+G+G     Y  +W+ +D      VAVK I+  F ++ +   TF  +E+  L
Sbjct: 9   RKYELVKKLGKGA----YGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMIL 62
Query: 249 SR-QRHRFVLQLMGACLEPPYRG-WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           +    H  ++ L+        R  +LV + + T L   +          R   L P  ++
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVI----------RANILEPVHKQ 112
Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLS-------- 357
                ++ + ++YLH     ++HRD+KPSNI L+   HV++ADFG +R F++        
Sbjct: 113 YV-VYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 358 -----------DGEMALTGTFV----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
                      D +  +   +V    Y APE+ +    Y++  D++S G IL EI+ G
Sbjct: 170 PLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           ++ + ++Y+H     +IHRDLKPSN+ +++   +RI DFG AR   +       T  Y A
Sbjct: 139 QLLRGLKYIH--SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRA 196
Query: 372 PEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           PE+ +    Y++  D++S G I+ E++ G   +   DY
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY 234

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I D G AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           EKIG+GT   +Y+A    G   A+K I  +    +E   +   +E+  L   +H  +++L
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLH----GLGSQRRKERMVPLPPFEERLARALEIAQ 315
               +    R  LV E L   LK+ L     GL S   K  +             L++  
Sbjct: 66  YD-VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-------------LQLLN 111
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            + Y H+++  V+HRDLKP N+ ++    ++IADFG AR         T   V   Y AP
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 373 EVIQ-CEPYSEKSDVYSFGIILNEIITG 399
           +V+   + YS   D++S G I  E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           EKIG+GT   +Y+A    G   A+K I  +    +E   +   +E+  L   +H  +++L
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLH----GLGSQRRKERMVPLPPFEERLARALEIAQ 315
               +    R  LV E L   LK+ L     GL S   K  +             L++  
Sbjct: 66  YD-VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-------------LQLLN 111
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAP 372
            + Y H+++  V+HRDLKP N+ ++    ++IADFG AR         T    T  Y AP
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 373 EVIQ-CEPYSEKSDVYSFGIILNEIITG 399
           +V+   + YS   D++S G I  E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           EKIG+GT   +Y+A    G   A+K I  +    +E   +   +E+  L   +H  +++L
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 260 MGACLEPPYRGWLVTELLGTTLKEWLH----GLGSQRRKERMVPLPPFEERLARALEIAQ 315
               +    R  LV E L   LK+ L     GL S   K  +             L++  
Sbjct: 66  YD-VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFL-------------LQLLN 111
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAP 372
            + Y H+++  V+HRDLKP N+ ++    ++IADFG AR         T    T  Y AP
Sbjct: 112 GIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAP 169
Query: 373 EVIQ-CEPYSEKSDVYSFGIILNEIITG 399
           +V+   + YS   D++S G I  E++ G
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I D G AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 23/205 (11%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           +G G   ++  A     GL VAVK +   F        T+  +E+  L   +H  V+ L+
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHENVIGLL 87
Query: 261 GA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
                   LE     +LVT L+G  L    + +  Q+  +  V    ++        I +
Sbjct: 88  DVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDHVQFLIYQ--------ILR 136
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEV- 374
            ++Y+H     +IHRDLKPSN+ +++   ++I D G AR   D       T  Y APE+ 
Sbjct: 137 GLKYIH--SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATRWYRAPEIM 194
Query: 375 IQCEPYSEKSDVYSFGIILNEIITG 399
           +    Y++  D++S G I+ E++TG
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 25/175 (14%)
Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMV 298
            FF +E D ++     +V+QL  A  +  Y   ++  + G  L   +            V
Sbjct: 120 AFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD--------V 171
Query: 299 PLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
           P     E+ A+    E+  A+  +H     +IHRD+KP N+ LD   H+++ADFG    +
Sbjct: 172 P-----EKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 224
Query: 357 SDGEMA----LTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPY 403
            +  M       GT  Y++PEV++ +     Y  + D +S G+ L E++ G+ P+
Sbjct: 225 DETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 72/140 (51%), Gaps = 22/140 (15%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNI-FLDDAKH--VRIADFGHARFLSDGEMALT--GT 366
           ++  A+ Y H Q   V+H+DLKP NI F D + H  ++I DFG A      E +    GT
Sbjct: 132 QMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI---------EKDYKPAKIAMEV 417
            +YMAPEV + +  + K D++S G+++  ++TG  P+          +  YK    A+E 
Sbjct: 190 ALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVEC 248
Query: 418 GEGKLRPALPEEDGQLRELI 437
                RP  P+    L++++
Sbjct: 249 -----RPLTPQAVDLLKQML 263

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/97 (38%), Positives = 58/97 (59%), Gaps = 8/97 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFG-HARFLSDGEMA-LTGT 366
           ++   + YLH  K  ++HRDLKP N+ L+  +    ++I DFG  A F +  +M    GT
Sbjct: 144 QVLSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGT 201
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APEV++ + Y EK DV+S G+IL  ++ G  P+
Sbjct: 202 AYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 100/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+ +  +E     F  E   
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEVY--SEQDELDFLMEALI 101
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 154
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 155 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 212
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 213 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 37/119 (31%), Positives = 62/119 (52%), Gaps = 17/119 (14%)
Query: 300 LPPFEERLARAL------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
           L  FE+RL   +      E+  A+  +H+     +HRD+KP NI +D   H+R+ADFG  
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 354 -RFLSDGEM---ALTGTFVYMAPEVIQCEP-----YSEKSDVYSFGIILNEIITGNHPY 403
            + + DG +      GT  Y++PE++Q        Y  + D +S G+ + E++ G  P+
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 320 LHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHARFLSDGE----MALTGTFVYMAP 372
           LH  +  V+HRDLKP N+ L        V++ADFG A    +GE        GT  Y++P
Sbjct: 135 LHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSP 193
Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
           EV++ +PY +  D+++ G+IL  ++ G  P+ ++D    ++  ++  G      PE D  
Sbjct: 194 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGAYDFPSPEWDTV 251
Query: 433 LRELIELI 440
             E  +LI
Sbjct: 252 TPEAKDLI 259

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 80/177 (45%), Gaps = 22/177 (12%)
Query: 238 VTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           V+ F +E D L     R++ QL  A  +  Y   ++   +G  L   L   G     ER+
Sbjct: 105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG-----ERI 159
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFL 356
               P E       EI  A+  +H  +   +HRD+KP NI LD   H+R+ADFG   +  
Sbjct: 160 ----PAEMARFYLAEIVMAIDSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213
Query: 357 SDG---EMALTGTFVYMAPEVIQC-------EPYSEKSDVYSFGIILNEIITGNHPY 403
           +DG    +   GT  Y++PE++Q          Y  + D ++ G+   E+  G  P+
Sbjct: 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF 270

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/127 (32%), Positives = 65/127 (51%), Gaps = 8/127 (6%)
Query: 320 LHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHARFLSDGEMA---LTGTFVYMAPE 373
           LH  +  V+HRDLKP N+ L        V++ADFG A  +   + A     GT  Y++PE
Sbjct: 117 LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPE 176
Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
           V++ E Y +  D+++ G+IL  ++ G  P+ ++D    K+  ++  G      PE D   
Sbjct: 177 VLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQH--KLYQQIKAGAYDFPSPEWDTVT 234
Query: 434 RELIELI 440
            E   LI
Sbjct: 235 PEAKNLI 241

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/123 (35%), Positives = 65/123 (52%), Gaps = 12/123 (9%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD----DAKHVRIADFGHARFL--SDGEMALTG 365
           ++   + Y H  K K++HRDLKP N+ L+    DA ++RI DFG +     S       G
Sbjct: 134 QVLSGITYXH--KNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTHFEASKKXKDKIG 190
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  Y+APEV+    Y EK DV+S G+IL  +++G  P+         I  +V +GK    
Sbjct: 191 TAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPF--NGANEYDILKKVEKGKYTFE 247
Query: 426 LPE 428
           LP+
Sbjct: 248 LPQ 250

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 3/98 (3%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           ++ + ++Y+H     +IHRDLKPSN+ +++   +RI DFG AR   +       T  Y A
Sbjct: 131 QLLRGLKYIH--SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATRWYRA 188
Query: 372 PEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           PE+ +    Y++  D++S G I+ E++ G   +   DY
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDY 226

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA- 362
           ER++  L ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M  
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMT 183
Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
               T  Y APEVI    Y E  D++S G+I+ E+I G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 54/98 (55%), Gaps = 5/98 (5%)
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA- 362
           ER++  L ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M  
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMT 183
Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
               T  Y APEVI    Y E  D++S G+I+ E+I G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 101
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 102 ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 154
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 155 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 212
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 213 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 48  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 104
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 105 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 157
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 158 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 215
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 216 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 267

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 71  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 127
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 180
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 181 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 239 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 290

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 87
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 88  ISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 140
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 141 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 198
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 199 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 250

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 40/250 (16%)
Query: 201 EKIGQGTTANIYRAI-WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           EK+G+GT   +Y+A   +G  VA+K I  D    +E   +   +E+  L    H  ++ L
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLD--AEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 260 MGA-----CLEPPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLPPFEERLARALE 312
           +       CL       LV E +   LK+ L  +  G Q  + ++     +  +L R + 
Sbjct: 85  IDVIHSERCLT------LVFEFMEKDLKKVLDENKTGLQDSQIKI-----YLYQLLRGVA 133
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVY 369
                   H  + +++HRDLKP N+ ++    +++ADFG AR       + T    T  Y
Sbjct: 134 --------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 370 MAPEVIQ-CEPYSEKSDVYSFGIILNEIITGN--HPYIEKDYKPAKIAMEVGEGKLRPAL 426
            AP+V+   + YS   D++S G I  E+ITG    P +  D +  KI   +G        
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN----- 240
Query: 427 PEEDGQLREL 436
           P E  Q++EL
Sbjct: 241 PREWPQVQEL 250

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 104/237 (43%), Gaps = 31/237 (13%)
Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQ 243
           +I  ++I L+ ++G+G    ++ A    L        VAVK +        ++    F +
Sbjct: 11  HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKD----FQR 66
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWL--HGL-------GSQRRK 294
           E + L+  +H  +++  G C +      +   +    L ++L  HG        G  R+ 
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126
Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
           +  + L    + L  A +IA  M YL  Q    +HRDL   N  +     V+I DFG +R
Sbjct: 127 KGELGL---SQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMSR 181
Query: 355 FLSDGEMALTGTFV-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE 405
            +   +    G        +M PE I    ++ +SDV+SFG+IL EI T G  P+ +
Sbjct: 182 DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 238

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 22  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 78
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 79  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 131
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 132 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 189
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 190 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 241

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 114/250 (45%), Gaps = 40/250 (16%)
Query: 201 EKIGQGTTANIYRAI-WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL 259
           EK+G+GT   +Y+A   +G  VA+K I  D    +E   +   +E+  L    H  ++ L
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLD--AEDEGIPSTAIREISLLKELHHPNIVSL 84
Query: 260 MGA-----CLEPPYRGWLVTELLGTTLKEWL--HGLGSQRRKERMVPLPPFEERLARALE 312
           +       CL       LV E +   LK+ L  +  G Q  + ++     +  +L R + 
Sbjct: 85  IDVIHSERCLT------LVFEFMEKDLKKVLDENKTGLQDSQIKI-----YLYQLLRGVA 133
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVY 369
                   H  + +++HRDLKP N+ ++    +++ADFG AR       + T    T  Y
Sbjct: 134 --------HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 370 MAPEVIQ-CEPYSEKSDVYSFGIILNEIITGN--HPYIEKDYKPAKIAMEVGEGKLRPAL 426
            AP+V+   + YS   D++S G I  E+ITG    P +  D +  KI   +G        
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN----- 240
Query: 427 PEEDGQLREL 436
           P E  Q++EL
Sbjct: 241 PREWPQVQEL 250

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 18/152 (11%)
Query: 301 PPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
           P  +E LA  +  ++  A+ YL  +   +IHRD+K  NI + +   +++ DFG A +L  
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182
Query: 359 GEMALT--GTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKD-------- 407
           G++  T  GT  Y APEV+   PY   + +++S G+ L  ++   +P+ E +        
Sbjct: 183 GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIH 242
Query: 408 --YKPAKIAMEVGEGKLRPALPEEDGQLRELI 437
             Y  +K  M +  G L+P +PE    L +L+
Sbjct: 243 PPYLVSKELMSLVSGLLQP-VPERRTTLEKLV 273

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 47  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 103
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 104 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 156
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 157 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 214
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 215 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 266

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 110/229 (48%), Gaps = 45/229 (19%)
Query: 201 EKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVL 257
           E +G+G  A +  A+    G + AVK I     H+         +EV+TL + Q ++ +L
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVF----REVETLYQCQGNKNIL 74
Query: 258 QLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           +L+    E   R +LV E L  G+ L         Q++K        F ER A  +  ++
Sbjct: 75  ELI-EFFEDDTRFYLVFEKLQGGSILAH------IQKQKH-------FNEREASRVVRDV 120
Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV---RIADF--GHARFLSDGEMALT---- 364
           A A+ +LH +   + HRDLKP NI  +  + V   +I DF  G    L++    +T    
Sbjct: 121 AAALDFLHTKG--IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 365 ----GTFVYMAPEVI-----QCEPYSEKSDVYSFGIILNEIITGNHPYI 404
               G+  YMAPEV+     Q   Y ++ D++S G++L  +++G  P++
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFV 227

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 37  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 93
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 94  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 146
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 147 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 204
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 205 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 256

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 97/232 (41%), Gaps = 32/232 (13%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 57  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 113
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 114 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 166
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGE 360
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR +    
Sbjct: 167 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 224
Query: 361 MALTGTFV-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
               G        +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 225 YYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 276

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 86
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 139
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 140 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 198 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 45  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 101
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 102 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-------RETRPRPSQPSSLAM 154
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 155 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 212
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 213 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 264

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 79/163 (48%), Gaps = 19/163 (11%)
Query: 243 QEVDTLSRQRHRFVLQLMGA-----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERM 297
           +E+  L   +H  V+ L+        LE     +LVT L+G  L    + +  Q+  +  
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLN---NIVKCQKLTDDH 126
Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V    ++        I + ++Y+H     +IHRDLKPSN+ +++   ++I DF  AR   
Sbjct: 127 VQFLIYQ--------ILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFYLARHTD 176
Query: 358 DGEMALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITG 399
           D       T  Y APE+ +    Y++  D++S G I+ E++TG
Sbjct: 177 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 219

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 87
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 140
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 141 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 198
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 199 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 250

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 30  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 86
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFL-------RETRPRPSQPSSLAM 139
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG AR      
Sbjct: 140 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 198 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 8/120 (6%)
Query: 327 VIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMA---LTGTFVYMAPEVIQCEPY 380
           ++HRDLKP N+ L        V++ADFG A  +   + A     GT  Y++PEV++ +PY
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 381 SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELI 440
            +  D+++ G+IL  ++ G  P+ ++D    ++  ++  G      PE D    E  +LI
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 27/208 (12%)
Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +K+G+GT A +Y+   +  D  VA+K I        E A     +EV  L   +H  ++ 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIR---LEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    +       LV E L   LK++L   G+       V L  F+        + + + 
Sbjct: 65  LHD-IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHN-VKLFLFQ--------LLRGLA 114
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS------DGEMALTGTFVYMAP 372
           Y H QK  V+HRDLKP N+ +++   +++ADFG AR  S      D E+    T  Y  P
Sbjct: 115 YCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV---TLWYRPP 169
Query: 373 EV-IQCEPYSEKSDVYSFGIILNEIITG 399
           ++ +    YS + D++  G I  E+ TG
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATG 197

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 8/120 (6%)
Query: 327 VIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMA---LTGTFVYMAPEVIQCEPY 380
           ++HRDLKP N+ L        V++ADFG A  +   + A     GT  Y++PEV++ +PY
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 381 SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELI 440
            +  D+++ G+IL  ++ G  P+ ++D    ++  ++  G      PE D    E  +LI
Sbjct: 184 GKPVDMWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 320 LHEQKPKVIHRDLKPSNIFLDD---AKHVRIADFGHARFLSDGE----MALTGTFVYMAP 372
           LH  +  V+HR+LKP N+ L        V++ADFG A    +GE        GT  Y++P
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSP 182
Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
           EV++ +PY +  D+++ G+IL  ++ G  P+ ++D    ++  ++  G      PE D  
Sbjct: 183 EVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH--RLYQQIKAGAYDFPSPEWDTV 240
Query: 433 LRELIELI 440
             E  +LI
Sbjct: 241 TPEAKDLI 248

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEMALTGTFV- 368
           +IA  M+YL      V+H+DL   N+ + D  +V+I+D G  R  + +D    L  + + 
Sbjct: 153 QIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 369 --YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             +MAPE I    +S  SD++S+G++L E+ + G  PY    Y    +   +   + R  
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC--GYSNQDVVEMI---RNRQV 265
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           LP  D     +  L+   W+   S RP F  I   L+
Sbjct: 266 LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 302

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR--FLSDGEMALTGTFV- 368
           +IA  M+YL      V+H+DL   N+ + D  +V+I+D G  R  + +D    L  + + 
Sbjct: 136 QIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 369 --YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             +MAPE I    +S  SD++S+G++L E+ + G  PY    Y    +   +   + R  
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC--GYSNQDVVEMI---RNRQV 248
Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
           LP  D     +  L+   W+   S RP F  I   L+
Sbjct: 249 LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 58/101 (57%), Gaps = 7/101 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDG-EM-ALTGT 366
           +I + + YLH+    ++H DLKP NI L        ++I DFG +R +    E+  + GT
Sbjct: 139 QILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGT 196
Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
             Y+APE++  +P +  +D+++ GII   ++T   P++ +D
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 39/224 (17%)
Query: 197 IDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
            +++ ++G+G T+ +YR   +G      L V  K +      T          E+  L R
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT----------EIGVLLR 104
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR- 309
             H  +++L     E P    LV EL+  T  E           +R+V    + ER A  
Sbjct: 105 LSHPNIIKLK-EIFETPTEISLVLELV--TGGELF---------DRIVEKGYYSERDAAD 152
Query: 310 -ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD----DAKHVRIADFGHARFLSDGEMALT 364
              +I +A+ YLHE    ++HRDLKP N+       DA  ++IADFG ++ +    +  T
Sbjct: 153 AVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAP-LKIADFGLSKIVEHQVLMKT 209
Query: 365 --GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK 406
             GT  Y APE+++   Y  + D++S GII   ++ G  P+ ++
Sbjct: 210 VCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 83/305 (27%), Positives = 135/305 (44%), Gaps = 52/305 (17%)
Query: 170 TPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANI-YRAIWRGLDVAVKCIYP 228
           +P L+Q D     S   +      PK++     +G G    I YR ++   DVAVK I P
Sbjct: 4   SPSLEQDDGDEETSVVIVGKISFCPKDV-----LGHGAEGTIVYRGMFDNRDVAVKRILP 58
Query: 229 DFFHTNENAVTFFAQEVDTL-SRQRHRFVLQLMGACLEPPYR-GWLVTELLGTTLKEWLH 286
           + F       +F  +EV  L     H  V++    C E   +  ++  EL   TL+E++ 
Sbjct: 59  ECF-------SFADREVQLLRESDEHPNVIRYF--CTEKDRQFQYIAIELCAATLQEYV- 108
Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK--- 343
               +++    + L P    +    +    + +LH     ++HRDLKP NI +       
Sbjct: 109 ----EQKDFAHLGLEP----ITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHG 158
Query: 344 --HVRIADFGHARFLSDGEMALT------GTFVYMAPEVI--QC-EPYSEKSDVYSFGII 392
                I+DFG  + L+ G  + +      GT  ++APE++   C E  +   D++S G +
Sbjct: 159 KIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCV 218
Query: 393 LNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE--EDGQLRELIE-LICLSWDGDA 448
              +I+ G+HP+ +   + A I +  G   L    PE  ED   RELIE +I +    D 
Sbjct: 219 FYYVISEGSHPFGKSLQRQANILL--GACSLDCLHPEKHEDVIARELIEKMIAM----DP 272
Query: 449 SVRPS 453
             RPS
Sbjct: 273 QKRPS 277

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 204 GQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA- 262
            QG     +  +  G++VAVK +   F   N+       +E+  L    H+ ++ L+   
Sbjct: 36  AQGIVCAAFDTV-LGINVAVKKLSRPF--QNQTHAKRAYRELVLLKCVNHKNIISLLNVF 92
Query: 263 ----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
                LE     +LV EL+   L + +H    +   ERM  L           ++   ++
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLCQVIH---MELDHERMSYL---------LYQMLCGIK 140
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQ 376
           +LH     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI 
Sbjct: 141 HLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 198
Query: 377 CEPYSEKSDVYSFGIILNEIITG 399
              Y+   D++S G I+ E++ G
Sbjct: 199 GMGYAANVDIWSVGCIMGELVKG 221

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 56/116 (48%), Gaps = 27/116 (23%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-------------------------AKH 344
            +EI +A+ YL  +K  + H DLKP NI LDD                         +  
Sbjct: 143 CIEILKALNYL--RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 345 VRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN 400
           +++ DFG A F SD   ++  T  Y APEVI    +   SD++SFG +L E+ TG+
Sbjct: 201 IKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 60/121 (49%), Gaps = 10/121 (8%)
Query: 295 ERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIAD 349
           ER+     F E  A  +  ++  A+ ++H+    V+HRDLKP N+     +D   ++I D
Sbjct: 95  ERIKKKKHFSETEASYIMRKLVSAVSHMHD--VGVVHRDLKPENLLFTDENDNLEIKIID 152
Query: 350 FGHARFLSDGEMALTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK 406
           FG AR        L     T  Y APE++    Y E  D++S G+IL  +++G  P+   
Sbjct: 153 FGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSH 212
Query: 407 D 407
           D
Sbjct: 213 D 213

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 31/220 (14%)
Query: 203 IGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
           IG+G    +  A      + VA+K I P F H      T   +E+  L R RH  ++ + 
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISP-FEHQTYCQRTL--REIKILLRFRHENIIGIN 107
Query: 261 GACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
                P        +LVT L+G  L + L    +Q      +             +I + 
Sbjct: 108 DIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHI--------CYFLYQILRG 156
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV-------Y 369
           ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG          Y
Sbjct: 157 LKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYVATRWY 213
Query: 370 MAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 5/98 (5%)
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA- 362
           ER++  L ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M  
Sbjct: 126 ERMSYLLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMT 183
Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
               T  Y APEVI    Y E  D++S G I+ E+I G
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 43/81 (53%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL--TGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M +    T  Y APEVI   
Sbjct: 143 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGM 202
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 203 GYKENVDIWSVGCIMGEMIKG 223

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMAL---TG 365
           +I +A++Y H+    +IHRD+KP  + L   +++  V++  FG A  L +  +      G
Sbjct: 140 QILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 197
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           T  +MAPEV++ EPY +  DV+  G+IL  +++G  P+
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 31/229 (13%)
Query: 196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           E ++ E IG G    +  A  R  G  VA+K I P+ F    NA     +E+  L   +H
Sbjct: 56  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTL-RELKILKHFKH 113
Query: 254 RFVLQLMGACLEP--PY----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
             ++ +    L P  PY      ++V +L+ + L + +H   SQ       PL   E   
Sbjct: 114 DNIIAIKD-ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS--SQ-------PLT-LEHVR 162
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL----SDGEMAL 363
               ++ + ++Y+H  +  VIHRDLKPSN+ +++   ++I DFG AR L    ++ +  +
Sbjct: 163 YFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 364 T---GTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           T    T  Y APE+ +    Y++  D++S G I  E++     +  K+Y
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 269

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 31/229 (13%)
Query: 196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
           E ++ E IG G    +  A  R  G  VA+K I P+ F    NA     +E+  L   +H
Sbjct: 55  EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTL-RELKILKHFKH 112
Query: 254 RFVLQLMGACLEP--PY----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
             ++ +    L P  PY      ++V +L+ + L + +H   SQ       PL   E   
Sbjct: 113 DNIIAIKD-ILRPTVPYGEFKSVYVVLDLMESDLHQIIHS--SQ-------PLT-LEHVR 161
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL----SDGEMAL 363
               ++ + ++Y+H  +  VIHRDLKPSN+ +++   ++I DFG AR L    ++ +  +
Sbjct: 162 YFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 364 T---GTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           T    T  Y APE+ +    Y++  D++S G I  E++     +  K+Y
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY 268

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/89 (38%), Positives = 49/89 (55%), Gaps = 6/89 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +  + + +LH     ++HRDLKP NI +     V++ADFG AR  S  +MALT   V   
Sbjct: 128 QFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALTPVVVTLW 184
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
           Y APEV+    Y+   D++S G I  E+ 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMAL---TG 365
           +I +A++Y H+    +IHRD+KP  + L   +++  V++  FG A  L +  +      G
Sbjct: 138 QILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           T  +MAPEV++ EPY +  DV+  G+IL  +++G  P+
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 51/84 (60%), Gaps = 4/84 (4%)
Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-GTFVYMA 371
           +  +  Y+H +K  + HRD+KPSNI +D    V+++DFG + ++ D ++  + GT+ +M 
Sbjct: 160 VLNSFSYIHNEK-NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMP 218
Query: 372 PEVIQCE-PYS-EKSDVYSFGIIL 393
           PE    E  Y+  K D++S GI L
Sbjct: 219 PEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 17/119 (14%)
Query: 300 LPPFEERLARAL------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
           L  FE++L   +      E+  A+  +H+     +HRD+KP N+ LD   H+R+ADFG  
Sbjct: 181 LSKFEDKLPEDMARFYIGEMVLAIDSIHQLH--YVHRDIKPDNVLLDVNGHIRLADFGSC 238
Query: 354 RFLSDG----EMALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPY 403
             ++D          GT  Y++PE++Q        Y  + D +S G+ + E++ G  P+
Sbjct: 239 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 60/119 (50%), Gaps = 17/119 (14%)
Query: 300 LPPFEERLARAL------EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
           L  FE++L   +      E+  A+  +H+     +HRD+KP N+ LD   H+R+ADFG  
Sbjct: 165 LSKFEDKLPEDMARFYIGEMVLAIDSIHQLH--YVHRDIKPDNVLLDVNGHIRLADFGSC 222
Query: 354 RFLSDG----EMALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPY 403
             ++D          GT  Y++PE++Q        Y  + D +S G+ + E++ G  P+
Sbjct: 223 LKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 34/233 (14%)
Query: 195 KEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           K I L   +G G    +Y     G       L VAVK + P+    +E     F  E   
Sbjct: 31  KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL-PEV--CSEQDELDFLMEALI 87
Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP----F 303
           +S+  H+ +++ +G  L+   R  L+  + G  LK +L       R+ R  P  P     
Sbjct: 88  ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFL-------RETRPRPSQPSSLAM 140
Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHAR------ 354
            + L  A +IA   QYL E     IHRD+   N  L      +  +I DFG A+      
Sbjct: 141 LDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRAS 198
Query: 355 FLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +   G  A+     +M PE      ++ K+D +SFG++L EI + G  PY  K
Sbjct: 199 YYRKGGCAML-PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 250

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 202 GYKENVDIWSVGCIMGEMIKG 222

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/84 (41%), Positives = 45/84 (53%), Gaps = 8/84 (9%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVYMAPEVI 375
           H     +IHRDLKPSNI +     ++I DFG AR     F+   E+    T  Y APEVI
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVV---TRYYRAPEVI 197
Query: 376 QCEPYSEKSDVYSFGIILNEIITG 399
               Y E  D++S G I+ E+I G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/81 (41%), Positives = 42/81 (51%), Gaps = 2/81 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITG 399
            Y E  D++S G I+ E+I G
Sbjct: 201 GYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 204 GQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA- 262
            QG     Y A+    +VA+K +   F   N+       +E+  +    H+ ++ L+   
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRAYRELVLMKXVNHKNIISLLNVF 92
Query: 263 ----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIAQAM 317
                LE     +LV EL+   L +             ++ +    ER++  L ++   +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLXQ-------------VIQMELDHERMSYLLYQMLXGI 139
Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVI 375
           ++LH     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y E  D++S G I+ E++     +  +DY
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 158 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 263

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 112 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 169
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 170 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 66/144 (45%), Gaps = 29/144 (20%)
Query: 275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKP 334
           ELLG +  ++L       +    +P P  + R   A ++ QA+++LH+ K  + H DLKP
Sbjct: 116 ELLGLSTFDFL-------KDNNYLPYPIHQVR-HMAFQLCQAVKFLHDNK--LTHTDLKP 165
Query: 335 SNIFLDDAKH-------------------VRIADFGHARFLSDGEMALTGTFVYMAPEVI 375
            NI   ++ +                   VR+ DFG A F  +    +  T  Y APEVI
Sbjct: 166 ENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHHSTIVSTRHYRAPEVI 225
Query: 376 QCEPYSEKSDVYSFGIILNEIITG 399
               +S+  DV+S G I+ E   G
Sbjct: 226 LELGWSQPCDVWSIGCIIFEYYVG 249

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 164 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 221
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 222 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 269

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 120 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 177
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 178 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 113 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 170
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 171 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 218

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 128 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 185
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 186 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA- 362
           ER++  L ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M  
Sbjct: 126 ERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT 183
Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               T  Y APEVI    Y E  D++S G I+ E++     +  +DY
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA- 362
           ER++  L ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M  
Sbjct: 119 ERMSYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMT 176
Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               T  Y APEVI    Y E  D++S G I+ E++     +  +DY
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 111 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 168
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 169 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 118 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 175
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 176 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 223

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 204 GQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA- 262
            QG     Y A+    +VA+K +   F   N+       +E+  +    H+ ++ L+   
Sbjct: 36  AQGIVCAAYDAVL-DRNVAIKKLSRPF--QNQTHAKRAYRELVLMKXVNHKNIISLLNVF 92
Query: 263 ----CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EIAQAM 317
                LE     +LV EL+   L +             ++ +    ER++  L ++   +
Sbjct: 93  TPQKTLEEFQDVYLVMELMDANLXQ-------------VIQMELDHERMSYLLYQMLCGI 139
Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVI 375
           ++LH     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI
Sbjct: 140 KHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y E  D++S G I+ E++     +  +DY
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 230

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 119 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 176
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 177 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 224

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 172 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEYV 190
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 57/108 (52%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 114 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 171
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 172 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 230

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 113 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 208

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVYMAPEVI 375
           H     +IHRDLKPSNI +     ++I DFG AR     F+ + E+    T  Y APEVI
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVI 197
Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y E  D++S G I+ E++     +  +DY
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVCHKILFPGRDY 230

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 58/98 (59%), Gaps = 8/98 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL--SDGEMALT---GT 366
           ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A     ++ E  L    GT
Sbjct: 112 QLMAGVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 169
Query: 367 FVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPY 403
             Y+APE+++  E ++E  DV+S GI+L  ++ G  P+
Sbjct: 170 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPW 207

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYV 192
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYV 192
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYV 188
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEYV 188
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH ++  + H DLKP NI L D       +++ DFG A  +  G     + G
Sbjct: 116 QILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 173
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH ++  + H DLKP NI L D       +++ DFG A  +  G     + G
Sbjct: 137 QILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 194
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 195 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 34/242 (14%)
Query: 199 LQEKIGQGTTANIYRAIWRGLDV--AVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L+  IG+G+   +  A+ +G  +  A K I P +F  +   V  F QE++ +    H  +
Sbjct: 13  LENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVED---VDRFKQEIEIMKSLDHPNI 68
Query: 257 LQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EI 313
           ++L     E     +LV EL   G   +  +H     +R  R       E   AR + ++
Sbjct: 69  IRLY-ETFEDNTDIYLVMELCTGGELFERVVH-----KRVFR-------ESDAARIMKDV 115
Query: 314 AQAMQYLHEQKPKVIHRDLKPSN-IFLDDAKH--VRIADFGHARFLSDGEMALT--GTFV 368
             A+ Y H  K  V HRDLKP N +FL D+    +++ DFG A     G+M  T  GT  
Sbjct: 116 LSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 173
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           Y++P+V++   Y  + D +S G+++  ++ G  P+        ++ +++ EG      PE
Sbjct: 174 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP--TDXEVMLKIREGTF--TFPE 228
Query: 429 ED 430
           +D
Sbjct: 229 KD 230

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 115/242 (47%), Gaps = 34/242 (14%)
Query: 199 LQEKIGQGTTANIYRAIWRGLDV--AVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L+  IG+G+   +  A+ +G  +  A K I P +F  +   V  F QE++ +    H  +
Sbjct: 30  LENTIGRGSWGEVKIAVQKGTRIRRAAKKI-PKYFVED---VDRFKQEIEIMKSLDHPNI 85
Query: 257 LQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-EI 313
           ++L     E     +LV EL   G   +  +H     +R  R       E   AR + ++
Sbjct: 86  IRLY-ETFEDNTDIYLVMELCTGGELFERVVH-----KRVFR-------ESDAARIMKDV 132
Query: 314 AQAMQYLHEQKPKVIHRDLKPSN-IFLDDAKH--VRIADFGHARFLSDGEMALT--GTFV 368
             A+ Y H  K  V HRDLKP N +FL D+    +++ DFG A     G+M  T  GT  
Sbjct: 133 LSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPY 190
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           Y++P+V++   Y  + D +S G+++  ++ G  P+        ++ +++ EG      PE
Sbjct: 191 YVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAP--TDXEVMLKIREGTF--TFPE 245
Query: 429 ED 430
           +D
Sbjct: 246 KD 247

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEYV 188
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 6/89 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +  + + +LH     ++HRDLKP NI +     V++ADFG AR  S  +MAL    V   
Sbjct: 120 QFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALAPVVVTLW 176
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
           Y APEV+    Y+   D++S G I  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 55/99 (55%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH ++  + H DLKP NI L D       +++ DFG A  +  G     + G
Sbjct: 123 QILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG 180
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 34/211 (16%)
Query: 202 KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVT--FFAQEVDTLSRQRHRFVL 257
           KIG+G+   +++   R  G  VA+K     F  + ++ V      +E+  L + +H  ++
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIK----KFLESEDDPVIKKIALREIRMLKQLKHPNLV 65
Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
            L+        R  LV E    T+   LH L    R +R VP     E L +++  +  Q
Sbjct: 66  NLL-EVFRRKRRLHLVFEYCDHTV---LHELD---RYQRGVP-----EHLVKSITWQTLQ 113
Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS------DGEMALTGTFVY 369
           A+ + H  K   IHRD+KP NI +     +++ DFG AR L+      D E+A   T  Y
Sbjct: 114 AVNFCH--KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA---TRWY 168
Query: 370 MAPEVIQCEP-YSEKSDVYSFGIILNEIITG 399
            +PE++  +  Y    DV++ G +  E+++G
Sbjct: 169 RSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 8/93 (8%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMALTGTFVYMAPEVI 375
           H     +IHRDLKPSNI +     ++I DFG AR     F+ + E+    T  Y APEVI
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVV---TRYYRAPEVI 197
Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y E  D++S G I+ E++     +  +DY
Sbjct: 198 LGMGYKENVDLWSVGCIMGEMVCHKILFPGRDY 230

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 105/270 (38%), Gaps = 68/270 (25%)
Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG-------WLVTELLGTTLKEWLHGLGSQRRKER 296
           EV +L   +H  +LQ +GA      RG       WL+T           H  GS     +
Sbjct: 68  EVYSLPGMKHENILQFIGA----EKRGTSVDVDLWLITAF---------HEKGSLSDFLK 114
Query: 297 MVPLPPFEERLARALEIAQAMQYLHE--------QKPKVIHRDLKPSNIFLDDAKHVRIA 348
              +  + E    A  +A+ + YLHE         KP + HRD+K  N+ L +     IA
Sbjct: 115 -ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 349 DFGHARFLSDGEMA-----LTGTFVYMAPEVIQCEPYSEKS-----DVYSFGIILNEIIT 398
           DFG A     G+ A       GT  YMAPEV++     ++      D+Y+ G++L E+ +
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 399 --------------------GNHPYIEKDYKPAKIAMEVGEGKLRPALPE---EDGQLRE 435
                               G HP +E       +   V   K RP L +   +   +  
Sbjct: 234 RCTAADGPVDEYMLPFEEEIGQHPSLE------DMQEVVVHKKKRPVLRDYWQKHAGMAM 287
Query: 436 LIELICLSWDGDASVRPSFSSITCSLKNIQ 465
           L E I   WD DA  R S   +   +  +Q
Sbjct: 288 LCETIEECWDHDAEARLSAGCVGERITQMQ 317

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 152 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 208
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 209 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 192
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 137 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 193
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           RH  +++     L P +   ++    G  L E +   G     E       F ++L   +
Sbjct: 73  RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF----FFQQLISGV 128
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADFGH--ARFLSDGEMALTGTF 367
             A AMQ        V HRDLK  N  LD   A  ++IADFG+  A  L     +  GT 
Sbjct: 129 SYAHAMQ--------VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTP 180
Query: 368 VYMAPEVIQCEPYSEK-SDVYSFGIILNEIITGNHPY 403
            Y+APEV+  + Y  K +DV+S G+ L  ++ G +P+
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 138 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 194
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 195 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 239

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 129 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 185
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 186 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 230

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 192
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 192
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 130 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 186
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 140 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 196
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 197 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 241

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 188
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 60/105 (57%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG------ 365
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 136 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXV 192
Query: 366 -TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            T  Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 193 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 60/105 (57%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG------ 365
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 137 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEXV 193
Query: 366 -TFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            T  Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 194 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 6/89 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +  + + +LH     ++HRDLKP NI +     V++ADFG AR  S  +MAL    V   
Sbjct: 120 QFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALDPVVVTLW 176
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
           Y APEV+    Y+   D++S G I  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 190
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/210 (24%), Positives = 96/210 (45%), Gaps = 34/210 (16%)
Query: 203 IGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVT--FFAQEVDTLSRQRHRFVLQLM 260
           +G+G+   + +   R  D         F  ++++ +      +E+  L + RH  ++ L+
Sbjct: 33  VGEGSYGMVMKC--RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90
Query: 261 GACLEPPYRGWLVTELLGTTLKEWL----HGLGSQRRKERMVPLPPFEERLARALEIAQA 316
             C +   R +LV E +  T+ + L    +GL  Q  ++ +              +I   
Sbjct: 91  EVC-KKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYL-------------FQIING 136
Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS------DGEMALTGTFVYM 370
           + + H     +IHRD+KP NI +  +  V++ DFG AR L+      D E+A   T  Y 
Sbjct: 137 IGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA---TRWYR 191
Query: 371 APEVIQCE-PYSEKSDVYSFGIILNEIITG 399
           APE++  +  Y +  DV++ G ++ E+  G
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 134 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 190
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 191 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 130 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 186
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 187 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 11/105 (10%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR ++D +   TG      
Sbjct: 132 QILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEYV 188
Query: 369 ----YMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               Y APE+ +  + Y++  D++S G IL E+++    +  K Y
Sbjct: 189 ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 195 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 224

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 305 ERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA- 362
           ER++  L ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M  
Sbjct: 164 ERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
               T  Y APEVI    Y E  D++S G I+ E++     +  +DY
Sbjct: 222 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 80/197 (40%), Gaps = 59/197 (29%)
Query: 306 RLARALEIAQAMQYLHEQ-------KPKVIHRDLKPSNIFLDDAKHVRIADFGHA----- 353
           RLA +  + + + YLH +       KP + HRDL   N+ + +     I+DFG +     
Sbjct: 115 RLAHS--VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 354 -RFLSDGE-----MALTGTFVYMAPEVIQ-------CEPYSEKSDVYSFGIILNEII--- 397
            R +  GE     ++  GT  YMAPEV++        E   ++ D+Y+ G+I  EI    
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 398 -------------------TGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ----LR 434
                               GNHP  E       + + V   K RP  PE   +    +R
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFE------DMQVLVSREKQRPKFPEAWKENSLAVR 286
Query: 435 ELIELICLSWDGDASVR 451
            L E I   WD DA  R
Sbjct: 287 SLKETIEDCWDQDAEAR 303

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 202 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 231

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 134 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 140 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 199
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 200 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 229

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 230

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 142 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 201
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 202 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 231

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 141 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 200
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 201 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 230

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 6/89 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV--- 368
           +  + + +LH     ++HRDLKP NI +     V++ADFG AR  S  +MAL    V   
Sbjct: 120 QFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYS-YQMALFPVVVTLW 176
Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEII 397
           Y APEV+    Y+   D++S G I  E+ 
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 195 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 224

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 238
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 239 GYKENVDIWSVGCIMGEMVRHKILFPGRDY 268

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 146 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 205
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 206 GYKENVDLWSVGCIMGEMVCHKILFPGRDY 235

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/108 (31%), Positives = 55/108 (50%), Gaps = 9/108 (8%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 158 FTEREASEIXKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 215
Query: 358 DGEMALTGTFV--YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
                 T  +   Y+APEV+  E Y +  D +S G+I   ++ G  P+
Sbjct: 216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYPPF 263

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 45/90 (50%), Gaps = 2/90 (2%)
Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVYMAPEVIQCE 378
           H     +IHRDLKPSNI +     ++I DFG AR      M      T  Y APEVI   
Sbjct: 135 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM 194
Query: 379 PYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            Y E  D++S G I+ E++     +  +DY
Sbjct: 195 GYKENVDLWSVGCIMGEMVCHKILFPGRDY 224

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 65/291 (22%)
Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFF------AQEVDTLSR 250
           L + +GQG TAN++R   +  G   A+K           N ++F        +E + L +
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVF---------NNISFLRPVDVQMREFEVLKK 63
Query: 251 QRHRFVLQLMGACLEPPYR-GWLVTEL-----LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             H+ +++L     E   R   L+ E      L T L+E  +  G            P  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL-----------PES 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHV-RIADFGHARFLSDGE 360
           E L    ++   M +L E    ++HR++KP NI     +D + V ++ DFG AR L D E
Sbjct: 113 EFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 361 --MALTGTFVYMAPEVIQ--------CEPYSEKSDVYSFGIILNEIITGNHPY--IEKDY 408
             ++L GT  Y+ P++ +         + Y    D++S G+      TG+ P+   E   
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 409 KPAKIAMEVGEGKLRPALP----EEDGQLRELIELICLSWDGDASVRPSFS 455
           +  ++  ++  GK   A+      E+G          + W GD  V  S S
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGP---------IDWSGDMPVSCSLS 272

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 59/109 (54%), Gaps = 11/109 (10%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +   I +A+QYLH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 112 FTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ET 168
Query: 358 DGEMALTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
               +LT    T  Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 169 TSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 121 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 178
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 121 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 178
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH    ++ H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +  +I  A+Q+LH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 106 FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 163
Query: 358 DGEMAL-TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              +     T  Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 164 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 210

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 8/107 (7%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLS 357
           F ER A  +  +I  A+Q+LH     + HRD+KP N+     +    +++ DFG A+  +
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT 182
Query: 358 DGEMAL-TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
              +     T  Y+APEV+  E Y +  D++S G+I+  ++ G  P+
Sbjct: 183 QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPF 229

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 193 DPKEIDLQEKIGQGT--TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           D    +L + IG G    A + R       VAVK     +    E       +E+     
Sbjct: 17  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVK-----YIERGEKIAANVKREIINHRS 71
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            RH  +++     L P +   ++    G  L E +   G     E       F ++L   
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF----FFQQLISG 127
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADFGHAR--FLSDGEMALTGT 366
           +    AMQ        V HRDLK  N  LD   A  ++I DFG+++   L     +  GT
Sbjct: 128 VSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 179
Query: 367 FVYMAPEVIQCEPYSEK-SDVYSFGIILNEIITGNHPY 403
             Y+APEV+  + Y  K +DV+S G+ L  ++ G +P+
Sbjct: 180 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/99 (32%), Positives = 54/99 (54%), Gaps = 8/99 (8%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADFGHARFLSDGE--MALTG 365
           +I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + G
Sbjct: 122 QILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG 179
Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
           T  ++APE++  EP   ++D++S G+I   +++G  P++
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 107 LQEELARSFFWQVLEAVRHCHNXG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 56/97 (57%), Gaps = 6/97 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL--DDAKHVRIADFGHARFLSDGEMALT--GTF 367
           +I + ++++H+    ++H DLKP NI     DAK ++I DFG AR     E      GT 
Sbjct: 195 QICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTP 252
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYI 404
            ++APEV+  +  S  +D++S G+I   +++G  P++
Sbjct: 253 EFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 203
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 204 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 159 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 216
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 217 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 262

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 154 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 140 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 139 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 127 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 184
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 139 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 111 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 139 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 139 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 196
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 197 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 242

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 127 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 184
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 140 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 126 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 183
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 126 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 183
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 184 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 229

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 127 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 184
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 185 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 230

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 140 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 140 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 197
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 198 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 243

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 111 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 168
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 169 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 214

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 134 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 191
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 192 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 237

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 112 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 112 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 107 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 112 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 169
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 170 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 215

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 154 LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 13/103 (12%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK--HVRIADFGHAR---FLSDGEM----A 362
           +I  A+ YLH Q   + HRD+KP N      K   +++ DFG ++    L++GE      
Sbjct: 176 QIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
Query: 363 LTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPY 403
             GT  ++APEV+    E Y  K D +S G++L+ ++ G  P+
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF 276

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 154 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 211
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 212 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 257

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 107 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 165 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 35/106 (33%), Positives = 59/106 (55%), Gaps = 7/106 (6%)
Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG 359
            +E LAR+   ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D 
Sbjct: 110 LQEELARSFFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 167
Query: 360 EMA-LTGTFVYMAPEVIQCEPYSEKS-DVYSFGIILNEIITGNHPY 403
                 GT VY  PE I+   Y  +S  V+S GI+L +++ G+ P+
Sbjct: 168 VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 213

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/237 (24%), Positives = 106/237 (44%), Gaps = 33/237 (13%)
Query: 180 VTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCI---YPDFFHTN 234
           V V Q  +  +Y      D+ E++G G    ++R + +  G     K I   YP   +T 
Sbjct: 42  VEVKQGSVYDYY------DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTV 95
Query: 235 ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK 294
           +N       E+  +++  H  ++ L  A  E  Y   L+ E L     E    + ++  K
Sbjct: 96  KN-------EISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGG--ELFDRIAAEDYK 145
Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADFGH 352
                     E +    +  + ++++HE    ++H D+KP NI  +   A  V+I DFG 
Sbjct: 146 MSEA------EVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 353 ARFLSDGEMA--LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           A  L+  E+    T T  + APE++  EP    +D+++ G++   +++G  P+  +D
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 254

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 58/111 (52%), Gaps = 20/111 (18%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV---RIADFGHARFLS-DGE------- 360
           ++A A+ +LH +   + HRDLKP NI  +    V   +I DFG    +  +G+       
Sbjct: 119 DVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTP 176
Query: 361 --MALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYI 404
             +   G+  YMAPEV++        Y ++ D++S G+IL  +++G  P++
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 120/291 (41%), Gaps = 65/291 (22%)
Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFF------AQEVDTLSR 250
           L + +GQG TAN++R   +  G   A+K           N ++F        +E + L +
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVF---------NNISFLRPVDVQMREFEVLKK 63
Query: 251 QRHRFVLQLMGACLEPPYR-GWLVTEL-----LGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             H+ +++L     E   R   L+ E      L T L+E  +  G            P  
Sbjct: 64  LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL-----------PES 112
Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHV-RIADFGHARFLSDGE 360
           E L    ++   M +L E    ++HR++KP NI     +D + V ++ DFG AR L D E
Sbjct: 113 EFLIVLRDVVGGMNHLREN--GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
Query: 361 --MALTGTFVYMAPEVIQ--------CEPYSEKSDVYSFGIILNEIITGNHPY--IEKDY 408
             + L GT  Y+ P++ +         + Y    D++S G+      TG+ P+   E   
Sbjct: 171 QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 409 KPAKIAMEVGEGKLRPALP----EEDGQLRELIELICLSWDGDASVRPSFS 455
           +  ++  ++  GK   A+      E+G          + W GD  V  S S
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGP---------IDWSGDMPVSCSLS 272

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 16/109 (14%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-------------GEM 361
           +A++ LH     VIHRDLKPSN+ ++    +++ DFG AR + +             G +
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 362 ALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  Y APEV +    YS   DV+S G IL E+      +  +DY+
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
           A  L   Q ++YLH+    ++HRDLKP+N+ LD+   +++ADFG A+       A     
Sbjct: 116 AYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQV 173
Query: 368 V---YMAPEVI-QCEPYSEKSDVYSFGIILNEII 397
           V   Y APE++     Y    D+++ G IL E++
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 29/168 (17%)
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
           + ++F+  LM           +  ELLG    E+L        KE      P       A
Sbjct: 110 KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--------KENNFQPYPLPHVRHMA 161
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-------------------VRIADFG 351
            ++  A+++LHE +  + H DLKP NI   +++                    +R+ADFG
Sbjct: 162 YQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 219
Query: 352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            A F  +    +  T  Y  PEVI    +++  DV+S G IL E   G
Sbjct: 220 SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 267

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 29/168 (17%)
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
           + ++F+  LM           +  ELLG    E+L        KE      P       A
Sbjct: 87  KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--------KENNFQPYPLPHVRHMA 138
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-------------------VRIADFG 351
            ++  A+++LHE +  + H DLKP NI   +++                    +R+ADFG
Sbjct: 139 YQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 196
Query: 352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            A F  +    +  T  Y  PEVI    +++  DV+S G IL E   G
Sbjct: 197 SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 244

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 69/168 (41%), Gaps = 29/168 (17%)
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
           + ++F+  LM           +  ELLG    E+L        KE      P       A
Sbjct: 78  KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL--------KENNFQPYPLPHVRHMA 129
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-------------------VRIADFG 351
            ++  A+++LHE +  + H DLKP NI   +++                    +R+ADFG
Sbjct: 130 YQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            A F  +    +  T  Y  PEVI    +++  DV+S G IL E   G
Sbjct: 188 SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 24/218 (11%)
Query: 193 DPKEIDLQEKIGQGT--TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           D    +L + IG G    A + R       VAVK     +    E       +E+     
Sbjct: 16  DSDRYELVKDIGSGNFGVARLMRDKQSNELVAVK-----YIERGEKIDENVKREIINHRS 70
Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            RH  +++     L P +   ++    G  L E +   G     E       F ++L   
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF----FFQQLISG 126
Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADFGHAR--FLSDGEMALTGT 366
           +    AMQ        V HRDLK  N  LD   A  ++I DFG+++   L     +  GT
Sbjct: 127 VSYCHAMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 178
Query: 367 FVYMAPEVIQCEPYSEK-SDVYSFGIILNEIITGNHPY 403
             Y+APEV+  + Y  K +DV+S G+ L  ++ G +P+
Sbjct: 179 PAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 25/169 (14%)
Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           RH  +++     L P +   ++    G  L E +   G             F E  AR  
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR------------FSEDEARFF 121
Query: 312 --EIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADFGHAR--FLSDGEMALTG 365
             ++   + Y H  +  + HRDLK  N  LD   A  ++I DFG+++   L     +  G
Sbjct: 122 FQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 179
Query: 366 TFVYMAPEVIQCEPYSEK-SDVYSFGIILNEIITGNHPYIE----KDYK 409
           T  Y+APEV+  + Y  K +DV+S G+ L  ++ G +P+ +    +DY+
Sbjct: 180 TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +++A  R     VA+K +  D    +E   +   +E+  L   +H+ +++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVR 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    L    +  LV E     LK++          E +              ++ + + 
Sbjct: 66  LHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF---------LFQLLKGLG 115
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEVI 375
           + H +   V+HRDLKP N+ ++    +++ADFG AR         +    T  Y  P+V+
Sbjct: 116 FCHSRN--VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 376 -QCEPYSEKSDVYSFGIILNEIITGNHP 402
              + YS   D++S G I  E+     P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAARP 201

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 80/199 (40%), Gaps = 34/199 (17%)
Query: 272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIH 329
           +V ELLG +  +++   G            PF     R  A +I +++ +LH  K  + H
Sbjct: 94  IVFELLGLSTYDFIKENG----------FLPFRLDHIRKMAYQICKSVNFLHSNK--LTH 141
Query: 330 RDLKPSNIFLDDAKH-------------------VRIADFGHARFLSDGEMALTGTFVYM 370
            DLKP NI    + +                   +++ DFG A +  +    L  T  Y 
Sbjct: 142 TDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR 201
Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           APEVI    +S+  DV+S G IL E   G   +   D K     ME   G L P    + 
Sbjct: 202 APEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPL-PKHMIQK 260
Query: 431 GQLRELIELICLSWDGDAS 449
            + R+      L WD  +S
Sbjct: 261 TRKRKYFHHDRLDWDEHSS 279

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 18/176 (10%)
Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELLGTTLKEWLHGLGSQRRK 294
           N      +E+  L R RH+ V+QL+     E   + ++V E     ++E L  +  +R  
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF- 106
Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
                  P  +      ++   ++YLH Q   ++H+D+KP N+ L     ++I+  G A 
Sbjct: 107 -------PVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAE 157
Query: 355 FL-----SDGEMALTGTFVYMAPEVIQ-CEPYSE-KSDVYSFGIILNEIITGNHPY 403
            L      D      G+  +  PE+    + +S  K D++S G+ L  I TG +P+
Sbjct: 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 57/111 (51%), Gaps = 20/111 (18%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV---RIADF---------GHARFLSDG 359
           ++A A+ +LH +   + HRDLKP NI  +    V   +I DF         G    +S  
Sbjct: 119 DVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 360 EMAL-TGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYI 404
           E+    G+  YMAPEV++        Y ++ D++S G+IL  +++G  P++
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV 227

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 16/109 (14%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-------------GEM 361
           +A++ LH     VIHRDLKPSN+ ++    +++ DFG AR + +             G  
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 362 ALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  Y APEV +    YS   DV+S G IL E+      +  +DY+
Sbjct: 181 EXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/109 (33%), Positives = 53/109 (48%), Gaps = 16/109 (14%)
Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD-------------GEM 361
           +A++ LH     VIHRDLKPSN+ ++    +++ DFG AR + +             G  
Sbjct: 123 RAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 362 ALTGTFVYMAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               T  Y APEV +    YS   DV+S G IL E+      +  +DY+
Sbjct: 181 EYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 168 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 225
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 226 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 257

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 221
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 158 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 215
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 216 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 247

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 166 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 223
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 224 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 221
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 253

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 135 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 192
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 193 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 224

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VRIADFGHARFLSDGEMALTGTF 367
           A  I Q +  LH  K ++IH DLKP NI L       +++ DFG + +          + 
Sbjct: 206 AHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSR 263
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            Y APEVI    Y    D++S G IL E++TG
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 209 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 266
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 267 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 298

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VRIADFGHARFLSDGEMALTGTF 367
           A  I Q +  LH  K ++IH DLKP NI L       +++ DFG + +          + 
Sbjct: 206 AHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSR 263
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            Y APEVI    Y    D++S G IL E++TG
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 143 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 200
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 201 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 142 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 83/162 (51%), Gaps = 23/162 (14%)
Query: 272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           +V E+LG  L   +     ++ + R +PL  + +++++ L +   + Y+H ++  +IH D
Sbjct: 107 MVFEVLGENLLALI-----KKYEHRGIPLI-YVKQISKQLLLG--LDYMH-RRCGIIHTD 157
Query: 332 LKPSNIFLD------DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSD 385
           +KP N+ ++      +   ++IAD G+A +  +       T  Y +PEV+   P+   +D
Sbjct: 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 217
Query: 386 VYSFGIILNEIITGN--------HPYIEKDYKPAKIAMEVGE 419
           ++S   ++ E+ITG+        H Y + D   A+I   +GE
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 83/162 (51%), Gaps = 23/162 (14%)
Query: 272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           +V E+LG  L   +     ++ + R +PL  + +++++ L +   + Y+H ++  +IH D
Sbjct: 107 MVFEVLGENLLALI-----KKYEHRGIPLI-YVKQISKQLLLG--LDYMH-RRCGIIHTD 157
Query: 332 LKPSNIFLD------DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSD 385
           +KP N+ ++      +   ++IAD G+A +  +       T  Y +PEV+   P+   +D
Sbjct: 158 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGAD 217
Query: 386 VYSFGIILNEIITGN--------HPYIEKDYKPAKIAMEVGE 419
           ++S   ++ E+ITG+        H Y + D   A+I   +GE
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 259

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 48/187 (25%)
Query: 313 IAQAMQYLHE---------QKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--- 360
           +++ + YLHE          KP + HRD K  N+ L       +ADFG A     G+   
Sbjct: 121 MSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPG 180
Query: 361 --MALTGTFVYMAPEVIQCEPYSEKS-----DVYSFGIILNEIIT--------------- 398
                 GT  YMAPEV++     ++      D+Y+ G++L E+++               
Sbjct: 181 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLP 240
Query: 399 -----GNHPYIEKDYKPAKIAMEVGEGKLRPALPE---EDGQLRELIELICLSWDGDASV 450
                G HP +E      ++   V   K+RP + +   +   L +L   I   WD DA  
Sbjct: 241 FEEEIGQHPSLE------ELQEVVVHKKMRPTIKDHWLKHPGLAQLCVTIEECWDHDAEA 294
Query: 451 RPSFSSI 457
           R S   +
Sbjct: 295 RLSAGCV 301

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 142 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 199
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 200 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 134 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 191
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 192 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 223

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 20/208 (9%)
Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           EKIG+GT   +++A  R     VA+K +  D    +E   +   +E+  L   +H+ +++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKNIVR 65
Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L    L    +  LV E     LK++          E +              ++ + + 
Sbjct: 66  LHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF---------LFQLLKGLG 115
Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TFVYMAPEVI 375
           + H +   V+HRDLKP N+ ++    +++A+FG AR         +    T  Y  P+V+
Sbjct: 116 FCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 376 -QCEPYSEKSDVYSFGIILNEIITGNHP 402
              + YS   D++S G I  E+     P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRP 201

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 130 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY 187
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 149 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 206
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 207 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 238

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 138 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 195
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 196 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 227

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VRIADFGHARFLSDGEMALTGTF 367
           A  I Q +  LH  K ++IH DLKP NI L       +++ DFG + +          + 
Sbjct: 206 AHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSR 263
Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            Y APEVI    Y    D++S G IL E++TG
Sbjct: 264 FYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 53/92 (57%), Gaps = 6/92 (6%)
Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFV 368
           ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  ++   +  
Sbjct: 131 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY 188
Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y APE+I     Y+   DV+S G +L E++ G
Sbjct: 189 YRAPELIFGATDYTSSIDVWSAGCVLAELLLG 220
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	472
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-109
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-95
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	7e-84
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-82
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-81
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-73
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-73
3soc_A	322	Activin receptor type-2A; structural genomics cons	6e-72
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-70
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-70
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-69
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-64
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-46
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-43
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-43
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-43
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-42
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-42
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-41
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-41
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-41
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	6e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-41
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	9e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-40
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-40
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-39
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	5e-39
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-39
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	9e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-38
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-38
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-38
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-38
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-38
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-37
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-37
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-37
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-37
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-37
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-36
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-36
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-35
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-35
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-35
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-35
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-34
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-34
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	8e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	5e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-33
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-32
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-31
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-31
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-29
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-29
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	5e-29
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	7e-29
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	8e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-28
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-28
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-28
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-28
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-28
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-27
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-27
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-27
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-26
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-26
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-25
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-25
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-25
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	5e-25
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	7e-25
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-25
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	9e-24
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-23
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-23
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-23
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-23
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-23
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-23
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	7e-23
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-22
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-22
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-22
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-19
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	7e-19
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-19
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-18
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-18
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-18
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-17
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-17
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-16
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-16
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-15
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	8e-15
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-14
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-14
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-12
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	5e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	7e-06

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  326 bits (837), Expect = e-109
 Identities = 104/325 (32%), Positives = 157/325 (48%), Gaps = 30/325 (9%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNG--WYIDPKEIDLQEKIGQGTTANIY 212
           H H H          T  L          Q  M+G    I   +++++EKIG G+   ++
Sbjct: 3   HHHHHHPMSDYDIPTTENLY--------FQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVH 54

Query: 213 RAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL 272
           RA W G DVAVK +    F  +   V  F +EV  + R RH  ++  MGA  +PP    +
Sbjct: 55  RAEWHGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-SI 111

Query: 273 VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           VTE L   +L   LH      +      L     RL+ A ++A+ M YLH + P ++HR+
Sbjct: 112 VTEYLSRGSLYRLLH------KSGAREQLDE-RRRLSMAYDVAKGMNYLHNRNPPIVHRN 164

Query: 332 LKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYS 388
           LK  N+ +D    V++ DFG +R  +       +  GT  +MAPEV++ EP +EKSDVYS
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYS 224

Query: 389 FGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DGQLRELIELICLSWDGD 447
           FG+IL E+ T   P+   +  PA++   VG    R  +P   + Q+  +IE  C  W  +
Sbjct: 225 FGVILWELATLQQPW--GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEG-C--WTNE 279

Query: 448 ASVRPSFSSITCSLKNIQMKVTETI 472
              RPSF++I   L+ +        
Sbjct: 280 PWKRPSFATIMDLLRPLIKSAVPPP 304

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  288 bits (740), Expect = 4e-95
 Identities = 95/283 (33%), Positives = 136/283 (48%), Gaps = 24/283 (8%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             ID KEI+++E +G+G    + +A WR  DVA+K I       +E+    F  E+  LS
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQI------ESESERKAFIVELRQLS 56

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           R  H  +++L GACL P     LV E   G +L   LH           +P       ++
Sbjct: 57  RVNHPNIVKLYGACLNPVC---LVMEYAEGGSLYNVLH-------GAEPLPYYTAAHAMS 106

Query: 309 RALEIAQAMQYLHEQKPK-VIHRDLKPSNIFLDDA-KHVRIADFGHARFLSDGEMALTGT 366
             L+ +Q + YLH  +PK +IHRDLKP N+ L      ++I DFG A  +        G+
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS 166

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             +MAPEV +   YSEK DV+S+GIIL E+IT   P+ E      +I   V  G  RP L
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPL 225

Query: 427 PEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV 468
            +     +  L+   C  W  D S RPS   I   + ++    
Sbjct: 226 IKNLPKPIESLMTR-C--WSKDPSQRPSMEEIVKIMTHLMRYF 265

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  286 bits (735), Expect = 1e-94
 Identities = 87/289 (30%), Positives = 132/289 (45%), Gaps = 29/289 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTF---FAQE 244
             +   EI+ +++IG+G    +++         VA+K +           +     F +E
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
           V  +S   H  +++L G    PP    +V E +    L   L          +  P+   
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLLD--------KAHPIKW- 121

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-----KHVRIADFGHARFLSD 358
             +L   L+IA  ++Y+  Q P ++HRDL+  NIFL           ++ADFG ++    
Sbjct: 122 SVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH 181

Query: 359 GEMALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
               L G F +MAPE I  E   Y+EK+D YSF +IL  I+TG  P+ E  Y   K    
Sbjct: 182 SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINM 241

Query: 417 VGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           + E  LRP +PE+   +LR +IEL C  W GD   RP FS I   L  +
Sbjct: 242 IREEGLRPTIPEDCPPRLRNVIEL-C--WSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  283 bits (727), Expect = 1e-93
 Identities = 67/284 (23%), Positives = 124/284 (43%), Gaps = 23/284 (8%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             ID K+++   K+ +  +  +++  W+G D+ VK +       +      F +E   L 
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVR--DWSTRKSRDFNEECPRLR 62

Query: 250 RQRHRFVLQLMGACLEPPYRG-WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
              H  VL ++GAC  PP     L+T  +   +L   LH       +     +    + +
Sbjct: 63  IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH-------EGTNFVVDQ-SQAV 114

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
             AL++A+ M +LH  +P +    L   ++ +D+    RI+                   
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ--SPGRMYAP 172

Query: 368 VYMAPEVIQCEPY---SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
            ++APE +Q +P       +D++SF ++L E++T   P+   D    +I M+V    LRP
Sbjct: 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF--ADLSNMEIGMKVALEGLRP 230

Query: 425 ALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
            +P      + +L++ IC   + D + RP F  I   L+ +Q K
Sbjct: 231 TIPPGISPHVSKLMK-IC--MNEDPAKRPKFDMIVPILEKMQDK 271

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  280 bits (719), Expect = 2e-92
 Identities = 92/287 (32%), Positives = 136/287 (47%), Gaps = 29/287 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             ID  E+ L+E IG G    +YRA W G +VAVK    D        +    QE    +
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             +H  ++ L G CL+ P    LV E   G  L   L G        + +P    +  + 
Sbjct: 62  MLKHPNIIALRGVCLKEPNL-CLVMEFARGGPLNRVLSG--------KRIPP---DILVN 109

Query: 309 RALEIAQAMQYLHEQKPK-VIHRDLKPSNIFLDDAKH--------VRIADFGHARFLSDG 359
            A++IA+ M YLH++    +IHRDLK SNI +             ++I DFG AR     
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT 169

Query: 360 E-MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG 418
             M+  G + +MAPEVI+   +S+ SDV+S+G++L E++TG  P+  +      +A  V 
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAVAYGVA 227

Query: 419 EGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             KL   +P        +L+E  C  W+ D   RPSF++I   L  I
Sbjct: 228 MNKLALPIPSTCPEPFAKLMED-C--WNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  260 bits (666), Expect = 7e-84
 Identities = 77/296 (26%), Positives = 135/296 (45%), Gaps = 38/296 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W I  +++++ E IG+G    +Y   W G +VA++ I  +    NE+ +  F +EV    
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIE--RDNEDQLKAFKREVMAYR 84

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           + RH  V+  MGAC+ PP+   ++T L  G TL   +        K  +       +   
Sbjct: 85  QTRHENVVLFMGACMSPPHLA-IITSLCKGRTLYSVVR-----DAKIVL----DVNKTRQ 134

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-------- 360
            A EI + M YLH +   ++H+DLK  N+F D+   V I DFG        +        
Sbjct: 135 IAQEIVKGMGYLHAKG--ILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKL 191

Query: 361 MALTGTFVYMAPEVIQ---------CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA 411
               G   ++APE+I+           P+S+ SDV++ G I  E+     P+  K     
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--KTQPAE 249

Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
            I  ++G G ++P L +     +E+ +++   W  +   RP+F+ +   L+ +  +
Sbjct: 250 AIIWQMGTG-MKPNLSQIGMG-KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  255 bits (653), Expect = 2e-82
 Identities = 91/289 (31%), Positives = 137/289 (47%), Gaps = 29/289 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W I   +I + ++IG G+   +Y+  W G DVAVK +           +  F  EV  L 
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLR 75

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           + RH  +L  MG    P     +VT+   G++L   LH        E    +    + + 
Sbjct: 76  KTRHVNILLFMGYSTAPQL--AIVTQWCEGSSLYHHLH------ASETKFEMK---KLID 124

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-----FLSDGEMAL 363
            A + A+ M YLH +   +IHRDLK +NIFL +   V+I DFG A        S     L
Sbjct: 125 IARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQL 182

Query: 364 TGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME-VGE 419
           +G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   +       +E VG 
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMVGR 240

Query: 420 GKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
           G L P L +      + +  L+          RPSF  I   ++ +  +
Sbjct: 241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  234 bits (598), Expect = 1e-73
 Identities = 79/333 (23%), Positives = 126/333 (37%), Gaps = 55/333 (16%)

Query: 172 LLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFF 231
           L++QS  + + S   +       K+I + ++IG+G    ++   WRG  VAVK      F
Sbjct: 14  LIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKV-----F 68

Query: 232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHG 287
            T E A  F   E+      RH  +L  + A ++        +L+T+     +L ++L  
Sbjct: 69  FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS 128

Query: 288 LGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ------KPKVIHRDLKPSNIFLDD 341
                           +  L  A      + +LH +      KP + HRDLK  NI +  
Sbjct: 129 -----------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177

Query: 342 AKHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVI------QCEPYSEKSDVYS 388
                IAD G A                  GT  YM PEV+              +D+YS
Sbjct: 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYS 237

Query: 389 FGIILNEIITGNHPYIE--------KDYKPAKIAME-----VGEGKLRPALPE---EDGQ 432
           FG+IL E+                  D  P+  + E     V   KLRP+ P     D  
Sbjct: 238 FGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDEC 297

Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
           LR++ +L+   W  + + R +   +  +L  + 
Sbjct: 298 LRQMGKLMTECWAHNPASRLTALRVKKTLAKMS 330

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  232 bits (593), Expect = 5e-73
 Identities = 79/305 (25%), Positives = 124/305 (40%), Gaps = 43/305 (14%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
               P ++   E +G+G      +   R  G  + +K +       +E     F +EV  
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELI----RFDEETQRTFLKEVKV 60

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           +    H  VL+ +G   +   R   +TE + G TL+  +         +   P     +R
Sbjct: 61  MRCLEHPNVLKFIGVLYKDK-RLNFITEYIKGGTLRGIIK------SMDSQYPWS---QR 110

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE------ 360
           ++ A +IA  M YLH     +IHRDL   N  + + K+V +ADFG AR + D +      
Sbjct: 111 VSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGL 168

Query: 361 -----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                        + G   +MAPE+I    Y EK DV+SFGI+L EII   +     DY 
Sbjct: 169 RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNAD--PDYL 226

Query: 410 PAKIAMEVG-EGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
           P  +   +   G L    P         +    C   D D   RPSF  +   L+ ++M 
Sbjct: 227 PRTMDFGLNVRGFLDRYCPPNCPPSFFPITVR-C--CDLDPEKRPSFVKLEHWLETLRMH 283

Query: 468 VTETI 472
           +   +
Sbjct: 284 LAGHL 288

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  229 bits (586), Expect = 6e-72
 Identities = 74/315 (23%), Positives = 113/315 (35%), Gaps = 55/315 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
            Y     + L E   +G    +++A      VAVK      F   +        EV +L 
Sbjct: 19  LYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKI-----FPIQDKQSWQNEYEVYSLP 73

Query: 250 RQRHRFVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
             +H  +LQ +GA           WL+T      +L ++L              +  + E
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----------NVVSWNE 122

Query: 306 RLARALEIAQAMQYLHE--------QKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
               A  +A+ + YLHE         KP + HRD+K  N+ L +     IADFG A    
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 358 DGE-----MALTGTFVYMAPEVIQCEP-----YSEKSDVYSFGIILNEIITGNHPY--IE 405
            G+         GT  YMAPEV++           + D+Y+ G++L E+ +         
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 406 KDYKPAKIAM------------EVGEGKLRPALPEE---DGQLRELIELICLSWDGDASV 450
            +Y                    V   K RP L +       +  L E I   WD DA  
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 451 RPSFSSITCSLKNIQ 465
           R S   +   +  +Q
Sbjct: 303 RLSAGCVGERITQMQ 317

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  223 bits (570), Expect = 9e-70
 Identities = 74/309 (23%), Positives = 117/309 (37%), Gaps = 55/309 (17%)

Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           ++I L E +G+G    ++R  W+G +VAVK      F + +    F   E+      RH 
Sbjct: 8   RDITLLECVGKGRYGEVWRGSWQGENVAVKI-----FSSRDEKSWFRETELYNTVMLRHE 62

Query: 255 FVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            +L  + + +   +     WL+T      +L ++L            +        L   
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----------LTTLDTVSCLRIV 111

Query: 311 LEIAQAMQYLHEQ------KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---- 360
           L IA  + +LH +      KP + HRDLK  NI +       IAD G A   S       
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171

Query: 361 ---MALTGTFVYMAPEVIQCEP------YSEKSDVYSFGIILNEIITGNHPYIEK----- 406
                  GT  YMAPEV+            ++ D+++FG++L E+               
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP 231

Query: 407 ---DYKPAKIAME-----VGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFS 455
              D  P   + E     V   + RP +P     D  L  L +L+   W  + S R +  
Sbjct: 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291

Query: 456 SITCSLKNI 464
            I  +L  I
Sbjct: 292 RIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  222 bits (568), Expect = 6e-69
 Identities = 79/315 (25%), Positives = 124/315 (39%), Gaps = 55/315 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
                + I LQE IG+G    ++R  WRG +VAVK      F + E    F   E+    
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKI-----FSSREERSWFREAEIYQTV 91

Query: 250 RQRHRFVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
             RH  +L  + A  +        WLV++     +L ++L+                 E 
Sbjct: 92  MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----------YTVTVEG 140

Query: 306 RLARALEIAQAMQYLHEQ------KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
            +  AL  A  + +LH +      KP + HRDLK  NI +       IAD G A      
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200

Query: 360 EMAL-------TGTFVYMAPEVI------QCEPYSEKSDVYSFGIILNEIITGNHPY-IE 405
              +        GT  YMAPEV+      +     +++D+Y+ G++  EI        I 
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260

Query: 406 KDYK----------PAKIAME--VGEGKLRPALPEE---DGQLRELIELICLSWDGDASV 450
           +DY+          P+   M   V E KLRP +P        LR + +++   W  + + 
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320

Query: 451 RPSFSSITCSLKNIQ 465
           R +   I  +L  + 
Sbjct: 321 RLTALRIKKTLSQLS 335

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  209 bits (533), Expect = 7e-64
 Identities = 73/334 (21%), Positives = 113/334 (33%), Gaps = 70/334 (20%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVD--T 247
             +D   + L E IG+G    +Y+       VAVK     F   N      F  E +   
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKV----FSFANRQN---FINEKNIYR 60

Query: 248 LSRQRHRFVLQLMGACLEPPYRG----WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           +    H  + + +         G     LV E     +L ++L                 
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-----------HTSD 109

Query: 303 FEERLARALEIAQAMQYLHEQ-------KPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           +      A  + + + YLH +       KP + HRDL   N+ + +     I+DFG +  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 356 LSDGE-----------MALTGTFVYMAPEVIQ-------CEPYSEKSDVYSFGIILNEII 397
           L+              ++  GT  YMAPEV++        E   ++ D+Y+ G+I  EI 
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 398 ---TGNHPY-IEKDYKPAKIAM------------EVGEGKLRPALPEE----DGQLRELI 437
              T   P     +Y+ A                 V   K RP  PE        +R L 
Sbjct: 230 MRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 438 ELICLSWDGDASVRPSFSSITCSLKNIQMKVTET 471
           E I   WD DA  R +       +  + M     
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  161 bits (409), Expect = 3e-46
 Identities = 69/266 (25%), Positives = 118/266 (44%), Gaps = 30/266 (11%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
              +IG+G+   +Y+ +     ++VA   +        ++    F +E + L   +H  +
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCEL--QDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 257 LQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--A 310
           ++   +            LVTEL+   TLK +L                  + ++ R   
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK------------VMKIKVLRSWC 135

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHARFLSDGEM-ALTGTFV 368
            +I + +Q+LH + P +IHRDLK  NIF+      V+I D G A         A+ GT  
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPE 195

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE 428
           +MAPE+ + E Y E  DVY+FG+ + E+ T  +PY E     A+I   V  G    +  +
Sbjct: 196 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFDK 253

Query: 429 -EDGQLRELIELICLSWDGDASVRPS 453
               +++E+IE  C+    +   R S
Sbjct: 254 VAIPEVKEIIEG-CIR--QNKDERYS 276

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  155 bits (394), Expect = 1e-43
 Identities = 77/278 (27%), Positives = 123/278 (44%), Gaps = 34/278 (12%)

Query: 202 KIGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM 260
            +G+G    +Y+  +  G  VAVK +  +     E     F  EV+ +S   HR +L+L 
Sbjct: 37  ILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQ---FQTEVEMISMAVHRNLLRLR 93

Query: 261 GACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF--EERLARALEIAQAM 317
           G C+ P  R  LV   +   ++   L      +        PP    +R   AL  A+ +
Sbjct: 94  GFCMTPTER-LLVYPYMANGSVASCLRERPESQ--------PPLDWPKRQRIALGSARGL 144

Query: 318 QYLHEQ-KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----GTFVYMAP 372
            YLH+   PK+IHRD+K +NI LD+     + DFG A+ +   +  +T    GT  ++AP
Sbjct: 145 AYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV-------GEGKLR-- 423
           E +     SEK+DV+ +G++L E+ITG   +           M +        E KL   
Sbjct: 205 EYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL 264

Query: 424 --PALPEE--DGQLRELIELICLSWDGDASVRPSFSSI 457
               L     D ++ +LI++  L        RP  S +
Sbjct: 265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEV 302

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  156 bits (396), Expect = 2e-43
 Identities = 85/325 (26%), Positives = 141/325 (43%), Gaps = 58/325 (17%)

Query: 164 HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG--LDV 221
           H   +Q PL ++S + +  +  K + W ++ +++ L E+IG+G    ++    R     V
Sbjct: 84  HLLSTQQPLTKKSGVVLHRAVPK-DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLV 142

Query: 222 AVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-G 278
           AVK           +    F QE   L +  H  +++L+G C   +P Y   +V EL+ G
Sbjct: 143 AVKSCRET---LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY---IVMELVQG 196

Query: 279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF 338
                +L      R +   + +      L    + A  M+YL  +    IHRDL   N  
Sbjct: 197 GDFLTFL------RTEGARLRVK---TLLQMVGDAAAGMEYLESKC--CIHRDLAARNCL 245

Query: 339 LDDAKHVRIADFGHARFLSDGEMALTGTFVY-----MAPEVIQCEPYSEKSDVYSFGIIL 393
           + +   ++I+DFG +R  +DG  A +G          APE +    YS +SDV+SFGI+L
Sbjct: 246 VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILL 305

Query: 394 NEIIT-GNHPY-----------IEKDYKPAKIAMEVGEGKLRPAL-PEEDGQLRELIELI 440
            E  + G  PY           +EK  +     +        P L P+       +  L+
Sbjct: 306 WETFSLGASPYPNLSNQQTREFVEKGGR-----LP------CPELCPD------AVFRLM 348

Query: 441 CLSWDGDASVRPSFSSITCSLKNIQ 465
              W  +   RPSFS+I   L++I+
Sbjct: 349 EQCWAYEPGQRPSFSTIYQELQSIR 373

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  152 bits (387), Expect = 4e-43
 Identities = 70/283 (24%), Positives = 117/283 (41%), Gaps = 54/283 (19%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
              E IG G    +++A  R  G    +K +     + NE A     +EV  L++  H  
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAE----REVKALAKLDHVN 65

Query: 256 VLQLMGACLEPPYRG---------------WLVTELL-GTTLKEWLHGLGSQRRKERMVP 299
           ++   G      Y                 ++  E     TL++W+     ++R+     
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-----EKRRGE--- 117

Query: 300 LPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
               ++ LA     +I + + Y+H +K  +I+RDLKPSNIFL D K V+I DFG    L 
Sbjct: 118 --KLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIFLVDTKQVKIGDFGLVTSLK 173

Query: 358 DGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
           +        GT  YM+PE I  + Y ++ D+Y+ G+IL E++       E       +  
Sbjct: 174 NDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDL-- 231

Query: 416 EVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSI 457
                     + +  D + + L++   LS       RP+ S I
Sbjct: 232 ------RDGIISDIFDKKEKTLLQK-LLS--KKPEDRPNTSEI 265

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  152 bits (385), Expect = 8e-43
 Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 33/290 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQE 244
             I  K++ L EK+G G+   + R  W       + VAVKC+ PD     E    F  +E
Sbjct: 13  CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI-RE 71

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPP 302
           V+ +    HR +++L G  L PP    +VTEL  LG+ L + L      R+ +    L  
Sbjct: 72  VNAMHSLDHRNLIRLYGVVLTPPM--KMVTELAPLGS-LLDRL------RKHQGHFLLGT 122

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-- 360
                  A+++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L   +  
Sbjct: 123 L---SRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177

Query: 361 -MALTGT---FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
            +        F + APE ++   +S  SD + FG+ L E+ T G  P+       ++I  
Sbjct: 178 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW--IGLNGSQILH 235

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
           ++ +   R  LP  +   +++  ++   W      RP+F ++   L   Q
Sbjct: 236 KIDKEGER--LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  150 bits (381), Expect = 3e-42
 Identities = 70/287 (24%), Positives = 129/287 (44%), Gaps = 34/287 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQE 244
           + I  +++ L   +G+G    +Y  ++       ++VAVK    D      +    F  E
Sbjct: 7   YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD---CTLDNKEKFMSE 63

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPP 302
              +    H  +++L+G   E P   W++ EL   G  L  +L       R +  + +  
Sbjct: 64  AVIMKNLDHPHIVKLIGIIEEEPT--WIIMELYPYGE-LGHYL------ERNKNSLKVLT 114

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-M 361
               +  +L+I +AM YL       +HRD+   NI +   + V++ DFG +R++ D +  
Sbjct: 115 L---VLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169

Query: 362 ALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
             + T +   +M+PE I    ++  SDV+ F + + EI++ G  P+     +   +   +
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF--FWLENKDVIGVL 227

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +G     LP+ D     L  L+   WD D S RP F+ + CSL ++
Sbjct: 228 EKGDR---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  151 bits (383), Expect = 3e-42
 Identities = 61/267 (22%), Positives = 108/267 (40%), Gaps = 31/267 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHR 254
               ++G G+   +++   +  G   AVK     F    + A      EV +  +  +H 
Sbjct: 60  QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL--AEVGSHEKVGQHP 117

Query: 255 FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEI 313
             ++L  A  E     +L TEL G +L         Q  +     LP  E ++     + 
Sbjct: 118 CCVRLEQAWEEG-GILYLQTELCGPSL--------QQHCEAWGASLP--EAQVWGYLRDT 166

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYMA 371
             A+ +LH Q   ++H D+KP+NIFL      ++ DFG    L          G   YMA
Sbjct: 167 LLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMA 224

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-D 430
           PE++Q   Y   +DV+S G+ + E+          +        ++ +G L P       
Sbjct: 225 PELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGWQ-----QLRQGYLPPEFTAGLS 278

Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
            +LR ++ +  L  + D  +R +  ++
Sbjct: 279 SELRSVLVM-ML--EPDPKLRATAEAL 302

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  154 bits (390), Expect = 6e-42
 Identities = 81/318 (25%), Positives = 133/318 (41%), Gaps = 36/318 (11%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           +        HR    T           +++     W I  + + L+ K+GQG    ++  
Sbjct: 149 YSKHADGLCHR--LTTVCPTSKPQTQGLAKDA---WEIPRESLRLEVKLGQGCFGEVWMG 203

Query: 215 IWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV 273
            W G   VA+K + P            F QE   + + RH  ++QL     E P   ++V
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA-----FLQEAQVMKKLRHEKLVQLYAVVSEEPI--YIV 256

Query: 274 TELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDL 332
           TE +   +L ++L     +    + + LP   + +  A +IA  M Y+       +HRDL
Sbjct: 257 TEYMSKGSLLDFL-----KGETGKYLRLP---QLVDMAAQIASGMAYVERMN--YVHRDL 306

Query: 333 KPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVYS 388
           + +NI + +    ++ADFG AR + D E            + APE      ++ KSDV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366

Query: 389 FGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDG 446
           FGI+L E+ T G  PY     +     +E G     P   PE       L +L+C  W  
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE------SLHDLMCQCWRK 420

Query: 447 DASVRPSFSSITCSLKNI 464
           +   RP+F  +   L++ 
Sbjct: 421 EPEERPTFEYLQAFLEDY 438

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  149 bits (379), Expect = 6e-42
 Identities = 81/294 (27%), Positives = 134/294 (45%), Gaps = 53/294 (18%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   + G   VAVK +       + +A   F  E + +
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG--SMSPDA---FLAEANLM 62

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L        K          + L
Sbjct: 63  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFL--------KTPSGIKLTINKLL 112

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGT 366
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E  A  G 
Sbjct: 113 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170

Query: 367 FV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKPA 411
                + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E+ Y+  
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYR-- 228

Query: 412 KIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              M       RP   PE      EL +L+ L W      RP+F  +   L++ 
Sbjct: 229 ---MV------RPDNCPE------ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  148 bits (377), Expect = 1e-41
 Identities = 69/286 (24%), Positives = 129/286 (45%), Gaps = 32/286 (11%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQE 244
           + I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQE 66

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
             T+ +  H  +++L+G   E P   W++ EL     L+ +L      + ++  + L   
Sbjct: 67  ALTMRQFDHPHIVKLIGVITENPV--WIIMELCTLGELRSFL------QVRKYSLDLASL 118

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MA 362
              +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D     
Sbjct: 119 ---ILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK 173

Query: 363 LTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
            +   +   +MAPE I    ++  SDV+ FG+ + EI+  G  P+  +  K   +   + 
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIE 231

Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            G+    LP        L  L+   W  D S RP F+ +   L  I
Sbjct: 232 NGER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  148 bits (377), Expect = 1e-41
 Identities = 82/293 (27%), Positives = 140/293 (47%), Gaps = 53/293 (18%)

Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           GW ++ KE+ L + IG+G   ++    +RG  VAVKCI  D   T +     F  E   +
Sbjct: 15  GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQA----FLAEASVM 68

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           ++ RH  ++QL+G  +E     ++VTE +   +L ++L      R + R   +   +  L
Sbjct: 69  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL------RSRGR--SVLGGDCLL 120

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
             +L++ +AM+YL       +HRDL   N+ + +    +++DFG  +   +         
Sbjct: 121 KFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGK 175

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKPAK 412
           +   + APE ++ + +S KSDV+SFGI+L EI + G  PY           +EK YK   
Sbjct: 176 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--- 232

Query: 413 IAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             M+       P   P        + E++   W  DA++RPSF  +   L++I
Sbjct: 233 --MD------APDGCPP------AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  149 bits (379), Expect = 2e-41
 Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 36/287 (12%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEV 245
           +   E    + +G G    +Y+ +W        + VA+K +      T+  A      E 
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEA 68

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPF 303
             ++   +  V +L+G CL       L+T+L   G  L +++     +  K+ +      
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGC-LLDYV-----REHKDNI----GS 116

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
           +  L   ++IA+ M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   E   
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 364 TGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
                     +MA E I    Y+ +SDV+S+G+ + E++T G+ PY       ++I+  +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--DGIPASEISSIL 232

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +G+ R  LP+      ++  ++   W  DA  RP F  +      +
Sbjct: 233 EKGE-R--LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKM 276

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  148 bits (376), Expect = 4e-41
 Identities = 71/298 (23%), Positives = 124/298 (41%), Gaps = 30/298 (10%)

Query: 184 QAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNENAV 238
           + K+    I  ++  L   +G+G   ++  A  +  D     VAVK +  D      + +
Sbjct: 12  KEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD--IIASSDI 69

Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLE-----PPYRGWLVTELL-GTTLKEWLHGLGSQR 292
             F +E   +    H  V +L+G  L            ++   +    L  +L       
Sbjct: 70  EEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL----AS 125

Query: 293 RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
           R        P +  +   ++IA  M+YL  +    IHRDL   N  L +   V +ADFG 
Sbjct: 126 RIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTVCVADFGL 183

Query: 353 ARFLSDGEM--ALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEK 406
           +R +  G+       + +   ++A E +    Y+  SDV++FG+ + EI+T G  PY   
Sbjct: 184 SRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGI 243

Query: 407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +   A+I   +  G     L +    + E+ +L+   W  D   RPSF+ +   L+NI
Sbjct: 244 E--NAEIYNYLIGGNR---LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI 296

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  146 bits (372), Expect = 4e-41
 Identities = 77/295 (26%), Positives = 127/295 (43%), Gaps = 55/295 (18%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDP E+   ++IG G    ++   W     VA+K I        +     F +E + +
Sbjct: 3   WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-----FIEEAEVM 57

Query: 249 SRQRHRFVLQLMGACL-EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            +  H  ++QL G CL + P    LVTE +    L ++L      R +  +         
Sbjct: 58  MKLSHPKLVQLYGVCLEQAPI--CLVTEFMEHGCLSDYL------RTQRGLFAAETL--- 106

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
           L   L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF+ D +  + TG
Sbjct: 107 LGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164

Query: 366 TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKP 410
           T     + +PEV     YS KSDV+SFG+++ E+ + G  PY           I   ++ 
Sbjct: 165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR- 223

Query: 411 AKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               +       +P L          + +++   W      RP+FS +   L  I
Sbjct: 224 ----LY------KPRLAST------HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  151 bits (383), Expect = 6e-41
 Identities = 79/295 (26%), Positives = 132/295 (44%), Gaps = 53/295 (17%)

Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
            W I  + + L++K+G G    ++ A +     VAVK + P            F  E + 
Sbjct: 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-----FLAEANV 236

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEER 306
           +   +H  +++L     + P   +++TE +   +L ++L     +  +    PLP   + 
Sbjct: 237 MKTLQHDKLVKLHAVVTKEPI--YIITEFMAKGSLLDFL-----KSDEGSKQPLP---KL 286

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTG 365
           +  + +IA+ M ++ ++    IHRDL+ +NI +  +   +IADFG AR + D E  A  G
Sbjct: 287 IDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344

Query: 366 TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYKP 410
                 + APE I    ++ KSDV+SFGI+L EI+T G  PY           +E+ Y+ 
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR- 403

Query: 411 AKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               M       RP   PE      EL  ++   W      RP+F  I   L + 
Sbjct: 404 ----MP------RPENCPE------ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  147 bits (372), Expect = 7e-41
 Identities = 87/297 (29%), Positives = 136/297 (45%), Gaps = 57/297 (19%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E   
Sbjct: 8   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAV 62

Query: 248 LSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFE 304
           +   +H  ++QL+G C    P Y   ++TE +    L ++L     Q             
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFY---IITEFMTYGNLLDYLRECNRQE--------VSAV 111

Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MAL 363
             L  A +I+ AM+YL E+K   IHRDL   N  + +   V++ADFG +R ++     A 
Sbjct: 112 VLLYMATQISSAMEYL-EKK-NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169

Query: 364 TGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDY 408
            G      + APE +    +S KSDV++FG++L EI T G  PY           +EKDY
Sbjct: 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY 229

Query: 409 KPAKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +     ME      RP   PE      ++ EL+   W  + S RPSF+ I  + + +
Sbjct: 230 R-----ME------RPEGCPE------KVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  146 bits (371), Expect = 8e-41
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 27/272 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++   IG G+     +   +  G  +  K +  D+    E        EV+ L   +H  
Sbjct: 9   EVLYTIGTGSYGRCQKIRRKSDGKILVWKEL--DYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 256 VLQLMGACLEPPYRG-WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALE 312
           +++     ++      ++V E   G  L   +      +  +    L   EE + R   +
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLD--EEFVLRVMTQ 119

Query: 313 IAQAMQYLHEQKP---KVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALT--GT 366
           +  A++  H +      V+HRDLKP+N+FLD  ++V++ DFG AR L  D   A T  GT
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGT 179

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             YM+PE +    Y+EKSD++S G +L E+     P+     K  ++A ++ EGK R  +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKIREGKFRR-I 236

Query: 427 PEE-DGQLRELIELICLSWDGDASVRPSFSSI 457
           P     +L E+I    L+       RPS   I
Sbjct: 237 PYRYSDELNEIITR-MLN--LKDYHRPSVEEI 265

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  147 bits (373), Expect = 9e-41
 Identities = 78/326 (23%), Positives = 138/326 (42%), Gaps = 40/326 (12%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           H H H +        + L+ +        Q K+    ID   + L + +G+G   ++   
Sbjct: 5   HHHHHHS--------SGLVPRGS---EELQNKLEDVVIDRNLLILGKILGEGEFGSVMEG 53

Query: 215 IWRGLD-----VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR 269
             +  D     VAVK +  D  ++++  +  F  E   +    H  V++L+G C+E   +
Sbjct: 54  NLKQEDGTSLKVAVKTMKLD--NSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111

Query: 270 G----WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK 324
           G     ++   +    L  +L       R E      P +  L   ++IA  M+YL  + 
Sbjct: 112 GIPKPMVILPFMKYGDLHTYLL----YSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167

Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTGTFV---YMAPEVIQCEP 379
              +HRDL   N  L D   V +ADFG ++ +  G+         +   ++A E +    
Sbjct: 168 --FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 225

Query: 380 YSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIE 438
           Y+ KSDV++FG+ + EI T G  PY     +  ++   +  G     L + +  L EL E
Sbjct: 226 YTSKSDVWAFGVTMWEIATRGMTPY--PGVQNHEMYDYLLHGHR---LKQPEDCLDELYE 280

Query: 439 LICLSWDGDASVRPSFSSITCSLKNI 464
           ++   W  D   RP+FS +   L+ +
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQLEKL 306

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  147 bits (372), Expect = 1e-40
 Identities = 70/315 (22%), Positives = 139/315 (44%), Gaps = 33/315 (10%)

Query: 168 SQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKC 225
                  Q  L   +    +  +        +++KIG+G  + +YRA     G+ VA+K 
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANF-------RIEKKIGRGQFSEVYRAACLLDGVPVALKK 64

Query: 226 IYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEW 284
           +   F   +  A     +E+D L +  H  V++   + +E      +V EL     L   
Sbjct: 65  V-QIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL-NIVLELADAGDLSRM 122

Query: 285 LHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK 343
           +     +  K++   +P  E  + +  +++  A++++H ++  V+HRD+KP+N+F+    
Sbjct: 123 I-----KHFKKQKRLIP--ERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATG 173

Query: 344 HVRIADFGHARFLSDGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            V++ D G  RF S  +     + V    YM+PE I    Y+ KSD++S G +L E+   
Sbjct: 174 VVKLGDLGLGRFFS-SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232

Query: 400 NHPYIEKDYKPAKIAMEVGEGKLRPALPEED--GQLRELIELICLSWDGDASVRPSFSSI 457
             P+         +  ++ +    P LP +    +LR+L+ + C++   D   RP  + +
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQCDYPP-LPSDHYSEELRQLVNM-CIN--PDPEKRPDVTYV 288

Query: 458 TCSLKNIQMKVTETI 472
               K +      ++
Sbjct: 289 YDVAKRMHACTASSL 303

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  151 bits (384), Expect = 1e-40
 Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 31/284 (10%)

Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
            W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE   
Sbjct: 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQV 315

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           + + RH  ++QL     E P   ++VTE +   +L ++L     +    + + LP   + 
Sbjct: 316 MKKLRHEKLVQLYAVVSEEPI--YIVTEYMSKGSLLDFL-----KGETGKYLRLP---QL 365

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT 366
           +  A +IA  M Y+       +HRDL+ +NI + +    ++ADFG AR + D E      
Sbjct: 366 VDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423

Query: 367 ----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK 421
                 + APE      ++ KSDV+SFGI+L E+ T G  PY     +     +E G   
Sbjct: 424 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 483

Query: 422 LRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P   PE       L +L+C  W  +   RP+F  +   L++ 
Sbjct: 484 PCPPECPE------SLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (382), Expect = 1e-40
 Identities = 81/319 (25%), Positives = 138/319 (43%), Gaps = 35/319 (10%)

Query: 157 HSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIW 216
           HS            P  +++   +       + W ++  +I ++ K+G G    +Y  +W
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVW 241

Query: 217 RG--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRGWL 272
           +   L VAVK +  D     E     F +E   +   +H  ++QL+G C    P Y   +
Sbjct: 242 KKYSLTVAVKTLKEDTMEVEE-----FLKEAAVMKEIKHPNLVQLLGVCTREPPFY---I 293

Query: 273 VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD 331
           +TE +    L ++L       R+     +      L  A +I+ AM+YL ++    IHR+
Sbjct: 294 ITEFMTYGNLLDYL-------RECNRQEVSA-VVLLYMATQISSAMEYLEKKN--FIHRN 343

Query: 332 LKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT----FVYMAPEVIQCEPYSEKSDVY 387
           L   N  + +   V++ADFG +R ++               + APE +    +S KSDV+
Sbjct: 344 LAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVW 403

Query: 388 SFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWD 445
           +FG++L EI T G  PY   D       +E      RP   PE      ++ EL+   W 
Sbjct: 404 AFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE------KVYELMRACWQ 457

Query: 446 GDASVRPSFSSITCSLKNI 464
            + S RPSF+ I  + + +
Sbjct: 458 WNPSDRPSFAEIHQAFETM 476

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  146 bits (370), Expect = 2e-40
 Identities = 72/289 (24%), Positives = 134/289 (46%), Gaps = 36/289 (12%)

Query: 190 WYIDPKEIDLQEK-IGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQE 244
            Y+D K + L++K +G G    + +  ++       VAVK +  +    +         E
Sbjct: 11  VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE--ANDPALKDELLAE 68

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPP 302
            + + +  + ++++++G C    +   LV E+  LG  L ++L       ++ R V    
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAESW--MLVMEMAELGP-LNKYL-------QQNRHVKDK- 117

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-- 360
               +    +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E  
Sbjct: 118 --NIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 173

Query: 361 -MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
             A T       + APE I    +S KSDV+SFG+++ E  + G  PY  +  K +++  
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTA 231

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            + +G+ R  +    G  RE+ +L+ L W  D   RP F+++   L+N 
Sbjct: 232 MLEKGE-R--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  145 bits (368), Expect = 2e-40
 Identities = 71/296 (23%), Positives = 127/296 (42%), Gaps = 57/296 (19%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
             +  +EI L +++G G    +    W+G  DVAVK I       +E     F QE  T+
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-----FFQEAQTM 57

Query: 249 SRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            +  H  +++  G C    P Y   +VTE +    L  +L   G      +++ +     
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIY---IVTEYISNGCLLNYLRSHGKGLEPSQLLEM----- 109

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALT 364
                 ++ + M +L   +   IHRDL   N  +D    V+++DFG  R++ D + ++  
Sbjct: 110 ----CYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163

Query: 365 GTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYK 409
           GT     + APEV     YS KSDV++FGI++ E+ + G  PY           + + ++
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR 223

Query: 410 PAKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                +       RP L  +       + +++   W      RP+F  +  S++ +
Sbjct: 224 -----LY------RPHLASD------TIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (379), Expect = 2e-40
 Identities = 80/327 (24%), Positives = 142/327 (43%), Gaps = 56/327 (17%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           +         R                  +   +GW ++ KE+ L + IG+G   ++   
Sbjct: 156 YTTDADGLCTRL---IKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLG 212

Query: 215 IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT 274
            +RG  VAVKCI  D   T +     F  E   +++ RH  ++QL+G  +E     ++VT
Sbjct: 213 DYRGNKVAVKCIKND--ATAQA----FLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266

Query: 275 ELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLK 333
           E +   +L ++L     + R   ++        L  +L++ +AM+YL       +HRDL 
Sbjct: 267 EYMAKGSLVDYL-----RSRGRSVLGGD---CLLKFSLDVCEAMEYLEGNN--FVHRDLA 316

Query: 334 PSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFG 390
             N+ + +    +++DFG  +   +         +   + APE ++ + +S KSDV+SFG
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFG 373

Query: 391 IILNEIIT-GNHPY-----------IEKDYKPAKIAMEVGEGKLRPAL-PEEDGQLRELI 437
           I+L EI + G  PY           +EK YK     M+       P   P        + 
Sbjct: 374 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK-----MD------APDGCPP------AVY 416

Query: 438 ELICLSWDGDASVRPSFSSITCSLKNI 464
           +++   W  DA+ RP+F  +   L++I
Sbjct: 417 DVMKNCWHLDAATRPTFLQLREQLEHI 443

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  146 bits (371), Expect = 2e-40
 Identities = 71/332 (21%), Positives = 127/332 (38%), Gaps = 48/332 (14%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR 213
            + H H        ++    Q +  +            I P  +  Q+ IG G    +Y+
Sbjct: 3   YYHHHHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYK 62

Query: 214 AIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL--E 265
            + +       + VA+K +        E     F  E   + +  H  +++L G     +
Sbjct: 63  GMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119

Query: 266 PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK 324
           P     ++TE +    L ++L      R K+    +    + +     IA  M+YL    
Sbjct: 120 PMM---IITEYMENGALDKFL------REKDGEFSVL---QLVGMLRGIAAGMKYLANMN 167

Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVY-----------MAPE 373
              +HRDL   NI ++     +++DFG +R L D   A      Y            APE
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-----TYTTSGGKIPIRWTAPE 220

Query: 374 VIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
            I    ++  SDV+SFGI++ E++T G  PY   +    ++   + +G     LP     
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPY--WELSNHEVMKAINDGFR---LPTPMDC 275

Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              + +L+   W  + + RP F+ I   L  +
Sbjct: 276 PSAIYQLMMQCWQQERARRPKFADIVSILDKL 307

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  145 bits (367), Expect = 3e-40
 Identities = 70/296 (23%), Positives = 135/296 (45%), Gaps = 57/296 (19%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W IDPK++   +++G G    +    WRG  DVA+K I       +E     F +E   +
Sbjct: 19  WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVM 73

Query: 249 SRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
               H  ++QL G C    P +   ++TE +    L  +L  +  + + ++++ +     
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIF---IITEYMANGCLLNYLREMRHRFQTQQLLEM----- 125

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALT 364
                 ++ +AM+YL  ++   +HRDL   N  ++D   V+++DFG +R++ D E  +  
Sbjct: 126 ----CKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179

Query: 365 GTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY-----------IEKDYK 409
           G+     +  PEV+    +S KSD+++FG+++ EI + G  PY           I +  +
Sbjct: 180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR 239

Query: 410 PAKIAMEVGEGKLRPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                +       RP L  E      ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 240 -----LY------RPHLASE------KVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  145 bits (368), Expect = 5e-40
 Identities = 76/337 (22%), Positives = 128/337 (37%), Gaps = 54/337 (16%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR 213
            H H H                      + Q   +      + +     +G+G    +  
Sbjct: 2   AHHHHHH------------HHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSL 49

Query: 214 AIWRGLD------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP 267
             +   +      VAVK +  D         + + QE+D L    H  +++  G C +  
Sbjct: 50  YCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106

Query: 268 YRG-WLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK 324
                LV E   LG+ L+++L      R    +  L  F      A +I + M YLH Q 
Sbjct: 107 AASLQLVMEYVPLGS-LRDYL-----PRHSIGLAQLLLF------AQQICEGMAYLHAQH 154

Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFV---YMAPEVIQCE 378
              IHRDL   N+ LD+ + V+I DFG A+ + +G               + APE ++  
Sbjct: 155 --YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 379 PYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPE-EDGQL--- 433
            +   SDV+SFG+ L E++T  +            I +  G+  +       E G+    
Sbjct: 213 KFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR 272

Query: 434 -----RELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
                 E+  L+   W+ +AS RP+F ++   LK + 
Sbjct: 273 PDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH 309

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (368), Expect = 6e-40
 Identities = 73/347 (21%), Positives = 134/347 (38%), Gaps = 67/347 (19%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           + H H        ++    Q    A+  +    +    + + +   +++G+G   ++   
Sbjct: 4   YHHHHHHDYDIPTTENLYFQG---AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMC 60

Query: 215 IWRGLD------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY 268
            +  L       VAVK +        E  +  F +E++ L   +H  +++  G C     
Sbjct: 61  RYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116

Query: 269 RG-WLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP 325
           R   L+ E L  G+ L+++L      ++ +  +        L    +I + M+YL  ++ 
Sbjct: 117 RNLKLIMEYLPYGS-LRDYL------QKHKERIDHIKL---LQYTSQICKGMEYLGTKR- 165

Query: 326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFV---YMAPEVIQCEP 379
             IHRDL   NI +++   V+I DFG  + L   +              + APE +    
Sbjct: 166 -YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 380 YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIEL 439
           +S  SDV+SFG++L E+ T    YIEK   P    M +          +    +  LIEL
Sbjct: 225 FSVASDVWSFGVVLYELFT----YIEKSKSPPAEFMRMIGND-----KQGQMIVFHLIEL 275

Query: 440 I----------------------CLSWDGDASVRPSFSSITCSLKNI 464
           +                      C  W+ + + RPSF  +   +  I
Sbjct: 276 LKNNGRLPRPDGCPDEIYMIMTEC--WNNNVNQRPSFRDLALRVDQI 320

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (366), Expect = 1e-39
 Identities = 62/289 (21%), Positives = 121/289 (41%), Gaps = 36/289 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQ 243
                 E+   + +G G    +++ +W        + V +K I      +   +      
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK---SGRQSFQAVTD 64

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLP 301
            +  +    H  +++L+G C        LVT+   LG+ L + +      R+    +   
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPGSSL--QLVTQYLPLGS-LLDHV------RQHRGALGPQ 115

Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
                L   ++IA+ M YL E    ++HR+L   N+ L     V++ADFG A  L   + 
Sbjct: 116 LL---LNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170

Query: 362 ALTGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
            L  +       +MA E I    Y+ +SDV+S+G+ + E++T G  PY     + A++  
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY--AGLRLAEVPD 228

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            + +G+ R  L +      ++  ++   W  D ++RP+F  +      +
Sbjct: 229 LLEKGE-R--LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  143 bits (364), Expect = 2e-39
 Identities = 74/296 (25%), Positives = 124/296 (41%), Gaps = 37/296 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       +      F 
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFL 76

Query: 243 QEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVP 299
            E   +       V++L+G     +P     ++ EL+    LK +L  L        ++ 
Sbjct: 77  NEASVMKEFNCHHVVRLLGVVSQGQPTL---VIMELMTRGDLKSYLRSLRPAMANNPVLA 133

Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
            P   + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + + 
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 191

Query: 360 EMALTGTFVY-----MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI 413
           +    G         M+PE ++   ++  SDV+SFG++L EI T    PY          
Sbjct: 192 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------QGLS 245

Query: 414 AMEVGE----GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
             +V      G L   L + D     L EL+ + W  +  +RPSF  I  S+K   
Sbjct: 246 NEQVLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  143 bits (363), Expect = 5e-39
 Identities = 70/312 (22%), Positives = 132/312 (42%), Gaps = 46/312 (14%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR 213
           +H H H +                    V     N ++   ++    +KIG+G+      
Sbjct: 1   MHHHHHHSS------------------GVDLGTENLYFQSMEKYVRLQKIGEGSFGKAIL 42

Query: 214 AIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW 271
                 G    +K I  +    +        +EV  L+  +H  ++Q   +  E     +
Sbjct: 43  VKSTEDGRQYVIKEI--NISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL-Y 99

Query: 272 LVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-ALEIAQAMQYLHEQKPKVIH 329
           +V +   G  L + +       +K  +      E+++    ++I  A++++H++K  ++H
Sbjct: 100 IVMDYCEGGDLFKRI-----NAQKGVLFQ----EDQILDWFVQICLALKHVHDRK--ILH 148

Query: 330 RDLKPSNIFLDDAKHVRIADFGHARFL-SDGEMALT--GTFVYMAPEVIQCEPYSEKSDV 386
           RD+K  NIFL     V++ DFG AR L S  E+A    GT  Y++PE+ + +PY+ KSD+
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDI 208

Query: 387 YSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DGQLRELIELICLSWD 445
           ++ G +L E+ T  H +         + +++  G   P +       LR L+        
Sbjct: 209 WALGCVLYELCTLKHAFEAGS--MKNLVLKIISGSFPP-VSLHYSYDLRSLVSQ-LFKR- 263

Query: 446 GDASVRPSFSSI 457
            +   RPS +SI
Sbjct: 264 -NPRDRPSVNSI 274

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  142 bits (359), Expect = 6e-39
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 33/287 (11%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNENAVTFFAQEVD 246
                +   E IG+G    +Y       D      AVK +      T+   V+ F  E  
Sbjct: 22  PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGI 78

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
            +    H  VL L+G CL       +V   +    L+ ++       R E     P  ++
Sbjct: 79  IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-------RNET--HNPTVKD 129

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
            +   L++A+ M+YL  +K   +HRDL   N  LD+   V++ADFG AR + D E     
Sbjct: 130 LIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVH 187

Query: 366 TFVY-------MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
                      MA E +Q + ++ KSDV+SFG++L E++T G  PY   D     I + +
Sbjct: 188 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYL 245

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +G+    L + +     L E++   W   A +RPSFS +   +  I
Sbjct: 246 LQGRR---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  141 bits (358), Expect = 7e-39
 Identities = 68/292 (23%), Positives = 120/292 (41%), Gaps = 54/292 (18%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCI-YPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           +  + +G+G    ++ A  +    + A+K I  P+     E  +    +EV  L++  H 
Sbjct: 8   EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVM----REVKALAKLEHP 63

Query: 255 FVLQLMGACLEPPYRGW-----------LVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
            +++   A LE                 +  +L     LK+W+       R      +  
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM-----NGRC----TIEE 114

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL-SDG 359
            E  +     L+IA+A+++LH +   ++HRDLKPSNIF      V++ DFG    +  D 
Sbjct: 115 RERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 360 EMALT--------------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           E                  GT +YM+PE I    YS K D++S G+IL E++   +P+  
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---YPF-S 228

Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
              +  +   +V   K  P   ++      +++   LS       RP   +I
Sbjct: 229 TQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQD-MLS--PSPMERPEAINI 277

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  141 bits (357), Expect = 9e-39
 Identities = 69/313 (22%), Positives = 125/313 (39%), Gaps = 64/313 (20%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQ 243
              + + +   +++G+G   ++    +  L       VAVK +        E  +  F +
Sbjct: 5   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFER 60

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG-WLVTELL--GTTLKEWLHGLGSQRRKERMVPL 300
           E++ L   +H  +++  G C     R   L+ E L  G+ L+++L      ++ +  +  
Sbjct: 61  EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS-LRDYL------QKHKERIDH 113

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
                 L    +I + M+YL  ++   IHRDL   NI +++   V+I DFG  + L   +
Sbjct: 114 IKL---LQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168

Query: 361 ---MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA 414
                         + APE +    +S  SDV+SFG++L E+ T    YIEK   P    
Sbjct: 169 EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT----YIEKSKSPPAEF 224

Query: 415 MEVGEGKLRPALPEEDGQLRELIELI----------------------CLSWDGDASVRP 452
           M +          +    +  LIEL+                      C  W+ + + RP
Sbjct: 225 MRMIGND-----KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTEC--WNNNVNQRP 277

Query: 453 SFSSITCSLKNIQ 465
           SF  +   +  I+
Sbjct: 278 SFRDLALRVDQIR 290

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (359), Expect = 9e-39
 Identities = 76/331 (22%), Positives = 127/331 (38%), Gaps = 44/331 (13%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMN------GWYIDPKEIDLQEKIGQGTT 208
           H H H +       Q  L +    A   +  +           I+   I +++ IG G +
Sbjct: 4   HHH-HSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDS 62

Query: 209 ANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC 263
             +     R      + VA+K +        E     F  E   + +  H  +++L G  
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDFLSEASIMGQFDHPNIIRLEGVV 119

Query: 264 L--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL 320
                     +VTE +   +L  +L      R  +    +    + +     +   M+YL
Sbjct: 120 TRGRLAM---IVTEYMENGSLDTFL------RTHDGQFTIM---QLVGMLRGVGAGMRYL 167

Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFV---YMAPEV 374
            +     +HRDL   N+ +D     +++DFG +R L D        TG  +   + APE 
Sbjct: 168 SDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225

Query: 375 IQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
           I    +S  SDV+SFG+++ E++  G  PY   +     +   V EG  R  LP   G  
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPY--WNMTNRDVISSVEEG-YR--LPAPMGCP 280

Query: 434 RELIELICLSWDGDASVRPSFSSITCSLKNI 464
             L +L+   W  D + RP FS I   L  +
Sbjct: 281 HALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  140 bits (356), Expect = 1e-38
 Identities = 62/289 (21%), Positives = 126/289 (43%), Gaps = 36/289 (12%)

Query: 190 WYIDPKEIDLQE-KIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQE 244
            ++    + + + ++G G   ++ + ++R     +DVA+K +      T +       +E
Sbjct: 4   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMRE 60

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPP 302
              + +  + ++++L+G C        LV E+   G  L ++L        K   +P+  
Sbjct: 61  AQIMHQLDNPYIVRLIGVCQAEAL--MLVMEMAGGGP-LHKFL------VGKREEIPVSN 111

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM- 361
                    +++  M+YL E+    +HRDL   N+ L +  + +I+DFG ++ L   +  
Sbjct: 112 V---AELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166

Query: 362 --ALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM 415
             A +       + APE I    +S +SDV+S+G+ + E ++ G  PY  K  K  ++  
Sbjct: 167 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMA 224

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            + +GK R  +        EL  L+   W      RP F ++   ++  
Sbjct: 225 FIEQGK-R--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  141 bits (358), Expect = 2e-38
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRF 255
           D +  IG G    +Y+ + R G  VA+K   P+      E     F  E++TLS  RH  
Sbjct: 42  DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEE-----FETEIETLSFCRHPH 96

Query: 256 VLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           ++ L+G C E      L+ + +  G  LK  L+G          + +  +E+RL   +  
Sbjct: 97  LVSLIGFCDERNEMI-LIYKYMENGN-LKRHLYGSDLPT-----MSMS-WEQRLEICIGA 148

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFV 368
           A+ + YLH     +IHRD+K  NI LD+    +I DFG ++  ++ +       + GT  
Sbjct: 149 ARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLG 206

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
           Y+ PE       +EKSDVYSFG++L E++     
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  141 bits (357), Expect = 2e-38
 Identities = 68/287 (23%), Positives = 128/287 (44%), Gaps = 36/287 (12%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEV 245
           +   E    + +G G    +Y+ +W        + VA+K +      T+  A      E 
Sbjct: 12  LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEA 68

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPF 303
             ++   +  V +L+G CL       L+T+L   G  L +++     +  K+ +      
Sbjct: 69  YVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGC-LLDYV-----REHKDNI----GS 116

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
           +  L   ++IA+ M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   E   
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 364 TGT-----FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
                     +MA E I    Y+ +SDV+S+G+ + E++T G+ PY       ++I+  +
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY--DGIPASEISSIL 232

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +G+ R  LP+      ++  ++   W  DA  RP F  +      +
Sbjct: 233 EKGE-R--LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  141 bits (358), Expect = 4e-38
 Identities = 85/342 (24%), Positives = 143/342 (41%), Gaps = 34/342 (9%)

Query: 138 SSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLA-VTVSQAKMNGWYIDPKE 196
           S     + +   + T L++ +    L+   + T  +  S L    V   +          
Sbjct: 31  SPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLI 90

Query: 197 IDLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           +   E IG+G    +Y       D      AVK +      T+   V+ F  E   +   
Sbjct: 91  VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDF 147

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            H  VL L+G CL       +V   +    L+ ++       R E     P  ++ +   
Sbjct: 148 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI-------RNET--HNPTVKDLIGFG 198

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV-- 368
           L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E          
Sbjct: 199 LQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256

Query: 369 -----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL 422
                +MA E +Q + ++ KSDV+SFG++L E++T G  PY   D     I + + +G+ 
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY--PDVNTFDITVYLLQGRR 314

Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              L + +     L E++   W   A +RPSFS +   +  I
Sbjct: 315 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  139 bits (354), Expect = 5e-38
 Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 46/290 (15%)

Query: 202 KIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG 261
           K+G+G    +Y+       VAVK +      T E     F QE+  +++ +H  +++L+G
Sbjct: 38  KMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLG 97

Query: 262 ACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL 320
              +      LV   +   +L + L  L          PL  +  R   A   A  + +L
Sbjct: 98  FSSDGDDL-CLVYVYMPNGSLLDRLSCLDGTP------PLS-WHMRCKIAQGAANGINFL 149

Query: 321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVI 375
           HE     IHRD+K +NI LD+A   +I+DFG AR             + GT  YMAPE  
Sbjct: 150 HE--NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-- 205

Query: 376 QCEPY-----SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA-----MEVGEGKLR-- 423
                     + KSD+YSFG++L EIITG    +++  +P  +      +E  E  +   
Sbjct: 206 ----ALRGEITPKSDIYSFGVVLLEIITGLPA-VDEHREPQLLLDIKEEIEDEEKTIEDY 260

Query: 424 --PALPEEDGQLRELIELI-----CLSWDGDASVRPSFSSITCSLKNIQM 466
               +   D     +  +      CL      + RP    +   L+ +  
Sbjct: 261 IDKKM--NDADSTSVEAMYSVASQCLH--EKKNKRPDIKKVQQLLQEMTA 306

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  140 bits (354), Expect = 6e-38
 Identities = 71/300 (23%), Positives = 122/300 (40%), Gaps = 41/300 (13%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQ 243
              + + +    ++G+G   ++    +  L       VAVK +         +    F +
Sbjct: 18  TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQR 73

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG-WLVTELL--GTTLKEWLHGLGSQRRKERMVPL 300
           E+  L      F+++  G    P  +   LV E L  G  L+++L      +R    +  
Sbjct: 74  EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC-LRDFL------QRHRARLDA 126

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
                 L  + +I + M+YL  ++   +HRDL   NI ++   HV+IADFG A+ L   +
Sbjct: 127 SRL---LLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

Query: 361 ---MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI 413
              +          + APE +    +S +SDV+SFG++L E+ T  +            +
Sbjct: 182 DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

Query: 414 AMEVGEGKLR--PALPEEDGQL-------RELIELICLSWDGDASVRPSFSSITCSLKNI 464
             E     L     L EE  +L        E+ EL+ L W      RPSFS++   L  +
Sbjct: 242 GCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  139 bits (352), Expect = 7e-38
 Identities = 69/295 (23%), Positives = 118/295 (40%), Gaps = 57/295 (19%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +    +GQG    + +A         A+K I        E  ++    EV  L+   H++
Sbjct: 9   EEIAVLGQGAFGQVVKARNALDSRYYAIKKI-----RHTEEKLSTILSEVMLLASLNHQY 63

Query: 256 VLQLMGACLEPPYRG------------WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           V++   A LE                 ++  E     TL + +H                
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL-----------N 112

Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
            +      L  +I +A+ Y+H Q   +IHRDLKP NIF+D++++V+I DFG A+ +    
Sbjct: 113 QQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSL 170

Query: 361 MALT-----------------GTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHP 402
             L                  GT +Y+A EV+     Y+EK D+YS GII  E+I     
Sbjct: 171 DILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--- 227

Query: 403 YIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                 +   I  ++    +      +D +++   ++I L  D D + RP   ++
Sbjct: 228 -FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTL 281

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (366), Expect = 1e-37
 Identities = 73/324 (22%), Positives = 136/324 (41%), Gaps = 37/324 (11%)

Query: 153 PLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIY 212
                SH   +        ++ + D     S      + I  + I+L   IG+G   +++
Sbjct: 351 KQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTRD---YEIQRERIELGRCIGEGQFGDVH 407

Query: 213 RAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP 267
           + I+       + VA+K        T+++    F QE  T+ +  H  +++L+G   E P
Sbjct: 408 QGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP 464

Query: 268 YRGWLVTEL--LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP 325
              W++ EL  LG  L+ +L       +  +          +  A +++ A+ YL  ++ 
Sbjct: 465 V--WIIMELCTLGE-LRSFL-------QVRK--FSLDLASLILYAYQLSTALAYLESKR- 511

Query: 326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-MALTGTFV---YMAPEVIQCEPYS 381
             +HRD+   N+ +     V++ DFG +R++ D      +   +   +MAPE I    ++
Sbjct: 512 -FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 382 EKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELI 440
             SDV+ FG+ + EI+  G  P+  +  K   +   +  G+    LP        L  L+
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPF--QGVKNNDVIGRIENGER---LPMPPNCPPTLYSLM 625

Query: 441 CLSWDGDASVRPSFSSITCSLKNI 464
              W  D S RP F+ +   L  I
Sbjct: 626 TKCWAYDPSRRPRFTELKAQLSTI 649

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  140 bits (355), Expect = 1e-37
 Identities = 73/326 (22%), Positives = 124/326 (38%), Gaps = 40/326 (12%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR 213
           LH  +    L    +        D   TV +       +D   I + + +G G    +  
Sbjct: 7   LHFGNGHLKLPGLRTFVDPHTFEDPTQTVHEFA---KELDATNISIDKVVGAGEFGEVCS 63

Query: 214 AIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL--EP 266
              +      + VA+K +        E     F  E   + +  H  +++L G     +P
Sbjct: 64  GRLKLPSKKEISVAIKTLKVG---YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120

Query: 267 PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP 325
                +VTE +   +L  +L      R+ +    +    + +     IA  M+YL +   
Sbjct: 121 VM---IVTEYMENGSLDSFL------RKHDAQFTVI---QLVGMLRGIASGMKYLSDMG- 167

Query: 326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------FVYMAPEVIQCEP 379
             +HRDL   NI ++     +++DFG  R L D   A   T        + +PE I    
Sbjct: 168 -YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 380 YSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIE 438
           ++  SDV+S+GI+L E+++ G  PY   +     +   V EG     LP        L +
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPY--WEMSNQDVIKAVDEGYR---LPPPMDCPAALYQ 281

Query: 439 LICLSWDGDASVRPSFSSITCSLKNI 464
           L+   W  D + RP F  I   L  +
Sbjct: 282 LMLDCWQKDRNNRPKFEQIVSILDKL 307

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  138 bits (349), Expect = 1e-37
 Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 35/297 (11%)

Query: 184 QAKMNGWYI--DPKEIDLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNEN 236
            A++    I  +         IG+G    +Y   +          A+K +      T   
Sbjct: 8   LAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQ 64

Query: 237 AVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKE 295
            V  F +E   +    H  VL L+G  L P     ++   +    L +++       R  
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-------RSP 117

Query: 296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
           +    P  ++ ++  L++A+ M+YL EQK   +HRDL   N  LD++  V++ADFG AR 
Sbjct: 118 Q--RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARD 173

Query: 356 LSDGE----MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           + D E           +   + A E +Q   ++ KSDV+SFG++L E++T G  PY  + 
Sbjct: 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPY--RH 231

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             P  +   + +G+    LP+ +     L +++   W+ D +VRP+F  +   ++ I
Sbjct: 232 IDPFDLTHFLAQGRR---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  138 bits (349), Expect = 2e-37
 Identities = 62/312 (19%), Positives = 119/312 (38%), Gaps = 64/312 (20%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQ 243
            + + + +     +G+G    +    +          VAVK + P+   +  N +    +
Sbjct: 16  THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE---SGGNHIADLKK 72

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG-WLVTELL--GTTLKEWLHGLGSQRRKERMVPL 300
           E++ L    H  +++  G C E    G  L+ E L  G+ LKE+L       + +  + L
Sbjct: 73  EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS-LKEYL------PKNKNKINL 125

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
                 L  A++I + M YL  ++   +HRDL   N+ ++    V+I DFG  + +   +
Sbjct: 126 KQQ---LKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180

Query: 361 ---MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA 414
                         + APE +    +   SDV+SFG+ L+E++T    Y + D  P  + 
Sbjct: 181 EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT----YCDSDSSPMALF 236

Query: 415 MEVGEGKLRPALPEEDGQLRELIELI----------------------CLSWDGDASVRP 452
           ++                +  L+  +                      C  W+   S R 
Sbjct: 237 LK------MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKC--WEFQPSNRT 288

Query: 453 SFSSITCSLKNI 464
           SF ++    + +
Sbjct: 289 SFQNLIEGFEAL 300

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  138 bits (350), Expect = 2e-37
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 23/225 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W    +++    +IG+G   ++ + +    G  +AVK I       +E        ++D 
Sbjct: 17  WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST---VDEKEQKQLLMDLDV 73

Query: 248 LSRQ-RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
           + R     +++Q  GA        W+  EL+ T+  ++   + S         +P  EE 
Sbjct: 74  VMRSSDCPYIVQFYGALFRE-GDCWICMELMSTSFDKFYKYVYSVLDD----VIP--EEI 126

Query: 307 LAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT- 364
           L +  L   +A+ +L E   K+IHRD+KPSNI LD + ++++ DFG +  L D  +A T 
Sbjct: 127 LGKITLATVKALNHLKENL-KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD-SIAKTR 184

Query: 365 --GTFVYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPY 403
             G   YMAPE I        Y  +SDV+S GI L E+ TG  PY
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPY 229

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  136 bits (345), Expect = 5e-37
 Identities = 62/303 (20%), Positives = 118/303 (38%), Gaps = 58/303 (19%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
             I  +++   E +GQGT   I++ + R +          V +K +     + +E+    
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSES---- 58

Query: 241 FAQEVDTLSRQRHRFVLQLMGACL-EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMV 298
           F +    +S+  H+ ++   G C+        LV E +   +L  +L       +K +  
Sbjct: 59  FFEAASMMSKLSHKHLVLNYGVCVCGDEN--ILVQEFVKFGSLDTYL-------KKNK-- 107

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--------DAKHVRIADF 350
                  +L  A ++A AM +L E    +IH ++   NI L         +   ++++D 
Sbjct: 108 NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165

Query: 351 GHARFLSDGEMALTGTFVY------MAPEVIQ-CEPYSEKSDVYSFGIILNEIIT-GNHP 402
           G +  +   ++              + PE I+  +  +  +D +SFG  L EI + G+ P
Sbjct: 166 GISITVLPKDI-------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

Query: 403 YIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK 462
                    +      +    PA P+      EL  LI    D +   RPSF +I   L 
Sbjct: 219 L--SALDSQRKLQFYEDRHQLPA-PKAA----ELANLINNCMDYEPDHRPSFRAIIRDLN 271

Query: 463 NIQ 465
           ++ 
Sbjct: 272 SLF 274

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  138 bits (349), Expect = 6e-37
 Identities = 83/387 (21%), Positives = 150/387 (38%), Gaps = 56/387 (14%)

Query: 107 DYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRY 166
               H         V +L       +  ++ + ++ S+ ++  +     + S        
Sbjct: 3   SSHHHHHHSQDPPAVHKLTKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPML 62

Query: 167 CSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD------ 220
              +      D            W     ++ L + +G+G    +  A   G+D      
Sbjct: 63  AGVSEYELPEDPK----------WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE 112

Query: 221 ---VAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACL--EPPYRGWLVT 274
              VAVK +  D     E  ++    E++ +    +H+ ++ L+GAC    P Y   ++ 
Sbjct: 113 AVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY---VIV 166

Query: 275 ELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR------ALEIAQAMQYLHEQKPKV 327
           E      L+E+L        +         EE++          ++A+ M+YL  QK   
Sbjct: 167 EYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--C 224

Query: 328 IHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--MALTGTFV---YMAPEVIQCEPYSE 382
           IHRDL   N+ + +   ++IADFG AR +++ +     T   +   +MAPE +    Y+ 
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 284

Query: 383 KSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV----GEGKLRPALPEEDGQLRELI 437
           +SDV+SFG+++ EI T G  PY      P     E+     EG     + +      EL 
Sbjct: 285 QSDVWSFGVLMWEIFTLGGSPY------PGIPVEELFKLLKEGHR---MDKPANCTNELY 335

Query: 438 ELICLSWDGDASVRPSFSSITCSLKNI 464
            ++   W    S RP+F  +   L  I
Sbjct: 336 MMMRDCWHAVPSQRPTFKQLVEDLDRI 362

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  137 bits (346), Expect = 7e-37
 Identities = 81/333 (24%), Positives = 121/333 (36%), Gaps = 56/333 (16%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           H H H  P   YC        SDL             +  K I L   +G G    +Y  
Sbjct: 3   HHHHHHNP--NYCFAGKTSSISDL-----------KEVPRKNITLIRGLGHGAFGEVYEG 49

Query: 215 IWRGLD-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL--E 265
              G+        VAVK +       +E     F  E   +S+  H+ +++ +G  L   
Sbjct: 50  QVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106

Query: 266 PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK 324
           P +   ++ EL+ G  LK +L      R +          + L  A +IA   QYL E  
Sbjct: 107 PRF---ILMELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160

Query: 325 PKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMALTGTFVY-----MAPEVIQ 376
              IHRD+   N  L         +I DFG AR +        G         M PE   
Sbjct: 161 --FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFM 218

Query: 377 CEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE----GKLRPALPEEDG 431
              ++ K+D +SFG++L EI + G  PY      P+K   EV E    G     +     
Sbjct: 219 EGIFTSKTDTWSFGVLLWEIFSLGYMPY------PSKSNQEVLEFVTSGGR---MDPPKN 269

Query: 432 QLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               +  ++   W      RP+F+ I   ++  
Sbjct: 270 CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  138 bits (349), Expect = 1e-36
 Identities = 86/341 (25%), Positives = 142/341 (41%), Gaps = 48/341 (14%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMN-GWYIDPKEIDLQEKIGQGTTANIY 212
            H H H        ++    Q     V+  +   +  W +    + L + +G+G    + 
Sbjct: 28  YHHH-HHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGKPLGEGAFGQVV 86

Query: 213 RAIWRGLD---------VAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGA 262
            A   GLD         VAVK +  D     E  ++    E++ +    +H+ ++ L+GA
Sbjct: 87  LAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143

Query: 263 CL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR------ALEI 313
           C    P Y   ++ E      L+E+L        +    P    EE+L+       A ++
Sbjct: 144 CTQDGPLY---VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--MALTGTFV--- 368
           A+ M+YL  +K   IHRDL   N+ + +   ++IADFG AR +   +     T   +   
Sbjct: 201 ARGMEYLASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 258

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV----GEGKLR 423
           +MAPE +    Y+ +SDV+SFG++L EI T G  PY      P     E+     EG   
Sbjct: 259 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY------PGVPVEELFKLLKEGHR- 311

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             + +      EL  ++   W    S RP+F  +   L  I
Sbjct: 312 --MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  135 bits (342), Expect = 1e-36
 Identities = 64/302 (21%), Positives = 110/302 (36%), Gaps = 43/302 (14%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
             I    +   E++G+     +Y+    G         VA+K +              F 
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK---AEGPLREEFR 60

Query: 243 QEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVP 299
            E    +R +H  V+ L+G     +P     ++        L E+L              
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLS---MIFSYCSHGDLHEFLVMRSPHSDVGSTDD 117

Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               +  L          +IA  M+YL      V+H+DL   N+ + D  +V+I+D G  
Sbjct: 118 DRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLNVKISDLGLF 175

Query: 354 RFLSDGEM--ALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           R +   +    L  + +   +MAPE I    +S  SD++S+G++L E+ + G  PY    
Sbjct: 176 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY---- 231

Query: 408 YKPAKIAMEV----GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
                   +V       ++   LP  D     +  L+   W+   S RP F  I   L+ 
Sbjct: 232 --CGYSNQDVVEMIRNRQV---LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 286

Query: 464 IQ 465
             
Sbjct: 287 WG 288

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  135 bits (342), Expect = 2e-36
 Identities = 66/255 (25%), Positives = 121/255 (47%), Gaps = 37/255 (14%)

Query: 199 LQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           + +K+G G  + +Y A    L+  VA+K I+       E  +  F +EV   S+  H+ +
Sbjct: 15  IVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQNI 73

Query: 257 LQL--MGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           + +  +    +  Y   LV E + G TL E++   G         PL   +  +    +I
Sbjct: 74  VSMIDVDEEDDCYY---LVMEYIEGPTLSEYIESHG---------PLSV-DTAINFTNQI 120

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV----Y 369
              +++ H+ +  ++HRD+KP NI +D  K ++I DFG A+ LS+  +  T   +    Y
Sbjct: 121 LDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME-VGE------GKL 422
            +PE  + E   E +D+YS GI+L E++ G  P+  +      IA++ + +        +
Sbjct: 179 FSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--AVSIAIKHIQDSVPNVTTDV 236

Query: 423 RPALPEEDGQLRELI 437
           R  +P+    L  +I
Sbjct: 237 RKDIPQS---LSNVI 248

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  135 bits (343), Expect = 2e-36
 Identities = 75/308 (24%), Positives = 118/308 (38%), Gaps = 53/308 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      +   + +G G    +  A   GL        VAVK + P     +        
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALM 74

Query: 243 QEVDTLSR-QRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWL--------HGLGS 290
            E+  LS    H  ++ L+GAC    P     ++TE      L  +L            S
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPTL---VITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 291 QRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
               E        E+ L+ + ++A+ M +L  +    IHRDL   NI L   +  +I DF
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDF 189

Query: 351 GHARFLSDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI 404
           G AR + +    +      +   +MAPE I    Y+ +SDV+S+GI L E+ + G+ PY 
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY- 248

Query: 405 EKDYKPAKIAME-----VGEGKL--RPAL-PEEDGQLRELIELICLSWDGDASVRPSFSS 456
                P           + EG     P   P       E+ +++   WD D   RP+F  
Sbjct: 249 -----PGMPVDSKFYKMIKEGFRMLSPEHAPA------EMYDIMKTCWDADPLKRPTFKQ 297

Query: 457 ITCSLKNI 464
           I   ++  
Sbjct: 298 IVQLIEKQ 305

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  135 bits (341), Expect = 2e-36
 Identities = 72/304 (23%), Positives = 122/304 (40%), Gaps = 50/304 (16%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
            +I  ++I L+ ++G+G    ++ A    L        VAVK +          A   F 
Sbjct: 10  QHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP----TLAARKDFQ 65

Query: 243 QEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVP 299
           +E + L+  +H  +++  G C   +P     +V E +    L ++L   G          
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLI---MVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122

Query: 300 LPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
               +  L        A +IA  M YL  Q    +HRDL   N  +     V+I DFG +
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLLVKIGDFGMS 180

Query: 354 RFLSDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKD 407
           R +   +       T +   +M PE I    ++ +SDV+SFG+IL EI T G  P+    
Sbjct: 181 RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW---- 236

Query: 408 YKPAKIAMEV----GEGKL--RPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSITCS 460
                   EV     +G++  RP + P+      E+ +++   W  +   R +   I   
Sbjct: 237 --FQLSNTEVIECITQGRVLERPRVCPK------EVYDVMLGCWQREPQQRLNIKEIYKI 288

Query: 461 LKNI 464
           L  +
Sbjct: 289 LHAL 292

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  135 bits (343), Expect = 3e-36
 Identities = 83/330 (25%), Positives = 139/330 (42%), Gaps = 49/330 (14%)

Query: 164 HRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD--- 220
           H + SQ P+L            K   W     ++ L + +G+G    +  A   G+D   
Sbjct: 7   HHHHSQDPMLAGVSEYELPEDPK---WEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63

Query: 221 ------VAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACL--EPPYRGW 271
                 VAVK +  D     E  ++    E++ +    +H+ ++ L+GAC    P Y   
Sbjct: 64  PKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY--- 117

Query: 272 LVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR------ALEIAQAMQYLHEQK 324
           ++ E      L+E+L        +         EE++          ++A+ M+YL  QK
Sbjct: 118 VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK 177

Query: 325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--MALTGTFV---YMAPEVIQCEP 379
              IHRDL   N+ + +   ++IADFG AR +++ +     T   +   +MAPE +    
Sbjct: 178 --CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 235

Query: 380 YSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV----GEGKLRPALPEEDGQLR 434
           Y+ +SDV+SFG+++ EI T G  PY      P     E+     EG     + +      
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPY------PGIPVEELFKLLKEGHR---MDKPANCTN 286

Query: 435 ELIELICLSWDGDASVRPSFSSITCSLKNI 464
           EL  ++   W    S RP+F  +   L  I
Sbjct: 287 ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  134 bits (340), Expect = 4e-36
 Identities = 80/290 (27%), Positives = 130/290 (44%), Gaps = 44/290 (15%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W I+  + +LQE IG G TA +  A    +   VA+K I  +     + ++    +E+  
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE---KCQTSMDELLKEIQA 66

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLG----TTLKEWLHGLGSQRRKERMVPLPPF 303
           +S+  H  ++    + +      WLV +LL       + + +   G  +           
Sbjct: 67  MSQCHHPNIVSYYTSFVVK-DELWLVMKLLSGGSVLDIIKHIVAKGEHKSG-------VL 118

Query: 304 EERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           +E     +  E+ + ++YLH+     IHRD+K  NI L +   V+IADFG + FL+ G  
Sbjct: 119 DESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD 176

Query: 362 ALTG----TFV----YMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK 412
                   TFV    +MAPEV+ Q   Y  K+D++SFGI   E+ TG  PY    Y P K
Sbjct: 177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH--KYPPMK 234

Query: 413 IAMEVGEG---KLRPALPEEDGQ------LRELIELICLSWDGDASVRPS 453
           + M   +     L   + +++         R++I L CL    D   RP+
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CL--QKDPEKRPT 281

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  133 bits (338), Expect = 5e-36
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 24/223 (10%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +   +++   ++G+G    + +      G  +AVK I       N         ++D   
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT---VNSQEQKRLLMDLDISM 60

Query: 250 RQ-RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           R     F +   GA        W+  EL+ T+L ++      ++  ++   +P  E+ L 
Sbjct: 61  RTVDCPFTVTFYGALFRE-GDVWICMELMDTSLDKFY-----KQVIDKGQTIP--EDILG 112

Query: 309 R-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--- 364
           + A+ I +A+++LH +   VIHRD+KPSN+ ++    V++ DFG + +L D ++A     
Sbjct: 113 KIAVSIVKALEHLHSKL-SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-DVAKDIDA 170

Query: 365 GTFVYMAPEVIQCE----PYSEKSDVYSFGIILNEIITGNHPY 403
           G   YMAPE I  E     YS KSD++S GI + E+     PY
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPY 213

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (338), Expect = 1e-35
 Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 43/300 (14%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
            +I  ++I L+ ++G+G    ++ A    L        VAVK +       +E+A   F 
Sbjct: 36  HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQ 91

Query: 243 QEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWL-----HGLGSQRRK 294
           +E + L+  +H+ +++  G C    P     +V E +    L  +L             +
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLL---MVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148

Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
           +         + LA A ++A  M YL       +HRDL   N  +     V+I DFG +R
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSR 206

Query: 355 FLSDGEMALTGTFV-----YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY 408
            +   +    G        +M PE I    ++ +SDV+SFG++L EI T G  P+     
Sbjct: 207 DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPW----- 261

Query: 409 KPAKIAMEV----GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                  E      +G+    L        E+  ++   W  +   R S   +   L+ +
Sbjct: 262 -YQLSNTEAIDCITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL 317

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  134 bits (338), Expect = 1e-35
 Identities = 64/335 (19%), Positives = 121/335 (36%), Gaps = 55/335 (16%)

Query: 141 TGSV-IASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKE-ID 198
           +GSV          L +                     + +T     ++  Y +    + 
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
            Q ++G+G+   ++R   +  G   AVK +  +          F  +E+   +      +
Sbjct: 62  HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE---------VFRVEELVACAGLSSPRI 112

Query: 257 LQLMGACLEPPYRGWLVTEL-----LGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA- 310
           + L GA  E P+   +  EL     LG  +K+                     E  A   
Sbjct: 113 VPLYGAVREGPWV-NIFMELLEGGSLGQLIKQM----------------GCLPEDRALYY 155

Query: 311 -LEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGEMA------ 362
             +  + ++YLH ++  ++H D+K  N+ L  D     + DFGHA  L    +       
Sbjct: 156 LGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTG 213

Query: 363 --LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG-E 419
             + GT  +MAPEV+  +P   K D++S   ++  ++ G HP+    Y    + +++  E
Sbjct: 214 DYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT--QYFRGPLCLKIASE 271

Query: 420 GKLRPALPEE-DGQLRELIELICLSWDGDASVRPS 453
                 +P        + I+   L    +   R S
Sbjct: 272 PPPIREIPPSCAPLTAQAIQE-GL--RKEPVHRAS 303

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  133 bits (337), Expect = 1e-35
 Identities = 76/279 (27%), Positives = 121/279 (43%), Gaps = 40/279 (14%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
            +  +++   ++G GT   +++      G  +AVK +       N+        ++D + 
Sbjct: 22  AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS---GNKEENKRILMDLDVVL 78

Query: 250 RQ-RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           +     +++Q  G  +      ++  EL+GT  ++          K    P+P  E  L 
Sbjct: 79  KSHDCPYIVQCFGTFITN-TDVFIAMELMGTCAEKLK--------KRMQGPIP--ERILG 127

Query: 309 R-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--- 364
           +  + I +A+ YL E+   VIHRD+KPSNI LD+   +++ DFG +  L D   A     
Sbjct: 128 KMTVAIVKALYYLKEKH-GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSA 185

Query: 365 GTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
           G   YMAPE I         Y  ++DV+S GI L E+ TG  PY  K+ K      EV  
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKT---DFEVLT 240

Query: 420 GKLR---PALPEEDGQLRELIELI--CLSWDGDASVRPS 453
             L+   P LP   G   +    +  CL    D   RP 
Sbjct: 241 KVLQEEPPLLPGHMGFSGDFQSFVKDCL--TKDHRKRPK 277

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  134 bits (339), Expect = 2e-35
 Identities = 77/342 (22%), Positives = 124/342 (36%), Gaps = 47/342 (13%)

Query: 146 ASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQ 205
               +Q+P ++ S            P    +    ++S        +  K I L   +G 
Sbjct: 26  MGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDL----KEVPRKNITLIRGLGH 81

Query: 206 GTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           G    +Y     G+        VAVK +       +E     F  E   +S+  H+ +++
Sbjct: 82  GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVR 138

Query: 259 LMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
            +G  L   P +   ++ EL+ G  LK +L      R +          + L  A +IA 
Sbjct: 139 CIGVSLQSLPRF---ILLELMAGGDLKSFLR---ETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMALTGTFVY--- 369
             QYL E     IHRD+   N  L         +I DFG AR +        G       
Sbjct: 193 GCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 250

Query: 370 --MAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE----GKL 422
             M PE      ++ K+D +SFG++L EI + G  PY      P+K   EV E    G  
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY------PSKSNQEVLEFVTSGGR 304

Query: 423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +         +  ++   W      RP+F+ I   ++  
Sbjct: 305 ---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  133 bits (336), Expect = 2e-35
 Identities = 75/296 (25%), Positives = 126/296 (42%), Gaps = 30/296 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      + L + +G+G    +  A   G+D       VAVK +         +      
Sbjct: 22  WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALM 78

Query: 243 QEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPL 300
            E+  L     H  V+ L+GAC +P     ++ E      L  +L    ++    ++ P 
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138

Query: 301 PPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR 354
             +++ L        + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLAR 196

Query: 355 FLSDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY 408
            +      +      +   +MAPE I    Y+ +SDV+SFG++L EI + G  PY     
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK- 255

Query: 409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +    + EG     +   D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 256 IDEEFCRRLKEGTR---MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (336), Expect = 2e-35
 Identities = 54/307 (17%), Positives = 120/307 (39%), Gaps = 46/307 (14%)

Query: 174 QQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFH 232
             S + +           +  +   + ++IG G ++ +++ +       A+K +  +   
Sbjct: 7   HSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEE 64

Query: 233 TNENAVTFFAQEVDTLSRQRH--RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGS 290
            +   +  +  E+  L++ +     +++L           ++V E     L  WL     
Sbjct: 65  ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD-YEITDQYIYMVMECGNIDLNSWL----- 118

Query: 291 QRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA 348
           +++K         +    ++    + +A+  +H+    ++H DLKP+N  + D   +++ 
Sbjct: 119 KKKK-------SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVDGM-LKLI 168

Query: 349 DFGHARFLSDGEMALT-----GTFVYMAPEVIQCEP-----------YSEKSDVYSFGII 392
           DFG A  +     ++      GT  YM PE I+               S KSDV+S G I
Sbjct: 169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 228

Query: 393 LNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELI--CLSWDGDASV 450
           L  +  G  P+ +   + +K+   + +       P+   +  +L +++  CL    D   
Sbjct: 229 LYYMTYGKTPFQQIINQISKL-HAIIDPNHEIEFPDIPEK--DLQDVLKCCLKR--DPKQ 283

Query: 451 RPSFSSI 457
           R S   +
Sbjct: 284 RISIPEL 290

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  133 bits (337), Expect = 3e-35
 Identities = 58/245 (23%), Positives = 107/245 (43%), Gaps = 23/245 (9%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +   + +   ++G G    +++      GL +A K I+ +             +E+  L 
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLH 86

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
                +++   GA         +  E + G +L + L   G          +P  E+ L 
Sbjct: 87  ECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKAG---------RIP--EQILG 134

Query: 309 R-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--G 365
           + ++ + + + YL E+  K++HRD+KPSNI ++    +++ DFG +  L D  MA +  G
Sbjct: 135 KVSIAVIKGLTYLREKH-KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVG 192

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  YM+PE +Q   YS +SD++S G+ L E+  G +P    D K  ++            
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252

Query: 426 LPEED 430
            P   
Sbjct: 253 TPPRP 257

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  132 bits (334), Expect = 3e-35
 Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 35/197 (17%)

Query: 278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPS 335
              LK+W+      RR          E  +   +  +IA+A+++LH +   ++HRDLKPS
Sbjct: 145 KENLKDWM-----NRRCSLEDR----EHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPS 193

Query: 336 NIFLDDAKHVRIADFGHARFLSDGEMALT---------------GTFVYMAPEVIQCEPY 380
           NIF      V++ DFG    +   E   T               GT +YM+PE I    Y
Sbjct: 194 NIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY 253

Query: 381 SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELI 440
           S K D++S G+IL E++      +E+     +I  +V   K      ++  Q   +++  
Sbjct: 254 SHKVDIFSLGLILFELLYSFSTQMER----VRIITDVRNLKFPLLFTQKYPQEHMMVQD- 308

Query: 441 CLSWDGDASVRPSFSSI 457
            LS     + RP  + I
Sbjct: 309 MLS--PSPTERPEATDI 323

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  132 bits (334), Expect = 4e-35
 Identities = 72/293 (24%), Positives = 127/293 (43%), Gaps = 32/293 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEV 245
             +D  +I  Q+ IG+G    + +A  +     +D A+K +       +++    FA E+
Sbjct: 20  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGEL 76

Query: 246 DTLSR-QRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
           + L +   H  ++ L+GAC      Y   L  E      L ++L                
Sbjct: 77  EVLCKLGHHPNIINLLGACEHRGYLY---LAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 302 PFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
                L+       A ++A+ M YL +++   IHRDL   NI + +    +IADFG +R 
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIADFGLSRG 191

Query: 356 LSDGEMALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPA 411
             +  +  T   +   +MA E +    Y+  SDV+S+G++L EI++ G  PY       A
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY--CGMTCA 248

Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           ++  ++ +G     L +      E+ +L+   W      RPSF+ I  SL  +
Sbjct: 249 ELYEKLPQGYR---LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 298

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  132 bits (333), Expect = 5e-35
 Identities = 66/291 (22%), Positives = 110/291 (37%), Gaps = 39/291 (13%)

Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           M           L + +GQG TAN++R   +  G   A+K      F    +      +E
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM---RE 57

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRG--WLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
            + L +  H+ +++L  A  E        L+ E     +L   L              LP
Sbjct: 58  FEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLE------EPSNAYGLP 110

Query: 302 PFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARF 355
              E     +  ++   M +L E    ++HR++KP NI      D     ++ DFG AR 
Sbjct: 111 ---ESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165

Query: 356 LSDGEMALT--GTFVYMAPEVIQ--------CEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           L D E  ++  GT  Y+ P++ +         + Y    D++S G+      TG+ P+  
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR- 224

Query: 406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSS 456
             ++  +   EV   K+    P       +  E   + W GD  V  S S 
Sbjct: 225 -PFEGPRRNKEVMY-KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  131 bits (332), Expect = 5e-35
 Identities = 54/214 (25%), Positives = 88/214 (41%), Gaps = 25/214 (11%)

Query: 199 LQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L+  +G+G   ++Y A     +  VA+K +       +    T   +E  T  R +   V
Sbjct: 38  LRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSS-DPVFRTRMQREARTAGRLQEPHV 96

Query: 257 LQL--MGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           + +   G   E   + ++   L+ G  L   L   G         PL P    +A   +I
Sbjct: 97  VPIHDFG---EIDGQLYVDMRLINGVDLAAMLRRQG---------PLAP-PRAVAIVRQI 143

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV----Y 369
             A+   H       HRD+KP NI +       + DFG A   +D ++   G  V    Y
Sbjct: 144 GSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           MAPE       + ++D+Y+   +L E +TG+ PY
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSPPY 235

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  132 bits (334), Expect = 6e-35
 Identities = 53/282 (18%), Positives = 115/282 (40%), Gaps = 46/282 (16%)

Query: 199 LQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RF 255
           + ++IG G ++ +++ +       A+K +  +    +   +  +  E+  L++ +     
Sbjct: 13  ILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           +++L           ++V E     L  WL     +++K         +    ++    +
Sbjct: 71  IIRLYD-YEITDQYIYMVMECGNIDLNSWL-----KKKK-------SIDPWERKSYWKNM 117

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-----GTFV 368
            +A+  +H+    ++H DLKP+N  + D   +++ DFG A  +     ++      GT  
Sbjct: 118 LEAVHTIHQHG--IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 369 YMAPEVIQCEP-----------YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
           YM PE I+               S KSDV+S G IL  +  G  P+ +   + +K+   +
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-HAI 233

Query: 418 GEGKLRPALPEEDGQLRELIELI--CLSWDGDASVRPSFSSI 457
            +       P+   +  +L +++  CL    D   R S   +
Sbjct: 234 IDPNHEIEFPDIPEK--DLQDVLKCCLKR--DPKQRISIPEL 271

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (344), Expect = 7e-35
 Identities = 64/334 (19%), Positives = 131/334 (39%), Gaps = 36/334 (10%)

Query: 146 ASPLVQTPLHQHSHQTPLHRYCSQTPLLQQ--SDLAVTVSQAKMNGWYIDPKEIDLQE-K 202
              L          +          P+             + K    ++    + + + +
Sbjct: 284 IDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIE 343

Query: 203 IGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
           +G G   ++ + ++R     +DVA+K +      T +       +E   + +  + ++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 259 LMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
           L+G C        LV E+  G  L ++L        K   +P+           +++  M
Sbjct: 401 LIGVCQAEAL--MLVMEMAGGGPLHKFL------VGKREEIPVS---NVAELLHQVSMGM 449

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT------FVYMA 371
           +YL E+    +HR+L   N+ L +  + +I+DFG ++ L   +   T          + A
Sbjct: 450 KYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           PE I    +S +SDV+S+G+ + E ++ G  PY  K  K  ++   + +GK R  +    
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAFIEQGK-R--MECPP 562

Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               EL  L+   W      RP F ++   ++  
Sbjct: 563 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  130 bits (330), Expect = 1e-34
 Identities = 73/309 (23%), Positives = 130/309 (42%), Gaps = 51/309 (16%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W    K + L + +G+G    + +A    L        VAVK +  +    + + +    
Sbjct: 18  WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLL 74

Query: 243 QEVDTLSRQRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWL-------------- 285
            E + L +  H  V++L GAC    P     L+ E     +L+ +L              
Sbjct: 75  SEFNVLKQVNHPHVIKLYGACSQDGPLL---LIVEYAKYGSLRGFLRESRKVGPGYLGSG 131

Query: 286 HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV 345
               S              + ++ A +I+Q MQYL E K  ++HRDL   NI + + + +
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAARNILVAEGRKM 189

Query: 346 RIADFGHARFLSDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-G 399
           +I+DFG +R + + +  +  +   +   +MA E +    Y+ +SDV+SFG++L EI+T G
Sbjct: 190 KISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249

Query: 400 NHPYIEKDYKPAKIAMEV----GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFS 455
            +PY      P      +      G     +   D    E+  L+   W  +   RP F+
Sbjct: 250 GNPY------PGIPPERLFNLLKTGHR---MERPDNCSEEMYRLMLQCWKQEPDKRPVFA 300

Query: 456 SITCSLKNI 464
            I+  L+ +
Sbjct: 301 DISKDLEKM 309

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (329), Expect = 2e-34
 Identities = 67/296 (22%), Positives = 111/296 (37%), Gaps = 38/296 (12%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           ID K     +K+G+G  + +        G   A+K I        +       +E D   
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRI----LCHEQQDREEAQREADMHR 81

Query: 250 RQRHRFVLQLMGACLEPP---YRGWLVTEL-LGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
              H  +L+L+  CL      +  WL+       TL   +     +R K++   L   E+
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-----ERLKDKGNFLT--ED 134

Query: 306 RLAR-ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG----- 359
           ++    L I + ++ +H       HRDLKP+NI L D     + D G             
Sbjct: 135 QILWLLLGICRGLEAIH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 360 -------EMALTGTFVYMAPEVIQCEPY---SEKSDVYSFGIILNEIITGNHPYIEKDYK 409
                    A   T  Y APE+   + +    E++DV+S G +L  ++ G  PY     K
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252

Query: 410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
              +A+ V      P  P     L +L+    ++   D   RP    +   L+ +Q
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLN-SMMT--VDPHQRPHIPLLLSQLEALQ 305

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  130 bits (330), Expect = 2e-34
 Identities = 87/366 (23%), Positives = 143/366 (39%), Gaps = 63/366 (17%)

Query: 141 TGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQ 200
           + +V  + L    L    H  P+  Y     LL    L+                 I+  
Sbjct: 5   SAAVTLTTLPSELLLDRLHPNPM--YQRMPLLLNPKLLS----------LEYPRNNIEYV 52

Query: 201 EKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH 253
             IG+G    +++A   GL        VAVK +  +    + +    F +E   ++   +
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDN 109

Query: 254 RFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWL--------HGLGSQRRKERMVPLPP 302
             +++L+G C   +P     L+ E +    L E+L          L       R     P
Sbjct: 110 PNIVKLLGVCAVGKPMC---LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166

Query: 303 FEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
               L+       A ++A  M YL E+K   +HRDL   N  + +   V+IADFG +R +
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENMVVKIADFGLSRNI 224

Query: 357 SDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKP 410
              +   A     +   +M PE I    Y+ +SDV+++G++L EI + G  PY       
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY------Y 278

Query: 411 AKIAMEV----GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM 466
                EV     +G +   L   +    EL  L+ L W    + RPSF SI   L+ +  
Sbjct: 279 GMAHEEVIYYVRDGNI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335

Query: 467 KVTETI 472
           +   T+
Sbjct: 336 RAEGTV 341

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (328), Expect = 2e-34
 Identities = 65/261 (24%), Positives = 113/261 (43%), Gaps = 42/261 (16%)

Query: 199 LQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L E +G G  + ++ A        VAVK +  D    + +    F +E    +   H  +
Sbjct: 16  LGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-ARDPSFYLRFRREAQNAAALNHPAI 74

Query: 257 LQL------MGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           + +             PY   +V E + G TL++ +H  G         P+ P +  +  
Sbjct: 75  VAVYDTGEAETPAGPLPY---IVMEYVDGVTLRDIVHTEG---------PMTP-KRAIEV 121

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----- 364
             +  QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D   ++T     
Sbjct: 122 IADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179

Query: 365 -GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME-VGE--- 419
            GT  Y++PE  + +    +SDVYS G +L E++TG  P+      P  +A + V E   
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDPI 237

Query: 420 --GKLRPALPEEDGQLRELIE 438
                   L  +   L  ++ 
Sbjct: 238 PPSARHEGLSAD---LDAVVL 255

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (329), Expect = 3e-34
 Identities = 24/260 (9%), Positives = 62/260 (23%), Gaps = 35/260 (13%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
            +++ L E +  G  + ++         D A+K       ++  + +    +     +R 
Sbjct: 61  ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENS-RSELERLHEATFAAARL 119

Query: 252 RHRFVLQLMG-------------------ACLEPPYRG------WLVTELLGTTLKEWLH 286
                 +                      A L P           L+       L+    
Sbjct: 120 LGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFS 179

Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR 346
            L                       ++ +    L  +   ++H    P N+F+     + 
Sbjct: 180 TLDFVYVFRG---DEGILALHILTAQLIRLAANLQSKG--LVHGHFTPDNLFIMPDGRLM 234

Query: 347 IADFGHARFLSDGEMALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYI 404
           + D      +     A +    Y   E +      ++   + +  G+ +  +     P+ 
Sbjct: 235 LGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294

Query: 405 EKDYKPAKIAMEVGEGKLRP 424
                               
Sbjct: 295 LVTPGIKGSWKRPSLRVPGT 314

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  134 bits (339), Expect = 3e-34
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 29/221 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +++E++G G    + R I +  G  VA+K    +    N         E+  + +  H  
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC---LEIQIMKKLNHPN 73

Query: 256 VLQL-----MGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           V+           L P     L  E   G  L+++L+      + E    L    E   R
Sbjct: 74  VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN------QFENCCGLK---EGPIR 124

Query: 310 AL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMALT 364
            L  +I+ A++YLHE +  +IHRDLKP NI L         +I D G+A+ L  GE+   
Sbjct: 125 TLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182

Query: 365 --GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             GT  Y+APE+++ + Y+   D +SFG +  E ITG  P+
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  128 bits (325), Expect = 4e-34
 Identities = 75/245 (30%), Positives = 116/245 (47%), Gaps = 28/245 (11%)

Query: 176 SDLAVTVSQAKMNGWYIDPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH 232
           +   V      M     DP+E+    EKIG+G+   +++ I       VA+K I  +   
Sbjct: 2   AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--- 58

Query: 233 TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQR 292
             E+ +    QE+  LS+    +V +  G+ L+   + W++ E LG          GS  
Sbjct: 59  EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGG---------GSAL 108

Query: 293 RKERMVPLPPFEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                 PL   E ++A  L EI + + YLH +K   IHRD+K +N+ L +   V++ADFG
Sbjct: 109 DLLEPGPLD--ETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFG 164

Query: 352 HARFLSDGEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
            A  L+D       TFV    +MAPEVI+   Y  K+D++S GI   E+  G  P+   +
Sbjct: 165 VAGQLTD-TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS--E 221

Query: 408 YKPAK 412
             P K
Sbjct: 222 LHPMK 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  131 bits (330), Expect = 8e-34
 Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 45/282 (15%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           +       ++ +G G    I    ++   DVAVK I P+ F   +       +EV  L  
Sbjct: 21  VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD-------REVQLLRE 73

Query: 251 -QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
              H  V++      +  ++ ++  EL   TL+E++     +++                
Sbjct: 74  SDEHPNVIRYFCTEKDRQFQ-YIAIELCAATLQEYV-----EQKDFA------HLGLEPI 121

Query: 310 AL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-----VRIADFGHARFLSDGEMA 362
            L  +    + +LH     ++HRDLKP NI +            I+DFG  + L+ G  +
Sbjct: 122 TLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179

Query: 363 LT------GTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK 412
            +      GT  ++APE++  +     +   D++S G +   +I+ G+HP+ +   + A 
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN 239

Query: 413 IAMEVGEGKLRPALPEEDGQLRELIE-LICLSWDGDASVRPS 453
           I +             ED   RELIE +I +    D   RPS
Sbjct: 240 ILLGACSLDCLHPEKHEDVIARELIEKMIAM----DPQKRPS 277

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  130 bits (328), Expect = 8e-34
 Identities = 54/292 (18%), Positives = 102/292 (34%), Gaps = 36/292 (12%)

Query: 191 YIDPKEI-DLQEKIGQG--TTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           ++      +L   IG+G      +  A     G  V V+ I  +    +   VTF   E+
Sbjct: 20  FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRI--NLEACSNEMVTFLQGEL 77

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
                  H  ++      +      W+VT  +           GS +       +    E
Sbjct: 78  HVSKLFNHPNIVPYRATFIAD-NELWVVTSFMA---------YGSAKDLICTHFMDGMNE 127

Query: 306 RLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD----- 358
                +   + +A+ Y+H      +HR +K S+I +     V ++       +       
Sbjct: 128 LAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQ 185

Query: 359 -----GEMALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA 411
                          +++PEV+Q   + Y  KSD+YS GI   E+  G+ P+  KD    
Sbjct: 186 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF--KDMPAT 243

Query: 412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN 463
           ++ +E   G   P L +      E + +       ++ +  S ++ T    N
Sbjct: 244 QMLLEKLNGT-VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSN 294

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  128 bits (323), Expect = 2e-33
 Identities = 47/255 (18%), Positives = 102/255 (40%), Gaps = 28/255 (10%)

Query: 168 SQTPLLQQSDLAVTVSQAKMNG-WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCI 226
           S   +L      + +++       YI+   I     + QG    I          A+K  
Sbjct: 5   SMKDILSNYSNLIYLNKYVKEKDKYINDYRI--IRTLNQGKFNKIILCEKDNKFYALKKY 62

Query: 227 Y-------PDFFHTNENAVTFFAQ------EVDTLSRQRHRFVLQLMGACLEPPYRGWLV 273
                    DF  +N + ++  ++      E+  ++  ++ + L   G  +      +++
Sbjct: 63  EKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYII 121

Query: 274 TELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHR 330
            E +   ++ ++        +            ++ + +   +  +  Y+H +K  + HR
Sbjct: 122 YEYMENDSILKFDEYFFVLDKNYT----CFIPIQVIKCIIKSVLNSFSYIHNEK-NICHR 176

Query: 331 DLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-GTFVYMAPEVIQCEP--YSEKSDVY 387
           D+KPSNI +D    V+++DFG + ++ D ++  + GT+ +M PE    E      K D++
Sbjct: 177 DVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIW 236

Query: 388 SFGIILNEIITGNHP 402
           S GI L  +     P
Sbjct: 237 SLGICLYVMFYNVVP 251

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  128 bits (323), Expect = 2e-33
 Identities = 71/310 (22%), Positives = 126/310 (40%), Gaps = 52/310 (16%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W    + ++  + +G G    +  A   G+        VAVK +       + +      
Sbjct: 40  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK---ADSSEREALM 96

Query: 243 QEVDTLSR-QRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWL------------- 285
            E+  +++   H  ++ L+GAC    P Y   L+ E      L  +L             
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIY---LIFEYCCYGDLLNYLRSKREKFSEDEIE 153

Query: 286 HGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV 345
           +    +  +E  + +  FE+ L  A ++A+ M++L  +    +HRDL   N+ +   K V
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVV 211

Query: 346 RIADFGHARFLSDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-G 399
           +I DFG AR +      +      +   +MAPE +    Y+ KSDV+S+GI+L EI + G
Sbjct: 212 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 271

Query: 400 NHPYIEKDYKPAKIAME-----VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSF 454
            +PY      P           +  G     + +      E+  ++   W  D+  RPSF
Sbjct: 272 VNPY------PGIPVDANFYKLIQNGFK---MDQPFYATEEIYIIMQSCWAFDSRKRPSF 322

Query: 455 SSITCSLKNI 464
            ++T  L   
Sbjct: 323 PNLTSFLGCQ 332

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  127 bits (321), Expect = 3e-33
 Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 55/307 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      +   + +G G    +  A   GL        VAVK +       + +      
Sbjct: 41  WEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEALM 97

Query: 243 QEVDTLSR-QRHRFVLQLMGACL--EPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMV 298
            E+  +S   +H  ++ L+GAC    P     ++TE      L  +L     + R     
Sbjct: 98  SELKIMSHLGQHENIVNLLGACTHGGPVL---VITEYCCYGDLLNFLR---RKSRVLETD 151

Query: 299 PLPPFEER-------LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
           P              L  + ++AQ M +L  +    IHRD+   N+ L +    +I DFG
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGHVAKIGDFG 209

Query: 352 HARFLSDGE--MALTGTFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE 405
            AR + +    +      +   +MAPE I    Y+ +SDV+S+GI+L EI + G +PY  
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY-- 267

Query: 406 KDYKPAKIAME-----VGEGKL--RPAL-PEEDGQLRELIELICLSWDGDASVRPSFSSI 457
               P  +        V +G    +PA  P+       +  ++   W  + + RP+F  I
Sbjct: 268 ----PGILVNSKFYKLVKDGYQMAQPAFAPK------NIYSIMQACWALEPTHRPTFQQI 317

Query: 458 TCSLKNI 464
              L+  
Sbjct: 318 CSFLQEQ 324

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  128 bits (322), Expect = 5e-33
 Identities = 53/282 (18%), Positives = 116/282 (41%), Gaps = 46/282 (16%)

Query: 199 LQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RF 255
           + ++IG G ++ +++ +       A+K +  +    +   +  +  E+  L++ +     
Sbjct: 60  ILKQIGSGGSSKVFQVLNEKKQIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           +++L    +   Y  ++V E     L  WL     +++K         +    ++    +
Sbjct: 118 IIRLYDYEITDQYI-YMVMECGNIDLNSWL-----KKKK-------SIDPWERKSYWKNM 164

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-----GTFV 368
            +A+  +H+    ++H DLKP+N  + D   +++ DFG A  +     ++      G   
Sbjct: 165 LEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 369 YMAPEVIQCEP-----------YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
           YM PE I+               S KSDV+S G IL  +  G  P+ +   + +K+   +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL-HAI 280

Query: 418 GEGKLRPALPEEDGQLRELIELI--CLSWDGDASVRPSFSSI 457
            +       P+   +  +L +++  CL    D   R S   +
Sbjct: 281 IDPNHEIEFPDIPEK--DLQDVLKCCLKR--DPKQRISIPEL 318

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (322), Expect = 5e-33
 Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 36/239 (15%)

Query: 187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           M           L + +GQG TAN++R   +  G   A+K      F    +      +E
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM---RE 57

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRG--WLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
            + L +  H+ +++L  A  E        L+ E     +L   L              LP
Sbjct: 58  FEVLKKLNHKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLE------EPSNAYGLP 110

Query: 302 PFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARF 355
              E     +  ++   M +L E    ++HR++KP NI      D     ++ DFG AR 
Sbjct: 111 ---ESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165

Query: 356 LSDGEMALT--GTFVYMAPEVIQ--------CEPYSEKSDVYSFGIILNEIITGNHPYI 404
           L D E  ++  GT  Y+ P++ +         + Y    D++S G+      TG+ P+ 
Sbjct: 166 LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  125 bits (315), Expect = 9e-33
 Identities = 64/268 (23%), Positives = 117/268 (43%), Gaps = 38/268 (14%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
             +G+GT   +Y        + +A+K I       +        +E+      +H+ ++Q
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQ 83

Query: 259 LMGACLEPPYRGWLVTELLGTTLK---EWLHGLGSQRR--KERMVPLPPFEERLAR-ALE 312
                    Y G   +      +K   E + G GS     + +  PL   E+ +     +
Sbjct: 84  ---------YLG---SFSENGFIKIFMEQVPG-GSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHARFLSD---GEMALTGTFV 368
           I + ++YLH+ +  ++HRD+K  N+ ++     ++I+DFG ++ L+         TGT  
Sbjct: 131 ILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ 188

Query: 369 YMAPEVIQCEP--YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
           YMAPE+I   P  Y + +D++S G  + E+ TG  P+ E   +P     +VG  K+ P +
Sbjct: 189 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG-EPQAAMFKVGMFKVHPEI 247

Query: 427 PEE-DGQLRELIELICLSWDGDASVRPS 453
           PE    + +  I   C   + D   R  
Sbjct: 248 PESMSAEAKAFILK-CF--EPDPDKRAC 272

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  126 bits (318), Expect = 1e-32
 Identities = 39/249 (15%), Positives = 85/249 (34%), Gaps = 40/249 (16%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFAQE 244
           +  K + +   +G+G  A +Y A    L+         +K   P     N        Q 
Sbjct: 62  LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQL 117

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
           ++ L        ++             LV EL    TL   ++   +   K         
Sbjct: 118 MERLKPSMQHMFMKFYS-AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK-------VM 169

Query: 304 EERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFL-----------DDAKHVRIADF 350
            + L    A+ +   ++ +H+ +  +IH D+KP N  L           D +  + + D 
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227

Query: 351 GHARFLS---DGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           G +  +     G +      T  +   E++  +P++ + D +     +  ++ G +  ++
Sbjct: 228 GQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287

Query: 406 KDYKPAKIA 414
            +    K  
Sbjct: 288 NEGGECKPE 296

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  124 bits (313), Expect = 1e-32
 Identities = 55/284 (19%), Positives = 106/284 (37%), Gaps = 50/284 (17%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL 257
           EKIG G   ++++ + R  G   A+K                  +EV   +   +H  V+
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRS--KKPLAGSVDEQNALREVYAHAVLGQHSHVV 74

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA--LEIAQ 315
           +   A  E      +  E           G  +    E    +  F+E   +   L++ +
Sbjct: 75  RYFSAWAED-DHMLIQNEYCN-------GGSLADAISENYRIMSYFKEAELKDLLLQVGR 126

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLD-------------------DAKHVRIADFGHARFL 356
            ++Y+H     ++H D+KPSNIF+                    +    +I D GH   +
Sbjct: 127 GLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184

Query: 357 SDGEMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
           S       G   ++A EV+Q    +  K+D+++  + +             D        
Sbjct: 185 SS-PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD------QW 237

Query: 416 -EVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSI 457
            E+ +G+L P +P+    +  EL+++  +    D   RPS  ++
Sbjct: 238 HEIRQGRL-PRIPQVLSQEFTELLKV-MI--HPDPERRPSAMAL 277

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  125 bits (315), Expect = 2e-32
 Identities = 65/233 (27%), Positives = 99/233 (42%), Gaps = 37/233 (15%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP  I +L E +G GT   +Y+      G   A+K +         +      QE++ L 
Sbjct: 21  DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-----DVTGDEEEEIKQEINMLK 75

Query: 250 RQ-RHRFVLQLMGACLEPPYRG-----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           +   HR +    GA ++    G     WLV E  G          GS     +       
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG---------AGSVTDLIKNTKGNTL 126

Query: 304 EERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
           +E     +  EI + + +LH+ K  VIHRD+K  N+ L +   V++ DFG +  L    +
Sbjct: 127 KEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR-TV 183

Query: 362 ALTGTFV----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIE 405
               TF+    +MAPEVI C+      Y  KSD++S GI   E+  G  P  +
Sbjct: 184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  129 bits (325), Expect = 3e-32
 Identities = 52/251 (20%), Positives = 88/251 (35%), Gaps = 43/251 (17%)

Query: 199 LQEKIGQGTTANIYRAIWRGLD---VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR- 254
           ++  I  G    IY A+ R ++   V +K +       +  A      E   L+   H  
Sbjct: 84  VKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPS 140

Query: 255 ------FVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
                 FV           Y   +V E + G +LK                 LP   E +
Sbjct: 141 IVQIFNFVEHTDRHGDPVGY---IVMEYVGGQSLKRSKGQ-----------KLPV-AEAI 185

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
           A  LEI  A+ YLH     +++ DLKP NI L +   +++ D G    ++       GT 
Sbjct: 186 AYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY-GTP 241

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            + APE+++  P +  +D+Y+ G  L  +               +    + E        
Sbjct: 242 GFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTR------NGRYVDGLPEDDPVLKTY 294

Query: 428 EEDGQLRELIE 438
           +       L+ 
Sbjct: 295 DS---YGRLLR 302

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  121 bits (307), Expect = 9e-32
 Identities = 66/235 (28%), Positives = 102/235 (43%), Gaps = 25/235 (10%)

Query: 183 SQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF 240
           S A   G  I+  ++     +G+G+ A +YRA     GL+VA+K I     +     V  
Sbjct: 1   SLATCIGEKIEDFKVG--NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQR 57

Query: 241 FAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVP 299
              EV    + +H  +L+L     E     +LV E+     +  +L      R K     
Sbjct: 58  VQNEVKIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLK----NRVK----- 107

Query: 300 LPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFL 356
             PF E  AR    +I   M YLH     ++HRDL  SN+ L    +++IADFG   +  
Sbjct: 108 --PFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163

Query: 357 SDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
              E   T  GT  Y++PE+     +  +SDV+S G +   ++ G  P+     K
Sbjct: 164 MPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK 218

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (307), Expect = 1e-31
 Identities = 56/226 (24%), Positives = 105/226 (46%), Gaps = 30/226 (13%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP E+ ++  ++G G    +Y+A  +  G   A K I       +E  +  +  E++ L+
Sbjct: 16  DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILA 71

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
              H ++++L+GA      + W++ E             G+       +     E ++  
Sbjct: 72  TCDHPYIVKLLGAYYHD-GKLWIMIEFCP---------GGAVDAIMLELDRGLTEPQIQV 121

Query: 310 AL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV 368
              ++ +A+ +LH ++  +IHRDLK  N+ +     +R+ADFG +       +    +F+
Sbjct: 122 VCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-TLQKRDSFI 178

Query: 369 ----YMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIE 405
               +MAPEV+ CE     PY  K+D++S GI L E+     P+ E
Sbjct: 179 GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  122 bits (307), Expect = 3e-31
 Identities = 65/224 (29%), Positives = 90/224 (40%), Gaps = 30/224 (13%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+++     +IG G+   +Y A        VA+K +      +NE       +EV  L 
Sbjct: 51  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK-WQDIIKEVRFLQ 109

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           + RH   +Q  G  L   +  WLV E             GS      +   P  E  +A 
Sbjct: 110 KLRHPNTIQYRGCYLRE-HTAWLVMEYCL----------GSASDLLEVHKKPLQEVEIAA 158

Query: 310 AL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV 368
                 Q + YLH     +IHRD+K  NI L +   V++ DFG A       MA   +FV
Sbjct: 159 VTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFV 211

Query: 369 ----YMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIE 405
               +MAPEVI       Y  K DV+S GI   E+     P   
Sbjct: 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 255

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  120 bits (304), Expect = 3e-31
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 33/224 (14%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DPK+     EKIGQG +  +Y A+    G +VA++ +        +        E+  + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMR 72

Query: 250 RQRHRFVLQLMGACLEPPYRG---WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
             ++  ++  + + L     G   W+V E L           GS         +   E +
Sbjct: 73  ENKNPNIVNYLDSYL----VGDELWVVMEYLA---------GGSLTDVVTETCMD--EGQ 117

Query: 307 LARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
           +A    E  QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++  E +   
Sbjct: 118 IAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRS 174

Query: 366 TFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           T V    +MAPEV+  + Y  K D++S GI+  E+I G  PY+ 
Sbjct: 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  120 bits (303), Expect = 5e-31
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 30/206 (14%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
              E +G G  + ++    R  G   A+KCI       + +       E+  L + +H  
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS----LENEIAVLKKIKHEN 67

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           ++ L     E     +LV +L+ G  L + +   G             + E+ A  +  +
Sbjct: 68  IVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGV------------YTEKDASLVIQQ 114

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEMA-LTGTF 367
           +  A++YLHE    ++HRDLKP N+      +++K + I DFG ++   +G M+   GT 
Sbjct: 115 VLSAVKYLHENG--IVHRDLKPENLLYLTPEENSK-IMITDFGLSKMEQNGIMSTACGTP 171

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIIL 393
            Y+APEV+  +PYS+  D +S G+I 
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVIT 197

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (301), Expect = 1e-30
 Identities = 62/224 (27%), Positives = 104/224 (46%), Gaps = 33/224 (14%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+ + D   KIG+G+T  +  A  +  G  VAVK +        +        EV  + 
Sbjct: 42  DPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR----KQQRRELLFNEVVIMR 97

Query: 250 RQRHRFVLQLMGACLEPPYRG---WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
             +H  V+++  + L     G   W++ E L           G+    + +  +   EE+
Sbjct: 98  DYQHFNVVEMYKSYL----VGEELWVLMEFLQ---------GGALT--DIVSQVRLNEEQ 142

Query: 307 LARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
           +A     + QA+ YLH Q   VIHRD+K  +I L     V+++DFG    +S  ++    
Sbjct: 143 IATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-DVPKRK 199

Query: 366 TFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
           + V    +MAPEVI    Y+ + D++S GI++ E++ G  PY  
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFS 243

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  122 bits (307), Expect = 3e-30
 Identities = 69/288 (23%), Positives = 118/288 (40%), Gaps = 43/288 (14%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR 213
           +H H H +          +     + V   + K+   Y          K+G G    +  
Sbjct: 1   MHHHHHHSSGRENLYFQGIAINPGMYVRKKEGKIGESY------FKVRKLGSGAYGEVLL 54

Query: 214 AIWR--GLDVAVKCI---------YPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA 262
              +    + A+K I         Y D     E        E+  L    H  +++L   
Sbjct: 55  CKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114

Query: 263 CLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQY 319
             E     +LVTE   G  L E            +++    F+E  A  +  +I   + Y
Sbjct: 115 F-EDKKYFYLVTEFYEGGELFE------------QIINRHKFDECDAANIMKQILSGICY 161

Query: 320 LHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEMALT--GTFVYMAPEV 374
           LH+    ++HRD+KP NI L++     +++I DFG + F S         GT  Y+APEV
Sbjct: 162 LHKHN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219

Query: 375 IQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL 422
           ++ + Y+EK DV+S G+I+  ++ G  P+  ++ +   I  +V +GK 
Sbjct: 220 LK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--DIIKKVEKGKY 264

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (299), Expect = 3e-30
 Identities = 66/305 (21%), Positives = 112/305 (36%), Gaps = 53/305 (17%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           +    + ++  + +G  A +Y A     G + A+K +        E       QEV  + 
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS----NEEEKNRAIIQEVCFMK 80

Query: 250 R-QRHRFVLQLMGACLEPPYRG-------WLVTELLGTTLKEWLHGLGSQRRKERMVPLP 301
           +   H  ++Q   A                L+TEL    L E+L  + S+          
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-------- 132

Query: 302 PFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
                    +  +  +A+Q++H QKP +IHRDLK  N+ L +   +++ DFG A  +S  
Sbjct: 133 -LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 360 ---------------EMALTGTFVYMAPEVI---QCEPYSEKSDVYSFGIILNEIITGNH 401
                          E+    T +Y  PE+I      P  EK D+++ G IL  +    H
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251

Query: 402 PYIEKDYKPAKIAMEVGEGKLR-PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS 460
           P+           + +  GK   P    +      LI    L    +   R S + +   
Sbjct: 252 PF------EDGAKLRIVNGKYSIPPHDTQYTVFHSLIR-AML--QVNPEERLSIAEVVHQ 302

Query: 461 LKNIQ 465
           L+ I 
Sbjct: 303 LQEIA 307

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  118 bits (298), Expect = 3e-30
 Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 27/221 (12%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
            P+E+ D+ EK+G+G+  ++Y+AI +  G  VA+K +        E+ +    +E+  + 
Sbjct: 26  QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV------PVESDLQEIIKEISIMQ 79

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           +     V++  G+  +     W+V E  G          GS     R+      E+ +A 
Sbjct: 80  QCDSPHVVKYYGSYFKN-TDLWIVMEYCG---------AGSVSDIIRLRNKTLTEDEIAT 129

Query: 310 AL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV 368
            L    + ++YLH  +   IHRD+K  NI L+   H ++ADFG A  L+D  MA   T +
Sbjct: 130 ILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQLTD-TMAKRNTVI 186

Query: 369 ----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE 405
               +MAPEVIQ   Y+  +D++S GI   E+  G  PY +
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYAD 227

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  119 bits (301), Expect = 7e-30
 Identities = 54/268 (20%), Positives = 106/268 (39%), Gaps = 47/268 (17%)

Query: 195 KEIDLQEKIGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QR 252
             +  ++ +G G++  +     ++G  VAVK +  DF             E+  L+    
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD-------IALMEIKLLTESDD 67

Query: 253 HRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
           H  V++   +     +  ++  EL    L++ +     + +      L   +E    +L 
Sbjct: 68  HPNVIRYYCSETTDRFL-YIALELCNLNLQDLV-----ESKNVSDENLKLQKEYNPISLL 121

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-------------VRIADFGHARFLS 357
            +IA  + +LH  K  +IHRDLKP NI +  +               + I+DFG  + L 
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLD 179

Query: 358 DGEMALT-------GTFVYMAPEVIQC-------EPYSEKSDVYSFGIILNEIIT-GNHP 402
            G+ +         GT  + APE+++           +   D++S G +   I++ G HP
Sbjct: 180 SGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

Query: 403 YIEKDYKPAKIAMEVGEGKLRPALPEED 430
           + +K  + + I   +        L +  
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRS 267

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (297), Expect = 8e-30
 Identities = 70/240 (29%), Positives = 116/240 (48%), Gaps = 39/240 (16%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHR 254
           +++E IG G+ +   R I +   ++ AVK I       ++   T   +E++ L R  +H 
Sbjct: 25  EVKEDIGVGSYSVCKRCIHKATNMEFAVKII-----DKSKRDPT---EEIEILLRYGQHP 76

Query: 255 FVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
            ++ L     +     ++VTEL+  G    E L         ++++    F ER A A+ 
Sbjct: 77  NIITLKDVY-DDGKYVYVVTELMKGG----ELL---------DKILRQKFFSEREASAVL 122

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEMALT-- 364
             I + ++YLH Q   V+HRDLKPSNI       + + +RI DFG A+ L      L   
Sbjct: 123 FTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTP 180

Query: 365 -GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP-YIEKDYKPAKIAMEVGEGKL 422
             T  ++APEV++ + Y    D++S G++L  ++TG  P     D  P +I   +G GK 
Sbjct: 181 CYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKF 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  118 bits (297), Expect = 1e-29
 Identities = 64/288 (22%), Positives = 118/288 (40%), Gaps = 37/288 (12%)

Query: 128 NKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKM 187
            +E +H   L+          L   P    +      +     P   ++    ++     
Sbjct: 23  RREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDE 82

Query: 188 NGWYIDPKEI----DLQEKIGQGTTANIYRAIWR--GLDVAVKCI----YPDFFHTNENA 237
              +   KE     D ++ IG+G ++ + R + R  G + AVK +            E  
Sbjct: 83  LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142

Query: 238 VTFFAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKE 295
                +E   L +   H  ++ L+ +  E     +LV +L+    L ++L    +     
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVA----- 196

Query: 296 RMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA 353
                    E+  R++   + +A+ +LH     ++HRDLKP NI LDD   +R++DFG +
Sbjct: 197 -------LSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRLSDFGFS 247

Query: 354 RFLSDGEMALT--GTFVYMAPEVIQC------EPYSEKSDVYSFGIIL 393
             L  GE      GT  Y+APE+++C        Y ++ D+++ G+IL
Sbjct: 248 CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (298), Expect = 1e-29
 Identities = 37/279 (13%), Positives = 75/279 (26%), Gaps = 44/279 (15%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P+ +     +GQ        A  +       V   Y        NA+    +EV  L   
Sbjct: 77  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT-ERPPSNAIKQMKEEVLRLRLL 135

Query: 252 RH----------------RFVLQLMGAC-----LEPPYRGWLVTELLGTTL--KEWLHGL 288
           R                   +++                 W+++                
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195

Query: 289 GSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA 348
                            RL   L++ + +  LH     ++H  L+P +I LD    V + 
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY--GLVHTYLRPVDIVLDQRGGVFLT 253

Query: 349 DFGHARFLSDGEMALTGTFV----YMAPEVIQCEP-----YSEKSDVYSFGIILNEIITG 399
            F H        ++  G         A  ++          +   D ++ G+ +  I   
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 400 NHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIE 438
           + P  +        +  +        +P+    +R L+E
Sbjct: 314 DLPNTDDA--ALGGSEWIFRSC--KNIPQP---VRALLE 345

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  115 bits (291), Expect = 2e-29
 Identities = 57/219 (26%), Positives = 100/219 (45%), Gaps = 24/219 (10%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++   +G+G   N+Y A  +     +A+K ++               +EV+  S  RH  
Sbjct: 12  EIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKA-GVEHQLRREVEIQSHLRHPN 70

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALE 312
           +L+L G       R +L+ E     T+   L      ++  +      F+E+       E
Sbjct: 71  ILRLYG-YFHDATRVYLILEYAPLGTVYREL------QKLSK------FDEQRTATYITE 117

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           +A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG +   +         GT  Y+
Sbjct: 118 LANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLCGTLDYL 174

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            PE+I+   + EK D++S G++  E + G  P+    Y+
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 213

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (292), Expect = 2e-29
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 27/229 (11%)

Query: 192 IDPKEI---DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           +DP+          +G+G  A  +           A K +         +     + E+ 
Sbjct: 9   VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEIS 67

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTEL-LGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
                 H+ V+   G   E     ++V EL    +L E       +RRK          E
Sbjct: 68  IHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH-----KRRK-------ALTE 114

Query: 306 RLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLSDGEMA 362
             AR    +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG   +   DGE  
Sbjct: 115 PEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172

Query: 363 LT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               GT  Y+APEV+  + +S + DV+S G I+  ++ G  P+     K
Sbjct: 173 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  116 bits (292), Expect = 3e-29
 Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 27/229 (11%)

Query: 192 IDPKEI---DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD 246
           +DP+          +G+G  A  +           A K +         +     + E+ 
Sbjct: 35  VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEIS 93

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
                 H+ V+   G   E     ++V EL    +L E       +RRK          E
Sbjct: 94  IHRSLAHQHVVGFHG-FFEDNDFVFVVLELCRRRSLLELH-----KRRK-------ALTE 140

Query: 306 RLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG-HARFLSDGEMA 362
             AR    +I    QYLH  +  VIHRDLK  N+FL++   V+I DFG   +   DGE  
Sbjct: 141 PEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198

Query: 363 LT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
               GT  Y+APEV+  + +S + DV+S G I+  ++ G  P+     K
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 247

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  117 bits (296), Expect = 3e-29
 Identities = 61/252 (24%), Positives = 108/252 (42%), Gaps = 38/252 (15%)

Query: 192 IDPKEI----DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE----NAVTFF 241
           + PK +     + + +G G    +  A  R     VA++ I    F        +     
Sbjct: 128 VYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNV 187

Query: 242 AQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPL 300
             E++ L +  H  ++++        Y  ++V EL+ G  L + + G             
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKVVGNKR---------- 235

Query: 301 PPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARF 355
              +E   +    ++  A+QYLHE    +IHRDLKP N+ L   ++   ++I DFGH++ 
Sbjct: 236 --LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291

Query: 356 LSDGEMALT--GTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
           L +  +  T  GT  Y+APEV+       Y+   D +S G+IL   ++G  P+ E     
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQ 350

Query: 411 AKIAMEVGEGKL 422
             +  ++  GK 
Sbjct: 351 VSLKDQITSGKY 362

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  118 bits (297), Expect = 5e-29
 Identities = 66/278 (23%), Positives = 118/278 (42%), Gaps = 36/278 (12%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRA 214
           H H H +       Q  L     + +T  +  ++  Y         +K+G G    +   
Sbjct: 3   HHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMY------QRVKKLGSGAYGEVLLC 56

Query: 215 IWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL 272
             +   ++ A+K I      T+ N+     +EV  L    H  +++L     E     +L
Sbjct: 57  RDKVTHVERAIKIIRKTSVSTSSNSK--LLEEVAVLKLLDHPNIMKLYDFF-EDKRNYYL 113

Query: 273 VTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIH 329
           V E   G  L +             ++    F E  A  +  ++   + YLH+    ++H
Sbjct: 114 VMECYKGGELFD------------EIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--IVH 159

Query: 330 RDLKPSNIFLDDAK---HVRIADFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKS 384
           RDLKP N+ L+  +    ++I DFG +    + +      GT  Y+APEV++ + Y EK 
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKC 218

Query: 385 DVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL 422
           DV+S G+IL  ++ G  P+  +  +  +I  +V +GK 
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQ--EILRKVEKGKY 254

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  114 bits (287), Expect = 6e-29
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 30/210 (14%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF--FAQEVDTLSRQRH 253
           ++ E++G G  A + +   +  G + A K I      ++   V+     +EV+ L   RH
Sbjct: 8   EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67

Query: 254 RFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
             ++ L     E      L+ EL+  G    E L         + +       E  A   
Sbjct: 68  PNIITLHDIF-ENKTDVVLILELVSGG----E-LF--------DFLAEKESLTEDEATQF 113

Query: 312 --EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEM--AL 363
             +I   + YLH ++  + H DLKP NI L         +++ DFG A  +  G     +
Sbjct: 114 LKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNI 171

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
            GT  ++APE++  EP   ++D++S G+I 
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (286), Expect = 7e-29
 Identities = 56/218 (25%), Positives = 101/218 (46%), Gaps = 24/218 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D+   +G+G   N+Y A  +     +A+K ++       E       +E++  S  RH  
Sbjct: 17  DIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPN 75

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALE 312
           +L++         R +L+ E      L + L      ++  R      F+E+ +     E
Sbjct: 76  ILRMYNY-FHDRKRIYLMLEFAPRGELYKEL------QKHGR------FDEQRSATFMEE 122

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           +A A+ Y HE+K  VIHRD+KP N+ +     ++IADFG +   +      T  GT  Y+
Sbjct: 123 LADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYL 179

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
            PE+I+ + + EK D++  G++  E + G  P+    +
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  114 bits (287), Expect = 8e-29
 Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 34/215 (15%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCI-----YPDFFHTNENAVTFFAQEVDTLSR 250
           + +E +G+G ++ + R I +    + AVK I             +       +EVD L +
Sbjct: 20  EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79

Query: 251 -QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
              H  ++QL     E     +LV +L+    L ++L    +              E+  
Sbjct: 80  VSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVT------------LSEKET 126

Query: 309 RAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-- 364
           R +   + + +  LH+    ++HRDLKP NI LDD  ++++ DFG +  L  GE      
Sbjct: 127 RKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184

Query: 365 GTFVYMAPEVIQC------EPYSEKSDVYSFGIIL 393
           GT  Y+APE+I+C        Y ++ D++S G+I+
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  114 bits (287), Expect = 1e-28
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 28/209 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF--FAQEVDTLSRQRH 253
           D+ E++G G  A + +   +  GL+ A K I       +   V+     +EV  L +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74

Query: 254 RFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
             V+ L     E      L+ EL+ G  L +             +       E  A +  
Sbjct: 75  HNVITLHDVY-ENRTDVVLILELVSGGELFD------------FLAQKESLSEEEATSFI 121

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEM--ALT 364
            +I   + YLH +K  + H DLKP NI L        H+++ DFG A  + DG     + 
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
           GT  ++APE++  EP   ++D++S G+I 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  114 bits (286), Expect = 4e-28
 Identities = 32/248 (12%), Positives = 73/248 (29%), Gaps = 44/248 (17%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE---------------- 235
           P+ +     +GQ        A  +  G    V   Y      +                 
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 236 --------NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG-WLVTELLGTTLKEWLH 286
                        F    D +   + + ++++     +      + +   + + L+ +  
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 287 GLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR 346
            L S     +         RL   L++ + +  LH     ++H  L+P +I LD    V 
Sbjct: 192 VLLSHSSTHK---SLVHHARLQLTLQVIRLLASLHHYG--LVHTYLRPVDIVLDQRGGVF 246

Query: 347 IADFGHARFLSDGEMALTGTFVYMAPEVIQCE-----------PYSEKSDVYSFGIILNE 395
           +  F H        +  + +  +  PE+                 +   D ++ G+++  
Sbjct: 247 LTGFEHLVRDGA-RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305

Query: 396 IITGNHPY 403
           I   + P 
Sbjct: 306 IWCADLPI 313

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  112 bits (283), Expect = 4e-28
 Identities = 57/221 (25%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 194 PKEI----DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE----NAVTFFAQ 243
           PK +     + + +G G    +  A  R     VA+K I    F        +       
Sbjct: 5   PKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVET 64

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E++ L +  H  ++++        Y  ++V EL+ G  L + + G               
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAEDY--YIVLELMEGGELFDKVVGNKR------------ 110

Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLS 357
            +E   +    ++  A+QYLHE    +IHRDLKP N+ L   ++   ++I DFGH++ L 
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

Query: 358 DGEMALT--GTFVYMAPEVIQ---CEPYSEKSDVYSFGIIL 393
           +  +  T  GT  Y+APEV+       Y+   D +S G+IL
Sbjct: 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  112 bits (283), Expect = 5e-28
 Identities = 52/208 (25%), Positives = 87/208 (41%), Gaps = 36/208 (17%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRF 255
             + +G+G+ +   + + +      AVK I       ++       +E+  L   + H  
Sbjct: 15  KDKPLGEGSFSICRKCVHKKSNQAFAVKII-------SKRMEANTQKEITALKLCEGHPN 67

Query: 256 VLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-- 311
           +++L           +LV ELL  G    E           ER+     F E  A  +  
Sbjct: 68  IVKLHEVF-HDQLHTFLVMELLNGG----ELF---------ERIKKKKHFSETEASYIMR 113

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT---G 365
           ++  A+ ++H+    V+HRDLKP N+     +D   ++I DFG AR        L     
Sbjct: 114 KLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF 171

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
           T  Y APE++    Y E  D++S G+IL
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVIL 199

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  111 bits (280), Expect = 6e-28
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 27/206 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D++E++G+G  + + R + +  GL+ A K I        +       +E     + +H  
Sbjct: 9   DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPN 66

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L  +  +     +LV +L+ G  L E +                 + E  A     +
Sbjct: 67  IVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF------------YSEADASHCIQQ 113

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEMALT--GTF 367
           I +++ Y H     ++HR+LKP N+ L        V++ADFG A  ++D E      GT 
Sbjct: 114 ILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 171

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIIL 393
            Y++PEV++ +PYS+  D+++ G+IL
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  114 bits (287), Expect = 8e-28
 Identities = 50/209 (23%), Positives = 93/209 (44%), Gaps = 32/209 (15%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            L E++G+G  + + R +    G + A   I        ++      +E       +H  
Sbjct: 14  QLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK--LEREARICRLLKHPN 71

Query: 256 VLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-- 311
           +++L  +        +L+ +L+  G    E           E +V    + E  A     
Sbjct: 72  IVRLHDSI-SEEGHHYLIFDLVTGG----ELF---------EDIVAREYYSEADASHCIQ 117

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEMALT--- 364
           +I +A+ + H+    V+HR+LKP N+ L      A  V++ADFG A  +   + A     
Sbjct: 118 QILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAA-VKLADFGLAIEVEGEQQAWFGFA 174

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
           GT  Y++PEV++ +PY +  D+++ G+IL
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (288), Expect = 9e-28
 Identities = 60/235 (25%), Positives = 102/235 (43%), Gaps = 29/235 (12%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
             Q  +G+G+   +     +  G + AVK I         +      +EV  L +  H  
Sbjct: 29  KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPN 87

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L     E     +LV E+  G  L +             ++    F E  A  +  +
Sbjct: 88  IMKLYEFF-EDKGYFYLVGEVYTGGELFD------------EIISRKRFSEVDAARIIRQ 134

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEM--ALTGTF 367
           +   + Y+H+ K  ++HRDLKP N+ L+      ++RI DFG +      +      GT 
Sbjct: 135 VLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTA 192

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL 422
            Y+APEV+    Y EK DV+S G+IL  +++G  P+   +     I  +V +GK 
Sbjct: 193 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEY--DILKKVEKGKY 244

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  112 bits (283), Expect = 9e-28
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 28/209 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVT--FFAQEVDTLSRQRH 253
           D+ E++G G  A + +   +  GL+ A K I       +   V      +EV  L +  H
Sbjct: 15  DIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74

Query: 254 RFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL- 311
             ++ L     E      L+ EL+ G  L +             +       E  A +  
Sbjct: 75  PNIITLHDVY-ENRTDVVLILELVSGGELFD------------FLAQKESLSEEEATSFI 121

Query: 312 -EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEM--ALT 364
            +I   + YLH +K  + H DLKP NI L        H+++ DFG A  + DG     + 
Sbjct: 122 KQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
           GT  ++APE++  EP   ++D++S G+I 
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  110 bits (278), Expect = 1e-27
 Identities = 56/250 (22%), Positives = 97/250 (38%), Gaps = 48/250 (19%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR 213
           +H H H +             +               Y      ++   +G+G+   + +
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAER--------------Y------NIVCMLGKGSFGEVLK 40

Query: 214 AIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW 271
              R    + AVK I        +   +   +EV+ L +  H  +++L     E     +
Sbjct: 41  CKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPNIMKLFEIL-EDSSSFY 97

Query: 272 LVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVI 328
           +V EL  G  L +             ++    F E  A  +  ++   + Y+H+    ++
Sbjct: 98  IVGELYTGGELFD------------EIIKRKRFSEHDAARIIKQVFSGITYMHKHN--IV 143

Query: 329 HRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT--GTFVYMAPEVIQCEPYSEK 383
           HRDLKP NI L   +    ++I DFG +             GT  Y+APEV++   Y EK
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR-GTYDEK 202

Query: 384 SDVYSFGIIL 393
            DV+S G+IL
Sbjct: 203 CDVWSAGVIL 212

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  111 bits (280), Expect = 1e-27
 Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 28/205 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            + E +G+G    ++R +          K +                +E+  L+  RHR 
Sbjct: 8   MIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-----KVKGTDQVLVKKEISILNIARHRN 62

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +L L  +  E      ++ E + G  + E ++    +             ER   +   +
Sbjct: 63  ILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFE-----------LNEREIVSYVHQ 110

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK--HVRIADFGHARFLSDGEM--ALTGTFV 368
           + +A+Q+LH     + H D++P NI     +   ++I +FG AR L  G+    L     
Sbjct: 111 VCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE 168

Query: 369 YMAPEVIQCEPYSEKSDVYSFGIIL 393
           Y APEV Q +  S  +D++S G ++
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLV 193

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  112 bits (281), Expect = 1e-27
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 23/208 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENA-VTFFAQEVDTLSRQRHR 254
           +L E IG+G  + + R I R  G   AVK +    F ++         +E       +H 
Sbjct: 27  ELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86

Query: 255 FVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-- 311
            +++L+          ++V E + G  L             +R      + E +A     
Sbjct: 87  HIVELLETY-SSDGMLYMVFEFMDGADLCF--------EIVKRADAGFVYSEAVASHYMR 137

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT---G 365
           +I +A++Y H+    +IHRD+KP  + L   +++  V++  FG A  L +  +      G
Sbjct: 138 QILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
           T  +MAPEV++ EPY +  DV+  G+IL
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  114 bits (288), Expect = 1e-27
 Identities = 58/178 (32%), Positives = 88/178 (49%), Gaps = 18/178 (10%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E   L +   RFV+ L     E      LV  L+ G  LK  ++ +G             
Sbjct: 234 EKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAG---------- 282

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  A   A EI   ++ LH ++  +++RDLKP NI LDD  H+RI+D G A  + +G+
Sbjct: 283 FPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340

Query: 361 MALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
                 GT  YMAPEV++ E Y+   D ++ G +L E+I G  P+ ++  K  +  +E
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  111 bits (280), Expect = 2e-27
 Identities = 52/206 (25%), Positives = 98/206 (47%), Gaps = 27/206 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D++E++G+G  + + R + +  GL+ A K I        +       +E     + +H  
Sbjct: 32  DVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPN 89

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L  +  +     +LV +L+ G  L E +                 + E  A     +
Sbjct: 90  IVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF------------YSEADASHCIQQ 136

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEMALT--GTF 367
           I +++ Y H     ++HR+LKP N+ L        V++ADFG A  ++D E      GT 
Sbjct: 137 ILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTP 194

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIIL 393
            Y++PEV++ +PYS+  D+++ G+IL
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVIL 220

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  113 bits (284), Expect = 3e-27
 Identities = 47/179 (26%), Positives = 82/179 (45%), Gaps = 19/179 (10%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E   L++   RF++ L     E      LV  ++ G  ++  ++ +              
Sbjct: 235 EKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-------- 285

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F+E  A     +I   +++LH++   +I+RDLKP N+ LDD  +VRI+D G A  L  G+
Sbjct: 286 FQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343

Query: 361 MALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
              T  +     +MAPE++  E Y    D ++ G+ L E+I    P+  +  K     +
Sbjct: 344 -TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL 401

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  110 bits (277), Expect = 3e-27
 Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 30/210 (14%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENA--VTFFAQEVDTLSRQRH 253
           D  E++G G  A + +   +  GL  A K I      ++          +EV  L   +H
Sbjct: 14  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 73

Query: 254 RFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
             V+ L     E      L+ EL+  G    E L         + +       E  A   
Sbjct: 74  PNVITLHEVY-ENKTDVILILELVAGG----E-LF--------DFLAEKESLTEEEATEF 119

Query: 312 --EIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKHVRIADFGHARFLSDGEM--AL 363
             +I   + YLH  +  + H DLKP NI L         ++I DFG A  +  G     +
Sbjct: 120 LKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
            GT  ++APE++  EP   ++D++S G+I 
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  109 bits (274), Expect = 1e-26
 Identities = 62/259 (23%), Positives = 107/259 (41%), Gaps = 41/259 (15%)

Query: 155 HQHSHQTPLHRYCSQTPLLQQSDLAVTV---SQAKMNGWYIDPKEID-------LQEKIG 204
           H H H + +            S +  +    + + +  ++ID    D       ++ ++G
Sbjct: 3   HHHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELG 62

Query: 205 QGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA 262
           +G T+ +YR   +      A+K +                 E+  L R  H  +++L   
Sbjct: 63  RGATSIVYRCKQKGTQKPYALKVL------KKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 263 CLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQY 319
             E P    LV EL+ G  L + +   G             + ER A     +I +A+ Y
Sbjct: 117 F-ETPTEISLVLELVTGGELFDRIVEKGY------------YSERDAADAVKQILEAVAY 163

Query: 320 LHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT--GTFVYMAPEV 374
           LHE    ++HRDLKP N+          ++IADFG ++ +    +  T  GT  Y APE+
Sbjct: 164 LHENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEI 221

Query: 375 IQCEPYSEKSDVYSFGIIL 393
           ++   Y  + D++S GII 
Sbjct: 222 LRGCAYGPEVDMWSVGIIT 240

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (273), Expect = 1e-26
 Identities = 57/271 (21%), Positives = 93/271 (34%), Gaps = 50/271 (18%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIY-PDFFHTNENAVTFFAQEVDTLSRQRHR 254
            L+  IGQG+   +  AI        A+K +        N   V     EV  + +  H 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 255 FVLQLMGACLEPPYRGWLVTELL-----------------------------GTTLKEWL 285
            + +L     E      LV EL                                  +   
Sbjct: 89  NIARLYEV-YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 286 HGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL--DD 341
             +       R        E+L   +  +I  A+ YLH Q   + HRD+KP N     + 
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--ICHRDIKPENFLFSTNK 205

Query: 342 AKHVRIADFGHARFLSDGEMA-------LTGTFVYMAPEVIQC--EPYSEKSDVYSFGII 392
           +  +++ DFG ++                 GT  ++APEV+    E Y  K D +S G++
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265

Query: 393 LNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
           L+ ++ G  P+   +   A    +V   KL 
Sbjct: 266 LHLLLMGAVPFPGVN--DADTISQVLNKKLC 294

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  108 bits (273), Expect = 1e-26
 Identities = 48/209 (22%), Positives = 85/209 (40%), Gaps = 38/209 (18%)

Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLSR-QRHR 254
           ++ +G G    +     R  G   A+K +Y  P              QEVD   +     
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR-----------QEVDHHWQASGGP 82

Query: 255 FVLQLMGACLEPPYRGW---LVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            ++ ++       +      ++ E + G  L   +   G Q           F ER A  
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA----------FTEREAAE 132

Query: 311 L--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMA-LT 364
           +  +I  A+Q+LH     + HRD+KP N+     +    +++ DFG A+  +   +    
Sbjct: 133 IMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPC 190

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
            T  Y+APEV+  E Y +  D++S G+I+
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  109 bits (273), Expect = 1e-26
 Identities = 57/243 (23%), Positives = 102/243 (41%), Gaps = 42/243 (17%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCI----YPDFFHTNENAVTFFAQEVDTLSRQ 251
                +G G    ++ A+ +    +V VK I      +     +  +     E+  LSR 
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQ-----RRKERMVPLPPFEER 306
            H  +++++    E      LV E          HG G        R  R+      +E 
Sbjct: 87  EHANIIKVLDI-FENQGFFQLVMEK---------HGSGLDLFAFIDRHPRL------DEP 130

Query: 307 LARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT 364
           LA  +  ++  A+ YL  +   +IHRD+K  NI + +   +++ DFG A +L  G++  T
Sbjct: 131 LASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188

Query: 365 --GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
             GT  Y APEV+   PY   + +++S G+ L  ++   +P+   + +      E  E  
Sbjct: 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF--CELE------ETVEAA 240

Query: 422 LRP 424
           + P
Sbjct: 241 IHP 243

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (273), Expect = 2e-26
 Identities = 63/277 (22%), Positives = 105/277 (37%), Gaps = 31/277 (11%)

Query: 126 TNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQA 185
             N  DQ      +    V ++  +   +   S +T         P        VT  Q 
Sbjct: 24  MKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQG 83

Query: 186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ 243
            +N +Y     +   E +G G    +++      GL +A K I        E        
Sbjct: 84  AVNSFY----TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE----VKN 135

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E+  +++  H  ++QL  A  E      LV E + G  L + +                 
Sbjct: 136 EISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYN----------- 183

Query: 303 FEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFL--DDAKHVRIADFGHARFLSD 358
             E        +I + ++++H+    ++H DLKP NI     DAK ++I DFG AR    
Sbjct: 184 LTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241

Query: 359 GEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIIL 393
            E      GT  ++APEV+  +  S  +D++S G+I 
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  106 bits (268), Expect = 3e-26
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 25/206 (12%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
             + K+G G   +++    R  GL+  +K I  D        +     E++ L    H  
Sbjct: 25  IFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQI---EAEIEVLKSLDHPN 81

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           ++++     E  +  ++V E   G  L E        R            E     L  +
Sbjct: 82  IIKIFEVF-EDYHNMYIVMETCEGGELLE--------RIVSAQARGKALSEGYVAELMKQ 132

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEMALT--GTF 367
           +  A+ Y H Q   V+H+DLKP NI   D      ++I DFG A      E +    GT 
Sbjct: 133 MMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTA 190

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIIL 393
           +YMAPEV +    + K D++S G+++
Sbjct: 191 LYMAPEVFK-RDVTFKCDIWSAGVVM 215

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  110 bits (276), Expect = 3e-26
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 28/215 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++   +G+G+   + +   R    + AVK I        +   +   +EV+ L +  H  
Sbjct: 25  NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD--TSTILREVELLKKLDHPN 82

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L     E     ++V EL  G  L +             ++    F E  A  +  +
Sbjct: 83  IMKLFEIL-EDSSSFYIVGELYTGGELFD------------EIIKRKRFSEHDAARIIKQ 129

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEM--ALTGTF 367
           +   + Y+H+    ++HRDLKP NI L+  +    ++I DFG +             GT 
Sbjct: 130 VFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTA 187

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
            Y+APEV++   Y EK DV+S G+IL  +++G  P
Sbjct: 188 YYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (268), Expect = 4e-26
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 25/169 (14%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLP 301
           E D +SR  H F ++L     +   + +        G    E L  +    RK       
Sbjct: 80  ERDVMSRLDHPFFVKLYFTF-QDDEKLYFGLSYAKNG----ELLKYI----RKIGS---- 126

Query: 302 PFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA-RFLSD 358
            F+E   R    EI  A++YLH +   +IHRDLKP NI L++  H++I DFG A     +
Sbjct: 127 -FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

Query: 359 GEMALTGTFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
            + A   +FV    Y++PE++  +   + SD+++ G I+ +++ G  P+
Sbjct: 184 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  106 bits (267), Expect = 6e-26
 Identities = 61/269 (22%), Positives = 102/269 (37%), Gaps = 42/269 (15%)

Query: 151 QTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTAN 210
               H  S   P   + +    L  + LA    +  +   Y       +   +G G   +
Sbjct: 5   HHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQY------QVGPLLGSGGFGS 58

Query: 211 IYRAIWR--GLDVAVKCIYPDFFHTNENAVTFF--AQEVDTLSRQRHRF--VLQLMGACL 264
           +Y  I     L VA+K +  D                EV  L +    F  V++L+    
Sbjct: 59  VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-F 117

Query: 265 EPPYRGWLVTELLGTTLKEWLHGLGSQ------RRKERMVPLPPFEERLARAL--EIAQA 316
           E P    L+ E               Q        +  +      +E LAR+   ++ +A
Sbjct: 118 ERPDSFVLILE----------RPEPVQDLFDFITERGAL------QEELARSFFWQVLEA 161

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGEMALT-GTFVYMAPEV 374
           +++ H     V+HRD+K  NI +D +   +++ DFG    L D       GT VY  PE 
Sbjct: 162 VRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEW 219

Query: 375 IQCEPYS-EKSDVYSFGIILNEIITGNHP 402
           I+   Y    + V+S GI+L +++ G+ P
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (269), Expect = 1e-25
 Identities = 52/255 (20%), Positives = 96/255 (37%), Gaps = 33/255 (12%)

Query: 154 LHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEID------LQEKIGQGT 207
            H H H     R     P +   D        K     ++ K+        + E++G G 
Sbjct: 4   SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63

Query: 208 TANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE 265
              ++R + +  G     K I   +             E+  +++  H  ++ L  A  E
Sbjct: 64  FGVVHRCVEKATGRVFVAKFINTPYPLDKYT----VKNEISIMNQLHHPKLINLHDAF-E 118

Query: 266 PPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHE 322
             Y   L+ E L G  L + +     +             E        +  + ++++HE
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYK-----------MSEAEVINYMRQACEGLKHMHE 167

Query: 323 QKPKVIHRDLKPSNIFLDDAK--HVRIADFGHARFLSDGEMALT--GTFVYMAPEVIQCE 378
               ++H D+KP NI  +  K   V+I DFG A  L+  E+      T  + APE++  E
Sbjct: 168 HS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDRE 225

Query: 379 PYSEKSDVYSFGIIL 393
           P    +D+++ G++ 
Sbjct: 226 PVGFYTDMWAIGVLG 240

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (273), Expect = 1e-25
 Identities = 48/206 (23%), Positives = 87/206 (42%), Gaps = 29/206 (14%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D+ E++G G    ++R   R  G + A K +       +E+      +E+ T+S  RH  
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVM----TPHESDKETVRKEIQTMSVLRHPT 215

Query: 256 VLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL-- 311
           ++ L  A  E      ++ E +  G    E    +  +  K          E  A     
Sbjct: 216 LVNLHDAF-EDDNEMVMIYEFMSGG----ELFEKVADEHNK--------MSEDEAVEYMR 262

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK--HVRIADFGHARFLSDGEM--ALTGTF 367
           ++ + + ++HE     +H DLKP NI     +   +++ DFG    L   +     TGT 
Sbjct: 263 QVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA 320

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIIL 393
            + APEV + +P    +D++S G++ 
Sbjct: 321 EFAAPEVAEGKPVGYYTDMWSVGVLS 346

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  104 bits (262), Expect = 4e-25
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 25/213 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            L + IG+G  A +  A     G +VA+K I  D    N  ++    +EV  +    H  
Sbjct: 18  RLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHPN 75

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L    +E     +L+ E   G  + ++L          RM      +E+ AR+   +
Sbjct: 76  IVKLF-EVIETEKTLYLIMEYASGGEVFDYL------VAHGRM------KEKEARSKFRQ 122

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           I  A+QY H+++  ++HRDLK  N+ LD   +++IADFG +   + G       G   Y 
Sbjct: 123 IVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYA 180

Query: 371 APEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
           APE+ Q + Y   + DV+S G+IL  +++G+ P
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  103 bits (259), Expect = 4e-25
 Identities = 52/206 (25%), Positives = 87/206 (42%), Gaps = 30/206 (14%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            L+  IG+G+   +  A+ +   +  A K I   F    +     F QE++ +    H  
Sbjct: 12  TLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPN 67

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L     E     +LV EL  G  L E +                 F E  A  +  +
Sbjct: 68  IIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRV------------FRESDAARIMKD 114

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMALT--GTF 367
           +  A+ Y H+    V HRDLKP N           +++ DFG A     G+M  T  GT 
Sbjct: 115 VLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTP 172

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIIL 393
            Y++P+V++   Y  + D +S G+++
Sbjct: 173 YYVSPQVLE-GLYGPECDEWSAGVMM 197

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  104 bits (261), Expect = 5e-25
 Identities = 46/204 (22%), Positives = 82/204 (40%), Gaps = 26/204 (12%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR-FVL 257
           +++G+G  A + + I +  G + A K +        ++       E+  L   +    V+
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFL--KKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 258 QLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIA 314
            L     E      L+ E   G  +             E         E     L  +I 
Sbjct: 93  NLHEVY-ENTSEIILILEYAAGGEIFSLC----LPELAEM------VSENDVIRLIKQIL 141

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVRIADFGHARFLSDGEM--ALTGTFVY 369
           + + YLH+    ++H DLKP NI L        ++I DFG +R +        + GT  Y
Sbjct: 142 EGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEY 199

Query: 370 MAPEVIQCEPYSEKSDVYSFGIIL 393
           +APE++  +P +  +D+++ GII 
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIA 223

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  104 bits (262), Expect = 7e-25
 Identities = 44/137 (32%), Positives = 61/137 (44%), Gaps = 12/137 (8%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F+E   +    E+  A+ YL  Q+  +IHRD+KP NI LD+  HV I DF  A  L    
Sbjct: 112 FKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169

Query: 361 MALT--GTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITGNHP-YIEKDYKPAKIA 414
              T  GT  YMAPE+        YS   D +S G+   E++ G  P +I       +I 
Sbjct: 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV 229

Query: 415 MEVGEGKLR--PALPEE 429
                  +    A  +E
Sbjct: 230 HTFETTVVTYPSAWSQE 246

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  104 bits (262), Expect = 9e-25
 Identities = 56/263 (21%), Positives = 98/263 (37%), Gaps = 41/263 (15%)

Query: 147 SPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQG 206
           +P         +   P  +     P         +  Q K N   ID  ++   + +G G
Sbjct: 16  APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNA-IIDDYKV-TSQVLGLG 73

Query: 207 TTANIYRAIWR--GLDVAVKCI--YPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMG 261
               + +   +      A+K +   P              +EV+   R  +   +++++ 
Sbjct: 74  INGKVLQIFNKRTQEKFALKMLQDCPKAR-----------REVELHWRASQCPHIVRIVD 122

Query: 262 AC---LEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
                        +V E L G  L   +   G Q           F ER A  +   I +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA----------FTEREASEIMKSIGE 172

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMALT--GTFVYM 370
           A+QYLH     + HRD+KP N+     +    +++ DFG A+  +      T   T  Y+
Sbjct: 173 AIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 230

Query: 371 APEVIQCEPYSEKSDVYSFGIIL 393
           APEV+  E Y +  D++S G+I+
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIM 253

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  104 bits (262), Expect = 1e-24
 Identities = 69/333 (20%), Positives = 130/333 (39%), Gaps = 62/333 (18%)

Query: 163 LHRYCSQTPLLQQSDLAVTVSQAK-----MNGWYIDPKEIDLQEKIGQGT---------- 207
           L+  C+ +PL ++ ++   +  AK     +    +  ++ ++ + IG+G           
Sbjct: 37  LYDECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLK 96

Query: 208 -TANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP 266
               ++         A+K +              F +E D L     +++  L  A  + 
Sbjct: 97  NADKVF---------AMKILNKWEM-LKRAETACFREERDVLVNGDSKWITTLHYA-FQD 145

Query: 267 PYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQ 323
               +LV +   G  L   L      + ++R        E +AR    E+  A+  +H+ 
Sbjct: 146 DNNLYLVMDYYVGGDLLTLL-----SKFEDR------LPEEMARFYLAEMVIAIDSVHQL 194

Query: 324 KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV----YMAPEVIQCEP 379
               +HRD+KP NI +D   H+R+ADFG    L +     +   V    Y++PE++Q   
Sbjct: 195 H--YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME 252

Query: 380 -----YSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGEGKLRPALPEEDGQ 432
                Y  + D +S G+ + E++ G  P+  +       KI       +    + +    
Sbjct: 253 GGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSEN 312

Query: 433 LRELIE-LIC-----LSWDGDASVR--PSFSSI 457
            ++LI  LIC     L  +G    +  P FS I
Sbjct: 313 AKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (257), Expect = 1e-24
 Identities = 57/218 (26%), Positives = 89/218 (40%), Gaps = 45/218 (20%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVL 257
           + +G+G  A +   I      + AVK I     H          +EV+ L + Q HR VL
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF----REVEMLYQCQGHRNVL 74

Query: 258 QLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           +L+    E   R +LV E +  G+ L               +     F E  A  +  ++
Sbjct: 75  ELIEFF-EEEDRFYLVFEKMRGGSIL-------------SHIHKRRHFNELEASVVVQDV 120

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIADFGHARFLSDGEMALT------ 364
           A A+ +LH +   + HRDLKP NI  +       V+I DF     +              
Sbjct: 121 ASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 365 ----GTFVYMAPEVI-----QCEPYSEKSDVYSFGIIL 393
               G+  YMAPEV+     +   Y ++ D++S G+IL
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 7e-24
 Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 31/218 (14%)

Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRR 293
           +   FF +E D ++     +V+QL  A  +     ++V E        ++ G  L +   
Sbjct: 111 SDSAFFWEERDIMAFANSPWVVQLFYA-FQDDRYLYMVME--------YMPGGDLVNLMS 161

Query: 294 KERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG 351
                      E+ AR    E+  A+  +H      IHRD+KP N+ LD + H+++ADFG
Sbjct: 162 NYD------VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 352 HARFLSDGEMALTGTFV----YMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPY 403
               ++   M    T V    Y++PEV++ +     Y  + D +S G+ L E++ G+ P+
Sbjct: 214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

Query: 404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELIC 441
                       ++   K     P+++   +E   LIC
Sbjct: 274 YADS--LVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  101 bits (253), Expect = 9e-24
 Identities = 39/123 (31%), Positives = 67/123 (54%), Gaps = 6/123 (4%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
           F E  AR  A +I    +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +    
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195

Query: 361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             L GT   +APE+I  + Y++  D ++ G+++ E+  G  P+      P +I  ++  G
Sbjct: 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSG 253

Query: 421 KLR 423
           K+R
Sbjct: 254 KVR 256

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  100 bits (252), Expect = 9e-24
 Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 32/218 (14%)

Query: 199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
              K+    T  I+         A+K +       N         E + L   +H F++ 
Sbjct: 35  QVRKVTGANTGKIF---------AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVD 85

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHG--LGSQRRKERMVPLPPFEERLAR--ALEIA 314
           L+    +   + +L+ E        +L G  L  Q  +E +     F E  A     EI+
Sbjct: 86  LI-YAFQTGGKLYLILE--------YLSGGELFMQLEREGI-----FMEDTACFYLAEIS 131

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--GTFVYMA 371
            A+ +LH++   +I+RDLKP NI L+   HV++ DFG  +  + DG +  T  GT  YMA
Sbjct: 132 MALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMA 189

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
           PE++    ++   D +S G ++ +++TG  P+  ++ K
Sbjct: 190 PEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK 227

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  100 bits (251), Expect = 9e-24
 Identities = 45/117 (38%), Positives = 72/117 (61%), Gaps = 9/117 (7%)

Query: 293 RKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
           RK +      F   +A+  A E+  A++YLH +   +I+RDLKP NI LD   H++I DF
Sbjct: 98  RKSQR-----FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF 150

Query: 351 GHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G A+++ D    L GT  Y+APEV+  +PY++  D +SFGI++ E++ G  P+ + +
Sbjct: 151 GFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  100 bits (250), Expect = 1e-23
 Identities = 53/220 (24%), Positives = 87/220 (39%), Gaps = 30/220 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPD--FFHTNENAVTFFAQEVDTLSR--- 250
            L   +G+G    ++        L VA+K I  +     +  +       EV  L +   
Sbjct: 34  RLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGA 93

Query: 251 -QRHRFVLQLMGACLEPPYRGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
              H  V++L+    E      LV E       L +++        K  +       E  
Sbjct: 94  GGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYI------TEKGPL------GEGP 140

Query: 308 ARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGEMALT 364
           +R    ++  A+Q+ H +   V+HRD+K  NI +D      ++ DFG    L D      
Sbjct: 141 SRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF 198

Query: 365 -GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
            GT VY  PE I    Y    + V+S GI+L +++ G+ P
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =   99 bits (250), Expect = 2e-23
 Identities = 43/120 (35%), Positives = 70/120 (58%), Gaps = 12/120 (10%)

Query: 293 RKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
            KE M     F E   +    E+A A+ +LH     +I+RDLKP NI LD+  H+++ DF
Sbjct: 118 SKEVM-----FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDF 170

Query: 351 GHAR-FLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G ++  +   + A +  GT  YMAPEV+    +++ +D +SFG+++ E++TG  P+  KD
Sbjct: 171 GLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  100 bits (252), Expect = 2e-23
 Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 35/225 (15%)

Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRK 294
             V+ F +E D L     R++ QL     +     +LV E   G  L   L      +  
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLL-----SKFG 156

Query: 295 ERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
           ER          +AR    EI  A+  +H      +HRD+KP NI LD   H+R+ADFG 
Sbjct: 157 ER------IPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 353 ARFLSDGEMALTGTFV----YMAPEVIQCEPYSEKSDVY-------SFGIILNEIITGNH 401
              L       +   V    Y++PE++Q       +  Y       + G+   E+  G  
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 402 PYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL----RELIE-LIC 441
           P+       A+   ++   K   +LP  D  +    R+ I+ L+C
Sbjct: 269 PFYADS--TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC 311

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  102 bits (256), Expect = 2e-23
 Identities = 68/388 (17%), Positives = 129/388 (33%), Gaps = 75/388 (19%)

Query: 64  CQQQHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLE 123
           C +     +  ++  E++           E      +RL  +++     +          
Sbjct: 72  CLKHLEEAKPLVEFYEEIKKY--------EKLETEEERLVCSREIFDTYIMKELLACSHP 123

Query: 124 LMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPLLQQSDLAVTVS 183
              +  E     L+       +  P ++  + Q+       ++       +         
Sbjct: 124 FSKSAIEHVQGHLVKKQVPPDLFQPYIEE-ICQNLRGDVFQKFIESDKFTRFCQWKNVEL 182

Query: 184 QAKMNGWYIDPKEIDLQEKIGQGT-----------TANIYRAIWRGLDVAVKCIYPDFF- 231
                   +   +  +   IG+G            T  +Y         A+KC+      
Sbjct: 183 NIH-----LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMY---------AMKCLDKKRIK 228

Query: 232 ------HT-NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKE 283
                    NE  +      +  +S     F++ +       P +   + +L+ G  L  
Sbjct: 229 MKQGETLALNERIM------LSLVSTGDCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHY 281

Query: 284 WLHGLGSQRRKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD 341
            L        +  +     F E   R  A EI   ++++H +   V++RDLKP+NI LD+
Sbjct: 282 HL-------SQHGV-----FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDE 327

Query: 342 AKHVRIADFGHARFLSDGEMALTGTFV----YMAPEVIQ-CEPYSEKSDVYSFGIILNEI 396
             HVRI+D G A   S  +       V    YMAPEV+Q    Y   +D +S G +L ++
Sbjct: 328 HGHVRISDLGLACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKL 384

Query: 397 ITGNHP-YIEKDYKPAKIAMEVGEGKLR 423
           + G+ P    K     +I        + 
Sbjct: 385 LRGHSPFRQHKTKDKHEIDRMTLTMAVE 412

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 37/113 (32%), Positives = 62/113 (54%), Gaps = 7/113 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
             E  AR  + EI+ A+ YLHE+   +I+RDLK  N+ LD   H+++ D+G  +  L  G
Sbjct: 107 LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
           +   T  GT  Y+APE+++ E Y    D ++ G+++ E++ G  P+       
Sbjct: 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 217

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 99.6 bits (249), Expect = 3e-23
 Identities = 40/110 (36%), Positives = 62/110 (56%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A++YLH +   V++RD+K  N+ LD   H++I DFG  +  +SDG
Sbjct: 102 FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  100 bits (250), Expect = 3e-23
 Identities = 43/120 (35%), Positives = 62/120 (51%), Gaps = 12/120 (10%)

Query: 293 RKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
           ++ER      F E  AR  A EIA A+ YLH     +++RDLKP NI LD   H+ + DF
Sbjct: 131 QRERC-----FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDF 183

Query: 351 GHA-RFLSDGEMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           G     +       T  GT  Y+APEV+  +PY    D +  G +L E++ G  P+  ++
Sbjct: 184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 21/152 (13%)

Query: 302 PFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
           P  E  AR    ++ + ++YLH QK  +IHRD+KPSN+ + +  H++IADFG +      
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 360 EMALT---GTFVYMAPEVIQ--CEPYS-EKSDVYSFGIILNEIITGNHPYIEKD----YK 409
           +  L+   GT  +MAPE +    + +S +  DV++ G+ L   + G  P++++     + 
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250

Query: 410 PAKIAMEVGEGKLR-PALPEEDGQLRELIELI 440
             KI        L  P  P+    L++LI  +
Sbjct: 251 --KIK----SQALEFPDQPDIAEDLKDLITRM 276

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 39/110 (35%), Positives = 65/110 (59%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F+E  AR  A EI  A+ +LH++   +I+RDLK  N+ LD   H ++ADFG  +  + +G
Sbjct: 121 FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
               T  GT  Y+APE++Q   Y    D ++ G++L E++ G+ P+  ++
Sbjct: 179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 97.5 bits (243), Expect = 6e-23
 Identities = 39/259 (15%), Positives = 73/259 (28%), Gaps = 44/259 (16%)

Query: 199 LQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L    G       ++A+   LD  VA+  + P      ++ +         LSR     V
Sbjct: 35  LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQG-VLPDDVLQETLSRTLRLSRIDKPGV 93

Query: 257 LQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
            +++   +     G +V E + G +L+E                  P    +     +A 
Sbjct: 94  ARVLDV-VHTRAGGLVVAEWIRGGSLQEVADT-----------SPSP-VGAIRAMQSLAA 140

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVI 375
           A    H     V      PS + +     V +A                     M     
Sbjct: 141 AADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA-----------------TMPDA-- 179

Query: 376 QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIAMEVGEGKLRPALPEEDGQLR 434
                + + D+   G  L  ++    P  E   +     A     G+       +     
Sbjct: 180 -----NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 435 ELIELICLSWDGDASVRPS 453
           ++  +   S  GD  +R +
Sbjct: 235 QISAVAARSVQGDGGIRSA 253

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 99.0 bits (247), Expect = 7e-23
 Identities = 37/113 (32%), Positives = 62/113 (54%), Gaps = 7/113 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
             E  AR  + EI+ A+ YLHE+   +I+RDLK  N+ LD   H+++ D+G  +  L  G
Sbjct: 150 LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
           +   T  GT  Y+APE+++ E Y    D ++ G+++ E++ G  P+       
Sbjct: 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 260

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 42/110 (38%), Positives = 65/110 (59%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F+E  A   A EIA  + +L  +   +I+RDLK  N+ LD   H++IADFG  +  + DG
Sbjct: 118 FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
               T  GT  Y+APE+I  +PY +  D ++FG++L E++ G  P+  +D
Sbjct: 176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 225

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 97.7 bits (244), Expect = 1e-22
 Identities = 39/110 (35%), Positives = 62/110 (56%), Gaps = 7/110 (6%)

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F+   A   A EI   +Q+LH +   +++RDLK  NI LD   H++IADFG  +  +   
Sbjct: 115 FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 172

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
               T  GT  Y+APE++  + Y+   D +SFG++L E++ G  P+  +D
Sbjct: 173 AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 222

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 97.3 bits (242), Expect = 2e-22
 Identities = 52/163 (31%), Positives = 83/163 (50%), Gaps = 16/163 (9%)

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE--MALTGTF 367
           + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR +      +      
Sbjct: 199 SFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY--IEKDYKPAKIAMEVGEGK 421
           +   +MAPE I    Y+ +SDV+SFG++L EI + G  PY  ++ D    +    + EG 
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID---EEFCRRLKEGT 313

Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            R   P+      E+ + +   W G+ S RP+FS +   L N+
Sbjct: 314 -RMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 55/170 (32%), Positives = 79/170 (46%), Gaps = 20/170 (11%)

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPP 302
           E   L   RH F+  L     +   R   V E   G  L   L        +ER+     
Sbjct: 198 ENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-------RERV----- 244

Query: 303 FEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDG 359
           F E  AR    EI  A+ YLH +K  V++RDLK  N+ LD   H++I DFG  +  + DG
Sbjct: 245 FSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
               T  GT  Y+APEV++   Y    D +  G+++ E++ G  P+  +D
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            ++E +G+G+   +  A        VA+K I         +      +E+  L   RH  
Sbjct: 12  IIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLL-KKSDMHMRVEREISYLKLLRHPH 70

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EI 313
           +++L    +  P    +V E  G  L +++        K+RM       E   R    +I
Sbjct: 71  IIKLY-DVITTPTDIVMVIEYAGGELFDYI------VEKKRM------TEDEGRRFFQQI 117

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYMA 371
             A++Y H  K  ++HRDLKP N+ LDD  +V+IADFG +  ++DG    T  G+  Y A
Sbjct: 118 ICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAA 175

Query: 372 PEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
           PEVI  + Y+  + DV+S GI+L  ++ G  P
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 54/233 (23%), Positives = 99/233 (42%), Gaps = 34/233 (14%)

Query: 185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFA 242
           AK+ G Y+      + + +G+G+   +            AVK +         N      
Sbjct: 1   AKLIGKYL------MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK 54

Query: 243 QEVDTLSRQRHRFVLQL---MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVP 299
           +E+  L R RH+ V+QL   +    E   + ++V E     ++E L  +  +R       
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYN--EEKQKMYMVMEYCVCGMQEMLDSVPEKR------- 105

Query: 300 LPPFEERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL- 356
              F    A     ++   ++YLH Q   ++H+D+KP N+ L     ++I+  G A  L 
Sbjct: 106 ---FPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISALGVAEALH 160

Query: 357 --SDGEMALT--GTFVYMAPEVIQ-CEPYS-EKSDVYSFGIILNEIITGNHPY 403
             +  +   T  G+  +  PE+    + +S  K D++S G+ L  I TG +P+
Sbjct: 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPF 213

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 24/214 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            L + +G GT   +     +  G  VAVK +       + + V    +E+  L   RH  
Sbjct: 14  VLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIR-SLDVVGKIKREIQNLKLFRHPH 72

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L    +  P   ++V E + G  L +++       +  R+      EE  AR L  +
Sbjct: 73  IIKLY-QVISTPTDFFMVMEYVSGGELFDYI------CKHGRV------EEMEARRLFQQ 119

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           I  A+ Y H     V+HRDLKP N+ LD   + +IADFG +  +SDGE   T  G+  Y 
Sbjct: 120 ILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177

Query: 371 APEVIQCEPYS-EKSDVYSFGIILNEIITGNHPY 403
           APEVI    Y+  + D++S G+IL  ++ G  P+
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPF 211

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 96.6 bits (240), Expect = 2e-21
 Identities = 51/162 (31%), Positives = 82/162 (50%), Gaps = 21/162 (12%)

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR- 309
           +  F+ QL  +C +   R + V E + G  L   +        +        F+E  A  
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-------QVGR-----FKEPHAVF 446

Query: 310 -ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR-FLSDGEMALT--G 365
            A EIA  + +L  +   +I+RDLK  N+ LD   H++IADFG  +  + DG    T  G
Sbjct: 447 YAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCG 504

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           T  Y+APE+I  +PY +  D ++FG++L E++ G  P+  +D
Sbjct: 505 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 546

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 15/131 (11%)

Query: 293 RKERMVPLPPFEERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF 350
            +        F E   +    EI  A+++LH+    +I+RD+K  NI LD   HV + DF
Sbjct: 151 SQRER-----FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDF 203

Query: 351 GHARFLSDGEMALTGTFV----YMAPEVIQCEPYSEKSDV--YSFGIILNEIITGNHPYI 404
           G ++     E      F     YMAP++++         V  +S G+++ E++TG  P+ 
Sbjct: 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

Query: 405 EKDYKPAKIAM 415
               K ++  +
Sbjct: 264 VDGEKNSQAEI 274

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 7e-21
 Identities = 55/259 (21%), Positives = 99/259 (38%), Gaps = 54/259 (20%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN-ENAVTFFAQEVDTLSRQRHRF 255
           ++   GQGT   +     +  G+ VA+K +  D    N E       Q +  L+   H  
Sbjct: 27  VERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE------LQIMQDLAVLHHPN 80

Query: 256 VLQLMGACLEPPYRG-------WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           ++QL  +                +V E +  TL         ++        PP   ++ 
Sbjct: 81  IVQLQ-SYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV-----APPPILIKV- 133

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMALTGTF 367
              ++ +++  LH     V HRD+KP N+ +++A    ++ DFG A+ LS  E       
Sbjct: 134 FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-PNVAYI 192

Query: 368 V---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
               Y APE+I   + Y+   D++S G I  E++ G                        
Sbjct: 193 CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-----------------------E 229

Query: 424 PALPEEDG--QLRELIELI 440
           P    ++   QL E++ ++
Sbjct: 230 PIFRGDNSAGQLHEIVRVL 248

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.2 bits (229), Expect = 2e-20
 Identities = 61/236 (25%), Positives = 104/236 (44%), Gaps = 31/236 (13%)

Query: 184 QAKMNGWYIDPKEIDLQE----KIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNE 235
           + K++      +  DL E    K+G+GT  ++Y+A  +      D A+K I  +    + 
Sbjct: 8   KVKLSSER--ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISM 63

Query: 236 NAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG-WLVTELLGTTLKEWLHGLGSQRRK 294
           +A     +E+  L   +H  V+ L    L    R  WL+ +     L   +    + +  
Sbjct: 64  SAC----REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119

Query: 295 ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVRIADF 350
           ++ V LP    + +   +I   + YLH     V+HRDLKP+NI +         V+IAD 
Sbjct: 120 KKPVQLPRGMVK-SLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 351 GHARFLSDGEMALTG------TFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           G AR  +     L        TF Y APE++     Y++  D+++ G I  E++T 
Sbjct: 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 34/217 (15%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFF----AQEVDTL---SRQ 251
            +IG G    +Y+A     G  VA+K +                    +EV  L      
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVR---VPNGGGGGGGLPISTVREVALLRRLEAF 71

Query: 252 RHRFVLQL----MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            H  V++L      +  +   +  LV E +   L+ +L             P P      
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL----------DKAPPPGLPAET 121

Query: 308 ARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
            + L  +  + + +LH     ++HRDLKP NI +     V++ADFG AR  S  +MALT 
Sbjct: 122 IKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGTVKLADFGLARIYSY-QMALTP 178

Query: 366 TFV---YMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
             V   Y APEV+    Y+   D++S G I  E+   
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 47/280 (16%), Positives = 92/280 (32%), Gaps = 70/280 (25%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPD------------------------FFH 232
           L + +G G+   +        G   A+K +  D                        +F+
Sbjct: 11  LGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFY 70

Query: 233 TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG-----WLVTELLGTTLKEWLHG 287
           T  +      Q  D  ++   +                      ++ E +  TL + L  
Sbjct: 71  TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130

Query: 288 LGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV-R 346
                R      +P     +    ++ +A+ ++H     + HRD+KP N+ ++   +  +
Sbjct: 131 FIRSGR-----SIPMNLISI-YIYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLK 182

Query: 347 IADFGHARFLSDGEMALTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHP 402
           + DFG A+ L   E           Y APE++     Y+   D++S G +  E+I G   
Sbjct: 183 LCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG--- 238

Query: 403 YIEKDYKPAKIAMEVGEGKLRPALPEEDG--QLRELIELI 440
                               +P    E    QL  +I+++
Sbjct: 239 --------------------KPLFSGETSIDQLVRIIQIM 258

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.8 bits (223), Expect = 2e-19
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 24/213 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            L + +G GT   +        G  VAVK +       + + V    +E+  L   RH  
Sbjct: 19  ILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPH 77

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++L    +  P   ++V E + G  L +++       +  R+      +E+ +R L  +
Sbjct: 78  IIKLY-QVISTPSDIFMVMEYVSGGELFDYI------CKNGRL------DEKESRRLFQQ 124

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           I   + Y H     V+HRDLKP N+ LD   + +IADFG +  +SDGE   T  G+  Y 
Sbjct: 125 ILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182

Query: 371 APEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
           APEVI    Y+  + D++S G+IL  ++ G  P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 86.9 bits (216), Expect = 2e-19
 Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 39/221 (17%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           DL + +G+G    +  A+ R     VAVK +           +    +E+       H  
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHEN 66

Query: 256 VLQLMGACLEPPYRGWLVTE------LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           V++  G         +L  E      L                  +R+ P     E  A+
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELF-----------------DRIEPDIGMPEPDAQ 108

Query: 310 AL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--- 364
               ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A              
Sbjct: 109 RFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 365 --GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
             GT  Y+APE+++   +  E  DV+S GI+L  ++ G  P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 22/208 (10%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           EK+G GT A +Y+ + +  G+ VA+K +  D    +E      A +E+  +   +H  ++
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLD----SEEGTPSTAIREISLMKELKHENIV 66

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
           +L         +  LV E +   LK+++                  E  L +    ++ Q
Sbjct: 67  RLYDVIHTEN-KLTLVFEFMDNDLKKYMDSRTVGNTPR------GLELNLVKYFQWQLLQ 119

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            + + HE K  ++HRDLKP N+ ++    +++ DFG AR         +   V   Y AP
Sbjct: 120 GLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAP 177

Query: 373 EVI-QCEPYSEKSDVYSFGIILNEIITG 399
           +V+     YS   D++S G IL E+ITG
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITG 205

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.0 bits (214), Expect = 5e-19
 Identities = 49/212 (23%), Positives = 92/212 (43%), Gaps = 26/212 (12%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           EKIG+GT   +++A  R     VA+K +  D    ++  V   A +E+  L   +H+ ++
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLD---DDDEGVPSSALREICLLKELKHKNIV 64

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
           +L         +  LV E     LK++                   +  + ++   ++ +
Sbjct: 65  RLHDVLHSDK-KLTLVFEFCDQDLKKYFDSCNG-----------DLDPEIVKSFLFQLLK 112

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            + + H +   V+HRDLKP N+ ++    +++A+FG AR         +   V   Y  P
Sbjct: 113 GLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170

Query: 373 EVI-QCEPYSEKSDVYSFGIILNEIITGNHPY 403
           +V+   + YS   D++S G I  E+     P 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.0 bits (218), Expect = 7e-19
 Identities = 56/234 (23%), Positives = 96/234 (41%), Gaps = 38/234 (16%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ---- 243
           + +  +  +L+  IG G    +  A       +VA+K +   F +         A+    
Sbjct: 58  FTVLKRYQNLK-PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQ------THAKRAYR 110

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG-----WLVTELLGTTLKEWLH-GLGSQRRKERM 297
           E+  +    H+ ++ L+               +LV EL+   L + +   L  +R    +
Sbjct: 111 ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLL 170

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
                         ++   +++LH     +IHRDLKPSNI +     ++I DFG AR   
Sbjct: 171 Y-------------QMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215

Query: 358 DGEMALTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
              M +T    T  Y APEVI    Y E  D++S G I+ E++     +  +DY
Sbjct: 216 TSFM-MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 87.1 bits (216), Expect = 9e-19
 Identities = 58/256 (22%), Positives = 102/256 (39%), Gaps = 56/256 (21%)

Query: 200 QEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVL 257
            + IG G+   +Y+A     G  VA+K +  D    N        +E+  + +  H  ++
Sbjct: 59  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHCNIV 110

Query: 258 QLMGACLEPPYRGW------LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           +L                  LV + +  T+          ++      LP    +L    
Sbjct: 111 RLR-YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ-----TLPVIYVKL-YMY 163

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMALTG---TF 367
           ++ +++ Y+H     + HRD+KP N+ LD    V ++ DFG A+ L  GE        + 
Sbjct: 164 QLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYICSR 220

Query: 368 VYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
            Y APE+I     Y+   DV+S G +L E++ G                       +P  
Sbjct: 221 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-----------------------QPIF 257

Query: 427 PEEDG--QLRELIELI 440
           P + G  QL E+I+++
Sbjct: 258 PGDSGVDQLVEIIKVL 273

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 52/268 (19%), Positives = 111/268 (41%), Gaps = 63/268 (23%)

Query: 201 EKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR----- 250
            K+G G  + ++ A  +     VA+K +             +      E+  L R     
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIV--------RGDKVYTEAAEDEIKLLQRVNDAD 76

Query: 251 ------QRHRFVLQLMGACLEPPYRGW------LVTELLGTTLKEWLHGLGSQRRKERMV 298
                      +L+L+       ++G       +V E+LG  L   +     ++ + R +
Sbjct: 77  NTKEDSMGANHILKLLDHFN---HKGPNGVHVVMVFEVLGENLLALI-----KKYEHRGI 128

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH------VRIADFGH 352
           PL  + +++++ L     + Y+H ++  +IH D+KP N+ ++          ++IAD G+
Sbjct: 129 PLI-YVKQISKQLL--LGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 184

Query: 353 ARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK 412
           A +  +       T  Y +PEV+   P+   +D++S   ++ E+ITG+  +         
Sbjct: 185 ACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF--------- 235

Query: 413 IAMEVGEGKLRPALPEEDGQLRELIELI 440
                 E     +  ++D  + ++IEL+
Sbjct: 236 ------EPDEGHSYTKDDDHIAQIIELL 257

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 201 EKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTL---SRQRH 253
            +IG+G    +++A      G  VA+K +      T E  +     +EV  L       H
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVR---VQTGEEGMPLSTIREVAVLRHLETFEH 73

Query: 254 RFVLQL----MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
             V++L      +  +   +  LV E +   L  +L            VP P       +
Sbjct: 74  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----------DKVPEPGVPTETIK 123

Query: 310 AL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
            +  ++ + + +LH    +V+HRDLKP NI +  +  +++ADFG AR  S  +MALT   
Sbjct: 124 DMMFQLLRGLDFLHSH--RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVV 180

Query: 368 V---YMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
           V   Y APEV+    Y+   D++S G I  E+   
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR 215

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 35/229 (15%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ----EVDT 247
            K     + IG G    +  A       +VA+K +   F +         A+    E+  
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ------THAKRAYRELVL 77

Query: 248 LSRQRHRFVLQLMGACLEPPYRG-----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
           +    H+ ++ L+               ++V EL+   L + +     +   ERM  L  
Sbjct: 78  MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHERMSYL-- 132

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
                    ++   +++LH     +IHRDLKPSNI +     ++I DFG AR      M 
Sbjct: 133 -------LYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM- 182

Query: 363 LTG---TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY 408
           +T    T  Y APEVI    Y E  D++S G I+ E+I G   +   D+
Sbjct: 183 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 52/221 (23%), Positives = 87/221 (39%), Gaps = 39/221 (17%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           DL + +G+G    +  A+ R     VAVK +           +    +E+       H  
Sbjct: 10  DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENI---KKEICINKMLNHEN 66

Query: 256 VLQLMGACLEPPYRGWLVTE------LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
           V++  G         +L  E      L                  +R+ P     E  A+
Sbjct: 67  VVKFYG-HRREGNIQYLFLEYCSGGELF-----------------DRIEPDIGMPEPDAQ 108

Query: 310 AL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--- 364
               ++   + YLH     + HRD+KP N+ LD+  +++I+DFG A              
Sbjct: 109 RFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166

Query: 365 --GTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
             GT  Y+APE+++   +  E  DV+S GI+L  ++ G  P
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 58/218 (26%), Positives = 87/218 (39%), Gaps = 40/218 (18%)

Query: 201 EKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR----- 250
             IG+G+   + +A        VA+K I        +N   F  Q   EV  L       
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKII--------KNKKAFLNQAQIEVRLLELMNKHD 111

Query: 251 --QRHRFVLQLMGACLEPPYRGWL--VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
              ++  V  L    +   +R  L  V E+L   L + L       R      +      
Sbjct: 112 TEMKYYIV-HLKRHFM---FRNHLCLVFEMLSYNLYDLL-------RNTNFRGVSL---N 157

Query: 307 LAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VRIADFGHARFLSDGEMA 362
           L R  A ++  A+ +L   +  +IH DLKP NI L + K   ++I DFG +  L      
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQ 217

Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN 400
              +  Y +PEV+   PY    D++S G IL E+ TG 
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 84.5 bits (210), Expect = 3e-18
 Identities = 54/207 (26%), Positives = 94/207 (45%), Gaps = 25/207 (12%)

Query: 201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVLQ 258
           EK+G+GT   +Y+A    G  VA+K I  D     +  +   A +E+  L    H  ++ 
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLD---AEDEGIPSTAIREISLLKELHHPNIVS 83

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQA 316
           L+           LV E +   LK+ L    +             ++   +    ++ + 
Sbjct: 84  LIDVIHSER-CLTLVFEFMEKDLKKVLDENKT-----------GLQDSQIKIYLYQLLRG 131

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPE 373
           + + H+ +  ++HRDLKP N+ ++    +++ADFG AR       + T   V   Y AP+
Sbjct: 132 VAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPD 189

Query: 374 VI-QCEPYSEKSDVYSFGIILNEIITG 399
           V+   + YS   D++S G I  E+ITG
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITG 216

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 85.5 bits (212), Expect = 3e-18
 Identities = 48/211 (22%), Positives = 89/211 (42%), Gaps = 28/211 (13%)

Query: 200 QEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
            + IG G+   +++A      +VA+K +  D    N        +E+  +   +H  V+ 
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--------RELQIMRIVKHPNVVD 96

Query: 259 LMGACLEPPYRGW-----LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           L         +       LV E +  T+          ++      +P    +L    ++
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ-----TMPMLLIKL-YMYQL 150

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV-RIADFGHARFLSDGEMALTG---TFVY 369
            +++ Y+H     + HRD+KP N+ LD    V ++ DFG A+ L  GE        +  Y
Sbjct: 151 LRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-PNVSYICSRYY 207

Query: 370 MAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
            APE+I     Y+   D++S G ++ E++ G
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.7 bits (210), Expect = 4e-18
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 42/223 (18%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ----EVDT 247
           PK       +G G   ++  AI +  G  VA+K +   F          FA+    E+  
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSE------IFAKRAYRELLL 76

Query: 248 LSRQRHRFVLQLMGACLEPPYRG------WLVTELLGTTLKEWLHGLGSQRRKERMVPLP 301
           L   +H  V+ L+     P          +LV   + T L             ++++ L 
Sbjct: 77  LKHMQHENVIGLLDV-FTPASSLRNFYDFYLVMPFMQTDL-------------QKIMGLK 122

Query: 302 PFEERLARAL-EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE 360
             EE++   + ++ + ++Y+H     V+HRDLKP N+ +++   ++I DFG AR      
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADA-- 178

Query: 361 MALTG---TFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
             +TG   T  Y APEVI     Y++  D++S G I+ E++TG
Sbjct: 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 83.3 bits (207), Expect = 4e-18
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 25/207 (12%)

Query: 201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVLQ 258
           EKIG+GT   +Y+A    G   A+K I  +     +  +     +E+  L   +H  +++
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLE---KEDEGIPSTTIREISILKELKHSNIVK 64

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQA 316
           L         R  LV E L   LK+ L                  E   A++   ++   
Sbjct: 65  LYDVIHTKK-RLVLVFEHLDQDLKKLLDVCEG-----------GLESVTAKSFLLQLLNG 112

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPE 373
           + Y H+++  V+HRDLKP N+ ++    ++IADFG AR         T   V   Y AP+
Sbjct: 113 IAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 374 VI-QCEPYSEKSDVYSFGIILNEIITG 399
           V+   + YS   D++S G I  E++ G
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 83.4 bits (207), Expect = 9e-18
 Identities = 50/219 (22%), Positives = 82/219 (37%), Gaps = 36/219 (16%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ-EVDTLSRQRHRFVL 257
            KIGQGT   +++A  R  G  VA+K +        +      A  E+  L   +H  V+
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKILQLLKHENVV 79

Query: 258 QLMGACLEPPYRGW-------LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            L+  C               LV +     L   L              L  F     + 
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-----------NVLVKFTLSEIKR 128

Query: 311 L--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF----LSDGEMALT 364
           +   +   + Y+H  K  ++HRD+K +N+ +     +++ADFG AR      +      T
Sbjct: 129 VMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 365 GTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
              V   Y  PE++     Y    D++  G I+ E+ T 
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 83.4 bits (207), Expect = 9e-18
 Identities = 51/208 (24%), Positives = 90/208 (43%), Gaps = 23/208 (11%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           + +G+G  A +Y+A  +     VA+K I        ++ +   A +E+  L    H  ++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
            L+ A         LV + + T L+  +                       +A      Q
Sbjct: 76  GLLDAFGHKS-NISLVFDFMETDLEVIIKDNSL-----------VLTPSHIKAYMLMTLQ 123

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            ++YLH+    ++HRDLKP+N+ LD+   +++ADFG A+       A T   V   Y AP
Sbjct: 124 GLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 181

Query: 373 EVI-QCEPYSEKSDVYSFGIILNEIITG 399
           E++     Y    D+++ G IL E++  
Sbjct: 182 ELLFGARMYGVGVDMWAVGCILAELLLR 209

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 53/227 (23%), Positives = 91/227 (40%), Gaps = 46/227 (20%)

Query: 198 DLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNENAV---TFFAQ----EV 245
            +Q  I  G+    Y A+  G+D     VA+K ++          +   +F  +    E+
Sbjct: 25  TVQRFISSGS----YGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLP 301
             L+   H  +L L    +          +LVTEL+ T L + +         ++ + + 
Sbjct: 81  RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVI--------HDQRIVIS 132

Query: 302 PFEER-----LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL 356
           P   +     +   L        LHE    V+HRDL P NI L D   + I DF  AR  
Sbjct: 133 PQHIQYFMYHILLGL------HVLHEAG--VVHRDLHPGNILLADNNDITICDFNLARED 184

Query: 357 SDGEMALTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           +      T       Y APE++ Q + +++  D++S G ++ E+   
Sbjct: 185 TADAN-KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 62/225 (27%), Positives = 98/225 (43%), Gaps = 38/225 (16%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ---- 243
           W +     DLQ  +G G    +  A+    G  VA+K +Y  F          FA+    
Sbjct: 21  WEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE------LFAKRAYR 73

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG-----WLVTELLGTTLKEWLHGLGSQRRKERMV 298
           E+  L   RH  V+ L+               +LV   +GT L + +     ++  E  +
Sbjct: 74  ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK---HEKLGEDRI 130

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
                  ++ + L      +Y+H     +IHRDLKP N+ +++   ++I DFG AR    
Sbjct: 131 QF--LVYQMLKGL------RYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADS 180

Query: 359 GEMALTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
               +TG  V   Y APEVI     Y++  D++S G I+ E+ITG
Sbjct: 181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 52/215 (24%), Positives = 85/215 (39%), Gaps = 30/215 (13%)

Query: 198 DLQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D  + IG G                VAVK I  +     +  V    +E+      RH  
Sbjct: 23  DFVKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENV---QREIINHRSLRHPN 77

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--E 312
           +++     +  P    ++ E   G  L E +          R        E  AR    +
Sbjct: 78  IVRFK-EVILTPTHLAIIMEYASGGELYERI------CNAGRF------SEDEARFFFQQ 124

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADFGHARFLSDGEMALT--GTFV 368
           +   + Y H  +  + HRDLK  N  LD   A  ++I DFG+++         +  GT  
Sbjct: 125 LLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182

Query: 369 YMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHP 402
           Y+APEV+  + Y  + +DV+S G+ L  ++ G +P
Sbjct: 183 YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 82.7 bits (205), Expect = 1e-17
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 27/208 (12%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
           +K+G+GT A +Y+   +     VA+K I  +    +E      A +EV  L   +H  ++
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLE----HEEGAPCTAIREVSLLKDLKHANIV 63

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQ 315
            L            LV E L   LK++L   G+                  +    ++ +
Sbjct: 64  TLHDIIHTEK-SLTLVFEYLDKDLKQYLDDCGN-----------IINMHNVKLFLFQLLR 111

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAP 372
            + Y H QK  V+HRDLKP N+ +++   +++ADFG AR  S          V   Y  P
Sbjct: 112 GLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPP 169

Query: 373 EVI-QCEPYSEKSDVYSFGIILNEIITG 399
           +++     YS + D++  G I  E+ TG
Sbjct: 170 DILLGSTDYSTQIDMWGVGCIFYEMATG 197

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 82.2 bits (204), Expect = 1e-17
 Identities = 46/205 (22%), Positives = 83/205 (40%), Gaps = 20/205 (9%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
            KIG+G+   +++   R  G  VA+K             +    +E+  L + +H  ++ 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKHPNLVN 66

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+        R  LV E    T+   L              +P    + +   +  QA+ 
Sbjct: 67  LLEVFRRKR-RLHLVFEYCDHTVLHEL--------DRYQRGVPEHLVK-SITWQTLQAVN 116

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEVI 375
           + H+     IHRD+KP NI +     +++ DFG AR L+              Y +PE++
Sbjct: 117 FCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELL 174

Query: 376 -QCEPYSEKSDVYSFGIILNEIITG 399
                Y    DV++ G +  E+++G
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSG 199

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 20/205 (9%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ 258
             +G+G+   + +   +  G  VA+K             +    +E+  L + RH  ++ 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAM--REIKLLKQLRHENLVN 88

Query: 259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQ 318
           L+  C +   R +LV E +  T+ + L        +     L     +     +I   + 
Sbjct: 89  LLEVCKKKK-RWYLVFEFVDHTILDDL--------ELFPNGLDYQVVQ-KYLFQIINGIG 138

Query: 319 YLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV---YMAPEVI 375
           + H     +IHRD+KP NI +  +  V++ DFG AR L+              Y APE++
Sbjct: 139 FCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELL 196

Query: 376 -QCEPYSEKSDVYSFGIILNEIITG 399
                Y +  DV++ G ++ E+  G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMG 221

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 40/226 (17%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ---- 243
           W +  +  +L   +G G   ++  A     GL VAVK +   F           A+    
Sbjct: 25  WEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI------IHAKRTYR 77

Query: 244 EVDTLSRQRHRFVLQLMGACLEPPYRG------WLVTELLGTTLKEWLHGLGSQRRKERM 297
           E+  L   +H  V+ L+     P          +LVT L+G  L   +     Q+  +  
Sbjct: 78  ELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDH 133

Query: 298 VPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS 357
           V       ++ R L      +Y+H     +IHRDLKPSN+ +++   ++I DFG AR  +
Sbjct: 134 VQF--LIYQILRGL------KYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183

Query: 358 DGEMALTG---TFVYMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           D    +TG   T  Y APE++     Y++  D++S G I+ E++TG
Sbjct: 184 D---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 41/207 (19%), Positives = 73/207 (35%), Gaps = 52/207 (25%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRF 255
             + +G G    + +   +      A+K +                +EV+   R  +   
Sbjct: 22  TSQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHWRASQCPH 72

Query: 256 VLQLMGAC---LEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           +++++              +V E L G  L          R ++R      F ER A  +
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFS--------RIQDR--GDQAFTEREASEI 122

Query: 312 --EIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALTGT 366
              I +A+QYLH     + HRD+KP N+          +++ DFG               
Sbjct: 123 MKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFG--------------- 165

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIIL 393
               A E    E Y +  D++S G+I+
Sbjct: 166 ---FAKETTG-EKYDKSCDMWSLGVIM 188

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 28/211 (13%)

Query: 201 EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA-QEVDTLSRQRHRFVL 257
            K+G+GT   +Y+AI       VA+K I  +     E  V   A +EV  L   +HR ++
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLE---HEEEGVPGTAIREVSLLKELQHRNII 96

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
           +L         R  L+ E     LK+++         ++   +     +     ++   +
Sbjct: 97  ELKSVIHHNH-RLHLIFEYAENDLKKYM---------DKNPDVSMRVIKSF-LYQLINGV 145

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVR-----IADFGHARFLSDGEMALTGTFV---Y 369
            + H ++   +HRDLKP N+ L  +         I DFG AR         T   +   Y
Sbjct: 146 NFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWY 203

Query: 370 MAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
             PE++     YS   D++S   I  E++  
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 80.5 bits (199), Expect = 1e-16
 Identities = 54/217 (24%), Positives = 83/217 (38%), Gaps = 42/217 (19%)

Query: 201 EKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR----- 250
           + IG+G+   + +A        VA+K +         N   F  Q   E+  L       
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMV--------RNEKRFHRQAAEEIRILEHLRKQD 154

Query: 251 --QRHRFVLQLMGACLEPPYRG--WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
                  +  ++       +R    +  ELL   L E +       +K +          
Sbjct: 155 KDNTMNVI-HMLENFT---FRNHICMTFELLSMNLYELI-------KKNKFQGFSL---P 200

Query: 307 LAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VRIADFGHARFLSDGEMA 362
           L R  A  I Q +  LH  K ++IH DLKP NI L       +++ DFG + +       
Sbjct: 201 LVRKFAHSILQCLDALH--KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258

Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
              +  Y APEVI    Y    D++S G IL E++TG
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG 295

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 79.2 bits (196), Expect = 3e-16
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 41/225 (18%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQ----EVDT 247
                    IG+G    +  A      + VA+K I P  F   E+    + Q    E+  
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--F---EHQT--YCQRTLREIKI 78

Query: 248 LSRQRHRFVLQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           L R RH  ++ +      P        ++V +L+ T L + L    +Q            
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLK---TQ----------HL 125

Query: 304 EERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
                     +I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR       
Sbjct: 126 SNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183

Query: 362 ---ALTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
               LT       Y APE++   + Y++  D++S G IL E+++ 
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 228

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 8/96 (8%)

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-VRIADFGHARFLSDGEMALTG---TF 367
           EI +A+ Y H     ++HRD+KP N+ +D     +R+ D+G A F   G+        + 
Sbjct: 138 EILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-EYNVRVASR 194

Query: 368 VYMAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHP 402
            +  PE++   + Y    D++S G +L  +I    P
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 76.4 bits (188), Expect = 4e-15
 Identities = 56/301 (18%), Positives = 103/301 (34%), Gaps = 83/301 (27%)

Query: 198 DLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQ----EVDT 247
           +++  IG G+    Y  +    D      VA+K I   F    E+ +    +    E+  
Sbjct: 56  EIRHLIGTGS----YGHVCEAYDKLEKRVVAIKKILRVF----EDLI--DCKRILREIAI 105

Query: 248 LSRQRHRFVLQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           L+R  H  V++++   +          ++V E+  +  K+      +             
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFR---TPV---------YL 153

Query: 304 EERLARAL--EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM 361
            E   + L   +   ++Y+H     ++HRDLKP+N  ++    V++ DFG AR +   E 
Sbjct: 154 TELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 362 ALTGTFV------------------------------YMAPEVI-QCEPYSEKSDVYSFG 390
             +   +                              Y APE+I   E Y+E  DV+S G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

Query: 391 IILNEIITGNHPYIE-----------KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIEL 439
            I  E++      +                P     + G           D QL  +  +
Sbjct: 272 CIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRD-QLNVIFNI 330

Query: 440 I 440
           +
Sbjct: 331 L 331

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 60/236 (25%)

Query: 200 QEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR--- 250
            + +G+G    +   I     G  VAVK +        +N   +      E+  L     
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIV--------KNVDRYCEAARSEIQVLEHLNT 70

Query: 251 ----QRHRFVLQLMGACLEPPYRG--WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
                  R V   M    E  + G   +V ELLG +  +++       ++   +P     
Sbjct: 71  TDPNSTFRCVQ--MLEWFE--HHGHICIVFELLGLSTYDFI-------KENGFLPFRL-- 117

Query: 305 ERLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH------------------ 344
               R  A +I +++ +LH  K  + H DLKP NI    + +                  
Sbjct: 118 -DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174

Query: 345 -VRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
            +++ DFG A +  +    L  T  Y APEVI    +S+  DV+S G IL E   G
Sbjct: 175 DIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 53/235 (22%), Positives = 84/235 (35%), Gaps = 62/235 (26%)

Query: 198 DLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQ----EVDT 247
            L+  +G+G     Y  +           VA+K I P F          FA     E+  
Sbjct: 14  QLKSLLGEGA----YGVVCSATHKPTGEIVAIKKIEP-FDKP------LFALRTLREIKI 62

Query: 248 LSRQRHRFVLQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPF 303
           L   +H  ++ +        +      +++ EL+ T L   +              L   
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI----------STQMLSDD 112

Query: 304 EER-----LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSD 358
             +       RA+      + LH     VIHRDLKPSN+ ++    +++ DFG AR + +
Sbjct: 113 HIQYFIYQTLRAV------KVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164

Query: 359 GEMA----------LTGTFV---YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
                         +        Y APEV+     YS   DV+S G IL E+   
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR 219

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 74.2 bits (183), Expect = 8e-15
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 10/92 (10%)

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHARFLS---DGEMALTGTFV--- 368
            ++Y+H     V+HRDLKP+N+F++     ++I DFG AR +      +  L+   V   
Sbjct: 132 GLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW 189

Query: 369 YMAPEVI-QCEPYSEKSDVYSFGIILNEIITG 399
           Y +P ++     Y++  D+++ G I  E++TG
Sbjct: 190 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 56/235 (23%), Positives = 89/235 (37%), Gaps = 60/235 (25%)

Query: 201 EKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR---- 250
             +G+GT   +   +        VA+K I         N   +      E++ L +    
Sbjct: 25  GNLGEGTFGKVVECLDHARGKSQVALKII--------RNVGKYREAARLEINVLKKIKEK 76

Query: 251 ---QRHRFVLQLMGACLEPPYRG--WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
               +   VL  M       + G   +  ELLG    E+L       ++    P P    
Sbjct: 77  DKENKFLCVL--MSDWFN--FHGHMCIAFELLGKNTFEFL-------KENNFQPYPL--- 122

Query: 306 RLAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH------------------- 344
              R  A ++  A+++LHE +  + H DLKP NI   +++                    
Sbjct: 123 PHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 345 VRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
           +R+ADFG A F  +    +  T  Y  PEVI    +++  DV+S G IL E   G
Sbjct: 181 IRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 73.6 bits (181), Expect = 3e-14
 Identities = 55/319 (17%), Positives = 108/319 (33%), Gaps = 80/319 (25%)

Query: 174 QQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIY 227
             S     +    +   ++      ++  IG+G+    Y  ++   D      VA+K + 
Sbjct: 6   HHSSGRENLYFQGIKNVHVPDN-YIIKHLIGRGS----YGYVYLAYDKNTEKNVAIKKVN 60

Query: 228 PDFFHTNENAVTFFAQ----EVDTLSRQRHRFVLQLMGACLEPPYRG----WLVTELLGT 279
             F            +    E+  L+R +  ++++L    +          ++V E+  +
Sbjct: 61  RMFEDL------IDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS 114

Query: 280 TLKEWLHGLGSQRRKERMVPLPPFEER-----LARALEIAQAMQYLHEQKPKVIHRDLKP 334
            LK+              + L     +     L           ++HE    +IHRDLKP
Sbjct: 115 DLKKLFK---------TPIFLTEEHIKTILYNLLLGE------NFIHESG--IIHRDLKP 157

Query: 335 SNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV-------------------------Y 369
           +N  L+    V++ DFG AR ++  +       +                         Y
Sbjct: 158 ANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWY 217

Query: 370 MAPEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-----PAKIAMEVGEGKLR 423
            APE+I   E Y++  D++S G I  E++     +I          P      +   +  
Sbjct: 218 RAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNS 277

Query: 424 PALPEEDG--QLRELIELI 440
             + E+    QL  +  +I
Sbjct: 278 KKVHEKSNRDQLNIIFNII 296

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 57/240 (23%), Positives = 83/240 (34%), Gaps = 64/240 (26%)

Query: 200 QEKIGQGTTANIYRAI--WRGLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR---- 250
             K+G GT   +            AVK +         N   +      E D L +    
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVV--------RNIKKYTRSAKIEADILKKIQND 91

Query: 251 --QRHRFVLQLMGACLEPPYRG--WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
               +  V           Y     L+ E LG +L E +        +            
Sbjct: 92  DINNNNIVK--YHGKFM--YYDHMCLIFEPLGPSLYEII-------TRNNYNGFHI---E 137

Query: 307 LAR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-------------------- 344
             +   +EI +A+ YL +    + H DLKP NI LDD                       
Sbjct: 138 DIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195

Query: 345 -----VRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG 399
                +++ DFG A F SD   ++  T  Y APEVI    +   SD++SFG +L E+ TG
Sbjct: 196 TKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTG 255

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.4 bits (178), Expect = 5e-14
 Identities = 61/252 (24%), Positives = 104/252 (41%), Gaps = 71/252 (28%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQ 243
            ++  K  +L +K+G+G     Y  +W+ +D      VAVK I+  F    +N+    AQ
Sbjct: 5   RHVLRK-YELVKKLGKGA----YGIVWKSIDRRTGEVVAVKKIFDAF----QNST--DAQ 53

Query: 244 ----EVDTLSR-QRHRFVLQLMGACLEPPYRG-WLVTELLGTTLKEWLHGLGSQRRKERM 297
               E+  L+    H  ++ L+        R  +LV + + T L   +    +       
Sbjct: 54  RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIR---AN------ 104

Query: 298 VPLPPFEER-----LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
             L P  ++     L + +      +YLH     ++HRD+KPSNI L+   HV++ADFG 
Sbjct: 105 -ILEPVHKQYVVYQLIKVI------KYLHSGG--LLHRDMKPSNILLNAECHVKVADFGL 155

Query: 353 ARFLSDGEMALTGTFV------------------------YMAPEVI-QCEPYSEKSDVY 387
           +R   +         +                        Y APE++     Y++  D++
Sbjct: 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMW 215

Query: 388 SFGIILNEIITG 399
           S G IL EI+ G
Sbjct: 216 SLGCILGEILCG 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 37/182 (20%), Positives = 68/182 (37%), Gaps = 62/182 (34%)

Query: 272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL--EIAQAMQYLHEQKPKVIH 329
           +V E+LG  L +W+      +   + +PLP       + +  ++ Q + YLH +  ++IH
Sbjct: 122 MVFEVLGHHLLKWI-----IKSNYQGLPLP-----CVKKIIQQVLQGLDYLHTKC-RIIH 170

Query: 330 RDLKPSNIFL-------------------------------------------------D 340
            D+KP NI L                                                  
Sbjct: 171 TDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNA 230

Query: 341 DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN 400
           +   V+IAD G+A ++         T  Y + EV+    Y+  +D++S   +  E+ TG+
Sbjct: 231 EKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

Query: 401 HP 402
           + 
Sbjct: 291 YL 292

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 39/202 (19%), Positives = 75/202 (37%), Gaps = 42/202 (20%)

Query: 199 LQEKIGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFF-------AQEVDTLSR 250
           +   IGQG    IY A +     V            ++N   F        A + + + +
Sbjct: 39  VGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 251 QRHRFVLQLMG----------ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPL 300
                 L+ +G                YR +++ +  G+ L + ++   ++R   + V  
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYR-FMIMDRFGSDL-QKIYEANAKRFSRKTV-- 154

Query: 301 PPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADFGHA-RFLS 357
                 L  +L I   ++Y+HE +   +H D+K SN+ L+  +   V + D+G A R+  
Sbjct: 155 ------LQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206

Query: 358 DGEM---------ALTGTFVYM 370
           +G              GT  + 
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFT 228

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.8 bits (136), Expect = 5e-09
 Identities = 26/208 (12%), Positives = 57/208 (27%), Gaps = 57/208 (27%)

Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEV----- 245
            +  +++   EKIG+G    +++ I     VA+K I  +       +     +E+     
Sbjct: 16  CLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 246 --------DTLSRQRHRFVLQLMGACL-----------------------------EPPY 268
                         R    + L                                      
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 269 RGWLVTELL--GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPK 326
           + ++V E    G  L++    L S                 +   ++  ++  + E   +
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSS------------LATAKSILHQLTASL-AVAEASLR 182

Query: 327 VIHRDLKPSNIFLDDAKHVRIADFGHAR 354
             HRDL   N+ L      ++    + +
Sbjct: 183 FEHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 38/203 (18%), Positives = 70/203 (34%), Gaps = 44/203 (21%)

Query: 199 LQEKIGQGTTANIYRAI----------WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           L+    +     +Y A            +    ++K    D    NE      A +   +
Sbjct: 46  LKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQV 105

Query: 249 SRQRHRFVLQLMGACLEPPYRGW---------LVTELLGTTLKEWLHGLGSQRRKERMVP 299
           ++ +  +   L+     P   G+         LV   LG +L+  L         ER V 
Sbjct: 106 NKWKKLYSTPLLAI---PTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV- 161

Query: 300 LPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL--DDAKHVRIADFGHA-RFL 356
                  L  A  +  A+++LHE +   +H ++   NIF+  +D   V +A +G A R+ 
Sbjct: 162 -------LQVACRLLDALEFLHENE--YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212

Query: 357 SDGE---------MALTGTFVYM 370
             G+             G   ++
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFI 235

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 39/204 (19%), Positives = 67/204 (32%), Gaps = 49/204 (24%)

Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCI------YPDFFHTNENAVTFFAQEVDTLSR 250
           L +KIG G    IY A    +    A   +          F   E        + D + +
Sbjct: 41  LGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFS--ELKFYQRVAKKDCIKK 98

Query: 251 QRHRFVLQLMG----------ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK--ERMV 298
              R  L  +G                YR ++V E LG  L++    +  Q     +  V
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYR-FMVMERLGIDLQK----ISGQNGTFKKSTV 153

Query: 299 PLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADFGHARFL 356
                   L   + +   ++Y+HE +   +H D+K +N+ L   +   V +AD+G +   
Sbjct: 154 --------LQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203

Query: 357 SDGEM----------ALTGTFVYM 370
                             GT  + 
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFT 227

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 59/223 (26%), Positives = 84/223 (37%), Gaps = 40/223 (17%)

Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQ---EVDTLSR-QR 252
           L  KIG G+  +IY    I  G +VA+K          E   T   Q   E       Q 
Sbjct: 13  LGRKIGSGSFGDIYLGTDIAAGEEVAIKL---------ECVKTKHPQLHIESKIYKMMQG 63

Query: 253 HRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
              +  +     E  Y   +V ELLG +L E L    S++   + V        L  A +
Sbjct: 64  GVGIPTIRWCGAEGDYN-VMVMELLGPSL-EDLFNFCSRKFSLKTV--------LLLADQ 113

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEM-------- 361
           +   ++Y+H +    IHRD+KP N  +        V I DFG A+   D           
Sbjct: 114 MISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 171

Query: 362 --ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
              LTGT  Y +         S + D+ S G +L     G+ P
Sbjct: 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 55/220 (25%), Positives = 83/220 (37%), Gaps = 34/220 (15%)

Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRF 255
           L  KIG G+   IY    I    +VA+K       H           E       Q    
Sbjct: 11  LGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ------LLYESKIYRILQGGTG 64

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           +  +    +E  Y   LV +LLG +L E L    S++   + V        L  A ++  
Sbjct: 65  IPNVRWFGVEGDYN-VLVMDLLGPSL-EDLFNFCSRKLSLKTV--------LMLADQMIN 114

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEM----------A 362
            ++++H +    +HRD+KP N  +     A  V I DFG A+   D              
Sbjct: 115 RVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 363 LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
           LTGT  Y +         S + D+ S G +L   + G+ P
Sbjct: 173 LTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 47/223 (21%), Positives = 83/223 (37%), Gaps = 38/223 (17%)

Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL-SRQRHRF 255
           +  +IG+G+   I+    +     VA+K                   E  T         
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ------LRDEYRTYKLLAGCTG 67

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           +  +     E  +   LV +LLG +L E L  L  ++   + V           A ++  
Sbjct: 68  IPNVYYFGQEGLHN-VLVIDLLGPSL-EDLLDLCGRKFSVKTV--------AMAAKQMLA 117

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFL------DDAKHVRIADFGHARFLSDGEM-------- 361
            +Q +HE+   +++RD+KP N FL       +A  + + DFG  +F  D           
Sbjct: 118 RVQSIHEKS--LVYRDIKPDN-FLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174

Query: 362 --ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP 402
              L+GT  YM+         S + D+ + G +    + G+ P
Sbjct: 175 KKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 6e-06
 Identities = 56/467 (11%), Positives = 134/467 (28%), Gaps = 143/467 (30%)

Query: 65  QQQHNRHQSTLKLEEQ----------VGDLTREVQRQKELRIIY--RKRLERTQDYLRHC 112
           + Q+ +++  L + E           V D+ + +  ++E+  I   +  +  T   L   
Sbjct: 13  EHQY-QYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT-LRLFWT 70

Query: 113 LQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPL 172
           L   Q+  V + +       ++ L+S      I +   Q  +    +     R  +   +
Sbjct: 71  LLSKQEEMVQKFVEEVLRINYKFLMSP-----IKTEQRQPSMMTRMYIEQRDRLYNDNQV 125

Query: 173 LQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFH 232
                       AK N   + P    L++ +                             
Sbjct: 126 F-----------AKYNVSRLQPYL-KLRQAL----------------------------- 144

Query: 233 TNENAVTFFAQEVDTLSRQRHRFV-LQLMGACLEPPYRG--WLVTELLGTTLKE------ 283
                          L  +  + V +  +         G  W+  ++  +   +      
Sbjct: 145 ---------------LELRPAKNVLIDGVLGS------GKTWVALDVCLSYKVQCKMDFK 183

Query: 284 --WLHGLGSQRRKE-RMVPL--------PPFEERLARALEIAQAMQYLHEQKPKVI-HRD 331
             WL+ L +    E  +  L        P +  R   +  I   +  +  +  +++  + 
Sbjct: 184 IFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242

Query: 332 LKPSNIFLDDAKHVRIAD-FG-HARFL---SDGEMA--LTGTFVYMAPEVIQCEPYSEKS 384
            +   + L + ++ +  + F    + L      ++   L+                +   
Sbjct: 243 YENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE 302

Query: 385 DVYSFGIILN--------EIITGNHPYIEKDYKPAKIAMEVGEGKLR--PALPE-----E 429
                   L+        E++T N         P ++++ + E  +R   A  +      
Sbjct: 303 VKSLLLKYLDCRPQDLPREVLTTN---------PRRLSI-IAE-SIRDGLATWDNWKHVN 351

Query: 430 DGQLRELIELICLSWDGDASVRPSFSSITCSL----KNIQMKVTETI 472
             +L  +IE   L+    A  R  F     S+     +I   +   I
Sbjct: 352 CDKLTTIIE-SSLNVLEPAEYRKMFDR--LSVFPPSAHIPTILLSLI 395

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 1e-05
 Identities = 76/505 (15%), Positives = 144/505 (28%), Gaps = 147/505 (29%)

Query: 13  GLLGSRKS----PVVSSAGQQRKPTSTGH--SRGCCRGFSDCMSMGSMVSKKQQNPQCQQ 66
           G+LGS K+     V  S   Q K        +   C      + M               
Sbjct: 157 GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM--------------L 202

Query: 67  QHNRHQSTLKLEEQVGDLTREVQRQKELRIIYRKRLERTQDYLRHCLQI---AQDNGVLE 123
           Q   +Q       +    +    R   ++    +RL +++ Y  +CL +    Q+     
Sbjct: 203 QKLLYQIDPNWTSRSDHSSNIKLRIHSIQ-AELRRLLKSKPY-ENCLLVLLNVQNAKAWN 260

Query: 124 ---------LMTNNKE--DQHQSLLSSNTGSVIASPLVQTPLHQHSHQTPLHRYCSQTPL 172
                    L T  K+  D     LS+ T + I+       L     ++ L +Y    P 
Sbjct: 261 AFNLSCKILLTTRFKQVTDF----LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRP- 315

Query: 173 LQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFH 232
               DL     +        +P+ + +               I   +         D   
Sbjct: 316 ---QDLP---REVLT----TNPRRLSI---------------IAESIR--------DGLA 342

Query: 233 TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQR 292
           T +N   +     D L+      +       LEP               ++    L    
Sbjct: 343 TWDN---WKHVNCDKLTTIIESSL-----NVLEPAE------------YRKMFDRLSVFP 382

Query: 293 RKERMVPLPPFEERLAR---ALEIAQAMQYLHE-QKPKVIHRDLKPS-----NIFLDDAK 343
                  +P     L+     +  +  M  +++  K  ++ +  K S     +I+L+   
Sbjct: 383 PS---AHIP--TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKV 437

Query: 344 HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNH- 401
            +      H   +            Y  P+    +       D Y +  I      G+H 
Sbjct: 438 KLENEYALHRSIVDH----------YNIPKTFDSDDLIPPYLDQYFYSHI------GHHL 481

Query: 402 ---PYIEKDYKPAKIAMEVG--EGKLR---PALPEEDGQLRELIEL------ICLSWDGD 447
               + E+      + ++    E K+R    A       L  L +L      IC   D D
Sbjct: 482 KNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYIC---DND 538

Query: 448 ASVRPSFSSITCSLKNIQMKVTETI 472
               P +  +  ++ +   K+ E +
Sbjct: 539 ----PKYERLVNAILDFLPKIEENL 559

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 47.0 bits (112), Expect = 7e-06
 Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 36/190 (18%)

Query: 199 LQEKIGQGTTANIYRA--IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RF 255
           + +KIG G    +     ++    VA+K          ++       E     +      
Sbjct: 13  VGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLGSGDG 66

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           + Q+        Y   +V ELLG +L E L  L  +    + V        L  A+++  
Sbjct: 67  IPQVYYFGPCGKYN-AMVLELLGPSL-EDLFDLCDRTFSLKTV--------LMIAIQLIS 116

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFL-----DDAKHVRIADFGHARFLSDGEM--------- 361
            M+Y+H +   +I+RD+KP N  +        + + I DF  A+   D E          
Sbjct: 117 RMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174

Query: 362 -ALTGTFVYM 370
            +LTGT  YM
Sbjct: 175 KSLTGTARYM 184

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	472
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.82
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.12
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.07
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.89
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	98.56
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.34
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.14
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.11
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.07
1lkk_A	105	Human P56 tyrosine kinase; complex (tyrosine kinas	97.93
1d4t_A	104	T cell signal transduction molecule SAP; SH2 domai	97.91
3maz_A	125	Signal-transducing adaptor protein 1; modular doma	97.91
1i3z_A	103	EWS/FLI1 activated transcript 2; SH2 domain phosph	97.87
2ysx_A	119	Signaling inositol polyphosphate phosphatase SHIP	97.86
2dly_A	121	FYN-related kinase; BRK family kinase, structural	97.86
1aot_F	106	FYN protein-tyrosine kinase; SH2 domain, signal tr	97.85
1ka6_A	128	SH2 domain protein 1A; SH2 domain, protein-peptide	97.84
2lqn_A	303	CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT	97.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.81
2ecd_A	119	Tyrosine-protein kinase ABL2; SH2 domain, phosphot	97.8
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
1rja_A	100	Tyrosine-protein kinase 6; human protein tyrosine	97.74
4fbn_A	246	1-phosphatidylinositol 4,5-bisphosphate phosphodi	97.69
1jyr_A	96	Growth factor receptor-bound protein 2; receptor b	97.66
1blj_A	114	P55 BLK protein tyrosine kinase; signal transducti	97.65
2el8_A	118	Signal-transducing adaptor protein 2; SH2 domain,	97.65
3k2m_A	112	Proto-oncogene tyrosine-protein kinase ABL1; engin	97.62
2dm0_A	125	Tyrosine-protein kinase TXK; TEC family kinase, st	97.6
4d8k_A	175	Tyrosine-protein kinase LCK; protein kinases, SH2	97.59
3s9k_A	118	Tyrosine-protein kinase ITK/TSK; proline isomeriza	97.57
1nrv_A	105	Growth factor receptor-bound protein 10; dimer, si	97.55
2ekx_A	110	Cytoplasmic tyrosine-protein kinase BMX; SH2 domai	97.55
3pqz_A	117	Growth factor receptor-bound protein 7; SH2, binds	97.55
2ge9_A	125	Tyrosine-protein kinase BTK; SH2 domain, structure	97.53
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.48
2gsb_A	119	RAS GTPase-activating protein 1; GAP, RAS P21 prot	97.47
3ov1_A	117	Growth factor receptor-bound protein 2; GRB2 SH2 d	97.46
1r1p_A	100	GRB2-related adaptor protein 2; SH2, GADS, phospho	97.46
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.44
3tkz_A	109	Tyrosine-protein phosphatase non-receptor type 11;	97.43
2cr4_A	126	3BP-2, SH3 domain-binding protein 2; structural ge	97.42
1h9o_A	112	Phosphatidylinositol 3-kinase; transferase/recepto	97.41
3us4_A	98	Megakaryocyte-associated tyrosine-protein kinase;	97.4
2cs0_A	119	Hematopoietic SH2 domain containing; ALX, FLJ14886	97.39
2dx0_A	138	Phospholipase C, gamma 2; phosphoric diester hydro	97.39
2dlz_A	118	Protein VAV-2; RHO family guanine nucleotide excha	97.37
2hdv_A	111	SH2-B PH domain containing signaling mediator 1 ga	97.37
3eaz_A	106	Tyrosine-protein kinase CSK; SH2, disulfide, oxidi	97.34
2eo6_A	141	B-cell linker protein; SH2, cytoplasmic adapter pr	97.33
2eo3_A	111	CRK-like protein; phosphorylation, repeat, SH2 dom	97.33
2aug_A	126	Growth factor receptor-bound protein 14; phosphory	97.33
1a81_A	254	SYK kinase; complex (transferase-peptide), SYK, ki	97.32
2kno_A	131	Tensin-like C1 domain-containing phosphatase; SH2	97.31
2cia_A	102	Cytoplasmic protein NCK2; SH2-domain, SH3 domain,	97.28
2oq1_A	254	Tyrosine-protein kinase ZAP-70; tandem SH2 domains	97.27
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.24
2eob_A	124	1-phosphatidylinositol-4,5-bisphosphate phosphodie	97.2
2hmh_A	152	Suppressor of cytokine signaling 3; SOCS3, GP130,	97.2
2crh_A	138	VAV proto-oncogene; oncoprotein, structural genomi	97.16
2bbu_A	164	Suppressor of cytokine signaling 3; SH2 domain, ex	97.16
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.13
2lnw_A	122	VAV-2, guanine nucleotide exchange factor VAV2; si	97.1
2iug_A	120	Phosphatidylinositol 3-kinase regulatory alpha sub	97.05
2oq1_A	254	Tyrosine-protein kinase ZAP-70; tandem SH2 domains	97.01
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	97.01
1a81_A	254	SYK kinase; complex (transferase-peptide), SYK, ki	97.0
3hhm_B	373	NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil	96.96
2y3a_B	302	Phosphatidylinositol 3-kinase regulatory subunit;	96.96
1ju5_A	109	CRK; CRK, SH2, SH3, adaptor protein, phosphopeptid	96.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	96.94
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.89
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.89
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.81
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.77
1mil_A	104	SHC adaptor protein; SH2 domain, phosphorylation,	96.66
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.63
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.58
2kk6_A	116	Proto-oncogene tyrosine-protein kinase FER; method	96.55
2vif_A	141	Suppressor of cytokine signalling 6; growth regula	96.55
2dvj_A	230	V-CRK sarcoma virus CT10 oncogene homolog, isoform	96.49
2eyz_A	304	V-CRK sarcoma virus CT10 oncogene homolog isoform	96.37
3qwx_X	174	Cell death abnormality protein 2; cell engulfment,	96.35
2c9w_A	169	Suppressor of cytokine signaling 2; growth regulat	96.33
3hhm_B	373	NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidil	95.96
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.96
2izv_A	187	Suppressor of cytokine signaling 4; signal transdu	95.91
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.75
3qwy_A	308	Cell death abnormality protein 2; cell engulfment,	95.63
3ps5_A	595	Tyrosine-protein phosphatase non-receptor type 6;	95.62
3ps5_A	595	Tyrosine-protein phosphatase non-receptor type 6;	95.62
1wqu_A	114	C-FES, proto-oncogene tyrosine-protein kinase FES/	95.55
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.54
2b3o_A	532	Tyrosine-protein phosphatase, non-receptor type 6;	95.22
2shp_A	525	SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin	94.36
2b3o_A	532	Tyrosine-protein phosphatase, non-receptor type 6;	94.23
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.87
2shp_A	525	SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin	93.63
1gri_A	217	Growth factor bound protein 2; SH2, SH3, signal tr	93.57
4fbn_A	246	1-phosphatidylinositol 4,5-bisphosphate phosphodi	92.48
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.67

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-57  Score=450.65  Aligned_cols=266  Identities=33%  Similarity=0.505  Sum_probs=221.7

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ...|+|+.+++++.++||+|+||+||+|.+++ .||||+++..  ....+..+.|.+|+.+|++++|||||+++|+|.+ 
T Consensus        28 ~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~--~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-  103 (307)
T 3omv_A           28 SYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVV--DPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-  103 (307)
T ss_dssp             -CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCS--SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-
T ss_pred             CcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEec--CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-
Confidence            34699999999999999999999999999876 5999998754  2355667889999999999999999999998764 


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++||||+.||+|.++|.....         ..++..++.++.|||.||+|||+++  ||||||||+||||++++.+|
T Consensus       104 ~~~~iVmEy~~gGsL~~~l~~~~~---------~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~K  172 (307)
T 3omv_A          104 DNLAIVTQWCEGSSLYKHLHVQET---------KFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVK  172 (307)
T ss_dssp             SSCEEEEECCSSCBHHHHHHTSCC---------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEE
T ss_pred             CeEEEEEEcCCCCCHHHHHhhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEE
Confidence            568899999999999999964321         2457889999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCC-----ccccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSDG-----EMALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~-----~~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||+|+.....     ....+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.+.+. ...+...+.
T Consensus       173 i~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~  251 (307)
T 3omv_A          173 IGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVG  251 (307)
T ss_dssp             ECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHH
T ss_pred             EeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHh
Confidence            9999999876532     234579999999999864   4699999999999999999999999987652 344555555


Q ss_pred             cCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+...+.++.. ..++..+.++|.+||..||++||||.+|++.|+.++..+
T Consensus       252 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          252 RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            66545544443 456788999999999999999999999999999886543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-57  Score=450.92  Aligned_cols=267  Identities=25%  Similarity=0.389  Sum_probs=226.3

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      +.|++++|.+.++||+|+||.||+|.+.       +..||||+++..    .....+.|.+|+++|++++|||||+++|+
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~g~   83 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA----SDNARKDFHREAELLTNLQHEHIVKFYGV   83 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC----CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC----ChHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            5688899999999999999999999874       567999999653    45567789999999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccc---cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRR---KERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      |.+.+..++||||+.+|+|.++|...+....   ........++..++.++.||+.||+|||+++  ||||||||+||||
T Consensus        84 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl  161 (299)
T 4asz_A           84 CVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLV  161 (299)
T ss_dssp             ECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             EeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEE
Confidence            9999999999999999999999986543211   1112234578999999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      ++++.+||+|||+|+.......     ...||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+  ..++
T Consensus       162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--~~~~  239 (299)
T 4asz_A          162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--NNEV  239 (299)
T ss_dssp             CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHH
T ss_pred             CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--HHHH
Confidence            9999999999999987653321     2358999999999999999999999999999999999 999998776  6677


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ...+..+. ++..|.  .++.++.++|.+||+.||++||||++|...|+++.+.
T Consensus       240 ~~~i~~~~-~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          240 IECITQGR-VLQRPR--TCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HHHHHHTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCC-CCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            78888776 334443  3566889999999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.5e-57  Score=451.99  Aligned_cols=268  Identities=24%  Similarity=0.371  Sum_probs=222.5

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      ..+.|..++|.+.++||+|+||.||+|.++       +..||||+++..    .....+.|.+|+++|++++|||||+++
T Consensus        34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~----~~~~~~~f~~E~~il~~l~HpnIV~l~  109 (329)
T 4aoj_A           34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA----SESARQDFQREAELLTMLQHQHIVRFF  109 (329)
T ss_dssp             CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC----SHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            346788899999999999999999999875       567999999653    456677899999999999999999999


Q ss_pred             EEEEcCCCceEEEEeccCCcHHHHHhhccccccc-----ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK-----ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       261 g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-----~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      |+|.+.+..++||||+.+|+|.++++........     .......++..++.++.|||.||+|||+++  ||||||||+
T Consensus       110 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~  187 (329)
T 4aoj_A          110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATR  187 (329)
T ss_dssp             EEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGG
T ss_pred             EEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHh
Confidence            9999999999999999999999999865432211     111234578999999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                      ||||++++.+||+|||+|+......     ....||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+  
T Consensus       188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--  265 (329)
T 4aoj_A          188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--  265 (329)
T ss_dssp             GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--
T ss_pred             hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--
Confidence            9999999999999999998765332     23468999999999999999999999999999999999 999998776  


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ..++...+..+. ++..|.  .++.++.++|.+||+.||++||||++|++.|+.+.+
T Consensus       266 ~~~~~~~i~~g~-~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~  319 (329)
T 4aoj_A          266 NTEAIDCITQGR-ELERPR--ACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ  319 (329)
T ss_dssp             HHHHHHHHHHTC-CCCCCT--TCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCC-CCCCcc--cccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence            666777777765 444444  356788999999999999999999999999998865

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.6e-57  Score=449.24  Aligned_cols=266  Identities=21%  Similarity=0.290  Sum_probs=223.8

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      -++|+.+++++.++||+|+||+||+|.+.       ++.||||+++...   .....+.|.+|+.+|++++|||||+++|
T Consensus        20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~---~~~~~~~f~~E~~il~~l~HpNIV~l~g   96 (308)
T 4gt4_A           20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA---EGPLREEFRHEAMLRARLQHPNVVCLLG   96 (308)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C---CC-CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc---ChHHHHHHHHHHHHHHhCCCCCCCCcce
Confidence            35678889999999999999999999973       4679999997542   3344567999999999999999999999


Q ss_pred             EEEcCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      +|.+++..++|+||+.+|+|.++|.........      .......++..++.++.|||.||+|||+++  ||||||||+
T Consensus        97 ~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~  174 (308)
T 4gt4_A           97 VVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATR  174 (308)
T ss_dssp             EECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             EEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCcccc
Confidence            999999999999999999999999754321110      111234568899999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCC-----ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~-----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                      ||||++++.+||+|||+|+.....     .....||+.|+|||++.++.|+.++|||||||++|||+| |..||.+.+  
T Consensus       175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--  252 (308)
T 4gt4_A          175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--  252 (308)
T ss_dssp             GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--
T ss_pred             ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--
Confidence            999999999999999999876432     223468999999999999999999999999999999999 999998776  


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ..++...+..+. +++.|.  .++..+.++|.+||+.||++||||.+|++.|+.+
T Consensus       253 ~~~~~~~i~~~~-~~~~p~--~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 NQDVVEMIRNRQ-VLPCPD--DCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHHHTTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHHcCC-CCCCcc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            667777787776 333443  4567889999999999999999999999999753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.4e-56  Score=447.16  Aligned_cols=272  Identities=27%  Similarity=0.416  Sum_probs=225.4

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-CceeE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQ  258 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~  258 (472)
                      ...|+|++++|++.++||+|+||.||+|.+.+       +.||||.++..   ......+.|.+|+.+|+.++| ||||+
T Consensus        56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~---~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            34699999999999999999999999999863       46999999764   344556779999999999965 89999


Q ss_pred             EEEEEEcC-CCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecC
Q 039082          259 LMGACLEP-PYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD  331 (472)
Q Consensus       259 l~g~~~~~-~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrD  331 (472)
                      ++|+|.++ +..++||||+.+|+|.++|+........      .......++..++.++.|||.||+|||+++  |||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRD  210 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  210 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCc
Confidence            99999775 5678999999999999999764432111      111234568899999999999999999999  99999


Q ss_pred             CCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          332 LKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       332 Lkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      |||+||||++++.+||+|||+|+.+....     ....||+.|||||++.+..|+.++|||||||++|||+| |..||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999775432     23458999999999999999999999999999999998 9999987


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .... ..+...+..+. ++..|..  ++.++.++|.+||+.||++||||.+|++.|+++.+.
T Consensus       291 ~~~~-~~~~~~i~~g~-~~~~p~~--~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKID-EEFCRRLKEGT-RMRAPDY--TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCS-HHHHHHHHHTC-CCCCCTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHH-HHHHHHHHcCC-CCCCCcc--CCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            6543 33445555554 5555543  456788999999999999999999999999988653

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.7e-55  Score=442.73  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=214.0

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      -++-+.++|+++++||+|+||+||+|+++  |+.||||++.+...  .....+.|.+|+.+|+.++|||||++++++.++
T Consensus        18 ~~f~sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   95 (350)
T 4b9d_A           18 LYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM--SSKEREESRREVAVLANMKHPNIVQYRESFEEN   95 (350)
T ss_dssp             CBCSCCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             cCCCcccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC--CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence            34455689999999999999999999986  78999999987643  445677899999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..|+||||+.||+|.++|...+.        ...+...++.++.||+.||+|||++|  ||||||||+||||+.+|.+|
T Consensus        96 ~~~yiVmEy~~gg~L~~~i~~~~~--------~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vK  165 (350)
T 4b9d_A           96 GSLYIVMDYCEGGDLFKRINAQKG--------VLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQ  165 (350)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEE
Confidence            999999999999999999964321        12346778899999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+|||+|+.+....   ...+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+  ...+...+..+...
T Consensus       166 l~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~~~  243 (350)
T 4b9d_A          166 LGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--MKNLVLKIISGSFP  243 (350)
T ss_dssp             ECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCC
T ss_pred             EcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCCCC
Confidence            99999999876432   34579999999999999999999999999999999999999998766  66777788877643


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .++  ...+.++.++|.+||..||++|||++++++
T Consensus       244 -~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 -PVS--LHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             -CCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCC--ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             222  335567899999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.9e-55  Score=438.79  Aligned_cols=246  Identities=27%  Similarity=0.344  Sum_probs=213.2

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .+.|+++++||+|+||.||+|.++  |..||||++.....    ...+.+.+|+.+|+.++|||||+++++|.+++..|+
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC----SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch----hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            457999999999999999999996  78999999975432    223457899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ||||+.||+|.+++....           .+...+..++.||+.||+|||++|  ||||||||+||||+.+|.+||+|||
T Consensus       149 vmEy~~gg~L~~~l~~~~-----------l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFG  215 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFG  215 (346)
T ss_dssp             EECCCTTEEHHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEeCCCCCcHHHHHHcCC-----------CCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCc
Confidence            999999999999996421           347889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      +|+.+...   ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+  ...+...+..+. .+.++.
T Consensus       216 la~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~-~~~~~~  292 (346)
T 4fih_A          216 FCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL-PPRLKN  292 (346)
T ss_dssp             TCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSS-CCCCSC
T ss_pred             CceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCC-CCCCCc
Confidence            99987543   345689999999999999999999999999999999999999998765  556666666543 334444


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+.++.++|.+||..||++|||++++++
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            4556778999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-54  Score=424.27  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc----CCCce
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE----PPYRG  270 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~----~~~~~  270 (472)
                      |++.++||+|+||.||+|.++  +..||||++.....  .....+.|.+|+++|+.++|||||+++++|..    ++..+
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~  105 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence            478889999999999999997  67899999976533  44566789999999999999999999999865    24467


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEEEee
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVRIAD  349 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vkL~D  349 (472)
                      +||||+.||+|.+++...+.          .++..+..++.||+.||+|||+++++||||||||+||||+. +|.+||+|
T Consensus       106 lvmEy~~gg~L~~~l~~~~~----------l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~D  175 (290)
T 3fpq_A          106 LVTELMTSGTLKTYLKRFKV----------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred             EEEeCCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEe
Confidence            89999999999999965332          34788899999999999999999878999999999999984 79999999


Q ss_pred             cccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          350 FGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       350 FGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ||+|+..... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+. ...+...+..+..++.++ 
T Consensus       176 FGla~~~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-~~~~~~~i~~~~~~~~~~-  252 (290)
T 3fpq_A          176 LGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVKPASFD-  252 (290)
T ss_dssp             TTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCCCGGGG-
T ss_pred             CcCCEeCCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-HHHHHHHHHcCCCCCCCC-
Confidence            9999865533 345679999999999875 599999999999999999999999976542 445555666654322222 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ...++++.++|.+||..||++|||++++++
T Consensus       253 -~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          253 -KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             223457889999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=8.1e-55  Score=435.85  Aligned_cols=254  Identities=21%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      +....+.|++.++||+|+||.||+|+++  |..||||+++.+..         +.+|+.+|+.++|||||+++++|.+++
T Consensus        53 ~~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---------~~~E~~il~~l~HpnIV~l~~~~~~~~  123 (336)
T 4g3f_A           53 YREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---------RVEELVACAGLSSPRIVPLYGAVREGP  123 (336)
T ss_dssp             CCBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---------CTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred             hhcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---------HHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            3344567899999999999999999986  78999999976532         247999999999999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vk  346 (472)
                      ..|+||||+.||+|.++|...+.          .++..+..++.||+.||+|||++|  ||||||||+||||+.+| .+|
T Consensus       124 ~~~ivmEy~~gg~L~~~l~~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vK  191 (336)
T 4g3f_A          124 WVNIFMELLEGGSLGQLIKQMGC----------LPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAA  191 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEE
T ss_pred             EEEEEEeccCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEE
Confidence            99999999999999999975432          357889999999999999999999  99999999999999987 699


Q ss_pred             EeecccceecCCCc--------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSDGE--------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~~--------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||+|+.+....        ...+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..  .+...+.
T Consensus       192 l~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~i~  269 (336)
T 4g3f_A          192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG--PLCLKIA  269 (336)
T ss_dssp             ECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS--CCHHHHH
T ss_pred             EeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH--HHHHHHH
Confidence            99999999875322        2347999999999999999999999999999999999999999876532  3444555


Q ss_pred             cCCCCC-CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRP-ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~-~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+.... .++  +..+..+.++|.+||..||++|||+.+|++.|.....++
T Consensus       270 ~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~  318 (336)
T 4g3f_A          270 SEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV  318 (336)
T ss_dssp             HSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             cCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence            543211 122  345677889999999999999999999999998877654

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5e-55  Score=432.61  Aligned_cols=247  Identities=25%  Similarity=0.388  Sum_probs=214.0

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|++.+.||+|+||+||+|+++  |+.||||++.+.... .....+.+.+|+++|+.++|||||+++++|.+++..|
T Consensus        30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII-KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            3478999999999999999999986  789999999764321 2234567899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +||||+.||+|.+++...+.          .+...+..++.||+.||+|||++|  ||||||||+||||+.+|.+||+||
T Consensus       109 ivmEy~~gG~L~~~i~~~~~----------l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DF  176 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF  176 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEc
Confidence            99999999999999975432          246788999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCC-----ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          351 GHARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       351 Gla~~~~~~-----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |+|+.+...     ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+  ...+...+..+.+  .
T Consensus       177 Gla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~~--~  252 (311)
T 4aw0_A          177 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EGLIFAKIIKLEY--D  252 (311)
T ss_dssp             TTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCC--C
T ss_pred             CCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCC--C
Confidence            999987532     235679999999999999999999999999999999999999998766  6677777877754  3


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      +|.  ..+.++.++|.+||..||++|||+++++
T Consensus       253 ~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 FPE--KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CCc--ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence            343  2455788999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.2e-54  Score=426.16  Aligned_cols=257  Identities=27%  Similarity=0.364  Sum_probs=207.1

Q ss_pred             CCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----Cce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----YRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----~~~  270 (472)
                      ++|.+.++||+|+||.||+|.++|+.||||+++..     ......+..|+..+..++|||||+++|+|.+++    ..+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~-----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~   77 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence            46899999999999999999999999999998542     222222334566667889999999999998765    367


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCceeecCCCCCcEEEcCCCc
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ------KPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~------~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +||||+.+|+|.++|+...           .++..++.++.|++.||+|||++      .++||||||||+||||+.++.
T Consensus        78 lV~Ey~~~gsL~~~l~~~~-----------l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~  146 (303)
T 3hmm_A           78 LVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             EEEECCTTCBHHHHHHHCC-----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             EEecCCCCCcHHHHHHhCC-----------CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC
Confidence            8999999999999996432           35788999999999999999987      123999999999999999999


Q ss_pred             EEEeecccceecCCCc-------cccccCCcccccccccCC------CCCchHHHHHHHHHHHHHHcCCCCCCCCC----
Q 039082          345 VRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPYIEKD----  407 (472)
Q Consensus       345 vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~------~~s~~sDvwSlGvll~elltG~~Pf~~~~----  407 (472)
                      +||+|||+|+......       ...+||+.|+|||++.+.      .|+.++|||||||++|||+||..||....    
T Consensus       147 ~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~  226 (303)
T 3hmm_A          147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             EEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccc
Confidence            9999999998775432       134699999999999754      46789999999999999999977653211    


Q ss_pred             ---------CCHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          408 ---------YKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       408 ---------~~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                               .....+...+..+..+|.+|..   ...+..+.+++.+||+.||++||||.+|++.|+++.++
T Consensus       227 p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                     1234555566677777777764   34667889999999999999999999999999988754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=7.7e-54  Score=440.44  Aligned_cols=247  Identities=27%  Similarity=0.342  Sum_probs=213.5

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +.+.|+++++||+|+||.||+|+++  |..||||++.....    ...+.+.+|+.+|+.++|||||+++++|.+.+..|
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~----~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ----QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC----SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch----hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            3467999999999999999999996  78999999976432    22345889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +||||+.||+|.+++....           .+...+..++.||+.||+|||++|  ||||||||+||||+.+|.+||+||
T Consensus       225 iVmEy~~gG~L~~~i~~~~-----------l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DF  291 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHTR-----------MNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDF  291 (423)
T ss_dssp             EEEECCTTEEHHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCC
T ss_pred             EEEeCCCCCcHHHHHhccC-----------CCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecC
Confidence            9999999999999985421           246889999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          351 GHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       351 Gla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      |+|+.+...   ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+  ...+...+..+. .+.++
T Consensus       292 Gla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--~~~~~~~i~~~~-~~~~~  368 (423)
T 4fie_A          292 GFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--PLKAMKMIRDNL-PPRLK  368 (423)
T ss_dssp             TTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-CCCCS
T ss_pred             ccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHcCC-CCCCc
Confidence            999987543   345679999999999999999999999999999999999999998765  556666666553 33344


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+.++.+||.+||..||++|||+.++++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            43456678899999999999999999999875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.6e-53  Score=415.76  Aligned_cols=245  Identities=25%  Similarity=0.357  Sum_probs=196.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||+||+|.++  |+.||||++.+.... .......+.+|+.+|+.++|||||++++++.+++..|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLA-KSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcC-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            58999999999999999999985  789999999876442 334456799999999999999999999999999888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      |||+ +|+|.+++...+.          .+...+..++.||+.||+|||++|  |+||||||+||||+.++.+||+|||+
T Consensus        92 mEy~-~g~L~~~l~~~~~----------l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGl  158 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDK----------MSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGL  158 (275)
T ss_dssp             EECC-CEEHHHHHHHSCS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSC
T ss_pred             EeCC-CCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCC
Confidence            8876 8899999965332          357889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      |+...+..  ...+||+.|+|||++.+..| +.++|||||||++|+|+||+.||.+.+  ...+...+..+..  .+|. 
T Consensus       159 a~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~--~~~~~~~i~~~~~--~~p~-  233 (275)
T 3hyh_A          159 SNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES--IPVLFKNISNGVY--TLPK-  233 (275)
T ss_dssp             C---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCC--CCCT-
T ss_pred             CeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCC--CCCC-
Confidence            98776433  35679999999999998876 579999999999999999999998765  5666677777643  3333 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ..+.++.++|.+||..||++|||++++++
T Consensus       234 -~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          234 -FLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             24567889999999999999999999876

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.5e-55  Score=456.09  Aligned_cols=348  Identities=22%  Similarity=0.348  Sum_probs=278.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccC
Q 039082           83 DLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQH  157 (472)
Q Consensus        83 ~~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~  157 (472)
                      ++++.++.+....++|||| +|+..+|.|+|||..     +..|+||+|...+++.|     +......|+++..++.++
T Consensus        81 ~ae~~L~~~~~~~G~FLvR-~s~~~~g~y~lsv~~~~~~~~~~v~H~~I~~~~~g~~-----~i~~~~~F~sl~eLv~~y  154 (454)
T 1qcf_A           81 DAERQLLAPGNMLGSFMIR-DSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGF-----YISPRSTFSTLQELVDHY  154 (454)
T ss_dssp             HHHHHHHSTTCCTTCEEEE-ECSSSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCE-----ESSSSSCBSSHHHHHHHH
T ss_pred             hhhhhhhcCCCCCceEEEE-ECcCCCCeEEEEEEecccCCCCceEEEEEEEcCCCcE-----EEeCccccCCHHHHHHHH
Confidence            3455555566678999999 999999999999965     77899999998888888     555556677776665554


Q ss_pred             CC-----CCccccccCCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCC
Q 039082          158 SH-----QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFF  231 (472)
Q Consensus       158 ~~-----~~~l~~~~~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~  231 (472)
                      ..     +..+..+|.....         ........|.++.++|++.+.||+|+||.||+|.++ +..||||+++... 
T Consensus       155 ~~~~~~l~~~~~~~~~~~~~---------~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-  224 (454)
T 1qcf_A          155 KKGNDGLCQKLSVPCMSSKP---------QKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-  224 (454)
T ss_dssp             TSSCTTSSSCCCSBCCCCCC---------CCCCCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-
T ss_pred             HhccCCccccccccccccCc---------cccccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-
Confidence            43     1222233322111         011235679999999999999999999999999997 6789999997642 


Q ss_pred             CCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHH
Q 039082          232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL  311 (472)
Q Consensus       232 ~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  311 (472)
                          ...+.|.+|+.+|+.++|||||++++++. .+..++|+|++.+|+|.+++......        ..++..++.++.
T Consensus       225 ----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~--------~~~~~~~~~~~~  291 (454)
T 1qcf_A          225 ----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGS--------KQPLPKLIDFSA  291 (454)
T ss_dssp             ----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHH--------TCCHHHHHHHHH
T ss_pred             ----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCC--------CCCHHHHHHHHH
Confidence                23566999999999999999999999986 56788999999999999999643211        124678889999


Q ss_pred             HHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHH
Q 039082          312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVY  387 (472)
Q Consensus       312 qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvw  387 (472)
                      ||+.||+|||+++  |+||||||+||||+.++.+||+|||+++......    ....+++.|+|||++....++.++|||
T Consensus       292 qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw  369 (454)
T 1qcf_A          292 QIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW  369 (454)
T ss_dssp             HHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHH
Confidence            9999999999999  9999999999999999999999999998765432    223357889999999989999999999


Q ss_pred             HHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          388 SFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       388 SlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ||||++|||+| |+.||.+.+  ...+...+..+. +...|  ..++..+.++|.+||..||++|||+++|++.|+++..
T Consensus       370 slG~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          370 SFGILLMEIVTYGRIPYPGMS--NPEVIRALERGY-RMPRP--ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHHTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             hHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence            99999999999 999998766  556666666654 33333  3456788999999999999999999999999988754

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.7e-55  Score=445.13  Aligned_cols=335  Identities=24%  Similarity=0.350  Sum_probs=259.1

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-CCccccccCCCCcc
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-QTPLHRYCSQTPLL  173 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-~~~l~~~~~~~p~~  173 (472)
                      .++|||| +|++.. .|+|||..++.|+||+|...++ .|      ......|+++...+.++.. ..++...   ... 
T Consensus        32 ~G~flvR-~s~~~~-~~~lsv~~~~~~~h~~i~~~~~-~~------~~~~~~F~sl~~LI~~y~~~~~~l~~~---~~~-   98 (377)
T 3cbl_A           32 SGDFLVR-ESQGKQ-EYVLSVLWDGLPRHFIIQSLDN-LY------RLEGEGFPSIPLLIDHLLSTQQPLTKK---SGV-   98 (377)
T ss_dssp             TTEEEEE-ECC--C-CEEEEC-----CCEEEC----C-CC------CC----CCSHHHHHHHHHHHTCCC--------C-
T ss_pred             CCCEEEE-EeCCCC-cEEEEEEECCCccchhhccccc-eE------EecceeccchHHHHHHHhhccCCcccc---cCc-
Confidence            5999999 998877 9999999999999999987654 44      3333557777776665543 2222110   000 


Q ss_pred             cccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc
Q 039082          174 QQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ  251 (472)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l  251 (472)
                            ..........|.++.++|++.+.||+|+||.||+|.++  +..||||+++..   ........|.+|+.+|+.+
T Consensus        99 ------~~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l  169 (377)
T 3cbl_A           99 ------VLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET---LPPDLKAKFLQEARILKQY  169 (377)
T ss_dssp             ------CCCEECCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT---SCHHHHTTTTHHHHHHTTC
T ss_pred             ------ccccCccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc---CCHHHHHHHHHHHHHHHhC
Confidence                  11122345689999999999999999999999999996  788999998754   2345556789999999999


Q ss_pred             CCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecC
Q 039082          252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD  331 (472)
Q Consensus       252 ~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrD  331 (472)
                      +|||||++++++...+..++|+|++.+|+|.+++...+..         .++..++.++.|++.||+|||++|  ++|||
T Consensus       170 ~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~LH~~~--ivHrD  238 (377)
T 3cbl_A          170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR---------LRVKTLLQMVGDAAAGMEYLESKC--CIHRD  238 (377)
T ss_dssp             CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGG---------CCHHHHHHHHHHHHHHHHHHHHTT--EECSC
T ss_pred             CCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCC---------CCHHHHHHHHHHHHHHHHHHHHCC--cCCcc
Confidence            9999999999999999999999999999999999753321         246789999999999999999999  99999


Q ss_pred             CCCCcEEEcCCCcEEEeecccceecCCCccc-----cccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          332 LKPSNIFLDDAKHVRIADFGHARFLSDGEMA-----LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       332 Lkp~NILl~~~~~vkL~DFGla~~~~~~~~~-----~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      |||+||||+.++.+||+|||+++........     ..+++.|+|||++.+..++.++|||||||++|||+| |..||.+
T Consensus       239 lkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             CSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544322     224678999999998899999999999999999999 9999987


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .+  ...+...+..+. +...|.  .++..+.++|.+||+.||++|||+.+|++.|+++..+
T Consensus       319 ~~--~~~~~~~~~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          319 LS--NQQTREFVEKGG-RLPCPE--LCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             SC--HHHHHHHHHTTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC--HHHHHHHHHcCC-CCCCCC--CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            66  555555666554 333333  3556788999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6e-54  Score=424.38  Aligned_cols=250  Identities=26%  Similarity=0.331  Sum_probs=205.7

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ..+++++|++++.||+|+||+||+|++.     ++.||||++++.....  .....+.+|+.+|+.++|||||++++++.
T Consensus        19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~   96 (304)
T 3ubd_A           19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV--RDRVRTKMERDILVEVNHPFIVKLHYAFQ   96 (304)
T ss_dssp             CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE--EECC------CCCCCCCCTTEECEEEEEE
T ss_pred             ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh--HHHHHHHHHHHHHHHCCCCCCCeEEEEEE
Confidence            3456689999999999999999999873     5689999997654322  22235789999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +++..|+||||+.||+|.+++.+.+.          .+...+..++.||+.||+|||++|  ||||||||+|||++.+|.
T Consensus        97 ~~~~~~ivmEy~~gg~L~~~l~~~~~----------l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~  164 (304)
T 3ubd_A           97 TEGKLYLILDFLRGGDLFTRLSKEVM----------FTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGH  164 (304)
T ss_dssp             ETTEEEEEECCCTTCEEHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSC
T ss_pred             ECCEEEEEEEcCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCC
Confidence            99999999999999999999975432          356889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          345 VRIADFGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       345 vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +||+|||+|+...+.   ....+||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+  ..++...+..+.
T Consensus       165 vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~  242 (304)
T 3ubd_A          165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--RKETMTMILKAK  242 (304)
T ss_dssp             EEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC
T ss_pred             EEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--HHHHHHHHHcCC
Confidence            999999999875432   345679999999999999999999999999999999999999998766  666777777765


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCH-----HHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSF-----SSITC  459 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~~ll~  459 (472)
                      .  .+|.  ..+.++.++|.+||..||++|||+     +++++
T Consensus       243 ~--~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 L--GMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C--CCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C--CCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            3  3333  345678899999999999999984     56653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.6e-54  Score=450.00  Aligned_cols=338  Identities=24%  Similarity=0.354  Sum_probs=268.1

Q ss_pred             HHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-----CCccccccCCC
Q 039082           96 IIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-----QTPLHRYCSQT  170 (472)
Q Consensus        96 ~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-----~~~l~~~~~~~  170 (472)
                      ++|||| +|++..|.|+|||..+..|+||+|... ++.+     +......|+++...+.++..     ++.+..++...
T Consensus       102 G~FlvR-~S~~~~g~~~Lsv~~~~~v~H~~I~~~-~~~~-----~i~~~~~F~sl~eLv~~y~~~~~~~~~~l~~~~~~~  174 (450)
T 1k9a_A          102 GLFLVR-ESTNYPGDYTLCVSCEGKVEHYRIMYH-ASKL-----SIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVME  174 (450)
T ss_dssp             TEEEEE-ECSSSTTSEEEEEECSSSEEEEEEEEE-TTEE-----ESSSSSCBSSHHHHHHHHHHCCTTSSSCCCEECCCT
T ss_pred             ceEEEE-ecCCCCCceEEEEEeCCeeeEEEEEec-CCce-----EeccccccccHHHHHhhhcccccchhhhcccccccc
Confidence            999999 999999999999988999999999544 4466     44444556666555544432     22222232211


Q ss_pred             CcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh
Q 039082          171 PLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR  250 (472)
Q Consensus       171 p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~  250 (472)
                      ..      ...........|.++.++|++.+.||+|+||.||+|.++|..||||+++.+.      ..+.|.+|+.+|+.
T Consensus       175 ~~------~~~~~~~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~  242 (450)
T 1k9a_A          175 GT------VAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA------TAQAFLAEASVMTQ  242 (450)
T ss_dssp             TC------EEHHHHHHHTTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT------TSHHHHHHHHHHHT
T ss_pred             Cc------ccchhhhcccccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch------HHHHHHHHHHHHHh
Confidence            11      0011112356899999999999999999999999999999999999997542      33568999999999


Q ss_pred             cCCCceeEEEEEEEcCC-CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceee
Q 039082          251 QRHRFVLQLMGACLEPP-YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIH  329 (472)
Q Consensus       251 l~HpnIv~l~g~~~~~~-~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiH  329 (472)
                      ++|||||++++++...+ ..++|+|++.+|+|.+++...+.        ...+...++.++.||+.||+|||+++  |+|
T Consensus       243 l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH  312 (450)
T 1k9a_A          243 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--------SVLGGDCLLKFSLDVCEAMEYLEGNN--FVH  312 (450)
T ss_dssp             CCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT--------TTCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             ccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence            99999999999988765 67889999999999999975432        12356788999999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCC
Q 039082          330 RDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDY  408 (472)
Q Consensus       330 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~  408 (472)
                      |||||+||||+.++.+||+|||+++..........+++.|+|||++.+..++.++|||||||++|||+| |..||.+.+.
T Consensus       313 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~  392 (450)
T 1k9a_A          313 RDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL  392 (450)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred             CCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999999999876654444567899999999999999999999999999999999 9999987764


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       409 ~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                        .++...+..+. ++..|  ..++..+.++|.+||..||++|||+.+|++.|+.+...
T Consensus       393 --~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          393 --KDVVPRVEKGY-KMDAP--DGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --TTHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --HHHHHHHHcCC-CCCCC--CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence              33555566654 33333  34567889999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1e-54  Score=454.43  Aligned_cols=347  Identities=24%  Similarity=0.372  Sum_probs=273.1

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++-|..+..-.++|||| +|+..+|.|+|||..     +..|+||+|...+++.|     +......|+++...+.++..
T Consensus        78 e~~L~~~~~~~G~FLvR-~s~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~-----~~~~~~~F~Sl~~Li~~y~~  151 (452)
T 1fmk_A           78 ERLLLNAENPRGTFLVR-ESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGF-----YITSRTQFNSLQQLVAYYSK  151 (452)
T ss_dssp             HHHHTCTTSCTTEEEEE-ECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCE-----ESSTTSEESSHHHHHHHHTT
T ss_pred             HHHhccCCCCCceEEEE-eCCCCCCceEEEEEeeccCCCCcEEEEEEEEcCCCCE-----EEecCcccCCHHHHHHHhhh
Confidence            33333344455999999 999999999999964     67899999999888888     55555667777777665543


Q ss_pred             -----CCccccccCCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCC
Q 039082          160 -----QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHT  233 (472)
Q Consensus       160 -----~~~l~~~~~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~  233 (472)
                           +..+..+|.......        .......|.++.++|++.+.||+|+||.||+|.+++ ..||||+++....  
T Consensus       152 ~~~~l~~~l~~~~~~~~~~~--------~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--  221 (452)
T 1fmk_A          152 HADGLCHRLTTVCPTSKPQT--------QGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--  221 (452)
T ss_dssp             CCTTSSSCCCEECCCCCCCC--------SSSSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--
T ss_pred             ccccchhhcccccccccccc--------CCCCccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--
Confidence                 233444553322110        112356799999999999999999999999999985 6799999976432  


Q ss_pred             ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHH
Q 039082          234 NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI  313 (472)
Q Consensus       234 ~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi  313 (472)
                         ..+.|.+|+.+|+.++||||+++++++.+ +..++|+|++.+|+|.+++.....        ...++..++.++.||
T Consensus       222 ---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~i~~qi  289 (452)
T 1fmk_A          222 ---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQI  289 (452)
T ss_dssp             ---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHH--------TTCCHHHHHHHHHHH
T ss_pred             ---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCC--------CCCCHHHHHHHHHHH
Confidence               23568999999999999999999999876 678899999999999999964221        123578899999999


Q ss_pred             HHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHH
Q 039082          314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSF  389 (472)
Q Consensus       314 a~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSl  389 (472)
                      +.||+|||+++  |+||||||+|||++.++.+||+|||+++.......    ...+++.|+|||++.+..++.++|||||
T Consensus       290 ~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwsl  367 (452)
T 1fmk_A          290 ASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSF  367 (452)
T ss_dssp             HHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred             HHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhH
Confidence            99999999999  99999999999999999999999999987654322    2336789999999998999999999999


Q ss_pred             HHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          390 GIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       390 Gvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ||++|||++ |..||.+..  ..++...+..+. ++..|  ..++..+.++|.+||..||++|||+++|++.|+++..
T Consensus       368 G~~l~el~t~g~~P~~~~~--~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          368 GILLTELTTKGRVPYPGMV--NREVLDQVERGY-RMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             HHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence            999999999 999998776  556666666654 33333  3456678899999999999999999999999988754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-54  Score=455.43  Aligned_cols=341  Identities=25%  Similarity=0.390  Sum_probs=274.3

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCCC-----Ccccccc
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQ-----TPLHRYC  167 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~~-----~~l~~~~  167 (472)
                      ...++|||| +|+..+|.|+|||..+..|+||+|...+++.+     +......|+.+..+++++...     +.+..+|
T Consensus       124 ~~~G~fLvR-~s~~~~~~~~lsv~~~~~v~h~~I~~~~~g~~-----~~~~~~~F~sl~eLv~~~~~~~~g~~~~l~~~~  197 (495)
T 1opk_A          124 GINGSFLVR-ESESSPGQRSISLRYEGRVYHYRINTASDGKL-----YVSSESRFNTLAELVHHHSTVADGLITTLHYPA  197 (495)
T ss_dssp             CCTTEEEEE-ECSSSTTCEEEEEEETTEEEEEECEECTTSCE-----ESSTTSCBSSHHHHHHHHTTCCTTSSSCCCEEC
T ss_pred             CCCceEEEE-eCCCCCCceEEEEeeCCeEEEEEEEecCCCce-----EeccCccchhHHHHhhhhcccccccchhccccc
Confidence            346999999 99999999999999999999999998888777     666666677777766665432     2233333


Q ss_pred             CCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHH
Q 039082          168 SQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEV  245 (472)
Q Consensus       168 ~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~  245 (472)
                      ........     .........|.+..++|++.+.||+|+||.||+|.++  +..||||+++.+.     ...+.|.+|+
T Consensus       198 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~E~  267 (495)
T 1opk_A          198 PKRNKPTI-----YGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEA  267 (495)
T ss_dssp             CCCSCCCC-----SSSCSSSSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-----SCHHHHHHHH
T ss_pred             cccccccc-----cccCccccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-----cchHHHHHHH
Confidence            22111000     0011235679999999999999999999999999997  6789999997542     2345699999


Q ss_pred             HHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 039082          246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP  325 (472)
Q Consensus       246 ~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~  325 (472)
                      .+|+.++|||||+++++|...+..++|+|++.+|+|.+++.....        ...++..++.++.||+.||+|||+++ 
T Consensus       268 ~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~LH~~~-  338 (495)
T 1opk_A          268 AVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEKKN-  338 (495)
T ss_dssp             HHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc--------CCCCHHHHHHHHHHHHHHHHHHHhCC-
Confidence            999999999999999999999999999999999999999975332        12356788999999999999999999 


Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CC
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN  400 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~  400 (472)
                       |+||||||+||||+.++.+||+|||+++.......    ...+++.|+|||++.+..++.++|||||||++|||+| |.
T Consensus       339 -ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~  417 (495)
T 1opk_A          339 -FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM  417 (495)
T ss_dssp             -EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSC
T ss_pred             -cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCC
Confidence             99999999999999999999999999997754332    2235788999999998899999999999999999999 99


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .||.+.+.  ..+...+..+. +...+  ..++..+.++|.+||..||++|||+.+|++.|+.+
T Consensus       418 ~p~~~~~~--~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          418 SPYPGIDL--SQVYELLEKDY-RMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             CSSTTCCG--GGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCCH--HHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            99988763  33444444443 33333  34556788999999999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.2e-53  Score=457.33  Aligned_cols=351  Identities=18%  Similarity=0.306  Sum_probs=272.0

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-----CCcccccc
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-----QTPLHRYC  167 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-----~~~l~~~~  167 (472)
                      ...++|||| +| +..|.|+|||..++.|+||+|....+|.|     +......|+++..++.+|..     .+.|..+|
T Consensus       182 ~~~G~FLvR-~s-~~~~~~~lsv~~~~~v~h~~I~~~~~g~~-----~~~~~~~F~sl~~Lv~~y~~~~~~l~~~L~~pC  254 (613)
T 2ozo_A          182 QTDGKFLLR-PR-KEQGTYALSLIYGKTVYHYLISQDKAGKY-----CIPEGTKFDTLWQLVEYLKLKADGLIYCLKEAC  254 (613)
T ss_dssp             CCTTCEEEE-EC-SSTTEEEEEEEETTEEEEEEEEECTTCCE-----ECTTSCEESSHHHHHHHHHHCCTTCSSCCCSBC
T ss_pred             CCCceEEEE-ec-CCCCCEEEEEEECCeEEEEEEEECCCCCE-----EECCCCCcCCHHHHHHHHhhCCCCceecccccc
Confidence            356999999 88 66789999999999999999998888888     44445667888777766653     34455666


Q ss_pred             CCCCcccc------------cc-------------------------hhh----h------------hhhcccCceeeCC
Q 039082          168 SQTPLLQQ------------SD-------------------------LAV----T------------VSQAKMNGWYIDP  194 (472)
Q Consensus       168 ~~~p~~~~------------~~-------------------------~~~----~------------~~~~~~~~~~i~~  194 (472)
                      ...+....            +.                         ...    +            ........|.+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (613)
T 2ozo_A          255 PNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKR  334 (613)
T ss_dssp             CC-----------------------------------------------------CCCCSCSSSSSCSCSSCCCCSBCCT
T ss_pred             ccccccccccccCcccCCCCccccccccccccccccCCCCCccccCCCCCCCCCCCccccccCCcCChhHhcccceeccc
Confidence            33210000            00                         000    0            0001123467777


Q ss_pred             CCeeEec-eeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          195 KEIDLQE-KIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       195 ~~~~l~~-~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +++.+.+ .||+|+||.||+|.++    +..||||+++...   .....+.|.+|+++|+.++|||||+++++|.. +..
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~---~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT---EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC---SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            8888877 8999999999999874    4579999997642   33445679999999999999999999999876 568


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|+|++.+|+|.+++.....         ..++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||+|
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~D  479 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKRE---------EIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISD  479 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTT---------TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC
T ss_pred             EEEEEeCCCCcHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEee
Confidence            899999999999999954321         2357889999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          350 FGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       350 FGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      ||+++.......      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+  ..++...+..+. 
T Consensus       480 FGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~-  556 (613)
T 2ozo_A          480 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAFIEQGK-  556 (613)
T ss_dssp             CSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--SHHHHHHHHTTC-
T ss_pred             ccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCC-
Confidence            999987653221      2235689999999999999999999999999999998 999998876  455666676665 


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                      ++..|.  .++..+.++|..||..+|++||++.+|++.|+.+...+..
T Consensus       557 ~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          557 RMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             CCCCCT--TCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             CCCCCC--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            333333  4567889999999999999999999999999999887654

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=6.5e-54  Score=457.54  Aligned_cols=349  Identities=24%  Similarity=0.370  Sum_probs=276.4

Q ss_pred             HHHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccC
Q 039082           83 DLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQH  157 (472)
Q Consensus        83 ~~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~  157 (472)
                      ++++-|.....-.++|||| +|+..+|.|+|||..     +..|+||+|...++++|     +......|+++..++.++
T Consensus       159 ~ae~~L~~~~~~~G~FLvR-~S~~~~g~y~lsv~~~~~~~~~~v~h~~I~~~~~g~~-----~i~~~~~F~SL~eLv~~y  232 (535)
T 2h8h_A          159 ESERLLLNAENPRGTFLVR-ESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGF-----YITSRTQFNSLQQLVAYY  232 (535)
T ss_dssp             HHHHHHTCTTCCTTEEEEE-ECSSSTTCEEEEEEEEETTTEEEEEEEEEBC-CCSCE-----EEETTEEESSHHHHHHHH
T ss_pred             HHHHHhccCCCCCCeEEEE-ecCCCCCcEEEEEEeeccCCCCceEEEEEEEcCCCcE-----EeeccccccChHHhheee
Confidence            3344443444456999999 999999999999964     67899999999888888     444455677777776555


Q ss_pred             CC-----CCccccccCCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCC
Q 039082          158 SH-----QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFF  231 (472)
Q Consensus       158 ~~-----~~~l~~~~~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~  231 (472)
                      ..     +..+...|......        ........|++..++|++.++||+|+||.||+|.+++ ..||||+++....
T Consensus       233 ~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~  304 (535)
T 2h8h_A          233 SKHADGLCHRLTTVCPTSKPQ--------TQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM  304 (535)
T ss_dssp             HHCCTTSSSCCCEECCCCCCC--------CSSSSTTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS
T ss_pred             ccccCcccccccccccccccc--------ccccCccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC
Confidence            43     23344455322111        0112356799999999999999999999999999985 6799999976432


Q ss_pred             CCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHH
Q 039082          232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL  311 (472)
Q Consensus       232 ~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  311 (472)
                           ..+.|.+|+.+|+.++|||||++++++.+ +..++|+|++.+|+|.+++.....        ...++..++.++.
T Consensus       305 -----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~  370 (535)
T 2h8h_A          305 -----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAA  370 (535)
T ss_dssp             -----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHH--------TTCCHHHHHHHHH
T ss_pred             -----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCC--------CCCCHHHHHHHHH
Confidence                 23568999999999999999999999876 678899999999999999964221        1234788999999


Q ss_pred             HHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHH
Q 039082          312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVY  387 (472)
Q Consensus       312 qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvw  387 (472)
                      ||+.||+|||+++  ||||||||+||||+.++.+||+|||+++......    ....+++.|+|||++.+..++.++|||
T Consensus       371 qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvw  448 (535)
T 2h8h_A          371 QIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW  448 (535)
T ss_dssp             HHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHH
T ss_pred             HHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHH
Confidence            9999999999999  9999999999999999999999999998765322    223467889999999989999999999


Q ss_pred             HHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          388 SFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       388 SlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ||||++|||++ |..||.+..  ..++...+..+. +...+  ..++..+.++|.+||..||++|||+++|++.|+.+..
T Consensus       449 SlGv~l~el~t~g~~P~~~~~--~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          449 SFGILLTELTTKGRVPYPGMV--NREVLDQVERGY-RMPCP--PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             HHHHHHHHHTTTTCCSSTTCC--HHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence            99999999999 999998776  556666666654 33333  3456678999999999999999999999999987653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.9e-51  Score=406.70  Aligned_cols=245  Identities=26%  Similarity=0.373  Sum_probs=191.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY----  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~----  268 (472)
                      ++|++++.||+|+||+||+|+++  |..||||+++..   ..+...+.+.+|+.+|+.++|||||++++++.+.+.    
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP---NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC---SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            36999999999999999999986  789999999754   345566789999999999999999999999876543    


Q ss_pred             --------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          269 --------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       269 --------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                              .|+||||+.||+|.+++.......       ......++.++.||+.||+|||++|  ||||||||+||||+
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~-------~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~  152 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-------ERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFT  152 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGG-------GSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCC-------hhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEEC
Confidence                    578999999999999997544321       1234567889999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc---------------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 039082          341 DAKHVRIADFGHARFLSDGE---------------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE  405 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~---------------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~  405 (472)
                      .+|.+||+|||+|+.+....               ...+||+.|||||++.+..|+.++|||||||++|||++   ||..
T Consensus       153 ~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          153 MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             TTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            99999999999998775322               23469999999999999999999999999999999996   7854


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .. ........+....    .|.. ....+.+.++|.+||..||++|||+.++++
T Consensus       230 ~~-~~~~~~~~~~~~~----~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          230 QM-ERVRTLTDVRNLK----FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH-HHHHHHHHHHTTC----CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc-HHHHHHHHHhcCC----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            32 1122233333333    2222 233455678999999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.1e-52  Score=454.11  Aligned_cols=360  Identities=21%  Similarity=0.331  Sum_probs=274.6

Q ss_pred             HHHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC---
Q 039082           83 DLTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH---  159 (472)
Q Consensus        83 ~~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~---  159 (472)
                      ++++-|+.+....++|||| +| +..|.|+|||..++.|+||+|....+|.|     +......|+++..++.+|..   
T Consensus       177 ~ae~~L~~~~~~~G~FLvR-~s-~~~g~y~lsv~~~~~v~h~~i~~~~~g~~-----~~~~~~~F~sl~~Lv~~y~~~~~  249 (635)
T 4fl3_A          177 ESEQIVLIGSKTNGKFLIR-AR-DNNGSYALCLLHEGKVLHYRIDKDKTGKL-----SIPEGKKFDTLWQLVEHYSYKAD  249 (635)
T ss_dssp             HHHHHHHSSSCCTTCEEEE-ES-SSSSCEEEEEEETTEEEEEEEEECTTSCE-----ESTTCCCBSSHHHHHHHHTTCCT
T ss_pred             HHHHHHHcCCCCCceEEEE-ec-CCCCCEEEEEEECCEEEEEEEEECCCCCE-----EeCCCCccCCHHHHHHHhhhCCC
Confidence            3343344334446999999 88 56689999999999999999988888888     55555578888877766664   


Q ss_pred             --CCccccccCCC-----------Ccccccc-------------------------------------hhh-h-------
Q 039082          160 --QTPLHRYCSQT-----------PLLQQSD-------------------------------------LAV-T-------  181 (472)
Q Consensus       160 --~~~l~~~~~~~-----------p~~~~~~-------------------------------------~~~-~-------  181 (472)
                        .+.|..+|...           |....+.                                     ... +       
T Consensus       250 ~l~~~L~~p~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (635)
T 4fl3_A          250 GLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAP  329 (635)
T ss_dssp             TSSSCCCSBCCC--------------------------------------------------------------------
T ss_pred             CCccccCccCcCccccccccccCCCCCCCcCccccccccccccccccccCCccccccccccccCCcccccCCCCCCCCCc
Confidence              44556666432           1000000                                     000 0       


Q ss_pred             -------------------------hhhcccCceeeCCCCeeEec-eeeccCceEEEEEEEC----CeeEEEEEeccCCC
Q 039082          182 -------------------------VSQAKMNGWYIDPKEIDLQE-KIGQGTTANIYRAIWR----GLDVAVKCIYPDFF  231 (472)
Q Consensus       182 -------------------------~~~~~~~~~~i~~~~~~l~~-~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~  231 (472)
                                               ........|.++...+.+.. +||+|+||.||+|.+.    +..||||+++... 
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-  408 (635)
T 4fl3_A          330 WAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-  408 (635)
T ss_dssp             --------CCCCGGGSTTSSCTTCSTTSCCCSSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-
T ss_pred             cccccCcccccCCCcccccccccCChhHcCcccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-
Confidence                                     00001123556666666644 8999999999999763    4679999997653 


Q ss_pred             CCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHH
Q 039082          232 HTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL  311 (472)
Q Consensus       232 ~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  311 (472)
                       ......+.|.+|+.+|+.++|||||++++++.. +..++|+|++.+|+|.+++....          ..++..++.++.
T Consensus       409 -~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~----------~l~~~~~~~i~~  476 (635)
T 4fl3_A          409 -NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----------HVKDKNIIELVH  476 (635)
T ss_dssp             -GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCT----------TCCHHHHHHHHH
T ss_pred             -CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCC----------CCCHHHHHHHHH
Confidence             234456779999999999999999999999864 55789999999999999996432          234788999999


Q ss_pred             HHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHH
Q 039082          312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSD  385 (472)
Q Consensus       312 qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sD  385 (472)
                      ||+.||+|||++|  ||||||||+||||+.++.+||+|||+++.+....      ....+|+.|+|||++.+..++.++|
T Consensus       477 qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sD  554 (635)
T 4fl3_A          477 QVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSD  554 (635)
T ss_dssp             HHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHH
T ss_pred             HHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHH
Confidence            9999999999999  9999999999999999999999999998765432      1233578899999999999999999


Q ss_pred             HHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          386 VYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       386 vwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ||||||++|||++ |..||.+.+  ...+...+..+. ++..+.  .++.++.++|..||..||++||++.+|++.|+++
T Consensus       555 vwSlGv~l~ellt~G~~Pf~~~~--~~~~~~~i~~~~-~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          555 VWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEKGE-RMGCPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             HHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTTC-CCCCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC-CCCCCC--CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            9999999999998 999998776  556666676665 333443  3567889999999999999999999999999999


Q ss_pred             HHHHh
Q 039082          465 QMKVT  469 (472)
Q Consensus       465 ~~~~~  469 (472)
                      ..++.
T Consensus       630 ~~~l~  634 (635)
T 4fl3_A          630 YYDVV  634 (635)
T ss_dssp             HHHHC
T ss_pred             HHHhc
Confidence            88763

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-49  Score=404.62  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=199.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC------
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP------  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~------  266 (472)
                      ++|++++.||+|+||.||+|+++  |..||||+++...  ......+.+.+|+.+|+.++|||||++++++...      
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~  131 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF--DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF  131 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc--cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence            68999999999999999999986  7899999997653  2445567789999999999999999999987643      


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...|+||||+ +|+|.+++...+          ..+...+..++.||+.||+|||++|  ||||||||+|||++.+|.+|
T Consensus       132 ~~~~ivmE~~-~g~L~~~i~~~~----------~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~K  198 (398)
T 4b99_A          132 KSVYVVLDLM-ESDLHQIIHSSQ----------PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELK  198 (398)
T ss_dssp             CCEEEEEECC-SEEHHHHHTSSS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEE
T ss_pred             CEEEEEEeCC-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEE
Confidence            4567777776 678999996432          2357889999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCC-------ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSDG-------EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~-------~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||+|+.+...       ....+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+  ..+....+.
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~--~~~~l~~I~  276 (398)
T 4b99_A          199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN--YVHQLQLIM  276 (398)
T ss_dssp             ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHH
T ss_pred             EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCC--HHHHHHHHH
Confidence            9999999876422       2356799999999998775 57999999999999999999999998776  334443333


Q ss_pred             cCCCC----------------------CCCCCC-----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 EGKLR----------------------PALPEE-----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ~~~~~----------------------~~l~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....                      +..+..     +....++.+||.+||..||++|||++++++
T Consensus       277 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          277 MVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            21100                      000100     123467889999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-48  Score=415.90  Aligned_cols=248  Identities=21%  Similarity=0.281  Sum_probs=214.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++...    .....+.+.+|+.+|+.++|||||+++++|.+....|+|
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~----~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv  232 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  232 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc----chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            58999999999999999999986  789999999753    344556788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC--CcEEEeec
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA--KHVRIADF  350 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~--~~vkL~DF  350 (472)
                      |||+.||+|.++|.....         ..+...+..++.||+.||+|||++|  |+||||||+|||++.+  +.+||+||
T Consensus       233 ~E~~~gg~L~~~i~~~~~---------~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DF  301 (573)
T 3uto_A          233 YEFMSGGELFEKVADEHN---------KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF  301 (573)
T ss_dssp             EECCCCCBHHHHHTCTTS---------CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EeecCCCcHHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeec
Confidence            999999999999853221         1246788999999999999999999  9999999999999854  89999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      |+|+.+....  ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+  .......+..+......+.
T Consensus       302 G~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~  379 (573)
T 3uto_A          302 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSA  379 (573)
T ss_dssp             SSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCCCCSGG
T ss_pred             cceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--HHHHHHHHHhCCCCCCccc
Confidence            9999887543  34679999999999999999999999999999999999999998776  6667777777654433222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......++.+||.+||..||++|||+.++++
T Consensus       380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          380 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2445678899999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.2e-47  Score=377.96  Aligned_cols=271  Identities=33%  Similarity=0.532  Sum_probs=218.0

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      .....|.++.++|++.+.||+|+||.||+|.++|..||||++.....  .......|.+|+.+|+.++||||+++++++.
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF--HAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC--SHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            34556888899999999999999999999999999999999976532  4556678999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ..+..++|++++.+++|.+++...+...       ..+...++.++.|++.||+|||++|++|+||||||+|||++.++.
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~  177 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGARE-------QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT  177 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHH-------HSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCC-------CCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc
Confidence            9999999999999999999997543211       134678899999999999999999877999999999999999999


Q ss_pred             EEEeecccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          345 VRIADFGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       345 vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +||+|||+++.....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+....
T Consensus       178 ~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~--~~~~~~~~~~~~  255 (309)
T 3p86_A          178 VKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN--PAQVVAAVGFKC  255 (309)
T ss_dssp             EEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHHSC
T ss_pred             EEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcC
Confidence            999999999865543   234568999999999999999999999999999999999999997765  555555554443


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+..++.  ..+..+.++|.+||..||.+|||+.+|++.|+.+....
T Consensus       256 ~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          256 KRLEIPR--NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             CCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             CCCCCCc--cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            3444443  34567889999999999999999999999999887643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-48  Score=414.65  Aligned_cols=253  Identities=25%  Similarity=0.320  Sum_probs=205.5

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC--ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT--NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~--~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .++.++|+++++||+|+||.||+|+++  |..||||++.+.....  ..........++.+++.++|||||+++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            345679999999999999999999986  7899999997643311  122222233446667778999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..|+||||+.||+|.++|...+.          .+...+..++.||+.||+|||++|  ||||||||+||||+.+|++|
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~----------l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vK  332 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGV----------FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVR  332 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEE
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEE
Confidence            999999999999999999975432          346788999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCC-ccccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-CHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLSDG-EMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-KPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~~~-~~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-~~~~i~~~i~~~~~~  423 (472)
                      |+|||+|+.+... ..+.+||+.|+|||++. +..|+.++|||||||++|||++|..||.+.+. ....+...+....  
T Consensus       333 L~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--  410 (689)
T 3v5w_A          333 ISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--  410 (689)
T ss_dssp             ECCCTTCEECSSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--
T ss_pred             ecccceeeecCCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--
Confidence            9999999987643 45678999999999996 45799999999999999999999999976443 2334444555543  


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      ..+|.  ..+.++.++|.+||..||++|++     +++|++
T Consensus       411 ~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 VELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            23333  34567889999999999999998     677653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-47  Score=387.50  Aligned_cols=243  Identities=21%  Similarity=0.276  Sum_probs=193.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~  268 (472)
                      ++|++.++||+|+||.||+|+++     +..||||.+.+..      ....+.+|+++|+.+ +|||||+++++|.+.+.
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~------~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS------HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS------CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc------CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            57999999999999999999874     5689999986531      224578999999998 79999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcEEE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHVRI  347 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~vkL  347 (472)
                      .|+||||+.||+|.+++..             .++.++..++.||+.||+|||++|  ||||||||+||||+.+ +.+||
T Consensus        95 ~~lvmE~~~g~~L~~~~~~-------------l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl  159 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILNS-------------LSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYAL  159 (361)
T ss_dssp             EEEEEECCCCCCHHHHHTT-------------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEEEEeCCCcccHHHHHcC-------------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEE
Confidence            9999999999999999842             246789999999999999999999  9999999999999876 89999


Q ss_pred             eecccceecCCCc-------------------------------cccccCCcccccccccCC-CCCchHHHHHHHHHHHH
Q 039082          348 ADFGHARFLSDGE-------------------------------MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNE  395 (472)
Q Consensus       348 ~DFGla~~~~~~~-------------------------------~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~e  395 (472)
                      +|||+|+...+..                               ...+||+.|+|||++.+. .|+.++||||+||++||
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~e  239 (361)
T 4f9c_A          160 VDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLS  239 (361)
T ss_dssp             CCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHH
Confidence            9999998654321                               134699999999999765 58999999999999999


Q ss_pred             HHcCCCCCCCCCCCHHHHHHHHhc--------------------------------------CCC-CC-----------C
Q 039082          396 IITGNHPYIEKDYKPAKIAMEVGE--------------------------------------GKL-RP-----------A  425 (472)
Q Consensus       396 lltG~~Pf~~~~~~~~~i~~~i~~--------------------------------------~~~-~~-----------~  425 (472)
                      |+||+.||...+.. .+....+..                                      ... .+           .
T Consensus       240 ll~G~~Pf~~~~~~-~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  318 (361)
T 4f9c_A          240 LLSGRYPFYKASDD-LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN  318 (361)
T ss_dssp             HHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred             HHHCCCCCCCCCCH-HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence            99999999654421 111111110                                      000 00           0


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.....+.++.+||.+||..||++|||++++++
T Consensus       319 ~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          319 LEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0011233467889999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.2e-46  Score=373.62  Aligned_cols=265  Identities=25%  Similarity=0.293  Sum_probs=220.3

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      .....|++..++|++.+.||+|+||.||+|.+.+..||||++...     ......+.+|+.+|+.++|||||++++++.
T Consensus        14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ-----DKQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC-----chHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            455679999999999999999999999999999999999998542     233445667999999999999999999998


Q ss_pred             cCCC----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCceeec
Q 039082          265 EPPY----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ----------KPKVIHR  330 (472)
Q Consensus       265 ~~~~----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~----------~~~iiHr  330 (472)
                      ....    .++|+|++.+|+|.+++....           .++..++.++.|++.||+|||+.          +  |+||
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~--ivH~  155 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKANV-----------VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA--ISHR  155 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHCC-----------BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE--EECS
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhcC-----------CCHHHHHHHHHHHHHHHHHHHhhccccccccCCC--EEeC
Confidence            8654    478889999999999996422           35788999999999999999998          8  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCC-----CCCchHHHHHHHHHHHHHHcCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGN  400 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~-----~~s~~sDvwSlGvll~elltG~  400 (472)
                      ||||+|||++.++.+||+|||+++......     ....||+.|+|||++.+.     .++.++|||||||++|||+||+
T Consensus       156 Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~  235 (322)
T 3soc_A          156 DIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC  235 (322)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             CCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCC
Confidence            999999999999999999999998765432     234689999999999863     4567899999999999999999


Q ss_pred             CCCCCCCC--------------CHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          401 HPYIEKDY--------------KPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       401 ~Pf~~~~~--------------~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      .||.+...              ....+...+..+..++.++..   ...+..+.++|.+||..||++|||+.++++.|+.
T Consensus       236 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          236 TAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             TTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            99975421              233444445555555555542   3456779999999999999999999999999999


Q ss_pred             HHHH
Q 039082          464 IQMK  467 (472)
Q Consensus       464 i~~~  467 (472)
                      +.+.
T Consensus       316 l~~~  319 (322)
T 3soc_A          316 MQRL  319 (322)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.6e-46  Score=378.99  Aligned_cols=274  Identities=26%  Similarity=0.410  Sum_probs=225.9

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCce
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFV  256 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnI  256 (472)
                      ...|.+..++|++.+.||+|+||.||+|.+.         +..||||+++..   ........+.+|+.+|+.+ +||||
T Consensus        73 ~~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpnI  149 (370)
T 2psq_A           73 DPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKNI  149 (370)
T ss_dssp             CTTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT---CBHHHHHHHHHHHHHHHHSCCCTTB
T ss_pred             cccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC---cCHHHHHHHHHHHHHHHHhcCCCCE
Confidence            4468888899999999999999999999873         346999999764   3455667899999999999 89999


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      ++++++|...+..++|+|++.+|+|.+++.........      .......++..++.++.||+.||+|||++|  |+||
T Consensus       150 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHr  227 (370)
T 2psq_A          150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHR  227 (370)
T ss_dssp             CCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECS
T ss_pred             eeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eecc
Confidence            99999999999999999999999999999764421100      001123467889999999999999999999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI  404 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~  404 (472)
                      ||||+||||+.++.+||+|||+++......     ....+|+.|+|||++.+..++.++|||||||++|||+| |..||.
T Consensus       228 Dlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             CCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999999998765432     23346789999999999999999999999999999999 999998


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                      +..  ...+...+..+. ++..+.  .++..+.++|.+||..||++||++.+|++.|+.+.....+
T Consensus       308 ~~~--~~~~~~~~~~~~-~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~~  368 (370)
T 2psq_A          308 GIP--VEELFKLLKEGH-RMDKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  368 (370)
T ss_dssp             TCC--GGGHHHHHHTTC-CCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             CCC--HHHHHHHHhcCC-CCCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhcc
Confidence            766  334555555554 333333  3556788999999999999999999999999999876543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=368.44  Aligned_cols=261  Identities=24%  Similarity=0.391  Sum_probs=219.8

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .+.+..++|++.+.||+|+||.||+|.++     +..||||+++..   ......+.|.+|+.+|+.++||||+++++++
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  119 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG---YTERQRRDFLSEASIMGQFDHPNIIRLEGVV  119 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            45677889999999999999999999984     346999999754   2455667899999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .+.+..++|+|++.+++|.+++.....         ..++..++.++.+++.||+|||++|  |+||||||+||||+.++
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~  188 (325)
T 3kul_A          120 TRGRLAMIVTEYMENGSLDTFLRTHDG---------QFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNL  188 (325)
T ss_dssp             CGGGCCEEEEECCTTCBHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTC
T ss_pred             EeCCccEEEeeCCCCCcHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCC
Confidence            998899999999999999999964321         2357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      .+||+|||+++.......      ...+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+..  ...+...
T Consensus       189 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--~~~~~~~  266 (325)
T 3kul_A          189 VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT--NRDVISS  266 (325)
T ss_dssp             CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHH
T ss_pred             CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCC--HHHHHHH
Confidence            999999999998764321      2235778999999998999999999999999999999 999997766  5556666


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +..+. +...+  ...+..+.++|..||..||++||++.+|++.|+.+....
T Consensus       267 ~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          267 VEEGY-RLPAP--MGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             HHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             HHcCC-CCCCC--CCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            66654 22222  345667899999999999999999999999999987654

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=374.01  Aligned_cols=274  Identities=26%  Similarity=0.403  Sum_probs=228.2

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEECC---------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCc
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG---------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRF  255 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g---------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~Hpn  255 (472)
                      ....|.+..++|.+.+.||+|+||.||+|.+.+         ..||||+++..   ........+.+|+.+++.+ +|||
T Consensus        60 ~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpn  136 (382)
T 3tt0_A           60 EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKN  136 (382)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             cCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc---cCHHHHHHHHHHHHHHHHhcCCch
Confidence            445789999999999999999999999999742         56999999764   3455667899999999999 9999


Q ss_pred             eeEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceee
Q 039082          256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIH  329 (472)
Q Consensus       256 Iv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiH  329 (472)
                      ||++++++...+..++|+|++.+++|.+++.........      .......++..++.++.||+.||+|||++|  |+|
T Consensus       137 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH  214 (382)
T 3tt0_A          137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIH  214 (382)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCC
T ss_pred             hhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--Eec
Confidence            999999999999999999999999999999764421100      011123568889999999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 039082          330 RDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY  403 (472)
Q Consensus       330 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf  403 (472)
                      |||||+||||+.++.+||+|||+++......     ....+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       215 ~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~  294 (382)
T 3tt0_A          215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY  294 (382)
T ss_dssp             SCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999998765322     23346889999999999999999999999999999999 99999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       404 ~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      .+.+  ...+...+..+. +...+  ...+..+.++|.+||..||++||++.+|++.|+.+.....
T Consensus       295 ~~~~--~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          295 PGVP--VEELFKLLKEGH-RMDKP--SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             TTCC--HHHHHHHHHTTC-CCCCC--SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCC--HHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            8766  555666665554 33333  3355678899999999999999999999999999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-45  Score=355.88  Aligned_cols=258  Identities=28%  Similarity=0.486  Sum_probs=218.7

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ..|.++.++|++.+.||+|+||.||+|.+. +..||||++.....     ..+.+.+|+.+++.++||||+++++++.+.
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   77 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ   77 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-----CHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            358899999999999999999999999985 77899999976432     224588999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...++|++++.+++|.+++.....         ..+...++.++.|++.||+|||++|  ++||||||+|||++.++.+|
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~k  146 (269)
T 4hcu_A           78 APICLVFEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIK  146 (269)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEE
T ss_pred             CceEEEEEeCCCCcHHHHHHhcCc---------ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEE
Confidence            999999999999999999964321         2357889999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCC
Q 039082          347 IADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       347 L~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      |+|||++.......    ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+  .......+..+.
T Consensus       147 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--~~~~~~~~~~~~  224 (269)
T 4hcu_A          147 VSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGF  224 (269)
T ss_dssp             ECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTC
T ss_pred             eccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--HHHHHHHHhcCc
Confidence            99999998665432    23346788999999998999999999999999999999 999998766  555666666553


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                       +...+  ...+..+.+++.+||..||++||++.++++.|+++.+
T Consensus       225 -~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          225 -RLYKP--RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             -CCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -cCCCC--CcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence             22222  2345678899999999999999999999999999875

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=360.66  Aligned_cols=260  Identities=27%  Similarity=0.422  Sum_probs=215.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .+.+..++|++.+.||+|+||.||+|.++  +..||+|++..    ........|.+|+.+|+.++||||+++++++.+.
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   79 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD   79 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC----CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc----CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence            35677889999999999999999999986  77899998854    3556778899999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.++.+|
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~k  148 (310)
T 3s95_A           80 KRLNFITEYIKGGTLRGIIKSMDS---------QYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVV  148 (310)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHCCT---------TSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEE
T ss_pred             CeeEEEEEecCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEE
Confidence            999999999999999999965321         2357889999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCcc-----------------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC
Q 039082          347 IADFGHARFLSDGEM-----------------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK  409 (472)
Q Consensus       347 L~DFGla~~~~~~~~-----------------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~  409 (472)
                      |+|||++........                 ...||+.|+|||++.+..++.++||||||+++|+|++|..||......
T Consensus       149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~  228 (310)
T 3s95_A          149 VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR  228 (310)
T ss_dssp             ECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred             EeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence            999999987653322                 346899999999999999999999999999999999999998653321


Q ss_pred             HHH---HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          410 PAK---IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       410 ~~~---i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ...   ...........+      ..+..+.+++.+||+.||++|||+.++++.|+.+...+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          229 TMDFGLNVRGFLDRYCPP------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             CTTSSBCHHHHHHHTCCT------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhhhhhccccccCCC------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            100   001111111111      223358889999999999999999999999999988764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=370.06  Aligned_cols=274  Identities=27%  Similarity=0.407  Sum_probs=223.9

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      ..|.+..++|++.+.||+|+||.||+|.+.+       ..||||+++..   ........|.+|+.+++.++||||++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~  116 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKLL  116 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3467888999999999999999999999864       78999999754   2445667899999999999999999999


Q ss_pred             EEEEcCCCceEEEEeccCCcHHHHHhhcccccc--------------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 039082          261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR--------------KERMVPLPPFEERLARALEIAQAMQYLHEQKPK  326 (472)
Q Consensus       261 g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~  326 (472)
                      +++.+.+..++|++++.+++|.+++........              ........++..++.++.||+.||+|||++|  
T Consensus       117 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--  194 (343)
T 1luf_A          117 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--  194 (343)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            999999999999999999999999976432110              0000134567889999999999999999999  


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeecccceecCCC-----ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CC
Q 039082          327 VIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN  400 (472)
Q Consensus       327 iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~-----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~  400 (472)
                      |+||||||+|||++.++.+||+|||++......     .....+|+.|+|||.+.+..++.++||||||+++|+|++ |.
T Consensus       195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  274 (343)
T 1luf_A          195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL  274 (343)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred             eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence            999999999999999999999999999865422     223457899999999998899999999999999999999 99


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhhc
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET  471 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~~  471 (472)
                      .||.+.+  ...+...+..+.. +..+  ...+..+.++|.+||..||++||++.++++.|+++..+.+..
T Consensus       275 ~p~~~~~--~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~~  340 (343)
T 1luf_A          275 QPYYGMA--HEEVIYYVRDGNI-LACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEGT  340 (343)
T ss_dssp             CTTTTSC--HHHHHHHHHTTCC-CCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-----
T ss_pred             CcCCCCC--hHHHHHHHhCCCc-CCCC--CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhhh
Confidence            9998766  5566666666653 2233  234567889999999999999999999999999998777654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.8e-45  Score=355.66  Aligned_cols=262  Identities=24%  Similarity=0.374  Sum_probs=220.3

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--  266 (472)
                      .+.+..++|++.+.||+|+||.||+|.+++..||||+++...  ......+.|.+|+.+++.++||||+++++++...  
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTT--CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            456778899999999999999999999999999999997653  2445667799999999999999999999999887  


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...++|++++.+++|.+++.....        ...++..++.++.|++.||+|||+++++++||||||+|||++.++.++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~  153 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTN--------FVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTAR  153 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSS--------CCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred             CCeEeeecccCCCcHHHHHhhccc--------CCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCccee
Confidence            677899999999999999965321        124578899999999999999999887799999999999999999999


Q ss_pred             EeecccceecCCCccccccCCcccccccccCCCCC---chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYS---EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s---~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+|||++.....  ....||+.|+|||.+.+..++   .++||||||+++|+|++|..||.+.+  .......+.....+
T Consensus       154 l~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~~~~~  229 (271)
T 3kmu_A          154 ISMADVKFSFQS--PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--NMEIGMKVALEGLR  229 (271)
T ss_dssp             EEGGGSCCTTSC--TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--HHHHHHHHHHSCCC
T ss_pred             EEeccceeeecc--cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--hHHHHHHHHhcCCC
Confidence            999998765432  335689999999999865544   48999999999999999999997765  55555555555545


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +.++.  ..+..+.+++.+||..||++|||++++++.|+++.+
T Consensus       230 ~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          230 PTIPP--GISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             CCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            55544  345678899999999999999999999999998754

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=3.2e-45  Score=354.79  Aligned_cols=258  Identities=34%  Similarity=0.535  Sum_probs=204.8

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++.++|++.+.||+|+||.||+|.+.|..||||+++...........+.+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            56789999999999999999999999999999998765433334446779999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-ceeecCCCCCcEEEcC--------C
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP-KVIHRDLKPSNIFLDD--------A  342 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~-~iiHrDLkp~NILl~~--------~  342 (472)
                      |++++.+++|.+++...           ..++..++.++.|++.||+|||+++. +++||||||+|||++.        +
T Consensus        84 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSGK-----------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             EEECCTTEEHHHHHTSS-----------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             EEEcCCCCCHHHHhhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccC
Confidence            99999999999998521           23568899999999999999999873 3789999999999986        7


Q ss_pred             CcEEEeecccceecCCCc-cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          343 KHVRIADFGHARFLSDGE-MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~-~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +.+||+|||++....... ....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+  .......+....
T Consensus       153 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~  230 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLAVAYGVAMNK  230 (271)
T ss_dssp             CCEEECCCCC-------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSC--HHHHHHHHHTSC
T ss_pred             cceEEccCCcccccccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHhhhcCC
Confidence            789999999998765432 34568999999999999999999999999999999999999998765  455555555554


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .....+  ...+..+.+++.+||..||++|||+.++++.|+++
T Consensus       231 ~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 LALPIP--STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCCC--cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            444433  33556788999999999999999999999999754

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-45  Score=371.05  Aligned_cols=273  Identities=27%  Similarity=0.403  Sum_probs=220.8

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCcee
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL  257 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv  257 (472)
                      ....|.++.++|++.+.||+|+||.||+|.+.       +..||||+++..   ......+.+.+|+.+|..+ +|||||
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc---CCHHHHHHHHHHHHHHHhhcCCccee
Confidence            45579999999999999999999999999853       367999999754   3445567799999999999 889999


Q ss_pred             EEEEEEEcCCC-ceEEEEeccCCcHHHHHhhccccccc------------------------------------------
Q 039082          258 QLMGACLEPPY-RGWLVTELLGTTLKEWLHGLGSQRRK------------------------------------------  294 (472)
Q Consensus       258 ~l~g~~~~~~~-~~~vve~~~ggsL~~~l~~~~~~~~~------------------------------------------  294 (472)
                      ++++++.+.+. .++|+|++.+|+|.+++.........                                          
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999988655 77888999999999999765421100                                          


Q ss_pred             --------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc
Q 039082          295 --------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE  360 (472)
Q Consensus       295 --------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~  360 (472)
                                    .......++..++.++.||+.||+|||++|  |+||||||+||||+.++.+||+|||++.......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  247 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP  247 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence                          000112567889999999999999999999  9999999999999999999999999998764322


Q ss_pred             -----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHH
Q 039082          361 -----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLR  434 (472)
Q Consensus       361 -----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~  434 (472)
                           ....||+.|+|||++.+..++.++|||||||++|+|+| |..||.+..... .+...+..+. ....+.  ..+.
T Consensus       248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~--~~~~  323 (359)
T 3vhe_A          248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT-RMRAPD--YTTP  323 (359)
T ss_dssp             TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTC-CCCCCT--TCCH
T ss_pred             cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCC-CCCCCC--CCCH
Confidence                 22347889999999999999999999999999999999 999998766433 2333333332 333332  3456


Q ss_pred             HHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          435 ELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       435 ~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .+.+++.+||..||++|||+.++++.|+++...
T Consensus       324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            788999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.5e-45  Score=364.70  Aligned_cols=245  Identities=26%  Similarity=0.365  Sum_probs=211.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.+.  |..||||++.+...  .......+.+|+.+|+.++||||+++++++...+..++|
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            68999999999999999999984  78999999976533  445667789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.+++|.+++...+.          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        93 ~e~~~~~~L~~~l~~~~~----------l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~  160 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAHGR----------MKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGF  160 (328)
T ss_dssp             ECCCTTCBHHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTC
T ss_pred             EECCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccC
Confidence            999999999999965332          346788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC--ccccccCCcccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG--EMALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~--~~~~~gt~~y~APE~~~~~~~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +......  ....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+  ...+...+..+..+  +|. 
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~--~p~-  235 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--LKELRERVLRGKYR--IPF-  235 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCC--CCT-
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC--CCC-
Confidence            9876543  2345799999999999888775 89999999999999999999998776  56667777776543  232 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ..+..+.++|.+||..||.+|||++++++
T Consensus       236 -~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          236 -YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             23456888999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=3.3e-45  Score=361.19  Aligned_cols=246  Identities=24%  Similarity=0.378  Sum_probs=207.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.+.  |..||||++.....    ...+.+.+|+.+++.++||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc----cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            358999999999999999999874  78999999875432    224568899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++.+++|.+++....           .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        95 v~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg  161 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTETC-----------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFG  161 (297)
T ss_dssp             EEECCTTCBHHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEECCCCCCHHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCC
Confidence            999999999999996422           346788999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+.... .+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~-~~~~~~  238 (297)
T 3fxz_A          162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNG-TPELQN  238 (297)
T ss_dssp             TCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHHC-SCCCSC
T ss_pred             CceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCC-CCCCCC
Confidence            998776432   34568999999999999999999999999999999999999997765  333333333322 222333


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+..+.++|.+||..||++|||++++++
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            3455677899999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1e-44  Score=354.46  Aligned_cols=260  Identities=31%  Similarity=0.498  Sum_probs=216.7

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHH---HHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAV---TFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~---~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      +..++|++.+.||+|+||.||+|.+.  +..||||++............   +.+.+|+.+++.++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            56689999999999999999999985  778999999765433332222   6789999999999999999999988654


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc--
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--  344 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~--  344 (472)
                      .  ++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|.+++||||||+|||++.++.  
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAH---------PIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTC
T ss_pred             C--eEEEEecCCCCHHHHHhcccC---------CccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCC
Confidence            4  689999999999998854221         245788999999999999999998877999999999999988776  


Q ss_pred             ---EEEeecccceecCCCccccccCCccccccccc--CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          345 ---VRIADFGHARFLSDGEMALTGTFVYMAPEVIQ--CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       345 ---vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~--~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                         +||+|||++...........||+.|+|||++.  ...++.++|||||||++|+|++|..||.............+..
T Consensus       165 ~~~~kl~Dfg~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             SCCEEECCCTTCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             ceeEEeCCCCccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence               99999999987776666678999999999984  4567899999999999999999999998877666555555555


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ...++.++.  ..+..+.++|.+||..||++|||++++++.|+++
T Consensus       245 ~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          245 EGLRPTIPE--DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             SCCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cCCCCCCCc--ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            554554444  3456788999999999999999999999999753

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.9e-45  Score=354.97  Aligned_cols=261  Identities=25%  Similarity=0.461  Sum_probs=217.6

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ....|.++.++|++.+.||+|+||.||+|.++ +..||||+++....     ....+.+|+.+++.++||||+++++++.
T Consensus        15 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           15 GYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             -CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-----CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-----CHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            45679999999999999999999999999987 45899999976432     2245889999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +....++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.++.
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~  158 (283)
T 3gen_A           90 KQRPIFIITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGV  158 (283)
T ss_dssp             SSSSEEEEECCCTTCBHHHHHHCGGG---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSC
T ss_pred             cCCCeEEEEeccCCCcHHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCC
Confidence            98889999999999999999965321         1357889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          345 VRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +||+|||++.......    ....+|+.|+|||.+.+..++.++||||||+++|+|+| |+.||...+  .......+..
T Consensus       159 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~--~~~~~~~~~~  236 (283)
T 3gen_A          159 VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQ  236 (283)
T ss_dssp             EEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHT
T ss_pred             EEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccC--hhHHHHHHhc
Confidence            9999999998765432    22346788999999998899999999999999999998 999997766  5556666665


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      +. +...+.  ..+..+.++|.+||..+|++|||+.++++.|.++..+
T Consensus       237 ~~-~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          237 GL-RLYRPH--LASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TC-CCCCCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cc-CCCCCC--cCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            53 222222  2345788899999999999999999999999988764

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.9e-45  Score=360.61  Aligned_cols=277  Identities=26%  Similarity=0.373  Sum_probs=224.7

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ  258 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~  258 (472)
                      ...|.+..++|++.+.||+|+||.||+|.+.       +..||||+++..   ......+.+.+|+.+++.+ +||||++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~i~~   91 (313)
T 1t46_A           15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVN   91 (313)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc---hhHHHHHHHHHHHHHHhhcccCCCeee
Confidence            4568899999999999999999999999862       468999999754   2344567799999999999 9999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc--------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK--------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      +++++...+..++|+|++.+++|.+++.........        .......++..++.++.|++.||+|||++|  ++||
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~  169 (313)
T 1t46_A           92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR  169 (313)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecC
Confidence            999999999999999999999999999764421100        001123467889999999999999999999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI  404 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~  404 (472)
                      ||||+|||++.++.+||+|||++........     ...+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.
T Consensus       170 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             CCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999987764432     2336788999999999999999999999999999999 999998


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhhcC
Q 039082          405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI  472 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~~i  472 (472)
                      +..... .....+..+ .+...+  ...+..+.++|.+||..||.+|||+.++++.|+++..+....|
T Consensus       250 ~~~~~~-~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~i  313 (313)
T 1t46_A          250 GMPVDS-KFYKMIKEG-FRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISESTNHI  313 (313)
T ss_dssp             TCCSSH-HHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTCC--
T ss_pred             cccchh-HHHHHhccC-CCCCCc--ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhhcCC
Confidence            766433 222333332 232222  3345678899999999999999999999999999998876654

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=371.07  Aligned_cols=268  Identities=25%  Similarity=0.340  Sum_probs=221.7

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      ..+.+..++|++.+.||+|+||.||+|.+.       +..||||+++..   ........+.+|+.+++.++|||||+++
T Consensus        64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~  140 (367)
T 3l9p_A           64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCI  140 (367)
T ss_dssp             GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc---cChhhHHHHHHHHHHHHhCCCCCCCeEE
Confidence            346778889999999999999999999954       457999998643   3445566789999999999999999999


Q ss_pred             EEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       261 g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      +++......++|+|++.+|+|.+++.......   ......++..++.++.||+.||+|||++|  |+||||||+||||+
T Consensus       141 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  215 (367)
T 3l9p_A          141 GVSLQSLPRFILLELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLT  215 (367)
T ss_dssp             EEECSSSSCEEEEECCTTEEHHHHHHHHSCCS---SSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEES
T ss_pred             EEEecCCCCEEEEEeCCCCCHHHHHHhhcccc---CccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEe
Confidence            99999999999999999999999997644221   11223467889999999999999999999  99999999999999


Q ss_pred             CCC---cEEEeecccceecCC-----CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHH
Q 039082          341 DAK---HVRIADFGHARFLSD-----GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPA  411 (472)
Q Consensus       341 ~~~---~vkL~DFGla~~~~~-----~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~  411 (472)
                      .+|   .+||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++ |..||...+  ..
T Consensus       216 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~  293 (367)
T 3l9p_A          216 CPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQ  293 (367)
T ss_dssp             CSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HH
T ss_pred             cCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HH
Confidence            555   599999999975431     2233457899999999999999999999999999999998 999998766  55


Q ss_pred             HHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       412 ~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+...+..+. ++..+  ...+..+.++|.+||..||++||++.+|++.|+.+....
T Consensus       294 ~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          294 EVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            6666666654 22222  334567889999999999999999999999999887643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.7e-45  Score=354.37  Aligned_cols=263  Identities=24%  Similarity=0.400  Sum_probs=209.0

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      ...|.+..++|++.+.||+|+||.||+|.+.     +..||||++...   ......+.|.+|+.+++.++||||+++++
T Consensus         7 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   83 (281)
T 1mp8_A            7 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIG   83 (281)
T ss_dssp             --CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc---CCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence            3468888999999999999999999999984     346999988653   34556678999999999999999999999


Q ss_pred             EEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ++. ++..++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  ++||||||+|||++.
T Consensus        84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~  151 (281)
T 1mp8_A           84 VIT-ENPVWIIMELCTLGELRSFLQVRKY---------SLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSS  151 (281)
T ss_dssp             EEC-SSSCEEEEECCTTEEHHHHHHHTTT---------TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEE
T ss_pred             EEc-cCccEEEEecCCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECC
Confidence            874 5667899999999999999964321         2357888999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          342 AKHVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      ++.+||+|||++.......    ....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+..  .......
T Consensus       152 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~--~~~~~~~  229 (281)
T 1mp8_A          152 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGR  229 (281)
T ss_dssp             TTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHH
T ss_pred             CCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCC--HHHHHHH
Confidence            9999999999998775432    22346789999999998999999999999999999997 999998766  3345555


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      +..+. +..++  ...+..+.++|.+||..||++||++.++++.|+++.++-.
T Consensus       230 i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  279 (281)
T 1mp8_A          230 IENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK  279 (281)
T ss_dssp             HHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhc
Confidence            55554 22233  3455678899999999999999999999999999987643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-45  Score=367.22  Aligned_cols=275  Identities=24%  Similarity=0.369  Sum_probs=216.7

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQL  259 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l  259 (472)
                      ..|.++.++|++.+.||+|+||.||+|.+.       +..||||+++...   .......+.+|+.+|+.+ +||||+++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~hp~iv~~  114 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNL  114 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc---CHHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            468999999999999999999999999972       4579999997542   233456789999999999 99999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhccccccc-------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK-------------ERMVPLPPFEERLARALEIAQAMQYLHEQKPK  326 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~-------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~  326 (472)
                      ++++...+..++|++++.+++|.+++.........             .......++..++.++.||+.||+|||++|  
T Consensus       115 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  192 (344)
T 1rjb_A          115 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--  192 (344)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            99999999999999999999999999764321100             000123467889999999999999999999  


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CC
Q 039082          327 VIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN  400 (472)
Q Consensus       327 iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~  400 (472)
                      |+||||||+||||+.++.+||+|||++........     ...||+.|+|||.+.+..++.++||||||+++|+|+| |.
T Consensus       193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~  272 (344)
T 1rjb_A          193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV  272 (344)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence            99999999999999999999999999987653322     2346889999999998999999999999999999998 99


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhhc
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET  471 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~~  471 (472)
                      .||.+..... .....+..+ .++..+.  ..+..+.++|.+||..||.+||++.+|++.|+.+.....+.
T Consensus       273 ~p~~~~~~~~-~~~~~~~~~-~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  339 (344)
T 1rjb_A          273 NPYPGIPVDA-NFYKLIQNG-FKMDQPF--YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEA  339 (344)
T ss_dssp             CSSTTCCCSH-HHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC------
T ss_pred             CCcccCCcHH-HHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHH
Confidence            9998776433 223333333 2333332  34567889999999999999999999999999998876653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.6e-44  Score=361.62  Aligned_cols=274  Identities=26%  Similarity=0.412  Sum_probs=225.6

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCc
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRF  255 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~Hpn  255 (472)
                      ....|.++.++|++.+.||+|+||.||+|.+.         +..||||+++..   ........+.+|+.+++.+ +|||
T Consensus        26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~  102 (334)
T 2pvf_A           26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD---ATEKDLSDLVSEMEMMKMIGKHKN  102 (334)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT---CCHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC---CcHHHHHHHHHHHHHHHHhhcCCC
Confidence            44568899999999999999999999999874         457999999754   2455667799999999999 9999


Q ss_pred             eeEEEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceee
Q 039082          256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIH  329 (472)
Q Consensus       256 Iv~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiH  329 (472)
                      |+++++++...+..++|++++.+++|.+++.........      .......++..++.++.||+.||+|||++|  |+|
T Consensus       103 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH  180 (334)
T 2pvf_A          103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIH  180 (334)
T ss_dssp             BCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EEC
T ss_pred             EeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeC
Confidence            999999999999999999999999999999764321100      000123467889999999999999999999  999


Q ss_pred             cCCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCC
Q 039082          330 RDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPY  403 (472)
Q Consensus       330 rDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf  403 (472)
                      |||||+|||++.++.+||+|||++.......     ....+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  260 (334)
T 2pvf_A          181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY  260 (334)
T ss_dssp             SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999998776432     22346788999999988889999999999999999999 99999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          404 IEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       404 ~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      .+..  ...+...+..+. +...+  ...+..+.++|.+||..+|.+||++.++++.|+++.....
T Consensus       261 ~~~~--~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          261 PGIP--VEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             TTCC--HHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CcCC--HHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            8765  455555555554 22233  3355678899999999999999999999999999987553

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.5e-45  Score=352.87  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=216.8

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECC-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      .|.+..++|++.+.||+|+||.||+|.+++ ..||||+++....     ....+.+|+.+++.++||||+++++++....
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   76 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY   76 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            467788999999999999999999999874 5799999976432     2245889999999999999999999999988


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|++++.+++|.+++...+.         ..++..++.++.|++.||+|||++|  ++||||||+|||++.++.+||
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l  145 (268)
T 3sxs_A           77 PIYIVTEYISNGCLLNYLRSHGK---------GLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKV  145 (268)
T ss_dssp             SEEEEEECCTTCBHHHHHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEE
T ss_pred             ceEEEEEccCCCcHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEE
Confidence            89999999999999999965432         1346889999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          348 ADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       348 ~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      +|||++........    ...+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...+  .......+..+. 
T Consensus       146 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~~~~~~-  222 (268)
T 3sxs_A          146 SDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYT--NSEVVLKVSQGH-  222 (268)
T ss_dssp             CCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSC--HHHHHHHHHTTC-
T ss_pred             ccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccC--hHHHHHHHHcCC-
Confidence            99999987764432    2235678999999998889999999999999999999 999997766  455555555554 


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ....+  ...+..+.+++..||..||++|||+.++++.|+.+.++
T Consensus       223 ~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          223 RLYRP--HLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             CCCCC--TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             CCCCC--CcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            22222  22345788999999999999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-44  Score=354.74  Aligned_cols=265  Identities=33%  Similarity=0.559  Sum_probs=211.0

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      .....|+|..++|++.+.||+|+||.||+|.+++ .||||+++...  ......+.|.+|+.+|+.++||||+++++++ 
T Consensus        14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-   89 (289)
T 3og7_A           14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTA--PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-   89 (289)
T ss_dssp             ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred             CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccC--CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence            3456789999999999999999999999998766 59999997653  3456677899999999999999999999965 


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ..+..++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.++.
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~  158 (289)
T 3og7_A           90 TAPQLAIVTQWCEGSSLYHHLHASET---------KFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNT  158 (289)
T ss_dssp             CSSSCEEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTE
T ss_pred             cCCccEEEEEecCCCcHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCC
Confidence            55667899999999999999954321         2357889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC-----ccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDG-----EMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~-----~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      +||+|||++......     .....||+.|+|||.+.   +..++.++||||||+++|+|++|..||.+... ...+...
T Consensus       159 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~  237 (289)
T 3og7_A          159 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIEM  237 (289)
T ss_dssp             EEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-HHHHHHH
T ss_pred             EEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-HHHHHHH
Confidence            999999999865432     12345899999999986   66789999999999999999999999977553 3445555


Q ss_pred             HhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       417 i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      +..+...+.++.. ...+..+.++|.+||..||++|||+.++++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          238 VGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            5555544444433 456678999999999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.9e-45  Score=358.57  Aligned_cols=272  Identities=26%  Similarity=0.395  Sum_probs=223.4

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ  258 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~  258 (472)
                      ....|.+..++|.+.+.||+|+||.||+|.+.       +..||||+++..   ........+.+|+.+|+.++||||++
T Consensus        14 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~   90 (314)
T 2ivs_A           14 EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN---ASPSELRDLLSEFNVLKQVNHPHVIK   90 (314)
T ss_dssp             CCTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             CCcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC---CCHHHHHHHHHHHHHHhhCCCCceee
Confidence            34568899999999999999999999999872       367999999754   34566678999999999999999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc--------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK--------------ERMVPLPPFEERLARALEIAQAMQYLHEQK  324 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~--------------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~  324 (472)
                      +++++.+.+..++|++++.+++|.+++.........              .......++..++.++.||+.||+|||++|
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  170 (314)
T 2ivs_A           91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK  170 (314)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence            999999999999999999999999999764421000              000112457889999999999999999999


Q ss_pred             CceeecCCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-
Q 039082          325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-  398 (472)
Q Consensus       325 ~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-  398 (472)
                        |+||||||+|||++.++.+||+|||++.......     ....+++.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       171 --ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             --EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence              9999999999999999999999999998775432     22346788999999998889999999999999999999 


Q ss_pred             CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          399 GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       399 G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      |..||.+...  ..+...+..+. .+..+  ...+..+.++|.+||..||++||++.+|++.|+++..+
T Consensus       249 g~~p~~~~~~--~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          249 GGNPYPGIPP--ERLFNLLKTGH-RMERP--DNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SCCSSTTCCG--GGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCH--HHHHHHhhcCC-cCCCC--ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            9999987663  33444444443 22222  33556788999999999999999999999999998754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=358.16  Aligned_cols=256  Identities=35%  Similarity=0.534  Sum_probs=207.1

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++.++|++.+.||+|+||.||+|.+++..||||.+..      +...+.|.+|+.+|+.++||||+++++++.  +..++
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence            5667899999999999999999999999999998853      234567899999999999999999999876  45788


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---cCCceeecCCCCCcEEEcCCCc-EEE
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE---QKPKVIHRDLKPSNIFLDDAKH-VRI  347 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~---~~~~iiHrDLkp~NILl~~~~~-vkL  347 (472)
                      |+|++.+++|.+++......       +..+...++.++.|++.||+|||+   +|  |+||||||+|||++.++. +||
T Consensus        77 v~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~--ivH~dlkp~NIll~~~~~~~kl  147 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPL-------PYYTAAHAMSWCLQCSQGVAYLHSMQPKA--LIHRDLKPPNLLLVAGGTVLKI  147 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSE-------ECCCHHHHHHHHHHHHHHHHHHHTCSSSC--CCCCCCSGGGEEEETTTTEEEE
T ss_pred             EEEcCCCCCHHHHHhccCCC-------CccCHHHHHHHHHHHHHHHHHHHhCCCCC--eecCCCChhHEEEeCCCCEEEE
Confidence            99999999999999753321       223567888999999999999999   77  999999999999998886 799


Q ss_pred             eecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          348 ADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       348 ~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      +|||++...........||+.|+|||++.+..++.++||||||+++|+|++|+.||.........+...+..+. ++..+
T Consensus       148 ~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  226 (307)
T 2eva_A          148 CDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLI  226 (307)
T ss_dssp             CCCCC------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTC-CCCCB
T ss_pred             cccccccccccccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCC-CCCcc
Confidence            99999987766555667999999999999999999999999999999999999999876555545555555544 22222


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                        ...+..+.+++.+||..||++|||++++++.|+.+...
T Consensus       227 --~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          227 --KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             --TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             --cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence              23456788999999999999999999999999988654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-44  Score=366.71  Aligned_cols=251  Identities=22%  Similarity=0.292  Sum_probs=211.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC--hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN--ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++++......  ....+.+.+|+.+|+.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   91 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV   91 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence            57999999999999999999986  78999999987543221  123466899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC----cEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVR  346 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~----~vk  346 (472)
                      +|+|++.|++|.+++...+          ..+...+..++.||+.||+|||++|  |+||||||+|||++.++    .+|
T Consensus        92 lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           92 LILELVSGGELFDFLAQKE----------SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             EEEECCCSCBHHHHHTTCS----------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEcCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCEE
Confidence            9999999999999996432          2357889999999999999999999  99999999999998777    799


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||++.......  ...+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+  .......+..+....
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~  237 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITAVSYDF  237 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhcCCCC
Confidence            99999999876542  34569999999999999999999999999999999999999998765  556666676664322


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+.....+..+.++|.+||..||++|||+.++++
T Consensus       238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            11111334567889999999999999999999884

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.8e-45  Score=354.36  Aligned_cols=262  Identities=29%  Similarity=0.481  Sum_probs=210.1

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ....+|.+..++|++.+.||+|+||.||+|.++|..||||+++.+      ...+.|.+|+.+++.++||||+++++++.
T Consensus        11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (278)
T 1byg_A           11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIV   84 (278)
T ss_dssp             ----CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhhccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecch------hHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            345679999999999999999999999999999999999998643      23456889999999999999999999976


Q ss_pred             cCC-CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          265 EPP-YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       265 ~~~-~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      +.+ ..++|++++.+++|.+++......        ..+...++.++.+++.||+|||++|  ++||||||+|||++.++
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~  154 (278)
T 1byg_A           85 EEKGGLYIVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDN  154 (278)
T ss_dssp             CC--CCEEEECCCTTEEHHHHHHHHHHH--------HCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTS
T ss_pred             cCCCceEEEEecCCCCCHHHHHHhcccc--------cCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCC
Confidence            654 677888888899999999653321        1246778899999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          344 HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      .+||+|||++...........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....  ..+...+..+. 
T Consensus       155 ~~~l~Dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~~~~-  231 (278)
T 1byg_A          155 VAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKGY-  231 (278)
T ss_dssp             CEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTTC-
T ss_pred             cEEEeeccccccccccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHhcCC-
Confidence            9999999999877665555668899999999998999999999999999999998 9999987653  33555555543 


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ++..+  ...+..+.++|.+||..||++||++.++++.|+.+...
T Consensus       232 ~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          232 KMDAP--DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCc--ccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            22232  34556788999999999999999999999999998764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.9e-44  Score=354.35  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=204.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh--cCCCceeEEEEEEEcC----C
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR--QRHRFVLQLMGACLEP----P  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~g~~~~~----~  267 (472)
                      .++|++.+.||+|+||.||+|.++|..||||++...       ....+.+|.+++..  ++||||+++++++...    .
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~   79 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST   79 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence            468999999999999999999999999999998542       23446677777776  7999999999987653    3


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceeecCCCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH--------EQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH--------~~~~~iiHrDLkp~NILl  339 (472)
                      ..++|++++.+|+|.+++...           ..++..++.++.|++.||+|||        +++  |+||||||+|||+
T Consensus        80 ~~~lv~e~~~~g~L~~~l~~~-----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill  146 (301)
T 3q4u_A           80 QLWLITHYHEMGSLYDYLQLT-----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILV  146 (301)
T ss_dssp             EEEEEECCCTTCBHHHHHTTC-----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEE
T ss_pred             eeEEehhhccCCCHHHHHhhc-----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEE
Confidence            467888888899999999532           1357889999999999999999        888  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCcc-------ccccCCcccccccccCC------CCCchHHHHHHHHHHHHHHcC-------
Q 039082          340 DDAKHVRIADFGHARFLSDGEM-------ALTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITG-------  399 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~-------~~~gt~~y~APE~~~~~------~~s~~sDvwSlGvll~elltG-------  399 (472)
                      +.++.+||+|||+++.......       ...||+.|+|||++.+.      .++.++|||||||++|||+||       
T Consensus       147 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~  226 (301)
T 3q4u_A          147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV  226 (301)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc
Confidence            9999999999999987654322       23689999999999876      455799999999999999999       


Q ss_pred             ---CCCCCCCC---CCHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          400 ---NHPYIEKD---YKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       400 ---~~Pf~~~~---~~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                         ..||....   .....+...+.....++.++..   ...+..+.+++.+||..||++|||+.++++.|+++
T Consensus       227 ~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence               88886532   1233344444444445555542   45678899999999999999999999999999876

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.1e-44  Score=356.86  Aligned_cols=257  Identities=24%  Similarity=0.401  Sum_probs=210.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||++..... ......+.|.+|+.+++.++||||+++++++.+.+..++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-EKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-ccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            368999999999999999999986  77899999866433 345667789999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++.|++|.+++...+.          .++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        89 v~e~~~g~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg  156 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESHGP----------LSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFG  156 (294)
T ss_dssp             EEECCCSCBHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCS
T ss_pred             EEeCCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCC
Confidence            9999999999999965331          357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          352 HARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       352 la~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ++.......    ....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+  ..................
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~  234 (294)
T 4eqm_A          157 IAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGET--AVSIAIKHIQDSVPNVTT  234 (294)
T ss_dssp             SSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSC--HHHHHHHHHSSCCCCHHH
T ss_pred             CccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhhccCCCcch
Confidence            998765332    23458999999999999999999999999999999999999998766  444444444333211100


Q ss_pred             -CCchhHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 039082          428 -EEDGQLRELIELICLSWDGDASVRP-SFSSITCSLKNIQ  465 (472)
Q Consensus       428 -~~~~~~~~l~~li~~cl~~dP~~RP-s~~~ll~~L~~i~  465 (472)
                       .....+..+.++|.+||..||.+|| +++++.+.|+.+.
T Consensus       235 ~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          235 DVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             hcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence             1134557889999999999999998 9999999887653

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.3e-44  Score=359.94  Aligned_cols=269  Identities=26%  Similarity=0.398  Sum_probs=205.4

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECC-----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      ...+.+..++|++.+.||+|+||.||+|.++.     ..||||+++.+..  .....+.|.+|+.+++.++||||+++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~   92 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII--ASSDIEEFLREAACMKEFDHPHVAKLVG   92 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC--------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc--CHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence            34577888999999999999999999998753     2799999976533  3345677999999999999999999999


Q ss_pred             EEEcCCCc------eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          262 ACLEPPYR------GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       262 ~~~~~~~~------~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      ++......      +++++++.+++|.+++.......    .....++..++.++.|++.||+|||++|  |+||||||+
T Consensus        93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~  166 (323)
T 3qup_A           93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE----NPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAAR  166 (323)
T ss_dssp             EEECC-------CEEEEEECCTTCBHHHHHHHHHC-------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccc----cccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcc
Confidence            99887665      88999999999999996433211    1123467889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                      |||++.++.+||+|||++........     ...+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+.+  
T Consensus       167 NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~--  244 (323)
T 3qup_A          167 NCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE--  244 (323)
T ss_dssp             GEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--
T ss_pred             eEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccC--
Confidence            99999999999999999987654322     2335788999999999999999999999999999999 999998766  


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ...+...+..+.. ...+  ...+..+.+++.+||..||++|||+.++++.|+++....
T Consensus       245 ~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          245 NAEIYNYLIGGNR-LKQP--PECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             GGGHHHHHHTTCC-CCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHhcCCC-CCCC--CccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            3345555555442 2222  345567899999999999999999999999999987643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.5e-45  Score=370.53  Aligned_cols=261  Identities=23%  Similarity=0.378  Sum_probs=209.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .+.+..++|++.+.||+|+||.||+|.++     +..||||+++..   ........|.+|+.+|+.++||||+++++++
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG---YTEKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc---cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            45677789999999999999999999875     567999999754   2455667899999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .+.+..++|+|++.+++|.+++...+.         ..++..++.++.||+.||+|||++|  |+||||||+|||++.++
T Consensus       116 ~~~~~~~lv~e~~~~~sL~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~  184 (373)
T 2qol_A          116 TKSKPVMIVTEYMENGSLDSFLRKHDA---------QFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNL  184 (373)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTC
T ss_pred             eeCCceEEEEeCCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCC
Confidence            999999999999999999999964321         2357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      .+||+|||+++.......      ...+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+  ...+...
T Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~--~~~~~~~  262 (373)
T 2qol_A          185 VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS--NQDVIKA  262 (373)
T ss_dssp             CEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCC--HHHHHHH
T ss_pred             CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHH
Confidence            999999999987754321      1234778999999999999999999999999999998 999997766  5556666


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +..+. +.  +.....+..+.++|.+||..||++||++.+|++.|+.+..+.
T Consensus       263 i~~~~-~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          263 VDEGY-RL--PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHTTE-EC--CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHcCC-CC--CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            65553 22  222345667899999999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.1e-44  Score=355.78  Aligned_cols=261  Identities=23%  Similarity=0.400  Sum_probs=208.6

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEE------CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~------~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ..+..++|++.+.||+|+||.||+|.+      .+..||||++...    .....+.|.+|+.+|+.++||||+++++++
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   80 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC   80 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC----CHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            346678999999999999999999985      3678999998653    456667899999999999999999999998


Q ss_pred             EcC--CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          264 LEP--PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       264 ~~~--~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ...  ...++|++++.+++|.+++......         .++..++.++.|++.||+|||+++  |+||||||+|||++.
T Consensus        81 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~---------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~  149 (295)
T 3ugc_A           81 YSAGRRNLKLIMEYLPYGSLRDYLQKHKER---------IDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVEN  149 (295)
T ss_dssp             CHHHHTSCEEEEECCTTCBHHHHHHHCGGG---------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEE
T ss_pred             ecCCCCceEEEEEeCCCCCHHHHHHhcccc---------cCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcC
Confidence            653  4578899999999999999754321         346788999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC------
Q 039082          342 AKHVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK------  409 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~------  409 (472)
                      ++.+||+|||++.......      ....+++.|+|||.+.+..++.++||||||+++|+|+||..||......      
T Consensus       150 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~  229 (295)
T 3ugc_A          150 ENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG  229 (295)
T ss_dssp             TTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHC
T ss_pred             CCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhc
Confidence            9999999999998765332      1234677899999999999999999999999999999999998543210      


Q ss_pred             -----H---HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          410 -----P---AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       410 -----~---~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                           .   ......+..+. +...+  ...+..+.++|.+||..||++|||+.+|++.|+.+..++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          230 NDKQGQMIVFHLIELLKNNG-RLPRP--DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             TTCCTHHHHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             CccccchhHHHHHHHHhccC-cCCCC--cCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence                 0   01122222222 22222  345678899999999999999999999999999998765

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-44  Score=358.36  Aligned_cols=264  Identities=23%  Similarity=0.376  Sum_probs=215.7

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECC------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      .-.+.+..++|++.+.||+|+||.||+|.++.      ..||||+++..   ........|.+|+.+++.++||||++++
T Consensus        36 ~~~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~  112 (333)
T 1mqb_A           36 KFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLE  112 (333)
T ss_dssp             --CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             hccccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence            34568889999999999999999999998752      35999999754   2445566799999999999999999999


Q ss_pred             EEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       261 g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      +++...+..++|+|++.+++|.+++.....         ..++..++.++.||+.||+|||++|  |+||||||+|||++
T Consensus       113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~  181 (333)
T 1mqb_A          113 GVISKYKPMMIITEYMENGALDKFLREKDG---------EFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVN  181 (333)
T ss_dssp             EEECSSSSEEEEEECCTTEEHHHHHHHTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred             EEEecCCCcEEEEeCCCCCcHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEEC
Confidence            999998899999999999999999964321         2357889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          341 DAKHVRIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      .++.+||+|||++........      ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+  ...+
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~  259 (333)
T 1mqb_A          182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEV  259 (333)
T ss_dssp             TTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHH
T ss_pred             CCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC--HHHH
Confidence            999999999999987654321      2235788999999999999999999999999999999 999997765  5556


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ...+..+. +...+  ...+..+.++|.+||..||++||++.++++.|+++.....
T Consensus       260 ~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          260 MKAINDGF-RLPTP--MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHHHHTTC-CCCCC--TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHHHCCC-cCCCc--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            66666653 22222  3455678899999999999999999999999999876543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.9e-44  Score=374.38  Aligned_cols=249  Identities=23%  Similarity=0.318  Sum_probs=214.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||+|++.....  .......+.+|+.+|+.++|||||++++++.+.+..++|
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL--SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC--HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            57899999999999999999985  78999999976543  344567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc---CCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~---~~~~vkL~D  349 (472)
                      +|++.||+|.+++...+          ..+...+..++.||+.||+|||++|  |+||||||+|||++   .++.+||+|
T Consensus        89 ~E~~~gg~L~~~i~~~~----------~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE----------YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             EEeCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEcc
Confidence            99999999999986432          2357888999999999999999999  99999999999998   568899999


Q ss_pred             cccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          350 FGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       350 FGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ||++.......   ....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+  ...+...+..+......
T Consensus       157 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~  234 (444)
T 3soa_A          157 FGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAYDFPS  234 (444)
T ss_dssp             CSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCCCCT
T ss_pred             CceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHHhCCCCCCc
Confidence            99998776433   23568999999999999999999999999999999999999997766  66677777777655544


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+..+.++|.+||..||++|||+.++++
T Consensus       235 ~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          235 PEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            444556778999999999999999999999985

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-44  Score=359.58  Aligned_cols=269  Identities=26%  Similarity=0.415  Sum_probs=223.3

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ  258 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~  258 (472)
                      ....|.+..++|++.+.||+|+||.||+|.++       +..||||++...   ........|.+|+.+++.++||||++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~   92 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVR   92 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc---cCHHHHHHHHHHHHHHHhcCCCCEee
Confidence            34578899999999999999999999999875       467999998653   23455567999999999999999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      +++++.+.+..++|++++.+++|.+++................++..++.++.|++.||+|||++|  |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIl  170 (322)
T 1p4o_A           93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCM  170 (322)
T ss_dssp             EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEE
T ss_pred             eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEE
Confidence            999999999999999999999999999765433222222234467889999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK  412 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~  412 (472)
                      ++.++.+||+|||++.......     ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+  ...
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~  248 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQ  248 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHH
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--HHH
Confidence            9999999999999998664332     22346889999999999999999999999999999999 899997765  555


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      +...+..+... ..+  ...+..+.++|.+||..||++||++.++++.|+++
T Consensus       249 ~~~~~~~~~~~-~~~--~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          249 VLRFVMEGGLL-DKP--DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHHHHHTTCCC-CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHHcCCcC-CCC--CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence            66666665432 222  34556788999999999999999999999999765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.7e-44  Score=347.18  Aligned_cols=257  Identities=28%  Similarity=0.488  Sum_probs=218.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      .|.++.++|++.+.||+|+||.||+|.+. +..||||++.....     ..+.+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   76 (267)
T 3t9t_A            2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQA   76 (267)
T ss_dssp             -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            58899999999999999999999999985 67899999976432     2246889999999999999999999999998


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..+++++++.+++|.+++.....         ..+...++.++.|++.||+|||++|  ++||||||+|||++.++.+||
T Consensus        77 ~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl  145 (267)
T 3t9t_A           77 PICLVTEFMEHGCLSDYLRTQRG---------LFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKV  145 (267)
T ss_dssp             SCEEEECCCTTCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEE
T ss_pred             CeEEEEeCCCCCcHHHHHhhCcc---------cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEE
Confidence            99999999999999999964321         2357888999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          348 ADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       348 ~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      +|||++.......    ....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+  .......+..+. 
T Consensus       146 ~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~i~~~~-  222 (267)
T 3t9t_A          146 SDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGF-  222 (267)
T ss_dssp             CCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTC-
T ss_pred             cccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--HHHHHHHHhcCC-
Confidence            9999998764322    23346788999999998899999999999999999999 999998765  555666666553 


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +...+.  ..+..+.+++.+||..||++||++.++++.|+++.+
T Consensus       223 ~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          223 RLYKPR--LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             CCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCCCc--cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            222222  345678899999999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-44  Score=360.92  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=212.6

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|++.+.||+|+||.||+|.++  |..||||++++.... .....+.+.+|+.+++.++||||+++++++.+....+
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            4578999999999999999999986  789999999754221 1233456889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|+|++.||+|.+++.....          .+...+..++.||+.||+|||++|  |+||||||+|||++.+|.+||+||
T Consensus        83 lv~e~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Df  150 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQR----------FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDF  150 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSS----------CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeec
Confidence            99999999999999965322          346778889999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          351 GHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       351 Gla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      |++..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+  .......+..+..+  +|.  
T Consensus       151 g~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~~~--~p~--  224 (318)
T 1fot_A          151 GFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNAELR--FPP--  224 (318)
T ss_dssp             SSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHCCCC--CCT--
T ss_pred             CcceecCCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCC--CCC--
Confidence            999988777777889999999999999999999999999999999999999997765  55566666665432  332  


Q ss_pred             hhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      ....++.++|.+||..||++||     +++++++
T Consensus       225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            2445788899999999999999     8888774

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.1e-44  Score=365.78  Aligned_cols=250  Identities=24%  Similarity=0.385  Sum_probs=214.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++.....  .......+.+|+.+|+.++|||||++++++.+.+..++|
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            47999999999999999999986  78999999976543  445567799999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC---CcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---KHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~---~~vkL~D  349 (472)
                      +|++.|++|.+++....          ..+...+..++.||+.||+|||++|  |+||||||+|||++.+   +.+||+|
T Consensus       107 ~e~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE----------FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEee
Confidence            99999999999985422          2357889999999999999999999  9999999999999864   4599999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+  ...+...+..+....+.+
T Consensus       175 fG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~  252 (362)
T 2bdw_A          175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPSP  252 (362)
T ss_dssp             CTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCTT
T ss_pred             cCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCcc
Confidence            99998776443  34578999999999999999999999999999999999999998765  566777777776544333


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .....+..+.++|.+||..||++||++.++++.
T Consensus       253 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          253 EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            334566789999999999999999999998753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.7e-44  Score=363.13  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=210.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +..++|++.+.||+|+||.||+|.++  |..||||++++.... .......+.+|+.+|+.++||||+++++++...+..
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~   80 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhh-hhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEE
Confidence            34578999999999999999999986  789999999754221 223456688999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|+|++.||+|..++...+          ..+...++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|
T Consensus        81 ~lv~E~~~gg~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~D  148 (337)
T 1o6l_A           81 CFVMEYANGGELFFHLSRER----------VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEee
Confidence            99999999999999996432          1346788899999999999999999  99999999999999999999999


Q ss_pred             cccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          350 FGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       350 FGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ||+++....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+  ...+...+..+..  .+
T Consensus       149 FG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~--~~  224 (337)
T 1o6l_A          149 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEI--RF  224 (337)
T ss_dssp             CTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC--CC
T ss_pred             ccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC--CC
Confidence            999986432   2345679999999999999999999999999999999999999997765  5556666665543  23


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      |.  ..+.++.++|.+||..||++||     ++++|++
T Consensus       225 p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            32  3456788999999999999999     8988875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-44  Score=361.08  Aligned_cols=258  Identities=24%  Similarity=0.416  Sum_probs=208.3

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      .+..++|++.+.||+|+||.||+|.+.  +.    +||+|.+...   ........|.+|+.+++.++||||++++++|.
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   87 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC----------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc---cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            456678999999999999999999974  33    3688877543   23344567999999999999999999999998


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ... .+++++++.+|+|.+++.....         ..++..++.++.||+.||+|||+++  |+||||||+|||++.++.
T Consensus        88 ~~~-~~~v~e~~~~g~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~  155 (327)
T 3poz_A           88 TST-VQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHSTT---------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTE
T ss_pred             cCC-eEEEEEecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCC
Confidence            754 7789999999999999965332         2356788999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          345 VRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +||+|||+++.......     ...+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+...  ..+...+.
T Consensus       156 ~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~  233 (327)
T 3poz_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE  233 (327)
T ss_dssp             EEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH
T ss_pred             EEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHH
Confidence            99999999987654322     2345889999999999999999999999999999999 9999987663  33444444


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+. +...+  ...+..+.+++.+||..||++||++.++++.|+.+....
T Consensus       234 ~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~  280 (327)
T 3poz_A          234 KGE-RLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             TTC-CCCCC--TTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred             cCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence            443 22222  345567889999999999999999999999999887543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=359.00  Aligned_cols=248  Identities=19%  Similarity=0.262  Sum_probs=210.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  +..||+|++...     ......+.+|+.+|+.++||||+++++++.+.+..++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEE
Confidence            368999999999999999999986  778999998642     2345668899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC--CCcEEEee
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIAD  349 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~--~~~vkL~D  349 (472)
                      |+|++.|++|.+++....         ...+...++.++.|++.||+|||++|  |+||||||+|||++.  ++.+||+|
T Consensus        79 v~e~~~g~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~D  147 (321)
T 1tki_A           79 IFEFISGLDIFERINTSA---------FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIE  147 (321)
T ss_dssp             EECCCCCCBHHHHHTSSS---------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECC
T ss_pred             EEEeCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEE
Confidence            999999999999995422         12357889999999999999999999  999999999999987  78999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+......+
T Consensus       148 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~  225 (321)
T 1tki_A          148 FGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEE  225 (321)
T ss_dssp             CTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCHH
T ss_pred             CCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--HHHHHHHHHcCCCCCChh
Confidence            99999876443  33568999999999998889999999999999999999999998766  556666676665332211


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+.++.++|.+||..||.+|||+.++++
T Consensus       226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11345678899999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4e-44  Score=348.85  Aligned_cols=262  Identities=27%  Similarity=0.459  Sum_probs=219.1

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ...|.+..++|++.+.||+|+||.||+|.++ +..||||++.....     ..+.|.+|+.+|+.++||||+++++++. 
T Consensus         5 ~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   78 (279)
T 1qpc_A            5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-----SPDAFLAEANLMKQLQHQRLVRLYAVVT-   78 (279)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             hhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-----cHHHHHHHHHHHHhCCCcCcceEEEEEc-
Confidence            4579999999999999999999999999987 46899999975422     2356889999999999999999999876 


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..++|++++.+++|.+++......        ..++..++.++.|++.||+|||++|  ++||||||+|||++.++.+
T Consensus        79 ~~~~~~v~e~~~~~~L~~~l~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~  148 (279)
T 1qpc_A           79 QEPIYIITEYMENGSLVDFLKTPSGI--------KLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSC  148 (279)
T ss_dssp             SSSCEEEEECCTTCBHHHHTTSHHHH--------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCE
T ss_pred             CCCcEEEEecCCCCCHHHHHhcCCCC--------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCE
Confidence            45678899999999999999643211        2346889999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcC
Q 039082          346 RIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       346 kL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ||+|||++........    ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+  ...+...+..+
T Consensus       149 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~~~  226 (279)
T 1qpc_A          149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLERG  226 (279)
T ss_dssp             EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHTT
T ss_pred             EECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--HHHHHHHHhcc
Confidence            9999999988764432    2345788999999998889999999999999999999 999998765  45555555554


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      . +...+  ...+..+.+++..||..||++|||+.+|++.|+++.....
T Consensus       227 ~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  272 (279)
T 1qpc_A          227 Y-RMVRP--DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE  272 (279)
T ss_dssp             C-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             c-CCCCc--ccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence            3 22222  3345678899999999999999999999999999987654

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=347.92  Aligned_cols=261  Identities=22%  Similarity=0.427  Sum_probs=219.7

Q ss_pred             ceeeCCCCeeEec-eeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQE-KIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~-~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .|.+..++|.+.+ .||+|+||.||+|.++    +..||||+++..   ......+.+.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc---cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            5778888999987 9999999999999863    668999999764   3455677899999999999999999999998


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                       ..+..++|++++.+++|.+++....         ...++..++.++.|++.||+|||++|  ++||||||+|||++.++
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~  147 (287)
T 1u59_A           80 -QAEALMLVMEMAGGGPLHKFLVGKR---------EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH  147 (287)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHTTCT---------TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETT
T ss_pred             -cCCCcEEEEEeCCCCCHHHHHHhCC---------ccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCC
Confidence             5566888999999999999995322         12357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      .+||+|||++.......      ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+  ...+...
T Consensus       148 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~  225 (287)
T 1u59_A          148 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAF  225 (287)
T ss_dssp             EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHH
T ss_pred             CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC--HHHHHHH
Confidence            99999999998775332      22345889999999988889999999999999999999 999998766  3445555


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      +..+. ++.++  ...+..+.++|..||..||++||++.++++.|+.+.....
T Consensus       226 i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          226 IEQGK-RMECP--PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             HHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HhcCC-cCCCC--CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            65554 33333  3355678899999999999999999999999999987654

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.7e-44  Score=359.17  Aligned_cols=273  Identities=24%  Similarity=0.357  Sum_probs=221.4

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQL  259 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l  259 (472)
                      ..|.++.++|++.+.||+|+||.||+|.+.+       ..||+|++...   ........+.+|+.+|+.+ +||||+++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~h~~iv~~  115 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST---AHADEKEALMSELKIMSHLGQHENIVNL  115 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc---cChHHHHHHHHHHHHHHhhcCCCCeeeE
Confidence            4688999999999999999999999999853       36999999754   2445567799999999999 89999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccccc----cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKE----RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~----~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      ++++...+..++|++++.+|+|.+++..........    ......+...++.++.|++.||+|||++|  |+||||||+
T Consensus       116 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~  193 (333)
T 2i1m_A          116 LGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAAR  193 (333)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccc
Confidence            999999999999999999999999997543211100    00123467889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                      |||++.++.+||+|||++........     ...+|+.|+|||.+.+..++.++||||||+++|+|+| |..||.+....
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            99999999999999999986643321     2335788999999998899999999999999999999 99999876643


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      . .....+..+ .....+.  ..+..+.++|..||..||.+|||+.+|++.|+++..+..
T Consensus       274 ~-~~~~~~~~~-~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  329 (333)
T 2i1m_A          274 S-KFYKLVKDG-YQMAQPA--FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQEDR  329 (333)
T ss_dssp             H-HHHHHHHHT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             H-HHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhhh
Confidence            3 222222332 2333332  345678899999999999999999999999999887654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.7e-44  Score=351.33  Aligned_cols=263  Identities=28%  Similarity=0.484  Sum_probs=221.9

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ....|.+..++|++.+.||+|+||.||+|.++  +..||||++..+     ....+.+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A            4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-----TMEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-----STHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-----HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            45679999999999999999999999999997  778999998653     23456789999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .+.+..++|++++.+++|.+++.....        ...++..++.++.+++.||+|||++|  ++||||||+|||++.++
T Consensus        79 ~~~~~~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~  148 (288)
T 3kfa_A           79 TREPPFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENH  148 (288)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHCCT--------TTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGG
T ss_pred             ccCCCEEEEEEcCCCCcHHHHHHhccc--------CCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCC
Confidence            999999999999999999999965332        12357888999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          344 HVRIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      .+||+|||++........    ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+.  ..+...+.
T Consensus       149 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~--~~~~~~~~  226 (288)
T 3kfa_A          149 LVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLE  226 (288)
T ss_dssp             CEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHH
T ss_pred             CEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh
Confidence            999999999987654332    2235788999999998999999999999999999999 9999987663  33444444


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ... +...+  ...+..+.+++..||..||.+|||+.++++.|+.+..+.
T Consensus       227 ~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          227 KDY-RMERP--EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             TTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccC-CCCCC--CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence            432 22222  334567889999999999999999999999999887754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.3e-44  Score=350.03  Aligned_cols=264  Identities=24%  Similarity=0.432  Sum_probs=217.3

Q ss_pred             ccCceeeCCCCeeEec-eeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          186 KMNGWYIDPKEIDLQE-KIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~-~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      ....+.++.++|++.+ .||+|+||.||+|.+.    +..||||+++...  ......+.|.+|+.+++.++||||++++
T Consensus         7 ~~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~   84 (291)
T 1xbb_A            7 RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEANVMQQLDNPYIVRMI   84 (291)
T ss_dssp             ----CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc--cCHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3456778889999998 9999999999999763    5689999997653  2344567799999999999999999999


Q ss_pred             EEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       261 g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      +++ ..+..++|++++.+++|.+++....          ..+...++.++.|++.||+|||++|  ++||||||+|||++
T Consensus        85 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~  151 (291)
T 1xbb_A           85 GIC-EAESWMLVMEMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLV  151 (291)
T ss_dssp             EEE-ESSSEEEEEECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEE
T ss_pred             EEE-CCCCcEEEEEeCCCCCHHHHHHhCc----------CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEe
Confidence            998 5667788999999999999996532          1346788999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          341 DAKHVRIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                      .++.+||+|||++........      ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+  ...+
T Consensus       152 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~  229 (291)
T 1xbb_A          152 TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEV  229 (291)
T ss_dssp             ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHH
T ss_pred             CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC--HHHH
Confidence            999999999999987754322      2335788999999998889999999999999999999 999998766  5556


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ...+..+. ++..+  ...+..+.++|..||..||++||++.++++.|+++.....
T Consensus       230 ~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          230 TAMLEKGE-RMGCP--AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             HHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            66666554 33333  3355678899999999999999999999999999988775

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.8e-44  Score=363.35  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=214.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      ...++|++.+.||+|+||.||+|.++  |..||||++.+.... .......+.+|+.+|+.++||||+++++++.+.+..
T Consensus        38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  116 (350)
T 1rdq_E           38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV-KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhc-cHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence            34578999999999999999999986  789999999654221 123346688999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|+|++.|++|.+++...+.          .+...++.++.||+.||+|||++|  |+||||||+|||++.+|.+||+|
T Consensus       117 ~lv~e~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~D  184 (350)
T 1rdq_E          117 YMVMEYVAGGEMFSHLRRIGR----------FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTD  184 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECC
T ss_pred             EEEEcCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEcc
Confidence            999999999999999965332          346788999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      ||+++.........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  ...+...+..+..  .+|. 
T Consensus       185 Fg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~--~~p~-  259 (350)
T 1rdq_E          185 FGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKV--RFPS-  259 (350)
T ss_dssp             CTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC--CCCT-
T ss_pred             cccceeccCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--HHHHHHHHHcCCC--CCCC-
Confidence            9999988777777889999999999999999999999999999999999999998765  6667777777653  2332 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                       ..+..+.++|.+||..||.+||+     +++|++
T Consensus       260 -~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          260 -HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             34567889999999999999998     777764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.6e-44  Score=356.19  Aligned_cols=251  Identities=23%  Similarity=0.265  Sum_probs=209.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC--hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN--ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +.|++.+.||+|+||.||+|.++  |..||||++........  ....+.+.+|+.+|+.++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46899999999999999999986  78999999976543221  123567899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC----cEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVR  346 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~----~vk  346 (472)
                      +|+|++.+++|.+++....          ..+...++.++.||+.||+|||++|  |+||||||+|||++.++    .+|
T Consensus        91 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKE----------SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSS----------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEEEcCCCCCHHHHHHhcC----------CcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEE
Confidence            9999999999999995422          2357889999999999999999999  99999999999999887    899


Q ss_pred             EeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..  .......+.......
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~  236 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVNYEF  236 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHTCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHHhcCCCc
Confidence            9999999887533  234568999999999999999999999999999999999999997765  444555555543221


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+.....+..+.++|.+||..||++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111334567889999999999999999999986

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=366.14  Aligned_cols=250  Identities=22%  Similarity=0.300  Sum_probs=206.3

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP  267 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~  267 (472)
                      .+..++|++.+.||+|+||.||+|.++  |..||||++++... ........+.+|+.+|..+ +||||+++++++.+.+
T Consensus        19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~-~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-LQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-HHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHh-cchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            356689999999999999999999986  67899999976422 1233456688999999988 7999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+|++.||+|..++...+.          .+...++.++.||+.||+|||++|  |+||||||+||||+.+|.+||
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL  165 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRR----------FDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKL  165 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEE
Confidence            99999999999999999965332          346788999999999999999999  999999999999999999999


Q ss_pred             eecccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||+|+....   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+  ...+...+..+... 
T Consensus       166 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~~-  242 (353)
T 3txo_A          166 ADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--EDDLFEAILNDEVV-  242 (353)
T ss_dssp             CCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCC-
T ss_pred             ccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCC-
Confidence            99999986432   2345679999999999998899999999999999999999999998766  66677777776532 


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCH------HHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSF------SSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~------~~ll~  459 (472)
                       +|.  .....+.++|.+||..||++||++      +++++
T Consensus       243 -~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          243 -YPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -CCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -CCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             232  244568889999999999999998      66653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-43  Score=344.19  Aligned_cols=250  Identities=24%  Similarity=0.389  Sum_probs=214.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  |..||+|++.....  .......+.+|+.+++.++||||+++++++...+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC--CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            368999999999999999999986  77999999976533  44556778999999999999999999999999988999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc---EEEe
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIA  348 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~---vkL~  348 (472)
                      +++++.+++|.+++....          ..+...+..++.|++.||+|||++|  ++||||||+|||++.++.   +||+
T Consensus        83 v~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~  150 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVARE----------FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLA  150 (284)
T ss_dssp             EECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEe
Confidence            999999999999886432          1356788999999999999999999  999999999999976654   9999


Q ss_pred             ecccceecCCCcc--ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          349 DFGHARFLSDGEM--ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       349 DFGla~~~~~~~~--~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      |||++........  ...||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.+  .......+..+......
T Consensus       151 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~  228 (284)
T 3kk8_A          151 DFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDYPS  228 (284)
T ss_dssp             CCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCT
T ss_pred             eceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc--hhHHHHHHHhccccCCc
Confidence            9999987764432  3568999999999999999999999999999999999999997765  56666677666655444


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+..+.++|.+||..||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            444556678899999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.8e-44  Score=357.60  Aligned_cols=257  Identities=18%  Similarity=0.198  Sum_probs=209.8

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCc
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~  269 (472)
                      -.++|++.+.||+|+||.||+|.+.  |..||||++......      ..+.+|+.+++.+ +||||+++++++...+..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA------PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS------CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch------HHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            3478999999999999999999974  789999998754221      2378999999999 999999999999998888


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc-----
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-----  344 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~-----  344 (472)
                      ++|++++ +++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.++.     
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~  148 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDR---------TFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQV  148 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTS
T ss_pred             EEEEEeC-CCCHHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCce
Confidence            8888888 9999999965321         2457889999999999999999999  999999999999998887     


Q ss_pred             EEEeecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHH
Q 039082          345 VRIADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKI  413 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i  413 (472)
                      +||+|||++.......          ....||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.. ....
T Consensus       149 ~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~  228 (330)
T 2izr_A          149 IHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKER  228 (330)
T ss_dssp             EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHH
T ss_pred             EEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHH
Confidence            9999999999765432          3456899999999999999999999999999999999999999875432 3333


Q ss_pred             HHHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ...+.........+.. ...+ ++.+++..||..||.+||++++|.+.|+++..+.
T Consensus       229 ~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          229 YQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             HHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence            3333332211111100 1233 8999999999999999999999999999887764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=366.91  Aligned_cols=255  Identities=25%  Similarity=0.329  Sum_probs=209.6

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..+.+..++|++.+.||+|+||.||+|.++  +..||||++.+.... .......+.+|+.+|+.++|||||+++++|.+
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~   86 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV-ERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD   86 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcc-cHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            356677889999999999999999999986  678999999654221 22345668899999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..++|++++.||+|..++....          ..+...+..++.||+.||+|||++|  |+||||||+||||+.+|.+
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~v  154 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQNV----------HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHV  154 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCE
Confidence            999999999999999999996432          2356788999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC--ccccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHHHHHHhc
Q 039082          346 RIADFGHARFLSDG--EMALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIAMEVGE  419 (472)
Q Consensus       346 kL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i~~~i~~  419 (472)
                      ||+|||++......  ....+||+.|+|||++..   ..|+.++|||||||++|+|++|..||...... ...+...+..
T Consensus       155 kL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~  234 (384)
T 4fr4_A          155 HITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET  234 (384)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH
T ss_pred             EEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh
Confidence            99999999987543  345679999999999863   45899999999999999999999999765432 3334444443


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC-HHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPS-FSSITC  459 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs-~~~ll~  459 (472)
                      ..  ...|  ...+..+.++|.+||..||++||+ +++|++
T Consensus       235 ~~--~~~p--~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 TV--VTYP--SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CC--CCCC--TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cc--cCCC--CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            32  1222  234567889999999999999998 666653

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.7e-43  Score=348.44  Aligned_cols=266  Identities=24%  Similarity=0.377  Sum_probs=210.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.+.  |..||||++..... ........+.+|+.+++.++||||+++++++...+..++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-MDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            357999999999999999999975  78999999976432 345566779999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|.+++......      ....+...++.++.+++.||+|||++|  ++||||||+|||++.++.+||+|||
T Consensus       110 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg  181 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQ------KRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLG  181 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC-
T ss_pred             EEecCCCCCHHHHHHHhccc------ccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEecc
Confidence            99999999999999643211      122356888999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++.......   ....|++.|+|||.+.+..++.++||||||+++|+|++|..||.+...........+..+...+..+ 
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  260 (310)
T 2wqm_A          182 LGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPS-  260 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCT-
T ss_pred             ceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcc-
Confidence            998765432   2345899999999999999999999999999999999999999876655556666666655332221 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhh
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTE  470 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~  470 (472)
                       ...+..+.++|.+||..||++||++.++++.|+++....++
T Consensus       261 -~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~  301 (310)
T 2wqm_A          261 -DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS  301 (310)
T ss_dssp             -TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             -cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence             33456788999999999999999999999999999887654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.1e-45  Score=375.16  Aligned_cols=255  Identities=22%  Similarity=0.350  Sum_probs=212.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .+.+..++|++.+.||+|+||.||+|.++  +..||||++.+.... .......+.+|+.+|+.++|||||+++++|.+.
T Consensus        63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI-KRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhh-hhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            45567789999999999999999999986  678999999652110 111223478999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++|+||+.||+|.+++....           .+...+..++.||+.||+|||++|  |+||||||+||||+.+|.+|
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~~-----------~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNYD-----------VPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcCC-----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEE
Confidence            99999999999999999986421           246778899999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc----cccccCCcccccccccCCC----CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          347 IADFGHARFLSDGE----MALTGTFVYMAPEVIQCEP----YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~----~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      |+|||+|+......    ...+||+.|+|||++.+..    |+.++|||||||++|||++|..||.+.+  .......+.
T Consensus       209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~  286 (410)
T 3v8s_A          209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--LVGTYSKIM  286 (410)
T ss_dssp             ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHH
T ss_pred             EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--hhhHHHHHH
Confidence            99999998876543    2567999999999998665    8899999999999999999999998766  556666666


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASV--RPSFSSITC  459 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~  459 (472)
                      .+.....+|.....+.++.++|.+||..+|.+  ||++++|++
T Consensus       287 ~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          287 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             THHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             hccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            55333344444445678899999999999988  999999875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-43  Score=348.18  Aligned_cols=260  Identities=18%  Similarity=0.235  Sum_probs=212.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~  268 (472)
                      +..++|++.+.||+|+||.||+|.+.  |..||||++.....      ...+.+|+.+++.+ +|+|++++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   80 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD------APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   80 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT------SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc------cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence            44578999999999999999999974  88999999865422      12377899999999 89999999999988888


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc----
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH----  344 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~----  344 (472)
                      .++|++++ +++|.+++...+.         ..++..++.++.||+.||+|||++|  |+||||||+|||++.++.    
T Consensus        81 ~~lv~e~~-~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~  148 (298)
T 1csn_A           81 NVLVIDLL-GPSLEDLLDLCGR---------KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNAN  148 (298)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTT
T ss_pred             eEEEEEec-CCCHHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCC
Confidence            88888888 9999999965321         2357889999999999999999999  999999999999987776    


Q ss_pred             -EEEeecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-CHHH
Q 039082          345 -VRIADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-KPAK  412 (472)
Q Consensus       345 -vkL~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-~~~~  412 (472)
                       +||+|||++.......          ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+. ....
T Consensus       149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  228 (298)
T 1csn_A          149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ  228 (298)
T ss_dssp             CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred             eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence             9999999998776432          234589999999999999999999999999999999999999987543 2333


Q ss_pred             HHHHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          413 IAMEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ....+..+......+.. ...+..+.+++..||..||++||++++|++.|+++..+..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          229 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            33333332211111111 2345688999999999999999999999999999988754

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-43  Score=352.38  Aligned_cols=244  Identities=27%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|+..+.||+|+||.||+|.++  |..||||++....    ....+.+.+|+.+++.++||||+++++++...+..++|+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK----QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc----hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            4778889999999999999986  7899999997542    233456889999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      |++.+++|.+++...           ..++..+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus       122 e~~~~~~L~~~l~~~-----------~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~  188 (321)
T 2c30_A          122 EFLQGGALTDIVSQV-----------RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSILLTLDGRVKLSDFGFC  188 (321)
T ss_dssp             CCCCSCBHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred             ecCCCCCHHHHHHhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCcEEEeeeeee
Confidence            999999999998532           1357889999999999999999999  999999999999999999999999999


Q ss_pred             eecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      ......   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...+  .......+.... .+.+....
T Consensus       189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~--~~~~~~~~~~~~-~~~~~~~~  265 (321)
T 2c30_A          189 AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS--PVQAMKRLRDSP-PPKLKNSH  265 (321)
T ss_dssp             EECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSS-CCCCTTGG
T ss_pred             eecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhcCC-CCCcCccc
Confidence            877543   234568999999999999999999999999999999999999997765  445555555543 23333334


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.++|.+||..||++|||+.++++
T Consensus       266 ~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          266 KVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             GSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            45678899999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.9e-44  Score=346.67  Aligned_cols=259  Identities=24%  Similarity=0.417  Sum_probs=212.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECC-----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .|.+..++|++.+.||+|+||.||+|.+.+     ..||||++...   ......+.|.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD---CTLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT---SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc---cCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            466778899999999999999999998742     35999998764   2445667899999999999999999999987


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .+ +..++|++++.+++|.+++.....         ..+...++.++.|++.||+|||++|  ++||||||+|||++.++
T Consensus        83 ~~-~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~  150 (281)
T 3cc6_A           83 EE-EPTWIIMELYPYGELGHYLERNKN---------SLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPE  150 (281)
T ss_dssp             CS-SSCEEEEECCTTCBHHHHHHHHTT---------TCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETT
T ss_pred             cC-CCCEEEEecCCCCCHHHHHHhccc---------cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCC
Confidence            64 456889999999999999964321         2346788999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          344 HVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      .+||+|||++.......    ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.....  ......+.
T Consensus       151 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~--~~~~~~~~  228 (281)
T 3cc6_A          151 CVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN--KDVIGVLE  228 (281)
T ss_dssp             EEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG--GGHHHHHH
T ss_pred             cEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh--HHHHHHHh
Confidence            99999999998765432    23346889999999998999999999999999999998 9999976653  23444444


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .+. +...+  ...+..+.++|.+||..||++||++.++++.|+.+...
T Consensus       229 ~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          229 KGD-RLPKP--DLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             HTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCC-CCCCC--CCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            443 22222  33456788999999999999999999999999988764

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1e-43  Score=355.41  Aligned_cols=253  Identities=24%  Similarity=0.325  Sum_probs=200.2

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEE-----CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~-----~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ...+..++|++.+.||+|+||.||+|.+     .|..||||++++............+.+|+.+|+.++||||+++++++
T Consensus        11 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   90 (327)
T 3a62_A           11 PEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF   90 (327)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence            3456678999999999999999999987     37789999998764433344556688999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      ...+..++|+|++.|++|.+++...+.          .+...+..++.||+.||+|||++|  |+||||||+||||+.++
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~  158 (327)
T 3a62_A           91 QTGGKLYLILEYLSGGELFMQLEREGI----------FMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQG  158 (327)
T ss_dssp             ECSSCEEEEEECCTTEEHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTS
T ss_pred             EcCCEEEEEEeCCCCCcHHHHHHhCCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCC
Confidence            999999999999999999999965332          246778889999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          344 HVRIADFGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      .+||+|||+++.....   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~  236 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--RKKTIDKILKC  236 (327)
T ss_dssp             CEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHT
T ss_pred             cEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhC
Confidence            9999999999865422   234568999999999999999999999999999999999999998765  45555566555


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      ..  .+|.  ..+..+.++|.+||..||++||     ++.++++
T Consensus       237 ~~--~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          237 KL--NLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             CC--CCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             CC--CCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            42  2332  3446788999999999999999     6777764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-43  Score=349.33  Aligned_cols=251  Identities=21%  Similarity=0.316  Sum_probs=200.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC----------------------hHHHHHHHHHHHH
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN----------------------ENAVTFFAQEVDT  247 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~----------------------~~~~~~f~~E~~i  247 (472)
                      +..++|++.+.||+|+||.||+|.++  +..||||++........                      ....+.+.+|+.+
T Consensus        10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   89 (298)
T 2zv2_A           10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI   89 (298)
T ss_dssp             CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred             eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence            44578999999999999999999985  78899999976532111                      1224568899999


Q ss_pred             HHhcCCCceeEEEEEEEc--CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 039082          248 LSRQRHRFVLQLMGACLE--PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKP  325 (472)
Q Consensus       248 l~~l~HpnIv~l~g~~~~--~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~  325 (472)
                      |+.++||||+++++++.+  .+..++|+|++.+++|.+++..           ...+...++.++.||+.||+|||++| 
T Consensus        90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~~-  157 (298)
T 2zv2_A           90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-----------KPLSEDQARFYFQDLIKGIEYLHYQK-  157 (298)
T ss_dssp             HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-----------SCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCC-
Confidence            999999999999999987  4567788888889998765421           12457889999999999999999999 


Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccceecCCCc---cccccCCcccccccccCCC---CCchHHHHHHHHHHHHHHcC
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITG  399 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~---~s~~sDvwSlGvll~elltG  399 (472)
                       |+||||||+|||++.++.+||+|||++.......   ....||+.|+|||.+.+..   ++.++|||||||++|+|++|
T Consensus       158 -ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          158 -IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             -EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             -eeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence             9999999999999999999999999998876432   3456899999999998665   47899999999999999999


Q ss_pred             CCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          400 NHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       400 ~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..||.+..  ...+...+......  .+.....+..+.++|.+||..||++||++.++++
T Consensus       237 ~~pf~~~~--~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          237 QCPFMDER--IMCLHSKIKSQALE--FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SCSSCCSS--HHHHHHHHHHCCCC--CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCCCCCcc--HHHHHHHHhcccCC--CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99997765  44455555554322  2333345667899999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.4e-43  Score=350.96  Aligned_cols=271  Identities=26%  Similarity=0.392  Sum_probs=212.3

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      ....+.+..++|.+.+.||+|+||.||+|.+.     +..||||+++...  ........+.+|+.+++.++||||++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~  102 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN--SSQREIEEFLSEAACMKDFSHPNVIRLL  102 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C--CCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc--cchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence            34567788899999999999999999999874     3479999987653  2445667799999999999999999999


Q ss_pred             EEEEcCCC-----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          261 GACLEPPY-----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       261 g~~~~~~~-----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      +++.+.+.     .++|++++.+++|.+++......    ......++..++.++.||+.||.|||++|  |+||||||+
T Consensus       103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~  176 (313)
T 3brb_A          103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLE----TGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAAR  176 (313)
T ss_dssp             EEEEC-------CEEEEEECCTTCBHHHHHHHTTBT----TSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGG
T ss_pred             EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhh----cCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcc
Confidence            99987654     37899999999999999543211    11233467889999999999999999999  999999999


Q ss_pred             cEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          336 NIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       336 NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                      |||++.++.+||+|||++.......     ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... 
T Consensus       177 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-  255 (313)
T 3brb_A          177 NCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-  255 (313)
T ss_dssp             GEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-
T ss_pred             eEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-
Confidence            9999999999999999998765432     22346889999999999999999999999999999999 9999987663 


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                       ......+..+. ++..+  ...+..+.++|.+||..||++||++.+|++.|+++...+.
T Consensus       256 -~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          256 -HEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             -GGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             -HHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence             33445555544 22222  3345678999999999999999999999999999988765

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.3e-44  Score=352.25  Aligned_cols=273  Identities=27%  Similarity=0.394  Sum_probs=220.1

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ  258 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~  258 (472)
                      ...|.+..++|++.+.||+|+||.||+|.+.       +..||||+++..   ........+.+|+.++..+ +||||++
T Consensus        19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC---CCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            4468889999999999999999999999863       468999999764   2445567799999999999 7999999


Q ss_pred             EEEEEEcCCC-ceEEEEeccCCcHHHHHhhcccccccc------cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecC
Q 039082          259 LMGACLEPPY-RGWLVTELLGTTLKEWLHGLGSQRRKE------RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD  331 (472)
Q Consensus       259 l~g~~~~~~~-~~~vve~~~ggsL~~~l~~~~~~~~~~------~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrD  331 (472)
                      +++++...+. .++|++++.+++|.+++..........      ......++..++.++.|++.||+|||++|  |+|||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~d  173 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRD  173 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--ccccc
Confidence            9999887654 778888888999999997644321100      00112457889999999999999999999  99999


Q ss_pred             CCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          332 LKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       332 Lkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      |||+|||++.++.+||+|||++........     ...||+.|+|||++.+..++.++||||||+++|+|+| |..||.+
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987654322     2346889999999999999999999999999999998 9999987


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ..... .+...+..+. +...+.  ..+..+.++|.+||..||.+|||+.++++.|+.+...-
T Consensus       254 ~~~~~-~~~~~~~~~~-~~~~~~--~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          254 VKIDE-EFCRRLKEGT-RMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             CCCSH-HHHHHHHHTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhH-HHHHHhccCc-cCCCCC--CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            66433 3333444433 222332  34567889999999999999999999999999987653

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-43  Score=363.16  Aligned_cols=249  Identities=20%  Similarity=0.338  Sum_probs=203.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE  265 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~  265 (472)
                      ...+..++|++.++||+|+||.||+|+++  +..||||++++.... .......+.+|+.+|..+ +|||||+++++|.+
T Consensus        46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~-~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~  124 (396)
T 4dc2_A           46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN-DDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT  124 (396)
T ss_dssp             ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC-----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE
Confidence            34566789999999999999999999986  678999999876442 233445678999999887 89999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..++|+|++.||+|..++...+.          .+...+..++.||+.||+|||++|  |+||||||+||||+.+|.+
T Consensus       125 ~~~~~lV~E~~~gg~L~~~l~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~i  192 (396)
T 4dc2_A          125 ESRLFFVIEYVNGGDLMFHMQRQRK----------LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHI  192 (396)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCE
T ss_pred             CCEEEEEEEcCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCE
Confidence            9999999999999999999965332          346888999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-------CHHHHHH
Q 039082          346 RIADFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-------KPAKIAM  415 (472)
Q Consensus       346 kL~DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-------~~~~i~~  415 (472)
                      ||+|||+|+...   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.....       ....+..
T Consensus       193 kL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~  272 (396)
T 4dc2_A          193 KLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ  272 (396)
T ss_dssp             EECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred             EEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence            999999998633   234456799999999999999999999999999999999999999964321       1233444


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                      .+..+..  .+|.  ....++.++|.+||..||++||++
T Consensus       273 ~i~~~~~--~~p~--~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          273 VILEKQI--RIPR--SLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHCCC--CCCT--TSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHhcccc--CCCC--cCCHHHHHHHHHHhcCCHhHcCCC
Confidence            4555432  3333  245578899999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.9e-44  Score=356.02  Aligned_cols=261  Identities=24%  Similarity=0.319  Sum_probs=204.7

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHH--HhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL--SRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il--~~l~HpnIv~l~g~~~~~  266 (472)
                      .+.++.++|++.+.||+|+||.||+|.+.+..||||++...       ....+..|.+++  ..++||||+++++.+...
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~   79 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA-------NRQNFINEKNIYRVPLMEHDNIARFIVGDERV   79 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc-------chhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence            45678899999999999999999999999999999998642       122344555554  458999999999865431


Q ss_pred             -----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCceeecCC
Q 039082          267 -----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ---------KPKVIHRDL  332 (472)
Q Consensus       267 -----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~---------~~~iiHrDL  332 (472)
                           ...++|+|++.+|+|.+++.....           ++..++.++.||+.||+|||+.         +  |+||||
T Consensus        80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~--ivH~Di  146 (336)
T 3g2f_A           80 TADGRMEYLLVMEYYPNGSLXKYLSLHTS-----------DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA--ISHRDL  146 (336)
T ss_dssp             CTTSCEEEEEEECCCTTCBHHHHHHHCCB-----------CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC--EECSSC
T ss_pred             ccCCCceEEEEEecCCCCcHHHHHhhccc-----------chhHHHHHHHHHHHHHHHHHhhhccccccccc--eeeccc
Confidence                 234678888889999999964332           4677889999999999999999         8  999999


Q ss_pred             CCCcEEEcCCCcEEEeecccceecCCCc-----------cccccCCcccccccccC-------CCCCchHHHHHHHHHHH
Q 039082          333 KPSNIFLDDAKHVRIADFGHARFLSDGE-----------MALTGTFVYMAPEVIQC-------EPYSEKSDVYSFGIILN  394 (472)
Q Consensus       333 kp~NILl~~~~~vkL~DFGla~~~~~~~-----------~~~~gt~~y~APE~~~~-------~~~s~~sDvwSlGvll~  394 (472)
                      ||+||||+.++.+||+|||++.......           ....||+.|+|||++.+       ..++.++|||||||++|
T Consensus       147 kp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~  226 (336)
T 3g2f_A          147 NSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW  226 (336)
T ss_dssp             SGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHH
T ss_pred             ccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHH
Confidence            9999999999999999999998765321           13458999999999986       45678999999999999


Q ss_pred             HHHcCCCCCCCCCC----------------CHHHHHHHHhcCCCCCCCCCC----chhHHHHHHHHHHhccCCCCCCCCH
Q 039082          395 EIITGNHPYIEKDY----------------KPAKIAMEVGEGKLRPALPEE----DGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       395 elltG~~Pf~~~~~----------------~~~~i~~~i~~~~~~~~l~~~----~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                      ||++|..||.....                ........+.....++.++..    ...+..+.++|.+||..||++|||+
T Consensus       227 ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~  306 (336)
T 3g2f_A          227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTA  306 (336)
T ss_dssp             HHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCH
T ss_pred             HHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcch
Confidence            99999777633211                122333334444445555543    4467789999999999999999999


Q ss_pred             HHHHHHHHHHHHHHh
Q 039082          455 SSITCSLKNIQMKVT  469 (472)
Q Consensus       455 ~~ll~~L~~i~~~~~  469 (472)
                      .++++.|+++....+
T Consensus       307 ~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          307 QXAEERMAELMMIWE  321 (336)
T ss_dssp             HHHHHHHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHH
Confidence            999999999886554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.5e-44  Score=355.89  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=201.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.....   ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   83 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc---cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            68999999999999999999986  77899999965422   22335688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.+++|.+++....          ..+...++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        84 ~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~  151 (323)
T 3tki_A           84 LEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL  151 (323)
T ss_dssp             EECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEcCCCCcHHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeec
Confidence            99999999999885322          1357889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC-----ccccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          353 ARFLSDG-----EMALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       353 a~~~~~~-----~~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +......     .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||..................   ..
T Consensus       152 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~---~~  228 (323)
T 3tki_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YL  228 (323)
T ss_dssp             CEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCT---TS
T ss_pred             cceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccc---cC
Confidence            9876422     234568999999999987765 78999999999999999999999776543333332222221   22


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +........+.++|.+||..||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            222445667889999999999999999999875

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=360.89  Aligned_cols=248  Identities=20%  Similarity=0.247  Sum_probs=209.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||+|++...    .......+.+|+.+|+.++||||+++++++.+....++|
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  126 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  126 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence            57999999999999999999986  778999998653    233455788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC--CCcEEEeec
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADF  350 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~--~~~vkL~DF  350 (472)
                      +|++.|++|.+++...+.         ..+...++.++.||+.||+|||++|  |+||||||+|||++.  ++.+||+||
T Consensus       127 ~E~~~gg~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DF  195 (387)
T 1kob_A          127 LEFLSGGELFDRIAAEDY---------KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDF  195 (387)
T ss_dssp             EECCCCCBHHHHTTCTTC---------CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEcCCCCcHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEec
Confidence            999999999999854321         2357889999999999999999999  999999999999974  578999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      |++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+..+......+.
T Consensus       196 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--~~~~~~~i~~~~~~~~~~~  273 (387)
T 1kob_A          196 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDA  273 (387)
T ss_dssp             TTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCCCSST
T ss_pred             ccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCccc
Confidence            9999876443  34568999999999999999999999999999999999999998765  4555555655543322222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+.++.++|.+||..||++|||+.++++
T Consensus       274 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          274 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            2445678899999999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.6e-44  Score=359.93  Aligned_cols=254  Identities=22%  Similarity=0.276  Sum_probs=207.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCC-CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++...... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            57899999999999999999986  789999998643211 111234668999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc---EEEe
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRIA  348 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~---vkL~  348 (472)
                      |+|++.|++|.+++......      ....+...++.++.||+.||+|||++|  |+||||||+|||++.++.   +||+
T Consensus       104 v~e~~~g~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADA------GFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             EEeCCCCCCHHHHHHHhccc------CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEEEe
Confidence            99999999999888543211      112356788899999999999999999  999999999999986554   9999


Q ss_pred             ecccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          349 DFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       349 DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |||++.......   ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+..   ......+..+.....
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~i~~~~~~~~  252 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---ERLFEGIIKGKYKMN  252 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---HHHHHHHHHTCCCCC
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---HHHHHHHHcCCCCCC
Confidence            999998876543   24568999999999999999999999999999999999999997643   445555555543221


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .......+..+.++|.+||..||++||++.++++
T Consensus       253 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          253 PRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            1111234567899999999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4e-44  Score=355.23  Aligned_cols=256  Identities=24%  Similarity=0.378  Sum_probs=202.5

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc--
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR--  269 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~--  269 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||+++.+.. ........|.+|+.+++.++||||+++++++......  
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTT-TSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCcccc-CCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            368999999999999999999975  78999999977543 3445667799999999999999999999998876654  


Q ss_pred             --eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          270 --GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       270 --~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                        ++|+|++.|++|.+++...+.          .+...++.++.|++.||+|||++|  |+||||||+|||++.++.+||
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl  157 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGP----------MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKV  157 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEE
T ss_pred             ccEEEEecCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEE
Confidence              788999989999999964321          347889999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          348 ADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       348 ~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      +|||++.......      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+  ............
T Consensus       158 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~--~~~~~~~~~~~~  235 (311)
T 3ork_A          158 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVRED  235 (311)
T ss_dssp             CCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCC
T ss_pred             eeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCC
Confidence            9999998765332      23458999999999999999999999999999999999999997765  444544444443


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHH-HHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSS-ITCSLKNI  464 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~-ll~~L~~i  464 (472)
                      ..+........+.++.++|.+||..||++||++.+ +...|..+
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            22211111335667899999999999999996554 44555443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-44  Score=361.04  Aligned_cols=249  Identities=23%  Similarity=0.346  Sum_probs=208.0

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP  267 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~  267 (472)
                      .+..++|++.+.||+|+||.||+|.++  |..||||++++.... .......+..|..++..+ +||||+++++++.+.+
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhh-hhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            356689999999999999999999986  788999999764221 123345678899999887 9999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+|++.||+|.+++...+.          .++..+..++.||+.||+|||++|  |+||||||+||||+.+|.+||
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL  159 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHK----------FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKI  159 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEE
Confidence            99999999999999999965332          346788899999999999999999  999999999999999999999


Q ss_pred             eecccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||+++....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+  ...+...+..+..  
T Consensus       160 ~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~--  235 (345)
T 1xjd_A          160 ADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDNP--  235 (345)
T ss_dssp             CCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC--
T ss_pred             eEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHHhCCC--
Confidence            99999986532   2345679999999999999999999999999999999999999998766  5566666666542  


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFS-SIT  458 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~-~ll  458 (472)
                      .+|.  ..+..+.++|.+||..||++||++. +|+
T Consensus       236 ~~p~--~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 FYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCCT--TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCc--ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            2332  2456788999999999999999987 554

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.1e-43  Score=354.93  Aligned_cols=246  Identities=21%  Similarity=0.349  Sum_probs=205.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~  268 (472)
                      +..++|++.+.||+|+||.||+|.++  +..||||++++... ........+.+|+.++..+ +|||||++++++.+.+.
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            34578999999999999999999986  78899999987644 3445667788999999988 89999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|+|++.||+|..++...+.          .+...++.++.||+.||+|||++|  |+||||||+||||+.+|.+||+
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~----------l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~  152 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRK----------LPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLT  152 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEE
Confidence            9999999999999999964321          346788999999999999999999  9999999999999999999999


Q ss_pred             ecccceecC---CCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-------CCHHHHHHHHh
Q 039082          349 DFGHARFLS---DGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD-------YKPAKIAMEVG  418 (472)
Q Consensus       349 DFGla~~~~---~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~-------~~~~~i~~~i~  418 (472)
                      |||+++...   ......+||+.|+|||++.+..++.++|||||||++|||++|..||....       .....+...+.
T Consensus       153 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~  232 (345)
T 3a8x_A          153 DYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL  232 (345)
T ss_dssp             CGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred             eccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence            999998643   22345679999999999999999999999999999999999999996532       12233444455


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                      .+..  .+|.  ..+..+.++|.+||..||.+||++
T Consensus       233 ~~~~--~~p~--~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          233 EKQI--RIPR--SLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HCCC--CCCT--TSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             cCCC--CCCC--CCCHHHHHHHHHHhcCCHhHCCCC
Confidence            5432  3333  345678889999999999999995

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.9e-44  Score=347.55  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=204.3

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEECC---------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWRG---------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~g---------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      .+..++|++.+.||+|+||.||+|.++.         ..||+|++...    .....+.|.+|+.+++.++||||+++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~   79 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA----HRNYSESFFEAASMMSKLSHKHLVLNYG   79 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG----GGGGHHHHHHHHHHHHTSCCTTBCCEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc----cHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence            4667899999999999999999998752         46999998653    3345567999999999999999999999


Q ss_pred             EEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          262 ACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ++...+..++|+|++.+++|.+++.....         ..++..++.++.||+.||+|||+++  |+||||||+|||++.
T Consensus        80 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~  148 (289)
T 4fvq_A           80 VCVCGDENILVQEFVKFGSLDTYLKKNKN---------CINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIR  148 (289)
T ss_dssp             EECCTTCCEEEEECCTTCBHHHHHHHTGG---------GCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEE
T ss_pred             EEEeCCCCEEEEECCCCCCHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEec
Confidence            99999999999999999999999975332         1346788999999999999999999  999999999999998


Q ss_pred             CCc--------EEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCC-CCCCCCCCCHH
Q 039082          342 AKH--------VRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGN-HPYIEKDYKPA  411 (472)
Q Consensus       342 ~~~--------vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~-~Pf~~~~~~~~  411 (472)
                      ++.        +||+|||++...... ....|++.|+|||++.+ ..++.++||||||+++|+|++|. .||...+  ..
T Consensus       149 ~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~--~~  225 (289)
T 4fvq_A          149 EEDRKTGNPPFIKLSDPGISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD--SQ  225 (289)
T ss_dssp             CCBGGGTBCCEEEECCCCSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--HH
T ss_pred             CCcccccccceeeeccCcccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc--hH
Confidence            887        999999998765432 33457899999999987 77999999999999999999954 5554443  22


Q ss_pred             HHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       412 ~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .........   ..++..  .+..+.++|.+||..||++|||+.++++.|+++.
T Consensus       226 ~~~~~~~~~---~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          226 RKLQFYEDR---HQLPAP--KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             HHHHHHHTT---CCCCCC--SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             HHHHHhhcc---CCCCCC--CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            222222221   122221  2335788889999999999999999999998764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.7e-44  Score=356.65  Aligned_cols=261  Identities=23%  Similarity=0.276  Sum_probs=207.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCC-CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH-TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~-~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.+.... ........+.+|+.+|+.++||||+++++++.+.+..++
T Consensus        26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  105 (345)
T 3hko_A           26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL  105 (345)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence            57899999999999999999986  678999998654221 133456779999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccc------------------------------cccCCCCCCHHHHHHHHHHHHHHHHHHH
Q 039082          272 LVTELLGTTLKEWLHGLGSQRR------------------------------KERMVPLPPFEERLARALEIAQAMQYLH  321 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~------------------------------~~~~~~~~~~~~~~~i~~qia~gL~yLH  321 (472)
                      |+|++.|++|.+++........                              ........+...++.++.||+.||+|||
T Consensus       106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  185 (345)
T 3hko_A          106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH  185 (345)
T ss_dssp             EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            9999999999999953211100                              0000111135667789999999999999


Q ss_pred             hcCCceeecCCCCCcEEEcCCC--cEEEeecccceecCCC-------ccccccCCcccccccccC--CCCCchHHHHHHH
Q 039082          322 EQKPKVIHRDLKPSNIFLDDAK--HVRIADFGHARFLSDG-------EMALTGTFVYMAPEVIQC--EPYSEKSDVYSFG  390 (472)
Q Consensus       322 ~~~~~iiHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~-------~~~~~gt~~y~APE~~~~--~~~s~~sDvwSlG  390 (472)
                      +++  |+||||||+|||++.++  .+||+|||++......       .....||+.|+|||++.+  ..++.++||||||
T Consensus       186 ~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          186 NQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            999  99999999999998776  8999999999876431       234568999999999975  6789999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          391 IILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       391 vll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      |++|+|++|..||.+.+  .......+..+......+.....+..+.++|.+||..||.+||++.++++
T Consensus       264 ~il~el~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVN--DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHCCCCCCCCC--hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            99999999999997766  55566666666544433333445678999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.8e-44  Score=354.50  Aligned_cols=263  Identities=28%  Similarity=0.428  Sum_probs=213.8

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ..++|++.+.||+|+||.||+|.++ |..||||++...    .....+.|.+|+.+++.++||||+++++++...+..++
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE----SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC----CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc----ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            4578999999999999999999986 789999988654    23445678999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|.+++......      ....++..++.++.|++.||+|||++|  ++||||||+|||++.++.+||+|||
T Consensus       113 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLP------TMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCC------SCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             EEEcCCCCcHHHHHhccCCC------ccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEeecc
Confidence            99999999999988543211      123467889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC----HHHHH-HHHhcCC
Q 039082          352 HARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK----PAKIA-MEVGEGK  421 (472)
Q Consensus       352 la~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~----~~~i~-~~i~~~~  421 (472)
                      ++.......     ....||+.|+|||++.+..++.++||||||+++|+|++|+.||......    ..... .....+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            998754321     2345899999999998889999999999999999999999999754321    11111 1111221


Q ss_pred             C----CCCCCC--CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          422 L----RPALPE--EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       422 ~----~~~l~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .    .+.+..  .+..+..+.+++.+||..||++|||+.++++.|+.+.+.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            1    111221  145678899999999999999999999999999988764

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.3e-43  Score=358.87  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=208.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPY  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~  268 (472)
                      +..++|++.+.||+|+||.||+|.++  |..||||++++.... .......+.+|+.+|..+ +||||+++++++.+.+.
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   95 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR   95 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhh-cchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence            55689999999999999999999997  568999999764321 123346688999999988 89999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|+|++.||+|.+++...+.          .+...++.++.||+.||+|||++|  |+||||||+||||+.+|.+||+
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~  163 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGR----------FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIA  163 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEE
Confidence            9999999999999999965332          346788999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          349 DFGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       349 DFGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |||+++....   .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+  ...+...+..+..  .
T Consensus       164 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~--~  239 (353)
T 2i0e_A          164 DFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNV--A  239 (353)
T ss_dssp             CCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC--C
T ss_pred             eCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--HHHHHHHHHhCCC--C
Confidence            9999986432   2345679999999999999999999999999999999999999998765  5667777776643  2


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      +|.  ..+.++.++|.+||..||.+||+     +++|++
T Consensus       240 ~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          240 YPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            332  34567889999999999999995     466653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=354.31  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=206.6

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--Cee----EEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLD----VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~----vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      .+..++|++.+.||+|+||.||+|.+.  +..    ||+|.+....   .......+.+|+.+++.++||||+++++++.
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence            466789999999999999999999985  443    5777765432   3344567899999999999999999999988


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ... .+++++++.+++|.+++.....         ..+...++.++.||+.||+|||++|  |+||||||+|||++.++.
T Consensus        88 ~~~-~~~v~~~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~  155 (327)
T 3lzb_A           88 TST-VQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQH  155 (327)
T ss_dssp             SSS-EEEEECCCSSCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTE
T ss_pred             cCC-ceEEEEecCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCC
Confidence            754 7789999999999999965322         2356788999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          345 VRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +||+|||++........     ...+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+...  ..+...+.
T Consensus       156 ~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~  233 (327)
T 3lzb_A          156 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILE  233 (327)
T ss_dssp             EEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHH
T ss_pred             EEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH
Confidence            99999999987653321     2345788999999999999999999999999999999 9999987663  33444444


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+. +...+  ...+..+.++|.+||..||.+||++.++++.|+++..+.
T Consensus       234 ~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          234 KGE-RLPQP--PICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             TTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             cCC-CCCCC--ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence            443 22222  335567889999999999999999999999999987543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6e-43  Score=347.79  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=210.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--  267 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--  267 (472)
                      +..++|++.+.||+|+||.||+|.++  |..||||++.....   ......+.+|+.+|+.++||||+++++++....  
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   82 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCc
Confidence            34568999999999999999999997  78999999975432   223456789999999999999999999988765  


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE----cCCC
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAK  343 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl----~~~~  343 (472)
                      ..++|++++.+++|.+++......       ...++..++.++.||+.||+|||++|  |+||||||+||||    +.++
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~  153 (319)
T 4euu_A           83 HKVLIMEFCPCGSLYTVLEEPSNA-------YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQS  153 (319)
T ss_dssp             CEEEEEECCTTCBHHHHHHSGGGT-------TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCE
T ss_pred             eEEEEEeCCCCCCHHHHHHHhccc-------cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCc
Confidence            567888999999999999754321       12457889999999999999999999  9999999999999    7888


Q ss_pred             cEEEeecccceecCCCc--cccccCCccccccccc--------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHH
Q 039082          344 HVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQ--------CEPYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPA  411 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~--------~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~  411 (472)
                      .+||+|||+++......  ....||+.|+|||++.        +..++.++|||||||++|||++|..||.....  ...
T Consensus       154 ~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  233 (319)
T 4euu_A          154 VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (319)
T ss_dssp             EEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH
T ss_pred             eEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH
Confidence            89999999998876443  3456899999999986        57789999999999999999999999964332  123


Q ss_pred             HHHHHHhcCCCCC-----------------CCCC----CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          412 KIAMEVGEGKLRP-----------------ALPE----EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       412 ~i~~~i~~~~~~~-----------------~l~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .+...+..+....                 .++.    .......+.++|.+||..||++|||++++++...+-
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            3444444332110                 1111    145667888999999999999999999999887653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8e-44  Score=355.40  Aligned_cols=258  Identities=22%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ..+..++|++.+.||+|+||.||+|.+.  +.    +||+|.+.....   ......+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG---RQSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS---CSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc---HHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            4467789999999999999999999985  33    378887754321   22223477899999999999999999987


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      . .+..++|++|+.+++|.+++.....         ..++..++.++.||+.||+|||++|  |+||||||+|||++.++
T Consensus        85 ~-~~~~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~  152 (325)
T 3kex_A           85 P-GSSLQLVTQYLPLGSLLDHVRQHRG---------ALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPS  152 (325)
T ss_dssp             C-BSSEEEEEECCTTCBSHHHHHSSGG---------GSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSS
T ss_pred             c-CCccEEEEEeCCCCCHHHHHHHccc---------cCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCC
Confidence            5 5668899999999999999965321         1235678899999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i  417 (472)
                      .+||+|||+++......     ....|++.|+|||.+.+..++.++|||||||++|+|+| |..||.+...  ..+...+
T Consensus       153 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~  230 (325)
T 3kex_A          153 QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL--AEVPDLL  230 (325)
T ss_dssp             CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT--THHHHHH
T ss_pred             eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH--HHHHHHH
Confidence            99999999998765432     23346889999999999999999999999999999999 9999987663  3344445


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ..+. +...+.  ..+..+.++|.+||..||++||++.++++.|+.+...
T Consensus       231 ~~~~-~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          231 EKGE-RLAQPQ--ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             HTTC-BCCCCT--TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             HcCC-CCCCCC--cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            5443 222222  2344678899999999999999999999999988654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-43  Score=348.60  Aligned_cols=254  Identities=26%  Similarity=0.382  Sum_probs=206.3

Q ss_pred             CCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc--CCCceeEEEEEEEcC----CC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ--RHRFVLQLMGACLEP----PY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l--~HpnIv~l~g~~~~~----~~  268 (472)
                      ++|++.+.||+|+||.||+|.++|..||||++...       ....+.+|.+++..+  +||||+++++++...    ..
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT-------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG-------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc-------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            57899999999999999999999999999998542       123345566666554  999999999999887    56


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc--------CCceeecCCCCCcEEEc
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ--------KPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~--------~~~iiHrDLkp~NILl~  340 (472)
                      .++|+|++.+++|.+++....           .++..++.++.|++.||+|||++        +  |+||||||+|||++
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dikp~Nill~  176 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKSTT-----------LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA--IAHRDLKSKNILVK  176 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----------BCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC--EECSCCCGGGEEEC
T ss_pred             eEEEEeccCCCcHHHHhhccC-----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC--EEecccchHHEEEC
Confidence            788999999999999995421           34678899999999999999998        7  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc-------cccccCCcccccccccCCCCCch------HHHHHHHHHHHHHHcC--------
Q 039082          341 DAKHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQCEPYSEK------SDVYSFGIILNEIITG--------  399 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~~~s~~------sDvwSlGvll~elltG--------  399 (472)
                      .++.+||+|||++.......       ....||+.|+|||++.+..++..      +|||||||++|||+||        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            99999999999998765332       13468999999999987766554      9999999999999999        


Q ss_pred             --CCCCCCCC---CCHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          400 --NHPYIEKD---YKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       400 --~~Pf~~~~---~~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                        ..||....   .........+.....++.++..   ..++..+.++|.+||..||++|||+.++++.|+.+.+..
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence              77775432   2233444445555555555543   467788999999999999999999999999999988754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.8e-43  Score=346.88  Aligned_cols=252  Identities=23%  Similarity=0.245  Sum_probs=197.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .++|++.+.||+|+||.||+|.++ |..||||++..+..  .......+.+|+.+|+.++||||+++++++.+....++|
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE--DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC--------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc--cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            478999999999999999999985 78899999976532  334456788999999999999999999999988888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++. ++|.+++.....         ..+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        98 ~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~  165 (311)
T 3niz_A           98 FEFME-KDLKKVLDENKT---------GLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGL  165 (311)
T ss_dssp             EECCS-EEHHHHHHTCTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EcCCC-CCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcC
Confidence            88775 588888754321         2356788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH-HHHhcCCCCCCC-
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA-MEVGEGKLRPAL-  426 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~-~~i~~~~~~~~l-  426 (472)
                      +......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....... ..+......... 
T Consensus       166 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  245 (311)
T 3niz_A          166 ARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP  245 (311)
T ss_dssp             CEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred             ceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence            9887533   234468999999999876 5689999999999999999999999987653322111 111111100000 


Q ss_pred             ----------------CC------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 ----------------PE------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ----------------~~------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                      ..      .+....++.++|.+||..||++|||++++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                            00      0123457889999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.3e-43  Score=357.94  Aligned_cols=251  Identities=24%  Similarity=0.285  Sum_probs=197.4

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      ....++|++.+.||+|+||.||+|.++  +..||||++.....     ..+.+.+|+.+++.++||||+++++++.....
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   90 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-----IDENVQREIINHRSLRHPNIVRFKEVILTPTH   90 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE
Confidence            455689999999999999999999986  77899999976432     12347899999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc--EE
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--VR  346 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~--vk  346 (472)
                      .++|++++.+++|.+++...+.          .+...++.++.|++.||+|||++|  |+||||||+||||+.++.  +|
T Consensus        91 ~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~k  158 (361)
T 3uc3_A           91 LAIIMEYASGGELYERICNAGR----------FSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLK  158 (361)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEE
T ss_pred             EEEEEEeCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEE
Confidence            9999999999999999964332          346889999999999999999999  999999999999987765  99


Q ss_pred             EeecccceecCC--CccccccCCcccccccccCCCCCch-HHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCC
Q 039082          347 IADFGHARFLSD--GEMALTGTFVYMAPEVIQCEPYSEK-SDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGK  421 (472)
Q Consensus       347 L~DFGla~~~~~--~~~~~~gt~~y~APE~~~~~~~s~~-sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~  421 (472)
                      |+|||+++....  ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...  ........+....
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~  238 (361)
T 3uc3_A          159 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK  238 (361)
T ss_dssp             ECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC
T ss_pred             EeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC
Confidence            999999985432  2344568999999999988888765 8999999999999999999976442  2233444444433


Q ss_pred             CCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       422 ~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .  .++.....+..+.++|.+||..||++|||+.++++.
T Consensus       239 ~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 Y--SIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             C--CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C--CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            2  333333455678899999999999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.4e-44  Score=372.94  Aligned_cols=258  Identities=20%  Similarity=0.284  Sum_probs=212.0

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..+.+..++|++.++||+|+||.||+|.++  +..||||++.+.... .......+.+|+.++..++||||++++++|.+
T Consensus        67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEML-KRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhh-hHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            345677789999999999999999999986  678999999653211 11122348899999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..++|+||+.||+|.+++.....         ..+...++.++.||+.||+|||++|  ||||||||+||||+.+|.+
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFED---------RLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCE
T ss_pred             CCEEEEEEecCCCCcHHHHHHHccC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCE
Confidence            9999999999999999999965321         2356888999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc----cccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          346 RIADFGHARFLSDGE----MALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       346 kL~DFGla~~~~~~~----~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      ||+|||+|+......    ...+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+.+  ..+....
T Consensus       215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--~~~~~~~  292 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--LVETYGK  292 (437)
T ss_dssp             EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHH
T ss_pred             EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--hhHHHHh
Confidence            999999998765432    2357999999999987     4678999999999999999999999998766  5556666


Q ss_pred             HhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCC--CCCHHHHHH
Q 039082          417 VGEGKLRPALPEE-DGQLRELIELICLSWDGDASV--RPSFSSITC  459 (472)
Q Consensus       417 i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~--RPs~~~ll~  459 (472)
                      +.....+..+|.. ...+.++.++|.+||..+|++  ||+++++++
T Consensus       293 i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          293 IMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            6543323334433 345667889999999888888  999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.3e-42  Score=342.85  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=211.8

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      .|...+.||+|+||.||+|.+++..||||++........+.....|.+|+.+++.++||||+++++++...+..++++++
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  111 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY  111 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence            34456899999999999999999999999997654334455677899999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +.+++|.+++.....       ....++..++.++.+++.||+|||++|  ++||||||+|||++.++.+||+|||++..
T Consensus       112 ~~~~~L~~~l~~~~~-------~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  182 (307)
T 2nru_A          112 MPNGSLLDRLSCLDG-------TPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKSANILLDEAFTAKISDFGLARA  182 (307)
T ss_dssp             CTTCBHHHHHHTGGG-------CCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhccC-------CCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEcCCCcEEEeecccccc
Confidence            999999999964322       123467889999999999999999999  99999999999999999999999999987


Q ss_pred             cCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHhcCC------C
Q 039082          356 LSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGEGK------L  422 (472)
Q Consensus       356 ~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--~~i~~~i~~~~------~  422 (472)
                      .....     ....||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......  ..+...+....      .
T Consensus       183 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (307)
T 2nru_A          183 SEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYI  261 (307)
T ss_dssp             CCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHS
T ss_pred             cccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhc
Confidence            65432     23458999999999875 48999999999999999999999997654221  12222222211      1


Q ss_pred             CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          423 RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       423 ~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      ...++.. ...+..+.+++.+||..||.+||++.++++.|+++..
T Consensus       262 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          262 DKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1122222 4567789999999999999999999999999998753

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6e-43  Score=348.31  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=209.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC--hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN--ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++........  ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            46899999999999999999986  77899999976543221  123567899999999999999999999999998899


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC----cEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVR  346 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~----~vk  346 (472)
                      +|+|++.+++|.+++.....          .+...++.++.|++.||+|||++|  |+||||||+|||++.++    .+|
T Consensus        92 lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQKES----------LSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             EEECCCCSCBHHHHHHTCSC----------EEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCEE
Confidence            99999999999999964321          346789999999999999999999  99999999999999887    799


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||++.......  ....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+  .......+..+... 
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~-  236 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANITSVSYD-  236 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHTTCCC-
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhcccc-
Confidence            99999998876543  34568999999999999999999999999999999999999997765  45555555554322 


Q ss_pred             CCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .+..  ...+..+.++|.+||..||++|||+.++++
T Consensus       237 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          237 -FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             1111  234567889999999999999999999985

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-42  Score=341.54  Aligned_cols=262  Identities=28%  Similarity=0.428  Sum_probs=211.6

Q ss_pred             ceeeCCC--CeeEeceeeccCceEEEEEEEC--C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          189 GWYIDPK--EIDLQEKIGQGTTANIYRAIWR--G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       189 ~~~i~~~--~~~l~~~LG~G~fG~Vy~a~~~--g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      .+.++..  .|.+.+.||+|+||.||+|.+.  +   ..||+|++...   ......+.|.+|+.+++.++||||+++++
T Consensus        13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   89 (298)
T 3pls_A           13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI---TEMQQVEAFLREGLLMRGLNHPNVLALIG   89 (298)
T ss_dssp             GGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             heEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc---ccHHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence            4445544  4556799999999999999873  2   26999998653   34456678999999999999999999999


Q ss_pred             EEEcCCCc-eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          262 ACLEPPYR-GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       262 ~~~~~~~~-~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ++.+.+.. +++++++.+++|.+++....         ...++..++.++.|++.||+|||++|  ++||||||+|||++
T Consensus        90 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~  158 (298)
T 3pls_A           90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---------RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLD  158 (298)
T ss_dssp             EECCSSSCCEEEECCCTTCBHHHHHHCTT---------CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             EEecCCCCcEEEEecccCCCHHHHHhccc---------cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEc
Confidence            99877665 78889999999999996422         12357889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc-------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCC-CCCCCCCHHH
Q 039082          341 DAKHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHP-YIEKDYKPAK  412 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~P-f~~~~~~~~~  412 (472)
                      .++.+||+|||++.......       ....+++.|+|||.+.+..++.++||||||+++|+|++|..| |...+  ...
T Consensus       159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~--~~~  236 (298)
T 3pls_A          159 ESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID--PFD  236 (298)
T ss_dssp             TTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--GGG
T ss_pred             CCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC--HHH
Confidence            99999999999998654322       234468899999999999999999999999999999995554 54444  334


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      +...+..+. ....+  ...+..+.+++.+||..||.+|||+.++++.|+++...+.
T Consensus       237 ~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          237 LTHFLAQGR-RLPQP--EYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHhhcCC-CCCCC--ccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            455555543 22222  3345678899999999999999999999999999988765

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.5e-43  Score=347.32  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=212.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEE------CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~------~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +....|++++.||+|+||.||++.+      .+..||||+++.+   ........|.+|+.+|+.++||||+++++++.+
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD---AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED  104 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc---cChHHHHHHHHHHHHHHhCCCcchhhEEEEEec
Confidence            4445569999999999999999876      3678999999764   345566779999999999999999999999987


Q ss_pred             C--CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          266 P--PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       266 ~--~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .  ...++|++++.+++|.+++....           .++..++.++.+++.||+|||++|  |+||||||+|||++.++
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~  171 (318)
T 3lxp_A          105 AGAASLQLVMEYVPLGSLRDYLPRHS-----------IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDR  171 (318)
T ss_dssp             TTTTEEEEEECCCTTCBHHHHGGGSC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTC
T ss_pred             CCCceEEEEEecccCCcHHHHHhhCC-----------CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCC
Confidence            4  45678888888999999995422           357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--------
Q 039082          344 HVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK--------  409 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--------  409 (472)
                      .+||+|||++.......      ....+|+.|+|||.+.+..++.++||||||+++|+|++|..||......        
T Consensus       172 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~  251 (318)
T 3lxp_A          172 LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA  251 (318)
T ss_dssp             CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC
T ss_pred             CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhccc
Confidence            99999999999876432      2234688899999999888999999999999999999999999653210        


Q ss_pred             -----HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhhc
Q 039082          410 -----PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET  471 (472)
Q Consensus       410 -----~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~~  471 (472)
                           ...+...+..+. +...+  ...+..+.++|.+||..||++|||+.++++.|+.+.+++..+
T Consensus       252 ~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          252 QGQMTVLRLTELLERGE-RLPRP--DKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             CHHHHHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             ccchhHHHHHHHHhccc-CCCCC--ccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence                 011222222222 22222  345678899999999999999999999999999999988654

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.3e-43  Score=345.21  Aligned_cols=259  Identities=23%  Similarity=0.386  Sum_probs=207.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEE------CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~------~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ..+....|++.+.||+|+||.||+|.+      .+..||||++....   .......+.+|+.+|+.++||||+++++++
T Consensus        16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES---GGNHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC--------CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc---cchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            345567799999999999999999985      37789999997643   233456789999999999999999999999


Q ss_pred             EcC--CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          264 LEP--PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       264 ~~~--~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ...  ...++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.
T Consensus        93 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~  161 (302)
T 4e5w_A           93 TEDGGNGIKLIMEFLPSGSLKEYLPKNKN---------KINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVES  161 (302)
T ss_dssp             EC---CCEEEEEECCTTCBHHHHHHHHTT---------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEE
T ss_pred             ecCCCceEEEEEEeCCCCcHHHHHHhccc---------cCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcC
Confidence            876  557888999999999999954321         2357889999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--------
Q 039082          342 AKHVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD--------  407 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~--------  407 (472)
                      ++.+||+|||++.......      ....||..|+|||.+.+..++.++||||||+++|+|++|..|+....        
T Consensus       162 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  241 (302)
T 4e5w_A          162 EHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG  241 (302)
T ss_dssp             TTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHC
T ss_pred             CCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccC
Confidence            9999999999998876433      23347888999999998899999999999999999999998863221        


Q ss_pred             -----CCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          408 -----YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       408 -----~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                           .....+...+..+. +...+  ...+..+.++|.+||..||.+|||+.++++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          242 PTHGQMTVTRLVNTLKEGK-RLPCP--PNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             SCCGGGHHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CcccccCHHHHHHHHhccC-CCCCC--CCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                 01122233333332 22222  345567899999999999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-44  Score=368.55  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=208.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .+.+..++|++.+.||+|+||.||+|.++  |..||||++++... ........+.+|+.+|..++||||++++++|.+.
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~-~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~  133 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDM-LKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE  133 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHh-hhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            45577789999999999999999999986  78999999965321 1122334588999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..|+|+||+.||+|.+++...+.         ..+...++.++.||+.||+|||++|  ||||||||+||||+.+|++|
T Consensus       134 ~~~~lVmE~~~gg~L~~~l~~~~~---------~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vk  202 (412)
T 2vd5_A          134 NYLYLVMEYYVGGDLLTLLSKFGE---------RIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIR  202 (412)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHSS---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEE
T ss_pred             CEEEEEEcCCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEE
Confidence            999999999999999999965331         2346778899999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc----cccccCCccccccccc-------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          347 IADFGHARFLSDGE----MALTGTFVYMAPEVIQ-------CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       347 L~DFGla~~~~~~~----~~~~gt~~y~APE~~~-------~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      |+|||+++......    ...+||+.|+|||++.       ...|+.++|||||||++|||++|+.||.+.+  ......
T Consensus       203 L~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~  280 (412)
T 2vd5_A          203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS--TAETYG  280 (412)
T ss_dssp             ECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHH
T ss_pred             EeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC--HHHHHH
Confidence            99999998876432    2357999999999987       3568999999999999999999999998766  555555


Q ss_pred             HHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCC---CCHHHHHH
Q 039082          416 EVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVR---PSFSSITC  459 (472)
Q Consensus       416 ~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~R---Ps~~~ll~  459 (472)
                      .+........+|.. ...+.++.++|.+||. +|.+|   |+++++++
T Consensus       281 ~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          281 KIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            55543212223321 3355678999999999 99998   68888864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.2e-43  Score=344.22  Aligned_cols=256  Identities=29%  Similarity=0.449  Sum_probs=207.9

Q ss_pred             CCeeEeceeeccCceEEEEEEECC-----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc-CCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE-PPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g-----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~-~~~  268 (472)
                      .+|++.+.||+|+||.||+|.+.+     ..||+|.+...   ........+.+|+.+++.++||||+++++++.. ++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC---CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC---CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            368899999999999999998742     25899988653   345566789999999999999999999999765 456


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|++++.+++|.+++....         ...++..++.++.|++.||+|||++|  ++||||||+|||++.++.+||+
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~  170 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET---------HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVA  170 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT---------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEEC
Confidence            678888888999999996422         12357888999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc-------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcC
Q 039082          349 DFGHARFLSDGE-------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       349 DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      |||++.......       ....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....  ......+..+
T Consensus       171 Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--~~~~~~~~~~  248 (298)
T 3f66_A          171 DFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQG  248 (298)
T ss_dssp             SCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT--TTHHHHHHTT
T ss_pred             cccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH--HHHHHHHhcC
Confidence            999998765432       22346788999999999999999999999999999999 6667766553  2344444444


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      . +...+  ...+..+.+++.+||+.||++|||+.++++.|+++...+.
T Consensus       249 ~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          249 R-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             C-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             C-CCCCC--ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            3 22222  2345678899999999999999999999999999988664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3.9e-43  Score=349.21  Aligned_cols=245  Identities=27%  Similarity=0.371  Sum_probs=198.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY----  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~----  268 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||+++...   .....+.+.+|+.+|+.++|||||+++++|.+.+.    
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN---RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS---TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC---chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence            47899999999999999999986  7899999997542   34456779999999999999999999999876543    


Q ss_pred             -----------------------------------------------------ceEEEEeccCCcHHHHHhhcccccccc
Q 039082          269 -----------------------------------------------------RGWLVTELLGTTLKEWLHGLGSQRRKE  295 (472)
Q Consensus       269 -----------------------------------------------------~~~vve~~~ggsL~~~l~~~~~~~~~~  295 (472)
                                                                           .++++|++.+++|.+++.......   
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~---  159 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE---  159 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG---
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc---
Confidence                                                                 678899999999999997644321   


Q ss_pred             cCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCc---------------
Q 039082          296 RMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---------------  360 (472)
Q Consensus       296 ~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~---------------  360 (472)
                          ...+..++.++.||+.||+|||++|  |+||||||+||||+.++.+||+|||++.......               
T Consensus       160 ----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T 3qd2_B          160 ----DREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH  233 (332)
T ss_dssp             ----GSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CC
T ss_pred             ----chhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccc
Confidence                1235668899999999999999999  9999999999999999999999999998876432               


Q ss_pred             cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC-chhHHHHHHH
Q 039082          361 MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE-DGQLRELIEL  439 (472)
Q Consensus       361 ~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~-~~~~~~l~~l  439 (472)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..|+..    .......+..+.    .+.. ......+.++
T Consensus       234 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----~~~~~~~~~~~~----~~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----RVRIITDVRNLK----FPLLFTQKYPQEHMM  305 (332)
T ss_dssp             CSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----HHHHHHHHHTTC----CCHHHHHHCHHHHHH
T ss_pred             cccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----HHHHHHHhhccC----CCcccccCChhHHHH
Confidence            234589999999999999999999999999999999998776522    122333333332    2222 3344677899


Q ss_pred             HHHhccCCCCCCCCHHHHHH
Q 039082          440 ICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       440 i~~cl~~dP~~RPs~~~ll~  459 (472)
                      |.+||..||++||++.++++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHccCCCCcCCCHHHHhh
Confidence            99999999999999999986

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.6e-44  Score=357.79  Aligned_cols=245  Identities=26%  Similarity=0.365  Sum_probs=199.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|.+.+.||+|+||.||+|.+.  +..||||++.+.... .......+.+|+.+|+.++||||+++++++......++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLK-KSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHcc-chhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            58999999999999999999984  789999998653221 112234688999999999999999999999998888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++ +|+|.+++...+.          .+...++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        88 ~E~~-~g~l~~~l~~~~~----------l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~  154 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKR----------MTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGL  154 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSC
T ss_pred             EECC-CCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEecc
Confidence            8877 8999999864322          357889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc--cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGE--MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~--~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +.......  ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.....  ....+..+.  ..+|  
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~~--~~~p--  228 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN--LFKKVNSCV--YVMP--  228 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT--CBCCCCSSC--CCCC--
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH--HHHHHHcCC--CCCc--
Confidence            98766443  34578999999999988776 789999999999999999999997654221  111111111  1222  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..||.+|||++++++
T Consensus       229 ~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          229 DFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            234567889999999999999999999875

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-43  Score=353.46  Aligned_cols=264  Identities=27%  Similarity=0.415  Sum_probs=209.8

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      .+.+..++|++.+.||+|+||.||+|.++ |..||||++.......   ....|.+|+.+++.++||||+++++++....
T Consensus        24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  100 (326)
T 3uim_A           24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQG---GELQFQTEVEMISMAVHRNLLRLRGFCMTPT  100 (326)
T ss_dssp             HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC--------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred             HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCch---HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence            34567789999999999999999999875 7889999997653221   2224889999999999999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc---CCceeecCCCCCcEEEcCCCc
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ---KPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~---~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ..++|++++.+++|.+++......      ....++..+..++.|++.||+|||++   |  |+||||||+|||++.++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~--ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A          101 ERLLVYPYMANGSVASCLRERPES------QPPLDWPKRQRIALGSARGLAYLHDHCDPK--IIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CCEEEEECCTTCBHHHHHHCCSTT------CCCCCHHHHHHHHHHHHHHHHHHHHSSSSC--EECCCCSGGGEEECTTCC
T ss_pred             ceEEEEEeccCCCHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEeCCCchhhEEECCCCC
Confidence            999999999999999999754321      22346788999999999999999999   8  999999999999999999


Q ss_pred             EEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCC------CCCHHHHH
Q 039082          345 VRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEK------DYKPAKIA  414 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~------~~~~~~i~  414 (472)
                      +||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|..||...      ........
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            9999999998765332    2344899999999998888999999999999999999999999521      11111111


Q ss_pred             HHHhcCC-C----CCCCC--CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          415 MEVGEGK-L----RPALP--EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       415 ~~i~~~~-~----~~~l~--~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      ....... .    ...+.  .....+..+.+++..||..||.+|||+.+|++.|+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            1111111 0    11111  124567889999999999999999999999999973

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.8e-43  Score=353.02  Aligned_cols=252  Identities=24%  Similarity=0.287  Sum_probs=204.8

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-----CCceeEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-----HRFVLQLMGA  262 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-----HpnIv~l~g~  262 (472)
                      ..+-.++|++.++||+|+||.||+|.+.  +..||||+++.     .......+..|+.+++.+.     |||||+++++
T Consensus        30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~  104 (360)
T 3llt_A           30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGK  104 (360)
T ss_dssp             TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEE
T ss_pred             ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-----chhhhhhhHHHHHHHHHhcccCCCCCCeecccce
Confidence            3344679999999999999999999984  77899999863     3345566788999999996     9999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-  341 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-  341 (472)
                      +...+..++|++++ +++|.+++.....        ...++..++.++.||+.||+|||++|  |+||||||+||||+. 
T Consensus       105 ~~~~~~~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          105 FMYYDHMCLIFEPL-GPSLYEIITRNNY--------NGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDDP  173 (360)
T ss_dssp             EEETTEEEEEECCC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCT
T ss_pred             eeECCeeEEEEcCC-CCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEccc
Confidence            99988888888887 9999999965332        12357889999999999999999999  999999999999975 


Q ss_pred             ------------------------CCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHH
Q 039082          342 ------------------------AKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEII  397 (472)
Q Consensus       342 ------------------------~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ell  397 (472)
                                              ++.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  253 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELY  253 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHH
Confidence                                    78999999999998777677778999999999999999999999999999999999


Q ss_pred             cCCCCCCCCCCCHHHHHHHHhcCCC------------------------CCCCCCCc------------------hhHHH
Q 039082          398 TGNHPYIEKDYKPAKIAMEVGEGKL------------------------RPALPEED------------------GQLRE  435 (472)
Q Consensus       398 tG~~Pf~~~~~~~~~i~~~i~~~~~------------------------~~~l~~~~------------------~~~~~  435 (472)
                      +|+.||...+  .......+.....                        ....|...                  .....
T Consensus       254 ~g~~pf~~~~--~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (360)
T 3llt_A          254 TGSLLFRTHE--HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL  331 (360)
T ss_dssp             HSSCSCCCSS--HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred             HCCCCCCCCc--HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence            9999997765  3333222221110                        00011110                  01156


Q ss_pred             HHHHHHHhccCCCCCCCCHHHHHH
Q 039082          436 LIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       436 l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.++|.+||..||++|||++++++
T Consensus       332 l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          332 FCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHhcCChhhCCCHHHHhc
Confidence            779999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-42  Score=347.79  Aligned_cols=253  Identities=27%  Similarity=0.389  Sum_probs=212.1

Q ss_pred             CCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh--cCCCceeEEEEEEEcCC----C
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR--QRHRFVLQLMGACLEPP----Y  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~--l~HpnIv~l~g~~~~~~----~  268 (472)
                      ++|++.+.||+|+||.||+|.++|..||||++...       ....+.+|++++..  ++||||+++++++...+    .
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            57899999999999999999999999999998532       23457789999988  79999999999998876    6


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCceeecCCCCCcEEEc
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH--------EQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH--------~~~~~iiHrDLkp~NILl~  340 (472)
                      .++|++++.+++|.+++....           .++..++.++.|++.||+|||        +.+  |+||||||+||||+
T Consensus       115 ~~lv~e~~~~g~L~~~l~~~~-----------~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLKSKNILVK  181 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC-----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCSGGGEEEC
T ss_pred             eEEEEeecCCCcHHHHHhccC-----------ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCCHHHEEEC
Confidence            788999999999999996421           347889999999999999999        778  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc-------cccccCCcccccccccCC------CCCchHHHHHHHHHHHHHHcC--------
Q 039082          341 DAKHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITG--------  399 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~------~~s~~sDvwSlGvll~elltG--------  399 (472)
                      .++.+||+|||++.......       ....||+.|+|||++.+.      .++.++|||||||++|+|+||        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998776433       334689999999999765      234789999999999999999        


Q ss_pred             --CCCCCCCCC---CHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          400 --NHPYIEKDY---KPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       400 --~~Pf~~~~~---~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                        ..||.....   ....+...+.....++.++..   ...+..+.++|.+||..||++|||+.++++.|+.+..+
T Consensus       262 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence              789866432   234555556666656666642   45677899999999999999999999999999998765

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.9e-43  Score=358.31  Aligned_cols=256  Identities=18%  Similarity=0.215  Sum_probs=205.5

Q ss_pred             eeeCCCCeeEeceeecc--CceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          190 WYIDPKEIDLQEKIGQG--TTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G--~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +....++|++.+.||+|  +||.||+|.++  |..||||++.....  .......+.+|+.+|+.++|||||++++++.+
T Consensus        20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC--SNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc--ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            44566789999999999  99999999996  78999999976533  44567788999999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..++|++++.+++|.+++.....        ...+...+..++.||+.||+|||++|  |+||||||+||||+.++.+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~  167 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFM--------DGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKV  167 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCT--------TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCE
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcc--------cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCE
Confidence            9999999999999999999965321        12357888999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC----------ccccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH
Q 039082          346 RIADFGHARFLSDG----------EMALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI  413 (472)
Q Consensus       346 kL~DFGla~~~~~~----------~~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i  413 (472)
                      ||+|||.+......          .....||+.|+|||++.+  ..|+.++|||||||++|+|++|+.||.+.+...  .
T Consensus       168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~  245 (389)
T 3gni_B          168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--M  245 (389)
T ss_dssp             EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--H
T ss_pred             EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--H
Confidence            99999998754321          123468999999999987  679999999999999999999999997755322  2


Q ss_pred             HHHHhcCCCCC------------------------------------------CCCCCchhHHHHHHHHHHhccCCCCCC
Q 039082          414 AMEVGEGKLRP------------------------------------------ALPEEDGQLRELIELICLSWDGDASVR  451 (472)
Q Consensus       414 ~~~i~~~~~~~------------------------------------------~l~~~~~~~~~l~~li~~cl~~dP~~R  451 (472)
                      ...+..+....                                          ..+........+.++|.+||..||++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  325 (389)
T 3gni_B          246 LLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR  325 (389)
T ss_dssp             HHHC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred             HHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence            22221111100                                          000112234678899999999999999


Q ss_pred             CCHHHHHH
Q 039082          452 PSFSSITC  459 (472)
Q Consensus       452 Ps~~~ll~  459 (472)
                      ||++++++
T Consensus       326 pta~ell~  333 (389)
T 3gni_B          326 PSASTLLN  333 (389)
T ss_dssp             CCHHHHTT
T ss_pred             CCHHHHhc
Confidence            99999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=356.00  Aligned_cols=245  Identities=23%  Similarity=0.252  Sum_probs=201.0

Q ss_pred             eEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      ...+.||+|+||.||+|.+.  |..||||+++..    .....+.|.+|+.+|+.++|||||++++++.+.+..++|+|+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR----GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc----ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            44678999999999999985  789999999764    234556799999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE--cCCCcEEEeecccc
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL--DDAKHVRIADFGHA  353 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl--~~~~~vkL~DFGla  353 (472)
                      +.+++|.+++.....         ..++..++.++.||+.||+|||+++  |+||||||+|||+  +.++.+||+|||++
T Consensus       168 ~~~~~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a  236 (373)
T 2x4f_A          168 VDGGELFDRIIDESY---------NLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLA  236 (373)
T ss_dssp             CTTCEEHHHHHHTGG---------GCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred             CCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence            999999998864321         1346778889999999999999999  9999999999999  56789999999999


Q ss_pred             eecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          354 RFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       354 ~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      +......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+.........+....
T Consensus       237 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~  314 (373)
T 2x4f_A          237 RRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--DAETLNNILACRWDLEDEEFQD  314 (373)
T ss_dssp             EECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCSCSGGGTT
T ss_pred             eecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhccCCCChhhhcc
Confidence            9876443  33468999999999999999999999999999999999999998765  5556666665543322221234


Q ss_pred             hHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.++.++|.+||..||.+||++.++++
T Consensus       315 ~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          315 ISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            5678899999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=359.96  Aligned_cols=262  Identities=29%  Similarity=0.455  Sum_probs=204.6

Q ss_pred             ceeeCCC--CeeEeceeeccCceEEEEEEEC---C--eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEE
Q 039082          189 GWYIDPK--EIDLQEKIGQGTTANIYRAIWR---G--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMG  261 (472)
Q Consensus       189 ~~~i~~~--~~~l~~~LG~G~fG~Vy~a~~~---g--~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g  261 (472)
                      .|.++..  .|++.+.||+|+||.||+|.+.   +  ..||||.++..   ......+.|.+|+.+|+.++||||+++++
T Consensus        81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~il~~l~hpnIv~~~~  157 (373)
T 3c1x_A           81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLG  157 (373)
T ss_dssp             TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC---SCSHHHHHHHHHHTTSTTCCCTTBCCCCE
T ss_pred             ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC---CCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            3445444  4678899999999999999874   2  35899988643   34456678999999999999999999999


Q ss_pred             EEEcC-CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          262 ACLEP-PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       262 ~~~~~-~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ++... +..++|+|++.+++|.+++.....         ..++..++.++.||+.||+|||++|  |+||||||+||||+
T Consensus       158 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  226 (373)
T 3c1x_A          158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLD  226 (373)
T ss_dssp             EECCCSSCCEEEEECCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred             EEEcCCCCeEEEEECCCCCCHHHHHhhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEEC
Confidence            97654 467788999999999999964321         2357888999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc-------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHH
Q 039082          341 DAKHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAK  412 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~  412 (472)
                      .++.+||+|||+++......       ....+|+.|+|||.+.+..++.++|||||||++|||+| |..||.+.+..  +
T Consensus       227 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~--~  304 (373)
T 3c1x_A          227 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--D  304 (373)
T ss_dssp             TTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSS--C
T ss_pred             CCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHH--H
Confidence            99999999999998664322       22346788999999999999999999999999999999 78888766533  2


Q ss_pred             HHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          413 IAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       413 i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      +...+..+. +...|  ...+..+.++|.+||..||++||++.++++.|+++...+.
T Consensus       305 ~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          305 ITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            444455544 22223  2345678899999999999999999999999999987654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.8e-43  Score=352.79  Aligned_cols=247  Identities=21%  Similarity=0.297  Sum_probs=192.9

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  +..||||+++...      ..+.+.+|+.+|+.++||||+++++++...+..++
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV------DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch------hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            357999999999999999999996  5689999997542      23457899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CCcEEEe
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIA  348 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~~vkL~  348 (472)
                      |+|++.+++|.+++...+          ..+...++.++.|++.||+|||++|  |+||||||+|||++.   ++.+||+
T Consensus       126 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~  193 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKG----------YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIA  193 (349)
T ss_dssp             EECCCCSCBHHHHHTTCS----------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEEC
T ss_pred             EEEeCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEc
Confidence            999999999999986432          2357889999999999999999999  999999999999975   8899999


Q ss_pred             ecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          349 DFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       349 DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      |||++.......  ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .......+..+......
T Consensus       194 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~~~~~~i~~~~~~~~~  272 (349)
T 2w4o_A          194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-DQFMFRRILNCEYYFIS  272 (349)
T ss_dssp             CCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-HHHHHHHHHTTCCCCCT
T ss_pred             cCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-cHHHHHHHHhCCCccCC
Confidence            999998765432  345689999999999999999999999999999999999999976553 33344555555433222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+..+.++|.+||..||++|||+.++++
T Consensus       273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            222455678899999999999999999999885

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2e-43  Score=360.02  Aligned_cols=246  Identities=24%  Similarity=0.328  Sum_probs=198.7

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHH-HHhcCCCceeEEEEEEEcCCC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT-LSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~i-l~~l~HpnIv~l~g~~~~~~~  268 (472)
                      +..++|++.+.||+|+||.||+|+++  +..||||++++.... .......+.+|..+ ++.++|||||++++++.+.+.
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~  113 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-KKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK  113 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC--------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence            44578999999999999999999986  678999999876442 22344556777777 567899999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .|+|+||+.||+|..++...+.          .+...++.++.||+.||+|||++|  |+||||||+||||+.+|.+||+
T Consensus       114 ~~lv~E~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~  181 (373)
T 2r5t_A          114 LYFVLDYINGGELFYHLQRERC----------FLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLT  181 (373)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEeCCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEe
Confidence            9999999999999999965332          245778889999999999999999  9999999999999999999999


Q ss_pred             ecccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          349 DFGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       349 DFGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |||+++....   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+  ...+...+..+...  
T Consensus       182 DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--~~~~~~~i~~~~~~--  257 (373)
T 2r5t_A          182 DFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--TAEMYDNILNKPLQ--  257 (373)
T ss_dssp             CCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--HHHHHHHHHHSCCC--
T ss_pred             eCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHhcccC--
Confidence            9999986432   2345679999999999999999999999999999999999999997765  56666677665432  


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSS  456 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~  456 (472)
                      ++  ...+..+.++|.+||..||.+||++.+
T Consensus       258 ~~--~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          258 LK--PNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CC--SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CC--CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            22  234567888999999999999999853

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=346.53  Aligned_cols=262  Identities=26%  Similarity=0.330  Sum_probs=193.9

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGAC  263 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~  263 (472)
                      ...+.+...+|++.+.||+|+||.||+|.+.  +..||||++...    .......+.+|+.+++.+. ||||+++++++
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~   95 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN----EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA   95 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC----chHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence            4567788889999999999999999999984  789999998653    4455677899999999996 99999999998


Q ss_pred             Ec-------CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCc
Q 039082          264 LE-------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN  336 (472)
Q Consensus       264 ~~-------~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~N  336 (472)
                      ..       ....+++++++.+|+|.+++.....       ....++..++.++.||+.||+|||+++++|+||||||+|
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~N  168 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES-------RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVEN  168 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHT-------TCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGG
T ss_pred             cccccccccCCceEEEEEEecCCCHHHHHHHhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCccc
Confidence            52       3334566666668999999864221       112467889999999999999999987779999999999


Q ss_pred             EEEcCCCcEEEeecccceecCCCcc---------------ccccCCcccccccc---cCCCCCchHHHHHHHHHHHHHHc
Q 039082          337 IFLDDAKHVRIADFGHARFLSDGEM---------------ALTGTFVYMAPEVI---QCEPYSEKSDVYSFGIILNEIIT  398 (472)
Q Consensus       337 ILl~~~~~vkL~DFGla~~~~~~~~---------------~~~gt~~y~APE~~---~~~~~s~~sDvwSlGvll~ellt  398 (472)
                      |||+.++.+||+|||++........               ...||+.|+|||++   .+..++.++|||||||++|+|++
T Consensus       169 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~  248 (337)
T 3ll6_A          169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF  248 (337)
T ss_dssp             CEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHh
Confidence            9999999999999999987653221               34589999999998   56778999999999999999999


Q ss_pred             CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          399 GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       399 G~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      |..||.....  .    .+..+....  +.....+..+.++|.+||..||++||++.++++.|+.+...
T Consensus       249 g~~p~~~~~~--~----~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          249 RQHPFEDGAK--L----RIVNGKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             SSCCC------------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCcchhH--H----HhhcCcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            9999965441  1    122222221  22223334578889999999999999999999999988764

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-43  Score=350.71  Aligned_cols=251  Identities=20%  Similarity=0.311  Sum_probs=200.8

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC--CceeEEEEEEEcCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RFVLQLMGACLEPP  267 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~g~~~~~~  267 (472)
                      .+..++|++.+.||+|+||.||+|.+. +..||||++....  ........|.+|+.+|+.++|  |||+++++++....
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc--cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            356678999999999999999999885 6789999997653  345566789999999999976  99999999999887


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|++ +.+++|.+++....          ..++..+..++.||+.||+|||++|  |+||||||+||||+ ++.+||
T Consensus        83 ~~~lv~e-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl  148 (343)
T 3dbq_A           83 YIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKL  148 (343)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHSC----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEE
T ss_pred             EEEEEEe-CCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEE
Confidence            7777766 78999999996532          2346788999999999999999999  99999999999997 678999


Q ss_pred             eecccceecCCCc-----cccccCCcccccccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH
Q 039082          348 ADFGHARFLSDGE-----MALTGTFVYMAPEVIQC-----------EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA  411 (472)
Q Consensus       348 ~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~-----------~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~  411 (472)
                      +|||++.......     ....||+.|+|||++.+           ..++.++|||||||++|+|++|+.||..... ..
T Consensus       149 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-~~  227 (343)
T 3dbq_A          149 IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QI  227 (343)
T ss_dssp             CCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-HH
T ss_pred             eecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-HH
Confidence            9999998765432     24568999999999864           6789999999999999999999999976543 22


Q ss_pred             HHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       412 ~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .....+.........+..  .+..+.++|.+||..||.+|||+.++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 SKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHHHHHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhcCCcccCCccc--CCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            333344443333334432  34578899999999999999999999853

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=7.6e-43  Score=342.08  Aligned_cols=249  Identities=24%  Similarity=0.307  Sum_probs=196.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      ++|++.+.||+|+||.||+|.++ |..||||++.....  .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc--ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            57999999999999999999986 78999999975432  2233456889999999999999999999999888888888


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      |++. ++|.+++.....         ..+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||++
T Consensus        80 e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~  147 (288)
T 1ob3_A           80 EHLD-QDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLA  147 (288)
T ss_dssp             ECCS-EEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             EecC-CCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECccc
Confidence            8775 599998864321         2346778899999999999999999  999999999999999999999999999


Q ss_pred             eecCCC---ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC------
Q 039082          354 RFLSDG---EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK------  421 (472)
Q Consensus       354 ~~~~~~---~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~------  421 (472)
                      ......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+  .......+..  +.      
T Consensus       148 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~  225 (288)
T 1ob3_A          148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNW  225 (288)
T ss_dssp             HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHHCCCChhhc
Confidence            876532   233468999999999876 458999999999999999999999998765  3333333221  00      


Q ss_pred             --------CCCCCCC---------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 --------LRPALPE---------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 --------~~~~l~~---------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              +.+.++.         ....+..+.++|.+||..||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                    0000100         0234567889999999999999999999875

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.3e-42  Score=339.12  Aligned_cols=250  Identities=21%  Similarity=0.217  Sum_probs=197.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++.....  .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD--DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS--STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC--cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            57999999999999999999986  77899999976542  444556788999999999999999999999998888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++. ++|..++....         ...+...++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~e~~~-~~l~~~~~~~~---------~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~  147 (292)
T 3o0g_A           80 FEFCD-QDLKKYFDSCN---------GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EECCS-EEHHHHHHHTT---------TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCC-CCHHHHHHhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeccc
Confidence            87775 46666664322         12357889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC----
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP----  424 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~-~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~----  424 (472)
                      +......   .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .......+......+    
T Consensus       148 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~-~~~~~~~i~~~~~~~~~~~  226 (292)
T 3o0g_A          148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTT
T ss_pred             ceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC-HHHHHHHHHHHhCCCChhh
Confidence            9877533   23446899999999997765 89999999999999999998888644332 333333322110000    


Q ss_pred             --------------C------CCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 --------------A------LPE-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 --------------~------l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                    .      +.. .+.....+.++|.+||..||++|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                          0      000 0234567889999999999999999999875

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9e-43  Score=347.72  Aligned_cols=267  Identities=27%  Similarity=0.404  Sum_probs=213.4

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Cee--EEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLD--VAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~--vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      ++.++|++.+.||+|+||.||+|.++  +..  +|||.+...   ........+.+|+.+++.+ +||||+++++++.+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~   98 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY---ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   98 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc---cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC
Confidence            44578999999999999999999875  554  599988653   2334456688999999999 999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      +..++|++++.+++|.+++.........      .......++..++.++.||+.||+|||++|  |+||||||+|||++
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG  176 (327)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred             CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEc
Confidence            9999999999999999999754311000      011223467889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCC--CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 039082          341 DAKHVRIADFGHARFLSD--GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~--~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i  417 (472)
                      .++.+||+|||++.....  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.+  ...+...+
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--~~~~~~~~  254 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL  254 (327)
T ss_dssp             GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHG
T ss_pred             CCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--HHHHHHHh
Confidence            999999999999975432  2233446889999999998889999999999999999998 999998766  55566666


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ..+. +...+  ...+..+.++|.+||..||++||++.++++.|+.+..+.
T Consensus       255 ~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          255 PQGY-RLEKP--LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             GGTC-CCCCC--TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             hcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            5553 22222  334567889999999999999999999999999987654

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2e-43  Score=368.10  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=202.1

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .+.+..++|++.+.||+|+||.||+|.++  |..||||++.++.. ........+.+|+.+|+.++||||++++++|...
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHH-C-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhh-hhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            34566678999999999999999999986  77999999976432 1233445688999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      +..++|+|++.+++|..++....          ..+...+..++.||+.||+|||+ +|  |+||||||+||||+.++.+
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~  288 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER----------VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHI  288 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCE
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCE
Confidence            99999999999999999986432          23467889999999999999998 88  9999999999999999999


Q ss_pred             EEeecccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          346 RIADFGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       346 kL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      ||+|||+|+.....   ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+  ...+...+..+..
T Consensus       289 kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--~~~~~~~i~~~~~  366 (446)
T 4ejn_A          289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HEKLFELILMEEI  366 (446)
T ss_dssp             EECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC
T ss_pred             EEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--HHHHHHHHHhCCC
Confidence            99999999864322   234679999999999999999999999999999999999999997766  5556666655543


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      +  +|.  ..+..+.++|.+||..||.+||     +++++++
T Consensus       367 ~--~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 R--FPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             C--CCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             C--CCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            2  232  2446788999999999999999     9999875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.3e-43  Score=341.12  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|++.+.||+|+||.||+|.++  +..||||++..... ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEecccc-chhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence            4478999999999999999999987  56899999865322 11223466889999999999999999999999998899


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|++++.+++|.+++.....          .+...++.++.|++.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus        86 lv~e~~~~~~l~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Df  153 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSK----------FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADF  153 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSC
T ss_pred             EEEecCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEec
Confidence            99999999999999965332          346788999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          351 GHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       351 Gla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      |++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+.....  .++. 
T Consensus       154 g~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~--~~~~-  228 (279)
T 3fdn_A          154 GWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRVEF--TFPD-  228 (279)
T ss_dssp             CEESCC--------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCC--CCCT-
T ss_pred             cccccCCcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--HHHHHHHHHhCCC--CCCC-
Confidence            998765433 234568999999999999999999999999999999999999998766  4445555554432  2222 


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                       ..+..+.++|.+||..||++||+++++++.
T Consensus       229 -~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          229 -FVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             -TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             -cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             244678889999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.4e-43  Score=347.39  Aligned_cols=254  Identities=22%  Similarity=0.321  Sum_probs=187.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  |..||||+++...   .......+.+|+.+|+.++||||+++++++..++..++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS---EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCS---TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc---ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            468999999999999999999886  7889999997653   22233558899999999999999999999998888888


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++. ++|.+++......    ......++..+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus        81 v~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg  153 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVG----NTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFG  153 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSS----SCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCS
T ss_pred             EEEecC-CCHHHHHHhcccc----ccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCc
Confidence            888776 6999998643211    11123457888899999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CCC---
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GKL---  422 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~~---  422 (472)
                      ++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  .......+.+  +..   
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~  231 (317)
T 2pmi_A          154 LARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN--DEEQLKLIFDIMGTPNES  231 (317)
T ss_dssp             SCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCTT
T ss_pred             cceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCChh
Confidence            99887533   234468999999999976 468999999999999999999999998765  3333333321  100   


Q ss_pred             -----------CCCCCC--------------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 -----------RPALPE--------------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 -----------~~~l~~--------------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 .+.++.              ......++.++|.+||..||++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                       000000              0123467899999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.9e-43  Score=347.75  Aligned_cols=265  Identities=26%  Similarity=0.357  Sum_probs=215.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      +.+..++|++.+.||+|+||.||+|.+.       +..||||++...   ........+.+|+.+++.++||||++++++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  101 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV---CSEQDELDFLMEALIISKFNHQNIVRCIGV  101 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc---cchhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence            4577789999999999999999999842       557999998643   244556679999999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-  341 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-  341 (472)
                      +...+..++|++++.+++|.+++.......   ......++..++.++.|++.||.|||++|  |+||||||+|||++. 
T Consensus       102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~  176 (327)
T 2yfx_A          102 SLQSLPRFILMELMAGGDLKSFLRETRPRP---SQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCP  176 (327)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTSCCS---SSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCS
T ss_pred             EcCCCCcEEEEecCCCCcHHHHHHhhcccc---cccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecC
Confidence            999989999999999999999997644221   11223467889999999999999999999  999999999999984 


Q ss_pred             --CCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHH
Q 039082          342 --AKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKI  413 (472)
Q Consensus       342 --~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i  413 (472)
                        +..+||+|||++.......     ....|++.|+|||.+.+..++.++||||||+++|+|+| |..||....  ...+
T Consensus       177 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~  254 (327)
T 2yfx_A          177 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEV  254 (327)
T ss_dssp             STTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHH
T ss_pred             CCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHH
Confidence              4569999999997654322     23457889999999998899999999999999999998 999997765  5556


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ...+..+. ++..+  ...+..+.++|.+||..||.+||++.+|++.|+.+..+
T Consensus       255 ~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          255 LEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            66666654 22222  23456788999999999999999999999999987654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.2e-42  Score=340.22  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=200.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|.+.+.||+|+||.||+|.++  +..||+|++.....   ....+.+.+|+.+|+.++||||+++++++.+....++|
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   98 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS---QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV   98 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc---chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEE
Confidence            47899999999999999999986  77899999976532   23346688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL~D  349 (472)
                      +|++.+++|.+++......      ....+...++.++.|++.||+|||++|  |+||||||+|||+   +.++.+||+|
T Consensus        99 ~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~D  170 (285)
T 3is5_A           99 METCEGGELLERIVSAQAR------GKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIID  170 (285)
T ss_dssp             ECCCSCCBHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEeCCCCcHHHHHHhhhhc------ccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEe
Confidence            9999999999998643211      122457889999999999999999999  9999999999999   4568899999


Q ss_pred             cccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++......  .....||+.|+|||++. ..++.++||||||+++|+|++|..||.+.+  .......+..........
T Consensus       171 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--~~~~~~~~~~~~~~~~~~  247 (285)
T 3is5_A          171 FGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--LEEVQQKATYKEPNYAVE  247 (285)
T ss_dssp             CCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCC-
T ss_pred             eecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--HHHHHhhhccCCcccccc
Confidence            9999876543  23456899999999986 568999999999999999999999998766  444444444433221111


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ....+..+.++|.+||..||++|||+.++++
T Consensus       248 -~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          248 -CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             1334567889999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.4e-43  Score=339.13  Aligned_cols=246  Identities=20%  Similarity=0.275  Sum_probs=206.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||+|.+.....    ...+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV----EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV   84 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc----chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence            46899999999999999999987  55899999876432    2345688999999999999999999999999889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL~D  349 (472)
                      ++++.+++|.+++.....          .+...++.++.|++.||+|||++|  ++||||||+|||+   +.++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~~~~~----------~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~D  152 (277)
T 3f3z_A           85 MELCTGGELFERVVHKRV----------FRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLID  152 (277)
T ss_dssp             EECCCSCBHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EeccCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEe
Confidence            999999999999864321          357889999999999999999999  9999999999999   7889999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....||+.|+|||.+.+. ++.++||||||+++|+|++|..||...+  .......+..+....+..
T Consensus       153 fg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~  229 (277)
T 3f3z_A          153 FGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT--DSEVMLKIREGTFTFPEK  229 (277)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCHH
T ss_pred             cccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCch
Confidence            99998776433  345689999999998755 8999999999999999999999997765  556666666664322111


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+..+.++|.+||..||++||++.++++
T Consensus       230 ~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11245678899999999999999999999885

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-43  Score=359.12  Aligned_cols=264  Identities=19%  Similarity=0.191  Sum_probs=202.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChH-------HHHHHHHHHHHHHhcCCCcee
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNEN-------AVTFFAQEVDTLSRQRHRFVL  257 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~-------~~~~f~~E~~il~~l~HpnIv  257 (472)
                      +..++|++.+.||+|+||.||+|.++       +..||||++.........+       ....+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            44678999999999999999999885       3679999986542100000       012244566677778899999


Q ss_pred             EEEEEEEcC----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCC
Q 039082          258 QLMGACLEP----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLK  333 (472)
Q Consensus       258 ~l~g~~~~~----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLk  333 (472)
                      ++++++...    ...++|++++ |++|.+++.....         ..++..++.++.||+.||+|||+++  |+|||||
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlk  179 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAK---------RFSRKTVLQLSLRILDILEYIHEHE--YVHGDIK  179 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCC
Confidence            999998875    3367777887 9999999965321         2457889999999999999999999  9999999


Q ss_pred             CCcEEEc--CCCcEEEeecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCC
Q 039082          334 PSNIFLD--DAKHVRIADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNH  401 (472)
Q Consensus       334 p~NILl~--~~~~vkL~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~  401 (472)
                      |+||||+  .++.+||+|||+++.+....          ....||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus       180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~  259 (364)
T 3op5_A          180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL  259 (364)
T ss_dssp             GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999  88999999999998765321          23348999999999999999999999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCC-------CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          402 PYIEKDYKPAKIAMEVGEGKLRPALPE-------EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       402 Pf~~~~~~~~~i~~~i~~~~~~~~l~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ||.+...............  +..++.       ....+.++.+++..||..+|++||++.+|++.|+++..+..
T Consensus       260 Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          260 PWEDNLKDPKYVRDSKIRY--RENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             TTGGGTTCHHHHHHHHHHH--HHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             CccccccCHHHHHHHHHHh--hhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            9986443332221111100  000000       02235678899999999999999999999999999887653

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.6e-43  Score=340.60  Aligned_cols=262  Identities=28%  Similarity=0.478  Sum_probs=206.8

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC---Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR---GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~---g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ...+..++|++.+.||+|+||.||+|.+.   +.  .||||+++.... ......+.+.+|+.+++.++||||+++++++
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (291)
T 1u46_A           12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVV   90 (291)
T ss_dssp             CEECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCcc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            34567789999999999999999999863   22  599999876533 2345667899999999999999999999998


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .... .++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  ++||||||+|||++.++
T Consensus        91 ~~~~-~~~v~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~  158 (291)
T 1u46_A           91 LTPP-MKMVTELAPLGSLLDRLRKHQG---------HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRD  158 (291)
T ss_dssp             CSSS-CEEEEECCTTCBHHHHHHHHGG---------GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETT
T ss_pred             ccCC-ceeeEecccCCCHHHHHHhccC---------CcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCC
Confidence            7754 7889999999999999965321         1346788999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      .+||+|||++........      ...+++.|+|||++.+..++.++||||||+++|+|++ |..||...+  ...+...
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--~~~~~~~  236 (291)
T 1u46_A          159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHK  236 (291)
T ss_dssp             EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHH
T ss_pred             CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--HHHHHHH
Confidence            999999999988754322      2346788999999998889999999999999999999 999997766  5556666


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      +.....+...+  ...+..+.++|.+||..||++||++.++++.|+++...
T Consensus       237 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          237 IDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             HHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             HHccCCCCCCC--cCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            65554333322  34567889999999999999999999999999887543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.5e-42  Score=353.90  Aligned_cols=252  Identities=19%  Similarity=0.303  Sum_probs=203.2

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC--CCceeEEEEEEEcC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR--HRFVLQLMGACLEP  266 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~--HpnIv~l~g~~~~~  266 (472)
                      ..+...+|++.+.||+|+||.||+|.+. +..||||++....  ........|.+|+.+|+.++  |||||++++++...
T Consensus        51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEeccc--ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            4455667999999999999999999886 7789999997653  24566778999999999996  59999999999988


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++|+| +.+++|.+++....          ..++..++.++.||+.||+|||+++  |+||||||+||||+ ++.+|
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~k  194 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLK  194 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEE
T ss_pred             CEEEEEEe-cCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEE
Confidence            88777777 78999999996533          1246778899999999999999999  99999999999996 58999


Q ss_pred             EeecccceecCCCc-----cccccCCcccccccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH
Q 039082          347 IADFGHARFLSDGE-----MALTGTFVYMAPEVIQC-----------EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP  410 (472)
Q Consensus       347 L~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~-----------~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~  410 (472)
                      |+|||+++.+....     ...+||+.|+|||++.+           ..++.++|||||||++|+|++|..||..... .
T Consensus       195 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~  273 (390)
T 2zmd_A          195 LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-Q  273 (390)
T ss_dssp             ECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-H
T ss_pred             EEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-H
Confidence            99999998765332     24569999999999865           4689999999999999999999999976542 3


Q ss_pred             HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       411 ~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ......+..+......+..  .+..+.++|.+||..||++||++.++++.
T Consensus       274 ~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          274 ISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHhCccccCCCCcc--chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            3344445554444444433  24578899999999999999999999853

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.8e-43  Score=347.50  Aligned_cols=263  Identities=24%  Similarity=0.280  Sum_probs=207.9

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..+.++.++|++.+.||+|+||.||+|.+.  |..||||++...    .......+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   97 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDREEAQREADMHRLFNHPNILRLVAYCLR   97 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES----SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC----CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence            447788899999999999999999999974  789999998653    44566779999999999999999999999873


Q ss_pred             ----CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          266 ----PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       266 ----~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                          ....++|++++.+++|.+++......      ....++..++.++.|++.||+|||+++  |+||||||+|||++.
T Consensus        98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~  169 (317)
T 2buj_A           98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDK------GNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGD  169 (317)
T ss_dssp             EETTEEEEEEEEECCTTCBHHHHHHHHHTT------TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT
T ss_pred             ccCCCceeEEEEEeCCCCcHHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcC
Confidence                34567889999999999999653211      123457889999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc------------cccccCCcccccccccCCC---CCchHHHHHHHHHHHHHHcCCCCCCCC
Q 039082          342 AKHVRIADFGHARFLSDGE------------MALTGTFVYMAPEVIQCEP---YSEKSDVYSFGIILNEIITGNHPYIEK  406 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~------------~~~~gt~~y~APE~~~~~~---~s~~sDvwSlGvll~elltG~~Pf~~~  406 (472)
                      ++.+||+|||++.......            ....||+.|+|||.+.+..   ++.++||||||+++|+|++|..||...
T Consensus       170 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  249 (317)
T 2buj_A          170 EGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMV  249 (317)
T ss_dssp             TSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHH
T ss_pred             CCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhh
Confidence            9999999999988654211            1234799999999987554   689999999999999999999999532


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      ..........+....   ..+.....+..+.++|.+||..||.+||++.++++.|+.+.
T Consensus       250 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          250 FQKGDSVALAVQNQL---SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HHTTSCHHHHHHCC-----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hcccchhhHHhhccC---CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            111111222222221   22333445667899999999999999999999999998764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-42  Score=338.20  Aligned_cols=251  Identities=21%  Similarity=0.299  Sum_probs=206.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC--hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN--ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||+++.......  ....+.|.+|+.+++.++||||+++++++......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            46899999999999999999996  78999999976543221  123567899999999999999999999999998899


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC----cEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVR  346 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~----~vk  346 (472)
                      +|++++.+++|.+++....          ..+...++.++.|++.||+|||++|  ++||||||+|||++.++    .+|
T Consensus        85 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE----------SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEE
T ss_pred             EEEeecCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceE
Confidence            9999999999999996422          2357889999999999999999999  99999999999998877    899


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||++.......  ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+.......
T Consensus       153 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~  230 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET--KQETLTNISAVNYDF  230 (283)
T ss_dssp             ECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCCCC
T ss_pred             EEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc--hHHHHHHhHhcccCC
Confidence            99999998775432  33458999999999999999999999999999999999999997765  444555555443221


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ........+..+.+++.+||..||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          231 DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            11111334567889999999999999999999987

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.1e-42  Score=341.30  Aligned_cols=247  Identities=24%  Similarity=0.384  Sum_probs=207.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++....    ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP----AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC----------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc----ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence            47899999999999999999986  7899999997542    22334588999999999999999999999999889999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL~D  349 (472)
                      ++++.+++|.+++...+          ..+...++.++.|++.||+|||++|  ++||||||+|||+   +.++.+||+|
T Consensus        85 ~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~D  152 (304)
T 2jam_A           85 MQLVSGGELFDRILERG----------VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITD  152 (304)
T ss_dssp             ECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCS
T ss_pred             EEcCCCccHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEcc
Confidence            99999999999986432          1346788999999999999999999  9999999999999   7889999999


Q ss_pred             cccceecCCCc-cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          350 FGHARFLSDGE-MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       350 FGla~~~~~~~-~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ||++....... ....|++.|+|||++.+..++.++||||||+++|+|++|..||...+  .......+..+......+.
T Consensus       153 fg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~  230 (304)
T 2jam_A          153 FGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGYYEFESPF  230 (304)
T ss_dssp             CSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHCCCCCCTTT
T ss_pred             CCcceecCCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCccc
Confidence            99998655432 23458999999999999999999999999999999999999997765  5556666666654433332


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+..+.++|.+||..||++||++.++++
T Consensus       231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          231 WDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            3455678999999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=2.4e-42  Score=348.81  Aligned_cols=247  Identities=23%  Similarity=0.263  Sum_probs=203.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.|++.+.||+|+||.||+|.+.  |..||||++..... ........|.+|+.+|+.++||||+++++++...+..++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            45899999999999999999974  78999999976432 2344557799999999999999999999999998888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++. |+|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus       133 ~e~~~-g~l~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~  200 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGS  200 (348)
T ss_dssp             EECCS-EEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTT
T ss_pred             EecCC-CCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccC
Confidence            88875 688888753221         2357888999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDGEMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +..... .....||+.|+|||++.   ...++.++|||||||++|||++|..||.+.+  .......+..+.... +. .
T Consensus       201 a~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~-~~-~  275 (348)
T 1u5q_A          201 ASIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPA-LQ-S  275 (348)
T ss_dssp             CBSSSS-BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCC-CC-C
T ss_pred             ceecCC-CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHHhcCCCC-CC-C
Confidence            987653 33457999999999984   5678999999999999999999999997765  444444555544222 21 1


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..||++|||++++++
T Consensus       276 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          276 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            334567889999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.3e-43  Score=370.00  Aligned_cols=249  Identities=24%  Similarity=0.324  Sum_probs=214.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++.+.... .......+.+|+.+|+.++|||||++++++.+....++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK-QKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-BSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcc-cchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            57999999999999999999986  789999999765432 233456789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL~D  349 (472)
                      ++++.+++|.+++....          ..+...++.++.||+.||+|||++|  |+||||||+|||+   +.++.+||+|
T Consensus       105 ~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D  172 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK----------RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIID  172 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS----------CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEe
Confidence            99999999999986432          2357889999999999999999999  9999999999999   5678999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+  ...+...+..+......+
T Consensus       173 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~  249 (484)
T 3nyv_A          173 FGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--EYDILKKVEKGKYTFELP  249 (484)
T ss_dssp             TTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCSG
T ss_pred             eeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--HHHHHHHHHcCCCCCCCc
Confidence            99998776443  34568999999999876 69999999999999999999999998766  667777888877665555


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+..+.++|.+||..||.+|||+.++++
T Consensus       250 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          250 QWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            54556778999999999999999999999885

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.7e-43  Score=366.44  Aligned_cols=248  Identities=26%  Similarity=0.374  Sum_probs=209.9

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|.+.+.||+|+||.||+|.++  |..||||++.+.... .......+.+|+.+|+.++||||+++++++...+..+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~   92 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIR-SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF   92 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHH-HTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhcc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3468999999999999999999986  789999999654221 1233467889999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|+|++.|++|.+++...+          ..+...++.++.||+.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus        93 lv~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DF  160 (476)
T 2y94_A           93 MVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADF  160 (476)
T ss_dssp             EEEECCSSEEHHHHTTSSS----------SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEeCCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEec
Confidence            9999999999999996432          2357889999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      |++.......  ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+  ...+...+..+...  .|
T Consensus       161 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~--~~~~~~~i~~~~~~--~p  236 (476)
T 2y94_A          161 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH--VPTLFKKICDGIFY--TP  236 (476)
T ss_dssp             SSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS--SHHHHHHHHTTCCC--CC
T ss_pred             cchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC--HHHHHHHHhcCCcC--CC
Confidence            9999876543  34579999999999988766 689999999999999999999998765  44566666666432  22


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .  .....+.++|.+||..||++|||+.++++
T Consensus       237 ~--~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          237 Q--YLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             T--TCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             c--cCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            2  23457889999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1e-42  Score=340.96  Aligned_cols=257  Identities=21%  Similarity=0.277  Sum_probs=199.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-CceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-YRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.+.  +..||||++......      ..+.+|+.+++.++|++++..++.+.... ..++
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~------~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C------CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc------hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            68999999999999999999974  789999987654321      23788999999999888887777765544 4455


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEEe
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIA  348 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL~  348 (472)
                      +++++ +++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||+   +.++.+||+
T Consensus        83 v~e~~-~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~  150 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSR---------KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYII  150 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTS---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEEC
T ss_pred             EEEcc-CCCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEe
Confidence            66666 9999999964321         2457889999999999999999999  9999999999999   788999999


Q ss_pred             ecccceecCCCcc----------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-HHHHHHH
Q 039082          349 DFGHARFLSDGEM----------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-AKIAMEV  417 (472)
Q Consensus       349 DFGla~~~~~~~~----------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-~~i~~~i  417 (472)
                      |||++........          ...||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+..... ......+
T Consensus       151 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  230 (296)
T 4hgt_A          151 DFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI  230 (296)
T ss_dssp             CCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred             cCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence            9999987764322          3468999999999999999999999999999999999999997644211 1111121


Q ss_pred             hcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          418 GEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       418 ~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      .........+.. ...+..+.++|..||+.||++||++.+|++.|+++..+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            111111111100 2234678999999999999999999999999999987653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.6e-43  Score=367.25  Aligned_cols=248  Identities=23%  Similarity=0.331  Sum_probs=211.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.+...  .......+.+|+.+|+.++|||||++++++.+....++|
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH--BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            57999999999999999999986  78999999865432  122346688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc---CCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~---~~~~vkL~D  349 (472)
                      ++++.+++|.+++...+.          .+...++.++.||+.||.|||++|  |+||||||+|||++   .++.+||+|
T Consensus       100 ~e~~~~~~L~~~~~~~~~----------~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D  167 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKR----------FSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID  167 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECS
T ss_pred             EEcCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEE
Confidence            999999999998864321          356889999999999999999999  99999999999995   456899999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+  ...+...+..+......+
T Consensus       168 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~  244 (486)
T 3mwu_A          168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLP  244 (486)
T ss_dssp             CSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSCSG
T ss_pred             CCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCCc
Confidence            99998765432  34568999999999976 59999999999999999999999998766  666777777777655555


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+..+.++|.+||..||.+|||+.++++
T Consensus       245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            54556778999999999999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.2e-43  Score=348.40  Aligned_cols=261  Identities=24%  Similarity=0.376  Sum_probs=210.1

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEE------CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~------~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      -.++.++|++.+.||+|+||.||+|.+      .+..||||++...    .....+.+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   93 (327)
T 3lxl_A           18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS----GPDQQRDFQREIQILKALHSDFIVKYRGVS   93 (327)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC----CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC----CHHHHHHHHHHHHHHHhcCCCceeEEEEEE
Confidence            346778999999999999999999985      3678999999753    445667799999999999999999999998


Q ss_pred             Ec--CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          264 LE--PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       264 ~~--~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ..  ....++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.
T Consensus        94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~  162 (327)
T 3lxl_A           94 YGPGRQSLRLVMEYLPSGCLRDFLQRHRA---------RLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVES  162 (327)
T ss_dssp             ECSSSCEEEEEEECCTTCBHHHHHHHHGG---------GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEE
T ss_pred             ecCCCceEEEEEeecCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECC
Confidence            74  3446788888889999999965332         1357889999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-------
Q 039082          342 AKHVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-------  408 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-------  408 (472)
                      ++.+||+|||++.......      ....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       
T Consensus       163 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~  242 (327)
T 3lxl_A          163 EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG  242 (327)
T ss_dssp             TTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC
T ss_pred             CCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc
Confidence            9999999999998775432      223468889999999988899999999999999999999999854321       


Q ss_pred             -----C-HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          409 -----K-PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       409 -----~-~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                           . ...+...+..+. +...+  ...+..+.++|.+||..||++|||+.+|++.|+.++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          243 CERDVPALSRLLELLEEGQ-RLPAP--PACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             ----CCHHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             cccccccHHHHHHHhhccc-CCCCC--CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence                 0 112222233332 22222  345677899999999999999999999999999887654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-43  Score=361.64  Aligned_cols=261  Identities=15%  Similarity=0.112  Sum_probs=197.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHH---HHHhcCCCceeEEE----
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD---TLSRQRHRFVLQLM----  260 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~---il~~l~HpnIv~l~----  260 (472)
                      |....++|++.+.||+|+||.||+|.++  |..||||++..... ......+.|.+|+.   +|+.++|||||+++    
T Consensus        68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~  146 (377)
T 3byv_A           68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  146 (377)
T ss_dssp             SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC--CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred             cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccc-cchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence            3444678999999999999999999975  78999999976433 23345677999994   55556899999998    


Q ss_pred             ---EEEEcCCC-----------------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHH
Q 039082          261 ---GACLEPPY-----------------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYL  320 (472)
Q Consensus       261 ---g~~~~~~~-----------------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yL  320 (472)
                         +++...+.                 .++++|++ +|+|.+++...+.....   ....++..++.++.||+.||+||
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~L  222 (377)
T 3byv_A          147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSST---HKSLVHHARLQLTLQVIRLLASL  222 (377)
T ss_dssp             CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTT---THHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccc---cccccHHHHHHHHHHHHHHHHHH
Confidence               66655432                 55666666 88999999754321100   00112466778999999999999


Q ss_pred             HhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccCC-----------CCCchHHHHHH
Q 039082          321 HEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCE-----------PYSEKSDVYSF  389 (472)
Q Consensus       321 H~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~-----------~~s~~sDvwSl  389 (472)
                      |++|  |+||||||+||||+.++.+||+|||+++..........| +.|+|||++.+.           .++.++|||||
T Consensus       223 H~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSl  299 (377)
T 3byv_A          223 HHYG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWAL  299 (377)
T ss_dssp             HHTT--EECSCCCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHH
T ss_pred             HhCC--eecCCCCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHH
Confidence            9999  999999999999999999999999999987665566678 999999999887           89999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH--HHHHHHHH
Q 039082          390 GIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC--SLKNIQMK  467 (472)
Q Consensus       390 Gvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~--~L~~i~~~  467 (472)
                      ||++|||++|+.||.+.+..  .....+..        .....+..+.++|.+||..||++||++.++++  .|..+...
T Consensus       300 G~il~elltg~~Pf~~~~~~--~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  369 (377)
T 3byv_A          300 GLVIYWIWCADLPITKDAAL--GGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  369 (377)
T ss_dssp             HHHHHHHHHSSCCC--------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCcccccc--cchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHHHH
Confidence            99999999999999665411  11111111        11234567889999999999999999999986  45555444


Q ss_pred             H
Q 039082          468 V  468 (472)
Q Consensus       468 ~  468 (472)
                      +
T Consensus       370 ~  370 (377)
T 3byv_A          370 L  370 (377)
T ss_dssp             H
T ss_pred             H
Confidence            3

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.7e-43  Score=345.13  Aligned_cols=259  Identities=20%  Similarity=0.227  Sum_probs=202.9

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||++..... ......+.+.+|+.+++.++||||+++++++...+..++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLS-SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGG-GSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccc-cCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            368999999999999999999985  78899999876432 234556779999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      +++++.+++|.+++...+          ..+...++.++.|++.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus       112 v~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg  179 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQG----------PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFG  179 (309)
T ss_dssp             EEECCCCEEHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCC
T ss_pred             EEEecCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCc
Confidence            999999999999996532          1357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          352 HARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       352 la~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ++.......    ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  ...+...+.... .....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~-~~~~~  256 (309)
T 2h34_A          180 IASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ--LSVMGAHINQAI-PRPST  256 (309)
T ss_dssp             C----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH--HHHHHHHHHSCC-CCGGG
T ss_pred             cCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch--HHHHHHHhccCC-CCccc
Confidence            998765432    23458999999999999999999999999999999999999997765  333333333322 11111


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRP-SFSSITCSLKNIQMKV  468 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RP-s~~~ll~~L~~i~~~~  468 (472)
                      .....+..+.++|.+||..||++|| +++++++.|+.+....
T Consensus       257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            1133456788899999999999999 9999999998765543

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-42  Score=366.39  Aligned_cols=248  Identities=23%  Similarity=0.303  Sum_probs=205.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.+....  ......+.+|+.+|+.++|||||+++++|.+....++|
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS--TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC--chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36999999999999999999996  678999999765432  22245688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~~vkL~D  349 (472)
                      ++++.+|+|.+++.....          .+...++.++.||+.||+|||++|  |+||||||+|||++.   ++.+||+|
T Consensus       115 ~e~~~~g~L~~~~~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~D  182 (494)
T 3lij_A          115 MECYKGGELFDEIIHRMK----------FNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVD  182 (494)
T ss_dssp             EECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EecCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEE
Confidence            999999999998864322          346788999999999999999999  999999999999976   45699999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+  ...+...+..+......+
T Consensus       183 fG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~~~  259 (494)
T 3lij_A          183 FGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQEILRKVEKGKYTFDSP  259 (494)
T ss_dssp             CTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCCSG
T ss_pred             CCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCch
Confidence            99998876443  3456899999999986 569999999999999999999999998766  666777777776544433


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+..+.++|.+||..||.+|||+.++++
T Consensus       260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            33455678899999999999999999999885

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2e-42  Score=355.93  Aligned_cols=247  Identities=20%  Similarity=0.279  Sum_probs=194.6

Q ss_pred             CCeeEe-ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHh-cCCCceeEEEEEEEc----C
Q 039082          195 KEIDLQ-EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHRFVLQLMGACLE----P  266 (472)
Q Consensus       195 ~~~~l~-~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~-l~HpnIv~l~g~~~~----~  266 (472)
                      ++|.+. +.||+|+||.||+|.++  |..||||++...         ..+.+|+.++.+ .+||||+++++++..    .
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~---------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~  131 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR  131 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc---------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence            467776 78999999999999986  778999998532         236688888754 589999999998875    4


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CC
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AK  343 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~  343 (472)
                      ...++|+|++.||+|.+++...+.        ...++..++.++.||+.||+|||++|  |+||||||+||||+.   ++
T Consensus       132 ~~~~lv~E~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~  201 (400)
T 1nxk_A          132 KCLLIVMECLDGGELFSRIQDRGD--------QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA  201 (400)
T ss_dssp             EEEEEEEECCCSEEHHHHHHCC-----------CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTC
T ss_pred             cEEEEEEEeCCCCcHHHHHHHhCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCc
Confidence            557788999999999999965332        12357889999999999999999999  999999999999997   78


Q ss_pred             cEEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHhc
Q 039082          344 HVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGE  419 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--~~i~~~i~~  419 (472)
                      .+||+|||+++.....  ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....  ......+..
T Consensus       202 ~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~  281 (400)
T 1nxk_A          202 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  281 (400)
T ss_dssp             CEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH
T ss_pred             cEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc
Confidence            9999999999876543  235678999999999999999999999999999999999999997654211  113344445


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      +.+....+.....+.++.++|.+||..||++|||+.++++.
T Consensus       282 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          282 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            54443333334566788999999999999999999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.1e-42  Score=350.60  Aligned_cols=245  Identities=27%  Similarity=0.377  Sum_probs=205.1

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++.+....        +.+|+++|.++ +||||+++++++.+.+..++
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~--------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l   93 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD--------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV   93 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC--------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC--------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence            57999999999999999999986  788999999765321        34688888888 79999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC----CcEEE
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA----KHVRI  347 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~----~~vkL  347 (472)
                      |+|++.||+|.+++...+          ..+...+..++.||+.||+|||++|  |+||||||+|||+.++    +.+||
T Consensus        94 v~E~~~gg~L~~~i~~~~----------~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl  161 (342)
T 2qr7_A           94 VTELMKGGELLDKILRQK----------FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRI  161 (342)
T ss_dssp             EECCCCSCBHHHHHHTCT----------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEE
T ss_pred             EEeCCCCCcHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEE
Confidence            999999999999986432          2357889999999999999999999  9999999999998533    35999


Q ss_pred             eecccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC-CCHHHHHHHHhcCCCC
Q 039082          348 ADFGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD-YKPAKIAMEVGEGKLR  423 (472)
Q Consensus       348 ~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~-~~~~~i~~~i~~~~~~  423 (472)
                      +|||++......   ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.. .....+...+..+...
T Consensus       162 ~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  241 (342)
T 2qr7_A          162 CDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS  241 (342)
T ss_dssp             CCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCC
T ss_pred             EECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcc
Confidence            999999876543   234578999999999988889999999999999999999999997643 3456677777777654


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+.....+..+.++|.+||..||++||++.++++
T Consensus       242 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            332222445678899999999999999999999875

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=345.95  Aligned_cols=262  Identities=23%  Similarity=0.395  Sum_probs=211.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEE------CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIW------RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~------~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ..+..++|++.+.||+|+||.||+|.+      .|..||||++...    .....+.|.+|+.+++.++||||+++++++
T Consensus        36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  111 (326)
T 2w1i_A           36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS----TEEHLRDFEREIEILKSLQHDNIVKYKGVC  111 (326)
T ss_dssp             -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC----CSHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC----CHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence            445667899999999999999999985      3778999999753    345667799999999999999999999998


Q ss_pred             EcCC--CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          264 LEPP--YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       264 ~~~~--~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                      ...+  ..++|++++.+++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||++.
T Consensus       112 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~  180 (326)
T 2w1i_A          112 YSAGRRNLKLIMEYLPYGSLRDYLQKHKE---------RIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVEN  180 (326)
T ss_dssp             CC----CCEEEECCCTTCBHHHHHHHSTT---------SSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEE
T ss_pred             EecCCCceEEEEECCCCCCHHHHHHhccc---------CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcC
Confidence            7654  67788899989999999965321         1356788999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC--------
Q 039082          342 AKHVRIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD--------  407 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~--------  407 (472)
                      ++.+||+|||++........      ...++..|+|||.+.+..++.++||||||+++|+|+||..||....        
T Consensus       181 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~  260 (326)
T 2w1i_A          181 ENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG  260 (326)
T ss_dssp             TTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHC
T ss_pred             CCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhc
Confidence            99999999999988764321      2346778999999998889999999999999999999999985321        


Q ss_pred             --CC-H---HHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          408 --YK-P---AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       408 --~~-~---~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                        .. .   ..+...+..+. +...+  ...+..+.++|.+||..||++||++.+|++.|+.+..++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~  325 (326)
T 2w1i_A          261 NDKQGQMIVFHLIELLKNNG-RLPRP--DGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA  325 (326)
T ss_dssp             TTCCTHHHHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             cccchhhhHHHHHHHhhcCC-CCCCC--CcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence              00 0   01122222222 22222  3456788999999999999999999999999999998763

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.8e-42  Score=336.22  Aligned_cols=253  Identities=25%  Similarity=0.352  Sum_probs=205.5

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC--
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP--  266 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~--  266 (472)
                      ..+...|++.+.||+|+||.||+|.+.  +..||+|++.....  .......+.+|+.+|+.++||||+++++++...  
T Consensus        22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh--CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            344556899999999999999999986  56899999876433  455677899999999999999999999988752  


Q ss_pred             --CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc-CCC
Q 039082          267 --PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAK  343 (472)
Q Consensus       267 --~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~-~~~  343 (472)
                        ...++|++++.+++|.+++....          ..++..++.++.+++.||+|||+++++++||||||+|||++ .++
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~  169 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFK----------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS
T ss_pred             CCceEEEEEEecCCCCHHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC
Confidence              34678888888999999996432          13467889999999999999999877799999999999997 789


Q ss_pred             cEEEeecccceecCCCc-cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          344 HVRIADFGHARFLSDGE-MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~-~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      .+||+|||++....... ....|++.|+|||++.+ .++.++||||||+++|+|++|..||..... .......+..+..
T Consensus       170 ~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-~~~~~~~~~~~~~  247 (290)
T 1t4h_A          170 SVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-AAQIYRRVTSGVK  247 (290)
T ss_dssp             CEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-HHHHHHHHTTTCC
T ss_pred             CEEEeeCCCcccccccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-HHHHHHHHhccCC
Confidence            99999999997655432 34568999999998874 589999999999999999999999977542 3444455555432


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...++  ...+..+.++|.+||..||++|||+.++++
T Consensus       248 ~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 PASFD--KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CGGGG--GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccC--CCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            22111  233467899999999999999999999985

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.8e-42  Score=339.42  Aligned_cols=257  Identities=21%  Similarity=0.269  Sum_probs=201.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-CCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-PYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-~~~~  270 (472)
                      .++|++.+.||+|+||.||+|.+.  |..||||++.....  .    ..+.+|+.+++.++|++++..++.+... +..+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--H----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--C----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--h----hHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            368999999999999999999974  88999999865432  1    2378999999999998877777766554 4455


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRI  347 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL  347 (472)
                      +|++++ +++|.+++.....         ..++..++.++.|++.||+|||++|  |+||||||+|||+   +.++.+||
T Consensus        82 lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl  149 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSR---------KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYI  149 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEEec-CCCHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEE
Confidence            666666 9999999964321         2457889999999999999999999  9999999999999   48899999


Q ss_pred             eecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHHHHH
Q 039082          348 ADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIAME  416 (472)
Q Consensus       348 ~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i~~~  416 (472)
                      +|||++.......          ....||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.... .......
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  229 (296)
T 3uzp_A          150 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER  229 (296)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHH
T ss_pred             eeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhh
Confidence            9999998776432          2446899999999999999999999999999999999999999764321 1111222


Q ss_pred             HhcCCCCCCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPE-EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       417 i~~~~~~~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +..+......+. ....+..+.+++.+||+.||++||++.+|++.|+++..+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          230 ISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            222111111100 0224467899999999999999999999999999988764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2e-42  Score=338.13  Aligned_cols=256  Identities=23%  Similarity=0.334  Sum_probs=193.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |.+..++|++.+.||+|+||.||+|.+.  |..||||+++...  ........+.++...++.++||||+++++++.+.+
T Consensus         2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A            2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            5677889999999999999999999984  7899999997642  23334455556666688889999999999999888


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCCCcEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ..++|++++. ++|.+++......      ....++..++.++.|++.||+|||++ |  ++||||||+|||++.++.+|
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~------~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~k  150 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDK------GQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVK  150 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEE
T ss_pred             CEEEEEehhc-cchHHHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEE
Confidence            8888888775 6888887542211      12345788999999999999999998 9  99999999999999999999


Q ss_pred             EeecccceecCCCc--cccccCCcccccccc----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVI----QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~----~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      |+|||++.......  ....||+.|+|||.+    ....++.++||||||+++|+|++|..||.........+...+...
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  230 (290)
T 3fme_A          151 MCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP  230 (290)
T ss_dssp             BCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC
T ss_pred             EeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC
Confidence            99999998765433  234689999999996    566789999999999999999999999976543333333333333


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .  +..+. ...+..+.++|.+||..||++|||+.++++
T Consensus       231 ~--~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 S--PQLPA-DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             C--CCCCT-TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C--CCccc-ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            2  22221 335567899999999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=342.85  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=193.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.++||+|+||.||+|.++  |..||||++.....  .......+..|+..+..+ +||||++++++|.+.+..++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR--GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC--SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc--ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            57999999999999999999996  78999999865432  334444556666666555 99999999999998888877


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++ +++|.+++...+.         ..++..++.++.||+.||+|||+++  |+||||||+||||+.++.+||+|||
T Consensus       135 v~e~~-~~~L~~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG  202 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGA---------SLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFG  202 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCT
T ss_pred             EEecc-CCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccce
Confidence            77776 8899998865321         2457889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          352 HARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       352 la~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      ++.......  ....||+.|+|||++.+ .++.++|||||||++|||++|..||.+..     ....+..+...+.++  
T Consensus       203 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~~~~~~~~~~~~--  274 (311)
T 3p1a_A          203 LLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQLRQGYLPPEFT--  274 (311)
T ss_dssp             TCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHHHTTTCCCHHHH--
T ss_pred             eeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHhccCCCcccc--
Confidence            998776432  34458999999999876 79999999999999999999976664322     233444443222111  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..||++|||++++++
T Consensus       275 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            234567899999999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-42  Score=349.42  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=198.6

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.+ .++|++.+.||+|+||.||+|.++  |..||||++....  ......+.+.+|+.+|+.++||||+++++++..
T Consensus        19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~   95 (367)
T 1cm8_A           19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFTP   95 (367)
T ss_dssp             SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred             ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence            34555 478999999999999999999985  7899999986542  244556778999999999999999999999987


Q ss_pred             CCC------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          266 PPY------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       266 ~~~------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      ...      .++|++++ +++|.+++...           ..+...+..++.||+.||+|||++|  |+||||||+||||
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----------~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll  161 (367)
T 1cm8_A           96 DETLDDFTDFYLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAV  161 (367)
T ss_dssp             CSSTTTCCCCEEEEECC-SEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEE
T ss_pred             CCccccCceEEEEEecC-CCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEE
Confidence            643      36666666 99999998642           1246778899999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          340 DDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +.++.+||+|||+++..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  .......+.
T Consensus       162 ~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~  239 (367)
T 1cm8_A          162 NEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEIM  239 (367)
T ss_dssp             CTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH
T ss_pred             cCCCCEEEEeeecccccccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence            99999999999999988766666788999999999877 679999999999999999999999998765  222222221


Q ss_pred             c--CCC------------------------CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 E--GKL------------------------RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ~--~~~------------------------~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .  |..                        ...+... +.....+.++|.+||..||++|||++++++
T Consensus       240 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            1  100                        0001111 234567889999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-42  Score=361.07  Aligned_cols=256  Identities=21%  Similarity=0.295  Sum_probs=184.8

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.+ .++|++.+.||+|+||.||+|.++  |..||||++....  ......+.+.+|+.+|+.++|||||++++++..
T Consensus        47 ~~~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  123 (458)
T 3rp9_A           47 SDWQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF--EDLIDCKRILREIAILNRLNHDHVVKVLDIVIP  123 (458)
T ss_dssp             SSCCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred             CcCcc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh--cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence            44555 378999999999999999999886  7789999996542  345566779999999999999999999999864


Q ss_pred             C-----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          266 P-----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       266 ~-----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      .     ...|+|++ +++++|..++....          ..+...+..++.||+.||+|||++|  ||||||||+||||+
T Consensus       124 ~~~~~~~~~~lv~e-~~~~~L~~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~  190 (458)
T 3rp9_A          124 KDVEKFDELYVVLE-IADSDFKKLFRTPV----------YLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVN  190 (458)
T ss_dssp             SCTTTCCCEEEEEC-CCSEEHHHHHHSSC----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEEC
T ss_pred             CCcccCceEEEEEe-ccccchhhhcccCC----------CCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEEC
Confidence            4     23445555 66899999986432          2357889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCC------------------------------ccccccCCcccccccc-cCCCCCchHHHHHH
Q 039082          341 DAKHVRIADFGHARFLSDG------------------------------EMALTGTFVYMAPEVI-QCEPYSEKSDVYSF  389 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~------------------------------~~~~~gt~~y~APE~~-~~~~~s~~sDvwSl  389 (472)
                      .++.+||+|||+|+.....                              ....+||+.|+|||++ ....|+.++|||||
T Consensus       191 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSl  270 (458)
T 3rp9_A          191 QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSI  270 (458)
T ss_dssp             TTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHH
T ss_pred             CCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHH
Confidence            9999999999999876422                              1234579999999986 56679999999999


Q ss_pred             HHHHHHHHc-----------CCCCCCCCCCCH------------------HHHHHHHhc--CC-----------------
Q 039082          390 GIILNEIIT-----------GNHPYIEKDYKP------------------AKIAMEVGE--GK-----------------  421 (472)
Q Consensus       390 Gvll~ellt-----------G~~Pf~~~~~~~------------------~~i~~~i~~--~~-----------------  421 (472)
                      ||++|||++           |+.+|.+.+..+                  .+....+..  |.                 
T Consensus       271 G~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~  350 (458)
T 3rp9_A          271 GCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRY  350 (458)
T ss_dssp             HHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHH
T ss_pred             HHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHH
Confidence            999999999           667776543100                  000000000  00                 


Q ss_pred             ---CC----CCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 ---LR----PALPE-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ---~~----~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                         +.    ..+.. .+....++.+||.+||..||++|||++++++
T Consensus       351 ~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~  396 (458)
T 3rp9_A          351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA  396 (458)
T ss_dssp             HTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence               00    00000 1233567899999999999999999999886

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-42  Score=365.38  Aligned_cols=250  Identities=25%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC---------hHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN---------ENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~---------~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ++|++.++||+|+||.||+|.++  +..||||++.+......         +...+.+.+|+.+|+.++|||||++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            68999999999999999999986  67899999976543211         13356788999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .+....++|++++.||+|.+++.....          .++..++.++.||+.||+|||++|  |+||||||+|||++.++
T Consensus       116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~----------~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          116 EDKKYFYLVTEFYEGGELFEQIINRHK----------FDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENKN  183 (504)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESSTT
T ss_pred             EcCCEEEEEEecCCCCcHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecCC
Confidence            999999999999999999999864322          357889999999999999999999  99999999999998776


Q ss_pred             ---cEEEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          344 ---HVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 ---~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                         .+||+|||++.......  ....||+.|+|||++. ..|+.++|||||||++|+|++|..||.+.+  ...+...+.
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~  260 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQDIIKKVE  260 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHH
T ss_pred             CCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence               69999999998876442  3456899999999987 469999999999999999999999998766  666777777


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+......+.....+..+.++|.+||..||.+|||++++++
T Consensus       261 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          261 KGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            77644332222345578899999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.3e-42  Score=337.44  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=209.1

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      .+..++|++.+.||+|+||.||+|.+.  +..||||++...... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A           10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccc-hHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            355578999999999999999999986  678999998653211 12234568899999999999999999999999888


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .++|++++.+++|.+++...+.          .+...++.++.|++.||+|||++|  ++||||||+|||++.++.+||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~  156 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGR----------FDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIA  156 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEe
Confidence            8899999999999999965321          346788999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          349 DFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       349 DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      |||++...... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  .......+.....  .++
T Consensus       157 Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~--~~~  232 (284)
T 2vgo_A          157 DFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS--HTETHRRIVNVDL--KFP  232 (284)
T ss_dssp             CCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCC--CCC
T ss_pred             cccccccCcccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC--HhHHHHHHhcccc--CCC
Confidence            99999876543 334568999999999999999999999999999999999999997765  4445555554432  223


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .  ..+..+.++|.+||..||.+||+++++++
T Consensus       233 ~--~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          233 P--FLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             T--TSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C--cCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            2  24467889999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1e-42  Score=348.05  Aligned_cols=244  Identities=23%  Similarity=0.324  Sum_probs=184.2

Q ss_pred             CeeEe---ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCc
Q 039082          196 EIDLQ---EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYR  269 (472)
Q Consensus       196 ~~~l~---~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~  269 (472)
                      +|++.   +.||+|+||.||+|.++  |..||||++.+.       ....+.+|+.+++.+. ||||+++++++.+....
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~   81 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT   81 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence            35554   78999999999999986  778999998542       3345779999999996 99999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC---cEE
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK---HVR  346 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~---~vk  346 (472)
                      ++|+|++.+++|.+++....          ..+...+..++.||+.||+|||++|  |+||||||+|||++.++   .+|
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~k  149 (325)
T 3kn6_A           82 FLVMELLNGGELFERIKKKK----------HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIK  149 (325)
T ss_dssp             EEEECCCCSCBHHHHHHHCS----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEE
T ss_pred             EEEEEccCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEE
Confidence            99999999999999996532          2357889999999999999999999  99999999999998765   899


Q ss_pred             EeecccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC-----CHHHHHHHHh
Q 039082          347 IADFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY-----KPAKIAMEVG  418 (472)
Q Consensus       347 L~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~-----~~~~i~~~i~  418 (472)
                      |+|||++.......   ...+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.     ....+...+.
T Consensus       150 l~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~  229 (325)
T 3kn6_A          150 IIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK  229 (325)
T ss_dssp             ECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT
T ss_pred             EeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH
Confidence            99999998765432   345689999999999999999999999999999999999999976432     2345666666


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT  458 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll  458 (472)
                      .+......+.....+.++.++|.+||..||++|||+++++
T Consensus       230 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          230 KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             TTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             cCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            6653322111133567889999999999999999999876

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=337.04  Aligned_cols=249  Identities=20%  Similarity=0.280  Sum_probs=198.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.+.  |..||||++....  ........+.+|+.+++.++||||+++++++...+..++|
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE--DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC--C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc--cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            57999999999999999999986  7899999986642  3445567788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|..++.....          .+...+..++.|++.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        81 ~e~~~~~~l~~~~~~~~~----------~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~  148 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRG----------VPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGF  148 (311)
T ss_dssp             EECCSEEHHHHHHHTSSC----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EEeCCCchHHHHHhhhcC----------CCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCC
Confidence            999999999988754321          356788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--C------
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--G------  420 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~------  420 (472)
                      +.......   ....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+  ..+....+..  +      
T Consensus       149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~  226 (311)
T 4agu_A          149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS--DVDQLYLIRKTLGDLIPRH  226 (311)
T ss_dssp             CEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCSCCHHH
T ss_pred             chhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhccccccc
Confidence            98776332   34468999999999876 678999999999999999999999997765  2222222111  0      


Q ss_pred             -----------CCCCCCCCC--------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 -----------KLRPALPEE--------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 -----------~~~~~l~~~--------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 ......+..        +..+..+.++|.+||..||++|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          227 QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                       000011110        234566889999999999999999999984

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=3.5e-43  Score=357.32  Aligned_cols=253  Identities=11%  Similarity=0.033  Sum_probs=184.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc--CCCceeEEE-------EE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ--RHRFVLQLM-------GA  262 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l--~HpnIv~l~-------g~  262 (472)
                      ..+|++.+.||+|+||.||+|.++  |..||||++..... ........+.+|+.+++.+  +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-NSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-THHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-ccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence            346899999999999999999986  78999999987533 2345566788886655555  599988865       44


Q ss_pred             EEcCC-----------------CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHH------HHHHHHHHHHHHH
Q 039082          263 CLEPP-----------------YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER------LARALEIAQAMQY  319 (472)
Q Consensus       263 ~~~~~-----------------~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~------~~i~~qia~gL~y  319 (472)
                      +....                 ..++|+|++. ++|.+++...+...         ....+      ..++.||+.||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~---------~~~~~~~~~vk~~i~~qi~~aL~~  209 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVY---------VFRGDEGILALHILTAQLIRLAAN  209 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcccc---------chhhhhhhhhHHHHHHHHHHHHHH
Confidence            44332                 2566777665 99999997542211         12233      6777999999999


Q ss_pred             HHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccC--CCCCchHHHHHHHHHHHHHH
Q 039082          320 LHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEII  397 (472)
Q Consensus       320 LH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~ell  397 (472)
                      ||++|  |+||||||+||||+.++.+||+|||+++..........+|+.|+|||++.+  ..++.++|||||||++|+|+
T Consensus       210 LH~~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          210 LQSKG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             HHHTT--EEETTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             HHHCC--CccCcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence            99999  999999999999999999999999999987665545667899999999987  67999999999999999999


Q ss_pred             cCCCCCCCCCCCHHHHHHH---HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          398 TGNHPYIEKDYKPAKIAME---VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       398 tG~~Pf~~~~~~~~~i~~~---i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +|+.||.+...........   ...+......+.....+..+.++|.+||..||++||++.++++
T Consensus       288 tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             hCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9999997764211000000   0111112223322455678999999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-41  Score=333.89  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=211.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC-----ChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-----NENAVTFFAQEVDTLSRQR-HRFVLQLMGACLE  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~-----~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~  265 (472)
                      .++|++.+.||+|+||.||+|.++  |..||||++.......     .....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            478999999999999999999985  6899999997643211     1233567889999999995 9999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      ....++|++++.+++|.+++....          ..+...++.++.||+.||+|||++|  ++||||||+|||++.++.+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKV----------TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcE
Confidence            888999999999999999996432          1346789999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc--cccccCCccccccccc------CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQ------CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~------~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      ||+|||++.......  ....|++.|+|||++.      ...++.++||||||+++|+|++|..||...+  .......+
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~  241 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMI  241 (298)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred             EEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--HHHHHHHH
Confidence            999999998776432  3456899999999985      4568899999999999999999999997765  55566666


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+......+.....+..+.++|.+||..||++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          242 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            666544444433556778999999999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=5.5e-42  Score=348.19  Aligned_cols=251  Identities=25%  Similarity=0.414  Sum_probs=209.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC----hHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN----ENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPP  267 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~----~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~  267 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++........    ....+.+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            46899999999999999999986  78999999976543222    22346688999999999 8999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+|++.|++|.+++....          ..+...+..++.||+.||.|||+.|  ++||||||+|||++.+|.+||
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKV----------ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence            9999999999999999996422          2356888999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc--cccccCCcccccccccC------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          348 ADFGHARFLSDGE--MALTGTFVYMAPEVIQC------EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       348 ~DFGla~~~~~~~--~~~~gt~~y~APE~~~~------~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +|||++.......  ....||+.|+|||++.+      ..++.++|||||||++|+|++|..||...+  .......+..
T Consensus       242 ~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~i~~  319 (365)
T 2y7j_A          242 SDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMIME  319 (365)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHH
T ss_pred             EecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHh
Confidence            9999998876432  34568999999999863      358899999999999999999999997755  5556666666


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +......+.....+..+.++|.+||..||++||++.++++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          320 GQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             TCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            6543322222344567899999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-42  Score=336.53  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc--CCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~--~~~~~  270 (472)
                      ++|++.+.||+|+||.||+|.++  |..||+|++.....  .....+.+.+|+.+++.++||||+++++++..  ....+
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC--CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            58999999999999999999986  78899999976532  45566789999999999999999999998854  45677


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CceeecCCCCCcEEEcCCCcEEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK---PKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~---~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      +|++++.+++|.+++......      ....++..++.++.|++.||+|||+.+   .+++||||||+|||++.++.+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl  157 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  157 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred             EEEeCCCCCCHHHHHHhhccc------CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence            888888899999999753321      122457889999999999999999987   24999999999999999999999


Q ss_pred             eecccceecCCCcc---ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSDGEM---ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~~~~---~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||++........   ...|++.|+|||.+.+..++.++||||||+++|+|++|..||...+  ...+...+..+.. +
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~~~-~  234 (279)
T 2w5a_A          158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREGKF-R  234 (279)
T ss_dssp             CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCC-C
T ss_pred             ecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--HHHHHHHHhhccc-c
Confidence            99999987654332   3458999999999999899999999999999999999999997765  5556666666653 2


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL  461 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L  461 (472)
                      .++.  ..+..+.++|.+||..||++||++.+|++.+
T Consensus       235 ~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          235 RIPY--RYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             CCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cCCc--ccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            3332  3456788999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.3e-42  Score=353.31  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=187.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCC--Cc
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPP--YR  269 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~--~~  269 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++....  ........+.+|+.+|+.+. ||||+++++++..++  ..
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~--~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF--QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC----CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc--cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            58999999999999999999986  7899999986542  24455677889999999997 999999999998654  45


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      |+|++++ +++|..++...           ..+...+..++.||+.||+|||+.|  |+||||||+||||+.++.+||+|
T Consensus        87 ~lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           87 YLVFDYM-ETDLHAVIRAN-----------ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             EEEEECC-SEEHHHHHHHT-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             EEEeccc-CcCHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecC
Confidence            5666665 57999988642           1346778889999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC------------------------ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 039082          350 FGHARFLSDG------------------------EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYI  404 (472)
Q Consensus       350 FGla~~~~~~------------------------~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~  404 (472)
                      ||+|+.....                        ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            9999875321                        123468999999999976 679999999999999999999999998


Q ss_pred             CCCCCHHHHHHHHhcCCCCC-----------------------------CCCC--------------CchhHHHHHHHHH
Q 039082          405 EKDYKPAKIAMEVGEGKLRP-----------------------------ALPE--------------EDGQLRELIELIC  441 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~-----------------------------~l~~--------------~~~~~~~l~~li~  441 (472)
                      +.+  .......+....-.+                             ....              .......+.++|.
T Consensus       233 ~~~--~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~  310 (388)
T 3oz6_A          233 GSS--TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLD  310 (388)
T ss_dssp             CSS--HHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHH
T ss_pred             CCC--HHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHH
Confidence            765  333333322100000                             0000              0123457889999


Q ss_pred             HhccCCCCCCCCHHHHHHH
Q 039082          442 LSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       442 ~cl~~dP~~RPs~~~ll~~  460 (472)
                      +||..||++|||++++++.
T Consensus       311 ~~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          311 KLLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HHCCSSGGGSCCHHHHTTS
T ss_pred             HhhccCcccCCCHHHHhCC
Confidence            9999999999999998753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=353.32  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=211.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC--
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP--  267 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~--  267 (472)
                      +..++|++.+.||+|+||.||+|.++  |..||||++.....   ......+.+|+++|+.++||||+++++++...+  
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~   82 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTR   82 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG---GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc---cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCC
Confidence            34568999999999999999999997  78999999975432   223456789999999999999999999998765  


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE----cCCC
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAK  343 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl----~~~~  343 (472)
                      ..++|++++.+++|.+++......       ...++..++.++.||+.||+|||++|  |+||||||+|||+    +.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~-------~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~  153 (396)
T 4eut_A           83 HKVLIMEFCPCGSLYTVLEEPSNA-------YGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQS  153 (396)
T ss_dssp             CEEEEECCCTTEEHHHHTTSGGGT-------TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCE
T ss_pred             eeEEEEecCCCCCHHHHHHhhhcc-------cCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCce
Confidence            567888888899999999653321       12457889999999999999999999  9999999999999    7788


Q ss_pred             cEEEeecccceecCCCc--cccccCCcccccccccC--------CCCCchHHHHHHHHHHHHHHcCCCCCCCCC--CCHH
Q 039082          344 HVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQC--------EPYSEKSDVYSFGIILNEIITGNHPYIEKD--YKPA  411 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~--------~~~s~~sDvwSlGvll~elltG~~Pf~~~~--~~~~  411 (472)
                      .+||+|||+++......  ....||+.|+|||++.+        ..++.++|||||||++|||++|+.||....  ....
T Consensus       154 ~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~  233 (396)
T 4eut_A          154 VYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK  233 (396)
T ss_dssp             EEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH
T ss_pred             eEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH
Confidence            89999999998876443  24568999999999865        567889999999999999999999996432  1233


Q ss_pred             HHHHHHhcCCCCC-----------------CCCC----CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          412 KIAMEVGEGKLRP-----------------ALPE----EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       412 ~i~~~i~~~~~~~-----------------~l~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .+...+..+....                 .++.    .......+.++|.+||..||++||++.++++.++++..
T Consensus       234 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          234 EVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            4444444443211                 1111    14466788899999999999999999999999988764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-42  Score=348.99  Aligned_cols=255  Identities=22%  Similarity=0.352  Sum_probs=207.7

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ...+..++|++.+.||+|+||.||+|.++  +..||+|++..+   ........+.+|+.+|+.++||||+++++++...
T Consensus        27 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  103 (360)
T 3eqc_A           27 VGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE---IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD  103 (360)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred             ccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc---cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence            34566789999999999999999999997  789999999764   2455667899999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCCCcE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      +..++|++++.+++|.+++...+.          .+...+..++.+++.||+|||+. |  |+||||||+|||++.++.+
T Consensus       104 ~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~  171 (360)
T 3eqc_A          104 GEISICMEHMDGGSLDQVLKKAGR----------IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEI  171 (360)
T ss_dssp             TEEEEEECCCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCE
T ss_pred             CEEEEEEECCCCCCHHHHHHHcCC----------CCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCE
Confidence            999999999999999999965332          34678889999999999999996 8  9999999999999999999


Q ss_pred             EEeecccceecCC-CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH-------------
Q 039082          346 RIADFGHARFLSD-GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA-------------  411 (472)
Q Consensus       346 kL~DFGla~~~~~-~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~-------------  411 (472)
                      ||+|||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+....             
T Consensus       172 kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  251 (360)
T 3eqc_A          172 KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA  251 (360)
T ss_dssp             EECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------
T ss_pred             EEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCC
Confidence            9999999975542 23345789999999999999999999999999999999999999976552111             


Q ss_pred             ---------------------------HHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          412 ---------------------------KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       412 ---------------------------~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                                 .....+..+. .+..+. ...+.++.++|.+||..||++|||++++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          252 ETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP-PPKLPS-GVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ----------------------CCCHHHHHHHHHHSC-CCCCCT-TTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCcccCCCcccccccCCCCcccchhhhhHHhccC-CCCCCc-ccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                       1111111111 111111 2345678999999999999999999999863

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=348.58  Aligned_cols=242  Identities=20%  Similarity=0.328  Sum_probs=200.4

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC----hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN----ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||+++.......    ......+.+|+.+|+.++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            57899999999999999999885  78999999987543221    1123447789999999999999999999999988


Q ss_pred             ceEEEEeccCC-cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          269 RGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       269 ~~~vve~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      .++|++++.+| +|..++....          ..+...++.++.||+.||+|||++|  |+||||||+|||++.++.+||
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHP----------RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCC----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEE
T ss_pred             EEEEEEeCCCCccHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEEE
Confidence            88999988765 9999996433          2357888999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc--cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||++.......  ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.....        ....    
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~----  239 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEA----  239 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTT----
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhh----
Confidence            9999998876443  34568999999999988876 8899999999999999999999965321        1111    


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ........+.++.++|.+||..||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111112345678999999999999999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=339.97  Aligned_cols=255  Identities=24%  Similarity=0.273  Sum_probs=195.2

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC-ChHHHHHHHHHHHHHHhcC---CCceeEEEEEEEcC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-NENAVTFFAQEVDTLSRQR---HRFVLQLMGACLEP  266 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~-~~~~~~~f~~E~~il~~l~---HpnIv~l~g~~~~~  266 (472)
                      ..++|++.+.||+|+||.||+|.++  |..||||++....... .......+.+|+.+++.++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3568999999999999999999974  7899999987532211 1112234667777777764   99999999999876


Q ss_pred             CC----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          267 PY----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       267 ~~----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      ..    .+++++++.+++|.+++.....        ...++..++.++.||+.||+|||+++  |+||||||+|||++.+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~  156 (308)
T 3g33_A           87 RTDREIKVTLVFEHVDQDLRTYLDKAPP--------PGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSG  156 (308)
T ss_dssp             CSSSEEEEEEEEECCCCBHHHHHHTCCT--------TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECTT
T ss_pred             CCCCceeEEEEehhhhcCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCC
Confidence            53    2344444456799999965332        12457889999999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          343 KHVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      +.+||+|||++......  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+  .......+...
T Consensus       157 ~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~  234 (308)
T 3g33_A          157 GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS--EADQLGKIFDL  234 (308)
T ss_dssp             SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS--HHHHHHHHHHH
T ss_pred             CCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHH
Confidence            99999999999876533  234568999999999999999999999999999999999999997765  33333333221


Q ss_pred             C--C----------------CCCCCC-----CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 K--L----------------RPALPE-----EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~--~----------------~~~l~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .  .                .+..+.     .+.....+.++|.+||..||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0  0                000000     0234567889999999999999999999875

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.5e-42  Score=334.81  Aligned_cols=248  Identities=22%  Similarity=0.271  Sum_probs=209.5

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|.+.+.||+|+||.||+|.++  +..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-cCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            457999999999999999999996  67899999876543 244566779999999999999999999999999988999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+|++.+++|.+++....          ..+...++.++.|++.||+|||++|  ++||||||+|||++.++.+||+|||
T Consensus        93 v~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg  160 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRK----------ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFG  160 (294)
T ss_dssp             EEECCTTCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             EEecCCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEecc
Confidence            999999999999886432          1346889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++......   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....  .......+..+..  .++.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~--~~~~  236 (294)
T 2rku_A          161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEY--SIPK  236 (294)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCC--CCCT
T ss_pred             CceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHhhccC--CCcc
Confidence            99876532   234568999999999999899999999999999999999999997765  4444455554432  2222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                        .....+.++|.+||..||++||+++++++.
T Consensus       237 --~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          237 --HINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --ccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence              344578889999999999999999998863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.6e-42  Score=343.61  Aligned_cols=247  Identities=26%  Similarity=0.353  Sum_probs=197.7

Q ss_pred             CCeeEe-ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQ-EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~-~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  270 (472)
                      +.|++. +.||+|+||.||+|.+.  +..||||++....    ......+.+|+.+|.++ +||||+++++++.+.+..+
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP----GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS----SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc----chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            578885 78999999999999875  7899999997642    23345688999999985 7999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc---EEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---VRI  347 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~---vkL  347 (472)
                      +|+|++.+++|.+++....          ..+...++.++.||+.||+|||++|  |+||||||+|||++.++.   +||
T Consensus        88 lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl  155 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRR----------HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKI  155 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEE
T ss_pred             EEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEE
Confidence            9999999999999996532          1346788899999999999999999  999999999999998765   999


Q ss_pred             eecccceecCCC----------ccccccCCcccccccccC-----CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC---
Q 039082          348 ADFGHARFLSDG----------EMALTGTFVYMAPEVIQC-----EPYSEKSDVYSFGIILNEIITGNHPYIEKDYK---  409 (472)
Q Consensus       348 ~DFGla~~~~~~----------~~~~~gt~~y~APE~~~~-----~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~---  409 (472)
                      +|||++......          .....||+.|+|||++..     ..++.++|||||||++|+|++|..||.+....   
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  235 (316)
T 2ac3_A          156 CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCG  235 (316)
T ss_dssp             CCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSC
T ss_pred             EEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccc
Confidence            999999765421          123458999999999875     55889999999999999999999999765421   


Q ss_pred             ----------HHHHHHHHhcCCCCCCCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          410 ----------PAKIAMEVGEGKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       410 ----------~~~i~~~i~~~~~~~~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                ...+...+..+...  ++..  ...+..+.++|.+||..||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          236 WDRGEACPACQNMLFESIQEGKYE--FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             C----CCHHHHHHHHHHHHHCCCC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccccccchhHHHHHHHHHhccCcc--cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                      12344445555432  2211  234567899999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.8e-42  Score=333.08  Aligned_cols=247  Identities=23%  Similarity=0.299  Sum_probs=203.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++....   .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR---AVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG---CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc---chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            47899999999999999999986  7899999997542   234456789999999999999999999999998888999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++.+++|.+++....          ..+...++.++.|++.||+|||++|  ++||||||+|||++.++.+||+|||+
T Consensus        84 ~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~  151 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL  151 (276)
T ss_dssp             EECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             EEecCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCC
Confidence            99999999998885321          2356889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC-----ccccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          353 ARFLSDG-----EMALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       353 a~~~~~~-----~~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +......     .....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||........... .+....  ...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~--~~~  228 (276)
T 2yex_A          152 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-DWKEKK--TYL  228 (276)
T ss_dssp             CEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH-HHHTTC--TTS
T ss_pred             ccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH-Hhhhcc--ccc
Confidence            9876422     234568999999999987765 7899999999999999999999977654332222 222221  112


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+..+.++|.+||..||++|||++++++
T Consensus       229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            222345667889999999999999999999875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.8e-42  Score=337.69  Aligned_cols=248  Identities=23%  Similarity=0.392  Sum_probs=201.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.+.||+|+||.||+|.++  +..||+|++...    .......+.+|+.+++.++||||+++++++...+..++
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   93 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK----SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWI   93 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC----CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEE
Confidence            468999999999999999999996  778999998654    22345678899999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|..++.....         ..+...++.++.+++.||.|||++|  ++||||||+|||++.++.+||+|||
T Consensus        94 v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg  162 (302)
T 2j7t_A           94 MIEFCPGGAVDAIMLELDR---------GLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFG  162 (302)
T ss_dssp             EEECCTTEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCH
T ss_pred             EEEeCCCCcHHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999864321         2357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCC---CccccccCCcccccccc-----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          352 HARFLSD---GEMALTGTFVYMAPEVI-----QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       352 la~~~~~---~~~~~~gt~~y~APE~~-----~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ++.....   ......|++.|+|||.+     ....++.++||||||+++|+|++|..||...+  .......+..+. .
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~  239 (302)
T 2j7t_A          163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSD-P  239 (302)
T ss_dssp             HHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-C
T ss_pred             CCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--HHHHHHHHhccC-C
Confidence            9764321   22345689999999998     46778999999999999999999999997765  444555555543 2


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +........+..+.++|.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            222222445678899999999999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=352.99  Aligned_cols=258  Identities=19%  Similarity=0.233  Sum_probs=197.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChH-------HHHHHHHHHHHHHhcCCCceeEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNEN-------AVTFFAQEVDTLSRQRHRFVLQL  259 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~-------~~~~f~~E~~il~~l~HpnIv~l  259 (472)
                      +..++|++.+.||+|+||.||+|.+.     +..||||++.........+       ....+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            34578999999999999999999985     4679999987642110000       11346788899999999999999


Q ss_pred             EEEEEc----CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCC
Q 039082          260 MGACLE----PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPS  335 (472)
Q Consensus       260 ~g~~~~----~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~  335 (472)
                      ++++..    ....++|++++ +++|.+++...+          ..++..++.++.||+.||+|||++|  |+||||||+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~  180 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG----------TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAA  180 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG----------BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGG
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHH
Confidence            999988    56677788888 999999986433          2357889999999999999999999  999999999


Q ss_pred             cEEEcCCC--cEEEeecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 039082          336 NIFLDDAK--HVRIADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY  403 (472)
Q Consensus       336 NILl~~~~--~vkL~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf  403 (472)
                      ||||+.++  .+||+|||+++.+....          ....||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       181 NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf  260 (345)
T 2v62_A          181 NLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPW  260 (345)
T ss_dssp             GEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence            99998877  99999999998764221          3346899999999999999999999999999999999999999


Q ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCC-------chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          404 IEKDYKPAKIAMEVGEGKLRPALPEE-------DGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       404 ~~~~~~~~~i~~~i~~~~~~~~l~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      .+...............  ...++..       ...+..+.++|..||..||++||++.+|++.|+.+
T Consensus       261 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          261 EQNLKDPVAVQTAKTNL--LDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             GGGTTCHHHHHHHHHHH--HHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             cccccccHHHHHHHHhh--cccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            65433333222221111  1112211       13456889999999999999999999999999764

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.1e-41  Score=335.81  Aligned_cols=246  Identities=28%  Similarity=0.402  Sum_probs=209.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .+.|++.+.||+|+||.||+|.++  +..||||++.....   ......+.+|+.+++.++||||+++++++......++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC---STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            457999999999999999999985  77899999976532   3345678999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|.+++...           ..+...++.++.|++.||.|||++|  ++||||||+|||++.++.+||+|||
T Consensus        98 v~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg  164 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEPG-----------PLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFG  164 (303)
T ss_dssp             EEECCTTEEHHHHHTTS-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             EEEeCCCCcHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecc
Confidence            99999999999998531           2357889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++.......   ....|++.|+|||.+.+..++.++||||||+++|+|++|..||....  .......+..+. .+.++ 
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~~-  240 (303)
T 3a7i_A          165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--PMKVLFLIPKNN-PPTLE-  240 (303)
T ss_dssp             TCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-CCCCC-
T ss_pred             cceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--HHHHHHHhhcCC-CCCCc-
Confidence            998776432   34568999999999999999999999999999999999999997655  445555555543 22222 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                       ...+..+.++|.+||..||++||++.++++.
T Consensus       241 -~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          241 -GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             -SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             -cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             2345678899999999999999999999864

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.8e-42  Score=365.89  Aligned_cols=251  Identities=22%  Similarity=0.299  Sum_probs=208.9

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      .+..++|++.+.||+|+||.||+|.++  |..||||++.+.... .......+.+|+.+|+.++||||+++++++.....
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK-KRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhh-hhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            356689999999999999999999986  789999999754321 12334668899999999999999999999999999


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .|+|++++.||+|..++......      ....+...++.++.||+.||+|||++|  |+||||||+||||+.+|.+||+
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~------~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~  331 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDED------NPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRIS  331 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTT------SCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcc------cccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEe
Confidence            99999999999999999654321      123457788899999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCCCC
Q 039082          349 DFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGKLR  423 (472)
Q Consensus       349 DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~~~  423 (472)
                      |||+++......   ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+...  ....+...+..+.. 
T Consensus       332 DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~-  410 (543)
T 3c4z_A          332 DLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV-  410 (543)
T ss_dssp             CCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC-
T ss_pred             ecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc-
Confidence            999999876443   235799999999999999999999999999999999999999976532  34555555655432 


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                       .+|  ...+..+.++|.+||..||++||++
T Consensus       411 -~~p--~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          411 -TYP--DKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             -CCC--TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             -CCC--cccCHHHHHHHHHhccCCHhHCCCC
Confidence             223  2345678889999999999999975

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.5e-43  Score=348.52  Aligned_cols=264  Identities=28%  Similarity=0.501  Sum_probs=211.1

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ....|.++.++|++.+.||+|+||.||+|.+++ .||+|+++....  .....+.|.+|+.+++.++||||+++++++..
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERD--NEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSC--CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCC--CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            456799999999999999999999999999876 599999876432  22233447789999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..+++++++.+++|.+++...+         ...++..++.++.||+.||+|||++|  ++||||||+|||++ ++.+
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~  168 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAK---------IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKV  168 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSC---------CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CC
T ss_pred             CCceEEEeecccCCcHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCE
Confidence            999999999999999999996432         12346789999999999999999999  99999999999998 6899


Q ss_pred             EEeecccceecCC--------CccccccCCcccccccccC---------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCC
Q 039082          346 RIADFGHARFLSD--------GEMALTGTFVYMAPEVIQC---------EPYSEKSDVYSFGIILNEIITGNHPYIEKDY  408 (472)
Q Consensus       346 kL~DFGla~~~~~--------~~~~~~gt~~y~APE~~~~---------~~~s~~sDvwSlGvll~elltG~~Pf~~~~~  408 (472)
                      ||+|||++.....        ......|++.|+|||++.+         ..++.++||||||+++|+|++|..||.... 
T Consensus       169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-  247 (319)
T 2y4i_B          169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP-  247 (319)
T ss_dssp             EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCC-
T ss_pred             EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCC-
Confidence            9999999876531        1223458999999999874         457999999999999999999999997765 


Q ss_pred             CHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          409 KPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       409 ~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                       .......+..+.. +..+. ...+..+.+++..||..||++|||+.++++.|+.+..+.
T Consensus       248 -~~~~~~~~~~~~~-~~~~~-~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          248 -AEAIIWQMGTGMK-PNLSQ-IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             -HHHHHHHHHTTCC-CCCCC-SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             -HHHHHHHhccCCC-CCCCc-CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence             5555556655542 22222 234456888999999999999999999999998877653

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.7e-42  Score=342.25  Aligned_cols=247  Identities=22%  Similarity=0.271  Sum_probs=209.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|.+.+.||+|+||.||++.++  +..||+|++..... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            468999999999999999999986  67899999876543 344566779999999999999999999999999988999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.+++|.+++....          ..++..++.++.||+.||+|||++|  |+||||||+|||++.++.+||+|||
T Consensus       119 v~e~~~~~~L~~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg  186 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRK----------ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFG  186 (335)
T ss_dssp             EECCCTTCBHHHHHHHHC----------SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCT
T ss_pred             EEecCCCCCHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeecc
Confidence            999999999999886432          1346889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ++......   .....|++.|+|||++.+..++.++||||||+++|+|++|..||....  .......+..+..  .++.
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~--~~~~  262 (335)
T 2owb_A          187 LATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--LKETYLRIKKNEY--SIPK  262 (335)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCC--CCCT
T ss_pred             CceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--HHHHHHHHhcCCC--CCCc
Confidence            99876532   234568999999999999999999999999999999999999997765  4445555555432  2222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        .....+.++|.+||..||++||+++++++
T Consensus       263 --~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          263 --HINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              23457888999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9.3e-42  Score=371.75  Aligned_cols=261  Identities=23%  Similarity=0.403  Sum_probs=217.2

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      ..|.+..++|++.+.||+|+||.||+|.+.     +..||||.++..   ......+.|.+|+.+|+.++|||||+++++
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~  459 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGV  459 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST---TCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            457778889999999999999999999985     346999988653   344566789999999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      +. ++..++|+|++.+|+|.+++...+.         ..++..++.++.|++.||+|||++|  |+||||||+|||++.+
T Consensus       460 ~~-~~~~~lv~E~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~  527 (656)
T 2j0j_A          460 IT-ENPVWIIMELCTLGELRSFLQVRKF---------SLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSN  527 (656)
T ss_dssp             EC-SSSCEEEEECCTTCBHHHHHHHTTT---------TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEET
T ss_pred             Ee-cCceEEEEEcCCCCcHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCC
Confidence            85 4668899999999999999964321         2357888999999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i  417 (472)
                      +.+||+|||+++.......    ...+|+.|+|||++.+..++.++|||||||++|||++ |..||.+..  ..++...+
T Consensus       528 ~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~--~~~~~~~i  605 (656)
T 2j0j_A          528 DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRI  605 (656)
T ss_dssp             TEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH
T ss_pred             CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHH
Confidence            9999999999987754322    2346789999999998999999999999999999997 999998766  55566666


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ..+. +..++  ...+..+.++|.+||..||++||++.+|++.|+++.++-
T Consensus       606 ~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~  653 (656)
T 2j0j_A          606 ENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  653 (656)
T ss_dssp             HHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HcCC-CCCCC--ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            6654 23333  335567889999999999999999999999999997653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.4e-42  Score=348.57  Aligned_cols=254  Identities=17%  Similarity=0.213  Sum_probs=204.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC----------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeE-----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR----------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQ-----  258 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~----------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~-----  258 (472)
                      .++|++.+.||+|+||.||+|.++          +..||||++...         ..+.+|+.+++.++||||++     
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~  111 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------GRLFNEQNFFQRAAKPLQVNKWKKL  111 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---------STHHHHHHHHHHHCCHHHHHHHHHH
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---------chHHHHHHHHHHhcccchhhhhhhh
Confidence            479999999999999999999985          568999998653         23789999999999999988     


Q ss_pred             ----------EEEEEEc-CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCce
Q 039082          259 ----------LMGACLE-PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKV  327 (472)
Q Consensus       259 ----------l~g~~~~-~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~i  327 (472)
                                +++++.. ....++|++++ +++|.+++.....        ...++..++.++.||+.||+|||++|  |
T Consensus       112 ~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~--i  180 (352)
T 2jii_A          112 YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK--------HVLSERSVLQVACRLLDALEFLHENE--Y  180 (352)
T ss_dssp             TTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHHTT--C
T ss_pred             ccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCc--------CCCCHHHHHHHHHHHHHHHHHHHhCC--c
Confidence                      6777776 45556677766 9999999975421        12357889999999999999999999  9


Q ss_pred             eecCCCCCcEEEcCCC--cEEEeecccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHH
Q 039082          328 IHRDLKPSNIFLDDAK--HVRIADFGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNE  395 (472)
Q Consensus       328 iHrDLkp~NILl~~~~--~vkL~DFGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~e  395 (472)
                      +||||||+|||++.++  .+||+|||+++......          ....||+.|+|||++.+..++.++|||||||++|+
T Consensus       181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e  260 (352)
T 2jii_A          181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK  260 (352)
T ss_dssp             BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence            9999999999999998  99999999998765321          23468999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCCCCHHHHHHHHh--cCCCCCCCCCC----chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          396 IITGNHPYIEKDYKPAKIAMEVG--EGKLRPALPEE----DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       396 lltG~~Pf~~~~~~~~~i~~~i~--~~~~~~~l~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      |++|+.||.........+.....  ... ...+...    ...+..+.++|.+||..||++||++++|++.|+.+..+.
T Consensus       261 l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          261 WLYGFLPWTNCLPNTEDIMKQKQKFVDK-PGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             HHHSCCTTGGGTTCHHHHHHHHHHHHHS-CCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHhCCCCcccCCcCHHHHHHHHHhccCC-hhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            99999999876533433333322  111 1111111    234578999999999999999999999999999998765

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.6e-42  Score=341.98  Aligned_cols=251  Identities=19%  Similarity=0.276  Sum_probs=205.3

Q ss_pred             CCeeEe-ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQ-EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~-~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  270 (472)
                      +.|.+. +.||+|+||.||+|.++  |..||||++.....  .......+.+|+.++..+ +||||+++++++...+..+
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~  105 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR--GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII  105 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET--TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence            356666 89999999999999986  78999999976532  334456788999999999 5699999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CCcEEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AKHVRI  347 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~~vkL  347 (472)
                      +|+|++.+++|.+++....        ....++..++.++.|++.||+|||++|  |+||||||+|||++.   ++.+||
T Consensus       106 lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~~~kL  175 (327)
T 3lm5_A          106 LILEYAAGGEIFSLCLPEL--------AEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLGDIKI  175 (327)
T ss_dssp             EEEECCTTEEGGGGGSSCC---------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBCCEEE
T ss_pred             EEEEecCCCcHHHHHHHhc--------ccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCCcEEE
Confidence            9999999999998884321        123457889999999999999999999  999999999999987   789999


Q ss_pred             eecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          348 ADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       348 ~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      +|||++.......  ....||+.|+|||++.+..++.++||||||+++|+|++|..||...+  .......+........
T Consensus       176 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~~~i~~~~~~~~  253 (327)
T 3lm5_A          176 VDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED--NQETYLNISQVNVDYS  253 (327)
T ss_dssp             CCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCCC
T ss_pred             eeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHHHhcccccC
Confidence            9999998876432  34568999999999999999999999999999999999999997766  4455555555443333


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.....+..+.++|.+||..||++|||++++++
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          254 EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            3333456677899999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.4e-42  Score=346.21  Aligned_cols=258  Identities=16%  Similarity=0.175  Sum_probs=208.5

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEE-----E--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC---CCce
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAI-----W--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR---HRFV  256 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~-----~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~---HpnI  256 (472)
                      ...+.+..++|.+.+.||+|+||.||+|.     .  .+..||||++...       ....+.+|+.+++.++   |+||
T Consensus        57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-------NPWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-------CHHHHHHHHHHHHHSCGGGGGGB
T ss_pred             ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-------ChhHHHHHHHHHHHhhhhhhhhh
Confidence            45678888999999999999999999994     2  3778999999653       1234778888888886   9999


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCc
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN  336 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~N  336 (472)
                      +++++++...+..++|+||+.+|+|.+++......     .....++..++.++.||+.||+|||++|  ||||||||+|
T Consensus       130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~N  202 (365)
T 3e7e_A          130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT-----PEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDN  202 (365)
T ss_dssp             CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTS-----TTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGG
T ss_pred             hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcc-----cccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHH
Confidence            99999999999999999999999999999653221     1223467889999999999999999999  9999999999


Q ss_pred             EEEcC-----------CCcEEEeecccceecCC---C--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC
Q 039082          337 IFLDD-----------AKHVRIADFGHARFLSD---G--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN  400 (472)
Q Consensus       337 ILl~~-----------~~~vkL~DFGla~~~~~---~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~  400 (472)
                      |||+.           ++.+||+|||+|+.+..   .  ....+||+.|+|||++.+..|+.++|||||||++|||+||+
T Consensus       203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~  282 (365)
T 3e7e_A          203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT  282 (365)
T ss_dssp             EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred             EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence            99998           89999999999986541   1  23456899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCC-CCHHHHHHHHHHHHHHH
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVR-PSFSSITCSLKNIQMKV  468 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~~ll~~L~~i~~~~  468 (472)
                      .||.......         ......+.. ......+.+++..|++.+|.+| |++.++.+.|+++..+.
T Consensus       283 ~pf~~~~~~~---------~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          283 YMKVKNEGGE---------CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             CCCEEEETTE---------EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             CccccCCCCc---------eeechhccc-cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            9996543211         000111111 1235567788889999999998 78999999998877654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.5e-41  Score=330.61  Aligned_cols=246  Identities=22%  Similarity=0.274  Sum_probs=201.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.....  .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA--GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT--TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            57899999999999999999996  78999999976533  334556788999999999 99999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC---------
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---------  342 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~---------  342 (472)
                      |+|++.+++|.+++......      ....+...++.++.||+.||+|||++|  |+||||||+|||++.+         
T Consensus        89 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRI------MSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------
T ss_pred             EEEecCCCcHHHHHHhhccc------ccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccc
Confidence            99999999999999753321      122357889999999999999999999  9999999999999844         


Q ss_pred             ----------CcEEEeecccceecCCCccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH
Q 039082          343 ----------KHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA  411 (472)
Q Consensus       343 ----------~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~  411 (472)
                                ..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+....    
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----  235 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----  235 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH----
T ss_pred             cccccccCCceEEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh----
Confidence                      479999999998876533 34689999999999765 56789999999999999999987764432    


Q ss_pred             HHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       412 ~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ....+..+. .+.++.  ..+..+.++|.+||..||++|||+.++++
T Consensus       236 -~~~~~~~~~-~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 -QWHEIRQGR-LPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -HHHHHHTTC-CCCCSS--CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHcCC-CCCCCc--ccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence             233444443 223332  34567889999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=336.43  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=201.5

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      ...++|++.+.||+|+||.||+|.++  |..||||++..+.      ....+.+|+.+++.++||||+++++++...+..
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   99 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES------DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL   99 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS------CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH------HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence            44578999999999999999999986  7899999997542      224588999999999999999999999998889


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|++++.+++|.+++....         ...+...++.++.+++.||.|||++|  ++|+||||+|||++.++.+||+|
T Consensus       100 ~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d  168 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLRN---------KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLAD  168 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHHT---------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEee
Confidence            99999999999999986322         12357889999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          350 FGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       350 FGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ||++......   .....|++.|+|||.+.+..++.++||||||+++|+|++|..||....  .......+.... .+.+
T Consensus       169 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~-~~~~  245 (314)
T 3com_A          169 FGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH--PMRAIFMIPTNP-PPTF  245 (314)
T ss_dssp             CTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSC-CCCC
T ss_pred             cccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcCC-Cccc
Confidence            9999876643   234568999999999999999999999999999999999999997665  333333333332 2222


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......+..+.++|.+||..||.+||++.++++
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            222345678899999999999999999999975

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-42  Score=344.62  Aligned_cols=248  Identities=23%  Similarity=0.265  Sum_probs=192.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.....   ......+.+|+.+|+.++||||+++++++...+..++|
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC---------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc---cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57999999999999999999986  77899999965421   11222356799999999999999999999988888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++. ++|.+++...+.         ..+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+
T Consensus        79 ~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~  146 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGN---------IINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGL  146 (324)
T ss_dssp             EECCS-EEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSE
T ss_pred             ecccc-cCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCcc
Confidence            87775 699998865332         2356788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC--C-CCCC
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG--K-LRPA  425 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~--~-~~~~  425 (472)
                      +.......   ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  ..+....+...  . ....
T Consensus       147 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~i~~~~~~~~~~~  224 (324)
T 3mtl_A          147 ARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGST--VEEQLHFIFRILGTPTEET  224 (324)
T ss_dssp             EECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTT
T ss_pred             cccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCCCChHh
Confidence            98665332   23457999999999876 568999999999999999999999998765  33333333221  1 0000


Q ss_pred             CCC-----------------------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPE-----------------------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~-----------------------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.                       .+.....+.++|.+||..||++|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          225 WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             STTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             chhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            110                       0123467889999999999999999999875

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.4e-42  Score=358.78  Aligned_cols=247  Identities=23%  Similarity=0.244  Sum_probs=191.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC---
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY---  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~---  268 (472)
                      .++|++++.||+|+||.||+|.+.  |..||||++....  ........+.+|+.+|+.++|||||++++++.....   
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG--GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc--cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            478999999999999999999986  7899999997642  244566778999999999999999999999976543   


Q ss_pred             ---ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          269 ---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       269 ---~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                         .++|+|++ +++|..++...            .+...+..++.||+.||+|||++|  |+||||||+||||+.++.+
T Consensus       139 ~~~~~lv~E~~-~~~l~~~~~~~------------l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~  203 (464)
T 3ttj_A          139 FQDVYLVMELM-DANLCQVIQME------------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  203 (464)
T ss_dssp             CCEEEEEEECC-SEEHHHHHTSC------------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCE
T ss_pred             CCeEEEEEeCC-CCCHHHHHhhc------------CCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCE
Confidence               35666666 55677766321            346778899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC--C
Q 039082          346 RIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG--K  421 (472)
Q Consensus       346 kL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~--~  421 (472)
                      ||+|||+++.....  ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+  ..+....+...  .
T Consensus       204 kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~--~~~~~~~i~~~lg~  281 (464)
T 3ttj_A          204 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGT  281 (464)
T ss_dssp             EECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCS
T ss_pred             EEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHhcCC
Confidence            99999999877643  234578999999999999999999999999999999999999998766  22222222110  0


Q ss_pred             C------------------CCCCCC--------------C----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 L------------------RPALPE--------------E----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 ~------------------~~~l~~--------------~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .                  .+....              .    ......+.++|.+||..||++|||++++++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0                  000000              0    011567899999999999999999999885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-42  Score=369.73  Aligned_cols=253  Identities=26%  Similarity=0.342  Sum_probs=210.7

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +..++|++.+.||+|+||.||+|.++  |..||||++.+.... .......+.+|+.+|+.++|||||++++++.+.+..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~-~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIK-KRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhh-hhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            66789999999999999999999986  789999999654221 122345688999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|||++.||+|.+++...+.        ...+...++.++.||+.||+|||++|  ||||||||+||||+.+|.+||+|
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~--------~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~D  329 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQ--------AGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISD  329 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSS--------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEe
Confidence            999999999999999965332        12357888999999999999999999  99999999999999999999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHHHhcCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~i~~~~~~~~  425 (472)
                      ||++.......  ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.....  ....+...+....  ..
T Consensus       330 FGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~--~~  407 (576)
T 2acx_A          330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP--EE  407 (576)
T ss_dssp             CTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC--CC
T ss_pred             cccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc--cc
Confidence            99999876443  346799999999999998999999999999999999999999977542  2344444444432  22


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      ++  ...+..+.++|.+||..||.+||     +++++++
T Consensus       408 ~p--~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          408 YS--ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CC--TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             CC--ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            23  23456788999999999999999     7788764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.5e-42  Score=344.28  Aligned_cols=250  Identities=21%  Similarity=0.257  Sum_probs=191.6

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|++.+.||+|+||.||+|.+.  +..||||+++...  ........+.+|+.+|+.++||||+++++++...+..+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC----------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc--cccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            3468999999999999999999885  7899999997653  23344566889999999999999999999999988888


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc-----CCCcE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-----DAKHV  345 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~-----~~~~v  345 (472)
                      +|+|++. ++|.+++.....          .++..++.++.||+.||+|||++|  |+||||||+|||++     .++.+
T Consensus       110 lv~e~~~-~~L~~~~~~~~~----------~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~  176 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKNPD----------VSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVL  176 (329)
T ss_dssp             EEEECCS-EEHHHHHHHCTT----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEE
T ss_pred             EEEecCC-CCHHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceE
Confidence            8887775 699999965332          357889999999999999999999  99999999999994     45569


Q ss_pred             EEeecccceecCCC---ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCC
Q 039082          346 RIADFGHARFLSDG---EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK  421 (472)
Q Consensus       346 kL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~  421 (472)
                      ||+|||++......   .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+  .......+....
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~~~~~  254 (329)
T 3gbz_A          177 KIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS--EIDQLFKIFEVL  254 (329)
T ss_dssp             EECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHH
T ss_pred             EECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCC--HHHHHHHHHHHh
Confidence            99999999876533   2334579999999999874 58999999999999999999999997765  333333332210


Q ss_pred             --C--------------CCCCCCC----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 --L--------------RPALPEE----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 --~--------------~~~l~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        .              ....+..          .....++.++|.+||..||++|||++++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence              0              0001100          013467889999999999999999999875

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.3e-42  Score=375.45  Aligned_cols=246  Identities=23%  Similarity=0.325  Sum_probs=207.4

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      +.+..++|++++.||+|+||.||+|.++  +..||||+++++... .......+..|..+|..+ +||||+++++++.+.
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~  414 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI-QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM  414 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHH-HTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence            4556789999999999999999999986  567999999764221 223345678899999988 799999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..|+||||+.||+|..++...+.          .++..++.++.||+.||+|||++|  ||||||||+||||+.+|.+|
T Consensus       415 ~~~~lV~E~~~gg~L~~~l~~~~~----------~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ik  482 (674)
T 3pfq_A          415 DRLYFVMEYVNGGDLMYHIQQVGR----------FKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIK  482 (674)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEE
T ss_pred             CEEEEEEeCcCCCcHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEE
Confidence            999999999999999999975432          346788999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCC---CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          347 IADFGHARFLSD---GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       347 L~DFGla~~~~~---~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |+|||+|+....   .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+  ..++...+..+.. 
T Consensus       483 L~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~-  559 (674)
T 3pfq_A          483 IADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--EDELFQSIMEHNV-  559 (674)
T ss_dssp             ECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHSSCC-
T ss_pred             EeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--HHHHHHHHHhCCC-
Confidence            999999986432   2345679999999999999999999999999999999999999998766  6677777777653 


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSF  454 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~  454 (472)
                       .+|.  ....++.++|.+||..||++||++
T Consensus       560 -~~p~--~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          560 -AYPK--SMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             -CCCT--TSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             -CCCc--cCCHHHHHHHHHHccCCHHHCCCC
Confidence             2333  345678899999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-41  Score=346.51  Aligned_cols=254  Identities=22%  Similarity=0.290  Sum_probs=200.1

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ....|.+. ++|.+.+.||+|+||.||+|.++  |..||||++....  ..+.....+.+|+.+++.++||||+++++++
T Consensus        34 ~~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  110 (371)
T 4exu_A           34 NKTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVF  110 (371)
T ss_dssp             TTEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             ccceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc--cchhHHHHHHHHHHHHHhcCCCCchhhhhhe
Confidence            44567775 68999999999999999999986  7899999997643  3455667889999999999999999999999


Q ss_pred             EcCCCc------eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcE
Q 039082          264 LEPPYR------GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI  337 (472)
Q Consensus       264 ~~~~~~------~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NI  337 (472)
                      ...+..      ++|++++ +++|.+++..            ..+...+..++.||+.||+|||++|  |+||||||+||
T Consensus       111 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NI  175 (371)
T 4exu_A          111 TPASSLRNFYDFYLVMPFM-QTDLQKIMGM------------EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNL  175 (371)
T ss_dssp             CSCSSSTTCCCCEEEEECC-CEEHHHHTTS------------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGE
T ss_pred             eccCCcccceeEEEEEccc-cccHHHHhhc------------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHe
Confidence            877654      5666665 5788887732            1357889999999999999999999  99999999999


Q ss_pred             EEcCCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          338 FLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       338 Ll~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      |++.++.+||+|||+++..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  ..+....
T Consensus       176 ll~~~~~~kL~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~  253 (371)
T 4exu_A          176 AVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQ  253 (371)
T ss_dssp             EECTTCCEEECSTTCC--------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH
T ss_pred             EECCCCCEEEEecCcccccccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHH
Confidence            9999999999999999987766667789999999999887 789999999999999999999999998765  3233322


Q ss_pred             Hhc--CCC---------------------CCCCCC----CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGE--GKL---------------------RPALPE----EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~--~~~---------------------~~~l~~----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..  +..                     ......    .+.....+.++|.+||..||++|||+.++++
T Consensus       254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            221  000                     000000    0233567899999999999999999999875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-42  Score=341.24  Aligned_cols=263  Identities=27%  Similarity=0.391  Sum_probs=190.5

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ...|.+..++|++.+.||+|+||.||+|.+  .+..||||++..+.   .......+.+|+.+++.++||||+++++++.
T Consensus         7 ~~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   83 (303)
T 2vwi_A            7 ALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK---CQTSMDELLKEIQAMSQCHHPNIVSYYTSFV   83 (303)
T ss_dssp             ------CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-------------------CCCCCCCTTBCCEEEEEE
T ss_pred             ccccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh---cchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence            456889999999999999999999999987  47899999886542   2234566889999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ..+..++|++++.+++|.+++.......  .......+...++.++.|++.||+|||++|  ++||||||+|||++.++.
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~--~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~  159 (303)
T 2vwi_A           84 VKDELWLVMKLLSGGSVLDIIKHIVAKG--EHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGS  159 (303)
T ss_dssp             SSSCEEEEEECCTTCBHHHHHHHHHHTT--TTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCC
T ss_pred             ecCCcEEEehhccCCchHHHHHHHhhcc--ccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCC
Confidence            9999999999999999999996432111  011223467889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC--------ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          345 VRIADFGHARFLSDG--------EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       345 vkL~DFGla~~~~~~--------~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      +||+|||++......        .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||......  ....
T Consensus       160 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~  237 (303)
T 2vwi_A          160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM--KVLM  237 (303)
T ss_dssp             EEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHH
T ss_pred             EEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh--hHHH
Confidence            999999999765432        123458999999999875 56899999999999999999999999776532  2222


Q ss_pred             HHhcCCCCCCCCC-------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVGEGKLRPALPE-------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~~~~~~~~l~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+. .+.++.       ....+..+.++|.+||..||.+||++.++++
T Consensus       238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          238 LTLQND-PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHHTSS-CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhccC-CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            232222 111111       1234567889999999999999999999986

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.9e-42  Score=335.53  Aligned_cols=247  Identities=26%  Similarity=0.327  Sum_probs=182.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.+.  |..||||++...... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhh-hhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            57999999999999999999984  789999998653211 122346688999999999999999999999998888999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|.+++....         ...+...++.++.|++.||+|||++|  ++||||||+|||++.++.+||+|||+
T Consensus        90 ~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~  158 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV---------KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGL  158 (278)
T ss_dssp             EECCTTEEHHHHHHTCS---------SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTT
T ss_pred             EecCCCCcHHHHHhhcc---------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeecc
Confidence            99999999999996432         12357889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE  429 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~  429 (472)
                      +......   .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.......  ....+....  ...+  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~--~~~~--  232 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TLNKVVLAD--YEMP--  232 (278)
T ss_dssp             CEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------CCSSC--CCCC--
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--HHHHHhhcc--cCCc--
Confidence            9876532   234568999999999998889999999999999999999999997765322  222222221  1122  


Q ss_pred             chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          430 DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       430 ~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..+.++|.+||..||++||+++++++
T Consensus       233 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          233 SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            234567889999999999999999999875

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.6e-41  Score=350.89  Aligned_cols=255  Identities=20%  Similarity=0.251  Sum_probs=193.5

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .|.+ .++|++.+.||+|+||.||+|.++  |..||||++....  ......+.+.+|+.+|+.++||||+++++++...
T Consensus        21 ~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           21 NVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF--EDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             GCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT--TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh--cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            3444 478999999999999999999986  6789999997542  3445667899999999999999999999998776


Q ss_pred             -----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          267 -----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       267 -----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                           ...|+|++ +++++|.+++....          ..+...+..++.||+.||+|||++|  |+||||||+||||+.
T Consensus        98 ~~~~~~~~~lv~e-~~~~~L~~~~~~~~----------~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~  164 (432)
T 3n9x_A           98 DLLKFDELYIVLE-IADSDLKKLFKTPI----------FLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQ  164 (432)
T ss_dssp             CTTTCCCEEEEEE-CCSEEHHHHHHSSC----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECT
T ss_pred             CCCcCCeEEEEEe-cCCcCHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECC
Confidence                 34556666 55789999986422          2357889999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc-------------------------cccccCCcccccccc-cCCCCCchHHHHHHHHHHHH
Q 039082          342 AKHVRIADFGHARFLSDGE-------------------------MALTGTFVYMAPEVI-QCEPYSEKSDVYSFGIILNE  395 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~-------------------------~~~~gt~~y~APE~~-~~~~~s~~sDvwSlGvll~e  395 (472)
                      ++.+||+|||+|+......                         ...+||+.|+|||++ ....|+.++|||||||++||
T Consensus       165 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~e  244 (432)
T 3n9x_A          165 DCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE  244 (432)
T ss_dssp             TCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             CCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHH
Confidence            9999999999998765321                         345689999999986 56679999999999999999


Q ss_pred             HHcCCCCC-----------CCCCCC---------------------------------------HHHHHHHHhcCCCCCC
Q 039082          396 IITGNHPY-----------IEKDYK---------------------------------------PAKIAMEVGEGKLRPA  425 (472)
Q Consensus       396 lltG~~Pf-----------~~~~~~---------------------------------------~~~i~~~i~~~~~~~~  425 (472)
                      |++|..||           .+.+.-                                       .......+........
T Consensus       245 ll~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  324 (432)
T 3n9x_A          245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKP  324 (432)
T ss_dssp             HHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCC
T ss_pred             HHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCC
Confidence            99854443           332210                                       0001111111111111


Q ss_pred             CCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPE---EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+.   .+..+.++.++|.+||..||++|||++++++
T Consensus       325 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  361 (432)
T 3n9x_A          325 INLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD  361 (432)
T ss_dssp             CCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100   0234567889999999999999999999985

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-41  Score=330.50  Aligned_cols=249  Identities=27%  Similarity=0.384  Sum_probs=200.4

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ..++|++.+.||+|+||.||+|.++  |..||||++..... ........+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKI-RSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccc-cchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEE
Confidence            4478999999999999999999986  78999999865321 11233467889999999999999999999999999899


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|++++.+++|.+++.....          .+...++.++.|++.||+|||++|  ++||||||+|||++.++.+||+||
T Consensus        88 lv~e~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~df  155 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGR----------VEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADF  155 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCC
T ss_pred             EEEeccCCCcHHHHHhccCC----------CCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeec
Confidence            99999999999999965321          346788999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      |++.......  ....|++.|+|||.+.+..+ +.++||||||+++|+|++|..||....  .......+..+..  .++
T Consensus       156 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~--~~~  231 (276)
T 2h6d_A          156 GLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--VPTLFKKIRGGVF--YIP  231 (276)
T ss_dssp             CGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC--CCC
T ss_pred             ccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--HHHHHHHhhcCcc--cCc
Confidence            9998765433  34468999999999988766 689999999999999999999997765  4455555555432  222


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      .  ..+..+.++|.+||..||++|||+.++++.
T Consensus       232 ~--~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          232 E--YLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             T--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             h--hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            2  234578889999999999999999999873

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=332.13  Aligned_cols=258  Identities=22%  Similarity=0.344  Sum_probs=204.6

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ....|.+..+++.....||+|+||.||+|.+.  +..||||++...    .......+.+|+.+++.++||||+++++++
T Consensus        13 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   88 (295)
T 2clq_A           13 DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIVQYLGSF   88 (295)
T ss_dssp             -CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC----CC---HHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC----chHHHHHHHHHHHHHHhCCCCCEeeEeeEE
Confidence            34456666677777889999999999999985  678999998754    234456689999999999999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-C
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-A  342 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~  342 (472)
                      ...+..++|++++.+++|.+++.....       ....+...+..++.|++.||+|||++|  ++||||||+|||++. +
T Consensus        89 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~  159 (295)
T 2clq_A           89 SENGFIKIFMEQVPGGSLSALLRSKWG-------PLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYS  159 (295)
T ss_dssp             EETTEEEEEEECCSEEEHHHHHHHTTC-------CCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTT
T ss_pred             EeCCcEEEEEEeCCCCCHHHHHHhhcc-------CCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCC
Confidence            999989999999999999999965321       112246778888999999999999999  999999999999987 8


Q ss_pred             CcEEEeecccceecCCC---ccccccCCcccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDG---EMALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~--~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      +.+||+|||++......   .....|++.|+|||++.+.  .++.++||||||+++|+|++|..||..............
T Consensus       160 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  239 (295)
T 2clq_A          160 GVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVG  239 (295)
T ss_dssp             CCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHH
T ss_pred             CCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhc
Confidence            99999999999876543   2345689999999998764  389999999999999999999999976543222222221


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .. ...+.++.  ..+..+.++|.+||..||++||++.+++.
T Consensus       240 ~~-~~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          240 MF-KVHPEIPE--SMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HH-CCCCCCCT--TSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cc-cccccccc--cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22 22333333  34567889999999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.9e-41  Score=336.40  Aligned_cols=248  Identities=23%  Similarity=0.305  Sum_probs=203.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEE---CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc------eeEEEEEEE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIW---RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF------VLQLMGACL  264 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~---~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn------Iv~l~g~~~  264 (472)
                      .++|++.+.||+|+||.||+|.+   .+..||||+++.     .......+.+|+.+++.++|++      ++++++++.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN-----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec-----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence            46899999999999999999987   377899999864     3345567889999999997765      999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---  341 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---  341 (472)
                      ..+..++|++++ +++|.+++...+.        ...+...++.++.||+.||+|||++|  |+||||||+|||++.   
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~  156 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGF--------LPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDY  156 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCE
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCC--------CCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEecccc
Confidence            988888888888 9999999965332        12357889999999999999999999  999999999999987   


Q ss_pred             ----------------CCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 039082          342 ----------------AKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE  405 (472)
Q Consensus       342 ----------------~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~  405 (472)
                                      ++.+||+|||++...........||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          157 TEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             EEEEC----CEEEEESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccCCccccccccccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                            6789999999999877766677899999999999999999999999999999999999999987


Q ss_pred             CCCCHHHHHHHHhc--CCC--------------------------------------CCCCCCCchhHHHHHHHHHHhcc
Q 039082          406 KDYKPAKIAMEVGE--GKL--------------------------------------RPALPEEDGQLRELIELICLSWD  445 (472)
Q Consensus       406 ~~~~~~~i~~~i~~--~~~--------------------------------------~~~l~~~~~~~~~l~~li~~cl~  445 (472)
                      .+.  ......+..  +..                                      ..........+..+.++|.+||.
T Consensus       237 ~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  314 (339)
T 1z57_A          237 HDS--KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE  314 (339)
T ss_dssp             SCH--HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCh--HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhC
Confidence            652  222221111  100                                      00011123456789999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 039082          446 GDASVRPSFSSITC  459 (472)
Q Consensus       446 ~dP~~RPs~~~ll~  459 (472)
                      .||.+|||+.++++
T Consensus       315 ~dP~~Rpt~~ell~  328 (339)
T 1z57_A          315 YDPAKRITLREALK  328 (339)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             cCcccccCHHHHhc
Confidence            99999999999985

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.2e-42  Score=332.15  Aligned_cols=247  Identities=26%  Similarity=0.351  Sum_probs=202.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc-------
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE-------  265 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~-------  265 (472)
                      .+|++.+.||+|+||.||+|.++  |..||||++....        ..+.+|+.+++.++||||+++++++..       
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            46899999999999999999996  7899999997542        136789999999999999999998864       


Q ss_pred             ---------CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCc
Q 039082          266 ---------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSN  336 (472)
Q Consensus       266 ---------~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~N  336 (472)
                               ....++|++++.+++|.+++.....        ...++..++.++.|++.||+|||++|  |+||||||+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~N  152 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG--------EKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSN  152 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGG--------SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGG
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHH
Confidence                     3346788888889999999964321        12356788999999999999999999  9999999999


Q ss_pred             EEEcCCCcEEEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH
Q 039082          337 IFLDDAKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA  414 (472)
Q Consensus       337 ILl~~~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~  414 (472)
                      ||++.++.+||+|||++.......  ....|++.|+|||.+.+..++.++||||||+++|+|++|..||...    ....
T Consensus       153 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----~~~~  228 (284)
T 2a19_B          153 IFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----SKFF  228 (284)
T ss_dssp             EEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----HHHH
T ss_pred             EEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----HHHH
Confidence            999999999999999998876432  3456899999999999999999999999999999999999887432    2233


Q ss_pred             HHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          415 MEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      ..+..+...      ...+..+.++|.+||..||.+||++.++++.|..+....+
T Consensus       229 ~~~~~~~~~------~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          229 TDLRDGIIS------DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             HHHHTTCCC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             HHhhccccc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence            334443322      1234568889999999999999999999999998876654

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.3e-42  Score=341.39  Aligned_cols=261  Identities=26%  Similarity=0.397  Sum_probs=185.6

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHH-HHHhcCCCceeEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVD-TLSRQRHRFVLQLMGA  262 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~-il~~l~HpnIv~l~g~  262 (472)
                      ....|.+..++|++.+.||+|+||.||+|.++  |..||||+++...   .......+..|+. +++.++||||++++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~~~~h~niv~~~~~   89 (327)
T 3aln_A           13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVVMRSSDCPYIVQFYGA   89 (327)
T ss_dssp             CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC---CHHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred             hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc---CchHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence            34578999999999999999999999999996  8899999997642   3344445666666 6777899999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~  341 (472)
                      +...+..++|++++. ++|.+++.....     ......+...+..++.+++.||.|||+. |  ++||||||+|||++.
T Consensus        90 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~  161 (327)
T 3aln_A           90 LFREGDCWICMELMS-TSFDKFYKYVYS-----VLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDR  161 (327)
T ss_dssp             EECSSEEEEEECCCS-EEHHHHHHHHHH-----TTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEET
T ss_pred             EEeCCceEEEEeecC-CChHHHHHHHHh-----hhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcC
Confidence            998887777777775 588888753211     1112345788899999999999999998 9  999999999999999


Q ss_pred             CCcEEEeecccceecCCCc--cccccCCcccccccc----cCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          342 AKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVI----QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~----~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      ++.+||+|||++.......  ....||+.|+|||++    .+..++.++||||||+++|+|++|..||...... .....
T Consensus       162 ~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~  240 (327)
T 3aln_A          162 SGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV-FDQLT  240 (327)
T ss_dssp             TTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------C
T ss_pred             CCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH-HHHHH
Confidence            9999999999998765432  233689999999998    4567899999999999999999999999764421 11222


Q ss_pred             HHhcCCCCCCCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVGEGKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~~~~~~~~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+..+. .+.++..  ...+..+.++|.+||..||++||++.++++
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          241 QVVKGD-PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSC-CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcCC-CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            222222 2222221  345678999999999999999999999976

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.6e-41  Score=332.22  Aligned_cols=248  Identities=23%  Similarity=0.328  Sum_probs=208.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++.....  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA--KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB--SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc--chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            57899999999999999999985  78999999976533  223456688999999999999999999999998888999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC---CcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---KHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~---~~vkL~D  349 (472)
                      ++++.+++|.+++....          ..+...++.++.|++.||+|||++|  ++||||||+|||++.+   +.+||+|
T Consensus       100 ~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~D  167 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK----------RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIID  167 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS----------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEECS
T ss_pred             EEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEec
Confidence            99999999999886432          1346889999999999999999999  9999999999999754   4799999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||++.......  ....|++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+  ...+...+..+......+
T Consensus       168 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~  244 (287)
T 2wei_A          168 FGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAFDLP  244 (287)
T ss_dssp             TTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCCCCSG
T ss_pred             cCcceeecCCCccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCCCCCCch
Confidence            99998765433  233578999999998764 8999999999999999999999997765  556667777776544444


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+..+.++|.+||..||++|||+.++++
T Consensus       245 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            33445678899999999999999999999987

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-41  Score=339.64  Aligned_cols=256  Identities=20%  Similarity=0.283  Sum_probs=202.9

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      +-++...++|++.+.||+|+||.||+|.++  |..||||++....  ........+.+|+.+++.++||||+++++++.+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   95 (331)
T 4aaa_A           18 NLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD--DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK   95 (331)
T ss_dssp             -CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS--SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC--CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence            345556789999999999999999999986  7899999987643  345556778899999999999999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      .+..++|++++.+++|..++....          ..++..+..++.|++.||+|||++|  |+||||||+||||+.++.+
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~  163 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLELFPN----------GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVV  163 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHHSTT----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCE
T ss_pred             CCEEEEEEecCCcchHHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcE
Confidence            999999999999998888764322          2357889999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC---ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--
Q 039082          346 RIADFGHARFLSDG---EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--  419 (472)
Q Consensus       346 kL~DFGla~~~~~~---~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--  419 (472)
                      ||+|||++......   .....|++.|+|||.+.+. .++.++|||||||++|+|++|..||.+.+  .......+..  
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~  241 (331)
T 4aaa_A          164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS--DIDQLYHIMMCL  241 (331)
T ss_dssp             EECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH
T ss_pred             EEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHh
Confidence            99999999876533   2345689999999999875 78999999999999999999999997765  2222222111  


Q ss_pred             ------------------CCCCCCCCCC-------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 ------------------GKLRPALPEE-------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ------------------~~~~~~l~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                        +...+.+...       +..+..+.++|.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                              0000111110       234577899999999999999999999885

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-43  Score=352.69  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=203.4

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEE-----CCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEE
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACL  264 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~-----~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~  264 (472)
                      .+..++|++.+.||+|+||.||+|.+     .|..||||++++............+.+|+.+|+.+ +||||+++++++.
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  129 (355)
T 1vzo_A           50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ  129 (355)
T ss_dssp             CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred             cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence            34557899999999999999999998     47899999997543211222334467899999999 6999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ..+..++|+|++.+++|.+++....          ..+...+..++.||+.||+|||+++  |+||||||+||||+.++.
T Consensus       130 ~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~  197 (355)
T 1vzo_A          130 TETKLHLILDYINGGELFTHLSQRE----------RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGH  197 (355)
T ss_dssp             ETTEEEEEECCCCSCBHHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSC
T ss_pred             eCceEEEEeecCCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCc
Confidence            9999999999999999999996432          1346788899999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc----cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCCCCCC--CHHHHHHH
Q 039082          345 VRIADFGHARFLSDGE----MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDY--KPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~~~~~--~~~~i~~~  416 (472)
                      +||+|||+++......    ....||+.|+|||++.+  ..++.++|||||||++|+|++|..||.....  ....+...
T Consensus       198 ~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  277 (355)
T 1vzo_A          198 VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR  277 (355)
T ss_dssp             EEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH
T ss_pred             EEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHH
Confidence            9999999998764322    23468999999999985  3578999999999999999999999975432  23444444


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCC-----CHHHHHHH
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRP-----SFSSITCS  460 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~~ll~~  460 (472)
                      +....  +..+  ...+..+.++|.+||..||++||     +++++++.
T Consensus       278 ~~~~~--~~~~--~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          278 ILKSE--PPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHCC--CCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HhccC--CCCC--cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            44432  2222  23445788899999999999999     89998764

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.9e-42  Score=348.42  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=183.7

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.+. ++|++.+.||+|+||.||+|.+.  |..||||++....  ........+.+|+.+|+.++||||+++++++..
T Consensus        23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~   99 (367)
T 2fst_X           23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   99 (367)
T ss_dssp             EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc--cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            456665 78999999999999999999985  7899999986542  244556778899999999999999999999875


Q ss_pred             CC-----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          266 PP-----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       266 ~~-----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ..     ..+++++++.+++|.+++...           ..+...+..++.||+.||+|||++|  |+||||||+||||+
T Consensus       100 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~-----------~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~  166 (367)
T 2fst_X          100 ARSLEEFNDVYLVTHLMGADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN  166 (367)
T ss_dssp             CSSGGGCCCCEEEEECCCEECC-----C-----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEC
T ss_pred             CCccccCCeEEEEecccCCCHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEEC
Confidence            42     233555555699999888531           2356888999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          341 DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      .++.+||+|||+++..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  .......+..
T Consensus       167 ~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~l~~i~~  244 (367)
T 2fst_X          167 EDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILR  244 (367)
T ss_dssp             TTCCEEECC---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHH
T ss_pred             CCCCEEEeeccccccccccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHH
Confidence            9999999999999987766666789999999999876 678999999999999999999999998766  2222222211


Q ss_pred             --CCC-------------------CCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 --GKL-------------------RPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 --~~~-------------------~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                        |..                   .+..+..      +.....+.++|.+||..||++|||+.++++
T Consensus       245 ~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          245 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence              100                   0001110      123466889999999999999999999975

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2.3e-41  Score=351.16  Aligned_cols=248  Identities=21%  Similarity=0.230  Sum_probs=200.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc------CCCceeEEEEEEEc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ------RHRFVLQLMGACLE  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l------~HpnIv~l~g~~~~  265 (472)
                      ..+|++.+.||+|+||.||+|.+.  +..||||+++.     .......+.+|+.+++.+      .|+||+++++++..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-----EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC-----ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence            357999999999999999999986  68999999864     334456688899998887      56799999999998


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc-
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH-  344 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~-  344 (472)
                      ....+++++++ +++|.+++.....        ...++..++.++.||+.||+|||+++  |+||||||+||||+.++. 
T Consensus       171 ~~~~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~  239 (429)
T 3kvw_A          171 RNHICMTFELL-SMNLYELIKKNKF--------QGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRS  239 (429)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSC
T ss_pred             CCeEEEEEecc-CCCHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCc
Confidence            88887777776 6799999865332        12357889999999999999999999  999999999999999887 


Q ss_pred             -EEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC--C
Q 039082          345 -VRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG--K  421 (472)
Q Consensus       345 -vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~--~  421 (472)
                       +||+|||++...........||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+  ..+....+...  .
T Consensus       240 ~vkL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~--~~~~l~~i~~~~~~  317 (429)
T 3kvw_A          240 GIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED--EGDQLACMIELLGM  317 (429)
T ss_dssp             CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCC
T ss_pred             ceEEeecccceecCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHcCC
Confidence             999999999888777777789999999999999999999999999999999999999998765  32222222110  0


Q ss_pred             --------------------CCC-------------------------CCCCC--------chhHHHHHHHHHHhccCCC
Q 039082          422 --------------------LRP-------------------------ALPEE--------DGQLRELIELICLSWDGDA  448 (472)
Q Consensus       422 --------------------~~~-------------------------~l~~~--------~~~~~~l~~li~~cl~~dP  448 (472)
                                          ...                         ..+..        ......+.++|.+||..||
T Consensus       318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP  397 (429)
T 3kvw_A          318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP  397 (429)
T ss_dssp             CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred             CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence                                000                         00000        0124568899999999999


Q ss_pred             CCCCCHHHHHH
Q 039082          449 SVRPSFSSITC  459 (472)
Q Consensus       449 ~~RPs~~~ll~  459 (472)
                      ++|||++++++
T Consensus       398 ~~Rpta~e~L~  408 (429)
T 3kvw_A          398 AVRMTPGQALR  408 (429)
T ss_dssp             TTSCCHHHHHT
T ss_pred             hhCCCHHHHhC
Confidence            99999999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-41  Score=341.84  Aligned_cols=247  Identities=24%  Similarity=0.252  Sum_probs=190.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----  267 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||++....  ........+.+|+.+++.++||||+++++++...+    
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc--CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            368999999999999999999985  7899999997643  24556677899999999999999999999998765    


Q ss_pred             --CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          268 --YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       268 --~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                        ..++|++++ +++|.+++...            .+...+..++.||+.||+|||++|  |+||||||+|||++.++.+
T Consensus       102 ~~~~~lv~e~~-~~~l~~~~~~~------------~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~  166 (371)
T 2xrw_A          102 FQDVYIVMELM-DANLCQVIQME------------LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL  166 (371)
T ss_dssp             CCEEEEEEECC-SEEHHHHHHSC------------CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCE
T ss_pred             ccceEEEEEcC-CCCHHHHHhhc------------cCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCE
Confidence              345566655 56888887421            246778899999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          346 RIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       346 kL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      ||+|||+++.....  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+  .......+......
T Consensus       167 kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--~~~~~~~i~~~~~~  244 (371)
T 2xrw_A          167 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLGT  244 (371)
T ss_dssp             EECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHC-CCC
T ss_pred             EEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCC
Confidence            99999999876543  234568999999999999999999999999999999999999998765  33333333221100


Q ss_pred             --------------------CCC--------------CCC----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 --------------------PAL--------------PEE----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 --------------------~~l--------------~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                          +..              |..    ......+.++|.+||..||++|||++++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence                                000              110    112567899999999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.5e-42  Score=355.29  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=193.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCC----ChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT----NENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~----~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      .++|.+.+.||+|+||.||+|.++  +..||||++.+.....    .......+.+|+.+|+.++|||||++++++.. +
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            368999999999999999999986  6789999997653321    11223358899999999999999999998754 4


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC---Cc
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA---KH  344 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~---~~  344 (472)
                      ..++|+|++.+++|.+++....          ..++..++.++.|++.||+|||+++  |+||||||+|||++.+   +.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSC----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSCC
T ss_pred             ceEEEEEcCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcce
Confidence            5788999999999988875322          2357889999999999999999999  9999999999999754   45


Q ss_pred             EEEeecccceecCCCc--cccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          345 VRIADFGHARFLSDGE--MALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       345 vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +||+|||+++......  ...+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||...... ......+..
T Consensus       281 ~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~i~~  359 (419)
T 3i6u_A          281 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITS  359 (419)
T ss_dssp             EEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS-CCHHHHHHT
T ss_pred             EEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch-HHHHHHHhc
Confidence            9999999998776433  34568999999999853   67889999999999999999999999765422 123344444


Q ss_pred             CCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 GKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.... .+.. ...+..+.++|.+||..||++||+++++++
T Consensus       360 ~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          360 GKYNF-IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TCCCC-CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCC-CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            43221 1111 334567899999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-41  Score=341.24  Aligned_cols=252  Identities=21%  Similarity=0.236  Sum_probs=192.9

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC-hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN-ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      .++|++.+.||+|+||.||+|.++  |..||||++........ ......+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   88 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   88 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence            368999999999999999999986  77899999975432211 122345889999999999999999999999888888


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|++++.+ +|..++.....         ..+...++.++.|++.||+|||++|  |+||||||+|||++.++.+||+||
T Consensus        89 lv~e~~~~-~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df  156 (346)
T 1ua2_A           89 LVFDFMET-DLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADF  156 (346)
T ss_dssp             EEEECCSE-EHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCC
T ss_pred             EEEEcCCC-CHHHHHHhcCc---------CCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEEec
Confidence            88888765 88888854321         1235678899999999999999999  999999999999999999999999


Q ss_pred             ccceecCCC---ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC--
Q 039082          351 GHARFLSDG---EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP--  424 (472)
Q Consensus       351 Gla~~~~~~---~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~--  424 (472)
                      |++......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+  .......+......+  
T Consensus       157 g~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~--~~~~~~~i~~~~~~~~~  234 (346)
T 1ua2_A          157 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTE  234 (346)
T ss_dssp             GGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCT
T ss_pred             ccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHHHcCCCCh
Confidence            999876533   234568999999999875 458999999999999999999999997765  333333332210000  


Q ss_pred             -C---------------CCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 -A---------------LPEE------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 -~---------------l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .               .+..      ...+..+.++|.+||..||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence             0               0000      223467899999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.6e-41  Score=339.36  Aligned_cols=249  Identities=22%  Similarity=0.260  Sum_probs=194.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC-----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP-----  267 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~-----  267 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||++.....  .......+.+|+.+|+.++||||+++++++....     
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC--SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc--cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            58999999999999999999985  78999999866533  2233445789999999999999999999998743     


Q ss_pred             ---CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          268 ---YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       268 ---~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                         ..++|++++ +++|..++.....         ..++..++.++.||+.||+|||++|  |+||||||+||||+.++.
T Consensus        95 ~~~~~~lv~e~~-~~~l~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~  162 (351)
T 3mi9_A           95 CKGSIYLVFDFC-EHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGV  162 (351)
T ss_dssp             --CEEEEEEECC-SEEHHHHHHCTTS---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSC
T ss_pred             CCceEEEEEecc-CCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCC
Confidence               345566655 5688887754221         2457889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC-------ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDG-------EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~-------~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      +||+|||++......       .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+  .......
T Consensus       163 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~  240 (351)
T 3mi9_A          163 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLAL  240 (351)
T ss_dssp             EEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH
T ss_pred             EEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC--hHHHHHH
Confidence            999999999876522       123457999999999876 568999999999999999999999998766  3333333


Q ss_pred             Hhc--CCCCCCCCCC-c-------------------------hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGE--GKLRPALPEE-D-------------------------GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~--~~~~~~l~~~-~-------------------------~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..  +...+..... .                         .....+.++|.+||..||++|||++++++
T Consensus       241 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          241 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            222  2211111110 0                         01356889999999999999999999885

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.9e-41  Score=333.73  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=198.1

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE  265 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~  265 (472)
                      ......++|++.+.||+|+||.||+|.+.  |..||||++.....     ....+.+|+.+++.+ +||||+++++++..
T Consensus        18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-----EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-----cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            33445679999999999999999999994  78999999865421     234588999999999 89999999999987


Q ss_pred             ------CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          266 ------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       266 ------~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                            .+..++|++++.+++|.+++.....        ...+...++.++.||+.||+|||++|  ++||||||+|||+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~  162 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG--------NTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLL  162 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSGG--------GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEE
Confidence                  3467788888889999999975321        12346778899999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH
Q 039082          340 DDAKHVRIADFGHARFLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA  411 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~  411 (472)
                      +.++.+||+|||++......   .....|++.|+|||++.     ...++.++|||||||++|+|++|..||.+..  ..
T Consensus       163 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~  240 (326)
T 2x7f_A          163 TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PM  240 (326)
T ss_dssp             CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC--HH
T ss_pred             cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc--HH
Confidence            99999999999999876532   23456899999999987     5678999999999999999999999997665  44


Q ss_pred             HHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          412 KIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       412 ~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....+....... +. ....+..+.++|.+||..||++||++.++++
T Consensus       241 ~~~~~~~~~~~~~-~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          241 RALFLIPRNPAPR-LK-SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHHHSCCCC-CS-CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhcCcccc-CC-ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            4444444433221 11 1334567889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=5.9e-41  Score=332.30  Aligned_cols=256  Identities=20%  Similarity=0.311  Sum_probs=203.0

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC--CCceeEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR--HRFVLQLMGA  262 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~--HpnIv~l~g~  262 (472)
                      ......+..++|++.+.||+|+||.||+|.+. +..||||++....  ........+.+|+.+++.++  ||||++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE--ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEecccc--ccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            44556778889999999999999999999886 6789999997653  24556778999999999997  5999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      +...+..+++++ +.+++|.+++....          ..+...++.++.|++.||+|||++|  |+||||||+|||+++ 
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-  162 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKKK----------SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-  162 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHCS----------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-
Confidence            988877766666 78999999996532          2346788899999999999999999  999999999999974 


Q ss_pred             CcEEEeecccceecCCCc-----cccccCCcccccccccC-----------CCCCchHHHHHHHHHHHHHHcCCCCCCCC
Q 039082          343 KHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQC-----------EPYSEKSDVYSFGIILNEIITGNHPYIEK  406 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~-----------~~~s~~sDvwSlGvll~elltG~~Pf~~~  406 (472)
                      +.+||+|||++.......     ....|++.|+|||.+.+           ..++.++||||||+++|+|++|..||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            899999999998765432     23458999999999875           47889999999999999999999999765


Q ss_pred             CCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          407 DYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       407 ~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ... ......+........++..  .+..+.++|.+||..||++||++.++++.
T Consensus       243 ~~~-~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          243 INQ-ISKLHAIIDPNHEIEFPDI--PEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CSH-HHHHHHHHCTTSCCCCCCC--SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH-HHHHHHHHhcccccCCccc--chHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            432 2333334444333333332  34578899999999999999999999863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.4e-41  Score=354.49  Aligned_cols=257  Identities=20%  Similarity=0.265  Sum_probs=202.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-CceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~g~~~~~~~~~  270 (472)
                      .++|++.++||+|+||.||+|.+.  +..||||++......      ..+.+|+++++.++| ++|..+..++...+..+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH------PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS------CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence            468999999999999999999985  789999988654322      127889999999977 45555555555555556


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE---cCCCcEEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRI  347 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl---~~~~~vkL  347 (472)
                      +|++++ +++|.+++.....         ..++..++.++.||+.||+|||++|  ||||||||+||||   +.++.+||
T Consensus        80 lvme~~-g~sL~~ll~~~~~---------~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL  147 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCSR---------KLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYI  147 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEE
T ss_pred             EEEECC-CCCHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEE
Confidence            666666 9999999964322         2457889999999999999999999  9999999999999   68899999


Q ss_pred             eecccceecCCCcc----------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHHHHH
Q 039082          348 ADFGHARFLSDGEM----------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIAME  416 (472)
Q Consensus       348 ~DFGla~~~~~~~~----------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i~~~  416 (472)
                      +|||+++.......          ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .......
T Consensus       148 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~  227 (483)
T 3sv0_A          148 IDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEK  227 (483)
T ss_dssp             CCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHH
T ss_pred             EeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHH
Confidence            99999988764332          456899999999999999999999999999999999999999875432 2223333


Q ss_pred             HhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          417 VGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       417 i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +........+... ...+.++.++|..||..+|++||++.+|++.|+++..+.
T Consensus       228 i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~  280 (483)
T 3sv0_A          228 ISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE  280 (483)
T ss_dssp             HHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence            3222211111111 233567899999999999999999999999999987654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.2e-41  Score=338.87  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=195.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCC----CChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFH----TNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~----~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~  268 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||++......    ........+.+|+.+|+.++||||+++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            47899999999999999999986  678999999764321    11223345889999999999999999999987654 


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc---E
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH---V  345 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~---v  345 (472)
                      .++|++++.+++|.+++....          ..+...++.++.||+.||+|||++|  |+||||||+|||++.++.   +
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTC----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSCCE
T ss_pred             eEEEEecCCCCcHHHHHhccC----------CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCCeE
Confidence            788899998999999885422          2346788899999999999999999  999999999999987654   9


Q ss_pred             EEeecccceecCCCc--cccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          346 RIADFGHARFLSDGE--MALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       346 kL~DFGla~~~~~~~--~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      ||+|||++.......  ....||+.|+|||++.   ...++.++|||||||++|+|++|..||...... ..+...+..+
T Consensus       157 kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~  235 (322)
T 2ycf_A          157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ-VSLKDQITSG  235 (322)
T ss_dssp             EECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS-SCHHHHHHHT
T ss_pred             EEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH-HHHHHHHHhC
Confidence            999999998876543  2345899999999974   567899999999999999999999999765432 1233334444


Q ss_pred             CCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ... ..+.. ...+..+.++|.+||..||++||++.++++
T Consensus       236 ~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          236 KYN-FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccc-cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            321 11111 234567899999999999999999999984

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=331.04  Aligned_cols=249  Identities=21%  Similarity=0.290  Sum_probs=199.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc--CCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~--~~~~~  270 (472)
                      ++|++.+.||+|+||.||+|.++  +..||||+++.............+.+|+.+++.++||||+++++++..  ....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            57999999999999999999985  678999999754322223455779999999999999999999999854  34566


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|+|++.++ |.+++.....        ...++..++.++.||+.||+|||++|  ++||||||+|||++.++.+||+||
T Consensus        85 lv~e~~~~~-l~~~~~~~~~--------~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPE--------KRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTT--------CSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred             EEehhccCC-HHHHHHhCcc--------cccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecc
Confidence            777776655 7777754321        12357889999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCc-----cccccCCcccccccccCCC--CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          351 GHARFLSDGE-----MALTGTFVYMAPEVIQCEP--YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       351 Gla~~~~~~~-----~~~~gt~~y~APE~~~~~~--~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      |++.......     ....|++.|+|||++.+..  ++.++||||||+++|+|++|..||.+.+  .......+..+.. 
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~i~~~~~-  230 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--IYKLFENIGKGSY-  230 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCC-
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--HHHHHHHHhcCCC-
Confidence            9998765321     2345899999999997644  3789999999999999999999998765  5556666666542 


Q ss_pred             CCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       424 ~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                       .++  ...+..+.++|.+||..||++||++.++++.
T Consensus       231 -~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 -AIP--GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -CCC--SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -CCC--CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             222  2345678899999999999999999999863

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=5.7e-41  Score=342.12  Aligned_cols=250  Identities=20%  Similarity=0.239  Sum_probs=197.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC--------CCceeEEEEEE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR--------HRFVLQLMGAC  263 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~--------HpnIv~l~g~~  263 (472)
                      .++|++.+.||+|+||.||+|.+.  +..||||+++.     .......+.+|+.+|+.++        ||||+++++++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec-----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            478999999999999999999885  78899999864     3455667899999999996        78899999998


Q ss_pred             E----cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEE
Q 039082          264 L----EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIF  338 (472)
Q Consensus       264 ~----~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NIL  338 (472)
                      .    .....++|++++ +++|.+++.....        ...++..++.++.||+.||+|||++ |  |+||||||+|||
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIl  179 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNY--------QGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENIL  179 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEE
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHee
Confidence            7    334455555555 8888877754321        1235788999999999999999998 9  999999999999


Q ss_pred             EcCCC-------------------------------------------------cEEEeecccceecCCCccccccCCcc
Q 039082          339 LDDAK-------------------------------------------------HVRIADFGHARFLSDGEMALTGTFVY  369 (472)
Q Consensus       339 l~~~~-------------------------------------------------~vkL~DFGla~~~~~~~~~~~gt~~y  369 (472)
                      |+.++                                                 .+||+|||++...........||+.|
T Consensus       180 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y  259 (397)
T 1wak_A          180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQY  259 (397)
T ss_dssp             ECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGG
T ss_pred             EeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcc
Confidence            99775                                                 79999999999887766677899999


Q ss_pred             cccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC----HHHHHHHHhc--CCC----------C----------
Q 039082          370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK----PAKIAMEVGE--GKL----------R----------  423 (472)
Q Consensus       370 ~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~----~~~i~~~i~~--~~~----------~----------  423 (472)
                      +|||++.+..++.++|||||||++|+|++|+.||...+..    .......+..  +..          .          
T Consensus       260 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  339 (397)
T 1wak_A          260 RSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDL  339 (397)
T ss_dssp             CCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSB
T ss_pred             cCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccc
Confidence            9999999999999999999999999999999999764421    1111111100  100          0          


Q ss_pred             ----C------------CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 ----P------------ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ----~------------~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                          .            ..+........+.++|.+||..||++|||++++++
T Consensus       340 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          340 KHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             SSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                0            00111345677899999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=336.42  Aligned_cols=252  Identities=23%  Similarity=0.304  Sum_probs=198.0

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      ..|.+. ++|.+.+.||+|+||.||+|.++  |..||||++....  ........+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   94 (353)
T 3coi_A           18 TAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF--QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTP   94 (353)
T ss_dssp             EEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred             cccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCCcccHhheEec
Confidence            456654 68999999999999999999986  7899999997643  344556778999999999999999999999987


Q ss_pred             CCCc------eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          266 PPYR------GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       266 ~~~~------~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      ....      +++++++ +++|.+++..            ..+...+..++.||+.||+|||++|  |+||||||+|||+
T Consensus        95 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~------------~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~  159 (353)
T 3coi_A           95 ASSLRNFYDFYLVMPFM-QTDLQKIMGL------------KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAV  159 (353)
T ss_dssp             CSSGGGCCCCEEEEECC-SEEGGGTTTS------------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEE
T ss_pred             ccccccceeEEEEeccc-cCCHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeE
Confidence            6543      5666665 5788776632            1356889999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          340 DDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +.++.+||+|||++...........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+  .......+.
T Consensus       160 ~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~~~~~~~i~  237 (353)
T 3coi_A          160 NEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQIL  237 (353)
T ss_dssp             CTTCCEEECSTTCTTC--------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC--HHHHHHHHH
T ss_pred             CCCCcEEEeecccccCCCCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH
Confidence            99999999999999887666566678999999999876 678999999999999999999999998765  222222221


Q ss_pred             c--C------------------------CCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 E--G------------------------KLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ~--~------------------------~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .  +                        ..+..++.. +..+..+.++|.+||..||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1  0                        001111111 345678899999999999999999999875

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.8e-40  Score=336.38  Aligned_cols=248  Identities=23%  Similarity=0.313  Sum_probs=195.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----  267 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----  267 (472)
                      ..+|++.+.||+|+||.||+|.+.  +..||||++...   ........+.+|+.+|+.++||||+++++++....    
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc---cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence            468999999999999999999986  778999999753   34455677999999999999999999999987653    


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ...++++++.+++|.+++....           .+...++.++.||+.||+|||++|  |+||||||+||||+.++.+||
T Consensus       103 ~~~~iv~e~~~~~L~~~l~~~~-----------~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl  169 (364)
T 3qyz_A          103 KDVYIVQDLMETDLYKLLKTQH-----------LSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKI  169 (364)
T ss_dssp             CCEEEEEECCSEEHHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEE
T ss_pred             ceEEEEEcccCcCHHHHHHhCC-----------CCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEE
Confidence            2344555555679999985421           346788999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc-
Q 039082          348 ADFGHARFLSDGE------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE-  419 (472)
Q Consensus       348 ~DFGla~~~~~~~------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~-  419 (472)
                      +|||++.......      ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+...  ....+.. 
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~  247 (364)
T 3qyz_A          170 CDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD--QLNHILGI  247 (364)
T ss_dssp             CCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG--HHHHHHHH
T ss_pred             EeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH--HHHHHHHH
Confidence            9999998765332      23468999999998654 558999999999999999999999998765322  2111110 


Q ss_pred             -CC----------------------CCCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 -GK----------------------LRPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 -~~----------------------~~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       +.                      .....+.   .+.....+.++|.+||..||++|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          248 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             00                      0000000   0223467899999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-40  Score=331.81  Aligned_cols=245  Identities=19%  Similarity=0.293  Sum_probs=196.2

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEc--CC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLE--PP  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~--~~  267 (472)
                      ..++|++.+.||+|+||.||+|.+.  +..||||+++..       ..+.+.+|+.+|+.++ ||||+++++++..  ..
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            4578999999999999999999885  789999998642       1345889999999997 9999999999987  55


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vk  346 (472)
                      ..++|++++.+++|..++..             .+...++.++.||+.||+|||++|  |+||||||+|||++.++ .+|
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~k  171 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT-------------LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLR  171 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG-------------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEE
T ss_pred             ceEEEEeccCchhHHHHHHh-------------CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEE
Confidence            67889999999999998843             235778899999999999999999  99999999999999776 899


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHH---------
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIA---------  414 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~---------  414 (472)
                      |+|||++.......  ....|++.|+|||++.+ ..++.++|||||||++|+|++|..||.........+.         
T Consensus       172 l~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~  251 (330)
T 3nsz_A          172 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE  251 (330)
T ss_dssp             ECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred             EEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCc
Confidence            99999998765432  34568999999999877 6799999999999999999999999965432211111         


Q ss_pred             ---HHHhcCCCCC------------------CCCC--CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          415 ---MEVGEGKLRP------------------ALPE--EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       415 ---~~i~~~~~~~------------------~l~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                         ..+.......                  ..+.  ....+.++.++|.+||..||++|||++++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               1111111000                  0000  0224678999999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-41  Score=341.15  Aligned_cols=251  Identities=19%  Similarity=0.281  Sum_probs=190.5

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |....++|++.+.||+|+||.||+|.+.  |..||||++..+...        +.+|+.+|+.++|||||+++++|....
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~--------~~~E~~il~~l~hpnIv~l~~~~~~~~   73 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY--------KNRELDIMKVLDHVNIIKLVDYFYTTG   73 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS--------CCHHHHHHTTCCCTTBCCEEEEEEEC-
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch--------HHHHHHHHHHcCCCCccchhheeeecC
Confidence            4566789999999999999999999985  789999998754321        237999999999999999999985432


Q ss_pred             C--------------------------------------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHH
Q 039082          268 Y--------------------------------------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR  309 (472)
Q Consensus       268 ~--------------------------------------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i  309 (472)
                      .                                      .++|++++ +++|.+++......      ....++..+..+
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~------~~~l~~~~~~~i  146 (383)
T 3eb0_A           74 DEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRS------GRSIPMNLISIY  146 (383)
T ss_dssp             ------------------------------------CCEEEEEECCC-SEEHHHHHHHHHHT------TCCCCHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccCCCceEEEEEEecC-CccHHHHHHHHHhc------CCCCCHHHHHHH
Confidence            2                                      44555555 57888887542211      123457889999


Q ss_pred             HHHHHHHHHHHHhcCCceeecCCCCCcEEEc-CCCcEEEeecccceecCCC--ccccccCCcccccccccCC-CCCchHH
Q 039082          310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCE-PYSEKSD  385 (472)
Q Consensus       310 ~~qia~gL~yLH~~~~~iiHrDLkp~NILl~-~~~~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~-~~s~~sD  385 (472)
                      +.||+.||+|||++|  |+||||||+|||++ .++.+||+|||+++.....  .....||+.|+|||.+.+. .++.++|
T Consensus       147 ~~qi~~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~D  224 (383)
T 3eb0_A          147 IYQLFRAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSID  224 (383)
T ss_dssp             HHHHHHHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHH
T ss_pred             HHHHHHHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchh
Confidence            999999999999999  99999999999998 6899999999999976543  3345689999999998764 5899999


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC-------------CCCCCCC----------CchhHHHHHHHH
Q 039082          386 VYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK-------------LRPALPE----------EDGQLRELIELI  440 (472)
Q Consensus       386 vwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~-------------~~~~l~~----------~~~~~~~l~~li  440 (472)
                      ||||||++|+|++|+.||.+.+  ..+....+..  +.             ....++.          ....+..+.++|
T Consensus       225 iwslG~il~ell~g~~pf~~~~--~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  302 (383)
T 3eb0_A          225 LWSIGCVFGELILGKPLFSGET--SIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL  302 (383)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHH
T ss_pred             hhhHHHHHHHHHhCCCCCCCCC--hHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHH
Confidence            9999999999999999998765  3333333221  00             0001111          012456789999


Q ss_pred             HHhccCCCCCCCCHHHHHH
Q 039082          441 CLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       441 ~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+||..||++|||+.++++
T Consensus       303 ~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          303 EQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHCCSSGGGSCCHHHHHT
T ss_pred             HHHccCChhhCCCHHHHhc
Confidence            9999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-40  Score=333.29  Aligned_cols=248  Identities=21%  Similarity=0.294  Sum_probs=200.9

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--C-eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc------eeEEEEEEE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--G-LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF------VLQLMGACL  264 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g-~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn------Iv~l~g~~~  264 (472)
                      .++|++.+.||+|+||.||+|.+.  + ..||||+++.     .......+.+|+.+++.++|++      ++.+++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~-----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN-----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc-----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence            478999999999999999999985  3 6899999864     3345567889999999998766      999999998


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE-----
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL-----  339 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl-----  339 (472)
                      ..+..++|+|++ +++|.+++.....        ...++..++.++.||+.||+|||++|  |+||||||+||||     
T Consensus        93 ~~~~~~lv~e~~-~~~l~~~l~~~~~--------~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~  161 (355)
T 2eu9_A           93 FHGHMCIAFELL-GKNTFEFLKENNF--------QPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEF  161 (355)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTT--------CCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCE
T ss_pred             eCCeEEEEEecc-CCChHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccc
Confidence            888888888877 7888887754321        12357889999999999999999999  9999999999999     


Q ss_pred             --------------cCCCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCC
Q 039082          340 --------------DDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIE  405 (472)
Q Consensus       340 --------------~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~  405 (472)
                                    +.++.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          162 ETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             EEEECCC-CCCEEEESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence                          567899999999999877776777899999999999999999999999999999999999999987


Q ss_pred             CCCCHHHHHHHHhc--CCC--------------------------------------CCCCCCCchhHHHHHHHHHHhcc
Q 039082          406 KDYKPAKIAMEVGE--GKL--------------------------------------RPALPEEDGQLRELIELICLSWD  445 (472)
Q Consensus       406 ~~~~~~~i~~~i~~--~~~--------------------------------------~~~l~~~~~~~~~l~~li~~cl~  445 (472)
                      .+.  ......+..  +..                                      .............+.++|.+||.
T Consensus       242 ~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  319 (355)
T 2eu9_A          242 HEN--REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE  319 (355)
T ss_dssp             SSH--HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred             CCH--HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence            652  222211111  110                                      00011113345688999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 039082          446 GDASVRPSFSSITC  459 (472)
Q Consensus       446 ~dP~~RPs~~~ll~  459 (472)
                      .||++|||+.++++
T Consensus       320 ~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          320 FDPAQRITLAEALL  333 (355)
T ss_dssp             SSTTTSCCHHHHTT
T ss_pred             CChhhCcCHHHHhc
Confidence            99999999999874

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-41  Score=339.44  Aligned_cols=261  Identities=18%  Similarity=0.254  Sum_probs=209.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCCh-------------HHHHHHHHHHHHHHhcCCCceeEEE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNE-------------NAVTFFAQEVDTLSRQRHRFVLQLM  260 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~-------------~~~~~f~~E~~il~~l~HpnIv~l~  260 (472)
                      .++|++.+.||+|+||.||+|.+.|..||||++.........             .....|.+|+.+++.++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            479999999999999999999999999999999754322111             1126689999999999999999999


Q ss_pred             EEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEE
Q 039082          261 GACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       261 g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl  339 (472)
                      +++.+.+..++|+|++.+++|.+++........  ......++..++.++.|++.||+|||+ +|  ++||||||+|||+
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~p~Nil~  185 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILM  185 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCCGGGEEE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCChHhEEE
Confidence            999999999999999999999988432111100  012334678899999999999999999 99  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCC-ccccccCCcccccccccCC-CCCc-hHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDG-EMALTGTFVYMAPEVIQCE-PYSE-KSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~-~~~~~gt~~y~APE~~~~~-~~s~-~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      +.++.+||+|||++...... .....|++.|+|||++.+. .++. ++||||||+++|+|++|..||...... ......
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~  264 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL-VELFNN  264 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS-HHHHHH
T ss_pred             cCCCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHH
Confidence            99999999999999886543 3345689999999999877 6666 999999999999999999999876532 445555


Q ss_pred             HhcCCCCCCCCC---------------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGEGKLRPALPE---------------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~~~~~~~l~~---------------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..+....+...               ....+..+.++|.+||..||.+||++.++++
T Consensus       265 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            655543221100               0234568899999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=329.45  Aligned_cols=258  Identities=25%  Similarity=0.369  Sum_probs=191.6

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ....|.+..++|++.+.||+|+||.||+|.++  |..||||++....  ........+.++..+++.++||||+++++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~   93 (318)
T 2dyl_A           16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCFGTF   93 (318)
T ss_dssp             SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence            34567778889999999999999999999996  7899999997652  2333444555666678888999999999999


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceeecCCCCCcEEEcCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiHrDLkp~NILl~~~  342 (472)
                      ...+..++|+|++ ++.+..+.....         ...+...++.++.+++.||+|||++ |  ++||||||+|||++.+
T Consensus        94 ~~~~~~~lv~e~~-~~~~~~l~~~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~  161 (318)
T 2dyl_A           94 ITNTDVFIAMELM-GTCAEKLKKRMQ---------GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDER  161 (318)
T ss_dssp             ECSSEEEEEECCC-SEEHHHHHHHHT---------SCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTT
T ss_pred             ecCCcEEEEEecc-CCcHHHHHHHhc---------cCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCC
Confidence            9988887888777 666666553221         1235678889999999999999995 9  9999999999999999


Q ss_pred             CcEEEeecccceecCCCc--cccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      +.+||+|||++.......  ....|++.|+|||++.     ...++.++||||||+++|+|++|..||..... ......
T Consensus       162 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-~~~~~~  240 (318)
T 2dyl_A          162 GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-DFEVLT  240 (318)
T ss_dssp             SCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-HHHHHH
T ss_pred             CCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-cHHHHH
Confidence            999999999997765432  2346899999999984     55789999999999999999999999976443 334444


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+..+. .+.++.....+..+.++|.+||..||.+||+++++++
T Consensus       241 ~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          241 KVLQEE-PPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHSC-CCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHhccC-CCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            444443 3344443445678899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-40  Score=326.32  Aligned_cols=243  Identities=28%  Similarity=0.412  Sum_probs=191.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC------
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP------  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~------  266 (472)
                      ++|++.+.||+|+||.||+|.+.  |..||||++..     .......+.+|+.+++.++||||+++++++.+.      
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            46899999999999999999985  78999999854     345567799999999999999999999988653      


Q ss_pred             -------CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          267 -------PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       267 -------~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                             ...++|++++.+++|.+++.....         ..+...++.++.|++.||+|||++|  ++||||||+|||+
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~  149 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENL---------NQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFI  149 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCG---------GGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEE
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhcccc---------ccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEE
Confidence                   346788888889999999975332         1235778899999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCC-----------------ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCC
Q 039082          340 DDAKHVRIADFGHARFLSDG-----------------EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNH  401 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~-----------------~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~  401 (472)
                      +.++.+||+|||++......                 .....|++.|+|||++.+. .++.++|||||||++|+|++   
T Consensus       150 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---  226 (303)
T 1zy4_A          150 DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---  226 (303)
T ss_dssp             CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---
T ss_pred             cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---
Confidence            99999999999999866422                 1234589999999999864 78999999999999999998   


Q ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          402 PYIEKDYKPAKIAMEVGEGKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       402 Pf~~~~~~~~~i~~~i~~~~~~~~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ||.... ........+.....  .++..  ...+..+.++|.+||..||++|||+.++++
T Consensus       227 p~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          227 PFSTGM-ERVNILKKLRSVSI--EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             CCSSHH-HHHHHHHHHHSTTC--CCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCch-hHHHHHHhcccccc--ccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            554321 12233344444322  22222  345567889999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-40  Score=337.54  Aligned_cols=256  Identities=19%  Similarity=0.277  Sum_probs=198.6

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-----------CC
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-----------HR  254 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-----------Hp  254 (472)
                      .+..+..++|++.+.||+|+||.||+|.+.  +..||||++..     .......+.+|+.+++.++           ||
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~   86 (373)
T 1q8y_A           12 KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN   86 (373)
T ss_dssp             TTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred             cCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-----CccchhhhhHHHHHHHHhhcccccchhccccc
Confidence            345567789999999999999999999985  78999999864     3344566889999999886           89


Q ss_pred             ceeEEEEEEEcCC----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCceee
Q 039082          255 FVLQLMGACLEPP----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-KPKVIH  329 (472)
Q Consensus       255 nIv~l~g~~~~~~----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-~~~iiH  329 (472)
                      ||+++++++...+    ..+++++++ +++|.+++......        ..++..++.++.||+.||+|||++ |  |+|
T Consensus        87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~--------~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH  155 (373)
T 1q8y_A           87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHR--------GIPLIYVKQISKQLLLGLDYMHRRCG--IIH  155 (373)
T ss_dssp             TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTS--------CCCHHHHHHHHHHHHHHHHHHHHTTC--EEC
T ss_pred             hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhcc--------CCcHHHHHHHHHHHHHHHHHHHhcCC--EEe
Confidence            9999999988654    344445554 99999999653321        135788999999999999999998 9  999


Q ss_pred             cCCCCCcEEEc------CCCcEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCC
Q 039082          330 RDLKPSNIFLD------DAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPY  403 (472)
Q Consensus       330 rDLkp~NILl~------~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf  403 (472)
                      |||||+||||+      ..+.+||+|||++...........||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       156 ~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  235 (373)
T 1q8y_A          156 TDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF  235 (373)
T ss_dssp             SCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred             cCCChHHeEEeccCCCcCcceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCC
Confidence            99999999994      445899999999998877666678999999999999999999999999999999999999999


Q ss_pred             CCCCCC----HHHHHHHHhc--CCCC------------------------------------CCCCCCchhHHHHHHHHH
Q 039082          404 IEKDYK----PAKIAMEVGE--GKLR------------------------------------PALPEEDGQLRELIELIC  441 (472)
Q Consensus       404 ~~~~~~----~~~i~~~i~~--~~~~------------------------------------~~l~~~~~~~~~l~~li~  441 (472)
                      ...+..    .......+..  +..+                                    .........+..+.++|.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  315 (373)
T 1q8y_A          236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS  315 (373)
T ss_dssp             ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred             CCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHH
Confidence            765421    1111111111  0000                                    000111345678899999


Q ss_pred             HhccCCCCCCCCHHHHHH
Q 039082          442 LSWDGDASVRPSFSSITC  459 (472)
Q Consensus       442 ~cl~~dP~~RPs~~~ll~  459 (472)
                      +||..||++|||++++++
T Consensus       316 ~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          316 PMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GGGCSSTTTCBCHHHHHT
T ss_pred             HHhccCccccCCHHHHhh
Confidence            999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.9e-40  Score=331.46  Aligned_cols=247  Identities=23%  Similarity=0.299  Sum_probs=194.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-----
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-----  266 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-----  266 (472)
                      .++|++.+.||+|+||.||+|.++  |..||||++...   ........+.+|+.+++.++||||+++++++...     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF---DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc---ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence            468999999999999999999986  789999999643   3445566788999999999999999999987764     


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...++|+++ .+++|.+++...           ..+...++.++.|++.||+|||++|  |+||||||+|||++.++.+|
T Consensus        87 ~~~~lv~e~-~~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~k  152 (353)
T 2b9h_A           87 NEVYIIQEL-MQTDLHRVISTQ-----------MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLK  152 (353)
T ss_dssp             CCEEEEECC-CSEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEE
T ss_pred             ceEEEEEec-cCccHHHHHhhc-----------CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEE
Confidence            334455555 567999988641           2356889999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc-------------cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHH
Q 039082          347 IADFGHARFLSDGE-------------MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK  412 (472)
Q Consensus       347 L~DFGla~~~~~~~-------------~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~  412 (472)
                      |+|||++.......             ....||+.|+|||++.. ..++.++|||||||++|+|++|..||.+.+.  ..
T Consensus       153 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~  230 (353)
T 2b9h_A          153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY--RH  230 (353)
T ss_dssp             ECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--HH
T ss_pred             EEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc--HH
Confidence            99999998765321             12457999999998754 7789999999999999999999999987662  22


Q ss_pred             HHHHHhc--CCCC--------------------CCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          413 IAMEVGE--GKLR--------------------PALPEE------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       413 i~~~i~~--~~~~--------------------~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+..  +...                    +..+..      +..+..+.++|.+||..||++|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          231 QLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            2211110  1000                    000000      234567889999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.4e-40  Score=333.47  Aligned_cols=200  Identities=24%  Similarity=0.307  Sum_probs=170.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CC-----ceeEEEEEEEc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HR-----FVLQLMGACLE  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-Hp-----nIv~l~g~~~~  265 (472)
                      .++|++.+.||+|+||.||+|.++  +..||||+++.     .......+.+|+.+++.++ |+     +|+++++++..
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN-----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS-----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec-----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            478999999999999999999986  77899999964     3344566788999998885 44     49999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc--CCC
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAK  343 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~--~~~  343 (472)
                      .+..++|+|++ +++|.+++.....        ...++..+..++.|++.||.|||++..+|+||||||+||||+  .++
T Consensus       128 ~~~~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          128 RNHLCLVFEML-SYNLYDLLRNTNF--------RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTT--------SCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC
T ss_pred             CCceEEEEecC-CCCHHHHHhhcCc--------CCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC
Confidence            88888888877 5699999965331        123578899999999999999995322399999999999994  578


Q ss_pred             cEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Q 039082          344 HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD  407 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~  407 (472)
                      .+||+|||+++..........||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+
T Consensus       199 ~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CEEECCCTTCEETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cEEEEeccCceecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            8999999999988777677789999999999999999999999999999999999999998765

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.5e-40  Score=328.95  Aligned_cols=251  Identities=22%  Similarity=0.287  Sum_probs=194.4

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc---CCCceeEEEEEEE---
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---RHRFVLQLMGACL---  264 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~g~~~---  264 (472)
                      .++|++.+.||+|+||.||+|.+.   |..||||+++......  .....+.+|+.+++.+   +||||+++++++.   
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc--cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            368999999999999999999983   6789999997543211  1122366788777766   8999999999987   


Q ss_pred             --cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          265 --EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       265 --~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                        .....++|++++ +++|.+++.....        ...+...++.++.|++.||+|||++|  |+||||||+|||++.+
T Consensus        88 ~~~~~~~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~  156 (326)
T 1blx_A           88 TDRETKLTLVFEHV-DQDLTTYLDKVPE--------PGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSS  156 (326)
T ss_dssp             CSSEEEEEEEEECC-SCBHHHHHHHSCT--------TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTT
T ss_pred             cCCCceEEEEEecC-CCCHHHHHHhccc--------CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCC
Confidence              334455555555 5799999965332        12357889999999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          343 KHVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      +.+||+|||++......  .....|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+  .......+...
T Consensus       157 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~i~~~  234 (326)
T 1blx_A          157 GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDV  234 (326)
T ss_dssp             CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHH
T ss_pred             CCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHH
Confidence            99999999999876532  234568999999999999999999999999999999999999998765  33333333211


Q ss_pred             C-------CC---------------CCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 K-------LR---------------PALPE-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~-------~~---------------~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .       +.               ..+.. ....+..+.++|.+||..||++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0       00               00000 1234567889999999999999999999984

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=327.13  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=188.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc------
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE------  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~------  265 (472)
                      .++|++.+.||+|+||.||+|.++  |..||||++...    .....+.+.+|+.+++.++||||+++++++..      
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   85 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLT   85 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC----SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC----ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccc
Confidence            478999999999999999999997  789999998653    45566789999999999999999999998743      


Q ss_pred             --------CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcE
Q 039082          266 --------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI  337 (472)
Q Consensus       266 --------~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NI  337 (472)
                              ....++|++++ +++|.+++...           ..+...++.++.|++.||+|||++|  |+||||||+||
T Consensus        86 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-----------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Ni  151 (320)
T 2i6l_A           86 DDVGSLTELNSVYIVQEYM-ETDLANVLEQG-----------PLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANL  151 (320)
T ss_dssp             C----CCSCSEEEEEEECC-SEEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGE
T ss_pred             cccccccccCceeEEeecc-CCCHHHHhhcC-----------CccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHE
Confidence                    23455666666 57999998531           1346788899999999999999999  99999999999


Q ss_pred             EEc-CCCcEEEeecccceecCCC------ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC
Q 039082          338 FLD-DAKHVRIADFGHARFLSDG------EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYK  409 (472)
Q Consensus       338 Ll~-~~~~vkL~DFGla~~~~~~------~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~  409 (472)
                      |++ +++.+||+|||++......      .....++..|+|||.+.. ..++.++||||||+++|+|++|+.||.+.+  
T Consensus       152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--  229 (320)
T 2i6l_A          152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH--  229 (320)
T ss_dssp             EEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             EEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC--
Confidence            997 5679999999999876432      123456899999998865 678999999999999999999999998765  


Q ss_pred             HHHHHHHHhcCCC-----------------------CCCCCC---CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          410 PAKIAMEVGEGKL-----------------------RPALPE---EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       410 ~~~i~~~i~~~~~-----------------------~~~l~~---~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .......+.....                       .+..+.   .+..+.++.++|.+||..||++||+++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            3333332222110                       000000   0234567899999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.6e-41  Score=335.63  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=198.8

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh--HHHHHHHHHHHHHHhcC--CCceeEEEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE--NAVTFFAQEVDTLSRQR--HRFVLQLMG  261 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~--~~~~~f~~E~~il~~l~--HpnIv~l~g  261 (472)
                      ..+..-.++|++.+.||+|+||.||+|.+.  +..||||++.........  .....+.+|+.+++.++  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            344556789999999999999999999985  789999999765432110  11234678999999996  599999999


Q ss_pred             EEEcCCCceEEEEeccC-CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          262 ACLEPPYRGWLVTELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       262 ~~~~~~~~~~vve~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ++...+..+++++++.+ ++|.+++...+.          .+...++.++.||+.||+|||++|  |+||||||+||||+
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~----------l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~  183 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERGA----------LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILID  183 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEE
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccCC----------CCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEe
Confidence            99999888899999876 899999965321          346788899999999999999999  99999999999999


Q ss_pred             -CCCcEEEeecccceecCCCc-cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          341 -DAKHVRIADFGHARFLSDGE-MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       341 -~~~~vkL~DFGla~~~~~~~-~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                       +++.+||+|||++....... ....||+.|+|||++.+..+ +.++||||||+++|+|++|..||....    .    +
T Consensus       184 ~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~----~----~  255 (320)
T 3a99_A          184 LNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----E----I  255 (320)
T ss_dssp             TTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----H----H
T ss_pred             CCCCCEEEeeCccccccccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----h----h
Confidence             78999999999998876443 34568999999999987665 688999999999999999999996432    1    1


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..  ..+  ...+..+.++|.+||..||++||++++|++
T Consensus       256 ~~~~~--~~~--~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          256 IRGQV--FFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHCCC--CCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcccc--ccc--ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12211  111  234467889999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.2e-40  Score=335.28  Aligned_cols=246  Identities=20%  Similarity=0.284  Sum_probs=188.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC-----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY-----  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~-----  268 (472)
                      .+|++.+.||+|+||.||+|.+. +..||+|.+..+...        ..+|+.+|+.++|||||+++++|.....     
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~--------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF--------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS--------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch--------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            57999999999999999999986 556999988654221        2369999999999999999999865443     


Q ss_pred             -ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc-CCCcEE
Q 039082          269 -RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVR  346 (472)
Q Consensus       269 -~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~-~~~~vk  346 (472)
                       .++|++++.+ ++...+......      ....+...++.++.||+.||+|||++|  |+||||||+||||+ .++.+|
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~k  182 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKL------KQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLK  182 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEE
Confidence             5566666654 554444321111      123456788899999999999999999  99999999999999 799999


Q ss_pred             EeecccceecCCC--ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC---
Q 039082          347 IADFGHARFLSDG--EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG---  420 (472)
Q Consensus       347 L~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~---  420 (472)
                      |+|||+|+.....  .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+  ..+....+...   
T Consensus       183 L~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~l~~i~~~~g~  260 (394)
T 4e7w_A          183 LIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGES--GIDQLVEIIKVLGT  260 (394)
T ss_dssp             ECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCC
T ss_pred             EeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhCC
Confidence            9999999876533  3345689999999998764 59999999999999999999999998765  33232222210   


Q ss_pred             ------------CCCCCCCCC----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 ------------KLRPALPEE----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ------------~~~~~l~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                  .....++..          ...+.++.++|.+||..||.+|||+.++++
T Consensus       261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                        001111110          124567899999999999999999999875

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.9e-40  Score=331.02  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=181.7

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC--
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY--  268 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~--  268 (472)
                      ..++|++.+.||+|+||.||+|.++  |..||||++..+....     ..+.+|+..+..++||||+++++++.....  
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR-----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC-----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc-----HHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            3468999999999999999999986  7899999986543222     236678888999999999999999876443  


Q ss_pred             -----ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCceeecCCCCCcEEEcC
Q 039082          269 -----RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH--EQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       269 -----~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH--~~~~~iiHrDLkp~NILl~~  341 (472)
                           .++|++++ +++|...+.....      .....+...+..++.|++.||.|||  ++|  |+||||||+||||+.
T Consensus        96 ~~~~~~~lv~e~~-~~~l~~~~~~~~~------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~--ivH~Dlkp~NIll~~  166 (360)
T 3e3p_A           96 RRDIYLNVVMEYV-PDTLHRCCRNYYR------RQVAPPPILIKVFLFQLIRSIGCLHLPSVN--VCHRDIKPHNVLVNE  166 (360)
T ss_dssp             TTCEEEEEEEECC-SCBHHHHHHHHHT------TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC--CBCSCCCGGGEEEET
T ss_pred             ccceeEEEEeecc-cccHHHHHHHHhh------cccCCCHHHHHHHHHHHHHHHHHHhCCCCC--eecCcCCHHHEEEeC
Confidence                 44555555 5566655532111      1223456778899999999999999  888  999999999999996


Q ss_pred             -CCcEEEeecccceecCCCc--cccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          342 -AKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       342 -~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                       ++.+||+|||++.......  ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+  .......+
T Consensus       167 ~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--~~~~~~~~  244 (360)
T 3e3p_A          167 ADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN--SAGQLHEI  244 (360)
T ss_dssp             TTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred             CCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC--hHHHHHHH
Confidence             8999999999998776433  345689999999998654 48999999999999999999999998765  33333333


Q ss_pred             hcCCCCC---------------------C------CCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRP---------------------A------LPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~---------------------~------l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......+                     .      ++.. ......+.++|.+||..||.+|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            2210000                     0      0000 224678999999999999999999999875

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.4e-40  Score=330.22  Aligned_cols=254  Identities=19%  Similarity=0.212  Sum_probs=190.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCC-------CChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFH-------TNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~-------~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      ...++|++.+.||+|+||.||+|.+. |..||||++......       ......+.+.+|+.+|+.++||||+++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            34578999999999999999999875 788999998654322       1233457799999999999999999999998


Q ss_pred             EcCC-----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          264 LEPP-----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       264 ~~~~-----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ...+     ..++|++++ +++|.+++....         ...+...+..++.||+.||+|||++|  |+||||||+|||
T Consensus        99 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~---------~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl  166 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELM-RTDLAQVIHDQR---------IVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNIL  166 (362)
T ss_dssp             EECCTTTCCEEEEEEECC-SEEHHHHHHCTT---------SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEE
T ss_pred             EeccCCCcceEEEEEccC-CCCHHHHHHhcc---------cCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCChHHEE
Confidence            6533     234555555 578888886322         12457889999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCC--ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~  415 (472)
                      ++.++.+||+|||++......  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  ......
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~  244 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST--FYNQLN  244 (362)
T ss_dssp             ECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHH
T ss_pred             EcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC--HHHHHH
Confidence            999999999999999865432  234568999999999876 679999999999999999999999998765  222222


Q ss_pred             HHhcC----------------------CCCCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          416 EVGEG----------------------KLRPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       416 ~i~~~----------------------~~~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+...                      ......+..      +.....+.++|.+||..||++|||+.++++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            22110                      000011111      233567889999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1e-39  Score=337.70  Aligned_cols=246  Identities=21%  Similarity=0.266  Sum_probs=188.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----C
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----Y  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----~  268 (472)
                      .+|++.+.||+|+||.||+|.++  |..||||++..+..        .+.+|+.+|+.++|||||+++++|....    .
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~  125 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE  125 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence            46999999999999999999995  78999999865421        1347999999999999999999886421    1


Q ss_pred             --ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-CcE
Q 039082          269 --RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-KHV  345 (472)
Q Consensus       269 --~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-~~v  345 (472)
                        .++|++++ .++|..++......      ....++..++.++.||+.||+|||++|  |+||||||+||||+.+ +.+
T Consensus       126 ~~~~lv~e~~-~~~l~~~~~~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~  196 (420)
T 1j1b_A          126 VYLNLVLDYV-PETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVL  196 (420)
T ss_dssp             EEEEEEEECC-CEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEE
T ss_pred             eeEEeehhcc-cccHHHHHHHHhhc------cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeE
Confidence              33455555 55777766432111      123457888999999999999999999  9999999999999965 678


Q ss_pred             EEeecccceecCCC--ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc---
Q 039082          346 RIADFGHARFLSDG--EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE---  419 (472)
Q Consensus       346 kL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~---  419 (472)
                      ||+|||+++.....  .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+  ..+....+..   
T Consensus       197 kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~--~~~~l~~i~~~lg  274 (420)
T 1j1b_A          197 KLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLG  274 (420)
T ss_dssp             EECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHC
T ss_pred             EeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHHHhC
Confidence            99999999976533  3345689999999998764 79999999999999999999999998765  2222222211   


Q ss_pred             ------------CCCCCCCCCC----------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 ------------GKLRPALPEE----------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ------------~~~~~~l~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                  ......++..          ...+.++.++|.+||..||.+||++.++++
T Consensus       275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                        0001111110          123467899999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=339.57  Aligned_cols=254  Identities=22%  Similarity=0.259  Sum_probs=175.9

Q ss_pred             CeeE-eceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc--CCC
Q 039082          196 EIDL-QEKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPY  268 (472)
Q Consensus       196 ~~~l-~~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~--~~~  268 (472)
                      .|++ .++||+|+||.||+|.++    +..||||++.....      ...+.+|+.+|+.++|||||++++++..  ...
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~------~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI------SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC------CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC------CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            3555 458999999999999975    56899999865422      1247899999999999999999999965  334


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE----cCCCc
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL----DDAKH  344 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl----~~~~~  344 (472)
                      .++|+++ ++++|.+++......... ......++..++.++.||+.||+|||++|  |+||||||+||||    +.++.
T Consensus        95 ~~lv~e~-~~~~l~~~~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDY-AEHDLWHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEEC-CSEEHHHHHHHHHHHC--------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeC-CCCCHHHHHHHhcccccc-ccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCCCc
Confidence            4445554 567898888643322111 11122457889999999999999999999  9999999999999    67889


Q ss_pred             EEEeecccceecCCC------ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH-------
Q 039082          345 VRIADFGHARFLSDG------EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP-------  410 (472)
Q Consensus       345 vkL~DFGla~~~~~~------~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~-------  410 (472)
                      +||+|||+++.....      .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....       
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            999999999876532      223568999999999987 458999999999999999999999997654210       


Q ss_pred             HHHHHHHhc--CCCCC-C------CCC---------------C----------chhHHHHHHHHHHhccCCCCCCCCHHH
Q 039082          411 AKIAMEVGE--GKLRP-A------LPE---------------E----------DGQLRELIELICLSWDGDASVRPSFSS  456 (472)
Q Consensus       411 ~~i~~~i~~--~~~~~-~------l~~---------------~----------~~~~~~l~~li~~cl~~dP~~RPs~~~  456 (472)
                      .+....+..  |.... .      ++.               .          ......+.++|.+||..||.+|||+++
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence            111111111  00000 0      000               0          001346789999999999999999999


Q ss_pred             HHH
Q 039082          457 ITC  459 (472)
Q Consensus       457 ll~  459 (472)
                      +++
T Consensus       331 ~L~  333 (405)
T 3rgf_A          331 AMQ  333 (405)
T ss_dssp             HHT
T ss_pred             Hhc
Confidence            885

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=6.1e-40  Score=329.23  Aligned_cols=248  Identities=20%  Similarity=0.313  Sum_probs=171.0

Q ss_pred             CCCeeEec-eeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc----C
Q 039082          194 PKEIDLQE-KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE----P  266 (472)
Q Consensus       194 ~~~~~l~~-~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~----~  266 (472)
                      .++|.+.+ .||+|+||.||+|.++  |..||||++...     ...   ..+....++.++||||+++++++..    .
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~---~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   98 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKA---RQEVDHHWQASGGPHIVCILDVYENMHHGK   98 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHH---HHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHH---HHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence            46788865 6999999999999997  789999998642     121   1222334566799999999999876    3


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CC
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AK  343 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~  343 (472)
                      ...++|+|++.+++|.+++.....        ...++..++.++.||+.||+|||++|  |+||||||+|||++.   ++
T Consensus        99 ~~~~lv~e~~~gg~L~~~l~~~~~--------~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~  168 (336)
T 3fhr_A           99 RCLLIIMECMEGGELFSRIQERGD--------QAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDA  168 (336)
T ss_dssp             EEEEEEEECCTTEEHHHHHHTC-C--------CCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTC
T ss_pred             ceEEEEEeccCCCCHHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCc
Confidence            346788888889999999975332        12457889999999999999999999  999999999999976   45


Q ss_pred             cEEEeecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH--HHHHHHhcC
Q 039082          344 HVRIADFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA--KIAMEVGEG  420 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~--~i~~~i~~~  420 (472)
                      .+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||........  .....+..+
T Consensus       169 ~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  248 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG  248 (336)
T ss_dssp             CEEECCCTTCEEC----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred             eEEEeccccceeccccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence            6999999999876543 2345689999999999888899999999999999999999999976542211  111222222


Q ss_pred             CCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ......+.....+..+.++|.+||..||++|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            222222222455678899999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=327.65  Aligned_cols=246  Identities=24%  Similarity=0.297  Sum_probs=190.0

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh--HHHHHHHHHHHHHHhc----CCCceeEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE--NAVTFFAQEVDTLSRQ----RHRFVLQLMG  261 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~--~~~~~f~~E~~il~~l----~HpnIv~l~g  261 (472)
                      ...-.++|++.+.||+|+||.||+|.++  +..||||++.........  .....+.+|+.++..+    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            3444578999999999999999999884  778999999765332111  1223466799999998    8999999999


Q ss_pred             EEEcCCCceEEEEe-ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          262 ACLEPPYRGWLVTE-LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       262 ~~~~~~~~~~vve~-~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      ++...+..++|+++ +.+++|.+++...+.          .++..++.++.||+.||+|||++|  |+||||||+|||++
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~----------~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~  173 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEKGP----------LGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILID  173 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEe
Confidence            99988888999998 679999999965321          347889999999999999999999  99999999999999


Q ss_pred             -CCCcEEEeecccceecCCCc-cccccCCcccccccccCCCCC-chHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          341 -DAKHVRIADFGHARFLSDGE-MALTGTFVYMAPEVIQCEPYS-EKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       341 -~~~~vkL~DFGla~~~~~~~-~~~~gt~~y~APE~~~~~~~s-~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                       .++.+||+|||++....... ....|++.|+|||++.+..+. .++||||||+++|+|++|+.||....    .+    
T Consensus       174 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----~~----  245 (312)
T 2iwi_A          174 LRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EI----  245 (312)
T ss_dssp             TTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----HH----
T ss_pred             CCCCeEEEEEcchhhhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH----HH----
Confidence             88999999999998876433 345689999999998877664 58999999999999999999996432    11    


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....  ..++  ......+.++|.+||..||++||+++++++
T Consensus       246 ~~~~--~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          246 LEAE--LHFP--AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HHTC--CCCC--TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             hhhc--cCCc--ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1221  1222  234557889999999999999999999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.2e-39  Score=338.55  Aligned_cols=247  Identities=22%  Similarity=0.334  Sum_probs=184.8

Q ss_pred             CeeEeceeeccCceEEEEE-EECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRA-IWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a-~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|.+.+.||+|+||+||.+ ...|..||||++..+       ....+.+|+.+|+.+ +|||||++++++.+....++|+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~   88 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIAL   88 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEE
Confidence            4566789999999999754 446899999998643       224578999999886 8999999999998888777777


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC-----------
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA-----------  342 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~-----------  342 (472)
                      |++ +|+|.+++...........   ......++.++.||+.||+|||++|  |+||||||+||||+.+           
T Consensus        89 E~~-~gsL~~~l~~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~~~  162 (434)
T 2rio_A           89 ELC-NLNLQDLVESKNVSDENLK---LQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGA  162 (434)
T ss_dssp             CCC-SEEHHHHHHTC---------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTTCC
T ss_pred             ecC-CCCHHHHHhccCCCchhhh---hccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCcccccccccCC
Confidence            777 5799999976443211100   0112235678999999999999999  9999999999999754           


Q ss_pred             --CcEEEeecccceecCCCc-------cccccCCcccccccccC-------CCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          343 --KHVRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQC-------EPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       343 --~~vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~-------~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                        +.+||+|||++.......       ....||+.|+|||++.+       ..++.++|||||||++|||+| |..||.+
T Consensus       163 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          163 ENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             CSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred             CceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence              489999999999876432       13468999999999975       678999999999999999999 9999976


Q ss_pred             CCCCHHHHHHHHhcCCCCC-CCCC--CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRP-ALPE--EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~-~l~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .....    ..+..+.... ..+.  ....+.++.++|.+||..||++|||+.++++
T Consensus       243 ~~~~~----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          243 KYSRE----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTTHH----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             chhhH----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            54222    2222332221 1111  1345678999999999999999999999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=337.13  Aligned_cols=251  Identities=25%  Similarity=0.345  Sum_probs=189.9

Q ss_pred             cCceeeCCCCeeEeceeeccCceEE-EEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANI-YRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACL  264 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~V-y~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~  264 (472)
                      ...+.+...+|.+.+.||+|+||.| |++...|+.||||++.++...       .+.+|+.+|+.+ +|||||++++++.
T Consensus        16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-------~~~~E~~~l~~l~~HpnIv~l~~~~~   88 (432)
T 3p23_A           16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-------FADREVQLLRESDEHPNVIRYFCTEK   88 (432)
T ss_dssp             --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-------ECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred             CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-------HHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            3457788889999999999999985 556667899999999764321       256899999999 8999999999998


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---  341 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---  341 (472)
                      +....++|+|++ +|+|.+++.......         ....++.++.||+.||+|||++|  |+||||||+||||+.   
T Consensus        89 ~~~~~~lv~E~~-~g~L~~~l~~~~~~~---------~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~  156 (432)
T 3p23_A           89 DRQFQYIAIELC-AATLQEYVEQKDFAH---------LGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNA  156 (432)
T ss_dssp             ETTEEEEEEECC-SEEHHHHHHSSSCCC---------CSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBT
T ss_pred             cCCEEEEEEECC-CCCHHHHHHhcCCCc---------cchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCC
Confidence            887777777766 579999996543211         11235688999999999999999  999999999999953   


Q ss_pred             --CCcEEEeecccceecCCC------ccccccCCccccccccc---CCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 039082          342 --AKHVRIADFGHARFLSDG------EMALTGTFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYK  409 (472)
Q Consensus       342 --~~~vkL~DFGla~~~~~~------~~~~~gt~~y~APE~~~---~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~  409 (472)
                        ...+||+|||+|+.....      .....||+.|+|||++.   ...++.++|||||||++|||++ |..||..... 
T Consensus       157 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-  235 (432)
T 3p23_A          157 HGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-  235 (432)
T ss_dssp             TTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-
T ss_pred             CCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-
Confidence              236889999999877533      22356899999999997   4567889999999999999999 9999965542 


Q ss_pred             HHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          410 PAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       410 ~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ........... .............+.++|.+||..||++|||+.++++
T Consensus       236 -~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          236 -RQANILLGACS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -HHHHHHTTCCC-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHhccCC-ccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             22222222222 1222222445566889999999999999999999983

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=9.3e-40  Score=337.34  Aligned_cols=251  Identities=16%  Similarity=0.120  Sum_probs=185.5

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-Cc--------------
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RF--------------  255 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pn--------------  255 (472)
                      ....|.+.+.||+|+||.||+|.+.  |..||||+++.... ......+.|.+|+.+++.++| +|              
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC-----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            4456888999999999999999987  88999999874322 223345679999999999977 21              


Q ss_pred             -eeEE------EEEEEcC----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 039082          256 -VLQL------MGACLEP----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK  324 (472)
Q Consensus       256 -Iv~l------~g~~~~~----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~  324 (472)
                       ++.+      ..++...    ...+++++++.+++|.+++.........   ....++..++.++.||+.||+|||++|
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST---HKSLVHHARLQLTLQVIRLLASLHHYG  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTT---SHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhccccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence             1111      1111111    2235677788899999998543211100   111235678888899999999999999


Q ss_pred             CceeecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccc----------cCCCCCchHHHHHHHHHHH
Q 039082          325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVI----------QCEPYSEKSDVYSFGIILN  394 (472)
Q Consensus       325 ~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~----------~~~~~s~~sDvwSlGvll~  394 (472)
                        ||||||||+||||+.++.+||+|||+++.........+| +.|+|||++          ....++.++|||||||++|
T Consensus       232 --iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          232 --LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             --EECSCCCGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             --cccCCcccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence              999999999999999999999999999987766666778 999999999          5566899999999999999


Q ss_pred             HHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          395 EIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       395 elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ||++|+.||...+..  .....+.        ......+..+.++|.+||..||++||++.++++.
T Consensus       309 elltg~~Pf~~~~~~--~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          309 WIWCADLPNTDDAAL--GGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HHHHSSCCCCTTGGG--SCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHCCCCCCCcchh--hhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999999765421  1111111        1112334678999999999999999998887653

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.7e-39  Score=317.61  Aligned_cols=237  Identities=16%  Similarity=0.098  Sum_probs=188.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      +-.++|++.+.||+|+||.||+|.+.  |+.||||++..... ........|.+|+.++..++||||+++++++.+.+..
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-LPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-cCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcE
Confidence            44578999999999999999999997  78999999976543 3355667899999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      ++|||++.|++|.+++...            +...++..++.|++.||+|||++|  |+||||||+||||+.+|.+||++
T Consensus       107 ~lv~e~~~g~~L~~~l~~~------------~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~  172 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVADTS------------PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAY  172 (286)
T ss_dssp             EEEEECCCEEEHHHHHTTC------------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECS
T ss_pred             EEEEEecCCCCHHHHHhcC------------CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEe
Confidence            9999999999999998431            123567889999999999999999  99999999999999999999986


Q ss_pred             cccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHH-HHHHHhcCCCCCCCCC
Q 039082          350 FGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAK-IAMEVGEGKLRPALPE  428 (472)
Q Consensus       350 FGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~-i~~~i~~~~~~~~l~~  428 (472)
                      +|.                 ++       .++.++|||||||++|+|+||+.||.+.+..... .......+...+....
T Consensus       173 ~~~-----------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T 3uqc_A          173 PAT-----------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADI  228 (286)
T ss_dssp             CCC-----------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHH
T ss_pred             ccc-----------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhc
Confidence            543                 22       3789999999999999999999999876521100 0000011110000000


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ....+..+.++|.+||..||++| |+.++++.|+.+....
T Consensus       229 ~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          229 DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            13355678999999999999999 9999999999876543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3e-38  Score=345.92  Aligned_cols=240  Identities=23%  Similarity=0.288  Sum_probs=198.1

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC--
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY--  268 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~--  268 (472)
                      .++|++.+.||+|+||.||+|.+.   |+.||||++...   ........|.+|+.+|+.++|||||++++++...+.  
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS---GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS---CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc---CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            478999999999999999999984   688999988653   344566778999999999999999999999988766  


Q ss_pred             ---ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          269 ---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       269 ---~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                         .|+|||++.|++|.+++..            ..++..++.++.||+.||+|||++|  ||||||||+||||+.+ .+
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~  220 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ------------KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QL  220 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C------------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CE
T ss_pred             CceeEEEEEeCCCCcHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cE
Confidence               5889999999999887642            2357889999999999999999999  9999999999999975 89


Q ss_pred             EEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          346 RIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       346 kL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      ||+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....               .
T Consensus       221 kl~DFG~a~~~~~~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------------~  283 (681)
T 2pzi_A          221 KLIDLGAVSRINSF-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------------G  283 (681)
T ss_dssp             EECCCTTCEETTCC-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------------S
T ss_pred             EEEecccchhcccC-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------------c
Confidence            99999999887654 456799999999998765 489999999999999999999888653211               1


Q ss_pred             CCCC---chhHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHHHHH
Q 039082          426 LPEE---DGQLRELIELICLSWDGDASVRP-SFSSITCSLKNIQMKV  468 (472)
Q Consensus       426 l~~~---~~~~~~l~~li~~cl~~dP~~RP-s~~~ll~~L~~i~~~~  468 (472)
                      ++..   ......+.++|.+||..||++|| +++++...|..+..++
T Consensus       284 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~  330 (681)
T 2pzi_A          284 LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV  330 (681)
T ss_dssp             CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred             ccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence            1111   22346788999999999999998 6777888888776554

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.1e-39  Score=345.44  Aligned_cols=258  Identities=24%  Similarity=0.315  Sum_probs=198.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc------C
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE------P  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~------~  266 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||+++..   ........|.+|+.+|+.++||||+++++++..      .
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~---~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE---LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC---CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc---CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence            67999999999999999999885  789999988654   245566779999999999999999999998765      5


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc--
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH--  344 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~--  344 (472)
                      +..++|++++.|++|.+++......       ...+...++.++.+++.||+|||+.|  |+||||||+|||++.++.  
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~-------~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~  161 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENC-------CGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRL  161 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCT-------TCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccC-------CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCce
Confidence            6678899999999999999753321       12345678899999999999999999  999999999999997765  


Q ss_pred             -EEEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH--------
Q 039082          345 -VRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI--------  413 (472)
Q Consensus       345 -vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i--------  413 (472)
                       +||+|||++.......  ....||+.|+|||.+.+..++.++|||||||++|+|++|..||..... +..+        
T Consensus       162 ~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-~~~~~~~i~~~~  240 (676)
T 3qa8_A          162 IHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-PVQWHGKVREKS  240 (676)
T ss_dssp             EEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-HHHSSTTCC---
T ss_pred             eEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-hhhhhhhhhccc
Confidence             9999999998876443  345689999999999999999999999999999999999999965421 0000        


Q ss_pred             HHH-----HhcCCC--CC--CCCC--CchhHHHHHHHHHHhccCCCCCCCCHHH-----HHHHHHHHH
Q 039082          414 AME-----VGEGKL--RP--ALPE--EDGQLRELIELICLSWDGDASVRPSFSS-----ITCSLKNIQ  465 (472)
Q Consensus       414 ~~~-----i~~~~~--~~--~l~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~-----ll~~L~~i~  465 (472)
                      ...     ...+..  ..  +.+.  ....+..+.++|..||..||++|||+.+     +.+.++++.
T Consensus       241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence            000     011110  11  1111  1446788999999999999999999988     445555443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.7e-37  Score=304.42  Aligned_cols=225  Identities=18%  Similarity=0.251  Sum_probs=175.0

Q ss_pred             CCeeEe-ceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHH-HhcCCCceeEEEEEEEc----C
Q 039082          195 KEIDLQ-EKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL-SRQRHRFVLQLMGACLE----P  266 (472)
Q Consensus       195 ~~~~l~-~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il-~~l~HpnIv~l~g~~~~----~  266 (472)
                      ++|.+. +.||+|+||.||+|.++  +..||||++...         ..+.+|+.++ +.++||||+++++++..    .
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~   87 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   87 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc---------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence            467777 78999999999999985  779999998532         2367888888 55699999999999876    5


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CC
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AK  343 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~  343 (472)
                      ...++|++++.+++|.+++.....        ...++..++.++.|++.||+|||++|  |+||||||+|||++.   ++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~  157 (299)
T 3m2w_A           88 KCLLIVMECLDGGELFSRIQDRGD--------QAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA  157 (299)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHCTT--------CCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTC
T ss_pred             ceEEEEEeecCCCcHHHHHHhccC--------CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCC
Confidence            567788888889999999975332        12457889999999999999999999  999999999999998   78


Q ss_pred             cEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCC
Q 039082          344 HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR  423 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~  423 (472)
                      .+||+|||++....                   +..++.++|||||||++|+|++|..||.+...  .............
T Consensus       158 ~~kl~Dfg~a~~~~-------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~--~~~~~~~~~~~~~  216 (299)
T 3m2w_A          158 ILKLTDFGFAKETT-------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG--LAISPGMKTRIRM  216 (299)
T ss_dssp             CEEECCCTTCEECT-------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------CCSCCSSCT
T ss_pred             cEEEeccccccccc-------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc--hhhhHHHHHHHhh
Confidence            99999999987543                   24478899999999999999999999976542  1111111111111


Q ss_pred             CCCCCC----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          424 PALPEE----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       424 ~~l~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...+..    ...+..+.++|.+||..||++|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            111111    234678899999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.9e-39  Score=322.03  Aligned_cols=245  Identities=16%  Similarity=0.142  Sum_probs=186.6

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCC----CChHHHHHHHHHHHHHHhcC---------CCceeE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFH----TNENAVTFFAQEVDTLSRQR---------HRFVLQ  258 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~----~~~~~~~~f~~E~~il~~l~---------HpnIv~  258 (472)
                      +..++|++.+.||+|+||.||+|+++|..||||++......    ......+.+.+|+.+|+.++         |||||+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            44568899999999999999999999999999999875432    12234466889999999886         777777


Q ss_pred             EEEEEE-----------------c-------------CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHH
Q 039082          259 LMGACL-----------------E-------------PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA  308 (472)
Q Consensus       259 l~g~~~-----------------~-------------~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~  308 (472)
                      +++++.                 +             .+..++|||++.+|++.+.+..           ...+...++.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----------~~~~~~~~~~  165 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----------KLSSLATAKS  165 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----------TCCCHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----------cCCCHHHHHH
Confidence            776643                 2             5678889999889876665532           1235788999


Q ss_pred             HHHHHHHHHHHHH-hcCCceeecCCCCCcEEEcCCC--------------------cEEEeecccceecCCCccccccCC
Q 039082          309 RALEIAQAMQYLH-EQKPKVIHRDLKPSNIFLDDAK--------------------HVRIADFGHARFLSDGEMALTGTF  367 (472)
Q Consensus       309 i~~qia~gL~yLH-~~~~~iiHrDLkp~NILl~~~~--------------------~vkL~DFGla~~~~~~~~~~~gt~  367 (472)
                      ++.||+.||+||| ++|  |+||||||+||||+.++                    .+||+|||+|+.....  ...||+
T Consensus       166 i~~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~  241 (336)
T 2vuw_A          166 ILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCC
T ss_pred             HHHHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEee
Confidence            9999999999999 899  99999999999999887                    8999999999987654  347999


Q ss_pred             cccccccccCCCCCchHHHHHHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHhcCC-CCCCCCC--CchhHHHHHHHHHHh
Q 039082          368 VYMAPEVIQCEPYSEKSDVYSFGII-LNEIITGNHPYIEKDYKPAKIAMEVGEGK-LRPALPE--EDGQLRELIELICLS  443 (472)
Q Consensus       368 ~y~APE~~~~~~~s~~sDvwSlGvl-l~elltG~~Pf~~~~~~~~~i~~~i~~~~-~~~~l~~--~~~~~~~l~~li~~c  443 (472)
                      .|+|||++.+.. +.++||||||++ .+++++|..||.+... .......+.... .....+.  ....+.++.++|.+|
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~  319 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW-LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM  319 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH-HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh-hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence            999999998766 999999998777 7778889999843210 011222222111 1111111  145678899999999


Q ss_pred             ccCCCCCCCCHHHHH
Q 039082          444 WDGDASVRPSFSSIT  458 (472)
Q Consensus       444 l~~dP~~RPs~~~ll  458 (472)
                      |..|     |+++++
T Consensus       320 L~~d-----sa~e~l  329 (336)
T 2vuw_A          320 LNFS-----SATDLL  329 (336)
T ss_dssp             GGSS-----SHHHHH
T ss_pred             hccC-----CHHHHH
Confidence            9976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.7e-31  Score=283.54  Aligned_cols=186  Identities=18%  Similarity=0.144  Sum_probs=130.6

Q ss_pred             eceeeccCceEEEEEEE--CCeeEEEEEeccCCCCC------ChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcCCCce
Q 039082          200 QEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHT------NENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~------~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~~~~~  270 (472)
                      ...++.|++|.+..++.  -|..||||++.++....      .+...+.|.+|+++|+++ .|+||+++++++.++...|
T Consensus       239 ~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~y  318 (569)
T 4azs_A          239 QNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGW  318 (569)
T ss_dssp             ECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEE
T ss_pred             hhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEE
Confidence            34677888887776543  48999999997653321      233456799999999999 7999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +||||+.|++|.++|...+..          +   ...|+.||+.||+|||++|  ||||||||+||||+.+|.+||+||
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l----------~---~~~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DF  383 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEI----------D---REKILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDF  383 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCC----------C---HHHHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCC
T ss_pred             EEEecCCCCcHHHHHHhCCCC----------C---HHHHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeec
Confidence            999999999999999654321          2   2357899999999999999  999999999999999999999999


Q ss_pred             ccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCC
Q 039082          351 GHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNH  401 (472)
Q Consensus       351 Gla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~  401 (472)
                      |+|+.....   ....+||+.|+|||++.+. +..++|+||+|++++++.+|..
T Consensus       384 GlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          384 GSIVTTPQDCSWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             TTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             ccCeeCCCCCccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccc
Confidence            999877543   2345699999999999754 6778999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.4e-28  Score=260.16  Aligned_cols=184  Identities=22%  Similarity=0.248  Sum_probs=148.6

Q ss_pred             EeceeeccCceEEEEEEECCeeEEEEEeccCCCCCC----hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEE
Q 039082          199 LQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTN----ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~----~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      ..+.||+|+||.||+|.+.+..+++|..........    ....+.|.+|+++|+.++||||+++..++...+..++|||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            357899999999999988899999998765433221    1124568999999999999999966556667778899999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccce
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHAR  354 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~  354 (472)
                      |+.|++|.+++..                  +..++.|++.||+|||+++  |+||||||+|||++.  .+||+|||+++
T Consensus       420 ~~~ggsL~~~l~~------------------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          420 YINGKLAKDVIED------------------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             CCCSEEHHHHSTT------------------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             CCCCCCHHHHHHH------------------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccCE
Confidence            9999999999853                  3467899999999999999  999999999999998  99999999999


Q ss_pred             ecCCCc----------cccccCCcccccccccC--CCCCchHHHHHHHHHHHHHHcCCCCCC
Q 039082          355 FLSDGE----------MALTGTFVYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYI  404 (472)
Q Consensus       355 ~~~~~~----------~~~~gt~~y~APE~~~~--~~~s~~sDvwSlGvll~elltG~~Pf~  404 (472)
                      ......          ....||+.|+|||++..  ..|+..+|+|+..+-..+.+.++.+|.
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            886532          24568999999999986  668888999999999999888877774

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=3.4e-24  Score=209.71  Aligned_cols=148  Identities=14%  Similarity=0.081  Sum_probs=116.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCC-----h---------HHHHHHHHHHHHHHhcCCCceeEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTN-----E---------NAVTFFAQEVDTLSRQRHRFVLQL  259 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~-----~---------~~~~~f~~E~~il~~l~HpnIv~l  259 (472)
                      ..|.+.+.||+|+||.||+|.+. |..||||+++.......     .         .....+.+|+.+|+.++  | +++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            34567799999999999999995 78999999965422111     0         24567899999999998  4 666


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      ++++. .+..++|||++.|++|.+ +..                .....++.|++.||.|||++|  |+||||||+||||
T Consensus       167 ~~~~~-~~~~~lvmE~~~g~~L~~-l~~----------------~~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl  226 (282)
T 1zar_A          167 PKVYA-WEGNAVLMELIDAKELYR-VRV----------------ENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLV  226 (282)
T ss_dssp             CCEEE-EETTEEEEECCCCEEGGG-CCC----------------SCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEE
T ss_pred             CeEEe-ccceEEEEEecCCCcHHH-cch----------------hhHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEE
Confidence            66543 356689999999999987 421                124468999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCccccccCCccccccccc
Q 039082          340 DDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQ  376 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~  376 (472)
                      + ++.+||+|||+|+.          +..+.|||.+.
T Consensus       227 ~-~~~vkl~DFG~a~~----------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE----------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE----------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE----------CCCCCHHHHHH
Confidence            9 99999999999974          34568888874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.82  E-value=1.1e-19  Score=175.29  Aligned_cols=140  Identities=24%  Similarity=0.191  Sum_probs=105.4

Q ss_pred             eeEeceeeccCceEEEEEEE--CCee--EEEEEeccCCCCCC--------------------hHHHHHHHHHHHHHHhcC
Q 039082          197 IDLQEKIGQGTTANIYRAIW--RGLD--VAVKCIYPDFFHTN--------------------ENAVTFFAQEVDTLSRQR  252 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~--~g~~--vAVK~l~~~~~~~~--------------------~~~~~~f~~E~~il~~l~  252 (472)
                      |++.+.||+|+||.||+|.+  .|..  ||||+++.......                    ......+.+|+.+|..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999998  6888  99999765421110                    112246889999999998


Q ss_pred             CCce--eEEEEEEEcCCCceEEEEeccC-C----cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHH-hcC
Q 039082          253 HRFV--LQLMGACLEPPYRGWLVTELLG-T----TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLH-EQK  324 (472)
Q Consensus       253 HpnI--v~l~g~~~~~~~~~~vve~~~g-g----sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH-~~~  324 (472)
                      |+++  ..+++.    ...++|||++.+ |    +|.++....             +...+..++.|++.||.||| +.|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~-------------~~~~~~~i~~qi~~~l~~lH~~~g  191 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL-------------KELDVEGIFNDVVENVKRLYQEAE  191 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG-------------GGSCHHHHHHHHHHHHHHHHHTSC
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc-------------ChHHHHHHHHHHHHHHHHHHHHCC
Confidence            8754  344432    356678888832 3    677664321             02336788999999999999 999


Q ss_pred             CceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       325 ~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                        |+||||||+|||++.  .++|+|||+|....
T Consensus       192 --ivHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          192 --LVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             --EECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             --EEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence              999999999999998  99999999997653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=1.2e-17  Score=169.13  Aligned_cols=141  Identities=11%  Similarity=0.076  Sum_probs=98.1

Q ss_pred             eeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCC-------------hH-----HHHHHHHHHHHHHhcCCCcee
Q 039082          197 IDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTN-------------EN-----AVTFFAQEVDTLSRQRHRFVL  257 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~-------------~~-----~~~~f~~E~~il~~l~HpnIv  257 (472)
                      |.+.+.||+|+||.||+|.+. |+.||||+++.......             ..     ......+|...|.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            789999999999999999875 88999999865321100             00     011123566677777544432


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcE
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNI  337 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NI  337 (472)
                      -..-+..  ...++|||++.|++|..+..                ......++.|++.+|.|||+.|  ||||||||.||
T Consensus       177 vp~p~~~--~~~~LVME~i~G~~L~~l~~----------------~~~~~~l~~qll~~l~~lH~~g--IVHrDLKp~NI  236 (397)
T 4gyi_A          177 VPEPIAQ--SRHTIVMSLVDALPMRQVSS----------------VPDPASLYADLIALILRLAKHG--LIHGDFNEFNI  236 (397)
T ss_dssp             CCCEEEE--ETTEEEEECCSCEEGGGCCC----------------CSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSE
T ss_pred             CCeeeec--cCceEEEEecCCccHhhhcc----------------cHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHE
Confidence            1111111  23468888888888754321                1124567889999999999999  99999999999


Q ss_pred             EEcCCC----------cEEEeecccceecC
Q 039082          338 FLDDAK----------HVRIADFGHARFLS  357 (472)
Q Consensus       338 Ll~~~~----------~vkL~DFGla~~~~  357 (472)
                      ||+++|          .+.|+||+-+....
T Consensus       237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          237 LIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EEeCCCCcccccccccceEEEEeCCcccCC
Confidence            998776          38999999876544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=9e-12  Score=119.28  Aligned_cols=141  Identities=17%  Similarity=0.135  Sum_probs=109.9

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      .|++...+|.|+++.||++...+..+++|+........    ...+.+|+.+|+.+. +..+.++++++...+..++||+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             cceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC----HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            57888899999999999998888899999886531111    123789999999984 6778889998888888889999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK------------------------------  324 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~------------------------------  324 (472)
                      ++.|.+|...+..               ......++.+++.+|+.||+..                              
T Consensus        91 ~i~G~~l~~~~~~---------------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           91 EADGVLCSEEYED---------------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             CCSSEEHHHHCCT---------------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             ecCCeehhhccCC---------------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            9999998775311               0113466789999999999810                              


Q ss_pred             ---------------------------CceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          325 ---------------------------PKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       325 ---------------------------~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                                                 ..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                       2399999999999998766677999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.12  E-value=4.1e-10  Score=106.80  Aligned_cols=135  Identities=19%  Similarity=0.160  Sum_probs=94.1

Q ss_pred             CeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc--eeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF--VLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~g~~~~~~~~~~v  272 (472)
                      ++.+....+.|..+.||++... |..+++|+.....       ...+.+|+.+++.+.+.+  +.+++++....+..++|
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v   93 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL   93 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEE
Confidence            3444444456677999999765 6789999875431       123778999999985544  55688887777777889


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK----------------------------  324 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~----------------------------  324 (472)
                      ++++.|.+|.  ....             .   ...++.+++..|+.||+..                            
T Consensus        94 ~e~i~G~~l~--~~~~-------------~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (264)
T 1nd4_A           94 LGEVPGQDLL--SSHL-------------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQ  155 (264)
T ss_dssp             EECCSSEETT--TSCC-------------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCT
T ss_pred             EEecCCcccC--cCcC-------------C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccc
Confidence            9999888874  2100             0   1234556666666666532                            


Q ss_pred             ----------------------------CceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          325 ----------------------------PKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       325 ----------------------------~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                                                  ..++|+|++|.|||+++++.+.|+|||.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          156 DDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                        1299999999999998776677999999754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.07  E-value=4.3e-10  Score=112.80  Aligned_cols=144  Identities=13%  Similarity=0.165  Sum_probs=103.5

Q ss_pred             eEeceeeccCceEEEEEEECCeeEEEEEec--cCCCCCChHHHHHHHHHHHHHHhcC--CCceeEEEEEEEcCC---Cce
Q 039082          198 DLQEKIGQGTTANIYRAIWRGLDVAVKCIY--PDFFHTNENAVTFFAQEVDTLSRQR--HRFVLQLMGACLEPP---YRG  270 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~--~~~~~~~~~~~~~f~~E~~il~~l~--HpnIv~l~g~~~~~~---~~~  270 (472)
                      .-++.|+.|.++.||+....+..+++|+..  +...   ......+.+|+.+|+.+.  +..+.++++++.+..   ..+
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~---~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL---LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECSSCEEEEECCCC-------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             ceEEEcCCcccceEEEEEECCceEEEEeCCCCCCCC---CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            346789999999999998888889999765  3211   112235778999999996  456788888877653   367


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ---------------------------  323 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~---------------------------  323 (472)
                      +||+++.|..+.+..            ....+......++.+++..|+.||+.                           
T Consensus       118 ~vme~v~G~~l~~~~------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQS------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQ  185 (359)
T ss_dssp             EEEECCCCBCCCCTT------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHH
T ss_pred             EEEEecCCeecCCCc------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHH
Confidence            888988887663211            11123456777888999999999972                           


Q ss_pred             -----------------------------CCceeecCCCCCcEEEcCCCc--EEEeecccceec
Q 039082          324 -----------------------------KPKVIHRDLKPSNIFLDDAKH--VRIADFGHARFL  356 (472)
Q Consensus       324 -----------------------------~~~iiHrDLkp~NILl~~~~~--vkL~DFGla~~~  356 (472)
                                                   ...++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       186 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          186 YKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                         135999999999999997753  689999998753

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.89  E-value=3.6e-09  Score=103.62  Aligned_cols=182  Identities=20%  Similarity=0.195  Sum_probs=113.4

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCc--eeEEEEEEEcCC---CceEEE
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRF--VLQLMGACLEPP---YRGWLV  273 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~Hpn--Iv~l~g~~~~~~---~~~~vv  273 (472)
                      ++.++.|.+..||+..   ..+++|+...      ......+.+|+.+|+.+ .+..  +.+++......+   ..++||
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm   95 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKH------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF   95 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESS------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCC------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence            4568999999999863   6799997632      24456688999999888 3322  334444433322   236788


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ------------------------------  323 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~------------------------------  323 (472)
                      +++.|.+|......            ..+..+...++.+++..|+.||+.                              
T Consensus        96 ~~i~G~~l~~~~~~------------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (304)
T 3sg8_A           96 TKIKGVPLTPLLLN------------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSR  163 (304)
T ss_dssp             ECCCCEECCHHHHH------------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTT
T ss_pred             cccCCeECCccccc------------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcc
Confidence            99988877643211            011233445555666666666541                              


Q ss_pred             --------------------------CCceeecCCCCCcEEEcC--CCcEEEeecccceecCCCccccccCCcc---ccc
Q 039082          324 --------------------------KPKVIHRDLKPSNIFLDD--AKHVRIADFGHARFLSDGEMALTGTFVY---MAP  372 (472)
Q Consensus       324 --------------------------~~~iiHrDLkp~NILl~~--~~~vkL~DFGla~~~~~~~~~~~gt~~y---~AP  372 (472)
                                                .+.++|+|++|.|||+++  ++.+.|+||+.+......... .....+   ..|
T Consensus       164 ~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~~~~~~  242 (304)
T 3sg8_A          164 ELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDDEEYGM  242 (304)
T ss_dssp             TSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTTTSCCH
T ss_pred             cCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhccccCH
Confidence                                      124899999999999998  556889999998765322110 001111   222


Q ss_pred             ccccC-----CCC---------CchHHHHHHHHHHHHHHcCCCCC
Q 039082          373 EVIQC-----EPY---------SEKSDVYSFGIILNEIITGNHPY  403 (472)
Q Consensus       373 E~~~~-----~~~---------s~~sDvwSlGvll~elltG~~Pf  403 (472)
                      +....     +..         ....+.|++|.++|.+.+|..+|
T Consensus       243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            22110     111         22368999999999999998776

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=98.56  E-value=1.2e-10  Score=121.32  Aligned_cols=132  Identities=11%  Similarity=0.004  Sum_probs=64.1

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccc-----cCCCCCccccccCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLH-----QHSHQTPLHRYCSQ  169 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~-----~~~~~~~l~~~~~~  169 (472)
                      .++|||| +|++.+|.|+|||..++.|+||+|..  +|.|     +.+. ..|+++..++.     ++...      + .
T Consensus        71 ~G~FLvR-~S~~~~g~~~Lsv~~~~~v~H~~I~~--~g~~-----~~~~-~~F~sl~~Lv~dGl~~~~~~~------~-~  134 (463)
T 3cxl_A           71 EGSYLIR-ESQRQPGTYTLALRFGSQTRNFRLYY--DGKH-----FVGE-KRFESIHDLVTDGLITLYIET------K-A  134 (463)
T ss_dssp             TTEEEEE-ECSSSTTCEEEEEECSSSEEEEECEE--SSSE-----ESSS-CCBSCHHHHHHHHHHHHHHHH------H-T
T ss_pred             CCeEEEe-ccCCCCCCEEEEEEECCEEEEEEEec--CCeE-----EECC-CccCCHHHHHHHHHHhhhccC------C-C
Confidence            4999999 99999999999999999999999987  5677     3332 46777776665     33211      0 0


Q ss_pred             CCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEEEEECC--eeEEE------EEeccCCCCCChHHHHHH
Q 039082          170 TPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG--LDVAV------KCIYPDFFHTNENAVTFF  241 (472)
Q Consensus       170 ~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g--~~vAV------K~l~~~~~~~~~~~~~~f  241 (472)
                              ....      ..+.++    .+.+.||   ||.||+|.+++  .+|||      |..+.+..  ..+....|
T Consensus       135 --------~~~~------l~~~i~----~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~--~~e~~~~~  191 (463)
T 3cxl_A          135 --------AEYI------AKMTIN----PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGV--SEKRLTSL  191 (463)
T ss_dssp             --------HHHH------HHTTSS----CSTTTSS---BCCC---------CCBGGGC----------------------
T ss_pred             --------cchh------hccccc----cccccCC---chhhhcccccccCCchhhhhccCccccccccc--cccccccc
Confidence                    0000      001111    4567777   99999999875  47888      76654322  33445678


Q ss_pred             HHHHHHHHhcCCCceeEEEEEEEc
Q 039082          242 AQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       242 ~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      .+|+.+++.++|||+++.+++...
T Consensus       192 ~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          192 VRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             ---------------CBCCCEEEE
T ss_pred             cccccccccccccccCCCcceEEe
Confidence            899999999999999999887643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=4.5e-06  Score=81.68  Aligned_cols=75  Identities=13%  Similarity=0.008  Sum_probs=54.5

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCC---ceeEEEEEEE-cCCCceEEEEe
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR---FVLQLMGACL-EPPYRGWLVTE  275 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hp---nIv~l~g~~~-~~~~~~~vve~  275 (472)
                      ++.++.|....||+.   |..+++|+..      .......+.+|+.+|..+.+.   .+.+.+.++. ..+..++||++
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPK------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEES------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecC------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence            456899999999988   7889999742      234456788999999999642   3556666654 34446788999


Q ss_pred             ccCCcHHH
Q 039082          276 LLGTTLKE  283 (472)
Q Consensus       276 ~~ggsL~~  283 (472)
                      +.|.+|..
T Consensus        95 i~G~~l~~  102 (306)
T 3tdw_A           95 VQGQILGE  102 (306)
T ss_dssp             CCSEECHH
T ss_pred             cCCeECch
Confidence            98877765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.41  E-value=4.2e-06  Score=79.83  Aligned_cols=132  Identities=18%  Similarity=0.159  Sum_probs=90.8

Q ss_pred             eeccCce-EEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEEeccC
Q 039082          203 IGQGTTA-NIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVTELLG  278 (472)
Q Consensus       203 LG~G~fG-~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve~~~g  278 (472)
                      +..|..| .||+....  +..+++|+-..       .....+.+|+..|+.+. +--+.++++++.+.+..++||+++.|
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET-------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC-------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            4445554 68987654  56799997643       23445788999998884 32366788888888888899999998


Q ss_pred             CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 039082          279 TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK----------------------------------  324 (472)
Q Consensus       279 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~----------------------------------  324 (472)
                      .++.+......              .....+..+++..|+-||...                                  
T Consensus       105 ~~~~~~~~~~~--------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (272)
T 4gkh_A          105 KTAFQVLEEYP--------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDE  170 (272)
T ss_dssp             EEHHHHHHHCG--------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGG
T ss_pred             ccccccccCCH--------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhcccc
Confidence            88776543211              112233445555555555311                                  


Q ss_pred             ----------------------CceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          325 ----------------------PKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       325 ----------------------~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                                            +.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       171 ~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          171 RNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             GTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                  1389999999999999887778999998854

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.14  E-value=1.2e-05  Score=80.03  Aligned_cols=83  Identities=6%  Similarity=-0.051  Sum_probs=55.1

Q ss_pred             eeEecee-eccCceEEEEEEEC--------CeeEEEEEeccCCC--CCChHHHHHHHHHHHHHHhcCC---CceeEEEEE
Q 039082          197 IDLQEKI-GQGTTANIYRAIWR--------GLDVAVKCIYPDFF--HTNENAVTFFAQEVDTLSRQRH---RFVLQLMGA  262 (472)
Q Consensus       197 ~~l~~~L-G~G~fG~Vy~a~~~--------g~~vAVK~l~~~~~--~~~~~~~~~f~~E~~il~~l~H---pnIv~l~g~  262 (472)
                      +...+.| +.|....+|+....        +..+++|+......  ...   ...+.+|+.+|+.+..   -.+.+++++
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~~~   98 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFP---TYRLDHQFEVIRLVGELTDVPVPRVRWI   98 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSS---CCCHHHHHHHHHHHHHHCCSCCCCEEEE
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCc---hhHHHHHHHHHHHHhhcCCCCCCcEEEE
Confidence            4456788 88999999988765        67899997654320  000   1236788888888742   346777877


Q ss_pred             EEcCC---CceEEEEeccCCcHH
Q 039082          263 CLEPP---YRGWLVTELLGTTLK  282 (472)
Q Consensus       263 ~~~~~---~~~~vve~~~ggsL~  282 (472)
                      +.+..   ..++||+++.|..+.
T Consensus        99 ~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           99 ETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             ECSSTTTSSCEEEEECCCCBCCC
T ss_pred             ccCCCccCCceEEEEecCCCChh
Confidence            65542   356888888776543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.11  E-value=4.4e-05  Score=74.93  Aligned_cols=31  Identities=23%  Similarity=0.560  Sum_probs=27.4

Q ss_pred             CceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       325 ~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            3499999999999998888999999998753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.07  E-value=1.3e-05  Score=81.17  Aligned_cols=79  Identities=14%  Similarity=0.106  Sum_probs=49.6

Q ss_pred             EeceeeccCceEEEEEEE--CCeeEEEEEeccCCCCCC---hHHHHHHHHHHHHHHhcCC--C-ceeEEEEEEEcCCCce
Q 039082          199 LQEKIGQGTTANIYRAIW--RGLDVAVKCIYPDFFHTN---ENAVTFFAQEVDTLSRQRH--R-FVLQLMGACLEPPYRG  270 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~--~g~~vAVK~l~~~~~~~~---~~~~~~f~~E~~il~~l~H--p-nIv~l~g~~~~~~~~~  270 (472)
                      -.+.||.|.++.||++..  .+..|+||...+......   ......+..|+++|+.+..  | .+.+++.+  +.+..+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            356899999999999964  467899998754321000   0122346778999888742  3 34466643  344567


Q ss_pred             EEEEeccCC
Q 039082          271 WLVTELLGT  279 (472)
Q Consensus       271 ~vve~~~gg  279 (472)
                      +||+++.|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            888888763

>1lkk_A Human P56 tyrosine kinase; complex (tyrosine kinase/peptide); HET: PTR; 1.00A {Homo sapiens} SCOP: d.93.1.1 PDB: 1lcj_A* 1bhf_A* 1bhh_A 1lkl_A* 1bhh_B 1fbz_A* 1ijr_A* 1cwd_L* 1cwe_A*

Probab=97.93  E-value=1.8e-08  Score=82.85  Aligned_cols=69  Identities=12%  Similarity=0.070  Sum_probs=53.4

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++.|.++....++|||| +|++.+|.|+|||..     ++.|+||+|...++|.|     +......|+++..++.+|..
T Consensus        17 e~lL~~~~~~~G~FLVR-~S~~~~g~~~LSv~~~~~~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LI~~y~~   90 (105)
T 1lkk_A           17 ERQLLAPGNTHGSFLIR-ESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGF-----YISPRITFPGLHELVRHYTN   90 (105)
T ss_dssp             HHHHTSTTCCTTCEEEE-ECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCE-----ESSTTSCBSSHHHHHHHHHH
T ss_pred             HHHHHhcCCCCceEEEE-ECCCCCCcEEEEEEEcccCCCCcEEEEEEEECCCCCE-----EECCCceeCCHHHHHHHHhh
Confidence            33343344567999999 999889999999965     68899999998877788     44445678888888777653

>1d4t_A T cell signal transduction molecule SAP; SH2 domain, tyrosine kinase, signal transduction, peptide recognition, signaling protein; 1.10A {Homo sapiens} SCOP: d.93.1.1 PDB: 1d1z_A 1d4w_A* 1m27_A*

Probab=97.91  E-value=7.5e-08  Score=78.97  Aligned_cols=65  Identities=11%  Similarity=-0.021  Sum_probs=51.3

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..++.|+||+|...++|.|.+..........|+++..++.+|..
T Consensus        25 ~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~~LV~~y~~   89 (104)
T 1d4t_A           25 LDGSYLLR-DSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQK   89 (104)
T ss_dssp             CTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCEEECBCTTSCCCCBSSHHHHHHHHTS
T ss_pred             CCCEEEEe-eCCCCCCCEEEEEEECCeEEEEEEEECCCCeEEEeccCCCCCcccCCHHHHHHHHhh
Confidence            56999999 999889999999999999999999987788884433111135678888888777764

>3maz_A Signal-transducing adaptor protein 1; modular domain, phosphotyrosine, specificity, cytoplasm, phosphoprotein, SH2 domain, signaling protein; HET: PTR; 1.90A {Homo sapiens}

Probab=97.91  E-value=2.4e-08  Score=83.63  Aligned_cols=74  Identities=8%  Similarity=-0.001  Sum_probs=54.8

Q ss_pred             HHHHHHHHHHHHhhhhhHHHHHHHHHHhh---cCCeEEEeccCCcccCcccccCCCC--CccCCCCCCCccccCCC----
Q 039082           89 QRQKELRIIYRKRLERTQDYLRHCLQIAQ---DNGVLELMTNNKEDQHQSLLSSNTG--SVIASPLVQTPLHQHSH----  159 (472)
Q Consensus        89 ~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~---~~~v~hy~i~~~~~~~~~~~s~~~~--s~~~~~~~~~~~~~~~~----  159 (472)
                      +.+....++|||| +|++.. .|+|||.+   +..|+||+|... +|+|     +..  ....|+++..++.+|..    
T Consensus        31 L~~~~~~GaFLVR-~Se~~~-~ySLSVR~~~~~~~VKHYkI~~~-~G~y-----~I~~~~~~~F~SL~eLV~yY~~~adG  102 (125)
T 3maz_A           31 LQKNPSLGNMILR-PGSDSR-NYSITIRQEIDIPRIKHYKVMSV-GQNY-----TIELEKPVTLPNLFSVIDYFVKETRG  102 (125)
T ss_dssp             HHHCGGGCSEEEE-ECTTSS-SEEEEEEECSSSCEEEEEEEEEE-TTEE-----EECSSSCEEESSHHHHHHHHHHHTTT
T ss_pred             HhccCCCCcEEEE-eCCCCC-CEEEEEEecCCCCCEeeeEEEEe-CCEE-----EEecCCCcCcCCHHHHHHHHHhCCCc
Confidence            3344558999999 898765 89999976   678999999988 6888     655  34579999998888764    


Q ss_pred             -CCccccccCCC
Q 039082          160 -QTPLHRYCSQT  170 (472)
Q Consensus       160 -~~~l~~~~~~~  170 (472)
                       +.++..+|...
T Consensus       103 l~~~L~~~c~~~  114 (125)
T 3maz_A          103 NLRPFIASTDEN  114 (125)
T ss_dssp             CCCBCCC-----
T ss_pred             Cccccccccccc
Confidence             67777787543

>1i3z_A EWS/FLI1 activated transcript 2; SH2 domain phosphotyrosine signal transduction lymphocyte, signaling protein; HET: PTR; 2.15A {Mus musculus} SCOP: d.93.1.1

Probab=97.87  E-value=8.8e-08  Score=78.40  Aligned_cols=65  Identities=9%  Similarity=0.004  Sum_probs=51.8

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|...++|.|.+..........|+++..++.+|..
T Consensus        24 ~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~~LV~~y~~   88 (103)
T 1i3z_A           24 VDGNFLIR-DSESVPGALCLCVSFKKLVYSYRIFREKHGYYRIETDAHTPRTIFPNLQELVSKYGK   88 (103)
T ss_dssp             STTEEEEE-ECSSSTTCEEEEEECSSSEEEEEEEECTTSCEEECBCTTSCCCEESSSHHHHHHTTS
T ss_pred             CCceEEEE-eCCCCCCCEEEEEEECCEEEEEEEEECCCCeEEEeccCCCCCcccCCHHHHHHHHhh
Confidence            56999999 999888999999999999999999977788885533211145678888888877764

>2ysx_A Signaling inositol polyphosphate phosphatase SHIP II; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens}

Probab=97.86  E-value=1.4e-07  Score=79.39  Aligned_cols=66  Identities=12%  Similarity=-0.049  Sum_probs=52.4

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ...++|||| +|++..|.|+|||..++.|+||+|....++.|.+......+...|+++..++.+|..
T Consensus        30 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~eLV~~y~~   95 (119)
T 2ysx_A           30 GKDGSFLVR-ASESISRAYALCVLYRNCVYTYRILPNEDDKFTVQASEGVSMRFFTKLDQLIEFYKK   95 (119)
T ss_dssp             CCTTEEEEE-ECSSCTTSEEEEEECSSCEEEEEEEECTTSCEEECCSCSSSCCCBSSHHHHHHHTTS
T ss_pred             CCCCEEEEE-eCCCCCCCEEEEEEECCEEEEEEEEEcCCCCEEEeccCCcCCcccCCHHHHHHHHhh
Confidence            356999999 999989999999999999999999987788885533221124678888888887764

>2dly_A FYN-related kinase; BRK family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Mus musculus}

Probab=97.86  E-value=3.1e-08  Score=83.69  Aligned_cols=62  Identities=6%  Similarity=-0.056  Sum_probs=50.9

Q ss_pred             HHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           92 KELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        92 ~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..-.++|||| +|++..|.|+|||..++.|+||+|...++|.|.     ......|+++..++.+|..
T Consensus        36 ~~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~-----l~~~~~F~sl~eLV~~y~~   97 (121)
T 2dly_A           36 ENQTGAFLIR-ESESQKGDFSLSVLDEGVVKHYRIRRLDEGGFF-----LTRRKVFSTLNEFVNYYTT   97 (121)
T ss_dssp             SCCTTCEEEE-ECSSSSSCEEEEEESSSCEEEEEEEECSSSCEE-----EETTEEESSHHHHHHHHTT
T ss_pred             CCCCCEEEEE-cCCCCCCceEEEEEECCeEEEEEEEEcCCCCEE-----ECCCCccCCHHHHHHHHhh
Confidence            3456999999 999889999999999999999999987788883     3345678888888777764

>1aot_F FYN protein-tyrosine kinase; SH2 domain, signal transduction, peptide complex, complex (proto-oncogene/early protein); HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1aou_F*

Probab=97.85  E-value=2.6e-08  Score=82.03  Aligned_cols=69  Identities=13%  Similarity=0.036  Sum_probs=52.7

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++-|.++..-.++|||| +|++.+|.|+|||..     ++.|+||+|...++|.|     +......|+++..++.+|..
T Consensus        18 e~lL~~~g~~~G~FLVR-~S~~~~g~~~LSv~~~~~~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~   91 (106)
T 1aot_F           18 ERQLLSFGNPRGTFLIR-ESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGY-----YITTRAQFETLQQLVQHYSE   91 (106)
T ss_dssp             HHHHHTTTCCTTEECCB-CBSSSSSBBCCEEECCBTTTBCCEEECCBEEETTTEE-----EEETTEEESSHHHHHHHHTT
T ss_pred             HHHHhhCCCCCcEEEEE-eCCCCCCCEEEEEEecccCCCCcEEEEEEEEeCCCCE-----EECCCCccCCHHHHHHHhcc
Confidence            33343344457999999 999888999999964     78999999998777778     33345678888888777764

>1ka6_A SH2 domain protein 1A; SH2 domain, protein-peptide complex, immune system; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1 PDB: 1ka7_A

Probab=97.84  E-value=1.4e-07  Score=80.36  Aligned_cols=65  Identities=11%  Similarity=-0.021  Sum_probs=51.9

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|...++|.|.+..........|+++..++.+|..
T Consensus        25 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~l~~~~g~~~~~F~sl~~LV~~y~~   89 (128)
T 1ka6_A           25 LDGSYLLR-DSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQK   89 (128)
T ss_dssp             CTTCEEEE-ECSSSTTCEEEEEESSSCEEEEEEEECTTSCEEEECSTTSCCCEESSHHHHHHHTTS
T ss_pred             CCCEEEEe-ecCCCCCCEEEEEEeCCEEEEEEEEECCCCeEEEeecCCCCCCccCCHHHHHHHHhh
Confidence            56999999 999888999999999999999999987788885543211145678888888877764

>2lqn_A CRK-like protein; SH2, SH3, V-CRK sarcoma virus CT10 oncogene homolog (avian)- signaling protein; NMR {Homo sapiens} PDB: 2lqw_A*

Probab=97.02  E-value=2.6e-06  Score=83.44  Aligned_cols=59  Identities=10%  Similarity=0.075  Sum_probs=50.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|....++.|.+     .. ..|+++..++.+|..
T Consensus        32 ~~G~FLvR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~~-----~~-~~F~sl~~Lv~~y~~   90 (303)
T 2lqn_A           32 RHGMFLVR-DSSTCPGDYVLSVSENSRVSHYIINSLPNRRFKI-----GD-QEFDHLPALLEFYKI   90 (303)
Confidence            77999999 9999999999999999999999999877777733     33 678888888888875

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.81  E-value=0.00013  Score=71.58  Aligned_cols=79  Identities=20%  Similarity=0.047  Sum_probs=61.4

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC---CCceeEEEEEEEcCCCceEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR---HRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~---HpnIv~l~g~~~~~~~~~~v  272 (472)
                      .+.-.+.|+.|.+..+|+....+..+++|+....       ....|..|+..|+.|.   ...+.++++++...+..++|
T Consensus        37 ~i~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           37 FIKHKEKLYSGEMNEIWLINDEVQTVFVKINERS-------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             CCCEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             ceeeeEEeCCccceeeeEEEECCCeEEEEeCCcc-------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            3445678999999999999877889999977432       2456889999998883   35678888887777778889


Q ss_pred             EEeccCCcH
Q 039082          273 VTELLGTTL  281 (472)
Q Consensus       273 ve~~~ggsL  281 (472)
                      |+++.|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999987653

>2ecd_A Tyrosine-protein kinase ABL2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.80  E-value=1.8e-07  Score=78.71  Aligned_cols=69  Identities=16%  Similarity=0.132  Sum_probs=55.1

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-----CCccccccC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-----QTPLHRYCS  168 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-----~~~l~~~~~  168 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|....+|.|     +......|+++..++.+|..     .+.|..+|.
T Consensus        36 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~~~~gl~~~L~~P~~  109 (119)
T 2ecd_A           36 INGSFLVR-ESESSPGQLSISLRYEGRVYHYRINTTADGKV-----YVTAESRFSTLAELVHHHSTVADGLVTTLHYPAP  109 (119)
T ss_dssp             CTTBEEEE-EESSSTTEEEEEEECSSCEEEECCCCCSSSCC-----CCCSSCCCSSHHHHHHHHHHCCTTSSSCCCBCCS
T ss_pred             CCCeEEEE-eCCCCCCCEEEEEEECCeEEEEEEEEcCCCCE-----EEcCCCcCCCHHHHHHHHhhCCCCCceECCCccC
Confidence            45999999 99988999999999999999999998888888     55556788888888777653     344555553

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=0.00016  Score=73.83  Aligned_cols=74  Identities=14%  Similarity=0.127  Sum_probs=46.2

Q ss_pred             CceeecCCCCCcEEEcCCCcEEEeecccceecCCCcc--cccc--CCcccccccccCCC---CCchHHHHHHHHHHHHHH
Q 039082          325 PKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM--ALTG--TFVYMAPEVIQCEP---YSEKSDVYSFGIILNEII  397 (472)
Q Consensus       325 ~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~--~~~g--t~~y~APE~~~~~~---~s~~sDvwSlGvll~ell  397 (472)
                      ..++|+|++|.|||++.++ ++|+||+.+........  ....  ...|.+|+......   -....++..+...+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            3599999999999999776 99999999876542111  0011  23466666543211   112344556777777766


Q ss_pred             cC
Q 039082          398 TG  399 (472)
Q Consensus       398 tG  399 (472)
                      ++
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>1rja_A Tyrosine-protein kinase 6; human protein tyrosine kinase-6 (PTK6/BRK), SRC homology 2(S domain, solution structure, backbone dynamics, transferase; NMR {Homo sapiens} SCOP: d.93.1.1

Probab=97.74  E-value=2.9e-08  Score=80.92  Aligned_cols=61  Identities=7%  Similarity=0.012  Sum_probs=50.4

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| +|++.+|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..
T Consensus        23 ~~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~   83 (100)
T 1rja_A           23 NATGAFLIR-VSEKPSADYVLSVRDTQAVRHYKIWRRAGGRL-----HLNEAVSFLSLPELVNYHRA   83 (100)
T ss_dssp             CSSCCEEEE-ECSSSSSCEEEEECTTSSCEEEEEEECSSSCE-----EEETTEEESSHHHHHHHHHH
T ss_pred             CCCCEEEEE-eCCCCCCCEEEEEEECCEEEEEEEEEcCCCcE-----EECCCCccCCHHHHHHHHhh
Confidence            457999999 99988899999999999999999998878888     33345678888888777653

>4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A*

Probab=97.69  E-value=3.8e-07  Score=86.63  Aligned_cols=60  Identities=8%  Similarity=-0.052  Sum_probs=49.4

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCccc---CcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQ---HQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~---~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..++.|+||+|...+++   .|     +......|+++..++.+|..
T Consensus        35 ~dG~FLVR-~S~s~~G~y~LSv~~~~~v~H~~I~~~~~~g~~~~-----~~~~~~~F~sl~~LV~~y~~   97 (246)
T 4fbn_A           35 PDGSFLVR-ESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKF-----FLTDNLVFDSLYDLITHYQQ   97 (246)
T ss_dssp             CTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEEECGGGCCEE-----EEETTEEESSHHHHHHHHHH
T ss_pred             CCCEEEEE-cCCCCCCCEEEEEEECCEEEEEEEEEECCCCceeE-----EecCCcccCCHHHHHHhHhh
Confidence            35899999 999999999999999999999999877764   34     44455678888888887754

>1jyr_A Growth factor receptor-bound protein 2; receptor binding, regulatory, inhibitor, signaling protein-I complex; HET: PTR; 1.55A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jyq_A* 1jyu_A 1qg1_E* 1x0n_A* 2aob_A* 2aoa_A* 3n7y_A* 1tze_E* 1zfp_E* 3mxc_A* 3mxy_A* 1cj1_A*

Probab=97.66  E-value=1.2e-07  Score=76.49  Aligned_cols=59  Identities=12%  Similarity=-0.007  Sum_probs=49.5

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..++.|+||+|...+++.|.+     .. ..|+++..++.+|..
T Consensus        24 ~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~l-----~~-~~F~sl~~LV~~y~~   82 (96)
T 1jyr_A           24 HDGAFLIR-ESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL-----WV-VKFNSLNELVDYHRS   82 (96)
T ss_dssp             STTBEEEE-ECSSSTTCEEEEEEETTEEEEEECEECTTSCEES-----SS-CEESSHHHHHHHTTS
T ss_pred             CCcEEEEE-ecCCCCCCEEEEEEeCCeEEEEEEEEcCCCCEEE-----CC-cccCCHHHHHHHHhh
Confidence            37999999 9998899999999999999999999887888844     22 578888888877764

>1blj_A P55 BLK protein tyrosine kinase; signal transduction, transferase, phosphotransferase, phosphorylation; NMR {Mus musculus} SCOP: d.93.1.1 PDB: 1blk_A

Probab=97.65  E-value=3.9e-08  Score=82.07  Aligned_cols=63  Identities=13%  Similarity=0.066  Sum_probs=50.2

Q ss_pred             HHHHHHHHHHhhhhhHHHHHHHHHHhh----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           91 QKELRIIYRKRLERTQDYLRHCLQIAQ----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        91 ~~~~~~~fl~R~~s~~~~~~~~Lsv~~----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +....++|||| +|++.+|.|+|||..    +..|+||+|...+++.|     +......|+++..++.+|..
T Consensus        31 ~g~~~G~FLVR-~S~~~~g~y~LSv~~~~~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~   97 (114)
T 1blj_A           31 PMNKAGSFLIR-ESESNKGAFSLSVKDITTQGEVVKHYKIRSLDNGGY-----YISPRITFPTLQALVQHYSK   97 (114)
T ss_dssp             TTCCTTCEEBC-BCTTCSSCEEEEECBCCTTTCBCCCEEEEEETTTEE-----EEETTEEESSHHHHHHHHHH
T ss_pred             CCCCCceEEEE-eCCCCCCCEEEEEEEecCCCCcEEEEEEEEcCCCCE-----EECCCcccCCHHHHHHHhhh
Confidence            34456999999 999989999999976    68899999998777777     33345678888888777653

>2el8_A Signal-transducing adaptor protein 2; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction, structural genomics; NMR {Homo sapiens}

Probab=97.65  E-value=2.4e-07  Score=77.79  Aligned_cols=58  Identities=7%  Similarity=-0.153  Sum_probs=47.5

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhh----cCCeEEEeccCCcccCcccccCCCCCccCC--CCCCCccccCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQ----DNGVLELMTNNKEDQHQSLLSSNTGSVIAS--PLVQTPLHQHS  158 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~--~~~~~~~~~~~  158 (472)
                      ..++|||| +|++.+|.|+|||..    ++.|+||+|.. +++.|     +......|  +++..++.+|.
T Consensus        42 ~~G~FLVR-~S~~~~g~y~LSv~~~~~~~~~v~H~~I~~-~~g~~-----~i~~~~~F~~~sL~eLV~~y~  105 (118)
T 2el8_A           42 ECGNLLLR-PSGDGADGVSVTTRQMHNGTHVVRHYKVKR-EGPKY-----VIDVEQPFSCTSLDAVVNYFV  105 (118)
T ss_dssp             TTCSBEEE-ECCSSSSSEEEEECCCBTTBCCCEEECBCC-BTTBC-----CBSSSSCCCCSSHHHHHHHHH
T ss_pred             CCcEEEEe-eCCCCCCceEEEEEEecCCCCcEEEEEEEE-cCCEE-----EEeCCCeECCCCHHHHHHHHh
Confidence            57999999 999999999999987    88999999988 67788     44444566  78877777664

>3k2m_A Proto-oncogene tyrosine-protein kinase ABL1; engineered binding protein, antibody mimic, protein-protein SH2 domain, ATP-binding, phosphoprotein; 1.75A {Homo sapiens} PDB: 3uyo_A 3t04_A 1ab2_A

Probab=97.62  E-value=2.4e-07  Score=77.01  Aligned_cols=70  Identities=17%  Similarity=0.152  Sum_probs=55.5

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-----CCccccccC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-----QTPLHRYCS  168 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-----~~~l~~~~~  168 (472)
                      -.++|||| +|++..|.|+|||..++.|+||+|....+|.|     +......|+++..++.+|..     .++|..+|.
T Consensus        25 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sl~~LV~~y~~~~~~l~~~L~~P~~   98 (112)
T 3k2m_A           25 INGSFLVR-ESESSPGQRSISLRYEGRVYHYRINTASDGKL-----YVSSESRFNTLAELVHHHSTVADGLITTLHYPAP   98 (112)
T ss_dssp             CTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCE-----ESSTTCCBSSHHHHHHHHHHCCTTSSSCCCEECC
T ss_pred             CCceEEEE-eCCCCCCCEEEEEEeCCcEEEEEEEECCCCcE-----EECCCCeECCHHHHHHHHhhCCCCCccCCCCCCC
Confidence            46999999 99999999999999999999999998888887     44455688888888777764     345555554


Q ss_pred             C
Q 039082          169 Q  169 (472)
Q Consensus       169 ~  169 (472)
                      .
T Consensus        99 ~   99 (112)
T 3k2m_A           99 K   99 (112)
T ss_dssp             C
T ss_pred             C
Confidence            3

>2dm0_A Tyrosine-protein kinase TXK; TEC family kinase, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.60  E-value=5.3e-07  Score=76.48  Aligned_cols=63  Identities=10%  Similarity=0.101  Sum_probs=49.1

Q ss_pred             HHHHHHHHHHHhhhhhHHHHHHHHHHhh------cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           90 RQKELRIIYRKRLERTQDYLRHCLQIAQ------DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        90 ~~~~~~~~fl~R~~s~~~~~~~~Lsv~~------~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++....++|||| +| ..+|.|+|||..      +..|+||+|...+++.|     +......|+++..++.+|..
T Consensus        33 ~~~~~~G~FLVR-~S-~~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~eLV~~y~~  101 (125)
T 2dm0_A           33 RQESKEGAFIVR-DS-RHLGSYTISVFMGARRSTEAAIKHYQIKKNDSGQW-----YVAERHAFQSIPELIWYHQH  101 (125)
T ss_dssp             HHHCSTTCBCEE-EE-TTEEEEEEEEECCCSSSSSCCEEEEEEEECTTCCE-----ESSSSCCCSSHHHHHHHHTT
T ss_pred             hhcCCCCEEEEE-ec-CCCCCEEEEEEeccccCCCCcEEEEEEEEcCCCCE-----EECCCCccCCHHHHHHHhhh
Confidence            333356999999 88 567889999965      56999999998888888     44445678888888877764

>4d8k_A Tyrosine-protein kinase LCK; protein kinases, SH2 domain, SH3 domain, structural genomics center for structural genomics, JCSG; 2.36A {Homo sapiens} PDB: 1lck_A* 1x27_A*

Probab=97.59  E-value=1.8e-07  Score=84.17  Aligned_cols=62  Identities=11%  Similarity=0.048  Sum_probs=51.2

Q ss_pred             HHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           92 KELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        92 ~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ....++|||| +|++..|.|+|||..     +..|+||+|....++.|     +......|+++..++.+|..
T Consensus        94 ~~~~G~FLVR-~S~~~~g~y~LSv~~~~~~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sl~~LV~~y~~  160 (175)
T 4d8k_A           94 GNTHGSFLIR-ESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGF-----YISPRITFPGLHELVRHYTN  160 (175)
T ss_dssp             TCCTTCEEEE-ECSSSTTCEEEEEEEECTTSCEEEEEEEEEECSSSCE-----ESSTTSEESSHHHHHHHHHH
T ss_pred             CCCCCEEEEE-ECCCCCCeEEEEEEeCcccCCCceEEEEEEECCCCCE-----EECCCCccCCHHHHHHHHhh
Confidence            3457999999 999999999999976     77899999998888888     55555688888888877764

>3s9k_A Tyrosine-protein kinase ITK/TSK; proline isomerization, CIS proline, domain swapped dimer, SH transferase; HET: CIT; 2.35A {Mus musculus} PDB: 2etz_A* 2eu0_A* 1lui_A 1luk_A 1lum_A 1lun_A 2k79_B 2k7a_B

Probab=97.57  E-value=3.2e-07  Score=76.89  Aligned_cols=65  Identities=5%  Similarity=-0.034  Sum_probs=49.2

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHhhc------CCeEEEec--cCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIAQD------NGVLELMT--NNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~------~~v~hy~i--~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++++....++|||| +| +..|.|+|||...      ..|+||+|  ....++.|     +......|+++..++.+|..
T Consensus        24 lL~~~~~~G~FLVR-~S-~~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~~~g~~-----~~~~~~~F~sl~~LV~~y~~   96 (118)
T 3s9k_A           24 LLLDTGKEGAFMVR-DS-RTPGTYTVSVFTKAIISENPCIKHYHIKETNDSPKRY-----YVAEKYVFDSIPLLIQYHQY   96 (118)
T ss_dssp             HHHHHCCTTCEEEE-EC-SSTTCEEEEEEECCSCSSSCEEEEEEEEECSCSSCCE-----EEECSCCCSCHHHHHHHHHH
T ss_pred             HHHhcCCCCeEEEE-ee-CCCCCEEEEEEecccccCCCceEEEEEeEEECCCCCE-----EECCCcccCCHHHHHHHhee
Confidence            44444457999999 88 7789999999765      89999999  45667777     43445678888888777764

>1nrv_A Growth factor receptor-bound protein 10; dimer, signaling protein; 1.65A {Homo sapiens} SCOP: d.93.1.1 PDB: 3m7f_A

Probab=97.55  E-value=2.9e-07  Score=75.55  Aligned_cols=71  Identities=11%  Similarity=0.027  Sum_probs=49.3

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCc-ccC--cccccCCCCCccCCCCCCCccccCCC
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKE-DQH--QSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~-~~~--~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++-|.++..-.++|||| +|++.+|.|+|||..++.|+||+|...+ +|+  |.+.    +....|+++..++.+|..
T Consensus        17 Ae~lL~~~g~~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~~g~~~~~~~----~~~~~F~sl~~LV~~y~~   90 (105)
T 1nrv_A           17 SHRIIKQQGLVDGLFLLR-DSQSNPKAFVLTLCHHQKIKNFQILPCEDDGQTFFSLD----DGNTKFSDLIQLVDFYQL   90 (105)
T ss_dssp             HHHHHHHTTCCTTEEEEE-ECSSCTTCEEEEEEETTEEEEEEEEEC-----CCEESS----TTSSCBSSHHHHHHHHTT
T ss_pred             HHHHHHhcCCCCceEEEE-eCCCCCCCEEEEEEeCCEEEEEEEEEEcCCCCEEEEEc----CCCcccCCHHHHHHHhhh
Confidence            333333333457999999 9998889999999999999999998764 553  3221    134678888888777664

>2ekx_A Cytoplasmic tyrosine-protein kinase BMX; SH2 domain, phosphotyrosine binding domain, protein tyrosine kinase, signal transduction; NMR {Homo sapiens}

Probab=97.55  E-value=2.6e-07  Score=76.58  Aligned_cols=64  Identities=13%  Similarity=0.092  Sum_probs=48.6

Q ss_pred             HHHHHHHHHHHHhhhhhHHHHHHHHHHhh------cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           89 QRQKELRIIYRKRLERTQDYLRHCLQIAQ------DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        89 ~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~------~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++....++|||| +| ..+|.|+|||..      +..|+||+|...++|.|     +......|+++..++.+|..
T Consensus        27 L~~~~~~G~FLVR-~S-~~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~   96 (110)
T 2ekx_A           27 LRQKGKEGAFMVR-NS-SQVGMYTVSLFSKAVNDKKGTVKHYHVHTNAENKL-----YLAENYCFDSIPKLIHYHQH   96 (110)
T ss_dssp             HHHTCCTTEEEEE-EC-SSTTCEEEEECCCCSSCSSCCCEEEECEECTTCCE-----ESSTTCCCSCHHHHHHHHHH
T ss_pred             HhccCCCceEEEE-ec-CCCCCEEEEEEeccccCCCCcEEEEEEEECCCCCE-----EECCCCccCCHHHHHHHHee
Confidence            3333356999999 88 468899999964      57999999998888888     43344678888888777654

>3pqz_A Growth factor receptor-bound protein 7; SH2, binds phosphotyrosine, tyrosine kinases, cytoplasmic, P binding; 2.41A {Homo sapiens} PDB: 1mw4_A* 2l4k_A* 2qms_A

Probab=97.55  E-value=1.6e-07  Score=78.78  Aligned_cols=64  Identities=9%  Similarity=0.015  Sum_probs=46.7

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCC-cccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNK-EDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~-~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| +|++..|.|+|||..++.|+||+|... ++|++....  ......|+++..++.+|..
T Consensus        35 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~~g~~~~~~--~~~~~~F~sl~~LV~~y~~   99 (117)
T 3pqz_A           35 LVDGLFLVR-ESQRNPQGFVLSLCHLQKVKHYLILPSEEEGRLYFSM--DDGQTRFTDLLQLVEFHQL   99 (117)
T ss_dssp             CCTTEEEEE-ECCC-CCCEEEEEEETTEEEEEEEEEECCTTCCEEES--STTSSCBSSHHHHHHHHHH
T ss_pred             CCCCEEEEE-ecCCCCCcEEEEEEeCCeeEEEEEEEecCCCCEEEEE--CCCCcccCCHHHHHHHHhh
Confidence            347999999 999988999999999999999999875 456541110  1134577888887776653

>2ge9_A Tyrosine-protein kinase BTK; SH2 domain, structure, transferase; NMR {Homo sapiens}

Probab=97.53  E-value=4.1e-07  Score=77.14  Aligned_cols=63  Identities=6%  Similarity=0.026  Sum_probs=48.4

Q ss_pred             HHHHHHHHHHHhhhhhHHHHHHHHHHhh------cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           90 RQKELRIIYRKRLERTQDYLRHCLQIAQ------DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        90 ~~~~~~~~fl~R~~s~~~~~~~~Lsv~~------~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++....++|||| +| +.+|.|+|||..      +..|+||+|...++|.|     +......|+++..++.+|..
T Consensus        28 ~~~g~~G~FLVR-~S-s~~g~y~LSv~~~~~~~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~eLV~~y~~   96 (125)
T 2ge9_A           28 KQEGKEGGFIVR-DS-SKAGKYTVSVFAKSTGDPQGVIRHYVVCSTPQSQY-----YLAEKHLFSTIPELINYHQH   96 (125)
T ss_dssp             HHHTCTTEEEEE-EC-SSSCCEEEEEEESSSSSTTCEEEEEECEEETTTEE-----ESSTTSCBSSHHHHHHHHHC
T ss_pred             hhcCCCceEEEE-ec-CCCCCEEEEEEeccccCCCCeEEEEEEEEcCCCCE-----EECCCCcCCCHHHHHHHhhh
Confidence            333356999999 88 568899999964      57899999998888878     44344678888888777654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.48  E-value=0.001  Score=63.89  Aligned_cols=78  Identities=19%  Similarity=0.127  Sum_probs=54.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC---CceeEEEEEEEcCCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH---RFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H---pnIv~l~g~~~~~~~~~  270 (472)
                      .++.-++.+|.|..+.||+.... |+.|.+|+......    .....|..|+..|+.|.-   --+.+++++    +..+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~----~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAP----ALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCC----CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCc----chhhHHHHHHHHHHHHHhhCCCCcceEEec----cCce
Confidence            45677889999999999999875 78999997654322    112347789999998842   134455554    2346


Q ss_pred             EEEEeccCCc
Q 039082          271 WLVTELLGTT  280 (472)
Q Consensus       271 ~vve~~~ggs  280 (472)
                      +|++++.++.
T Consensus        87 lv~e~l~~~~   96 (288)
T 3f7w_A           87 LAMEWVDERP   96 (288)
T ss_dssp             EEEECCCCCC
T ss_pred             EEEEeecccC
Confidence            7888887553

>2gsb_A RAS GTPase-activating protein 1; GAP, RAS P21 protein activator, P120GAP, rasgap, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.47  E-value=2.6e-07  Score=77.70  Aligned_cols=58  Identities=3%  Similarity=-0.069  Sum_probs=48.6

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .++|||| +|++..|.|+|||..++.|+||+|...+++.|.+.     . ..|+++..++.+|..
T Consensus        38 ~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~l~-----~-~~F~sl~~LI~~y~~   95 (119)
T 2gsb_A           38 VCSFLVR-PSDNTPGDYSLYFRTNENIQRFKICPTPNNQFMMG-----G-RYYNSIGDIIDHYRK   95 (119)
T ss_dssp             SSEEEEE-ECSSSTTCEEEEEECSSCBCCCCEEEETTTEEEES-----S-CCBSCHHHHHHHHTT
T ss_pred             CCeEEEE-eCCCCCCceEEEEEECCEEEEEEEEEcCCCCEEEC-----C-cccCCHHHHHHHHhh
Confidence            4899999 99998999999999999999999998878888442     2 468888888777765

>3ov1_A Growth factor receptor-bound protein 2; GRB2 SH2 domain, phosphotyrosine binding, signaling protein, signaling protein-antagonist complex; HET: PTR; 1.60A {Homo sapiens} SCOP: d.93.1.1 PDB: 3imj_A* 3in7_A* 3imd_A* 3kfj_A* 3n8m_A* 3in8_A* 3s8l_A* 3s8n_A* 3s8o_A* 2huy_A* 2h5k_A* 2huw_A* 2h46_E* 3c7i_A* 3n84_A* 1fhs_A 1bm2_A* 1bmb_A* 3ove_A* 1fyr_A* ...

Probab=97.46  E-value=3.2e-07  Score=76.92  Aligned_cols=66  Identities=11%  Similarity=0.011  Sum_probs=52.5

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQ  160 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~~  160 (472)
                      +++.....++|||| +|++..|.|+|||..++.|+||+|....+|.|.+     .. ..|+++..++.+|...
T Consensus        21 lL~~~~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~l-----~~-~~F~sl~eLV~~y~~~   86 (117)
T 3ov1_A           21 MLSKQRHDGAFLIR-ESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL-----WV-VKFNSLNELVDYHRST   86 (117)
T ss_dssp             HHHTCCSTTBEEEE-ECSSSTTCEEEEEEETTEEEEEECEECTTSCEES-----SS-CEESSHHHHHHHTTTS
T ss_pred             HHhCCCCCCcEEEE-eCCCCCCCEEEEEecCCceEEEEEEECCCCeEEE-----CC-CCcCCHHHHHHHHhhC
Confidence            33444456999999 9999999999999999999999998878888844     33 4788888888777653

>1r1p_A GRB2-related adaptor protein 2; SH2, GADS, phosphopeptide, peptide binding protein; HET: PTR; 1.80A {Mus musculus} SCOP: d.93.1.1 PDB: 1r1q_A* 1r1s_A*

Probab=97.46  E-value=4.4e-07  Score=73.82  Aligned_cols=59  Identities=7%  Similarity=0.001  Sum_probs=48.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++.+|.|+|||..++.|+||+|...++|.|.+.     . ..|+++..++.+|..
T Consensus        29 ~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~l~-----~-~~F~sl~~LV~~y~~   87 (100)
T 1r1p_A           29 DIGFFIIR-ASQSSPGDFSISVRHEDDVQHFKVMRDTKGNYFLW-----T-EKFPSLNKLVDYYRT   87 (100)
T ss_dssp             CTTBEEEE-ECSSSTTCEEEEEECSSSEEEEECEECTTCCEESS-----S-CEESSHHHHHHHHTT
T ss_pred             CCCEEEEE-ecCCCCCCEEEEEEECCEEEEEEEEEcCCCCEEEe-----C-CEeCCHHHHHHHHHh
Confidence            47999999 99998999999999999999999998777788442     2 477888888777653

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.44  E-value=0.00052  Score=66.48  Aligned_cols=71  Identities=14%  Similarity=0.025  Sum_probs=43.7

Q ss_pred             eceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCce-eEEEEEEEcCCCceEEEEec-c
Q 039082          200 QEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV-LQLMGACLEPPYRGWLVTEL-L  277 (472)
Q Consensus       200 ~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnI-v~l~g~~~~~~~~~~vve~~-~  277 (472)
                      ++.|+.|....+|+.    ..+++|+........     ....+|+.+++.+....+ .++++.  ..+..+++++++ .
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~~-----~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~   91 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEEY-----INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAG   91 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC----C-----CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTT
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccce-----eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCC
Confidence            678999999999998    679999875431111     112467777777632222 455543  333456788888 5


Q ss_pred             CCcH
Q 039082          278 GTTL  281 (472)
Q Consensus       278 ggsL  281 (472)
                      |.+|
T Consensus        92 g~~l   95 (301)
T 3dxq_A           92 AQTM   95 (301)
T ss_dssp             CEEC
T ss_pred             CccC
Confidence            5444

>3tkz_A Tyrosine-protein phosphatase non-receptor type 11; SH2 domain, protein protein interactions, PTR residues, HYDR peptide complex; HET: PTR; 1.80A {Homo sapiens} PDB: 3tl0_A* 1aya_A* 1ayb_A* 1ayc_A* 1ayd_A

Probab=97.43  E-value=5.6e-07  Score=74.37  Aligned_cols=59  Identities=7%  Similarity=-0.027  Sum_probs=47.0

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..++.|+||+|... ++.|.     ......|+++..++.+|..
T Consensus        28 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~-~~~~~-----~~~~~~F~sl~~LV~~y~~   86 (109)
T 3tkz_A           28 VDGSFLAR-PSKSNPGDFTLSVRRNGAVTHIKIQNT-GDYYD-----LYGGEKFATLAELVQYYME   86 (109)
T ss_dssp             CTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEEEC-SSCEE-----SSSSCCBSSHHHHHHHHHH
T ss_pred             CCCEEEEE-ecCCCCCCEEEEEEECCEEEEEEEEeC-CCEEE-----ecCCcccCCHHHHHHHHHh
Confidence            57999999 999889999999999999999999875 44552     3344568888888777654

>2cr4_A 3BP-2, SH3 domain-binding protein 2; structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=97.42  E-value=5.9e-07  Score=76.19  Aligned_cols=56  Identities=13%  Similarity=0.043  Sum_probs=47.0

Q ss_pred             HHHHHhhhhhHHHHHHHHHHhhc--CCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           96 IIYRKRLERTQDYLRHCLQIAQD--NGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        96 ~~fl~R~~s~~~~~~~~Lsv~~~--~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++|||| +|+ .+|.|+|||..+  +.|+||+|...++ +|     +......|+++..++.+|..
T Consensus        45 G~FLVR-~S~-~~g~y~LSv~~~~~~~vkH~rI~~~~~-~~-----~i~~~~~F~sL~eLV~hY~~  102 (126)
T 2cr4_A           45 GLYCIR-NSS-TKSGKVLVVWDETSNKVRNYRIFEKDS-KF-----YLEGEVLFVSVGSMVEHYHT  102 (126)
T ss_dssp             TCEEEE-ECS-STTCEEEEEEETTTTEECCEECEEETT-EE-----ESSSSCEESSHHHHHHHHTT
T ss_pred             CeEEEE-ecC-CCCCEEEEEEeCCCCCEEEEEEEECCC-eE-----EEcCCccCCCHHHHHHHHhh
Confidence            999999 999 889999999888  8999999998776 67     55555678888888777764

>1h9o_A Phosphatidylinositol 3-kinase; transferase/receptor, complex (phosphotransferase/receptor), phosphotransferase, SH2 domain; HET: PTR; 1.79A {Homo sapiens} SCOP: d.93.1.1 PDB: 1pic_A* 1bfi_A 1bfj_A 1qad_A

Probab=97.41  E-value=3.8e-07  Score=75.83  Aligned_cols=59  Identities=8%  Similarity=-0.063  Sum_probs=47.6

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      ...++|||| +| +.+|.|+|||..++.|+||+|...+++.+     .......|+++..++.+|.
T Consensus        29 ~~~G~FLVR-~S-~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sl~~LV~~y~   87 (112)
T 1h9o_A           29 KRDGTFLVR-ES-SKQGCYACSVVVDGEVKHCVINKTATGYG-----FAEPYNLYSSLKELVLHYQ   87 (112)
T ss_dssp             CCTTEEEEE-EC-SSTTCEEEEEEETTEEEEEEEEEETTEEE-----SSTTCCCBSSHHHHHHHHH
T ss_pred             CCCceEEEe-ec-CCCCCEEEEEEECCEEEEEEEEEcCCceE-----EeCCCCCcCCHHHHHHHHh
Confidence            457999999 88 77889999999999999999998877654     3334567888888877664

>3us4_A Megakaryocyte-associated tyrosine-protein kinase; SH2 domain, signaling protein, structural genomics, joint CE structural genomics, JCSG; 1.50A {Homo sapiens} SCOP: d.93.1.1 PDB: 1jwo_A

Probab=97.40  E-value=4.4e-07  Score=73.48  Aligned_cols=59  Identities=12%  Similarity=0.054  Sum_probs=47.6

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..++.|+||+|... ++.|     +......|+++..++.+|..
T Consensus        25 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~-~~~~-----~~~~~~~F~sl~~Lv~~y~~   83 (98)
T 3us4_A           25 EDGLFLVR-ESARHPGDYVLCVSFGRDVIHYRVLHR-DGHL-----TIDEAVFFCNLMDMVEHYSK   83 (98)
T ss_dssp             CTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEEE-TTEE-----ESSSSSEESSHHHHHHHHHH
T ss_pred             CCcEEEEE-eCCCCCCcEEEEEEECCceEEEEEEEe-CCEE-----EECCCCccCCHHHHHHHhhh
Confidence            46999999 999999999999999999999999874 5577     44445677888887776653

>2cs0_A Hematopoietic SH2 domain containing; ALX, FLJ14886, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} SCOP: d.93.1.1

Probab=97.39  E-value=1.5e-06  Score=72.94  Aligned_cols=61  Identities=11%  Similarity=0.061  Sum_probs=49.1

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| +|++..+ |+|||..++.|+||+|...++|.|.+.    +....|+++..++.+|..
T Consensus        35 ~~~G~FLVR-~S~~~~~-y~LSv~~~~~v~H~~I~~~~~g~~~l~----~~~~~F~sl~eLV~~y~~   95 (119)
T 2cs0_A           35 QPLGSFLIR-VSHSHVG-YTLSYKAQSSCCHFMVKLLDDGTFMIP----GEKVAHTSLDALVTFHQQ   95 (119)
T ss_dssp             SCTTCEEEE-ECSSSSS-EEEEECCSSSCEEEEEEECTTSCEECT----TCSCCBSSHHHHHHHHTT
T ss_pred             CCCCEEEEE-ecCCCCC-EEEEEEECCEEEEEEEEEcCCCcEEEe----cCCCcCCCHHHHHHHHhh
Confidence            345999999 9998888 999999999999999998888788332    135678888888777764

>2dx0_A Phospholipase C, gamma 2; phosphoric diester hydrolase, structural genomics, NPPSFA, national project on protein structural and functional analyses; 2.50A {Mus musculus}

Probab=97.39  E-value=7.2e-07  Score=77.02  Aligned_cols=61  Identities=7%  Similarity=-0.073  Sum_probs=50.6

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCccc---CcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQ---HQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~---~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ...++|||| +|++..|.|+|||..++.|+||+|...+++   +|     +......|+++..++.+|..
T Consensus        48 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~gg~~~~-----~l~~~~~F~sl~eLI~~y~~  111 (138)
T 2dx0_A           48 AKDGTFLVR-ESETFPNDYTLSFWRSGRVQHCRIRSTMENGVMKY-----YLTDNLTFNSIYALIQHYRE  111 (138)
T ss_dssp             CCTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEEEEETTEEEE-----ESSTTSCBSSHHHHHHHTTT
T ss_pred             CCCCEEEEE-eCCCCCCCeEEEEEECCeEEEEEEEEecCCCceEE-----EeCCCCcCCCHHHHHHHHhh
Confidence            467999999 999888999999999999999999987654   56     44445788888888887764

>2dlz_A Protein VAV-2; RHO family guanine nucleotide exchange factor, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.37  E-value=1.1e-06  Score=73.59  Aligned_cols=59  Identities=15%  Similarity=0.085  Sum_probs=48.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++.+|.|+|||..++.|+||+|... ++.|     +......|+++..++.+|..
T Consensus        36 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~-~g~~-----~l~~~~~F~sl~~LV~~y~~   94 (118)
T 2dlz_A           36 ASGTYLIR-ERPAEAERFAISIKFNDEVKHIKVVEK-DNWI-----HITEAKKFDSLLELVEYYQC   94 (118)
T ss_dssp             CTTBEEEE-CCSCSSCCEEEEEECSSSEEEEEEEEE-TTEE-----ESTTSCCBSSHHHHHHHHTT
T ss_pred             CCCEEEEE-eCCCCCCCEEEEEEECCcEEEEEEEEc-CCEE-----EEeCCcccCCHHHHHHHHhh
Confidence            46999999 999888999999999999999999875 5677     44444788888888877764

>2hdv_A SH2-B PH domain containing signaling mediator 1 gamma isoform; adapter protein, signaling protein; 2.00A {Mus musculus} PDB: 2hdx_A* 1rpy_A 1rqq_C*

Probab=97.37  E-value=4.2e-07  Score=75.43  Aligned_cols=59  Identities=7%  Similarity=-0.044  Sum_probs=49.2

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..+..|+||+|...++|.|.+     . ...|+++..++.+|..
T Consensus        32 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~l-----~-~~~F~sl~~LV~~y~~   90 (111)
T 2hdv_A           32 SHGVFLVR-QSETRRGECVLTFNFQGKAKHLRLSLNAAGQCRV-----Q-HLHFQSIFDMLEHFRV   90 (111)
T ss_dssp             GTTEEEEE-ECSSCTTEEEEEEEETTEEEEEEEEECTTCCEEE-----T-TEEESSHHHHHHHHTT
T ss_pred             CCCeEEEE-ecCCCCCCEEEEEEeCCeEEEEEEEEcCCCCEEe-----C-CceeCCHHHHHHHHhh
Confidence            67999999 9999999999999999999999999877777743     2 3677888888777653

>3eaz_A Tyrosine-protein kinase CSK; SH2, disulfide, oxidized reduced, ATP-binding, cell membrane, cytoplasm, membrane, nucleotide-binding, phosphoprotein; 1.31A {Homo sapiens} PDB: 3eac_A

Probab=97.34  E-value=7.9e-07  Score=73.07  Aligned_cols=59  Identities=10%  Similarity=-0.035  Sum_probs=48.2

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|... ++.|     +......|+++..++.+|..
T Consensus        28 ~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~-~g~~-----~l~~~~~F~sl~~Lv~~y~~   86 (106)
T 3eaz_A           28 ETGLFLVR-ESTNYPGDYTLCVSSDGKVEHYRIMYH-ASKL-----SIDEEVYFENLMQLVEHYTS   86 (106)
T ss_dssp             CTTEEEEE-ECTTSTTCEEEEEEETTEEEEEECEEE-TTEE-----ESSSSSCBSSHHHHHHHHHH
T ss_pred             CCCEEEEE-ECCCCCCcEEEEEEeCCceEEEEEEec-CCEE-----EECCCCccCCHHHHHHHHhh
Confidence            46999999 999999999999999999999999864 5677     44445678888888776654

>2eo6_A B-cell linker protein; SH2, cytoplasmic adapter protein, B-cell adapter containing SH2 domain protein; NMR {Mus musculus}

Probab=97.33  E-value=1e-06  Score=76.26  Aligned_cols=70  Identities=11%  Similarity=-0.012  Sum_probs=50.9

Q ss_pred             HHHHHHHHHHHHHhhhhhH--HHHHHHHHHhhcCCeEEEeccCCcccC-cccccCCCCCccCCCCCCCccccCCC
Q 039082           88 VQRQKELRIIYRKRLERTQ--DYLRHCLQIAQDNGVLELMTNNKEDQH-QSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~--~~~~~~Lsv~~~~~v~hy~i~~~~~~~-~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++++....++|||| +|++  ..|.|+|||..++.|+||+|...++++ |.+... ......|+++..++.+|..
T Consensus        38 lL~~~~~~G~FLVR-~S~~~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~~l~~~-~~~~~~F~sl~eLV~~y~~  110 (141)
T 2eo6_A           38 ALHRSNKDGSFLIR-KSSGHDSKQPYTLVAFFNKRVYNIPVRFIEATKQYALGKK-KNGEEYFGSVVEIVNSHQH  110 (141)
T ss_dssp             HHHHHCCTTCBCEE-ECSTTCSSCSEEEEEEETTEEEEEEECEETTTTEECSSSC-CTTCCCBSSHHHHHHHHHH
T ss_pred             HhhccCCCceEEEE-ECCCCCCCCCEEEEEEECCEEEEEEEEEeCCCCEEEEccc-cCCCCccCCHHHHHHHHhh
Confidence            33443458999999 8887  678999999999999999998766666 522211 1135678888888777754

>2eo3_A CRK-like protein; phosphorylation, repeat, SH2 domain, SH3 domain, structural genomics, NPPSFA; NMR {Homo sapiens}

Probab=97.33  E-value=4.9e-07  Score=75.01  Aligned_cols=60  Identities=8%  Similarity=0.003  Sum_probs=49.5

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ...++|||| +|++.+|.|+|||..+..|+||+|....++.|.+.      ...|+++..++.+|..
T Consensus        38 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~~l~------~~~F~sl~~LV~~y~~   97 (111)
T 2eo3_A           38 QRHGMFLVR-DSSTCPGDYVLSVSENSRVSHYIINSLPNRRFKIG------DQEFDHLPALLEFYKI   97 (111)
T ss_dssp             CCTTCEEEE-ECSSSSSCEEEEEEETTEEEEEEEEEETTTEEEET------TCCBSSHHHHHHHHTT
T ss_pred             CCCceEEEE-eecCCCCCEEEEEEeCCeEEEEEEEEcCCCCEEEC------CcccCCHHHHHHHHhh
Confidence            356999999 99988899999999999999999998777788542      2578888888777764

>2aug_A Growth factor receptor-bound protein 14; phosphorylation, SH2 domain, signaling protein; 2.30A {Homo sapiens}

Probab=97.33  E-value=3.9e-07  Score=77.40  Aligned_cols=64  Identities=6%  Similarity=-0.048  Sum_probs=47.8

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCc-ccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKE-DQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~-~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| +|++.+|.|+|||..++.|+||+|...+ +|.|.+..  ......|+++..++.+|..
T Consensus        47 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~~G~~~~~l--~~~~~~F~SL~eLV~~y~~  111 (126)
T 2aug_A           47 LVDGVFLVR-DSQSNPKTFVLSMSHGQKIKHFQIIPVEDDGEMFHTL--DDGHTRFTDLIQLVEFYQL  111 (126)
T ss_dssp             CCTTEEEEE-ECSSSSCCEEEEEEETTEEEEEEEEEEEETTEEEEES--STTSSCBSSHHHHHHHHTT
T ss_pred             CCCCEEEEe-ecCCCCCCEEEEEEcCCeEEEEEEEEECCCCeEEEEe--CCCCCccCCHHHHHHHHhh
Confidence            346999999 9998889999999999999999998753 56552100  1134578888888777654

>1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A*

Probab=97.32  E-value=1.5e-06  Score=82.94  Aligned_cols=70  Identities=10%  Similarity=-0.003  Sum_probs=55.0

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++-|..+..-.++|||| +|++.+|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..
T Consensus        17 Ae~lL~~~g~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~eLv~~y~~   86 (254)
T 1a81_A           17 AEDYLVQGGMSDGLYLLR-QSRNYLGGFALSVAHGRKAHHYTIERELNGTY-----AIAGGRTHASPADLCHYHSQ   86 (254)
T ss_dssp             HHHHHHHTTCCTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCE-----EETTSCCBSSHHHHHHHHTT
T ss_pred             HHHHHhcCCCCCcEEEEE-ecCCCCCCEEEEEEECCeeEEEEEEEcCCCCE-----EeCCCCCcCCHHHHHHHHHh
Confidence            333343344467999999 99999999999999999999999998778888     44335678888888777764

>2kno_A Tensin-like C1 domain-containing phosphatase; SH2 domain, TENC1, solution structure, cell junctio membrane, hydrolase, membrane, metal-binding; NMR {Homo sapiens} PDB: 2l6k_A

Probab=97.31  E-value=1.8e-06  Score=73.82  Aligned_cols=62  Identities=11%  Similarity=-0.076  Sum_probs=48.3

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhc---------------CCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQD---------------NGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~---------------~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      -.++|||| +|++.+|.|+|||...               +.|+||+|...+++ |.+..  ......|+++..++.+|.
T Consensus        40 ~~G~FLVR-~S~s~~g~y~LSv~~~~~~~~~~~~~g~~~~~~v~H~~I~~~~~g-~~l~g--~~~~~~F~SL~eLV~~y~  115 (131)
T 2kno_A           40 DPGAFLIR-DSHSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKG-VKIKG--CPSEPYFGSLSALVSQHS  115 (131)
T ss_dssp             CTTBEEEE-ECSSSTTEEEEEEECSCCSSSSSSCCSCHHHHHEEEEEEECCSSC-CCEET--CSSCCCCCSHHHHHHTTT
T ss_pred             CCCeEEEe-cCCCCCCCEEEEEEeCCCCcccccccccccCCceEEEEEEECCCC-CEEec--CCCCCccCCHHHHHHHHh
Confidence            47999999 9999999999999654               48999999988776 73311  034567888888888876


Q ss_pred             C
Q 039082          159 H  159 (472)
Q Consensus       159 ~  159 (472)
                      .
T Consensus       116 ~  116 (131)
T 2kno_A          116 I  116 (131)
T ss_dssp             T
T ss_pred             h
Confidence            4

>2cia_A Cytoplasmic protein NCK2; SH2-domain, SH3 domain, phosphorylation, binding specificity; HET: PTR MPD; 1.45A {Homo sapiens} PDB: 1z3k_A 2ci9_A* 2ci8_A*

Probab=97.28  E-value=4.8e-07  Score=73.86  Aligned_cols=64  Identities=3%  Similarity=-0.044  Sum_probs=49.7

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++++....++|||| +|++..|.|+|||..++.|+||+|. ..++.|.+.     . ..|+++..++.+|..
T Consensus        20 lL~~~~~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~-~~~g~~~l~-----~-~~F~sl~~LV~~y~~   83 (102)
T 2cia_A           20 ALNERGVEGDFLIR-DSESSPSDFSVSLKASGKNKHFKVQ-LVDNVYCIG-----Q-RRFHTMDELVEHYKK   83 (102)
T ss_dssp             HHHHHCCTTEEEEE-ECSSSTTCEEEEECCSSSCEEEEEE-EETTEEEET-----T-EEESSHHHHHHHHHH
T ss_pred             HHhhCCCCcEEEEE-ECCCCCCCEEEEEEeCCeeEEEEEE-ecCCEEEEC-----C-cCcCCHHHHHHHHhh
Confidence            33333466999999 9999889999999999999999999 566778442     2 467888887777653

>2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A

Probab=97.27  E-value=1.7e-06  Score=82.59  Aligned_cols=80  Identities=9%  Similarity=-0.010  Sum_probs=59.7

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC----
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH----  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~----  159 (472)
                      +++-|..+..-.++|||| +|++.+|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..    
T Consensus        18 Ae~lL~~~~~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~~~~~   91 (254)
T 2oq1_A           18 AEEHLKLAGMADGLFLLR-QCLRSLGGYVLSLVHDVRFHHFPIERQLNGTY-----AIAGGKAHCGPAELCEFYSRDPDG   91 (254)
T ss_dssp             HHHHHHHTTCCTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCE-----EETTSCCBSSHHHHHHHHHHCCTT
T ss_pred             HHHHHhccCCCCcEEEEE-eCCCCCCCEEEEEEECCeEEEEEEEEeCCCCE-----EeCCCCccCCHHHHHHHHHhCCCC
Confidence            344444444567999999 99999999999999999999999998778888     43334678888888777654    


Q ss_pred             -CCccccccCC
Q 039082          160 -QTPLHRYCSQ  169 (472)
Q Consensus       160 -~~~l~~~~~~  169 (472)
                       ...|..+|..
T Consensus        92 l~~~L~~p~~~  102 (254)
T 2oq1_A           92 LPCNLRKPCNR  102 (254)
T ss_dssp             SSSCCCSBCCC
T ss_pred             cccccccccCC
Confidence             3345555543

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.24  E-value=0.002  Score=63.12  Aligned_cols=32  Identities=25%  Similarity=0.435  Sum_probs=27.9

Q ss_pred             ceeecCCCCCcEEEcCC----CcEEEeecccceecC
Q 039082          326 KVIHRDLKPSNIFLDDA----KHVRIADFGHARFLS  357 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~----~~vkL~DFGla~~~~  357 (472)
                      .++|+|+.+.|||++.+    +.+.|+||+.+..-.
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            59999999999999874    689999999987654

>2eob_A 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma 2; SH2, phosphoinositide phospholipase C, PLC-gamma-2, phospholipase C-gamma-2; NMR {Rattus norvegicus}

Probab=97.20  E-value=1.4e-06  Score=73.82  Aligned_cols=58  Identities=10%  Similarity=-0.008  Sum_probs=46.3

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|+ .++.|+|||..++.|+||+|... ++.|.     ......|+++..++.+|..
T Consensus        40 ~~G~FLVR-~S~-~~g~y~LSv~~~~~v~H~~I~~~-~~~~~-----~~~~~~F~sl~~LV~~y~~   97 (124)
T 2eob_A           40 RDGAFLIR-KRE-GTDSYAITFRARGKVKHCRINRD-GRHFV-----LGTSAYFESLVELVSYYEK   97 (124)
T ss_dssp             SSSEEEEE-CCT-TSSCEEEEEEETTEEEEEEEEES-SSCEE-----SSSSCCBSSHHHHHHHHTT
T ss_pred             CCCEEEEE-ecC-CCCCEEEEEEeCCeEEEEEEEEC-CCEEE-----ECCCCcCCCHHHHHHHHhh
Confidence            45999999 998 88999999999999999999864 45663     3344558888888877764

>2hmh_A Suppressor of cytokine signaling 3; SOCS3, GP130, PTyr, peptide complex, cytokine regulator; HET: PTR; 2.00A {Mus musculus}

Probab=97.20  E-value=1.8e-06  Score=75.66  Aligned_cols=65  Identities=20%  Similarity=0.125  Sum_probs=50.4

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCC--CCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSN--TGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~--~~s~~~~~~~~~~~~~~~~  159 (472)
                      ...++|||| +|++..|.|+|||..++.|+||+|.. .++.|.+....  ......|+++..++.+|..
T Consensus        53 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~rI~~-~~g~f~l~~~~~~~~~~~~F~SL~eLV~~Y~~  119 (152)
T 2hmh_A           53 EPAGTFLIR-DSSDQRHFFTLSVKTQSGTKNLRIQX-EGGSFSLQSDPRSTQPVPRFDXVLKLVHHYMP  119 (152)
T ss_dssp             SCTTEEEEE-ECCSTTCSEEEEEEETTEEEEEEEEC-GGGCBEECBCTTCSSCCCCBSSHHHHHHHTCC
T ss_pred             CCCCcEEEE-eCCCCCCcEEEEEEcCCceEEEEEEe-cCCEEEEecccccccccCccCCHHHHHHHHhh
Confidence            346999999 99998999999999999999999998 67788443321  1122678888888887764

>2crh_A VAV proto-oncogene; oncoprotein, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} PDB: 2ror_A* 2lct_A*

Probab=97.16  E-value=2.8e-06  Score=73.24  Aligned_cols=59  Identities=10%  Similarity=-0.009  Sum_probs=47.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++.+|.|+|||..++.|+||+|. ..++.|.     ......|+++..++.+|..
T Consensus        46 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~-~~~g~~~-----l~~~~~F~sl~eLV~~y~~  104 (138)
T 2crh_A           46 SDGTFLVR-QRVKDAAEFAISIKYNVEVKHIKIM-TAEGLYR-----ITEKKAFRGLTELVEFYQQ  104 (138)
T ss_dssp             CTTEEEEE-CCSSTTCCCEEEEEETTEEEEEECE-EETTEEE-----SSTTCCBSSHHHHHHHHTT
T ss_pred             CCCEEEEE-ECCCCCCCEEEEEEECCeEEEEEEE-eCCCEEE-----ECCCCccCCHHHHHHHHHh
Confidence            35999999 9998889999999999999999996 5667783     3334678888888777654

>2bbu_A Suppressor of cytokine signaling 3; SH2 domain, extended SH2 subdomain, PEST motif, protein complex, cytokine regulator; HET: PTR; NMR {Mus musculus}

Probab=97.16  E-value=4.2e-06  Score=74.17  Aligned_cols=66  Identities=20%  Similarity=0.109  Sum_probs=51.1

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCC--CCCccCCCCCCCccccCCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSN--TGSVIASPLVQTPLHQHSHQ  160 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~--~~s~~~~~~~~~~~~~~~~~  160 (472)
                      ...++|||| +|++..|.|+|||..++.|+||+|.. .++.|.+....  ......|+++..++.+|...
T Consensus        42 ~~~GtFLVR-~S~s~~g~y~LSvr~~~~v~H~rI~~-~~g~f~l~~~~~~~~~~~~F~SL~eLV~~Y~~~  109 (164)
T 2bbu_A           42 EPAGTFLIR-DSSDQRHFFTLSVKTQSGTKNLRIQC-EGGSFSLQSDPRSTQPVPRFDCVLKLVHHYMPP  109 (164)
T ss_dssp             SSTTCCEEE-ECSTTSCCEEEEECCTTCCEEEECEE-ETTEEESSSCCCCCSSCTTCCHHHHHHHHHSCC
T ss_pred             CCCCCEEEE-ECCCCCCCEEEEEEECCceEEEEEEe-CCCeEEEecCcccccCCCccCCHHHHHHHHhhC
Confidence            457999999 99998999999999999999999996 56788443221  11236788888888877653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.13  E-value=0.0024  Score=62.13  Aligned_cols=154  Identities=14%  Similarity=0.085  Sum_probs=80.0

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc--eeEEEEE------EEcCC
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF--VLQLMGA------CLEPP  267 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~g~------~~~~~  267 (472)
                      +..-.+.|+.|....+|+....+..+++|+.....   .   ...+..|+.++..+....  +.+++..      ....+
T Consensus        23 ~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~---~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g   96 (322)
T 2ppq_A           23 SLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV---E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSG   96 (322)
T ss_dssp             CEEEEEEECC---EEEEEEEESSCCEEEEEECC---------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETT
T ss_pred             cceEeeccCCCcccceEEEEeCCccEEEEEeCCCC---C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECC
Confidence            44556788889999999998776689999886521   1   122456777777663211  2233311      11223


Q ss_pred             CceEEEEeccCCcHH-----------HH---Hhhccccccccc--CCCCCCHHHHHHH------------HHHHHHHHHH
Q 039082          268 YRGWLVTELLGTTLK-----------EW---LHGLGSQRRKER--MVPLPPFEERLAR------------ALEIAQAMQY  319 (472)
Q Consensus       268 ~~~~vve~~~ggsL~-----------~~---l~~~~~~~~~~~--~~~~~~~~~~~~i------------~~qia~gL~y  319 (472)
                      ..+++++++.|..+.           ..   ++..........  ......|.....-            ...+...+++
T Consensus        97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~  176 (322)
T 2ppq_A           97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY  176 (322)
T ss_dssp             EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred             EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence            456778888765421           11   111100000000  0000011111000            0124445566


Q ss_pred             HHhc-----CCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          320 LHEQ-----KPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       320 LH~~-----~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      ++..     ...++|+|+.+.|||+++++.+.|+||+.+..
T Consensus       177 l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          177 LAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            6532     12499999999999999876668999998753

>2lnw_A VAV-2, guanine nucleotide exchange factor VAV2; signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2lnx_A

Probab=97.10  E-value=1.9e-06  Score=72.63  Aligned_cols=59  Identities=14%  Similarity=0.074  Sum_probs=47.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++..|.|+|||..++.|+||+|...+ +.|     +......|+++..++.+|..
T Consensus        42 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~-~~~-----~l~~~~~F~sl~eLV~~y~~  100 (122)
T 2lnw_A           42 ASGTYLIR-ERPAEAERFAISIKFNDEVKHIKVVEKD-NWI-----HITEAKKFDSLLELVEYYQC  100 (122)
T ss_dssp             CTTBEEEE-ECCCSSEEEEEEEECSSCEEEEEEEEET-TEE-----ESSSSCCBSSHHHHHHHHHH
T ss_pred             CCCeEEEE-eCCCCCCcEEEEEEeCCcEEEEEEEEcC-CEE-----EECCCCeECCHHHHHHHHhh
Confidence            37999999 9998889999999999999999998654 466     44445678888887776654

>2iug_A Phosphatidylinositol 3-kinase regulatory alpha subunit; transferase, polymorphism, UBL conjugation, phosphorylation, SH2, PI3K, SH2 domain; 1.89A {Homo sapiens} PDB: 2iuh_A* 2iui_A* 1fu5_A* 1fu6_A 1oo3_A 1oo4_A* 2pna_A 2pnb_A

Probab=97.05  E-value=2.6e-06  Score=71.66  Aligned_cols=59  Identities=7%  Similarity=0.022  Sum_probs=47.6

Q ss_pred             HHHHHHHhhhhhHH-HHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQD-YLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~-~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++. +|.|+|||..++.|+||+|... ++.|.+     .....|+++..++.+|..
T Consensus        31 ~~G~FLVR-~S~~~~~g~y~LSv~~~~~v~H~~I~~~-~g~~~l-----~~~~~F~sl~~LI~~y~~   90 (120)
T 2iug_A           31 ADGTFLVR-DASTKMHGDYTLTLRKGGNNKLIKIFHR-DGKYGF-----SDPLTFSSVVELINHYRN   90 (120)
T ss_dssp             CTTEEEEE-ECSSGGGCSEEEEEEETTEEEEEEEEEE-TTEEES-----SSSCCBSSHHHHHHHHHH
T ss_pred             CCcEEEEE-CCCCCCCCcEEEEEEECCEEEEEEEEEc-CCEEEE-----CCCCccCCHHHHHHHHHh
Confidence            46999999 99887 8999999999999999999886 667733     334678888887776653

>2oq1_A Tyrosine-protein kinase ZAP-70; tandem SH2 domains, ZAP-70, tyrosine kinase, transferase; HET: PTR; 1.90A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1m61_A

Probab=97.01  E-value=2.7e-06  Score=81.21  Aligned_cols=60  Identities=7%  Similarity=-0.046  Sum_probs=49.8

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ...++|||| +| +.+|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..
T Consensus       180 ~~~G~FLVR-~S-~~~g~~~LSv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sl~~LV~~y~~  239 (254)
T 2oq1_A          180 QTDGKFLLR-PR-KEQGTYALSLIYGKTVYHYLISQDKAGKY-----CIPEGTKFDTLWQLVEYLKL  239 (254)
T ss_dssp             CCTTEEEEE-EC-SSTTEEEEEEEETTEEEEEEEEECTTSCE-----ESTTSCCBSSHHHHHHHHHH
T ss_pred             CCCceEEEE-ec-CCCCCEEEEEEECCeEEEEEEEEcCCCCE-----EECCCceECCHHHHHHHHHh
Confidence            467999999 88 78899999999999999999998888888     44445778888888777653

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=97.01  E-value=8.4e-06  Score=88.02  Aligned_cols=80  Identities=10%  Similarity=0.010  Sum_probs=62.3

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC-----
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH-----  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~-----  159 (472)
                      ++-|+.+....++|||| +|++..|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..     
T Consensus        26 e~~L~~~~~~~G~FLvR-~S~~~~g~y~lsv~~~~~v~h~~i~~~~~g~~-----~~~~~~~f~sl~~Lv~~y~~~~~~l   99 (635)
T 4fl3_A           26 EDYLVQGGMSDGLYLLR-QSRNYLGGFALSVAHGRKAHHYTIERELNGTY-----AIAGGRTHASPADLCHYHSQESDGL   99 (635)
T ss_dssp             HHHHHHTTCCTTEEEEE-ECTTSSSCEEEEEEETTEEEEEEEEECTTSCE-----ESTTCCCBSSHHHHHHHHTTCCTTS
T ss_pred             HHHHhcCCCCCceEEEe-ecccCCCCEEEEEEeCCEEEeEEEEEcCCCCE-----EeCCCCccCCHHHHHHHHhhCCCCC
Confidence            33344444457999999 99999999999999999999999998888888     55555678888888877765     


Q ss_pred             CCccccccCCC
Q 039082          160 QTPLHRYCSQT  170 (472)
Q Consensus       160 ~~~l~~~~~~~  170 (472)
                      .+.|..+|...
T Consensus       100 ~~~L~~p~~~~  110 (635)
T 4fl3_A          100 VCLLKKPFNRP  110 (635)
T ss_dssp             SSCCCEECCCC
T ss_pred             eeccCCcCCCc
Confidence            35566677543

>1a81_A SYK kinase; complex (transferase-peptide), SYK, kinase, SH2 domain; HET: PTR; 3.00A {Homo sapiens} SCOP: d.93.1.1 d.93.1.1 PDB: 1csy_A* 1csz_A*

Probab=97.00  E-value=3.9e-06  Score=80.06  Aligned_cols=60  Identities=10%  Similarity=0.003  Sum_probs=50.0

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ...++|||| +| +.+|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..
T Consensus       179 ~~~G~FLVR-~S-~~~g~~~LSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~  238 (254)
T 1a81_A          179 KTNGKFLIR-AR-DNNGSYALCLLHEGKVLHYRIDKDKTGKL-----SIPEGKKFDTLWQLVEHYSY  238 (254)
T ss_dssp             CCTTCEEEE-EC-SSSSCEEEEEEETTEEEEEEEEECTTSCE-----ECTTSCCBSCHHHHHHHHTT
T ss_pred             CCCceEEEE-ec-CCCCCEEEEEEECCEEEEEEEEEcCCCCE-----EecCCcccCCHHHHHHHHHH
Confidence            367999999 88 77899999999999999999998888888     44445778888888877754

>3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A

Probab=96.96  E-value=0.00012  Score=73.23  Aligned_cols=51  Identities=10%  Similarity=-0.059  Sum_probs=0.0

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQ  151 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~  151 (472)
                      ..++|||| +| +.+|.|+|||..++.|+||+|...++|.|     +......|+++.
T Consensus       321 ~~G~FLVR-~S-s~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~SL~  371 (373)
T 3hhm_B          321 RDGTFLVR-ES-SKQGCYACSVVVDGEVKHCVINKTATGYG-----FAEPYNLYSSLK  371 (373)
T ss_dssp             ----------------------------------------------------------
T ss_pred             CCCcEEEE-ec-CCCCCEEEEEEECCeEEEEEEEEcCCCcE-----EeCCCCCCCChh
Confidence            67999999 99 88999999999999999999999888766     444444555543

>2y3a_B Phosphatidylinositol 3-kinase regulatory subunit; transferase, phosphoinositide 3-kinase, RTK; HET: GD9; 3.30A {Mus musculus}

Probab=96.96  E-value=1.3e-05  Score=77.81  Aligned_cols=60  Identities=7%  Similarity=-0.074  Sum_probs=48.6

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| +| +.+|.|+|||..++.|+||+|...++|.+     ...+...|+++..++.+|..
T Consensus       213 ~~~GtFLVR-~S-s~~g~y~LSv~~~~~V~H~rI~~~~~g~~-----~~~~~~~F~SL~eLV~~Y~~  272 (302)
T 2y3a_B          213 KRDGTFLIR-ES-SQRGCYACSVVVDGDTKHCVIYRTATGFG-----FAEPYNLYGSLKELVLHYQH  272 (302)
T ss_dssp             SCTTBEEBC-CC-SSTTCEEEEEECSSSEEEEEEEEETTEEE-----SBTTBCCCSSHHHHHHTTSS
T ss_pred             CCCCcEEEE-ec-cCCCceEEEEEeCCeeEEEEEEECCCceE-----EeCCCCCCCCHHHHHHHHHh
Confidence            356999999 88 78899999999999999999998877644     33445678888888877764

>1ju5_A CRK; CRK, SH2, SH3, adaptor protein, phosphopeptide, protein binding/transferase complex; HET: PTR; NMR {Homo sapiens} SCOP: d.93.1.1

Probab=96.96  E-value=2.6e-06  Score=70.31  Aligned_cols=38  Identities=11%  Similarity=0.162  Sum_probs=33.9

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcc
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKED  131 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~  131 (472)
                      .-.++|||| +|++.+|.|+|||..++.|+||+|...++
T Consensus        19 ~~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~   56 (109)
T 1ju5_A           19 QRHGVFLVR-DSSTSPGDYVLSVSENSRVSHYIINSSGP   56 (109)
T ss_dssp             CCTTEEEEE-ECSSSTTEEEEEEECSSCEEEEEEECCSS
T ss_pred             CCCCEEEEE-ecCCCCCCEEEEEEECCeEEEEEEEECCC
Confidence            346999999 99988899999999999999999987764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=96.94  E-value=8.1e-06  Score=87.75  Aligned_cols=81  Identities=9%  Similarity=-0.009  Sum_probs=62.4

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC----
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH----  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~----  159 (472)
                      +++-|..+..-.++|||| +|++..|.|+|||..++.|+||+|...++|.|     +......|+++..++.+|..    
T Consensus        20 ae~~L~~~~~~~G~fLvR-~s~~~~g~~~ls~~~~~~~~h~~i~~~~~g~~-----~~~~~~~f~sl~~Lv~~y~~~~~~   93 (613)
T 2ozo_A           20 AEEHLKLAGMADGLFLLR-QCLRSLGGYVLSLVHDVRFHHFPIERQLNGTY-----AIAGGKAHCGPAELCEFYSRDPDG   93 (613)
T ss_dssp             HHHHHHTTTCCTTEEEEE-ECTTBTTCEEEEEEETTEEEEEEEEECTTSCE-----EETTSCCBSSHHHHHHHHTSCCTT
T ss_pred             HHHHHhccCCCCCeEEEE-ecCCCCCCEEEEEEECCeEEEEEEEECCCCcE-----EECCCCCcCCHHHHHHHHhhCCCC
Confidence            334444444446999999 99999999999999999999999998888888     55555668888888777764    


Q ss_pred             -CCccccccCCC
Q 039082          160 -QTPLHRYCSQT  170 (472)
Q Consensus       160 -~~~l~~~~~~~  170 (472)
                       .+.|..+|...
T Consensus        94 l~~~L~~p~~~~  105 (613)
T 2ozo_A           94 LPCNLRKPCNRP  105 (613)
T ss_dssp             SSSCCCSBCCCC
T ss_pred             CCccCCccCCCC
Confidence             45677777553

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.89  E-value=0.0023  Score=64.44  Aligned_cols=155  Identities=18%  Similarity=0.218  Sum_probs=84.5

Q ss_pred             ceee-CCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCcee
Q 039082          189 GWYI-DPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVL  257 (472)
Q Consensus       189 ~~~i-~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv  257 (472)
                      .|.- +.++++ ++.|.-|....+|+....         +..|++|+.-+.     ......+.+|..+++.+. +.-..
T Consensus        44 ~W~~~~~~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-----~~~~~~~~rE~~vl~~L~~~gv~P  117 (379)
T 3feg_A           44 AWRRVQPEELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-----LQGVDSLVLESVMFAILAERSLGP  117 (379)
T ss_dssp             GGGGCCGGGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC--------CCHHHHHHHHHHHHHHHHTTSSC
T ss_pred             cCCCCCcCceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-----cchHHHHHHHHHHHHHHHhcCCCC
Confidence            4642 334454 456777888999998863         367999975221     112334568999998883 33345


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHH--------------HHHhhcccccccccCCCCCC--HHHHHHHHHHHH-------
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLK--------------EWLHGLGSQRRKERMVPLPP--FEERLARALEIA-------  314 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~--------------~~l~~~~~~~~~~~~~~~~~--~~~~~~i~~qia-------  314 (472)
                      ++++.+.+    .+|++++.|.+|.              ..|........  .....+.  +..+..+..++.       
T Consensus       118 ~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~--~~~~~~~~l~~~i~~w~~~~~~~~~~~~  191 (379)
T 3feg_A          118 QLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEM--PFTKEPHWLFGTMERYLKQIQDLPPTGL  191 (379)
T ss_dssp             CEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCC--SSCCSCCHHHHHHHHHHHHHHHCCCCSC
T ss_pred             eEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCC--CCCCCcccHHHHHHHHHHHHHhccCccc
Confidence            66766533    3788888875442              11111111000  0011121  233333332221       


Q ss_pred             ------------HHHHHHH----hc--CCceeecCCCCCcEEEcCC----CcEEEeeccccee
Q 039082          315 ------------QAMQYLH----EQ--KPKVIHRDLKPSNIFLDDA----KHVRIADFGHARF  355 (472)
Q Consensus       315 ------------~gL~yLH----~~--~~~iiHrDLkp~NILl~~~----~~vkL~DFGla~~  355 (472)
                                  ..+..|.    ..  ...++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       192 ~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          192 PEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             CSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             chhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                        2233333    21  2259999999999999876    7899999999864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.89  E-value=0.0023  Score=63.74  Aligned_cols=73  Identities=14%  Similarity=0.080  Sum_probs=43.2

Q ss_pred             EeceeeccCceEEEEEEECC----------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc-eeEEEEEEEcCC
Q 039082          199 LQEKIGQGTTANIYRAIWRG----------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPP  267 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g----------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~g~~~~~~  267 (472)
                      -.+.|+.|....+|+....+          ..+++|+......     .......|+.+++.+...+ +.++++.+    
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~~~~~E~~~l~~L~~~g~~P~~~~~~----  107 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-----ELYNTISEFEVYKTMSKYKIAPQLLNTF----  107 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-----GTSCHHHHHHHHHHHHHTTSSCCEEEEE----
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-----ceecHHHHHHHHHHHHhcCCCCceEEec----
Confidence            35678889889999998764          6899997644211     1111357888888774333 44666543    


Q ss_pred             CceEEEEeccCCc
Q 039082          268 YRGWLVTELLGTT  280 (472)
Q Consensus       268 ~~~~vve~~~ggs  280 (472)
                      ..++|++++.|..
T Consensus       108 ~~~~v~e~i~G~~  120 (369)
T 3c5i_A          108 NGGRIEEWLYGDP  120 (369)
T ss_dssp             TTEEEEECCCSEE
T ss_pred             CCcEEEEEecCCc
Confidence            2357888887644

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.81  E-value=0.016  Score=59.65  Aligned_cols=74  Identities=11%  Similarity=-0.029  Sum_probs=47.4

Q ss_pred             EeceeeccCceEEEEEEECC--eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc-eeEEEEEEEcCCCceEEEEe
Q 039082          199 LQEKIGQGTTANIYRAIWRG--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF-VLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~g--~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn-Iv~l~g~~~~~~~~~~vve~  275 (472)
                      -++.|+.|-...+|+....+  ..+++|+..+.....-.     ..+|+.++..|...+ ..++++.+.    .++|+++
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~id-----R~~E~~vl~~L~~~gl~P~ll~~~~----~G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIIN-----REREKKISCILYNKNIAKKIYVFFT----NGRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSC-----HHHHHHHHHHHTTSSSBCCEEEEET----TEEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcC-----HHHHHHHHHHHHhcCCCCCEEEEeC----CeEEEEe
Confidence            35678889999999999876  78999987443111100     247888898885433 357777662    2468888


Q ss_pred             ccCCcH
Q 039082          276 LLGTTL  281 (472)
Q Consensus       276 ~~ggsL  281 (472)
                      +.|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            876443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.77  E-value=0.0092  Score=58.05  Aligned_cols=74  Identities=9%  Similarity=0.005  Sum_probs=43.5

Q ss_pred             ceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCc--eeEEEEE-----EEcCCCceEE
Q 039082          201 EKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF--VLQLMGA-----CLEPPYRGWL  272 (472)
Q Consensus       201 ~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~Hpn--Iv~l~g~-----~~~~~~~~~v  272 (472)
                      +.|+ |....||+.... |..+++|...+...  .   ...+..|..++..+....  +++++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC--C---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 888899988764 56899998865321  1   234566888877773211  3444432     1112334567


Q ss_pred             EEeccCCc
Q 039082          273 VTELLGTT  280 (472)
Q Consensus       273 ve~~~ggs  280 (472)
                      ++++.|..
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            77776643

>1mil_A SHC adaptor protein; SH2 domain, phosphorylation, collagen, growth regulation, transforming protein, alternative initiation; 2.70A {Homo sapiens} SCOP: d.93.1.1 PDB: 1tce_A*

Probab=96.66  E-value=6e-06  Score=67.52  Aligned_cols=57  Identities=14%  Similarity=-0.062  Sum_probs=45.1

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .++|||| +|++.+|.|+|||..++.|+||+|. ..+|.|.+      ....|+++..++.+|..
T Consensus        26 ~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~-~~~g~~~~------~~~~F~sl~~LI~~y~~   82 (104)
T 1mil_A           26 NGDFLVR-ESTTTPGQYVLTGLQSGQPKHLLLV-DPEGVVRT------KDHRFESVSHLISYHMD   82 (104)
T ss_dssp             TTEEEEE-ECCSSCSSEEEEEEETTEEEEEEEB-CTTSSEEC------SSCEESSHHHHHHHHHH
T ss_pred             CCcEEEE-eCCCCCCCEEEEEEECCEEEEEEEE-eCCCEEEE------CCceeCCHHHHHHHHhh
Confidence            5899999 9998889999999999999999997 44566733      23567777777766653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.63  E-value=0.008  Score=61.41  Aligned_cols=73  Identities=11%  Similarity=0.096  Sum_probs=48.2

Q ss_pred             eEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCC
Q 039082          198 DLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPP  267 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~  267 (472)
                      .-++.|+.|....||++...         +..+++|+....   ..   ...+.+|+.+++.+. +....++++.+.+  
T Consensus        76 ~~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~---~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~--  147 (429)
T 1nw1_A           76 LRISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG--  147 (429)
T ss_dssp             EEEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred             eEEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC---Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC--
Confidence            34567889999999999874         367999977331   11   123557999998884 3333567765432  


Q ss_pred             CceEEEEeccCCc
Q 039082          268 YRGWLVTELLGTT  280 (472)
Q Consensus       268 ~~~~vve~~~ggs  280 (472)
                        ++|++++.|.+
T Consensus       148 --g~v~e~l~G~~  158 (429)
T 1nw1_A          148 --GRLEEYIPSRP  158 (429)
T ss_dssp             --EEEECCCCEEE
T ss_pred             --CEEEEEeCCcc
Confidence              37888886533

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.58  E-value=0.051  Score=49.95  Aligned_cols=99  Identities=17%  Similarity=0.117  Sum_probs=64.6

Q ss_pred             CCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEeecccceec
Q 039082          278 GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFL  356 (472)
Q Consensus       278 ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~  356 (472)
                      ..+|.+.|...+.         +...+++|.++.|.+.+|.-+-. ..  -..+=+.|..|++..+|.|-+.+ +.+.  
T Consensus        32 ~vSL~eIL~~~~~---------PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~--   97 (229)
T 2yle_A           32 ALSLEEILRLYNQ---------PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD--   97 (229)
T ss_dssp             EEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-----
T ss_pred             cccHHHHHHHcCC---------CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc--
Confidence            3578898865443         34578999999999999877622 22  12344567999999999988764 2111  


Q ss_pred             CCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc
Q 039082          357 SDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT  398 (472)
Q Consensus       357 ~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt  398 (472)
                             .....+.|||... ...+.+.=|||||+++|..+-
T Consensus        98 -------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence                   1233466888763 345788999999999999986

>2kk6_A Proto-oncogene tyrosine-protein kinase FER; methods development, SH2, NESG, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein; NMR {Homo sapiens}

Probab=96.55  E-value=7.5e-06  Score=68.33  Aligned_cols=57  Identities=11%  Similarity=0.018  Sum_probs=46.3

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .++|||| +|++.+|.|+|||..++.|+||+|.. .+|.|.+     . ...|+++..++.+|..
T Consensus        36 ~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~-~~g~y~~-----~-~~~F~sl~eLV~~y~~   92 (116)
T 2kk6_A           36 QGDFLVR-ESHGKPGEYVLSVYSDGQRRHFIIQY-VDNMYRF-----E-GTGFSNIPQLIDHHYT   92 (116)
T ss_dssp             TTCEEEE-ECTTCTTCEEEEEEETTEEEEEEEEE-ETTEEES-----S-SCEESCHHHHHHHHHH
T ss_pred             CCcEEEE-ECCCCCCcEEEEEEECCeEEEEEEEe-cCCEEEE-----C-CCEeCCHHHHHHHHhh
Confidence            5999999 99998899999999999999999996 5567744     2 3577888887777653

>2vif_A Suppressor of cytokine signalling 6; growth regulation, signal transduction inhibitor, KIT regula phosphotyrosine, signaling protein; HET: PTR; 1.45A {Homo sapiens}

Probab=96.55  E-value=8.6e-06  Score=70.44  Aligned_cols=62  Identities=10%  Similarity=0.058  Sum_probs=49.4

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..+.|+|||..++.|+||+|... +|.|.+...  .....|+++..++.+|..
T Consensus        44 ~~G~FLVR-~S~~~~~~~~LSv~~~~~v~H~~I~~~-~g~~~l~~~--~~~~~F~sl~eLI~~y~~  105 (141)
T 2vif_A           44 PDGSFLVR-DSSDDRYLLSLSFRSHGKTLHTRIEHS-NGRFSFYEQ--PDVEGHTSIVDLIEHSIG  105 (141)
T ss_dssp             CTTCEEEE-ECSSTTCSEEEEEEETTEEEEEEEEEE-TTEEEETTC--CSCCCBSSHHHHHHHHHH
T ss_pred             CCceEEEE-ecCCCCCCEEEEEEECCEEEEEEEEEE-CCEEEEeec--CCCCccCCHHHHHHHHhh
Confidence            46999999 999988999999998999999999887 678844321  145678888888777754

>2dvj_A V-CRK sarcoma virus CT10 oncogene homolog, isoform A; SH3, SH2, signal transduction, adapter molecule, signaling protein; HET: PTR; NMR {Homo sapiens} PDB: 2eyy_A 2eyv_A 2eyw_A

Probab=96.49  E-value=4e-05  Score=71.86  Aligned_cols=59  Identities=8%  Similarity=0.023  Sum_probs=47.1

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCccc-----------------CcccccCCCCCccCCCCCCCcccc
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQ-----------------HQSLLSSNTGSVIASPLVQTPLHQ  156 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~-----------------~~~~~s~~~~s~~~~~~~~~~~~~  156 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|....++                 .|.     . ....|+++..++.+
T Consensus        33 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~~~~~g~~~~~~~-----~-~~~~F~sl~~LV~~  105 (230)
T 2dvj_A           33 RHGVFLVR-DSSTSPGDYVLSVSENSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLR-----I-GDQEFDSLPALLEF  105 (230)
T ss_dssp             SSSCBEEE-CCSSCTTSCEEECCCSSSCCCEECBCCCSCCSSSSSSSSTTTSCCCCCEE-----S-SSCEESSHHHHHTT
T ss_pred             CCceEEEE-eCCCCCCCEEEEEEECCEEEEEEEEeCCCCcccccccccccccccceEEE-----e-CCceeCCHHHHHHH
Confidence            46999999 999999999999999999999999987642                 231     1 24578888888887


Q ss_pred             CCC
Q 039082          157 HSH  159 (472)
Q Consensus       157 ~~~  159 (472)
                      |..
T Consensus       106 y~~  108 (230)
T 2dvj_A          106 YKI  108 (230)
T ss_dssp             STT
T ss_pred             Hhh
Confidence            765

>2eyz_A V-CRK sarcoma virus CT10 oncogene homolog isoform A; SH2, SH3, signaling protein; NMR {Homo sapiens} PDB: 2l3s_A 2l3p_A 2l3q_A 2ggr_A

Probab=96.37  E-value=9.3e-05  Score=72.37  Aligned_cols=59  Identities=8%  Similarity=0.040  Sum_probs=46.9

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCC-----------------cccCcccccCCCCCccCCCCCCCcccc
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNK-----------------EDQHQSLLSSNTGSVIASPLVQTPLHQ  156 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~-----------------~~~~~~~~s~~~~s~~~~~~~~~~~~~  156 (472)
                      ..++|||| +|++..|.|+|||..+..|+||+|...                 .++.|.+      ....|+++..++.+
T Consensus        31 ~~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~F~sl~~LV~~  103 (304)
T 2eyz_A           31 RHGVFLVR-DSSTSPGDYVLSVSENSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLRI------GDQEFDSLPALLEF  103 (304)
T ss_dssp             CSSCEECC-SCCSSSSCCEEEECSSSSCEEEECCCCSSCCSSCCCCCCCSSSSSCCCCCB------TTBCCSCHHHHHTT
T ss_pred             CCCEEEEE-eCCCCCCCEEEEEEECCEEEEEEEeeccccccccccccccccccCCCeEEe------CCcEECCHHHHHHH
Confidence            45999999 999988999999999999999999983                 3344422      24578888888888


Q ss_pred             CCC
Q 039082          157 HSH  159 (472)
Q Consensus       157 ~~~  159 (472)
                      |..
T Consensus       104 y~~  106 (304)
T 2eyz_A          104 YKI  106 (304)
T ss_dssp             TTT
T ss_pred             hhh
Confidence            775

>3qwx_X Cell death abnormality protein 2; cell engulfment, signaling protein; 2.01A {Caenorhabditis elegans}

Probab=96.35  E-value=1.6e-05  Score=71.16  Aligned_cols=58  Identities=14%  Similarity=0.121  Sum_probs=44.2

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCC---eEEEeccC---Ccc----cCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNG---VLELMTNN---KED----QHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~---v~hy~i~~---~~~----~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +| +..|.|+|||..++.   |+||+|..   .++    +.|.+     . ...|+++..++.++..
T Consensus        34 ~~G~FLVR-~S-~~~g~y~LSv~~~~~~~~v~H~~I~~~~~~~~g~~~~~~~~-----~-~~~F~sl~eLv~~y~~  101 (174)
T 3qwx_X           34 SIGTFLMR-DS-SRPGEYSLTVREADEGNAVCHYLIERGEPKEDGTAAAGVKI-----A-NQSFPDIPALLNHFKM  101 (174)
T ss_dssp             CTTEEEEE-EC-SSTTCEEEEEECCSSSSCEEEEEEEECCCCTTSSSCCCEEE-----T-TEEESSHHHHHHHTTS
T ss_pred             CCCeEEEE-ec-CCCCCEEEEEEECCCCCceEEEEEEeccCCCCCcccceEEE-----C-CeecCcHHHHhhhhhc
Confidence            35999999 99 888999999988888   99999987   434    36633     2 4567777777666654

>2c9w_A Suppressor of cytokine signaling 2; growth regulation, SH2 domain, signal transduction inhibitor nuclear protein; 1.9A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1

Probab=96.33  E-value=1.5e-05  Score=71.03  Aligned_cols=64  Identities=11%  Similarity=0.005  Sum_probs=48.0

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCC--CCccCCCCCCCccccCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNT--GSVIASPLVQTPLHQHS  158 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~--~s~~~~~~~~~~~~~~~  158 (472)
                      .-.++|||| +|++..|.|+|||..+++|+||+|... +|.|.+.....  .....|+++..++.+|.
T Consensus        36 ~~~G~FLVR-~S~~~~~~~~LSv~~~~~v~H~rI~~~-~g~~~l~~~~~~~~~~~~F~sl~eLI~~y~  101 (169)
T 2c9w_A           36 APEGTFLIR-DSSHSDYLLTISVKTSAGPTNLRIEYQ-DGKFRLDSIICVKSKLKQFDSVVHLIDYYV  101 (169)
T ss_dssp             SCTTCEEEE-ECCSTTCSEEEEEEETTEEEEEEEEEE-TTEEEECTTTTTGGGCCCBSCHHHHHHHHH
T ss_pred             CCCcEEEEe-cCCCCCCeEEEEEEECCeeEEEEEEEe-CCEEEEccccCccccCCCCCCHHHHHHHHH
Confidence            457999999 999988999999999999999999884 67784433210  01156777777776664

>3hhm_B NISH2 P85alpha; PI3KCA, PI3K, PIK3R1, phosphatidilynositol 3,4,5- triphosphate, wortmannin, H1047R, ATP-binding, disease mutation, kinase; HET: KWT; 2.80A {Homo sapiens} PDB: 3hiz_B 2rd0_B 4a55_B* 3mtt_A

Probab=95.96  E-value=0.00011  Score=73.58  Aligned_cols=59  Identities=7%  Similarity=-0.002  Sum_probs=47.5

Q ss_pred             HHHHHHHhhhhhHH-HHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQD-YLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~-~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++. +|.|+|||..++.|+||+|... +|.|     +......|+++..++.+|..
T Consensus        30 ~dG~FLVR-~S~s~~~g~y~LSvr~~~~v~H~rI~~~-~g~y-----~l~~~~~F~SL~eLV~~Y~~   89 (373)
T 3hhm_B           30 ADGTFLVR-DASTKMHGDYTLTLRKGGNNKLIKIFHR-DGKY-----GFSDPLTFSSVVELINHYRN   89 (373)
T ss_dssp             CTTEEEEE-ECSCC--CCEEEEEEETTEEEEEEECCS-SSCB-----CSSSSCCBSSSHHHHHHHHH
T ss_pred             CCCCEEEe-ccCCCCCCCEEEEEEECCeeEEEEEEec-CCeE-----EeCCCCCcCCHHHHHHHHhh
Confidence            46899999 99987 8999999999999999999875 5678     44555668888888777654

>2izv_A Suppressor of cytokine signaling 4; signal transduction inhibitor, growth regulation, signal transduction, SH2 domain, nuclear protein; 2.55A {Homo sapiens} SCOP: a.271.1.1 d.93.1.1

Probab=95.91  E-value=3.3e-05  Score=69.84  Aligned_cols=63  Identities=13%  Similarity=0.105  Sum_probs=45.1

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++..+.|+|||..+++|+||+|... ++.|.+..... ....|+++..++.+|..
T Consensus        54 ~dGtFLVR-~S~~~~~~lsLSvr~~~~v~H~rI~~~-~g~f~l~~~~~-~~~~F~SL~eLV~hY~~  116 (187)
T 2izv_A           54 PEGTFLLR-DSAQEDYLFSVSFRRYSRSLHARIEQW-NHNFSFDAHDP-CVFHSPDITGLLEHYKD  116 (187)
T ss_dssp             CTTEEEEE-ECSSTTCSEEEEEEETTEEEEEECEEE-TTEEESCTTCT-TSCCBSSHHHHHHHTCC
T ss_pred             CCCcEEEE-ECCCCCceEEEEEeeCCeEEEEEEEEC-CCEEEEeccCC-CccccCCHHHHHHHHHh
Confidence            45999999 998765668889988899999999887 56774322110 01367778777777753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.75  E-value=0.034  Score=54.68  Aligned_cols=32  Identities=16%  Similarity=0.425  Sum_probs=28.3

Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccceecC
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLS  357 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~  357 (472)
                      .++|+|+.+.||+++.++.+.|+||+.+....
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~  238 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPMLAP  238 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEEEC
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCeeCC
Confidence            59999999999999988889999999886543

>3qwy_A Cell death abnormality protein 2; cell engulfment, signaling protein; 2.52A {Caenorhabditis elegans}

Probab=95.63  E-value=4.7e-05  Score=74.64  Aligned_cols=59  Identities=8%  Similarity=0.084  Sum_probs=43.8

Q ss_pred             HHHHHHHHHhhhhhHHHHHHHHHHhhcCC---eEEEeccC-Ccc------cCcccccCCCCCccCCCCCCCccccCC
Q 039082           92 KELRIIYRKRLERTQDYLRHCLQIAQDNG---VLELMTNN-KED------QHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        92 ~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~---v~hy~i~~-~~~------~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      ....++|||| +| +.+|.|+|||..++.   |+||+|.. .++      +.|.+     .. ..|+++..++.++.
T Consensus        61 ~~~~G~FLVR-~S-~~~g~y~LSv~~~~~~~~v~H~~I~~~~~~~~g~~~g~~~~-----~~-~~F~Sl~eLv~~y~  129 (308)
T 3qwy_A           61 QVSIGTFLMR-DS-SRPGEYSLTVREADEGNAVCHYLIERGEPKEDGTAAAGVKI-----AN-QSFPDIPALLNHFK  129 (308)
T ss_dssp             TCCTTEEEEE-EC-SSTTCEEEEEECCSSSSCEEEEEEEECCCCTTTTCCCCEEE-----TT-EEESSHHHHHHHHH
T ss_pred             CCCCceEEEE-cc-CCCCCEEEEEEeCCCCCceEEEEEeeccCCCcCcccceEEE-----eC-eeeCCHHHHHHHHh
Confidence            4556999999 99 888999999988888   99999987 443      56633     22 56666666655443

>3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens}

Probab=95.62  E-value=0.00016  Score=77.36  Aligned_cols=65  Identities=6%  Similarity=0.024  Sum_probs=50.7

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++.+....++|||| +|++.+|.|+|||..++.|+||+|... ++.|     +......|+++..++.+|..
T Consensus        17 lL~~~~~~G~FLvR-~S~~~~g~y~LSv~~~~~v~H~~I~~~-~~~~-----~~~~~~~F~sl~eLv~~y~~   81 (595)
T 3ps5_A           17 LLKGRGVHGSFLAR-PSRKNQGDFSLSVRVGDQVTHIRIQNS-GDFY-----DLYGGEKFATLTELVEYYTQ   81 (595)
T ss_dssp             HHHHHCCTTCEEEE-ECSSSTTSEEEEEEETTEEEEEEEEEC-SSCE-----ESSSSCCBSSHHHHHHHHHT
T ss_pred             HHhhCCCCCEEEEe-ecCCCCCceEEEEEECCEEEEEEEEeC-CCcE-----EEecCccccchhhhhhhhcc
Confidence            44444357999999 999999999999999999999999854 4466     44455568888887776654

>3ps5_A Tyrosine-protein phosphatase non-receptor type 6; SH2, PTP, hydrolase, signaling protein; 3.10A {Homo sapiens}

Probab=95.62  E-value=0.00012  Score=78.32  Aligned_cols=61  Identities=13%  Similarity=0.083  Sum_probs=49.0

Q ss_pred             HHHHHHHHHhhhhhHHHHHHHHHHhhcC---------CeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           92 KELRIIYRKRLERTQDYLRHCLQIAQDN---------GVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        92 ~~~~~~fl~R~~s~~~~~~~~Lsv~~~~---------~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ....++|||| +|++.+|.|+|||..++         .|+||+|.. ++++|     +......|+++..++.+|..
T Consensus       127 ~~~~G~FLVR-~S~~~~g~y~LSv~~~~~~~~~~~~~~v~H~~I~~-~~~~~-----~~~~~~~F~sl~~LV~~y~~  196 (595)
T 3ps5_A          127 KGEPWTFLVR-ESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMC-EGGRY-----TVGGLETFDSLTDLVEHFKK  196 (595)
T ss_dssp             HCCTTEEEEE-ECSSSTTCEEEEEEEEEESSSTTSCEEEEEEEEBC-GGGCB-----BSSSSCCBSSHHHHHHHHHH
T ss_pred             cCCCceEEEE-ecCCCCCcEEEEEEECCccccccCCCceEEEEEEE-eCCEE-----EEcCCcCCCCHHHHHHHHhc
Confidence            3346799999 99999999999997766         899999986 55678     55666688888887777753

>1wqu_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; SH2 domain, feline sarcoma oncogene, structural genomics; NMR {Homo sapiens} PDB: 2dcr_A

Probab=95.55  E-value=5.5e-05  Score=62.79  Aligned_cols=56  Identities=11%  Similarity=0.010  Sum_probs=44.4

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .++|||| +|++.. .|+|||..++.|+||+|...+ +.|.+      ....|+++..++.+|..
T Consensus        35 ~G~FLVR-~S~~~~-~y~LSv~~~~~v~H~~I~~~~-g~~~~------~~~~F~sl~~LV~~y~~   90 (114)
T 1wqu_A           35 SGDFLVR-ESQGKQ-EYVLSVLWDGLPRHFIIQSLD-NLYRL------EGEGFPSIPLLIDHLLS   90 (114)
T ss_dssp             TTEEEEE-ECSSSC-CEEEEEEETTEEEEEECEECS-SSEES------SSCCBSSHHHHHHHHHH
T ss_pred             CCeEEEE-EcCCCC-CEEEEEEECCEEEEEEEEecC-CEEEE------CCCCCCCHHHHHHHHHH
Confidence            5999999 888877 999999999999999998764 56633      23677888887777653

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.54  E-value=0.095  Score=53.31  Aligned_cols=74  Identities=9%  Similarity=-0.023  Sum_probs=47.4

Q ss_pred             eEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCC
Q 039082          198 DLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPP  267 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~  267 (472)
                      .-++.|..|....+|+....         +..|++++........     -...+|..+++.+. +.-..++++.+    
T Consensus        73 ~~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~-----idR~~E~~~l~~L~~~gi~P~l~~~~----  143 (424)
T 3mes_A           73 IEVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF-----YDSKVELDVFRYLSNINIAPNIIADF----  143 (424)
T ss_dssp             EEEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC-----CCHHHHHHHHHHHHHTTSSCCEEEEE----
T ss_pred             eEEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh-----cCHHHHHHHHHHHHhcCCCCCEEEEc----
Confidence            34567778889999999876         5789999764321111     11347888888774 33345666533    


Q ss_pred             CceEEEEeccCCc
Q 039082          268 YRGWLVTELLGTT  280 (472)
Q Consensus       268 ~~~~vve~~~ggs  280 (472)
                      ..++|++++.|..
T Consensus       144 ~~~~I~efI~G~~  156 (424)
T 3mes_A          144 PEGRIEEFIDGEP  156 (424)
T ss_dssp             TTEEEEECCCSEE
T ss_pred             CCCEEEEEeCCcc
Confidence            2367888888755

>2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A*

Probab=95.22  E-value=0.00017  Score=76.09  Aligned_cols=59  Identities=8%  Similarity=0.026  Sum_probs=46.4

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||..++.|+||+|.. .++.|.+     .....|+++..++.+|..
T Consensus        23 ~~G~FLvR-~S~~~~g~~~Lsv~~~~~v~H~~I~~-~~~~~~~-----~~~~~F~sl~~Lv~~y~~   81 (532)
T 2b3o_A           23 VHGSFLAR-PSRKNQGDFSLSVRVGDQVTHIRIQN-SGDFYDL-----YGGEKFATLTELVEYYTQ   81 (532)
T ss_dssp             CTTEEEEE-ECSSSSSEEEEEEEETTEEEEEEEEC-SSSCEEE-----TTSCEESCHHHHHHHHHT
T ss_pred             CCCCEEEe-cCCCCCCceEEEEEECCEEEEEEEEe-cCCEEEE-----CCCcccCCHHHHHHHHHh
Confidence            56999999 99999999999999999999999986 4456633     334457777777766653

>2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1

Probab=94.36  E-value=0.0003  Score=74.00  Aligned_cols=59  Identities=8%  Similarity=-0.007  Sum_probs=45.9

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|... ++.|.+     .....|+++..++.+|..
T Consensus        25 ~~G~FLvR-~S~~~~g~~~Lsv~~~~~v~H~~I~~~-~~~~~l-----~~~~~F~sl~eLv~~y~~   83 (525)
T 2shp_A           25 VDGSFLAR-PSKSNPGDLTLSVRRNGAVTHIKIQNT-GDYYDL-----YGGEKFATLAELVQYYME   83 (525)
T ss_dssp             CTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEECS-SSCEEE-----TTSCEESSHHHHHHHHHT
T ss_pred             CCCcEEee-ccCCCCCcEEEEEEECCEEEEEEEEec-CCeEEE-----CCCCeECCHHHHHHHHHh
Confidence            56999999 999999999999999999999999864 446633     234567777777666543

>2b3o_A Tyrosine-protein phosphatase, non-receptor type 6; protein tyrosine phosphatase, SHP-1, signaling, hydrolase; 2.80A {Homo sapiens} PDB: 1x6c_A 2rmx_A* 2yu7_A*

Probab=94.23  E-value=0.0005  Score=72.46  Aligned_cols=64  Identities=11%  Similarity=0.072  Sum_probs=48.5

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcC---------CeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIAQDN---------GVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~---------~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      ++++....++|||| +|++.+|.|+|||...+         .|+||+|... ++.|     +.+....|+++..++.+|.
T Consensus       123 lL~~~~~~G~FLVR-~S~~~~g~y~Lsv~~~~~~~~~~~~~~v~h~~I~~~-~g~~-----~l~~~~~F~sl~eLV~~y~  195 (532)
T 2b3o_A          123 LLQAKGEPWTFLVR-ESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCE-GGRY-----TVGGLETFDSLTDLVEHFK  195 (532)
T ss_dssp             HHHHHCCTTEEEEE-ECSSSTTCEEEEEEEEEEC----CCEEEEEEEEBCC-TTSB-----BSSSSCCBSSHHHHHHHHH
T ss_pred             HHhcCCCCceEEEe-cCCCCCCceEEEEEecCccccccCCCceEEEEEEEc-CCce-----eeCCCcccCcHHHHHhhcc
Confidence            34444345899999 99999999999997665         8999999886 5677     4444567777777776654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.87  E-value=0.25  Score=49.68  Aligned_cols=30  Identities=23%  Similarity=0.472  Sum_probs=25.6

Q ss_pred             eeecCCCCCcEEE------cCCCcEEEeecccceec
Q 039082          327 VIHRDLKPSNIFL------DDAKHVRIADFGHARFL  356 (472)
Q Consensus       327 iiHrDLkp~NILl------~~~~~vkL~DFGla~~~  356 (472)
                      ++|+|+.+.|||+      ++++.+.++||.+|...
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            6799999999999      45678999999998653

>2shp_A SHP-2, SYP, SHPTP-2; tyrosine phosphatase, insulin signaling, SH2 protein; HET: CAT; 2.00A {Homo sapiens} SCOP: c.45.1.2 d.93.1.1 d.93.1.1

Probab=93.63  E-value=0.00046  Score=72.63  Aligned_cols=59  Identities=10%  Similarity=0.050  Sum_probs=45.8

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcC----------CeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDN----------GVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~----------~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++.+|.|+|||...+          .|+||+|... ++.|     +.+....|+++..++.+|..
T Consensus       131 ~~G~FLVR-~S~~~~g~y~LSv~~~~~~~~~~~~~~~v~H~~I~~~-~g~~-----~l~~~~~F~sL~eLV~~y~~  199 (525)
T 2shp_A          131 KHGSFLVR-ESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQ-ELKY-----DVGGGERFDSLTDLVEHYKK  199 (525)
T ss_dssp             CTTEEEEE-ECSSSTTCEEEEEEECC-----CCCCCEEEEEEEEEE-TTEE-----ESSSSCCBSSHHHHHHHHHH
T ss_pred             CCceEEEE-ecCCCCCCEEEEEEECCccccccccccceEEEEEEec-CCeE-----EECCCceeCcHHHHHHhhhc
Confidence            45999999 99999999999996665          8999999877 5567     33444567777777666543

>1gri_A Growth factor bound protein 2; SH2, SH3, signal transduction adaptor; 3.10A {Homo sapiens} SCOP: b.34.2.1 b.34.2.1 d.93.1.1 PDB: 1aze_A 2a37_A 2azv_A 2a36_A 2azs_A

Probab=93.57  E-value=0.00027  Score=65.30  Aligned_cols=45  Identities=13%  Similarity=0.030  Sum_probs=38.9

Q ss_pred             HHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCccc
Q 039082           91 QKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSL  136 (472)
Q Consensus        91 ~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~  136 (472)
                      +....++|||| +|++.+|.|+||+..+..|+||+|....++.|.+
T Consensus        76 ~~~~~G~fLvR-~S~~~~g~~~LSv~~~~~v~h~~I~~~~~g~~~~  120 (217)
T 1gri_A           76 KQRHDGAFLIR-ESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL  120 (217)
T ss_dssp             TCSSTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECSSSCEES
T ss_pred             ccCCCceEEEE-ccCCCCCCEEEEEEECCEEEEEEEEEcCCCCEEE
Confidence            33456899999 9999999999999999999999999988888733

>4fbn_A 1-phosphatidylinositol 4,5-bisphosphate phosphodi gamma-1; SH2 domain, plcgamma specific array, interaction domain, FIB growth factor receptor 1; 2.40A {Homo sapiens} PDB: 4ey0_A* 3gqi_B* 2fci_A* 2pld_A* 2ple_A*

Probab=92.48  E-value=0.00027  Score=66.80  Aligned_cols=57  Identities=5%  Similarity=-0.059  Sum_probs=42.8

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|+ ..|.|+|||..++.|+||+|... ++.|      ......|+++..++.+|..
T Consensus       143 ~~G~FLVR-~s~-~~g~y~Lsv~~~~~v~H~~I~~~-~~~~------~~~~~~F~sL~~Lv~~y~~  199 (246)
T 4fbn_A          143 RDGAFLVR-KRN-EPNSYAISFRAEGKIKHCRVQQE-GQTV------MLGNSEFDSLVDLISYYEK  199 (246)
T ss_dssp             CTTEEEEE-ECS-STTEEEEEEEETTEEEEEEEEEE-TTEE------EETTEEESCHHHHHHHHHH
T ss_pred             CCCeEEEE-ecC-CCCCEEEEEEeCCCeEEEEEEeC-CCEE------EeCCCccCCHHHHHHHhCc
Confidence            35999999 774 46889999999999999999864 3334      2233457888888877753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.67  E-value=3  Score=38.00  Aligned_cols=79  Identities=15%  Similarity=0.169  Sum_probs=57.6

Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccceecCCCccccccCCcccccccccCCCCC
Q 039082          302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYS  381 (472)
Q Consensus       302 ~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s  381 (472)
                      +...+++++.+|+....+++.    -+|--|.|+||+++.++.++|.-.|+-..+              +|.     .++
T Consensus        79 ~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~f~~~~~p~i~~RGik~~l--------------~P~-----~~~  135 (215)
T 4ann_A           79 TKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELFFTRDGLPIAKTRGLQNVV--------------DPL-----PVS  135 (215)
T ss_dssp             CHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEEECTTSCEEESCCEETTTB--------------SCC-----CCC
T ss_pred             CHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEEEcCCCCEEEEEccCccCC--------------CCC-----CCC
Confidence            357788889898887755543    378899999999999999999888764322              121     123


Q ss_pred             chHHHHHHHHHHHHHHcCCCCC
Q 039082          382 EKSDVYSFGIILNEIITGNHPY  403 (472)
Q Consensus       382 ~~sDvwSlGvll~elltG~~Pf  403 (472)
                      ...=+-.+=+++..+++++..|
T Consensus       136 ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          136 EAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             HHHHHHHHHHHHHHHHCTTCCH
T ss_pred             HHHHHHHHHHHHHHHHcCCCCH
Confidence            3333446888999999998887

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	472
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-61
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	7e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-53
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-53
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	8e-53
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-52
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-51
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	3e-50
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-49
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-49
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-49
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-49
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-49
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-48
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-48
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-47
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-47
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-46
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-46
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-46
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	8e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-45
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-45
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-45
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-44
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-44
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-43
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-42
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-42
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-41
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-39
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-39
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-32
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-31
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	5e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-26
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-17

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 8e-63
 Identities = 91/286 (31%), Positives = 137/286 (47%), Gaps = 27/286 (9%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           W I   +I + ++IG G+   +Y+  W G DVAVK +           +  F  EV  L 
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVT--APTPQQLQAFKNEVGVLR 59

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           + RH  +L  MG    P     +VT+   G++L   LH + ++             + + 
Sbjct: 60  KTRHVNILLFMGYSTAPQL--AIVTQWCEGSSLYHHLHIIETK---------FEMIKLID 108

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MAL 363
            A + AQ M YLH +   +IHRDLK +NIFL +   V+I DFG A   S          L
Sbjct: 109 IARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166

Query: 364 TGTFVYMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
           +G+ ++MAPEVI+ +   PYS +SDVY+FGI+L E++TG  PY   +    +I   VG G
Sbjct: 167 SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN-NRDQIIFMVGRG 225

Query: 421 KLRPALPEEDGQL-RELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
            L P L +      + +  L+          RP F  I  S++ + 
Sbjct: 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 3e-61
 Identities = 76/278 (27%), Positives = 133/278 (47%), Gaps = 21/278 (7%)

Query: 189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           GW ++ KE+ L + IG+G   ++    +RG  VAVKCI       N+     F  E   +
Sbjct: 1   GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCI------KNDATAQAFLAEASVM 54

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           ++ RH  ++QL+G  +E     ++VTE +   +L ++L   G              +  L
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGG--------DCLL 106

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
             +L++ +AM+YL       +HRDL   N+ + +    +++DFG  +  S  +       
Sbjct: 107 KFSLDVCEAMEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 164

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            + APE ++ + +S KSDV+SFGI+L EI +              +   V +G  +   P
Sbjct: 165 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGY-KMDAP 222

Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
             DG    + E++   W  DA++RPSF  +   L++I+
Sbjct: 223 --DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 7e-55
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 24/274 (8%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
            D + +    +IG+G+   +Y+ +     ++VA   +        ++    F +E + L 
Sbjct: 6   NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLK 63

Query: 250 RQRHRFVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEE 305
             +H  +++   +            LVTEL+   TLK +L                  + 
Sbjct: 64  GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV----------MKIKV 113

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVRIADFGHARFLSDGEM-AL 363
             +   +I + +Q+LH + P +IHRDLK  NIF+      V+I D G A         A+
Sbjct: 114 LRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV 173

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
            GT  +MAPE+ + E Y E  DVY+FG+ + E+ T  +PY  +    A+I   V  G   
Sbjct: 174 IGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPY-SECQNAAQIYRRVTSGVKP 231

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            +  +    + E+ E+I      +   R S   +
Sbjct: 232 ASFDKVA--IPEVKEIIEGCIRQNKDERYSIKDL 263

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 23/270 (8%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           ++   IG G+     +   +  G  +  K +        E        EV+ L   +H  
Sbjct: 7   EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPN 64

Query: 256 VLQLMGACLEPPYRG-WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
           +++     ++      ++V E   G  L   +     +R+      L   E  L    ++
Sbjct: 65  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-----YLDE-EFVLRVMTQL 118

Query: 314 AQAMQYLHEQ---KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG---TF 367
             A++  H +      V+HRDLKP+N+FLD  ++V++ DFG AR L+           T 
Sbjct: 119 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTP 178

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            YM+PE +    Y+EKSD++S G +L E+     P+    +   ++A ++ EGK R    
Sbjct: 179 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKFRRIPY 236

Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSI 457
               +L E+I    L+       RPS   I
Sbjct: 237 RYSDELNEIITR-MLNL--KDYHRPSVEEI 263

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 2e-53
 Identities = 73/280 (26%), Positives = 116/280 (41%), Gaps = 25/280 (8%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-VAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W I  + + L+ K+GQG    ++   W G   VA+K + P            F QE   +
Sbjct: 12  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-----FLQEAQVM 66

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
            + RH  ++QL     E P   ++VTE +         G      K          + + 
Sbjct: 67  KKLRHEKLVQLYAVVSEEPI--YIVTEYMS-------KGSLLDFLKGETGKYLRLPQLVD 117

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---- 364
            A +IA  M Y+       +HRDL+ +NI + +    ++ADFG AR + D E        
Sbjct: 118 MAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAK 175

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
               + APE      ++ KSDV+SFGI+L E+ T             ++  +V  G   P
Sbjct: 176 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGYRMP 234

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
             PE       L +L+C  W  +   RP+F  +   L++ 
Sbjct: 235 CPPECP---ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 3e-53
 Identities = 70/281 (24%), Positives = 123/281 (43%), Gaps = 27/281 (9%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           W +  + + L E++G G    ++   +     VAVK +       +      F  E + +
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-----FLAEANLM 62

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            + +H+ +++L     + P   +++TE +   +L ++L      +            + L
Sbjct: 63  KQLQHQRLVRLYAVVTQEPI--YIITEYMENGSLVDFLKTPSGIK--------LTINKLL 112

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--- 364
             A +IA+ M ++ E+    IHRDL+ +NI + D    +IADFG AR + D E       
Sbjct: 113 DMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 170

Query: 365 -GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
                + APE I    ++ KSDV+SFGI+L EI+T             ++   +  G  R
Sbjct: 171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERG-YR 228

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              P  D    EL +L+ L W      RP+F  +   L++ 
Sbjct: 229 MVRP--DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 8e-53
 Identities = 64/273 (23%), Positives = 112/273 (41%), Gaps = 28/273 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W ++  + ++   +G+G   N+Y A  +     +A+K ++               +EV+ 
Sbjct: 3   WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQL-EKAGVEHQLRREVEI 59

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
            S  RH  +L+L G   +      ++      T+   L  L              F+E+ 
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS------------KFDEQR 107

Query: 308 AR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA-LT 364
                 E+A A+ Y H ++  VIHRD+KP N+ L  A  ++IADFG +          L 
Sbjct: 108 TATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 165

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP 424
           GT  Y+ PE+I+   + EK D++S G++  E + G  P+    Y+     +   E     
Sbjct: 166 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD 225

Query: 425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            + E         +LI      + S RP    +
Sbjct: 226 FVTE------GARDLISRLLKHNPSQRPMLREV 252

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 5e-52
 Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 27/280 (9%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           IDP E+   ++IG G    ++   W     VA+K I        +     F +E + + +
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-----FIEEAEVMMK 56

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR 309
             H  ++QL G CLE      LV E +    L ++L              L   E  L  
Sbjct: 57  LSHPKLVQLYGVCLEQAPI-CLVFEFMEHGCLSDYLR---------TQRGLFAAETLLGM 106

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----G 365
            L++ + M YL E    VIHRDL   N  + + + ++++DFG  RF+ D +   +     
Sbjct: 107 CLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF 164

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
              + +PEV     YS KSDV+SFG+++ E+ +      E +   +++  ++  G  R  
Sbjct: 165 PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTG-FRLY 222

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
            P        + +++   W      RP+FS +   L  I 
Sbjct: 223 KPRLAST--HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 4e-51
 Identities = 67/279 (24%), Positives = 130/279 (46%), Gaps = 27/279 (9%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR 250
           IDPK++   +++G G    +    WR   DVA+K I       +E     F +E   +  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-----FIEEAKVMMN 55

Query: 251 QRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
             H  ++QL G C +     +++TE          +G      +E        ++ L   
Sbjct: 56  LSHEKLVQLYGVCTKQRPI-FIITEY-------MANGCLLNYLREMRHRFQT-QQLLEMC 106

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----GT 366
            ++ +AM+YL  ++   +HRDL   N  ++D   V+++DFG +R++ D E   +      
Sbjct: 107 KDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 164

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             +  PEV+    +S KSD+++FG+++ EI + G  PY  + +  ++ A  + +G LR  
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY--ERFTNSETAEHIAQG-LRLY 221

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            P    +  ++  ++   W   A  RP+F  +  ++ ++
Sbjct: 222 RPHLASE--KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  171 bits (433), Expect = 2e-50
 Identities = 74/281 (26%), Positives = 120/281 (42%), Gaps = 25/281 (8%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           W ++  +I ++ K+G G    +Y  +W+   L VAVK +  D     E     F +E   
Sbjct: 12  WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-----FLKEAAV 66

Query: 248 LSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           +   +H  ++QL+G C   P    +   +    L ++L     Q               L
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV--------VLL 118

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTF 367
             A +I+ AM+YL   K   IHRDL   N  + +   V++ADFG +R ++          
Sbjct: 119 YMATQISSAMEYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA 176

Query: 368 V----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
                + APE +    +S KSDV++FG++L EI T                 E+ E   R
Sbjct: 177 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG--IDLSQVYELLEKDYR 234

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              PE  G   ++ EL+   W  + S RPSF+ I  + + +
Sbjct: 235 MERPE--GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-50
 Identities = 68/301 (22%), Positives = 124/301 (41%), Gaps = 38/301 (12%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W    + ++  + +G G    +  A   G+        VAVK +       + +      
Sbjct: 32  WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALM 88

Query: 243 QEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHG------------- 287
            E+  +++   H  ++ L+GAC       +L+ E      L  +L               
Sbjct: 89  SELKMMTQLGSHENIVNLLGACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147

Query: 288 LGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI 347
              +  +E  + +  FE+ L  A ++A+ M++L  +    +HRDL   N+ +   K V+I
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAARNVLVTHGKVVKI 205

Query: 348 ADFGHARFLSDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNH 401
            DFG AR +      +          +MAPE +    Y+ KSDV+S+GI+L EI + G +
Sbjct: 206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265

Query: 402 PYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSL 461
           PY            ++ +   +   P    +  E+  ++   W  D+  RPSF ++T  L
Sbjct: 266 PY--PGIPVDANFYKLIQNGFKMDQPFYATE--EIYIIMQSCWAFDSRKRPSFPNLTSFL 321

Query: 462 K 462
            
Sbjct: 322 G 322

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (434), Expect = 4e-50
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 19/216 (8%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +   ++G G    +++   +  GL +A K I+ +             +E+  L      +
Sbjct: 9   EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPY 65

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           ++   GA         +  E + G +L + L   G          +P  +     ++ + 
Sbjct: 66  IVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAG---------RIPE-QILGKVSIAVI 114

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-ALTGTFVYMAPE 373
           + + YL E K K++HRD+KPSNI ++    +++ DFG +  L D    +  GT  YM+PE
Sbjct: 115 KGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPE 173

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK 409
            +Q   YS +SD++S G+ L E+  G +P    D K
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 209

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-49
 Identities = 63/280 (22%), Positives = 119/280 (42%), Gaps = 35/280 (12%)

Query: 192 IDPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           ++P++  ++  ++G G    +Y+A  +   +  A K I       +E  +  +  E+D L
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDIL 63

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           +   H  +++L+ A        W++ E   G  +   +  L             P  E  
Sbjct: 64  ASCDHPNIVKLLDAFYYENNL-WILIEFCAGGAVDAVMLELER-----------PLTESQ 111

Query: 308 AR--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT- 364
            +    +   A+ YLH+ K  +IHRDLK  NI       +++ADFG +   +        
Sbjct: 112 IQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169

Query: 365 --GTFVYMAPEVIQCE-----PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
             GT  +MAPEV+ CE     PY  K+DV+S GI L E+     P+   +  P ++ +++
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH--HELNPMRVLLKI 227

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            + +  P L +         + +    + +   R + S +
Sbjct: 228 AKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-49
 Identities = 78/287 (27%), Positives = 128/287 (44%), Gaps = 29/287 (10%)

Query: 191 YIDPKEIDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFAQEV 245
            I  K++ L EK+G G+   + R  W     + + VAVKC+ PD   +   A+  F +EV
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREV 62

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           + +    HR +++L G  L PP    +VTEL          G    R ++          
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPPM--KMVTELA-------PLGSLLDRLRKHQGHFLL-GT 112

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT- 364
               A+++A+ M YL  ++   IHRDL   N+ L     V+I DFG  R L   +     
Sbjct: 113 LSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170

Query: 365 -----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG 418
                  F + APE ++   +S  SD + FG+ L E+ T G  P+I  +   ++I  ++ 
Sbjct: 171 QEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKID 228

Query: 419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ 465
           +   R   PE+  Q  ++  ++   W      RP+F ++   L   Q
Sbjct: 229 KEGERLPRPEDCPQ--DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 2e-49
 Identities = 67/287 (23%), Positives = 129/287 (44%), Gaps = 34/287 (11%)

Query: 191 YIDPKEIDLQEK-IGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           Y+D K + L++K +G G    + +  ++       VAVK +  +    +         E 
Sbjct: 2   YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA--NDPALKDELLAEA 59

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFE 304
           + + +  + ++++++G C    +   LV E+     L ++L          +   +   +
Sbjct: 60  NVMQQLDNPYIVRMIGICEAESW--MLVMEMAELGPLNKYLQ---------QNRHVKD-K 107

Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT 364
             +    +++  M+YL E     +HRDL   N+ L    + +I+DFG ++ L   E    
Sbjct: 108 NIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165

Query: 365 ------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
                     + APE I    +S KSDV+SFG+++ E  + G  PY  +  K +++   +
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY--RGMKGSEVTAML 223

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +G+ R   P   G  RE+ +L+ L W  D   RP F+++   L+N 
Sbjct: 224 EKGE-RMGCPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 64/272 (23%), Positives = 98/272 (36%), Gaps = 26/272 (9%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DP+++     +IG G+   +Y A        VA+K +      +NE       +EV  L 
Sbjct: 12  DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNE-KWQDIIKEVRFLQ 70

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           + RH   +Q  G  L      WLV E   G+              K+ +       E  A
Sbjct: 71  KLRHPNTIQYRGCYLREHTA-WLVMEYCLGSASDLLEV------HKKPL----QEVEIAA 119

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFV 368
                 Q + YLH     +IHRD+K  NI L +   V++ DFG A  ++       GT  
Sbjct: 120 VTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-FVGTPY 176

Query: 369 YMAPEVIQCE---PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           +MAPEVI       Y  K DV+S GI   E+     P    +         + + +    
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPA- 233

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
             +           +          RP+   +
Sbjct: 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVL 264

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 8e-49
 Identities = 74/310 (23%), Positives = 118/310 (38%), Gaps = 55/310 (17%)

Query: 195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHR 254
           + I LQE IG+G    ++R  WRG +VAVK        + E    F   E+      RH 
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIF-----SSREERSWFREAEIYQTVMLRHE 57

Query: 255 FVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            +L  + A  +        WLV++     +L ++L+                 E  +  A
Sbjct: 58  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLA 106

Query: 311 LEIAQAMQYLHEQ------KPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT 364
           L  A  + +LH +      KP + HRDLK  NI +       IAD G A         + 
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 166

Query: 365 -------GTFVYMAPEVIQCE------PYSEKSDVYSFGIILNEIITGNHPY-------- 403
                  GT  YMAPEV+            +++D+Y+ G++  EI               
Sbjct: 167 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL 226

Query: 404 -----IEKDYKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFS 455
                +  D    ++   V E KLRP +P        LR + +++   W  + + R +  
Sbjct: 227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 286

Query: 456 SITCSLKNIQ 465
            I  +L  + 
Sbjct: 287 RIKKTLSQLS 296

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 4e-48
 Identities = 62/296 (20%), Positives = 128/296 (43%), Gaps = 34/296 (11%)

Query: 190 WYIDPKEIDLQE-KIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQE 244
            ++    + + + ++G G   ++ + ++R     +DVA+K +      T +       +E
Sbjct: 3   LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMRE 59

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
              + +  + ++++L+G C        LV E+  G  L ++L G   +          P 
Sbjct: 60  AQIMHQLDNPYIVRLIGVCQAEAL--MLVMEMAGGGPLHKFLVGKREE---------IPV 108

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
                   +++  M+YL E+    +HRDL   N+ L +  + +I+DFG ++ L   +   
Sbjct: 109 SNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY 166

Query: 364 T------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME 416
           T          + APE I    +S +SDV+S+G+ + E ++ G  PY  K  K  ++   
Sbjct: 167 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY--KKMKGPEVMAF 224

Query: 417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTETI 472
           + +GK     PE   +L  L+   C  +  +   RP F ++   ++     +   +
Sbjct: 225 IEQGKRMECPPECPPELYALMSD-CWIYKWED--RPDFLTVEQRMRACYYSLASKV 277

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 7e-48
 Identities = 75/289 (25%), Positives = 121/289 (41%), Gaps = 31/289 (10%)

Query: 190 WYIDPKE--IDLQEKIGQGTTANIYRAIW-----RGLDVAVKCIYPDFFHTNENAVTFFA 242
             I P    +   E IG+G    +Y         + +  AVK +      T+   V+ F 
Sbjct: 20  VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFL 76

Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPP 302
            E   +    H  VL L+G CL       +V   +            +          P 
Sbjct: 77  TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--------PT 128

Query: 303 FEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA 362
            ++ +   L++A+ M++L  +K   +HRDL   N  LD+   V++ADFG AR + D E  
Sbjct: 129 VKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186

Query: 363 LT-------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAM 415
                        +MA E +Q + ++ KSDV+SFG++L E++T   P    D     I +
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-DVNTFDITV 245

Query: 416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            + +G+ R   PE       L E++   W   A +RPSFS +   +  I
Sbjct: 246 YLLQGR-RLLQPEYCPD--PLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-47
 Identities = 66/272 (24%), Positives = 115/272 (42%), Gaps = 28/272 (10%)

Query: 193 DPKEI-DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           DPK+     EKIGQG +  +Y A+    G +VA++ +        +        E+  + 
Sbjct: 17  DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ----QQPKKELIINEILVMR 72

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
             ++  ++  + + L      W+V E L G +L + +                   +  A
Sbjct: 73  ENKNPNIVNYLDSYLVGDEL-WVVMEYLAGGSLTDVVTETC-----------MDEGQIAA 120

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---G 365
              E  QA+++LH  +  VIHRD+K  NI L     V++ DFG    ++  +   +   G
Sbjct: 121 VCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG 178

Query: 366 TFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
           T  +MAPEV+  + Y  K D++S GI+  E+I G  PY+ ++  P +    +      P 
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNG-TPE 235

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
           L   +       + +    D D   R S   +
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  163 bits (414), Expect = 2e-47
 Identities = 63/287 (21%), Positives = 110/287 (38%), Gaps = 33/287 (11%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD-----VAVKCIYPDFFHTNENAVTFFAQEVD 246
           ID   + +++ IG G    +     +        VA+K +   +    E     F  E  
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY---TEKQRRDFLSEAS 79

Query: 247 TLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEER 306
            + +  H  V+ L G   +      ++TE +     +            +        + 
Sbjct: 80  IMGQFDHPNVIHLEGVVTKSTPV-MIITEFMENGSLDSFL--------RQNDGQFTVIQL 130

Query: 307 LARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-- 364
           +     IA  M+YL +     +HRDL   NI ++     +++DFG +RFL D     T  
Sbjct: 131 VGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT 188

Query: 365 ------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEV 417
                     + APE IQ   ++  SDV+S+GI++ E+++ G  PY   D     +   +
Sbjct: 189 SALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMTNQDVINAI 246

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +      LP        L +L+   W  D + RP F  I  +L  +
Sbjct: 247 EQD---YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (409), Expect = 1e-46
 Identities = 69/297 (23%), Positives = 114/297 (38%), Gaps = 31/297 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      +   + +G G    +  A   GL        VAVK + P     +        
Sbjct: 18  WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALM 74

Query: 243 QEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPL 300
            E+  LS    H  ++ L+GAC        ++TE      L  +L          +  P 
Sbjct: 75  SELKVLSYLGNHMNIVNLLGACTIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 301 P--------PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
                      E+ L+ + ++A+ M +L  +    IHRDL   NI L   +  +I DFG 
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLTHGRITKICDFGL 191

Query: 353 ARFLSDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           AR + +    +          +MAPE I    Y+ +SDV+S+GI L E+ +         
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
              +K   ++ +   R   PE      E+ +++   WD D   RP+F  I   ++  
Sbjct: 252 PVDSKF-YKMIKEGFRMLSPEH--APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 30/285 (10%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRGLD------VAVKCIYPDFFHTNENAVTFFAQEV 245
           I P  +  Q+ IG G    +Y+ + +         VA+K +   +    E     F  E 
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY---TEKQRVDFLGEA 60

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
             + +  H  +++L G   +      ++TE          +G   +  +E+        +
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPM-MIITE-------YMENGALDKFLREKDGEFSV-LQ 111

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT- 364
            +     IA  M+YL       +HRDL   NI ++     +++DFG +R L D   A   
Sbjct: 112 LVGMLRGIAAGMKYLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169

Query: 365 -----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE 419
                    + APE I    ++  SDV+SFGI++ E++T        +    ++   + +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAIND 228

Query: 420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           G  R   P +      + +L+   W  + + RP F+ I   L  +
Sbjct: 229 G-FRLPTPMD--CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 5e-46
 Identities = 69/287 (24%), Positives = 122/287 (42%), Gaps = 24/287 (8%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWRG----LDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           +D  +I  Q+ IG+G    + +A  +     +D A+K +     + +++    FA E++ 
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE---YASKDDHRDFAGELEV 63

Query: 248 LSR-QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLP---- 301
           L +   H  ++ L+GAC    Y  +L  E      L ++L                    
Sbjct: 64  LCKLGHHPNIINLLGACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 122

Query: 302 --PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDG 359
               ++ L  A ++A+ M YL +   + IHRDL   NI + +    +IADFG +R     
Sbjct: 123 TLSSQQLLHFAADVARGMDYLSQ--KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 360 EMALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
                      +MA E +    Y+  SDV+S+G++L EI++            A++  ++
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKL 239

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +G  R   P       E+ +L+   W      RPSF+ I  SL  +
Sbjct: 240 PQGY-RLEKPLNCDD--EVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 8e-46
 Identities = 74/294 (25%), Positives = 123/294 (41%), Gaps = 26/294 (8%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W      + L + +G+G    +  A   G+D       VAVK +     H+   A    +
Sbjct: 8   WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA--LMS 65

Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
           +    +    H  V+ L+GAC +P     ++ E      L  +L    ++    ++ P  
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 302 ------PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF 355
                   E  +  + ++A+ M++L  +K   IHRDL   NI L +   V+I DFG AR 
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 356 LSDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
           +      +          +MAPE I    Y+ +SDV+SFG++L EI +            
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 411 AKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
            +    + EG  R   P  D    E+ + +   W G+ S RP+FS +   L N+
Sbjct: 244 EEFCRRLKEGT-RMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (402), Expect = 1e-45
 Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 23/288 (7%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAVTFFA 242
           W +  ++I +  ++GQG+   +Y  + +G+        VA+K +       +      F 
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFL 71

Query: 243 QEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLP 301
            E   +       V++L+G   +      ++ EL+    LK +L  L        ++  P
Sbjct: 72  NEASVMKEFNCHHVVRLLGVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 302 PFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE- 360
              + +  A EIA  M YL+  K   +HRDL   N  + +   V+I DFG  R + + + 
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 188

Query: 361 ----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME 416
                       +M+PE ++   ++  SDV+SFG++L EI T      +      ++   
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRF 247

Query: 417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           V EG L   L + D     L EL+ + W  +  +RPSF  I  S+K  
Sbjct: 248 VMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  159 bits (402), Expect = 1e-45
 Identities = 71/306 (23%), Positives = 121/306 (39%), Gaps = 37/306 (12%)

Query: 186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLD-------VAVKCIYPDFFHTNENAV 238
           K+         I+    IG+G    +++A   GL        VAVK +  +    + +  
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQ 60

Query: 239 TFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQ------ 291
             F +E   ++   +  +++L+G C        L+ E +    L E+L  +         
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 292 --------RRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK 343
                   R      P     E+L  A ++A  M YL E+K   +HRDL   N  + +  
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLATRNCLVGENM 177

Query: 344 HVRIADFGHARFLSDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT 398
            V+IADFG +R +   +             +M PE I    Y+ +SDV+++G++L EI +
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 399 GNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
                        ++   V +G +            EL  L+ L W    + RPSF SI 
Sbjct: 238 YGLQPYY-GMAHEEVIYYVRDGNILACPENCP---LELYNLMRLCWSKLPADRPSFCSIH 293

Query: 459 CSLKNI 464
             L+ +
Sbjct: 294 RILQRM 299

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 3e-45
 Identities = 67/284 (23%), Positives = 121/284 (42%), Gaps = 28/284 (9%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQE 244
           + I  + I+L   IG+G   ++++ I+       L VA+K        T+++    F QE
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQE 58

Query: 245 VDTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
             T+ +  H  +++L+G   E P   W++ EL          G      + R   L    
Sbjct: 59  ALTMRQFDHPHIVKLIGVITENPV--WIIMEL-------CTLGELRSFLQVRKYSLDL-A 108

Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT 364
             +  A +++ A+ YL  ++   +HRD+   N+ +     V++ DFG +R++ D      
Sbjct: 109 SLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA 166

Query: 365 ----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
                   +MAPE I    ++  SDV+ FG+ + EI+       +   K   +   +  G
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENG 225

Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +  P  P     L  L+   C ++  D S RP F+ +   L  I
Sbjct: 226 ERLPMPPNCPPTLYSLMTK-CWAY--DPSRRPRFTELKAQLSTI 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  157 bits (399), Expect = 1e-44
 Identities = 53/267 (19%), Positives = 106/267 (39%), Gaps = 25/267 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D+ E++G G    ++R   R  G + A K +       +E+      +E+ T+S  RH  
Sbjct: 29  DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPT 84

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           ++ L  A  +      ++ E + G  L E +          +M      +E +    ++ 
Sbjct: 85  LVNLHDAFEDDNEM-VMIYEFMSGGELFEKVA-----DEHNKM----SEDEAVEYMRQVC 134

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFL--DDAKHVRIADFGHARFLSDGEMALT--GTFVYM 370
           + + ++HE     +H DLKP NI      +  +++ DFG    L   +      GT  + 
Sbjct: 135 KGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 192

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           APEV + +P    +D++S G++   +++G  P+  ++    +    V             
Sbjct: 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSAFS 250

Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
           G   +  + I      D + R +    
Sbjct: 251 GISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 19/253 (7%)

Query: 195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           ++  +   +G G+   ++    R  G   A+K +  +        V     E   LS   
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVT 62

Query: 253 HRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
           H F++++ G   +      ++  + G  L   L                P       A E
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR----------KSQRFPNPVAKFYAAE 112

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAP 372
           +  A++YLH +   +I+RDLKP NI LD   H++I DFG A+++ D    L GT  Y+AP
Sbjct: 113 VCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAP 170

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
           EV+  +PY++  D +SFGI++ E++ G  P+ + +       +   E +  P   E+   
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED--- 227

Query: 433 LRELIELICLSWD 445
           +++L+    ++ D
Sbjct: 228 VKDLLSR-LITRD 239

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 6e-44
 Identities = 58/271 (21%), Positives = 105/271 (38%), Gaps = 32/271 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           DL + +G+G    +  A+ R     VAVK +         +      +E+       H  
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK---RAVDCPENIKKEICINKMLNHEN 64

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALE 312
           V++  G   E   + +L  E   G  L + +                   E  A+    +
Sbjct: 65  VVKFYGHRREGNIQ-YLFLEYCSGGELFDRIEPDI------------GMPEPDAQRFFHQ 111

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTF 367
           +   + YLH     + HRD+KP N+ LD+  +++I+DFG A              + GT 
Sbjct: 112 LMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169

Query: 368 VYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
            Y+APE+++   + +E  DV+S GI+L  ++ G  P+ +      + +    +       
Sbjct: 170 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 229

Query: 427 PEEDGQLRELIELICLSWDGDASVRPSFSSI 457
            + D     L+    L    + S R +   I
Sbjct: 230 KKIDSAPLALLHK-ILVE--NPSARITIPDI 257

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-43
 Identities = 75/297 (25%), Positives = 126/297 (42%), Gaps = 32/297 (10%)

Query: 190 WYIDPKEIDLQEKIGQGTTANIYRAIWRGLD---------VAVKCIYPDFFHTNENAVTF 240
           W +    + L + +G+G    +  A   GLD         VAVK +  D     E  ++ 
Sbjct: 8   WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---TEKDLSD 64

Query: 241 FAQEVDTLSR-QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMV 298
              E++ +    +H+ ++ L+GAC +     +++ E      L+E+L        +    
Sbjct: 65  LISEMEMMKMIGKHKNIINLLGACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYN 123

Query: 299 PLPPFEERLAR------ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH 352
           P    EE+L+       A ++A+ M+YL     K IHRDL   N+ + +   ++IADFG 
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLAS--KKCIHRDLAARNVLVTEDNVMKIADFGL 181

Query: 353 ARFLSDGEMALT-----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           AR +   +             +MAPE +    Y+ +SDV+SFG++L EI T         
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-G 240

Query: 408 YKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
               ++   + EG  R   P       EL  ++   W    S RP+F  +   L  I
Sbjct: 241 VPVEELFKLLKEGH-RMDKPSN--CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 4e-43
 Identities = 64/276 (23%), Positives = 123/276 (44%), Gaps = 32/276 (11%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
             P++    + +G+G+ + +  A       + A+K +        EN V +  +E D +S
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMS 63

Query: 250 RQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
           R  H F ++L     +     +          L +++  +G             F+E   
Sbjct: 64  RLDHPFFVKLYFTFQDDEKL-YFGLSYAKNGELLKYIRKIG------------SFDETCT 110

Query: 309 R--ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLS-DGEMALTG 365
           R    EI  A++YLH     +IHRDLKP NI L++  H++I DFG A+ LS + + A   
Sbjct: 111 RFYTAEIVSALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168

Query: 366 TFV----YMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGK 421
           +FV    Y++PE++  +   + SD+++ G I+ +++ G  P+  +      I  ++ + +
Sbjct: 169 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLE 226

Query: 422 LRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                PE+     +  +L+      DA+ R     +
Sbjct: 227 YDF--PEKFFP--KARDLVEKLLVLDATKRLGCEEM 258

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  151 bits (382), Expect = 5e-43
 Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 31/276 (11%)

Query: 194 PKEID----LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDT 247
           P  +     L E +G G  + ++ A       DVAVK +  D    + +    F +E   
Sbjct: 2   PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQN 60

Query: 248 LSRQRHRFVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPF 303
            +   H  ++ +          G   ++V E + G TL++ +H  G         P+ P 
Sbjct: 61  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---------PMTP- 110

Query: 304 EERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMAL 363
           +  +    +  QA+ + H+    +IHRD+KP+NI +     V++ DFG AR ++D   ++
Sbjct: 111 KRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 168

Query: 364 T------GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV 417
           T      GT  Y++PE  + +    +SDVYS G +L E++TG  P+      P  +A + 
Sbjct: 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSPVSVAYQH 226

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS 453
                 P     +G   +L  ++  +   +   R  
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 8e-43
 Identities = 59/284 (20%), Positives = 116/284 (40%), Gaps = 30/284 (10%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR------GLDVAVKCIYPDFFHTNENAVTFFAQEV 245
           +   E    + +G G    +Y+ +W        + VA+K +      T+  A      E 
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEA 62

Query: 246 DTLSRQRHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
             ++   +  V +L+G CL    +  +   +    L +++                  + 
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVR---------EHKDNIGSQY 112

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT- 364
            L   ++IA+ M YL +++  ++HRDL   N+ +   +HV+I DFG A+ L   E     
Sbjct: 113 LLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170

Query: 365 ----GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
                   +MA E I    Y+ +SDV+S+G+ + E++T      +     ++I+  + +G
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKG 229

Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
           +  P  P     +  ++   C   D D+  RP F  +      +
Sbjct: 230 ERLPQPPICTIDVYMIMVK-CWMIDADS--RPKFRELIIEFSKM 270

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 32/277 (11%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHT-----NENAVTFFAQEVDTLSR 250
           + +E +G+G ++ + R I +    + AVK I      +      +       +EVD L +
Sbjct: 6   EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65

Query: 251 -QRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLA 308
              H  ++QL        +  +LV +L+    L ++L            V L   +E   
Sbjct: 66  VSGHPNIIQLKDTYETNTFF-FLVFDLMKKGELFDYLT---------EKVTLSE-KETRK 114

Query: 309 RALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGT 366
               + + +  LH+    ++HRDLKP NI LDD  ++++ DFG +  L  GE    + GT
Sbjct: 115 IMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGT 172

Query: 367 FVYMAPEVIQCEP------YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG 420
             Y+APE+I+C        Y ++ D++S G+I+  ++ G+ P+  +      +   +  G
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSG 230

Query: 421 KLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
             +   PE D     + +L+          R +    
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 51/267 (19%), Positives = 101/267 (37%), Gaps = 25/267 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D+ E++G G    ++R + +  G     K I   +             E+  +++  H  
Sbjct: 32  DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT----VKNEISIMNQLHHPK 87

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIA 314
           ++ L  A  +      L+ E L G  L + +          +M       E +    +  
Sbjct: 88  LINLHDAFEDKYEM-VLILEFLSGGELFDRIA-----AEDYKM----SEAEVINYMRQAC 137

Query: 315 QAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADFGHARFLSDGEMA--LTGTFVYM 370
           + ++++HE    ++H D+KP NI  +   A  V+I DFG A  L+  E+    T T  + 
Sbjct: 138 EGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           APE++  EP    +D+++ G++   +++G  P+        +    V             
Sbjct: 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF--AGEDDLETLQNVKRCDWEFDEDAFS 253

Query: 431 GQLRELIELICLSWDGDASVRPSFSSI 457
               E  + I      +   R +    
Sbjct: 254 SVSPEAKDFIKNLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (378), Expect = 4e-42
 Identities = 70/294 (23%), Positives = 127/294 (43%), Gaps = 39/294 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D ++ +G G  + +  A  +     VA+KCI        E +      E+  L + +H  
Sbjct: 12  DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS---MENEIAVLHKIKHPN 68

Query: 256 VLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALE 312
           ++ L        +  +L+ +L+ G  L + +   G             + ER A     +
Sbjct: 69  IVALDDIYESGGHL-YLIMQLVSGGELFDRIVEKG------------FYTERDASRLIFQ 115

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFL---DDAKHVRIADFGHARFLSDGEMALT--GTF 367
           +  A++YLH+    ++HRDLKP N+     D+   + I+DFG ++    G +  T  GT 
Sbjct: 116 VLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTP 173

Query: 368 VYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
            Y+APEV+  +PYS+  D +S G+I   ++ G  P+ +++   AK+  ++ + +     P
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYEFDSP 231

Query: 428 EEDGQLRELIELICLSWDGDASVRPS---------FSSITCSLKNIQMKVTETI 472
             D       + I    + D   R +          +  T   KNI   V+E I
Sbjct: 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-41
 Identities = 51/274 (18%), Positives = 105/274 (38%), Gaps = 30/274 (10%)

Query: 195 KEI----DLQEKIGQGTTANIYRAIWRGLD--VAVKCIYPDFFHTNENAVTFFAQEVDTL 248
           KE+     + E +G+G    ++R +          K +                +E+  L
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-----KVKGTDQVLVKKEISIL 55

Query: 249 SRQRHRFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERL 307
           +  RHR +L L  +         ++ E + G  + E +              L    E +
Sbjct: 56  NIARHRNILHLHESFESMEEL-VMIFEFISGLDIFERI--------NTSAFELNE-REIV 105

Query: 308 ARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADFGHARFLSDGEMALT- 364
           +   ++ +A+Q+LH     + H D++P NI      +  ++I +FG AR L  G+     
Sbjct: 106 SYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL 163

Query: 365 -GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLR 423
                Y APEV Q +  S  +D++S G ++  +++G +P++ +     +I   +   +  
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYT 221

Query: 424 PALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                      E ++ +      +   R + S  
Sbjct: 222 FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-40
 Identities = 55/266 (20%), Positives = 108/266 (40%), Gaps = 27/266 (10%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
            L + +G+G+   ++ A ++      A+K +  D    +++      ++        H F
Sbjct: 5   ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEI 313
           +  +           +++  L G  L   +                 F+   A   A EI
Sbjct: 65  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH------------KFDLSRATFYAAEI 112

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFVYM 370
              +Q+LH +   +++RDLK  NI LD   H++IADFG  +    G+       GT  Y+
Sbjct: 113 ILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYI 170

Query: 371 APEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           APE++  + Y+   D +SFG++L E++ G  P+  +D +    ++ +        L +  
Sbjct: 171 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEK-- 228

Query: 431 GQLRELIELICLSWDGDASVRPSFSS 456
               E  +L+   +  +   R     
Sbjct: 229 ----EAKDLLVKLFVREPEKRLGVRG 250

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  142 bits (359), Expect = 1e-39
 Identities = 51/285 (17%), Positives = 96/285 (33%), Gaps = 36/285 (12%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           +  +IG+G+   I+          VA+K           +       E  T         
Sbjct: 9   VGRRIGEGSFGVIFEGTNLLNNQQVAIKFE------PRRSDAPQLRDEYRTYKLLAGCTG 62

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           +  +    +      LV +LLG +L++ L   G              +     A ++   
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCG---------RKFSVKTVAMAAKQMLAR 113

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDD-----AKHVRIADFGHARFLSDGEMA--------- 362
           +Q +HE+   +++RD+KP N  +       A  + + DFG  +F  D             
Sbjct: 114 VQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171

Query: 363 -LTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME-VGEG 420
            L+GT  YM+         S + D+ + G +    + G+ P+        K   E +GE 
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231

Query: 421 KLRPALPEEDGQL-RELIELICLSWDGDASVRPSFSSITCSLKNI 464
           K    L E       E  + +  + +      P +  +      +
Sbjct: 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 4e-39
 Identities = 56/286 (19%), Positives = 93/286 (32%), Gaps = 34/286 (11%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L  KIG G+  +IY       G +VA+K       H           E       +    
Sbjct: 11  LGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ------LHIESKIYKMMQGGVG 64

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           +  +  C        +V ELLG +L++  +                 +  L  A ++   
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLGPSLEDLFN---------FCSRKFSLKTVLLLADQMISR 115

Query: 317 MQYLHEQKPKVIHRDLKPSNIF---LDDAKHVRIADFGHARFLSDGEMA----------L 363
           ++Y+H +    IHRD+KP N           V I DFG A+   D              L
Sbjct: 116 IEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173

Query: 364 TGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN-HPYIEKDYKPAKIAMEVGEGKL 422
           TGT  Y +         S + D+ S G +L     G+      K     +    + E K+
Sbjct: 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233

Query: 423 RPALPEEDGQL-RELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
              +         E    +          +P +S +    +N+  +
Sbjct: 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  142 bits (360), Expect = 5e-39
 Identities = 65/263 (24%), Positives = 105/263 (39%), Gaps = 23/263 (8%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF--FAQEVDTLSRQRH 253
            +   IG+G    +Y       G   A+KC+        +           +  +S    
Sbjct: 7   SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66

Query: 254 RFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
            F++ +  A   P      + +L+ G  L   L   G               +    A E
Sbjct: 67  PFIVCMSYAFHTPDKL-SFILDLMNGGDLHYHLSQHGVFSE----------ADMRFYAAE 115

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT-GTFVYMA 371
           I   ++++H +   V++RDLKP+NI LD+  HVRI+D G A   S  +   + GT  YMA
Sbjct: 116 IILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMA 173

Query: 372 PEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           PEV+Q    Y   +D +S G +L +++ G+ P+        K   E+    L  A+   D
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF---RQHKTKDKHEIDRMTLTMAVELPD 230

Query: 431 GQLRELIELICLSWDGDASVRPS 453
               EL  L+      D + R  
Sbjct: 231 SFSPELRSLLEGLLQRDVNRRLG 253

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-38
 Identities = 63/271 (23%), Positives = 103/271 (38%), Gaps = 26/271 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAV--TFFAQEVDTLSRQRH 253
           D  E++G G  A + +   +  GL  A K I      ++   V      +EV  L   +H
Sbjct: 13  DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72

Query: 254 RFVLQLMGACLEPPYRGWLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
             V+ L            L+ EL+ G  L ++L        KE +      EE      +
Sbjct: 73  PNVITLHEVYENKTDV-ILILELVAGGELFDFLA------EKESLTE----EEATEFLKQ 121

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDD----AKHVRIADFGHARFLSDGEMA--LTGT 366
           I   + YLH  +  + H DLKP NI L D       ++I DFG A  +  G     + GT
Sbjct: 122 ILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGT 179

Query: 367 FVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
             ++APE++  EP   ++D++S G+I   +++G  P++       +    V         
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVNYEFED 237

Query: 427 PEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                      + I      D   R +    
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-37
 Identities = 57/280 (20%), Positives = 104/280 (37%), Gaps = 34/280 (12%)

Query: 192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           ID  ++   + +G G    + +   +      A+K +                +EV+   
Sbjct: 10  IDDYKV-TSQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHW 59

Query: 250 RQ-RHRFVLQLMGACLEPPYRG---WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFE 304
           R  +   +++++              +V E L G  L   +   G Q   ER        
Sbjct: 60  RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-------- 111

Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKHVRIADFGHARFLSDGEM 361
           E       I +A+QYLH     + HRD+KP N+          +++ DFG A+  +    
Sbjct: 112 EASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS 169

Query: 362 ALT--GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEV 417
             T   T  Y+APEV+  E Y +  D++S G+I+  ++ G  P+           +   +
Sbjct: 170 LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229

Query: 418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSI 457
             G+     PE      E+  LI      + + R + +  
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 8e-36
 Identities = 58/266 (21%), Positives = 99/266 (37%), Gaps = 24/266 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D  + +G+GT   +     +  G   A+K +  +     ++ V     E   L   RH F
Sbjct: 8   DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPF 66

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           +  L  A        +++    G  L   L          R       E       EI  
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLS---------RERVFTE-ERARFYGAEIVS 116

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE---MALTGTFVYMAP 372
           A++YLH +   V++RD+K  N+ LD   H++I DFG  +             GT  Y+AP
Sbjct: 117 ALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174

Query: 373 EVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
           EV++   Y    D +  G+++ E++ G  P+  +D++     + + E +    L      
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP---- 230

Query: 433 LRELIELICLSWDGDASVRPSFSSIT 458
             E   L+      D   R       
Sbjct: 231 --EAKSLLAGLLKKDPKQRLGGGPSD 254

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (334), Expect = 2e-35
 Identities = 52/252 (20%), Positives = 101/252 (40%), Gaps = 23/252 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           D  + +G G+   +     +  G   A+K +           +     E   L      F
Sbjct: 44  DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPF 102

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR--ALEI 313
           +++L  +  +      ++  + G  +   L  +G             F E  AR  A +I
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG------------RFSEPHARFYAAQI 150

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPE 373
               +YLH     +I+RDLKP N+ +D   ++++ DFG A+ +      L GT   +APE
Sbjct: 151 VLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPE 208

Query: 374 VIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
           +I  + Y++  D ++ G+++ E+  G  P+           +  G+ +       +   L
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSD---L 265

Query: 434 RELIELICLSWD 445
           ++L+    L  D
Sbjct: 266 KDLLR-NLLQVD 276

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (327), Expect = 5e-35
 Identities = 55/268 (20%), Positives = 99/268 (36%), Gaps = 19/268 (7%)

Query: 201 EKIGQGTTANIYRAIWRGLD--VAVKCIYPDFF-HTNENAVTFFAQEVDTLSRQRHRFVL 257
           + +G+G  A +Y+A  +  +  VA+K I         +       +E+  L    H  ++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAM 317
            L+ A         LV + + T L+  +           + P        A  L   Q +
Sbjct: 64  GLLDAFGHKSNI-SLVFDFMETDLEVIIK-----DNSLVLTP----SHIKAYMLMTLQGL 113

Query: 318 QYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFVYMAPEV 374
           +YLH+    ++HRDLKP+N+ LD+   +++ADFG A+       A T    T  Y APE+
Sbjct: 114 EYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

Query: 375 IQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQL 433
           +     Y    D+++ G IL E++                 +    G        +   L
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 231

Query: 434 RELIELICLSWDGDASVRPSFSSITCSL 461
            + +            +  +       L
Sbjct: 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDL 259

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 9e-35
 Identities = 62/271 (22%), Positives = 103/271 (38%), Gaps = 36/271 (13%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTF--FAQEVDTLSR--Q 251
            +   +G G   ++Y  I     L VA+K +  D                EV  L +   
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLAR-- 309
               V++L+     P     L+ E               Q   + +      +E LAR  
Sbjct: 67  GFSGVIRLLDWFERPDSF-VLILERPE----------PVQDLFDFITERGALQEELARSF 115

Query: 310 ALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGEM-ALTGTF 367
             ++ +A+++ H     V+HRD+K  NI +D +   +++ DFG    L D       GT 
Sbjct: 116 FWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTR 173

Query: 368 VYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL 426
           VY  PE I+   Y    + V+S GI+L +++ G+ P+   +       +  G+   R  +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRV 227

Query: 427 PEEDGQLRELIELICLSWDGDASVRPSFSSI 457
                   E   LI        S RP+F  I
Sbjct: 228 SS------ECQHLIRWCLALRPSDRPTFEEI 252

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 4e-34
 Identities = 49/212 (23%), Positives = 83/212 (39%), Gaps = 12/212 (5%)

Query: 198 DLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTF-FAQEVDTLSRQRH 253
           +   +IG+G    +++A      G  VA+K +            T      +  L    H
Sbjct: 10  ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 254 RFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEI 313
             V++L   C            L+     E +    +    +   P  P E       ++
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVF----EHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125

Query: 314 AQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT--GTFVYMA 371
            + + +LH  +  V+HRDLKP NI +  +  +++ADFG AR  S      +   T  Y A
Sbjct: 126 LRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 372 PEVIQCEPYSEKSDVYSFGIILNEIITGNHPY 403
           PEV+    Y+   D++S G I  E+      +
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 2e-33
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 19/216 (8%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
              EKIG+GT   +Y+A  +  G  VA+K I  D     E   +   +E+  L    H  
Sbjct: 5   QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPN 62

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           +++L+          +LV E L   LK+++            +   P     +   ++ Q
Sbjct: 63  IVKLLDVIHTENKL-YLVFEFLHQDLKKFMD--------ASALTGIPLPLIKSYLFQLLQ 113

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFVYMAP 372
            + + H  +  V+HRDLKP N+ ++    +++ADFG AR         T    T  Y AP
Sbjct: 114 GLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171

Query: 373 EVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKD 407
           E++    Y S   D++S G I  E++T    +    
Sbjct: 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 61/282 (21%), Positives = 105/282 (37%), Gaps = 29/282 (10%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
               IG+G    +  A      + VA+K I P     ++       +E+  L R RH  +
Sbjct: 12  NLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENI 68

Query: 257 LQLMGACLEPPYRG----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
           + +      P        +LVT L+G  L + L       + + +      +       +
Sbjct: 69  IGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-------KTQHL----SNDHICYFLYQ 117

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT------GT 366
           I + ++Y+H     V+HRDLKPSN+ L+    ++I DFG AR                 T
Sbjct: 118 ILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 367 FVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
             Y APE++     Y++  D++S G IL E+++    +  K Y      +    G     
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
                  L+    L+ L           F +      ++  K
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDK 277

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 3e-32
 Identities = 55/273 (20%), Positives = 97/273 (35%), Gaps = 17/273 (6%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +   KIGQGT   +++A  R  G  VA+K +  +  +  E       +E+  L   +H  
Sbjct: 13  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLKHEN 70

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           V+ L+  C             +        H L        +       E       +  
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQMLLN 128

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-------MALTGTFV 368
            + Y+H  K  ++HRD+K +N+ +     +++ADFG AR  S  +            T  
Sbjct: 129 GLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 369 YMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP 427
           Y  PE++  E  Y    D++  G I+ E+ T +        +     +    G + P + 
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 428 EEDGQLRELIELICLSWDGDASVRPSFSSITCS 460
                  EL E + L       V+    +    
Sbjct: 247 PNVDNY-ELYEKLELVKGQKRKVKDRLKAYVRD 278

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 5e-32
 Identities = 57/273 (20%), Positives = 98/273 (35%), Gaps = 26/273 (9%)

Query: 198 DLQEKIGQGTTANIYRAI-----WRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR 252
           +L + +G G    ++          G   A+K +                 E   L   R
Sbjct: 27  ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86

Query: 253 HR-FVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
              F++ L  A         ++  + G  L   L          +        E      
Sbjct: 87  QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---------QRERFTE-HEVQIYVG 136

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT----GTF 367
           EI  A+++LH+    +I+RD+K  NI LD   HV + DFG ++     E        GT 
Sbjct: 137 EIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 368 VYMAPEVIQC--EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA 425
            YMAP++++     + +  D +S G+++ E++TG  P+     K ++  +     K  P 
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 254

Query: 426 LPEEDGQLRELIELICLSWDGDASVRPSFSSIT 458
            P+E        +LI      D   R       
Sbjct: 255 YPQEMSA--LAKDLIQRLLMKDPKKRLGCGPRD 285

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 9e-32
 Identities = 51/227 (22%), Positives = 94/227 (41%), Gaps = 29/227 (12%)

Query: 194 PKEID--LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS 249
           P+E+     + IG G+   +Y+A     G  VA+K +  D          F  +E+  + 
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD--------KRFKNRELQIMR 68

Query: 250 RQRHRFVLQLMGACLEPPYRG-----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFE 304
           +  H  +++L         +       LV + +  T+          ++        P  
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT------LPVI 122

Query: 305 ERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGEMAL 363
                  ++ +++ Y+H     + HRD+KP N+ LD D   +++ DFG A+ L  GE  +
Sbjct: 123 YVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180

Query: 364 TGTFV--YMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKD 407
           +      Y APE+I     Y+   DV+S G +L E++ G   +    
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  118 bits (295), Expect = 9e-31
 Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 21/275 (7%)

Query: 198 DLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
              EKIG+GT   +Y+A    G   A+K I  +    +E   +   +E+  L   +H  +
Sbjct: 5   HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLE--KEDEGIPSTTIREISILKELKHSNI 62

Query: 257 LQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQA 316
           ++L            LV E L   LK+ L        +  +          +  L++   
Sbjct: 63  VKLYDVIHTKKRL-VLVFEHLDQDLKKLLD-----VCEGGL----ESVTAKSFLLQLLNG 112

Query: 317 MQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGT---FVYMAPE 373
           + Y H+++  V+HRDLKP N+ ++    ++IADFG AR         T       Y AP+
Sbjct: 113 IAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPD 170

Query: 374 VIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQ 432
           V+   + YS   D++S G I  E++ G   +       A   M +      P        
Sbjct: 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRILGTPNSKNWPNV 228

Query: 433 LRELIELICLSWDGDASVRPSFSSITCSLKNIQMK 467
                     +             +  S  ++  K
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 2e-29
 Identities = 58/274 (21%), Positives = 104/274 (37%), Gaps = 23/274 (8%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
             + +G G    +  A+    G  VA+K +Y  F   +E       +E+  L   RH  V
Sbjct: 22  DLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENV 79

Query: 257 LQLMGACLEPPYRG-----WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           + L+               +LV   +GT L + +       + E++      +       
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-------KHEKL----GEDRIQFLVY 128

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           ++ + ++Y+H      IHRDLKP N+ +++   ++I DFG AR           T  Y A
Sbjct: 129 QMLKGLRYIHAAGI--IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRA 186

Query: 372 PEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           PEVI     Y++  D++S G I+ E+ITG   +   D+      +    G       +  
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246

Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                   +  L            ++ +    N+
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 5e-28
 Identities = 46/212 (21%), Positives = 85/212 (40%), Gaps = 20/212 (9%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRF 255
           +  EKIG+GT   +++A  R     VA+K +  D    +E   +   +E+  L   +H+ 
Sbjct: 5   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLLKELKHKN 62

Query: 256 VLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQ 315
           +++L            +         K +    G              E   +   ++ +
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP----------EIVKSFLFQLLK 112

Query: 316 AMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALT---GTFVYMAP 372
            + + H +   V+HRDLKP N+ ++    +++A+FG AR         +    T  Y  P
Sbjct: 113 GLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170

Query: 373 EVIQCEP-YSEKSDVYSFGIILNEIITGNHPY 403
           +V+     YS   D++S G I  E+     P 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (272), Expect = 3e-27
 Identities = 49/215 (22%), Positives = 87/215 (40%), Gaps = 31/215 (14%)

Query: 198 DLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSR-QRHR 254
            L  K+G+G  + ++ AI       V VK + P              +E+  L   +   
Sbjct: 38  QLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-------KKKIKREIKILENLRGGP 90

Query: 255 FVLQLMGACLEPPYRG-WLVTELL-GTTLKEWLHGLGSQRRKERMVPLPPFEERLARALE 312
            ++ L     +P  R   LV E +  T  K+    L     +  M              E
Sbjct: 91  NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-------------YE 137

Query: 313 IAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIADFGHARFLSDGE--MALTGTFVY 369
           I +A+ Y H     ++HRD+KP N+ +D + + +R+ D+G A F   G+       +  +
Sbjct: 138 ILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYF 195

Query: 370 MAPEV-IQCEPYSEKSDVYSFGIILNEIITGNHPY 403
             PE+ +  + Y    D++S G +L  +I    P+
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  109 bits (272), Expect = 6e-27
 Identities = 42/226 (18%), Positives = 84/226 (37%), Gaps = 20/226 (8%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
           L  K+G G  + ++ A        VA+K +  D  +T          E+  L R      
Sbjct: 17  LVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-----AEDEIKLLQRVNDADN 71

Query: 257 LQLMGACLEPPYRGWLVTE------LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARA 310
            +          +            +    + E L        K+      P       +
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 311 LEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK------HVRIADFGHARFLSDGEMALT 364
            ++   + Y+H ++  +IH D+KP N+ ++          ++IAD G+A +  +      
Sbjct: 132 KQLLLGLDYMH-RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190

Query: 365 GTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP 410
            T  Y +PEV+   P+   +D++S   ++ E+ITG+  +   +   
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 2e-26
 Identities = 58/274 (21%), Positives = 103/274 (37%), Gaps = 13/274 (4%)

Query: 194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ 251
           P+       +G G   ++  A     GL VAVK +   F   +        +E+  L   
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHM 74

Query: 252 RHRFVLQLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           +H  V+ L+            + E     L   L G        +   L     +     
Sbjct: 75  KHENVIGLLDVFTPARS----LEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIY- 128

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTGTFVYMA 371
           +I + ++Y+H     +IHRDLKPSN+ +++   ++I DFG AR   D       T  Y A
Sbjct: 129 QILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 186

Query: 372 PEVI-QCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED 430
           PE++     Y++  D++S G I+ E++TG   +   D+      +    G     L ++ 
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246

Query: 431 GQLRELIELICLSWDGDASVRPSFSSITCSLKNI 464
                   +  L+     +    F        ++
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 5e-26
 Identities = 57/240 (23%), Positives = 92/240 (38%), Gaps = 25/240 (10%)

Query: 199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFV 256
             + IG G    +  A       +VA+K +   F   N+       +E+  +    H+ +
Sbjct: 21  NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF--QNQTHAKRAYRELVLMKCVNHKNI 78

Query: 257 LQLMGAC-----LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARAL 311
           + L+        LE     +LV EL+   L + +                  E       
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME------------LDHERMSYLLY 126

Query: 312 EIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMA--LTGTFVY 369
           ++   +++LH      IHRDLKPSNI +     ++I DFG AR      M      T  Y
Sbjct: 127 QMLCGIKHLHSAGI--IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYY 184

Query: 370 MAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEE 429
            APEVI    Y E  D++S G I+ E++     +  +DY      +    G   P   ++
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.4 bits (187), Expect = 8e-17
 Identities = 27/215 (12%), Positives = 69/215 (32%), Gaps = 39/215 (18%)

Query: 197 ID-LQEKIGQGTTANIYRAI-WRGLDVAVKCIYPD------FFHTNENAVTFFAQEVDTL 248
           +D + + +G+G  + ++     +  +  VK                +     F+      
Sbjct: 1   VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 249 SRQRHRFVLQLMGACLEPPY---RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEE 305
           +R   R + +L G  +   Y      ++ EL+       +                   +
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVR--------------VENPD 106

Query: 306 RLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEMALTG 365
            +     I + +   + +   ++H DL   N+ + + + + I DF  +  + + E     
Sbjct: 107 EVLD--MILEEVAKFYHRG--IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGE-EGWR-- 158

Query: 366 TFVYMAPEVIQ---CEPYSEKSDVYSFGIILNEII 397
             +      I       Y  + D+ S    ++ I+
Sbjct: 159 EILERDVRNIITYFSRTYRTEKDINS---AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	472
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.49
d2oq1a1	130	Tyrosine-protein kinase zap-70 {Human (Homo sapien	98.44
d1i3za_	103	Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus	98.11
d1a81a1	129	Syk tyrosine kinase {Human (Homo sapiens) [TaxId:	98.01
d1qcfa2	103	Hemopoetic cell kinase Hck {Human (Homo sapiens) [	98.01
d1rjaa_	100	Tyrosine-protein kinase 6 (Breast tumor kinase, Br	97.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d1d4ta_	104	The Xlp protein Sap {Human (Homo sapiens) [TaxId:	97.8
d2oq1a2	124	Tyrosine-protein kinase zap-70 {Human (Homo sapien	97.77
d1lkka_	105	p56-lck tyrosine kinase {Human (Homo sapiens) [Tax	97.71
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.71
d1a81a2	125	Syk tyrosine kinase {Human (Homo sapiens) [TaxId:	97.7
d1opka2	101	Abl tyrosine kinase {Mouse (Mus musculus) [TaxId:	97.68
d1nrva_	105	Growth factor receptor-bound protein 10, GRB10 {Hu	97.66
d1k9aa2	101	Carboxyl-terminal src kinase (csk) {Human (Homo sa	97.62
d1blja_	114	P55 Blk protein tyrosine kinase {Mouse (Mus muscul	97.59
d1o48a_	106	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	97.56
d1jwoa_	97	Csk homologous kinase Chk {Human (Homo sapiens) [T	97.53
d2qmsa1	113	Growth factor receptor-bound protein 7 {Human (Hom	97.53
d1jyra_	96	Growth factor receptor-bound protein 2 (GRB2) {Hum	97.45
d1r1qa_	97	GRB2-related adaptor protein 2 (MONA, GRID) {Mouse	97.38
d2shpa2	109	Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T	97.36
d2eyva1	109	Crk proto-oncogen {Human (Homo sapiens) [TaxId: 96	97.2
d1rpya_	86	Adaptor protein Aps {Rat (Rattus norvegicus) [TaxI	96.99
d1luia_	108	Itk/tsk protein tyrosine kinase {Mouse (Mus muscul	96.97
d1g83a2	104	Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId:	96.96
d1qada_	107	Phosphatidylinositol 3-kinase, p85-alpha subunit {	96.6
d2cs0a1	106	Hematopoietic SH2 domain containing protein HSH2D	96.53
d2izva2	112	Suppressor of cytokine signaling 4, SOCS-4 {Human	96.5
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.46
d2fcia1	105	Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId:	96.39
d1mila_	104	Shc adaptor protein {Human (Homo sapiens) [TaxId:	96.31
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.1
d2c9wa2	103	Suppressor of cytokine signaling 2, SOCS-2 {Human	96.09
d1fu6a_	111	Phosphatidylinositol 3-kinase, p85-alpha subunit {	96.05
d2shpa3	108	Tyrosine phoshatase shp-2 {Human (Homo sapiens) [T	95.92
d1xa6a2	141	Beta-chimaerin, N-terminal domain {Human (Homo sap	95.83
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.52
d1uura3	131	STAT homologue {Dictyostelium discoideum [TaxId: 4	92.1

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-56  Score=434.18  Aligned_cols=265  Identities=34%  Similarity=0.550  Sum_probs=220.3

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      ..|+|+.++|++.+.||+|+||.||+|.+++ .||||+++....  +....+.|.+|+.+|++++|||||+++|++.+ +
T Consensus         1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~   76 (276)
T d1uwha_           1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAP--TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-P   76 (276)
T ss_dssp             CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSC--CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-c
Confidence            3699999999999999999999999998765 599999976533  44567789999999999999999999998754 5


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+||+.+|+|.+++...+.         ..++..++.++.||+.||+|||+++  ||||||||+||||+.++.+||
T Consensus        77 ~~~lv~Ey~~~g~L~~~l~~~~~---------~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl  145 (276)
T d1uwha_          77 QLAIVTQWCEGSSLYHHLHIIET---------KFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKI  145 (276)
T ss_dssp             SCEEEEECCCEEEHHHHHHTSCC---------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEE
T ss_pred             EEEEEEecCCCCCHHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEE
Confidence            67899999999999999964332         2457889999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCc-----cccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          348 ADFGHARFLSDGE-----MALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       348 ~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +|||+|+......     ....||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+.+. ...+...+..
T Consensus       146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~  224 (276)
T d1uwha_         146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGR  224 (276)
T ss_dssp             CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHH
T ss_pred             ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhc
Confidence            9999998765322     23568999999999864   3589999999999999999999999987653 3344555555


Q ss_pred             CCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       420 ~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      +...+.++.. ..++.++.++|.+||+.||++||||++|++.|+.+.+.+
T Consensus       225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            5544444332 456678999999999999999999999999999988764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-54  Score=425.02  Aligned_cols=262  Identities=27%  Similarity=0.445  Sum_probs=219.7

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      +....|+|+.++|++.++||+|+||+||+|.++  |..||||+++.+.     ...+.|.+|+.+|+.++|||||+++|+
T Consensus         7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (287)
T d1opja_           7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-----MEVEEFLKEAAVMKEIKHPNLVQLLGV   81 (287)
T ss_dssp             TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-----SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-----chHHHHHHHHHHHHhCCCCCEecCCcc
Confidence            445679999999999999999999999999996  7789999987542     224569999999999999999999999


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      |.+.+..++++||+.+|+|.+++.....        ...++..++.++.||+.||+|||++|  ||||||||+||||+++
T Consensus        82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~--------~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~  151 (287)
T d1opja_          82 CTREPPFYIITEFMTYGNLLDYLRECNR--------QEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGEN  151 (287)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHSCT--------TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGG
T ss_pred             EeeCCeeEEEeecccCcchHHHhhhccc--------cchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCC
Confidence            9999999999999999999999964322        23457888999999999999999999  9999999999999999


Q ss_pred             CcEEEeecccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          343 KHVRIADFGHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +.+||+|||+|+.......    ...|++.|+|||++.+..|+.++|||||||++|||++|..||.... ....+...+.
T Consensus       152 ~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~-~~~~~~~~i~  230 (287)
T d1opja_         152 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLE  230 (287)
T ss_dssp             GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC-CHHHHHHHHH
T ss_pred             CcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc-hHHHHHHHHh
Confidence            9999999999987764432    2237899999999999999999999999999999999766654332 2444444444


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      .+ .++..|.  ..+.++.++|.+||..||++|||+++|++.|+.+.
T Consensus       231 ~~-~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         231 KD-YRMERPE--GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             TT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cC-CCCCCCc--cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            44 3544443  35567899999999999999999999999998763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=420.61  Aligned_cols=263  Identities=22%  Similarity=0.416  Sum_probs=224.0

Q ss_pred             ceeeCCCCeeEece-eeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEK-IGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~-LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .|.+.+++|.+.+. ||+|+||.||+|.++    +..||||+++..   ......+.|.+|+++|++++|||||+++|+|
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~   78 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG---TEKADTEEMMREAQIMHQLDNPYIVRLIGVC   78 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS---CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh---cCHHHHHHHHHHHHHHHhCCCCCEeeEeeee
Confidence            46788889999984 999999999999875    447999999764   3455677899999999999999999999998


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      .. +..++||||+.+|+|.+++.....         ..++..++.++.||+.||+|||+++  ||||||||+||||+.++
T Consensus        79 ~~-~~~~lvmE~~~~g~L~~~l~~~~~---------~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~  146 (285)
T d1u59a_          79 QA-EALMLVMEMAGGGPLHKFLVGKRE---------EIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRH  146 (285)
T ss_dssp             ES-SSEEEEEECCTTEEHHHHHTTCTT---------TSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETT
T ss_pred             cc-CeEEEEEEeCCCCcHHHHhhcccc---------CCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCC
Confidence            65 567899999999999999854321         2357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~  416 (472)
                      .+||+|||+|+.+....      ....||+.|+|||++....++.++|||||||++|||+| |..||.+.+  ..++...
T Consensus       147 ~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~--~~~~~~~  224 (285)
T d1u59a_         147 YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK--GPEVMAF  224 (285)
T ss_dssp             EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--THHHHHH
T ss_pred             ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC--HHHHHHH
Confidence            99999999999876432      23457999999999999999999999999999999998 999998766  4556677


Q ss_pred             HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHhhc
Q 039082          417 VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVTET  471 (472)
Q Consensus       417 i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~~~  471 (472)
                      +..+. ++..|.  ..+.++.++|.+||+.||++||||.+|.+.|+.++..+..+
T Consensus       225 i~~~~-~~~~p~--~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~  276 (285)
T d1u59a_         225 IEQGK-RMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  276 (285)
T ss_dssp             HHTTC-CCCCCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHcCC-CCCCCC--cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence            77765 444544  35568889999999999999999999999999988777654

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=415.45  Aligned_cols=254  Identities=28%  Similarity=0.477  Sum_probs=208.9

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      |++++|++.+.||+|+||.||+|.++ +..||||+++.+..     ..+.|.+|+.+|+.++|||||+++|+|..++..+
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            67889999999999999999999996 66899999875422     2346899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|+||+.+|+|.+++....         ...++..++.++.|||.||+|||+++  |+||||||+||||++++.+||+||
T Consensus        77 lv~E~~~~g~L~~~l~~~~---------~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DF  145 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQR---------GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDF  145 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTT---------TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSC
T ss_pred             EEEEecCCCcHHHHhhccc---------cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEeccc
Confidence            9999999999999986432         22457888999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          351 GHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       351 Gla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |+++.......    ...||+.|+|||++.+..|+.++|||||||++|||+| |..||...+  ...+...+..+. ++.
T Consensus       146 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~--~~~~~~~i~~~~-~~~  222 (263)
T d1sm2a_         146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--NSEVVEDISTGF-RLY  222 (263)
T ss_dssp             C------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC--HHHHHHHHHHTC-CCC
T ss_pred             chheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC--HHHHHHHHHhcC-CCC
Confidence            99987754322    3457999999999999999999999999999999999 566665544  556666676664 443


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .|.  .++.++.++|.+||+.||++|||+++|++.|+++.+
T Consensus       223 ~p~--~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         223 KPR--LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Ccc--ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            443  345678899999999999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-54  Score=416.41  Aligned_cols=260  Identities=26%  Similarity=0.442  Sum_probs=219.0

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ....|+|+.++|++.++||+|+||.||+|.++ +..||||+++.+.     ...+.|.+|+.+|++++|||||+++|++.
T Consensus         4 ~~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_           4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-----MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-----SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-----CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            45689999999999999999999999999997 5689999997542     22356999999999999999999999875


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      + +..++||||+.+|+|.+++......        ..++..++.++.||+.||.|||+++  |+||||||+||||++++.
T Consensus        79 ~-~~~~iv~Ey~~~g~L~~~~~~~~~~--------~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~  147 (272)
T d1qpca_          79 Q-EPIYIITEYMENGSLVDFLKTPSGI--------KLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLS  147 (272)
T ss_dssp             S-SSCEEEEECCTTCBHHHHTTSHHHH--------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSC
T ss_pred             c-CCeEEEEEeCCCCcHHHHHhhcCCC--------CCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccc
Confidence            4 5678999999999999988543321        1357889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHhc
Q 039082          345 VRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN-HPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       345 vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~-~Pf~~~~~~~~~i~~~i~~  419 (472)
                      +||+|||+|+......    ....||+.|+|||++....|+.++|||||||++|||+||. .||...+  ...+...+..
T Consensus       148 ~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~~  225 (272)
T d1qpca_         148 CKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLER  225 (272)
T ss_dssp             EEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT
T ss_pred             eeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC--HHHHHHHHHh
Confidence            9999999999876543    2345789999999999889999999999999999999954 4554444  5566666666


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +. ++..|.  ..+.++.++|.+||+.||++|||+++|++.|+++..
T Consensus       226 ~~-~~~~p~--~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         226 GY-RMVRPD--NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             TC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC-CCCCcc--cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            54 444443  355678899999999999999999999999999865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.3e-53  Score=420.09  Aligned_cols=259  Identities=24%  Similarity=0.382  Sum_probs=212.7

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--C---eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--G---LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g---~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ++++.++|++.+.||+|+||.||+|.++  |   ..||||.+...   ......+.|.+|+.+|+.++|||||+++|+|.
T Consensus        21 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   97 (299)
T d1jpaa_          21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG---YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT   97 (299)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence            4677889999999999999999999985  2   25889988654   34556678999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +.+..++||||+.+|+|.+++.....         ..++..++.++.||+.||+|||+++  ||||||||+||||+.++.
T Consensus        98 ~~~~~~iv~Ey~~~g~L~~~~~~~~~---------~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~  166 (299)
T d1jpaa_          98 KSTPVMIITEFMENGSLDSFLRQNDG---------QFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLV  166 (299)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHTTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCC
T ss_pred             eCCEEEEEEEecCCCcceeeeccccC---------CCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCc
Confidence            99999999999999999998864321         2457889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCcc--------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHH
Q 039082          345 VRIADFGHARFLSDGEM--------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAM  415 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~--------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~  415 (472)
                      +||+|||+|+.+.....        ...||+.|+|||.+.+..|+.++|||||||++|||+| |..||.+.+  ..++..
T Consensus       167 ~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~  244 (299)
T d1jpaa_         167 CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVIN  244 (299)
T ss_dssp             EEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHH
T ss_pred             EEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHH
Confidence            99999999987654321        1346899999999999999999999999999999998 899998766  566777


Q ss_pred             HHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          416 EVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       416 ~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .+..+. +++.|  ...+..+.++|.+||+.||++|||+.+|++.|+++.++
T Consensus       245 ~i~~~~-~~~~~--~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         245 AIEQDY-RLPPP--MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHcCC-CCCCC--ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            776664 33333  34567789999999999999999999999999988764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-54  Score=426.89  Aligned_cols=266  Identities=25%  Similarity=0.377  Sum_probs=216.4

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQL  259 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l  259 (472)
                      ..|+|++++|++.++||+|+||+||+|++++       ..||||.+....   .......|.+|+.+|.++ +|||||++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA---DSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC---------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc---CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            4699999999999999999999999999853       259999986542   334456689999999998 89999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccc-------------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR-------------KERMVPLPPFEERLARALEIAQAMQYLHEQKPK  326 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~-------------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~  326 (472)
                      +++|.+.+..++|+||+.+|+|.++|........             ........++..++.++.||+.||+|||+++  
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--  184 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--  184 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            9999999999999999999999999975432110             0111234568889999999999999999999  


Q ss_pred             eeecCCCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CC
Q 039082          327 VIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GN  400 (472)
Q Consensus       327 iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~  400 (472)
                      ||||||||+|||++.++.+||+|||+|+.......     ...||+.|+|||++.+..|+.++|||||||++|||+| |.
T Consensus       185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~  264 (325)
T d1rjba_         185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV  264 (325)
T ss_dssp             EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred             eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence            99999999999999999999999999987654322     3447999999999999999999999999999999998 99


Q ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHH
Q 039082          401 HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLK  462 (472)
Q Consensus       401 ~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~  462 (472)
                      .||.+.+...  ....+..+..++..|.  ..+.++.++|.+||+.||++|||+++|++.|.
T Consensus       265 ~Pf~~~~~~~--~~~~~~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         265 NPYPGIPVDA--NFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSSTTCCCSH--HHHHHHHTTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCHHH--HHHHHHhcCCCCCCCC--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            9998766432  3334444444555544  34567899999999999999999999999885

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-54  Score=414.13  Aligned_cols=257  Identities=29%  Similarity=0.479  Sum_probs=213.9

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-C
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-P  267 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-~  267 (472)
                      +|+|+.++|++.+.||+|+||.||+|.++|+.||||+++.+      ...+.|.+|+++|++++|||||+++|+|.++ +
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~------~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC------C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH------HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            69999999999999999999999999999999999999653      2335689999999999999999999998764 5


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..++|+||+.+|+|.+++......        ..++..++.++.||+.||.|||+++  |+||||||+|||++.+|.+||
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~--------~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl  144 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRS--------VLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKV  144 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHH--------HCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEE
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCC--------CCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEee
Confidence            578999999999999999653321        1247889999999999999999999  999999999999999999999


Q ss_pred             eecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          348 ADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       348 ~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      +|||+++..........+++.|+|||++.+..++.++|||||||++|||+| |+.||...+  ...+...+..+. ++.+
T Consensus       145 ~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~--~~~~~~~i~~~~-~~~~  221 (262)
T d1byga_         145 SDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP--LKDVVPRVEKGY-KMDA  221 (262)
T ss_dssp             CCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC--GGGHHHHHTTTC-CCCC
T ss_pred             cccccceecCCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHcCC-CCCC
Confidence            999999988776667778999999999999999999999999999999998 788887765  445666776665 5555


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      |..  .+.++.++|.+||..||++|||+.+|++.|+.++.
T Consensus       222 ~~~--~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         222 PDG--CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             CTT--CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             Ccc--CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            543  44678899999999999999999999999998865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=412.42  Aligned_cols=250  Identities=24%  Similarity=0.394  Sum_probs=214.1

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      .|.+  ++|++.+.||+|+||.||+|+++  |..||||++.+.... .......+.+|+.+|+.++|||||++++++.++
T Consensus         2 ~~~l--~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~   78 (263)
T d2j4za1           2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLE-KAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   78 (263)
T ss_dssp             CCCG--GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             Ccch--hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHcc-ChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC
Confidence            3544  68999999999999999999996  678999998654321 223456688999999999999999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++||||+.+|+|.+++...+.          .+...++.++.||+.||+|||++|  ||||||||+||||+.++.+|
T Consensus        79 ~~~~ivmEy~~~g~L~~~l~~~~~----------l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~k  146 (263)
T d2j4za1          79 TRVYLILEYAPLGTVYRELQKLSK----------FDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELK  146 (263)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEE
T ss_pred             CEEEEEEeecCCCcHHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEe
Confidence            999999999999999999965332          346789999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          347 IADFGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       347 L~DFGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |+|||+|...... .....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+  ...+...+..+..  .
T Consensus       147 l~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~--~  222 (263)
T d2j4za1         147 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--YQETYKRISRVEF--T  222 (263)
T ss_dssp             ECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHTTCC--C
T ss_pred             ecccceeeecCCCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--HHHHHHHHHcCCC--C
Confidence            9999999877644 345679999999999999999999999999999999999999997765  5666666666542  3


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +|.  ..+.++.++|.+||..||++|||++++++
T Consensus       223 ~p~--~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 FPD--FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCc--cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            333  34567888999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-53  Score=412.11  Aligned_cols=258  Identities=24%  Similarity=0.420  Sum_probs=213.6

Q ss_pred             eCCCCeeEe-ceeeccCceEEEEEEEC----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQ-EKIGQGTTANIYRAIWR----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~-~~LG~G~fG~Vy~a~~~----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      ++.+.+.+. ++||+|+||.||+|.++    ++.||||+++.+..  +....+.|.+|+++|++++|||||+++|+|.. 
T Consensus         3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-   79 (277)
T d1xbba_           3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN--DPALKDELLAEANVMQQLDNPYIVRMIGICEA-   79 (277)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-
T ss_pred             echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC--CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-
Confidence            344445554 57999999999999874    35799999976532  34556789999999999999999999999865 


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      +..++||||+.+|+|.+++....          ..++..++.++.||+.||+|||+++  ||||||||+||||+.++.+|
T Consensus        80 ~~~~lvmE~~~~g~L~~~l~~~~----------~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~k  147 (277)
T d1xbba_          80 ESWMLVMEMAELGPLNKYLQQNR----------HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAK  147 (277)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHCT----------TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEE
T ss_pred             CCEEEEEEcCCCCcHHHHHhhcc----------CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCccc
Confidence            56789999999999999986433          2357889999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhc
Q 039082          347 IADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       347 L~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      |+|||+|+.......      ...||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+  ..++...+..
T Consensus       148 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--~~~~~~~i~~  225 (277)
T d1xbba_         148 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--GSEVTAMLEK  225 (277)
T ss_dssp             ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT
T ss_pred             ccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--HHHHHHHHHc
Confidence            999999997754322      2458999999999999999999999999999999998 999998766  5667777777


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHHh
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKVT  469 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~~  469 (472)
                      +. ++..|.  .++.++.++|.+||+.||++|||+++|.+.|+.+..++.
T Consensus       226 ~~-~~~~p~--~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~  272 (277)
T d1xbba_         226 GE-RMGCPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  272 (277)
T ss_dssp             TC-CCCCCT--TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CC-CCCCCc--ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhcC
Confidence            65 444444  355678899999999999999999999999998876654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=414.00  Aligned_cols=246  Identities=25%  Similarity=0.379  Sum_probs=209.0

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++.++||+|+||.||+|.++  |..||||+++....    ...+.+.+|+.+|+.++|||||++++++.+++..|+
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   94 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ----PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC----SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC----hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence            357999999999999999999986  88999999975422    234568999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ||||+.||+|.+++....           .+...++.++.||+.||+|||++|  ||||||||+||||+.+|.+||+|||
T Consensus        95 vmEy~~gg~L~~~~~~~~-----------l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG  161 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTETC-----------MDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFG  161 (293)
T ss_dssp             EEECCTTCBHHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCT
T ss_pred             EEEecCCCcHHHHhhccC-----------CCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccch
Confidence            999999999999875421           346789999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      +|+.+...   ....+||+.|+|||++.+..|+.++|||||||++|+|+||..||.+.+  .......+..+. .+.++.
T Consensus       162 ~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~~~~~~-~~~~~~  238 (293)
T d1yhwa1         162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--PLRALYLIATNG-TPELQN  238 (293)
T ss_dssp             TCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHHC-SCCCSS
T ss_pred             hheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--HHHHHHHHHhCC-CCCCCC
Confidence            99987533   334569999999999999999999999999999999999999997765  444444444332 222333


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+..+.++|.+||..||++|||++++++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3445678899999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-53  Score=406.79  Aligned_cols=251  Identities=25%  Similarity=0.462  Sum_probs=216.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      +++++|++.++||+|+||+||+|+++ +..||||+++++..     ..+.|.+|+.++++++|||||+++|+|.+++..+
T Consensus         1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            46789999999999999999999997 56899999986532     2346899999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +|+||+.+|+|..++.....         ..++..++.++.|++.||+|||++|  |+||||||+||||++++.+||+||
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~Df  144 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH---------RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDF  144 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG---------CCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCC
T ss_pred             EEEEccCCCcHHHhhhcccc---------CCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcc
Confidence            99999999999999754332         2346788999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCCcc----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          351 GHARFLSDGEM----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       351 Gla~~~~~~~~----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |+++.......    ...||+.|+|||.+.+..|+.++|||||||++|||+| |+.||.+.+  ..++...+..+. ++.
T Consensus       145 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--~~~~~~~i~~~~-~~~  221 (258)
T d1k2pa_         145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--NSETAEHIAQGL-RLY  221 (258)
T ss_dssp             SSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--HHHHHHHHHTTC-CCC
T ss_pred             hhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--HHHHHHHHHhCC-CCC
Confidence            99987654322    3457999999999999999999999999999999998 899998776  666777777765 444


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKN  463 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~  463 (472)
                      .|.  ..+..+.++|.+||+.||++||||++|++.|.+
T Consensus       222 ~p~--~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         222 RPH--LASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             Ccc--cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            444  345678899999999999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=408.00  Aligned_cols=259  Identities=22%  Similarity=0.350  Sum_probs=212.4

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEECC------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWRG------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~g------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      +|++++|++.+.||+|+||.||+|.+++      ..||||+++..   ..+.....|.+|+.+|+.++|||||+++|++.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG---YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc---cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            5778899999999999999999998763      36999999654   34455667999999999999999999999999


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +.+..++|+|++.+++|.+++.....         ..++..++.++.||+.||+|||+++  |+||||||+||||+.++.
T Consensus        80 ~~~~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~  148 (283)
T d1mqba_          80 KYKPMMIITEYMENGALDKFLREKDG---------EFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLV  148 (283)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHHTTT---------CSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCC
T ss_pred             cCCceEEEEEecccCcchhhhhcccc---------cccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCe
Confidence            99999999999999999988754321         2457889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCc------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh
Q 039082          345 VRIADFGHARFLSDGE------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       345 vkL~DFGla~~~~~~~------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +||+|||+|+......      ....||+.|+|||++.+..|+.++|||||||++|||++|..||.... ....+...+.
T Consensus       149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~-~~~~~~~~i~  227 (283)
T d1mqba_         149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL-SNHEVMKAIN  227 (283)
T ss_dssp             EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC-CHHHHHHHHH
T ss_pred             EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC-CHHHHHHHHh
Confidence            9999999998765432      12347999999999999999999999999999999999655554332 2556666666


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      .+. ++..|.  ..+..+.++|.+||+.||++|||+.+|++.|+++.+.
T Consensus       228 ~~~-~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         228 DGF-RLPTPM--DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             TTC-CCCCCT--TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ccC-CCCCch--hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            664 444443  3556789999999999999999999999999988764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-53  Score=410.91  Aligned_cols=247  Identities=22%  Similarity=0.277  Sum_probs=202.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||+||+|+++  |..||||++.....   .+..+.|.+|+.+|+.++|||||++++++.+++..++|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA---VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc---chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            58999999999999999999986  78999999976432   23345689999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      |||+.||+|.+++...+          ..++..++.++.||+.||+|||++|  ||||||||+|||+++++.+||+|||+
T Consensus        82 mEy~~gg~L~~~l~~~~----------~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~  149 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGL  149 (271)
T ss_dssp             EECCTTEEGGGGSBTTT----------BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTT
T ss_pred             EeccCCCcHHHHHhcCC----------CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchh
Confidence            99999999999985432          2357888999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC-----ccccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          353 ARFLSDG-----EMALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       353 a~~~~~~-----~~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      |+.....     ....+||+.|+|||++.+..+ +.++|||||||++|||+||+.||..................   ..
T Consensus       150 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~---~~  226 (271)
T d1nvra_         150 ATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YL  226 (271)
T ss_dssp             CEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT---TS
T ss_pred             heeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC---CC
Confidence            9976532     234579999999999988876 57899999999999999999999766543333322222221   12


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +.....+.++.++|.+||..||++|||++++++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            222345567889999999999999999999865

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=409.39  Aligned_cols=252  Identities=26%  Similarity=0.355  Sum_probs=203.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc--CCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE--PPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~--~~~~~  270 (472)
                      ++|++++.||+|+||.||+|+++  |+.||||++.....  ++...+.|.+|+.+|+.++|||||++++++.+  ....+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   81 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM--TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   81 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS--CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC--CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence            68999999999999999999986  78999999977543  45567789999999999999999999999875  34578


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcC---CceeecCCCCCcEEEcCCCcEEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQK---PKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~---~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      +||||+.||+|.+++......      ....++..++.++.||+.||.|||+++   .+||||||||+||||+.++.+||
T Consensus        82 ivmEy~~~g~L~~~i~~~~~~------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl  155 (269)
T d2java1          82 IVMEYCEGGDLASVITKGTKE------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL  155 (269)
T ss_dssp             EEEECCTTEEHHHHHHHHHHH------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEE
T ss_pred             EEEecCCCCcHHHHHHhcccc------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEE
Confidence            899999999999999653321      122357889999999999999999865   24999999999999999999999


Q ss_pred             eecccceecCCCc---cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSDGE---MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~~~---~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +|||+|+.+....   ....||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+  ..++...+..+... 
T Consensus       156 ~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--~~~~~~~i~~~~~~-  232 (269)
T d2java1         156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--QKELAGKIREGKFR-  232 (269)
T ss_dssp             CCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHTCCC-
T ss_pred             eeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--HHHHHHHHHcCCCC-
Confidence            9999998876432   34578999999999999999999999999999999999999997765  66777777777643 


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .+|.  ..+.++.++|.+||..||++|||+++|++
T Consensus       233 ~~~~--~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 RIPY--RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             CCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCc--ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            2332  34567889999999999999999999875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=407.65  Aligned_cols=260  Identities=24%  Similarity=0.405  Sum_probs=211.6

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .|+|++++|++.+.||+|+||.||+|.+.     +..||||.++..   ......+.|.+|+.+|++++|||||+++|++
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~   77 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC---TSDSVREKFLQEALTMRQFDHPHIVKLIGVI   77 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT---TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            49999999999999999999999999885     245888888543   3456667899999999999999999999998


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      . ++..++|+|++.+|+|.+++.....         ..++..++.++.||+.||+|||+++  +|||||||+|||++.++
T Consensus        78 ~-~~~~~iv~E~~~~g~l~~~~~~~~~---------~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~  145 (273)
T d1mp8a_          78 T-ENPVWIIMELCTLGELRSFLQVRKY---------SLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSND  145 (273)
T ss_dssp             C-SSSCEEEEECCTTEEHHHHHHHTTT---------TSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETT
T ss_pred             e-cCeEEEEEEeccCCcHHhhhhccCC---------CCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCC
Confidence            5 5678899999999999998754321         2357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          344 HVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      .+||+|||+|+......    ....||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+  ..++...+.
T Consensus       146 ~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~--~~~~~~~i~  223 (273)
T d1mp8a_         146 CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK--NNDVIGRIE  223 (273)
T ss_dssp             EEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC--GGGHHHHHH
T ss_pred             cEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCC--HHHHHHHHH
Confidence            99999999998765332    23457999999999999999999999999999999998 899998766  455666677


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+. ++.+|.  ..+..+.++|.+||..||++|||+.+|++.|+++.++-
T Consensus       224 ~~~-~~~~~~--~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         224 NGE-RLPMPP--NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             TTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cCC-CCCCCC--CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            765 333433  45667899999999999999999999999999987653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-53  Score=413.42  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=210.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.|++++.||+|+||.||+|+++  |..||||++...    .....+.|.+|+++|+.++|||||++++++.+++..++|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lv   87 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK----SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   87 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS----SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC----CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEE
Confidence            46899999999999999999986  678999999754    233455688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      |||+.||+|.+++.....         ..+...+..++.||+.||.|||++|  ||||||||+||||+.+|.+||+|||+
T Consensus        88 mEy~~~g~L~~~~~~~~~---------~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~  156 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELER---------PLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGV  156 (288)
T ss_dssp             EECCTTEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             EecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechh
Confidence            999999999999854321         2356789999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCC---ccccccCCccccccccc-----CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          353 ARFLSDG---EMALTGTFVYMAPEVIQ-----CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       353 a~~~~~~---~~~~~gt~~y~APE~~~-----~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+.....   ....+||+.|+|||++.     ...|+.++|||||||++|||+||+.||.+.+  ..++...+..+. .+
T Consensus       157 a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~--~~~~~~~i~~~~-~~  233 (288)
T d2jfla1         157 SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLKIAKSE-PP  233 (288)
T ss_dssp             CEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC--GGGHHHHHHHSC-CC
T ss_pred             hhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC--HHHHHHHHHcCC-CC
Confidence            9876532   23467999999999984     4568999999999999999999999998766  445666666654 23


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .++.....+.++.++|.+||..||++|||++++++
T Consensus       234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            33333456678999999999999999999999976

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.9e-53  Score=414.91  Aligned_cols=269  Identities=27%  Similarity=0.401  Sum_probs=224.5

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEECC-------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWRG-------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL  259 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g-------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l  259 (472)
                      ...|++++++|++.+.||+|+||+||+|+++|       ..||||+++.+   ......+.|.+|+.+|+.++||||+++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~il~~l~h~niv~~   81 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE---ASADMQADFQREAALMAEFDNPNIVKL   81 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT---CCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh---cChHHHHHHHHHHHHHHhcCCCCcccc
Confidence            34588999999999999999999999999864       57999998754   345567789999999999999999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccc--------------cccCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRR--------------KERMVPLPPFEERLARALEIAQAMQYLHEQKP  325 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~  325 (472)
                      +++|...+..+++++++.+|+|.+++........              ........++..++.++.|++.||+|||+++ 
T Consensus        82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~-  160 (301)
T d1lufa_          82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-  160 (301)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC-
Confidence            9999999999999999999999999975432111              0111223467889999999999999999999 


Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN  400 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~  400 (472)
                       +|||||||+||||+.++.+||+|||+|+......     ....|++.|+|||.+.+..|+.++|||||||++|||++|.
T Consensus       161 -ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         161 -FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             -CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             -eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence             9999999999999999999999999998664322     2345789999999999999999999999999999999975


Q ss_pred             -CCCCCCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          401 -HPYIEKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       401 -~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                       .||.+.+  ..++...+.++. ++..|.  ..+.++.++|.+||+.+|++||||.+|++.|+++.
T Consensus       240 ~~p~~~~~--~~e~~~~v~~~~-~~~~p~--~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMA--HEEVIYYVRDGN-ILACPE--NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSC--HHHHHHHHHTTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCC--HHHHHHHHHcCC-CCCCCc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             6786665  667777888876 444443  34567889999999999999999999999998864

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-52  Score=411.98  Aligned_cols=248  Identities=22%  Similarity=0.335  Sum_probs=199.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      +.|++.+.||+|+||+||+|.++  |..||||++.+....   .....+.+|+.+|+.++|||||++++++.+++..|+|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE---GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            56999999999999999999986  778999999765432   2335688999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc---CCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~---~~~~vkL~D  349 (472)
                      |||+.||+|.+++...+          ..+...+..++.||+.||+|||++|  ||||||||+|||+.   +++.+||+|
T Consensus        86 mE~~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~D  153 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKG----------FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISD  153 (307)
T ss_dssp             ECCCCSCBHHHHHHTCS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred             EeccCCCcHHHhhhccc----------CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEec
Confidence            99999999999996432          2357889999999999999999999  99999999999994   578999999


Q ss_pred             cccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 039082          350 FGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALP  427 (472)
Q Consensus       350 FGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~  427 (472)
                      ||+|+......  ...+||+.|+|||++.+..|+.++|||||||++|||++|..||.+..  .......+..+......+
T Consensus       154 FG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~  231 (307)
T d1a06a_         154 FGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--DAKLFEQILKAEYEFDSP  231 (307)
T ss_dssp             C------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHTTCCCCCTT
T ss_pred             cceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHhccCCCCCCc
Confidence            99998776443  34579999999999999999999999999999999999999998766  666777777776554444


Q ss_pred             CCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          428 EEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       428 ~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.++.++|.+||..||++|||++++++
T Consensus       232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            44556678999999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-52  Score=401.25  Aligned_cols=247  Identities=25%  Similarity=0.368  Sum_probs=204.4

Q ss_pred             eeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc----CCCce
Q 039082          197 IDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE----PPYRG  270 (472)
Q Consensus       197 ~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~----~~~~~  270 (472)
                      |++.++||+|+||+||+|.++  +..||+|++.....  .....+.|.+|+++|+.++|||||++++++..    ....+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL--TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            478889999999999999986  66899999976533  44556779999999999999999999999865    23467


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc-CCCcEEEee
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD-DAKHVRIAD  349 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~-~~~~vkL~D  349 (472)
                      +||||+.+|+|.+++.....          .++..++.++.||+.||+|||+++++||||||||+||||+ +++.+||+|
T Consensus        89 ivmE~~~~g~L~~~l~~~~~----------~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~D  158 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKV----------MKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGD  158 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             EEEeCCCCCcHHHHHhcccc----------ccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence            88999999999999965332          3467889999999999999999887799999999999996 578999999


Q ss_pred             cccceecCCC-ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          350 FGHARFLSDG-EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       350 FGla~~~~~~-~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      ||+|+..... ....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.. ....+...+..+..++.++ 
T Consensus       159 FGla~~~~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~-~~~~~~~~i~~~~~~~~~~-  235 (270)
T d1t4ha_         159 LGLATLKRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ-NAAQIYRRVTSGVKPASFD-  235 (270)
T ss_dssp             TTGGGGCCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS-SHHHHHHHHTTTCCCGGGG-
T ss_pred             cCcceeccCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc-cHHHHHHHHHcCCCCcccC-
Confidence            9999866543 345679999999999875 59999999999999999999999997654 2445556666654322222 


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       ....+++.++|.+||..||++|||++++++
T Consensus       236 -~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         236 -KVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             -GCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -ccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence             234456889999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=414.24  Aligned_cols=252  Identities=23%  Similarity=0.378  Sum_probs=206.7

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      |..++|+++++||+|+||.||+|+++  |..||||+++.+.   .......+.+|+.+|+.++|||||+++++|.+++..
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~---~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~   79 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI   79 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC---CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            55689999999999999999999986  7899999997652   334456789999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      ++||||+.||+|.+++.+.+.          .++..+..++.|++.||.|||+ +|  |+||||||+||||+.+|.+||+
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~~----------l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~  147 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAGR----------IPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLC  147 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEEC
T ss_pred             EEEEEcCCCCcHHHHHhhcCC----------CCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEe
Confidence            999999999999999965332          3468889999999999999997 48  9999999999999999999999


Q ss_pred             ecccceecCC-CccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH-----------
Q 039082          349 DFGHARFLSD-GEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME-----------  416 (472)
Q Consensus       349 DFGla~~~~~-~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~-----------  416 (472)
                      |||+|+...+ .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.........           
T Consensus       148 DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~  227 (322)
T d1s9ja_         148 DFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP  227 (322)
T ss_dssp             CCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred             eCCCccccCCCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence            9999987653 3345689999999999999999999999999999999999999997765332111100           


Q ss_pred             -----------------------------HhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          417 -----------------------------VGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       417 -----------------------------i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                                                   +... ..+.++. .....++.++|.+||..||++|||++++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE-PPPKLPS-GVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ------------------CCCCHHHHHHHHHTS-CCCCCCB-TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccccccchhHHHHHhhhhcc-CCccCcc-ccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                         0000 0111111 1234678899999999999999999999873

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=409.00  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=211.1

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      .+++|++.+.||+|+||.||+|.++  |..||||++.+... ..+.....+.+|+.+|++++|||||++++++.+++..|
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHI-IKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHc-cCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            3468999999999999999999986  77999999975432 12234567999999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeec
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADF  350 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DF  350 (472)
                      +||||+.||+|.+++...+.          .+...++.++.|++.||+|||++|  ||||||||+||||+++|.+||+||
T Consensus        85 ivmEy~~gg~L~~~~~~~~~----------l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DF  152 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGS----------FDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDF  152 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEccCCCCHHHhhhccCC----------CCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccc
Confidence            99999999999999875432          346788999999999999999999  999999999999999999999999


Q ss_pred             ccceecCCC-----ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCC
Q 039082          351 GHARFLSDG-----EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPA  425 (472)
Q Consensus       351 Gla~~~~~~-----~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~  425 (472)
                      |+|+.+...     ....+||+.|+|||++.+..|+.++|||||||++|||+||..||.+.+  ...+...+..+..  .
T Consensus       153 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~--~  228 (288)
T d1uu3a_         153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--EYLIFQKIIKLEY--D  228 (288)
T ss_dssp             TTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHTTCC--C
T ss_pred             ccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--HHHHHHHHHcCCC--C
Confidence            999987532     224569999999999999999999999999999999999999998765  6667777777653  3


Q ss_pred             CCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          426 LPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       426 l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +|.  ..+.++.++|.+||..||++|||+++++.
T Consensus       229 ~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 FPE--KFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            333  34567889999999999999999998754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-51  Score=407.46  Aligned_cols=246  Identities=23%  Similarity=0.248  Sum_probs=208.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      .|+++++||+|+||.||+|+++  |..||||++..... ......+.|.+|+.+|+.++|||||++++++.+++..++||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            4899999999999999999986  77899999976543 23455677999999999999999999999999999999999


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      ||+.+|+|..++...+          ..++..++.++.||+.||.|||++|  ||||||||+||||+.++.+||+|||+|
T Consensus        95 E~~~~g~l~~~~~~~~----------~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a  162 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK----------PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSA  162 (309)
T ss_dssp             ECCSEEHHHHHHHHTS----------CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTC
T ss_pred             EecCCCchHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccc
Confidence            9999999987664322          2357889999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCccccccCCcccccccccC---CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCc
Q 039082          354 RFLSDGEMALTGTFVYMAPEVIQC---EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEED  430 (472)
Q Consensus       354 ~~~~~~~~~~~gt~~y~APE~~~~---~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~  430 (472)
                      ..... .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+.+  .......+..+......+  .
T Consensus       163 ~~~~~-~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--~~~~~~~i~~~~~~~~~~--~  237 (309)
T d1u5ra_         163 SIMAP-ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--AMSALYHIAQNESPALQS--G  237 (309)
T ss_dssp             BSSSS-BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--HHHHHHHHHHSCCCCCSC--T
T ss_pred             cccCC-CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--HHHHHHHHHhCCCCCCCC--C
Confidence            87654 345679999999999864   458999999999999999999999998765  555666666655332222  3


Q ss_pred             hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          431 GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       431 ~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+..+.++|.+||..||++|||++++++
T Consensus       238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            45567899999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-52  Score=404.49  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=212.8

Q ss_pred             cccCceeeCCCCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEE
Q 039082          185 AKMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGAC  263 (472)
Q Consensus       185 ~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~  263 (472)
                      .....|+|+.++|++.+.||+|+||.||+|+++ +..||||+++....     ..+.|.+|+.+|++++|||||+++|+|
T Consensus         7 ~~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-----~~~~~~~E~~~l~~l~h~nIv~~~g~~   81 (285)
T d1fmka3           7 LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-----SPEAFLQEAQVMKKLRHEKLVQLYAVV   81 (285)
T ss_dssp             SSTTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-----CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-----CHHHHHHHHHHHHhcccCCEeEEEEEE
Confidence            356789999999999999999999999999997 45799999975432     235699999999999999999999998


Q ss_pred             EcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          264 LEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       264 ~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                      . ++..++|+||+.+|+|..++.....        ...++..++.++.||+.||+|||+++  |+||||||+||||+.++
T Consensus        82 ~-~~~~~lv~Ey~~~g~l~~~~~~~~~--------~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~  150 (285)
T d1fmka3          82 S-EEPIYIVTEYMSKGSLLDFLKGETG--------KYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENL  150 (285)
T ss_dssp             C-SSSCEEEECCCTTCBHHHHHSHHHH--------TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGG
T ss_pred             e-cCCeEEEEEecCCCchhhhhhhccc--------ccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCC
Confidence            5 4567899999999999998864321        12467899999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCCc----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc
Q 039082          344 HVRIADFGHARFLSDGE----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE  419 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~  419 (472)
                      .+||+|||+|+......    ....||+.|+|||.+..+.++.++|||||||++|||+||..||.... ....+...+..
T Consensus       151 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~-~~~~~~~~i~~  229 (285)
T d1fmka3         151 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM-VNREVLDQVER  229 (285)
T ss_dssp             CEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC-CHHHHHHHHHT
T ss_pred             cEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC-CHHHHHHHHHh
Confidence            99999999998765332    23458999999999999999999999999999999999655554433 24556666666


Q ss_pred             CCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHH
Q 039082          420 GKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQ  465 (472)
Q Consensus       420 ~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~  465 (472)
                      +. +++.+.  ..+.++.++|.+||+.||++||++++|++.|+++.
T Consensus       230 ~~-~~~~~~--~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         230 GY-RMPCPP--ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             TC-CCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             cC-CCCCCc--ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            54 333333  45567899999999999999999999999888754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=407.74  Aligned_cols=268  Identities=25%  Similarity=0.403  Sum_probs=228.0

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQL  259 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l  259 (472)
                      ...|+|+.++|++.++||+|+||.||+|.++       ++.||||+++..   ........|.+|+.++++++|||||++
T Consensus        12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~---~~~~~~~~~~~E~~il~~l~h~nIv~~   88 (308)
T d1p4oa_          12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA---ASMRERIEFLNEASVMKEFNCHHVVRL   88 (308)
T ss_dssp             CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT---SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc---cChHHHHHHHHHHHHHHHcCCCCEeee
Confidence            3479999999999999999999999999875       357999999754   344566779999999999999999999


Q ss_pred             EEEEEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEE
Q 039082          260 MGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFL  339 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl  339 (472)
                      +|+|..++..++|+|++.+|+|.+++................++..+..++.+++.||.|||+++  |+||||||+||||
T Consensus        89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLl  166 (308)
T d1p4oa_          89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMV  166 (308)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEE
T ss_pred             eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceee
Confidence            99999999999999999999999999765544433344445578889999999999999999999  9999999999999


Q ss_pred             cCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcC-CCCCCCCCCCHHHH
Q 039082          340 DDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG-NHPYIEKDYKPAKI  413 (472)
Q Consensus       340 ~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG-~~Pf~~~~~~~~~i  413 (472)
                      ++++.+||+|||+|+.+....     ....||+.|+|||.+.+..++.++|||||||++|||+|| ..||.+.+  ...+
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~--~~~~  244 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQV  244 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHH
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC--HHHH
Confidence            999999999999998765432     223579999999999999999999999999999999997 57886655  6667


Q ss_pred             HHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          414 AMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       414 ~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ...+.++. ++..|.  ..+..+.++|.+||+.+|++|||+++|++.|++.
T Consensus       245 ~~~i~~~~-~~~~p~--~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         245 LRFVMEGG-LLDKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHHHTTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHHHhCC-CCCCcc--cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            77777766 333333  3556789999999999999999999999998754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=402.12  Aligned_cols=257  Identities=28%  Similarity=0.481  Sum_probs=207.7

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC---C--eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEc
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR---G--LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLE  265 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~---g--~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~  265 (472)
                      .|+.++|++.+.||+|+||.||+|+++   +  ..||||+++++.. ..++..+.|.+|+.+|++++|||||+++|+|.+
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~-~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~   82 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVL-SQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   82 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC---------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            366789999999999999999999874   2  3699999977654 334556789999999999999999999999965


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                       +..++|+||+.+|+|.+++.....         ..++..++.++.||+.||.|||++|  |+||||||+||||+.++.+
T Consensus        83 -~~~~lv~e~~~~~~l~~~~~~~~~---------~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~v  150 (273)
T d1u46a_          83 -PPMKMVTELAPLGSLLDRLRKHQG---------HFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLV  150 (273)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHGG---------GSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEE
T ss_pred             -cchheeeeeecCcchhhhhhcccC---------CCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccce
Confidence             567899999999999998864332         1347889999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCcc------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          346 RIADFGHARFLSDGEM------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       346 kL~DFGla~~~~~~~~------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      ||+|||+++.......      ...|+..|+|||.+.+..++.++|||||||++|||+| |..||.+.+  ..++...+.
T Consensus       151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--~~~~~~~i~  228 (273)
T d1u46a_         151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--GSQILHKID  228 (273)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHH
T ss_pred             eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--HHHHHHHHH
Confidence            9999999998754322      2346889999999999999999999999999999998 899998766  666777776


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNI  464 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i  464 (472)
                      ....++..+.  ..+..+.++|.+||+.||++||||.+|.+.|++.
T Consensus       229 ~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         229 KEGERLPRPE--DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TSCCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hCCCCCCCcc--cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            6655554443  3556788999999999999999999999988865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-51  Score=402.90  Aligned_cols=251  Identities=23%  Similarity=0.277  Sum_probs=213.7

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC--hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN--ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~--~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~  270 (472)
                      ++|++.+.||+|+||+||+|+++  |..||||++++......  ....+.|.+|+.+|+.++|||||+++++|.+.+..+
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57999999999999999999986  78999999976544322  234577999999999999999999999999999999


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC----cEE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK----HVR  346 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~----~vk  346 (472)
                      +||||+.||+|.+++...+.          .+...++.++.|++.||+|||+++  ||||||||+|||++.++    .+|
T Consensus        90 iv~E~~~gg~L~~~i~~~~~----------l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKES----------LTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEEEcCCCccccchhccccc----------cchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceE
Confidence            99999999999999965332          357889999999999999999999  99999999999998776    599


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||+|.......  ....||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+  ..+....+..+....
T Consensus       158 l~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--~~~~~~~i~~~~~~~  235 (293)
T d1jksa_         158 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--KQETLANVSAVNYEF  235 (293)
T ss_dssp             ECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHTTCCCC
T ss_pred             ecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCC--HHHHHHHHHhcCCCC
Confidence            99999999876443  34568999999999999999999999999999999999999998766  666677777765332


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+.....+..+.++|.+||..||++|||++++++
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            21111345567889999999999999999999975

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.9e-51  Score=411.74  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=214.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|+++  |..||||++...    .....+.+.+|+.+|+.++|||||++++++.+++..++|
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~----~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP----HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC----SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc----chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            58999999999999999999986  889999999654    344567789999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc--CCCcEEEeec
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADF  350 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~--~~~~vkL~DF  350 (472)
                      ||++.||+|.+++.....         ..++..+..++.||+.||+|||++|  ||||||||+|||++  .++.+||+||
T Consensus       102 mE~~~gg~L~~~l~~~~~---------~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DF  170 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHN---------KMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDF  170 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTS---------CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCC
T ss_pred             EEcCCCCCHHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeec
Confidence            999999999999853221         2357889999999999999999999  99999999999995  4688999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      |+|+.+....  ....||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+  ..+....+..+......+.
T Consensus       171 G~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~  248 (350)
T d1koaa2         171 GLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNMDDSA  248 (350)
T ss_dssp             TTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHTCCCSCCGG
T ss_pred             chheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCccc
Confidence            9999876543  34679999999999999999999999999999999999999998765  6667777777654433222


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+.++.++|.+||..||++|||++++++
T Consensus       249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         249 FSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            2445678899999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-51  Score=403.52  Aligned_cols=272  Identities=26%  Similarity=0.394  Sum_probs=210.8

Q ss_pred             ccCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCcee
Q 039082          186 KMNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL  257 (472)
Q Consensus       186 ~~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv  257 (472)
                      ....|+|++++|++.++||+|+||.||+|.+.       ++.||||+++..   ......+.+.+|..++.++ +|+|||
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~~~~~e~~~l~~~~~h~~iv   80 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG---ATHSEHRALMSELKILIHIGHHLNVV   80 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc---cCcHHHHHHHHHHHHHHhhcCCCeEE
Confidence            44679999999999999999999999999974       257999998754   2445566788888888877 689999


Q ss_pred             EEEEEEEcCC-CceEEEEeccCCcHHHHHhhccccccc------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          258 QLMGACLEPP-YRGWLVTELLGTTLKEWLHGLGSQRRK------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       258 ~l~g~~~~~~-~~~~vve~~~ggsL~~~l~~~~~~~~~------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      .+++++..++ ..++||||+.+|+|.+++.........      .......++..++.++.||+.||+|||+++  ||||
T Consensus        81 ~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHr  158 (299)
T d1ywna1          81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHR  158 (299)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             EeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCC
Confidence            9999987755 567888999999999999754321110      011223467889999999999999999999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcC-CCCCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITG-NHPYI  404 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG-~~Pf~  404 (472)
                      ||||+||||++++.+||+|||+|+......     ....||+.|+|||++.+..++.++|||||||++|||+|| ..||.
T Consensus       159 DlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~  238 (299)
T d1ywna1         159 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  238 (299)
T ss_dssp             CCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCC
Confidence            999999999999999999999998765322     234689999999999999999999999999999999996 56787


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      +.... ..+...+..+. ++..|.  ..+.++.++|.+||..||++|||+++|++.|+++.+
T Consensus       239 ~~~~~-~~~~~~~~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         239 GVKID-EEFCRRLKEGT-RMRAPD--YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             TCCCS-HHHHHHHHHTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHH-HHHHHHHhcCC-CCCCCc--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            65533 33444455554 444443  345678999999999999999999999999998753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=405.92  Aligned_cols=258  Identities=24%  Similarity=0.417  Sum_probs=212.0

Q ss_pred             eeCCCCeeEeceeeccCceEEEEEEEC--Ce----eEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          191 YIDPKEIDLQEKIGQGTTANIYRAIWR--GL----DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       191 ~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~----~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      .+..++|++++.||+|+||+||+|.+.  |.    +||||.++..   ......+.|.+|+.+|++++|||||+++|+|.
T Consensus         5 ~~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   81 (317)
T d1xkka_           5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA---TSPKANKEILDEAYVMASVDNPHVCRLLGICL   81 (317)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-------CTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             cCCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc---cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            355678999999999999999999985  32    5899988653   23344567999999999999999999999998


Q ss_pred             cCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          265 EPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       265 ~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                      ++ ..+++++++.+++|.+++.....         ..++..++.++.||+.||+|||+++  ||||||||+||||+.++.
T Consensus        82 ~~-~~~~v~e~~~~~~l~~~~~~~~~---------~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~  149 (317)
T d1xkka_          82 TS-TVQLITQLMPFGCLLDYVREHKD---------NIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQH  149 (317)
T ss_dssp             SS-SEEEEEECCTTCBHHHHHHHTSS---------SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTE
T ss_pred             cC-CeeEEEEeccCCccccccccccc---------CCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCC
Confidence            64 56789999999999998864322         2357889999999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHh
Q 039082          345 VRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIEKDYKPAKIAMEVG  418 (472)
Q Consensus       345 vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~~~~~~~~i~~~i~  418 (472)
                      +||+|||+|+.......     ...||+.|+|||++.++.|+.++|||||||++|||+| |..||.+.+  ...+...+.
T Consensus       150 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~--~~~~~~~i~  227 (317)
T d1xkka_         150 VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--ASEISSILE  227 (317)
T ss_dssp             EEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--GGGHHHHHH
T ss_pred             eEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH
Confidence            99999999997754322     2347999999999999999999999999999999999 899998766  344555566


Q ss_pred             cCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       419 ~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      .+. ++..|.  .++..+.++|.+||..||++|||+.+|++.|..+..+.
T Consensus       228 ~~~-~~~~p~--~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         228 KGE-RLPQPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             HTC-CCCCCT--TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             cCC-CCCCCc--ccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence            654 444443  35567899999999999999999999999999886543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.6e-51  Score=408.58  Aligned_cols=248  Identities=20%  Similarity=0.248  Sum_probs=213.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++++.||+|+||.||+|.++  |..||||+++..    .......+.+|+.+|+.++|||||+++++|.+++..++|
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP----YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC----SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc----chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            57999999999999999999986  789999999764    234456788999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc--CCCcEEEeec
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD--DAKHVRIADF  350 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~--~~~~vkL~DF  350 (472)
                      ||++.||+|.+++...+.         ..+..+++.++.||+.||+|||++|  ||||||||+||||+  .++.+||+||
T Consensus       105 mE~~~gg~L~~~~~~~~~---------~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DF  173 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDY---------KMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDF  173 (352)
T ss_dssp             EECCCCCBHHHHTTCTTC---------CBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCC
T ss_pred             EEcCCCChHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeec
Confidence            999999999988754321         2357889999999999999999999  99999999999998  6789999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      |+|.......  ....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+  .......+..+......+.
T Consensus       174 Gla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~  251 (352)
T d1koba_         174 GLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--DLETLQNVKRCDWEFDEDA  251 (352)
T ss_dssp             TTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--HHHHHHHHHHCCCCCCSST
T ss_pred             ccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCCccc
Confidence            9999887543  34568999999999999999999999999999999999999998766  5667777777654433322


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+.++.++|.+||..||++|||+.++++
T Consensus       252 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         252 FSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            3456678899999999999999999999975

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-51  Score=400.30  Aligned_cols=269  Identities=27%  Similarity=0.413  Sum_probs=220.3

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEECC---------eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCcee
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWRG---------LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVL  257 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~g---------~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv  257 (472)
                      ..|.|+.++|++.+.||+|+||.||+|++.+         ..||||+++++   ........+.+|...+.++ +|||||
T Consensus         6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~e~~~l~~~~~HpnIv   82 (299)
T d1fgka_           6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD---ATEKDLSDLISEMEMMKMIGKHKNII   82 (299)
T ss_dssp             TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT---CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc---cChHHHHHHHHHHHHHHHhcCCCeEE
Confidence            3599999999999999999999999998642         36999999765   3455667799999999888 899999


Q ss_pred             EEEEEEEcCCCceEEEEeccCCcHHHHHhhccccc------ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecC
Q 039082          258 QLMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQR------RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRD  331 (472)
Q Consensus       258 ~l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrD  331 (472)
                      +++++|.+++..++|+||+.+|+|.+++.......      .........++..++.++.||+.||+|||+++  |||||
T Consensus        83 ~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrD  160 (299)
T d1fgka_          83 NLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRD  160 (299)
T ss_dssp             CEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSC
T ss_pred             ecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeee
Confidence            99999999999999999999999999997543211      01111233468899999999999999999999  99999


Q ss_pred             CCCCcEEEcCCCcEEEeecccceecCCCc-----cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCCC
Q 039082          332 LKPSNIFLDDAKHVRIADFGHARFLSDGE-----MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYIE  405 (472)
Q Consensus       332 Lkp~NILl~~~~~vkL~DFGla~~~~~~~-----~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~~  405 (472)
                      |||+|||++.++.+||+|||+++......     ....|++.|+|||.+.++.|+.++|||||||++|||++ |..||.+
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            99999999999999999999999776432     23457999999999999999999999999999999998 7999976


Q ss_pred             CCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHH
Q 039082          406 KDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQM  466 (472)
Q Consensus       406 ~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~  466 (472)
                      .+  ...+...+..+. ++..|.  ..+.++.++|.+||+.||++|||+.+|++.|+++.+
T Consensus       241 ~~--~~~~~~~i~~~~-~~~~p~--~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         241 VP--VEELFKLLKEGH-RMDKPS--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             CC--HHHHHHHHHTTC-CCCCCS--SCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CC--HHHHHHHHHcCC-CCCCCc--cchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            66  556666666654 444443  345678999999999999999999999999998854

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.5e-51  Score=404.91  Aligned_cols=247  Identities=26%  Similarity=0.412  Sum_probs=214.7

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++++.||+|+||+||+|+++  |..||||+++++.. ......+.+.+|+.+|+.++|||||++++++.+.+..|+
T Consensus         3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            368999999999999999999986  78999999975432 122345678999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ||||+.||+|..++.....          .+...+..++.||+.||+|||++|  ||||||||+||||+.+|.+||+|||
T Consensus        82 vmE~~~gg~l~~~~~~~~~----------~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG  149 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQR----------FPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFG  149 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSS----------CCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             EeeecCCcccccccccccc----------ccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCc
Confidence            9999999999998865432          235677888999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       352 la~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      +|+.........+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+  ...+...+..+..  .+|.  .
T Consensus       150 ~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~--~~p~--~  223 (316)
T d1fota_         150 FAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--TMKTYEKILNAEL--RFPP--F  223 (316)
T ss_dssp             SCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHCCC--CCCT--T
T ss_pred             cceEeccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--HHHHHHHHHcCCC--CCCC--C
Confidence            99999888888899999999999999999999999999999999999999998766  6667777777653  2332  2


Q ss_pred             hHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      .+.++.++|.+||..||.+||     |+++|++
T Consensus       224 ~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         224 FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             SCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            445788899999999999995     8888875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.7e-50  Score=393.46  Aligned_cols=256  Identities=24%  Similarity=0.380  Sum_probs=211.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCC----
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPY----  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~----  268 (472)
                      ++|++.+.||+|+||.||+|.++  |+.||||+++++.. .+......|.+|+.+|+.++|||||++++++...+.    
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLA-RDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTT-TCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhc-cCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            57999999999999999999986  88999999987644 345566789999999999999999999999887654    


Q ss_pred             ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEe
Q 039082          269 RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIA  348 (472)
Q Consensus       269 ~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~  348 (472)
                      .|+||||+.|++|..++...+.          .++.+++.++.||+.||+|||++|  ||||||||+||||+.++.++|+
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~----------l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~  153 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGP----------MTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVM  153 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEEC
T ss_pred             EEEEEECCCCCEehhhhcccCC----------CCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceee
Confidence            6789999999999998865432          347889999999999999999999  9999999999999999999999


Q ss_pred             ecccceecCCC------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCC
Q 039082          349 DFGHARFLSDG------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKL  422 (472)
Q Consensus       349 DFGla~~~~~~------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~  422 (472)
                      |||.+......      ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+  ..+....+..+..
T Consensus       154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--~~~~~~~~~~~~~  231 (277)
T d1o6ya_         154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--PVSVAYQHVREDP  231 (277)
T ss_dssp             CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHCCC
T ss_pred             hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--HHHHHHHHHhcCC
Confidence            99998766432      234568999999999999999999999999999999999999998765  5556666555543


Q ss_pred             CCCCCCCchhHHHHHHHHHHhccCCCCCCC-CHHHHHHHHHHHH
Q 039082          423 RPALPEEDGQLRELIELICLSWDGDASVRP-SFSSITCSLKNIQ  465 (472)
Q Consensus       423 ~~~l~~~~~~~~~l~~li~~cl~~dP~~RP-s~~~ll~~L~~i~  465 (472)
                      .+.....+..+.++.++|.+||..||++|| |+++++..|.++.
T Consensus       232 ~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            332222345667899999999999999999 8999999988764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=404.88  Aligned_cols=249  Identities=22%  Similarity=0.312  Sum_probs=213.2

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYR  269 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~  269 (472)
                      |+.++|++++.||+|+||.||+|+++  |..||||++++.... .....+.+.+|+.+|+.++|||||++++++.+.+..
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~   80 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVII-AKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL   80 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhcc-CHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence            45678999999999999999999986  789999999764321 223456788999999999999999999999999999


Q ss_pred             eEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEee
Q 039082          270 GWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIAD  349 (472)
Q Consensus       270 ~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~D  349 (472)
                      |+|+||+.||+|..++...+.          .+...++.++.||+.||+|||++|  ||||||||+||||+.+|.+||+|
T Consensus        81 ~iv~ey~~gg~L~~~~~~~~~----------~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~D  148 (337)
T d1o6la_          81 CFVMEYANGGELFFHLSRERV----------FTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITD  148 (337)
T ss_dssp             EEEEECCTTCBHHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECC
T ss_pred             ccceeccCCCchhhhhhcccC----------CcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEee
Confidence            999999999999999975432          245778899999999999999999  99999999999999999999999


Q ss_pred             cccceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 039082          350 FGHARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPAL  426 (472)
Q Consensus       350 FGla~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l  426 (472)
                      ||+|+.....   ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+  ...+...+..+..  .+
T Consensus       149 FG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~--~~~~~~~i~~~~~--~~  224 (337)
T d1o6la_         149 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--HERLFELILMEEI--RF  224 (337)
T ss_dssp             CTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCC--CC
T ss_pred             cccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcC--HHHHHHHHhcCCC--CC
Confidence            9999876432   234679999999999999999999999999999999999999998876  5666677776643  33


Q ss_pred             CCCchhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          427 PEEDGQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       427 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      |.  ..+.++.++|.+||..||++||+     ++++++
T Consensus       225 p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             Cc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            43  34557889999999999999995     777765

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=397.98  Aligned_cols=272  Identities=25%  Similarity=0.360  Sum_probs=222.3

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC-------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR-------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQ  258 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~-------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~  258 (472)
                      ...|+++.++|++.++||+|+||.||+|.++       +..||||++++.   ........|.+|+.+++.+ +|||||+
T Consensus        15 ~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~E~~~~~~l~~HpnIv~   91 (311)
T d1t46a_          15 DHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS---AHLTEREALMSELKVLSYLGNHMNIVN   91 (311)
T ss_dssp             CGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT---CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc---cCHHHHHHHHHHHHHHHhccCCCCEEE
Confidence            4479999999999999999999999999874       357999999765   2445567799999999999 7999999


Q ss_pred             EEEEEEcCCCceEEEEeccCCcHHHHHhhccccccc--------ccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeec
Q 039082          259 LMGACLEPPYRGWLVTELLGTTLKEWLHGLGSQRRK--------ERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHR  330 (472)
Q Consensus       259 l~g~~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~--------~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHr  330 (472)
                      ++|+|.+.+..++++|++.+|+|.+++.........        .......++..+..++.||+.||+|||+++  +|||
T Consensus        92 ~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHr  169 (311)
T d1t46a_          92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHR  169 (311)
T ss_dssp             EEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCS
T ss_pred             EEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeec
Confidence            999999999999999999999999999764422111        111224567889999999999999999999  9999


Q ss_pred             CCCCCcEEEcCCCcEEEeecccceecCCCcc-----ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHc-CCCCCC
Q 039082          331 DLKPSNIFLDDAKHVRIADFGHARFLSDGEM-----ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIIT-GNHPYI  404 (472)
Q Consensus       331 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-----~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~ellt-G~~Pf~  404 (472)
                      ||||+|||++.++.+||+|||+++.......     ...||+.|+|||.+....++.++|||||||++|||+| |..||.
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999997764322     2457999999999999999999999999999999999 566665


Q ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          405 EKDYKPAKIAMEVGEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       405 ~~~~~~~~i~~~i~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ..... ..+. .+.....++..+.  ..+..+.++|.+||+.||++||||++|++.|+++..+
T Consensus       250 ~~~~~-~~~~-~~i~~~~~~~~~~--~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         250 GMPVD-SKFY-KMIKEGFRMLSPE--HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             TCCSS-HHHH-HHHHHTCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHH-HHHH-HHHhcCCCCCCcc--cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            55432 2233 3333333544443  3456789999999999999999999999999987654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-50  Score=406.62  Aligned_cols=247  Identities=22%  Similarity=0.342  Sum_probs=215.3

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceE
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      .++|++++.||+|+||.||+|+++  |..||||++.+... ......+.+.+|+.+|+.++|||||++++++.+....++
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV-VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH-HHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHc-cCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence            368999999999999999999986  78999999965432 122345678999999999999999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |++++.||+|..++...+.          .+...++.++.||+.||.|||++|  ||||||||+||||+.+|.+||+|||
T Consensus       119 v~e~~~~g~l~~~l~~~~~----------l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG  186 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGR----------FSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFG  186 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCC----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ccccccccchhhhHhhcCC----------CCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeece
Confidence            9999999999999965432          346889999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCch
Q 039082          352 HARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPEEDG  431 (472)
Q Consensus       352 la~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~~~~  431 (472)
                      +|+..........||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+  ...+...+..+...  .|  ..
T Consensus       187 ~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--~~~~~~~i~~~~~~--~p--~~  260 (350)
T d1rdqe_         187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--PIQIYEKIVSGKVR--FP--SH  260 (350)
T ss_dssp             TCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCCCC--CC--TT
T ss_pred             eeeecccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--HHHHHHHHhcCCCC--CC--cc
Confidence            99998877778889999999999999999999999999999999999999998765  66677777776532  22  23


Q ss_pred             hHHHHHHHHHHhccCCCCCCC-----CHHHHHH
Q 039082          432 QLRELIELICLSWDGDASVRP-----SFSSITC  459 (472)
Q Consensus       432 ~~~~l~~li~~cl~~dP~~RP-----s~~~ll~  459 (472)
                      .+.++.++|.+||..||.+|+     ++++|++
T Consensus       261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            456788999999999999994     8998875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9e-50  Score=388.35  Aligned_cols=252  Identities=23%  Similarity=0.330  Sum_probs=216.6

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC-----hHHHHHHHHHHHHHHhcC-CCceeEEEEEEEc
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN-----ENAVTFFAQEVDTLSRQR-HRFVLQLMGACLE  265 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~-----~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~  265 (472)
                      .++|++.+.||+|+||+||+|+++  |+.||||++.+......     +...+.+.+|+.+|++++ |||||++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            378999999999999999999985  78999999977544322     223456889999999997 9999999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      ++..|+||||+.||+|.+++...+.          .++..++.++.||+.||+|||++|  |+||||||+||||+.++.+
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~----------l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~  149 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVT----------LSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNI  149 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCe
Confidence            9999999999999999999964332          357889999999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCC--ccccccCCcccccccccC------CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          346 RIADFGHARFLSDG--EMALTGTFVYMAPEVIQC------EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       346 kL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~------~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      ||+|||+++.....  .....||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.+  .......+
T Consensus       150 kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~--~~~~~~~i  227 (277)
T d1phka_         150 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMI  227 (277)
T ss_dssp             EECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred             EEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC--HHHHHHHH
Confidence            99999999987653  344568999999999863      357889999999999999999999998776  66677777


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ..+......+.....+.++.++|.+||..||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            777655544444567788999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=397.52  Aligned_cols=266  Identities=27%  Similarity=0.387  Sum_probs=216.3

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--Ce--eEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEcC
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GL--DVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLEP  266 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~--~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~~  266 (472)
                      |+.++|++.++||+|+||.||+|.++  |.  .||||.++...   ..+..+.|.+|+++|+++ +|||||+++|+|.+.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~   83 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA---SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR   83 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC---------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc---ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence            56689999999999999999999986  33  47888875432   334456699999999998 799999999999999


Q ss_pred             CCceEEEEeccCCcHHHHHhhccccc------ccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQR------RKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD  340 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~------~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~  340 (472)
                      +..++|++|+.+|+|.++|+......      .........++..++.++.||+.||.|||+++  ||||||||+|||++
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~  161 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVG  161 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEc
Confidence            99999999999999999997543211      01112234467889999999999999999999  99999999999999


Q ss_pred             CCCcEEEeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCCCCHHHHHHHH
Q 039082          341 DAKHVRIADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGN-HPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       341 ~~~~vkL~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~-~Pf~~~~~~~~~i~~~i  417 (472)
                      .++.+||+|||+|+......  ....||..|+|||.+....|+.++|||||||++|||++|. .||.+.+  ..++...+
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i  239 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKL  239 (309)
T ss_dssp             GGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHG
T ss_pred             CCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC--HHHHHHHH
Confidence            99999999999998665332  3445899999999999999999999999999999999965 5776665  66777777


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ..+. ++..|.  ..+.++.++|.+||+.||++|||+++|++.|+++.++
T Consensus       240 ~~~~-~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         240 PQGY-RLEKPL--NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             GGTC-CCCCCT--TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhcC-CCCCCc--cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            7765 444443  3556889999999999999999999999999998754

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-49  Score=400.00  Aligned_cols=250  Identities=26%  Similarity=0.335  Sum_probs=201.6

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHH---HHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFA---QEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~---~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      +.++|++.+.||+|+||.||+|+++  |..||||++.+.... .......+.   +|+.+++.++|||||++++++.+.+
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHH-HHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcc-hhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            4579999999999999999999986  789999999654321 111222334   4466777778999999999999999


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRI  347 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL  347 (472)
                      ..|+||||+.||+|.+++.....          .+...++.++.||+.||+|||++|  ||||||||+||||+.+|.+||
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~----------~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl  148 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGV----------FSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRI  148 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEE
T ss_pred             EEEEEEEecCCCcHHHHHHhccc----------ccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEE
Confidence            99999999999999999965332          246788899999999999999999  999999999999999999999


Q ss_pred             eecccceecCCC-ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHH-HHHHHHhcCCCCC
Q 039082          348 ADFGHARFLSDG-EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPA-KIAMEVGEGKLRP  424 (472)
Q Consensus       348 ~DFGla~~~~~~-~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~-~i~~~i~~~~~~~  424 (472)
                      +|||+|+..... ....+||+.|+|||++.. ..|+.++|||||||++|||+||+.||.+.+.... .+...+...  ..
T Consensus       149 ~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~--~~  226 (364)
T d1omwa3         149 SDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM--AV  226 (364)
T ss_dssp             CCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSC--CC
T ss_pred             eeeceeeecCCCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC--CC
Confidence            999999987644 345679999999999864 5689999999999999999999999987654322 222222222  22


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      .++  ...+.++.++|.+||..||++|||     ++++++
T Consensus       227 ~~~--~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         227 ELP--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCC--SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCC--CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            222  335567899999999999999999     677764

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-49  Score=393.08  Aligned_cols=247  Identities=19%  Similarity=0.269  Sum_probs=210.9

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|.++  |..||||+++.+     ......+.+|+.+|+.++|||||++++++.+++..|+|
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-----~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv   79 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC-----cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence            67999999999999999999986  778999999754     22345588999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC--CCcEEEeec
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD--AKHVRIADF  350 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~--~~~vkL~DF  350 (472)
                      |||+.||+|.+++...+.         ..+..+++.++.||+.||+|||++|  |+||||||+|||++.  .+.+||+||
T Consensus        80 mE~~~gg~L~~~i~~~~~---------~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DF  148 (321)
T d1tkia_          80 FEFISGLDIFERINTSAF---------ELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEF  148 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSC---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCC
T ss_pred             EecCCCCcHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEccc
Confidence            999999999999964321         2357889999999999999999999  999999999999985  458999999


Q ss_pred             ccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          351 GHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       351 Gla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      |+++......  ....||+.|+|||.+.+..|+.++|||||||++|+|++|..||.+.+  ...+...+..+......+.
T Consensus       149 G~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~  226 (321)
T d1tkia_         149 GQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFDEEA  226 (321)
T ss_dssp             TTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--HHHHHHHHHHTCCCCCHHH
T ss_pred             chhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC--HHHHHHHHHhCCCCCChhh
Confidence            9999876443  34568999999999999999999999999999999999999998776  6667777777654322111


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ....+.++.++|.+||..||++|||++++++
T Consensus       227 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1345567899999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=389.15  Aligned_cols=257  Identities=27%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             CCeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC----Cce
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP----YRG  270 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~----~~~  270 (472)
                      ++|.+.++||+|+||.||+|+++|..||||+++.+     ......+..|+..+..++|||||+++|+|.+++    ..+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~-----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~   77 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW   77 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc-----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence            47889999999999999999999999999998542     222222334555556789999999999998765    367


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCceeecCCCCCcEEEcCCCc
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ------KPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~------~~~iiHrDLkp~NILl~~~~~  344 (472)
                      +|+||+.+|+|.++++...           .++..++.++.++|.||+|||+.      ..+||||||||+||||+.++.
T Consensus        78 lv~Ey~~~g~L~~~l~~~~-----------l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~  146 (303)
T d1vjya_          78 LVSDYHEHGSLFDYLNRYT-----------VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT  146 (303)
T ss_dssp             EEEECCTTCBHHHHHHHCC-----------BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC
T ss_pred             EEEecccCCCHHHHHhcCC-----------CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC
Confidence            8999999999999996432           35788999999999999999973      113999999999999999999


Q ss_pred             EEEeecccceecCCCc-------cccccCCcccccccccCCC------CCchHHHHHHHHHHHHHHcCCCCCCCCC----
Q 039082          345 VRIADFGHARFLSDGE-------MALTGTFVYMAPEVIQCEP------YSEKSDVYSFGIILNEIITGNHPYIEKD----  407 (472)
Q Consensus       345 vkL~DFGla~~~~~~~-------~~~~gt~~y~APE~~~~~~------~s~~sDvwSlGvll~elltG~~Pf~~~~----  407 (472)
                      +||+|||+++......       ....||+.|+|||++.+..      ++.++|||||||++|||+||..||....    
T Consensus       147 ~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~  226 (303)
T d1vjya_         147 CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL  226 (303)
T ss_dssp             EEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC
T ss_pred             eEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCccccccc
Confidence            9999999998775432       2346899999999987542      6779999999999999999988763211    


Q ss_pred             ---------CCHHHHHHHHhcCCCCCCCCCC---chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          408 ---------YKPAKIAMEVGEGKLRPALPEE---DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       408 ---------~~~~~i~~~i~~~~~~~~l~~~---~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                               .....+...+..+..++.++..   ...+..+.+++.+||..||++|||+.+|++.|+++..+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         227 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                     2344555566666667776664   34567799999999999999999999999999988764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=393.95  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=207.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHH-hcCCCceeEEEEEEEcCCCceE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLS-RQRHRFVLQLMGACLEPPYRGW  271 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~-~l~HpnIv~l~g~~~~~~~~~~  271 (472)
                      ++|++.+.||+|+||+||+|.++  |+.||||+++++... .....+.+..|..++. .++|||||++++++.+.+..|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHH-HTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhcc-ChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            68999999999999999999995  789999999764321 1233455667777665 6899999999999999999999


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      ||||+.+|+|.+++.....          .+...++.++.||+.||+|||++|  ||||||||+|||++.++.+||+|||
T Consensus        81 vmEy~~~g~L~~~i~~~~~----------~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG  148 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHK----------FDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFG  148 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSS----------CCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEeecCCCcHHHHhhccCC----------CCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccc
Confidence            9999999999999975432          246788999999999999999999  9999999999999999999999999


Q ss_pred             cceecCCC---ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 039082          352 HARFLSDG---EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRPALPE  428 (472)
Q Consensus       352 la~~~~~~---~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~~l~~  428 (472)
                      +|+.....   .....||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+  ...+...+..+.  +.+|.
T Consensus       149 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~--~~~~~~~i~~~~--~~~p~  224 (320)
T d1xjda_         149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--EEELFHSIRMDN--PFYPR  224 (320)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHCC--CCCCT
T ss_pred             hhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHcCC--CCCCc
Confidence            99865532   234568999999999999999999999999999999999999998766  666777776654  33343


Q ss_pred             CchhHHHHHHHHHHhccCCCCCCCCHH-HHH
Q 039082          429 EDGQLRELIELICLSWDGDASVRPSFS-SIT  458 (472)
Q Consensus       429 ~~~~~~~l~~li~~cl~~dP~~RPs~~-~ll  458 (472)
                        ..+.++.++|.+||..||++||++. +|+
T Consensus       225 --~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         225 --WLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             --TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence              2456788999999999999999985 665

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-49  Score=387.57  Aligned_cols=253  Identities=28%  Similarity=0.435  Sum_probs=207.9

Q ss_pred             eEeceeeccCceEEEEEEECC-----eeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC-CCceE
Q 039082          198 DLQEKIGQGTTANIYRAIWRG-----LDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP-PYRGW  271 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~g-----~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~-~~~~~  271 (472)
                      .+.++||+|+||+||+|.+..     ..||||.+++.   .+....+.|.+|+++|++++|||||+++|++... ...++
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~---~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l  106 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  106 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC---CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc---cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEE
Confidence            446789999999999999842     25899998643   3566678899999999999999999999998764 46788


Q ss_pred             EEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecc
Q 039082          272 LVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFG  351 (472)
Q Consensus       272 vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFG  351 (472)
                      |+||+.+|+|.+++.....         ..++..++.++.|++.||.|||+.+  |+||||||+||||++++.+||+|||
T Consensus       107 v~E~~~~g~l~~~~~~~~~---------~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG  175 (311)
T d1r0pa_         107 VLPYMKHGDLRNFIRNETH---------NPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFG  175 (311)
T ss_dssp             EEECCTTCBHHHHHHCTTC---------CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSG
T ss_pred             EEEEeecCchhhhhccccc---------cchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEeccc
Confidence            9999999999999864322         2346778899999999999999999  9999999999999999999999999


Q ss_pred             cceecCCCcc-------ccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          352 HARFLSDGEM-------ALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       352 la~~~~~~~~-------~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      +++.......       ...||+.|+|||.+....++.++||||||+++|||+||..||.... ...++...+..+. ++
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~-~~~~~~~~i~~g~-~~  253 (311)
T d1r0pa_         176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR-RL  253 (311)
T ss_dssp             GGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC-CC
T ss_pred             chhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC-CHHHHHHHHHcCC-CC
Confidence            9987653321       2347999999999999999999999999999999999877775543 2344566666665 44


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ..|.  ..+..+.++|.+||..||++||++.+|++.|+++...+
T Consensus       254 ~~p~--~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         254 LQPE--YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             CCCT--TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             CCcc--cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence            4444  34567889999999999999999999999999998754

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=386.99  Aligned_cols=244  Identities=20%  Similarity=0.297  Sum_probs=195.9

Q ss_pred             CCeeEec-eeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc-CCCceeEEEEEEEc----C
Q 039082          195 KEIDLQE-KIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ-RHRFVLQLMGACLE----P  266 (472)
Q Consensus       195 ~~~~l~~-~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l-~HpnIv~l~g~~~~----~  266 (472)
                      ++|++.. .||+|+||.||+|.++  |..||||+++..         ..+.+|+.++.++ +|||||+++++|.+    .
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~---------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~   81 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC---------PKARREVELHWRASQCPHIVRIVDVYENLYAGR   81 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS---------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc---------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence            5788875 5999999999999986  779999998542         2367899987655 89999999999875    3


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC---CC
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD---AK  343 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~---~~  343 (472)
                      ...|+||||+.||+|.+++...+..        ..++.+++.++.||+.||+|||++|  |+||||||+|||++.   ++
T Consensus        82 ~~~~ivmEy~~gg~L~~~i~~~~~~--------~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~  151 (335)
T d2ozaa1          82 KCLLIVMECLDGGELFSRIQDRGDQ--------AFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNA  151 (335)
T ss_dssp             EEEEEEEECCCSEEHHHHHHSCSCC--------CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHhcCCC--------CcCHHHHHHHHHHHHHHHHHHHHcC--Cccccccccccccccccccc
Confidence            5578888999999999999653321        2357889999999999999999999  999999999999985   56


Q ss_pred             cEEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCH--HHHHHHHhc
Q 039082          344 HVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKP--AKIAMEVGE  419 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~--~~i~~~i~~  419 (472)
                      .+||+|||+|+.....  ....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+...  ..+...+..
T Consensus       152 ~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~  231 (335)
T d2ozaa1         152 ILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM  231 (335)
T ss_dssp             CEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS
T ss_pred             cccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc
Confidence            7999999999977643  345679999999999999999999999999999999999999997654322  112222233


Q ss_pred             CCCCCCCCCC--chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 GKLRPALPEE--DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 ~~~~~~l~~~--~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..  .+|..  ...+.++.++|.+||..||++|||+.++++
T Consensus       232 ~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 GQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             CSS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCC--CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            322  23322  345678999999999999999999999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-48  Score=379.57  Aligned_cols=247  Identities=21%  Similarity=0.205  Sum_probs=192.2

Q ss_pred             EeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC-hHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEEEe
Q 039082          199 LQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN-ENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLVTE  275 (472)
Q Consensus       199 l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~-~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vve~  275 (472)
                      .+++||+|+||+||+|+++  |+.||||+++....... +.....+.+|+.+|+.++|||||++++++..++..++|||+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4688999999999999985  77899999976543222 12235688999999999999999999999999999999999


Q ss_pred             ccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          276 LLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       276 ~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      +.++++..+.....          ..+...+..++.||+.||+|||++|  |+||||||+|||++.++.+||+|||+|+.
T Consensus        82 ~~~~~~~~~~~~~~----------~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~  149 (299)
T d1ua2a_          82 METDLEVIIKDNSL----------VLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKS  149 (299)
T ss_dssp             CSEEHHHHHTTCCS----------SCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             hcchHHhhhhhccc----------CCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccc
Confidence            88877766553221          1234678899999999999999999  99999999999999999999999999987


Q ss_pred             cCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC--CC-------
Q 039082          356 LSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG--KL-------  422 (472)
Q Consensus       356 ~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~--~~-------  422 (472)
                      .....   ...+||+.|+|||++.. ..|+.++|||||||++|||+||..||.+.+  ..+....+...  ..       
T Consensus       150 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~--~~~~l~~i~~~~~~~~~~~~~~  227 (299)
T d1ua2a_         150 FGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS--DLDQLTRIFETLGTPTEEQWPD  227 (299)
T ss_dssp             TTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCCCTTTSSS
T ss_pred             cCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCC--HHHHHHHHHHhcCCCChhhccc
Confidence            66432   34568999999999864 568999999999999999999999998765  44443333221  00       


Q ss_pred             ---------CCCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 ---------RPALPEE------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ---------~~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                               ....+..      .....++.++|.+||..||++|||++++++
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                     0001110      123467899999999999999999999975

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=375.78  Aligned_cols=251  Identities=24%  Similarity=0.321  Sum_probs=196.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|+++++||+|+||.||+|.++  |+.||||+++.+..  .+.....+.+|+++|+.++|||||++++++.+.+..|+|
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE--TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC---------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            68999999999999999999986  78999999976532  233456789999999999999999999999998888888


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      +|++. +++..++....        ....++..+..++.||+.||+|||++|  ||||||||+|||++.++.+||+|||+
T Consensus        80 ~e~~~-~~~~~~~~~~~--------~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~  148 (298)
T d1gz8a_          80 FEFLH-QDLKKFMDASA--------LTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGL  148 (298)
T ss_dssp             EECCS-EEHHHHHHHTT--------TTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred             EeecC-Cchhhhhhhhc--------ccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCc
Confidence            88875 45555553221        112457889999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCc---cccccCCcccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC-----
Q 039082          353 ARFLSDGE---MALTGTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK-----  421 (472)
Q Consensus       353 a~~~~~~~---~~~~gt~~y~APE~~~~~~-~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~-----  421 (472)
                      |+......   ....||+.|+|||.+.... ++.++|||||||++|+|++|+.||.+.+  ..+....+..  +.     
T Consensus       149 a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~--~~~~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         149 ARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS--EIDQLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             HHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTT
T ss_pred             ceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCC--HHHHHHHHHHhcCCCchhh
Confidence            98776433   2346899999999977655 5889999999999999999999998765  3333333211  00     


Q ss_pred             ---------CCCCCCCC---------chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          422 ---------LRPALPEE---------DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       422 ---------~~~~l~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                               .....+..         .....++.++|.+||..||++|||++++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence                     00011110         1234678899999999999999999999863

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-48  Score=376.83  Aligned_cols=241  Identities=24%  Similarity=0.343  Sum_probs=196.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCCh--HHHHHHHHHHHHHHhcC--CCceeEEEEEEEcCCC
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNE--NAVTFFAQEVDTLSRQR--HRFVLQLMGACLEPPY  268 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~--~~~~~f~~E~~il~~l~--HpnIv~l~g~~~~~~~  268 (472)
                      ++|++.+.||+|+||.||+|+++  |..||||++.++......  .....+.+|+.+|+.++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999986  789999999765432211  11233678999999996  8999999999999999


Q ss_pred             ceEEEEeccC-CcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-CCcEE
Q 039082          269 RGWLVTELLG-TTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-AKHVR  346 (472)
Q Consensus       269 ~~~vve~~~g-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-~~~vk  346 (472)
                      .++|||++.+ +++.+++.....          .+...++.++.||+.||+|||++|  |+||||||+|||++. ++.+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~----------l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vk  151 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGA----------LQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELK  151 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCS----------CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEE
T ss_pred             EEEEEEeccCcchHHHHHhccCC----------CCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEE
Confidence            9999999975 688888754322          346888999999999999999999  999999999999985 47999


Q ss_pred             EeecccceecCCCc-cccccCCcccccccccCCCC-CchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcCCCCC
Q 039082          347 IADFGHARFLSDGE-MALTGTFVYMAPEVIQCEPY-SEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEGKLRP  424 (472)
Q Consensus       347 L~DFGla~~~~~~~-~~~~gt~~y~APE~~~~~~~-s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~~~~~  424 (472)
                      |+|||+|+...... ....||+.|+|||++.+..+ +.++|||||||++|||+||+.||...+        .+..+..  
T Consensus       152 l~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~i~~~~~--  221 (273)
T d1xwsa_         152 LIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQV--  221 (273)
T ss_dssp             ECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHHCCC--
T ss_pred             ECccccceecccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch--------HHhhccc--
Confidence            99999998766443 45679999999999987765 577999999999999999999996532        1223321  


Q ss_pred             CCCCCchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          425 ALPEEDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       425 ~l~~~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      .++  ...+.++.++|.+||..||++|||++++++
T Consensus       222 ~~~--~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 FFR--QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             CCS--SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCC--CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            122  234467889999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4.8e-47  Score=370.43  Aligned_cols=249  Identities=24%  Similarity=0.292  Sum_probs=197.2

Q ss_pred             CCeeEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWLV  273 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~vv  273 (472)
                      ++|+++++||+|+||+||+|+++ |..||||+++.+..  .+...+.|.+|+.+|++++|||||++++++..++..++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE--DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG--GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc--ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            68999999999999999999987 78999999976532  3344567999999999999999999999999998888887


Q ss_pred             EeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeecccc
Q 039082          274 TELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGHA  353 (472)
Q Consensus       274 e~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGla  353 (472)
                      +++.++.+..+....+          ..+...+..++.||+.||+|||+++  ||||||||+||||+.++.+||+|||+|
T Consensus        80 e~~~~~~~~~~~~~~~----------~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a  147 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEG----------GLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLA  147 (286)
T ss_dssp             ECCSEEHHHHHHTSTT----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHH
T ss_pred             EeehhhhHHHHHhhcC----------CcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccc
Confidence            7776666666553222          2357889999999999999999999  999999999999999999999999999


Q ss_pred             eecCCCc---cccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CC------
Q 039082          354 RFLSDGE---MALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GK------  421 (472)
Q Consensus       354 ~~~~~~~---~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~------  421 (472)
                      .......   ....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.+  ..+....+..  +.      
T Consensus       148 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~--~~~~~~~i~~~~~~~~~~~~  225 (286)
T d1ob3a_         148 RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS--EADQLMRIFRILGTPNSKNW  225 (286)
T ss_dssp             HHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHHCCCCTTTS
T ss_pred             eecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCC--HHHHHHHHHHhhCCCChhhc
Confidence            8765432   33458999999999875 457999999999999999999999997765  3333333221  00      


Q ss_pred             --------CC------CCCC--C-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          422 --------LR------PALP--E-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       422 --------~~------~~l~--~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              ..      ...+  . .......+.++|.+||..||++|||++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         226 PNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    00      0000  0 0233467889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=373.83  Aligned_cols=250  Identities=21%  Similarity=0.241  Sum_probs=190.8

Q ss_pred             CCeeEeceeeccCceEEEEEEEC---CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhc---CCCceeEEEEEEEcC--
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR---GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQ---RHRFVLQLMGACLEP--  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~---g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l---~HpnIv~l~g~~~~~--  266 (472)
                      ++|+++++||+|+||+||+|++.   ++.||||+++.+....  .....+.+|+.+|+.+   +|||||+++++|...  
T Consensus         7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE--GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT--SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc--hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            68999999999999999999984   4579999997643321  2222356788777766   799999999998642  


Q ss_pred             ---CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          267 ---PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       267 ---~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                         ...++++|++.++.+.......         ....++..++.++.|++.||+|||+++  ||||||||+|||++.++
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~  153 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVP---------EPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSG  153 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSC---------TTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTC
T ss_pred             ccCceEEEEEEeccCCchhhhhhcc---------CCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCC
Confidence               2345666666665554333221         122356788899999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCC--ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC-
Q 039082          344 HVRIADFGHARFLSDG--EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG-  420 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~-  420 (472)
                      .+||+|||++......  .....||+.|+|||++.+..|+.++|||||||++|||+||+.||.+.+  ..+....+... 
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~--~~~~~~~i~~~~  231 (305)
T d1blxa_         154 QIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS--DVDQLGKILDVI  231 (305)
T ss_dssp             CEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHHH
T ss_pred             CeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCC--HHHHHHHHHHhh
Confidence            9999999999866533  345679999999999999999999999999999999999999998765  43333333210 


Q ss_pred             -C--------------------CCCCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 -K--------------------LRPALPE-EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 -~--------------------~~~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                       .                    .....+. .......+.+||.+||..||++|||++++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             0                    0000000 1233467888999999999999999999875

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-46  Score=368.86  Aligned_cols=256  Identities=22%  Similarity=0.285  Sum_probs=197.5

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|++.+.||+|+||.||+|++.  |+.||||++..+...      ..+..|+++++.++|+|+|..++.+......+++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH------PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS------CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC------HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence            46999999999999999999986  789999998764321      2377899999999888777666666665666666


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEc---CCCcEEEee
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLD---DAKHVRIAD  349 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~---~~~~vkL~D  349 (472)
                      ++++++++|...+.....         ..++..+..++.|++.||+|||++|  ||||||||+|||++   .+..+||+|
T Consensus        81 vme~~~~~l~~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~D  149 (299)
T d1ckia_          81 VMELLGPSLEDLFNFCSR---------KFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIID  149 (299)
T ss_dssp             EEECCCCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECC
T ss_pred             EEEEcCCchhhhhhhccC---------CCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeec
Confidence            667778888877754321         2357889999999999999999999  99999999999986   355799999


Q ss_pred             cccceecCCCc----------cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHH-HHHHh
Q 039082          350 FGHARFLSDGE----------MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKI-AMEVG  418 (472)
Q Consensus       350 FGla~~~~~~~----------~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i-~~~i~  418 (472)
                      ||+|+...+..          ....||+.|+|||++.+..++.++|||||||++|||+||..||.......... .....
T Consensus       150 FG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~  229 (299)
T d1ckia_         150 FGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS  229 (299)
T ss_dssp             CSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred             cCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence            99999876432          23468999999999999999999999999999999999999997655322111 11111


Q ss_pred             cCCCCCCCCC-CchhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHH
Q 039082          419 EGKLRPALPE-EDGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMK  467 (472)
Q Consensus       419 ~~~~~~~l~~-~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~  467 (472)
                      ......+.+. ....+.++.++|..||..+|++||++++|.+.|+.+..+
T Consensus       230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence            1111111111 123456789999999999999999999999999887653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-46  Score=374.41  Aligned_cols=255  Identities=23%  Similarity=0.303  Sum_probs=199.4

Q ss_pred             cCceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEE
Q 039082          187 MNGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACL  264 (472)
Q Consensus       187 ~~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~  264 (472)
                      ...|++ .++|+++++||+|+||+||+|.++  |+.||||++++..  ..+...+.+.+|+.+|+.++|||||+++++|.
T Consensus        11 ~~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~   87 (346)
T d1cm8a_          11 KTAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF--QSELFAKRAYRELRLLKHMRHENVIGLLDVFT   87 (346)
T ss_dssp             SSEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT--SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEEC
T ss_pred             Cceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh--cChHHHHHHHHHHHHHHhcCCCCeeEEEEEec
Confidence            345777 579999999999999999999986  7899999997643  35556678999999999999999999999998


Q ss_pred             cCCC------ceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEE
Q 039082          265 EPPY------RGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIF  338 (472)
Q Consensus       265 ~~~~------~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NIL  338 (472)
                      ..+.      .++|++++ +.+|..+++..           ..+...++.++.||+.||+|||++|  ||||||||+|||
T Consensus        88 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~-----------~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL  153 (346)
T d1cm8a_          88 PDETLDDFTDFYLVMPFM-GTDLGKLMKHE-----------KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLA  153 (346)
T ss_dssp             SCSSTTTCCCCEEEEECC-SEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEE
T ss_pred             cCccccccceEEEEEecc-cccHHHHHHhc-----------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhh
Confidence            7653      45565555 88888877432           1357889999999999999999999  999999999999


Q ss_pred             EcCCCcEEEeecccceecCCCccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Q 039082          339 LDDAKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEV  417 (472)
Q Consensus       339 l~~~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i  417 (472)
                      ++.++.+||+|||+|+..........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+  ........
T Consensus       154 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~--~~~~~~~~  231 (346)
T d1cm8a_         154 VNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD--HLDQLKEI  231 (346)
T ss_dssp             ECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHH
T ss_pred             cccccccccccccceeccCCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCC--hHHHHHHH
Confidence            999999999999999998877777889999999999876 457899999999999999999999997765  22222111


Q ss_pred             hc--CC------------------------CCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHH
Q 039082          418 GE--GK------------------------LRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCS  460 (472)
Q Consensus       418 ~~--~~------------------------~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~  460 (472)
                      ..  +.                        ....++.. ......+.+||.+||..||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         232 MKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             HHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11  00                        00011111 2334678899999999999999999999863

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=372.37  Aligned_cols=251  Identities=24%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             eeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC
Q 039082          190 WYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP  267 (472)
Q Consensus       190 ~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~  267 (472)
                      |.|+ ++|+++++||+|+||+||+|.++  |+.||||++.+.   ......+.+++|+.+|+.++|||||++++++....
T Consensus         4 ~~i~-~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           4 FDVG-PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF---EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCCC-TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT---TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCcC-CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh---cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            4444 35999999999999999999986  889999999753   24555677999999999999999999999987654


Q ss_pred             ----CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC
Q 039082          268 ----YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK  343 (472)
Q Consensus       268 ----~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~  343 (472)
                          ..+++++|+.+|+|.+++...           ..++..++.++.||+.||+|||++|  ||||||||+||||+.++
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~-----------~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~  146 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ-----------HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTC  146 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTC
T ss_pred             ccccceEEEEEeecCCchhhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCC
Confidence                346888999999999999532           1357889999999999999999999  99999999999999999


Q ss_pred             cEEEeecccceecCCC------ccccccCCccccccccc-CCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          344 HVRIADFGHARFLSDG------EMALTGTFVYMAPEVIQ-CEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       344 ~vkL~DFGla~~~~~~------~~~~~gt~~y~APE~~~-~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      .+||+|||+|......      ....+||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.+.  .+....
T Consensus       147 ~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~--~~~~~~  224 (345)
T d1pmea_         147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNH  224 (345)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHH
T ss_pred             CEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH--HHHHHH
Confidence            9999999999876532      23345899999999985 45678999999999999999999999977652  111111


Q ss_pred             Hhc--CC--------------------CCCCCCC-----CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGE--GK--------------------LRPALPE-----EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~--~~--------------------~~~~l~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...  +.                    .....+.     .+....++.++|.+||..||++|||++++++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            110  00                    0000000     0223356889999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-47  Score=376.78  Aligned_cols=252  Identities=23%  Similarity=0.297  Sum_probs=203.0

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC-----CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-CceeEEEEEEEc
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR-----GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQLMGACLE  265 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~-----g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~g~~~~  265 (472)
                      +..++|+++++||+|+||+||+|.+.     |+.||||++++.....+....+.+.+|+.+|++++| |||+++++++.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            45578999999999999999999872     678999999765432333344558899999999977 899999999999


Q ss_pred             CCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcE
Q 039082          266 PPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHV  345 (472)
Q Consensus       266 ~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~v  345 (472)
                      ....++++|++.+|+|..++...+.          .+......++.||+.||+|||++|  ||||||||+|||++.+|.+
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~----------~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~v  168 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRER----------FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHV  168 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCE
T ss_pred             CCceeeeeecccccHHHHHHHhccc----------ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCE
Confidence            9999999999999999999965442          135678888999999999999999  9999999999999999999


Q ss_pred             EEeecccceecCCCc----cccccCCcccccccccCC--CCCchHHHHHHHHHHHHHHcCCCCCCCCCCC--HHHHHHHH
Q 039082          346 RIADFGHARFLSDGE----MALTGTFVYMAPEVIQCE--PYSEKSDVYSFGIILNEIITGNHPYIEKDYK--PAKIAMEV  417 (472)
Q Consensus       346 kL~DFGla~~~~~~~----~~~~gt~~y~APE~~~~~--~~s~~sDvwSlGvll~elltG~~Pf~~~~~~--~~~i~~~i  417 (472)
                      ||+|||+|+.+....    ....|++.|+|||.+.+.  .++.++|||||||+||+|+||..||.+....  ...+....
T Consensus       169 kL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~  248 (322)
T d1vzoa_         169 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI  248 (322)
T ss_dssp             EESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH
T ss_pred             EEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999998775332    245689999999999754  4788999999999999999999999765432  22233322


Q ss_pred             hcCCCCCCCCCCchhHHHHHHHHHHhccCCCCCCCC-----HHHHHH
Q 039082          418 GEGKLRPALPEEDGQLRELIELICLSWDGDASVRPS-----FSSITC  459 (472)
Q Consensus       418 ~~~~~~~~l~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~~ll~  459 (472)
                      ..+  .+.+|  ...+.++.++|.+||..||++|||     ++++++
T Consensus       249 ~~~--~~~~~--~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 LKS--EPPYP--QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHC--CCCCC--TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccC--CCCCc--ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            232  22233  345678899999999999999994     788875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.7e-45  Score=359.47  Aligned_cols=257  Identities=19%  Similarity=0.241  Sum_probs=202.8

Q ss_pred             CCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC-CceeEEEEEEEcCCCce
Q 039082          194 PKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH-RFVLQLMGACLEPPYRG  270 (472)
Q Consensus       194 ~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H-pnIv~l~g~~~~~~~~~  270 (472)
                      .++|++.++||+|+||.||+|++.  |+.||||++......      ..+.+|+++++.+.| +|++.+++++.+....+
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~------~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~   77 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNV   77 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS------CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc------HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccE
Confidence            468999999999999999999986  789999998654221      236789999999965 89999999888777666


Q ss_pred             EEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC-----CCcE
Q 039082          271 WLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD-----AKHV  345 (472)
Q Consensus       271 ~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~-----~~~v  345 (472)
                      +|+++ ++++|.+++...+.         ..+...+..++.|++.||+|||++|  ||||||||+||||+.     ++.+
T Consensus        78 ~vme~-~~~~l~~~~~~~~~---------~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~v  145 (293)
T d1csna_          78 LVIDL-LGPSLEDLLDLCGR---------KFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMI  145 (293)
T ss_dssp             EEEEC-CCCBHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCE
T ss_pred             EEEEe-cCCCHHHHHHhhcc---------chhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCce
Confidence            66555 58999998865332         2356888999999999999999999  999999999999974     5789


Q ss_pred             EEeecccceecCCC----------ccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCC-HHHHH
Q 039082          346 RIADFGHARFLSDG----------EMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYK-PAKIA  414 (472)
Q Consensus       346 kL~DFGla~~~~~~----------~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~-~~~i~  414 (472)
                      ||+|||+|+...+.          .....||+.|+|||++.+..++.++|||||||++|||+||..||.+.... .....
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~  225 (293)
T d1csna_         146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY  225 (293)
T ss_dssp             EECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH
T ss_pred             EEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHH
Confidence            99999999986532          12346999999999999999999999999999999999999999865543 22222


Q ss_pred             HHHhcCCCCCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHHHHHHHHHHH
Q 039082          415 MEVGEGKLRPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITCSLKNIQMKV  468 (472)
Q Consensus       415 ~~i~~~~~~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~~L~~i~~~~  468 (472)
                      ..+.........+.. ...+.++.+++..||..+|++||+++.+.+.|+++..+.
T Consensus       226 ~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         226 ERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             HHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence            233222111111110 234467889999999999999999999999998887654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-45  Score=363.13  Aligned_cols=249  Identities=21%  Similarity=0.235  Sum_probs=189.0

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC------
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP------  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~------  266 (472)
                      ++|+++++||+|+||+||+|+++  |+.||||++..+..  .+.....+.+|+.+|+.++||||+++++++...      
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE--KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C--TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence            68999999999999999999986  78999999876532  334456688999999999999999999998663      


Q ss_pred             --CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCc
Q 039082          267 --PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKH  344 (472)
Q Consensus       267 --~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~  344 (472)
                        ...+++++++.++.+..+....          ...+...++.++.||+.||.|||++|  |+||||||+||||+.++.
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~----------~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~  155 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVL----------VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGV  155 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTT----------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSC
T ss_pred             cCceEEEEEeccCCCccchhhhcc----------cccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCc
Confidence              3356677777666555443221          12346778899999999999999999  999999999999999999


Q ss_pred             EEEeecccceecCCC-------ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Q 039082          345 VRIADFGHARFLSDG-------EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAME  416 (472)
Q Consensus       345 vkL~DFGla~~~~~~-------~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~  416 (472)
                      +||+|||+++.....       ....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+  .......
T Consensus       156 ~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~--~~~~~~~  233 (318)
T d3blha1         156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT--EQHQLAL  233 (318)
T ss_dssp             EEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHH
T ss_pred             EEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCC--HHHHHHH
Confidence            999999999876532       2234689999999998764 68999999999999999999999997765  3333222


Q ss_pred             Hhc--CCCCCCCC----------------C-Cc---------hhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          417 VGE--GKLRPALP----------------E-ED---------GQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       417 i~~--~~~~~~l~----------------~-~~---------~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      +..  +...+...                . ..         .....+.++|.+||..||++|||++++++
T Consensus       234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            211  11110000                0 00         01245678999999999999999999985

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-45  Score=355.26  Aligned_cols=250  Identities=21%  Similarity=0.222  Sum_probs=201.3

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCCCceEE
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPPYRGWL  272 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~~~~~v  272 (472)
                      ++|+++++||+|+||+||+|+++  |+.||||+++.+.  ..+.....+.+|+.+|+.++|||||++++++.+.+..+++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC--SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh--CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            58999999999999999999986  6789999997653  3445677899999999999999999999999999999999


Q ss_pred             EEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEEEeeccc
Q 039082          273 VTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVRIADFGH  352 (472)
Q Consensus       273 ve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vkL~DFGl  352 (472)
                      ++++.+++|..++...+.          .+...++.++.|++.||+|||++|  ||||||||+|||++.++.+||+|||.
T Consensus        80 ~~~~~~~~l~~~~~~~~~----------~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~  147 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGD----------LDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGL  147 (292)
T ss_dssp             EECCSEEHHHHHHHTTTC----------CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTT
T ss_pred             eeeccccccccccccccc----------cchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecch
Confidence            999989988887754322          246788999999999999999999  99999999999999999999999999


Q ss_pred             ceecCCCcc---ccccCCcccccccccCCC-CCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc--CCC----
Q 039082          353 ARFLSDGEM---ALTGTFVYMAPEVIQCEP-YSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE--GKL----  422 (472)
Q Consensus       353 a~~~~~~~~---~~~gt~~y~APE~~~~~~-~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~--~~~----  422 (472)
                      |+.......   ...+++.|+|||.+.... ++.++|||||||++|||++|+.||..... ..+....+..  +..    
T Consensus       148 a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~  226 (292)
T d1unla_         148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-VDDQLKRIFRLLGTPTEEQ  226 (292)
T ss_dssp             CEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-HHHHHHHHHHHHCCCCTTT
T ss_pred             hhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-HHHHHHHHHhhcCCCChhh
Confidence            998764332   334688999999987654 69999999999999999999999755442 2222222211  000    


Q ss_pred             ------------------CCCCCCC-chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          423 ------------------RPALPEE-DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       423 ------------------~~~l~~~-~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                        ....... ......+.++|.+||..||.+|||++++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                              0000001 233467889999999999999999999875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-45  Score=370.00  Aligned_cols=253  Identities=24%  Similarity=0.312  Sum_probs=202.6

Q ss_pred             ceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC
Q 039082          189 GWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP  266 (472)
Q Consensus       189 ~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~  266 (472)
                      -|.++ ++|+++++||+|+||+||+|+++  |+.||||++.+..  .+....+.+.+|+.+|+.++|||||++++++...
T Consensus        13 ~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          13 IWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF--QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             EEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT--SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             cccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh--cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            47774 78999999999999999999986  8899999997653  2445566789999999999999999999998643


Q ss_pred             -----CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcC
Q 039082          267 -----PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDD  341 (472)
Q Consensus       267 -----~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~  341 (472)
                           ...+++++|+.||+|.+++...           ..+...+..++.||+.||+|||++|  |+||||||+|||++.
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~-----------~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~  156 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKCQ-----------KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNE  156 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTTC-----------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECT
T ss_pred             cccccCceEEEEEeecCCchhhhcccc-----------cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccc
Confidence                 3457899999999999998532           1357889999999999999999999  999999999999999


Q ss_pred             CCcEEEeecccceecCCCccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhcC
Q 039082          342 AKHVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGEG  420 (472)
Q Consensus       342 ~~~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~~  420 (472)
                      +|.+|++|||++...........|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+  .......+...
T Consensus       157 ~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~--~~~~~~~i~~~  234 (348)
T d2gfsa1         157 DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD--HIDQLKLILRL  234 (348)
T ss_dssp             TCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS--HHHHHHHHHHH
T ss_pred             cccccccccchhcccCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCC--HHHHHHHHHHh
Confidence            9999999999998887777777899999999987665 56899999999999999999999998765  22222222211


Q ss_pred             CCC---------------------CCCCCC------chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          421 KLR---------------------PALPEE------DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       421 ~~~---------------------~~l~~~------~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                      ...                     ...+..      ......+.+||.+||..||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            100                     011110      123467889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-44  Score=361.73  Aligned_cols=245  Identities=21%  Similarity=0.277  Sum_probs=187.8

Q ss_pred             CeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcCC------
Q 039082          196 EIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEPP------  267 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~~------  267 (472)
                      +|+.+++||+|+||+||+|+++  |+.||||+++.+...        +.+|+.+|+.++|||||+++++|....      
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~--------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~   92 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF--------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV   92 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS--------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH--------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence            6899999999999999999996  789999999765321        347999999999999999999986432      


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vk  346 (472)
                      ..++|+||+. +++...+.....      .....++..+..++.||+.||+|||++|  |+||||||+|||++.++ .+|
T Consensus        93 ~~~lv~Ey~~-~~~~~~l~~~~~------~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~k  163 (350)
T d1q5ka_          93 YLNLVLDYVP-ETVYRVARHYSR------AKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLK  163 (350)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHH------TTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEE
T ss_pred             EEEEEEeccC-CccHHHHHhhhh------ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCcee
Confidence            2456666664 445444432111      1123457889999999999999999999  99999999999999775 899


Q ss_pred             EeecccceecCCC--ccccccCCcccccccccC-CCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHhc----
Q 039082          347 IADFGHARFLSDG--EMALTGTFVYMAPEVIQC-EPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVGE----  419 (472)
Q Consensus       347 L~DFGla~~~~~~--~~~~~gt~~y~APE~~~~-~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~~----  419 (472)
                      |+|||++......  .....|++.|+|||.+.+ ..|+.++|||||||++|||++|+.||...+  ..+....+.+    
T Consensus       164 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~--~~~~l~~i~~~~g~  241 (350)
T d1q5ka_         164 LCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS--GVDQLVEIIKVLGT  241 (350)
T ss_dssp             ECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS--HHHHHHHHHHHHCC
T ss_pred             EecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCC--HHHHHHHHHHHhCC
Confidence            9999999887643  344578999999998765 578999999999999999999999997765  3333322211    


Q ss_pred             -----------CCCCCCCCC----------CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          420 -----------GKLRPALPE----------EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       420 -----------~~~~~~l~~----------~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                 ......++.          .+....++.+||.+||..||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       111111111          1234567899999999999999999999985

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=6.9e-44  Score=354.63  Aligned_cols=244  Identities=20%  Similarity=0.300  Sum_probs=192.7

Q ss_pred             CCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcC--C
Q 039082          193 DPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEP--P  267 (472)
Q Consensus       193 ~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~--~  267 (472)
                      ..++|+++++||+|+||+||+|+++  |+.||||++++.       ..+.+.+|+.+|+.++ ||||++++++|...  .
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-------KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            3468999999999999999999986  789999998643       1345889999999995 99999999998754  4


Q ss_pred             CceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCC-cEE
Q 039082          268 YRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAK-HVR  346 (472)
Q Consensus       268 ~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~-~vk  346 (472)
                      ..++|||++.+++|..+.+             ..+...+..++.||+.||+|||++|  ||||||||+||||+.++ .+|
T Consensus       106 ~~~~v~e~~~~~~L~~~~~-------------~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vk  170 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLYQ-------------TLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLR  170 (328)
T ss_dssp             SEEEEEECCCSCBGGGTTT-------------SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEE
T ss_pred             ceeEEEeecCCCcHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeee
Confidence            5788999999999876542             1346778999999999999999999  99999999999998655 699


Q ss_pred             EeecccceecCCC--ccccccCCcccccccccCC-CCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh-----
Q 039082          347 IADFGHARFLSDG--EMALTGTFVYMAPEVIQCE-PYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG-----  418 (472)
Q Consensus       347 L~DFGla~~~~~~--~~~~~gt~~y~APE~~~~~-~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~-----  418 (472)
                      |+|||+|+.....  .....||+.|+|||.+.+. .++.++|||||||++|+|++|+.||........ ....+.     
T Consensus       171 l~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~-~~~~i~~~~g~  249 (328)
T d3bqca1         171 LIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGT  249 (328)
T ss_dssp             ECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCH
T ss_pred             ecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHH-HHHHHHHHHCC
Confidence            9999999887643  3445689999999998765 579999999999999999999999976542211 111100     


Q ss_pred             --------cCCC--------------CC----CCCC--CchhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 --------EGKL--------------RP----ALPE--EDGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 --------~~~~--------------~~----~l~~--~~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                              ....              +.    ..+.  ......++.+||.+||..||++|||++++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                    0000              00    0000  1234567899999999999999999999975

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-44  Score=358.09  Aligned_cols=246  Identities=22%  Similarity=0.236  Sum_probs=186.6

Q ss_pred             CCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCCCceeEEEEEEEcC------
Q 039082          195 KEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRHRFVLQLMGACLEP------  266 (472)
Q Consensus       195 ~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~HpnIv~l~g~~~~~------  266 (472)
                      ++|+++++||+|+||+||+|.++  |..||||++.+...  +......+.+|+.+|+.++|||||+++++|...      
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~--~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ--NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS--SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc--CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            57999999999999999999986  88999999987643  455667789999999999999999999999754      


Q ss_pred             CCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCCCcEE
Q 039082          267 PYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDAKHVR  346 (472)
Q Consensus       267 ~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~~~vk  346 (472)
                      ...|+|+|++. +++...+..            ..++..++.++.||+.||+|||++|  |+||||||+|||++.++.+|
T Consensus        95 ~~~~iv~Ey~~-~~l~~~~~~------------~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~k  159 (355)
T d2b1pa1          95 QDVYLVMELMD-ANLCQVIQM------------ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK  159 (355)
T ss_dssp             CEEEEEEECCS-EEHHHHHTS------------CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEE
T ss_pred             ceeEEEEeccc-hHHHHhhhc------------CCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCcccccccccccee
Confidence            34566777664 555554421            1246888999999999999999999  99999999999999999999


Q ss_pred             EeecccceecCCCc--cccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCCCHHHHHHHHh------
Q 039082          347 IADFGHARFLSDGE--MALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDYKPAKIAMEVG------  418 (472)
Q Consensus       347 L~DFGla~~~~~~~--~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~~~~~i~~~i~------  418 (472)
                      ++|||+++......  ....||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+  .......+.      
T Consensus       160 l~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~--~~~~~~~i~~~~~~~  237 (355)
T d2b1pa1         160 ILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLGTP  237 (355)
T ss_dssp             ECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS--HHHHHHHHHHHHCCC
T ss_pred             eechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCC--HHHHHHHHHHhccCC
Confidence            99999988766432  34468999999999999999999999999999999999999997765  222222111      


Q ss_pred             ----------------cCCCCC------------CCCCC----chhHHHHHHHHHHhccCCCCCCCCHHHHHH
Q 039082          419 ----------------EGKLRP------------ALPEE----DGQLRELIELICLSWDGDASVRPSFSSITC  459 (472)
Q Consensus       419 ----------------~~~~~~------------~l~~~----~~~~~~l~~li~~cl~~dP~~RPs~~~ll~  459 (472)
                                      .+....            ..+..    .....++.+||.+||..||++|||++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             CHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                            110000            00000    224567899999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-39  Score=327.66  Aligned_cols=253  Identities=18%  Similarity=0.244  Sum_probs=187.9

Q ss_pred             eCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-----------CCceeE
Q 039082          192 IDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-----------HRFVLQ  258 (472)
Q Consensus       192 i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-----------HpnIv~  258 (472)
                      +...+|+++++||+|+||+||+|+++  |..||||+++++     ....+.+.+|+.+++.++           |+|||+
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~   84 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   84 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence            44567999999999999999999985  789999999653     334456788999988875           578999


Q ss_pred             EEEEEEcCC--CceEEEEeccCC-cHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCceeecCCCC
Q 039082          259 LMGACLEPP--YRGWLVTELLGT-TLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHE-QKPKVIHRDLKP  334 (472)
Q Consensus       259 l~g~~~~~~--~~~~vve~~~gg-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~-~~~~iiHrDLkp  334 (472)
                      +++++....  ..++++++...+ ....+.....        ....+...+..++.||+.||+|||+ .|  |+||||||
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp  154 (362)
T d1q8ya_          85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--------HRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKP  154 (362)
T ss_dssp             CCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTT--------TSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSG
T ss_pred             EEEEeeeccccceeeeeeeccccccccccccccc--------ccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCCh
Confidence            999886543  344455555433 3333332111        2234567889999999999999998 88  99999999


Q ss_pred             CcEEEcCCC------cEEEeecccceecCCCccccccCCcccccccccCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCC
Q 039082          335 SNIFLDDAK------HVRIADFGHARFLSDGEMALTGTFVYMAPEVIQCEPYSEKSDVYSFGIILNEIITGNHPYIEKDY  408 (472)
Q Consensus       335 ~NILl~~~~------~vkL~DFGla~~~~~~~~~~~gt~~y~APE~~~~~~~s~~sDvwSlGvll~elltG~~Pf~~~~~  408 (472)
                      +||||+.++      .++|+|||.+...........||+.|+|||++.+..|+.++||||+||++++|++|+.||...+.
T Consensus       155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~  234 (362)
T d1q8ya_         155 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG  234 (362)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred             hHeeeeccCcccccceeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence            999998655      39999999999888777778899999999999999999999999999999999999999975432


Q ss_pred             C----HHHHHHHHhc--C------------------------CCCC------------CCCCCchhHHHHHHHHHHhccC
Q 039082          409 K----PAKIAMEVGE--G------------------------KLRP------------ALPEEDGQLRELIELICLSWDG  446 (472)
Q Consensus       409 ~----~~~i~~~i~~--~------------------------~~~~------------~l~~~~~~~~~l~~li~~cl~~  446 (472)
                      .    ..........  |                        ....            ...........+.+||.+||..
T Consensus       235 ~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  314 (362)
T d1q8ya_         235 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL  314 (362)
T ss_dssp             ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred             ccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCC
Confidence            1    1111100000  0                        0000            0001134567889999999999


Q ss_pred             CCCCCCCHHHHHH
Q 039082          447 DASVRPSFSSITC  459 (472)
Q Consensus       447 dP~~RPs~~~ll~  459 (472)
                      ||.+|||++++++
T Consensus       315 dP~~Rpta~e~L~  327 (362)
T d1q8ya_         315 DPRKRADAGGLVN  327 (362)
T ss_dssp             STTTCBCHHHHHT
T ss_pred             ChhHCcCHHHHhc
Confidence            9999999999975

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=1.9e-24  Score=197.00  Aligned_cols=166  Identities=13%  Similarity=0.100  Sum_probs=117.2

Q ss_pred             eEeceeeccCceEEEEEEEC-CeeEEEEEeccCCCCC--------------ChHHHHHHHHHHHHHHhcCCCceeEEEEE
Q 039082          198 DLQEKIGQGTTANIYRAIWR-GLDVAVKCIYPDFFHT--------------NENAVTFFAQEVDTLSRQRHRFVLQLMGA  262 (472)
Q Consensus       198 ~l~~~LG~G~fG~Vy~a~~~-g~~vAVK~l~~~~~~~--------------~~~~~~~f~~E~~il~~l~HpnIv~l~g~  262 (472)
                      .+.++||+|+||.||+|.+. |..||||+++......              .......+.+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            57899999999999999875 8899999986532210              01122445678899999999999998865


Q ss_pred             EEcCCCceEEEEeccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhcCCceeecCCCCCcEEEcCC
Q 039082          263 CLEPPYRGWLVTELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQKPKVIHRDLKPSNIFLDDA  342 (472)
Q Consensus       263 ~~~~~~~~~vve~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~~~~iiHrDLkp~NILl~~~  342 (472)
                      .    ..+++|+++.+..+..+                 +......++.|++.||+|||++|  |+||||||+|||++++
T Consensus        83 ~----~~~lvme~~~~~~~~~l-----------------~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~  139 (191)
T d1zara2          83 E----GNAVLMELIDAKELYRV-----------------RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE  139 (191)
T ss_dssp             E----TTEEEEECCCCEEGGGC-----------------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT
T ss_pred             c----CCEEEEEeeccccccch-----------------hhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC
Confidence            2    23567777766544221                 11225578899999999999999  9999999999999965


Q ss_pred             CcEEEeecccceecCCCccccccCCccccc------ccccCCCCCchHHHHHHHHHH
Q 039082          343 KHVRIADFGHARFLSDGEMALTGTFVYMAP------EVIQCEPYSEKSDVYSFGIIL  393 (472)
Q Consensus       343 ~~vkL~DFGla~~~~~~~~~~~gt~~y~AP------E~~~~~~~s~~sDvwSlGvll  393 (472)
                      + ++|+|||.|.....+...     .|...      +. ..+.|+.++|+||+.--+
T Consensus       140 ~-~~liDFG~a~~~~~~~~~-----~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 G-IWIIDFPQSVEVGEEGWR-----EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             E-EEECCCTTCEETTSTTHH-----HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             C-EEEEECCCcccCCCCCcH-----HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            4 899999999876533211     11111      11 135678889999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.49  E-value=9.8e-07  Score=81.51  Aligned_cols=141  Identities=18%  Similarity=0.138  Sum_probs=91.7

Q ss_pred             CeeEeceeeccCceEEEEEEECCeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCceeEEEEEEEcCCCceEEEE
Q 039082          196 EIDLQEKIGQGTTANIYRAIWRGLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFVLQLMGACLEPPYRGWLVT  274 (472)
Q Consensus       196 ~~~l~~~LG~G~fG~Vy~a~~~g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnIv~l~g~~~~~~~~~~vve  274 (472)
                      .|++.+..+-++.+.||+....+..+.||.........    ...+.+|+..+..+. +--+.+++.++..++..++|++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~----~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT----TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS----TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc----hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            45666665555667999988778889999875432211    223667888887773 3235667777777777888999


Q ss_pred             eccCCcHHHHHhhcccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------
Q 039082          275 ELLGTTLKEWLHGLGSQRRKERMVPLPPFEERLARALEIAQAMQYLHEQ-------------------------------  323 (472)
Q Consensus       275 ~~~ggsL~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qia~gL~yLH~~-------------------------------  323 (472)
                      ++.|.++.........               ...++.+++..|+.||+.                               
T Consensus        91 ~l~G~~~~~~~~~~~~---------------~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          91 EADGVLCSEEYEDEQS---------------PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             CCSSEEHHHHTTTCSC---------------HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             eccccccccccccccc---------------HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence            9988887654321100               112233333344444421                               


Q ss_pred             --------------------------CCceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          324 --------------------------KPKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       324 --------------------------~~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                                                ...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                      11389999999999999877677999998853

>d2oq1a1 d.93.1.1 (A:5-134) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine-protein kinase zap-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.44  E-value=6.7e-11  Score=99.19  Aligned_cols=108  Identities=8%  Similarity=0.034  Sum_probs=73.5

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC----
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH----  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~----  159 (472)
                      +++-|+++..-.++|||| +|++..|.|+|||..++.|+||+|....++.|.+     .....|+++..++.+|+.    
T Consensus        18 Ae~~L~~~g~~~G~FLVR-~S~~~~g~yvLSv~~~~~v~H~~I~~~~~g~~~l-----~~~~~F~sl~~Lv~~Y~~~~~g   91 (130)
T d2oq1a1          18 AEEHLKLAGMADGLFLLR-QCLRSLGGYVLSLVHDVRFHHFPIERQLNGTYAI-----AGGKAHCGPAELCEFYSRDPDG   91 (130)
T ss_dssp             HHHHHHHTTCCTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCEEE-----TTSCCBSSHHHHHHHHHHCCTT
T ss_pred             HHHHHHhcCCCCceEEEE-ecCCCCccEEEEEeeCCceEEEEEEEcCCCceec-----cCCCCcCCHHHHHHHHhhCCCC
Confidence            334444444456999999 9999999999999999999999999888888844     334568888888877653    


Q ss_pred             -CCccccccCCCCcccccchhhhhhhcccCceeeCCCCeeEeceeeccCceEEEE
Q 039082          160 -QTPLHRYCSQTPLLQQSDLAVTVSQAKMNGWYIDPKEIDLQEKIGQGTTANIYR  213 (472)
Q Consensus       160 -~~~l~~~~~~~p~~~~~~~~~~~~~~~~~~~~i~~~~~~l~~~LG~G~fG~Vy~  213 (472)
                       .++|..+|........          ....|.      .+.+.+|+|.||.||+
T Consensus        92 L~~~L~~P~~r~~~~~~----------~~~~~~------~~~~~~~~~~~~~~w~  130 (130)
T d2oq1a1          92 LPCNLRKPCNRPSGLEP----------QPGVFD------CLRDAMVRDYVRQTWK  130 (130)
T ss_dssp             SSSCCCSBCCCCTTCCC----------BCCHHH------HHHHHHHHHHHHHHHC
T ss_pred             CCccCCccCCCCCCCCC----------CcchHH------HHHHHHHHhhccCccC
Confidence             3445556643322110          111111      1346889999998874

>d1i3za_ d.93.1.1 (A:) Ews/fli1 activated transcript 2, Eat2 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Ews/fli1 activated transcript 2, Eat2
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=98.11  E-value=6.8e-09  Score=83.18  Aligned_cols=72  Identities=8%  Similarity=-0.007  Sum_probs=58.1

Q ss_pred             HHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           87 EVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        87 ~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++.+....++|||| +|++.+|.|+|||..++.|+||+|....++.|.+..........|+++..++.+|..
T Consensus        17 ~lL~~~~~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~~~~~~~~~~~~F~sl~~LV~~y~~   88 (103)
T d1i3za_          17 ALLLKGGVDGNFLIR-DSESVPGALCLCVSFKKLVYSYRIFREKHGYYRIETDAHTPRTIFPNLQELVSKYGK   88 (103)
T ss_dssp             HHHHTTCSTTEEEEE-ECSSSTTCEEEEEECSSSEEEEEEEECTTSCEEECBCTTSCCCEESSSHHHHHHTTS
T ss_pred             HHHHhCCCCCeEEEE-ecCCCCCCEEEEEEeCCeEEEEEeEEcCCCcEEEeccCCcCccccCCHHHHHHHhhh
Confidence            344444456999999 999999999999999999999999888888887665555556678889888887764

>d1a81a1 d.93.1.1 (A:9-137) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Syk tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.01  E-value=1.4e-08  Score=84.61  Aligned_cols=76  Identities=11%  Similarity=0.037  Sum_probs=59.1

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCCC-----Cc
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSHQ-----TP  162 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~~-----~~  162 (472)
                      |.++..-.++|||| +|++..|.|+|||..++.|+||+|....++.|     +......|+++..++.+|...     ++
T Consensus        21 L~~~g~~dG~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~i~~~~~F~sl~eLV~~Y~~~~~gl~~~   94 (129)
T d1a81a1          21 LVQGGMSDGLYLLR-QSRNYLGGFALSVAHGRKAHHYTIERELNGTY-----AIAGGRTHASPADLCHYHSQESDGLVCL   94 (129)
T ss_dssp             HHHTTCCTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCE-----EETTSCCBSSHHHHHHHHTTCCTTSSSC
T ss_pred             HHhcCCCCccEEEE-ccCCCCcceEEEeeecccceEEEEEEcCCCCe-----eecCCcccCCHHHHHHHHhhCCCCCccc
Confidence            33333355999999 99999999999999999999999998888888     445556689999998888752     34


Q ss_pred             cccccCC
Q 039082          163 LHRYCSQ  169 (472)
Q Consensus       163 l~~~~~~  169 (472)
                      |..+|+.
T Consensus        95 L~~P~~~  101 (129)
T d1a81a1          95 LKKPFNR  101 (129)
T ss_dssp             CCEECCC
T ss_pred             CCCCCCC
Confidence            5556643

>d1qcfa2 d.93.1.1 (A:146-248) Hemopoetic cell kinase Hck {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Hemopoetic cell kinase Hck
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.01  E-value=1.1e-08  Score=81.89  Aligned_cols=70  Identities=9%  Similarity=0.017  Sum_probs=55.3

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHh-----hcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIA-----QDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~-----~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      +++.|.++..-.++|||| +|++.+|.|+|||.     .+..|+||+|...+++.|     +..+...|+++..++.+|.
T Consensus        13 Ae~~L~~~~~~~G~FLVR-~S~~~~g~~~Lsv~~~~~~~~~~v~H~~i~~~~~g~~-----~~~~~~~F~sl~~LV~~y~   86 (103)
T d1qcfa2          13 AERQLLAPGNMLGSFMIR-DSETTKGSYSLSVRDYDPRQGDTVKHYKIRTLDNGGF-----YISPRSTFSTLQELVDHYK   86 (103)
T ss_dssp             HHHHHHSTTCCTTCEEEE-ECSSSTTSEEEEEEEEETTTEEEEEEEEEEECTTSCE-----ESSSSSCBSSHHHHHHHHT
T ss_pred             HHHHHhhcCCCCCcEEEE-ccCCCCCCeEEEEEecCCCcCceEEEEEEEEcCCCce-----eecCCcccCCHHHHHHHHh
Confidence            444454555567999999 99999999999993     467899999999988888     5555567889988887766


Q ss_pred             C
Q 039082          159 H  159 (472)
Q Consensus       159 ~  159 (472)
                      .
T Consensus        87 ~   87 (103)
T d1qcfa2          87 K   87 (103)
T ss_dssp             S
T ss_pred             h
Confidence            4

>d1rjaa_ d.93.1.1 (A:) Tyrosine-protein kinase 6 (Breast tumor kinase, Brk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine-protein kinase 6 (Breast tumor kinase, Brk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.98  E-value=2.7e-09  Score=85.07  Aligned_cols=69  Identities=9%  Similarity=0.057  Sum_probs=53.5

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++-|+++..-.++|||| +|++..|.|+|||..++.|+||+|...++++|     +......|+++..++.+|..
T Consensus        15 e~~L~~~~~~~G~FLvR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~   83 (100)
T d1rjaa_          15 VRRLQAEGNATGAFLIR-VSEKPSADYVLSVRDTQAVRHYKIWRRAGGRL-----HLNEAVSFLSLPELVNYHRA   83 (100)
T ss_dssp             HHHHSSTTCSSCCEEEE-ECSSSSSCEEEEECTTSSCEEEEEEECSSSCE-----EEETTEEESSHHHHHHHHHH
T ss_pred             HHHHhccCCCCCeEEee-cCCCCCCCEEEEEEcCCCceEEEEEECCCCCE-----EecCCCccCCHHHHHHHHhh
Confidence            33333333345899999 99999999999999999999999998888888     44444568888888877653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=3.1e-05  Score=70.61  Aligned_cols=146  Identities=18%  Similarity=0.131  Sum_probs=81.3

Q ss_pred             eeeccC-ceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcCC--CceeEEEEEEEcCCCceEEEEecc
Q 039082          202 KIGQGT-TANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQRH--RFVLQLMGACLEPPYRGWLVTELL  277 (472)
Q Consensus       202 ~LG~G~-fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~H--pnIv~l~g~~~~~~~~~~vve~~~  277 (472)
                      .+..|. -+.||+.... +..+++|.......  .     .+..|+..|+.+..  -.+.+++++..+.+..++|++++.
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~--~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~   89 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL--N-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   89 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT--S-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH--h-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence            334444 3679998876 45689997755421  1     26678888877732  235667777777777788888887


Q ss_pred             CCcHHH--------------HHhhcccccccccCCCCCCHHHHHHHHH--------------------HHHHHHHHHHhc
Q 039082          278 GTTLKE--------------WLHGLGSQRRKERMVPLPPFEERLARAL--------------------EIAQAMQYLHEQ  323 (472)
Q Consensus       278 ggsL~~--------------~l~~~~~~~~~~~~~~~~~~~~~~~i~~--------------------qia~gL~yLH~~  323 (472)
                      |.++..              .+........... ..............                    .....+..+...
T Consensus        90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATC-PFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGC-CCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             ccccccccccHHHHHHHHHHHHHHHccCChhhC-CCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence            755421              1111110000000 00000110000000                    112223333332


Q ss_pred             C-----CceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          324 K-----PKVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       324 ~-----~~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      .     +.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            1     1389999999999999877778999998754

>d1d4ta_ d.93.1.1 (A:) The Xlp protein Sap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: The Xlp protein Sap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.80  E-value=6.1e-08  Score=77.50  Aligned_cols=70  Identities=10%  Similarity=-0.041  Sum_probs=54.9

Q ss_pred             HHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           89 QRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        89 ~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++....++|||| +|++..|.|+|||..++.|+||+|...+++.+.+..........|+++..++.+|..
T Consensus        20 L~~~~~~G~FLVR-~S~~~~g~~~Lsv~~~~~v~H~~I~~~~~~~~~~~~~~~~~~~~F~sl~~Li~~y~~   89 (104)
T d1d4ta_          20 LLATGLDGSYLLR-DSESVPGVYCLCVLYHGYIYTYRVSQTETGSWSAETAPGVHKRYFRKIKNLISAFQK   89 (104)
T ss_dssp             HHHHCCTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEEECTTSCEEECBCTTSCCCCBSSHHHHHHHHTS
T ss_pred             HhhCCCCCeEEEE-ecCCCCCCEEEEEecCCCceEEEEEEcCCCcEEEeeccCCCCcccCCHHHHHHHHhh
Confidence            3333345999999 999999999999999999999999998888875554444555678888888777653

>d2oq1a2 d.93.1.1 (A:135-258) Tyrosine-protein kinase zap-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine-protein kinase zap-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.77  E-value=2.8e-08  Score=82.14  Aligned_cols=60  Identities=7%  Similarity=-0.059  Sum_probs=48.6

Q ss_pred             HHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           93 ELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        93 ~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .-.++|||| +|+. .|.|+|||..++.|+||+|....++.|     .......|+++..++.+|..
T Consensus        50 ~~dGtFLVR-~S~~-~g~yvLSv~~~~~v~H~~I~~~~~g~~-----~l~~~~~F~sl~~LV~~y~~  109 (124)
T d2oq1a2          50 QTDGKFLLR-PRKE-QGTYALSLIYGKTVYHYLISQDKAGKY-----CIPEGTKFDTLWQLVEYLKL  109 (124)
T ss_dssp             CCTTEEEEE-ECSS-TTEEEEEEEETTEEEEEEEEECTTSCE-----ESTTSCCBSSHHHHHHHHHH
T ss_pred             CCCceEEeE-ecCC-CCCEEEEeecCCceEEEEEEECCCCCE-----EeCCCcccCCHHHHHHHHhh
Confidence            445999999 7765 688999999999999999999888888     33445668888888877763

>d1lkka_ d.93.1.1 (A:) p56-lck tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: p56-lck tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.71  E-value=3.4e-08  Score=79.26  Aligned_cols=69  Identities=12%  Similarity=0.070  Sum_probs=52.7

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhh-----cCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIAQ-----DNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~-----~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++-|+++....++|||| +|++.+|.|+|||..     +..|+||.|...+++.|     +..+...|+++..++.+|+.
T Consensus        17 e~~L~~~~~~~GtFLVR-~S~~~~g~~~lsv~~~~~~~~~~v~h~~i~~~~~~~~-----~~~~~~~F~sl~~LV~~y~~   90 (105)
T d1lkka_          17 ERQLLAPGNTHGSFLIR-ESESTAGSFSLSVRDFDQNQGEVVKHYKIRNLDNGGF-----YISPRITFPGLHELVRHYTN   90 (105)
T ss_dssp             HHHHTSTTCCTTCEEEE-ECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCE-----ESSTTSCBSSHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCcEEEE-ccCCCCCCEEEEEEEcccCCCccEEEEEEEEcCCCCE-----EecCCcccCCHHHHHHHHhh
Confidence            33444444556999999 999999999999933     34599999999888888     55555678899888876653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.71  E-value=0.00013  Score=71.36  Aligned_cols=90  Identities=14%  Similarity=0.158  Sum_probs=50.5

Q ss_pred             CceeeCCCCeeEeceeeccCceEEEEEEEC--CeeEEEEEeccCCCCCC---hHHHHHHHHHHHHHHhcC-C--CceeEE
Q 039082          188 NGWYIDPKEIDLQEKIGQGTTANIYRAIWR--GLDVAVKCIYPDFFHTN---ENAVTFFAQEVDTLSRQR-H--RFVLQL  259 (472)
Q Consensus       188 ~~~~i~~~~~~l~~~LG~G~fG~Vy~a~~~--g~~vAVK~l~~~~~~~~---~~~~~~f~~E~~il~~l~-H--pnIv~l  259 (472)
                      .++......++ .+.||.|....||+....  +..|+||.-.+......   .........|++.|+.+. +  ..+.++
T Consensus        20 lg~~~~~~~l~-~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v   98 (392)
T d2pula1          20 LGLFPSKSTLT-CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRV   98 (392)
T ss_dssp             TTC-----CCE-EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCE
T ss_pred             cCCCCCCCCee-EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceE
Confidence            34433444444 557899999999999754  56799997544211100   111223446888887662 2  346666


Q ss_pred             EEEEEcCCCceEEEEeccCCc
Q 039082          260 MGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       260 ~g~~~~~~~~~~vve~~~ggs  280 (472)
                      +.+  +++..++|||++.+..
T Consensus        99 ~~~--d~~~~~lvmE~L~~~~  117 (392)
T d2pula1          99 FYS--DTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             EEE--ETTTTEEEECCCTTSE
T ss_pred             EEE--cCCCCEEEEeccCCcc
Confidence            654  4555668888886643

>d1a81a2 d.93.1.1 (A:138-262) Syk tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Syk tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.70  E-value=6.1e-08  Score=80.22  Aligned_cols=66  Identities=11%  Similarity=-0.030  Sum_probs=50.5

Q ss_pred             HHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           87 EVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        87 ~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -++++..-.++|||| +|+. .+.|+|||..++.|+||+|...++++|     ...+...|+++..++.+|..
T Consensus        44 lL~~~g~~~G~FLVR-~S~~-~~~yvLSv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sL~~LI~~y~~  109 (125)
T d1a81a2          44 IVLIGSKTNGKFLIR-ARDN-NGSYALCLLHEGKVLHYRIDKDKTGKL-----SIPEGKKFDTLWQLVEHYSY  109 (125)
T ss_dssp             HHHSSCCCTTCEEEE-ECSS-SSCEEEEEEETTEEEEEEEEECTTSCE-----ECTTSCCBSCHHHHHHHHTT
T ss_pred             HHHhcCCCCceEEEE-ecCC-CCCEEEEeeccccceeEeeeEcCCCcE-----eccCCcccCCHHHHHHHHhh
Confidence            333344446999999 7765 578999999999999999998888888     44444568888888876653

>d1opka2 d.93.1.1 (A:140-240) Abl tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Abl tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.68  E-value=1e-07  Score=75.75  Aligned_cols=60  Identities=15%  Similarity=0.132  Sum_probs=50.2

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++..|.|+|||..++.|+||+|....++.|     ...+...|+++..++.+|..
T Consensus        25 ~~G~FLVR-~S~~~~~~~~LSv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sl~~LI~~y~~   84 (101)
T d1opka2          25 INGSFLVR-ESESSPGQRSISLRYEGRVYHYRINTASDGKL-----YVSSESRFNTLAELVHHHST   84 (101)
T ss_dssp             CTTEEEEE-ECSSSTTCEEEEEEETTEEEEEECEECTTSCE-----ESSTTSCBSSHHHHHHHHTT
T ss_pred             CCCeEEEE-ecCCCCCCEEEEEEcCcceEEEEeEECCCCCE-----EeCCCcccCCHHHHHHHHhh
Confidence            46899999 99999999999999999999999999888888     44445568888888877654

>d1nrva_ d.93.1.1 (A:) Growth factor receptor-bound protein 10, GRB10 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Growth factor receptor-bound protein 10, GRB10
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.66  E-value=9.5e-08  Score=76.56  Aligned_cols=74  Identities=11%  Similarity=0.058  Sum_probs=48.9

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++-|.++..-.++|||| +|++.+|.|+|||..++.|+||+|....++...... -......|+++..++.+|..
T Consensus        17 Ae~lL~~~g~~dG~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~~~~~~~~-~~~~~~~F~sl~~LV~~y~~   90 (105)
T d1nrva_          17 SHRIIKQQGLVDGLFLLR-DSQSNPKAFVLTLCHHQKIKNFQILPCEDDGQTFFS-LDDGNTKFSDLIQLVDFYQL   90 (105)
T ss_dssp             HHHHHHHTTCCTTEEEEE-ECSSCTTCEEEEEEETTEEEEEEEEEC-----CCEE-SSTTSSCBSSHHHHHHHHTT
T ss_pred             HHHHHhhcCCCCceEEEE-eCCCCCCCEEEEEEECCceeEEEEEEecCCCeEEEE-ECCCCcccCCHHHHHHHhcc
Confidence            333344444446999999 999999999999999999999999876653221101 11223467888888877754

>d1k9aa2 d.93.1.1 (A:77-177) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=5e-08  Score=77.67  Aligned_cols=57  Identities=9%  Similarity=-0.042  Sum_probs=46.8

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      .++|||| +|++..|.|+|||..++.|+||+|...++ .|     +......|+++..++.+|.
T Consensus        25 ~G~FLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~-~~-----~~~~~~~F~sl~~LV~~y~   81 (101)
T d1k9aa2          25 TGLFLVR-ESTNYPGDYTLCVSCEGKVEHYRIMYHAS-KL-----SIDEEVYFENLMQLVEHYT   81 (101)
T ss_dssp             TTEEEEE-ECSSSTTSEEEEEECSSSEEEEEEEEETT-EE-----ESSSSSCBSSHHHHHHHHH
T ss_pred             CCCEEEe-ccCCCCCCEEEEEEeCCccEEEEEEEcCC-Cc-----eecCCcccCCHHHHHHHHh
Confidence            5999999 99999999999999999999999987655 55     3334456888888887765

>d1blja_ d.93.1.1 (A:) P55 Blk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: P55 Blk protein tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.59  E-value=2.5e-08  Score=81.31  Aligned_cols=69  Identities=14%  Similarity=0.097  Sum_probs=53.1

Q ss_pred             HHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHh----hcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           85 TREVQRQKELRIIYRKRLERTQDYLRHCLQIA----QDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        85 ~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~----~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++.|.++....++|||| +|++.+|.|+|||.    ++..|+||+|...+++.|     +..+...|+++..++.+|..
T Consensus        25 e~~L~~~~~~~G~FLVR-~S~~~~g~~~Lsv~~~~~~~~~v~H~~i~~~~~g~~-----~l~~~~~F~sl~eLV~~y~~   97 (114)
T d1blja_          25 ERQLLAPMNKAGSFLIR-ESESNKGAFSLSVKDITTQGEVVKHYKIRSLDNGGY-----YISPRITFPTLQALVQHYSK   97 (114)
T ss_dssp             HHHHSSTTCCTTCEEBC-BCTTCSSCEEEEECBCCTTTCBCCCEEEEEETTTEE-----EEETTEEESSHHHHHHHHHH
T ss_pred             HHHHHhcCCCCceEEEe-ccCCCCCCeEEEEEeeccCCCEEEEEEEEEcCCCCE-----EecCCceECCHHHHHHHHhh
Confidence            33344445557999999 99999999999993    456799999999888888     44455568888888877654

>d1o48a_ d.93.1.1 (A:) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.56  E-value=8.1e-08  Score=77.11  Aligned_cols=66  Identities=14%  Similarity=0.043  Sum_probs=51.2

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHh-----hcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIA-----QDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~-----~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      |+++....++|||| +|++..|.|+|||.     ....|.||.|...+++.|     +......|+++..++.+|..
T Consensus        21 L~~~~~~~G~FLVR-~S~~~~g~y~LSv~~~~~~~~~~i~h~~i~~~~~g~~-----~~~~~~~F~sl~eLV~~y~~   91 (106)
T d1o48a_          21 LLNAENPRGTFLVR-ESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGF-----YITSRTQFNSLQQLVAYYSK   91 (106)
T ss_dssp             HCCTTCCTTCEEEE-ECSSSTTCEEEEEEEEETTTEEEEEEEEEEECTTSCE-----ESSTTSEESSHHHHHHHHTT
T ss_pred             HHhcCCCCCcEEEE-cccCCCCCEEEEEEecccCcccceEEEEEEEecCCCE-----EEcCCeeECCHHHHHHHHhh
Confidence            33334446999999 99999999999993     335689999999988888     44555678899888877754

>d1jwoa_ d.93.1.1 (A:) Csk homologous kinase Chk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Csk homologous kinase Chk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.53  E-value=1.8e-07  Score=73.79  Aligned_cols=57  Identities=11%  Similarity=0.064  Sum_probs=46.7

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      .++|||| +|++.+|.|+|||..++.|+||+|...++ .|     +......|+++..++.+|.
T Consensus        25 ~G~FLVR-~S~~~~g~~vLSv~~~~~v~H~~I~~~~~-~~-----~~~~~~~F~sl~~LI~~y~   81 (97)
T d1jwoa_          25 DGLFLVR-ESARHPGDYVLCVSFGRDVIHYRVLHRDG-HL-----TIDEAVFFCNLMDMVEHYS   81 (97)
T ss_dssp             TTCEEEE-ECSSSTTCEEEEEEETTEEEEEEEEESSS-EE-----SSTTSCCBSCHHHHHHHHH
T ss_pred             CCeEEEE-ecCCCCccEEEEEEecCceEEEEEEEcCC-cE-----EecCCcccCCHHHHHHHHh
Confidence            5899999 99999999999999999999999977654 56     4444567888888887765

>d2qmsa1 d.93.1.1 (A:420-532) Growth factor receptor-bound protein 7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Growth factor receptor-bound protein 7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.53  E-value=2e-07  Score=75.69  Aligned_cols=74  Identities=12%  Similarity=0.081  Sum_probs=50.7

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      +++-|.++....++|||| +|++.+|.|+|||..++.|+||+|...+++........ .....|+++..++.+|..
T Consensus        22 Ae~lL~~~g~~dG~FLvR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~~~~~~~~~~-~~~~~F~sl~~LI~~y~~   95 (113)
T d2qmsa1          22 SQRLIGQQGLVDGLFLVR-ESQRNPQGFVLSLCHLQKVKHYLILPSEEEGRLYFSMD-DGQTRFTDLLQLVEFHQL   95 (113)
T ss_dssp             HHHHHHHTTCCTTEEEEE-ECSSCTTCEEEEEEETTEEEEEEEEEEESSSCEEEESS-TTSSCBSSHHHHHHHHTT
T ss_pred             HHHHHhccCCCCccEEEE-eccCCCCCEEEEEEeCCeEEEEEEEEeCCCCeEEEEec-CCCcccCCHHHHHHHhcc
Confidence            334444444556999999 99999999999999999999999977654321000111 233457888888877764

>d1jyra_ d.93.1.1 (A:) Growth factor receptor-bound protein 2 (GRB2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Growth factor receptor-bound protein 2 (GRB2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.45  E-value=1.7e-07  Score=73.65  Aligned_cols=59  Identities=14%  Similarity=0.022  Sum_probs=48.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++.+|.|+|||..++.|+||+|..++++.|.+      ....|+++..++.+|..
T Consensus        24 ~~G~FLvR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~~------~~~~F~sl~~LV~~y~~   82 (96)
T d1jyra_          24 HDGAFLIR-ESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFL------WVVKFNSLNELVDYHRS   82 (96)
T ss_dssp             STTBEEEE-ECSSSTTCEEEEEEETTEEEEEECEECTTSCEES------SSCEESSHHHHHHHTTS
T ss_pred             CCCeEEEE-ecCCCCCCEEEEEEeCCceEEEEEEECCCCeEEe------CCccCCCHHHHHHHHhh
Confidence            35999999 9999999999999999999999999988877733      23348888888877753

>d1r1qa_ d.93.1.1 (A:) GRB2-related adaptor protein 2 (MONA, GRID) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: GRB2-related adaptor protein 2 (MONA, GRID)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=97.38  E-value=4.3e-07  Score=71.46  Aligned_cols=59  Identities=7%  Similarity=-0.017  Sum_probs=49.5

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++.+|.|+|||..++.|+||+|....++.|.+     .. ..|+++..++.+|..
T Consensus        26 ~~G~FLVR-~S~~~~g~~~LSv~~~~~v~H~~I~~~~~g~~~~-----~~-~~F~sl~~LV~~y~~   84 (97)
T d1r1qa_          26 DIGFFIIR-ASQSSPGDFSISVRHEDDVQHFKVMRDTKGNYFL-----WT-EKFPSLNKLVDYYRT   84 (97)
T ss_dssp             CTTCEEEE-ECSSSTTCEEEEEECSSSEEEEECEECTTCCEES-----SS-CCBSSHHHHHHHTTT
T ss_pred             CCCCEEEe-ecCCCCCCEEEEEEecCCeEEEEEEEcCCCeEEe-----CC-CCcCCHHHHHHHHcc
Confidence            37999999 9999999999999999999999999998887743     22 358888888887754

>d2shpa2 d.93.1.1 (A:2-110) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine phoshatase shp-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.36  E-value=2.4e-07  Score=74.62  Aligned_cols=63  Identities=8%  Similarity=-0.012  Sum_probs=49.4

Q ss_pred             HHHHHHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           90 RQKELRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        90 ~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .+....++|||| +|++..|.|+|||..++.|+||+|...++ .|     +......|+++..++.+|..
T Consensus        20 ~~~~~~G~FLvR-~S~~~~g~y~LSv~~~~~v~H~~I~~~~~-~~-----~~~~~~~F~sl~~LV~~y~~   82 (109)
T d2shpa2          20 LTRGVDGSFLAR-PSKSNPGDLTLSVRRNGAVTHIKIQNTGD-YY-----DLYGGEKFATLAELVQYYME   82 (109)
T ss_dssp             HHHCCTTEEEEE-ECSSSTTCEEEEEEETTEEEEEEEECSSS-CE-----EETTSCEESSHHHHHHHHHT
T ss_pred             hhCCCCCeEEEE-ecCCCCCCEEEEEEeCCcEEEEEEEEcCC-eE-----EEcCCcccCCHHHHHHHHHH
Confidence            333346999999 99999999999999999999999987765 56     33334568888888877753

>d2eyva1 d.93.1.1 (A:12-120) Crk proto-oncogen {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Crk proto-oncogen
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.20  E-value=1.7e-06  Score=69.36  Aligned_cols=65  Identities=9%  Similarity=-0.002  Sum_probs=47.0

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCC-----------CccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTG-----------SVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~-----------s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|++..|.|+|||..++.|+||.|...+++.+........           ....|+++..++.+|..
T Consensus        20 ~~G~FLVR-~S~~~~~~~~LS~~~~~~v~H~~I~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~F~sl~~LV~~y~~   95 (109)
T d2eyva1          20 RHGVFLVR-DSSTSPGDYVLSVSENSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKI   95 (109)
T ss_dssp             STTCEEEE-CCCSSSSCEEEEEEETTEEEEEEEECCCCSSCCCSSSSCCCCSCCCCCEEETTEEESSHHHHHHHSSS
T ss_pred             CCCeEEee-ecCCCCCCEEEEEEECCEEEEEEEEEcCCcceeeccccccccccccceEEeCCeeeCCHHHHHHHHhh
Confidence            35999999 9999999999999999999999999988765422221111           11246777777766643

>d1rpya_ d.93.1.1 (A:) Adaptor protein Aps {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Adaptor protein Aps
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=96.99  E-value=2.5e-06  Score=65.31  Aligned_cols=40  Identities=8%  Similarity=-0.056  Sum_probs=32.4

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCc
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQ  134 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~  134 (472)
                      ..++|||| +|++..|.|+|||..++.|+||+|....++.+
T Consensus        28 ~dG~FLvR-~S~~~~g~~~Lsv~~~~~v~h~~I~~~~~~~~   67 (86)
T d1rpya_          28 SHGLFVIR-QSETRPGECVLTFNFQGKAKHLRLSLNGHGQC   67 (86)
T ss_dssp             GTTCEEEE-ECSSSTTCEEEEEEETTEEEEEEC----CCCH
T ss_pred             CCceEEEE-ecCCCCCcEEEEEEECCceEEEEEEEcCCceE
Confidence            45999999 99999999999999999999999998887655

>d1luia_ d.93.1.1 (A:) Itk/tsk protein tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Itk/tsk protein tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.97  E-value=2.7e-06  Score=68.16  Aligned_cols=67  Identities=4%  Similarity=-0.009  Sum_probs=46.7

Q ss_pred             HHHHHHHHHHHHHhhhhhHHHHHHHHHHh------hcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           88 VQRQKELRIIYRKRLERTQDYLRHCLQIA------QDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        88 ~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~------~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ++++....++|||| +|++ .|.|+|||.      ....|+||+|....++....   +......|+++..++.+|..
T Consensus        21 lL~~~~~~G~FLVR-~S~~-~g~y~LSv~~~~~~~~~~~i~h~~I~~~~~~~~~~---~~~~~~~F~sl~~LV~~y~~   93 (108)
T d1luia_          21 LLLDTGKEGAFMVR-DSRT-PGTYTVSVFTKAIISENPCIKHYHIKETNDSPKRY---YVAEKYVFDSIPLLIQYHQY   93 (108)
T ss_dssp             HHHHHCCTTEEEEE-ECCT-TTCEEEEEECSCCTTTCSCEEEEECEECCCSSCCE---ESSSSCCBSSHHHHHHHHHT
T ss_pred             HHHhcCCCCeEEEE-ecCC-CCCEEEEEEecCCcccCCceeEEEEEEecCCCcee---ecCCCcccCCHHHHHHHHhh
Confidence            33333446999999 8865 689999983      35679999998776643210   34455678888888877754

>d1g83a2 d.93.1.1 (A:142-245) Tyrosine kinase Fyn {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine kinase Fyn
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.96  E-value=4.9e-07  Score=72.10  Aligned_cols=70  Identities=13%  Similarity=0.032  Sum_probs=52.6

Q ss_pred             HHHHHHHHHHHHHHHHHhhhhhHHHHHHHHHHh-----hcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           84 LTREVQRQKELRIIYRKRLERTQDYLRHCLQIA-----QDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        84 ~~~~~~~~~~~~~~fl~R~~s~~~~~~~~Lsv~-----~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      +++.|++...-.++|||| +|++.+|.|+|||.     ....|.||+|...+++.|     +......|+++..++.+|+
T Consensus        18 Ae~~L~~~g~~~G~FLVR-~S~~~~g~~~Lsv~~~~~~~~~~v~h~~i~~~~~g~~-----~~~~~~~F~sl~~LV~~y~   91 (104)
T d1g83a2          18 AERQLLSFGNPRGTFLIR-ESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGY-----YITTRAQFETLQQLVQHYS   91 (104)
T ss_dssp             HHHHHHSTTCCTTCEEEE-ECSSSTTCEEEEEEEECSSSCEEEEEEEEEECTTSCE-----EETTTEEESSHHHHHHHHH
T ss_pred             HHHHHHhcCCCCCcEEEe-ccCCCCCCeEEEEEEeecCcCCeEEEEEEEEcCCCCE-----EecCCcccCCHHHHHHHHh
Confidence            344444444456999999 99999999999994     345699999998888877     4444556888888887775


Q ss_pred             C
Q 039082          159 H  159 (472)
Q Consensus       159 ~  159 (472)
                      .
T Consensus        92 ~   92 (104)
T d1g83a2          92 E   92 (104)
T ss_dssp             H
T ss_pred             h
Confidence            3

>d1qada_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Phosphatidylinositol 3-kinase, p85-alpha subunit
species: Cow (Bos taurus) [TaxId: 9913]

Probab=96.60  E-value=5e-06  Score=66.39  Aligned_cols=59  Identities=10%  Similarity=-0.029  Sum_probs=46.1

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|+ ..+.|+|||..++.|+||+|...+++.+     .......|+++..++.+|..
T Consensus        29 ~~G~FLVR-~S~-~~~~y~Lsv~~~~~v~H~~I~~~~~g~~-----~~~~~~~F~sl~~LI~~Y~~   87 (107)
T d1qada_          29 RDGTFLVR-ESS-KQGCYACSVVVDGEVKHCVINKTATGYG-----FAEPYNLYSSLKELVLHYQH   87 (107)
T ss_dssp             CTTEEEEE-EC----CCEEEEEEETTEEEEEEEEEETTEEE-----SSTTCCCBSSHHHHHHHHHH
T ss_pred             CCCcEEEE-ecC-CCCCEEEEEEecCCeEEEEEEECCCCeE-----EcCCCCccCCHHHHHHHHHh
Confidence            45999999 885 4688999999999999999999888776     44455568888888877754

>d2cs0a1 d.93.1.1 (A:8-113) Hematopoietic SH2 domain containing protein HSH2D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Hematopoietic SH2 domain containing protein HSH2D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.53  E-value=1e-05  Score=64.30  Aligned_cols=60  Identities=12%  Similarity=0.066  Sum_probs=47.7

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|....+ |+|+|..++.++||.|...+++.|.+    .++...|+++..++.+|..
T Consensus        29 ~~G~FLvR-~S~~~~~-y~Lsv~~~~~~~h~~I~~~~~g~~~~----~~~~~~F~sl~eLV~~y~~   88 (106)
T d2cs0a1          29 PLGSFLIR-VSHSHVG-YTLSYKAQSSCCHFMVKLLDDGTFMI----PGEKVAHTSLDALVTFHQQ   88 (106)
T ss_dssp             CTTCEEEE-ECSSSSS-EEEEECCSSSCEEEEEEECTTSCEEC----TTCSCCBSSHHHHHHHHTT
T ss_pred             CCCcEEEE-ecCCCCC-EEEEEEecCCceeEEEEEcCCCCEEE----ecCCccCCCHHHHHHHHHH
Confidence            46999999 7876665 99999999999999999988887722    2344568888888877764

>d2izva2 d.93.1.1 (A:274-385) Suppressor of cytokine signaling 4, SOCS-4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Suppressor of cytokine signaling 4, SOCS-4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.50  E-value=8.9e-06  Score=65.43  Aligned_cols=63  Identities=13%  Similarity=0.090  Sum_probs=47.9

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      -.++|||| +|++..+.|+|||..++.|+||+|...+ +.|.+.... .....||++..++.+|..
T Consensus        31 ~~GtFLVR-~S~~~~~~~~LSv~~~~~v~H~~I~~~~-~~~~l~~~~-~~~~~F~sl~~LV~~Y~~   93 (112)
T d2izva2          31 PEGTFLLR-DSAQEDYLFSVSFRRYSRSLHARIEQWN-HNFSFDAHD-PCVFHSPDITGLLEHYKD   93 (112)
T ss_dssp             CTTEEEEE-ECSSTTCSEEEEEEETTEEEEEECEEET-TEEESCTTC-TTSCCBSSHHHHHHHTCC
T ss_pred             CCCcEEEe-ecCCCCCCeEEEEEecCCceEEEEEEeC-CeEEEeecc-cCcccCCCHHHHHHHHhc
Confidence            35999999 9999899999999999999999998754 566432221 122357888888887764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.46  E-value=0.0046  Score=58.24  Aligned_cols=40  Identities=13%  Similarity=0.073  Sum_probs=28.5

Q ss_pred             ceEEEEEEEC-CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC
Q 039082          208 TANIYRAIWR-GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR  252 (472)
Q Consensus       208 fG~Vy~a~~~-g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~  252 (472)
                      --.||++... |..|++|+.++...     ..+.+..|...|..|.
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~~~-----s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPERW-----TADQILEEHQFALQLV   75 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTTTS-----CHHHHHHHHHHHHHHH
T ss_pred             cceeEEEEcCCCCEEEEEEeCCCCC-----CHHHHHHHHHHHHHHH
Confidence            3589999874 78899998876532     2234667888887774

>d2fcia1 d.93.1.1 (A:1-105) Phospholipase C-gamma-1 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Phospholipase C-gamma-1
species: Cow (Bos taurus) [TaxId: 9913]

Probab=96.39  E-value=3.2e-06  Score=67.27  Aligned_cols=57  Identities=5%  Similarity=-0.063  Sum_probs=42.6

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      ..++|||| +|+ ..|.|+|||..++.|+||+|... ++.|.      .....|+++..++.+|..
T Consensus        30 ~~G~FLVR-~S~-~~~~yvLSv~~~~~v~H~~I~~~-~~~~~------~~~~~F~sl~~LV~~y~~   86 (105)
T d2fcia1          30 RDGAFLVR-KRN-EPNSYAISFRAEGKIKHCRVQQE-GQTVM------LGNSEFDSLVDLISYYEK   86 (105)
T ss_dssp             SSCCEEEE-ECS-STTCEEEEEEETTEECCCEEBCC-SSCEE------CSSSEESTTHHHHHHHHH
T ss_pred             CCCeEEEE-ecC-CCCCEEEEEEeccccEEEEEEec-CCeEe------cCCcccCCHHHHHHHHhh
Confidence            35999999 784 57889999999999999999764 33442      223457888888777753

>d1mila_ d.93.1.1 (A:) Shc adaptor protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Shc adaptor protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.31  E-value=5.5e-06  Score=65.76  Aligned_cols=56  Identities=14%  Similarity=-0.063  Sum_probs=44.6

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      .++|||| +|++..|.|+|||..++.|+||+|... ++.|.+     . ...|+++..++.+|.
T Consensus        26 ~G~FLVR-~S~~~~g~~vLSv~~~~~v~H~~I~~~-~~~~~~-----~-~~~F~sl~~LV~~y~   81 (104)
T d1mila_          26 NGDFLVR-ESTTTPGQYVLTGLQSGQPKHLLLVDP-EGVVRT-----K-DHRFESVSHLISYHM   81 (104)
T ss_dssp             TTEEEEE-ECCSSCSSEEEEEEETTEEEEEEEBCT-TSSEEC-----S-SCEESSHHHHHHHHH
T ss_pred             CCcEEEE-ecCCCCCCEEEEEEEccccceEEEEeC-CCEEEe-----C-CeeECCHHHHHHHHh
Confidence            4899999 999999999999999999999999765 446622     2 245788888877775

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.10  E-value=0.0056  Score=59.28  Aligned_cols=82  Identities=11%  Similarity=0.207  Sum_probs=51.0

Q ss_pred             Ccee-eCCCCeeEeceeeccCceEEEEEEEC---------CeeEEEEEeccCCCCCChHHHHHHHHHHHHHHhcC-CCce
Q 039082          188 NGWY-IDPKEIDLQEKIGQGTTANIYRAIWR---------GLDVAVKCIYPDFFHTNENAVTFFAQEVDTLSRQR-HRFV  256 (472)
Q Consensus       188 ~~~~-i~~~~~~l~~~LG~G~fG~Vy~a~~~---------g~~vAVK~l~~~~~~~~~~~~~~f~~E~~il~~l~-HpnI  256 (472)
                      ..|. ++.+++++ +.|+-|-.-.+|++...         ...|.+++.- ..  ..  . -...+|..+++.+. +.-.
T Consensus        35 ~~W~~~~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~--~~--~-idr~~E~~i~~~ls~~gl~  107 (395)
T d1nw1a_          35 GAWKTVPLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP--ET--E-SHLVAESVIFTLLSERHLG  107 (395)
T ss_dssp             THHHHCCGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC--CC--H-HHHHHHHHHHHHHHHTTSS
T ss_pred             ccccCCCccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc--ch--h-hHHHHHHHHHHHHHhCCCC
Confidence            3353 34455555 67888999999999864         2357777653 21  11  1 23457889998884 4444


Q ss_pred             eEEEEEEEcCCCceEEEEeccCCc
Q 039082          257 LQLMGACLEPPYRGWLVTELLGTT  280 (472)
Q Consensus       257 v~l~g~~~~~~~~~~vve~~~ggs  280 (472)
                      .++++++..    ++|++++.|..
T Consensus       108 Pkll~~~~~----g~I~efi~g~~  127 (395)
T d1nw1a_         108 PKLYGIFSG----GRLEEYIPSRP  127 (395)
T ss_dssp             SCEEEEETT----EEEECCCCEEE
T ss_pred             CeEEEEcCC----ceEEEEecccc
Confidence            577877632    46777776643

>d2c9wa2 d.93.1.1 (A:32-134) Suppressor of cytokine signaling 2, SOCS-2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Suppressor of cytokine signaling 2, SOCS-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.09  E-value=7.3e-06  Score=64.87  Aligned_cols=63  Identities=10%  Similarity=0.003  Sum_probs=45.1

Q ss_pred             HHHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCC--CCCccCCCCCCCccccCC
Q 039082           94 LRIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSN--TGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        94 ~~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~--~~s~~~~~~~~~~~~~~~  158 (472)
                      -.++|||| +|++.+|.|+|||..+++|+||+|...++ .|......  ......|+++..++.+|.
T Consensus        35 ~~GtFLVR-~S~~~~~~~~LSv~~~~~v~H~~I~~~~~-~~~~~~~~~~~~~~~~F~sl~~LI~~y~   99 (103)
T d2c9wa2          35 PEGTFLIR-DSSHSDYLLTISVKTSAGPTNLRIEYQDG-KFRLDSIICVKSKLKQFDSVVHLIDYYV   99 (103)
T ss_dssp             CTTCEEEE-ECCSTTCSEEEEEEETTEEEEEEEEEETT-EEEECTTTTTGGGCCCBSCHHHHHHHHH
T ss_pred             CCCceEEe-ccCCCCCCEEEEEEECCEEEEEEEEEcCC-eEeeCCccccccCCCccCCHHHHHHHHH
Confidence            35899999 99999999999999899999999986653 45332221  123345677666665553

>d1fu6a_ d.93.1.1 (A:) Phosphatidylinositol 3-kinase, p85-alpha subunit {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Phosphatidylinositol 3-kinase, p85-alpha subunit
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=96.05  E-value=1.4e-05  Score=63.98  Aligned_cols=58  Identities=5%  Similarity=0.015  Sum_probs=45.7

Q ss_pred             HHHHHHhhhhhHHH-HHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCCC
Q 039082           95 RIIYRKRLERTQDY-LRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHSH  159 (472)
Q Consensus        95 ~~~fl~R~~s~~~~-~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~~  159 (472)
                      .++|||| +|++.. +.|+||+..++.+.||+|...+ +.|     +......|+++..++.+|..
T Consensus        32 ~G~FLVR-~S~~~~~~~~~ls~~~~~~~~H~~I~~~~-~~~-----~~~~~~~F~sl~~LV~~y~~   90 (111)
T d1fu6a_          32 DGTFLVR-DASTKMHGDYTLTLRKGGNNKSIKIFHRD-GKY-----GFSDPLTFNSVVELINHYRN   90 (111)
T ss_dssp             SCCCCCB-SSCCSSSCCSBCEEEETTEEEECCCCCTT-TCC-----CTTTTSCCCCTTHHHHHHHT
T ss_pred             CCEEEEE-eccCCCCccEEEEEecCCceEEEEEEEcC-CeE-----EECCCcccCCHHHHHHHHhh
Confidence            5999999 776654 5699999999999999998654 567     44555678888888877754

>d2shpa3 d.93.1.1 (A:111-218) Tyrosine phoshatase shp-2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Tyrosine phoshatase shp-2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.92  E-value=1e-05  Score=64.50  Aligned_cols=64  Identities=13%  Similarity=0.051  Sum_probs=45.4

Q ss_pred             HHHHHHHHHHHHhhhhhHHHHHHHHHHhhcC----------CeEEEeccCCcccCcccccCCCCCccCCCCCCCccccCC
Q 039082           89 QRQKELRIIYRKRLERTQDYLRHCLQIAQDN----------GVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPLHQHS  158 (472)
Q Consensus        89 ~~~~~~~~~fl~R~~s~~~~~~~~Lsv~~~~----------~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~~~~~  158 (472)
                      +++....++|||| +|++.+|.|+|||...+          .++||.|...+. .|     +......|+++..++.+|.
T Consensus        16 L~~~~~~G~FLVR-~S~~~~g~~~LSv~~~~~~~~~~~~~~~~~h~~i~~~~~-~~-----~~~~~~~F~sl~~LV~~y~   88 (108)
T d2shpa3          16 LTEKGKHGSFLVR-ESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQEL-KY-----DVGGGERFDSLTDLVEHYK   88 (108)
T ss_dssp             HHHTCCTTEEEEE-ECSSSTTCEEEEEEECC-----CCCCCEEEEEEEEEETT-EE-----ESSSSCCBSSHHHHHHHHH
T ss_pred             HhhcCCCCeEEEE-ecCCCCCCeEEEEEecCccccccccccceeeEEEEeCCC-ce-----EeCCCcccCCHHHHHHHHh
Confidence            3333346999999 99999999999996543          467777765443 45     3444567888888887775


Q ss_pred             C
Q 039082          159 H  159 (472)
Q Consensus       159 ~  159 (472)
                      .
T Consensus        89 ~   89 (108)
T d2shpa3          89 K   89 (108)
T ss_dssp             H
T ss_pred             h
Confidence            3

>d1xa6a2 d.93.1.1 (A:21-161) Beta-chimaerin, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: Beta-chimaerin, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=95.83  E-value=3.3e-05  Score=64.46  Aligned_cols=51  Identities=14%  Similarity=0.025  Sum_probs=39.2

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhhcCCeEEEeccCCcccCcccccCCCCCccCCCCCCCcc
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQDNGVLELMTNNKEDQHQSLLSSNTGSVIASPLVQTPL  154 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~~~~v~hy~i~~~~~~~~~~~s~~~~s~~~~~~~~~~~  154 (472)
                      .++|||| +|++..|.|+|||..++.|+||+|..+  +++     +... ..|+++..++
T Consensus        55 dGsFLVR-~S~~~~g~y~LSv~~~~~v~H~~I~~~--g~~-----~~~~-~~F~sl~eLV  105 (141)
T d1xa6a2          55 EGAYILR-ESQRQPGCYTLALRFGNQTLNYRLFHD--GKH-----FVGE-KRFESIHDLV  105 (141)
T ss_dssp             TTBEEEE-ECSSSTTCEEEEEEETTEEEECCCEES--SSE-----ECSS-SCCCCSSHHH
T ss_pred             CCeEEEE-ecCCCCCCEEEEEEECCEEEEEEEEEC--CCE-----EECC-CeECCHHHHH
Confidence            4999999 999989999999999999999999753  344     2222 2466766654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.52  E-value=0.044  Score=50.56  Aligned_cols=30  Identities=33%  Similarity=0.369  Sum_probs=26.9

Q ss_pred             ceeecCCCCCcEEEcCCCcEEEeeccccee
Q 039082          326 KVIHRDLKPSNIFLDDAKHVRIADFGHARF  355 (472)
Q Consensus       326 ~iiHrDLkp~NILl~~~~~vkL~DFGla~~  355 (472)
                      ++||+|+.++||+++++...-|.||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccCCcchhhhhcccccceeEeccccccc
Confidence            499999999999999888778999998853

>d1uura3 d.93.1.1 (A:577-707) STAT homologue {Dictyostelium discoideum [TaxId: 44689]}

class: Alpha and beta proteins (a+b)
fold: SH2-like
superfamily: SH2 domain
family: SH2 domain
domain: STAT homologue
species: Dictyostelium discoideum [TaxId: 44689]

Probab=92.10  E-value=0.0011  Score=54.21  Aligned_cols=36  Identities=3%  Similarity=-0.032  Sum_probs=30.9

Q ss_pred             HHHHHHhhhhhHHHHHHHHHHhh---cCCeEEEeccCCcc
Q 039082           95 RIIYRKRLERTQDYLRHCLQIAQ---DNGVLELMTNNKED  131 (472)
Q Consensus        95 ~~~fl~R~~s~~~~~~~~Lsv~~---~~~v~hy~i~~~~~  131 (472)
                      .++|||| .|++..|.|+||+..   ...|+||.|...+.
T Consensus        30 ~GtFLvR-~S~s~~g~~~ls~~~~~~~~~v~h~~i~~~~~   68 (131)
T d1uura3          30 PGTFIIR-FSERNPGQFGIAYIGVEMPARIKHYLVQPNDT   68 (131)
T ss_dssp             TTCEEEE-ECSSSTTCEEEEEECSSSSCCEEEEECCGGGS
T ss_pred             CCeEEEE-ecCCCCCcEEEEEEEecCCCcEEEEEEeecCC
Confidence            5999999 999999999999953   46799999987654